PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Joseph, TL; Lane, DP; Verma, CS				Joseph, Thomas L.; Lane, David P.; Verma, Chandra S.			Stapled BH3 Peptides against MCL-1: Mechanism and Design Using Atomistic Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-PROTEIN INTERACTIONS; FREE-ENERGY CALCULATIONS; AMBER FORCE-FIELD; NUCLEIC-ACIDS; P53 PEPTIDE; CELL-DEATH; BCL-XL; APOPTOSIS; BINDING	Atomistic simulations of a set of stapled alpha helical peptides derived from the BH3 helix of MCL-1 (Stewart et al. (2010) Nat Chem Biol 6: 595-601) complexed to a fragment (residues 172-320) of MCL-1 revealed that the highest affinity is achieved when the staples engage the surface of MCL-1 as has also been demonstrated for p53-MDM2 (Joseph et al. (2010) Cell Cycle 9: 4560-4568; Baek et al. (2012) J Am Chem Soc 134: 103-106). Affinity is also modulated by the ability of the staples to pre-organize the peptides as helices. Molecular dynamics simulations of these stapled BH3 peptides were carried out followed by determination of the energies of interactions using MM/GBSA methods. These show that the location of the staple is a key determinant of a good binding stapled peptide from a bad binder. The good binder derives binding affinity from interactions between the hydrophobic staple and a hydrophobic patch on MCL-1. The position of the staple was varied, guiding the design of new stapled peptides with higher affinities.	[Joseph, Thomas L.; Verma, Chandra S.] ASTAR, Bioinformat Inst, Singapore, Singapore; [Lane, David P.] ASTAR, Lab P53, Singapore, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Joseph, TL (corresponding author), ASTAR, Bioinformat Inst, Singapore, Singapore.	chandra@bii.a-star.edu.sg		Lane, David/0000-0003-0551-3545	Agency for Science, Technology & Research (A*Star) of Singapore	Agency for Science, Technology & Research (A*Star) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology & Research (A*Star) of Singapore (http://www.a-star.edu.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman N, 2011, BIOCHEM SOC T, V39, P1327, DOI 10.1042/BST0391327; Arumugam M, 2009, CELL CYCLE, V8, P2828; Azmi AS, 2011, EXPERT OPIN EMERG DR, V16, P59, DOI 10.1517/14728214.2010.515210; Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Bernardo PH, 2010, J MED CHEM, V53, P2314, DOI 10.1021/jm901469p; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Case D, 2006, AMBER 9; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Czerski L, 2004, J MOL CELL CARDIOL, V37, P643, DOI 10.1016/j.yjmcc.2004.04.016; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; Dastidar SG, 2012, CELL CYCLE, V11, P2239, DOI 10.4161/cc.20333; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Faver JC, 2011, J CHEM THEORY COMPUT, V7, P790, DOI 10.1021/ct100563b; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harrison RS, 2010, P NATL ACAD SCI USA, V107, P11686, DOI 10.1073/pnas.1002498107; Hayes JM, 2011, J R SOC INTERFACE IN, P171, DOI [10.5772/37107, DOI 10.5772/37107]; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jayaram B, 1998, J PHYS CHEM B, V102, P9571, DOI 10.1021/jp982007x; Jiang W, 2010, J CHEM THEORY COMPUT, V6, P2559, DOI 10.1021/ct1001768; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph TL, 2010, CELL CYCLE, V9, P4560, DOI 10.4161/cc.9.22.13816; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kim YW, 2009, BIOORG MED CHEM LETT, V19, P2533, DOI 10.1016/j.bmcl.2009.03.022; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Lee EF, 2011, CHEMBIOCHEM, V12, P2025, DOI 10.1002/cbic.201100314; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mendes J, 1999, PROTEINS, V37, P530; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Ng YW, 2010, STRUCTURE, V18, P879, DOI 10.1016/j.str.2010.04.011; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Phillips C, 2011, J AM CHEM SOC, V133, P9696, DOI 10.1021/ja202946k; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Simonian PL, 1997, BLOOD, V90, P1208, DOI 10.1182/blood.V90.3.1208.1208_1208_1216; Singh N, 2010, PROTEINS, V78, P1705, DOI 10.1002/prot.22687; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Sviridov DO, 2011, BIOCHEM BIOPH RES CO, V410, P446, DOI 10.1016/j.bbrc.2011.05.154; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Valkov E, 2012, TOP CURR CHEM, V317, P145, DOI 10.1007/128_2011_265; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2012, J CLIN ONCOL, V30, P554, DOI 10.1200/JCO.2011.37.9339; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wilk S, 2005, SCI STKE, V285, ptr16; Wolfson W, 2009, CHEM BIOL, V16, P910, DOI 10.1016/j.chembiol.2009.09.008; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	76	37	41	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43985	10.1371/journal.pone.0043985	http://dx.doi.org/10.1371/journal.pone.0043985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952838	Green Submitted, gold, Green Published			2022-12-27	WOS:000308221300039
J	Kim, YW; Kwon, C; Liu, JL; Kim, SH; Kim, S				Kim, Yong-Wan; Kwon, ChangHyuk; Liu, Juinn-Lin; Kim, Se Hoon; Kim, Sunghoon			Cancer Association Study of Aminoacyl-tRNA Synthetase Signaling Network in Glioblastoma	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; HIGH-GRADE GLIOMA; GENE-EXPRESSION; MOLECULAR PHARMACOLOGY; CORE PATHWAYS; REVEALS; PROFILES; SURVIVAL; DISEASE; MICROARRAY	Aminoacyl-tRNA synthetases (ARSs) and ARS-interacting multifunctional proteins (AIMPs) exhibit remarkable functional versatility beyond their catalytic activities in protein synthesis. Their non-canonical functions have been pathologically linked to cancers. Here we described our integrative genome-wide analysis of ARSs to show cancer-associated activities in glioblastoma multiforme (GBM), the most aggressive malignant primary brain tumor. We first selected 23 ARS/AIMPs (together referred to as ARSN), 124 cancer-associated druggable target genes (DTGs) and 404 protein-protein interactors (PPIs) of ARSs using NCI's cancer gene index. 254 GBM affymetrix microarray data in The Cancer Genome Atlas (TCGA) were used to identify the probe sets whose expression were most strongly correlated with survival (Kaplan-Meier plots versus survival times, log-rank t-test <0.05). The analysis identified 122 probe sets as survival signatures, including 5 of ARSN (VARS, QARS, CARS, NARS, FARS), and 115 of DTGs and PPIs (PARD3, RXRB, ATP5C1, HSP90AA1, CD44, THRA, TRAF2, KRT10, MED12, etc). Of note, 61 survival-related probes were differentially expressed in three different prognosis subgroups in GBM patients and showed correlation with established prognosis markers such as age and phenotypic molecular signatures. CARS and FARS also showed significantly higher association with different molecular networks in GBM patients. Taken together, our findings demonstrate evidence for an ARSN biology-dominant contribution in the biology of GBM.	[Kim, Yong-Wan] Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Seoul, South Korea; [Kwon, ChangHyuk] Seoul Natl Univ, Syst Biomed Informat Natl Core Res Ctr, Seoul, South Korea; [Liu, Juinn-Lin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Kim, Se Hoon] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea; [Kim, Sunghoon] Seoul Natl Univ, WCU Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Catholic University of Korea; Seoul National University (SNU); University of Texas System; UTMD Anderson Cancer Center; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU)	Kim, YW (corresponding author), Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Seoul, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	Kim, Se Hoon/0000-0001-7516-7372; kim, sunghoon/0000-0002-1570-3230	National Research Foundation [NRF-M1AXA002-2010-0029785]; Ministry of Education, Science and Technology of Korea	National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Global Frontier Project grant (NRF-M1AXA002-2010-0029785) of the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel TW, 2009, MOL CANCER RES, V7, P645, DOI 10.1158/1541-7786.MCR-08-0477; Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; [Anonymous], 2008, NATURE, V455, P1061; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Arsham AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006068; Bogdahn U, 2011, NEURO-ONCOLOGY, V13, P132, DOI 10.1093/neuonc/noq142; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cavenee WK, 2002, CARCINOGENESIS, V23, P683, DOI 10.1093/carcin/23.5.683; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; CHRISTODOULOU K, 1995, HUM MOL GENET, V4, P1629, DOI 10.1093/hmg/4.9.1629; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Frank I, 2003, J UROLOGY, V170, P2225, DOI 10.1097/01.ju.0000095541.10333.a7; Gemma A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-174; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Gursel Demirkan B, 2011, Cancers (Basel), V3, P2655, DOI 10.3390/cancers3022655; Hjelmeland AB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000319; Huttner AJ, 2010, PEDIATR BLOOD CANCER, V54, P890, DOI 10.1002/pbc.22462; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kayton M L, 2001, Curr Opin Investig Drugs, V2, P136; Kim S, 2011, Novel uses of GRS proteins or fragments thereof, Patent No. 0905829; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; KUSHNER JP, 1976, P SOC EXP BIOL MED, V153, P273; Ladha J, 2010, CANCER RES, V70, P6437, DOI 10.1158/0008-5472.CAN-10-0819; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; MATHEWS MB, 1984, J EXP MED, V160, P420, DOI 10.1084/jem.160.2.420; Micallef J, 2009, CANCER RES, V69, P7548, DOI 10.1158/0008-5472.CAN-08-4783; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Pasternak K, 1997, Ann Univ Mariae Curie Sklodowska Med, V52, P29; Patard JJ, 2004, J CLIN ONCOL, V22, P3316, DOI 10.1200/JCO.2004.09.104; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Reifenberger G, 1996, CANCER RES, V56, P5141; Scandurro AB, 2001, INT J ONCOL, V19, P129; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Tzima E, 2006, TRENDS BIOCHEM SCI, V31, P7, DOI 10.1016/j.tibs.2005.11.002; Vasselli JR, 2003, P NATL ACAD SCI USA, V100, P6958, DOI 10.1073/pnas.1131754100; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022566; Wasenius VM, 2003, CLIN CANCER RES, V9, P68; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	51	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e40960	10.1371/journal.pone.0040960	http://dx.doi.org/10.1371/journal.pone.0040960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952576	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300002
J	Wei, CZ; Zheng, HF; Li, Q; Lu, XT; Yu, Q; Zhang, HY; Chen, QS; He, NP; Kardol, P; Liang, WJ; Han, XG				Wei, Cunzheng; Zheng, Huifen; Li, Qi; Lu, Xiaotao; Yu, Qiang; Zhang, Haiyang; Chen, Quansheng; He, Nianpeng; Kardol, Paul; Liang, Wenju; Han, Xingguo			Nitrogen Addition Regulates Soil Nematode Community Composition through Ammonium Suppression	PLOS ONE			English	Article							FOREST ECOSYSTEMS; PLANT-COMMUNITIES; FOOD-WEBS; DIVERSITY; MINERALIZATION; BIODIVERSITY; INDICATORS; DEPOSITION; AGROECOSYSTEMS; FERTILIZATION	Nitrogen (N) enrichment resulting from anthropogenic activities has greatly changed the composition and functioning of soil communities. Nematodes are one of the most abundant and diverse groups of soil organisms, and they occupy key trophic positions in the soil detritus food web. Nematodes have therefore been proposed as useful indicators for shifts in soil ecosystem functioning under N enrichment. Here, we monitored temporal dynamics of the soil nematode community using a multi-level N addition experiment in an Inner Mongolia grassland. Measurements were made three years after the start of the experiment. We used structural equation modeling (SEM) to explore the mechanisms regulating nematode responses to N enrichment. Across the N enrichment gradient, significant reductions in total nematode abundance, diversity (H' and taxonomic richness), maturity index (MI), and the abundance of root herbivores, fungivores and omnivores-predators were found in August. Root herbivores recovered in September, contributing to the temporal variation of total nematode abundance across the N gradient. Bacterivores showed a hump-shaped relationship with N addition rate, both in August and September. Ammonium concentration was negatively correlated with the abundance of total and herbivorous nematodes in August, but not in September. Ammonium suppression explained 61% of the variation in nematode richness and 43% of the variation in nematode trophic group composition. Ammonium toxicity may occur when herbivorous nematodes feed on root fluid, providing a possible explanation for the negative relationship between herbivorous nematodes and ammonium concentration in August. We found a significantly positive relationship between fungivores and fungal phospholipid fatty acids (PLFA), suggesting bottom-up control of fungivores. No such relationship was found between bacterivorous nematodes and bacterial PLFA. Our findings contribute to the understanding of effects of N enrichment in semiarid grassland on soil nematode trophic groups, and the cascading effects in the detrital soil food web.	[Wei, Cunzheng; Zheng, Huifen; Chen, Quansheng; Han, Xingguo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Wei, Cunzheng; Li, Qi; Lu, Xiaotao; Yu, Qiang; Zhang, Haiyang; Liang, Wenju; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Wei, Cunzheng; Zheng, Huifen] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [He, Nianpeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Kardol, Paul] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Swedish University of Agricultural Sciences	Wei, CZ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weicunzheng@ibcas.ac.cn; xghan@ibcas.ac.cn	Kardol, Paul/A-2600-2010; Chen, Quansheng/AGH-8083-2022; Kardol, Paul/N-8383-2015; LI, Qi/N-2673-2017; Han, Xingguo/K-7552-2016; Yu, Qiang/E-2097-2011; Lu (ü), Xiao-Tao/B-3905-2008; Cunzheng, Wei/A-4360-2009	Chen, Quansheng/0000-0003-2498-3278; Kardol, Paul/0000-0001-7065-3435; LI, Qi/0000-0002-8652-8396; Han, Xingguo/0000-0002-1836-975X; Yu, Qiang/0000-0002-5480-0623; Lu (ü), Xiao-Tao/0000-0001-5571-1895; Cunzheng, Wei/0000-0001-9309-2722; he, nianpeng/0000-0002-0458-5953	Key Project of National Natural Science Foundation of China [30830026]; State Key Basic Research Development Program [2007CB106801]	Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Development Program	This work was supported by the Key Project of National Natural Science Foundation of China (30830026, http://www.nsfc.gov.cn/), the State Key Basic Research Development Program (2007CB106801, http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; [Anonymous], 1960, NEMATOLOGY; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Collange B, 2011, CROP PROT, V30, P1251, DOI 10.1016/j.cropro.2011.04.016; De Deyn GB, 2004, OIKOS, V106, P576, DOI 10.1111/j.0030-1299.2004.13265.x; DERUITER PC, 1993, J APPL ECOL, V30, P95, DOI 10.2307/2404274; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Grace JB., 2015, STRUCTURAL EQUATION; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hu C, 2010, EUR J SOIL BIOL, V46, P230, DOI 10.1016/j.ejsobi.2010.04.002; JOHNSON DW, 1980, SOIL SCI SOC AM J, V44, P610, DOI 10.2136/sssaj1980.03615995004400030036x; Kardol P, 2005, BIOL CONSERV, V126, P317, DOI 10.1016/j.biocon.2005.06.005; Li Q, 2010, APPL SOIL ECOL, V46, P111, DOI 10.1016/j.apsoil.2010.06.016; Liang WJ, 2009, SOIL BIOL BIOCHEM, V41, P883, DOI 10.1016/j.soilbio.2008.06.018; Manning P, 2006, ECOL LETT, V9, P1015, DOI 10.1111/j.1461-0248.2006.00959.x; Manning P, 2008, SOIL BIOL BIOCHEM, V40, P688, DOI 10.1016/j.soilbio.2007.08.023; Mulder C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003573; Murray PJ, 2006, APPL SOIL ECOL, V33, P199, DOI 10.1016/j.apsoil.2005.11.004; Neher DA, 2001, J NEMATOL, V33, P161; Oka Y, 2007, CROP PROT, V26, P1556, DOI 10.1016/j.cropro.2007.01.003; PERSSON H, 1980, Acta Phytogeographica Suecica, V68, P101; [齐莎 Qi Sha], 2010, [生态学报, Acta Ecologica Sinica], V30, P5518; RODRIGUEZKABANA R, 1986, J NEMATOL, V18, P129; Sarathchandra SU, 2001, SOIL BIOL BIOCHEM, V33, P953, DOI 10.1016/S0038-0717(00)00245-5; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; SOHLENIUS B, 1984, J APPL ECOL, V21, P327, DOI 10.2307/2403057; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Veen GF, 2010, ECOLOGY, V91, P828, DOI 10.1890/09-0134.1; VERHOEF HA, 1990, BIOGEOCHEMISTRY, V11, P175, DOI 10.1007/BF00004496; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wall ME, 1940, SCIENCE, V91, P221, DOI 10.1126/science.91.2357.221-a; Wardle D., 2002, COMMUNITIES ECOSYSTE; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WARDLE DA, 1993, OECOLOGIA, V93, P303, DOI 10.1007/BF00317685; WARDLE DA, 1995, PLANT SOIL, V170, P35, DOI 10.1007/BF02183053; WARREN KS, 1962, NATURE, V195, P47, DOI 10.1038/195047a0; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xu GL, 2007, J ENVIRON SCI-CHINA, V19, P603, DOI 10.1016/S1001-0742(07)60100-4; Yeates GW, 1999, ANNU REV PHYTOPATHOL, V37, P127, DOI 10.1146/annurev.phyto.37.1.127; Yeates GW, 2003, BIOL FERT SOILS, V37, P199, DOI 10.1007/s00374-003-0586-5; YEATES GW, 1993, J NEMATOL, V25, P315; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x	50	64	75	19	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43384	10.1371/journal.pone.0043384	http://dx.doi.org/10.1371/journal.pone.0043384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952671	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000308221300013
J	Yonemori, K; Hirakawa, A; Ando, M; Hirata, T; Yunokawa, M; Shimizu, C; Tamura, K; Fujiwara, Y				Yonemori, Kan; Hirakawa, Akihiro; Ando, Masashi; Hirata, Taizo; Yunokawa, Mayu; Shimizu, Chikako; Tamura, Kenji; Fujiwara, Yasuhiro			Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal	PLOS ONE			English	Review							INFORMATION; TRIALS	Background: The oncology market represents one of the largest pharmaceutical markets in any medical field, and printed advertising in medical journals is an important channel by which pharmaceutical companies communicate with healthcare professionals. The aim of the present study was to analyze the volume and content of and trends and changes in oncology-related advertising intended for healthcare professionals in a peer-reviewed medical journal. Information that could be included in advertisements to promote drug development and improve treatment strategies for cancer patients is discussed on the basis of the results of the analysis. Methods/Principal Findings: Overall, 6,720 advertisements covering 13,039 pages in a leading oncology medical journal published (by the American Society of Clinical Oncology) between January 2005 and December 2009 were analyzed. The advertisements targeting pharmaceuticals and clinical trials, in particular, were reviewed. A total of 6,720 advertisements covering 13,039 pages were included in the analysis. For the years 2005-2009, the percentages of total journal pages dedicated to advertising were 24.0%, 45.7%, 49.8%, 46.8%, and 49.8%, respectively. Package insert information and efficacy and safety explanations appeared in more than 80% of advertisements intended for pharmaceutical promotion. From 2005 to 2009, the overall quantity of drug advertisements decreased by approximately 13%, whereas advertisements calling for the enrollment of patients into registration trials increased by approximately 11%. Conclusion/Significance: Throughout the study period, oncology-related pharmaceutical advertisements occupied a considerable number of pages relative to other journal content. The proportion of advertisements on ongoing clinical trials increased progressively throughout the study period.	[Yonemori, Kan; Ando, Masashi; Hirata, Taizo; Yunokawa, Mayu; Shimizu, Chikako; Tamura, Kenji; Fujiwara, Yasuhiro] Natl Canc Ctr, Breast & Med Oncol Div, Tokyo, Japan; [Hirakawa, Akihiro] Nagoya Univ, Ctr Adv Med & Clin Res, Grad Sch Med, Nagoya, Aichi 4648601, Japan	National Cancer Center - Japan; Nagoya University	Yonemori, K (corresponding author), Natl Canc Ctr, Breast & Med Oncol Div, 1-1 Tsukiji,5 Chome, Tokyo, Japan.	kyonemor@ncc.go.jp	Hirakawa, Akihiro/AAE-5936-2019	Hirakawa, Akihiro/0000-0002-1193-8104; Fujiwara, Yasuhiro/0000-0002-1229-5446	Ministry of Health, Labour and Welfare [200916011A]; Sanofi Aventis; Wyeth; Novartis; GlaxoSmithKline; MSD (a subsidiary of Merck); Pfizer; Chugai pharmaceutical; Eisai; Daiichi Sankyo; Taiho pharmaceutical; Nihon Kayaku; Amgen; Takeda pharmaceutical; Astra-Zeneca	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Sanofi Aventis(Sanofi-Aventis); Wyeth(Wyeth); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); MSD (a subsidiary of Merck); Pfizer(Pfizer); Chugai pharmaceutical; Eisai(Eisai Co Ltd); Daiichi Sankyo(Daiichi Sankyo Company Limited); Taiho pharmaceutical; Nihon Kayaku; Amgen(Amgen); Takeda pharmaceutical(Takeda Pharmaceutical Company Ltd); Astra-Zeneca(AstraZeneca)	This study was supported by a science research grant (200916011A) from the Ministry of Health, Labour and Welfare (for research on infrastructure development for clinical trials). URL for the funder's website is http://mhlw-grants.niph.go.jp/niph/search/NIDD00.do [Accessed online on 13/Feb/2012]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. The potential conflicts of interest does not alter the authors' adherence to all the PLoS One policies on sharing data and materials. Financial: Ownership of Stocks or Shares: no authors. Paid employment or consultancy: no authors. Board membership: no authors. Patent application: no authors. Research grants: The following authors received unrestricted research grants for patient enrollment in industry-sponsored registration clinical trials from commercial sources. Masashi Ando: Sanofi Aventis, Wyeth, Novartis, GlaxoSmithKline. Tamura Kenji: MSD (a subsidiary of Merck). Yasuhiro Fujiwara: Pfizer, GlaxoSmithKline, Chugai pharmaceutical, Eisai, Daiichi Sankyo, Taiho pharmaceutical, Nihon Kayaku, Amgen, Novartis, Takeda pharmaceutical, Astra-Zeneca. Travel grants and honoraria for speaking or participation at meetings: The following authors had honoraria for speaking from commercial sources. Kan Yonemori: Taiho Pharmaceutical. Masashi Ando: Astra-Zeneca, Novartis. Chikako Shimizu: Esai, Daiichi Sankyo, Novartis, Chugai pharmaceutical, Astra-Zeneca, Sanofi Aventis, GlaxoSmithKline, Bristrol Myers Squibb, Takeda Pharmaceutical, Kyowa Hakko Kirin. Kenji Tamura: Bristrol Myers Squibb, Chugai Pharmaceutical, Novartis, Pfizer. Yasuhiro Fujiwara: Ono Pharmaceutical, Astra-Zeneca, Taiho Pharmaceutical, Sanofi Aventis, Eli Lilly, Chugai Pharmaceutical. Gifts: no authors. Non-Financial: Professional: Acting as an expert witness: no authors. Membership in a government or other advisory board: The following authors are external expert members in Japanese regulatory agency (Pharmaceuticals and Medical Devices Agency) or Ministry of Health, Labour and Welfare of Japan. Kan Yonemori: Pharmaceuticals and Medical Devices Agency. Masashi Ando: Pharmaceuticals and Medical Devices Agency, Ministry of Health, Labour and Welfare. Kenji Tamura: Pharmaceuticals and Medical Devices Agency. Yasuhiro Fujiwara: Pharmaceuticals and Medical Devices Agency, Ministry of Health, Labour and Welfare. Membership in lobbying or advocacy organizations: no authors. Writing or consulting for an educational company: no authors. Personal: no authors.	Bauschke R, 2012, HEALTH POLICY, V104, P12, DOI 10.1016/j.healthpol.2011.10.009; European Union, COMM COD REL MED PRO; International Committee of Medical Journal Editors, 2010, UN REQ MAN; International Federation of Pharmaceutical Manufacturers and Associations, 2010, ETH PROM MED; Joyce GF, 2011, AM J MANAG CARE, V17, pE462; Korenstein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023336; Mano MS, 2006, EUR J CANCER, V42, P2675, DOI 10.1016/j.ejca.2006.02.028; Mc Daid C, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-16; McGettigan P, 2001, BRIT J CLIN PHARMACO, V51, P184; Ministry of Health Labour and Welfare, 2010, REG PHARM MED DEV AD; Neslin S, 2001, RAPP STUDY EXECUTIVE; O'Connor AB, 2009, JAMA-J AM MED ASSOC, V302, P191, DOI 10.1001/jama.2009.973; Othman N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006350; Prosser H, 2003, FAM PRACT, V20, P61, DOI 10.1093/fampra/20.1.61; Sieber DL, 2009, AM J CLIN ONCOL-CANC, V32, P92, DOI 10.1097/COC.0b013e31816a8c38; Thomson Reuters, 2010, J CIT REP; Treweek S, 2010, COCHRANE DATABASE SY; U. S. Food and Drug Administration, OPDP REG INF; Witteles RM, 2012, J CLIN ONCOL, V30, P1916, DOI 10.1200/JCO.2011.40.4012; World Health Organization, 2010, ETH CRIT MED DRUG PR	20	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44393	10.1371/journal.pone.0044393	http://dx.doi.org/10.1371/journal.pone.0044393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952970	gold, Green Submitted, Green Published			2022-12-27	WOS:000308221300087
J	Pezzulo, AA; Hornick, EE; Rector, MV; Estin, M; Reisetter, AC; Taft, PJ; Butcher, SC; Carter, AB; Manak, JR; Stoltz, DA; Zabner, J				Pezzulo, Alejandro A.; Hornick, Emma E.; Rector, Michael V.; Estin, Miriam; Reisetter, Anna C.; Taft, Peter J.; Butcher, Stephen C.; Carter, A. Brent; Manak, J. Robert; Stoltz, David A.; Zabner, Joseph			Expression of Human Paraoxonase 1 Decreases Superoxide Levels and Alters Bacterial Colonization in the Gut of Drosophila melanogaster	PLOS ONE			English	Article							HUMAN SERUM PARAOXONASE; LOW-DENSITY-LIPOPROTEIN; PATTERN-RECOGNITION RECEPTOR; MICROBIAL COLONIZATION; BIOLOGICAL-ACTIVITY; IMMUNE HOMEOSTASIS; GENE-EXPRESSION; NADPH OXIDASE; INFECTION; HOST	Paraoxonases (PON) are a family of proteins (PON1, 2 and 3) with multiple enzymatic activities. PON1 interferes with homoserine lactone-mediated quorum sensing in bacteria and with reactive oxygen species (ROS) in humans and mice. PON1 gene mutations have been linked to multiple traits, including aging, and diseases of the cardiovascular, nervous and gastrointestinal system. The overlapping enzymatic activities in the PON family members and high linkage disequilibrium rates within their polymorphisms confound animal and human studies of PON1 function. In contrast, arthropods such as Drosophila melanogaster have no PON homologs, resulting in an ideal model to study interactions between PON genotype and host phenotypes. We hypothesized that expression of PON1 in D. melanogaster would alter ROS. We found that PON1 alters expression of multiple oxidative stress genes and decreases superoxide anion levels in normal and germ-free D. melanogaster. We also found differences in the composition of the gut microbiota, with a remarkable increase in levels of Lactobacillus plantarum and associated changes in expression of antimicrobial and cuticle-related genes. PON1 expression directly decreased superoxide anion levels and altered bacterial colonization of the gut and its gene expression profile, highlighting the complex nature of the interaction between host genotype and gut microbiota. We speculate that the interaction between some genotypes and human diseases may be mediated by the presence of certain gut bacteria that can induce specific immune responses in the gut and other host tissues.	[Pezzulo, Alejandro A.; Hornick, Emma E.; Rector, Michael V.; Estin, Miriam; Reisetter, Anna C.; Taft, Peter J.; Carter, A. Brent; Stoltz, David A.; Zabner, Joseph] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Manak, J. Robert] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Butcher, Stephen C.; Manak, J. Robert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Free Rad & Radiat Biol Program, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Pezzulo, AA (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA.	joseph-zabner@uiowa.edu		Zabner, Joseph/0000-0002-9606-1339; Pezzulo, Alejandro/0000-0001-7544-5109; Stoltz, David/0000-0003-0893-9015; Manak, John/0000-0002-6562-7694	National Institutes of Health [NIHLPPG HL091842-02, ES015981, ES014871]; Insitutional Commitment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981, R01ES014871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Insitutional Commitment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding from the National Institute of Health and Insitutional Commitment to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the National Institutes of Health, NIHLPPG HL091842-02 (JZ) and ES015981 and ES014871 (ABC)	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117; Altura MA, 2011, CELL MICROBIOL, V13, P527, DOI 10.1111/j.1462-5822.2010.01552.x; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Aviram M, 1998, ARTERIOSCL THROM VAS, V18, P1617, DOI 10.1161/01.ATV.18.10.1617; Aviram M, 1999, FREE RADICAL BIO MED, V26, P892, DOI 10.1016/S0891-5849(98)00272-X; BAKULA M, 1969, J INVERTEBR PATHOL, V14, P365, DOI 10.1016/0022-2011(69)90163-3; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Boehm D, 2009, INFLAMM BOWEL DIS, V15, P93, DOI 10.1002/ibd.20582; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chun CK, 2004, P NATL ACAD SCI USA, V101, P3587, DOI 10.1073/pnas.0308750101; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Erlich PM, 2006, HUM MOL GENET, V15, P77, DOI 10.1093/hmg/ddi428; Estin ML, 2010, ADV EXP MED BIOL, V660, P183, DOI 10.1007/978-1-60761-350-3_17; Goswami B, 2009, CLIN CHIM ACTA, V410, P1, DOI 10.1016/j.cca.2009.09.025; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Huen K, 2011, ENVIRON MOL MUTAGEN, V52, P105, DOI 10.1002/em.20567; Hughes DT, 2010, P NATL ACAD SCI USA, V107, P9831, DOI 10.1073/pnas.1002551107; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jakubowski H, 2010, ADV EXP MED BIOL, V660, P113, DOI 10.1007/978-1-60761-350-3_11; Jarvik GP, 2003, ARTERIOSCL THROM VAS, V23, P1465, DOI 10.1161/01.ATV.0000081635.96290.D3; Kabaroglu C, 2004, ACTA CARDIOL, V59, P606, DOI 10.2143/AC.59.6.2005242; Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042; Kellermayer R, 2011, FASEB J, V25, P1449, DOI 10.1096/fj.10-172205; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mackness B, 2004, BIOCHEM BIOPH RES CO, V318, P680, DOI 10.1016/j.bbrc.2004.04.056; Motulsky H., 1995, INTUITIVE BIOSTATIST; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Peng Y, 2008, APPL ENVIRON MICROB, V74, P3943, DOI 10.1128/AEM.02607-07; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodrigo L, 2001, BIOCHEM J, V354, P1, DOI 10.1042/0264-6021:3540001; Rothem L, 2007, FREE RADICAL BIO MED, V43, P730, DOI 10.1016/j.freeradbiomed.2007.05.003; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Shih DM, 2010, ADV EXP MED BIOL, V660, P73, DOI 10.1007/978-1-60761-350-3_8; Stoltz D, 2008, J CLIN INVEST; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359	66	10	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43777	10.1371/journal.pone.0043777	http://dx.doi.org/10.1371/journal.pone.0043777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952763	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206500022
J	Arora, T; Loo, RL; Anastasovska, J; Gibson, GR; Tuohy, KM; Sharma, RK; Swann, JR; Deaville, ER; Sleeth, ML; Thomas, EL; Holmes, E; Bell, JD; Frost, G				Arora, Tulika; Loo, Ruey Leng; Anastasovska, Jelena; Gibson, Glenn R.; Tuohy, Kieran M.; Sharma, Raj Kumar; Swann, Jonathan R.; Deaville, Eddie R.; Sleeth, Michele L.; Thomas, E. Louise; Holmes, Elaine; Bell, Jimmy D.; Frost, Gary			Differential Effects of Two Fermentable Carbohydrates on Central Appetite Regulation and Body Composition	PLOS ONE			English	Article							HIGH-FAT-DIET; GLUCAGON-LIKE PEPTIDE-1; CORONARY-HEART-DISEASE; GUT MICROBIAL ECOLOGY; IN-SITU HYBRIDIZATION; INULIN-TYPE FRUCTANS; INSULIN SENSITIVITY; RESISTANT STARCH; NERVOUS-SYSTEM; MICE	Background: Obesity is rising at an alarming rate globally. Different fermentable carbohydrates have been shown to reduce obesity. The aim of the present study was to investigate if two different fermentable carbohydrates (inulin and beta-glucan) exert similar effects on body composition and central appetite regulation in high fat fed mice. Methodology/Principal Findings: Thirty six C57BL/6 male mice were randomized and maintained for 8 weeks on a high fat diet containing 0% (w/w) fermentable carbohydrate, 10% (w/w) inulin or 10% (w/w) beta-glucan individually. Fecal and cecal microbial changes were measured using fluorescent in situ hybridization, fecal metabolic profiling was obtained by proton nuclear magnetic resonance (H-1 NMR), colonic short chain fatty acids were measured by gas chromatography, body composition and hypothalamic neuronal activation were measured using magnetic resonance imaging (MRI) and manganese enhanced MRI (MEMRI), respectively, PYY (peptide YY) concentration was determined by radioimmunoassay, adipocyte cell size and number were also measured. Both inulin and beta-glucan fed groups revealed significantly lower cumulative body weight gain compared with high fat controls. Energy intake was significantly lower in beta-glucan than inulin fed mice, with the latter having the greatest effect on total adipose tissue content. Both groups also showed an increase in the numbers of Bifidobacterium and Lactobacillus-Enterococcus in cecal contents as well as feces. beta-glucan appeared to have marked effects on suppressing MEMRI associated neuronal signals in the arcuate nucleus, ventromedial hypothalamus, paraventricular nucleus, periventricular nucleus and the nucleus of the tractus solitarius, suggesting a satiated state. Conclusions/Significance: Although both fermentable carbohydrates are protective against increased body weight gain, the lower body fat content induced by inulin may be metabolically advantageous. beta-glucan appears to suppress neuronal activity in the hypothalamic appetite centers. Differential effects of fermentable carbohydrates open new possibilities for nutritionally targeting appetite regulation and body composition.	[Arora, Tulika; Sleeth, Michele L.; Frost, Gary] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Invest Med, Nutr & Dietet Res Grp, London, England; [Anastasovska, Jelena; Thomas, E. Louise; Bell, Jimmy D.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, Metab & Mol Imaging Grp, London, England; [Gibson, Glenn R.; Tuohy, Kieran M.; Swann, Jonathan R.; Deaville, Eddie R.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Loo, Ruey Leng; Holmes, Elaine] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Arora, Tulika; Sharma, Raj Kumar] Natl Dairy Res Inst, Div Anim Biochem, Karnal 132001, Haryana, India; [Tuohy, Kieran M.] Fdn Edmund Mach San Michele allAdige, Res & Innovat Ctr, Nutr & Nutrigen Grp, Dept Food Qual & Nutr, Trento, Italy; [Loo, Ruey Leng] Univ Kent & Greenwich, Medway Sch Pharm, Kent, England	Imperial College London; Imperial College London; University of Reading; Imperial College London; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Fondazione Edmund Mach	Arora, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Invest Med, Nutr & Dietet Res Grp, London, England.	g.frost@imperial.ac.uk	Holmes, Elaine/ABE-6606-2020; Tuohy, Kieran M/G-9142-2011; Thomas, Elizabeth Louise/AIF-0055-2022; Holmes, Elaine/A-2189-2015	Holmes, Elaine/0000-0002-0556-8389; Tuohy, Kieran M/0000-0001-6882-7192; Arora, Tulika/0000-0001-8821-8191; Bell, Jimmy/0000-0003-3804-1281; Swann, Jonathan/0000-0002-6485-4529; Loo, Ruey Leng/0000-0001-5307-5709; Thomas, Elizabeth/0000-0003-4235-4694	MRC; BBSRC; NIHR; Integrative Mammalian Biology (IMB) Capacity Building Award; NIHR Imperial Biomedical Research Centre Funding Scheme; NIHR senior investigator award; Commonwealth split site scholarship;  [FP7-HEALTH-2009-241592 EurOCHIP]; BBSRC [BB/I023054/1, BB/H004971/1] Funding Source: UKRI; MRC [G1002151, MC_U120061305] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I023054/1, BB/H004971/1] Funding Source: researchfish; Medical Research Council [G0801056B, G1002151, MC_U120061305] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR(National Institute for Health Research (NIHR)); Integrative Mammalian Biology (IMB) Capacity Building Award; NIHR Imperial Biomedical Research Centre Funding Scheme; NIHR senior investigator award; Commonwealth split site scholarship; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Department is funded by grants from the MRC, BBSRC, NIHR, an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7-HEALTH-2009-241592 EurOCHIP grant and funding from the NIHR Imperial Biomedical Research Centre Funding Scheme. Gary Frost is supported by an NIHR senior investigator award, Tulika Arora was supported by a Commonwealth split site scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2; Anastasovska J, 2012, OBESITY; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Cani PD, 2005, OBES RES, V13, P1000, DOI 10.1038/oby.2005.117; Choi JS, 2010, MOL NUTR FOOD RES, V54, P1004, DOI 10.1002/mnfr.200900127; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009; Eriksson L., 2002, MULTI MEGAVARIATE DA; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Frost G, 1998, METABOLISM, V47, P1245, DOI 10.1016/S0026-0495(98)90331-6; Frost GS, 1998, DIABETIC MED, V15, P1003, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1003::AID-DIA715>3.0.CO;2-2; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Kaji I, 2010, J MOL HISTOL; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kleessen B, 2001, BRIT J NUTR, V86, P291, DOI 10.1079/BJN2001403; Kuo YT, 2006, NMR BIOMED, V19, P1028, DOI 10.1002/nbm.1070; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martin-Pelaez S, 2008, FEMS MICROBIOL ECOL, V66, P608, DOI 10.1111/j.1574-6941.2008.00610.x; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Parkinson JRC, 2008, AM J PHYSIOL-ENDOC M, V294, pE698, DOI 10.1152/ajpendo.00405.2007; Parkinson JRC, 2009, NEUROENDOCRINOLOGY, V89, P121, DOI 10.1159/000163751; Parkinson JRC, 2009, NEUROIMAGE, V44, P1022, DOI 10.1016/j.neuroimage.2008.09.047; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Patel AD, 2006, REGUL PEPTIDES, V134, P17, DOI 10.1016/j.regpep.2005.11.001; RICHARDSON AJ, 1989, LETT APPL MICROBIOL, V9, P5, DOI 10.1111/j.1472-765X.1989.tb00278.x; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Saric J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000254; Snart J, 2006, APPL ENVIRON MICROB, V72, P1925, DOI 10.1128/AEM.72.3.1925-1931.2006; So PW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001309; Tuohy KM, 2001, BRIT J NUTR, V86, P341, DOI 10.1079/BJN2001394; Vitaglione P, 2009, APPETITE, V53, P338, DOI 10.1016/j.appet.2009.07.013; Wanders AJ, 2011, OBES REV, V12, P724, DOI 10.1111/j.1467-789X.2011.00895.x; Zhou J, 2006, OBESITY, V14, P683, DOI 10.1038/oby.2006.77; Zhou J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1160, DOI 10.1152/ajpendo.90637.2008	42	55	60	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43263	10.1371/journal.pone.0043263	http://dx.doi.org/10.1371/journal.pone.0043263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952656	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000308206000028
J	Pashler, H; Coburn, N; Harris, CR				Pashler, Harold; Coburn, Noriko; Harris, Christine R.			Priming of Social Distance? Failure to Replicate Effects on Social and Food Judgments	PLOS ONE			English	Article							IDENTIFICATION; FACILITATION; RECOGNITION; BEHAVIOR; CONTEXT; WORDS; FALSE; BIAS	Williams and Bargh (2008) reported an experiment in which participants were simply asked to plot a single pair of points on a piece of graph paper, with the coordinates provided by the experimenter specifying a pair of points that lay at one of three different distances (close, intermediate, or far, relative to the range available on the graph paper). The participants who had graphed a more distant pair reported themselves as being significantly less close to members of their own family than did those who had plotted a more closely-situated pair. In another experiment, people's estimates of the caloric content of different foods were reportedly altered by the same type of spatial distance priming. Direct replications of both results were attempted, with precautions to ensure that the experimenter did not know what condition the participant was assigned to. The results showed no hint of the priming effects reported by Williams and Bargh (2008).	[Pashler, Harold; Coburn, Noriko; Harris, Christine R.] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pashler, H (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	hpashler@ucsd.edu		Lauwereyns, Jan/0000-0003-0551-2550	James S. McDonnell Foundation; National Science Foundation [SBE-5820542013]	James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF))	This work was supported a collaborative activity grant from the James S. McDonnell Foundation and by the National Science Foundation (Grant SBE-5820542013 to the University of California San Diego Temporal Dynamics of Learning Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2012, PSYCHOL TODAY B 0511; Bartlett Tom, 2012, CHRONICLE HIGHER ED; Bower B, 2012, SCI NEWS, P181; Carter TJ, 2011, PSYCHOL SCI, V22, P1011, DOI 10.1177/0956797611414726; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Fujita K, 2008, J EXP SOC PSYCHOL, V44, P562, DOI 10.1016/j.jesp.2007.10.005; Huber DE, 2002, MEM COGNITION, V30, P745, DOI 10.3758/BF03196430; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JOHNSTON JC, 1984, ATTENTION PERFORM, V10, P243; McGraw AP, 2010, PSYCHOL SCI, V21, P1141, DOI 10.1177/0956797610376073; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; MORTON J, 1969, PSYCHOL REV, V76, P165, DOI 10.1037/h0027366; Pashler HE, 1998, PSYCHOL ATTENTION; Pautasso M, 2010, SCIENTOMETRICS, V85, P193, DOI 10.1007/s11192-010-0233-5; RATCLIFF R, 1989, J EXP PSYCHOL LEARN, V15, P378, DOI 10.1037/0278-7393.15.3.378; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; SCHVANEVELDT RW, 1981, J EXP PSYCHOL HUMAN, V7, P673, DOI 10.1037/0096-1523.7.3.673; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Williams LE, 2008, PSYCHOL SCI, V19, P302, DOI 10.1111/j.1467-9280.2008.02084.x; Yap MJ, 2013, J EXP PSYCHOL LEARN, V39, P140, DOI 10.1037/a0028520; Yong E., 2012, DISCOVER MAGAZINE; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	26	91	91	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42510	10.1371/journal.pone.0042510	http://dx.doi.org/10.1371/journal.pone.0042510			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZC	22952597	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000008
J	von Chamier, M; Allam, A; Brown, MB; Reinhard, MK; Reyes, L				von Chamier, Maria; Allam, Ayman; Brown, Mary B.; Reinhard, Mary K.; Reyes, Leticia			Host Genetic Background Impacts Disease Outcome During Intrauterine Infection with Ureaplasma parvum	PLOS ONE			English	Article							RAT STRAINS DIFFER; AMNIOTIC-FLUID; INFLAMMATORY RESPONSE; MYCOPLASMA-HOMINIS; INTRAAMNIOTIC INFECTION; TRACT-INFECTION; PRETERM LABOR; UREALYTICUM; CHORIOAMNIONITIS; MACROPHAGES	Ureaplasma parvum, an opportunistic pathogen of the human urogenital tract, has been implicated in contributing to chorioamnionitis, fetal morbidity, and fetal mortality. It has been proposed that the host genetic background is a critical factor in adverse pregnancy outcome as sequela to U. parvum intra-amniotic infection. To test this hypothesis we assessed the impact of intrauterine U. parvum infection in the prototypical TH1/M1 C57BL/6 and TH2/M2 BALB/c mouse strain. Sterile medium or U. parvum was inoculated into each uterine horn and animals were evaluated for intra-amniotic infection, fetal infection, chorioamnionitis and fetal pathology at 72 hours post-inoculation. Disease outcome was assessed by microbial culture, in situ detection of U. parvum in fetal and utero-placental tissues, grading of chorioamnionitis, and placental gene expression of IL-1 alpha, IL-1 beta, IL-6, TNF-alpha, S100A8, and S100A9. Placental infection and colonization rates were equivalent in both strains. The in situ distribution of U. parvum in placental tissues was also similar. However, a significantly greater proportion of BALB/c fetuses were infected (P<0.02). C57BL/6 infected animals predominantly exhibited mild to moderate chorioamnionitis (P<0.0001), and a significant reduction in placental expression of IL-1 alpha, IL-1 beta, IL-6, TNF-alpha, S100A8, and S100A9 compared to sham controls (P<0.02). Conversely, severe protracted chorioamnionitis with cellular necrosis was the predominant lesion phenotype in BALB/c mice, which also exhibited a significant increase in placental expression of IL-1a, IL-1 beta, IL-6, TNF-alpha, S100A8, and S100A9 (P<0.01). Fetal pathology in BALB/c was multi-organ and included brain, lung, heart, liver, and intestine, whereas fetal pathology in C57BL/6 was only detected in the liver and intestines. These results confirm that the host genetic background is a major determinant in ureaplasmal induced chorioamnionitis with fetal infection and fetal inflammatory response.	[von Chamier, Maria; Reinhard, Mary K.] Univ Florida, Anim Care Serv, Gainesville, FL USA; [Allam, Ayman; Brown, Mary B.; Reyes, Leticia] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL USA; [Allam, Ayman; Brown, Mary B.; Reyes, Leticia] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	von Chamier, M (corresponding author), Univ Florida, Anim Care Serv, Gainesville, FL USA.	lreyes@ufl.edu	Reyes, Leticia/H-7338-2019; Allam, Ayman/AAJ-7852-2020	Allam, Ayman/0000-0002-6726-089X	Animal Care Services Research and Graduate Program; National Institute of Diabetes And Digestive and Kidney Diseases (NIDDK) [K08DK075651]; University of Florida Open-Access Publishing Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK075651] Funding Source: NIH RePORTER	Animal Care Services Research and Graduate Program; National Institute of Diabetes And Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Florida Open-Access Publishing Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by the Animal Care Services Research and Graduate Program. A. Allam was supported by an American Recovery & Reinvestment Act supplement to K08DK075651 from the National Institute of Diabetes And Digestive and Kidney Diseases (NIDDK). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen R, 2007, BJOG-INT J OBSTET GY, V114, P1432, DOI 10.1111/j.1471-0528.2007.01410.x; Allam AB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-101; Allenbach C, 2006, J IMMUNOL, V176, P6656, DOI 10.4049/jimmunol.176.11.6656; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Buhimschi CS, 2009, CURR OPIN INFECT DIS, V22, P235, DOI 10.1097/QCO.0b013e32832a5963; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; Charmoy M, 2007, J LEUKOCYTE BIOL, V82, P288, DOI 10.1189/jlb.0706440; Collins JJP, 2010, AM J PHYSIOL-LUNG C, V299, pL852, DOI 10.1152/ajplung.00183.2010; CROUSE DT, 1993, CLIN INFECT DIS, V17, pS122, DOI 10.1093/clinids/17.Supplement_1.S122; Dando SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029856; De Dooy JJ, 2001, EUR J PEDIATR, V160, P457, DOI 10.1007/s004310100785; DISCHE MR, 1979, AM J CLIN PATHOL, V72, P167; Espinoza J, 2002, J Matern Fetal Neonatal Med, V12, P304, DOI 10.1080/713605697; Estrada-Gutierrez G, 2010, INFECT IMMUN, V78, P4792, DOI 10.1128/IAI.00522-10; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Gerber S, 2003, J INFECT DIS, V187, P518, DOI 10.1086/368205; Goldenberg RL, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.033; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Gravett MG, 2007, J PROTEOME RES, V6, P89, DOI 10.1021/pr060149v; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; HOROWITZ S, 1995, J REPROD MED, V40, P375; HOROWITZ S, 1995, ACTA OBSTET GYN SCAN, V74, P132, DOI 10.3109/00016349509008922; Kasper DC, 2010, DIAGN MICR INFEC DIS, V67, P117, DOI 10.1016/j.diagmicrobio.2009.12.023; Kemp MW, 2011, REPROD SCI, V18, P1128, DOI 10.1177/1933719111408114; Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49; Knox CL, 2010, BIOL REPROD, V83, P415, DOI 10.1095/biolreprod.109.083121; Kuroda E, 2002, J IMMUNOL, V168, P5477, DOI 10.4049/jimmunol.168.11.5477; Kuroda E, 2003, J IMMUNOL, V170, P757, DOI 10.4049/jimmunol.170.2.757; Li YH, 2001, BIOL NEONATE, V80, P124, DOI 10.1159/000047131; Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001; Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012; Menon R, 2008, AM J OBSTET GYNECOL, V198; Menon R, 2007, REPROD SCI, V14, P253, DOI 10.1177/1933719107301336; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Moss TJM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.065; Nagamatsu T, 2010, REPROD SCI, V17, P209, DOI 10.1177/1933719109349962; Normann E, 2009, PEDIATR RES, V65, P430, DOI 10.1203/PDR.0b013e31819984ce; Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508; Okogbule-Wonodi AC, 2011, PEDIATR RES, V69, P442, DOI 10.1203/PDR.0b013e3182111827; Olomu IN, 2009, PEDIATRICS, V123, P1329, DOI 10.1542/peds.2008-1113; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.068; Oue S, 2009, ARCH DIS CHILD-FETAL, V94, pF17, DOI 10.1136/adc.2008.138321; Perni SC, 2004, AM J OBSTET GYNECOL, V191, P1382, DOI 10.1016/j.ajog.2004.05.070; Polglase GR, 2010, AM J PHYSIOL-LUNG C, V299, pL232, DOI 10.1152/ajplung.00369.2009; Redline RW, 2006, SEMIN FETAL NEONAT M, V11, P296, DOI 10.1016/j.siny.2006.02.011; Redline RW, 2012, SEMIN FETAL NEONAT M, V17, P20, DOI 10.1016/j.siny.2011.08.003; Reyes L, 2004, AM J REPROD IMMUNOL, V51, P211, DOI 10.1111/j.1600-0897.2004.00144.x; Reyes L, 2006, INFECT IMMUN, V74, P6656, DOI 10.1128/IAI.00984-06; Reyes L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-9; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Romero R, 2010, J MATERN-FETAL NEO M, V23, P261, DOI 10.3109/14767050903067386; Romero Roberto, 2002, Semin Neonatol, V7, P259, DOI 10.1053/siny.2002.0121; Salminen A, 2008, PEDIATR RES, V63, P280, DOI 10.1203/PDR.0b013e318163a8b2; SANCHEZ PJ, 1990, PEDIATR INFECT DIS J, V9, P398, DOI 10.1097/00006454-199006000-00006; Schelonka RL, 2007, SEMIN PERINATOL, V31, P2, DOI 10.1053/j.semperi.2007.01.001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sung Tae-Jung, 2010, Korean J Pediatr, V53, P989, DOI 10.3345/kjp.2010.53.12.989; Sung TJ, 2011, PEDIATR INFECT DIS J, V30, P379, DOI 10.1097/INF.0b013e318202ac3a; Velez DR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003283; Velez DR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.051; Viscardi RM, 2008, J PERINATOL, V28, P759, DOI 10.1038/jp.2008.98; Viscardi R, 2006, PEDIATR DEVEL PATHOL, V9, P143, DOI 10.2350/10-05-0112.1; Viscardi RM, 2006, PEDIATR RES, V60, P141, DOI 10.1203/01.pdr.0000228322.73777.05; Voloshchuk I. N., 1994, Arkhiv Patologii, V56, P76; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; WAITES KB, 1988, LANCET, V1, P17; Waites KB, 2009, SEMIN FETAL NEONAT M, V14, P190, DOI 10.1016/j.siny.2008.11.009; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Yoder BA, 2003, PEDIATR RES, V54, P797, DOI 10.1203/01.PDR.0000091284.84322.16	72	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44047	10.1371/journal.pone.0044047	http://dx.doi.org/10.1371/journal.pone.0044047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952869	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000074
J	Lake, MC; Nguyen, QD; Ali, S; Aboagye, EO				Lake, Madryn C.; Quang-De Nguyen; Ali, Simak; Aboagye, Eric O.			Development of a Novel Molecular Sensor for Imaging Estrogen Receptor-Coactivator Protein-Protein Interactions	PLOS ONE			English	Article							FRAGMENT-ASSISTED COMPLEMENTATION; SERUM TAMOXIFEN CONCENTRATIONS; SURGICAL ADJUVANT BREAST; ATHYMIC NUDE-MOUSE; CONFORMATIONAL-CHANGES; POSTMENOPAUSAL WOMEN; HORMONE-RECEPTORS; NUCLEAR RECEPTORS; CANCER PATIENTS; LUCIFERASE	Anti-estrogens, in particular tissue selective anti-estrogens, have been the bedrock of adjuvant therapy for patients with estrogen receptor alpha (ER alpha) positive breast cancer. Though current therapies have greatly enhanced patient prognosis, there continues to be an impetus for the development of improved anti-estrogens. ER alpha is a nuclear receptor transcription factor which activates gene expression through the recruitment of transcriptional coactivator proteins. The SRC family of coactivators, which includes AIB1, has been shown to be of particular importance for ER alpha mediated transcription. ER alpha-AIB1 interactions are indicative of gene expression and are inhibited by anti-estrogen treatment. We have exploited the interaction between ER alpha and AIB1 as a novel method for imaging ER alpha activity using a split luciferase molecular sensor. By producing a range of ER alpha ligand binding domain (ER-LBD) and AIB1 nuclear receptor interacting domain (AIB-RID) N- and C-terminal firefly luciferase fragment fusion proteins, constructs which exhibited more than a 10-fold increase in luciferase activity with E2 stimulation were identified. The specificity of the E2-stimulated luciferase activity to ER alpha-AIB1 interaction was validated through Y537S and L539/540A ER-LBD fusion protein mutants. The primed nature of the split luciferase assay allowed changes in ER alpha activity, with respect to the protein-protein interactions preceding transcription, to be assessed soon after drug treatment. The novel assay split luciferase detailed in this report enabled modulation of ER alpha activity to be sensitively imaged in vitro and in living subjects and potentially holds much promise for imaging the efficacy of novel ER alpha specific therapies.	[Lake, Madryn C.; Quang-De Nguyen; Aboagye, Eric O.] Univ London Imperial Coll Sci Technol & Med, Comprehens Canc Imaging Ctr, London, England; [Ali, Simak] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	Imperial College London; Imperial College London	Lake, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Comprehens Canc Imaging Ctr, London, England.	eric.aboagye@imperial.ac.uk	Ali, Simak/N-4740-2019; Ali, Simak/M-6912-2018	Ali, Simak/0000-0002-1320-0816; Ali, Simak/0000-0002-1320-0816; ABOAGYE, Eric/0000-0003-2276-6771; Coombes, Raoul Charles/0000-0002-4811-1100	Cancer Research United Kingdom [C2536/A10337, C2536/A7991]; Department of Health; National Institute for Health Research Biomedical Research Centre; Cancer Research UK [12011, 10337] Funding Source: researchfish	Cancer Research United Kingdom(Cancer Research UK); Department of Health; National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)	This study was supported by grants from Cancer Research United Kingdom (C2536/A10337 and C2536/A7991) and the Department of Health-funded Imperial College Cancer Medicine Centre (ECMC) grant. The authors are also grateful for support received from the National Institute for Health Research Biomedical Research Centre funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; Anderson E, 2002, BREAST CANCER RES, V4, P197, DOI 10.1186/bcr452; Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; Bramlett KS, 2001, MOL ENDOCRINOL, V15, P909, DOI 10.1210/me.15.6.909; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Costantino JP, 1997, J NATL CANCER I, V89, P776, DOI 10.1093/jnci/89.11.776; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DEGREGORIO MW, 1989, CANCER CHEMOTH PHARM, V23, P68; DEGREGORIO MW, 1987, CANCER CHEMOTH PHARM, V20, P316; Della Torre S, 2011, ENDOCRINOLOGY, V152, P2256, DOI 10.1210/en.2011-0173; Ferlay J, 2010, IARC CANCERBASE, V10; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; Galande AK, 2005, CHEMBIOCHEM, V6, P1991, DOI 10.1002/cbic.200500083; Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619; Gunther JR, 2008, ACS CHEM BIOL, V3, P282, DOI 10.1021/cb800056r; Gustaftson JA, 2003, TRENDS PHARMACOL SCI, V24, P479, DOI 10.1016/S0165-6147(03)00229-3; Hartman J, 2009, STEROIDS, V74, P635, DOI 10.1016/j.steroids.2009.02.005; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; Kim SB, 2007, ACS CHEM BIOL, V2, P484, DOI 10.1021/cb7000439; Kim SB, 2007, ANAL CHEM, V79, P4820, DOI 10.1021/ac0621571; Kisanga ER, 2003, J STEROID BIOCHEM, V84, P361, DOI 10.1016/S0960-0760(03)00051-7; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; Kraichely DM, 2000, ENDOCRINOLOGY, V141, P3534, DOI 10.1210/en.141.10.3534; KRISTENSEN B, 1994, J CLIN ONCOL, V12, P992, DOI 10.1200/JCO.1994.12.5.992; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Liu JW, 2003, MOL ENDOCRINOL, V17, P346, DOI 10.1210/me.2002-0331; Llopis J, 2000, P NATL ACAD SCI USA, V97, P4363, DOI 10.1073/pnas.97.8.4363; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Rando G, 2010, MOL ENDOCRINOL, V24, P735, DOI 10.1210/me.2009-0514; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rodriguez AL, 2004, J MED CHEM, V47, P600, DOI 10.1021/jm030404c; RUTQVIST LE, 1993, J NATL CANCER I, V85, P1398, DOI 10.1093/jnci/85.17.1398; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Soto AM, 2006, BEST PRACT RES CL EN, V20, P15, DOI 10.1016/j.beem.2005.09.001; Taneoka A, 2009, BIOSENS BIOELECTRON, V25, P76, DOI 10.1016/j.bios.2009.06.004; Tikkanen MK, 2000, P NATL ACAD SCI USA, V97, P12536, DOI 10.1073/pnas.220427297; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; WAKELING AE, 1991, CANCER RES, V51, P3867; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; White R, 1997, EMBO J, V16, P1427, DOI 10.1093/emboj/16.6.1427; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; Zhou GC, 1998, MOL ENDOCRINOL, V12, P1594, DOI 10.1210/me.12.10.1594	58	4	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44160	10.1371/journal.pone.0044160	http://dx.doi.org/10.1371/journal.pone.0044160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952913	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600086
J	Sun, LM; Ai, XY; Li, WY; Guo, WW; Deng, XX; Hu, CG; Zhang, JZ				Sun, Lei-Ming; Ai, Xiao-Yan; Li, Wen-Yang; Guo, Wen-Wu; Deng, Xiu-Xin; Hu, Chun-Gen; Zhang, Jin-Zhi			Identification and Comparative Profiling of miRNAs in an Early Flowering Mutant of Trifoliate Orange and Its Wild Type by Genome-Wide Deep Sequencing	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; SMALL RNAS; TRANSCRIPTION FACTOR; CONSERVED MICRORNAS; PLANT; TARGET; BIOGENESIS; DISCOVERY; TIME; ANNOTATION	MicroRNAs (miRNAs) are a new class of small, endogenous RNAs that play a regulatory role in various biological and metabolic processes by negatively affecting gene expression at the post-transcriptional level. While the number of known Arabidopsis and rice miRNAs is continuously increasing, information regarding miRNAs from woody plants such as citrus remains limited. Solexa sequencing was performed at different developmental stages on both an early flowering mutant of trifoliate orange (precocious trifoliate orange, Poncirus trifoliata L. Raf.) and its wild-type in this study, resulting in the obtainment of 141 known miRNAs belonging to 99 families and 75 novel miRNAs in four libraries. A total of 317 potential target genes were predicted based on the 51 novel miRNAs families, GO and KEGG annotation revealed that high ranked miRNA-target genes are those implicated in diverse cellular processes in plants, including development, transcription, protein degradation and cross adaptation. To characterize those miRNAs expressed at the juvenile and adult development stages of the mutant and its wild-type, further analysis on the expression profiles of several miRNAs through real-time PCR was performed. The results revealed that most miRNAs were down-regulated at adult stage compared with juvenile stage for both the mutant and its wild-type. These results indicate that both conserved and novel miRNAs may play important roles in citrus growth and development, stress responses and other physiological processes.	[Sun, Lei-Ming; Ai, Xiao-Yan; Li, Wen-Yang; Guo, Wen-Wu; Deng, Xiu-Xin; Hu, Chun-Gen; Zhang, Jin-Zhi] Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University	Sun, LM (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	chungen@mail.hzau.edu.cn; jinzhizhang@mail.hzau.edu.cn		Xiuxin, Deng/0000-0003-4490-4514; Zhang, Jin-Zhi/0000-0002-3820-889X	National Natural Science Foundation of China [30971973, 30921002, 31071777, 31130046, 31101528]; 863 Project of China [2011AA100205]; International Foundation for Science [C/5148-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project of China(National High Technology Research and Development Program of China); International Foundation for Science(International Foundation for Science)	This research was supported financially by the National Natural Science Foundation of China (grant Nos. 30971973, 30921002, 31071777, 31130046, and 31101528), the 863 Project of China (2011AA100205) and the International Foundation for Science No C/5148-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen MJ, 2006, PLANT J, V46, P823, DOI 10.1111/j.1365-313X.2006.02740.x; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2005, MOL CELLS, V19, P1; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lee H, 2010, NUCLEIC ACIDS RES, V38, P1; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liang S., 1999, ZHE JIANG CITRUS, V16, P2; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Luo QJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000457; MCNELLIS TW, 1994, PLANT CELL, V6, P1391, DOI 10.1105/tpc.6.10.1391; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Oh TJ, 2008, NEW PHYTOL, V179, P67, DOI 10.1111/j.1469-8137.2008.02448.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pang XiaoMing, 2003, Acta Horticulturae Sinica, V30, P394; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Schmid R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-180; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Takeda S, 2004, DEVELOPMENT, V131, P425, DOI 10.1242/dev.00938; Tan FC, 2007, PHYSIOL PLANTARUM, V131, P481, DOI 10.1111/j.1399-3054.2007.00971.x; Wang C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-122; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002012; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wu XM, 2011, TREE GENET GENOMES, V7, P117, DOI 10.1007/s11295-010-0319-5; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Yu HP, 2011, PHYSIOL PLANTARUM, V141, P56, DOI 10.1111/j.1399-3054.2010.01411.x; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang JZ, 2012, MOL BIOTECHNOL, V51, P44, DOI 10.1007/s12033-011-9439-x; Zhang JZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-63; Zhang JZ, 2009, GENE, V430, P95, DOI 10.1016/j.gene.2008.09.023; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3	72	33	38	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43760	10.1371/journal.pone.0043760	http://dx.doi.org/10.1371/journal.pone.0043760			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952759	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600042
J	Paredes-Sabja, D; Cofre-Araneda, G; Brito-Silva, C; Pizarro-Guajardo, M; Sarker, MR				Paredes-Sabja, Daniel; Cofre-Araneda, Glenda; Brito-Silva, Christian; Pizarro-Guajardo, Marjorie; Sarker, Mahfuzur R.			Clostridium difficile Spore-Macrophage Interactions: Spore Survival	PLOS ONE			English	Article							BACILLUS-ANTHRACIS SPORES; PERFRINGENS SPORES; MURINE MACROPHAGES; UV-RADIATION; MOIST HEAT; GERMINATION; PROTEINS; RESISTANCE; ACID; PHAGOCYTOSIS	Background: Clostridium difficile is the main cause of nosocomial infections including antibiotic associated diarrhea, pseudomembranous colitis and toxic megacolon. During the course of Clostridium difficile infections (CDI), C. difficile undergoes sporulation and releases spores to the colonic environment. The elevated relapse rates of CDI suggest that C. difficile spores has a mechanism(s) to efficiently persist in the host colonic environment. Methodology/Principal Findings: In this work, we provide evidence that C. difficile spores are well suited to survive the host's innate immune system. Electron microscopy results show that C. difficile spores are recognized by discrete patchy regions on the surface of macrophage Raw 264.7 cells, and phagocytosis was actin polymerization dependent. Fluorescence microscopy results show that >80% of Raw 264.7 cells had at least one C. difficile spore adhered, and that similar to 60% of C. difficile spores were phagocytosed by Raw 264.7 cells. Strikingly, presence of complement decreased Raw 264.7 cells' ability to phagocytose C. difficile spores. Due to the ability of C. difficile spores to remain dormant inside Raw 264.7 cells, they were able to survive up to 72 h of macrophage infection. Interestingly, transmission electron micrographs showed interactions between the surface proteins of C. difficile spores and the phagosome membrane of Raw 264.7 cells. In addition, infection of Raw 264.7 cells with C. difficile spores for 48 h produced significant Raw 264.7 cell death as demonstrated by trypan blue assay, and nuclei staining by ethidium homodimer-1. Conclusions/Significance: These results demonstrate that despite efficient recognition and phagocytosis of C. difficile spores by Raw 264.7 cells, spores remain dormant and are able to survive and produce cytotoxic effects on Raw 264.7 cells.	[Paredes-Sabja, Daniel; Cofre-Araneda, Glenda; Brito-Silva, Christian; Pizarro-Guajardo, Marjorie] Univ Andres Bello, Dept Ciencias Biol, Fac Ciencias Biol, Lab Mecanismos Patogenesis Bacteriana, Santiago, Chile; [Paredes-Sabja, Daniel; Sarker, Mahfuzur R.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Sarker, Mahfuzur R.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Universidad Andres Bello; Oregon State University; Oregon State University	Paredes-Sabja, D (corresponding author), Univ Andres Bello, Dept Ciencias Biol, Fac Ciencias Biol, Lab Mecanismos Patogenesis Bacteriana, Santiago, Chile.	daniel.paredes.sabja@gmail.com; sarkerm@oregonstate.edu	Paredes-Sabja, Daniel/ABI-4293-2020; Pizarro-Guajardo, Marjorie/ABG-8107-2020	Pizarro-Guajardo, Marjorie/0000-0002-8089-5398	MECESUP [UAB0802]; Fondo Nacional de Ciencia y Tecnologia de Chile [FONDECYT REGULAR 1110569]; Research Office of Universidad Andres Bello [DI-35-11/R]; Agricultural Research Foundation of Oregon State University; Department of Defense Multi-disciplinary University Research Initiative (MURI) award through the U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-09-1-0286]	MECESUP; Fondo Nacional de Ciencia y Tecnologia de Chile; Research Office of Universidad Andres Bello; Agricultural Research Foundation of Oregon State University; Department of Defense Multi-disciplinary University Research Initiative (MURI) award through the U.S. Army Research Laboratory; U.S. Army Research Office	MECESUP UAB0802, Fondo Nacional de Ciencia y Tecnologia de Chile (FONDECYT REGULAR 1110569), by a grant from the Research Office of Universidad Andres Bello (DI-35-11/R) (to D.P.-S); grant from the Agricultural Research Foundation of Oregon State University and by a Department of Defense Multi-disciplinary University Research Initiative (MURI) award through the U.S. Army Research Laboratory and the U.S. Army Research Office under contract number W911NF-09-1-0286 (to MRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Baines SD, 2009, J ANTIMICROB CHEMOTH, V63, P520, DOI 10.1093/jac/dkn502; Chung MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018119; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Giebel JD, 2009, J BACTERIOL, V191, P5569, DOI 10.1128/JB.00408-09; Goulding D, 2009, INFECT IMMUN, V77, P5478, DOI 10.1128/IAI.00551-09; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Guidi-Rontani C, 1999, MOL MICROBIOL, V31, P9, DOI 10.1046/j.1365-2958.1999.01137.x; Guidi-Rontani C, 1999, MOL MICROBIOL, V33, P407, DOI 10.1046/j.1365-2958.1999.01485.x; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; Hasegawa M, 2011, J IMMUNOL, V186, P4872, DOI 10.4049/jimmunol.1003761; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; HORWITZ MA, 1984, CELL, V36, P27, DOI 10.1016/0092-8674(84)90070-9; Hu HJ, 2007, FEMS MICROBIOL LETT, V272, P245, DOI 10.1111/j.1574-6968.2007.00766.x; Kang TJ, 2005, INFECT IMMUN, V73, P7495, DOI 10.1128/IAI.73.11.7495-7501.2005; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; May JA, 1998, PLATELETS, V9, P227, DOI 10.1080/09537109876744; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; Mueller-Ortiz SL, 2001, INFECT IMMUN, V69, P7501, DOI 10.1128/IAI.69.12.7501-7511.2001; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; O'Brien DK, 2000, CELL MICROBIOL, V2, P505, DOI 10.1046/j.1462-5822.2000.00074.x; Okumura Y, 1999, FEBS LETT, V442, P39, DOI 10.1016/S0014-5793(98)01612-3; Paredes-Sabja D, 2012, J MED MICRO IN PRESS; Paredes-Sabja D, 2011, J MED MICRO IN PRESS; Paredes-Sabja D, 2008, J BACTERIOL, V190, P4648, DOI 10.1128/JB.00325-08; Paredes-Sabja D, 2008, APPL ENVIRON MICROB, V74, P3730, DOI 10.1128/AEM.00169-08; Paredes-Sabja D, 2008, INT J FOOD MICROBIOL, V122, P333, DOI 10.1016/j.ijfoodmicro.2007.12.006; Paredes-Sabja D, 2012, ANAEROBE, V18, P148, DOI 10.1016/j.anaerobe.2011.12.019; Paredes-Sabja D, 2011, ANAEROBE, V17, P78, DOI 10.1016/j.anaerobe.2011.02.001; Pelczar PL, 2007, J BACTERIOL, V189, P1090, DOI 10.1128/JB.01606-06; Raju D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-50; Raju D, 2007, APPL ENVIRON MICROB, V73, P2048, DOI 10.1128/AEM.02500-06; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Ryan A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002076; Sarker MR, 2012, FUTURE MICR IN PRESS; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Wheeldon LJ, 2011, J APPL MICROBIOL; WUST J, 1982, J CLIN MICROBIOL, V16, P1096	47	43	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43635	10.1371/journal.pone.0043635	http://dx.doi.org/10.1371/journal.pone.0043635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952726	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800048
J	Almog, N; Ma, LL; Schwager, C; Brinkmann, BG; Beheshti, A; Vajkoczy, P; Folkman, J; Hlatky, L; Abdollahi, A				Almog, Nava; Ma, Lili; Schwager, Christian; Brinkmann, Bastian G.; Beheshti, Afshin; Vajkoczy, Peter; Folkman, Judah; Hlatky, Lynn; Abdollahi, Amir			Consensus Micro RNAs Governing the Switch of Dormant Tumors to the Fast-Growing Angiogenic Phenotype	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER DORMANCY; ANGIOSTATIN; MECHANISMS; CELLS; BV8; SUPPRESSION; CARCINOMA; NETWORK; MODEL	Tumor dormancy refers to a critical stage in cancer development in which tumor cells remain occult for a prolonged period of time until they eventually progress and become clinically apparent. We previously showed that the switch of dormant tumors to fast-growth is angiogenesis dependent and requires a stable transcriptional reprogramming in tumor cells. Considering microRNAs (miRs) as master regulators of transcriptome, we sought to investigate their role in the control of tumor dormancy. We report here the identification of a consensus set of 19 miRs that govern the phenotypic switch of human dormant breast carcinoma, glioblastoma, osteosarcoma, and liposarcoma tumors to fast-growth. Loss of expression of dormancy-associated miRs (DmiRs, 16/19) was the prevailing regulation pattern correlating with the switch of dormant tumors to fast-growth. The expression pattern of two DmiRs (miR-580 and 190) was confirmed to correlate with disease stage in human glioma specimens. Reconstitution of a single DmiR (miR-580, 588 or 190) led to phenotypic reversal of fast-growing angiogenic tumors towards prolonged tumor dormancy. Of note, 60% of angiogenic glioblastoma and 100% of angiogenic osteosarcoma over-expressing miR190 remained dormant during the entire observation period of similar to 120 days. Next, the ability of DmiRs to regulate angiogenesis and dormancy-associated genes was evaluated. Transcriptional reprogramming of tumors via DmiR-580, 588 or 190 over-expression resulted in downregulation of pro-angiogenic factors such as TIMP-3, bFGF and TGFalpha. In addition, a G-CSF independent downregulation of Bv8 was found as a common target of all three DmiRs and correlated with decreased tumor recruitment of bone marrow-derived CD11b+ Gr-1+ myeloid cells. In contrast, antiangiogenic and dormancy promoting pathways such as EphA5 and Angiomotin were upregulated in DmiR over-expressing tumors. This work suggests novel means to reverse the malignant tumor phenotype into an asymptomatic dormant state and may provide promising targets for early detection or prevention of cancer.	[Almog, Nava; Ma, Lili; Beheshti, Afshin; Hlatky, Lynn; Abdollahi, Amir] Tufts Univ, Sch Med, Steward Res & Specialty Projects Corp, Ctr Canc Syst Biol,St Elizabeths Med Ctr, Boston, MA 02111 USA; [Schwager, Christian; Abdollahi, Amir] Heidelberg Univ, Sch Med, Heidelberg Ion Therapy Ctr, Heidelberg, Germany; [Ma, Lili; Abdollahi, Amir] German Canc Res Ctr, Natl Ctr Tumor Dis, D-6900 Heidelberg, Germany; [Brinkmann, Bastian G.; Vajkoczy, Peter] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Folkman, Judah] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Folkman, Judah] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA	St. Elizabeth's Medical Center; Tufts University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Almog, N (corresponding author), Tufts Univ, Sch Med, Steward Res & Specialty Projects Corp, Ctr Canc Syst Biol,St Elizabeths Med Ctr, Boston, MA 02111 USA.	Nava.Almog@Tufts.edu; Amir.Abdollahi@Tufts.edu	Beheshti, Afshin/AAH-7267-2019; Beheshti, Afshin/N-2241-2014	Beheshti, Afshin/0000-0003-4643-531X	National Aeronautics and Space Administration Specialized Center of Research (NSCOR) [NNJ06HA28G]; German Krebshilfe (Deutsche Krebshilfe) [108876]; German Research Foundation [SPP1190]; National Center for Tumor diseases (Heidelberg, Germany); German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung) [BMBF 03NUK004C]	National Aeronautics and Space Administration Specialized Center of Research (NSCOR); German Krebshilfe (Deutsche Krebshilfe)(Deutsche Krebshilfe); German Research Foundation(German Research Foundation (DFG)); National Center for Tumor diseases (Heidelberg, Germany); German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This material is based upon work supported by the National Aeronautics and Space Administration Specialized Center of Research (NSCOR, grant no. NNJ06HA28G) issued through the Human Research Program. It was also supported in part by the German Krebshilfe (Deutsche Krebshilfe, Max-Eder 108876), German Research Foundation National Priority Research Program: the Tumor-Vessel Interface "SPP1190", Intramural Grants of the National Center for Tumor diseases (Heidelberg, Germany) and the German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung - BMBF 03NUK004C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2010, CANC LETT; Almog N, 2006, FASEB J, V20, P947, DOI 10.1096/fj.05-3946fje; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brackstone M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1677; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Domhan S, 2008, MOL CANCER THER, V7, P1656, DOI 10.1158/1535-7163.MCT-08-0193; Fainaru O, 2009, FASEB J; Favaro E, 2008, APMIS, V116, P648, DOI 10.1111/j.1600-0463.2008.01025.x; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Gilead A, 2004, INT J CANCER, V108, P524, DOI 10.1002/ijc.11583; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Indraccolo S, 2009, CANCER RES, V69, P1314, DOI 10.1158/0008-5472.CAN-08-2791; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; Lee TY, 2009, BLOOD, V114, P1987, DOI 10.1182/blood-2008-12-197236; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Naumov GN, 2008, CLIN EXP METASTASIS; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Shaked Y, 2009, BBA-REV CANCER, V1796, P1, DOI 10.1016/j.bbcan.2009.07.002; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Tang Y, 2009, INT J CANCER, V124, P1545, DOI 10.1002/ijc.24118; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864; Uhr JW, 1997, NAT MED, V3, P505, DOI 10.1038/nm0597-505; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	35	55	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44001	10.1371/journal.pone.0044001	http://dx.doi.org/10.1371/journal.pone.0044001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952847	Green Submitted, gold, Green Published			2022-12-27	WOS:000308221300040
J	Milliman, EJ; Yadav, N; Chen, YC; Muddukrishna, B; Karunanithi, S; Yu, MC				Milliman, Eric J.; Yadav, Neelu; Chen, Yin-Chu; Muddukrishna, Bhavana; Karunanithi, Sheelarani; Yu, Michael C.			Recruitment of Rpd3 to the Telomere Depends on the Protein Arginine Methyltransferase Hmt1	PLOS ONE			English	Article							HISTONE DEACETYLASE COMPLEX; GENETIC INTERACTION MAP; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; SILENT CHROMATIN; IN-VIVO; INTERACTION NETWORKS; METHYLATION; YEAST; ACETYLATION	In the yeast Saccharomyces cerevisiae, the establishment and maintenance of silent chromatin at the telomere requires a delicate balance between opposing activities of histone modifying enzymes. Previously, we demonstrated that the protein arginine methyltransferase Hmt1 plays a role in the formation of yeast silent chromatin. To better understand the nature of the Hmt1 interactions that contribute to this phenomenon, we carried out a systematic reverse genetic screen using a null allele of HMT1 and the synthetic genetic array (SGA) methodology. This screen revealed interactions between HMT1 and genes encoding components of the histone deacetylase complex Rpd3L (large). A double mutant carrying both RPD3 and HMT1 deletions display increased telomeric silencing and Sir2 occupancy at the telomeric boundary regions, when comparing to a single mutant carrying Hmt1-deletion only. However, the dual rpd3/hmt1-null mutant behaves like the rpd3-null single mutant with respect to silencing behavior, indicating that RPD3 is epistatic to HMT1. Mutants lacking either Hmt1 or its catalytic activity display an increase in the recruitment of histone deacetylase Rpd3 to the telomeric boundary regions. Moreover, in such loss-of-function mutants the levels of acetylated H4K5, which is a substrate of Rpd3, are altered at the telomeric boundary regions. In contrast, the level of acetylated H4K16, a target of the histone deacetylase Sir2, was increased in these regions. Interestingly, mutants lacking either Rpd3 or Sir2 display various levels of reduction in dimethylated H4R3 at these telomeric boundary regions. Together, these data provide insight into the mechanism whereby Hmt1 promotes the proper establishment and maintenance of silent chromatin at the telomeres.	[Milliman, Eric J.; Yadav, Neelu; Chen, Yin-Chu; Muddukrishna, Bhavana; Karunanithi, Sheelarani; Yu, Michael C.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Milliman, EJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	mcyu@buffalo.edu	Yu, Michael C/GON-5550-2022	Yu, Michael/0000-0002-3611-9295	Scientist Development grant [0830279N]; American Heart Association; Julian Park Fund; College of Arts and Sciences, University at Buffalo; Direct For Biological Sciences [1051350] Funding Source: National Science Foundation	Scientist Development grant; American Heart Association(American Heart Association); Julian Park Fund; College of Arts and Sciences, University at Buffalo; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a Scientist Development grant (0830279N) from the American Heart Association, to MCY. The publication costs of this article were supported by the Julian Park Fund, College of Arts and Sciences, University at Buffalo. The funders had no role in study design, data collection, data interpretation, or the decision to prepare and publish of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Buhler M, 2009, EMBO J, V28, P2149, DOI 10.1038/emboj.2009.185; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chang CS, 2009, GENETICS, V183, P149, DOI 10.1534/genetics.109.103846; Chavel CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000883; Chen YC, 2010, MOL CELL BIOL, V30, P5245, DOI 10.1128/MCB.00359-10; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; DeRubertis F, 1996, NATURE, V384, P589; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Ehrentraut S, 2010, P NATL ACAD SCI USA, V107, P5522, DOI 10.1073/pnas.0909169107; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Henry MF, 1996, MOL CELL BIOL, V16, P3668; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Hung ML, 2010, NUCLEIC ACIDS RES, V38, P3351, DOI 10.1093/nar/gkq033; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Hyun S, 2008, CHEMBIOCHEM, V9, P2790, DOI 10.1002/cbic.200800544; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Inai T, 2007, MOL CELL BIOL, V27, P1254, DOI 10.1128/MCB.01661-06; Jacobson S, 2009, MOL CELL BIOL, V29, P6033, DOI 10.1128/MCB.00542-09; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 2009, BBA-GENE REGUL MECH, V1789, P395, DOI 10.1016/j.bbagrm.2009.03.004; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lei EP, 2002, GENE DEV, V16, P2761, DOI 10.1101/gad.1032902; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh I, 2009, GENETICS, V181, P289, DOI 10.1534/genetics.108.092981; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Sun ZW, 1999, GENETICS, V152, P921; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Vannier D, 1996, GENETICS, V144, P1343; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yu MC, 2006, GENE DEV, V20, P3249, DOI 10.1101/gad.1495206; Zhou J, 2009, NUCLEIC ACIDS RES, V37, P3699, DOI 10.1093/nar/gkp233	62	4	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44656	10.1371/journal.pone.0044656	http://dx.doi.org/10.1371/journal.pone.0044656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22953000	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300104
J	Poore, GCB; Bruce, NL				Poore, Gary C. B.; Bruce, Niel L.			Global Diversity of Marine Isopods (Except Asellota and Crustacean Symbionts)	PLOS ONE			English	Review							INDIAN-OCEAN CRUSTACEA; REPRODUCTIVE STRATEGIES; CRYPTIC SPECIATION; SOCIETY-ISLANDS; PERACARIDA; SPHAEROMATIDAE; BIOGEOGRAPHY; PHYLOGENY; GENUS; ECOLOGY	The crustacean order Isopoda (excluding Asellota, crustacean symbionts and freshwater taxa) comprise 3154 described marine species in 379 genera in 37 families according to the WoRMS catalogue. The history of taxonomic discovery over the last two centuries is reviewed. Although a well defined order with the Peracarida, their relationship to other orders is not yet resolved but systematics of the major subordinal taxa is relatively well understood. Isopods range in size from less than 1 mm to Bathynomus giganteus at 365 mm long. They inhabit all marine habitats down to 7280 m depth but with few doubtful exceptions species have restricted biogeographic and bathymetric ranges. Four feeding categories are recognised as much on the basis of anecdotal evidence as hard data: detritus feeders and browsers, carnivores, parasites, and filter feeders. Notable among these are the Cymothooidea that range from predators and scavengers to external blood-sucking micropredators and parasites. Isopods brood 10-1600 eggs depending on individual species. Strong sexual dimorphism is characteristic of several families, notably in Gnathiidae where sessile males live with a harem of females while juvenile praniza stages are ectoparasites of fish. Protandry is known in Cymothoidae and protogyny in Anthuroidea. Some Paranthuridae are neotenous. About half of all coastal, shelf and upper bathyal species have been recorded in the MEOW temperate realms, 40% in tropical regions and the remainder in polar seas. The greatest concentration of temperate species is in Australasia; more have been recorded from temperate North Pacific than the North Atlantic. Of tropical regions, the Central Indo-Pacific is home to more species any other region. Isopods are decidedly asymmetrical latitudinally with 1.35 times as many species in temperate Southern Hemisphere than the temperate North Atlantic and northern Pacific, and almost four times as many Antarctic as Arctic species. More species are known from the bathyal and abyssal Antarctic than Arctic GOODS provinces, and more from the larger Pacific than Atlantic oceans. Two areas with many species known are the New Zealand-Kermadec and the Northern North Pacific provinces. Deep hard substrates such as found on seamounts and the slopes are underrepresented in samples. This, the documented numbers of undescribed species in recent collections and probable cryptic species suggest a large as yet undocumented fauna, potentially an order of magnitude greater than presently known.	[Poore, Gary C. B.] Museum Victoria, Melbourne, Vic, Australia; [Bruce, Niel L.] James Cook Univ, Museum Trop Queensland, Townsville, Qld 4811, Australia; [Bruce, Niel L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Bruce, Niel L.] Univ Johannesburg, Dept Zool, Auckland Pk, South Africa	Museum Victoria; James Cook University; James Cook University; University of Johannesburg	Poore, GCB (corresponding author), Museum Victoria, Melbourne, Vic, Australia.	gpoore@museum.vic.gov.au						ADLARD RD, 1995, AUST J ZOOL, V43, P271, DOI 10.1071/ZO9950271; [Anonymous], 2003, SPHAEROMATID ISOPODS; BAMBER RN, 1985, J MAR BIOL ASSOC UK, V65, P181, DOI 10.1017/S0025315400060896; Barber PH, 2009, J BIOGEOGR, V36, P1845, DOI 10.1111/j.1365-2699.2009.02198.x; Barnard K. H., 1940, Annals of the South African Museum, V32, P381; Barnard KH, 1959, ANN MAG NAT HIST  13, V1, P715; Barradas-Ortiz C, 2003, DEEP-SEA RES PT I, V50, P495, DOI 10.1016/S0967-0637(03)00036-0; BASTIDA R, 1970, Bulletin du Museum National d'Histoire Naturelle, V42, P392; Beddard F. E., 1886, ZOOLOGY, V17, P1; Beddard FE, 1884, ZOOLOGY, V11, P1; Bostrom C, 2005, CRUSTACEANA, V78, P185, DOI 10.1163/1568540054020541; BOWMAN T E, 1971, Journal of Paleontology, V45, P540; Brandt A, 2003, INVERTEBR SYST, V17, P893, DOI 10.1071/IS02032; Brandt A, 1990, ANTARCT RES SER, DOI DOI 10.1029/AR032P0063; Brandt A, 1988, ANTARCTIC VALVIFERAN; Brandt A, 2007, DEEP-SEA RES PT II, V54, P1760, DOI 10.1016/j.dsr2.2007.07.015; BREARLEY A, 1993, MARINE FLORA AND FAUNA OF ROTTNEST ISLAND, WEST AUSTRALIA, VOLS 1 AND 2, P415; BREY T, 1994, NATURE, V368, P297, DOI 10.1038/368297a0; Brokeland W, 2001, ORG DIVERS EVOL, V1, P83, DOI 10.1078/1439-6092-00007; BRUCE N L, 1987, Records of the Australian Museum, V39, P355; Bruce Niel, 1997, P198; Bruce Niel L., 1997, Memoirs of the Museum of Victoria, V56, P145; Bruce Niel L., 2003, Memoirs of Museum Victoria, V60, P309; Bruce Niel L., 2008, Zootaxa, V1908, P51; Bruce NL, 2002, J MAR BIOL ASSOC UK, V82, P51, DOI 10.1017/S0025315402005179; BRUCE NL, 1994, J NAT HIST, V28, P1077, DOI 10.1080/00222939400770571; BRUCE NL, 1995, CRUSTACEANA, V68, P123, DOI 10.1163/156854095X01231; Bruce NL, 1986, MARINE BORING FOULIN, V6, P1; BRUCE NL, 1986, RECORDS AUSTR MUSE S, V6, P1, DOI DOI 10.3853/J.0812-7387.6.1986.98; Bruce NL, 2009, NATL I WATER ATMOSPH, P1; BRUSCA R C, 1984, Transactions of the San Diego Society of Natural History, V20, P99; BRUSCA R C, 1991, Memoirs of the Queensland Museum, V31, P143; BRUSCA RC, 1981, ZOOL J LINN SOC-LOND, V73, P117, DOI 10.1111/j.1096-3642.1981.tb01592.x; Brusca RC, 1981, J FISH BIOL, V73, P117; Bunkley-Williams L, 1998, J PARASITOL, V84, P893, DOI 10.2307/3284615; Clarke A, 2008, J EXP MAR BIOL ECOL, V366, P48, DOI 10.1016/j.jembe.2008.07.008; Cohen Brian F., 1994, Memoirs of the Museum of Victoria, V54, P271; COOKSON L J, 1991, Memoirs of the Museum of Victoria, V52, P137; Cookson LJ, 1991, D91 SECURESCM, V52, P137; Cuesta J.A., 1996, Limnetica, V12, P41; Delaney PM, 1989, CONTRIBUTIONS SCI NA, V409, P1, DOI DOI 10.5962/P.226815; Dreyer H, 2002, J CRUSTACEAN BIOL, V22, P217, DOI 10.1651/0278-0372(2002)022[0217:TSTNAT]2.0.CO;2; Dreyer H, 2001, ZOOL-ANAL COMPLEX SY, V103, P157; Ebbe Brigitte, 2010, P139, DOI 10.1002/9781444325508.ch8; Feldmann RM, 2006, NEW ZEAL J GEOL GEOP, V49, P411, DOI 10.1080/00288306.2006.9515177; Feldmann RM, 2011, J CRUSTACEAN BIOL, V31, P317, DOI 10.1651/10-3406.1; Feldmann RM, 2009, J CRUSTACEAN BIOL, V29, P373, DOI 10.1651/08-3096.1; Fogelman RM, 2009, INT J PARASITOL, V39, P577, DOI 10.1016/j.ijpara.2008.10.013; GUARINO SM, 1993, J MAR BIOL ASSOC UK, V73, P785, DOI 10.1017/S002531540003472X; Guinot D, 2005, J PALEONTOL, V79, P954, DOI 10.1666/0022-3360(2005)079[0954:JIMPFR]2.0.CO;2; Hale H. M., 1925, Transactions and Proceedings Royal Society South Australia, V49, P128; Hale HM, 1929, CRUSTACEANS S AUST 2, P202; Hansen HJ, 1905, Q J MICROSC SCI, V49, P69; Hansen HJ, 1906, J LINN SOC LOND, V29, P337; HARRISON K, 1984, ZOOL J LINN SOC-LOND, V82, P363, DOI 10.1111/j.1096-3642.1984.tb00870.x; Held C, 2000, MOL PHYLOGENET EVOL, V15, P165, DOI 10.1006/mpev.1999.0739; Held C, 2005, SCI MAR, V69, P175, DOI 10.3989/scimar.2005.69s2175; Held C, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P135; HURLEY DE, 1968, T ROY SOC NZ ZOOL, V10, P241; Jenner RA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-21; JONES DA, 1971, J ZOOL, V165, P201; Jormalainen V, 1999, MAR FRESHW BEHAV PHY, V32, P39, DOI 10.1080/10236249909379036; Kensley B, 1998, CORAL REEFS, V17, P83, DOI 10.1007/s003380050100; Kensley B, 2002, J NAT HIST, V36, P1421, DOI 10.1080/00222930110050401; Kensley B, 2001, CRUSTACEAN ISS, V13, P205; KENSLEY B, 1988, Bulletin of the Biological Society of Washington, P40; KENSLEY B, 1984, PSZNI MAR ECOL, V5, P29; Kensley B, 1989, GUID MARINE ISOPODS; Kensley B, 1988, FIELD GUIDE SEASHORE, V8, P40; Kensley B., 1989, GUIDE MARINE ISOPOD; Kensley B, 2007, P BIOL SOC WASH, V120, P429, DOI 10.2988/0006-324X(2007)120[429:NSAROV]2.0.CO;2; Kensley B, 2009, P BIOL SOC WASH, V122, P32, DOI 10.2988/07-16.1; Ketmaier V, 2008, J ZOOL SYST EVOL RES, V46, P19, DOI 10.1111/j.1439-0469.2007.00423.x; Kussakin O.G, 1982, OPREDELITELI FAUNE S, V131, P1; Kussakin OG., 1982, OPREDELITELI FAUNE S, V131, P1; Leese F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-19; Lowry James K., 2006, Memoires du Museum National d'Histoire Naturelle, V193, P163; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; McDermott JJ, 2001, OPHELIA, V55, P123, DOI 10.1080/00785236.2001.10409479; Menzies R.J., 1962, LUNDS UNIVERSITETS R, V57, P1; MENZIES ROBERT J., 1950, WASMANN JOUR BIOL, V8, P155; MENZIES ROBERT JAMES, 1957, BULL MARINE SCI GULF AND CARIBBEAN, V7, P101; Miers E.J., 1877, P ZOOL SOC LOND, V1877, P653; MIERS EJ, 1881, J LINN SOC LOND, V16, P1, DOI DOI 10.1111/J.1096-3642.1881.TB02274A.X; Milne Edwards H, 1840, HIST NATURELLE CRUST, V3; Monod T., 1930, ANN SCI NAT ZOOL, V13, P129; MONOD THEODORE, 1926, MEM SOC SCI NAT MAROC, V13, P1; Moore W, 2003, J NAT HIST, V37, P1329, DOI 10.1080/00222930110108335; Moreira P.S., 1973, Boletim Fac Filos Cienc Univ S Paulo (Zool & Biol marinha) NS, VNo. 30, P217; Muller Hans-Georg, 1993, Mitteilungen aus dem Zoologischen Museum in Berlin, V69, P3; MULLER HG, 1991, CAH BIOL MAR, V32, P83; MULLER HG, 1993, CAH BIOL MAR, V34, P289; MULLER HG, 1991, CAH BIOL MAR, V32, P451; Naylor E., 1972, SYNOPSES BRIT FAUNA, V3; Nierstrasz HF, 1941, SIBOGA EXPED, V19, P235; Polz Hermann, 2005, Archaeopteryx, V23, P67; POORE G C B, 1987, Memoirs of the Museum of Victoria, V48, P141; POORE GCB, 1994, DEEP-SEA RES PT I, V41, P677, DOI 10.1016/0967-0637(94)90049-3; Poore GCB, 1996, J CRUSTACEAN BIOL, V16, P384, DOI 10.2307/1548894; Poore GCB, 2001, CRUSTACEAN ISS, V13, P63; POORE GCB, 1984, J NAT HIST, V18, P697, DOI 10.1080/00222938400770601; Poore GCB, 2001, J CRUSTACEAN BIOL, V21, P205, DOI 10.1651/0278-0372(2001)021[0205:IVDARO]2.0.CO;2; Poore GCB, 2005, NAUPLIUS, V13, P1; Prevorcnik S, 2010, ZOOL J LINN SOC-LOND, V159, P1, DOI 10.1111/j.1096-3642.2009.00593.x; Ray DL, 1959, 14 NIWA, P46; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; Riseman SF, 2002, ZOOL J LINN SOC-LOND, V134, P57, DOI 10.1046/j.1096-3642.2002.00002.x; ROMESTAND B, 1977, ANN PARASIT HUM COMP, V52, P171; Sars G. O., 1896, ACCOUNT CRUSTACEA NO, VII; Sars GO, 1896, ANTARCTIC ISOPODA VA, V2; Schioedte J.C., 1879, NATURHISTORISK TIDSS, V12, P321, DOI DOI 10.5962/BHL.TITLE.10300; Schotte M, 2005, J NAT HIST, V39, P1211, DOI 10.1080/00222930400005757; Schotte M., 1995, WORLD LIST MARINE FR; Schotte M., 2008, WORLD LIST MARINE FR; Semmens BX, 2006, J FISH BIOL, V69, P933, DOI 10.1111/j.1095-8649.2006.01129.x; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; SHUSTER SM, 1991, CRUSTACEAN SEXUAL BIOLOGY, P91; SHUSTER SM, 1989, EVOLUTION, V43, P1683, DOI 10.1111/j.1558-5646.1989.tb02618.x; Smit N. J., 2004, ADV PARASIT, V58, P290; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stebbing T. R. R., 1913, London Abstr Proc Zool Soc, V1912, P231; Stebbing TRR, 1900, ZOOLOGICAL RESULTS B, P609; Tabacaru Ionel, 2011, Travaux de l'Institut de Speologie "Emile Racovitza", V50, P87; Tanaka Katsuhiko, 2006, Aquabiology (Tokyo), V28, P82; Tanaka Katsuhiko, 2006, Aquabiology (Tokyo), V28, P199; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; van Tussenbroek BI, 1998, MAR FRESHWATER RES, V49, P525, DOI 10.1071/MF97242; Wagele J.-W., 1989, Zoologica (Stuttgart), V47, P1; Wagele J.W., 1981, ZOOL STUTTG, V132, P1; WAGELE JW, 1987, PHILOS T ROY SOC B, V316, P429, DOI 10.1098/rstb.1987.0031; WAGELE JW, 1979, ZOOL ANZ, V203, P334; WAGELE JW, 1985, POLAR BIOL, V4, P33, DOI 10.1007/BF00286815; Wetzer R, 2001, CONTRIB ZOOL, V70, P23, DOI 10.1163/18759866-07001002; White M.G., 1972, Bulletin Br Antarct Surv, VNo. 27, P139; Williams JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035350; Wilson GDF, 1998, DEEP-SEA RES PT II, V45, P279, DOI 10.1016/S0967-0645(97)00046-5; Wilson GDF, 2008, HYDROBIOLOGIA, V595, P231, DOI 10.1007/s10750-007-9019-z; Wilson GDF, 2011, J CRUSTACEAN BIOL, V31, P509, DOI 10.1651/10-3432.1; Wilson George D. F., 2009, Arthropod Systematics & Phylogeny, V67, P159; Wong YM, 1996, ESTUAR COAST SHELF S, V42, P247, DOI 10.1006/ecss.1996.0018; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1111/J.1439-0469.2007.00423.X; [No title captured], DOI DOI 10.1016/J.DSR2.2007.07.015; [No title captured]; [No title captured]; [No title captured]; [No title captured]	148	118	128	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43529	10.1371/journal.pone.0043529	http://dx.doi.org/10.1371/journal.pone.0043529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952700	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000308221300017
J	Almada, VC; Almada, F; Francisco, SM; Castilho, R; Robalo, JI				Almada, Vitor C.; Almada, Frederico; Francisco, Sara M.; Castilho, Rita; Robalo, Joana I.			Unexpected High Genetic Diversity at the Extreme Northern Geographic Limit of Taurulus bubalis (Euphrasen, 1786)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; MEDITERRANEAN SEA; ATLANTIC; PHYLOGEOGRAPHY; PLEISTOCENE; EXPANSION; REFUGIA; FISH; POPULATIONS; LOBSTER	The longspined bullhead (Taurulus bubalis, Euphrasen 1786) belongs to the family Cottidae and is a rocky shore species that inhabits the intertidal zones of the Eastern Atlantic since Iceland, southward to Portugal and also the North Sea and Baltic, northward to the Gulf of Finland, with some occurrences in the northern Mediterranean coasts eastward to the Gulf of Genoa. We analysed the phylogeographic patterns of this species using mitochondrial and nuclear markers in populations throughout most of its distributional range in west Europe. We found that T. bubalis has a relatively shallow genealogy with some differentiation between Atlantic and North Sea. Genetic diversity was homogeneous across all populations studied. The possibility of a glacial refugium near the North Sea is discussed. In many, but not all, marine temperate organisms, patterns of diversity are similar across the species range. If this phenomenon proves to be most common in cold adapted species, it may reflect the availability of glacial refugia not far from their present-day northern limits.	[Almada, Vitor C.; Almada, Frederico; Francisco, Sara M.; Robalo, Joana I.] ISPA Univ Inst, Ecoethol Res Unit, Lisbon, Portugal; [Castilho, Rita] Univ Algarve, Ctr Ciencias Mar CCMAR, CIMAR Associate Lab, Faro, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade do Algarve	Almada, VC (corresponding author), ISPA Univ Inst, Ecoethol Res Unit, Lisbon, Portugal.	sara_francisco@ispa.pt	Robalo, Joana I./HIK-2365-2022; Francisco, Sara/K-8239-2013; Robalo, Joana Isabel/N-9960-2014; Castilho, Rita/B-6185-2008; Almada, Frederico/AAC-4340-2020	Robalo, Joana I./0000-0002-7470-0574; Francisco, Sara/0000-0003-0907-7453; Robalo, Joana Isabel/0000-0002-7470-0574; Castilho, Rita/0000-0003-0727-3688; Almada, Frederico/0000-0002-1389-8951	ASSEMBLE project [SBRmm -4]; European Science Foundation; Eco-Ethology Research Unit [331/94]; FEDER; FCT grant (Fundacao para a Ciencia e a Tecnologia) [SFRH/BPD/63170/2009]	ASSEMBLE project; European Science Foundation(European Science Foundation (ESF)European Commission); Eco-Ethology Research Unit; FEDER(European Commission); FCT grant (Fundacao para a Ciencia e a Tecnologia)	We are in debt to Wilfried Thomas and Laurent Leveque (Service d'expedition de modeles biologiques) from Station Biologique de Roscoff, France, for taking care of specimens' collection at Roscoff, financed by ASSEMBLE project #SBRmm -4: "Marine phylogeographic patterns of the North Eastern Atlantic Coast". We also would like to thank Halvor Knutsen (IMR - Norway) and Nicole Aberle-Malzahn and Arne Malzahn (Alfred Wegener Institute - Helgoland) for North Sea samples. We are grateful to Rafael Banon (Direccion Xeral de Ordenacion e Xestion dos Recursos Marinos Conselleria do Mar - Xunta de Galicia, Spain) for sample collection in Galicia. We appreciate the skilful technical assistance provided by S. Chenu, Hanne Sannaes, Pedro Coelho and Nicole Hielscher. We are grateful to Marta Pascual and Ferran Palero, from the University of Barcelona, for their assistance in implementing the Salicrutest of haplotype diversity.; This study was funded by the European Science Foundation's MarinERA project "Marine phylogeographic structuring during climate change: the signature of leading and rear edge of range shifting populations" and by the Eco-Ethology Research Unit (331/94) pluriannual financing programme (Fundacao para a Ciencia e Tecnologia (partially FEDER funded). FA (SFRH/BPD/63170/2009) research was supported by an FCT grant (Fundacao para a Ciencia e a Tecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almada VC, 2008, MOL PHYLOGENET EVOL, V46, P391, DOI 10.1016/j.ympev.2007.05.024; Alveirinho-Dias J, 1997, ESTUDOS Q, V1, P53; [Anonymous], 1984, QUATERNARY RES, V21, P123, DOI 10.1016/0033-5894(84)90098-X; [Anonymous], 2014, TRACER V1 6; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco J. C., 1992, LIBRO ROJO VERTEBRAD; Bowen BW, 1997, EVOLUTION, V51, P1601, DOI 10.1111/j.1558-5646.1997.tb01483.x; Bowen BW, 2006, J HERED, V97, P1, DOI 10.1093/jhered/esj006; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; CABRAL M. J., 2006, LIVRO VERMELHO VERTE; Chevolot M, 2006, MOL ECOL, V15, P3693, DOI 10.1111/j.1365-294X.2006.03043.x; Chow S, 1998, MOL ECOL, V7, P1255; *CLIMAP PROJ MEMB, 1981, GSA MAP CHART SER; Consuegra S, 2002, MOL ECOL, V11, P2037, DOI 10.1046/j.1365-294X.2002.01592.x; Dabney A, 2006, Q VALUE ESTIMATION F; de Abreu L, 2003, MAR GEOL, V196, P1, DOI 10.1016/S0025-3227(03)00046-X; Debes PV, 2008, MOL ECOL, V17, P3873, DOI 10.1111/j.1365-294X.2008.03872.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eschmeyer WN, 1983, FIELD GUIDE PACIFIC; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier Laurent, 2003, Human Genomics, V1, P7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Francisco SM, 2011, J EXP MAR BIOL ECOL, V403, P14, DOI 10.1016/j.jembe.2011.03.020; Francisco SM, 2009, MAR BIOL, V156, P1421, DOI 10.1007/s00227-009-1182-5; Fu YX, 1997, GENETICS, V147, P915; Gibson R.N., 1999, P97, DOI 10.1016/B978-012356040-7/50007-X; Gysels ES, 2004, MOL ECOL, V13, P403, DOI 10.1046/j.1365-294X.2003.02087.x; Hayes A, 2005, QUATERNARY SCI REV, V24, P999, DOI 10.1016/j.quascirev.2004.02.018; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Kettle AJ, 2011, CLIM PAST, V7, P181, DOI 10.5194/cp-7-181-2011; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Makinen HS, 2008, MOL PHYLOGENET EVOL, V46, P167, DOI 10.1016/j.ympev.2007.06.011; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; *NOAA, 2006, COMM LAND DAT; Ostellari L, 1996, ANIM GENET, V27, P423; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Robalo JI, 2012, ECOL EVOL, V2, P153, DOI 10.1002/ece3.77; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SALICRU M, 1993, COMMUN STAT-THEOR M, V22, P2015, DOI 10.1080/03610929308831131; Stamatis C, 2004, MOL ECOL, V13, P1377, DOI 10.1111/j.1365-294X.2004.02165.x; TAJIMA F, 1983, GENETICS, V105, P437; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tortonese E., 1986, FISHES NE ATLANTIC M, V2; Triantafyllidis A, 2005, MAR BIOL, V146, P223, DOI 10.1007/s00227-004-1435-2; Uriarte A, 2011, EARTHS CLIMATE HIST; Wares JP, 2001, EVOLUTION, V55, P2455; Watanabe M, 1969, FAUNA JAPONICA COTTI; Wilson AB, 2010, MOL ECOL, V19, P4535, DOI 10.1111/j.1365-294X.2010.04811.x; Yabe M., 1985, COMP OSTEOLOGY MYOLO	57	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44404	10.1371/journal.pone.0044404	http://dx.doi.org/10.1371/journal.pone.0044404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952971	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206500068
J	Li, SX; Sun, GQ; Murai, K; Ye, P; Shi, YH				Li, Shengxiu; Sun, Guoqiang; Murai, Kiyohito; Ye, Peng; Shi, Yanhong			Characterization of TLX Expression in Neural Stem Cells and Progenitor Cells in Adult Brains	PLOS ONE			English	Article							NUCLEAR RECEPTOR TLX; SUBVENTRICULAR ZONE; REGULATORY LOOP; NEUROGENESIS; TAILLESS; PROLIFERATION; BROMODEOXYURIDINE; DIFFERENTIATION; MIGRATION; NEURONS	TLX has been shown to play an important role in regulating the self-renewal and proliferation of neural stem cells in adult brains. However, the cellular distribution of endogenous TLX protein in adult brains remains to be elucidated. In this study, we used immunostaining with a TLX-specific antibody to show that TLX is expressed in both neural stem cells and transit-amplifying neural progenitor cells in the subventricular zone (SVZ) of adult mouse brains. Then, using a double thymidine analog labeling approach, we showed that almost all of the self-renewing neural stem cells expressed TLX. Interestingly, most of the TLX-positive cells in the SVZ represented the thymidine analog-negative, relatively quiescent neural stem cell population. Using cell type markers and short-term BrdU labeling, we demonstrated that TLX was also expressed in the Mash1+ rapidly dividing type C cells. Furthermore, loss of TLX expression dramatically reduced BrdU label-retaining neural stem cells and the actively dividing neural progenitor cells in the SVZ, but substantially increased GFAP staining and extended GFAP processes. These results suggest that TLX is essential to maintain the self-renewing neural stem cells in the SVZ and that the GFAP+ cells in the SVZ lose neural stem cell property upon loss of TLX expression. Understanding the cellular distribution of TLX and its function in specific cell types may provide insights into the development of therapeutic tools for neurodegenerative diseases by targeting TLX in neural stem/progenitors cells.	[Li, Shengxiu; Sun, Guoqiang; Murai, Kiyohito; Ye, Peng; Shi, Yanhong] Beckman Res Inst City Hope, Ctr Canc, Dept Neurosci, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope	Li, SX (corresponding author), Beckman Res Inst City Hope, Ctr Canc, Dept Neurosci, Duarte, CA USA.	yshi@coh.org		Shi, Yanhong/0000-0002-3938-5839	NIH NINDS [R01 NS059546, RC1 NS068370]; California Institute for Regenerative medicine [TR2-01832]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059546, RC1NS068370] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH NINDS R01 NS059546, RC1 NS068370 and California Institute for Regenerative medicine TR2-01832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; Chavali PL, 2011, J BIOL CHEM, V286, P9393, DOI 10.1074/jbc.M110.167445; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Leuner B, 2009, J COMP NEUROL, V517, P123, DOI 10.1002/cne.22107; Li WW, 2008, MOL ENDOCRINOL, V22, P56, DOI 10.1210/me.2007-0290; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Obernier K, 2011, STEM CELLS, V29, P1415, DOI 10.1002/stem.682; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Stenman JM, 2003, J NEUROSCI, V23, P10568; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	39	26	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43324	10.1371/journal.pone.0043324	http://dx.doi.org/10.1371/journal.pone.0043324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952666	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500010
J	Tophkhane, C; Yang, SH; Jiang, YB; Ma, ZK; Subramaniam, D; Anant, S; Yogosawa, S; Sakai, T; Liu, WG; Edgerton, S; Thor, A; Yang, XH				Tophkhane, Chaitali; Yang, Shi-He; Jiang, Yunbo; Ma, Zhikun; Subramaniam, Dharmalingam; Anant, Shrikant; Yogosawa, Shingo; Sakai, Toshiyuki; Liu, Wan-Guo; Edgerton, Susan; Thor, Ann; Yang, Xiaohe			p53 Inactivation Upregulates p73 Expression through E2F-1 Mediated Transcription	PLOS ONE			English	Article							BREAST-CANCER; DNA-DAMAGE; TUMOR-SUPPRESSOR; FEEDBACK LOOP; GENE; OVEREXPRESSION; APOPTOSIS; ISOFORMS; CELLS; IDENTIFICATION	While p73 overexpression has been associated with increased apoptosis in cancer tissues, p73 overexpressing tumors appear to be of high grade malignancy. Why this putative tumor suppressor is overexpressed in cancer cells and what the function of overexpressed p73 is in breast cancers are critical questions to be addressed. By investigating the effect of p53 inactivation on p73 expression, we found that both protein and mRNA levels of TAp73 were increased in MCF-7/p53siRNA cells, MCF-7/p53mt135 cells and HCT-116/p532/2 cells, as compared to wild type control, suggesting that p53 inactivation by various forms upregulates p73. We showed that p53 knockdown induced p73 was mainly regulated at the transcriptional level. However, although p53 has a putative binding site in the TAp73 promoter, deletion of this binding site did not affect p53 knockdown mediated activation of TAp73 promoter. Chromatin immuno-precipitation (ChIP) data demonstrated that loss of p53 results in enhanced occupancy of E2F-1 in the TAp73 promoter. The responsive sequence of p53 inactivation mediated p73 upregulation was mapped to the proximal promoter region of the TAp73 gene. To test the role of E2F-1 in p53 inactivation mediated regulation of p73 transcription, we found that p53 knockdown enhanced E2F-1 dependent p73 transcription, and mutations in E2F-1 binding sites in the TAp73 promoter abrogated p53 knockdown mediated activation of TAp73 promoter. Moreover, we demonstrated that p21 is a mediator of p53-E2F crosstalk in the regulation of p73 transcription. We concluded that p53 knockdown/inactivation may upregulate TAp73 expression through E2F-1 mediated transcriptional regulation. p53 inactivation mediated upregulation of p73 suggests an intrinsic rescuing mechanism in response to p53 mutation/inactivation. These findings support further analysis of the correlation between p53 status and p73 expression and its prognostic/predictive significance in human cancers.	[Tophkhane, Chaitali; Yang, Shi-He; Jiang, Yunbo; Yang, Xiaohe] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Subramaniam, Dharmalingam; Anant, Shrikant] Univ Kansas, KU Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS USA; [Yogosawa, Shingo; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Dept Prevent Med, Kyoto, Japan; [Liu, Wan-Guo] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Edgerton, Susan; Thor, Ann] Univ Colorado, Denver Sch Med, Dept Pathol, Aurora, CO USA; [Ma, Zhikun; Yang, Xiaohe] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Kannapolis, NC USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Kansas; University of Kansas Medical Center; Kyoto Prefectural University of Medicine; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; North Carolina Central University	Tophkhane, C (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA.	xyang@nccu.edu	Anant, Shrikant/AAF-8020-2020		Seed Grant from the University of Oklahoma Cancer Center Institutional Research Grant from the American Cancer Society ASC-IRG [IRG-05-066-01]; Research Scholar Grant from American Cancer Society [RSG-08-138-01-CNE]	Seed Grant from the University of Oklahoma Cancer Center Institutional Research Grant from the American Cancer Society ASC-IRG; Research Scholar Grant from American Cancer Society	This work was supported in part by a Seed Grant to Dr. XH Yang from the University of Oklahoma Cancer Center Institutional Research Grant from the American Cancer Society ASC-IRG #IRG-05-066-01 (http://www.cancer.org/), and by a Research Scholar Grant from American Cancer Society (RSG-08-138-01-CNE, http://www.cancer.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YYC, 2000, CARCINOGENESIS, V21, P683, DOI 10.1093/carcin/21.4.683; CERUTTI P, 1994, CANCER RES, V54, pS1934; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Corn PG, 1999, CANCER RES, V59, P3352; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Ding Y, 1999, DNA Res, V6, P347, DOI 10.1093/dnares/6.5.347; Dominguez G, 2006, J CLIN ONCOL, V24, P805, DOI 10.1200/JCO.2005.02.2350; Dominguez G, 2001, BREAST CANCER RES TR, V66, P183, DOI 10.1023/A:1010624717311; Dulloo I, 2005, J BIOL CHEM, V280, P28203, DOI 10.1074/jbc.M501702200; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Guan M, 2003, JPN J CLIN ONCOL, V33, P215, DOI 10.1093/jjco/hyg045; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Kawano S, 1999, BLOOD, V94, P1113; Lee CW, 1998, ONCOGENE, V16, P2695, DOI 10.1038/sj.onc.1201818; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; MILNER J, 1995, NAT MED, V1, P879, DOI 10.1038/nm0995-879; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Oberst A, 2005, BIOCHEM BIOPH RES CO, V331, P707, DOI 10.1016/j.bbrc.2005.03.158; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Seelan RS, 2002, NEOPLASIA, V4, P195, DOI 10.1038/sj.neo.7900237; Sigal A, 2000, CANCER RES, V60, P6788; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Tsai KKC, 2003, CANCER RES, V63, P3418; Willis AC, 2003, ONCOGENE, V22, P5481, DOI 10.1038/sj.onc.1206505; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yamamoto T, 2002, ONCOL REP, V9, P729; Yokomizo A, 1999, ONCOGENE, V18, P1629, DOI 10.1038/sj.onc.1202474; Zaika AI, 1999, CANCER RES, V59, P3257	42	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43564	10.1371/journal.pone.0043564	http://dx.doi.org/10.1371/journal.pone.0043564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952705	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206500013
J	Akatsuka, S; Yamashita, Y; Ohara, H; Liu, YT; Izumiya, M; Abe, K; Ochiai, M; Jiang, L; Nagai, H; Okazaki, Y; Murakami, H; Sekido, Y; Arai, E; Kanai, Y; Hino, O; Takahashi, T; Nakagama, H; Toyokuni, S				Akatsuka, Shinya; Yamashita, Yoriko; Ohara, Hiroki; Liu, Yu-Ting; Izumiya, Masashi; Abe, Koichiro; Ochiai, Masako; Jiang, Li; Nagai, Hirotaka; Okazaki, Yasumasa; Murakami, Hideki; Sekido, Yoshitaka; Arai, Eri; Kanai, Yae; Hino, Okio; Takahashi, Takashi; Nakagama, Hitoshi; Toyokuni, Shinya			Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; WISTAR RATS; INDUCED CARCINOGENESIS; DOWN-REGULATION; ALLELIC LOSS; IRON; DNA; NITRILOTRIACETATE; AMPLIFICATION	Iron overload has been associated with carcinogenesis in humans. Intraperitoneal administration of ferric nitrilotriacetate initiates a Fenton reaction in renal proximal tubules of rodents that ultimately leads to a high incidence of renal cell carcinoma (RCC) after repeated treatments. We performed high-resolution microarray comparative genomic hybridization to identify characteristics in the genomic profiles of this oxidative stress-induced rat RCCs. The results revealed extensive large-scale genomic alterations with a preference for deletions. Deletions and amplifications were numerous and sometimes fragmented, demonstrating that a Fenton reaction is a cause of such genomic alterations in vivo. Frequency plotting indicated that two of the most commonly altered loci corresponded to a Cdkn2a/2b deletion and a Met amplification. Tumor sizes were proportionally associated with Met expression and/or amplification, and clustering analysis confirmed our results. Furthermore, we developed a procedure to compare whole genomic patterns of the copy number alterations among different species based on chromosomal syntenic relationship. Patterns of the rat RCCs showed the strongest similarity to the human RCCs among five types of human cancers, followed by human malignant mesothelioma, an iron overload-associated cancer. Therefore, an iron-dependent Fenton chemical reaction causes large-scale genomic alterations during carcinogenesis, which may result in distinct genomic profiles. Based on the characteristics of extensive genome alterations in human cancer, our results suggest that this chemical reaction may play a major role during human carcinogenesis.	[Akatsuka, Shinya; Yamashita, Yoriko; Ohara, Hiroki; Jiang, Li; Nagai, Hirotaka; Okazaki, Yasumasa; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4648601, Japan; [Akatsuka, Shinya; Yamashita, Yoriko; Ohara, Hiroki; Jiang, Li; Nagai, Hirotaka; Okazaki, Yasumasa; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Biol Responses, Showa Ku, Nagoya, Aichi 4648601, Japan; [Liu, Yu-Ting; Nagai, Hirotaka] Kyoto Univ, Grad Sch Med, Sakyo Ku, Dept Pathol & Biol Dis, Kyoto, Japan; [Izumiya, Masashi; Abe, Koichiro; Ochiai, Masako; Nakagama, Hitoshi] Natl Canc Ctr, Div Canc Dev Syst, Chuo Ku, Res Inst, Tokyo 104, Japan; [Abe, Koichiro] Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo 173, Japan; [Murakami, Hideki; Sekido, Yoshitaka] Aichi Canc Ctr, Div Mol Oncol, Chikusa Ku, Res Inst, Nagoya, Aichi 464, Japan; [Arai, Eri; Kanai, Yae] Natl Canc Ctr, Res Inst, Div Mol Pathol, Chuo Ku, Tokyo 104, Japan; [Hino, Okio] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Bunkyo Ku, Tokyo 113, Japan	Nagoya University; Nagoya University; Kyoto University; National Cancer Center - Japan; Teikyo University; Aichi Cancer Center; National Cancer Center - Japan; Juntendo University	Akatsuka, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4648601, Japan.	toyokuni@med.nagoya-u.ac.jp	Izumiya, Masashi/AAL-3763-2020; Kanai, Yae/AAE-6987-2019; Sekido, Yoshitaka/P-9756-2015; Nagai, Hirotaka/GYJ-4926-2022; Akatsuka, Shinya/C-9806-2010; Toyokuni, Shinya/C-1358-2010; Takahashi, Takashi/I-7262-2014; Yamashita, Yoriko/B-9810-2011; Nagai, Hirotaka/C-9713-2010; OKAZAKI, Yasumasa/E-7895-2010; Toyokuni, Shinya/ABE-7714-2021	Nagai, Hirotaka/0000-0003-0983-8670; Akatsuka, Shinya/0000-0002-9944-8803; Toyokuni, Shinya/0000-0002-5757-1109; Takahashi, Takashi/0000-0003-0615-7001; Nagai, Hirotaka/0000-0003-0983-8670; OKAZAKI, Yasumasa/0000-0003-1054-9403; Toyokuni, Shinya/0000-0002-5757-1109; Sekido, Yoshitaka/0000-0002-2428-3848	Princess Takamatsu Cancer Research Fund [10-24213]; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23790456] Funding Source: KAKEN	Princess Takamatsu Cancer Research Fund; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Princess Takamatsu Cancer Research Fund (10-24213); a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan; and a Grant-in Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovic T, 2009, CANCER RES, V69, P5159, DOI 10.1158/0008-5472.CAN-08-4038; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Arai E, 2008, CLIN CANCER RES, V14, P5531, DOI 10.1158/1078-0432.CCR-08-0443; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Campbell JM, 2008, GENOME, V51, P1032, DOI 10.1139/G08-086; CHENG JQ, 1994, CANCER RES, V54, P5547; EBINA Y, 1986, J NATL CANCER I, V76, P107; Evangelou K, 2004, BIOTECH HISTOCHEM, V79, P5, DOI 10.1080/10520290310001659466; Femia AP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-194; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; GRUIS NA, 1995, NAT GENET, V10, P351, DOI 10.1038/ng0795-351; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; Halliwell B., 2007, FREE RADICALS BIOL M; Hellman A, 2002, CANCER CELL, V1, P89, DOI 10.1016/S1535-6108(02)00017-X; Herzog CR, 2006, BIOCHEM BIOPH RES CO, V341, P856, DOI 10.1016/j.bbrc.2006.01.043; Hino O, 2004, CURR MOL MED, V4, P807, DOI 10.2174/1566524043359692; Hiroyasu M, 2002, AM J PATHOL, V160, P419, DOI 10.1016/S0002-9440(10)64860-2; Hisada M, 1998, JNCI-J NATL CANCER I, V90, P606, DOI 10.1093/jnci/90.8.606; Hu Q, 2010, LAB INVEST, V90, P360, DOI 10.1038/labinvest.2009.140; Huang X, 2003, MUTAT RES-FUND MOL M, V533, P153, DOI 10.1016/j.mrfmmm.2003.08.023; Jean D, 2011, AM J PATHOL, V178, P881, DOI 10.1016/j.ajpath.2010.10.039; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Klijn C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1143; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; LI JL, 1987, CANCER RES, V47, P1867; LIU YP, 2007, J JISHOU UNIV, V28, P1; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; MacConaill LE, 2011, CANCER DISCOV, V1, P297, DOI 10.1158/2159-8290.CD-11-0110; Martinez C, 2010, CELL CYCLE, V9, P2275, DOI 10.4161/cc.9.12.11865; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Nagai H, 2011, P NATL ACAD SCI US; Nagai H, 2011, CANCER SCI, V102, P2118, DOI 10.1111/j.1349-7006.2011.02087.x; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nishiyama Y, 1995, JPN J CANCER RES, V86, P1150, DOI 10.1111/j.1349-7006.1995.tb03308.x; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pfeifer GP, 2011, CURR OPIN ONCOL, V23, P62, DOI 10.1097/CCO.0b013e3283414d00; Reuschenbach M, 2008, INT J CANCER, V123, P2626, DOI 10.1002/ijc.23837; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Sasaki K, 2011, MOL MED REP, V4, P913, DOI 10.3892/mmr.2011.518; Takabatake T, 2006, RADIAT RES, V166, P61, DOI 10.1667/RR3575.1; Tanaka T, 2004, ONCOGENE, V23, P3980, DOI 10.1038/sj.onc.1207555; Tanaka T, 1999, ONCOGENE, V18, P3793, DOI 10.1038/sj.onc.1202707; Torres EM, 2010, COLD SH Q B, V75, P445, DOI 10.1101/sqb.2010.75.025; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; TOYOKUNI S, 1990, CANCER RES, V50, P5574; Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x; TOYOKUNI S, 1994, INT J CANCER, V57, P123, DOI 10.1002/ijc.2910570122; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; Toyokuni S, 1997, LAB INVEST, V76, P365; TOYOKUNI S, 1992, J INORG BIOCHEM, V47, P241, DOI 10.1016/0162-0134(92)84069-Y; TOYOKUNI S, 1994, P NATL ACAD SCI USA, V91, P2616, DOI 10.1073/pnas.91.7.2616; Toyokuni S, 1997, FREE RADICAL BIO MED, V22, P1019, DOI 10.1016/S0891-5849(96)00489-3; Toyokuni S, 2006, J CLIN BIOCHEM NUTR, V39, P3, DOI 10.3164/jcbn.39.3; Toyokuni S, 2009, NAGOYA J MED SCI, V71, P1; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Weinberg RA, 2007, BIOL CANC; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; WULLICH B, 1994, ANTICANCER RES, V14, P577; XIAO S, 1995, ONCOGENE, V11, P511; Yeung RS, 2004, CURR MOL MED, V4, P799, DOI 10.2174/1566524043359791; Zhang DX, 1997, CANCER RES, V57, P2410	68	74	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43403	10.1371/journal.pone.0043403	http://dx.doi.org/10.1371/journal.pone.0043403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952676	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206000033
J	Ren, F; Guo, QQ; Chang, LL; Chen, L; Zhao, CZ; Zhong, H; Li, XB				Ren, Feng; Guo, Qian-Qian; Chang, Li-Li; Chen, Liang; Zhao, Cai-Zhi; Zhong, Hui; Li, Xue-Bao			Brassica napus PHR1 Gene Encoding a MYB-Like Protein Functions in Response to Phosphate Starvation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; MOLECULAR CHARACTERIZATION; ROOT-SYSTEM; PLANTS; PHOSPHORUS; ACQUISITION; EXPRESSION; AVAILABILITY; MICRORNA	Phosphorus (P) is one of the essential nutrient elements for plant development. In this work, BnPHR1 encoding a MYB transcription activator was isolated from Brassica napus. The characterization of nuclear localization and transcription activation ability suggest BnPHR1 is a transcriptional activator. The tissue expression and histochemical assay showed that BnPHR1 was predominantly expressed in roots and modulated by exogenous Pi in transcriptional level in roots under Pi deficiency conditions. Furthermore, overexpression of BnPHR1 in both Arabidopsis and B. napus remarkably enhanced the expression of the Pi-starvation-induced genes including ATPT2 and BnPT2 encoding the high-affinity Pi transporter. Additionally, BnPHR1 can in vivo bind the promoter sequence of ATPT2 and BnPT2 in both Arabidopsis and B. napus. Possibly, due to the activation of ATPT2 and BnPT2, or even more high-affinity Pi transporters, the excessive Pi was accumulated in transgenic plants, resulting in the crucially Pi toxicity to cells and subsequently retarding plant growth. Given the data together, BnPHR1, as crucial regulator, is regulated by exogenous Pi and directly activates those genes, which promote the uptake and homeostasis of Pi for plant growth.	[Ren, Feng; Guo, Qian-Qian; Chang, Li-Li; Chen, Liang; Zhao, Cai-Zhi; Zhong, Hui; Li, Xue-Bao] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China	Central China Normal University	Ren, F (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	xbli@mail.ccnu.edu.cn			Chenguang Project of Wuhan Municipality [200950431185]	Chenguang Project of Wuhan Municipality	This work was supported by the Chenguang Project of Wuhan Municipality (Grant No. 200950431185). The funders had no role in study design, data colection and analysis, decision to publish, or preparation of manuscript.	Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; BARIOLA PA, 1994, PLANT J, V6, P673, DOI 10.1046/j.1365-313X.1994.6050673.x; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Chen YF, 2009, PLANT CELL, V21, P3554, DOI 10.1105/tpc.108.064980; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colby T, 2006, PLANT PHYSIOL, V142, P318, DOI 10.1104/pp.106.085415; del Pozo JC, 1999, PLANT J, V19, P579, DOI 10.1046/j.1365-313X.1999.00562.x; Devaiah BN, 2007, PLANT PHYSIOL, V143, P1789, DOI 10.1104/pp.106.093971; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Dodds PN, 1996, PLANT MOL BIOL, V31, P227, DOI 10.1007/BF00021786; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Fischer K, 1997, PLANT CELL, V9, P453, DOI 10.1105/tpc.9.3.453; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Hammond JP, 2003, PLANT PHYSIOL, V132, P578, DOI 10.1104/pp.103.020941; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Nilsson L, 2007, PLANT CELL ENVIRON, V30, P1499, DOI 10.1111/j.1365-3040.2007.01734.x; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Ren F, 2011, PLANT GROWTH REGUL, V65, P65, DOI 10.1007/s10725-011-9575-0; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Valdes-Lopez O, 2008, PLANT CELL ENVIRON, V31, P1834, DOI 10.1111/j.1365-3040.2008.01883.x; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; Weigel D., 2001, ARABIDOPSIS LAB MANU; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Yang XJ, 2010, ANN BOT-LONDON, V105, P513, DOI 10.1093/aob/mcq015; Yi KK, 2005, PLANT PHYSIOL, V138, P2087, DOI 10.1104/pp.105.063115; Zhang ZT, 2010, J EXP BOT, V61, P3331, DOI 10.1093/jxb/erq155; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443	40	61	73	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44005	10.1371/journal.pone.0044005	http://dx.doi.org/10.1371/journal.pone.0044005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952851	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206000068
J	Hudson, C; Howe, PDL; Little, DR				Hudson, Charlotte; Howe, Piers D. L.; Little, Daniel R.			Hemifield Effects in Multiple Identity Tracking	PLOS ONE			English	Article							SHORT-TERM-MEMORY; OBJECT TRACKING; ATTENTIONAL TRACKING; BINDING; RESOURCES; TARGETS; SPEED	In everyday life, we often need to attentively track moving objects. A previous study has claimed that this tracking occurs independently in the left and right visual hemifields (Alvarez & Cavanagh, 2005, Psychological Science, 16, 637-647). Specifically, it was shown that observers were much more accurate at tracking objects that were spread over both visual hemifields as opposed to when all were confined to a single visual hemifield. In that study, observers were not required to remember the identities of the objects. Conversely, in real life, there is seldom any benefit to tracking an object unless you can also recall its identity. It has been predicted that when observers are required to remember the identities of the tracked objects a bilateral advantage should no longer be observed (Oksama & Hyona, 2008, Cognitive Psychology, 56, 237-283). We tested this prediction and found that a bilateral advantage still occurred, though it was not as strong as when observers were not required to remember the identities of the targets. Even in the later case we found that tracking was not completely independent in the two visual hemifields. We present a combined model of multiple object tracking and multiple identity tracking that can explain our data.	[Hudson, Charlotte; Howe, Piers D. L.; Little, Daniel R.] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia	University of Melbourne	Hudson, C (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia.	pdhowe@unimelb.edu.au	Little, Daniel/J-5034-2019	Little, Daniel/0000-0003-3607-5525; Howe, Piers/0000-0001-6171-1381				Allen R, 2004, APPL COGNITIVE PSYCH, V18, P337, DOI 10.1002/acp.975; Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; Alvarez GA, 2007, J VISION, V7, DOI 10.1167/7.13.14; Barker K, 2010, EXP PSYCHOL, V57, P208, DOI 10.1027/1618-3169/a000026; Battelli L, 2009, J COGNITIVE NEUROSCI, V21, P1946, DOI 10.1162/jocn.2008.21149; Bettencourt KC, 2009, J VISION, V9, DOI 10.1167/9.7.9; Botterill K, 2011, EXP PSYCHOL, V58, P196, DOI 10.1027/1618-3169/a000085; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Cohen MA, 2011, ATTEN PERCEPT PSYCHO, V73, P1422, DOI 10.3758/s13414-011-0089-7; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Delvenne JF, 2005, COGNITION, V96, pB79, DOI 10.1016/j.cognition.2004.12.007; Franconeri SL, 2008, PSYCHON B REV, V15, P802, DOI 10.3758/PBR.15.4.802; Franconeri SL, 2010, PSYCHOL SCI, V21, P920, DOI 10.1177/0956797610373935; Holcombe AO, 2012, COGNITION, V123, P218, DOI 10.1016/j.cognition.2011.10.003; Horowitz TS, 2007, PERCEPT PSYCHOPHYS, V69, P172, DOI 10.3758/BF03193740; Howe P, 2009, ENCY CONSCIOUSNESS, P61; HUBEL DH, 1979, SCI AM, V241, P150, DOI 10.1038/scientificamerican0979-150; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; King-Smith PE, 1993, VISION RES, V34, P885; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pinto Y, 2010, J VISION, V10, DOI 10.1167/10.10.4; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Pylyshyn ZW, 2004, VIS COGN, V11, P801, DOI 10.1080/13506280344000518; Scholl BJ, 2001, COGNITION, V80, P159, DOI 10.1016/S0010-0277(00)00157-8; Scholl BJ, 2009, COMPUTATION, COGNITION, AND PYLYSHYN, P49; Shim WM, 2008, PSYCHON B REV, V15, P390, DOI 10.3758/PBR.15.2.390; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	37	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43796	10.1371/journal.pone.0043796	http://dx.doi.org/10.1371/journal.pone.0043796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952767	Green Published, gold			2022-12-27	WOS:000308213600043
J	Baca-Lopez, K; Mayorga, M; Hidalgo-Miranda, A; Gutierrez-Najera, N; Hernandez-Lemus, E				Baca-Lopez, Karol; Mayorga, Miguel; Hidalgo-Miranda, Alfredo; Gutierrez-Najera, Nora; Hernandez-Lemus, Enrique			The Role of Master Regulators in the Metabolic/Transcriptional Coupling in Breast Carcinomas	PLOS ONE			English	Article							HISTOLOGIC GRADE; CANCER PATIENTS; GENE; EXPRESSION; TRANSCRIPTION; SIGNATURE; DNA; IDENTIFICATION; HYBRIDIZATION; PREVENTION	Metabolic transformations have been reported as involved in neoplasms survival. This suggests a role of metabolic pathways as potential cancer pharmacological targets. Modulating tumor's energy production pathways may become a substantial research area for cancer treatment. The significant role of metabolic deregulation as inducing transcriptional instabilities and consequently whole-system failure, is thus of foremost importance. By using a data integration approach that combines experimental evidence for high-throughput genome wide gene expression, a non-equilibrium thermodynamics analysis, nonlinear correlation networks as well as database mining, we were able to outline the role that transcription factors MEF2C and MNDA may have as main master regulators in primary breast cancer phenomenology, as well as the possible interrelationship between malignancy and metabolic dysfunction. The present findings are supported by the analysis of 1191 whole genome gene expression experiments, as well as probabilistic inference of gene regulatory networks, and non-equilibrium thermodynamics of such data. Other evidence sources include pathway enrichment and gene set enrichment analyses, as well as motif comparison with a comprehensive gene regulatory network (of homologue genes) in Arabidopsis thaliana. Our key finding is that the non-equilibrium free energies provide a realistic description of transcription factor activation that when supplemented with gene regulatory networks made us able to find deregulated pathways. These analyses also suggest a novel potential role of transcription factor energetics at the onset of primary tumor development. Results are important in the molecular systems biology of cancer field, since deregulation and coupling mechanisms between metabolic activity and transcriptional regulation can be better understood by taking into account the way that master regulators respond to physicochemical constraints imposed by different phenotypic conditions.	[Baca-Lopez, Karol; Hernandez-Lemus, Enrique] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Baca-Lopez, Karol; Mayorga, Miguel] Autonomous Univ State Mexico, Sch Sci, Toluca, Mexico; [Hidalgo-Miranda, Alfredo] Natl Inst Genom Med, Canc Genom Lab, Mexico City, DF, Mexico; [Gutierrez-Najera, Nora] Natl Inst Genom Med, Prote Core Facil, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City 04510, DF, Mexico	Instituto Nacional de Medicina Genomica; Universidad Autonoma del Estado de Mexico; Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico	Baca-Lopez, K (corresponding author), Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico.	ehernandez@inmegen.gob.mx	Mayorga, Miguel/B-3458-2016; Hidalgo-Miranda, Alfredo/B-2123-2010	Mayorga, Miguel/0000-0001-7527-5197; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Hernandez-Lemus, Enrique/0000-0002-1872-1397	El Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF) [PIUTE10-92, 281-2010]; National Institute of Genomic Medicine (Mexico)	El Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF); National Institute of Genomic Medicine (Mexico)	The authors gratefully acknowledge support by grant: PIUTE10-92 El Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF) [Contract 281-2010], as well as federal funding from the National Institute of Genomic Medicine (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; [Anonymous], REV ONCOLOGIA; Baca-Lopez K, 2009, REV MEX FIS, V55, P456; Beger M, 2001, J MOL MED, V79, P314, DOI 10.1007/s001090100211; Bhardwaj V, 2010, ANTICANCER RES, V30, P743; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BURRUS GR, 1992, J CELL BIOCHEM, V48, P190, DOI 10.1002/jcb.240480210; Carlon E, 2006, PHYSICA A, V362, P433, DOI 10.1016/j.physa.2005.09.067; Chavez Montes RA, ARA BIDOPSIS THALIAN; CHEN M, 1993, J MATH PHYS, V34, P3012, DOI 10.1063/1.530060; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Dennison JB, 2009, BRIT J HAEMATOL, V147, P297, DOI 10.1111/j.1365-2141.2009.07850.x; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Duan H, 2008, ONCOGENE, V27, P6720, DOI 10.1038/onc.2008.286; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Galant NJ, 2009, J PHYS CHEM A, V113, P9138, DOI 10.1021/jp809116n; Geschwind Jean-Francois, 2004, Expert Rev Anticancer Ther, V4, P449, DOI 10.1586/14737140.4.3.449; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Lemus EH, 2009, J NON-EQUIL THERMODY, V34, P371, DOI 10.1515/JNETDY.2009.019; Hernandez-Lemus E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021558; Hernandez-Lemus E, 2009, PHYSICA A, V388, P5057, DOI 10.1016/j.physa.2009.08.013; HERNANDEZLEMUS E, 2010, NEW TRENDS STAT PHYS; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; JOU D, 1985, PHYS REV A, V31, P2502, DOI 10.1103/PhysRevA.31.2502; Knight LA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-38; Komorowski M, 2010, BIOPHYS J, V98, P2759, DOI 10.1016/j.bpj.2010.03.032; Kong YCM, 2010, ANN NY ACAD SCI, V1183, P222, DOI 10.1111/j.1749-6632.2009.05138.x; Lee AW, 2011, MOL IMMUNOL, V48, P1160, DOI 10.1016/j.molimm.2011.02.010; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Matsuura I, 2010, BIOCHEM J, V426, P327, DOI 10.1042/BJ20090990; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Merry C, 2010, CELL CYCLE, V9, P279, DOI 10.4161/cc.9.2.10445; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Ni IBP, 2010, PATHOL RES PRACT, V206, P223, DOI 10.1016/j.prp.2009.11.006; Norris AJ, 2003, MOL ENDOCRINOL, V17, P193, DOI 10.1210/me.2002-0201; Ostrander JH, 2007, CANC RES, V67, P9; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Peasland A, 2011, BRIT J CANCER, V105, P372, DOI 10.1038/bjc.2011.243; Pedram A, 2009, MOL BIOL CELL, V20, P3374, DOI 10.1091/mbc.E09-01-0085; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Pittman AM, 2008, HUM MOL GENET, V17, P3720, DOI 10.1093/hmg/ddn267; Reguera D, 2005, J PHYS CHEM B, V109, P21502, DOI 10.1021/jp052904i; Ressler S, 2011, EXPERT REV ANTICANC, V11, P333, DOI [10.1586/era.11.13, 10.1586/ERA.11.13]; Roy D, 2001, MOL CARCINOG, V31, P4; Salim NS, 2009, METHODS, V47; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Schuetz CS, 2006, CANC RES, V66, P10; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shen Q, 2003, J MAMMARY GLAND BIOL, V8, P45, DOI 10.1023/A:1025783221557; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan EY, 2007, CLIN CANCER RES, V13, P467, DOI 10.1158/1078-0432.CCR-06-1466; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tonon G, 2008, FUTURE ONCOL, V4, P569, DOI 10.2217/14796694.4.4.569; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang K, 2010, CANCER GENET CYTOGEN, V200, P40, DOI 10.1016/j.cancergencyto.2010.03.006; WHITE MRH, 1995, J CELL SCI, V108, P441; Xie J, 1998, J CELL BIOCHEM, V70; Yilmaz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022986; Yu J, 2006, AIDS RES HUM RETRO S, V311; Zhao C, 2008, ONCOGENE, V27, P63, DOI 10.1038/sj.onc.1210637	71	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42678	10.1371/journal.pone.0042678	http://dx.doi.org/10.1371/journal.pone.0042678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952604	gold, Green Submitted, Green Published			2022-12-27	WOS:000308044800009
J	Cao, L; Zhang, YP; Cao, YX; Edvinsson, L; Xu, CB				Cao, Lei; Zhang, Yaping; Cao, Yong-Xiao; Edvinsson, Lars; Xu, Cang-Bao			Secondhand Smoke Exposure Causes Bronchial Hyperreactivity via Transcriptionally Upregulated Endothelin and 5-hydroxytryptamine 2A Receptors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PROTEIN-KINASE PATHWAYS; AIRWAY HYPERRESPONSIVENESS; CIGARETTE-SMOKE; PASSIVE SMOKING; IN-VITRO; CELL-PROLIFERATION; INHIBITOR GW5074; TOBACCO-SMOKE; MESSENGER-RNA	Background: Cigarette smoke exposure is strongly associated with airway hyperreactivity (AHR) which is the main characteristic seen in asthma. The intracellular MAPK signaling pathways are suggested to be associated with the airway damage to the AHR. In the present study, we hypothesize that secondhand cigarette smoke (SHS) exposure upregulates the bronchial contractile receptors via activation of the Raf/ERK/MAPK pathway. Methodology/Principal Findings: Rats were exposed to SHS for 3 h daily for up to 8 weeks. The receptor agonists-induced bronchial contractile reactivity was analyzed with a sensitive myograph system. The mRNA transcription and protein translation of the target receptors and the kinases in Raf/ERK/MAPK pathway were investigated by real-time PCR, Western blotting and immunofluorescence, respectively. Compared with exposure to fresh air, SHS induced enhanced bronchial contractile responses mediated by the 5-hydroxytryptamine 2A (5-HT2A) receptors as well as the endothelin type B (ETB) and type A (ETA) receptors. The response curves were shifted toward the left with an increased maximal contraction (E-max) demonstrating that SHS induced AHR. Additionally, the mRNA and protein levels of the 5-HT2A, ETB and ETA receptors were increased. Furthermore, SHS exposure increased the phosphorylation of Raf-1 and ERK1/2, but it did not alter p38 or JNK. A Raf-1 inhibitor (GW5074) suppressed the SHS-induced increase in the expression of 5-HT2A and ETA receptors and the receptor-mediated AHR. Conclusions/Significance: Our findings show that SHS exposure induces transcriptional upregulation of the 5-HT2A, ETB and ETA receptors in rat bronchial smooth muscle cells, which mediates AHR. The Raf/ERK/MAPK pathway is involved in SHS-associated receptor upregulation and AHR.	[Cao, Lei; Zhang, Yaping; Edvinsson, Lars; Xu, Cang-Bao] Lund Univ, Inst Clin Sci Lund, Div Expt Vasc Res, Lund, Sweden; [Cao, Yong-Xiao] Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian 710049, Shaanxi, Peoples R China	Lund University; Xi'an Jiaotong University	Cao, L (corresponding author), Lund Univ, Inst Clin Sci Lund, Div Expt Vasc Res, Lund, Sweden.	Cang-Bao.Xu@med.lu.se		Zhang, Yaping/0000-0002-9264-3120; Edvinsson, Lars/0000-0002-1805-1346; Xu, Cang-Bao/0000-0003-3421-3306	Swedish Research Council [5958]; Swedish Heart-Lung Foundation [20070273]; Flight Attendant Medical Research Institute (FAMRI, USA); National Natural Science Foundation of China [30772566]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Flight Attendant Medical Research Institute (FAMRI, USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Swedish Research Council (Grant 5958, http://www.vr.se); the Swedish Heart-Lung Foundation (Grant 20070273, www.hjart-lungfonden.se); the Flight Attendant Medical Research Institute (FAMRI, USA, www.famri.org); and the National Natural Science Foundation of China (Grant 30772566, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adner M, 1996, BRIT J PHARMACOL, V119, P1159, DOI 10.1111/j.1476-5381.1996.tb16018.x; Bergren Dale R., 2009, Inflammation & Allergy Drug Targets, V8, P340; Bryborn M, 2004, CLIN EXP ALLERGY, V34, P1291, DOI 10.1111/j.1365-2222.2004.02031.x; Cai Y, 2011, INT IMMUNOL, V23, P443, DOI 10.1093/intimm/dxr032; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033008; Cao L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-109; CARTIER A, 1982, J ALLERGY CLIN IMMUN, V70, P170, DOI 10.1016/0091-6749(82)90038-0; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Chiba Y, 2005, AM J RESP CELL MOL, V33, P574, DOI 10.1165/rcmb.2005-0177OC; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Daher N, 2010, ATMOS ENVIRON, V44, P8, DOI 10.1016/j.atmosenv.2009.10.004; De Bie JJ, 1998, BRIT J PHARMACOL, V124, P857, DOI 10.1038/sj.bjp.0701901; ERIKSEN MP, 1988, ANNU REV PUBL HEALTH, V9, P47, DOI 10.1146/annurev.pu.09.050188.000403; Esamai FO, 1998, E AFR MED J, V75, P47; GERRARD JW, 1980, AM REV RESPIR DIS, V122, P577; Granstrom Bengt W, 2006, BMC Pulm Med, V6, P6, DOI 10.1186/1471-2466-6-6; Granstrom BW, 2004, BASIC CLIN PHARMACOL, V95, P43, DOI 10.1111/j.1742-7843.2004.pto950109.x; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hirota S, 2005, CAN J PHYSIOL PHARM, V83, P725, DOI 10.1139/Y05-070; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Jang AS, 2004, J KOREAN MED SCI, V19, P214, DOI 10.3346/jkms.2004.19.2.214; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lei Y, 2011, EUR J PHARMACOL, V650, P629, DOI 10.1016/j.ejphar.2010.10.038; Lei Y, 2010, EUR J PHARMACOL, V634, P149, DOI 10.1016/j.ejphar.2010.02.020; Lei Y, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-71; MARTINEZ FD, 1988, AM REV RESPIR DIS, V138, P518, DOI 10.1164/ajrccm/138.3.518; Moller S, 1999, EUR J PHARMACOL, V365, pR1, DOI 10.1016/S0014-2999(98)00864-4; MURRAY AB, 1986, J ALLERGY CLIN IMMUN, V77, P575, DOI 10.1016/0091-6749(86)90348-9; OCONNOR GT, 1987, AM REV RESPIR DIS, V135, P800, DOI 10.1164/arrd.1987.135.4.800; Patel BD, 2004, THORAX, V59, P682, DOI 10.1136/thx.2003.010215; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Postma DS, 1998, AM J RESP CRIT CARE, V158, pS187, DOI 10.1164/ajrccm.158.supplement_2.13tac170; Rennard SI, 1996, J ALLERGY CLIN IMMUN, V98, pS278, DOI 10.1016/S0091-6749(96)70076-3; Schuh K, 2009, BIOCHEM PHARMACOL, V77, P1827, DOI 10.1016/j.bcp.2009.03.012; SEKHON HS, 1994, AM J PHYSIOL-LUNG C, V267, pL557, DOI 10.1152/ajplung.1994.267.5.L557; Tani Eiichi, 2004, Current Vascular Pharmacology, V2, P13, DOI 10.2174/1570161043476492; Xu CB, 2010, BASIC CLIN PHARMACOL, V107, P940, DOI 10.1111/j.1742-7843.2010.00610.x; Zhang Y, 2004, CLIN EXP ALLERGY, V34, P1480, DOI 10.1111/j.1365-2222.2004.02040.x; Zhang YP, 2010, THESCIENTIFICWORLDJO, V10, P2157, DOI 10.1100/tsw.2010.204; Zhang YP, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-29	43	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44170	10.1371/journal.pone.0044170	http://dx.doi.org/10.1371/journal.pone.0044170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952915	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800100
J	Inami, K; Yoshioka-Akiyama, C; Morita, Y; Yamasaki, M; Teraoka, T; Arie, T				Inami, Keigo; Yoshioka-Akiyama, Chizu; Morita, Yasuaki; Yamasaki, Mutsuko; Teraoka, Tohru; Arie, Tsutomu			A Genetic Mechanism for Emergence of Races in Fusarium oxysporum f. sp lycopersici: Inactivation of Avirulence Gene AVR1 by Transposon Insertion	PLOS ONE			English	Article							I-3-MEDIATED RESISTANCE; GENOME SEQUENCE; PROTEIN; PATHOGENICITY; PLANTS; LOCUS	Compatible/incompatible interactions between the tomato wilt fungus Fusarium oxysporum f. sp. lycopersici (FOL) and tomato Solanum lycopersicum are controlled by three avirulence genes (AVR1-3) in FOL and the corresponding resistance genes (I-I3) in tomato. The three known races (1, 2 and 3) of FOL carry AVR genes in different combinations. The current model to explain the proposed order of mutations in AVR genes is: i) FOL race 2 emerged from race 1 by losing the AVR1 and thus avoiding host resistance mediated by I (the resistance gene corresponding to AVR1), and ii) race 3 emerged when race 2 sustained a point mutation in AVR2, allowing it to evade I2-mediated resistance of the host. Here, an alternative mechanism of mutation of AVR genes was determined by analyses of a race 3 isolate, KoChi-1, that we recovered from a Japanese tomato field in 2008. Although KoChi-1 is race 3, it has an AVR1 gene that is truncated by the transposon Hormin, which belongs to the hAT family. This provides evidence that mobile genetic elements may be one of the driving forces underlying race evolution. KoChi-1 transformants carrying a wild type AVR1 gene from race 1 lost pathogenicity to cultivars carrying I, showing that the truncated KoChi-1 avr1 is not functional. These results imply that KoChi-1 is a new race 3 biotype and propose an additional path for emergence of FOL races: Race 2 emerged from race 1 by transposon-insertion into AVR1, not by deletion of the AVR1 locus; then a point mutation in race 2 AVR2 resulted in emergence of race 3.	[Inami, Keigo; Yoshioka-Akiyama, Chizu; Yamasaki, Mutsuko; Teraoka, Tohru; Arie, Tsutomu] TUAT, Grad Sch Agr, Fuchu, Tokyo, Japan; [Morita, Yasuaki; Yamasaki, Mutsuko] Kochi Agr Res Ctr, Nankoku, Japan	Tokyo University of Agriculture & Technology	Inami, K (corresponding author), TUAT, Grad Sch Agr, Fuchu, Tokyo, Japan.	arie@cc.tuat.ac.jp	Teraoka, Tohru/D-1566-2013; ARIE, Tsutomu/C-2831-2013	Teraoka, Tohru/0000-0002-2037-2456; ARIE, Tsutomu/0000-0002-4604-6608	Japan Society for the Promotion of Science [18380030, 22405018, 22-8126]; Ministry of Agricuture, Forestry and Fisheries Research Council of Japan [H23-25 B5 102]; Grants-in-Aid for Scientific Research [22405018] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agricuture, Forestry and Fisheries Research Council of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was financially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to TA (18380030 and 22405018) and to KI (22-8126)(http://www.jsps.go.jp/j-grantsinaid/index.html). This work was supported in part by a grant from the Ministry of Agricuture, Forestry and Fisheries Research Council of Japan (H23-25 B5 102) (http://www.s.affrc.go.jp/docs/project/2011/pdf/2011_kekka_07.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios GN, 2005, PLANT PATHOLOGY; Aime S, 2008, PHYSIOL MOL PLANT P, V73, P9, DOI 10.1016/j.pmpp.2008.10.001; Arie T, 2000, MOL PLANT MICROBE IN, V13, P1330, DOI 10.1094/MPMI.2000.13.12.1330; Arie T, 2010, J GEN PLANT PATHOL, V76, P403, DOI 10.1007/s10327-010-0264-z; ARMSTRONG GM, 1981, FUSARIUM DIS BIOL TA, P391; Barve MP, 2003, FUNGAL GENET BIOL, V39, P151, DOI 10.1016/S1087-1845(03)00015-X; Cai G, 2003, PHYTOPATHOLOGY, V93, P1014, DOI 10.1094/PHYTO.2003.93.8.1014; Chuma I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002147; Escobosa ARC, 2011, FUNGAL GENET BIOL, V48, P886, DOI 10.1016/j.fgb.2011.06.004; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1640, DOI 10.1094/Phyto-77-1640; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Fudal I, 2005, FUNGAL GENET BIOL, V42, P761, DOI 10.1016/j.fgb.2005.05.001; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Houterman PM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000061; Hua-Van A, 2000, CURR GENET, V37, P339, DOI 10.1007/s002940050537; Huang CC, 1997, EUPHYTICA, V93, P145, DOI 10.1023/A:1002943805229; Inami K, 2010, J GEN PLANT PATHOL, V76, P116, DOI 10.1007/s10327-010-0224-7; Kang S, 2001, MOL PLANT MICROBE IN, V14, P671, DOI 10.1094/MPMI.2001.14.5.671; Kawabe Masato, 2005, Journal of General Plant Pathology, V71, P263, DOI 10.1007/s10327-005-0203-6; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kistler HC, 1997, PHYTOPATHOLOGY, V87, P474, DOI 10.1094/PHYTO.1997.87.4.474; Komada H., 2011, FUSARIUM; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie J. F., 2006, FUSARIUM LAB MANUAL, P212; Li W, 2009, MOL PLANT MICROBE IN, V22, P411, DOI 10.1094/MPMI-22-4-0411; Lievens B, 2009, FEMS MICROBIOL LETT, V300, P201, DOI 10.1111/j.1574-6968.2009.01783.x; Luderer R, 2002, MOL MICROBIOL, V45, P875, DOI 10.1046/j.1365-2958.2002.03060.x; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Maor R, 2005, CURR OPIN MICROBIOL, V8, P399, DOI 10.1016/j.mib.2005.06.008; Masunaga T., 1998, ANN PHYTOPATHOL SOC, V64, P435; Mes JJ, 1999, PHYTOPATHOLOGY, V89, P1131, DOI 10.1094/PHYTO.1999.89.12.1131; Michielse CB, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000637; O'Donnell K, 2009, FUNGAL GENET BIOL, V46, P936, DOI 10.1016/j.fgb.2009.08.006; Parlange F, 2009, MOL MICROBIOL, V71, P851, DOI 10.1111/j.1365-2958.2008.06547.x; Rep M, 2005, MOL PLANT MICROBE IN, V18, P15, DOI 10.1094/MPMI-18-0015; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Sacristan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007463; Saitoh Ken-ichiro, 2006, Journal of General Plant Pathology, V72, P348, DOI 10.1007/s10327-006-0300-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoffelmeer EAM, 2001, MOL GENET GENOMICS, V265, P143, DOI 10.1007/s004380000402; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Does HC, 2008, FUNGAL GENET BIOL, V45, P1257, DOI 10.1016/j.fgb.2008.06.002; van der Does HC, 2008, ENVIRON MICROBIOL, V10, P1475, DOI 10.1111/j.1462-2920.2007.01561.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zhou EX, 2007, FUNGAL GENET BIOL, V44, P1024, DOI 10.1016/j.fgb.2007.02.003	49	36	40	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44101	10.1371/journal.pone.0044101	http://dx.doi.org/10.1371/journal.pone.0044101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952887	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800095
J	Kitchen, JL; Allaby, RG				Kitchen, James L.; Allaby, Robin G.			The Limits of Mean-Field Heterozygosity Estimates under Spatial Extension in Simulated Plant Populations	PLOS ONE			English	Article							PREDATOR-PREY DYNAMICS; GENETIC DIVERSITY; DOMESTICATION; SPECIATION; EVOLUTION; SELECTION; DISTANCE; MODELS; DENSITY; MARKERS	Computational models of evolutionary processes are increasingly required to incorporate multiple and diverse sources of data. A popular feature to include in population genetics models is spatial extension, which reflects more accurately natural populations than does a mean field approach. However, such models necessarily violate the mean field assumptions of classical population genetics, as do natural populations in the real world. Recently, it has been questioned whether classical approaches are truly applicable to the real world. Individual based models (IBM) are a powerful and versatile approach to achieve integration in models. In this study an IBM was used to examine how populations of plants deviate from classical expectations under spatial extension. Populations of plants that used three different mating strategies were placed in a range of arena sizes giving crowded to sparse occupation densities. Using a measure of population density, the pollen communication distance (P-cd), the deviation exhibited by outbreeding populations differed from classical mean field expectations by less than 5% when P-cd was less than 1, and over this threshold value the deviation significantly increased. Populations with an intermediate mating strategy did not have such a threshold and deviated directly with increasing isolation between individuals. Populations with a selfing strategy were influenced more by the mating strategy than by increased isolation. In all cases pollen dispersal was more influential than seed dispersal. The IBM model showed that mean field calculations can be reasonably applied to natural outbreeding plant populations that occur at a density in which individuals are less than the average pollen dispersal distance from their neighbors.	[Kitchen, James L.; Allaby, Robin G.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Kitchen, JL (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	r.g.allaby@warwick.ac.uk			Leverhulme Trust [F/00 215/BC]	Leverhulme Trust(Leverhulme Trust)	This work is supported by the Leverhulme Trust F/00 215/BC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby R, 2010, J EXP BOT, V61, P935, DOI 10.1093/jxb/erp382; Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; Allaby RG, 2010, VEG HIST ARCHAEOBOT, V19, P151, DOI 10.1007/s00334-009-0232-8; Allphin L, 1998, AM J BOT, V85, P1251, DOI 10.2307/2446635; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett MD, 2012, AM J BOT, V99, pE14, DOI 10.3732/ajb.1100357; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Cuddington KM, 2000, THEOR POPUL BIOL, V58, P259, DOI 10.1006/tpbi.2000.1493; Dering M, 2012, SCAND J FOREST RES, V27, P2, DOI 10.1080/02827581.2011.631934; DEROOS AM, 1991, P ROY SOC B-BIOL SCI, V246, P117, DOI 10.1098/rspb.1991.0132; Doligez A, 1998, GENETICS, V148, P905; Douaihy B, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr003; Durrett R, 2000, HEREDITY, V84, P9, DOI 10.1046/j.1365-2540.2000.00566.x; Finkel R. A., 1974, Acta Informatica, V4, P1, DOI 10.1007/BF00288933; Garroway CJ, 2011, MOL ECOL, V20, P3978, DOI 10.1111/j.1365-294X.2011.05243.x; Gavrilets S, 1998, P ROY SOC B-BIOL SCI, V265, P1483, DOI 10.1098/rspb.1998.0461; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hartl DL, 1997, PRINCIPLES POPULATIO, P141; Hartman PJ, 2012, THEOR ECOL-NETH, V5, P219, DOI 10.1007/s12080-011-0117-1; Jones KN, 2001, AM J BOT, V88, P447, DOI 10.2307/2657109; KARRON JD, 1995, HEREDITY, V75, P175, DOI 10.1038/hdy.1995.121; King TL, 2011, CONSERV GENET RESOUR, V4, P39; Kuparinen A, 2007, ECOL MODEL, V202, P476, DOI 10.1016/j.ecolmodel.2006.11.015; Landguth EL, 2010, MOL ECOL RESOUR, V10, P156, DOI 10.1111/j.1755-0998.2009.02719.x; LEVIN DA, 1973, EVOLUTION, V27, P144, DOI [10.2307/2407128, 10.1111/j.1558-5646.1973.tb05926.x]; MAYR E, 1978, SYST ZOOL, V27, P83, DOI 10.2307/2412818; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; Millar MA, 2012, CONSERV GENET RESOUR, V4, P51, DOI 10.1007/s12686-011-9473-9; Muir K, 2007, SILVAE GENET, V56, P222, DOI 10.1515/sg-2007-0033; Olivier A, 1998, PLANT SYST EVOL, V209, P33, DOI 10.1007/BF00991522; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Pritchard JK, 2010, SCI AM, V303, P41, DOI 10.1038/scientificamerican1010-40; Rasic G, 2012, MOL ECOL, V21, P223, DOI 10.1111/j.1365-294X.2011.05280.x; Restoux G, 2008, WEB ECOL, V8, P94, DOI [DOI 10.5194/we-8-94-2008, 10.5194/WE--8--94-2008]; RICE WR, 1984, EVOLUTION, V38, P1251, DOI 10.1111/j.1558-5646.1984.tb05647.x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sadedin S, 2009, MOL ECOL, V18, P4006, DOI 10.1111/j.1365-294X.2009.04320.x; Savill NJ, 1998, P ROY SOC B-BIOL SCI, V265, P25, DOI 10.1098/rspb.1998.0259; SMITH WG, 1979, BIOCHEM SYST ECOL, V7, P121, DOI 10.1016/0305-1978(79)90019-X; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; TEMPLETON AR, 1980, GENETICS, V94, P1011; Weis AE, 2004, AM J BOT, V91, P825, DOI 10.3732/ajb.91.6.825; WILSON WG, 1993, THEOR POPUL BIOL, V43, P91, DOI 10.1006/tpbi.1993.1005; WILSON WG, 1995, B MATH BIOL, V57, P507, DOI 10.1016/S0092-8240(05)80754-2; Wohrmann T, 2011, GENET RESOUR CROP EV, V58, P1157, DOI 10.1007/s10722-010-9648-3; Wright S, 1943, GENETICS, V28, P114	49	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43254	10.1371/journal.pone.0043254	http://dx.doi.org/10.1371/journal.pone.0043254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952655	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800025
J	Yu, GJ; Wang, M; Huang, J; Yin, YL; Chen, YJ; Jiang, S; Jin, YX; Lan, XQ; Wong, BHC; Liang, Y; Sun, H				Yu, Guo-Jun; Wang, Man; Huang, Jie; Yin, Ya-Lin; Chen, Yi-Jie; Jiang, Shuai; Jin, Yan-Xia; Lan, Xian-Qing; Wong, Barry Hon Cheung; Liang, Yi; Sun, Hui			Deep Insight into the Ganoderma lucidum by Comprehensive Analysis of Its Transcriptome	PLOS ONE			English	Article							LING ZHI-8 LZ-8; MONOCYTIC LEUKEMIA-CELLS; WHITE-ROT FUNGI; MOLECULAR-CLONING; GENOME SEQUENCE; GENE-EXPRESSION; IMMUNOMODULATORY PROTEIN; SUBMERGED FERMENTATION; LENTINULA-EDODES; FR. KARST	Background: Ganoderma lucidum is a basidiomycete white rot fungus and is of medicinal importance in China, Japan and other countries in the Asiatic region. To date, much research has been performed in identifying the medicinal ingredients in Ganoderma lucidum. Despite its important therapeutic effects in disease, little is known about Ganoderma lucidum at the genomic level. In order to gain a molecular understanding of this fungus, we utilized Illumina high-throughput technology to sequence and analyze the transcriptome of Ganoderma lucidum. Methodology/Principal Findings: We obtained 6,439,690 and 6,416,670 high-quality reads from the mycelium and fruiting body of Ganoderma lucidum, and these were assembled to form 18,892 and 27,408 unigenes, respectively. A similarity search was performed against the NCBI non-redundant nucleotide database and a customized database composed of five fungal genomes. 11,098 and 8, 775 unigenes were matched to the NCBI non-redundant nucleotide database and our customized database, respectively. All unigenes were subjected to annotation by Gene Ontology, Eukaryotic Orthologous Group terms and Kyoto Encyclopedia of Genes and Genomes. Differentially expressed genes from the Ganoderma lucidum mycelium and fruiting body stage were analyzed, resulting in the identification of 13 unigenes which are involved in the terpenoid backbone biosynthesis pathway. Quantitative real-time PCR was used to confirm the expression levels of these unigenes. Ganoderma lucidum was also studied for wood degrading activity and a total of 22 putative FOLymes (fungal oxidative lignin enzymes) and 120 CAZymes (carbohydrate-active enzymes) were predicted from our Ganoderma lucidum transcriptome. Conclusions: Our study provides comprehensive gene expression information on Ganoderma lucidum at the transcriptional level, which will form the foundation for functional genomics studies in this fungus. The use of Illumina sequencing technology has made de novo transcriptome assembly and gene expression analysis possible in species that lack full genome information.	[Yu, Guo-Jun; Wang, Man; Huang, Jie; Yin, Ya-Lin; Chen, Yi-Jie; Jiang, Shuai; Jin, Yan-Xia; Lan, Xian-Qing; Wong, Barry Hon Cheung; Liang, Yi; Sun, Hui] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liang, Yi] Guangdong Med Coll, Dept Clin Immunol, Dongguan, Peoples R China; [Sun, Hui] Hubei Univ Technol, Minist Educ, Key Lab Fermentat Engn, Wuhan, Peoples R China; [Sun, Hui] Wuhan Univ, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discove, Wuhan 430072, Peoples R China	Wuhan University; Guangdong Medical University; Hubei University of Technology; Wuhan University	Yu, GJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	sunhui@whu.edu.cn	Jin, Yanxia/W-8478-2019	Huang, Jie/0000-0003-3842-6181	National Key Technologies RD Program [2009ZX09103-676]; Natural Science Foundation of China (NSFC) [30771501, 81102850]; Major State Basic Research Development Program of China, 973 Program [2011CB811302]; National Mega Project on Major Drug Development [2009ZX09301-014-1]; Chinese 111 project [B06018]; Wuhan municipal project [201160923296]	National Key Technologies RD Program(National Key Technology R&D Program); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China, 973 Program(National Basic Research Program of China); National Mega Project on Major Drug Development; Chinese 111 project(Ministry of Education, China - 111 Project); Wuhan municipal project	The present research project was funded by the National Key Technologies R&D Program [2009ZX09103-676] (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.htm), the Natural Science Foundation of China (NSFC) program [30771501, 81102850] (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), the Major State Basic Research Development Program of China, 973 Program [2011CB811302], National Mega Project on Major Drug Development [2009ZX09301-014-1], the Chinese 111 project [B06018] and Wuhan municipal project [No. 201160923296]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Nature, V467, P1026, DOI 10.1038/4671026a; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bao XF, 2000, ACTA BIOCH BIOPH SIN, V32, P557; Bao XF, 2001, CARBOHYD RES, V332, P67, DOI 10.1016/S0008-6215(01)00075-1; Bao XF, 2002, PHYTOCHEMISTRY, V59, P175, DOI 10.1016/S0031-9422(01)00450-2; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chan WK, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-9; Cheng KC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-411; Ding N, 2010, J PHARMACEUT BIOMED, V53, P1224, DOI 10.1016/j.jpba.2010.07.025; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; Dudhgaonkar S, 2009, INT IMMUNOPHARMACOL, V9, P1272, DOI 10.1016/j.intimp.2009.07.011; Ekker SC, 2007, ZEBRAFISH, V4, P239, DOI 10.1089/zeb.2007.9979; Fei X, 2006, J MICROBIOL, V44, P515; Gao YH, 2005, IMMUNOL INVEST, V34, P171, DOI 10.1081/IMM-200055813; Gao YH, 2002, LIFE SCI, V72, P731, DOI 10.1016/S0024-3205(02)02301-9; GARCIA S, 1987, APPL ENVIRON MICROB, V53, P2384, DOI 10.1128/AEM.53.10.2384-2387.1987; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guo L, 2009, INT IMMUNOPHARMACOL, V9, P1175, DOI 10.1016/j.intimp.2009.06.005; Hayashizaki Y, 2003, COLD SPRING HARB SYM, V68, P195, DOI 10.1101/sqb.2003.68.195; Huang L, 2009, PROTEINS, V75, P524, DOI 10.1002/prot.22346; Huie CW, 2002, ANAL BIOANAL CHEM, V373, P23, DOI 10.1007/s00216-002-1265-3; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jiang JH, 2008, INT J MOL MED, V21, P577; Joo SS, 2008, MOL CELLS, V25, P112; Kimura Y, 2002, ANTICANCER RES, V22, P3309; KINO K, 1991, INT J IMMUNOPHARMACO, V13, P1109; KINO K, 1990, DIABETOLOGIA, V33, P713, DOI 10.1007/BF00400340; KINO K, 1989, J BIOL CHEM, V264, P472; Ko EM, 2001, APPL MICROBIOL BIOT, V57, P98, DOI 10.1007/s002530100727; Ko HH, 2008, PHYTOCHEMISTRY, V69, P234, DOI 10.1016/j.phytochem.2007.06.008; Larsen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009780; Leonowicz A, 1999, FUNGAL GENET BIOL, V27, P175, DOI 10.1006/fgbi.1999.1150; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li SX, 2010, J MICROBIOL BIOTECHN, V20, P474, DOI 10.4014/jmb.0909.09014; Liang C, 2011, ONCOL REP; Liu J, 2010, PLANTA MED, V76, P137, DOI 10.1055/s-0029-1186035; Luo Hongmei, 2010, Chin Med, V5, P9, DOI 10.1186/1749-8546-5-9; Luo Jun, 2002, Yaoxue Xuebao, V37, P574; Lyashenko AV, 2011, ACTA CRYSTALLOGR F, V67, P926, DOI 10.1107/S1744309111021129; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Miyazaki Y, 2005, FUNGAL GENET BIOL, V42, P493, DOI 10.1016/j.fgb.2005.03.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Sakamoto Y, 2005, CURR GENET, V47, P244, DOI 10.1007/s00294-005-0563-7; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; Sato S, 2009, CURR GENET, V55, P273, DOI 10.1007/s00294-009-0243-0; Shang CH, 2008, BIOSCI BIOTECH BIOCH, V72, P1333, DOI 10.1271/bbb.80011; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; TANAKA S, 1989, J BIOL CHEM, V264, P16372; Tang YJ, 2010, BIOTECHNOL PROGR, V26, P417, DOI 10.1002/btpr.352; Tang YJ, 2009, BIORESOURCE TECHNOL, V100, P1852, DOI 10.1016/j.biortech.2008.10.005; Tang YJ, 2003, ENZYME MICROB TECH, V32, P478, DOI 10.1016/S0141-0229(02)00338-1; Trombetti GA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S22; Vanden Wymelenberg A, 2006, FUNGAL GENET BIOL, V43, P343, DOI 10.1016/j.fgb.2006.01.003; Walbot V, 2000, NATURE, V408, P794, DOI 10.1038/35048685; Wang X, 2006, APPL MICROBIOL BIOT, V72, P508, DOI 10.1007/s00253-006-0314-9; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wanke M, 2001, ACTA BIOCHIM POL, V48, P663; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; Xu JW, 2010, APPL MICROBIOL BIOT, V87, P457, DOI 10.1007/s00253-010-2576-5; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zhang CR, 2008, NAT PROD RES, V22, P1137, DOI 10.1080/14786410601129721; Zhang W, 2008, BIOTECHNOL PROGR, V24, P1249, DOI 10.1002/btpr.36; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106; Zhou XW, 2007, AM J CHINESE MED, V35, P559, DOI 10.1142/S0192415X07005065	83	48	55	7	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44031	10.1371/journal.pone.0044031	http://dx.doi.org/10.1371/journal.pone.0044031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952861	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800089
J	Chueh, TH; Lu, HHS				Chueh, Tung-Hung; Lu, Henry Horng-Shing			Inference of Biological Pathway from Gene Expression Profiles by Time Delay Boolean Networks	PLOS ONE			English	Article							REGULATORY NETWORKS; BAYESIAN NETWORKS; LARGE-SCALE; COEXPRESSION; IDENTIFICATION; KNOWLEDGE; MODELS	One great challenge of genomic research is to efficiently and accurately identify complex gene regulatory networks. The development of high-throughput technologies provides numerous experimental data such as DNA sequences, protein sequence, and RNA expression profiles makes it possible to study interactions and regulations among genes or other substance in an organism. However, it is crucial to make inference of genetic regulatory networks from gene expression profiles and protein interaction data for systems biology. This study will develop a new approach to reconstruct time delay Boolean networks as a tool for exploring biological pathways. In the inference strategy, we will compare all pairs of input genes in those basic relationships by their corresponding p-scores for every output gene. Then, we will combine those consistent relationships to reveal the most probable relationship and reconstruct the genetic network. Specifically, we will prove that O(log n) state transition pairs are sufficient and necessary to reconstruct the time delay Boolean network of n nodes with high accuracy if the number of input genes to each gene is bounded. We also have implemented this method on simulated and empirical yeast gene expression data sets. The test results show that this proposed method is extensible for realistic networks.	[Chueh, Tung-Hung] Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu, Taiwan; [Lu, Henry Horng-Shing] Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan	Industrial Technology Research Institute - Taiwan; National Yang Ming Chiao Tung University	Chueh, TH (corresponding author), Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu, Taiwan.	hslu@stat.nctu.edu.tw			National Science Council; National Center for Theoretical Sciences; Shing-Tung Yau Center; Center of Mathematical Modeling and Scientic Computing at the National Chiao Tung University in Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Center for Theoretical Sciences; Shing-Tung Yau Center; Center of Mathematical Modeling and Scientic Computing at the National Chiao Tung University in Taiwan	The authors acknowledge support from the National Science Council, National Center for Theoretical Sciences, Shing-Tung Yau Center, and Center of Mathematical Modeling and Scientic Computing at the National Chiao Tung University in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 1999, Pac Symp Biocomput, P17; Akutsu T, 2003, THEOR COMPUT SCI, V298, P235, DOI 10.1016/S0304-3975(02)00425-5; Akutsu T., 1998, P 9 ANN ACM SIAM S D, P695; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Balakrishnan S, 2006, BAYESIAN ANAL, V1, P345, DOI 10.1214/06-BA112; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Bosl WJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-13; Dealy S, 2005, COMPLEXITY, V11, P52, DOI 10.1002/cplx.20100; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P206; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Huang S, 1999, J MOL MED-JMM, V77, P469, DOI 10.1007/s001099900023; Ideker T. E., 2000, PAC S BIOC, V5, P302; Imoto Seiya, 2004, J Bioinform Comput Biol, V2, P77, DOI 10.1142/S021972000400048X; Jensen FV, 2007, BAYESIAN NETWORKS DE; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li LM, 2005, J COMPUT BIOL, V12, P170, DOI 10.1089/cmb.2005.12.170; Liu TF, 2006, INT J ARTIF INTELL T, V15, P353, DOI 10.1142/S0218213006002710; Moler EJ, 2000, PHYSIOL GENOMICS, V4, P127, DOI 10.1152/physiolgenomics.2000.4.2.127; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Rawool SB, 2007, BIOSYSTEMS, V90, P636, DOI 10.1016/j.biosystems.2007.02.003; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Scharfe C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000374; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Socolar JES, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.068702; Somogyi R, 1996, COMPLEXITY, V1, P45, DOI DOI 10.1002/CPLX.6130010612; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tzeng J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-179; Veliz-Cuba A, 2011, J COMPUT BIOL, V18, P783, DOI 10.1089/cmb.2011.0031; Wang HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020074; Zhang R, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.045202	41	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42095	10.1371/journal.pone.0042095	http://dx.doi.org/10.1371/journal.pone.0042095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952589	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300005
J	Finger, RP; Kupitz, DG; Fenwick, E; Balasubramaniam, B; Ramani, RV; Holz, FG; Gilbert, CE				Finger, Robert P.; Kupitz, David G.; Fenwick, Eva; Balasubramaniam, Bharath; Ramani, Ramanathan V.; Holz, Frank G.; Gilbert, Clare E.			The Impact of Successful Cataract Surgery on Quality of Life, Household Income and Social Status in South India	PLOS ONE			English	Article							VISION FUNCTION QUESTIONNAIRE; VISUAL IMPAIRMENT; WEALTH RANKING; POVERTY; HEALTH; BLINDNESS; PHILIPPINES; SERVICES; KENYA; CARE	Background: To explore the hypothesis that sight restoring cataract surgery provided to impoverished rural communities will improve not only visual acuity and vision-related quality of life (VRQoL) but also poverty and social status. Methods: Participants were recruited at outreach camps in Tamil Nadu, South India, and underwent free routine manual small incision cataract surgery (SICS) with intra-ocular lens (IOL) implantation, and were followed up one year later. Poverty was measured as monthly household income, being engaged in income generating activities and number of working household members. Social status was measured as rates of re-marriage amongst widowed participants. VRQoL was measured using the IND-VFQ-33. Associations were explored using logistic regression (SPSS 19). Results: Of the 294 participants, mean age +/- standard deviation (SD) 60 +/- 8 years, 54% men, only 11% remained vision impaired at follow up (67% at baseline; p < 0.001). At one year, more participants were engaged in income generating activities (44.7% to 77.7%; p < 0.001) and the proportion of households with a monthly income,1000 Rps. decreased from 50.5% to 20.5% (p < 0.05). Overall VRQoL improved (p < 0.001). Participants who had successful cataract surgery were less likely to remain in the lower categories of monthly household income (OR 0.05-0.22; p < 0.02) and more likely to be engaged in income earning activities one year after surgery (OR 3.28; p = 0.006). Participants widowed at baseline who had successful cataract surgery were less likely to remain widowed at one year (OR 0.02; p = 0.008). Conclusion: These findings indicate the broad positive impact of sight restoring cataract surgery on the recipients' as well as their families' lives. Providing free high quality cataract surgery to marginalized rural communities will not only alleviate avoidable blindness but also - to some extent - poverty in the long run.	[Finger, Robert P.; Kupitz, David G.; Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Finger, Robert P.; Fenwick, Eva] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Balasubramaniam, Bharath; Ramani, Ramanathan V.] Sankara Eye Care Inst, Coimbatore, Tamil Nadu, India; [Gilbert, Clare E.] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England	University of Bonn; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of London; London School of Hygiene & Tropical Medicine	Finger, RP (corresponding author), Univ Bonn, Dept Ophthalmol, Bonn, Germany.	robertfinger@gmx.net		Finger, Robert P/0000-0003-4253-7597	German Ophthalmological Society (DOG); German Research Foundation (DFG); Indian Academy of Science	German Ophthalmological Society (DOG); German Research Foundation (DFG)(German Research Foundation (DFG)); Indian Academy of Science	The project was supported by the German Ophthalmological Society (DOG), the German Research Foundation (DFG) and the Indian Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 1997, WORLD DEV, V25, P1165, DOI 10.1016/S0305-750X(97)00024-7; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; BHAT M, 1984, POP STUD-J DEMOG, V38, P89, DOI 10.1080/00324728.1984.10412824; Chen M, 1992, ECON POLIT WEEKLY, V27, P24; Dandona L, 2003, CLIN EXP OPHTHALMOL, V31, P23, DOI 10.1046/j.1442-9071.2003.00595.x; Dandona L, 2001, BRIT MED J, V323, P455; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Department of Planning, 2006, SURV POV LIN FAM; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finger RP, 2007, OPHTHAL EPIDEMIOL, V14, P327, DOI 10.1080/01658100701486814; Finger RP, 2007, OPHTHAL EPIDEMIOL, V14, P112, DOI 10.1080/09286580601114967; Finger RP, 2011, INVEST OPHTH VIS SCI, V52, P6081, DOI 10.1167/iovs.11-7388; Finger RP, 2011, TROPICAL MED INT HLT; Foley D, 2007, SOC POLICY ADMIN, V41, P372, DOI 10.1111/j.1467-9515.2007.00559.x; Fraser S, 2001, BMJ-BRIT MED J, V322, P639, DOI 10.1136/bmj.322.7287.639; Gilbert CE, 2008, BMJ-BRIT MED J, V336, P29, DOI 10.1136/bmj.39395.500046.AE; GOODING K, 2006, POVERTY BLINDNESS SU; Gupta SK, 2005, BRIT J OPHTHALMOL, V89, P621, DOI 10.1136/bjo.2004.050732; Hargreaves JR, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-4; Kessy JP, 2007, BRIT J OPHTHALMOL, V91, P1114, DOI 10.1136/bjo.2006.112474; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Kuper H, 2008, PLOS MED, V5, P1716, DOI 10.1371/journal.pmed.0050244; Kuper H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015431; Lewallen S, 2008, PLOS MED, V5, P1647, DOI 10.1371/journal.pmed.0050245; Linacre JM, 2008, WINSTEPS RASCH MEAS; Murthy GVS, 2008, INDIAN J OPHTHALMOL, V56, P489, DOI 10.4103/0301-4738.42774; Murthy GVS, 2005, BRIT J OPHTHALMOL, V89, P498, DOI 10.1136/bjo.2004.047217; Nirmalan PK, 2004, BRIT J OPHTHALMOL, V88, P1237, DOI 10.1136/bjo.2004.042606; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Office of the Registrar General and Census Commissioner, 2001, CENS IND CENS DAT 20; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Polack S, 2010, OPHTHAL EPIDEMIOL, V17, P387, DOI 10.3109/09286586.2010.528136; Polack S, 2010, OPHTHAL EPIDEMIOL, V17, P152, DOI 10.3109/09286581003731536; Polack S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010913; Sengupta Manisha, 2002, J Cross Cult Gerontol, V17, P313, DOI 10.1023/A:1023079219538; Sloan Jeff A, 2005, COPD, V2, P57; TAYLOR HR, 1991, B WORLD HEALTH ORGAN, V69, P335; United Nations, 2012, UN MILL DEV GOALS; Wolfe E W, 1999, J Outcome Meas, V3, P134; World Bank, 1990, WORLD DEV REP POV; World Health Organization, 2004, CAT SURG RAT SE AS R; Zimmer Z, 2008, SOC SCI MED, V66, P57, DOI 10.1016/j.socscimed.2007.08.032	42	50	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44268	10.1371/journal.pone.0044268	http://dx.doi.org/10.1371/journal.pone.0044268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998EY	22952945	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000308221300072
J	Moussa, MN; Steen, MR; Laurienti, PJ; Hayasaka, S				Moussa, Malaak N.; Steen, Matthew R.; Laurienti, Paul J.; Hayasaka, Satoru			Consistency of Network Modules in Resting-State fMRI Connectome Data	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; COMMUNITY STRUCTURE; HUMAN BRAIN; DEFAULT MODE; HEAD MOTION; SMALL-WORLD; ORGANIZATION; MULTISCALE; CORTEX	At rest, spontaneous brain activity measured by fMRI is summarized by a number of distinct resting state networks (RSNs) following similar temporal time courses. Such networks have been consistently identified across subjects using spatial ICA (independent component analysis). Moreover, graph theory-based network analyses have also been applied to resting-state fMRI data, identifying similar RSNs, although typically at a coarser spatial resolution. In this work, we examined resting-state fMRI networks from 194 subjects at a voxel-level resolution, and examined the consistency of RSNs across subjects using a metric called scaled inclusivity (SI), which summarizes consistency of modular partitions across networks. Our SI analyses indicated that some RSNs are robust across subjects, comparable to the corresponding RSNs identified by ICA. We also found that some commonly reported RSNs are less consistent across subjects. This is the first direct comparison of RSNs between ICAs and graph-based network analyses at a comparable resolution.	[Moussa, Malaak N.] Wake Forest Univ, Bowman Gray Sch Med, Neurosci Program, Winston Salem, NC 27103 USA; [Steen, Matthew R.; Laurienti, Paul J.; Hayasaka, Satoru] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC USA; [Hayasaka, Satoru] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Moussa, MN (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Neurosci Program, Winston Salem, NC 27103 USA.	shayasak@wakehealth.edu			National Institute of Neurological Disorders and Stroke [NS070917]; National Institute on Alcohol Abuse and Alcoholism [T32-AA007565]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007565] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Institute of Neurological Disorders and Stroke (NS070917). MNM is supported by the National Institute on Alcohol Abuse and Alcoholism (T32-AA007565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Ding JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026596; Doucet G, 2011, J NEUROPHYSIOL, V105, P2753, DOI 10.1152/jn.00895.2010; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Laurienti PJ, 2011, PHYSICA A, V390, P3608, DOI 10.1016/j.physa.2011.05.011; Luo C, 2012, HUM BRAIN MAPP, V33, P1279, DOI 10.1002/hbm.21286; Meunier David, 2009, Front Neuroinform, V3, P37, DOI 10.3389/neuro.11.037.2009; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ruan JH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016104; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Simpson SL, 2012, NEUROIMAGE, V60, P1117, DOI 10.1016/j.neuroimage.2012.01.071; Steen M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016111; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019608; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	44	111	112	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44428	10.1371/journal.pone.0044428	http://dx.doi.org/10.1371/journal.pone.0044428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952978	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300091
J	Nfonsam, LE; Cano, C; Mudge, J; Schilkey, FD; Curtiss, J				Nfonsam, Landry E.; Cano, Carlos; Mudge, Joann; Schilkey, Faye D.; Curtiss, Jennifer			Analysis of the Transcriptomes Downstream of Eyeless and the Hedgehog, Decapentaplegic and Notch Signaling Pathways in Drosophila melanogaster	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TWIN-OF-EYELESS; RETINAL DETERMINATION GENES; HOMEOBOX-CONTAINING GENE; ECTOPIC EYE DEVELOPMENT; WING IMAGINAL DISC; HUMAN PAX6 GENE; SINE-OCULIS; MORPHOGENETIC FURROW; PRONEURAL GENE	Tissue-specific transcription factors are thought to cooperate with signaling pathways to promote patterned tissue specification, in part by co-regulating transcription. The Drosophila melanogaster Pax6 homolog Eyeless forms a complex, incompletely understood regulatory network with the Hedgehog, Decapentaplegic and Notch signaling pathways to control eye-specific gene expression. We report a combinatorial approach, including mRNAseq and microarray analyses, to identify targets co-regulated by Eyeless and Hedgehog, Decapentaplegic or Notch. Multiple analyses suggest that the transcriptomes resulting from co-misexpression of Eyeless+signaling factors provide a more complete picture of eye development compared to previous efforts involving Eyeless alone: (1) Principal components analysis and two-way hierarchical clustering revealed that the Eyeless+signaling factor transcriptomes are closer to the eye control transcriptome than when Eyeless is misexpressed alone; (2) more genes are upregulated at least three-fold in response to Eyeless+signaling factors compared to Eyeless alone; (3) based on gene ontology analysis, the genes upregulated in response to Eyeless+signaling factors had a greater diversity of functions compared to Eyeless alone. Through a secondary screen that utilized RNA interference, we show that the predicted gene CG4721 has a role in eye development. CG4721 encodes a neprilysin family metalloprotease that is highly up-regulated in response to Eyeless+Notch, confirming the validity of our approach. Given the similarity between D. melanogaster and vertebrate eye development, the large number of novel genes identified as potential targets of Ey+signaling factors will provide novel insights to our understanding of eye development in D. melanogaster and humans.	[Nfonsam, Landry E.; Cano, Carlos; Curtiss, Jennifer] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Mudge, Joann; Schilkey, Faye D.] Natl Ctr Genome Resources, Santa Fe, NM USA	New Mexico State University; National Center for Genome Resources (NCGR)	Nfonsam, LE (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	curtij01@nmsu.edu		Mudge, Joann/0000-0002-2972-1640; Mudge, Joseph/0000-0001-6091-2966; Nfonsam, Landry/0000-0002-5715-2545	NIH NCRR [P20RR016480]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER	NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH NCRR P20RR016480 (http://www.ncrr.nih.gov/research_infrastructure/institutional_development_award/idea_networks_of_biomedical_research_excellence/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aerts S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000435; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; Baker NE, 1997, CURR BIOL, V7, P122, DOI 10.1016/S0960-9822(06)00056-X; Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; Baker NE, 2011, BIOESSAYS, V33, P538, DOI 10.1002/bies.201000131; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Baonza A, 2002, DEVELOPMENT, V129, P5313, DOI 10.1242/dev.00096; Baonza A, 2001, CURR BIOL, V11, P396, DOI 10.1016/S0960-9822(01)00125-7; Baonza A, 2001, DEVELOPMENT, V128, P3889; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Belacortu Y, 2011, DEV DYNAM, V240, P2379, DOI 10.1002/dvdy.22753; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Berger J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000085; Bessa J, 2005, DEVELOPMENT, V132, P5011, DOI 10.1242/dev.02082; BLACKMAN RK, 1987, CELL, V49, P497, DOI 10.1016/0092-8674(87)90452-1; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Bland ND, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-16; Boggiano JC, 2012, DEV CELL, V22, P695, DOI 10.1016/j.devcel.2012.03.013; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Boyle M, 1997, DEVELOPMENT, V124, P971; Bramblett DE, 2004, NEURON, V43, P779, DOI 10.1016/j.neuron.2004.08.032; Bramblett DE, 2002, GENOMICS, V79, P402, DOI 10.1006/geno.2002.6708; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown KE, 2006, DEV BIOL, V300, P710, DOI 10.1016/j.ydbio.2006.08.003; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Canon J, 2000, SEMIN CELL DEV BIOL, V11, P327, DOI 10.1006/scdb.2000.0185; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chauhan BK, 2002, J BIOL CHEM, V277, P11539, DOI 10.1074/jbc.M110531200; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chen KC, 1999, P NATL ACAD SCI USA, V96, P5055, DOI 10.1073/pnas.96.9.5055; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Chen R, 1999, DEVELOPMENT, V126, P935; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Chow RL, 1999, DEVELOPMENT, V126, P4213; Clouthier DE, 2010, AM J MED GENET A, V152A, P2962, DOI 10.1002/ajmg.a.33568; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Curtiss J, 2000, DEVELOPMENT, V127, P1325; Curtiss J, 2002, NAT CELL BIOL, V4, pE48, DOI 10.1038/ncb0302-e48; Curtiss J, 2007, DEV BIOL, V306, P685, DOI 10.1016/j.ydbio.2007.04.006; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; da Cruz AB, 2005, MOL BIOL CELL, V16, P2433, DOI 10.1091/mbc.E04-11-1004; Daull P, 2007, J CARDIOVASC PHARM, V50, P247, DOI 10.1097/FJC.0b013e31813c6ca5; deCelis JF, 1996, DEVELOPMENT, V122, P359; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Ditch LM, 2005, DEVELOPMENT, V132, P155, DOI 10.1242/dev.01568; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311; Dominguez M, 1999, DEVELOPMENT, V126, P2345; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Duparc RH, 2007, DEV BIOL, V301, P374, DOI 10.1016/j.ydbio.2006.11.006; Emerald BS, 2003, DEVELOPMENT, V130, P1171, DOI 10.1242/dev.00323; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Firth LC, 2005, DEV CELL, V8, P541, DOI 10.1016/j.devcel.2005.01.017; Firth LC, 2009, DEV BIOL, V327, P366, DOI 10.1016/j.ydbio.2008.12.021; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Frankfort BJ, 2002, DEVELOPMENT, V129, P1295; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Freeman M, 1997, DEVELOPMENT, V124, P261; Fu WM, 2003, DEVELOPMENT, V130, P5229, DOI 10.1242/dev.00764; Fullaondo A, 2011, MOL CELL BIOL, V31, P2960, DOI 10.1128/MCB.01397-10; Furman DP, 2011, INT J DEV BIOL, V55, P133, DOI 10.1387/ijdb.103129df; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Glasscock E, 2005, GENETICS, V169, P2137, DOI 10.1534/genetics.104.028357; Go MJ, 1998, DEVELOPMENT, V125, P2031; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Greenwood S, 1999, DEVELOPMENT, V126, P5795; Guo R, 2002, BIOCHEM BIOPH RES CO, V297, P38, DOI 10.1016/S0006-291X(02)02125-3; Hakeda-Suzuki S, 2011, NAT NEUROSCI, V14, P314, DOI 10.1038/nn.2756; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Halder G, 1998, DEVELOPMENT, V125, P2181; Hallermann S, 2010, HFSP J, V4, P72, DOI 10.2976/1.3338710; Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Higuchi M, 2005, BBA-PROTEINS PROTEOM, V1751, P60, DOI 10.1016/j.bbapap.2005.02.013; HILL RE, 1992, NATURE, V355, P750, DOI 10.1038/355750a0; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hoang CQ, 2010, DEV DYNAM, V239, P2367, DOI 10.1002/dvdy.22380; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hsiung F, 2002, HUM MOL GENET, V11, P1207, DOI 10.1093/hmg/11.10.1207; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Johnston RJ, 2011, CELL, V145, P956, DOI 10.1016/j.cell.2011.05.003; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; Kenyon KL, 2003, DEV CELL, V5, P403, DOI 10.1016/S1534-5807(03)00243-0; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; Kiselev Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031915; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Kronhamn J, 2002, DEVELOPMENT, V129, P1015; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Li YX, 2001, CURR BIOL, V11, P330, DOI 10.1016/S0960-9822(01)00093-8; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Loosli F, 1998, MECH DEVELOP, V74, P159, DOI 10.1016/S0925-4773(98)00055-0; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Mann K, 2012, DEVELOPMENT, V139, P760, DOI 10.1242/dev.074104; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; MARDON G, 1994, DEVELOPMENT, V120, P3473; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; MASUCCI JD, 1990, GENE DEV, V4, P2011, DOI 10.1101/gad.4.11.2011; McDonald EC, 2010, DEV BIOL, V347, P122, DOI 10.1016/j.ydbio.2010.08.016; Megason SG, 2002, DEVELOPMENT, V129, P2087; Meier-Stiegen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011481; Melicharek D, 2008, GENETICS, V180, P2095, DOI 10.1534/genetics.108.093302; Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100; Miller Neil A, 2008, J Comput Sci Syst Biol, V1, P132; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; MOHLER J, 1988, GENETICS, V120, P1061; Morrison CM, 2010, GENESIS, V48, P3, DOI 10.1002/dvg.20571; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Nelson BR, 2006, DEV NEUROSCI-BASEL, V28, P128, DOI 10.1159/000090759; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Niimi T, 1999, DEVELOPMENT, V126, P2253; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; O'Keefe DD, 2009, DEV BIOL, V333, P143, DOI 10.1016/j.ydbio.2009.06.032; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Ostrin EJ, 2006, GENOME RES, V16, P466, DOI 10.1101/gr.4673006; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Pappu KS, 2005, DEVELOPMENT, V132, P2895, DOI 10.1242/dev.01869; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pueyo JI, 2000, DEVELOPMENT, V127, P5391; Punzo C, 2004, DEVELOPMENT, V131, P3943, DOI 10.1242/dev.01278; Punzo C, 2002, DEVELOPMENT, V129, P625; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Rawlings N.D., 2004, HDB PROTEOLYTIC ENZY, P231; Repiso A, 2011, DEV GROWTH DIFFER, V53, P177, DOI 10.1111/j.1440-169X.2010.01247.x; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Rodriguez DD, 2002, DEVELOPMENT, V129, P3995; Rogers EM, 2005, DEVELOPMENT, V132, P4833, DOI 10.1242/dev.02061; Roignant JY, 2010, DEVELOPMENT, V137, P273, DOI 10.1242/dev.041244; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Rowe PSN, 2005, BONE, V36, P33, DOI 10.1016/j.bone.2004.09.015; Sambandan D, 2006, GENETICS, V174, P1349, DOI 10.1534/genetics.106.060574; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; SHELLENBARGER DL, 1975, GENETICS, V81, P143; Shen WP, 1997, DEVELOPMENT, V124, P45; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Storey John D, 2003, Methods Mol Biol, V224, P149; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sumitomo M, 2005, BBA-PROTEINS PROTEOM, V1751, P52, DOI 10.1016/j.bbapap.2004.11.001; Sun Y, 1998, DEVELOPMENT, V125, P3731; Suzanne M, 2003, DEV BIOL, V260, P465, DOI 10.1016/S0012-1606(03)00249-5; Testori J, 2011, BLOOD, V117, P2735, DOI 10.1182/blood-2010-07-293209; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Tsuji T, 2000, DEVELOPMENT, V127, P4315; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Uehara M, 2007, DEV BIOL, V302, P399, DOI 10.1016/j.ydbio.2006.09.045; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; VANDERMEERDEJONG R, 1990, GENOMICS, V7, P270, DOI 10.1016/0888-7543(90)90550-E; Vining MS, 2005, DEV BIOL, V287, P19, DOI 10.1016/j.ydbio.2005.08.017; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang Yang, 2010, Zhonghua Er Ke Za Zhi, V48, P397; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Wasserman JD, 2000, GENE DEV, V14, P1651; Weasner B, 2007, DEV BIOL, V303, P756, DOI 10.1016/j.ydbio.2006.10.040; WELSHONS WJ, 1965, SCIENCE, V150, P1122, DOI 10.1126/science.150.3700.1122; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Whiteford N, 2009, BIOINFORMATICS, V25, P2194, DOI 10.1093/bioinformatics/btp383; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Wolf LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004159; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xie P, 2011, J BIOL CHEM, V286, P34131, DOI 10.1074/jbc.M111.241778; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang TY, 2006, DEVELOPMENT, V133, P4881, DOI 10.1242/dev.02669; Zheng R, 2006, ONCOGENE, V25, P5942, DOI 10.1038/sj.onc.1209586; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	223	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44583	10.1371/journal.pone.0044583	http://dx.doi.org/10.1371/journal.pone.0044583			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952997	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300101
J	Provost, V; Langlois, A; Chouinard, F; Rola-Pleszczynski, M; Chakir, J; Flamand, N; Laviolette, M				Provost, Veronique; Langlois, Anick; Chouinard, Francois; Rola-Pleszczynski, Marek; Chakir, Jamila; Flamand, Nicolas; Laviolette, Michel			Leukotriene D-4 and Interleukin-13 Cooperate to Increase the Release of Eotaxin-3 by Airway Epithelial Cells	PLOS ONE			English	Article							GENE-EXPRESSION; UP-REGULATION; FUNCTIONAL-CHARACTERIZATION; EOSINOPHIL TRANSMIGRATION; CYSTEINYL LEUKOTRIENES; ALLERGEN CHALLENGE; MESSENGER-RNA; HUMAN LUNG; TGF-BETA; KAPPA-B	Introduction: Airway epithelial cells play a central role in the physiopathology of asthma. They release eotaxins when treated with T(H)2 cytokines such as interleukin (IL)-4 or IL-13, and these chemokines attract eosinophils and potentiate the biosynthesis of cysteinyl leukotrienes (cysLTs), which in turn induce bronchoconstriction and mucus secretion. These effects of cysLTs mainly mediated by CysLT(1) and CysLT(2) receptors on epithelial cell functions remain largely undefined. Because the release of inflammatory cytokines, eotaxins, and cysLTs occur relatively at the same time and location in the lung tissue, we hypothesized that they regulate inflammation cooperatively rather than redundantly. We therefore investigated whether cysLTs and the T(H)2 cytokines would act in concert to augment the release of eotaxins by airway epithelial cells. Methods: A549 cells or human primary bronchial epithelial cells were incubated with or without IL-4, IL-13, and/or LTD4. The release of eotaxin-3 and the expression of cysLT receptors were assessed by ELISA, RT-PCR, and flow cytometry, respectively. Results: IL-4 and IL-13 induced the release of eotaxin-3 by airway epithelial cells. LTD4 weakly induced the release of eotaxin-3 but clearly potentiated the IL-13-induced eotaxin-3 release. LTD4 had no effect on IL-4-stimulated cells. Epithelial cells expressed CysLT(1) but not CysLT(2). CysLT(1) expression was increased by IL-13 but not by IL-4 and/or LTD4. Importantly, the upregulation of CysLT(1) by IL-13 preceded eotaxin-3 release. Conclusions: These results demonstrate a stepwise cooperation between IL-13 and LTD4. IL-13 upregulates CysLT(1) expression and consequently the response to cysLTs This results in an increased release of eotaxin-3 by epithelial cells which at its turn increases the recruitment of leukocytes and their biosynthesis of cysLTs. This positive amplification loop involving epithelial cells and leukocytes could be implicated in the recruitment of eosinophils observed in asthmatics.	[Provost, Veronique; Langlois, Anick; Chouinard, Francois; Chakir, Jamila; Flamand, Nicolas; Laviolette, Michel] Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Rola-Pleszczynski, Marek] Univ Sherbrooke, Fac Med, Immunol Unit, Sherbrooke, PQ, Canada	Laval University; University of Sherbrooke	Provost, V (corresponding author), Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	Nicolas.Flamand@criucpq.ulaval.ca; Michel.Laviolette@med.ulaval.ca	Flamand, Nicolas/H-5823-2019	Flamand, Nicolas/0000-0001-5944-7200	Canadian Institutes of Health Research (CIHR); Respiratory Health Network of the Fonds de la recherche en sante du Quebec (FRSQ); CIHR; FRSQ	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Respiratory Health Network of the Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant to ML from the Canadian Institutes of Health Research (CIHR), a doctoral studentships to VP from the Respiratory Health Network of the Fonds de la recherche en sante du Quebec (FRSQ) and to FC from the CIHR and a Scholarship to NF from the FRSQ. CIHR and FRSQ had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonyo BO, 2006, CYTOKINE, V36, P237, DOI 10.1016/j.cyto.2007.01.001; Akaiwa M, 2001, CYTOKINE, V13, P75, DOI 10.1006/cyto.2000.0814; Asakura T, 2004, J ALLERGY CLIN IMMUN, V114, P310, DOI 10.1016/j.jaci.2004.04.037; Bandeira-Melo C, 2001, AM J RESP CELL MOL, V24, P653, DOI 10.1165/ajrcmb.24.6.f209; Banwell ME, 2002, CYTOKINE, V17, P317, DOI 10.1006/cyto.2002.1021; Berkman N, 2001, AM J RESP CELL MOL, V24, P682, DOI 10.1165/ajrcmb.24.6.4301; Blanchard C, 2005, INT J BIOCHEM CELL B, V37, P2559, DOI 10.1016/j.biocel.2005.06.010; Bosse Y, 2008, CLIN EXP ALLERGY, V38, P113, DOI 10.1111/j.1365-2222.2007.02873.x; Bosse Y, 2008, INT ARCH ALLERGY IMM, V146, P138, DOI 10.1159/000113517; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Chakir J, 2001, J ALLERGY CLIN IMMUN, V107, P36, DOI 10.1067/mai.2001.111929; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chibana K, 2003, J IMMUNOL, V170, P4290, DOI 10.4049/jimmunol.170.8.4290; Chouinard F, 2011, J IMMUNOL, V186, P3188, DOI 10.4049/jimmunol.1002853; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; Early SB, 2007, AM J RESP CELL MOL, V36, P715, DOI 10.1165/rcmb.2006-0252OC; Espinosa K, 2003, J ALLERGY CLIN IMMUN, V111, P1032, DOI 10.1067/mai.2003.1451; Ferland C, 2001, J LEUKOCYTE BIOL, V69, P772; Figueroa DJ, 2001, AM J RESP CRIT CARE, V163, P226, DOI 10.1164/ajrccm.163.1.2003101; Flamand N, 2007, CELL MOL LIFE SCI, V64, P2657, DOI 10.1007/s00018-007-7228-2; Guilbert M, 1999, AM J RESP CELL MOL, V21, P97, DOI 10.1165/ajrcmb.21.1.3517; Hebenstreit D, 2005, MOL IMMUNOL, V42, P295, DOI 10.1016/j.molimm.2004.09.004; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Kagami S, 2005, CLIN EXP IMMUNOL, V141, P459, DOI 10.1111/j.1365-2249.2005.02875.x; Kawano T, 2003, J ALLERGY CLIN IMMUN, V112, P369, DOI 10.1067/mai.2003.1636; Komiya A, 2003, CELL IMMUNOL, V225, P91, DOI 10.1016/j.cellimm.2003.10.001; Langlois A, 2006, J ALLERGY CLIN IMMUN, V118, P113, DOI 10.1016/j.jaci.2006.03.010; Lee KS, 2007, J ALLERGY CLIN IMMUN, V119, P141, DOI 10.1016/j.jaci.2006.09.001; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Lynch KR, 1999, NATURE, V399, P789; Matsukura S, 2001, AM J RESP CELL MOL, V24, P755, DOI 10.1165/ajrcmb.24.6.4351; Matsukura S, 1999, J IMMUNOL, V163, P6876; Mattoli S, 1997, BIOCHEM BIOPH RES CO, V236, P299, DOI 10.1006/bbrc.1997.6958; Mellor EA, 2002, J EXP MED, V195, P583, DOI 10.1084/jem.20020044; Menard G, 2000, AM J RESP CELL MOL, V23, P572, DOI 10.1165/ajrcmb.23.4.4152; Milano S, 1996, PARASITOLOGY, V112, P13, DOI 10.1017/S0031182000065033; Mita H, 2001, CLIN EXP ALLERGY, V31, P1714, DOI 10.1046/j.1365-2222.2001.01184.x; Nicosia S, 2001, PULM PHARMACOL THER, V14, P3, DOI 10.1006/pupt.2000.0262; Oh CK, 2010, EUR RESPIR REV, V19, P46, DOI 10.1183/09059180.00007609; Pease James E., 2001, Current Opinion in Pharmacology, V1, P248, DOI 10.1016/S1471-4892(01)00044-3; Perng DW, 2006, AM J RESP CELL MOL, V34, P101, DOI 10.1165/rcmb.2005-0068OC; Ravensberg AJ, 2005, J ALLERGY CLIN IMMUN, V115, P779, DOI 10.1016/j.jaci.2004.11.045; Rola-Pleszczynski M, 2007, THESCIENTIFICWORLDJO, V7, P1348, DOI 10.1100/tsw.2007.183; Saito M, 2005, INT J CANCER, V116, P1, DOI 10.1002/ijc.20995; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; STANKOVA J, 1993, J IMMUNOL, V150, P4041; Suzuki S, 2008, PHARMACOLOGY, V81, P221, DOI 10.1159/000112866; Wong GW, 2002, J BIOL CHEM, V277, P41906, DOI 10.1074/jbc.M205868200; Woszczek G, 2005, J IMMUNOL, V175, P5152, DOI 10.4049/jimmunol.175.8.5152; YAMAOKA KA, 1993, EUR J IMMUNOL, V23, P2392, DOI 10.1002/eji.1830231003; Yasunaga S, 2003, CYTOKINE, V24, P293, DOI 10.1016/j.cyto.2003.08.006; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Zhou L, 2012, BIOORGAN MED CHEM, V20, P750, DOI 10.1016/j.bmc.2011.12.006; Zhu L, 2005, AM J RESP CELL MOL, V33, P531, DOI 10.1165/rcmb.2005-0124OC	55	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43544	10.1371/journal.pone.0043544	http://dx.doi.org/10.1371/journal.pone.0043544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952702	gold, Green Published, Green Submitted			2022-12-27	WOS:000308221300018
J	Zong, Y; Sun, L; Liu, B; Deng, YS; Zhan, D; Chen, YL; He, Y; Liu, J; Zhang, ZJ; Sun, J; Lu, D				Zong, Yi; Sun, Lin; Liu, Bin; Deng, Yi-Shu; Zhan, Dong; Chen, Yuan-Li; He, Ying; Liu, Jing; Zhang, Zong-Ji; Sun, Jun; Lu, Di			Resveratrol Inhibits LPS-Induced MAPKs Activation via Activation of the Phosphatidylinositol 3-Kinase Pathway in Murine RAW 264.7 Macrophage Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; PROTEIN-KINASE PATHWAYS; TNF-ALPHA PRODUCTION; INDUCED THP-1 CELLS; PHOSPHOINOSITIDE 3-KINASE; SIGNALING PATHWAYS; INFLAMMATORY RESPONSES; GENE-EXPRESSION; LIPOPOLYSACCHARIDE	Background: Resveratrol is a natural polyphenolic compound that has cardioprotective, anticancer and anti-inflammatory properties. We investigated the capacity of resveratrol to protect RAW 264.7 cells from inflammatory insults and explored mechanisms underlying inhibitory effects of resveratrol on RAW 264.7 cells. Methodology/Principal Findings: Murine RAW 264.7 cells were treated with resveratrol (1, 5, and 10 mu M) and/or LPS (5 mu g/ml). Nitric oxide (NO) and prostaglandin E2 (PGE2) were measured by Griess reagent and ELISA. The mRNA and protein levels of proinflammatory proteins and cytokines were analysed by ELISA, RT-PCR and double immunofluorescence labeling, respectively. Phosphorylation levels of Akt, cyclic AMP-responsive element-binding protein (CREB), mitogen-activated protein kinases (MAPKs) cascades, AMP-activated protein kinase (AMPK) and expression of SIRT1(Silent information regulator T1) were measured by western blot. Wortmannin (1 mM), a specific phosphatidylinositol 3-kinase (PI3-K) inhibitor, was used to determine if PI3-K/Akt signaling pathway might be involved in resveratrol's action on RAW 264.7 cells. Resveratrol significantly attenuated the LPS-induced expression of nitric oxide (NO), prostaglandin E2 (PGE2), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in RAW 264.7 cells. Resveratrol increased Akt phosphorylation in a time-dependent manner. Wortmannin, a specific phosphatidylinositol 3-kinase (PI3-K) inhibitor, blocked the effects of resveratrol on LPS-induced RAW 264.7 cells activation. In addition, PI3-K inhibition partially abolished the inhibitory effect of resveratrol on the phosphorylation of cyclic AMP-responsive element-binding protein (CREB) and mitogen-activated protein kinases (MAPKs) cascades. Meanwhile, PI3-K is essential for resveratrol-mediated phosphorylation of AMPK and expression of SIRT1. Conclusion and Implications: This investigation demonstrates that PI3-K/Akt activation is an important signaling in resveratrol-mediated activation of AMPK phosphorylation and SIRT1 expression, and inhibition of phosphorylation of CREB and MAPKs activation, proinflammatory mediators and cytokines production in response to LPS in RAW 264.7 cells.	[Zong, Yi; Zhan, Dong; Chen, Yuan-Li; He, Ying; Sun, Jun; Lu, Di] Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China; [Sun, Lin] Kunming Med Univ, Affiliated Hosp 2, Dept Cardiol, Kunming, Yunnan, Peoples R China; [Liu, Bin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Yi-Shu] Dept Resp Med, Kunming, Yunnan, Peoples R China; [Liu, Jing; Zhang, Zong-Ji] Kunming Med Univ, Dept Pathol, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Sun Yat Sen University; Kunming Medical University	Zong, Y (corresponding author), Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China.	zhzji@sina.com; sunjun6661@126.com; ludi20040609@126.com			National Natural Sciences Foundation of China [30860336, 30560170]; Department of Science and Technology of Yunnan Province [2008CC007, 2008CD207, 2008CD122, 2009CI033]; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University [2011FB193, 2011FB177, 2010CD156]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University	This work was supported in part by grants (30860336 and 30560170) from the National Natural Sciences Foundation of China, grants (2008CC007, 2008CD207, 2008CD122 and 2009CI033) from the Department of Science and Technology of Yunnan Province, and grants (2011FB193, 2011FB177 and 2010CD156) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Amri A, 2012, J CONTROL RELEASE, V158, P182, DOI 10.1016/j.jconrel.2011.09.083; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bi XL, 2005, INT IMMUNOPHARMACOL, V5, P185, DOI 10.1016/j.intimp.2004.08.008; Campbell A, 2004, ANN NY ACAD SCI, V1035, P117, DOI 10.1196/annals.1332.008; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cantrell DA, 2001, J CELL SCI, V114, P1439; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Centeno-Baez C, 2011, AM J PHYSIOL-ENDOC M, V301, pE922, DOI 10.1152/ajpendo.00530.2010; Chiou WF, 2011, EUR J PHARMACOL, V650, P102, DOI 10.1016/j.ejphar.2010.10.004; Chung EY, 2003, PLANTA MED, V69, P710, DOI 10.1055/s-2003-42787; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; De Simone R, 2010, CHEM BIOL DRUG DES, V76, P17, DOI 10.1111/j.1747-0285.2010.00984.x; Ehlting C, 2011, J BIOL CHEM, V286, P24113, DOI 10.1074/jbc.M111.235275; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; Hsieh TP, 2011, PHYTOMEDICINE, V18, P176, DOI 10.1016/j.phymed.2010.04.003; Huang ZQ, 2008, BIOCHEM BIOPH RES CO, V374, P517, DOI 10.1016/j.bbrc.2008.07.058; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kharitonov Sergei A., 2007, V14, P83, DOI 10.1159/000107056; Kim JH, 2006, BIOCHEM PHARMACOL, V71, P1198, DOI 10.1016/j.bcp.2005.12.031; Kristof AS, 2006, J BIOL CHEM, V281, P23958, DOI 10.1074/jbc.M513918200; Lee YG, 2011, FRONT BIOSCI-LANDMRK, V16, P517, DOI 10.2741/3702; Li XQ, 2009, INT IMMUNOPHARMACOL, V9, P1032, DOI 10.1016/j.intimp.2009.04.010; Liu HE, 2011, SHOCK, V35, P191, DOI 10.1097/SHK.0b013e3181f0e9a8; Liu K, 2010, BIOCHIMIE, V92, P789, DOI 10.1016/j.biochi.2010.02.024; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; Malemud CJ, 2007, CURR OPIN PHARMACOL, V7, P339, DOI 10.1016/j.coph.2006.11.012; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Murakami A, 2003, CANCER LETT, V195, P17, DOI 10.1016/S0304-3835(03)00058-2; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Oh YC, 2009, AM J CHINESE MED, V37, P1203, DOI 10.1142/S0192415X09007600; Olas B, 2008, PLATELETS, V19, P70, DOI 10.1080/09537100701708506; Park JH, 2004, ARCH PHARM, V337, P20, DOI 10.1002/ardp.200300791; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sebai H, 2010, ARCH BIOCHEM BIOPHYS, V495, P56, DOI 10.1016/j.abb.2009.12.019; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Shin JS, 2011, BRIT J PHARMACOL, V164, P145, DOI 10.1111/j.1476-5381.2011.01351.x; Sung MJ, 2009, INT IMMUNOPHARMACOL, V9, P319, DOI 10.1016/j.intimp.2008.12.005; Vaillancourt F, 2007, J CELL BIOCHEM, V100, P1217, DOI 10.1002/jcb.21110; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; Wang MJ, 2007, J IMMUNOL, V179, P6204, DOI 10.4049/jimmunol.179.9.6204; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Yi CO, 2011, ANAT CELL BIOL, V44, P194, DOI 10.5115/acb.2011.44.3.194; Youn HS, 2005, J IMMUNOL, V175, P3339, DOI 10.4049/jimmunol.175.5.3339; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104	62	113	121	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44107	10.1371/journal.pone.0044107	http://dx.doi.org/10.1371/journal.pone.0044107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952890	gold, Green Published, Green Submitted			2022-12-27	WOS:000308221300051
J	Bethell, EJ; Holmes, A; MacLarnon, A; Semple, S				Bethell, Emily J.; Holmes, Amanda; MacLarnon, Ann; Semple, Stuart			Evidence That Emotion Mediates Social Attention in Rhesus Macaques	PLOS ONE			English	Article							SELECTIVE ATTENTION; FACIAL EXPRESSIONS; NONHUMAN-PRIMATES; BEHAVIOR; ANXIETY; TESTOSTERONE; THREAT; FACES; STRESS; GAZE	Background: Recent work on non-human primates indicates that the allocation of social attention is mediated by characteristics of the attending animal, such as social status and genotype, as well as by the value of the target to which attention is directed. Studies of humans indicate that an individual's emotion state also plays a crucial role in mediating their social attention; for example, individuals look for longer towards aggressive faces when they are feeling more anxious, and this bias leads to increased negative arousal and distraction from other ongoing tasks. To our knowledge, no studies have tested for an effect of emotion state on allocation of social attention in any non-human species. Methodology: We presented captive adult male rhesus macaques with pairs of adult male conspecific face images - one with an aggressive expression, one with a neutral expression - and recorded gaze towards these images. Each animal was tested twice, once during a putatively stressful condition (i.e. following a veterinary health check), and once during a neutral (or potentially positive) condition (i.e. a period of environmental enrichment). Initial analyses revealed that behavioural indicators of anxiety and stress were significantly higher after the health check than during enrichment, indicating that the former caused a negative shift in emotional state. Principle Findings: The macaques showed initial vigilance for aggressive faces across both conditions, but subsequent responses differed between conditions. Following the health check, initial vigilance was followed by rapid and sustained avoidance of aggressive faces. By contrast, during the period of enrichment, the macaques showed sustained attention towards the same aggressive faces. Conclusions/Significance: These data provide, to our knowledge, the first evidence that shifts in emotion state mediate social attention towards and away from facial cues of emotion in a non-human animal. This work provides novel insights into the evolution of emotion-attention interactions in humans, and mechanisms of social behaviour in non-human primates, and may have important implications for understanding animal psychological wellbeing.	[Bethell, Emily J.; MacLarnon, Ann; Semple, Stuart] Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England; [Holmes, Amanda] Univ Roehampton, Dept Psychol, London, England	Roehampton University; Roehampton University	Bethell, EJ (corresponding author), Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England.	E.J.Bethell@ljmu.ac.uk	Bethell, Emily J/F-8506-2011	Bethell, Emily J/0000-0002-0371-8873; MacLarnon, Ann/0000-0003-2722-4998; Semple, Stuart/0000-0003-0452-8104	Roehampton University; Universities Federation for Animal Welfare; Primate Society of Great Britain	Roehampton University; Universities Federation for Animal Welfare; Primate Society of Great Britain	This work was supported by a postgraduate bursary from Roehampton University and grants from Universities Federation for Animal Welfare and the Primate Society of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amaral DG, 2003, GENES BRAIN BEHAV, V2, P295, DOI 10.1034/j.1601-183X.2003.00043.x; Anestis SF, 2010, EVOL ANTHROPOL, V19, P66, DOI 10.1002/evan.20253; Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; Aureli F., 2003, PRIMATE PSYCHOL; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bar-Haim Y, 2011, J CHILD PSYCHOL PSYC, V52, P861, DOI 10.1111/j.1469-7610.2011.02368.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Chichinadze K, 2011, PHYSIOL BEHAV, V94, P595; Clark DM, 1999, BEHAV RES THER, V37, pS5, DOI 10.1016/S0005-7967(99)00048-0; Coss RG, 2002, PRIMATES, V43, P217, DOI 10.1007/BF02629649; Dalmaso M, BIOL LETT IN PRESS; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; Derakshan N, 2007, COGNITION EMOTION, V21, P1585, DOI 10.1080/02699930701499857; Dobson S, 2012, PHILOS T R SOC B, V367, P1901, DOI 10.1098/rstb.2011.0224; Doyle LA, 2008, AM J PRIMATOL, V70, P542, DOI 10.1002/ajp.20526; Einhauser W, 2006, VISION RES, V46, P1194, DOI 10.1016/j.visres.2005.08.032; Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009; Fernandes AC, 2010, 40 ANN M NEUR; Fontenot MB, 2006, J AM ASSOC LAB ANIM, V45, P35; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Fridmun EP, 2002, MED PRIMATOLOGY HIST; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; Green MJ, 2004, NEUROSCI BIOBEHAV R, V28, P333, DOI 10.1016/j.neubiorev.2004.03.006; Heistermann M, 2006, AM J PRIMATOL, V68, P257, DOI 10.1002/ajp.20222; Higham JP, 2011, P ROY SOC B-BIOL SCI, V278, P3452, DOI 10.1098/rspb.2011.0052; Holmes A, 2008, BIOL PSYCHOL, V77, P159, DOI 10.1016/j.biopsycho.2007.10.003; Holmes A, 2009, PSYCHOPHYSIOLOGY, V46, P62, DOI 10.1111/j.1469-8986.2008.00750.x; Honess PE, 2006, NEUROSCI BIOBEHAV R, V30, P390, DOI 10.1016/j.neubiorev.2005.04.003; Honess PE, 2006, NEUROSCI BIOBEHAV R, V30, P413, DOI 10.1016/j.neubiorev.2005.05.002; Josephs RA, 2012, PSYCHONEUROENDOCRINO, V37, P752, DOI 10.1016/j.psyneuen.2011.09.006; Kalin NH, 1998, BEHAV NEUROSCI, V112, P286, DOI 10.1037/0735-7044.112.2.286; King HM, 2012, PSYCHONEUROENDOCRINO, V37, P396, DOI 10.1016/j.psyneuen.2011.07.010; Klein JT, 2009, CURR BIOL, V19, pR958, DOI 10.1016/j.cub.2009.08.010; Lacreuse A, 2010, HORM BEHAV, V58, P854, DOI 10.1016/j.yhbeh.2010.08.010; LEDOUX JE, 1996, EMOTION BRAIN MYSTER; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; Machado CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026598; MAESTRIPIERI D, 1993, ETHOLOGY, V95, P19; Mahajan N, 2011, J PERS SOC PSYCHOL, V100, P387, DOI 10.1037/a0022459; Major CA, 2009, LIFE SCI, V85, P753, DOI 10.1016/j.lfs.2009.10.003; Marechal L, 2011, BIOL CONSERV, V144, P2188, DOI 10.1016/j.biocon.2011.05.010; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Mosher CP, 2011, BEHAV NEUROSCI, V125, P639, DOI 10.1037/a0024264; Mundry R, 1999, ANIM BEHAV, V58, P1143, DOI 10.1006/anbe.1999.1246; NC3Rs, 2011, NAT CTR REPL REF RED; Nelson EE, 2009, NEUROPSYCHOPHARMACOL, V34, P90, DOI 10.1038/npp.2008.150; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Reamer L, 2010, APPL ANIM BEHAV SCI, V124, P68, DOI 10.1016/j.applanim.2010.01.012; Richards AB, 2009, HORM BEHAV, V56, P140, DOI 10.1016/j.yhbeh.2009.03.021; Richards A, 2002, EMOTION, V2, P273, DOI 10.1037/1528-3542.2.3.273; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Shepherd SV, 2010, CURR BIOL, V20, P649, DOI 10.1016/j.cub.2010.02.032; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Shively CA, 2009, NEUROSCI BIOBEHAV R, V33, P133, DOI 10.1016/j.neubiorev.2008.06.006; van Honk J, 1999, HORM BEHAV, V36, P17, DOI 10.1006/hbeh.1999.1521; Waller BM, 2008, PHYSIOL BEHAV, V95, P93, DOI 10.1016/j.physbeh.2008.05.002; Watson KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004156; West B. T., 2007, LINEAR MIXED MODELS; WHITESIDE JA, 1976, CHILD DEV, V47, P290; Wirth MM, 2007, PHYSIOL BEHAV, V90, P496, DOI 10.1016/j.physbeh.2006.10.016; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698	69	71	71	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44387	10.1371/journal.pone.0044387	http://dx.doi.org/10.1371/journal.pone.0044387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952968	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500067
J	Bojunga, J; Dauth, N; Berner, C; Meyer, G; Holzer, K; Voelkl, L; Herrmann, E; Schroeter, H; Zeuzem, S; Friedrich-Rust, M				Bojunga, Joerg; Dauth, Nina; Berner, Christian; Meyer, Gesine; Holzer, Katharina; Voelkl, Lisa; Herrmann, Eva; Schroeter, Hartmut; Zeuzem, Stefan; Friedrich-Rust, Mireen			Acoustic Radiation Force Impulse Imaging for Differentiation of Thyroid Nodules	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; IN-VIVO; ELASTOGRAPHY; DIAGNOSIS; BENIGN; ELASTICITY; US; PERFORMANCE; MALIGNANCY; MANAGEMENT	Background: Acoustic Radiation Force Impulse (ARFI)-Imaging is an ultrasound-based elastography method enabling quantitative measurement of tissue stiffness. The aim of the present study was to evaluate sensitivity and specificity of ARFI-imaging for differentiation of thyroid nodules and to compare it to the well evaluated qualitative real-time elastography (RTE). Methods: ARFI-imaging involves the mechanical excitation of tissue using acoustic pulses to generate localized displacements resulting in shear-wave propagation which is tracked using correlation-based methods and recorded in m/s. Inclusion criteria were: nodules >= 5 mm, and cytological/histological assessment. All patients received conventional ultrasound, real-time elastography (RTE) and ARFI-imaging. Results: One-hundred-fifty-eight nodules in 138 patients were available for analysis. One-hundred-thirty-seven nodules were benign on cytology/histology, and twenty-one nodules were malignant. The median velocity of ARFI-imaging in the healthy thyroid tissue, as well as in benign and malignant thyroid nodules was 1.76 m/s, 1.90 m/s, and 2.69 m/s, respectively. While no significant difference in median velocity was found between healthy thyroid tissue and benign thyroid nodules, a significant difference was found between malignant thyroid nodules on the one hand and healthy thyroid tissue (p = 0.0019) or benign thyroid nodules (p = 0.0039) on the other hand. No significant difference of diagnostic accuracy for the diagnosis of malignant thyroid nodules was found between RTE and ARFI-imaging (0.74 vs. 0.69, p = 0.54). The combination of RTE with ARFI did not improve diagnostic accuracy. Conclusions: ARFI can be used as an additional tool in the diagnostic work up of thyroid nodules with high negative predictive value and comparable results to RTE.	[Bojunga, Joerg; Dauth, Nina; Berner, Christian; Meyer, Gesine; Zeuzem, Stefan; Friedrich-Rust, Mireen] JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany; [Holzer, Katharina] JW Goethe Univ Hosp, Dept Gen & Visceral Surg, Frankfurt, Germany; [Voelkl, Lisa] JW Goethe Univ Hosp, Inst Pathol, Frankfurt, Germany; [Herrmann, Eva] Goethe Univ Frankfurt, Fac Med, Inst Biostat & Math Modelling, Frankfurt, Germany; [Schroeter, Hartmut] Praxis Klin Diagnost PKD Staedel, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Bojunga, J (corresponding author), JW Goethe Univ Hosp, Dept Internal Med 1, Frankfurt, Germany.	Mireen.Friedrich-Rust@kgu.de	Zeuzem, Stefan/AAE-7435-2019; Meyer, Gesine/ABD-7219-2021		Siemens	Siemens(Siemens AG)	MFR received lecture fees from Siemens. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.	Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Asteria C, 2008, THYROID, V18, P523, DOI 10.1089/thy.2007.0323; Bojunga J, 2010, THYROID, V20, P1145, DOI 10.1089/thy.2010.0079; Dietlein M, 2003, EUR J ENDOCRINOL, V148, P377, DOI 10.1530/eje.0.1480377; Ding JR, 2011, J ULTRAS MED, V30, P1259, DOI 10.7863/jum.2011.30.9.1259; Frey H, 2003, RADIOLOGE, V43, P850, DOI 10.1007/s00117-003-0943-2; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Friedrich-Rust M, 2012, ULTRASONICS, V52, P69, DOI 10.1016/j.ultras.2011.06.012; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P1, DOI 10.4158/10024.GL; Goertz RS, 2011, EUR J RADIOL, V80, pE226, DOI 10.1016/j.ejrad.2010.09.025; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Iannuccilli JD, 2004, J ULTRAS MED, V23, P1455, DOI 10.7863/jum.2004.23.11.1455; Ivanac G, 2007, ULTRASCHALL MED, V28, P502, DOI 10.1055/s-2007-963023; KASAI C, 1985, IEEE T SON ULTRASON, V32, P458, DOI 10.1109/T-SU.1985.31615; LAROSA GL, 1991, CANCER, V67, P2137, DOI 10.1002/1097-0142(19910415)67:8<2137::AID-CNCR2820670822>3.0.CO;2-Y; Lippolis PV, 2011, J CLIN ENDOCR METAB, V96, pE1826, DOI 10.1210/jc.2011-1021; Moon HJ, 2012, RADIOLOGY, V262, P1002, DOI 10.1148/radiol.11110839; Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; Nightingale KR, 2006, ULTRASON, P1156; Ning CP, 2012, EUR J RADIOL, V81, P286, DOI 10.1016/j.ejrad.2010.12.010; Oertel YC, 2007, THYROID, V17, P1061, DOI 10.1089/thy.2007.0159; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Peng Y, 2008, DIAGN CYTOPATHOL, V36, P916, DOI 10.1002/dc.20943; Reiners C, 2004, THYROID, V14, P926, DOI 10.1089/thy.2004.14.926; Rubaltelli L, 2009, ULTRASCHALL MED, V30, P175, DOI 10.1055/s-2008-1027442; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Sebag F, 2010, J CLIN ENDOCR METAB, V95, P5281, DOI 10.1210/jc.2010-0766; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Suen KC, 1996, MODERN PATHOL, V9, P710; Tee YY, 2007, ANN SURG, V246, P714, DOI 10.1097/SLA.0b013e3180f61adc; Vorlander C, 2010, LANGENBECK ARCH SURG, V395, P865, DOI 10.1007/s00423-010-0685-3; Wang Y, 2010, J INT MED RES, V38, P466, DOI 10.1177/147323001003800210; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	35	84	98	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42735	10.1371/journal.pone.0042735	http://dx.doi.org/10.1371/journal.pone.0042735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952609	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206000011
J	Licastro, D; Mutarelli, M; Peluso, I; Neveling, K; Wieskamp, N; Rispoli, R; Vozzi, D; Athanasakis, E; D'Eustacchio, A; Pizzo, M; D'Amico, F; Ziviello, C; Simonelli, F; Fabretto, A; Scheffer, H; Gasparini, P; Banfi, S; Nigro, V				Licastro, Danilo; Mutarelli, Margherita; Peluso, Ivana; Neveling, Kornelia; Wieskamp, Nienke; Rispoli, Rossella; Vozzi, Diego; Athanasakis, Emmanouil; D'Eustacchio, Angela; Pizzo, Mariateresa; D'Amico, Francesca; Ziviello, Carmela; Simonelli, Francesca; Fabretto, Antonella; Scheffer, Hans; Gasparini, Paolo; Banfi, Sandro; Nigro, Vincenzo			Molecular Diagnosis of Usher Syndrome: Application of Two Different Next Generation Sequencing-Based Procedures	PLOS ONE			English	Article							GENETIC-HETEROGENEITY; CAUSE DEAFNESS; MUTATIONS; PROTEIN; FAMILIES; PREVALENCE; ISOFORM; PATIENT; WHIRLIN; CDH23	Usher syndrome (USH) is a clinically and genetically heterogeneous disorder characterized by visual and hearing impairments. Clinically, it is subdivided into three subclasses with nine genes identified so far. In the present study, we investigated whether the currently available Next Generation Sequencing (NGS) technologies are already suitable for molecular diagnostics of USH. We analyzed a total of 12 patients, most of which were negative for previously described mutations in known USH genes upon primer extension-based microarray genotyping. We enriched the NGS template either by whole exome capture or by Long-PCR of the known USH genes. The main NGS sequencing platforms were used: SOLiD for whole exome sequencing, Illumina (Genome Analyzer II) and Roche 454 (GS FLX) for the Long-PCR sequencing. Long-PCR targeting was more efficient with up to 94% of USH gene regions displaying an overall coverage higher than 256, whereas whole exome sequencing yielded a similar coverage for only 50% of those regions. Overall this integrated analysis led to the identification of 11 novel sequence variations in USH genes (2 homozygous and 9 heterozygous) out of 18 detected. However, at least two cases were not genetically solved. Our result highlights the current limitations in the diagnostic use of NGS for USH patients. The limit for whole exome sequencing is linked to the need of a strong coverage and to the correct interpretation of sequence variations with a non obvious, pathogenic role, whereas the targeted approach suffers from the high genetic heterogeneity of USH that may be also caused by the presence of additional causative genes yet to be identified.	[Licastro, Danilo] Cluster Biomed CBM Scrl Genom, Trieste, Italy; [Mutarelli, Margherita; Peluso, Ivana; Rispoli, Rossella; Pizzo, Mariateresa; Ziviello, Carmela; Banfi, Sandro; Nigro, Vincenzo] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Neveling, Kornelia; Wieskamp, Nienke; Scheffer, Hans] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vozzi, Diego; Athanasakis, Emmanouil; D'Eustacchio, Angela; Fabretto, Antonella; Gasparini, Paolo] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [D'Amico, Francesca; Banfi, Sandro; Nigro, Vincenzo] Seconda Univ Napoli, Dipartimento Patol Gen, Naples, Italy; [Simonelli, Francesca] Seconda Univ Napoli, Dipartimento Oftalmol, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Radboud University Nijmegen; IRCCS Burlo Garofolo; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Licastro, D (corresponding author), Cluster Biomed CBM Scrl Genom, Area Sci Pk, Trieste, Italy.	gasparini@burlo.trieste.it; banfi@tigem.it; vincenzo.nigro@unina2.it	Nigro, Vincenzo/AAB-2274-2022; Simonelli, Francesca/AHE-7571-2022; Neveling, K./L-4544-2015; Banfi, Sandro/K-3963-2018; Scheffer, Hans/E-4644-2012; Mutarelli, Margherita/K-1910-2019; Gasparini, Paolo/B-6173-2014; Athanasakis, Emmanouil/K-1326-2018	Simonelli, Francesca/0000-0001-8520-6769; Banfi, Sandro/0000-0002-6541-8833; Scheffer, Hans/0000-0002-2986-0915; Nigro, Vincenzo/0000-0002-3378-5006; Athanasakis, Emmanouil/0000-0002-7707-2665; Mutarelli, Margherita/0000-0002-2168-5059; vozzi, diego/0000-0002-2902-8184; Licastro, Danilo/0000-0001-8372-9355; Gasparini, Paolo/0000-0002-0859-0856	European Union [223143]; Italian Telethon Foundation; Retina Italia	European Union(European Commission); Italian Telethon Foundation(Fondazione Telethon); Retina Italia	This work was supported by European Union FP7/2007-2013 under grant agreement no. 223143 (project acronym: TECHGENE), by the Italian Telethon Foundation and by Retina Italia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Astuto LM, 2000, AM J HUM GENET, V67, P1569, DOI 10.1086/316889; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Baux D, 2007, HUM MUTAT, V28, P781, DOI 10.1002/humu.20513; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bonnal RJP, 2010, ANAL BIOCHEM, V406, P176, DOI 10.1016/j.ab.2010.07.022; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Chou LS, 2010, CLIN CHEM, V56, P62, DOI 10.1373/clinchem.2009.132639; Cremers FPM, 2007, J MED GENET, V44, P153, DOI 10.1136/jmg.2006.044784; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Espinos C, 1998, Community Genet, V1, P223, DOI 10.1159/000016167; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hope CI, 1997, BRIT J OPHTHALMOL, V81, P46, DOI 10.1136/bjo.81.1.46; Iannaccone A, 2004, INVEST OPHTH VIS SCI, V45, P784, DOI 10.1167/iovs.03-0906; Jaijo T, 2009, INVEST OPHTH VIS SCI, V51, P1311; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kikkawa Y, 2003, HUM MOL GENET, V12, P453, DOI 10.1093/hmg/ddg042; Le Gueard-Mereuze S, 2010, HUM MUTAT, V31, P347, DOI 10.1002/humu.21193; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; MOLLER CG, 1989, LARYNGOSCOPE, V99, P73; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Ng S, 2009, NAT GENET, V42, P30; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; PiekeDahl S, 1996, J MED GENET, V33, P753, DOI 10.1136/jmg.33.9.753; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Spandau UHM, 2002, GRAEF ARCH CLIN EXP, V240, P495, DOI 10.1007/s00417-002-0485-8; Stabej PL, 2012, J MED GENET, V49, P27, DOI 10.1136/jmedgenet-2011-100468; Summerer D, 2009, GENOMICS, V94, P363, DOI 10.1016/j.ygeno.2009.08.012; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Voelkerding KV, 2010, J MOL DIAGN, V12, P539, DOI 10.2353/jmoldx.2010.100043; Vozzi D, 2011, MOL VIS, V17, P1662; Wei XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029500; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 2000, AM J HUM GENET, V66, P1199, DOI 10.1086/302855; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Weston MD, 1996, AM J HUM GENET, V59, P1074; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3	53	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43799	10.1371/journal.pone.0043799	http://dx.doi.org/10.1371/journal.pone.0043799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952768	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000051
J	Lillo, P; Mioshi, E; Burrell, JR; Kiernan, MC; Hodges, JR; Hornberger, M				Lillo, Patricia; Mioshi, Eneida; Burrell, James R.; Kiernan, Matthew C.; Hodges, John R.; Hornberger, Michael			Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT EXPANSION; LOBAR DEGENERATION; WHOLE-BRAIN; CLINICAL CHARACTERISTICS; COGNITIVE IMPAIRMENT; BEHAVIORAL VARIANT; C9ORF72; TDP-43; ATROPHY; PATTERNS	There is increasing evidence that amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) lie on a clinical, pathological and genetic continuum with patients of one disease exhibiting features of the other. Nevertheless, to date, the underlying grey matter and white matter changes across the ALS-FTD disease continuum have not been explored. In this study fifty-three participants with ALS (n = 10), ALS-FTD (n = 10) and behavioural variant FTD (bvFTD; n = 15) as well as controls (n = 18), underwent detailed clinical assessment plus structural imaging using voxel-based morphometry (VBM) and diffusion tensor imaging (DTI) analysis of magnetic resonance brain imaging to examine grey and white matter differences and commonalities across the continuum. Importantly, patient groups were matched for age, education, gender and disease duration. VBM and DTI results showed that changes in the ALS group were confined mainly to the motor cortex and anterior cingulate as well as their underlying white matter tracts. ALS-FTD and bvFTD showed widespread grey matter and white matter changes involving frontal and temporal lobes. Extensive prefrontal cortex changes emerged as a marker for bvFTD compared to other subtypes, while ALS-FTD could be distinguished from ALS by additional temporal lobe grey and white matter changes. Finally, ALS could be mainly distinguished from the other two groups by corticospinal tract degeneration. The present study shows for the first time that FTD and ALS overlap in anterior cingulate, motor cortex and related white matter tract changes across the whole continuum. Nevertheless, frontal and temporal atrophy as well as corticospinal tract degeneration emerged as marker for subtype classification, which will inform future diagnosis and target disease management across the continuum.	[Lillo, Patricia; Mioshi, Eneida; Burrell, James R.; Kiernan, Matthew C.; Hodges, John R.; Hornberger, Michael] Neurosci Res Australia, Sydney, NSW, Australia; [Lillo, Patricia; Mioshi, Eneida; Burrell, James R.; Kiernan, Matthew C.; Hodges, John R.; Hornberger, Michael] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Hodges, John R.; Hornberger, Michael] ARC Ctr Excellence Cognit & Disorders, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Lillo, P (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	m.hornberger@neura.edu.au	Hodges, John R/B-9907-2012; Kiernan, Matthew C/E-4460-2011; Mioshi, Eneida/AAZ-1043-2020; Hornberger, Michael/C-9610-2011; Lillo, Patricia/B-9730-2013	Hornberger, Michael/0000-0002-2214-3788; Kiernan, Matthew/0000-0001-9054-026X; Burrell, James/0000-0001-9638-2768; Lillo, Patricia/0000-0001-7398-7203	Comision Nacional de Investigacion Cientifica y Tecnologica, Government of Chile (CONICYT scholarship); Faculty of Medicine, University of Chile; NHMRC post-doctoral fellowship [1016399]; NHMRC; Australian Research Council Federation Fellowship [FF077622]; Australian Research Council Research Fellowship [DP110104202]	Comision Nacional de Investigacion Cientifica y Tecnologica, Government of Chile (CONICYT scholarship); Faculty of Medicine, University of Chile; NHMRC post-doctoral fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Federation Fellowship(Australian Research Council); Australian Research Council Research Fellowship(Australian Research Council)	PL is supported by Comision Nacional de Investigacion Cientifica y Tecnologica, Government of Chile (CONICYT scholarship) and Faculty of Medicine, University of Chile; EM is supported by an NHMRC post-doctoral fellowship (1016399); JRB is supported by the NHMRC; MCK is supported by the NHMRC; JRH is supported by an Australian Research Council Federation Fellowship (FF077622); and MH is supported by an Australian Research Council Research Fellowship (DP110104202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, NONLINEAR REGISTRATI; Bak TH, 2001, J NEUROL, V248, P260, DOI 10.1007/s004150170199; Boeve BF, 2012, BRAIN, V135, P765, DOI 10.1093/brain/aws004; Boxer AL, 2011, J NEUROL NEUROSUR PS, V82, P196, DOI 10.1136/jnnp.2009.204081; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; Chen ZY, 2010, AMYOTROPH LATERAL SC, V11, P549, DOI 10.3109/17482968.2010.516265; Chio A, 2012, BRAIN, V135, P784, DOI 10.1093/brain/awr366; Cooper-Knock J, 2012, BRAIN, V135, P751, DOI 10.1093/brain/awr365; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Hodges J, 2012, BRAIN, V135, P652, DOI 10.1093/brain/aws033; Hsiung GYR, 2012, BRAIN, V135, P709, DOI 10.1093/brain/awr354; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Li J, 2011, NEUROBIOL AGING, DOI org/10.10161j.neurobiolaging.2011.04.007; Lillo P, 2012, AMYOTROPH LATERAL SC, V13, P102, DOI 10.3109/17482968.2011.639376; Lillo P, 2011, AMYOTROPH LATERAL SC, V12, P45, DOI 10.3109/17482968.2010.520718; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mori H, 2007, AM J NEURORADIOL, V28, P1511, DOI 10.3174/ajnr.A0624; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Phukan J, 2011, J NEUROL NEUROSURG P; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Simon-Sanchez J, 2012, BRAIN, V135, P723, DOI 10.1093/brain/awr353; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Strong MJ, 2003, ANN NEUROL, V54, pS20, DOI 10.1002/ana.10574; Tsujimoto M, 2011, J NEUROL SCI; Turner MR, 2011, LANCET NEUROL, V10, P400, DOI 10.1016/S1474-4422(11)70049-7; Wedderburn C, 2008, J NEUROL NEUROSUR PS, V79, P500, DOI 10.1136/jnnp.2007.122028; Whitwell JL, 2006, NEUROLOGY, V66, P102, DOI 10.1212/01.wnl.0000191395.69438.12; Witgert M, 2010, EUR J NEUROL, V17, P103, DOI 10.1111/j.1468-1331.2009.02801.x; Woolley SC, 2011, AMYOTROPH LATERAL SC, V12, P52, DOI 10.3109/17482968.2010.521842; Woolley SC, 2010, AMYOTROPH LATERAL SC, V11, P303, DOI 10.3109/17482961003727954; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	52	132	133	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43993	10.1371/journal.pone.0043993	http://dx.doi.org/10.1371/journal.pone.0043993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952843	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000066
J	Backlund, L; Lavebratt, C; Frisen, L; Nikamo, P; Sudic, DH; Traskman-Bendz, L; Landen, M; Edman, G; Vawter, MP; Osby, U; Schalling, M				Backlund, Lena; Lavebratt, Catharina; Frisen, Louise; Nikamo, Pernilla; Sudic, Dzana Hukic; Traskman-Bendz, Lil; Landen, Mikael; Edman, Gunnar; Vawter, Marquis P.; Osby, Urban; Schalling, Martin			P2RX7: Expression Responds to Sleep Deprivation and Associates with Rapid Cycling in Bipolar Disorder Type 1	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NEUROTROPHIC FACTOR BDNF; SYNTHASE KINASE-3; P2X(7) RECEPTORS; PHASE-SHIFTS; MOOD; GENE; LITHIUM; ANTIDEPRESSANTS; GLUTAMATE	Context: Rapid cycling is a severe form of bipolar disorder with an increased rate of episodes that is particularly treatment-responsive to chronotherapy and stable sleep-wake cycles. We hypothesized that the P2RX7 gene would be affected by sleep deprivation and be implicated in rapid cycling. Objectives: To assess whether P2RX7 expression is affected by total sleep deprivation and if variation in P2RX7 is associated with rapid cycling in bipolar patients. Design: Gene expression analysis in peripheral blood mononuclear cells (PBMCs) from healthy volunteers and case-case and case-control SNP/haplotype association analyses in patients. Participants: Healthy volunteers at the sleep research center, University of California, Irvine Medical Center (UCIMC), USA (n = 8) and Swedish outpatients recruited from specialized psychiatric clinics for bipolar disorder, diagnosed with bipolar disorder type 1 (n = 569; rapid cycling: n = 121) and anonymous blood donor controls (n = 1,044). Results: P2RX7 RNA levels were significantly increased during sleep deprivation in PBMCs from healthy volunteers (p = 2.3*10(-9)). The P2RX7 rs2230912_A allele was more common (OR = 2.2, p = 0.002) and the ACGTTT haplotype in P2RX7 (rs1718119 to rs1621388) containing the protective rs2230912_G allele (OR = 0.45-0.49, p = 0.003-0.005) was less common, among rapid cycling cases compared to non-rapid cycling bipolar patients and blood donor controls. Conclusions: Sleep deprivation increased P2RX7 expression in healthy persons and the putatively low-activity P2RX7 rs2230912 allele A variant was associated with rapid cycling in bipolar disorder. This supports earlier findings of P2RX7 associations to affective disorder and is in agreement with that particularly rapid cycling patients have a more vulnerable diurnal system.	[Backlund, Lena; Frisen, Louise; Landen, Mikael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lavebratt, Catharina; Frisen, Louise; Nikamo, Pernilla; Sudic, Dzana Hukic; Edman, Gunnar; Osby, Urban; Schalling, Martin] Karolinska Inst, Neurogenet Unit, Dept Mol Med & Surg, Stockholm, Sweden; [Lavebratt, Catharina; Frisen, Louise; Nikamo, Pernilla; Sudic, Dzana Hukic; Edman, Gunnar; Osby, Urban; Schalling, Martin] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Traskman-Bendz, Lil] Univ Lund Hosp, Dept Clin Sci, S-22185 Lund, Sweden; [Landen, Mikael] Gothenburg Univ, Inst Neurosci & Physiol, Sahlgrenska Acad, S-41124 Gothenburg, Sweden; [Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Funct Genom Lab, Sch Med, Irvine, CA 92717 USA; [Edman, Gunnar; Osby, Urban] Tiohundra AB, Dept Psychiat, Norrtalje, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; University of Gothenburg; University of California System; University of California Irvine	Backlund, L (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	lena.backlund@sll.se	Landen, Mikael/AAD-7917-2020; Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922; Backlund, Lena/0000-0001-9399-5024; Lavebratt, Catharina/0000-0003-4987-2718	Karolinska Institutet; Swedish Research Council; Soderstrom-Konigska Foundation; Royal Physiographic Society in Lund; Fredrik and Ingrid Thuring Foundation; Psychiatry Southwest, Stockholm; Stockholm County Council; National Institute of Mental Health (NIMH) [R01MH085801]; Bristol-Myers Squibb; Janssen-Cilag; AstraZeneca; Eli Lilly; Pfizer; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801] Funding Source: NIH RePORTER	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderstrom-Konigska Foundation; Royal Physiographic Society in Lund; Fredrik and Ingrid Thuring Foundation; Psychiatry Southwest, Stockholm; Stockholm County Council(Stockholm County Council); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Pfizer(Pfizer); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by grants from Karolinska Institutet, the Swedish Research Council, The Soderstrom-Konigska Foundation, The Royal Physiographic Society in Lund, the Fredrik and Ingrid Thuring Foundation and Psychiatry Southwest, Stockholm. Financial support was also provided through the regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institutet. The research was further supported by the William Lion Penzner Foundation (Department of Psychiatry and Human Behavior, University of California, Irvine), and National Institute of Mental Health (NIMH) grant R01MH085801 (MPV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: LB has received consultancy fees from Bristol-Myers Squibb and has been reimbursed by Eli Lilly and Bristol-Myers Squibb for attending conferences and presenting lectures. UO has received grant/research support from Bristol-Myers Squibb and Janssen-Cilag and has been a consultant for or received fees for speaking and attending conferences from AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Pfizer. GE has been a consultant for AstraZeneca and Janssen-Cilag and his wife is a shareholder of AstraZeneca. ML has been reimbursed by Eli Lilly, AstraZeneca and Wyeth for lectures, serves on advisory boards for AstraZeneca and Lundbeck, and has received research grants from AstraZeneca. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angst J, 2000, BIOL PSYCHIAT, V48, P445, DOI 10.1016/S0006-3223(00)00909-4; Armstrong JN, 2002, J NEUROSCI, V22, P5938; Ashman SB, 1999, PSYCHIAT RES, V86, P1, DOI 10.1016/S0165-1781(99)00019-0; Avasthi A, 1999, J AFFECT DISORDERS, V54, P67, DOI 10.1016/S0165-0327(98)00135-9; Azorin JM, 2008, CNS SPECTRUMS, V13, P780, DOI 10.1017/S1092852900013900; Backlund L, 2011, BIPOLAR DISORD, V13, P500, DOI 10.1111/j.1399-5618.2011.00952.x; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Bauer M, 2008, BIPOLAR DISORD, V10, P153, DOI 10.1111/j.1399-5618.2007.00560.x; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Coryell W, 2003, ARCH GEN PSYCHIAT, V60, P914, DOI 10.1001/archpsyc.60.9.914; Csolle C, 2012, INT J NEUROPSYCHOPH, V16, P1; Cusin C, 2001, J PSYCHIAT RES, V35, P217, DOI 10.1016/S0022-3956(01)00026-7; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Denlinger LC, 2006, CLIN CHEM, V52, P995, DOI 10.1373/clinchem.2005.065425; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Dubovsky S L, 2001, Curr Psychiatry Rep, V3, P451, DOI 10.1007/s11920-001-0038-6; Erhardt A, 2007, J AFFECT DISORDERS, V101, P159, DOI 10.1016/j.jad.2006.11.016; FeldmanNaim S, 1997, J CLIN PSYCHIAT, V58, P79, DOI 10.4088/JCP.v58n0205; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Green EK, 2006, BRIT J PSYCHIAT, V188, P21, DOI 10.1192/bjp.bp.105.009969; Green EK, 2009, AM J MED GENET B, V150B, P1063, DOI 10.1002/ajmg.b.30931; Grunze H, 2002, NEUROPSYCHOBIOLOGY, V45, P20, DOI 10.1159/000049257; Hamshere ML, 2009, BIPOLAR DISORD, V11, P610, DOI 10.1111/j.1399-5618.2009.00736.x; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johansson AS, 2011, J BIOL RHYTHM, V26, P541, DOI 10.1177/0748730411419775; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kim DY, 2005, EUR J NEUROSCI, V21, P1215, DOI 10.1111/j.1460-9568.2005.03950.x; Kirov G, 1998, MOL PSYCHIATR, V3, P342, DOI 10.1038/sj.mp.4000385; Kupka RW, 2005, AM J PSYCHIAT, V162, P1273, DOI 10.1176/appi.ajp.162.7.1273; Kupka RW, 2003, J CLIN PSYCHIAT, V64, P1483, DOI 10.4088/JCP.v64n1213; KURIAN SM, 2009, MOL PSYCHIAT; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Lavebratt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009407; Leibenluft E, 1996, PSYCHIAT RES, V63, P161, DOI 10.1016/0165-1781(96)02854-5; Licht RW, 2008, ACTA PSYCHIAT SCAND, V118, P337, DOI 10.1111/j.1600-0447.2008.01237.x; Liu YD, 2007, J BIOL CHEM, V282, P8594, DOI 10.1074/jbc.M610230200; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; McQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6; Muller DJ, 2006, BRIT J PSYCHIAT, V189, P317, DOI 10.1192/bjp.bp.105.010587; Murray G, 2010, BIPOLAR DISORD, V12, P459, DOI 10.1111/j.1399-5618.2010.00843.x; Niculescu AB, 2010, AM J MED GENET B, V153B, P847, DOI 10.1002/ajmg.b.31076; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Perlis RH, 2009, AM J PSYCHIAT, V166, P718, DOI 10.1176/appi.ajp.2009.08111633; Rosa AR, 2010, J CLIN PSYCHIAT, V71, P1000, DOI 10.4088/JCP.09m05026gre; Rousseva A, 2003, PHARMACOGENOMICS J, V3, P101, DOI 10.1038/sj.tpj.6500156; Ryden E, 2009, ACTA PSYCHIAT SCAND, V120, P239, DOI 10.1111/j.1600-0447.2009.01399.x; Schneck CD, 2004, AM J PSYCHIAT, V161, P1902, DOI 10.1176/appi.ajp.161.10.1902; Schulze TG, 2005, AM J PSYCHIAT, V162, P2101, DOI 10.1176/appi.ajp.162.11.2101; Shink E, 2005, MOL PSYCHIATR, V10, P545, DOI 10.1038/sj.mp.4001601; Sjoholm LK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012632; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tamaru T, 2000, J NEUROSCI, V20, P7525; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Young A, 2009, EVID-BASED MENT HEAL, V12, P49, DOI 10.1136/ebmh.12.2.49	68	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43057	10.1371/journal.pone.0043057	http://dx.doi.org/10.1371/journal.pone.0043057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952630	Green Published, gold			2022-12-27	WOS:000308213600013
J	Drelon, C; Berthon, A; Ragazzon, B; Tissier, F; Bandiera, R; Sahut-Barnola, I; de Joussineau, C; Batisse-Lignier, M; Lefrancois-Martinez, AM; Bertherat, J; Martinez, A; Val, P				Drelon, Coralie; Berthon, Annabel; Ragazzon, Bruno; Tissier, Frederique; Bandiera, Roberto; Sahut-Barnola, Isabelle; de Joussineau, Cyrille; Batisse-Lignier, Marie; Lefrancois-Martinez, Anne-Marie; Bertherat, Jerome; Martinez, Antoine; Val, Pierre			Analysis of the Role of Igf2 in Adrenal Tumour Development in Transgenic Mouse Models	PLOS ONE			English	Article							GROWTH-FACTOR-II; BETA-CATENIN; ADRENOCORTICAL TUMORS; BECKWITH-WIEDEMANN; SONIC-HEDGEHOG; INTESTINAL ADENOMA; BINDING PROTEIN-2; EXPRESSION; PROLIFERATION; CANCER	Adrenal cortical carcinomas (ACC) are rare but aggressive tumours associated with poor prognosis. The two most frequent alterations in ACC in patients are overexpression of the growth factor IGF2 and constitutive activation of Wnt/beta-catenin signalling. Using a transgenic mouse model, we have previously shown that constitutive active beta-catenin is a bona fide adrenal oncogene. However, although all these mice developed benign adrenal hyperplasia, malignant progression was infrequent, suggesting that secondary genetic events were required for aggressive tumour development. In the present paper, we have tested IGF2 oncogenic properties by developing two distinct transgenic mouse models of Igf2 overexpression in the adrenal cortex. Our analysis shows that despite overexpression levels ranging from 7 (basal) to 87 (ACTH-induced) fold, Igf2 has no tumour initiating potential in the adrenal cortex. However, it induces aberrant accumulation of Gli1 and Pod1-positive progenitor cells, in a hedgehog-independent manner. We have also tested the hypothesis that Igf2 may cooperate with Wnt signalling by mating Igf2 overexpressing lines with mice that express constitutive active beta-catenin in the adrenal cortex. We show that the combination of both alterations has no effect on tumour phenotype at stages when beta-catenin-induced tumours are benign. However, there is a mild promoting effect at later stages, characterised by increased Weiss score and proliferation. Formation of malignant tumours is nonetheless a rare event, even when Igf2 expression is further increased by ACTH treatment. Altogether these experiments suggest that the growth factor IGF2 is a mild contributor to malignant adrenocortical tumourigenesis.	[Drelon, Coralie; Berthon, Annabel; Sahut-Barnola, Isabelle; de Joussineau, Cyrille; Batisse-Lignier, Marie; Lefrancois-Martinez, Anne-Marie; Martinez, Antoine; Val, Pierre] Univ Blaise Pascal, Clermont Univ, GReD, Clermont Ferrand, France; [Drelon, Coralie; Berthon, Annabel; Sahut-Barnola, Isabelle; de Joussineau, Cyrille; Batisse-Lignier, Marie; Lefrancois-Martinez, Anne-Marie; Martinez, Antoine; Val, Pierre] GReD, CNRS UMR 6293, Aubiere, France; [Drelon, Coralie; Berthon, Annabel; Sahut-Barnola, Isabelle; de Joussineau, Cyrille; Batisse-Lignier, Marie; Lefrancois-Martinez, Anne-Marie; Martinez, Antoine; Val, Pierre] GReD, Inserm U1103, Aubiere, France; [Ragazzon, Bruno; Tissier, Frederique; Bertherat, Jerome] Univ Paris 05, Inst Cochin, CNRS UMR 8104, Paris, France; [Ragazzon, Bruno; Tissier, Frederique; Bertherat, Jerome] Inserm U1016, Paris, France; [Ragazzon, Bruno; Tissier, Frederique; Bertherat, Jerome] Hop Cochin, AP HP, Dept Endocrinol, Reference Ctr Rare Adrenal Dis, F-75674 Paris, France; [Bandiera, Roberto] Inserm UMR636, Nice, France; [Batisse-Lignier, Marie] Ctr Hosp Univ, Fac Med, Serv Endocrinol, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand	Drelon, C (corresponding author), Univ Blaise Pascal, Clermont Univ, GReD, Clermont Ferrand, France.	pierre.val@univ-bpclermont.fr	Ragazzon, Bruno/E-6541-2017; Berthon, Annabel/T-1729-2019; Berthon, Annabel/AAG-6890-2019	Ragazzon, Bruno/0000-0001-9476-4973; BERTHERAT, Jerome/0000-0003-2551-3008; Val, Pierre/0000-0001-7648-5567; Berthon, Annabel/0000-0002-5576-9525	Universite Blaise Pascal; Universite d'Auvergne; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Association pour la Recherche contre le Cancer (ARC) [SFI 20101201397]; La Ligue Regionale Contre le Cancer, Allier committee	Universite Blaise Pascal; Universite d'Auvergne; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); La Ligue Regionale Contre le Cancer, Allier committee	This project was supported by Universite Blaise Pascal; Universite d'Auvergne; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Association pour la Recherche contre le Cancer (ARC, grant #SFI 20101201397) and La Ligue Regionale Contre le Cancer, Allier committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Almeida MQ, 2008, J CLIN ENDOCR METAB, V93, P3524, DOI 10.1210/jc.2008-0065; Assie G, 2007, J CLIN ENDOCR METAB, V92, P148, DOI 10.1210/jc.2006-0706; Barlaskar FM, 2009, J CLIN ENDOCR METAB, V94, P204, DOI 10.1210/jc.2008-1456; Berruti A, 2005, ENDOCR-RELAT CANCER, V12, P657, DOI 10.1677/erc.1.01025; Berthon A, 2012, MOL CELL ENDOCRINOL, V351, P87, DOI 10.1016/j.mce.2011.09.009; Berthon A, 2010, HUM MOL GENET, V19, P1561, DOI 10.1093/hmg/ddq029; Bielinska M, 2006, VET PATHOL, V43, P97, DOI 10.1354/vp.43-2-97; Boulle N, 1998, J CLIN ENDOCR METAB, V83, P1713, DOI 10.1210/jc.83.5.1713; Corcoran RB, 2008, CANCER RES, V68, P8788, DOI 10.1158/0008-5472.CAN-08-2135; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de Fraipont F, 2005, J CLIN ENDOCR METAB, V90, P1819, DOI 10.1210/jc.2004-1075; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fernandez C, 2010, DEV NEUROSCI-BASEL, V32, P59, DOI 10.1159/000274458; Gaujoux S, 2011, CLIN CANCER RES, V17, P328, DOI 10.1158/1078-0432.CCR-10-2006; Gicquel C, 1997, J CLIN ENDOCR METAB, V82, P2559, DOI 10.1210/jc.82.8.2559; Gicquel C, 2001, CANCER RES, V61, P6762; Giordano TJ, 2003, AM J PATHOL, V162, P521, DOI 10.1016/S0002-9440(10)63846-1; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hardouin SN, 2011, DEVELOPMENT, V138, P203, DOI 10.1242/dev.054916; Harper J, 2006, CANCER RES, V66, P1940, DOI 10.1158/0008-5472.CAN-05-2036; Hartmann W, 2005, AM J PATHOL, V166, P1153, DOI 10.1016/S0002-9440(10)62335-8; Hassan AB, 2000, CANCER RES, V60, P1070; Hoeflich A, 2000, CANCER RES, V60, P834; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Hu MC, 1999, ENDOCRINOLOGY, V140, P5609, DOI 10.1210/en.140.12.5609; Icard P, 2001, WORLD J SURG, V25, P891, DOI 10.1007/s00268-001-0047-y; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; King P, 2009, P NATL ACAD SCI USA, V106, P21185, DOI 10.1073/pnas.0909471106; Lambert-Langlais S, 2009, MOL CELL ENDOCRINOL, V300, P197, DOI 10.1016/j.mce.2008.10.045; Laufer E, 2012, MOL CELL ENDOCRINOL, V351, P19, DOI 10.1016/j.mce.2011.10.002; Lefrancois-Martinez AM, 2004, J CLIN ENDOCR METAB, V89, P3010, DOI 10.1210/jc.2003-031830; Mattos GE, 2011, CELL TISSUE RES, V345, P343, DOI 10.1007/s00441-011-1220-8; MCCAULEY RGK, 1991, AM J ROENTGENOL, V157, P549, DOI 10.2214/ajr.157.3.1872243; Moorehead RA, 2003, ONCOGENE, V22, P853, DOI 10.1038/sj.onc.1206188; Moorehead RA, 2001, CELL DEATH DIFFER, V8, P16, DOI 10.1038/sj.cdd.4400762; Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660; Papotti Mauro, 2011, Hormones & Cancer, V2, P333, DOI 10.1007/s12672-011-0088-0; Romero DG, 2007, ENDOCRINOLOGY, V148, P2644, DOI 10.1210/en.2006-1509; Rump P, 2005, AM J MED GENET A, V136A, P95, DOI 10.1002/ajmg.a.30729; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Taurin S, 2008, AM J PHYSIOL-CELL PH, V294, pC1169, DOI 10.1152/ajpcell.00096.2008; Terzolo M, 2007, NEW ENGL J MED, V356, P2372, DOI 10.1056/NEJMoa063360; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Val P, 2006, DEV BIOL, V299, P250, DOI 10.1016/j.ydbio.2006.07.030; Verras M, 2005, MOL ENDOCRINOL, V19, P391, DOI 10.1210/me.2004-0208; Wajchenberg BL, 2000, CANCER-AM CANCER SOC, V88, P711, DOI 10.1002/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W; Weber MM, 1997, EUR J ENDOCRINOL, V136, P296, DOI 10.1530/eje.0.1360296; Weber MM, 1999, ENDOCRINOLOGY, V140, P1537, DOI 10.1210/en.140.4.1537; Zini L, 2011, EUR UROL, V60, P1055, DOI 10.1016/j.eururo.2011.07.062	58	60	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44171	10.1371/journal.pone.0044171	http://dx.doi.org/10.1371/journal.pone.0044171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952916	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600087
J	Hart, AB; Engelhardt, BE; Wardle, MC; Sokoloff, G; Stephens, M; de Wit, H; Palmer, AA				Hart, Amy B.; Engelhardt, Barbara E.; Wardle, Margaret C.; Sokoloff, Greta; Stephens, Matthew; de Wit, Harriet; Palmer, Abraham A.			Genome-Wide Association Study of d-Amphetamine Response in Healthy Volunteers Identifies Putative Associations, Including Cadherin 13 (CDH13)	PLOS ONE			English	Article							SMOKING-CESSATION SUCCESS; MOLECULAR-GENETICS; SUBJECTIVE RESPONSE; NICOTINE DEPENDENCE; ALCOHOL; BRAIN; STIMULANT; VARIANTS; GENOTYPE; HUMANS	Both the subjective response to d-amphetamine and the risk for amphetamine addiction are known to be heritable traits. Because subjective responses to drugs may predict drug addiction, identifying alleles that influence acute response may also provide insight into the genetic risk factors for drug abuse. We performed a Genome Wide Association Study (GWAS) for the subjective responses to amphetamine in 381 non-drug abusing healthy volunteers. Responses to amphetamine were measured using a double-blind, placebo-controlled, within-subjects design. We used sparse factor analysis to reduce the dimensionality of the data to ten factors. We identified several putative associations; the strongest was between a positive subjective drug-response factor and a SNP (rs3784943) in the 8th intron of cadherin 13 (CDH13; P = 4.58 x 10(-8)), a gene previously associated with a number of psychiatric traits including methamphetamine dependence. Additionally, we observed a putative association between a factor representing the degree of positive affect at baseline and a SNP (rs472402) in the 1st intron of steroid-5-alpha-reductase-alpha-polypeptide-1 (SRD5A1; P = 2.53 x 10(-7)), a gene whose protein product catalyzes the rate-limiting step in synthesis of the neurosteroid allopregnanolone. This SNP belongs to an LD-block that has been previously associated with the expression of SRD5A1 and differences in SRD5A1 enzymatic activity. The purpose of this study was to begin to explore the genetic basis of subjective responses to stimulant drugs using a GWAS approach in a modestly sized sample. Our approach provides a case study for analysis of high-dimensional intermediate pharmacogenomic phenotypes, which may be more tractable than clinical diagnoses.	[Hart, Amy B.; Engelhardt, Barbara E.; Sokoloff, Greta; Stephens, Matthew; Palmer, Abraham A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Engelhardt, Barbara E.] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [Wardle, Margaret C.; de Wit, Harriet; Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Hart, AB (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	aap@uchicago.edu	Palmer, Abraham/L-2158-2014; Wardle, Margaret/M-5157-2016	Palmer, Abraham/0000-0003-3634-0747; Wardle, Margaret/0000-0001-6071-6105; de Wit, Harriet/0000-0002-7211-8994; Engelhardt, Barbara/0000-0002-6139-7334; Sokoloff, Greta/0000-0003-3651-1980	NIH [DA007255, HG006265, HG002585, DA02812, DA021336, DA024845]; Bioinformatics Research Development Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585, R00HG006265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021336, R01DA002812, R21DA024845, T32DA007255] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bioinformatics Research Development Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants, DA007255 (ABH and MCW), HG006265 (to BEE), HG002585 (to MS), DA02812 (to HdW), and DA021336 and DA024845 (to AAP). BEE was also funded through the Bioinformatics Research Development Fund, supported by Kathryn and George Gould. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DE, 2011, MOL PSYCHIATR, V16, P321, DOI 10.1038/mp.2010.14; Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; Alliey-Rodriguez N, 2011, PSYCHIAT GENET, V21, P190, DOI 10.1097/YPG.0b013e3283457a31; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arias-Vasquez A, 2011, GENES BRAIN BEHAV; Best T, 2011, NAT MED, V17, P941, DOI 10.1038/nm.2407; Brot MD, 1997, EUR J PHARMACOL, V325, P1, DOI 10.1016/S0014-2999(97)00096-4; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; CHAIT LD, 1985, DRUG ALCOHOL DEPEN, V15, P229, DOI 10.1016/0376-8716(85)90002-X; Chen XG, 2003, NICOTINE TOB RES, V5, P455, DOI 10.1080/14622200307239; Childs E, 2010, EXP CLIN PSYCHOPHARM, V18, P78, DOI 10.1037/a0018060; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; CRABBE JC, 1983, ACTA GENET MED GEMEL, V32, P139, DOI 10.1017/S0001566000006425; Daly AK, 2010, NAT REV GENET, V11, P241, DOI 10.1038/nrg2751; de Moor MHM, 2010, MOL PSYCHIAT; de Wit H, 2004, NEBR SYM MOTIV, V50, P19; de Wit H, 2001, PSYCHONEUROENDOCRINO, V26, P697, DOI 10.1016/S0306-4530(01)00024-5; DiFranza JR, 2004, ADDICT BEHAV, V29, P261, DOI 10.1016/j.addbeh.2003.08.002; Dlugos A, 2007, BIOL PSYCHIAT, V61, P1296, DOI 10.1016/j.biopsych.2006.09.031; Dlugos AM, 2010, NEUROPSYCHOPHARMACOL, V35, P613, DOI 10.1038/npp.2009.166; Dlugos AM, 2009, PSYCHOPHARMACOLOGY, V206, P501, DOI 10.1007/s00213-009-1628-y; Drgon T, 2009, MOL MED, V15, P21, DOI 10.2119/molmed.2008.00096; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Ellis JA, 2005, J HUM GENET, V50, P534, DOI 10.1007/s10038-005-0289-x; Engelhardt BE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001117; Fergusson DM, 2003, ARCH GEN PSYCHIAT, V60, P1033, DOI 10.1001/archpsyc.60.10.1033; Flanagin BA, 2006, AM J MED GENET B, V141B, P576, DOI 10.1002/ajmg.b.30327; FOLTIN RW, 1991, DRUG ALCOHOL DEPEN, V28, P3, DOI 10.1016/0376-8716(91)90052-Z; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Goldman David, 2007, ScientificWorldJournal, V7, P124; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Hamidovic A, 2010, PSYCHIAT GENET, V20, P85, DOI 10.1097/YPG.0b013e32833a1f3c; Hamidovic A, 2009, EXP CLIN PSYCHOPHARM, V17, P374, DOI 10.1037/a0017840; Hamidovic A, 2010, BEHAV GENET, V40, P255, DOI 10.1007/s10519-009-9331-7; Hart AB, 2012, BHEAV NEUROGENETICS; Hodgkinson CA, 2010, P NATL ACAD SCI USA, V107, P8695, DOI 10.1073/pnas.0908134107; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; JOHANSON CE, 1980, PSYCHOPHARMACOLOGY, V71, P269, DOI 10.1007/BF00433061; Johnson C, 2006, AM J MED GENET B, V141B, P844, DOI 10.1002/ajmg.b.30346; Johnson CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016491, 10.1371/journal.pone.0021046, 10.1371/journal.pone.0019210]; King AC, 2011, ARCH GEN PSYCHIAT, V68, P389, DOI 10.1001/archgenpsychiatry.2011.26; Kirisci L, 2007, PSYCHOL ADDICT BEHAV, V21, P287, DOI 10.1037/0893-164X.21.3.287; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Le Strat Y, 2009, ADDICTION, V104, P1710, DOI 10.1111/j.1360-0443.2009.02680.x; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Lott DC, 2006, AM J ADDICTION, V15, P327, DOI 10.1080/10550490600859868; Lott DC, 2005, NEUROPSYCHOPHARMACOL, V30, P602, DOI 10.1038/sj.npp.1300637; Lynskey MT, 2007, DRUG ALCOHOL DEPEN, V86, P147, DOI 10.1016/j.drugalcdep.2006.05.023; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Milivojevic V, 2011, ALCOHOL CLIN EXP RES, V35, P946, DOI 10.1111/j.1530-0277.2010.01425.x; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P906, DOI 10.1016/j.jaac.2010.06.007; NURNBERGER JI, 1982, PSYCHONEUROENDOCRINO, V7, P163, DOI 10.1016/0306-4530(82)90009-9; Palmer AA, 2012, HUM GENET, V131, P931, DOI 10.1007/s00439-011-1123-5; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; R Core Development Team, 2009, R LANG ENV STAT COMP; Rivero O, 2013, EUR NEUROPSYCHOPHARM, V23, P492, DOI 10.1016/j.euroneuro.2012.06.009; Roweis S, 1998, ADV NEUR IN, V10, P626; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Soderpalm AHV, 2004, PSYCHONEUROENDOCRINO, V29, P339, DOI 10.1016/S0306-4530(03)00033-7; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; Tanaka Y, 2011, HUMAN MOL GENETICS; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Terracciano A, 2010, BIOL PSYCHIAT, V68, P811, DOI 10.1016/j.biopsych.2010.06.030; THIGPEN AE, 1993, J CLIN INVEST, V92, P903, DOI 10.1172/JCI116665; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Uher R, 2010, AM J PSYCHIAT, V167, P555, DOI 10.1176/appi.ajp.2009.09070932; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Uhl GR, 2010, PHARMACOGENOMICS, V11, P357, DOI [10.2217/pgs.09.156, 10.2217/PGS.09.156]; Veenstra-VanderWeele J, 2006, NEUROPSYCHOPHARMACOL, V31, P1056, DOI 10.1038/sj.npp.1300936; Verbeek J, 2002, IAS UVA; Weber F, 2011, PHARMACOGENOMICS J; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Yang B-Z, 2011, NEUROPSYCHOPHARMACOL; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhou KX, 2008, AM J MED GENET B, V147B, P1392, DOI 10.1002/ajmg.b.30878	87	56	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42646	10.1371/journal.pone.0042646	http://dx.doi.org/10.1371/journal.pone.0042646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952603	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600007
J	Li, YL; Zhao, L; Sun, HG; Yu, JK; Li, N; Liang, JW; Wang, Y; He, M; Bai, XF; Yu, ZJ; Zheng, ZH; Mi, XY; Wang, EH; Wei, MJ				Li, Yanlin; Zhao, Lin; Sun, Haigang; Yu, Jiankun; Li, Na; Liang, Jingwei; Wang, Yan; He, Miao; Bai, Xuefeng; Yu, Zhaojin; Zheng, Zhihong; Mi, Xiaoyi; Wang, Enhua; Wei, Minjie			Gene Silencing of FANCF Potentiates the Sensitivity to Mitoxantrone through Activation of JNK and p38 Signal Pathways in Breast Cancer Cells	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; ANEMIA/BRCA PATHWAY; FA/BRCA PATHWAY; PROMOTER HYPERMETHYLATION; INDUCED APOPTOSIS; TOPOISOMERASE-II; DNA-DAMAGE; RESISTANCE; INHIBITORS; EXPRESSION	Fanconi anemia complementation group-F (FANCF) is a key factor to maintain the function of FA/BRCA, a DNA-damage response pathway. However, the functional role of FANCF in breast cancer has not been elucidated. In this study, we examined the effects and mechanisms of FANCF-RNAi on the sensitivity of breast cancer cells to mitoxantrone (MX). FANCF silencing by FANCF-shRNA blocked functions of FA/BRCA pathway through inhibition of FANCD2 mono-ubiquitination in breast cancer cell lines MCF-7 and T-47D. In addition, FANCF shRNA inhibited cell proliferation, induced apoptosis, and chromosome fragmentation in both breast cancer cells. We also found that FANCF silencing potentiated the sensitivity to MX in breast cancer cells, accompanying with an increase in intracellular MX accumulation and a decrease in BCRP expression. Furthermore, we found that the blockade of FA/BRCA pathway by FANCF-RNAi activated p38 and JNK MAPK signal pathways in response to MX treatment. BCRP expression was restored by p38 inhibitor SB203580, but not by JNK inhibitor SP600125. FANCF silencing increased JNK and p38 mediated activation of p53 in MX-treated breast cancer cells, activated the mitochondrial apoptosis pathway. Our findings indicate that FANCF shRNA potentiates the sensitivity of breast cancer cells to MX, suggesting that FANCF may be a potential target for therapeutic strategies for the treatment of breast tumors.	[Li, Yanlin; Zhao, Lin; Sun, Haigang; Yu, Jiankun; Li, Na; Liang, Jingwei; Wang, Yan; He, Miao; Bai, Xuefeng; Yu, Zhaojin; Wei, Minjie] China Med Univ, Dept Pharmacol, Shenyang, Liaoning, Peoples R China; [Zheng, Zhihong; Mi, Xiaoyi; Wang, Enhua; Wei, Minjie] China Med Univ, Inst Pathophysiol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Wei, MJ (corresponding author), China Med Univ, Dept Pharmacol, Shenyang, Liaoning, Peoples R China.	weiminjiecmu@163.com			National Natural Science Foundation of China [30873097, 30973559]; Specialized Research Fund for the Doctoral Program of Higher Education [20092104110020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Natural Science Foundation of China (No 30873097 and No 30973559) and this study was also supported by the Specialized Research Fund for the Doctoral Program of Higher Education (No 20092104110020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alan D, 2010, NEW ENGL J MED, V362, P1909, DOI DOI 10.1056/NEJMRA0809889; Alpi AF, 2009, DNA REPAIR, V8, P430, DOI 10.1016/j.dnarep.2009.01.019; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bakker ST, 2011, J PATHOLOGY; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Briot D, 2008, BLOOD, V111, P1913, DOI 10.1182/blood-2007-07-099218; Casado JA, 2008, MOL CANCER THER, V7, P1309, DOI 10.1158/1535-7163.MCT-07-2432; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; Cleator SJ, 2005, ANN ONCOL, V16, P267, DOI 10.1093/annonc/mdi049; D'Andrea AD, 2003, CELL CYCLE, V2, P290, DOI 10.4161/cc.2.4.413; Evseenko DA, 2007, DRUG METAB DISPOS, V35, P595, DOI 10.1124/dmd.106.011478; Follin-Arbelet V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-301; Hazlehurst LA, 2006, CANCER RES, V66, P2338, DOI 10.1158/0008-5472.CAN-05-3256; HOULBROOK S, 1995, BRIT J CANCER, V72, P1454, DOI 10.1038/bjc.1995.529; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Jang JY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-262; Kachnic LA, 2011, CANCER LETT, V305, P86, DOI 10.1016/j.canlet.2011.02.030; Kanagasabai R, 2011, J BIOL CHEM, V286, P33289, DOI 10.1074/jbc.M111.249102; Kim J, 2011, J BREAST CANCER, V14, P39, DOI 10.4048/jbc.2011.14.1.39; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Klaude M, 1996, MUTAT RES-DNA REPAIR, V363, P89, DOI 10.1016/0921-8777(95)00063-1; Kumpulainen EJ, 2008, ACTA ONCOL, V47, P120, DOI 10.1080/02841860701518074; Lim SL, 2008, BRIT J CANCER, V98, P1452, DOI 10.1038/sj.bjc.6604325; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lyakhovich A, 2007, CELL CYCLE, V6, P1019, DOI 10.4161/cc.6.9.4223; Marsit CJ, 2004, ONCOGENE, V23, P1000, DOI 10.1038/sj.onc.1207256; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Mooney LM, 2002, BRIT J CANCER, V87, P909, DOI 10.1038/sj.bjc.6600541; Nam C, 2006, NEUROTOXICOL TERATOL, V28, P664, DOI 10.1016/j.ntt.2006.09.021; Narayan G, 2004, CANCER RES, V64, P2994, DOI 10.1158/0008-5472.CAN-04-0245; Neveling K, 2007, CYTOGENET GENOME RES, V118, P166, DOI 10.1159/000108297; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Peng H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005676; Qi XD, 2011, ANTI-CANCER DRUG, V22, P556, DOI 10.1097/CAD.0b013e328345b4e7; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Sabisz M, 2010, BIOCHEM PHARMACOL, V79, P1387, DOI 10.1016/j.bcp.2009.12.023; Salerno S, 2010, CURR MED CHEM, V17, P4270, DOI 10.2174/092986710793361252; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stadheim TA, 2002, LEUKEMIA RES, V26, P55, DOI 10.1016/S0145-2126(01)00099-6; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tang D, 2011, ONCOGENE, V30, P1851, DOI 10.1038/onc.2010.573; Tischkowitz M, 2003, BRIT J HAEMATOL, V123, P469, DOI 10.1046/j.1365-2141.2003.04640.x; Tumini E, 2011, DNA REPAIR, V10, P149, DOI 10.1016/j.dnarep.2010.10.006; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang Zuomin, 2006, CHINESE J STOMATOLOG, V5, P5, DOI DOI 10.1021/0L060112G	53	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44254	10.1371/journal.pone.0044254	http://dx.doi.org/10.1371/journal.pone.0044254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952942	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600099
J	Dibaj, P; Zschuntzsch, J; Steffens, H; Scheffel, J; Goricke, B; Weishaupt, JH; Le Meur, K; Kirchhoff, F; Hanisch, UK; Schomburg, ED; Neusch, C				Dibaj, Payam; Zschuentzsch, Jana; Steffens, Heinz; Scheffel, Joerg; Goericke, Bettina; Weishaupt, Jochen H.; Le Meur, Karim; Kirchhoff, Frank; Hanisch, Uwe-Karsten; Schomburg, Eike D.; Neusch, Clemens			Influence of Methylene Blue on Microglia-Induced Inflammation and Motor Neuron Degeneration in the SOD1(G93A) Model for ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; MOUSE MODEL; GLIAL-CELLS; SPINAL-CORD; UNIT LOSS; MDX MICE; DISEASE; PROGRESSION; AGGREGATION	Mutations in SOD1 cause hereditary variants of the fatal motor neuron disease amyotrophic lateral sclerosis (ALS). Pathophysiology of the disease is non-cell-autonomous, with toxicity deriving also from glia. In particular, microglia contribute to disease progression. Methylene blue (MB) inhibits the effect of nitric oxide, which mediates microglial responses to injury. In vivo 2P-LSM imaging was performed in ALS-linked transgenic SOD1(G93A) mice to investigate the effect of MB on microglia-mediated inflammation in the spinal cord. Local superfusion of the lateral spinal cord with MB inhibited the microglial reaction directed at a laser-induced axon transection in control and SOD1(G93A) mice. In vitro, MB at high concentrations inhibited cytokine and chemokine release from microglia of control and advanced clinical SOD1(G93A) mice. Systemic MB-treatment of SOD1(G93A) mice at early preclinical stages significantly delayed disease onset and motor dysfunction. However, an increase of MB dose had no additional effect on disease progression; this was unexpected in view of the local anti-inflammatory effects. Furthermore, in vivo imaging of systemically MB-treated mice also showed no alterations of microglia activity in response to local lesions. Thus although systemic MB treatment had no effect on microgliosis, instead, its use revealed an important influence on motor neuron survival as indicated by an increased number of lumbar anterior horn neurons present at the time of disease onset. Thus, potentially beneficial effects of locally applied MB on inflammatory events contributing to disease progression could not be reproduced in SOD1(G93A) mice via systemic administration, whereas systemic MB application delayed disease onset via neuroprotection.	[Dibaj, Payam; Steffens, Heinz; Le Meur, Karim; Kirchhoff, Frank] Max Planck Inst Expt Med, D-3400 Gottingen, Germany; [Zschuentzsch, Jana; Goericke, Bettina; Weishaupt, Jochen H.; Neusch, Clemens] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany; [Steffens, Heinz; Schomburg, Eike D.] Univ Gottingen, Inst Physiol, Gottingen, Germany; [Scheffel, Joerg; Hanisch, Uwe-Karsten] Univ Gottingen, Inst Neuropathol, Gottingen, Germany; [Steffens, Heinz] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Weishaupt, Jochen H.; Neusch, Clemens] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Le Meur, Karim; Kirchhoff, Frank] Univ Saarland, Dept Mol Physiol, D-6650 Homburg, Germany; [Le Meur, Karim] Univ Gottingen, Syst Neurosci Grp, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen; University of Gottingen; Max Planck Society; Ulm University; Saarland University; University of Gottingen	Dibaj, P (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-3400 Gottingen, Germany.	Dibaj@em.mpg.de	Dibaj, Payam/AAS-5479-2021; Dibaj, Payam/GQH-9423-2022; Kirchhoff, Frank/B-9335-2008	Dibaj, Payam/0000-0003-1585-6330; Kirchhoff, Frank/0000-0002-2324-2761	Deutsche Forschungsgemeinschaft [NE-767/3-3, SCHO 37/16-1, SFB/TRR43]; Tom-Wahlig-Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tom-Wahlig-Foundation	This work was supported by grants from the Deutsche Forschungsgemeinschaft (NE-767/3-3 to CN and SCHO 37/16-1 to EDS and SFB/TRR43 to UKH) and the Tom-Wahlig-Foundation (to CN and FK). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Audet JN, 2012, NEUROSCIENCE, V209, P136, DOI 10.1016/j.neuroscience.2011.12.047; Barbe C, 2002, INHAL TOXICOL, V14, P273, DOI 10.1080/08958370252809059; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2008, M S-MED SCI, V24, P124, DOI 10.1051/medsci/2008242124; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Braak H, 2010, ACTA NEUROPATHOL, V120, P67, DOI 10.1007/s00401-010-0683-0; Carre-Pierrat M, 2011, NEUROMUSCULAR DISORD, V21, P313, DOI 10.1016/j.nmd.2011.01.005; Carreras I, 2010, BRAIN RES, V1313, P192, DOI 10.1016/j.brainres.2009.11.051; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; Dibaj P, 2011, NEUROSCI LETT, V497, P148, DOI 10.1016/j.neulet.2011.04.049; Dibaj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017910; Dibaj P, 2011, NEUROSCI LETT, V487, P107, DOI 10.1016/j.neulet.2010.10.005; Dibaj P, 2010, J NEUROSCI RES, V88, P2431, DOI 10.1002/jnr.22402; Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993; Duan YL, 2003, J NEUROBIOL, V57, P183, DOI 10.1002/neu.10262; Duan YL, 2009, DEV NEUROBIOL, V69, P60, DOI 10.1002/dneu.20689; Golumbek PT, 2007, NEUROMUSCULAR DISORD, V17, P376, DOI 10.1016/j.nmd.2007.02.005; Guegan C, 2003, J CLIN INVEST, V111, P153, DOI 10.1172/JCI200317610; Gura T, 2008, NAT MED, V14, P894, DOI 10.1038/nm0908-894; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Hegedus J, 2009, MUSCLE NERVE, V39, P318, DOI 10.1002/mus.21160; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaiser M, 2006, J NEUROCHEM, V99, P900, DOI 10.1111/j.1471-4159.2006.04131.x; Kulkarni SK, 2007, EUR J PHARMACOL, V569, P77, DOI 10.1016/j.ejphar.2007.05.002; Liebetanz D, 2004, EUR J NEUROSCI, V20, P3115, DOI 10.1111/j.1460-9568.2004.03769.x; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lougheed R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023141; Martinez JA, 2008, NEUROSCIENCE, V157, P908, DOI 10.1016/j.neuroscience.2008.08.073; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neusch C, 2007, MUSCLE NERVE, V35, P712, DOI 10.1002/mus.20768; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ozdinler PH, 2011, J NEUROSCI, V31, P4166, DOI 10.1523/JNEUROSCI.4184-10.2011; OLEARY JL, 1968, STAIN TECHNOL, V43, P197, DOI 10.3109/10520296809115068; Oz M, 2009, MED RES REV; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Regen T, 2011, BRAIN BEHAV IMMUN, V25, P957, DOI 10.1016/j.bbi.2010.10.009; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saywell SA, 2011, J NEUROPHYSIOL, V105, P806, DOI 10.1152/jn.00738.2010; Synofzik M, 2010, J NEUROL NEUROSUR PS, V81, P764, DOI 10.1136/jnnp.2009.181719; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; van Rossum D, 2008, GLIA, V56, P271, DOI 10.1002/glia.20611; Walter-Sack I, 2009, EUR J CLIN PHARMACOL, V65, P179, DOI 10.1007/s00228-008-0563-x; WONG PC, 1995, CURR OPIN NEUROL, V8, P294, DOI 10.1097/00019052-199508000-00008; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yamanaka K, 2006, ANN NEUROL, V60, P95, DOI 10.1002/ana.20888; Yamashita M, 2009, FEBS LETT, V583, P2419, DOI 10.1016/j.febslet.2009.06.042	57	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43963	10.1371/journal.pone.0043963	http://dx.doi.org/10.1371/journal.pone.0043963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952827	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800079
J	Janes, H; Frahm, N; DeCamp, A; Rolland, M; Gabriel, E; Wolfson, J; Hertz, T; Kallas, E; Goepfert, P; Friedrich, DP; Corey, L; Mullins, JI; McElrath, MJ; Gilbert, P				Janes, Holly; Frahm, Nicole; DeCamp, Allan; Rolland, Morgane; Gabriel, Erin; Wolfson, Julian; Hertz, Tomer; Kallas, Esper; Goepfert, Paul; Friedrich, David P.; Corey, Lawrence; Mullins, James I.; McElrath, M. Juliana; Gilbert, Peter			MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load	PLOS ONE			English	Article							FALSE DISCOVERY RATE; MEDIATED-IMMUNITY; STEP; GAG; EPITOPES; ESCAPE; CTL	Background: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune response and acute viral load data to explore mechanisms for and consequences of the observed sieve effect. Methods: Ninety-one male participants (37 placebo and 54 vaccine recipients) were included; viral sequences were obtained at the time of HIV-1 diagnosis. T-cell responses were measured 4 weeks post-second vaccination and at the first or second week post-diagnosis. Acute viral load was obtained at RNA-positive and antibody-negative visits. Findings: Vaccine recipients had a greater magnitude of post-infection CD8+ T cell response than placebo recipients (median 1.68% vs 1.18%; p = 0.04) and greater breadth of post-infection response (median 4.5 vs 2; p = 0.06). Viral sequences for vaccine recipients were marginally more divergent from the insert than placebo sequences in regions of Nef targeted by pre-infection immune responses (p = 0.04; Pol p = 0.13; Gag p = 0.89). Magnitude and breadth of pre-infection responses did not correlate with distance of the viral sequence to the insert (p. 0.50). Acute log viral load trended lower in vaccine versus placebo recipients (estimated mean 4.7 vs 5.1) but the difference was not significant (p = 0.27). Neither was acute viral load associated with distance of the viral sequence to the insert (p>0.30). Interpretation: Despite evidence of anamnestic responses, the sieve effect was not well explained by available measures of T-cell immunogenicity. Sequence divergence from the vaccine was not significantly associated with acute viral load. While point estimates suggested weak vaccine suppression of viral load, the result was not significant and more viral load data would be needed to detect suppression.	[Janes, Holly; Frahm, Nicole; DeCamp, Allan; Hertz, Tomer; Friedrich, David P.; Corey, Lawrence; McElrath, M. Juliana; Gilbert, Peter] Fred Hutchinson Canc Res Ctr, Div Vaccines & Infect Dis, Seattle, WA 98104 USA; [Janes, Holly; Gabriel, Erin; Gilbert, Peter] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Frahm, Nicole] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Rolland, Morgane] US Mil HIV Res Program MHRP, Rockville, MD USA; [Wolfson, Julian] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Kallas, Esper] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Goepfert, Paul] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Corey, Lawrence; McElrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA USA; [Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Walter Reed Army Institute of Research (WRAIR); University of Minnesota System; University of Minnesota Twin Cities; Universidade de Sao Paulo; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Janes, H (corresponding author), Fred Hutchinson Canc Res Ctr, Div Vaccines & Infect Dis, 1124 Columbia St, Seattle, WA 98104 USA.	hjanes@fhcrc.org	Corey, Lawrence/AAE-1796-2020; Hertz, Tomer/S-5744-2016; Wolfson, Julian/G-6332-2011	Corey, Lawrence/0000-0002-2179-2436; Hertz, Tomer/0000-0002-0561-1578; Wolfson, Julian/0000-0002-2032-0875; Gabriel, Erin/0000-0002-0504-8404; Kallas, Esper/0000-0003-2026-6925	National Institute of Allergy and Infectious Diseases [R37AI054165-08, UM1AI068635, UM1AI068618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, U01AI068635, UM1AI068614, U01AI068614, UM1AI068618, R37AI054165, U01AI068618, K25AI087397] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R37AI054165-08, UM1AI068635, and UM1AI068618 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Fitzgerald DW, 2011, J INFECT DIS, V203, P765, DOI 10.1093/infdis/jiq114; Frahm N, 2012, J CLIN INVE IN PRESS; Harrer T, 1998, J IMMUNOL, V161, P4875; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Heckerman D, 2007, J COMPUT BIOL, V14, P736, DOI 10.1089/cmb.2007.R013; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; JOHNSON RP, 1991, J IMMUNOL, V147, P1512; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rubin DB, 2004, MULTIPLE IMPUTATION; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Troyer RM, 2009, PLOS PATHOG IN PRESS	22	26	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43396	10.1371/journal.pone.0043396	http://dx.doi.org/10.1371/journal.pone.0043396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952672	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800029
J	Tietjen, I; Hovingh, GK; Singaraja, RR; Radomski, C; Barhdadi, A; McEwen, J; Chan, E; Mattice, M; Legendre, A; Franchini, PL; Dube, MP; Kastelein, JJP; Hayden, MR				Tietjen, Ian; Hovingh, G. Kees; Singaraja, Roshni R.; Radomski, Chris; Barhdadi, Amina; McEwen, Jason; Chan, Elden; Mattice, Maryanne; Legendre, Annick; Franchini, Patrick L.; Dube, Marie-Pierre; Kastelein, John J. P.; Hayden, Michael R.			Segregation of LIPG, CETP, and GALNT2 Mutations in Caucasian Families with Extremely High HDL Cholesterol	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ESTER TRANSFER PROTEIN; CORONARY-ARTERY-DISEASE; ENDOTHELIAL LIPASE; COMMON DISEASES; TANGIER-DISEASE; HIGH-RISK; DEFICIENCY; IDENTIFICATION; ANACETRAPIB	To date, few mutations are described to underlie highly-elevated HDLc levels in families. Here we sequenced the coding regions and adjacent sequence of the LIPG, CETP, and GALNT2 genes in 171 unrelated Dutch Caucasian probands with HDLc >= 90th percentile and analyzed segregation of mutations with lipid phenotypes in family members. In these probands, mutations were most frequent in LIPG (12.9%) followed by GALNT2 (2.3%) and CETP (0.6%). A total of 6 of 10 mutations in these three genes were novel (60.0%), and mutations segregated with elevated HDLc in families. Interestingly, the LIPG mutations N396S and R476W, which usually result in elevated HDLc, were unexpectedly found in 6 probands with low HDLc (i.e., <= 10th percentile). However, 5 of these probands also carried mutations in ABCA1, LCAT, or LPL. Finally, no CETP and GALNT2 mutations were found in 136 unrelated probands with low HDLc. Taken together, we show that rare coding and splicing mutations in LIPG, CETP, and GALNT2 are enriched in persons with hyperalphalipoproteinemia and segregate with elevated HDLc in families. Moreover, LIPG mutations do not overcome low HDLc in individuals with ABCA1 and possibly LCAT and LPL mutations, indicating that LIPG affects HDLc levels downstream of these proteins.	[Tietjen, Ian; Singaraja, Roshni R.; Radomski, Chris; McEwen, Jason; Chan, Elden; Mattice, Maryanne; Legendre, Annick; Franchini, Patrick L.] Xenon Pharmaceut Inc, Burnaby, BC, Canada; [Hovingh, G. Kees; Kastelein, John J. P.] Univ Amsterdam, Dept Vasc Med, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Singaraja, Roshni R.; Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Barhdadi, Amina; Dube, Marie-Pierre] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada	Xenon Pharmaceuticals Inc.; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; Universite de Montreal	Tietjen, I (corresponding author), Xenon Pharmaceut Inc, Burnaby, BC, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011; Kastelein, John/AAF-7950-2020; Dubé, Marie-Pierre/B-9364-2008	Hayden, Michael R/0000-0001-5159-1419; Dubé, Marie-Pierre/0000-0001-8442-4393; Singaraja, Roshni/0000-0002-3418-3867; Tietjen, Ian/0000-0002-8991-6490	Xenon Pharmaceuticals Inc.	Xenon Pharmaceuticals Inc.	The funders, Xenon Pharmaceuticals Inc., did have a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript, since some of the authors are employees of this company.	Ali M, 2009, WORLD HLTH STAT 2009; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bauer RC, 2011, CURR OPIN LIPIDOL, V22, P123, DOI 10.1097/MOL.0b013e32834469b3; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; deLemos AS, 2002, CIRCULATION, V106, P1321, DOI 10.1161/01.CIR.0000028423.07623.6A; Edmondson AC, 2009, J CLIN INVEST, V119, P1042, DOI 10.1172/JCI37176; FUNKE H, 1991, P NATL ACAD SCI USA, V88, P4855, DOI 10.1073/pnas.88.11.4855; Gauthier A, 2005, ARTERIOSCL THROM VAS, V25, P2177, DOI 10.1161/01.ATV.0000183613.13929.13; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HEISS G, 1980, CIRCULATION, V62, P116; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Hovingh GK, 2004, J AM COLL CARDIOL, V44, P1429, DOI 10.1016/j.jacc.2004.06.070; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Ishida T, 2003, J CLIN INVEST, V111, P347, DOI [10.1172/JCI200316306, 10.1172/JCI16306]; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Khetarpal SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002393; Khovidhunkit W, 2012, AM J CARDIOL, V110, P62, DOI 10.1016/j.amjcard.2012.02.052; Klos KLE, 2007, CURR OPIN CARDIOL, V22, P344, DOI 10.1097/HCO.0b013e3281a8acad; KOIZUMI J, 1985, ATHEROSCLEROSIS, V58, P175, DOI 10.1016/0021-9150(85)90064-4; Krishna R, 2009, BRIT J CLIN PHARMACO, V68, P535, DOI 10.1111/j.1365-2125.2009.03465.x; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Muntner P, 2011, AM J MED SCI, V341, P173, DOI 10.1097/MAJ.0b013e3181f97e4a; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Plump AS, 2009, J AM COLL CARDIOL, V53, P1089, DOI 10.1016/j.jacc.2008.11.050; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; REYMER PWA, 1995, NAT GENET, V10, P28, DOI 10.1038/ng0595-28; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; Rogozin IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200; Strauss JG, 2001, J BIOL CHEM, V276, P36083, DOI 10.1074/jbc.M104430200; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tietjen I, 2012, BBA-MOL CELL BIOL L, V1821, P416, DOI 10.1016/j.bbalip.2011.08.006; van der Steeg WA, 2007, J LIPID RES, V48, P674, DOI 10.1194/jlr.M600405-JLR200; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; VONECKARDSTEIN A, 1991, J CLIN INVEST, V87, P1724, DOI 10.1172/JCI115190; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739	48	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e37437	10.1371/journal.pone.0037437	http://dx.doi.org/10.1371/journal.pone.0037437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952570	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800001
J	Williams, JA; Thomas, AM; Li, GD; Kong, B; Zhan, L; Inaba, Y; Xie, W; Ding, WX; Guo, GL				Williams, Jessica A.; Thomas, Ann M.; Li, Guodong; Kong, Bo; Zhan, Le; Inaba, Yuka; Xie, Wen; Ding, Wen-Xing; Guo, Grace L.			Tissue Specific Induction of p62/Sqstm1 by Farnesoid X Receptor	PLOS ONE			English	Article							BILE-ACID RECEPTOR; TRANSCRIPTION FACTOR NRF2; ORPHAN NUCLEAR RECEPTOR; KAPPA-B ACTIVATION; FXR; P62; AUTOPHAGY; LIVER; IDENTIFICATION; CHOLESTEROL	Background: Farnesoid X Receptor (FXR) is a member of the nuclear receptor superfamily and is a ligand-activated transcription factor essential for maintaining liver and intestinal homeostasis. FXR is protective against carcinogenesis and inflammation in liver and intestine as demonstrated by the development of inflammation and tumors in the liver and intestine of FXR knock-out mice. However, mechanisms for the protective effects of FXR are not completely understood. This study reports a novel role of FXR in regulating expression of Sqstm1, which encodes for p62 protein. p62 plays an important role in maintaining cellular homeostasis through selective autophagy and activating signal transduction pathways, such as NF-kappa B to support cell survival and caspase-8 to initiate apoptosis. FXR regulation of Sqstm1 may serve as a protective mechanism. Methods and Results: This study showed that FXR bound to the Sqstm1 gene in both mouse livers and ileums as determined by chromatin immunoprecipitation. In addition, FXR activation enhanced transcriptional activation of Sqstm1 in vitro. However, wild-type mice treated with GW4064, a synthetic FXR ligand, showed that FXR activation induced mRNA and protein expression of Sqstm1/p62 in ileum, but not in liver. Interestingly, FXR-transgenic mice showed induced mRNA expression of Sqstm1 in both liver and ileum compared to wild-type mice. Conclusions: Our current study has identified a novel role of FXR in regulating the expression of p62, a key factor in protein degradation and cell signaling. Regulation of p62 by FXR indicates tissue-specific and gene-dosage effects. Furthermore, FXR-mediated induction of p62 may implicate a protective mechanism of FXR.	[Williams, Jessica A.; Thomas, Ann M.; Li, Guodong; Kong, Bo; Zhan, Le; Ding, Wen-Xing; Guo, Grace L.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Li, Guodong] Harbin Med Univ, Affiliated Hosp 4, Canc Treatment Ctr, Dept Abdominal Surg, Harbin, Peoples R China; [Inaba, Yuka; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA	University of Kansas; University of Kansas Medical Center; Harbin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Williams, JA (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	gracelguo@yahoo.com	Xie, Wen/M-1768-2016; Kong, Bo/G-7650-2014	Kong, Bo/0000-0002-8200-7817; Inaba, Yuka/0000-0001-9757-9669	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [DK081343]; National Center for Research Resources (NCRR) [P20-RR021940]; National Institute of Environmental Health Sciences [5 T32 ES007079]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007079] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grant DK081343], the National Center for Research Resources (NCRR) [Grant P20-RR021940] and J.A. Williams was supported by the "Training Program in Environmental Toxicology" [grant 5 T32 ES007079] from the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5; De Gottardi A, 2004, DIGEST DIS SCI, V49, P982; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kim MS, 2003, J BIOL CHEM, V278, P8988, DOI 10.1074/jbc.M212633200; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Li GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035895; Li GD, 2010, MOL ENDOCRINOL, V24, P1404, DOI 10.1210/me.2010-0014; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Maynard AA, 2010, AM J PHYSIOL-GASTR L, V299, pG614, DOI 10.1152/ajpgi.00076.2010; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhu Y, 2011, PHARMACOL RES, V63, P259, DOI 10.1016/j.phrs.2010.12.018	42	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43961	10.1371/journal.pone.0043961	http://dx.doi.org/10.1371/journal.pone.0043961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952826	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308044800078
J	West, JM; Zvonok, N; Whitten, KM; Vadivel, SK; Bowman, AL; Makriyannis, A				West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Vadivel, Subramanian K.; Bowman, Anna L.; Makriyannis, Alexandros			Biochemical and Mass Spectrometric Characterization of Human N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition	PLOS ONE			English	Article							HUMAN MONOACYLGLYCEROL LIPASE; PROTEOLYTIC ACTIVATION; CANNABINOID RECEPTOR; BETA-LACTONE; ACTIVE-SITE; HYDROLASE; CERAMIDASE; PALMITOYLETHANOLAMIDE; PURIFICATION; CYSTEINE	The mechanism of inactivation of human enzyme N-acylethanolamine-hydrolyzing acid amidase (hNAAA), with selected inhibitors identified in a novel fluorescent based assay developed for characterization of both reversible and irreversible inhibitors, was investigated kinetically and using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). 1-Isothiocyanatopentadecane (AM9023) was found to be a potent, selective and reversible hNAAA inhibitor, while two others, 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701) and N-Benzyloxycarbonyl-L-serine beta-lactone (N-Cbz-serine beta-lactone), inhibited hNAAA in a covalent and irreversible manner. MS analysis of the hNAAA/covalent inhibitor complexes identified modification only of the N-terminal cysteine (Cys126) of the beta-subunit, confirming a suggested mechanism of hNAAA inactivation by the beta-lactone containing inhibitors. These experiments provide direct evidence of the key role of Cys126 in hNAAA inactivation by different classes of covalent inhibitors, confirming the essential role of cysteine for catalysis and inhibition in this cysteine N-terminal nucleophile hydrolase enzyme. They also provide a methodology for the rapid screening and characterization of large libraries of compounds as potential inhibitors of NAAA, and subsequent characterization or their mechanism through MALDI-TOF MS based bottom up-proteomics.	[West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Vadivel, Subramanian K.; Bowman, Anna L.; Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA	Northeastern University	West, JM (corresponding author), Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA.	a.makriyannis@neu.edu	Makriyannis, Alexandros/GRF-1518-2022; Bowman, Anna/B-3771-2010	Makriyannis, Alexandros/0000-0003-3272-3687; Bowman, Anna/0000-0002-3287-1949	National Institutes of Health/National Institute on Drug Abuse [DA003801, DA007312, DA009158]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009158, R37DA003801, R01DA003801, T32DA007312] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants DA003801, DA007312, and DA009158 from the National Institutes of Health/National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Alvarez-Jaimes LJ, CURR PHARM BIOTECHNO; Armirotti A, 2012, ACS MED CHEM LETT; BERNARDO K, 1995, J BIOL CHEM, V270, P11098, DOI 10.1074/jbc.270.19.11098; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Godlewski G, 2009, PROSTAG OTH LIPID M, V89, P105, DOI 10.1016/j.prostaglandins.2009.07.001; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karageorgos I, 2010, MOL BIOSYST, V6, P1381, DOI 10.1039/c004515b; KITZ R, 1962, J BIOL CHEM, V237, P3245; Labar G, 2007, CHEM BIODIVERS, V4, P1882, DOI 10.1002/cbdv.200790157; Lall MS, 1999, ORG LETT, V1, P803, DOI 10.1021/ol990148r; Li C, 2005, J MED CHEM, V48, P6423, DOI 10.1021/jm050272i; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Lodola A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032397; Mileni M, 2008, P NATL ACAD SCI USA, V105, P12820, DOI 10.1073/pnas.0806121105; MORSE KL, 1995, LIFE SCI, V56, P1957, DOI 10.1016/0024-3205(95)00176-7; Naidoo V., 2012, NEUROTHERAPEUTICS; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; Picone RP, 2005, MOL PHARMACOL, V68, P1623, DOI 10.1124/mol.105.014407; Ramarao MK, 2005, ANAL BIOCHEM, V343, P143, DOI 10.1016/j.ab.2005.04.032; Rossocha M, 2005, BIOCHEMISTRY-US, V44, P5739, DOI 10.1021/bi0473206; Saario SM, 2007, BASIC CLIN PHARMACOL, V101, P287, DOI 10.1111/j.1742-7843.2007.00130.x; Saario SM, 2007, CHEM BIODIVERS, V4, P1903, DOI 10.1002/cbdv.200790158; Saturnino C, 2010, BIOORG MED CHEM LETT, V20, P1210, DOI 10.1016/j.bmcl.2009.11.134; Shtraizent N, 2008, J BIOL CHEM, V283, P11253, DOI 10.1074/jbc.M709166200; Solorzano C, 2010, J MED CHEM, V53, P5770, DOI 10.1021/jm100582w; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Tsuboi K, 2007, CHEM BIODIVERS, V4, P1914, DOI 10.1002/cbdv.200790159; Wang J, 2008, BBA-MOL CELL BIOL L, V1781, P710, DOI 10.1016/j.bbalip.2008.08.004; West JM, 2012, J PROTEOME RES, V11, P972, DOI 10.1021/pr200735a; West JM, 2011, MASS SPECTROMETRIC C, pP3; Yin J, 2005, J MOL BIOL, V354, P854, DOI 10.1016/j.jmb.2005.09.074; Zhao LY, 2007, BBA-MOL CELL BIOL L, V1771, P1397, DOI 10.1016/j.bbalip.2007.10.002; Zvonok N, 2008, CHEM BIOL, V15, P854, DOI 10.1016/j.chembiol.2008.06.008; Zvonok N, 2008, J PROTEOME RES, V7, P2158, DOI 10.1021/pr700839z	37	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43877	10.1371/journal.pone.0043877	http://dx.doi.org/10.1371/journal.pone.0043877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952796	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300030
J	Sangha, JS; Sun, XL; Wally, OSD; Zhang, KB; Ji, XH; Wang, ZM; Wang, YW; Zidichouski, J; Prithiviraj, B; Zhang, JZ				Sangha, Jatinder S.; Sun, Xiaoli; Wally, Owen S. D.; Zhang, Kaibin; Ji, Xiuhong; Wang, Zhimin; Wang, Yanwen; Zidichouski, Jeffrey; Prithiviraj, Balakrishnan; Zhang, Junzeng			Liuwei Dihuang (LWDH), a Traditional Chinese Medicinal Formula, Protects against beta-Amyloid Toxicity in Transgenic Caenorhabditis elegans	PLOS ONE			English	Article							BILOBA EXTRACT EGB-761; INCREASES LIFE-SPAN; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; INDUCED IMPAIRMENT; GENE-EXPRESSION; MOUSE MODEL; C-ELEGANS; DECOCTION; AGGREGATION	Liuwei Dihuang (LWDH), a classic Chinese medicinal formula, has been used to improve or restore declined functions related to aging and geriatric diseases, such as impaired mobility, vision, hearing, cognition and memory. Here, we report on the effect and possible mechanisms of LWDH mediated protection of beta-amyloid (A beta) induced paralysis in Caenorhabditis elegans using ethanol extract (LWDH-EE) and water extract (LWDH-WE). Chemical profiling and quantitative analysis revealed the presence of different levels of bioactive components in these extracts. LWDH-WE was rich in polar components such as monosaccharide dimers and trimers, whereas LWDH-EE was enriched in terms of phenolic compounds such as gallic acid and paeonol. In vitro studies revealed higher DPPH radical scavenging activity for LWDH-EE as compared to that found for LWDH-WE. Neither LWDH-EE nor LWDH-WE were effective in inhibiting aggregation of Ab in vitro. By contrast, LWDH-EE effectively delayed A beta induced paralysis in the transgenic C. elegans (CL4176) model which expresses human A beta 1-42. Western blot revealed no treatment induced reduction in Ab accumulation in CL4176 although a significant reduction was observed at an early stage with respect to beta-amyloid deposition in C. elegans strain CL2006 which constitutively expresses human A beta 1-42. In addition, LWDH-EE reduced in vivo reactive oxygen species (ROS) in C. elegans (CL4176) that correlated with increased survival of LWDH-EE treated N2 worms under juglone-induced oxidative stress. Analysis with GFP reporter strain TJ375 revealed increased expression of hsp16.2::GFP after thermal stress whereas a minute induction was observed for sod3::GFP. Quantitative gene expression analysis revealed that LWDH-EE repressed the expression of amy1 in CL4176 while up-regulating hsp16.2 induced by elevating temperature. Taken together, these results suggest that LWDH extracts, particularly LWDH-EE, alleviated beta-amyloid induced toxicity, in part, through up-regulation of heat shock protein, antioxidant activity and reduced ROS in C. elegans.	[Sangha, Jatinder S.; Wally, Owen S. D.; Prithiviraj, Balakrishnan] Nova Scotia Agr Coll, Dept Environm Sci, Truro, NS B2N 5E3, Canada; [Sun, Xiaoli; Zhang, Kaibin; Ji, Xiuhong; Wang, Yanwen; Zidichouski, Jeffrey; Zhang, Junzeng] Natl Res Council Canada, Inst Nutrisci & Hlth, Charlottetown, PE, Canada; [Sun, Xiaoli; Zhang, Kaibin; Wang, Zhimin] China Acad Chinese Med Sci, Inst Chinese Materia Med, Beijing, Peoples R China; [Sun, Xiaoli] Capital Med Univ, Sch Tradit Chinese Med, Beijing, Peoples R China; [Wang, Yanwen] Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE C1A 4P3, Canada; [Zhang, Junzeng] Univ Prince Edward Isl, Dept Chem, Charlottetown, PE C1A 4P3, Canada	Dalhousie University; National Research Council Canada; China Academy of Chinese Medical Sciences; Capital Medical University; University of Prince Edward Island; University of Prince Edward Island	Sangha, JS (corresponding author), Nova Scotia Agr Coll, Dept Environm Sci, Truro, NS B2N 5E3, Canada.	bprithiviraj@nsac.ca; Junzeng.zhang@nrc.gc.ca		Prithiviraj, Balakrishnan/0000-0002-9822-5261	National Research Council Canada - Institute for Nutrisciences and Health; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences; Natural Sciences and Engineering Council of Canada (NSERC), Nova Scotia Department of Agriculture and Acadian Seaplants Limited; Canadian Institutes of Health Research (CIHR)	National Research Council Canada - Institute for Nutrisciences and Health; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences; Natural Sciences and Engineering Council of Canada (NSERC), Nova Scotia Department of Agriculture and Acadian Seaplants Limited; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Financial support for X. Sun and K. Zhang from National Research Council Canada - Institute for Nutrisciences and Health (Drs. Y. Wang, J. Zidichouski, and J. Zhang) and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences (Dr. Z. Wang) is appreciated. B. Prithiviraj's Lab is supported by grants from the Natural Sciences and Engineering Council of Canada (NSERC), Nova Scotia Department of Agriculture and Acadian Seaplants Limited. Y. Wang and J. Zhang are also supported through Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, PHYTOMEDICINE, V17, P902, DOI 10.1016/j.phymed.2010.03.008; Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Arya U, 2009, EXP GERONTOL, V44, P462, DOI 10.1016/j.exger.2009.02.010; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Cao ZM, 2007, J GERONTOL A-BIOL, V62, P1337, DOI 10.1093/gerona/62.12.1337; Cheng XR, 2007, FITOTERAPIA, V78, P175, DOI 10.1016/j.fitote.2006.11.006; Cheng Xiao-rui, 2006, Chinese Pharmacological Bulletin, V22, P921; DaSilva KA, 2010, EXP NEUROL, V223, P311, DOI 10.1016/j.expneurol.2009.08.032; Dosanjh LE, 2010, J ALZHEIMERS DIS, V19, P681, DOI 10.3233/JAD-2010-1267; Dostal V, 2010, JOVE-J VIS EXP, V44, pe2252; Dostal V, 2010, GENETICS, V186, P857, DOI 10.1534/genetics.110.120436; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Ewald CY, 2010, BRAIN STRUCT FUNCT, V214, P263, DOI 10.1007/s00429-009-0235-3; Feng J, 2010, SHANDONG J TRADITION, V29, P264; Fonte V, 2008, J BIOL CHEM, V283, P784, DOI 10.1074/jbc.M703339200; Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Howes MJR, 2003, PHARMACOL BIOCHEM BE, V75, P513, DOI 10.1016/S0091-3057(03)00128-X; Hsieh MT, 2003, BIOL PHARM BULL, V26, P156, DOI 10.1248/bpb.26.156; Janusz M, 2009, FEBS LETT, V583, P190, DOI 10.1016/j.febslet.2008.11.053; Jiang HL, 2003, CURR MED CHEM, V10, P2231, DOI 10.2174/0929867033456747; Johnson JR, 2010, BIOCHEM SOC T, V38, P559, DOI 10.1042/BST0380559; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kampkotter A, 2007, PHARMACOL RES, V55, P139, DOI 10.1016/j.phrs.2006.11.006; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Liu J, 2011, PHARM CLIN RES CHINE, V19, P227; Liu YanHui, 2009, Chinese Journal of Gerontology, V29, P2455; Luo Y, 2006, LIFE SCI, V78, P2066, DOI 10.1016/j.lfs.2005.12.004; Ma Yuan, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P325; Miksys SL, 2010, CLIN PHARMACOL THER, V88, P427, DOI 10.1038/clpt.2010.198; Moreira Paula I, 2006, Expert Rev Neurother, V6, P897, DOI 10.1586/14737175.6.6.897; Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208; National Pharmacopoeia Committee, 2005, PHARM PEOPL REP CHIN, V1; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Re F, 2010, CURR MED CHEM, V17, P2990, DOI 10.2174/092986710791959729; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Smith JV, 2003, J ALZHEIMERS DIS, V5, P287, DOI 10.3233/JAD-2003-5404; Strayer A, 2003, FASEB J, V17, P2305, DOI 10.1096/fj.03-0376fje; Szeto YT, 2009, INT J FOOD SCI NUTR, V60, P662, DOI 10.3109/09637480802012209; Wei X L, 2000, Sheng Li Ke Xue Jin Zhan, V31, P227; Wolozin B, 2011, PROG MOL BIOL TRANSL, V100, P499, DOI 10.1016/B978-0-12-384878-9.00015-7; Wu CR, 2007, J ETHNOPHARMACOL, V113, P79, DOI 10.1016/j.jep.2007.05.003; Wu YJ, 2010, NEUROBIOL AGING, V31, P1055, DOI 10.1016/j.neurobiolaging.2008.07.013; Wu Yanjue, 2005, Current Alzheimer Research, V2, P37, DOI 10.2174/1567205052772768; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Xia S, 2010, SHANXI J TRADITIONAL, V31, P614; Xie BG, 2008, J PHARMACEUT BIOMED, V48, P1261, DOI 10.1016/j.jpba.2008.09.011; Yan H, 2007, CLIN INTERV AGING, V2, P201; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang S, 2006, J ETHNOPHARMACOL, V106, P166, DOI 10.1016/j.jep.2005.12.017; Ye J, 2009, J PHARMACEUT BIOMED, V49, P638, DOI 10.1016/j.jpba.2008.12.009; Yin F, 2011, NEUROSCI LETT, V492, P76, DOI 10.1016/j.neulet.2011.01.055; Yin F, 2011, NEUROCHEM INT, V58, P399, DOI 10.1016/j.neuint.2010.12.017; Yu YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009339; Zarse K, 2011, HORM METAB RES, V43, P241, DOI 10.1055/s-0030-1270524; Zhang Q, 2006, J APPL PHYCOL, V18, P445, DOI 10.1007/s10811-006-9048-4; Zhang Wei-Wei, 2011, Sheng Li Xue Bao, V63, P245; Zhao XF, 2007, J CHROMATOGR SCI, V45, P549, DOI 10.1093/chromsci/45.8.549; Zhu K, 2006, CHIN J EXP TRADIT ME, V12, P44; 王迪, 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P524; 蒋宁, 2007, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V23, P45	68	69	75	3	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43990	10.1371/journal.pone.0043990	http://dx.doi.org/10.1371/journal.pone.0043990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952840	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206500036
J	Ballantyne, G; Willmer, P				Ballantyne, Gavin; Willmer, Pat			Nectar Theft and Floral Ant-Repellence: A Link between Nectar Volume and Ant-Repellent Traits?	PLOS ONE			English	Article							PLANT-POLLINATOR INTERACTIONS; EXTRAFLORAL NECTARIES; REABSORPTION; VISITATION; PATTERNS; COSTS; CONSEQUENCES; MUTUALISM; FLOWERS; POLLEN	As flower visitors, ants rarely benefit a plant. They are poor pollinators, and can also disrupt pollination by deterring other flower visitors, or by stealing nectar. Some plant species therefore possess floral ant-repelling traits. But why do particular species have such traits when others do not? In a dry forest in Costa Rica, of 49 plant species around a third were ant-repellent at very close proximity to a common generalist ant species, usually via repellent pollen. Repellence was positively correlated with the presence of large nectar volumes. Repellent traits affected ant species differently, some influencing the behaviour of just a few species and others producing more generalised ant-repellence. Our results suggest that ant-repellent floral traits may often not be pleiotropic, but instead could have been selected for as a defence against ant thieves in plant species that invest in large volumes of nectar. This conclusion highlights to the importance of research into the cost of nectar production in future studies into ant-flower interactions.	[Ballantyne, Gavin; Willmer, Pat] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of St Andrews	Ballantyne, G (corresponding author), Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland.	gab32@st-andrews.ac.uk		Ballantyne, Gavin/0000-0001-7494-0642	Sir Harold Mitchell Scholarship Fund; University of St Andrews Russell Trust Award	Sir Harold Mitchell Scholarship Fund; University of St Andrews Russell Trust Award	This work was supported by Sir Harold Mitchell Scholarship Fund and University of St Andrews Russell Trust Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VM, 2008, ECOL ENTOMOL, V33, P59, DOI 10.1111/j.1365-2311.2007.00938.x; Altshuler DL, 1999, OECOLOGIA, V119, P600, DOI 10.1007/s004420050825; Apple JL, 2001, OECOLOGIA, V127, P409, DOI 10.1007/s004420000605; Armbruster S., 2000, SCANDINAVIAN ASS POL, V39, P179; BEATTIE AJ, 1985, AM J BOT, V72, P606, DOI 10.2307/2443594; Blancafort X, 2005, ACTA OECOL, V28, P49, DOI 10.1016/j.actao.2005.02.004; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; de Vega C, 2009, ANN BOT-LONDON, V103, P1065, DOI 10.1093/aob/mcp049; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dworschak K, 2010, ECOL ENTOMOL, V35, P216, DOI 10.1111/j.1365-2311.2010.01174.x; Galen C, 2003, OIKOS, V101, P521, DOI 10.1034/j.1600-0706.2003.12144.x; Galen C, 2011, AM NAT, V177, P258, DOI 10.1086/657993; Ghazoul J, 2001, ECOL LETT, V4, P295, DOI 10.1046/j.1461-0248.2001.00229.x; Golubov J, 2004, PLANT ECOL, V170, P267, DOI 10.1023/B:VEGE.0000021698.74964.a3; GUERRANT EO, 1981, BIOTROPICA, V13, P25, DOI 10.2307/2388067; Hansen DM, 2009, BIOTROPICA, V41, P202, DOI 10.1111/j.1744-7429.2008.00473.x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Hodson AK, 2006, BIOTROPICA, V38, P127; Irwin RE, 2001, OECOLOGIA, V129, P161, DOI 10.1007/s004420100739; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Junker R, 2007, ECOL RES, V22, P665, DOI 10.1007/s11284-006-0306-3; Junker RR, 2008, EVOL ECOL RES, V10, P295; Junker RR, 2011, ECOL MONOGR, V81, P295, DOI 10.1890/10-1367.1; Junker RR, 2010, ANN BOT-LONDON, V105, P777, DOI 10.1093/aob/mcq045; Koopowitz H, 1998, AM J BOT, V85, P508, DOI 10.2307/2446434; Lach L, 2008, ECOL ENTOMOL, V33, P155, DOI 10.1111/j.1365-2311.2007.00969.x; Lach L, 2008, DIVERS DISTRIB, V14, P281, DOI 10.1111/j.1472-4642.2007.00410.x; Leiss KA, 2004, HEREDITY, V92, P446, DOI 10.1038/sj.hdy.6800439; Lennartsson T, 2002, ECOLOGY, V83, P3060; Luyt R, 2002, BIOTROPICA, V34, P442, DOI 10.1111/j.1744-7429.2002.tb00558.x; Maloof JE, 2000, ECOLOGY, V81, P2651, DOI 10.1890/0012-9658(2000)081[2651:ANRCOM]2.0.CO;2; Nepi M, 2007, PLANT BIOLOGY, V9, P93, DOI 10.1055/s-2006-924287; Ness JH, 2006, OIKOS, V113, P506, DOI 10.1111/j.2006.0030-1299.14143.x; Nicklen EF, 2006, OECOLOGIA, V148, P81, DOI 10.1007/s00442-006-0359-6; NICOLSON SW, 1995, FUNCT ECOL, V9, P584, DOI 10.2307/2390148; Oliver TH, 2007, POPUL ECOL, V49, P265, DOI 10.1007/s10144-007-0044-6; Ollerton J, 2007, TAXON, V56, P717, DOI 10.2307/25065856; Opler PA, 1983, BIOL NECTARIES; Ordano M, 2005, J TROP ECOL, V21, P541, DOI 10.1017/S026646740500266X; PYKE GH, 1991, NATURE, V350, P58, DOI 10.1038/350058a0; Raguso RA, 2004, ECOLOGY, V85, P1486, DOI 10.1890/03-0410; Raine NE, 2007, ARTHROPOD-PLANT INTE, V1, P101, DOI 10.1007/s11829-007-9010-7; Sagers CL, 2000, OECOLOGIA, V123, P582, DOI 10.1007/PL00008863; Schatz B, 1999, J INSECT BEHAV, V12, P641, DOI 10.1023/A:1020927703689; SCHEMSKE DW, 1980, J ECOL, V68, P959, DOI 10.2307/2259468; SOUTHWICK EE, 1984, ECOLOGY, V65, P1775, DOI 10.2307/1937773; Stanton ML, 2002, ECOL MONOGR, V72, P347, DOI 10.1890/0012-9615(2002)072[0347:CCTOIA]2.0.CO;2; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Suarez AV, 1998, BIOTROPICA, V30, P480, DOI 10.1111/j.1744-7429.1998.tb00083.x; Tillberg CV, 2004, OECOLOGIA, V140, P506, DOI 10.1007/s00442-004-1601-8; Willmer P., 2011, POLLINATION FLORAL E; Willmer PG, 2009, FUNCT ECOL, V23, P888, DOI 10.1111/j.1365-2435.2009.01632.x; Willmer PG, 1997, NATURE, V388, P165, DOI 10.1038/40610; WILLMER PG, 1986, J ANIM ECOL, V55, P941, DOI 10.2307/4426; Zhang SC, 2012, P ROY SOC B-BIOL SCI, V279, P1824, DOI 10.1098/rspb.2011.2193	56	26	30	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43869	10.1371/journal.pone.0043869	http://dx.doi.org/10.1371/journal.pone.0043869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952793	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000056
J	Ku, MJ; Dossin, FD; Hansen, MAE; Genovesio, A; Ayong, L; Freitas-Junior, LH				Ku, Min-Je; Dossin, Fernando de M.; Hansen, Michael A. E.; Genovesio, Auguste; Ayong, Lawrence; Freitas-Junior, Lucio H.			An Image-Based Drug Susceptibility Assay Targeting the Placental Sequestration of Plasmodium falciparum-Infected Erythrocytes	PLOS ONE			English	Article							CHONDROITIN-SULFATE-A; CELL-LINE; ADHESION; MALARIA; CYTOADHERENCE; BINDING; PARASITES; RECEPTOR; PROTEIN; CD36	Placental malaria is a significant cause of all malaria-related deaths globally for which no drugs have been developed to specifically disrupt its pathogenesis. To facilitate the discovery of antimalarial drugs targeting the cytoadherence process of Plasmodium-infected erythrocytes in the placenta microvasculature, we have developed an automated image-based assay for high-throughput screening for potent cytoadherence inhibitors in vitro. Parasitized erythrocytes were drug-treated for 24 h and then allowed to adhere on a monolayer of placental BeWo cells prior to red blood cell staining with glycophorin A antibodies. Upon image-acquisition, drug effects were quantified as the proportion of treated parasitized erythrocytes to BeWo cells compared to the binding of untreated iRBCs. We confirmed the reliability of this new assay by comparing the binding ratios of CSA- and CD36-panned parasites on the placental BeWo cells, and by quantifying the effects of chondroitin sulfate A, brefeldin A, and artemisinin on the binding. By simultaneously examining the drug effects on parasite viability, we could discriminate between cytoadherence-specific inhibitors and other schizonticidal compounds. Taken together, our data establish that the developed assay is highly suitable for drug studies targeting placental malaria, and will facilitate the discovery and rapid development of new therapies against malaria.	[Ku, Min-Je; Dossin, Fernando de M.; Ayong, Lawrence; Freitas-Junior, Lucio H.] Inst Pasteur Korea, Ctr Neglected Dis Drug Discovery CND3, Songnam, Gyeonggi Do, South Korea; [Hansen, Michael A. E.; Genovesio, Auguste] Inst Pasteur Korea, Ctr Core Technol Image Min, Songnam, Gyeonggi Do, South Korea	Institut Pasteur Korea; Institut Pasteur Korea	Ku, MJ (corresponding author), Inst Pasteur Korea, Ctr Neglected Dis Drug Discovery CND3, Songnam, Gyeonggi Do, South Korea.	freitasjunior@ip-korea.org	GENOVESIO, Auguste/I-1656-2017; Freitas-Junior, Lucio H/C-8677-2011; Hansen, Michael Adsetts Edberg/C-9028-2011	Freitas-Junior, Lucio H/0000-0002-8904-7897; Hansen, Michael Adsetts Edberg/0000-0001-7879-2106; Genovesio, Auguste/0000-0003-1877-5595	National Research Foundation of Korea (NRF); Korea government (MEST), Gyeonggi-do [2012-00011]; KISTI	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST), Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST)(No. 2012-00011), Gyeonggi-do and KISTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APLIN JD, 1992, J CELL SCI, V103, P435; Chaisavaneeyakorn S, 2004, AM J TROP MED HYG, V70, P149, DOI 10.4269/ajtmh.2004.70.149; Chen QJ, 2000, CLIN MICROBIOL REV, V13, P439, DOI 10.1128/CMR.13.3.439-450.2000; Cohen J, 2002, APPL MULTIPLE REGRES; Cojean S, 2008, PARASITE, V15, P163, DOI 10.1051/parasite/2008152163; Cortina JM, 1997, PSYCHOL METHODS, V2, P161, DOI 10.1037/1082-989X.2.2.161; Costa FTM, 2006, BRAZ J MED BIOL RES, V39, P1525, DOI 10.1590/S0100-879X2006001200003; Crabb BS, 2010, INT J PARASITOL, V40, P509, DOI 10.1016/j.ijpara.2010.02.002; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fernandez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012558; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; HANDUNNETTI SM, 1992, BLOOD, V80, P2097; Hughes KR, 2010, MOL BIOCHEM PARASIT, V169, P71, DOI 10.1016/j.molbiopara.2009.09.007; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Moon H, 2008, 2008 9TH IEEE/ACM INTERNATIONAL CONFERENCE ON GRID COMPUTING, P334, DOI 10.1109/GRID.2008.4662818; Rafael G., 2007, DIGITAL IMAGE PROCES, V2nd; Scherf A, 2001, CELL MICROBIOL, V3, P125, DOI 10.1046/j.1462-5822.2001.00109.x; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; van der Heyde HC, 2006, INFECT IMMUN, V74, P2717, DOI 10.1128/IAI.74.5.2717-2725.2006; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Viebig NK, 2006, EXP PARASITOL, V112, P121, DOI 10.1016/j.exppara.2005.09.007; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Xu LL, 2006, MOL BIOCHEM PARASIT, V146, P142, DOI 10.1016/j.molbiopara.2005.11.005; Yosaatmadja F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-51; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e41765	10.1371/journal.pone.0041765	http://dx.doi.org/10.1371/journal.pone.0041765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952585	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000005
J	Soler-Cantero, A; Jove, M; Cacabelos, D; Boada, J; Naudi, A; Romero, MP; Cassanye, A; Serrano, JCE; Arola, L; Valls, J; Bellmunt, MJ; Prat, J; Pamplona, R; Portero-Otin, M; Motilva, MJ				Soler-Cantero, Arantza; Jove, Mariona; Cacabelos, Daniel; Boada, Jordi; Naudi, Alba; Romero, Maria-Paz; Cassanye, Anna; Serrano, Jose C. E.; Arola, Lluis; Valls, Josep; Josep Bellmunt, Maria; Prat, Joan; Pamplona, Reinald; Portero-Otin, Manuel; Motilva, Maria-Jose			Plant-Derived Phenolics Inhibit the Accrual of Structurally Characterised Protein and Lipid Oxidative Modifications	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HEPATOMA HEPG2 CELLS; OLIVE OIL PHENOLS; ANTIOXIDANT ACTIVITY; GALLIC ACID; ALPHA-TOCOPHEROL; RED WINE; LDL; PEROXIDATION; SUPPLEMENTATION	Epidemiological data suggest that plant-derived phenolics beneficial effects include an inhibition of LDL oxidation. After applying a screening method based on 2,4-dinitrophenyl hydrazine-protein carbonyl reaction to 21 different plant-derived phenolic acids, we selected the most antioxidant ones. Their effect was assessed in 5 different oxidation systems, as well as in other model proteins. Mass-spectrometry was then used, evidencing a heterogeneous effect on the accumulation of the structurally characterized protein carbonyl glutamic and aminoadipic semialdehydes as well as for malondialdehyde-lysine in LDL apoprotein. After TOF based lipidomics, we identified the most abundant differential lipids in Cu++-incubated LDL as 1-palmitoyllysophosphatidylcholine and 1-stearoyl-sn-glycero-3-phosphocholine. Most of selected phenolic compounds prevented the accumulation of those phospholipids and the cellular impairment induced by oxidized LDL. Finally, to validate these effects in vivo, we evaluated the effect of the intake of a phenolic-enriched extract in plasma protein and lipid modifications in a well-established model of atherosclerosis (diet-induced hypercholesterolemia in hamsters). This showed that a dietary supplement with a phenolic-enriched extract diminished plasma protein oxidative and lipid damage. Globally, these data show structural basis of antioxidant properties of plant-derived phenolic acids in protein oxidation that may be relevant for the health-promoting effects of its dietary intake.	[Soler-Cantero, Arantza; Romero, Maria-Paz; Motilva, Maria-Jose] Univ Lleida, Escola Tecn Super Engn Agraria, Dept Food Technol, CeRTA TPV, Lleida, Spain; [Jove, Mariona; Cacabelos, Daniel; Boada, Jordi; Naudi, Alba; Cassanye, Anna; Serrano, Jose C. E.; Josep Bellmunt, Maria; Prat, Joan; Pamplona, Reinald; Portero-Otin, Manuel] Lleida Univ, Lleida IRBLLEIDA, Dept Expt Med, NUTREN Nutrigen Ctr, Lleida, Spain; [Arola, Lluis] Univ Rovira & Virgili, Nutrigen Res Grp, Dept Biochem & Biotechnol, Tarragona, Spain; [Valls, Josep] Shirota Funct Foods, SL, Reus, Spain	Universitat de Lleida; Universitat de Lleida; Universitat Rovira i Virgili	Soler-Cantero, A (corresponding author), Univ Lleida, Escola Tecn Super Engn Agraria, Dept Food Technol, CeRTA TPV, Lleida, Spain.	manuel.portero@mex.udl.cat; motilva@tecal.udl.cat	Motilva, María/U-1506-2019; Fonayet, Josep Valls/AAB-3378-2020; Pamplona, Reinald/A-7359-2010; Portero-Otin, Manuel/B-7122-2009; Arola, Lluís/C-6074-2011; Motilva, Maria-Jose/B-4223-2011; Boada, Jordi/AAG-3075-2019; Prat Sala, Joan/HCI-3331-2022; Naudí, Alba/B-5594-2009; Curcó, Maria Josep Bellmunt/C-3784-2011; Serrano, Jose C. E./C-6557-2011; Romero, Maria-Paz/H-3431-2011; Jové, Mariona/M-9104-2016; Boada, Jordi/B-5586-2009	Fonayet, Josep Valls/0000-0002-1359-4114; Pamplona, Reinald/0000-0003-4337-6107; Portero-Otin, Manuel/0000-0002-1823-0299; Arola, Lluís/0000-0003-2767-1974; Motilva, Maria-Jose/0000-0003-3823-3953; Boada, Jordi/0000-0001-5109-4244; Naudí, Alba/0000-0003-0699-1004; Curcó, Maria Josep Bellmunt/0000-0002-3187-1576; Serrano, Jose C. E./0000-0001-6714-6061; Romero, Maria-Paz/0000-0001-9892-4874; Jové, Mariona/0000-0001-5577-6162; Boada, Jordi/0000-0001-5109-4244; Casane, Anna/0000-0003-3157-7403; Motilva, Maria Jose/0000-0001-8985-7737	Spanish Ministry of Education and Science [BFU2006-14495/BFI, AGL2005-07881-C02-01, AGL2006-12433]; Generalitat of Catalunya [2005SGR00101]; Spanish Ministry of Health [FIS 04-0355, 05-2214, 05-2241]; COST B-35 Action; CENIT program from the Spanish Minister of Industry; La Morella Nuts S.A. (Reus, Catalonia, Spain); Shirota Functional Foods, S. L.; KRAFT; BTSA, Biotecnologias Aplicadas, S. L.; Seleccion Batalle, S. A.; Industrial Tecnica Pecuaria, S. A.; Neuron BioPharma, S. A.; Grupo Leche Pascual, S. A. U.; Innaves, S. A.	Spanish Ministry of Education and Science(Spanish Government); Generalitat of Catalunya(Generalitat de Catalunya); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); COST B-35 Action; CENIT program from the Spanish Minister of Industry; La Morella Nuts S.A. (Reus, Catalonia, Spain); Shirota Functional Foods, S. L.; KRAFT; BTSA, Biotecnologias Aplicadas, S. L.; Seleccion Batalle, S. A.; Industrial Tecnica Pecuaria, S. A.; Neuron BioPharma, S. A.; Grupo Leche Pascual, S. A. U.; Innaves, S. A.	This study was supported in part by Research and Development grants from the Spanish Ministry of Education and Science (BFU2006-14495/BFI) and the Generalitat of Catalunya (2005SGR00101) to RP; the Spanish Ministry of Health (FIS 04-0355, 05-2214 and 05-2241) to MPO, Spanish Ministry of Education and Science (AGL2005-07881-C02-01 and AGL2006-12433) to MJM and MPO. Supported partially by the COST B-35 Action. The present work was supported by the CENIT program from the Spanish Minister of Industry and by a consortium of companies led by La Morella Nuts S.A. (Reus, Catalonia, Spain) with the following companies: Shirota Functional Foods, S. L.; KRAFT; BTSA, Biotecnologias Aplicadas, S. L.; Seleccion Batalle, S. A.; Industrial Tecnica Pecuaria, S. A.; Neuron BioPharma, S. A.; Grupo Leche Pascual, S. A. U.; Innaves, S. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY M, 1993, AM J CLIN NUTR, V58, P525, DOI 10.1093/ajcn/58.4.525; Agarwal C, 2006, MOL CANCER THER, V5, P3294, DOI 10.1158/1535-7163.MCT-06-0483; Artajo LS, 2006, J AGR FOOD CHEM, V54, P6079, DOI 10.1021/jf060874q; Auger C, 2004, J AGR FOOD CHEM, V52, P5297, DOI 10.1021/jf040125d; BALLA G, 1991, ARTERIOSCLER THROMB, V11, P1700, DOI 10.1161/01.ATV.11.6.1700; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; BORS W, 1990, METHOD ENZYMOL, V186, P343; Bouguerne B, 2011, ANTIOXID REDOX SIGN, V14, P2093, DOI 10.1089/ars.2010.3321; Brenes M, 1999, J AGR FOOD CHEM, V47, P3535, DOI 10.1021/jf990009o; Briante R, 2004, CHEM BIODIVERS, V1, P1716, DOI 10.1002/cbdv.200490130; Brown JE, 1998, BIOCHEM J, V330, P1173; Carluccio MA, 2003, ARTERIOSCL THROM VAS, V23, P622, DOI 10.1161/01.ATV.0000062884.69432.A0; Chen CC, 1999, PLANTA MED, V65, P709, DOI 10.1055/s-1999-14093; Chen CY, 2007, J NUTR BIOCHEM, V18, P785, DOI 10.1016/j.jnutbio.2006.12.015; Covas MI, 2007, PHARMACOL RES, V55, P175, DOI 10.1016/j.phrs.2007.01.010; Covas MI, 2003, DRUG EXP CLIN RES, V29, P203; Di Benedetto R, 2007, NUTR METAB CARDIOVAS, V17, P535, DOI 10.1016/j.numecd.2006.03.005; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Fukuzawa K, 1997, FREE RADICAL BIO MED, V22, P923, DOI 10.1016/S0891-5849(96)00485-6; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Goya L, 2007, MOL NUTR FOOD RES, V51, P536, DOI 10.1002/mnfr.200600228; Goya L, 2007, EUR J NUTR, V46, P70, DOI 10.1007/s00394-006-0633-8; Grassi D, 2008, J NUTR, V138, P1554; Hamdi HK, 2005, BIOCHEM BIOPH RES CO, V334, P769, DOI 10.1016/j.bbrc.2005.06.161; Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744, DOI 10.1161/01.ATV.17.11.2744; HAZELL LJ, 1993, BIOCHEM J, V290, P165, DOI 10.1042/bj2900165; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hou LF, 2004, CHEM PHYS LIPIDS, V129, P209, DOI 10.1016/j.chemphyslip.2004.02.001; Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480; Hseu YC, 2008, FOOD CHEM TOXICOL, V46, P105, DOI 10.1016/j.fct.2007.07.003; Hsieh CL, 2005, J AGR FOOD CHEM, V53, P6151, DOI 10.1021/jf050707a; Hsu CL, 2007, J AGR FOOD CHEM, V55, P7359, DOI 10.1021/jf071223c; Jeong YJ, 2007, BRIT J NUTR, V97, P447, DOI 10.1017/S0007114507657894; JIALAL I, 1993, CIRCULATION, V88, P2780, DOI 10.1161/01.CIR.88.6.2780; Kamiyama M, 2009, J NUTR SCI VITAMINOL, V55, P471, DOI 10.3177/jnsv.55.471; Kostyuk VA, 2003, FEBS LETT, V537, P146, DOI 10.1016/S0014-5793(03)00113-3; LARANJINHA JAN, 1994, BIOCHEM PHARMACOL, V48, P487, DOI 10.1016/0006-2952(94)90278-X; Leenen R, 2002, J AGR FOOD CHEM, V50, P1290, DOI 10.1021/jf010968u; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Locatelli C, 2008, BIOORGAN MED CHEM, V16, P3791, DOI 10.1016/j.bmc.2008.01.049; Long LH, 2000, BIOCHEM BIOPH RES CO, V273, P50, DOI 10.1006/bbrc.2000.2895; Mazziotti A, 2006, J AGR FOOD CHEM, V54, P7444, DOI 10.1021/jf060982c; Menendez JA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-80; Nakagawa K, 1999, J AGR FOOD CHEM, V47, P3967, DOI 10.1021/jf981195l; Natella F, 2007, AM J CLIN NUTR, V86, P604, DOI 10.1093/ajcn/86.3.604; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Oorni K, 1997, J BIOL CHEM, V272, P21303, DOI 10.1074/jbc.272.34.21303; Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200; Pannala A, 1997, BIOCHEM BIOPH RES CO, V232, P164, DOI 10.1006/bbrc.1997.6254; Pulido R, 2000, J AGR FOOD CHEM, V48, P3396, DOI 10.1021/jf9913458; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Stupans I, 2002, J AGR FOOD CHEM, V50, P2464, DOI 10.1021/jf0112320; SUARNA C, 1993, BIOCHIM BIOPHYS ACTA, V1166, P163, DOI 10.1016/0005-2760(93)90092-N; Terra X, 2011, J NUTR BIOCHEM, V22, P380, DOI 10.1016/j.jnutbio.2010.03.006; Vieira O, 1998, BRIT J PHARMACOL, V123, P565, DOI 10.1038/sj.bjp.0701624; Vissers MN, 2004, EUR J CLIN NUTR, V58, P955, DOI 10.1038/sj.ejcn.1601917; Vuorela S, 2005, J AGR FOOD CHEM, V53, P5922, DOI 10.1021/jf050554r; Wagner P, 1997, ARTERIOSCL THROM VAS, V17, P3338, DOI 10.1161/01.ATV.17.11.3338; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wikoff WR, 2007, CLIN CHEM, V53, P2169, DOI 10.1373/clinchem.2007.089011; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yan LJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P165, DOI 10.1006/abbi.1996.9867	67	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43308	10.1371/journal.pone.0043308	http://dx.doi.org/10.1371/journal.pone.0043308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952663	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000031
J	Koita, K; Rao, CV				Koita, Khushnuma; Rao, Christopher V.			Identification and Analysis of the Putative Pentose Sugar Efflux Transporters in Escherichia coli	PLOS ONE			English	Article							BETA-D-THIOGALACTOPYRANOSIDE; L-ARABINOSE; RESISTANCE; ENCODES; GENES; K-12; PROTEIN; METHYLGLYOXAL; ACCUMULATION; METABOLITES	Escherichia coli possesses a number of proteins that transport sugars out of the cell. We identified 31 candidate sugar efflux transporters based on their similarity to known sugar efflux transporters. We then tested whether these transporters affect arabinose and xylose metabolism. We identified 13 transporters - setC, cmr, ynfM, mdtD, yfcJ, yhhS, emrD, ydhC, ydeA, ybdA, ydeE, mhpT, and kgtP - that appeared to increase or decrease intracellular arabinose concentrations when respectively deleted or over- expressed. None of the candidate transporters affected xylose concentrations. These results indicate that E. coli possesses multiple arabinose efflux transporters. They also provide a novel target for future metabolic engineering.	[Koita, Khushnuma; Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Koita, K (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	chris@scs.uiuc.edu			Energy Biosciences Institute	Energy Biosciences Institute	This work was funded by the Energy Biosciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN RS, 1974, J BACTERIOL, V119, P357, DOI 10.1128/JB.119.2.357-362.1974; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Bohn C, 1998, J BACTERIOL, V180, P6072, DOI 10.1128/JB.180.22.6072-6075.1998; Bost S, 1999, J BACTERIOL, V181, P2185, DOI 10.1128/JB.181.7.2185-2191.1999; Carole S, 1999, J BACTERIOL, V181, P5123; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chubiz LM, 2010, J BACTERIOL, V192, P4786, DOI 10.1128/JB.00371-10; Danchin A, 2009, BIOESSAYS, V31, P769, DOI 10.1002/bies.200900024; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Desai TA, 2010, APPL ENVIRON MICROB, V76, P1524, DOI 10.1128/AEM.01970-09; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; ENGLESBERG E, 1962, J BACTERIOL, V84, P137, DOI 10.1128/JB.84.1.137-146.1962; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; Han XL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-35; Hayashi M, 2010, FEMS MICROBIOL LETT, V304, P12, DOI 10.1111/j.1574-6968.2009.01879.x; LINDSAY SE, 1995, APPL MICROBIOL BIOT, V43, P70, DOI [10.1007/s002530050372, 10.1007/BF00170625]; Liu JY, 1999, MOL MICROBIOL, V31, P1845, DOI 10.1046/j.1365-2958.1999.01321.x; Liu JY, 1999, J BIOL CHEM, V274, P22977, DOI 10.1074/jbc.274.33.22977; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NARODITSKAYA V, 1993, BIOCHEM BIOPH RES CO, V196, P803, DOI 10.1006/bbrc.1993.2320; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rosner JL, 2009, J BACTERIOL, V191, P5283, DOI 10.1128/JB.00507-09; Schleif R, 2000, TRENDS GENET, V16, P559, DOI 10.1016/S0168-9525(00)02153-3; SEOL W, 1991, P NATL ACAD SCI USA, V88, P3802, DOI 10.1073/pnas.88.9.3802; Song SG, 1997, J BACTERIOL, V179, P7025, DOI 10.1128/jb.179.22.7025-7032.1997; Staub JM, 2012, J IND MICROBIOL BIOT, V39, P641, DOI 10.1007/s10295-011-1057-x; Sun Y, 2011, J BACTERIOL, V193, P143, DOI 10.1128/JB.01008-10; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Zgurskaya HI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00189	33	37	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43700	10.1371/journal.pone.0043700	http://dx.doi.org/10.1371/journal.pone.0043700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952739	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600037
J	Lyimo, MA; Mosi, MN; Housman, ML; Zain-Ul-Abideen, M; Lee, FV; Howell, AL; Connor, RI				Lyimo, Magdalena A.; Mosi, Matilda Ngarina; Housman, Molly L.; Zain-Ul-Abideen, Muhammad; Lee, Frederick V.; Howell, Alexandra L.; Connor, Ruth I.			Breast Milk from Tanzanian Women Has Divergent Effects on Cell-Free and Cell-Associated HIV-1 Infection In Vitro	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; SUBCLINICAL MASTITIS; VIROLOGICAL SYNAPSES; RISK; PREVENTION; PREGNANCY; GLYCOSAMINOGLYCANS; GLYCOPROTEIN	Transmission of HIV-1 during breastfeeding is a significant source of new pediatric infections in sub-Saharan Africa. Breast milk from HIV-positive mothers contains both cell-free and cell-associated virus; however, the impact of breast milk on HIV-1 infectivity remains poorly understood. In the present study, breast milk was collected from HIV-positive and HIV-negative Tanzanian women attending antenatal clinics in Dar es Salaam. Milk was analyzed for activity in vitro against both cell-free and cell-associated HIV-1. Potent inhibition of cell-free R5 and X4 HIV-1 occurred in the presence of milk from all donors regardless of HIV-1 serostatus. Inhibition of cell-free HIV-1 infection positively correlated with milk levels of sialyl-Lewis(X) from HIV-positive donors. In contrast, milk from 8 of 16 subjects enhanced infection with cell-associated HIV-1 regardless of donor serostatus. Milk from two of these subjects contained high levels of multiple pro-inflammatory cytokines including TNF alpha, IL-1 beta, IL-6, IL-8, MIP-1 alpha, MIP-1 beta, MCP-1 and IP-10, and enhanced cell-associated HIV-1 infection at dilutions as high as 1:500. These findings indicate that breast milk contains innate factors with divergent activity against cell-free and cell-associated HIV-1 in vitro. Enhancement of cell-associated HIV-1 infection by breast milk may be associated with inflammatory conditions in the mother and may contribute to infant infection during breastfeeding.	[Lyimo, Magdalena A.] Geisel Sch Med Dartmouth, Dept Physiol, Lebanon, NH USA; [Lyimo, Magdalena A.] Geisel Sch Med Dartmouth, Program Expt & Mol Med, Lebanon, NH USA; [Housman, Molly L.; Zain-Ul-Abideen, Muhammad; Lee, Frederick V.; Howell, Alexandra L.; Connor, Ruth I.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA; [Lyimo, Magdalena A.; Mosi, Matilda Ngarina] Muhimbili Natl Hosp, Dar Es Salaam, Tanzania; [Lyimo, Magdalena A.] Muhimbili Univ Hlth & Allied Sci, Dept Hematol, Dar Es Salaam, Tanzania; [Howell, Alexandra L.] Vet Affairs Med Ctr, White River Jct, VT USA	Dartmouth College; Dartmouth College; Dartmouth College; Muhimbili University of Health & Allied Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lyimo, MA (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Hematol, Dar Es Salaam, Tanzania.	Ruth.I.Connor@Dartmouth.edu			National Institutes of Health (NIH) AIDS International Training and Research Program/Fogarty International Center at The Geisel School of Medicine at Dartmouth; Howard Hughes Medical Institute Undergraduate Research Award; Veterans Affairs Merit Review Award	National Institutes of Health (NIH) AIDS International Training and Research Program/Fogarty International Center at The Geisel School of Medicine at Dartmouth(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Undergraduate Research Award(Howard Hughes Medical Institute); Veterans Affairs Merit Review Award(US Department of Veterans Affairs)	This study was supported by the National Institutes of Health (NIH) AIDS International Training and Research Program/Fogarty International Center at The Geisel School of Medicine at Dartmouth, Howard Hughes Medical Institute Undergraduate Research Award, and a Veterans Affairs Merit Review Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrovandi GM, 2010, J INFECT DIS, V202, pS366, DOI 10.1086/655972; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Alfsen A, 2005, MOL BIOL CELL, V16, P4267, DOI 10.1091/mbc.E05-03-0192; Arsenault JE, 2010, J INFECT DIS, V202, P370, DOI 10.1086/653706; Becquart P, 2006, AIDS, V20, P1453, DOI 10.1097/01.aids.0000233581.64467.55; Chama CM, 2010, J OBSTET GYNAECOL, V30, P362, DOI 10.3109/01443611003672104; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Habte HH, 2008, NEONATOLOGY, V93, P162, DOI 10.1159/000108414; Habte HH, 2007, NEONATOLOGY, V92, P96, DOI 10.1159/000100808; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Kantarci S, 2007, JAIDS-J ACQ IMM DEF, V46, P651, DOI 10.1097/QAI.0b013e31815b2db2; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Lehman DA, 2008, AIDS, V22, P1475, DOI 10.1097/QAD.0b013e328302cc11; Lunney KM, 2010, CLIN INFECT DIS, V50, P762, DOI 10.1086/650535; Lyimo MA, 2009, JAIDS-J ACQ IMM DEF, V51, P117, DOI 10.1097/QAI.0b013e3181a3908d; Means RE, 2000, J VIROL, V74, P11181, DOI 10.1128/JVI.74.23.11181-11190.2000; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Newburg DS, 2009, J ANIM SCI, V87, P26, DOI 10.2527/jas.2008-1347; NEWBURG DS, 1995, J NUTR, V125, P419; PearcePratt R, 1996, BIOL REPROD, V54, P173, DOI 10.1095/biolreprod54.1.173; Petitjean G, 2007, J CLIN VIROL, V39, P1, DOI 10.1016/j.jcv.2007.02.004; Puigdomenech I, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-32; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Saeland E, 2009, MOL IMMUNOL, V46, P2309, DOI 10.1016/j.molimm.2009.03.025; Semba RD, 2000, ANN NY ACAD SCI, V918, P156; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shapiro RL, 2005, J INFECT DIS, V192, P713, DOI 10.1086/432489; Slyker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029777; Southern S O, 1998, J Hum Virol, V1, P328; Sun JF, 2001, VIROLOGY, V284, P26, DOI 10.1006/viro.2001.0889; Valea D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-34; Vasiliver-Shamis G, 2010, VIRUSES-BASEL, V2, P1239, DOI 10.3390/v2051239; Vet JAM, 1999, P NATL ACAD SCI USA, V96, P6394, DOI 10.1073/pnas.96.11.6394; Villamor E, 2007, AM J CLIN NUTR, V86, P682, DOI 10.1093/ajcn/86.3.682; Viveros-Rogel M, 2004, ADV EXP MED BIOL, V554, P481; Walter J, 2009, J INFECT DIS, V200, P1498, DOI 10.1086/644603; Willumsen JF, 2000, ADV EXP MED BIOL, V478, P211	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43815	10.1371/journal.pone.0043815	http://dx.doi.org/10.1371/journal.pone.0043815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952771	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600046
J	Price, NN; Martz, TR; Brainard, RE; Smith, JE				Price, Nichole N.; Martz, Todd R.; Brainard, Russell E.; Smith, Jennifer E.			Diel Variability in Seawater pH Relates to Calcification and Benthic Community Structure on Coral Reefs	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; OCEAN ACIDIFICATION; CLIMATE-CHANGE; FLUCTUATIONS; TEMPERATURE; METABOLISM; RESPONSES; PATTERNS; SYSTEM; IMPACT	Community structure and assembly are determined in part by environmental heterogeneity. While reef-building corals respond negatively to warming (i.e. bleaching events) and ocean acidification (OA), the extent of present-day natural variability in pH on shallow reefs and ecological consequences for benthic assemblages is unknown. We documented high resolution temporal patterns in temperature and pH from three reefs in the central Pacific and examined how these data relate to community development and net accretion rates of early successional benthic organisms. These reefs experienced substantial diel fluctuations in temperature (0.78 degrees C) and pH (>0.2) similar to the magnitude of 'warming' and 'acidification' expected over the next century. Where daily pH within the benthic boundary layer failed to exceed pelagic climatological seasonal lows, net accretion was slower and fleshy, non-calcifying benthic organisms dominated space. Thus, key aspects of coral reef ecosystem structure and function are presently related to natural diurnal variability in pH.	[Price, Nichole N.; Martz, Todd R.; Smith, Jennifer E.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Brainard, Russell E.] Natl Ocean & Atmospher Adm, Pacific Isl Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA	Price, NN (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	nprice@ucsd.edu; smithj@ucsd.edu	Smith, Jennifer/E-5207-2013	Martz, Todd/0000-0002-1996-7145; Price, Nichole/0000-0001-6773-3215	Gordon and Betty Moore Foundation; Coral Reef Conservation Program (NOAA); Nature Conservancy; WWW Foundation; Scripps Institution of Oceanography Development Office	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Coral Reef Conservation Program (NOAA); Nature Conservancy; WWW Foundation; Scripps Institution of Oceanography Development Office	This research was supported by grants from the Gordon and Betty Moore Foundation, the Coral Reef Conservation Program (NOAA), the Nature Conservancy, the WWW Foundation, the Scripps Institution of Oceanography Development Office and by generous donations from Scott and Karin Wilson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agegian CR, 1985, BIOGEOCHEMICAL ECOLO; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andersson AJ, 2009, BIOGEOSCIENCES, V6, P1811, DOI 10.5194/bg-6-1811-2009; Arp G, 2003, J SEDIMENT RES, V73, P105, DOI 10.1306/071002730105; Bates NR, 2010, BIOGEOSCIENCES, V7, P2509, DOI 10.5194/bg-7-2509-2010; Bates NR, 2002, LIMNOL OCEANOGR, V47, P43, DOI 10.4319/lo.2002.47.1.0043; Buckley BA, 2001, J EXP BIOL, V204, P3571; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cobb K, 2002, CORAL RECORDS EL NIN; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; de Putron SJ, 2011, CORAL REEFS, V30, P321, DOI 10.1007/s00338-010-0697-z; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Dickson A.G., 2007, GUIDE BEST PRACTICES; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fussel HM, 2009, CLIMATIC CHANGE, V97, P469, DOI 10.1007/s10584-009-9648-5; Gattuso J.-P., 1996, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P39; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; IPCC Climate Change, 2022, CLIMATE CHANGE 2022; Jiang LQ, 2010, LIMNOL OCEANOGR, V55, P2424, DOI 10.4319/lo.2010.55.6.2424; Key R. M., 2004, GLOBAL BIOGEOCHEMICA, V18; Kinsey D. W., 1979, BIOGEOCHEMICAL CYCLI, P131; Kinsey D.W., 1977, P 3 INT COR REEF S; Kinsey D. W, 1979, CARBON TURNOVER ACCU; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Lombardi C, 2010, MARINE ECOLOGY; Mallela J, 2007, CORAL REEFS, V26, P775, DOI 10.1007/s00338-007-0260-8; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Morse JW, 2007, CHEM REV, V107, P342, DOI 10.1021/cr050358j; Ohde S, 1999, B MAR SCI, V65, P559; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pierrot D.E., 2006, ORNLCDIAC105A DEP EN; Putnam HM, 2011, J EXP MAR BIOL ECOL, V396, P216, DOI 10.1016/j.jembe.2010.10.026; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Shamberger KEF, 2011, MARINE CHEM; Silverman J, 2007, BIOGEOCHEMISTRY, V84, P67, DOI 10.1007/s10533-007-9075-5; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; SMITH SV, 1977, SCIENCE, V197, P556, DOI 10.1126/science.197.4303.556-a; SMITH SV, 1974, PAC SCI, V28, P225; SMITH SV, 1978, ATOLL RES B, V221, P15; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Tremolada F, 2004, MAR MICROPALEONTOL, V52, P107, DOI 10.1016/j.marmicro.2004.04.002; Webb MD, 1979, PATHWAYS CO2 O2 CO2; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yates KK, 2006, BIOGEOSCIENCES, V3, P357, DOI 10.5194/bg-3-357-2006; Yates KK, 2003, CORAL REEFS, V22, P247, DOI 10.1007/s00338-003-0314-5; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zeebe RE, 1999, MAR CHEM, V65, P135, DOI 10.1016/S0304-4203(98)00092-9	67	115	115	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43843	10.1371/journal.pone.0043843	http://dx.doi.org/10.1371/journal.pone.0043843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952785	gold, Green Published			2022-12-27	WOS:000308213600051
J	Ramella, NA; Schinella, GR; Ferreira, ST; Prieto, ED; Vela, ME; Rios, JL; Tricerri, MA; Rimoldi, OJ				Ramella, Nahuel A.; Schinella, Guillermo R.; Ferreira, Sergio T.; Prieto, Eduardo D.; Vela, Maria E.; Luis Rios, Jose; Alejandra Tricerri, M.; Rimoldi, Omar J.			Human Apolipoprotein A-I Natural Variants: Molecular Mechanisms Underlying Amyloidogenic Propensity	PLOS ONE			English	Article							SYSTEMIC AMYLOIDOSIS; HEREDITARY AMYLOIDOSIS; HYDROSTATIC-PRESSURE; ALZHEIMERS-DISEASE; CHOLESTEROL EFFLUX; BUNDLE PROTEIN; HUMAN LYSOZYME; MUTATION; BETA; FLUORESCENCE	Human apolipoprotein A-I (apoA-I)-derived amyloidosis can present with either wild-type (Wt) protein deposits in atherosclerotic plaques or as a hereditary form in which apoA-I variants deposit causing multiple organ failure. More than 15 single amino acid replacement amyloidogenic apoA-I variants have been described, but the molecular mechanisms involved in amyloid-associated pathology remain largely unknown. Here, we have investigated by fluorescence and biochemical approaches the stabilities and propensities to aggregate of two disease-associated apoA-I variants, apoA-IGly26Arg, associated with polyneuropathy and kidney dysfunction, and apoA-ILys107-0, implicated in amyloidosis in severe atherosclerosis. Results showed that both variants share common structural properties including decreased stability compared to Wt apoA-I and a more flexible structure that gives rise to formation of partially folded states. Interestingly, however, distinct features appear to determine their pathogenic mechanisms. ApoA-ILys107-0 has an increased propensity to aggregate at physiological pH and in a pro-inflammatory microenvironment than Wt apoA-I, whereas apoA-IGly26Arg elicited macrophage activation, thus stimulating local chronic inflammation. Our results strongly suggest that some natural mutations in apoA-I variants elicit protein tendency to aggregate, but in addition the specific interaction of different variants with macrophages may contribute to cellular stress and toxicity in hereditary amyloidosis.	[Ramella, Nahuel A.; Prieto, Eduardo D.; Alejandra Tricerri, M.; Rimoldi, Omar J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina; [Schinella, Guillermo R.] Univ Nacl La Plata, Fac Ciencias Med, Catedra Farmacol Basica, La Plata, Buenos Aires, Argentina; [Schinella, Guillermo R.] Pcia Buenos Aires, Comis Invest Cient, La Plata, Buenos Aires, Argentina; [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, Program Biochem & Cellular Biophys, Rio De Janeiro, Brazil; [Vela, Maria E.] Univ Nacl La Plata, CONICET, Inst Invest Fis Quim Teor & Aplicadas INIFTA, La Plata, Buenos Aires, Argentina; [Luis Rios, Jose] Univ Valencia, Fac Farm, Dept Farmacol, E-46010 Valencia, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Comision de Investigaciones Cientificas; Universidade Federal do Rio de Janeiro; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA; University of Valencia	Ramella, NA (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.	aletricerri@yahoo.com	Schinella, Guillermo/V-9937-2018; Ferreira, Sergio/AAZ-1576-2020; Neurociencia, Inct/I-1011-2013	Schinella, Guillermo/0000-0001-9541-9688; Ferreira, Sergio/0000-0001-7160-9866; Ramella, Nahuel/0000-0002-6275-3193; Vela, Maria Elena/0000-0003-4502-5618	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [2106-2008, 26228]; Universidad Nacional de La Plata [M158]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112-200801-00953]; Spanish government (MICIIN) [SAF2009-10059-C03-01]; National Institute of Translational Neuroscience (Brazil); Conselho Nacional de Pesquisas (CNPq/Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil); Spanish government (FEDER) [SAF2009-10059-C03-01]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Universidad Nacional de La Plata(National University of La Plata); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Spanish government (MICIIN); National Institute of Translational Neuroscience (Brazil); Conselho Nacional de Pesquisas (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Spanish government (FEDER)(European Commission)	The work presented here was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, grants Numbers 2106-2008 to MAT, and Number 26228 to Horacio Garda; Universidad Nacional de La Plata (grant Number M158 to MAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 112-200801-00953 to MAT and HG); and grant SAF2009-10059-C03-01 from the Spanish government (MICIIN and FEDER) to JLR. STF is supported by grants from National Institute of Translational Neuroscience (Brazil), Conselho Nacional de Pesquisas (CNPq/Brazil) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 1998, BIOCHEM BIOPH RES CO, V242, P534, DOI 10.1006/bbrc.1997.8005; ARAKI K, 1994, BBA-LIPID LIPID MET, V1214, P272; Booth DR, 1996, J CLIN INVEST, V97, P2714, DOI 10.1172/JCI118725; Botelho MG, 2003, J BIOL CHEM, V278, P34259, DOI 10.1074/jbc.M303189200; Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t; Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200; Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje; De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje; Eriksson M, 2009, J MOL DIAGN, V11, P257, DOI 10.2353/jmoldx.2009.080161; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Ferreira ST, 2006, CELL BIOCHEM BIOPHYS, V44, P539, DOI 10.1385/CBB:44:3:539; Gonzalez MC, 2008, ARCH BIOCHEM BIOPHYS, V473, P34, DOI 10.1016/j.abb.2008.02.021; Gregorini G, 2005, J AM SOC NEPHROL, V16, P3680, DOI 10.1681/ASN.2005040382; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Gursky O, 2012, BIOCHEMISTRY-US, V51, P10, DOI 10.1021/bi2017014; Hamidi Asl K, 1999, BIOCHEM BIOPH RES CO, V257, P584, DOI DOI 10.1006/BBRC.1999.0518; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Jaureguiberry MS, 2010, J MEMBRANE BIOL, V234, P183, DOI 10.1007/s00232-010-9245-6; Kazama JJ, 2001, NEPHROL DIAL TRANSPL, V16, P31, DOI 10.1093/ndt/16.suppl_4.31; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Lachmann HJ, 2002, NEW ENGL J MED, V346, P1786, DOI 10.1056/NEJMoa013354; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627; Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200; Martins SM, 2002, EUR J BIOCHEM, V269, P5484, DOI 10.1046/j.1432-1033.2002.03248.x; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Miettinen HE, 1997, ARTERIOSCL THROM VAS, V17, P3021, DOI 10.1161/01.ATV.17.11.3021; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Munishkina LA, 2007, BBA-BIOMEMBRANES, V1768, P1862, DOI 10.1016/j.bbamem.2007.03.015; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6; Obici L, 1999, AM J PATHOL, V155, P695, DOI 10.1016/S0002-9440(10)65167-X; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883; RADER DJ, 1992, J LIPID RES, V33, P755; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2; Smoot AL, 2001, BIOCHEMISTRY-US, V40, P4484, DOI 10.1021/bi001822b; SOUTAR AK, 1992, P NATL ACAD SCI USA, V89, P7389, DOI 10.1073/pnas.89.16.7389; TAKADA Y, 1990, BIOCHIM BIOPHYS ACTA, V1043, P169, DOI 10.1016/0005-2760(90)90292-6; Testro AG, 2007, LIVER TRANSPLANT, V13, P1028, DOI 10.1002/lt.21176; TillyKiesi M, 1997, ARTERIOSCL THROM VAS, V17, P873, DOI 10.1161/01.ATV.17.5.873; Tricerri MA, 2000, BIOCHEMISTRY-US, V39, P14682, DOI 10.1021/bi0014251; Tricerri MA, 2001, BIOCHEMISTRY-US, V40, P5065, DOI 10.1021/bi002815q; VANALLEN MW, 1969, NEUROLOGY, V19, P10, DOI 10.1212/WNL.19.1.10; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; VIGUSHIN DM, 1994, Q J MED, V87, P149; VOLLMER E, 1991, VIRCHOWS ARCH A, V419, P79, DOI 10.1007/BF01600220; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	58	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43755	10.1371/journal.pone.0043755	http://dx.doi.org/10.1371/journal.pone.0043755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952757	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600040
J	Shukla, NM; Salunke, DB; Balakrishna, R; Mutz, CA; Malladi, SS; David, SA				Shukla, Nikunj M.; Salunke, Deepak B.; Balakrishna, Rajalakshmi; Mutz, Cole A.; Malladi, Subbalakshmi S.; David, Sunil A.			Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; THIOCYANATE ELUTION; STRUCTURAL BIOLOGY; PROTEIN ANTIGENS; CELL-ACTIVATION; PREDICTION; ANTIBODY; PEPTIDE; AGONISTS; INNATE	Engagement of toll-like receptors (TLRs) serve to link innate immune responses with adaptive immunity and can be exploited as powerful vaccine adjuvants for eliciting both primary and anamnestic immune responses. TLR7 agonists are highly immunostimulatory without inducing dominant proinflammatory cytokine responses. We synthesized a dendrimeric molecule bearing six units of a potent TLR7/TLR8 dual-agonistic imidazoquinoline to explore if multimerization of TLR7/8 would result in altered activity profiles. A complete loss of TLR8-stimulatory activity with selective retention of the TLR7-agonistic activity was observed in the dendrimer. This was reflected by a complete absence of TLR8-driven proinflammatory cytokine and interferon (IFN)-gamma induction in human PBMCs, with preservation of TLR7-driven IFN-alpha induction. The dendrimer was found to be superior to the imidazoquinoline monomer in inducing high titers of high-affinity antibodies to bovine alpha-lactalbumin. Additionally, epitope mapping experiments showed that the dendrimer induced immunoreactivity to more contiguous peptide epitopes along the amino acid sequence of the model antigen.	[Shukla, Nikunj M.; Salunke, Deepak B.; Balakrishna, Rajalakshmi; Mutz, Cole A.; Malladi, Subbalakshmi S.; David, Sunil A.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of Kansas	Shukla, NM (corresponding author), Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA.	sdavid@ku.edu		Salunke, Deepak/0000-0002-1241-9146	National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN272200900033C]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases contract HHSN272200900033C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S., 1902, ADV IMMUNOL, V78, P1; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Gorski KS, 2006, INT IMMUNOL, V18, P1115, DOI 10.1093/intimm/dxl046; Hood J.D., 2010, HUM VACCINES, V6, P1; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kandimalla ER, 2011, CELL IMMUNOL, V270, P126, DOI 10.1016/j.cellimm.2011.03.027; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; MACDONALD RA, 1988, J IMMUNOL METHODS, V106, P191, DOI 10.1016/0022-1759(88)90196-2; Nguyen TB, 2008, MOL PHARMACEUT, V5, P1131, DOI 10.1021/mp8001123; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Ponomarenko JV, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-64; PULLEN GR, 1986, J IMMUNOL METHODS, V86, P83, DOI 10.1016/0022-1759(86)90268-1; Shukla NM, 2012, J MED CHEM, V55, P1106, DOI 10.1021/jm2010207; Shukla NM, 2011, BIOORG MED CHEM LETT, V21, P3232, DOI 10.1016/j.bmcl.2011.04.050; Shukla NM, 2010, BIOORG MED CHEM LETT, V20, P6384, DOI 10.1016/j.bmcl.2010.09.093; Shukla NM, 2010, J MED CHEM, V53, P4450, DOI 10.1021/jm100358c; Shukla NM, 2009, BIOORG MED CHEM LETT, V19, P2211, DOI 10.1016/j.bmcl.2009.02.100; Sil D, 2007, ANTIMICROB AGENTS CH, V51, P2811, DOI 10.1128/AAC.00200-07; Warshakoon HJ, 2009, HUM VACCINES, V5, P381, DOI 10.4161/hv.5.6.8175	31	62	63	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43612	10.1371/journal.pone.0043612	http://dx.doi.org/10.1371/journal.pone.0043612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952720	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600034
J	Ravimohan, S; Gama, L; Engle, EL; Zink, MC; Clements, JE				Ravimohan, Shruthi; Gama, Lucio; Engle, Elizabeth L.; Zink, M. Christine; Clements, Janice E.			Early Emergence and Selection of a SIV-LTR C/EBP Site Variant in SIV-Infected Macaques That Increases Virus Infectivity	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTIONAL INHIBITORY PROTEIN; CD4(+) T-CELLS; BINDING-PROTEIN; HIV-1 REPLICATION; IMMUNE-RESPONSES; COGNITIVE IMPAIRMENT; GENE-EXPRESSION	CCAAT/enhancer binding protein (C/EBP)beta, and C/EBP binding sites in the HIV/SIV-long terminal repeat (LTR) are crucial for regulating transcription and for IFN beta-mediated suppression of virus replication in macrophages, the predominant source of productive virus replication in the brain. We investigated sequence variation within the SIV-LTR C/EBP sites that may be under selective pressure in vivo and therefore associated with disease progression. Using the SIV-macaque model, we examined viral LTR sequences derived from the spleen, a site of macrophage and lymphocyte infection, and the brain from macaques euthanized at 10, 21, 42, 48 and 84 days postinoculation (p.i.). A dominant variant, DS1C/A, containing an adenine-to-guanine substitution and a linked cytosine-to-adenine substitution in the downstream (DS1) C/EBP site, was detected in the spleen at 10 days p.i. The DS1C/A genotype was not detected in the brain until 42 days p.i., after which it was the predominant replicating genotype in both brain and spleen. Functional characterization of the DS1C/A containing SIV showed increased infectivity with or without IFN beta treatment over the wild-type virus, SIV/17E-Fr. The DS1C/A C/EBP site had higher affinity for both protein isoforms of C/EBP beta compared to the wild-type DS1 C/EBP site. Cytokine expression in spleen compared to brain implicated IFN beta and IL-6 responses as part of the selective pressures contributing to emergence of the DS1C/A genotype in vivo. These studies demonstrate selective replication of virus containing the DS1C/A genotype that either emerges very early in spleen and spreads to the brain, or evolves independently in the brain when IFN beta and IL-6 levels are similar to that found in spleen earlier in infection.	[Ravimohan, Shruthi] Univ Penn, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gama, Lucio; Engle, Elizabeth L.; Zink, M. Christine; Clements, Janice E.] Johns Hopkins Univ, Dept Mol & Comparat Pathobiol, Sch Med, Baltimore, MD USA; [Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Zink, M. Christine; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ravimohan, S (corresponding author), Univ Penn, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA.	shruthiravimohan@gmail.com		Gama, Lucio/0000-0001-9511-012X	NIH [R01NS047984, R01NS055648, P01MH070306, AI076113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047984, R01NS055648] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants: R01NS047984, R01NS055648, P01MH070306, AI076113 (JEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; AMEDEE AM, 1995, J VIROL, V69, P7982, DOI 10.1128/JVI.69.12.7982-7990.1995; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; ANDERSON MG, 1992, VIROLOGY, V191, P559, DOI 10.1016/0042-6822(92)90231-D; ANDERSON MG, 1991, J VIROL, V65, P51, DOI 10.1128/JVI.65.1.51-60.1991; Babas T, 2006, AIDS, V20, P197, DOI 10.1097/01.aids.0000198078.24584.21; Babas T, 2003, J VIROL, V77, P208, DOI 10.1128/JVI.77.1.208-216.2003; Babas T, 2001, VIROLOGY, V287, P371, DOI 10.1006/viro.2001.1043; Barber SA, 2006, J INFECT DIS, V193, P963, DOI 10.1086/500983; Barber SA, 2004, J NEUROVIROL, V10, P15, DOI 10.1080/13550280490268179; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Burdo TH, 2004, DNA CELL BIOL, V23, P261, DOI 10.1089/104454904773819842; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dudaronek JM, 2007, J IMMUNOL, V179, P7262, DOI 10.4049/jimmunol.179.11.7262; Dumais N, 2002, J IMMUNOL, V168, P274, DOI 10.4049/jimmunol.168.1.274; Ellis Ronald J, 2007, PLoS Clin Trials, V2, pe15, DOI 10.1371/journal.pctr.0020015; FALK S, 1990, RES VIROLOGY, V141, P161, DOI 10.1016/0923-2516(90)90018-E; Flaherty MT, 1997, J VIROL, V71, P5790, DOI 10.1128/JVI.71.8.5790-5798.1997; GARTNER S, 1990, AIDS RES HUM RETROV, V6, P1017, DOI 10.1089/aid.1990.6.1017; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Henderson AJ, 1996, IMMUNITY, V5, P91, DOI 10.1016/S1074-7613(00)80313-1; Hogan TH, 2003, J NEUROVIROL, V9, P55, DOI 10.1080/13550280390173292; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; Hungness ES, 2002, J CELL PHYSIOL, V192, P64, DOI 10.1002/jcp.10116; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; KOOP BF, 1993, BIOTECHNIQUES, V14, P442; KORNBLUTH RS, 1994, RES IMMUNOL, V145, P664, DOI 10.1016/S0923-2494(05)80051-3; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Mameli G, 2007, J GEN VIROL, V88, P631, DOI 10.1099/vir.0.82487-0; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McIlroy D, 1996, RES VIROLOGY, V147, P115, DOI 10.1016/0923-2516(96)80225-1; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; MURPHEYCORB M, 1991, AIDS, V5, P655, DOI 10.1097/00002030-199106000-00003; Niehof M, 2001, J BIOL CHEM, V276, P9016, DOI 10.1074/jbc.M009284200; Nonnemacher MR, 2003, BIOMED PHARMACOTHER, V57, P34, DOI 10.1016/S0753-3322(02)00334-7; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Price R W, 1988, Ann N Y Acad Sci, V540, P162, DOI 10.1111/j.1749-6632.1988.tb27059.x; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Ravimohan S, 2010, J BIOL CHEM, V285, P2268, DOI 10.1074/jbc.M109.075929; Roos JW, 2000, VIROLOGY, V273, P307, DOI 10.1006/viro.2000.0431; Ross HL, 2001, J NEUROVIROL, V7, P235; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Smith DB, 1997, J GEN VIROL, V78, P1511, DOI 10.1099/0022-1317-78-7-1511; Spooner CJ, 2007, MOL IMMUNOL, V44, P1384, DOI 10.1016/j.molimm.2006.05.004; SPOUGE JL, 1992, P NATL ACAD SCI USA, V89, P7581, DOI 10.1073/pnas.89.16.7581; Steiniger B, 2005, SPLEEN ENCY LIFE SCI; Szeto GLBA, 2009, J INFECT DIS; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Weiden M, 2000, J IMMUNOL, V165, P2028, DOI 10.4049/jimmunol.165.4.2028; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Witwer KW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008129; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; ZHANG JY, 1988, J INFECT DIS, V158, P1277, DOI 10.1093/infdis/158.6.1277; Zink MC, 1998, J NEUROVIROL, V4, P249, DOI 10.3109/13550289809114526; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003; Zink MC, 1997, AM J PATHOL, V151, P793	73	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42801	10.1371/journal.pone.0042801	http://dx.doi.org/10.1371/journal.pone.0042801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952612	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800013
J	Vieira, FG; Foret, S; He, XL; Rozas, J; Field, LM; Zhou, JJ				Vieira, Filipe G.; Foret, Sylvain; He, Xiaoli; Rozas, Julio; Field, Linda M.; Zhou, Jing-Jiang			Unique Features of Odorant-Binding Proteins of the Parasitoid Wasp Nasonia vitripennis Revealed by Genome Annotation and Comparative Analyses	PLOS ONE			English	Article							MOSQUITO AEDES-AEGYPTI; PHEROMONE-BINDING; ANOPHELES-GAMBIAE; BOMBYX-MORI; HYMENOPTERA-PTEROMALIDAE; DROSOPHILA-MELANOGASTER; PHYLOGENETIC INFERENCE; CHEMOSENSORY PROTEINS; MAXIMUM-LIKELIHOOD; SEXUAL ATTRACTION	Insects are the most diverse group of animals on the planet, comprising over 90% of all metazoan life forms, and have adapted to a wide diversity of ecosystems in nearly all environments. They have evolved highly sensitive chemical senses that are central to their interaction with their environment and to communication between individuals. Understanding the molecular bases of insect olfaction is therefore of great importance from both a basic and applied perspective. Odorant binding proteins (OBPs) are some of most abundant proteins found in insect olfactory organs, where they are the first component of the olfactory transduction cascade, carrying odorant molecules to the olfactory receptors. We carried out a search for OBPs in the genome of the parasitoid wasp Nasonia vitripennis and identified 90 sequences encoding putative OBPs. This is the largest OBP family so far reported in insects. We report unique features of the N. vitripennis OBPs, including the presence and evolutionary origin of a new subfamily of double-domain OBPs (consisting of two concatenated OBP domains), the loss of conserved cysteine residues and the expression of pseudogenes. This study also demonstrates the extremely dynamic evolution of the insect OBP family: (i) the number of different OBPs can vary greatly between species; (ii) the sequences are highly diverse, sometimes as a result of positive selection pressure with even the canonical cysteines being lost; (iii) new lineage specific domain arrangements can arise, such as the double domain OBP subfamily of wasps and mosquitoes.	[Vieira, Filipe G.; Rozas, Julio] Univ Barcelona, Dept Genet, Barcelona, Spain; [Vieira, Filipe G.; Rozas, Julio] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Foret, Sylvain] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Foret, Sylvain] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [He, Xiaoli; Field, Linda M.; Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	University of Barcelona; University of Barcelona; James Cook University; Australian National University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Vieira, FG (corresponding author), Univ Calif Berkeley, Ctr Theoret Evolutionary Genom, Berkeley, CA 94720 USA.	jing-jiang.zhou@rothamsted.ac.uk	Rozas, Julio/A-1733-2009; Garrett Vieira, Filipe/B-9464-2015; FORET, Sylvain/B-9207-2012	Rozas, Julio/0000-0002-6839-9148; Garrett Vieira, Filipe/0000-0002-8464-7770; Field, Linda/0000-0002-3328-2513	BBSRC of the UK; 'Fundacao para a Ciencia e a Tecnologia' (Portugal) [SFRH/BD/22360/2005]; 'Direccion General de Investigacion Cientifica y Tecnica' (Spain) [BFU2007-62927, BFU2010-15484]; ICREA Academia (Generalitat de Catalunya); BBSRC [BBS/E/C/00004947] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004947] Funding Source: researchfish	BBSRC of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 'Fundacao para a Ciencia e a Tecnologia' (Portugal)(Portuguese Foundation for Science and Technology); 'Direccion General de Investigacion Cientifica y Tecnica' (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives grant-aided support from the BBSRC of the UK. The authors thank Prof. David M. Shuker, University of Edinburgh, UK, who provided us with N. vitripennis. FGV was supported by a predoctoral fellowship SFRH/BD/22360/2005 from the 'Fundacao para a Ciencia e a Tecnologia' (Portugal). This work was funded by grants BFU2007-62927 and BFU2010-15484 from the 'Direccion General de Investigacion Cientifica y Tecnica' (Spain) to JR. JR was partially supported by ICREA Academia (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Gotzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016289; Gotzek D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007713; Gu SH, 2011, ARCH INSECT BIOCHEM, V77, P81, DOI 10.1002/arch.20427; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Junier T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/bioinformatics/16.2.178; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KING BH, 1991, ANIM BEHAV, V42, P23, DOI 10.1016/S0003-3472(05)80602-5; KING PE, 1970, J EXP BIOL, V53, P245; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lewis S.E., 2003, GENOME BIOL, V3, P1, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Ruther J, 2008, J CHEM ECOL, V34, P99, DOI 10.1007/s10886-007-9411-1; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sanchez-Gracia A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-323; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Schurmann D, 2009, NATURWISSENSCHAFTEN, V96, P383, DOI 10.1007/s00114-008-0490-9; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Steiner S, 2006, J CHEM ECOL, V32, P1687, DOI 10.1007/s10886-006-9102-3; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Turlings Ted C. J., 1993, P51; VANDENBERG MJ, 1991, J INSECT PHYSIOL, V37, P79, DOI 10.1016/0022-1910(91)90022-R; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; WYLIE HG, 1979, CAN ENTOMOL, V111, P105, DOI 10.4039/Ent111105-1; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007	52	45	48	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43034	10.1371/journal.pone.0043034	http://dx.doi.org/10.1371/journal.pone.0043034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952629	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000308044800018
J	Wu, ZY; Chen, YJ; Yang, T; Gao, QQ; Yuan, M; Ma, L				Wu, Ziyan; Chen, Yuejun; Yang, Tong; Gao, Qinqin; Yuan, Man; Ma, Lan			Targeted Ubiquitination and Degradation of G-Protein-Coupled Receptor Kinase 5 by the DDB1-CUL4 Ubiquitin Ligase Complex	PLOS ONE			English	Article							DNA-DAMAGE; DEPENDENT DEGRADATION; SELECTIVE REGULATION; COP9 SIGNALOSOME; NDR KINASE; S-PHASE; PROTEOLYSIS; CELLS; DDB1; PHOSPHORYLATION	The G protein-coupled receptor kinases (GRKs) phosphorylate agonist occupied G protein-coupled receptors (GPCRs) and desensitize GPCR-mediated signaling. Recent studies indicate they also function non-catalytically via interaction with other proteins. In this study, a proteomic approach was used to screen interacting proteins of GRK5 in MDA-MB-231 cells and HUVEC cells. Mass spectrometry analysis reveals several proteins in the GRK5 immunocomplex including damaged DNA-binding protein 1 (DDB1), an adaptor subunit of the CUL4-ROC1 E3 ubiquitin ligase complex. Co-immunoprecipitation experiments confirmed the association of GRK5 with DDB1-CUL4 complex, and reveal that DDB1 acts as an adapter to link GRK5 to CUL4 to form the complex. Overexpression of DDB1 promoted, whereas knockdown of DDB1 inhibited the ubiquitination of GRK5, and the degradation of GRK5 was reduced in cells deficient of DDB1. Furthermore, the depletion of DDB1 decreased Hsp90 inhibitor-induced GRK5 destabilization and UV irradiation-induced GRK5 degradation. Thus, our study identified potential GRK5 interacting proteins, and reveals the association of GRK5 with DDB1 in cell and the regulation of GRK5 level by DDB1-CUL4 ubiquitin ligase complex-dependent proteolysis pathway.	[Wu, Ziyan] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; Fudan Univ, Pharmacol Res Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China; Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wu, ZY (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	yuejunchen@fudan.edu.cn	Ma, Lan/B-9295-2009; chen, yuejun/AAL-4070-2020	Chen, Yuejun/0000-0002-4625-2604; Ma, Lan/0000-0001-9034-5472	Ministry of Science and Technology [2009CB522006]; National Natural Science Foundation of China [30830042, 31121061, 30900852]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Ministry of Science and Technology grant 2009CB522006 (to LM) and National Natural Science Foundation of China grants 30830042 and 31121061 (to Lan Ma), and 30900852 (to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Barthet G, 2009, EMBO J, V28, P2706, DOI 10.1038/emboj.2009.215; Blencowe BJ, 2000, RNA, V6, P111, DOI 10.1017/S1355838200991982; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Chen XQ, 2010, J BIOL CHEM, V285, P12823, DOI 10.1074/jbc.M109.094243; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Chen YJ, 2011, J CELL BIOL, V194, P905, DOI 10.1083/jcb.201104114; Elorza A, 2003, J BIOL CHEM, V278, P29164, DOI 10.1074/jbc.M304314200; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kim JI, 2012, J UROLOGY, V187, P322, DOI 10.1016/j.juro.2011.09.049; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Loudon RP, 1996, BLOOD, V88, P4547, DOI 10.1182/blood.V88.12.4547.bloodjournal88124547; Luo JS, 2003, J BIOL CHEM, V278, P50908, DOI 10.1074/jbc.M307637200; Michal AM, 2012, J BIOL CHEM, V287, P6928, DOI 10.1074/jbc.M111.298034; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Nogues L, 2011, J BIOL CHEM, V286, P1165, DOI 10.1074/jbc.M110.203406; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Salim S, 2007, J PHARMACOL EXP THER, V320, P1106, DOI 10.1124/jpet.106.114835; Sawada Y, 2000, BBA-GENE STRUCT EXPR, V1492, P191, DOI 10.1016/S0167-4781(00)00065-8; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549	54	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43997	10.1371/journal.pone.0043997	http://dx.doi.org/10.1371/journal.pone.0043997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952844	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800086
J	Deng, JY; Sun, D; Pan, Y; Zhang, L; Zhang, RP; Wang, DC; Hao, XS; Liang, H				Deng, Jingyu; Sun, Dan; Pan, Yuan; Zhang, Li; Zhang, Rupeng; Wang, Dianchang; Hao, Xishan; Liang, Han			Ratio between Negative and Positive Lymph Nodes Is Suitable for Evaluation the Prognosis of Gastric Cancer Patients with Positive Node Metastasis	PLOS ONE			English	Article							AMERICAN-JOINT-COMMITTEE; CANCER/INTERNATIONAL-UNION; STAGE MIGRATION; N-RATIO; SURVIVAL; CLASSIFICATION; LYMPHADENECTOMY; CARCINOMA; NUMBER; IMPACT	Objective: To date, there is no consensus to evaluate the most appropriate category of the nodal metastasis for precise predication the prognosis of gastric cancer patients with positive node metastasis after curative surgery. Methods: We retrospectively analyzed the clinicopathologic characteristics and overall survival (OS) of 299 gastric cancer patients with positive node metastasis after curative surgery for evaluation the optimal category of the nodal metastasis. Results: With the univariate and multivariate survival analyses, the depth of primary tumor invasion was identified as the independent predicators with the OS of 299 gastric cancer patients with nodal metastasis postoperatively, as were the number of positive lymph nodes (PLNs), the number of negative lymph nodes (NLNs), and the ratio between negative and positive lymph nodes (RNPL). The RNPL was identified to be more suitable for predication the OS of gastric cancer patients with positive node metastasis than the ratio between positive and dissected lymph nodes (RPDL) by using the stratum procedure of survival analysis. Besides, we found both PLNs and NLNs were independently correlated with OS of gastric cancer patients with nodal metastasis when RNPL, instead of RPDL, was controlled in the partial correlation model. Conclusions: RNPL, a new category of the nodal metastasis, was suitable for predication the OS of gastric cancer patients with nodal metastasis after curative resection, as were the PLNs, and NLNs.	[Deng, Jingyu; Pan, Yuan; Zhang, Li; Zhang, Rupeng; Hao, Xishan; Liang, Han] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Gastr Canc Surg Div, Tianjin, Peoples R China; [Sun, Dan] Tianjin Med Univ, Gen Hosp, Inst Lung Canc, Tianjin, Peoples R China; [Wang, Dianchang] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Hepatobilliary Canc Surg Div, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Deng, JY (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Gastr Canc Surg Div, Tianjin, Peoples R China.	tjlianghan@sohu.com			National Basic Research Program of China (973 Program) [2010CB529301]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by a grant from the National Basic Research Program of China (973 Program) 2010CB529301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; Aurello P, 2007, AM SURGEON, V73, P359; Bilici A, 2010, MED ONCOL, V27, P975, DOI 10.1007/s12032-009-9319-4; Bilici A, 2010, ONKOLOGIE, V33, P101, DOI 10.1159/000277927; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Bouvier AM, 2002, CANCER, V94, P2862, DOI 10.1002/cncr.10550; BUNT AMG, 1995, J CLIN ONCOL, V13, P19, DOI 10.1200/JCO.1995.13.1.19; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Deng JY, 2008, J SURG ONCOL, V98, P343, DOI 10.1002/jso.21119; Deng JY, 2011, LANGENBECK ARCH SURG, V396, P615, DOI 10.1007/s00423-011-0753-3; Deng JY, 2010, ANN SURG ONCOL, V17, P1259, DOI 10.1245/s10434-010-0939-x; Deng JY, 2010, ANN SURG ONCOL, V17, P1043, DOI 10.1245/s10434-009-0863-0; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Fukuda N, 2009, WORLD J SURG, V33, P2378, DOI 10.1007/s00268-009-0205-1; Funada T, 2011, HEPATO-GASTROENTEROL, V58, P642; HERMANEK P, 1994, SEMIN SURG ONCOL, V10, P12, DOI 10.1002/ssu.2980100105; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Huang CM, 2008, WORLD J GASTROENTERO, V14, P4383, DOI 10.3748/wjg.14.4383; Huang CM, 2010, WORLD J GASTROENTERO, V16, P2055, DOI 10.3748/wjg.v16.i16.2055; Ichikura T, 1999, CANCER-AM CANCER SOC, V86, P553, DOI 10.1002/(SICI)1097-0142(19990815)86:4<553::AID-CNCR2>3.0.CO;2-D; JAEHNE J, 1992, ARCH SURG-CHICAGO, V127, P290; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016; Katai H, 2000, CANCER-AM CANCER SOC, V88, P1796, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1796::AID-CNCR6>3.3.CO;2-U; Kulig J, 2009, BRIT J SURG, V96, P910, DOI 10.1002/bjs.6653; Kunisaki C, 2004, ANN SURG ONCOL, V11, P203, DOI 10.1245/ASO.2004.06.012; Lee SY, 2010, INT J ONCOL, V36, P1461, DOI 10.3892/ijo_00000632; Maduekwe UN, 2010, ANN SURG ONCOL, V17, P1267, DOI 10.1245/s10434-010-0914-6; Marchet A, 2008, EJSO-EUR J SURG ONC, V34, P159, DOI 10.1016/j.ejso.2007.04.018; Marchet A, 2007, ANN SURG, V245, P543, DOI 10.1097/01.sla.0000250423.43436.e1; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; Sasako M, 2007, DIGEST SURG, V24, P101, DOI 10.1159/000101896; Sianesi M, 2010, J GASTROINTEST SURG, V14, P614, DOI 10.1007/s11605-009-1142-x; Smith DD, 2005, J CLIN ONCOL, V23, P7114, DOI 10.1200/JCO.2005.14.621; Sobin L, 1997, INT UNION CANC UICC; Tokunaga M, 2010, ANN SURG ONCOL, V17, P2031, DOI 10.1245/s10434-010-0969-4; Wang W, 2011, ANN SURG ONCOL, V18, P1060, DOI 10.1245/s10434-010-1424-2; Wu CW, 2004, BRIT J SURG, V91, P283, DOI 10.1002/bjs.4433	37	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43925	10.1371/journal.pone.0043925	http://dx.doi.org/10.1371/journal.pone.0043925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952812	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300035
J	Rodger, S; Stephens, E; Clark, M; Ash, S; Hurst, C; Graves, N				Rodger, Sylvia; Stephens, Elizabeth; Clark, Michele; Ash, Susan; Hurst, Cameron; Graves, Nicholas			Productivity and Time Use during Occupational Therapy and Nutrition/Dietetics Clinical Education: A Cohort Study	PLOS ONE			English	Article							LEVEL-II FIELDWORK; DIETETIC INTERNSHIPS; BENEFITS; STUDENTS; COST	Background: Currently in the Australian higher education sector higher productivity from allied health clinical education placements is a contested issue. This paper will report results of a study that investigated output changes associated with occupational therapy and nutrition/dietetics clinical education placements in Queensland, Australia. Supervisors' and students' time use during placements and how this changes for supervisors compared to when students are not present in the workplace is also presented. Methodology/Principal Findings: A cohort design was used with students from four Queensland universities, and their supervisors employed by Queensland Health. There was an increasing trend in the number of occasions of service delivered when the students were present, and a statistically significant increase in the daily mean length of occasions of service delivered during the placement compared to pre-placement levels. Conclusions/Significance: A novel method for estimating productivity and time use changes during clinical education programs for allied health disciplines has been applied. During clinical education placements there was a net increase in outputs, suggesting supervisors engage in longer consultations with patients for the purpose of training students, while maintaining patient numbers. Other activities were reduced. This paper is the first time these data have been shown in Australia and form a sound basis for future assessments of the economic impact of student placements for allied health disciplines.	[Rodger, Sylvia] Univ Queensland, Div Occupat Therapy, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Stephens, Elizabeth; Clark, Michele; Ash, Susan; Hurst, Cameron; Graves, Nicholas] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia	University of Queensland; Queensland University of Technology (QUT)	Rodger, S (corresponding author), Univ Queensland, Div Occupat Therapy, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	elizabeth.stephens@qut.edu.au	Hurst, Cameron P/P-5175-2017; Ash, Susan/I-9664-2012; Hurst, Cameron/AAD-5753-2019; Martin, Elizabeth/O-3573-2019	Hurst, Cameron P/0000-0002-4577-8962; Ash, Susan/0000-0003-2078-7560; Hurst, Cameron/0000-0002-4577-8962; Martin, Elizabeth/0000-0003-0252-8303; Graves, Nicholas/0000-0002-5559-3267	Queensland Health ClinED Queensland research grant	Queensland Health ClinED Queensland research grant	This manuscript was made possible with funding from Queensland Health ClinED Queensland research grant 2009-2010 (http://www.health.qld.gov.au/clinedq/default.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown S, 1990, J AM DENT ASSOC S, V90, pA; BURKHARDT BF, 1985, AM J OCCUP THER, V39, P35, DOI 10.5014/ajot.39.1.35; Campbell AR, 2011, AM J PHARM EDUC, V75, DOI 10.5688/ajpe7518; Chisholm MA, 1997, HOSP PHARM, V32, P370; Chung Y I, 1980, Inquiry, V17, P216; CHUNG YI, 1983, AM J OCCUP THER, V37, P681, DOI 10.5014/ajot.37.10.681; CONKLIN MT, 1994, J AM DIET ASSOC, V94, P174, DOI 10.1016/0002-8223(94)90243-7; Conklin MT, 1995, TOP CLIN NUTR, V10, P71; Demory-Luce D, 1990, J AM DENT ASSOC S, V90, pA; Dietitians Association of Australia, 2009, NAT COMP STAND ENTR; Dillon Loretta Schoen, 2003, J Allied Health, V32, P261; Gilbride JA, 1996, J AM DIET ASSOC, V96, P758, DOI 10.1016/S0002-8223(96)00211-8; Haines TP., 2011, FOCUS HEALTH PROF ED, V12, P53; Kincaid C, 2005, 30 ANN SAS US GROUP; Ladyshewsky RK, 1998, PHYS THER, V78, P1288, DOI 10.1093/ptj/78.12.1288; Ladyshewsky RW, 1994, PHYSIOTHER CAN, V46, P89; Leiken A M, 1983, Inquiry, V20, P88; LEIKEN AM, 1983, PHYS THER, V63, P56, DOI 10.1093/ptj/63.1.56; MacKinnon J R, 1986, J Allied Health, V15, P225; McAllister L, 2005, ADV SPEECH LANGUAGE, V7, P138, DOI DOI 10.1080/14417040500181239; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; Mersfelder TL, 2012, ANN PHARMACOTHER, V46, P541, DOI 10.1345/aph.1Q544; MUELLER BA, 1990, DICP ANN PHARMAC, V24, P422, DOI 10.1177/106002809002400416; Murray E, 2000, MED EDUC, V34, P871, DOI 10.1046/j.1365-2923.2000.00757.x; National Allied Health Casemix Committee, 1997, AUSTR ALL HLTH CLASS; PAGE GG, 1987, PHYS THER, V67, P238, DOI 10.1093/ptj/67.2.238; Rodger Sylvia, 2008, J Allied Health, V37, P53; Rose M, 2005, ADV SPEECH LANGUAGE, V7, P158, DOI [10.1080/14417040500181353, DOI 10.1080/14417040500181353]; SHALIK H, 1988, AM J OCCUP THER, V42, P164, DOI 10.5014/ajot.42.3.164; SHALIK LD, 1987, AM J OCCUP THER, V41, P638, DOI 10.5014/ajot.41.10.638; Verbeke G, 2009, SPRINGER SER STAT, P1; World Federation of Occupational Therapists, 2002, MIN STAND ED OCC THE	32	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44356	10.1371/journal.pone.0044356	http://dx.doi.org/10.1371/journal.pone.0044356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952964	gold, Green Submitted, Green Published			2022-12-27	WOS:000308221300086
J	Bazakos, C; Manioudaki, ME; Therios, I; Voyiatzis, D; Kafetzopoulos, D; Awada, T; Kalaitzis, P				Bazakos, Christos; Manioudaki, Maria E.; Therios, Ioannis; Voyiatzis, Demetrios; Kafetzopoulos, Dimitris; Awada, Tala; Kalaitzis, Panagiotis			Comparative Transcriptome Analysis of Two Olive Cultivars in Response to NaCl-Stress	PLOS ONE			English	Article							OLEA-EUROPAEA; SALT TOLERANCE; SALINITY STRESS; ABIOTIC STRESS; WATER RELATIONS; DROUGHT STRESS; GAS-EXCHANGE; ION CONTENT; GENES; EXPRESSION	Background: Olive (Olea europaea L.) cultivation is rapidly expanding and low quality saline water is often used for irrigation. The molecular basis of salt tolerance in olive, though, has not yet been investigated at a system level. In this study a comparative transcriptomics approach was used as a tool to unravel gene regulatory networks underlying salinity response in olive trees by simulating as much as possible olive growing conditions in the field. Specifically, we investigated the genotype-dependent differences in the transcriptome response of two olive cultivars, a salt-tolerant and a salt-sensitive one. Methodology/Principal Findings: A 135-day long salinity experiment was conducted using one-year old trees exposed to NaCl stress for 90 days followed by 45 days of post-stress period during the summer. A cDNA library made of olive seedling mRNAs was sequenced and an olive microarray was constructed. Total RNA was extracted from root samples after 15, 45 and 90 days of NaCl-treatment as well as after 15 and 45 days of post-treatment period and used for microarray hybridizations. SAM analysis between the NaCl-stress and the post-stress time course resulted in the identification of 209 and 36 differentially expressed transcripts in the salt-tolerant and salt-sensitive cultivar, respectively. Hierarchical clustering revealed two major, distinct clusters for each cultivar. Despite the limited number of probe sets, transcriptional regulatory networks were constructed for both cultivars while several hierarchically-clustered interacting transcription factor regulators such as JERF and bZIP homologues were identified. Conclusions/Significance: A systems biology approach was used and differentially expressed transcripts as well as regulatory interactions were identified. The comparison of the interactions among transcription factors in olive with those reported for Arabidopsis might indicate similarities in the response of a tree species with Arabidopsis at the transcriptional level under salinity stress.	[Bazakos, Christos; Manioudaki, Maria E.; Kalaitzis, Panagiotis] Mediterranean Agron Inst Chania MAICh, Dept Hort Genet & Biotechnol, Iraklion, Greece; [Bazakos, Christos; Therios, Ioannis; Voyiatzis, Demetrios] Aristotle Univ Thessaloniki, Dept Hort, GR-54006 Thessaloniki, Greece; [Kafetzopoulos, Dimitris] Fdn Res & Technol FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Awada, Tala] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA	Aristotle University of Thessaloniki; University of Nebraska System; University of Nebraska Lincoln	Bazakos, C (corresponding author), Mediterranean Agron Inst Chania MAICh, Dept Hort Genet & Biotechnol, Iraklion, Greece.	panagiot@maich.gr	Bazakos, Christos/AAI-3198-2020	Kalaitzis, Panagiotis/0000-0003-2694-4977	GSRT General Secretariat for Research and Technology, Greek Ministry of Development [GSRT-KP_14]; European Economic Area Financial Mechanism [EL-0075]	GSRT General Secretariat for Research and Technology, Greek Ministry of Development; European Economic Area Financial Mechanism	The project was funded by the GSRT-KP_14 grant, GSRT General Secretariat for Research and Technology, Greek Ministry of Development (http://www.gsrt.gr/) and the European Economic Area Financial Mechanism grant EL-0075, (http://www.eeagrants.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; BENLLOCH M, 1991, HORTSCIENCE, V26, P867, DOI 10.21273/HORTSCI.26.7.867; Bonnet E, 2010, BIOINFORMATICS, V26, pi638, DOI 10.1093/bioinformatics/btq395; Bonnet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010162; Bracci T, 2011, PLANT CELL REP, V30, P449, DOI 10.1007/s00299-010-0991-9; Chartzoulakis K, 2002, SCI HORTIC-AMSTERDAM, V96, P235, DOI 10.1016/S0304-4238(02)00067-5; Chartzoulakis KS, 2005, AGR WATER MANAGE, V78, P108, DOI 10.1016/j.agwat.2005.04.025; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Conde C, 2007, PLANT CELL PHYSIOL, V48, P42, DOI 10.1093/pcp/pcl035; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conti L, 2008, PLANT CELL, V20, P2894, DOI 10.1105/tpc.108.058669; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Cresti M., 1994, Advances in Horticultural Science, V8, P211; Demiral Mehmet Ali, 2005, Turkish Journal of Agriculture and Forestry, V29, P267; Deyholos MK, 2010, PLANT CELL ENVIRON, V33, P648, DOI 10.1111/j.1365-3040.2009.02092.x; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Gucci R, 1997, TREE PHYSIOL, V17, P13, DOI 10.1093/treephys/17.1.13; He XL, 2011, FEBS LETT, V585, P1231, DOI 10.1016/j.febslet.2011.03.055; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hwang EW, 2005, J BIOSCIENCES, V30, P657, DOI 10.1007/BF02703566; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Klein I., 1994, ACTA HORTIC, V356, P176, DOI DOI 10.17660/ACTAH0RTIC.1994.356.37; Labarga A, 2007, NUCL ACIDS RES, V35; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Loreto F, 2003, ENVIRONMENT, P595; Mane SP, 2008, FUNCT PLANT BIOL, V35, P669, DOI 10.1071/FP07293; Melgar JC, 2009, AGR WATER MANAGE, V96, P1105, DOI 10.1016/j.agwat.2009.02.009; Michoel T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S5; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; Michoel T, 2009, ANN NY ACAD SCI, V1158, P36, DOI 10.1111/j.1749-6632.2008.03943.x; Miura K, 2007, CURR OPIN PLANT BIOL, V10, P495, DOI 10.1016/j.pbi.2007.07.002; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rabello AR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-485; Rodrigues FA, 2009, PLANT SCI, V176, P286, DOI 10.1016/j.plantsci.2008.11.007; Rugini E., 1990, OLIVE OLEA EUROPAEA; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sioson AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-215; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Sun W, 2010, PLANT CELL PHYSIOL, V51, P997, DOI 10.1093/pcp/pcq056; Taji T, 2004, MINERALOGICAL SOC A, V135, P1, DOI [10.1104/pp.104.039909.1993, DOI 10.1104/PP.104.039909.1993]; Tattini M, 2002, TREE PHYSIOL, V22, P403, DOI 10.1093/treephys/22.6.403; Tattini M, 1996, PHYSIOL PLANTARUM, V98, P117, DOI 10.1111/j.1399-3054.1996.tb00682.x; TATTINI M, 1992, J PLANT NUTR, V15, P1467, DOI 10.1080/01904169209364412; TATTINI M, 1995, PHYSIOL PLANTARUM, V95, P203, DOI 10.1111/j.1399-3054.1995.tb00828.x; Tattini M, 2009, ENVIRON EXP BOT, V65, P72, DOI 10.1016/j.envexpbot.2008.01.005; Therios I., 2009, OLIVES; Therios IN, 1991, SCI ANN, P29; Thon M, 2010, NUCLEIC ACIDS RES, V38, P1098, DOI 10.1093/nar/gkp1091; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vermeirssen V, 2009, MOL BIOSYST, V5, P1817, DOI [10.1039/b908108a, 10.1039/B908108a]; Wan XR, 2011, J BIOSCI BIOENG, V111, P478, DOI 10.1016/j.jbiosc.2010.11.021; Wong CE, 2006, PLANT PHYSIOL, V140, P1437, DOI 10.1104/pp.105.070508; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zhang HW, 2004, PLANTA, V220, P262, DOI 10.1007/s00425-004-1347-x	68	35	36	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e42931	10.1371/journal.pone.0042931	http://dx.doi.org/10.1371/journal.pone.0042931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952621	Green Published, gold			2022-12-27	WOS:000308206500007
J	Beaumont, LJ; Duursma, D				Beaumont, Linda J.; Duursma, Daisy			Global Projections of 21st Century Land-Use Changes in Regions Adjacent to Protected Areas	PLOS ONE			English	Article							CLIMATE-CHANGE; USE TRANSITIONS; WOOD-HARVEST; BIODIVERSITY; SECONDARY; CONSERVATION; FORESTS; WORLDS; SCENARIOS	The conservation efficiency of Protected Areas (PA) is influenced by the health and characteristics of the surrounding landscape matrix. Fragmentation of adjacent lands interrupts ecological flows within PAs and will decrease the ability of species to shift their distribution as climate changes. For five periods across the 21st century, we assessed changes to the extent of primary land, secondary land, pasture and crop land projected to occur within 50 km buffers surrounding IUCN-designated PAs. Four scenarios of land-use were obtained from the Land-Use Harmonization Project, developed for the Intergovernmental Panel on Climate Change's Fifth Assessment Report (AR5). The scenarios project the continued decline of primary lands within buffers surrounding PAs. Substantial losses are projected to occur across buffer regions in the tropical forest biomes of Indo-Malayan and the Temperate Broadleaf forests of the Nearctic. A number of buffer regions are projected to have negligible primary land remaining by 2100, including those in the Afrotropic's Tropical/Subtropical Grassland/Savanna/Shrubland. From 2010-2050, secondary land is projected to increase within most buffer regions, although, as with pasture and crops within tropical and temperate forests, projections from the four land-use scenarios may diverge substantially in magnitude and direction of change. These scenarios demonstrate a range of alternate futures, and show that although effective mitigation strategies may reduce pressure on land surrounding PAs, these areas will contain an increasingly heterogeneous matrix of primary and human-modified landscapes. Successful management of buffer regions will be imperative to ensure effectiveness of PAs and to facilitate climate-induced shifts in species ranges.	[Beaumont, Linda J.; Duursma, Daisy] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Beaumont, LJ (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	linda.beaumont@mq.edu.au	Beaumont, Linda J/D-5499-2012	Beaumont, Linda J/0000-0001-6307-1680				Anand MO, 2010, BIOL CONSERV, V143, P2363, DOI 10.1016/j.biocon.2010.01.013; Barlow J, 2007, BIOL CONSERV, V136, P212, DOI 10.1016/j.biocon.2006.11.021; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Beyer HL, 2010, GEOSPATIAL MODELLING; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; ESRI Inc, 2010, ARCGIS 10 0; Gardner TA, 2010, BIOL CONSERV, V143, P2293, DOI 10.1016/j.biocon.2010.05.017; GOB, 2010, GLOB BIOD OUTL 3; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hurtt GC, 2006, GLOBAL CHANGE BIOL, V12, P1208, DOI 10.1111/j.1365-2486.2006.01150.x; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; ITTO, 2002, ITTO GUID REST MAN R; Jackson SF, 2008, GLOBAL CHANGE BIOL, V14, P2132, DOI 10.1111/j.1365-2486.2008.01628.x; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Smith P, 2010, PHILOS T R SOC B, V365, P2941, DOI 10.1098/rstb.2010.0127; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Thomson AM, 2010, P NATL ACAD SCI USA, V107, P19633, DOI 10.1073/pnas.0910467107; UNEP-WCMC, 2010, DAT STAND WORLD DAT; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; van Vuuren DP, 2011, GLOBAL ENVIRON CHANG, V21, P575, DOI 10.1016/j.gloenvcha.2010.11.003; Willis KJ, 2010, TRENDS ECOL EVOL, V25, P583, DOI 10.1016/j.tree.2010.07.006	34	19	19	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43714	10.1371/journal.pone.0043714	http://dx.doi.org/10.1371/journal.pone.0043714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952744	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500020
J	Calero, O; Bullido, MJ; Clarimon, J; Frank-Garcia, A; Martinez-Martin, P; Lleo, A; Rey, MJ; Sastre, I; Rabano, A; de Pedro-Cuesta, J; Ferrer, I; Calero, M				Calero, Olga; Bullido, Maria J.; Clarimon, Jordi; Frank-Garcia, Ana; Martinez-Martin, Pablo; Lleo, Alberto; Jesus Rey, Maria; Sastre, Isabel; Rabano, Alberto; de Pedro-Cuesta, Jesus; Ferrer, Isidro; Calero, Miguel			A Common BACE1 Polymorphism Is a Risk Factor for Sporadic Creutzfeldt-Jakob Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CELLULAR PRION PROTEIN; MILD COGNITIVE IMPAIRMENT; BETA-SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; SENILE PLAQUES; ASSOCIATION; GENE; ALLELE	The beta site APP cleaving enzyme 1 (BACE1) is the rate-limiting beta-secretase enzyme in the amyloidogenic processing of APP and A beta formation, and therefore it has a prominent role in Alzheimer's disease (AD) pathology. Recent evidence suggests that the prion protein (PrP) interacts directly with BACE1 regulating its beta-secretase activity. Moreover, PrP has been proposed as the cellular receptor involved in the impairment of synaptic plasticity and toxicity caused by Ab oligomers. Provided that common pathophysiologic mechanisms are shared by Alzheimer's and Creutzfeldt-Jakob (CJD) diseases, we investigated for the first time to the best of our knowledge a possible association of a common synonymous BACE1 polymorphism (rs638405) with sporadic CJD (sCJD). Our results indicate that BACE1 C-allele is associated with an increased risk for developing sCJD, mainly in PRNP M129M homozygous subjects with early onset. These results extend the very short list of genes (other than PRNP) involved in the development of human prion diseases; and support the notion that similar to AD, in sCJD several loci may contribute with modest overall effects to disease risk. These findings underscore the interplay in both pathologies of APP, A beta oligomers, ApoE, PrP and BACE1, and suggest that aging and perhaps vascular risk factors may modulate disease pathologies in part through these key players.	[Calero, Olga; Bullido, Maria J.; Clarimon, Jordi; Frank-Garcia, Ana; Martinez-Martin, Pablo; Lleo, Alberto; Sastre, Isabel; de Pedro-Cuesta, Jesus; Ferrer, Isidro; Calero, Miguel] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Calero, Olga; Calero, Miguel] CNM ISCIII, Unidad Encefalopatias Espongiformes, Madrid, Spain; [Bullido, Maria J.; Sastre, Isabel] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Bullido, Maria J.; Frank-Garcia, Ana; Sastre, Isabel] Inst Sanitary Res Hosp la Paz IdIPaz, Madrid, Spain; [Clarimon, Jordi; Lleo, Alberto] Univ Autonoma Barcelona, Hosp Santa Creu & Sant Pau, Dept Neurol, E-08193 Barcelona, Spain; [Frank-Garcia, Ana] Hosp Univ La Paz UAM, Neurol Serv, Madrid, Spain; [Martinez-Martin, Pablo] Alzheimer Ctr Reina Sofia Fdn, Carlos III Inst Hlth, Alzheimer Dis Res Unit, CIEN Fdn, Madrid, Spain; [Jesus Rey, Maria] Univ Barcelona Hosp Clin, Banco Tejidos Neurol, Barcelona, Spain; [Rabano, Alberto] Alzheimer Ctr Reina Sofia Fdn, Carlos III Inst Hlth, CIEN Fdn, Banco Tejidos Fdn CIEN, Madrid, Spain; [de Pedro-Cuesta, Jesus] Ctr Nacl Epidemiol Inst Salud Carlos III CNM ISC, Area Epidemiol Aplicada, Madrid, Spain; [Ferrer, Isidro] Univ Barcelona, Hospitalet LLobregat, IDIBELL Hosp Univ Bellvitge, Inst Neuropathol INP, Barcelona, Spain	CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Hospital Universitario La Paz; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); CIBERNED; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Calero, O (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	mcalero@isciii.es	Martinez-Martin, Pablo/N-9909-2019; Lleó, Alberto/K-5783-2019; Calero, Miguel/H-5691-2015; García, Ana Frank/I-5159-2015; Bullido, maria j/C-8509-2014; Martinez-Martin, Pablo/E-1329-2013	Martinez-Martin, Pablo/0000-0003-0837-5280; Calero, Miguel/0000-0001-5366-3324; García, Ana Frank/0000-0003-3858-9116; Bullido, maria j/0000-0002-6477-1117; Clarimon, Jordi/0000-0002-6824-6942	Ministerio de Ciencia e Innovacion, DGSP from Ministerio de Sanidad, Politica Social e Igualdad [FIS 05/0912]; DGSP of the Spanish National Health Ministry; Spanish CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas) network	Ministerio de Ciencia e Innovacion, DGSP from Ministerio de Sanidad, Politica Social e Igualdad; DGSP of the Spanish National Health Ministry; Spanish CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas) network	This work was supported by grants FIS 05/0912 from the Ministerio de Ciencia e Innovacion, DGSP from Ministerio de Sanidad, Politica Social e Igualdad (MC), the DGSP of the Spanish National Health Ministry (MC), and the Spanish CIBERNED (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas) network (AL, JdPC, IF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Armstrong RA, 2005, NEUROPATHOLOGY, V25, P111, DOI 10.1111/j.1440-1789.2005.00605.x; Barnham KJ, 2006, TRENDS BIOCHEM SCI, V31, P465, DOI 10.1016/j.tibs.2006.06.006; Beck JA, 2008, J MED GENET, V45, P813, DOI 10.1136/jmg.2008.061804; Brown DR, 2001, TRENDS NEUROSCI, V24, P85, DOI 10.1016/S0166-2236(00)01689-1; Calero O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022090; Calero O, 2009, PRION, V3, P146, DOI 10.4161/pri.3.3.9339; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Checler F, 1999, IUBMB LIFE, V48, P33, DOI 10.1080/152165499307396; Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Clarimon J, 2012, PRION IN PRESS; Cole SL, 2009, NEUROBIOL AGING, V30, P1535, DOI 10.1016/j.neurobiolaging.2007.12.012; Combarros O, 2009, NEUROBIOL AGING, V30, P1333, DOI 10.1016/j.neurobiolaging.2007.11.027; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cortina-Borja Mario, 2009, BMC Res Notes, V2, P105, DOI 10.1186/1756-0500-2-105; de Pedro-Cuesta J, 2011, J NEUROL NEUROSUR PS, V82, P204, DOI 10.1136/jnnp.2009.188425; Debatin L, 2008, NEURODEGENER DIS, V5, P347, DOI 10.1159/000121389; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Endres K, 2009, NEUROBIOL DIS, V36, P233, DOI 10.1016/j.nbd.2009.07.015; Ewers M, 2008, BRAIN, V131, P1252, DOI 10.1093/brain/awn034; Ewers M, 2011, J ALZHEIMERS DIS, V25, P373, DOI 10.3233/JAD-2011-091153; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Ferrer I, 2004, NEUROPATH APPL NEURO, V30, P329, DOI 10.1111/j.1365-2990.2003.00534.x; Ferrer I, 2000, NEUROSCIENCE, V97, P715, DOI 10.1016/S0306-4522(00)00045-2; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gambetti P, 1998, NEPHROL DIAL TRANSPL, V13, P33, DOI 10.1093/ndt/13.suppl_7.33; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Glatzel M, 2001, BRAIN RES REV, V36, P241, DOI 10.1016/S0165-0173(01)00100-X; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Hampel H, 2010, EXP NEUROL, V223, P334, DOI 10.1016/j.expneurol.2009.09.024; Holsinger RMD, 2006, NEUROLOGY, V67, P1105; Holsinger RMD, 2004, ANN NEUROL, V55, P898, DOI 10.1002/ana.20144; Hooper NM, 2008, TRENDS BIOCHEM SCI, V33, P151, DOI 10.1016/j.tibs.2008.01.004; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Kapaki E, 2001, J NEUROL NEUROSUR PS, V71, P401, DOI 10.1136/jnnp.71.3.401; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lewis V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031754; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lloyd S, 2011, TOP CURR CHEM, V305, P1, DOI 10.1007/128_2011_157; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2011, HUM MOL GENET; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Mowrer KR, 2009, J NEUROCHEM, V109, P1008, DOI 10.1111/j.1471-4159.2009.06026.x; Mulder SD, 2010, J ALZHEIMERS DIS, V20, P253, DOI 10.3233/JAD-2010-1367; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Otto M, 2000, NEUROLOGY, V54, P1099, DOI 10.1212/WNL.54.5.1099; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; PRICE DL, 1993, P NATL ACAD SCI USA, V90, P6381, DOI 10.1073/pnas.90.14.6381; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Soldevila M, 2006, GENOME RES, V16, P231, DOI 10.1101/gr.4345506; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102; Zhong ZY, 2007, ARCH GEN PSYCHIAT, V64, P718, DOI 10.1001/archpsyc.64.6.718	72	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43926	10.1371/journal.pone.0043926	http://dx.doi.org/10.1371/journal.pone.0043926			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952813	Green Published, gold			2022-12-27	WOS:000308206500029
J	Kelley, LC; Weed, SA				Kelley, Laura C.; Weed, Scott A.			Cortactin Is a Substrate of Activated Cdc42-Associated Kinase 1 (ACK1) during Ligand-induced Epidermal Growth Factor Receptor Downregulation	PLOS ONE			English	Article							CLATHRIN-COATED PITS; SQUAMOUS-CELL CARCINOMA; TYROSINE KINASE; MEDIATED ENDOCYTOSIS; ACTIN CYTOSKELETON; ARP2/3 COMPLEX; EGF RECEPTOR; N-WASP; MEMBRANE DYNAMICS; BINDING PROTEIN	Background: Epidermal growth factor receptor (EGFR) internalization following ligand binding controls EGFR downstream pathway signaling activity. Internalized EGFR is poly-ubiquitinated by Cbl to promote lysosome-mediated degradation and signal downregulation. ACK1 is a non-receptor tyrosine kinase that interacts with ubiquitinated EGFR to facilitate EGFR degradation. Dynamic reorganization of the cortical actin cytoskeleton controlled by the actin related protein (Arp)2/3 complex is important in regulating EGFR endocytosis and vesicle trafficking. How ACK1-mediated EGFR internalization cooperates with Arp2/3-based actin dynamics during EGFR downregulation is unclear. Methodology/Principal Findings: Here we show that ACK1 directly binds and phosphorylates the Arp2/3 regulatory protein cortactin, potentially providing a direct link to Arp2/3-based actin dynamics during EGFR degradation. Co-immunoprecipitation analysis indicates that the cortactin SH3 domain is responsible for binding to ACK1. In vitro kinase assays demonstrate that ACK1 phosphorylates cortactin on key tyrosine residues that create docking sites for adaptor proteins responsible for enhancing Arp2/3 nucleation. Analysis with phosphorylation-specific antibodies determined that EGFR-induced cortactin tyrosine phosphorylation is diminished coincident with EGFR degradation, whereas ERK1/2 cortactin phosphorylation utilized in promoting activation of the Arp2/3 regulator N-WASp is sustained during EGFR downregulation. Cortactin and ACK1 localize to internalized vesicles containing EGF bound to EGFR visualized by confocal microscopy. RNA interference and rescue studies indicate that ACK1 and the cortactin SH3 domain are essential for ligand-mediated EGFR internalization. Conclusions/Significance: Cortactin is a direct binding partner and novel substrate of ACK1. Tyrosine phosphorylation of cortactin by ACK1 creates an additional means to amplify Arp2/3 dynamics through N-WASp activation, potentially contributing to the overall necessary tensile and/or propulsive forces utilized during EGFR endocytic internalization and trafficking involved in receptor degradation.	[Kelley, Laura C.; Weed, Scott A.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Dept Neurobiol & Anat, Morgantown, WV USA; [Kelley, Laura C.; Weed, Scott A.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Program Canc Cell Biol, Morgantown, WV USA	West Virginia University; West Virginia University	Kelley, LC (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	sweed@hsc.wvu.edu		Weed, Scott/0000-0001-7033-9999	United States National Institutes of Health (NIH) [DE014364, DE014578]; West Virginia University Office of Research and Graduate Education; NIH [P20 RR16440, P30 RR032138/GM103488];  [RR16440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032138, P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014578, K22DE014364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Virginia University Office of Research and Graduate Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health (NIH) Grants DE014364, DE014578 and a subproject of RR16440 to SAW. LCK was supported in part by the West Virginia University Office of Research and Graduate Education. The West Virginia University Microscope Imaging Facility, Mary Babb Randolph Cancer Center is supported by NIH grants P20 RR16440 and P30 RR032138/GM103488. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Campbell DH, 1999, CANCER RES, V59, P5376; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chan W, 2011, BIOCH J; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Chua BT, 2010, MOL ONCOL, V4, P323, DOI 10.1016/j.molonc.2010.03.001; Crostella L, 2001, ONCOGENE, V20, P3735, DOI 10.1038/sj.onc.1204474; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Garcia-Castillo J, 2009, J BIOL CHEM, V284, P25302, DOI 10.1074/jbc.M109.001982; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Grassart A, 2010, TRAFFIC; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Howlin J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2087; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang JH, 2003, J BIOL CHEM, V278, P48367, DOI 10.1074/jbc.M308213200; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kaksonen M, 2000, J CELL SCI, V113, P4421; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kapus A, 2000, J BIOL CHEM, V275, P32289, DOI 10.1074/jbc.M003172200; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Kato-Stankiewicz J, 2001, BIOCHEM BIOPH RES CO, V284, P470, DOI 10.1006/bbrc.2001.5004; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kelley LC, 2010, J CELL SCI, V123, P3923, DOI 10.1242/jcs.075200; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Le Clainche C, 2007, EMBO J, V26, P1199, DOI 10.1038/sj.emboj.7601576; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Lin Q, 2010, MOL CELL BIOL, V30, P1541, DOI 10.1128/MCB.00013-10; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Ohashi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019942; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Prieto-Echague V., 2011, J SIGNAL TRANSDUCT, V2011; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; SACKS PG, 1988, CANCER RES, V48, P2858; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schroeder B, 2010, EMBO J, V29, P3039, DOI 10.1038/emboj.2010.190; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Shen HY, 2011, MOL BIOL CELL, V22, P493, DOI 10.1091/mbc.E10-07-0637; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Singh B, 2001, CANCER RES, V61, P4506; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stoorvogel W, 2004, J BIOL CHEM, V279, P11562, DOI 10.1074/jbc.M308449200; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; Timpson P, 2005, CANCER RES, V65, P3273, DOI 10.1158/0008-5472.CAN-04-2118; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yamazaki T, 2002, J CELL SCI, V115, P1791; Yokoyama N, 2005, J BIOL CHEM, V280, P42219, DOI 10.1074/jbc.M506996200; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Zhu JW, 2007, J BIOL CHEM, V282, P16086, DOI 10.1074/jbc.M701997200; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668	80	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44363	10.1371/journal.pone.0044363	http://dx.doi.org/10.1371/journal.pone.0044363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952966	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500065
J	Rautava, J; Willberg, J; Louvanto, K; Wideman, L; Syrjanen, K; Grenman, S; Syrjanen, S				Rautava, Jaana; Willberg, Jaana; Louvanto, Karolina; Wideman, Lilli; Syrjanen, Kari; Grenman, Seija; Syrjanen, Stina			Prevalence, Genotype Distribution and Persistence of Human Papillomavirus in Oral Mucosa of Women: A Six-Year Follow-Up Study	PLOS ONE			English	Article							NATURAL-HISTORY; HPV INFECTIONS; CANCER; TRANSMISSION; CARCINOMAS; CAVITY; ADULTS; HEAD; DNA; PCR	Background: Human papillomavirus (HPV) infections have been linked to a subset of oral and oropharyngeal cancers. However, little is known on the natural history of oral HPV infections. We designed the prospective Finnish HPV Family Study to assess the dynamics of HPV infections in parents and their infants. This study reports HPV genotype distribution and virus persistence in oral mucosa of the mothers. Materials and Methods: Totally, 324 pregnant women were enrolled at the 3rd trimester of pregnancy and followed-up for 6 years. Oral scrapings taken with a brush were collected and HPV-genotyping was performed with nested PCR and Multimetrix (R) test (Progen, Heidelberg, Germany). The predictors of persistent oral HPV species 7/9 infections were analyzed using generalized estimating equation models. Results: The point prevalence of oral HPV varied from 15% to 24% during the 6-year follow-up. Altogether, 18 HPV genotypes were identified either as single or multiple-type oral infections. HPV16 was the most prevalent type at 9.7%-18.4%, followed by HPV18, HPV6, and multiple infections. Altogether, 74 women had persistent oral HPV infection determined as at least two consecutive samples positive with the same HPV genotype. HPV16 and HPV6 were the two most frequent types to persist (76% and 9%) for a mean of 18.6 and 20.2 months, respectively, followed by multiple infections (8%) for 18.3 months. An increased risk for persistent oral HPV infection with species 7/9 was associated with being seropositive for low-risk (LR)-HPV-types at baseline, whereas the use of oral contraceptives and a second pregnancy during follow-up were protective. Clinical oral lesions were detected in 17% of these women, one-third of whom had persistent oral HPV-infections. Conclusion: HPV16 and HPV6 were the most common genotypes in oral HPV-infections and were also most likely to persist. Use of oral contraceptives and a second pregnancy protected against oral HPV persistence.	[Rautava, Jaana; Willberg, Jaana; Louvanto, Karolina; Wideman, Lilli; Syrjanen, Stina] Univ Turku, Inst Dent, Dept Oral Pathol, Fac Med, Turku, Finland; [Rautava, Jaana; Willberg, Jaana; Louvanto, Karolina; Wideman, Lilli; Syrjanen, Stina] Univ Turku, Fac Med, Medicity Res Lab, Turku, Finland; [Syrjanen, Kari] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Grenman, Seija] Turku Univ Hosp, Dept Obstet & Gynecol, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Rautava, J (corresponding author), Univ Turku, Inst Dent, Dept Oral Pathol, Fac Med, Turku, Finland.	stina.syrjanen@utu.fi	Louvanto, Karolina/GXG-3296-2022	Louvanto, Karolina/0000-0002-1172-363X; Syrjanen, Kari/0000-0001-7180-7491; Syrjanen, Stina/0000-0003-0738-5698	Academy of Finland [116438/2006, 130204/2008]; Finnish Cancer Foundation; Sohlberg Foundation; Finnish Dental Society; Government Special Foundation (EVO)	Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sohlberg Foundation; Finnish Dental Society; Government Special Foundation (EVO)	This study was supported by the Academy of Finland (#116438/2006, #130204/2008), Finnish Cancer Foundation, Sohlberg Foundation, Finnish Dental Society, the Government Special Foundation (EVO) to Turku University Hospital. The funders had no role in the study design and data analysis, decision to publish, or preparation of the manuscript.	Anttila M, 1999, GYNECOL ONCOL, V72, P337, DOI 10.1006/gyno.1998.5264; Castellsague X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-74; D'Souza G, 2007, INT J CANCER, V121, P143, DOI 10.1002/ijc.22667; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Esquenazi D, 2010, BRAZ J OTORHINOLAR, V76, P78, DOI 10.1590/S1808-86942010000100013; Hardin JW, 2012, GEN ESTIMATING EQUAT; KELLOKOSKI J, 1992, ORAL MICROBIOL IMMUN, V7, P19, DOI 10.1111/j.1399-302X.1992.tb00014.x; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kurose K, 2004, ORAL SURG ORAL MED O, V98, P91, DOI 10.1016/j.tripleo.2003.12.029; Louvanto K, 2010, J INFECT DIS, V202, P436, DOI 10.1086/653826; Miller CS, 1996, ORAL SURG ORAL MED O, V82, P57, DOI 10.1016/S1079-2104(96)80378-7; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Rintala MAM, 2005, J CLIN MICROBIOL, V43, P376, DOI 10.1128/JCM.43.1.376-381.2005; Sanchez-Vargas L, 2010, INFECT AGENTS CANCER, V5, P25, DOI DOI 10.1186/1750-9378-5-25; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Smith E M, 2004, Infect Dis Obstet Gynecol, V12, P45; SNIJDERS PJF, 1990, J GEN VIROL, V71, P173, DOI 10.1099/0022-1317-71-1-173; Syrjanen S, 2007, NEW ENGL J MED, V356, P1993, DOI 10.1056/NEJMe078004; SYRJANEN K, 2000, PAPILLOMAVIRUS INFEC, P1; Syrjanen S, 2003, MED MICROBIOL IMMUN, V192, P123, DOI 10.1007/s00430-002-0173-7; Syrjanen S, 2011, ORAL DIS, V17, P58, DOI 10.1111/j.1601-0825.2011.01792.x; Terai M, 1999, ORAL MICROBIOL IMMUN, V14, P201, DOI 10.1034/j.1399-302X.1999.140401.x	27	55	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e42171	10.1371/journal.pone.0042171	http://dx.doi.org/10.1371/journal.pone.0042171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952591	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206500004
J	Scotland, PB; Heath, JL; Conway, AE; Porter, NB; Armstrong, MB; Walker, JA; Klebig, ML; Lavau, CP; Wechsler, DS				Scotland, Paula B.; Heath, Jessica L.; Conway, Amanda E.; Porter, Natasha B.; Armstrong, Michael B.; Walker, Jennifer A.; Klebig, Mitchell L.; Lavau, Catherine P.; Wechsler, Daniel S.			The PICALM Protein Plays a Key Role in Iron Homeostasis and Cell Proliferation	PLOS ONE			English	Article							CLATHRIN ASSEMBLY PROTEIN; ENDOCYTIC ACCESSORY PROTEINS; SYNAPTIC VESICLE ENDOCYTOSIS; ACUTE MYELOID-LEUKEMIA; ALZHEIMERS-DISEASE; FITNESS1(4226SB) LOCUS; RNA INTERFERENCE; COATED PITS; CALM; FUSION	The ubiquitously expressed phosphatidylinositol binding clathrin assembly (PICALM) protein associates with the plasma membrane, binds clathrin, and plays a role in clathrin-mediated endocytosis. Alterations of the human PICALM gene are present in aggressive hematopoietic malignancies, and genome-wide association studies have recently linked the PICALM locus to late-onset Alzheimer's disease. Inactivating and hypomorphic Picalm mutations in mice cause different degrees of severity of anemia, abnormal iron metabolism, growth retardation and shortened lifespan. To understand PICALM's function, we studied the consequences of PICALM overexpression and characterized PICALM-deficient cells derived from mutant fit1 mice. Our results identify a role for PICALM in transferrin receptor (TfR) internalization and demonstrate that the C-terminal PICALM residues are critical for its association with clathrin and for the inhibitory effect of PICALM overexpression on TfR internalization. Murine embryonic fibroblasts (MEFs) that are deficient in PICALM display several characteristics of iron deficiency (increased surface TfR expression, decreased intracellular iron levels, and reduced cellular proliferation), all of which are rescued by retroviral PICALM expression. The proliferation defect of cells that lack PICALM results, at least in part, from insufficient iron uptake, since it can be corrected by iron supplementation. Moreover, PICALM-deficient cells are particularly sensitive to iron chelation. Taken together, these data reveal that PICALM plays a critical role in iron homeostasis, and offer new perspectives into the pathogenesis of PICALM-associated diseases.	[Scotland, Paula B.; Heath, Jessica L.; Porter, Natasha B.; Armstrong, Michael B.; Walker, Jennifer A.; Lavau, Catherine P.; Wechsler, Daniel S.] Duke Univ, Med Ctr, Div Pediat Hematol Oncol, Durham, NC 27706 USA; [Conway, Amanda E.; Wechsler, Daniel S.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Klebig, Mitchell L.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Duke University; Duke University; Mayo Clinic	Scotland, PB (corresponding author), Duke Univ, Med Ctr, Div Pediat Hematol Oncol, Durham, NC 27706 USA.	dan.wechsler@duke.edu	Lavau, Catherine/Q-2928-2019; Heath, Jessica/O-9948-2019	Lavau, Catherine/0000-0003-4800-1320	NCI [R01 CA 109281]; St. Baldrick's Foundation; V Foundation; NATIONAL CANCER INSTITUTE [R01CA109281] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Baldrick's Foundation; V Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI R01 CA 109281 (DSW), a Research Grant to DSW from the St. Baldrick's Foundation (www.stbaldricks.org), a Fellow Grant to JAW from the St. Baldrick's Foundation and a Research Grant to DSW from the V Foundation (www.jimmyv.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archangelo LF, 2006, ONCOGENE, V25, P4099, DOI 10.1038/sj.onc.1209438; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Asnafi V, 2003, BLOOD, V102, P1000, DOI 10.1182/blood-2002-09-2913; Bushlin I, 2008, J NEUROSCI, V28, P10257, DOI 10.1523/JNEUROSCI.2471-08.2008; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x; Caudell D, 2008, LEUKEMIA, V22, P678, DOI 10.1038/sj.leu.2405074; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Di Fiore PP, 2009, MOL ONCOL, V3, P273, DOI 10.1016/j.molonc.2009.06.002; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Du CC, 1999, BLOOD, V94, P793, DOI 10.1182/blood.V94.2.793.414k43_793_802; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Hao WH, 1999, J BIOL CHEM, V274, P22785, DOI 10.1074/jbc.274.32.22785; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Huh JY, 2010, KOREAN J LAB MED, V30, P117, DOI 10.3343/kjlm.2010.30.2.117; Hupalowska A, 2012, TRAFFIC, V13, P9, DOI 10.1111/j.1600-0854.2011.01249.x; Jones L, 2010, BBA-MOL CELL BIOL L, V1801, P754, DOI 10.1016/j.bbalip.2010.04.005; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; KAPLAN J, 1991, J BIOL CHEM, V266, P2997; Kim HL, 2000, EXP MOL MED, V32, P222, DOI 10.1038/emm.2000.36; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Klebig ML, 2003, P NATL ACAD SCI USA, V100, P8360, DOI 10.1073/pnas.1432634100; Kumon K, 1999, GENE CHROMOSOME CANC, V25, P33, DOI 10.1002/(SICI)1098-2264(199905)25:1<33::AID-GCC5>3.0.CO;2-3; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Morgan JR, 2000, J NEUROSCI, V20, P8667; Morgan JR, 1999, J NEUROSCI, V19, P10201; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Oshiro S., 2011, ADV PHARM SCI, V2011, DOI DOI 10.1155/2011/378278; Petralia RS, 2007, J COMP NEUROL, V504, P314, DOI 10.1002/cne.21454; POTTER MD, 1995, MAMM GENOME, V6, P70, DOI 10.1007/BF00303247; Potter MD, 1997, BLOOD, V90, P1850, DOI 10.1182/blood.V90.5.1850; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; Savage NM, 2010, CANCER GENET CYTOGEN, V202, P129, DOI 10.1016/j.cancergencyto.2010.07.126; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schultze AE, 1998, COMP HAEMATOL INT, V8, P72, DOI 10.1007/BF02642494; Schultze AE, 1997, COMP HAEMATOL INT, V7, P143, DOI 10.1007/BF02652592; Schultze AE, 1999, LAB ANIM SCI, V49, P260; Schwartz CM, 2010, J COMP NEUROL, V518, P3803, DOI 10.1002/cne.22425; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Silliman CC, 1998, LEUKEMIA, V12, P1404, DOI 10.1038/sj.leu.2401109; Smith MA, 2010, J ALZHEIMERS DIS, V19, P363, DOI 10.3233/JAD-2010-1239; Suzuki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031854; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Wechsler DS, 2003, GENE CHROMOSOME CANC, V36, P26, DOI 10.1002/gcc.10136; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Yao PJ, 2005, J COMP NEUROL, V481, P58, DOI 10.1002/cne.20362; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	61	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44252	10.1371/journal.pone.0044252	http://dx.doi.org/10.1371/journal.pone.0044252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952941	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206500058
J	Wu, QP; Xie, YZ; Deng, ZQ; Li, XM; Yang, WN; Jiao, CW; Fang, L; Li, SZ; Pan, HH; Yee, AJ; Lee, DY; Li, C; Zhang, Z; Guo, J; Yang, BB				Wu, Qing-Ping; Xie, Yi-Zhen; Deng, Zhaoqun; Li, Xiang-Min; Yang, Weining; Jiao, Chun-Wei; Fang, Ling; Li, Sen-Zhu; Pan, Hong-Hui; Yee, Albert J.; Lee, Daniel Y.; Li, Chong; Zhang, Zhi; Guo, Jun; Yang, Burton B.			Ergosterol Peroxide Isolated from Ganoderma lucidum Abolishes MicroRNA miR-378-Mediated Tumor Cells on Chemoresistance	PLOS ONE			English	Article							CANCER CELLS; T-LYMPHOCYTES; FR KARST; EXPRESSION; BREAST; GROWTH; MACROPHAGES; SENSITIVITY; ACTIVATION; MECHANISM	Due to an altered expression of oncogenic factors and tumor suppressors, aggressive cancer cells have an intrinsic or acquired resistance to chemotherapeutic agents. This typically contributes to cancer recurrence after chemotherapy. microRNAs are short non-coding RNAs that are involved in both cell self-renewal and cancer development. Here we report that tumor cells transfected with miR-378 acquired properties of aggressive cancer cells. Overexpression of miR-378 enhanced both cell survival and colony formation, and contributed to multiple drug resistance. Higher concentrations of chemotherapeutic drugs were needed to induce death of miR-378-transfected cells than to induce death of control cells. We found that the biologically active component isolated from Ganoderma lucidum could overcome the drug-resistance conferred by miR-378. We purified and identified the biologically active component of Ganoderma lucidum as ergosterol peroxide. We demonstrated that ergosterol peroxide produced greater activity in inducing death of miR-378 cells than the GFP cells. Lower concentrations of ergosterol peroxide were needed to induce death of the miR-378-transfected cells than in the control cells. With further clinical development, ergosterol peroxide represents a promising new reagent that can overcome the drug-resistance of tumor cells.	[Wu, Qing-Ping; Xie, Yi-Zhen; Li, Xiang-Min; Jiao, Chun-Wei; Li, Sen-Zhu; Pan, Hong-Hui; Li, Chong; Zhang, Zhi; Guo, Jun] Minist Guangdong Prov Jointly Breeding Base, State Key Lab Appl Microbiol S China, Guangzhou, Guangdong, Peoples R China; [Wu, Qing-Ping; Xie, Yi-Zhen; Li, Xiang-Min; Jiao, Chun-Wei; Li, Sen-Zhu; Pan, Hong-Hui; Li, Chong; Zhang, Zhi; Guo, Jun] Guangdong Inst Microbiol, Guangzhou, Guangdong, Peoples R China; [Xie, Yi-Zhen; Li, Sen-Zhu; Pan, Hong-Hui] Guangdong Yuewei Edible Fungi Technol Co Ltd, Guangzhou, Guangdong, Peoples R China; [Deng, Zhaoqun; Yang, Weining; Jiao, Chun-Wei; Fang, Ling; Yee, Albert J.; Lee, Daniel Y.; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Deng, Zhaoqun; Jiao, Chun-Wei; Fang, Ling; Lee, Daniel Y.; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Wu, QP (corresponding author), Minist Guangdong Prov Jointly Breeding Base, State Key Lab Appl Microbiol S China, Guangzhou, Guangdong, Peoples R China.	byang@sri.utoronto.ca			Canadian Institutes of Health Research [MOP-102635, MOP-111171]; Heart and Stroke Foundation of Ontario [CI 7418]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by grants from Canadian Institutes of Health Research (MOP-102635, MOP-111171) to BBY, who is the recipient of a Career Investigator Award (CI 7418) from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Duarte N, 2007, PHYTOTHER RES, V21, P601, DOI 10.1002/ptr.2119; El-Mekkawy S, 1998, PHYTOCHEMISTRY, V49, P1651, DOI 10.1016/S0031-9422(98)00254-4; Fang L, ONCOGENE, V30, P806; Gao YH, 2002, LIFE SCI, V72, P731, DOI 10.1016/S0024-3205(02)02301-9; Hsu MJ, 2002, J LEUKOCYTE BIOL, V72, P207; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jeyapalan Z, NUCL ACIDS RES, V39, P3026; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kawasaki H, 2003, NATURE, V426, P100, DOI 10.1038/nature02141; Kim DH, 2005, ARCH PHARM RES, V28, P541, DOI 10.1007/BF02977755; Kobori M, 2007, BRIT J PHARMACOL, V150, P209, DOI 10.1038/sj.bjp.0706972; KOHDA H, 1985, CHEM PHARM BULL, V33, P1367; Kuo YC, 2003, BRIT J PHARMACOL, V140, P895, DOI 10.1038/sj.bjp.0705500; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee D. Y., PLOS ONE, V5; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; LIEU CW, 1992, ANTICANCER RES, V12, P1211; MARUYAMA H, 1989, J PHARMACOBIO-DYNAM, V12, P118, DOI 10.1248/bpb1978.12.118; MURASUGI A, 1991, J BIOL CHEM, V266, P2486; Park EJ, 1997, BIOL PHARM BULL, V20, P417, DOI 10.1248/bpb.20.417; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shatseva T, J CELL SCI, V124, P2826; Shiao MS, 2003, CHEM REC, V3, P172, DOI 10.1002/tcr.10058; Sliva D, 2003, J ALTERN COMPLEM MED, V9, P491, DOI 10.1089/107555303322284776; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Wu TS, 2001, J NAT PROD, V64, P1121, DOI 10.1021/np010115w; Xu S, ENDOCRINOLOGY, V152, P3941; Yang X, 2012, CELL CYCLE, V11; Ye G, J CELL SCI, V124, P359; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhao SF, 2011, INT J ONCOL, V38, P1319, DOI 10.3892/ijo.2011.965; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	42	68	71	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44579	10.1371/journal.pone.0044579	http://dx.doi.org/10.1371/journal.pone.0044579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952996	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500078
J	Barker, CS; Samatey, FA				Barker, Clive S.; Samatey, Fadel A.			Cross-Complementation Study of the Flagellar Type III Export Apparatus Membrane Protein FlhB	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; SUBSTRATE-SPECIFICITY; ELECTRON-TRANSPORT; CRYSTAL-STRUCTURE; SALMONELLA; BIOSYNTHESIS; COMPONENTS; GENE; DELIVERY; PATHWAY	The bacterial type III export apparatus is found in the flagellum and in the needle complex of some pathogenic Gram-negative bacteria. In the needle complex its function is to secrete effector proteins for infection into Eukaryotic cells. In the bacterial flagellum it exports specific proteins for the building of the flagellum during its assembly. The export apparatus is composed of about five membrane proteins and three soluble proteins. The mechanism of the export apparatus is not fully understood. The five membrane proteins are well conserved and essential. Here a cross-complementation assay was performed: substituting in the flagellar system of Salmonella one of these membrane proteins, FlhB, by the FlhB ortholog from Aquifex aeolicus (an evolutionary distant hyperthermophilic bacteria) or a chimeric protein (AquSalFlhB) made by the combination of the trans-membrane domain of A. aeolicus FlhB with the cytoplasmic domain of Salmonella FlhB dramatically reduced numbers of flagella and motility. From cells expressing the chimeric AquSalFlhB protein, suppressor mutants with enhanced motility were isolated and the mutations were identified using whole genome sequencing. Gain-offunction mutations were found in the gene encoding FlhA, another membrane protein of the type III export apparatus. Also, mutations were identified in genes encoding 4-hydroxybenzoate octaprenyltransferase, ubiquinone/menaquinone biosynthesis methyltransferase, and 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase, which are required for ubiquinone biosynthesis. The mutations were shown by reversed-phase high performance liquid chromatography to reduce the quinone pool of the cytoplasmic membrane. Ubiquinone biosynthesis could be restored for the strain bearing a mutated gene for 4-hydroxybenzoate octaprenyltransferase by the addition of excess exogenous 4-hydroxybenzoate. Restoring the level of ubiquinone reduced flagella biogenesis with the AquSalFlhB chimera demonstrating that the respiratory chain quinone pool is responsible for this phenomenon.	[Barker, Clive S.; Samatey, Fadel A.] Okinawa Inst Sci & Technol, Trans Membrane Trafficking Unit, Kunigami, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Barker, CS (corresponding author), Okinawa Inst Sci & Technol, Trans Membrane Trafficking Unit, Kunigami, Okinawa, Japan.	f.a.samatey@oist.jp	Samatey, Fadel/A-3204-2012	Samatey, Fadel/0000-0002-0733-2863				Altincicek B, 2001, J BACTERIOL, V183, P2411, DOI 10.1128/JB.183.8.2411-2416.2001; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; Barker CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001143; BARTANA J, 1977, J BACTERIOL, V130, P787, DOI 10.1128/JB.130.2.787-792.1977; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Erhardt M, 2010, MOL MICROBIOL, V75, P1272, DOI 10.1111/j.1365-2958.2010.07050.x; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GARZA AG, 1995, P NATL ACAD SCI USA, V92, P1970, DOI 10.1073/pnas.92.6.1970; GINOCCHIO CC, 1995, INFECT IMMUN, V63, P729, DOI 10.1128/IAI.63.2.729-732.1995; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022417; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HERTZ R, 1977, J BACTERIOL, V132, P1034, DOI 10.1128/JB.132.3.1034-1035.1977; JIANG WH, 1995, J BACTERIOL, V177, P6411, DOI 10.1128/jb.177.22.6411-6421.1995; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kihara M, 2001, J BACTERIOL, V183, P1655, DOI 10.1128/JB.183.5.1655-1662.2001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee M, 2010, J MOL BIOL, V404, P600, DOI 10.1016/j.jmb.2010.09.050; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Meganathan R, 2009, ECOSAL ESCHERICHIA C; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Minamino T, 2010, J BACTERIOL, V192, P1929, DOI 10.1128/JB.01328-09; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Morris DP, 2010, BIOCHEMISTRY-US, V49, P6386, DOI 10.1021/bi100487p; Ohnishi K, 1997, J BACTERIOL, V179, P6092, DOI 10.1128/jb.179.19.6092-6099.1997; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Qi J, 2010, BIOINFORMATICS, V26, P127, DOI 10.1093/bioinformatics/btp615; Rekittke I, 2011, FEBS LETT, V585, P447, DOI 10.1016/j.febslet.2010.12.012; RYU J, 1990, BIOTECHNIQUES, V8, P43; Singh S, 2008, J BIOL CHEM, V283, P22628, DOI 10.1074/jbc.M800503200; Skinner MM, 2000, STRUCTURE, V8, P1189, DOI 10.1016/S0969-2126(00)00522-0; Toker AS, 1996, J BACTERIOL, V178, P7069, DOI 10.1128/jb.178.24.7069-7079.1996; Yakushi T, 2006, J BACTERIOL, V188, P1466, DOI 10.1128/JB.188.4.1466-1472.2006; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P255; YOUNG IG, 1972, J BACTERIOL, V110, P18, DOI 10.1128/JB.110.1.18-25.1972; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436; Zhu K, 2002, BIOCHEMISTRY-US, V41, P9516, DOI 10.1021/bi0203280	50	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44030	10.1371/journal.pone.0044030	http://dx.doi.org/10.1371/journal.pone.0044030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952860	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206000070
J	Kano, F; Nakatsu, D; Noguchi, Y; Yamamoto, A; Murata, M				Kano, Fumi; Nakatsu, Daiki; Noguchi, Yoshiyuki; Yamamoto, Akitsugu; Murata, Masayuki			A Resealed-Cell System for Analyzing Pathogenic Intracellular Events: Perturbation of Endocytic Pathways under Diabetic Conditions	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; STREPTOLYSIN-O; GOLGI-COMPLEX; CDC2 KINASE; MDCK CELLS; RECONSTITUTION; TRANSPORT; ALPHA; PHOSPHORYLATION	Cell-based assay systems that can serve as cellular models of aberrant function in pathogenic organs would be novel and useful tools for screening drugs and clarifying the molecular mechanisms of various diseases. We constructed model cells that replicated the conditions in diabetic hepatocytes by using the cell resealing technique, which enables the exchange of cytosol. The plasma membrane of HeLa cells was permeabilized with the streptococcal toxin streptolysin O, and cytosol that had been prepared from wild-type or db/db diabetic mice was introduced into the resulting semi-intact cells. By resealing the plasma membrane by exposure to Ca2+, we created WT or Db model cells, in which the cytosolic conditions replicated those of healthy or diabetic liver. Interestingly, phosphorylation of p38 MAPK was promoted, whereas the level of endosomal phosphatidylinositol-3-phosphate was decreased, in Db cells. We investigated several endocytic pathways in WT and Db cells, and found that retrograde endosome-to-Golgi transport was delayed in a p38 MAPK-dependent manner in Db cells. Furthermore, the degradation pathway of the EGF receptor from endosomes to lysosomes was enhanced in Db cells, and this did not depend on the activation of p38 MAPK. The disease model cell system should become a powerful tool for the detection of aberrant processes in cells under pathogenic conditions and for therapeutic applications.	[Kano, Fumi; Nakatsu, Daiki; Noguchi, Yoshiyuki; Murata, Masayuki] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Kano, Fumi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Dept Cell Biol, Nagahama, Shiga, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Kano, F (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	mmurata@bio.c.u-tokyo.ac.jp			Kanagawa Academy of Science and Technology; PRESTO, Japan Science Technology Agency; Grants-in-Aid for Scientific Research [23657124] Funding Source: KAKEN	Kanagawa Academy of Science and Technology; PRESTO, Japan Science Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from Kanagawa Academy of Science and Technology (to M. M.) and PRESTO, Japan Science Technology Agency (to F. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; Adachi S, 2009, CANCER LETT, V277, P108, DOI 10.1016/j.canlet.2008.11.034; Apodaca G, 1996, EMBO J, V15, P1471, DOI 10.1002/j.1460-2075.1996.tb00491.x; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; BALCH WE, 1987, J CELL BIOL, V104, P749, DOI 10.1083/jcb.104.3.749; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Dahmane A, 1996, EUR J CELL BIOL, V69, P335; DEDIEGO JG, 1992, EXP CELL RES, V200, P77, DOI 10.1016/S0014-4827(05)80073-4; Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136, DOI 10.1152/ajpregu.1999.276.1.R136; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gum RJ, 2003, MOL ENDOCRINOL, V17, P1131, DOI 10.1210/me.2002-0288; Hakelien AM, 2002, NAT BIOTECHNOL, V20, P460, DOI 10.1038/nbt0502-460; HELMS JB, 1990, J BIOL CHEM, V265, P20027; Hemi R, 2011, DIABETES, V60, P1134, DOI 10.2337/db09-1323; Husmann M, 2006, BIOCHEM BIOPH RES CO, V344, P1128, DOI 10.1016/j.bbrc.2006.03.241; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kano F, 2005, GENES CELLS, V10, P989, DOI 10.1111/j.1365-2443.2005.00894.x; Kano F, 2005, GENES CELLS, V10, P333, DOI 10.1111/j.1365-2443.2005.00837.x; Kano F, 2004, MOL BIOL CELL, V15, P4289, DOI 10.1091/mbc.E03-11-0822; Kano F, 2000, J CELL BIOL, V149, P357, DOI 10.1083/jcb.149.2.357; Kano F, 2000, MOL BIOL CELL, V11, P3073, DOI 10.1091/mbc.11.9.3073; Kano F, 2011, BBA-MOL CELL RES, V1813, P784, DOI 10.1016/j.bbamcr.2011.01.023; Kano F, 2009, J CELL SCI, V122, P2218, DOI 10.1242/jcs.043414; Kano Fumi, 2006, V322, P357; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Kloft N, 2009, BIOCHEM BIOPH RES CO, V385, P503, DOI 10.1016/j.bbrc.2009.05.121; KRISCHER J, 1993, DIABETES, V42, P1303, DOI 10.2337/diabetes.42.9.1303; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAFONT F, 1994, NATURE, V372, P801; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; LEVRAN A, 1986, BIOCHEM BIOPH RES CO, V137, P258, DOI 10.1016/0006-291X(86)91204-0; Li C, 2001, J MUSCLE RES CELL M, V22, P521, DOI 10.1023/A:1015026530258; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Monte MJ, 2008, AM J PHYSIOL-GASTR L, V295, pG54, DOI 10.1152/ajpgi.00592.2007; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; PETERS R, 1986, BIOCHIM BIOPHYS ACTA, V864, P305, DOI 10.1016/0304-4157(86)90003-1; Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; RUOHOLA H, 1988, J CELL BIOL, V107, P1465, DOI 10.1083/jcb.107.4.1465; Schram K, 2010, CELL MOL BIOL LETT, V15, P551, DOI 10.2478/s11658-010-0027-z; SEKIYA K, 1993, J BACTERIOL, V175, P5953, DOI 10.1128/JB.175.18.5953-5961.1993; Shaik GM, 2009, CELL SIGNAL, V21, P1337, DOI 10.1016/j.cellsig.2009.04.001; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stassen M, 2003, INFECT IMMUN, V71, P6171, DOI 10.1128/IAI.71.11.6171-6177.2003; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Vergarajauregui S, 2006, TRAFFIC, V7, P686, DOI 10.1111/j.1600-0854.2006.00420.x; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Walev I, 2001, FASEB J, V15, P237, DOI 10.1096/fj.01-0572fje; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Yan KF, 2012, MOL MED, V18, P10, DOI 10.2119/molmed.2011.00243; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200	56	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44127	10.1371/journal.pone.0044127	http://dx.doi.org/10.1371/journal.pone.0044127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952896	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000085
J	Angulo, B; Conde, E; Suarez-Gauthier, A; Plaza, C; Martinez, R; Redondo, P; Izquierdo, E; Rubio-Viqueira, B; Paz-Ares, L; Hidalgo, M; Lopez-Rios, F				Angulo, Barbara; Conde, Esther; Suarez-Gauthier, Ana; Plaza, Carlos; Martinez, Rebeca; Redondo, Pilar; Izquierdo, Elisa; Rubio-Viqueira, Belen; Paz-Ares, Luis; Hidalgo, Manuel; Lopez-Rios, Fernando			A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR MUTATIONS; POLYMERASE-CHAIN-REACTION; TYROSINE KINASE INHIBITORS; GENE COPY NUMBER; PERSONALIZED MEDICINE; ACTIVATING MUTATIONS; GEFITINIB TREATMENT; PROTEIN EXPRESSION; CANCER	The objective of this study is to compare two EGFR testing methodologies (a commercial real-time PCR kit and a specific EGFR mutant immunohistochemistry), with direct sequencing and to investigate the limit of detection (LOD) of both PCR-based methods. We identified EGFR mutations in 21 (16%) of the 136 tumours analyzed by direct sequencing. Interestingly, the Therascreen EGFR Mutation Test kit was able to characterize as wild-type one tumour that could not be analyzed by direct sequencing of the PCR product. We then compared the LOD of the kit and that of direct sequencing using the available mutant tumours. The kit was able to detect the presence of a mutation in a 1% dilution of the total DNA in nine of the 18 tumours (50%), which tested positive with the real-time quantitative PCR method. In all cases, EGFR mutation was identified at a dilution of 5%. Where the mutant DNA represented 30% of the total DNA, sequencing was able to detect mutations in 12 out of 19 cases (63%). Additional experiments with genetically defined standards (EGFR Delta E746-A750/+ and EGFR L858R/+) yielded similar results. Immunohistochemistry (IHC) staining with exon 19-specific antibody was seen in eight out of nine cases with E746-A750del detected by direct sequencing. Neither of the two tumours with complex deletions were positive. Of the five L858R-mutated tumours detected by the PCR methods, only two were positive for the exon 21-specific antibody. The specificity was 100% for both antibodies. The LOD of the real-time PCR method was lower than that of direct sequencing. The mutation specific IHC produced excellent specificity.	[Angulo, Barbara; Conde, Esther; Suarez-Gauthier, Ana; Plaza, Carlos; Martinez, Rebeca; Redondo, Pilar; Izquierdo, Elisa; Rubio-Viqueira, Belen; Hidalgo, Manuel; Lopez-Rios, Fernando] Univ San Pablo CEU, Hosp HM Univ Sanchinarro, Ctr Integral Oncol Clara Campal, Lab Dianas Terapeut,Fac Med, Madrid, Spain; [Rubio-Viqueira, Belen; Hidalgo, Manuel] Spanish Natl Canc Res Ctr, Gastrointestinal Canc Clin Res Unit, Madrid, Spain; [Paz-Ares, Luis] Hosp Univ Virgen del Rocio, Seville, Spain; [Paz-Ares, Luis] Inst Biomed Sevilla IBIS, Dept Oncol, Seville, Spain	San Pablo CEU University; Centro Nacional de Investigaciones Oncologicas (CNIO); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)	Angulo, B (corresponding author), Univ San Pablo CEU, Hosp HM Univ Sanchinarro, Ctr Integral Oncol Clara Campal, Lab Dianas Terapeut,Fac Med, Madrid, Spain.	flopezrios@hospitaldemadrid.com	IZQUIERDO, ELISA/AAE-2922-2021; Diez Redondo, Pilar/GQZ-7708-2022; Paz-Ares, Luis/AAH-2750-2019; HIDALGO, MANUEL/I-4995-2015	IZQUIERDO, ELISA/0000-0002-3054-5832; HIDALGO, MANUEL/0000-0002-3765-3318; Plaza, Jose Carlos/0000-0001-9911-4814	Fundacion Mutua Madrilena; Fondo de Investigaciones Sanitarias	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was partially funded by Fundacion Mutua Madrilena and Fondo de Investigaciones Sanitarias (PIs: Esther Conde, Luis Paz-Ares and Fernando Lopez-Rios). DxS Limited provided some tests kits free of charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2005, J MOL DIAGN, V7, P36, DOI 10.1016/S1525-1578(10)60006-2; Angulo B, 2011, J THORAC ONCOL, V6, pS1061; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Asano H, 2006, CLIN CANCER RES, V12, P43, DOI 10.1158/1078-0432.CCR-05-0934; Azuma K, 2012, J THORAC ONCOL, V7, P122, DOI 10.1097/JTO.0b013e31822eeba2; Bai H, 2012, J CONTRACEPT FERTIL; Benedettini E, 2010, AM J PATHOL, V177, P415, DOI 10.2353/ajpath.2010.090863; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Chen ZY, 2012, ONCOLOGIST, V17, P978, DOI 10.1634/theoncologist.2011-0385; Clayton SJ, 2000, CLIN CHEM, V46, P1929; Conde E, 2006, CLIN CANCER RES, V12, P710, DOI 10.1158/1078-0432.CCR-05-1362; Conde E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012209; Dacic S, 2011, ARCH PATHOL LAB MED, V135, P1242, DOI 10.5858/arpa.2011-0223-ED; De Pas T, 2011, J THORAC ONCOL, V6, P1895, DOI 10.1097/JTO.0b013e318227e8c6; Eberhard DA, 2008, J CLIN ONCOL, V26, P983, DOI 10.1200/JCO.2007.12.9858; Ellison G, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-132; Endo K, 2005, LUNG CANCER, V50, P375, DOI 10.1016/j.lungcan.2005.08.009; Hirsch FR, 2010, CLIN CANCER RES, V16, P4909, DOI 10.1158/1078-0432.CCR-10-2005; Ilie MI, 2010, VIRCHOWS ARCH, V457, P483, DOI 10.1007/s00428-010-0963-z; Janku F, 2011, J THORAC ONCOL, V6, P1601, DOI 10.1097/JTO.0b013e31822944b3; Janne PA, 2006, CLIN CANCER RES, V12, P751, DOI 10.1158/1078-0432.CCR-05-2047; Kato Y, 2010, J THORAC ONCOL, V5, P1551, DOI 10.1097/JTO.0b013e3181e9da60; Kawahara A, 2010, CLIN CANCER RES, V16, P3163, DOI 10.1158/1078-0432.CCR-09-3239; Kimura H, 2006, CANCER SCI, V97, P642, DOI 10.1111/j.1349-7006.2006.00216.x; Kitamura A, 2010, CLIN CANCER RES, V16, P3349, DOI 10.1158/1078-0432.CCR-10-0129; Kozu Y, 2011, LUNG CANCER, V73, P45, DOI 10.1016/j.lungcan.2010.11.003; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2006, NEW ENGL J MED, V354, P526; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Miyamae Y, 2010, J MOL DIAGN, V12, P257, DOI 10.2353/jmoldx.2010.090105; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mok TSK, 2011, NAT REV CLIN ONCOL, V8, P661, DOI 10.1038/nrclinonc.2011.126; Nomoto K, 2006, AM J CLIN PATHOL, V126, P608, DOI 10.1309/N5PQNGW2QKMX09X7; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan QL, 2005, J MOL DIAGN, V7, P396, DOI 10.1016/S1525-1578(10)60569-7; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pirker Robert, 2010, J Thorac Oncol, V5, P1706, DOI 10.1097/JTO.0b013e3181f1c8de; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Salto-Tellez M, 2011, J THORAC ONCOL, V6, P1663, DOI 10.1097/JTO.0b013e318227816a; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Simonetti S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-135; Thelwell N, 2000, NUCLEIC ACIDS RES, V28, P3752, DOI 10.1093/nar/28.19.3752; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Whitehall V, 2009, J MOL DIAGN, V11, P543, DOI 10.2353/jmoldx.2009.090057; Willmore-Payne C, 2006, HUM PATHOL, V37, P755, DOI 10.1016/j.humpath.2006.02.004; Yasuda H, 2012, LANCET ONCOL, V13, pE23, DOI 10.1016/S1470-2045(11)70129-2; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739; Zhou CC, 2006, CANCER J, V12, P33, DOI 10.1097/00130404-200601000-00007; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	54	73	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43842	10.1371/journal.pone.0043842	http://dx.doi.org/10.1371/journal.pone.0043842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952784	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800065
J	Chiang, CY; Yu, MC; Shih, HC; Yen, MY; Hsu, YL; Yang, SL; Lin, TP; Bai, KJ				Chiang, Chen-Yuan; Yu, Ming-Chih; Shih, Hsiu-Chen; Yen, Muh-Yong; Hsu, Yu-Ling; Yang, Shiang-Lin; Lin, Tao-Ping; Bai, Kuan-Jen			Improved Consistency in Dosing Anti-Tuberculosis Drugs in Taipei, Taiwan	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SERVICES; RIFAMPIN; DOSAGES	Background: It was reported that 35.5% of tuberculosis (TB) cases reported in 2003 in Taipei City had no recorded pretreatment body weight and that among those who had, inconsistent dosing of anti-TB drugs was frequent. Taiwan Centers for Disease Control (CDC) have taken actions to strengthen dosing of anti-TB drugs among general practitioners. Prescribing practices of anti-TB drugs in Taipei City in 2007-2010 were investigated to assess whether interventions on dosing were effective. Methodology/Principal Findings: Lists of all notified culture positive TB cases in 2007-2010 were obtained from National TB Registry at Taiwan CDC. A medical audit of TB case management files was performed to collect pretreatment body weight and regimens prescribed at commencement of treatment. Dosages prescribed were compared with dosages recommended. The proportion of patients with recorded pre-treatment body weight was 64.5% in 2003, which increased to 96.5% in 2007-2010 (p<0.001). The proportion of patients treated with consistent dosing of a 3-drug fixed-dose combination (FDC) increased from 73.9% in 2003 to 87.7% in 2007-2010 (p<0.001), and that for 2-drug FDC from 76.0% to 86.1% (p = 0.024), for rifampicin (RMP) from 62.8% to 85.5% (p<0.001), and for isoniazid from 87.8% to 95.3% (p<0.001). In 2007-2010, among 2917 patients treated with either FDCs or RMP in single-drug preparation, the dosage of RMP was adequate (8-12 mg/kg) in 2571(88.1%) patients, too high in 282(9.7%), too low in 64(2.2%). In multinomial logistic regression models, factors significantly associated with adequate dosage of RMP were body weight and preparations of RMP. Patients weighting <40kg (relative risk ratio (rrr) 6010.5, 95% CI 781.1-46249.7) and patients weighting 40-49 kg (rrr 1495.3, 95% CI 200.6-11144.6) were more likely to receive higher-than-recommended dose of RMP. Conclusions/Significance: Prescribing practice in the treatment of TB in Taipei City has remarkably improved after health authorities implemented a series of interventions.	[Chiang, Chen-Yuan] Int Union TB & Lung Dis, Paris, France; [Chiang, Chen-Yuan; Yu, Ming-Chih; Bai, Kuan-Jen] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chiang, Chen-Yuan; Yu, Ming-Chih; Bai, Kuan-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Shih, Hsiu-Chen; Yen, Muh-Yong] Taipei City Govt, Taipei City Hosp, Dept Dis Control & Prevent, Taipei, Taiwan; [Hsu, Yu-Ling; Yang, Shiang-Lin] Ctr Dis Control, Dept Hlth, Taipei, Taiwan; [Lin, Tao-Ping] Taiwan AntiTB Assoc, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei City Hospital; Centers For Disease Control - Taiwan	Chiang, CY (corresponding author), Int Union TB & Lung Dis, Paris, France.	kjbai@wanfang.gov.tw			Centers for Disease Control, Department of Health, Taiwan, People's Republic of China	Centers for Disease Control, Department of Health, Taiwan, People's Republic of China	This work was funded by Centers for Disease Control, Department of Health, Taiwan, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Centers for Disease Control. Department of Health. Republic of China, 2011, MOB ALL CIT RED TUB; Chan P-C, 2009, INT J TUBERC LUNG S, V13, ps207; Chiang CY, 2007, INT J TUBERC LUNG D, V11, P739; Chiang CY, 2010, INT J TUBERC LUNG D, V14, P878; Diop AH, 2002, INT J TUBERC LUNG D, V6, P215; Harries AD, 2004, INT J TUBERC LUNG D, V8, P724; Hoa NB, 2012, PUBLIC HEALTH ACTION, V2, P15, DOI [10.5588/pha.11.0024, 10.5588/pha.11.0015]; International Union against Tuberculosis and Lung Disease, 2010, MAN TUB GUID ESS GOO; Kimerling ME, 1998, CHEST, V113, P1178, DOI 10.1378/chest.113.5.1178; Li Y-P, 2009, INT J TUBERC LUNG S, V13, ps107; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Norval PY, 2010, INT J TUBERC LUNG D, V14, P795; Ruslami R, 2007, ANTIMICROB AGENTS CH, V51, P2546, DOI 10.1128/AAC.01550-06; Steingart KR, 2011, INT J TUBERC LUNG D, V15, P305; Taiwan Centers for Disease Control Department of Health, 2008, TAIW GUID TUB DIAGN; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2010, RAP ADV TREATM TUB C	20	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44133	10.1371/journal.pone.0044133	http://dx.doi.org/10.1371/journal.pone.0044133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952900	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800097
J	Dorval, V; Smith, PY; Delay, C; Calvo, E; Planel, E; Zommer, N; Buee, L; Hebert, SS				Dorval, Veronique; Smith, Pascal Y.; Delay, Charlotte; Calvo, Ezequiel; Planel, Emmanuel; Zommer, Nadege; Buee, Luc; Hebert, Sebastien S.			Gene Network and Pathway Analysis of Mice with Conditional Ablation of Dicer in Post-Mitotic Neurons	PLOS ONE			English	Article							ADULT FOREBRAIN NEURONS; MICRORNA EXPRESSION; MAMMALIAN MICRORNAS; MICROARRAY ANALYSIS; DNA METHYLATION; MESSENGER-RNAS; HUMAN TISSUES; RIP-CHIP; BRAIN; DIFFERENTIATION	Background: The small non-protein-coding microRNAs (miRNAs) have emerged as critical regulators of neuronal differentiation, identity and survival. To date, however, little is known about the genes and molecular networks regulated by neuronal miRNAs in vivo, particularly in the adult mammalian brain. Methodology/Principal Findings: We analyzed whole genome microarrays from mice lacking Dicer, the enzyme responsible for miRNA production, specifically in postnatal forebrain neurons. A total of 755 mRNA transcripts were significantly (P<0.05, FDR<0.25) misregulated in the conditional Dicer knockout mice. Ten genes, including Tnrc6c, Dnmt3a, and Limk1, were validated by real time quantitative RT-PCR. Upregulated transcripts were enriched in nonneuronal genes, which is consistent with previous studies in vitro. Microarray data mining showed that upregulated genes were enriched in biological processes related to gene expression regulation, while downregulated genes were associated with neuronal functions. Molecular pathways associated with neurological disorders, cellular organization and cellular maintenance were altered in the Dicer mutant mice. Numerous miRNA target sites were enriched in the 3' untranslated region (3'UTR) of upregulated genes, the most significant corresponding to the miR-124 seed sequence. Interestingly, our results suggest that, in addition to miR-124, a large fraction of the neuronal miRNome participates, by order of abundance, in coordinated gene expression regulation and neuronal maintenance. Conclusions/Significance: Taken together, these results provide new clues into the role of specific miRNA pathways in the regulation of brain identity and maintenance in adult mice.	[Dorval, Veronique; Smith, Pascal Y.; Delay, Charlotte; Calvo, Ezequiel; Planel, Emmanuel; Hebert, Sebastien S.] Ctr Rech CHUQ CHUL, Quebec City, PQ, Canada; [Dorval, Veronique; Smith, Pascal Y.; Delay, Charlotte; Calvo, Ezequiel; Planel, Emmanuel; Hebert, Sebastien S.] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Zommer, Nadege; Buee, Luc] INSERM, UMR837, F-59045 Lille, France; [Zommer, Nadege; Buee, Luc] Univ Lille Nord France, Fac Med, UDSL, Lille, France	Laval University; Laval University; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Dorval, V (corresponding author), Ctr Rech CHUQ CHUL, Quebec City, PQ, Canada.	sebastien.hebert@crchul.ulaval.ca	Hébert, Sébastien S./Q-2729-2017; Delay, Charlotte/F-3139-2011; BUEE, Luc/B-3126-2010	BUEE, Luc/0000-0002-6261-4230; Planel, Emmanuel/0000-0001-5128-0565; Hebert, Sebastien/0000-0002-0391-9325	Natural Sciences and Engineering Research Council of Canada; Scottish Rite Charitable Foundation of Canada; Alzheimer Society of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Scottish Rite Charitable Foundation of Canada; Alzheimer Society of Canada	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Scottish Rite Charitable Foundation of Canada, and the Alzheimer Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hebert SS, 2012, EXP NEUROL, V235, P397, DOI 10.1016/j.expneurol.2011.12.004; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hohjoh H, 2007, BIOCHEM BIOPH RES CO, V362, P360, DOI 10.1016/j.bbrc.2007.07.189; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lau P, 2010, BRAIN RES, V1338, P14, DOI 10.1016/j.brainres.2010.04.002; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Manakov SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-419; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Qureshi IA, 2009, NEUROSCI LETT, V466, P73, DOI 10.1016/j.neulet.2009.07.093; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smith P, 2011, J NEUROCHEM; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910	49	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44060	10.1371/journal.pone.0044060	http://dx.doi.org/10.1371/journal.pone.0044060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952873	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800093
J	Paglia, MG; Bevilacqua, N; Haji, HS; Vairo, F; Girardi, E; Nicastri, E; Muhsin, J; Racalbuto, V; Jiddawi, MS; Ippolito, G				Paglia, Maria G.; Bevilacqua, Nazario; Haji, Haji Said; Vairo, Francesco; Girardi, Enrico; Nicastri, Emanuele; Muhsin, Juma; Racalbuto, Vincenzo; Jiddawi, Mohammed S.; Ippolito, Giuseppe			Improvement of Tuberculosis Laboratory Capacity on Pemba Island, Zanzibar: A Health Cooperation Project	PLOS ONE			English	Article							DELAYS	Low-income countries with high Tuberculosis burden have few reference laboratories able to perform TB culture. In 2006, the Zanzibar National TB Control Programme planned to decentralize TB diagnostics. The Italian Cooperation Agency with the scientific support of the "L. Spallanzani" National Institute for Infectious Diseases sustained the project through the implementation of a TB reference laboratory in a low-income country with a high prevalence of TB. The implementation steps were: 1) TB laboratory design according to the WHO standards; 2) laboratory equipment and reagent supplies for microscopy, cultures, and identification; 3) on-the-job training of the local staff; 4) web-and telemedicine-based supervision. From April 2007 to December 2010, 921 sputum samples were received from 40 peripheral laboratories: 120 TB cases were diagnosed. Of all the smear-positive cases, 74.2% were culture-positive. During the year 2010, the smear positive to culture positive rate increased up to 100%. In March 20, 2010 the Ministry of Health and Social Welfare of Zanzibar officially recognized the Public Health Laboratory-Ivo de Carneri as the National TB Reference Laboratory for the Zanzibar Archipelago. An advanced TB laboratory can represent a low cost solution to strengthen the TB diagnosis, to provide capacity building and mid-term sustainability.	[Paglia, Maria G.; Bevilacqua, Nazario; Vairo, Francesco; Girardi, Enrico; Nicastri, Emanuele; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani, Microbiol Lab, Dept Epidemiol, Rome, Italy; [Paglia, Maria G.; Bevilacqua, Nazario; Vairo, Francesco; Girardi, Enrico; Nicastri, Emanuele; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani, Microbiol Lab, Clin Dept, Rome, Italy; [Haji, Haji Said] Publ Hlth Lab Ivo De Carneri, Pemba Isl, Zanzibar, Tanzania; [Muhsin, Juma] Minist Hlth & Social Welf, Natl TB & Leprosy Programme, Unguja Isl, Zanzibar, Tanzania; [Vairo, Francesco; Racalbuto, Vincenzo] Italian Minist Foreign Affairs, Italian Cooperat Agcy, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Paglia, MG (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Microbiol Lab, Dept Epidemiol, Rome, Italy.	nazario.bevilacqua@inmi.it	Ippolito, Giuseppe/J-7207-2017; nicastri, emanuele/K-7780-2016; Paglia, Maria Grazia/B-8849-2017; Vairo, Francesco/M-5676-2013	nicastri, emanuele/0000-0002-5606-8712; Girardi, Enrico/0000-0001-8182-5896; Ippolito, Giuseppe/0000-0002-1076-2979; Paglia, Maria Grazia/0000-0002-3469-6216; Vairo, Francesco/0000-0002-8375-7468	Italian Cooperation and Ministry of Foreign Affairs of Italy [8282]	Italian Cooperation and Ministry of Foreign Affairs of Italy	This work was part of the activities carried out by the Programme Aid 8282 in Tanzania, entirely funded by the Italian Cooperation and Ministry of Foreign Affairs of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimiku AG, 2009, AM J CLIN PATHOL, V131, P875, DOI 10.1309/AJCPELMG6GX6RQSM; Hepple P, 2011, INT J TUBERC LUNG D, V15, P405; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Massambu C, 2009, AM J CLIN PATHOL, V131, P861, DOI 10.1309/AJCP3ZAAFUPCIXIG; Mfinanga SG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-158; Ministry of Health and Social Welfare Zanzibar, HLTH MAN INF SYST UN; Odusanya OO, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-18; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P59; Shin SS, 2008, EMERG INFECT DIS, V14, P701, DOI 10.3201/eid1405.070721; TACAIDS - Tanzania Commission for HIV and AIDS, TANZ COMM HIV AIDS U; UNAIDS, 2010, REP GLOB AIDS EP; Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P133; World Health Organization, GLOB TUB CONTR EP ST; World Health Organization, 2011, GLOB TUB CONTR WHO R; World Health Organization, 2010, ROADM ENS QUAL TUB D	15	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44109	10.1371/journal.pone.0044109	http://dx.doi.org/10.1371/journal.pone.0044109			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952891	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800096
J	Qin, XJ; Chen, HM; Guo, L; Guo, YY				Qin, Xue-jiao; Chen, Hong-mei; Guo, Liang; Guo, Yong-yuan			Low-Dose Strontium-90 Irradiation Is Effective in Preventing the Recurrence of Pterygia: A Ten-Year Study	PLOS ONE			English	Article							BETA-IRRADIATION; POSTOPERATIVE IRRADIATION; COMPLICATIONS; RADIATION; SURGERY; REMOVAL	Background: To study the long-term effects of low-dosage strontium-90 (Sr90) irradiation on the recurrence of pterygium. Methodology/Principal Findings: One hundred twenty eyes from 104 patients with primary or recurrent pterygia were treated with surgery followed by Sr90 irradiation. In brief, starting on the sixth day after surgery, patients were treated with irradiation three times every other day at a total combined dosage of 2000 cGy to 3000 cGy. Corneal topography was used to evaluate ocular surface regularity before and after treatment. Patient follow-up was performed 2 days, 5 days, 2 weeks, 1 month, 3 months, 1 year, 5 years, and 10 years after surgery. Recurrence of pterygium was not observed in any of the patients in this study. Obvious cataract progression was observed in 6 eyes, which may be due to aging. During follow-up studies, only one eye was reported with dryness and foreign-body sensation. Significant pterygium-induced astigmatism was observed in corneal topography, which decreased after surgery. Conclusions/Significance: Sr90 irradiation is effective in preventing the recurrence of primary and recurrent pterygia. We recommend delivering a total combined dosage of 2000 cGy to 3000 cGy of Sr90 irradiation administered in three batches every other day starting from the sixth day after surgery. Surgery is important in the rapid recovery of the cornea from pterygium-induced astigmatism.	[Qin, Xue-jiao; Chen, Hong-mei; Guo, Liang; Guo, Yong-yuan] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China	Shandong University	Qin, XJ (corresponding author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China.	qinxuejiao@hotmail.com			Scientific Research Foundation for the Returned Overseas Chinese Scholars, the State Education Ministry; Natural Science Foundation of Shandong Province [ZR2012HM024]; Independent Innovation Foundation to Universities and Colleges by Jinan Science and Technology Bureau [201202036]; Independent Innovation Foundation of Shandong University [2010JQ009]	Scientific Research Foundation for the Returned Overseas Chinese Scholars, the State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Independent Innovation Foundation to Universities and Colleges by Jinan Science and Technology Bureau; Independent Innovation Foundation of Shandong University	The Project was sponsored partly by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, the State Education Ministry (2005), the Natural Science Foundation of Shandong Province (ZR2012HM024), the Independent Innovation Foundation to Universities and Colleges by Jinan Science and Technology Bureau (201202036); and the Independent Innovation Foundation of Shandong University (2010JQ009). The funders were not involved in the study design, data collection and analysis, publishing decisions, or preparation of the manuscript.	ALANIZCAMINO F, 1982, OPHTHALMIC SURG LAS, V13, P1022; Ali AM, 2011, CANCER RADIOTHER, V15, P140, DOI 10.1016/j.canrad.2010.03.020; Ang LPK, 2007, CURR OPIN OPHTHALMOL, V18, P308, DOI 10.1097/ICU.0b013e3281a7ecbb; Aswad M, 1987, Trans Am Ophthalmol Soc, V85, P273; Avisar R, 2001, ISRAEL MED ASSOC J, V3, P836; BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981, DOI 10.1016/0360-3016(82)90459-X; BERNSTEIN M, 1960, AM J OPHTHALMOL, V49, P1024, DOI 10.1016/0002-9394(60)91828-6; COOPER JS, 1980, RADIOLOGY, V135, P743, DOI 10.1148/radiology.135.3.7384465; Hoffman RS, 1999, INT OPHTHALMOL CLIN, V39, P15, DOI 10.1097/00004397-199903910-00004; Isohashi F, 2006, STRAHLENTHER ONKOL, V182, P437, DOI 10.1007/s00066-006-1484-1; JAROS PA, 1988, SURV OPHTHALMOL, V33, P41, DOI 10.1016/0039-6257(88)90071-9; Jurgenliemk-Schulz IM, 2004, INT J RADIAT ONCOL, V59, P1138, DOI 10.1016/j.ijrobp.2003.12.021; Kirwan JF, 2003, EYE, V17, P207, DOI 10.1038/sj.eye.6700306; LEVINE DJ, 1994, ARCH OPHTHALMOL-CHIC, V112, P1016, DOI 10.1001/archopht.1994.01090200018003; MAHAR PS, 1993, BRIT J OPHTHALMOL, V77, P433, DOI 10.1136/bjo.77.7.433; Monteiro-Grillo I, 2000, INT J RADIAT ONCOL, V48, P865, DOI 10.1016/S0360-3016(00)00701-X; MORIARTY AP, 1992, BRIT J OPHTHALMOL, V76, P766, DOI 10.1136/bjo.76.12.766; Nishimura Y, 2000, INT J RADIAT ONCOL, V46, P137, DOI 10.1016/S0360-3016(99)00419-8; Pajic B, 2005, RADIOTHER ONCOL, V74, P25, DOI 10.1016/j.radonc.2004.08.022; PAVILACK MA, 1995, J REFRACT SURG, V11, P92; ROWEN G E, 1968, Rocky Mountain Medical Journal, V65, P47; Smith R A, 2001, J Miss State Med Assoc, V42, P167; Solomon A, 2001, OPHTHALMOLOGY, V108, P449, DOI 10.1016/S0161-6420(00)00567-4; Solomon AS, 2006, BRIT J OPHTHALMOL, V90, P665, DOI 10.1136/bjo.2006.091413; Song C, 1994, ATLAS SURG VOLUME OP, P276; Tafti MRF, 2011, CORNEA, V30, P127, DOI 10.1097/ICO.0b013e3181e16d67; TARR KH, 1980, BRIT J OPHTHALMOL, V64, P496, DOI 10.1136/bjo.64.7.496; Viani Gustavo Arruda, 2012, Int J Radiat Oncol Biol Phys, V82, pe181, DOI 10.1016/j.ijrobp.2010.11.017; WILDER RB, 1992, INT J RADIAT ONCOL, V23, P533, DOI 10.1016/0360-3016(92)90008-6	29	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43500	10.1371/journal.pone.0043500	http://dx.doi.org/10.1371/journal.pone.0043500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952695	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800034
J	Zhang, W; Shi, Q; Xu, XT; Chen, H; Lin, W; Zhang, FC; Zeng, XF; Zhang, X; Ba, DN; He, W				Zhang, Wen; Shi, Qun; Xu, Xiaotian; Chen, Hua; Lin, Wei; Zhang, Fengchun; Zeng, Xiaofeng; Zhang, Xuan; Ba, Denian; He, Wei			Aberrant CD40-Induced NF-kappa B Activation in Human Lupus B Lymphocytes	PLOS ONE			English	Article							SOLUBLE CD40 LIGAND; LIPID RAFTS; ERYTHEMATOSUS; EXPRESSION; CELLS; TRAF2; CD154; GLOMERULONEPHRITIS; UBIQUITINATION; TRANSLOCATION	Auto-reactive B lymphocytes and its abnormal CD40 signaling play important roles in the pathogenesis of systemic lupus erythematosus (SLE). In this study, we analyzed CD40 expression and CD40/CD154 induced activation of NF-kappa B signaling pathway in B cells from SLE patients. B cells from healthy volunteers and tonsilar B cells from chronic tonsillitis were used as negative and positive controls. Results showed CD40-induced NF-kappa B signaling was constitutively activated in B cells from active lupus patients, including decreased CD40 in raft portion, increased phosphorylation and degradation of I kappa B alpha, phosphorylation of P65, as well as increased nuclear translocation of P65, P50, c-Rel, which could be blocked by anti-CD154. CD154 stimulation could induce further phosphorylation and degradation of I kappa B alpha, as well as phosphorylation of P65 and nuclear translocation of P65. In addition, CD40-induced kinase activities in B cells from lupus patients mimicked that of tonsil B cells, in that IKK alpha/beta were more activated compared to normal B cells. CD40-induced NF-kappa B activity was blocked by both I kappa B phosphorylation and proteosome degradation inhibitors in both lupus and normal B cells. All together, our findings revealed that canonical NF-kappa B signaling is constitutively activated in active lupus and is mediated by CD154/CD40. CD40 induced NF-kappa B activation is different in human lupus B lymphocytes compared with normal B cells.	[Zhang, Wen; Shi, Qun; Xu, Xiaotian; Chen, Hua; Lin, Wei; Zhang, Fengchun; Zeng, Xiaofeng; Zhang, Xuan] Peking Union Med Coll, Dept Rheumatol, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China; [Ba, Denian; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Ba, Denian; He, Wei] Peking Union Med Coll, Dept Immunol, Sch Basic Med, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, W (corresponding author), Peking Union Med Coll, Dept Rheumatol, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China.	zxpumch2003@yahoo.com.cn	zhang, xu/GRX-9733-2022; zhang, xuan/GQO-8953-2022; zhang, xuan/AAN-9914-2020	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699	National Natural Science Foundation of China [81172858, 30972731]; National High Technology Research and Development Project of China (973 Project) [2007CB512405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Project of China (973 Project)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (81172858, 30972731), National High Technology Research and Development Project of China (973 Project) (2007CB512405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardila-Osorio H, 2005, INT J CANCER, V113, P267, DOI 10.1002/ijc.20503; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Blossom S, 1997, J IMMUNOL, V159, P4580; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Caproni M, 2007, J RHEUMATOL, V34, P2412; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cherukuri Anu, 2004, Methods Mol Biol, V271, P213; Crow MK, 2001, CURR OPIN RHEUMATOL, V13, P361, DOI 10.1097/00002281-200109000-00004; de Sanctis JB, 2009, AUTOIMMUNITY, V42, P263, DOI 10.1080/08916930902827942; Dejica D I, 2006, Roum Arch Microbiol Immunol, V65, P66; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Gladman DD, 2002, J RHEUMATOL, V29, P288; Grammer AC, 1999, J IMMUNOL, V163, P4150; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Harigai M, 1999, LUPUS, V8, P227, DOI 10.1191/096120399678847678; Hillion S, 2007, J IMMUNOL, V179, P6790, DOI 10.4049/jimmunol.179.10.6790; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; Hostager BS, 2007, IMMUNOL RES, V39, P105, DOI 10.1007/s12026-007-0082-3; Jabara HH, 2009, INT IMMUNOL, V21, P477, DOI 10.1093/intimm/dxp013; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Liu Z, 2011, EUR J IMMUNOL, V41, P588, DOI 10.1002/eji.201041354; Loh C, 2011, EUR J IMMUNOL, V41, P527, DOI 10.1002/eji.201040983; Mehta J, 2010, ARTHRITIS RHEUM-US, V62, P2499, DOI 10.1002/art.27554; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Withers DR, 2007, BLOOD, V109, P4856, DOI 10.1182/blood-2006-08-043414; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; XIA ZP, 2005, SCI STKE, pE7; Yellin MJ, 1997, ARTHRITIS RHEUM, V40, P124, DOI 10.1002/art.1780400117	32	24	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e41644	10.1371/journal.pone.0041644	http://dx.doi.org/10.1371/journal.pone.0041644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952582	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800005
J	Matarraz, S; Teodosio, C; Fernandez, C; Albors, M; Jara-Acevedo, M; Lopez, A; Gonzalez-Gonzalez, M; Gutierrez, ML; Flores-Montero, J; Cervero, C; Pizarro-Perea, M; Garrastazul, MP; Caballero, G; Gutierrez, O; Mendez, GD; Gonzalez-Silva, M; Laranjeira, P; Orfao, A				Matarraz, Sergio; Teodosio, Cristina; Fernandez, Carlos; Albors, Manuel; Jara-Acevedo, Maria; Lopez, Antonio; Gonzalez-Gonzalez, Maria; Laura Gutierrez, Maria; Flores-Montero, Juan; Cervero, Carlos; Pizarro-Perea, Marlies; Paz Garrastazul, Maria; Caballero, Gonzalo; Gutierrez, Oliver; Daniel Mendez, Guy; Gonzalez-Silva, Manuel; Laranjeira, Paula; Orfao, Alberto			The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome	PLOS ONE			English	Article							PROGNOSTIC SCORING SYSTEM; DNA-CONTENT; HEMATOPOIETIC-CELLS; GENE-EXPRESSION; RISK-ASSESSMENT; CLASSIFICATION; CYTOGENETICS; APOPTOSIS; SURVIVAL; DENSITY	Myelodysplastic syndromes (MDS) are clonal stem cell disorders which frequently show a hypercellular dysplastic bone marrow (BM) associated with inefficient hematopoiesis and peripheral cytopenias due to increased apoptosis and maturation blockades. Currently, little is known about the role of cell proliferation in compensating for the BM failure syndrome and in determining patient outcome. Here, we analyzed the proliferation index (PI) of different compartments of BM hematopoietic cells in 106 MDS patients compared to both normal/reactive BM (n = 94) and acute myeloid leukemia (AML; n = 30 cases) using multiparameter flow cytometry. Our results show abnormally increased overall BM proliferation profiles in MDS which significantly differ between early/low-risk and advanced/high-risk cases. Early/low-risk patients showed increased proliferation of non-lymphoid CD34(+) precursors, maturing neutrophils and nucleated red blood cells (NRBC), while the PI of these compartments of BM precursors progressively fell below normal values towards AML levels in advanced/high-risk MDS. Decreased proliferation of non-lymphoid CD34(+) and NRBC precursors was significantly associated with adverse disease features, shorter overall survival (OS) and transformation to AML, both in the whole series and when low-and high-risk MDS patients were separately considered, the PI of NRBC emerging as the most powerful independent predictor for OS and progression to AML. In conclusion, assessment of the PI of NRBC, and potentially also of other compartments of BM precursors (e. g.: myeloid CD34(+) HPC), could significantly contribute to a better management of MDS.	[Matarraz, Sergio; Teodosio, Cristina; Fernandez, Carlos; Jara-Acevedo, Maria; Lopez, Antonio; Gonzalez-Gonzalez, Maria; Laura Gutierrez, Maria; Flores-Montero, Juan; Laranjeira, Paula; Orfao, Alberto] Univ Salamanca, Inst Biol Celular & Mol Canc, CSIC USAL, Ctr Invest Canc,IBSAL,Serv Citometria, E-37008 Salamanca, Spain; [Matarraz, Sergio; Teodosio, Cristina; Fernandez, Carlos; Jara-Acevedo, Maria; Lopez, Antonio; Gonzalez-Gonzalez, Maria; Laura Gutierrez, Maria; Flores-Montero, Juan; Laranjeira, Paula; Orfao, Alberto] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain; [Albors, Manuel] Hosp Juan Canalejo, Serv Hematol, La Coruna, Spain; [Cervero, Carlos] Hosp Virgen de la Luz, Serv Hematol, Cuenca, Spain; [Pizarro-Perea, Marlies] Hosp Lucus Augusti, Serv Hematol, Lugo, Spain; [Paz Garrastazul, Maria] Hosp Punta de Europa, Serv Hematol, Algeciras, Spain; [Caballero, Gonzalo] Hosp San Jorge, Serv Hematol, Huesca, Spain; [Gutierrez, Oliver] Hosp Rio Hortega, Serv Hematol, Valladolid, Spain; [Daniel Mendez, Guy] Hosp Jerez de la Frontera, Serv Hematol, Cadiz, Spain; [Gonzalez-Silva, Manuel] Hosp La Linea, Serv Hematol, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; University of Salamanca; Complejo Hospitalario Universitario A Coruna; Hospital Universitario Lucus Augusti-Lugo; Hospital Universidad San Jorge; Hospital del Rio Hortega	Matarraz, S (corresponding author), Univ Salamanca, Inst Biol Celular & Mol Canc, CSIC USAL, Ctr Invest Canc,IBSAL,Serv Citometria, E-37008 Salamanca, Spain.	orfao@usal.es	Gutiérrez, María Laura/AAY-9195-2020; Orfao, Alberto/B-5801-2017; Laranjeira, Paula/B-3806-2014; Gutiérrez, María Laura ML/J-4313-2016; Matarraz, Sergio/AAE-8249-2019; Caballero, Gonzalo/GZG-3828-2022; Mendez, Guy D/AAE-9169-2020; Flores-Montero, Juan/AAA-2312-2020	Gutiérrez, María Laura/0000-0003-2997-6317; Laranjeira, Paula/0000-0002-1136-6118; Gutiérrez, María Laura ML/0000-0003-2997-6317; Flores-Montero, Juan/0000-0002-1119-4387; Fernandez-Gimenez, Carlos/0000-0002-6871-454X; Jara-Acevedo, Maria/0000-0001-7965-7512; , Maria Gonzalez-Gonzalez/0000-0001-8115-1086; MATARRAZ, SERGIO/0000-0003-4634-8005; Teodosio, Cristina/0000-0002-2097-7199	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain [RTICC RD06/0020/0035]; Programa Personal Tecnico de Apoyo a la Investigacion, Ministerio de Ciencia e Innovacion - Universidad de Salamanca, Spain	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; Programa Personal Tecnico de Apoyo a la Investigacion, Ministerio de Ciencia e Innovacion - Universidad de Salamanca, Spain	This work has been partially supported by the following grants: RTICC RD06/0020/0035 - Fondo Europeo de Desarrollo Regional FEDER) - from the Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; M.J.-A. was supported by a grant from the Programa Personal Tecnico de Apoyo a la Investigacion, Ministerio de Ciencia e Innovacion - Universidad de Salamanca, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agool A, 2006, J NUCL MED, V47, P1592; Alexandrakis MG, 2004, J MOL HISTOL, V35, P857, DOI 10.1007/s10735-004-2341-0; ALIMENA G, 1985, CANCER GENET CYTOGEN, V16, P207, DOI 10.1016/0165-4608(85)90047-0; Cazzola M, 2011, HAEMATOL-HEMATOL J, V96, P349, DOI 10.3324/haematol.2010.030023; Cazzola M, 2010, HEMATOL ONCOL CLIN N, V24, P459, DOI 10.1016/j.hoc.2010.02.005; Darzynkiewicz Z, 1998, Hum Cell, V11, P3; Economopoulou C, 2010, ANN HEMATOL, V89, P349, DOI 10.1007/s00277-009-0835-2; FONATSCH C, 1994, LEUKEMIA, V8, P1318; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Gueller S, 2010, EXP HEMATOL, V38, P718, DOI 10.1016/j.exphem.2010.04.018; Head DR, 2011, BONE MARROW RES, DOI 10.1155/2011/950934; Hofmann WK, 2006, LEUKEMIA RES, V30, P1347, DOI 10.1016/j.leukres.2006.03.015; Kantarjian H, 2008, CANCER-AM CANCER SOC, V113, P1351, DOI 10.1002/cncr.23697; Ketterling RP, 2002, LEUKEMIA RES, V26, P235, DOI 10.1016/S0145-2126(01)00117-5; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Malcovati L, 2011, HAEMATOL-HEMATOL J, V96, P1433, DOI 10.3324/haematol.2011.044602; Matarraz S, 2008, LEUKEMIA, V22, P1175, DOI 10.1038/leu.2008.49; Matarraz S, 2011, CYTOM PART B-CLIN CY, V80B, P354, DOI 10.1002/cyto.b.20605; Matarraz S, 2010, CYTOM PART B-CLIN CY, V78B, P154, DOI 10.1002/cyto.b.20513; Mitelman F, 1995, ISCN INT SYSTEM HUMA, P78; MONTECUCCO C, 1983, CYTOMETRY, V4, P238, DOI 10.1002/cyto.990040308; MONTECUCCO C, 1983, CANCER, V52, P1190, DOI 10.1002/1097-0142(19831001)52:7<1190::AID-CNCR2820520711>3.0.CO;2-R; Mossner M, 2010, EXP HEMATOL, V38, P661, DOI 10.1016/j.exphem.2010.03.022; Naqvi K, 2011, J CLIN ONCOL, V29, P2240, DOI 10.1200/JCO.2010.31.3353; Parker JE, 2000, BLOOD, V96, P3932, DOI 10.1182/blood.V96.12.3932.h8003932_3932_3938; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; PETERS SW, 1986, BRIT J HAEMATOL, V62, P239, DOI 10.1111/j.1365-2141.1986.tb02927.x; Primo D, 2006, BRIT J HAEMATOL, V135, P43, DOI 10.1111/j.1365-2141.2006.06265.x; Rajapaksa R, 1996, BLOOD, V88, P4275; Saunthararajah Y, 2012, SEMIN ONCOL, V39, P97, DOI 10.1053/j.seminoncol.2011.11.011; Swerts K, 2007, CLIN CHIM ACTA, V379, P154, DOI 10.1016/j.cca.2006.12.008; Teodosio C, 2010, J ALLERGY CLIN IMMUN, V125, P719, DOI 10.1016/j.jaci.2009.10.020; Teofili L, 1998, EXP HEMATOL, V26, P1133; Valencia A, 2010, LEUKEMIA RES, V35, P479; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Varma N, 2008, INDIAN J PATHOL MICR, V51, P97, DOI 10.4103/0377-4929.40416; Vasikova A, 2010, LEUKEMIA RES, V34, P1566, DOI 10.1016/j.leukres.2010.02.021	38	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44321	10.1371/journal.pone.0044321	http://dx.doi.org/10.1371/journal.pone.0044321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952954	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300080
J	McCracken, GF; Westbrook, JK; Brown, VA; Eldridge, M; Federico, P; Kunz, TH				McCracken, Gary F.; Westbrook, John K.; Brown, Veronica A.; Eldridge, Melanie; Federico, Paula; Kunz, Thomas H.			Bats Track and Exploit Changes in Insect Pest Populations	PLOS ONE			English	Article							FREE-TAILED BATS; TADARIDA-BRASILIENSIS-MEXICANA; DIETARY VARIATION; ARTHROPOD PREY; CORN-EARWORM; DNA; PCR; LEPIDOPTERA; MOLOSSIDAE; EMERGENCE	The role of bats or any generalist predator in suppressing prey populations depends on the predator's ability to track and exploit available prey. Using a qPCR fecal DNA assay, we document significant association between numbers of Brazilian free-tailed bats (Tadarida brasiliensis) consuming corn earworm (CEW) moths (Helicoverpa zea) and seasonal fluctuations in CEW populations. This result is consistent with earlier research linking the bats' diet to patterns of migration, abundance, and crop infestation by important insect pests. Here we confirm opportunistic feeding on one of the world's most destructive insects and support model estimates of the bats' ecosystem services. Regression analysis of CEW consumption versus the moth's abundance at four insect trapping sites further indicates that bats track local abundance of CEW within the regional landscape. Estimates of CEW gene copies in the feces of bats are not associated with seasonal or local patterns of CEW abundance, and results of captive feeding experiments indicate that our qPCR assay does not provide a direct measure of numbers or biomass of prey consumed. Our results support growing evidence for the role of generalist predators, and bats specifically, as agents for biological control and speak to the value of conserving indigenous generalist predators.	[McCracken, Gary F.; Brown, Veronica A.; Eldridge, Melanie; Federico, Paula] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Westbrook, John K.] ARS, Areawide Pest Management Res Unit, USDA, College Stn, TX USA; [Eldridge, Melanie] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Federico, Paula] Capital Univ, Dept Math Comp Sci & Phys, Columbus, OH USA; [Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville; Capital University; Boston University	McCracken, GF (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	gmccrack@utk.edu		McCracken, Gary/0000-0002-2493-8103	NSF [EIA-0326483]; Bat Conservation International; University of Tennessee, Knoxville	NSF(National Science Foundation (NSF)); Bat Conservation International; University of Tennessee, Knoxville	This work was supported by NSF Grant EIA-0326483 (TH Kunz, PI, M Betke, GF McCracken, P Morton, and JK Westbrook, CoPI's); Bat Conservation International; and The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEERWINKLE KR, 1994, ENVIRON ENTOMOL, V23, P676, DOI 10.1093/ee/23.3.676; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Chang Gary C., 1999, P103, DOI 10.1017/CBO9780511542077.009; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Ehler LE, 1998, BIOL CONTROL, V13, P127, DOI 10.1006/bcon.1998.0649; Federico P, 2008, ECOL APPL, V18, P826, DOI 10.1890/07-0556.1; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gould F, 2002, P NATL ACAD SCI USA, V99, P16581, DOI 10.1073/pnas.242382499; Keeley B. W., 1999, 3 INT C WILDL EC TRA; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; KUNZ TH, 1995, OECOLOGIA, V101, P407, DOI 10.1007/BF00329419; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Lee YF, 2005, J MAMMAL, V86, P67, DOI 10.1644/1545-1542(2005)086&lt;0067:DVOBFB&gt;2.0.CO;2; Lee YF, 2002, ECOSCIENCE, V9, P306, DOI 10.1080/11956860.2002.11682717; Lee YF, 2001, ZOOL STUD, V40, P309; LINGREN PD, 1993, J ECON ENTOMOL, V86, P1429, DOI 10.1093/jee/86.5.1429; Liu H, 1992, MOL PHYLOGENET EVOL, V1, P41, DOI 10.1016/1055-7903(92)90034-E; McCracken GF, 2008, INTEGR COMP BIOL, V48, P107, DOI 10.1093/icb/icn033; Puechmaille SJ, 2007, ACTA CHIROPTEROL, V9, P269, DOI 10.3161/1733-5329(2007)9[269:GDFBD]2.0.CO;2; Reichard JD, 2009, J MAMMAL, V90, P1478, DOI 10.1644/08-MAMM-A-266R1.1; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell A.L., 2006, FUNCTIONAL EVOLUTION, P227; Sansone C, 2002, PUBLICATION TEXAS B; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; WESTBROOK JK, 1995, AGR FOREST METEOROL, V73, P67, DOI 10.1016/0168-1923(94)02171-F; Whitaker JO, 1996, J MAMMAL, V77, P716, DOI 10.2307/1382676; Whitaker Jr JO, 2009, ECOLOGICAL BEHAV MET, P569; WOLF WW, 1990, PHILOS T R SOC B, V328, P619, DOI 10.1098/rstb.1990.0132; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	37	111	119	3	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43839	10.1371/journal.pone.0043839	http://dx.doi.org/10.1371/journal.pone.0043839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952782	gold, Green Published			2022-12-27	WOS:000308221300029
J	Walcott, BP; Sheth, SA; Nahed, BV; Coumans, JV				Walcott, Brian P.; Sheth, Sameer A.; Nahed, Brian V.; Coumans, Jean-Valery			Conflict of Interest in Spine Research Reporting	PLOS ONE			English	Article							CLINICAL-TRIALS; FUSION; COMPLICATIONS; PHYSICIANS	Background: Medical studies are more likely to report favorable findings when a conflict of interest is declared. We aim to quantify and determine the effect of author disclosure of conflict of interest on scientific reporting. Methods: Abstracts from an international spine research meeting (North American Spine Society 2010) were selected that specifically evaluated a device, biologic, or proprietary procedure. They were then made anonymous to reviewers. An item of interest was established in each of the abstracts in order to standardize evaluation. Next, three blinded reviewers independently rated the abstracts as favorable, neutral, or unfavorable with regard to the item of interest. Additionally, the blinded reviewers attempted to predict whether a related disclosure was made. The meeting disclosure index was used to tabulate the minimum US dollar value attributable to disclosures. Results: Of the 344 total abstracts, 76 met inclusion criteria. In 79%, a related conflict of interest was reported. The amount of the disclosure was incompletely reported in 30% of cases. Where available, it averaged a cumulative minimum of $219,634 USD per abstract. The results of the abstracts were judged to be favorable, neutral, and unfavorable in 63%, 32% and 5% of abstracts, respectively. There was no correlation between the presence of a related disclosure and the findings of the studies (p = 0.81), although interpretation of this is limited by a small sample size and an overall apparent bias to report favorable studies. Additionally, the blinded reviewers were unable to predict whether a related disclosure was made (p = 0.40). Conclusion: No association existed between the presence of a related disclosure and the results of the studies. While the actual compliance with reporting a potential conflict of interest is unable to be determined, the value amount related to the disclosures made was inadequately reported according to meeting guidelines.	[Walcott, Brian P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Walcott, BP (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA.	walcott.brian@mgh.harvard.edu	Nahed, Brian/E-4239-2014	Nahed, Brian/0000-0001-8537-106X	Council of State Neurological Societies Socioeconomic fellowship	Council of State Neurological Societies Socioeconomic fellowship	Dr. Walcott is supported by the Council of State Neurological Societies Socioeconomic fellowship (2012-2013). http://www.csnsonline.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu MA, 2011, J NEUROL NEUROSUR PS, V82, P948, DOI 10.1136/jnnp.2010.231860; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956; Cowan JA, 2006, NEUROSURGERY, V59, P15, DOI 10.1227/01.NEU.0000219836.54861.CD; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Hopewell S, 2009, COCHRANE DATABASE SY, V1; Ju BL, 2011, SPINE J, V11, P1, DOI 10.1016/j.spinee.2010.08.022; Medicare and Medicaid Services C, 2012, PHYS FEE SCHED; NASS, 2010, 2010 NASS ANN M PROG; Okike K, 2007, J BONE JOINT SURG AM, V89A, P608, DOI 10.2106/JBJS.F.00994; Okike K, 2009, NEW ENGL J MED, V361, P1466, DOI 10.1056/NEJMsa0807160; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shah RV, 2005, SPINE, V30, P1099, DOI 10.1097/01.brs.0000161004.15308.b4; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Society NAS, 2012, DISCL ETH PROF; Steinbrook R, 2008, NEW ENGL J MED, V359, P559, DOI 10.1056/NEJMp0805309; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Walcott BP, 2011, SURGICAL NEUROLOGY I, V2; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44327	10.1371/journal.pone.0044327	http://dx.doi.org/10.1371/journal.pone.0044327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952956	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300082
J	Yan, C; Bi, Y; Yin, D; Zhao, ZY				Yan, Cheung; Bi, Yu; Yin, Da; Zhao, Zhongying			A Method for Rapid and Simultaneous Mapping of Genetic Loci and Introgression Sizes in Nematode Species	PLOS ONE			English	Article							CAENORHABDITIS-BRIGGSAE; REPRODUCTIVE ISOLATION; REGULATORY ELEMENTS; ELEGANS; DROSOPHILA; EVOLUTION; CELL; TRANSCRIPTION; SPECIATION; PATTERNS	Caenorhabditis briggsae is emerging as an attractive model organism not only in studying comparative biology against C. elegans, but also in developing novel experimentation avenues. In particular, recent identification of a new Caenorhabditis species, C. sp.9 with which it can mate and produce viable progeny provides an opportunity for studying the genetics of hybrid incompatibilities (HI) between the two. Mapping of a specific HI locus demands repeated backcrossing to get hold of the specific genomic region underlying an observed phenotype. To facilitate mapping of HI loci between C. briggsae and C. sp.9, an efficient mapping method and a genetic map ideally consisting of dominant markers are required for systematic introgression of genomic fragments between the two species. We developed a fast and cost-effective method for high throughput mapping of dominant loci with resolution up to 1 million bps in C. briggsae. The method takes advantage of the introgression between C. briggsae and C. sp.9 followed by PCR genotyping using C. briggsae specific primers. Importantly, the mapping results can not only serve as an effective way for estimating the chromosomal position of a genetic locus in C. briggsae, but also provides size information for the introgression fragment in an otherwise C. sp.9 background. In addition, it also helps generate introgression line as a side-product that is invaluable for the subsequent mapping of HI loci. The method will greatly facilitate the construction of a genetic map consisting of dominant markers and pave the way for systematic isolation of HI loci between C. briggsae and C. sp.9 which has so far not been attempted between nematode species. The method is designed for mapping of a dominant allele, but can be easily adapted for mapping of any other type of alleles in any other species if introgression between a sister species pair is feasible.	[Yan, Cheung; Bi, Yu; Yin, Da; Zhao, Zhongying] Hong Kong Baptist Univ, Dept Biol, Fac Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University	Yan, C (corresponding author), Hong Kong Baptist Univ, Dept Biol, Fac Sci, Hong Kong, Hong Kong, Peoples R China.	zyzhao@hkbu.edu.hk	Zhao, Zhongying/C-3261-2015; Yin, Da/AAM-1339-2021; Zhao, Zhongying/ABF-9458-2021	Yin, Da/0000-0002-5336-2772; Zhao, Zhongying/0000-0003-2743-9008; Yu, Bi/0000-0003-2154-400X	Hong Kong Baptist University Faculty Research Grant Category II [FRG2/11-12/058, FRG2/10-11/065]; Hong Kong Baptist University Faculty Start-up Fund	Hong Kong Baptist University Faculty Research Grant Category II; Hong Kong Baptist University Faculty Start-up Fund	The work was supported by Hong Kong Baptist University Faculty Research Grant Category II (FRG2/11-12/058, FRG2/10-11/065), Hong Kong Baptist University Faculty Start-up Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2003, CURR BIOL, V13, P37, DOI 10.1016/S0960-9822(02)01399-4; Baird SE, 2000, EVOL DEV, V2, P9, DOI 10.1046/j.1525-142x.2000.00031.x; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Cutter AD, 2006, GENETICS, V173, P2021, DOI 10.1534/genetics.106.058651; Cutter AD, 2010, MOL ECOL, V19, P798, DOI 10.1111/j.1365-294X.2009.04491.x; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Etges WJ, 2007, EVOLUTION, V61, P1106, DOI 10.1111/j.1558-5646.2007.00104.x; GuhaThakurta D, 2004, GENOME RES, V14, P2457, DOI 10.1101/gr.2961104; Hillier LW, 2007, PLOS BIOL, V5, P1603, DOI 10.1371/journal.pbio.0050167; Hoyos E, 2011, CURR BIOL, V21, P527, DOI 10.1016/j.cub.2011.02.040; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kao KC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001038; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Koboldt DC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-236; Kozlowska JL, 2012, EVOLUTION, V66, P1180, DOI 10.1111/j.1558-5646.2011.01514.x; Maheshwari S, 2010, ANN REV GENET; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; Matute DR, 2010, SCIENCE, V329, P1518, DOI 10.1126/science.1193440; Penigault JB, 2011, DEV BIOL, V357, P419, DOI 10.1016/j.ydbio.2011.05.675; Praitis V, 2001, GENETICS, V157, P1217; Ross JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002174; Rozen S, 2000, Methods Mol Biol, V132, P365; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Uyar B, 2012, GENOME RES; Vergara IA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-516; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023; Woodruff GC, 2010, GENETICS, V186, P997, DOI 10.1534/genetics.110.120550; Zhao ZY, 2008, DEV BIOL, V314, P93, DOI 10.1016/j.ydbio.2007.11.015; Zhao ZY, 2010, GENETICS, V184, P853, DOI 10.1534/genetics.109.110270; Zhao ZY, 2005, J BIOL CHEM, V280, P38787, DOI 10.1074/jbc.M505701200; Zhao ZY, 2004, BIOCHEM BIOPH RES CO, V323, P104, DOI 10.1016/j.bbrc.2004.08.068	35	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43770	10.1371/journal.pone.0043770	http://dx.doi.org/10.1371/journal.pone.0043770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952761	gold, Green Published, Green Submitted			2022-12-27	WOS:000308221300027
J	Song, JY; Shi, LC; Li, DZ; Sun, YZ; Niu, YY; Chen, ZD; Luo, HM; Pang, XH; Sun, ZY; Liu, C; Lv, AP; Deng, YP; Larson-Rabin, Z; Wilkinson, M; Chen, SL				Song, Jingyuan; Shi, Linchun; Li, Dezhu; Sun, Yongzhen; Niu, Yunyun; Chen, Zhiduan; Luo, Hongmei; Pang, Xiaohui; Sun, Zhiying; Liu, Chang; Lv, Aiping; Deng, Youping; Larson-Rabin, Zachary; Wilkinson, Mike; Chen, Shilin			Extensive Pyrosequencing Reveals Frequent Intra-Genomic Variations of Internal Transcribed Spacer Regions of Nuclear Ribosomal DNA	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SPECIES IDENTIFICATION; DRAFT SEQUENCE; LIFE-HISTORY; RNA GENES; ITS2; EVOLUTIONARY; PHYLOGENY; BARCODE; DIVERSITY	Background: Internal transcribed spacer of nuclear ribosomal DNA (nrDNA) is already one of the most popular phylogenetic and DNA barcoding markers. However, the existence of its multiple copies has complicated such usage and a detailed characterization of intra-genomic variations is critical to address such concerns. Methodology/Principal Findings: In this study, we used sequence-tagged pyrosequencing and genome-wide analyses to characterize intra-genomic variations of internal transcribed spacer 2 (ITS2) regions from 178 plant species. We discovered that mutation of ITS2 is frequent, with a mean of 35 variants per species. And on average, three of the most abundant variants make up 91% of all ITS2 copies. Moreover, we found different congeneric species share identical variants in 13 genera. Interestingly, different species across different genera also share identical variants. In particular, one minor variant of ITS2 in Eleutherococcus giraldii was found identical to the ITS2 major variant of Panax ginseng, both from Araliaceae family. In addition, DNA barcoding gap analysis showed that the intra-genomic distances were markedly smaller than those of the intra-specific or inter-specific variants. When each of 5543 variants were examined for its species discrimination efficiency, a 97% success rate was obtained at the species level. Conclusions: Identification of identical ITS2 variants across intra-generic or inter-generic species revealed complex species evolutionary history, possibly, horizontal gene transfer and ancestral hybridization. Although intra-genomic multiple variants are frequently found within each genome, the usage of the major variants alone is sufficient for phylogeny construction and species determination in most cases. Furthermore, the inclusion of minor variants further improves the resolution of species identification.	[Song, Jingyuan; Shi, Linchun; Sun, Yongzhen; Niu, Yunyun; Luo, Hongmei; Pang, Xiaohui; Sun, Zhiying; Liu, Chang; Chen, Shilin] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Li, Dezhu; Larson-Rabin, Zachary] Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Chen, Zhiduan] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Lv, Aiping] China Acad Chinese Med Sci, Beijing, Peoples R China; [Deng, Youping] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Wilkinson, Mike] Univ Adelaide, Adelaide, SA, Australia	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; China Academy of Chinese Medical Sciences; Rush University; University of Adelaide	Song, JY (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China.	cliu6688@yahoo.com; slchen@implad.ac.cn	Liu, Chang/A-1148-2014; Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Wilkinson, Michael/0000-0002-9881-6993	National Natural Science Foundation of China [30970307, 81130069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the National Natural Science Foundation of China (No. 30970307, No. 81130069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Budd AF, 2010, SCIENCE, V328, P1558, DOI 10.1126/science.1188947; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2009, SCI SIGNAL; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; De Schrijver JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-269; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gough NR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3128eg5; Hasselmann M, 2010, P NATL ACAD SCI USA, V107, P13378, DOI 10.1073/pnas.1005617107; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Hribova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017863; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; Wen J, 2008, J SYST EVOL, V46, P322, DOI 10.3724/SP.J.1002.2008.08050; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; KELLOGG EA, 1995, GENETICS, V140, P325; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lee C, 2004, MOL PHYLOGENET EVOL, V31, P894, DOI 10.1016/j.ympev.2003.10.009; Lee S, 2001, AM J BOT, V88, P150, DOI 10.2307/2657135; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li DZ, 2011, J SYST EVOL, V49, P165, DOI 10.1111/j.1759-6831.2011.00137.x; Li Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-268; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Michaud M, 2011, PLANT J, V66, P80, DOI 10.1111/j.1365-313X.2011.04490.x; Mitchell A, 2005, SYST BOT, V30, P872, DOI 10.1600/036364405775097761; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Nei M, 1998, SCIENCE, V282, P1428, DOI 10.1126/science.282.5393.1428; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Pang X, 2012, PLANT BIOLOGY, V14, P839, DOI 10.1111/j.1438-8677.2011.00554.x; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Razafimandimbison SG, 2004, SYST BIOL, V53, P177, DOI 10.1080/10635150490423278; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Ruhl MW, 2010, MOL PHYLOGENET EVOL, V54, P664, DOI 10.1016/j.ympev.2009.07.036; Sanderson MJ, 2008, SCIENCE, V321, P121, DOI 10.1126/science.1154449; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz J, 2009, SCI SIGNAL; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thomas C, 2009, SCIENCE, V325, P526, DOI 10.1126/science.325_526; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiemers M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-300; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Yang SH, 2010, P NATL ACAD SCI USA, V107, P10395, DOI 10.1073/pnas.0914506107; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhu S, 2003, PLANTA MED, V69, P647, DOI 10.1055/s-2003-41117	79	80	119	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43971	10.1371/journal.pone.0043971	http://dx.doi.org/10.1371/journal.pone.0043971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952830	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500032
J	Civiero, L; Vancraenenbroeck, R; Belluzzi, E; Beilina, A; Lobbestael, E; Reyniers, L; Gao, FY; Micetic, I; De Maeyer, M; Bubacco, L; Baekelandt, V; Cookson, MR; Greggio, E; Taymans, JM				Civiero, Laura; Vancraenenbroeck, Renee; Belluzzi, Elisa; Beilina, Alexandra; Lobbestael, Evy; Reyniers, Lauran; Gao, Fangye; Micetic, Ivan; De Maeyer, Marc; Bubacco, Luigi; Baekelandt, Veerle; Cookson, Mark R.; Greggio, Elisa; Taymans, Jean-Marc			Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; GTP-BINDING; ROC DOMAIN; DOMINANT PARKINSONISM; ALPHA-SYNUCLEIN; LRRK2; GENE; LEUCINE-RICH-REPEAT-KINASE-2; PROTEINS	Leucine-rich repeat kinase 1 and 2 (LRRK1 and LRRK2) are large multidomain proteins containing kinase, GTPase and multiple protein-protein interaction domains, but only mutations in LRRK2 are linked to familial Parkinson's disease (PD). Independent studies suggest that LRRK2 exists in the cell as a complex compatible with the size of a dimer. However, whether this complex is truly a homodimer or a heterologous complex formed by monomeric LRRK2 with other proteins has not been definitively proven due to the limitations in obtaining highly pure proteins suitable for structural characterization. Here, we used stable expression of LRRK1 and LRRK2 in HEK293T cell lines to produce recombinant LRRK1 and LRRK2 proteins of greater than 90% purity. Both purified LRRKs are folded, with a predominantly alpha-helical secondary structure and are capable of binding GTP with similar affinity. Furthermore, recombinant LRRK2 exhibits robust autophosphorylation activity, phosphorylation of model peptides in vitro and ATP binding. In contrast, LRRK1 does not display significant autophosphorylation activity and fails to phosphorylate LRRK2 model substrates, although it does bind ATP. Using these biochemically validated proteins, we show that LRRK1 and LRRK2 are capable of forming homodimers as shown by single-particle transmission electron microscopy and immunogold labeling. These LRRK dimers display an elongated conformation with a mean particle size of 145 angstrom and 175 angstrom respectively, which is disrupted by addition of 6M guanidinium chloride. Immunogold staining revealed double-labeled particles also in the pathological LRRK2 mutant G2019S and artificial mutants disrupting GTPase and kinase activities, suggesting that point mutations do not hinder the dimeric conformation. Overall, our findings indicate for the first time that purified and active LRRK1 and LRRK2 can form dimers in their full-length conformation.	[Civiero, Laura; Belluzzi, Elisa; Micetic, Ivan; Bubacco, Luigi; Greggio, Elisa] Univ Padua, Dept Biol, Padua, Italy; [Vancraenenbroeck, Renee; Lobbestael, Evy; Reyniers, Lauran; Gao, Fangye; Baekelandt, Veerle; Taymans, Jean-Marc] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Louvain, Belgium; [Vancraenenbroeck, Renee; De Maeyer, Marc] Katholieke Univ Leuven, Lab Biomol Modelling, B-3001 Heverlee, Belgium; [Beilina, Alexandra; Cookson, Mark R.] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, Bethesda, MD 20892 USA	University of Padua; KU Leuven; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Civiero, L (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	elisa.greggio@unipd.it; jean-marc.taymans@med.kuleuven.be	Cookson, Mark/AAW-2516-2021; Civiero, Laura/GXG-2968-2022; Baekelandt, Veerle/ABB-9736-2020; Mičetić, Ivan/A-7146-2015; Taymans, Jean-Marc/M-9175-2018; Greggio, Elisa/H-6119-2013; Civiero, Laura/K-7665-2016; Lobbestael, Evy/H-7537-2018; Belluzzi, Elisa/K-4622-2016; Bubacco, Luigi/B-5602-2012	Cookson, Mark/0000-0002-1058-3831; Civiero, Laura/0000-0002-5334-155X; Baekelandt, Veerle/0000-0001-8966-2921; Mičetić, Ivan/0000-0003-1691-8425; Taymans, Jean-Marc/0000-0001-5503-5524; Greggio, Elisa/0000-0002-8172-3598; Lobbestael, Evy/0000-0002-6417-4670; Belluzzi, Elisa/0000-0003-1129-2574; Bubacco, Luigi/0000-0001-7927-9208; Vancraenenbroeck, Renee/0000-0003-2685-2749	Michael J Fox Foundation; Rientro dei Cervelli Program (lncentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero) from the Italian Ministry of Education, University and Research; PRIN2008 [55YP79]; Intramural Research Program of the National Institutes of Health, National Institute on Aging; Research Foundation - Flanders Fonds Wetenschappelijk Onderzoek (FWO) [G.0666.09]; project Neuro-TARGET [IWT SBO/80020]; KULeuven [OT/08/052A, IOF-KP/07/001]	Michael J Fox Foundation; Rientro dei Cervelli Program (lncentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero) from the Italian Ministry of Education, University and Research; PRIN2008; Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Research Foundation - Flanders Fonds Wetenschappelijk Onderzoek (FWO)(FWO); project Neuro-TARGET; KULeuven(KU Leuven)	Funding provided by the Michael J Fox Foundation; the Rientro dei Cervelli Program (lncentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero) from the Italian Ministry of Education, University and Research (EG); PRIN2008 (55YP79) (LB); the Intramural Research Program of the National Institutes of Health, National Institute on Aging; the Research Foundation - Flanders Fonds Wetenschappelijk Onderzoek (FWO project G.0666.09, PhD fellowships to RVC, EL and senior researcher fellowship to J-MT); the IWT SBO/80020 project Neuro-TARGET; the KULeuven (OT/08/052A and IOF-KP/07/001); and the Fund Druwe-Eerdekens managed by the King Baudouin Foundation (J-MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Baekelandt V, 2002, HUM GENE THER, V13, P841, DOI 10.1089/10430340252899019; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Carlessi R, 2011, EMBO REP, V12, P917, DOI 10.1038/embor.2011.126; Covy JP, 2010, J NEUROCHEM, V115, P36, DOI 10.1111/j.1471-4159.2010.06894.x; Daniels V, 2011, J NEUROCHEM, V116, P304, DOI 10.1111/j.1471-4159.2010.07105.x; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Gillardon F, 2009, NEUROSCIENCE, V163, P533, DOI 10.1016/j.neuroscience.2009.06.051; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Gotthardt K, 2008, EMBO J, V27, P2352, DOI 10.1038/emboj.2008.167; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Hanafusa H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1161; Haugarvoll K, 2007, NEUROSCI LETT, V416, P299, DOI 10.1016/j.neulet.2007.02.020; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Ito G, 2012, BIOCHEM J, V441, P987, DOI 10.1042/BJ20111215; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Klein CL, 2009, J NEUROCHEM, V111, P703, DOI 10.1111/j.1471-4159.2009.06358.x; Korr D, 2006, CELL SIGNAL, V18, P910, DOI 10.1016/j.cellsig.2005.08.015; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Lewis PA, 2009, BIOL CELL, V101, P183, DOI 10.1042/BC20080053; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Liu M, 2011, BIOCHEMISTRY-US, V50, P9399, DOI 10.1021/bi201173d; Lu B, 2010, BBA-PROTEINS PROTEOM, V1804, P1780, DOI 10.1016/j.bbapap.2010.05.004; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; Marin I, 2008, J MOL EVOL, V67, P41, DOI 10.1007/s00239-008-9122-4; Marin I, 2006, MOL BIOL EVOL, V23, P2423, DOI 10.1093/molbev/msl114; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Rudenko IN, 2012, BIOCH J; Sen S, 2009, ANTIOXID REDOX SIGN, V11, P2167, DOI [10.1089/ars.2009.2430, 10.1089/ARS.2009.2430]; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Taylor JP, 2007, NEUROGENETICS, V8, P95, DOI 10.1007/s10048-006-0075-8; Taymans JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023207; Taymans JM, 2010, BIOESSAYS, V32, P227, DOI 10.1002/bies.200900163; Titz B, 2010, ONCOGENE, V29, P5895, DOI 10.1038/onc.2010.331; Vancraenenbroeck R, 2011, CNS NEUROL DISORD-DR, V10, P724, DOI 10.2174/187152711797247858; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zhang JW, 2012, BIOORG MED CHEM LETT, V22, P1864, DOI 10.1016/j.bmcl.2012.01.084; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	63	76	79	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43472	10.1371/journal.pone.0043472	http://dx.doi.org/10.1371/journal.pone.0043472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952686	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000037
J	Shaw, LH; Lin, LC; Tsai, TH				Shaw, Lee-Hsin; Lin, Lie-Chwen; Tsai, Tung-Hu			HPLC-MS/MS Analysis of a Traditional Chinese Medical Formulation of Bu-Yang-Huan-Wu-Tang and Its Pharmacokinetics after Oral Administration to Rats	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; RADIX-SCUTELLARIAE EXTRACT; GASTRIC PH; DECOCTION; METABOLISM; CONSTITUENTS; ASTRAGALI; PLASMA; IDENTIFICATION; LIGUSTILIDE	Bu-yang-huan-wu-tang (BYHWT) is one of the most popular formulated traditional Chinese medicine prescriptions, and is widely for prevention of ischemic cardio-cerebral vascular diseases and stroke-induced disability. A specific high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) has been developed and validated for simultaneous quantification of the nine main bioactive components, i.e., astragaloside I, astragaloside II, astragaloside IV, formononetin, ononin, calycosin, calycosin-7-O-beta-d-glucoside, ligustilide and paeoniflorin in rat plasma after oral administration of BYHWT extract. This method was applied to investigate the pharmacokinetics in conscious and freely moving rats. No significant matrix effects were observed. The overall analytical procedure was rapid and reproducible, which makes it suitable for quantitative analysis of a large number of samples. Among them, three astragalosides and four isoflavones in A. membranaceus, ligustilide in Radix Angelicae Sinensis and Rhizoma Ligustici Chuanxiong and paeoniflorin in Radix Paeoniae Rubra were identified. This developed method was then successfully applied to pharmacokinetic studies of the nine bioactive constituents after oral administration of BYHWT extracts in rats. The pharmacokinetic data demonstrated that astragaloside I, astragaloside II, astragaloside IV and ligustilide presented the phenomenon of double peaks. The other herbal ingredients of formononetin, ononin, calycosin, calycosin-7-O-beta-d-glucoside and paeoniflorin appeared together in a single and plateau absorption phase. These phenomenona suggest that these components may have multiple absorption sites, regulation of enterohepatic circulation or the gastric emptying rate, or there is ingredient-ingredient interaction. These pharmacokinetic results provide a constructive contribution to better understand the absorption mechanism of BYHWT and to support additional clinical evaluation.	[Shaw, Lee-Hsin; Lin, Lie-Chwen; Tsai, Tung-Hu] Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan; [Lin, Lie-Chwen] Natl Res Inst Chinese Med, Taipei, Taiwan; [Tsai, Tung-Hu] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan; [Tsai, Tung-Hu] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine; China Medical University Taiwan; Taipei City Hospital	Shaw, LH (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan.	thtsai@ym.edu.tw	Tsai, Tung-Hu/AAG-4558-2021	Tsai, Tung-Hu/0000-0002-9007-2547	National Science Council, Taiwan [NSC99-2113-M-010-001-MY3, NSC99-2628-B-010-008-MY3]; Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan [CCMP99 -RD-024]; Taipei City Hospital, Taipei, Taiwan [10001-62-007];  [TCH 96001-62-014]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan; Taipei City Hospital, Taipei, Taiwan; 	Funding for this study was provided in part by research grants from the National Science Council (NSC99-2113-M-010-001-MY3, NSC99-2628-B-010-008-MY3) Taiwan; Committee on Chinese Medicine and Pharmacy, Department of Health (CCMP99 -RD-024) Taiwan and TCH 96001-62-014; 10001-62-007 from Taipei City Hospital, Taipei, Taiwan.	Chen YJ, 2008, INT J PHARMACEUT, V350, P230, DOI 10.1016/j.ijpharm.2007.08.052; Hsieh YJ, 2006, J CHROMATOGR B, V844, P1, DOI 10.1016/j.jchromb.2006.06.024; Huang Y, 2007, BIOPHARM DRUG DISPOS, V28, P361, DOI 10.1002/bdd.556; Ji Bo, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P30; Li P, 2007, ANAL BIOANAL CHEM, V389, P2259, DOI 10.1007/s00216-007-1612-5; Lin LC, 2008, J PHARMACEUT BIOMED, V48, P909, DOI 10.1016/j.jpba.2008.07.013; Liu EH, 2010, BIOMED CHROMATOGR, V24, P125, DOI 10.1002/bmc.1269; Liu EH, 2009, BIOMED CHROMATOGR, V23, P828, DOI 10.1002/bmc.1193; Lu Q, 2006, EUR J PHARMACOL, V542, P136, DOI 10.1016/j.ejphar.2006.04.023; Lu T, 2007, J ETHNOPHARMACOL, V110, P412, DOI 10.1016/j.jep.2006.09.036; Ma XF, 2004, J CHROMATOGR A, V1023, P311, DOI 10.1016/j.chroma.2003.10.014; Mostafavi SA, 2003, INT J PHARMACEUT, V255, P81, DOI 10.1016/S0378-5173(03)00037-1; MUMMANENI V, 1995, PHARM RES-DORDR, V12, P780, DOI 10.1023/A:1016284214708; Qi LW, 2008, J SEP SCI, V31, P97, DOI 10.1002/jssc.200700286; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Tong L, 2010, BIOMED CHROMATOGR, V24, P1324, DOI 10.1002/bmc.1443; Tsai PL, 2002, ANAL LETT, V35, P2459, DOI 10.1081/AL-120016537; Tsai TH, 2005, PLANTA MED, V71, P640, DOI 10.1055/s-2005-871270; Wang D, 2006, J SEP SCI, V29, P2012, DOI 10.1002/jssc.200500486; Wang HW, 2011, J ETHNOPHARMACOL, V138, P22, DOI 10.1016/j.jep.2011.06.033; Wang WR, 2011, J ETHNOPHARMACOL, V137, P214, DOI 10.1016/j.jep.2011.05.008; Wen XD, 2009, J PHARMACEUT BIOMED, V50, P100, DOI 10.1016/j.jpba.2009.03.038; Wu YT, 2011, J TRADITION COMPLEME, V2, P30; Wu YT, 2010, J AGR FOOD CHEM, V58, P108, DOI 10.1021/jf902872j; Xiao HB, 2004, J CHROMATOGR A, V1032, P117, DOI 10.1016/j.chroma.2003.09.032; Yan R, 2008, DRUG METAB DISPOS, V36, P400, DOI 10.1124/dmd.107.017707; Yesilada E, 2005, J ETHNOPHARMACOL, V96, P71, DOI 10.1016/j.jep.2004.08.036; Yin OQP, 2003, CLIN PHARMACOKINET, V42, P179, DOI 10.2165/00003088-200342020-00005; Zhang Dongqing, 2011, Zhongguo Zhong Yao Za Zhi, V36, P3502; Zhang H, 2010, J ETHNOPHARMACOL, V130, P98, DOI 10.1016/j.jep.2010.04.017; Zhang JY, 2011, BIOMED CHROMATOGR, V25, P450, DOI 10.1002/bmc.1466; Zhao LD, 2012, J ETHNOPHARMACOL, V140, P339, DOI 10.1016/j.jep.2012.01.026; Zhou SF, 2004, LIFE SCI, V74, P935, DOI 10.1016/j.lfs.2003.09.035; Zhu ZY, 2010, J CHROMATOGR B, V878, P2184, DOI 10.1016/j.jchromb.2010.06.021; Zu YG, 2009, J SEP SCI, V32, P517, DOI 10.1002/jssc.200800499	35	66	74	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43848	10.1371/journal.pone.0043848	http://dx.doi.org/10.1371/journal.pone.0043848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952787	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000055
J	Sulistyoningrum, DC; Green, TJ; Lear, SA; Devlin, AM				Sulistyoningrum, Dian C.; Green, Timothy J.; Lear, Scott A.; Devlin, Angela M.			Ethnic-Specific Differences in Vitamin D Status Is Associated with Adiposity	PLOS ONE			English	Article							SERUM 25(OH)D CONCENTRATIONS; 1,25-DIHYDROXYVITAMIN D-3; RISK-FACTORS; HEALTH; TISSUE; BONE; METABOLISM; CALCIUM; DISEASE	Background: Low circulating 25 hydroxyvitamin D [25(OH) D] concentrations are common in obesity (BMI >= 30 kg/m(2)) and a negative relationship with body fat distribution has recently been reported. Ethnic-specific differences in body fat distribution have been described with South Asians are reported to have greater visceral adipose tissue (VAT), which could influence circulating 25(OH) D concentrations. The objective of this study is to investigate the relationship between plasma 25(OH) D, adiposity, and body fat distribution in Europeans and South Asians. Methods/Principal Findings: 187 Europeans and 192 South Asians were assessed for demographics, anthropometrics, and plasma 25(OH) D concentrations. Subcutaneous adipose tissue (SAT) and VAT were quantified by CT scan, and percent body fat by DEXA. Data were assessed by general linear models. South Asians had lower (P<0.001) plasma 25(OH) D concentrations and higher VAT (P = 0.04) than Europeans. Plasma 25(OH) D concentrations were negatively (P<0.05) associated with BMI, waist circumference, percent body fat, total adipose tissue, VAT, and SAT in unadjusted models and negatively (P<0.05) associated with VAT, SAT, and percent body fat after adjusting for BMI, ethnicity, age, and season of blood collection in males and females. When percent body fat, VAT, and SAT were included in the same model, only VAT remained negatively (P<0.05) associated with plasma 25(OH) D concentrations. Ethnicity remained significant in all models (P<0.001). Conclusion: Compared to other adipose tissue compartments, VAT may have a distinct role in determining plasma 25(OH) D concentrations, which may account for the lower levels in South Asians.	[Sulistyoningrum, Dian C.; Devlin, Angela M.] Univ British Columbia, Dept Pathol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Sulistyoningrum, Dian C.; Devlin, Angela M.] Univ British Columbia, Child & Family Res Inst, Lab Med, Vancouver, BC V5Z 1M9, Canada; [Green, Timothy J.] Univ British Columbia, Child & Family Res Inst, Dept Food Nutr & Hlth, Vancouver, BC V5Z 1M9, Canada; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Lear, Scott A.] Providence Hlth Care, Div Cardiol, Vancouver, BC, Canada; [Devlin, Angela M.] Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; Simon Fraser University; Child & Family Research Institute; University of British Columbia	Sulistyoningrum, DC (corresponding author), Univ British Columbia, Dept Pathol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada.	adevlin@cfri.ubc.ca	Green, Tim/AAA-8601-2019	Green, Tim/0000-0002-0667-4300; Devlin, Angela/0000-0002-1390-6587	Canadian Institutes of Health Research, Institute of Circulatory and Respiratory Health; Child and Family Research Institute; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research, Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by a grant from the Canadian Institutes of Health Research, Institute of Circulatory and Respiratory Health to AM Devlin. DC Sulistyoningrum was supported by a graduate studentship from the Child and Family Research Institute. SA Lear is a Pfizer/Heart and Stroke Foundation of Canada Chair in Cardiovascular Disease Prevention Research and a Canadian Institutes of Health Research New Investigator. AM Devlin was supported by a New Investigator award from the Heart and Stroke Foundation of Canada and an Investigatorship from the Child and Family Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awumey EMK, 1998, J CLIN ENDOCR METAB, V83, P169, DOI 10.1210/jc.83.1.169; Caron-Jobin M, 2011, OBESITY, V19, P1335, DOI 10.1038/oby.2011.90; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Delvin EE, 2010, J NUTR, V140, P987, DOI 10.3945/jn.109.112250; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Farrar MD, 2011, AM J CLIN NUTR BETHE, P1224; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Freedman BI, 2010, J CLIN ENDOCR METAB, V95, P1076, DOI 10.1210/jc.2009-1797; Gozdzik A, 2011, J STEROID BIOCHEM, V127, P405, DOI 10.1016/j.jsbmb.2011.05.009; Gutin B, 2007, OBESITY, V15, P1029, DOI 10.1038/oby.2007.602; Hamson C, 2003, POSTGRAD MED J, V79, P279, DOI 10.1136/pmj.79.931.279; Heaney RP, 2011, J CLIN ENDOCR METAB, V96, pE447, DOI 10.1210/jc.2010-2230; IOM, 2011, DIET REF INT CALC VI; KVIST H, 1986, INT J OBESITY, V10, P53; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lear SA, 2007, STROKE, V38, P2422, DOI 10.1161/STROKEAHA.107.484113; Lee J, 2001, INT J EPIDEMIOL, V30, P983, DOI 10.1093/ije/30.5.983; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Liu Richard, 2010, Open Med, V4, pe143; Mason RS, 2011, CLIMACTERIC, V14, P197, DOI 10.3109/13697137.2010.514366; MATSUOKA LY, 1987, J CLIN ENDOCR METAB, V64, P1165, DOI 10.1210/jcem-64-6-1165; MATSUOKA LY, 1992, J CLIN ENDOCR METAB, V75, P1099, DOI 10.1210/jc.75.4.1099; McGill AT, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-4; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Raiten DJ, 2004, AM J CLIN NUTR, V80, p1673S, DOI 10.1093/ajcn/80.6.1673S; Rosenblum JL, 2012, AM J CLIN NUTR, V95, P101, DOI 10.3945/ajcn.111.019489; Roy DK, 2007, BONE, V40, P200, DOI 10.1016/j.bone.2006.07.004; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Young KA, 2009, J CLIN ENDOCR METAB, V94, P3306, DOI 10.1210/jc.2009-0079; Zehnder D, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133621	34	45	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43159	10.1371/journal.pone.0043159	http://dx.doi.org/10.1371/journal.pone.0043159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952641	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000019
J	Kulkarni, S; Augoff, K; Rivera, L; McCue, B; Khoury, T; Groman, A; Zhang, L; Tian, LL; Sossey-Alaoui, K				Kulkarni, Swati; Augoff, Katarzyna; Rivera, Louis; McCue, Brian; Khoury, Thaer; Groman, Adrienne; Zhang, Li; Tian, Lili; Sossey-Alaoui, Khalid			Increased Expression Levels of WAVE3 Are Associated with the Progression and Metastasis of Triple Negative Breast Cancer	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; PERIPHERAL-BLOOD; LAMELLIPODIA FORMATION; PROGNOSTIC-FACTORS; GENE; MICRORNA; INVASION; PATTERNS; THERAPY	Background: Breast Cancer (BC) is a heterogeneous disease comprised of at least five genetically distinct subtypes, which together form the second leading cause of cancer death in women in the United States. Within BC subtypes, those classified as Triple Negative BCs (TNBCs) exhibit dismal survival rates due to their propensity to develop distant metastases. We have identified the WAVE3 protein, which is a critical regulator of actin cytoskeleton dynamics that are required for the motility and invasion of cancer cells through its activation of the Arp2/3 complex, as a key regulator of the different steps of the invasion-metastasis cascade in BC, especially in the more aggressive TNBCs. Our published studies have also shown that elevated expression levels of WAVE3 in the TNBC cell lines directly contribute to their increased invasion and metastasis potentials both in vitro and in vivo in murine models of BC metastasis. Methodology/Principal Findings: Herein, we utilized both immunohistochemistry (IHC) of primary human BC tumors as well as quantitative real-time RT-PCR of WAVE3 in the peripheral blood of BC patients to clearly establish that WAVE3 is a predictive marker of overall BC patients' survival. High levels of WAVE3 were predictive for reduced distant recurrence-free survival as well as for decreased disease-specific mortality. Our analysis of WAVE3 expression levels in the peripheral blood of BC patients showed that WAVE3 is highly expressed in the blood of patients who developed metastatic breast cancer compared to those who did not. WAVE3 expression was also highly upregulated in the blood of BC patients with the more aggressive TNBC subtype. Conclusions: Together, these findings establish WAVE3 as a novel marker for increased risk of breast-cancer-specific mortality and for the metastatic potential of the TNBCs, and also identify WAVE3 as an attractive therapeutic target for the treatment of metastatic BC.	[Kulkarni, Swati] Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA; [Augoff, Katarzyna; McCue, Brian; Sossey-Alaoui, Khalid] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Rivera, Louis] USN, Dept Surg, San Diego Med Ctr, San Diego, CA 92152 USA; [Khoury, Thaer] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Groman, Adrienne] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Zhang, Li] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Tian, Lili] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA	University of Chicago; University of Chicago Medical Center; Cleveland Clinic Foundation; United States Department of Defense; United States Navy; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Cleveland Clinic Foundation; Roswell Park Cancer Institute	Kulkarni, S (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA.	skulkarni@surgery.bsd.uchicago.edu; sosseyk@ccf.org		Augoff, Katarzyna/0000-0002-6133-3621	Cleveland Clinic Foundation, U.S. Department of Defense [W81XWH-08-1-0236]; National Institutes of Health [P01HL073311, P50HL077107]; Case Comprehensive Cancer Center [P30 CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107, P01HL073311] Funding Source: NIH RePORTER	Cleveland Clinic Foundation, U.S. Department of Defense; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Cleveland Clinic Foundation, U.S. Department of Defense grant number W81XWH-08-1-0236 to KSA, by National Institutes of Health grants P01HL073311 and P50HL077107, and by pilot funding from the Case Comprehensive Cancer Center (P30 CA043703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Anders C, 2008, ONCOLOGY-NY, V22, P1233; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Apostolaki S, 2007, ANN ONCOL, V18, P851, DOI 10.1093/annonc/mdl502; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Cristofanilli M, 2007, CLIN BREAST CANCER, V7, P471, DOI 10.3816/CBC.2007.n.004; Elston C W, 2002, Histopathology, V41, P154; Feng L, 2012, MED ONCOL, V29, P856, DOI 10.1007/s12032-011-9823-1; Finnegan Timothy J, 2007, Future Oncol, V3, P55, DOI 10.2217/14796694.3.1.55; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang Z, 2011, CELL CYCLE, V10, P1563, DOI 10.4161/cc.10.10.15703; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobodasch K, 2007, BREAST, V16, P211, DOI 10.1016/j.breast.2006.12.005; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oda A, 2005, BLOOD, V105, P3141, DOI 10.1182/blood-2003-04-1319; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Ring A, 2004, LANCET ONCOL, V5, P79, DOI 10.1016/S1470-2045(04)01381-6; Ring AE, 2005, BRIT J CANCER, V92, P906, DOI 10.1038/sj.bjc.6602418; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2002, ONCOGENE, V21, P5967, DOI 10.1038/sj.onc.1205734; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Sossey-Alaoui K, 2011, INT J CANCER, V129, P1331, DOI 10.1002/ijc.25793; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Spaderna S, 2007, Verh Dtsch Ges Pathol, V91, P21; Stathopoulou A, 2002, J CLIN ONCOL, V20, P3404, DOI 10.1200/JCO.2002.08.135; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	53	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42895	10.1371/journal.pone.0042895	http://dx.doi.org/10.1371/journal.pone.0042895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952619	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800016
J	Rodrigues, R; Shet, A; Antony, J; Sidney, K; Arumugam, K; Krishnamurthy, S; D'Souza, G; DeCosta, A				Rodrigues, Rashmi; Shet, Anita; Antony, Jimmy; Sidney, Kristi; Arumugam, Karthika; Krishnamurthy, Shubha; D'Souza, George; DeCosta, Ayesha			Supporting Adherence to Antiretroviral Therapy with Mobile Phone Reminders: Results from a Cohort in South India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; MEDICATION ADHERENCE; IMPROVING ADHERENCE; CELLULAR PHONES; CLINICAL-TRIALS; SYSTEM; CARE	Background: Adherence is central to the success of antiretroviral therapy. Supporting adherence has gained importance in HIV care in many national treatment programs. The ubiquity of mobile phones, even in resource-constrained settings, has provided an opportunity to utilize an inexpensive, contextually feasible technology for adherence support in HIV in these settings. We aimed to assess the influence of mobile phone reminders on adherence to antiretroviral therapy in South India. Participant experiences with the intervention were also studied. This is the first report of such an intervention for antiretroviral adherence from India, a country with over 800 million mobile connections. Methods: Study design: Quasi-experimental cohort study involving 150 HIV-infected individuals from Bangalore, India, who were on antiretroviral therapy between April and July 2010. The intervention: All participants received two types of adherence reminders on their mobile phones, (i) an automated interactive voice response (IVR) call and (ii) A non-interactive neutral picture short messaging service (SMS), once a week for 6 months. Adherence measured by pill count, was assessed at study recruitment and at months one, three, six, nine and twelve. Participant experiences were assessed at the end of the intervention period. Results: The mean age of the participants was 38 years, 27% were female and 90% urban. Overall, 3,895 IVRs and 3,073 SMSs were sent to the participants over 6 months. Complete case analysis revealed that the proportion of participants with optimal adherence increased from 85% to 91% patients during the intervention period, an effect that was maintained 6 months after the intervention was discontinued (p = 0.016). Both, IVR calls and SMS reminders were considered non-intrusive and not a threat to privacy. A significantly higher proportion agreed that the IVR was helpful compared to the SMS (p < 0.001). Conclusion: Mobile phone reminders may improve medication adherence in HIV infected individuals in this setting, the effect of which was found to persist for at least 6 months after cessation of the intervention.	[Rodrigues, Rashmi; Shet, Anita; Sidney, Kristi; DeCosta, Ayesha] Karolinska Inst, Div Global Hlth, Stockholm, Sweden; [Rodrigues, Rashmi] St Johns Natl Acad Hlth Sci, Dept Community Hlth, Bangalore, Karnataka, India; [Antony, Jimmy; Arumugam, Karthika; Krishnamurthy, Shubha] St Johns Natl Acad Hlth Sci, HIVIND Project, Bangalore, Karnataka, India; [D'Souza, George] St Johns Natl Acad Hlth Sci, Div Chest Dis, Bangalore, Karnataka, India; [Shet, Anita] St Johns Natl Acad Hlth Sci, Dept Pediat, Bangalore, Karnataka, India	Karolinska Institutet; St. John's National Academy of Health Sciences; St. John's National Academy of Health Sciences; St. John's National Academy of Health Sciences; St. John's National Academy of Health Sciences	Rodrigues, R (corresponding author), Karolinska Inst, Div Global Hlth, Stockholm, Sweden.	rashmijr@gmail.com	Rodrigues, Rashmi J/H-1901-2012; Annerstedt, Kristi/AAJ-8678-2020	Rodrigues, Rashmi J/0000-0002-0656-0178; Annerstedt, Kristi/0000-0002-8798-4027; Shet, Anita/0000-0002-7204-8164	National AIDS Control Organisation; European Commission	National AIDS Control Organisation; European Commission(European CommissionEuropean Commission Joint Research Centre)	Authors would like to thank Ravience Digital, Mumbai, India for technical assistance with the intervention, the National AIDS Control Organisation for their support, the staff at the Infectious Disease Clinic, St. John's National Academy of Health Sciences, Bangalore, India; Mr. As Mohammad, Swaroop N, Ashwini GS and Navya CJ from the department of Community Medicine, St. John's Medical College, for their assistance with the study data.; This work was funded by a European Commission FP7 grant for the HIVIND project. [URL: http://cordis.europa.eu/fetch?CALLER=FP7_PROJ_EN&ACTION=D&DOC=1&CAT=PROJ&QUERY=0132a68e52ee:51ac:213dc128&RCN=90123]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2010, ARCH INTERN MED, V170, P109, DOI 10.1001/archinternmed.2009.459; Armstrong AW, 2009, ARCH DERMATOL, V145, P1230, DOI 10.1001/archdermatol.2009.269; Bartlett JA, 2002, J ACQ IMMUN DEF SYND, V29, pS2, DOI 10.1097/00126334-200202011-00002; Bastard M, 2011, JAIDS-J ACQ IMM DEF, V57, P55, DOI 10.1097/QAI.0b013e318211b43b; Bhat VG, 2010, EUR J CLIN MICROBIOL, V29, P947, DOI 10.1007/s10096-010-0949-4; Boyer EW, 2010, J MED TOXICOL, V6, P212, DOI 10.1007/s13181-010-0080-z; Cauldbeck M., 2009, AIDS RES THERAPY; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Cote JK, 2005, INT J STD AIDS, V16, P335, DOI 10.1258/0956462053888934; Crankshaw T, 2010, AIDS PATIENT CARE ST, V24, P729, DOI 10.1089/apc.2010.0146; De Costa A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-25; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; Granger BB, 2011, CURR OPIN CARDIOL, V26, P279, DOI 10.1097/HCO.0b013e328347c150; Hardy H, 2011, AIDS PATIENT CARE ST, V25, P153, DOI 10.1089/apc.2010.0006; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Ickovics JR, 1997, J CLIN EPIDEMIOL, V50, P385, DOI 10.1016/S0895-4356(97)00041-3; Kalichman SC, 2011, AIDS PATIENT CARE ST, V25, P303, DOI 10.1089/apc.2010.0367; Kaplan WA, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-9; Kunutsor S, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/872396; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lyon ME, 2003, AIDS PATIENT CARE ST, V17, P299, DOI 10.1089/108729103322108175; Mbuagbaw L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-5; Milam J, 2005, JAIDS-J ACQ IMM DEF, V40, P356, DOI 10.1097/01.qai.0000159710.98960.81; Nachega JB, 2011, AIDS S4, V24, P1273; *NACO, 2007, ANT THER GUID HIV IN; NACO, 2011, NAT AIDS CONTR ORG A; NIAID Adult AIDS Clinical Trials Group, 2003, Q10777 NIAID AD AIDS; Nyanzi-Wakholi B, 2012, AIDS CARE, V24, P137, DOI 10.1080/09540121.2011.596518; Perrine R, 2011, JAIDS-J ACQ IMM DEF, V57, pS40, DOI 10.1097/QAI.0b013e318222b5c2; Person AK, 2011, TELEMED E-HEALTH, V17, P189, DOI 10.1089/tmj.2010.0164; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Puccio JA, 2006, AIDS PATIENT CARE ST, V20, P438, DOI 10.1089/apc.2006.20.438; Read T, 2003, INTERN MED J, V33, P254, DOI 10.1046/j.1445-5994.2003.00333.x; Reidel K, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-46; Reynolds NR, 2008, JAIDS-J ACQ IMM DEF, V47, P62, DOI 10.1097/QAI.0b013e3181582d54; Rigsby MO, 2000, J GEN INTERN MED, V15, P841, DOI 10.1046/j.1525-1497.2000.00127.x; Roberts KJ, 2000, AIDS PATIENT CARE ST, V14, P155, DOI 10.1089/108729100317948; RUDD P, 1989, CLIN PHARMACOL THER, V46, P169, DOI 10.1038/clpt.1989.122; Safren SA, 2003, AIDS CARE, V15, P787, DOI 10.1080/09540120310001618630; Shet A, 2010, AIDS BEHAV, V14, P716, DOI 10.1007/s10461-009-9658-3; Sidney K, 2012, AIDS CARE, V24, P612, DOI 10.1080/09540121.2011.630357; Simoni Jane M, 2008, Curr Infect Dis Rep, V10, P515, DOI 10.1007/s11908-008-0083-y; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tesoriero J, 2003, JAIDS-J ACQ IMM DEF, V33, P484, DOI 10.1097/00126334-200308010-00009; TRAI, 2011, IND TEL SERV PERF IN; Uzma Qudsia, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P373, DOI 10.1177/1545109710383175; Vital Wave Consulting, 2009, MHEALTH DEV OPP MOB; Woods SP, 2008, ARCH CLIN NEUROPSYCH, V23, P257, DOI 10.1016/j.acn.2007.12.006	50	77	79	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e40723	10.1371/journal.pone.0040723	http://dx.doi.org/10.1371/journal.pone.0040723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952574	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800003
J	Satti, H; Motsamai, S; Chetane, P; Marumo, L; Barry, DJ; Riley, J; McLaughlin, MM; Seung, KJ; Mukherjee, JS				Satti, Hind; Motsamai, Sophie; Chetane, Palesa; Marumo, Leshoboro; Barry, Donna J.; Riley, Jennifer; McLaughlin, Megan M.; Seung, Kwonjune J.; Mukherjee, Joia S.			Comprehensive Approach to Improving Maternal Health and Achieving MDG 5: Report from the Mountains of Lesotho	PLOS ONE			English	Article							STRATEGIES; MORTALITY; SURVIVAL; NEWBORN; CARE	Background: Although it is now widely recognized that reductions in maternal mortality and improvements in women's health cannot be achieved through simple, vertical strategies, few programs have provided successful models for how to integrate services into a comprehensive program for maternal health. We report our experience in rural Lesotho, where Partners In Health (PIH) in partnership with the Ministry of Health and Social Welfare implemented a program that provides comprehensive care of pregnant women from the community to the clinic level. Methods: Between May and July 2009, PIH trained 100 women, many of whom were former traditional birth attendants, to serve as clinic-affiliated maternal health workers. They received performance-based incentives for accompanying pregnant women during antenatal care (ANC) visits and facility-based delivery. A nurse-midwife provided ANC and delivery care and supervised the maternal health workers. To overcome geographic barriers to delivering at the clinic, women who lived far from the clinic stayed at a maternal lying-in house prior to their expected delivery dates. We analyzed data routinely collected from delivery and ANC registers to compare service utilization before and after implementation of the program. Results: After the establishment of the program, the average number first ANC visits increased from 20 to 31 per month. The clinic recorded 178 deliveries in the first year of the program and 216 in the second year, compared to 46 in the year preceding the program. During the first two years of the program, 49 women with complications were successfully transported to the district hospital, and no maternal deaths occurred among the women served by the program. Conclusions: Our results demonstrate that it is possible to achieve dramatic improvements in the utilization of maternal health services and facility-based delivery by strengthening human resource capacity, implementing active follow-up in the community, and de-incentivizing home births.	[Satti, Hind; Motsamai, Sophie; Chetane, Palesa; Marumo, Leshoboro] Partners Hlth Lesotho, Maseru, Lesotho; [Satti, Hind; Mukherjee, Joia S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Barry, Donna J.; Riley, Jennifer; McLaughlin, Megan M.; Seung, Kwonjune J.; Mukherjee, Joia S.] Partners Hlth, Boston, MA USA; [Barry, Donna J.; McLaughlin, Megan M.; Seung, Kwonjune J.; Mukherjee, Joia S.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital	Satti, H (corresponding author), Partners Hlth Lesotho, Maseru, Lesotho.	hsatti@pih.org			Elton John AIDS Foundation UK	Elton John AIDS Foundation UK	The Elton John AIDS Foundation UK provided funding for the pilot program at Bobete Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2003, BRIT MED BULL, V67, P13, DOI 10.1093/bmb/ldg014; Ana J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3308; Ana J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3310; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Government of Lesotho Ministry of Health and Social Welfare, 2010, NAT GUID PREV MOTH C; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hunt P, 2007, REDUCING MATERNAL MO; ICF Macro, 2010, LESOTHO DEMOGRAPHIC; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Partners In Health, 2008, PARTN HLTH ACC TRAIN; Partners In Health, 2012, MAT MORT RED PROGR A; United Nations, 2010, GEN UN GEN ASS 64 SE; WHO UNICEF UNFPA The World Bank Maternal Mortality Estimation Inter-Agency Group, 2008, MAT MORT 1990 2008; World Health Organization, 2011, TB DAT TUB COUNTR PR	16	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42700	10.1371/journal.pone.0042700	http://dx.doi.org/10.1371/journal.pone.0042700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952607	gold, Green Published, Green Submitted			2022-12-27	WOS:000308044800010
J	Serang, O				Serang, Oliver			Conic Sampling: An Efficient Method for Solving Linear and Quadratic Programming by Randomly Linking Constraints within the Interior	PLOS ONE			English	Article							MASS-SPECTROMETRY; ALGORITHM	Linear programming (LP) problems are commonly used in analysis and resource allocation, frequently surfacing as approximations to more difficult problems. Existing approaches to LP have been dominated by a small group of methods, and randomized algorithms have not enjoyed popularity in practice. This paper introduces a novel randomized method of solving LP problems by moving along the facets and within the interior of the polytope along rays randomly sampled from the polyhedral cones defined by the bounding constraints. This conic sampling method is then applied to randomly sampled LPs, and its runtime performance is shown to compare favorably to the simplex and primal affine-scaling algorithms, especially on polytopes with certain characteristics. The conic sampling method is then adapted and applied to solve a certain quadratic program, which compute a projection onto a polytope; the proposed method is shown to outperform the proprietary software Mathematica on large, sparse QP problems constructed from mass spectometry-based proteomics.	[Serang, Oliver] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Serang, Oliver] Boston Childrens Hosp, Dept Pathol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Serang, O (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	Oliver.Serang@Childrens.Harvard.edu						BARNES ER, 1986, MATH PROGRAM, V36, P174, DOI 10.1007/BF02592024; Bland R. G., 1977, Mathematics of Operations Research, V2, P103, DOI 10.1287/moor.2.2.103; Dantzig GB, 1947, LINEAR PROGRAMMING E; Forrest J. J. H., 1972, MATH PROGRAM, V2, P263; Glocker B, 2008, MED IMAGE ANAL, V12, P731, DOI 10.1016/j.media.2008.03.006; Hauskrecht M, 2004, NIPS; Kalai G, 1985, SOME COMPUTATIONAL E, P85; Kalai G, 1991, SUBEXPONENTIAL UNPUB; KARMARKAR N, 1984, COMBINATORICA, V4, P373, DOI 10.1007/BF02579150; Khachiyan LG, 1979, SOV MATH DOKL, V20, P191; Klee V, 1972, INEQUALITIES, P159; Murty KG, 1988, LINEAR COMPLEMENTARI; REID JK, 1982, MATH PROGRAM, V24, P55, DOI 10.1007/BF01585094; Sanghavi S, 2008, NIPS, P1273; Serang O, 2012, STAT INTERFACE, V5, P3; Serang O, 2010, J PROTEOME RES, V9, P5346, DOI 10.1021/pr100594k; Tsuda K, 2004, IMAGE RECONSTRUCTION; VANDERBEI R. J, 1996, LINEAR PROGRAMMING F; Vanderbei RJ, 1986, ALGORITHMICA, V1, P395, DOI 10.1007/BF01840454; Wright SJ, 1997, INTERIOR POINT METHO; Y RS, 1991, SMALL DIMENSIONAL LI; Yanover C, 2006, J MACH LEARN RES, V7, P1887; Zhang B, 2007, J PROTEOME RES, V6, P3549, DOI 10.1021/pr070230d	24	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43706	10.1371/journal.pone.0043706	http://dx.doi.org/10.1371/journal.pone.0043706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952741	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800052
J	Valdes, V; Valenzuela, JI; Salas, DA; Jaureguiberry-Bravo, M; Otero, C; Thiede, C; Schmidt, CF; Couve, A				Valdes, Viviana; Ignacio Valenzuela, Jose; Salas, Daniela A.; Jaureguiberry-Bravo, Matias; Otero, Carolina; Thiede, Christina; Schmidt, Christoph F.; Couve, Andres			Endoplasmic Reticulum Sorting and Kinesin-1 Command the Targeting of Axonal GABA(B) Receptors	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; TRANSPORT; DENDRITES; PROTEINS; TRAFFICKING; DISTINCT; CELLS; SUBUNITS; LOCALIZATION; MICROTUBULES	In neuronal cells the intracellular trafficking machinery controls the availability of neurotransmitter receptors at the plasma membrane, which is a critical determinant of synaptic strength. Metabotropic c amino-butyric acid (GABA) type B receptors (GABA(B)Rs) are neurotransmitter receptors that modulate synaptic transmission by mediating the slow and prolonged responses to GABA. GABA(B)Rs are obligatory heteromers constituted by two subunits, GABA(B)R1 and GABA(B)R2. GABA(B)R1a and GABA(B)R1b are the most abundant subunit variants. GABA(B)R1b is located in the somatodendritic domain whereas GABA(B)R1a is additionally targeted to the axon. Sushi domains located at the N-terminus of GABA(B)R1a constitute the only difference between both variants and are necessary and sufficient for axonal targeting. The precise targeting machinery and the organelles involved in sorting and transport have not been described. Here we demonstrate that GABA(B)Rs require the Golgi apparatus for plasma membrane delivery but that axonal sorting and targeting of GABA(B)R1a operate in a pre-Golgi compartment. In the axon GABA(B)R1a subunits are enriched in the endoplasmic reticulum (ER), and their dynamic behavior and colocalization with other secretory organelles like the ER-to-Golgi intermediate compartment (ERGIC) suggest that they employ a local secretory route. The transport of axonal GABA(B)R1a is microtubule-dependent and kinesin-1, a molecular motor of the kinesin family, determines axonal localization. Considering that progression of GABA(B)Rs through the secretory pathway is regulated by an ER retention motif our data contribute to understand the role of the axonal ER in non-canonical sorting and targeting of neurotransmitter receptors.	[Valdes, Viviana; Ignacio Valenzuela, Jose; Salas, Daniela A.; Jaureguiberry-Bravo, Matias; Couve, Andres] Univ Chile, Fac Med, BNI, Santiago 7, Chile; [Valdes, Viviana; Ignacio Valenzuela, Jose; Salas, Daniela A.; Jaureguiberry-Bravo, Matias; Couve, Andres] Univ Chile, Fac Med, Program Physiol & Biophys, Inst Biomed Sci ICBM, Santiago 7, Chile; [Jaureguiberry-Bravo, Matias] Univ Andres Bello, Fac Biol Sci, Sch Biochem, Santiago, Chile; [Otero, Carolina] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; [Thiede, Christina; Schmidt, Christoph F.] Univ Gottingen, Fak Phys, Drittes Phys Inst Biophys, Gottingen, Germany	Universidad de Chile; Universidad de Chile; Universidad Andres Bello; Pontificia Universidad Catolica de Chile; University of Gottingen	Valdes, V (corresponding author), Univ Chile, Fac Med, BNI, Santiago 7, Chile.	andres@neuro.med.uchile.cl	couve, andres/I-2249-2013; Schmidt, Christoph F/G-3787-2011; Salas, Daniela A./GRF-6423-2022	couve, andres/0000-0003-4216-8672; Schmidt, Christoph F/0000-0003-2864-6973; Salas, Daniela A./0000-0003-4951-0688; Jaureguiberry, Matias/0000-0001-9937-7008; Otero, Carolina/0000-0002-8608-9813	Iniciativa Cientifica Milenio (ICM) [P09-015-F]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1100137]; ICM [P09-015-F]; Lower Saxony Grant [11-76251-99-26/08 (ZN2440)]; Deutsche Forschungsgemeinschaft (DFG)-CONICYT [AZ: 444 CHL-113/26/0-1]; Center for Molecular Physiology of the Brain (CMPB); DFG; FONDECYT [1100137]	Iniciativa Cientifica Milenio (ICM); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICM; Lower Saxony Grant; Deutsche Forschungsgemeinschaft (DFG)-CONICYT; Center for Molecular Physiology of the Brain (CMPB); DFG(German Research Foundation (DFG)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	VV was supported by Iniciativa Cientifica Milenio (ICM) P09-015-F. JIV was supported by Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT). MJB was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1100137 and ICM P09-015-F. CT was supported in part by the Lower Saxony Grant No 11-76251-99-26/08 (ZN2440). CO was supported by Deutsche Forschungsgemeinschaft (DFG)-CONICYT international grant AZ: 444 CHL-113/26/0-1. CFS was supported by the Center for Molecular Physiology of the Brain (CMPB), funded by the DFG. AC was supported by FONDECYT 1100137 and ICM P09-015-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2001, J NEUROSCI RES, V65, P236, DOI 10.1002/jnr.1147; Aridor M, 2009, TRAFFIC, V10, P1669, DOI 10.1111/j.1600-0854.2009.00974.x; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; BROADWELL RD, 1984, J COMP NEUROL, V230, P231, DOI 10.1002/cne.902300208; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Calver AR, 2001, J NEUROSCI, V21, P1203; Casanova E, 2009, GENESIS, V47, P595, DOI 10.1002/dvg.20535; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Goslin K., 1991, CULTURING NERVE CELL, P251; Herpers B, 2004, MOL BIOL CELL, V15, P5306, DOI 10.1091/mbc.E04-05-0398; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kulik A, 2003, J NEUROSCI, V23, P11026; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Ramirez O, 2010, J MICROSC-OXFORD, V239, P173, DOI 10.1111/j.1365-2818.2010.03369.x; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Ramirez OA, 2009, J BIOL CHEM, V284, P13077, DOI 10.1074/jbc.M900575200; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Shah JV, 2002, CURR OPIN CELL BIOL, V14, P58, DOI 10.1016/S0955-0674(01)00294-0; Soza A, 2004, J BIOL CHEM, V279, P17376, DOI 10.1074/jbc.M313197200; Terada S, 2010, EMBO J, V29, P843, DOI 10.1038/emboj.2009.389; TSUKITA S, 1976, J ELECTRON MICROSC, V25, P141; Vidal RL, 2007, MOL CELL NEUROSCI, V35, P501, DOI 10.1016/j.mcn.2007.04.008; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; WECLEWICZ K, 1993, J NEUROCYTOL, V22, P616, DOI 10.1007/BF01181488; Weclewicz K, 1998, BRAIN RES BULL, V46, P353, DOI 10.1016/S0361-9230(98)00013-6; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Yogev S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000505; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289	50	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44168	10.1371/journal.pone.0044168	http://dx.doi.org/10.1371/journal.pone.0044168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952914	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800099
J	Hoek, W; Schuurmans, J; Koot, HM; Cuijpers, P				Hoek, Willemijn; Schuurmans, Josien; Koot, Hans M.; Cuijpers, Pim			Effects of Internet-Based Guided Self-Help Problem-Solving Therapy for Adolescents with Depression and Anxiety: A Randomized Controlled Trial	PLOS ONE			English	Article							HOSPITAL ANXIETY; DISC-IV; SYMPTOMS; SCALE; VALIDATION; PREVENTION; DISORDERS; VERSIONS; CHILDREN; EFFICACY	Background: Symptoms of depression and anxiety are highly prevalent in adolescence and they are the cause of considerable suffering. Even so, adolescents are not inclined to seek professional help for emotional problems. Internet-based preventive interventions have been suggested as a feasible method of providing appropriate care to adolescents with internalizing symptoms. The objective of this study was to evaluate the effects of preventive Internet-based (guided) self-help problem-solving therapy (PST) for adolescents reporting mild to moderate symptoms of depression and/or anxiety as compared to a waiting list control group (WL). Methodology/Principal Findings: A total of 45 participants were randomized to the 2 conditions. PST consisted of 5 weekly lessons. Participants were supported by e-mail. Self-report measures of depression and anxiety were filled in at baseline and after 3 weeks, 5 weeks, and 4 months. Of the 45 participants, 28 (62.2%) completed questionnaires after 3 weeks, 28 (62.2%) after 5 weeks, and 27 (60%) after 4 months. Hierarchical linear modeling analyses revealed overall improvement over time for both groups on depressive and anxiety symptoms. However, no significant group x time interactions were found. No differences were found between completers and non-completers. Conclusions/Significance: Results show that depressive and anxiety symptoms declined in both groups. No support was found, however, for the assumption that Internet-based PST was efficacious in reducing depression and anxiety in comparison to the waiting list control group. This finding could represent lack of power.	[Hoek, Willemijn; Schuurmans, Josien; Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Hoek, Willemijn; Koot, Hans M.] EMGO Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Hoek, W (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	n.w.hoek@vu.nl	Cuijpers, Pim/G-1703-2013	Koot, Hans/0000-0002-9643-2363; Cuijpers, Pim/0000-0001-5497-2743; Schuurmans, Josien/0000-0003-4029-1810	ZonMw - the Netherlands organisation for Health Research and Development [120610006]	ZonMw - the Netherlands organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This study is funded by ZonMw - the Netherlands organisation for Health Research and Development, grant number 120610006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles P, 2009, BEHAV COGN PSYCHOTH, V37, P151, DOI 10.1017/S1352465808005067; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Calear AL, 2009, J CONSULT CLIN PSYCH, V77, P1021, DOI 10.1037/a0017391; Christensen H, 2002, MED J AUSTRALIA, V177, pS122; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Cole DA, 1998, J CONSULT CLIN PSYCH, V66, P451, DOI 10.1037/0022-006X.66.3.451; Cuijpers P, 1997, J BEHAV THER EXP PSY, V28, P139, DOI 10.1016/S0005-7916(97)00005-0; Cuijpers P, 2008, EUR CHILD ADOLES PSY, V17, P32, DOI 10.1007/s00787-007-0631-2; Cuijpers P, 2007, EUR PSYCHIAT, V22, P9, DOI 10.1016/j.eurpsy.2006.11.001; Cunningham MJ, 2009, EUR CHILD ADOLES PSY, V18, P125, DOI 10.1007/s00787-008-0703-y; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; GARRISON CZ, 1991, J AM ACAD CHILD PSY, V30, P636, DOI 10.1097/00004583-199107000-00017; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Hoek W, 2012, EUR CHILD A IN PRESS; Hoek W, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-93; Malouff JM, 2007, CLIN PSYCHOL REV, V27, P46, DOI 10.1016/j.cpr.2005.12.005; Nguyen T D, 1983, Eval Program Plann, V6, P299, DOI 10.1016/0149-7189(83)90010-1; O'Kearney Richard, 2006, Cognitive Behaviour Therapy, V35, P43, DOI 10.1080/16506070500303456; O'Kearney R, 2009, DEPRESS ANXIETY, V26, P65, DOI 10.1002/da.20507; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sawyer MG, 2009, J AFFECT DISORDERS, V117, P48, DOI 10.1016/j.jad.2008.12.013; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Spence SH, 2006, J CONSULT CLIN PSYCH, V74, P614, DOI 10.1037/0022-006X.74.3.614; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Tillett J, 2005, J PERINAT NEONAT NUR, V19, P112, DOI 10.1097/00005237-200504000-00007; van der Zanden R, 2012, J MED INTERNET RES, V14, P274, DOI 10.2196/jmir.2033; van Lang NDJ, 2006, BEHAV RES THER, V44, P849, DOI 10.1016/j.brat.2005.06.004; Warmerdam L, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.954; Wasserman GA, 2002, J AM ACAD CHILD PSY, V41, P314, DOI 10.1097/00004583-200203000-00011; WELLS KB, 1988, J PSYCHIAT RES, V22, P207, DOI 10.1016/0022-3956(88)90006-4; White D, 1999, BRIT J PSYCHIAT, V175, P452, DOI 10.1192/bjp.175.5.452; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	49	51	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43485	10.1371/journal.pone.0043485	http://dx.doi.org/10.1371/journal.pone.0043485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998EY	22952691	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300016
J	Sakamoto, K; Schmidt, JW; Wagner, KU				Sakamoto, Kazuhito; Schmidt, Jeffrey W.; Wagner, Kay-Uwe			Generation of a Novel MMTV-tTA Transgenic Mouse Strain for the Targeted Expression of Genes in the Embryonic and Postnatal Mammary Gland	PLOS ONE			English	Article							EPITHELIAL-CELLS; STEM-CELLS; IN-VIVO; MICE; NEU; TUMORIGENESIS; ACTIVATION; ONCOGENE; TISSUES; SYSTEM	We have generated a new and improved transgenic mouse strain that permits a temporally controlled expression of transgenes throughout mammary gland development. High expression of the tetracycline-regulatible transactivator (tTA) under control of the mouse mammary tumor virus long terminal repeat (MMTV-LTR) is restricted to mammary epithelial cells and the salivary gland. The novel MMTV-tTA mouse strain induces a sustained transactivation of responder transgenes, which can be swiftly suppressed through administration of doxycycline (Dox). An important characteristic of this strain is its expression in early progenitor cells of mammary gland anlagen beginning at day 13.5 of embryonic development. We show here that the MMTV-tTA can be used in combination with GFP reporter strains to visualize CK8/CK14-dual positive progenitors in newborn females and their derived basal and luminal epithelial cell lineages in adult females. Our observations suggest that the novel MMTV-tTA can be utilized to express exogenous proteins in multipotent mammary progenitors during the earliest stages of mammary gland development to assess their biological significance throughout mammogenesis. Moreover, we demonstrate that the expression of the MMTV-tTA is sustained during mammary gland tumorigenesis in female mice expressing wildtype ErbB2. This makes this strain particular valuable to target the expression of exogenous proteins into developing mammary tumors to assess their significance in biological processes, such as tumor cell growth and survival, metabolism, and metastasis.	[Sakamoto, Kazuhito; Schmidt, Jeffrey W.; Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sakamoto, K (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ksakamoto@unmc.edu; kuwagner@unmc.edu	Wagner, Kay-Uwe/B-6044-2009	Wagner, Kay-Uwe/0000-0002-5081-0226	Public Health Service grants [CA93797, CA117930]; National Cancer Institute; Nebraska Cancer and Smoking Disease Research Program [NE DHHS LB506 2012-44]; Susan G. Komen Breast Cancer Foundation [PDF0600835]; UNMC Cancer Research Training Program [CA009476]; Program of Excellence Graduate Assistantship from the UNMC Graduate Studies Office; Department of Defense Congressionally Directed Medical Research Program [BC100147]; NATIONAL CANCER INSTITUTE [R01CA093797, T32CA009476, R01CA117930] Funding Source: NIH RePORTER	Public Health Service grants(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Cancer and Smoking Disease Research Program; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); UNMC Cancer Research Training Program; Program of Excellence Graduate Assistantship from the UNMC Graduate Studies Office; Department of Defense Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the Public Health Service grants CA93797 and CA117930 and (to KUW) from the National Cancer Institute. Additional financial support provided to KUW by the Nebraska Cancer and Smoking Disease Research Program (NE DHHS LB506 2012-44) was imperative to finance the maintenance of the mouse models. KS received a postdoctoral fellowship from the Susan G. Komen Breast Cancer Foundation (PDF0600835). JWS received a graduate fellowship through the UNMC Cancer Research Training Program (CA009476), a Program of Excellence Graduate Assistantship from the UNMC Graduate Studies Office as well as a Breast Cancer Predoctoral Traineeship Award from the Department of Defense Congressionally Directed Medical Research Program (BC100147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Challen GA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002357; Creamer BA, 2010, MOL CELL BIOL, V30, P2957, DOI 10.1128/MCB.00851-09; Creamer BA, 2009, GENESIS, V47, P234, DOI 10.1002/dvg.20480; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hennighausen L, 1995, J CELL BIOCHEM, V59, P463, DOI 10.1002/jcb.240590407; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; Iavnilovitch E, 2004, INT J CANCER, V112, P607, DOI 10.1002/ijc.20484; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Parmar H, 2004, ENDOCR-RELAT CANCER, V11, P437, DOI 10.1677/erc.1.00659; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Rose-Hellekant TA, 2003, ONCOGENE, V22, P4664, DOI 10.1038/sj.onc.1206619; SAKAKURA T, 1979, J NATL CANCER I, V63, P733, DOI 10.1093/jnci/63.3.733; Spike BT, 2012, CELL STEM CELL, V10, P183, DOI 10.1016/j.stem.2011.12.018; Triplett AA, 2008, NEOPLASIA, V10, P1325, DOI 10.1593/neo.08524; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wagner Kay-Uwe, 1997, Genes and Function, V1, P233; Zeng X, 2010, ONCOGENE, V29, P5103, DOI 10.1038/onc.2010.253; Zhang Q, 2010, TRANSGENIC RES, V19, P499, DOI 10.1007/s11248-009-9329-1	27	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43778	10.1371/journal.pone.0043778	http://dx.doi.org/10.1371/journal.pone.0043778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952764	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300028
J	Pei, LM; Wang, JM; Li, KP; Li, YJ; Li, B; Gao, F; Yang, AF				Pei, Laming; Wang, Jiemin; Li, Kunpeng; Li, Yongjun; Li, Bei; Gao, Feng; Yang, Aifang			Overexpression of Thellungiella halophila H+-pyrophosphatase Gene Improves Low Phosphate Tolerance in Maize	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; SALT TOLERANCE; PPASE GENE; PHOSPHORUS; GROWTH; PHOTOSYNTHESIS; RHIZOSPHERE; TRANSPORT; DROUGHT; ROOTS	Low phosphate availability is a major constraint on plant growth and agricultural productivity. Engineering a crop with enhanced low phosphate tolerance by transgenic technique could be one way of alleviating agricultural losses due to phosphate deficiency. In this study, we reported that transgenic maize plants that overexpressed the Thellungiella halophila vacuolar H+-pyrophosphatase gene (TsVP) were more tolerant to phosphate deficit stress than the wild type. Under phosphate sufficient conditions, transgenic plants showed more vigorous root growth than the wild type. When phosphate deficit stress was imposed, they also developed more robust root systems than the wild type, this advantage facilitated phosphate uptake, which meant that transgenic plants accumulated more phosphorus. So the growth and development in the transgenic maize plants were not damaged as much as in the wild type plants under phosphate limitation. Overexpression of TsVP increased the expression of genes involved in auxin transport, which indicated that the development of larger root systems in transgenic plants might be due in part to enhanced auxin transport which controls developmental events in plants. Moreover, transgenic plants showed less reproductive development retardation and a higher grain yield per plant than the wild type plants when grown in a low phosphate soil. The phenotypes of transgenic maize plants suggested that the overexpression of TsVP led to larger root systems that allowed transgenic maize plants to take up more phosphate, which led to less injury and better performance than the wild type under phosphate deficiency conditions. This study describes a feasible strategy for improving low phosphate tolerance in maize and reducing agricultural losses caused by phosphate deficit stress.	[Pei, Laming; Wang, Jiemin; Li, Kunpeng; Li, Yongjun; Li, Bei; Gao, Feng; Yang, Aifang] Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Shandong University	Pei, LM (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	aifangyang@sdu.edu.cn		Li, Kunpeng/0000-0003-1807-4545	Transgenic New Crops Variety Breeding Major Project of China's Ministry of Agriculture [2011ZX08003-005]	Transgenic New Crops Variety Breeding Major Project of China's Ministry of Agriculture	This work was funded by the Transgenic New Crops Variety Breeding Major Project of China's Ministry of Agriculture (2011ZX08003-005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLAASSEN N, 1974, PLANT PHYSIOL, V54, P564, DOI 10.1104/pp.54.4.564; Corrales I, 2007, J PLANT NUTR, V30, P887, DOI 10.1080/15226510701375085; DEMICHELIS MI, 1986, PLANT PHYSIOL, V81, P542, DOI 10.1104/pp.81.2.542; Dietz KJ, 1997, BOOKS SOIL PLANT ENV, P951; DREW MC, 1978, J EXP BOT, V29, P435, DOI 10.1093/jxb/29.2.435; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Gao F, 2006, J EXP BOT, V57, P3259, DOI 10.1093/jxb/erl090; George TS, 2002, SOIL BIOL BIOCHEM, V34, P1487, DOI 10.1016/S0038-0717(02)00093-7; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; JACOB J, 1991, J EXP BOT, V42, P1003, DOI 10.1093/jxb/42.8.1003; Lai F, 2007, PLANT J, V50, P545, DOI 10.1111/j.1365-313X.2007.03070.x; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; Li B, 2008, PLANT BIOTECHNOL J, V6, P146, DOI 10.1111/j.1467-7652.2007.00301.x; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Li KP, 2007, PLANT SCI, V172, P255, DOI 10.1016/j.plantsci.2006.09.004; LIN TI, 1977, ANAL BIOCHEM, V77, P10, DOI 10.1016/0003-2697(77)90284-6; Liu Y, 2004, PLANT SCI, V167, P217, DOI 10.1016/j.plantsci.2004.02.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv S, 2008, PLANT CELL PHYSIOL, V49, P1150, DOI 10.1093/pcp/pcn090; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; MUSICK G. J., 1965, CROP SCI, V5, P601, DOI 10.2135/cropsci1965.0011183X000500060040x; NATR L, 1992, PHOTOSYNTHETICA, V27, P271; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pasapula V, 2011, PLANT BIOTECHNOL J, V9, P88, DOI 10.1111/j.1467-7652.2010.00535.x; Plenet D, 2000, PLANT SOIL, V223, P119, DOI 10.1023/A:1004877111238; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Smart LB, 1998, PLANT PHYSIOL, V116, P1539, DOI 10.1104/pp.116.4.1539; Smith FW, 2000, BBA-BIOMEMBRANES, V1465, P236, DOI 10.1016/S0005-2736(00)00141-3; Smith FW, 2003, PLANT SOIL, V248, P71, DOI 10.1023/A:1022376332180; Smith FW, 2001, PLANT SOIL, V232, P109, DOI 10.1023/A:1010390120820; TADANO T, 1991, SOIL SCI PLANT NUTR, V37, P129, DOI 10.1080/00380768.1991.10415018; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Yang H, 2007, PLANT BIOTECHNOL J, V5, P735, DOI 10.1111/j.1467-7652.2007.00281.x	34	52	57	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43501	10.1371/journal.pone.0043501	http://dx.doi.org/10.1371/journal.pone.0043501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952696	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500012
J	Abdo, DA; Bellchambers, LM; Evans, SN				Abdo, David A.; Bellchambers, Lynda M.; Evans, Scott N.			Turning up the Heat: Increasing Temperature and Coral Bleaching at the High Latitude Coral Reefs of the Houtman Abrolhos Islands	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; RANGE SHIFTS; WESTERN; IMPACTS; THRESHOLDS; MORTALITY; REPRODUCTION; COMMUNITIES; DIVERSITY	Background: Coral reefs face increasing pressures particularly when on the edge of their distributions. The Houtman Abrolhos Islands (Abrolhos) are the southernmost coral reef system in the Indian Ocean, and one of the highest latitude reefs in the world. These reefs have a unique mix of tropical and temperate marine fauna and flora and support 184 species of coral, dominated by Acropora species. A significant La Nina event during 2011 produced anomalous conditions of increased temperature along the whole Western Australian coastline, producing the first-recorded widespread bleaching of corals at the Abrolhos. Methodology/Principal Findings: We examined long term trends in the marine climate at the Abrolhos using historical sea surface temperature data (HadISST data set) from 1900-2011. In addition in situ water temperature data for the Abrolhos (from data loggers installed in 2008, across four island groups) were used to determine temperature exposure profiles. Coupled with the results of coral cover surveys conducted annually since 2007; we calculated bleaching thresholds for monitoring sites across the four Abrolhos groups. Conclusions/Significance: In situ temperature data revealed maximum daily water temperatures reached 29.54 degrees C in March 2011 which is 4.2 degrees C above mean maximum daily temperatures (2008-2010). The level of bleaching varied across sites with an average of similar to 12% of corals bleached. Mortality was high, with a mean similar to 50% following the 2011 bleaching event. Prior to 2011, summer temperatures reached a mean (across all monitoring sites) of 25.1 degrees C for 2.5 days. However, in 2011 temperatures reached a mean of 28.1 degrees C for 3.3 days. Longer term trends (1900-2011) showed mean annual sea surface temperatures increase by 0.01 degrees C per annum. Long-term temperature data along with short-term peaks in 2011, outline the potential for corals to be exposed to more frequent bleaching risk with consequences for this high latitude coral reef system at the edge of its distribution.	[Abdo, David A.; Bellchambers, Lynda M.; Evans, Scott N.] Govt Western Australia, Dept Fisheries, Biodivers & Biosecur Branch, Marine Ecol & Monitoring Sect, Hillarys, WA, Australia		Abdo, DA (corresponding author), Govt Western Australia, Dept Fisheries, Biodivers & Biosecur Branch, Marine Ecol & Monitoring Sect, Hillarys, WA, Australia.	dave.abdo@fish.wa.gov.au	Abdo, David/F-5480-2010		Department of Fisheries, Government of Western Australia	Department of Fisheries, Government of Western Australia	Funding was provided by the Department of Fisheries, Government of Western Australia (www.fish.wa.gov.au). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Addessi L, 2001, CORAL REEFS, V19, P220, DOI 10.1007/PL00006957; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2011, AUSTR CORAL REEFS CH; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; Berkelmans R., 2009, V205, P103; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Caputi N, 2009, MAR FRESHWATER RES, V60, P129, DOI 10.1071/MF08199; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Celliers L, 2002, MAR POLLUT BULL, V44, P1380, DOI 10.1016/S0025-326X(02)00302-8; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; CRESSWELL GR, 1980, DEEP-SEA RES, V27, P449, DOI 10.1016/0198-0149(80)90055-2; CROSSLAND CJ, 1984, MAR ECOL PROG SER, V15, P135, DOI 10.3354/meps015135; Department of Fisheries, 2011, 2011 DEP FISH; Department of Fisheries, 2007, MAN HOUTM ABR SYST D; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; English S., 1997, SURVEY MANUAL TROPIC; Evans SN, 2010, MAR FRESHWATER RES, V61, P1327, DOI 10.1071/MF10007; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Fromont J, 1999, CORAL REEFS, V18, P340, DOI 10.1007/s003380050209; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; Heyward AJ, 2010, CORAL REEFS, V29, P631, DOI 10.1007/s00338-009-0578-5; Hill JJ, 2004, METHODS ECOLOGICAL M; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P391, DOI 10.1007/978-94-007-0114-4_22; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUTCHINS JB, 1994, B MAR SCI, V54, P245; JOHANNES RE, 1983, MAR ECOL PROG SER, V11, P105, DOI 10.3354/meps011105; Kleypas JA, 1999, AM ZOOLOGIST, P39; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Leggat W, 2006, CORAL REEFS, V25, P452, DOI 10.1007/s00338-006-0128-3; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Logan M, 2020, BIOSTATISTICAL DESIG, DOI DOI 10.1002/9781444319620; Lough J., 2008, GEOPHYS RES LETT, V35; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2011, GLOBAL CHANGE BIOL, V17, P2023, DOI 10.1111/j.1365-2486.2011.02395.x; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Noreen AME, 2009, P ROY SOC B-BIOL SCI, V276, P3927, DOI 10.1098/rspb.2009.1050; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pearce A., 2011, MARINE HEAT WAVE W A; Pearce A, 2007, MAR FRESHWATER RES, V58, P914, DOI 10.1071/MF07082; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Smale DA, 2012, CORAL REEFS, V31, P441, DOI 10.1007/s00338-012-0873-4; Sun C, 2012, CLIMATE CHA IN PRESS; Thomson DP, 2010, CORAL REEFS, V29, P923, DOI 10.1007/s00338-010-0650-1; Trewin B.C., 2007, ROLE CLIMATOLOGICAL; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Veron J.E.N., 1988, HERMATYPIC CORALS W; VERON JEN, 1995, CORALS SPACE TIME BI; Webster F, 2002, ASSESSMENT NATURAL H; Wells FE, 1994, INTRO MARINE ENV HOU; Whitaker K, 2006, MAR ECOL PROG SER, V306, P115, DOI 10.3354/meps306115; WILKINSON C, 2002, STATUS CORAL REEFS W; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	70	51	51	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43878	10.1371/journal.pone.0043878	http://dx.doi.org/10.1371/journal.pone.0043878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952797	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000057
J	Cheung, T; Oberoi, S				Cheung, Tracy; Oberoi, Snehlata			Three Dimensional Assessment of the Pharyngeal Airway in Individuals with Non-Syndromic Cleft Lip and Palate	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; NASAL AIRWAY; NASOPHARYNGEAL CHARACTERISTICS; CHILDREN; AGE	Introduction: Children with cleft lip and palate (CLP) are known to have airway problems. Previous studies have shown that individuals with CLP have a 30% reduction in nasal airway size compared to non-cleft controls. No reports have been found on cross-sectional area and volume of the pharyngeal airway in clefts. Introduction of Cone-Beam CT (CBCT) and imaging software has facilitated generation of 3D images for assessment of the cross-sectional area and volume of the airway. Objective: To assess the pharyngeal airway in individuals with CLP using CBCT by measuring volume and smallest cross-sectional areas and compare with 19 age-and sex-matched non-cleft controls. Methods: Retrospective study of CBCT data of pre-adolescent individuals (N = 19, Mean age = 10.6, 7 females, 12 males, UCLP = 6, BCLP = 3) from the Center for Craniofacial Anomalies. Volumetric analysis was performed using image segmentation features in CB Works 3.0. Volume and smallest cross-sectional were studied in both groups. Seven measurements were repeated to verify reliability using Pearson correlation coefficient. Volume and cross-sectional area differences were analyzed using paired t-tests. Results: The method was found to be reliable. Individuals with CLP did not exhibit smaller total airway volume and cross sectional area than non-CLP controls. Conclusion: 3D imaging using CBCT and CB Works is reliable for assessing airway volume. Previous studies have shown that the nasal airway is restricted in individuals with CLP. In our study, we found that the pharyngeal airway is not compromised in these individuals.	[Cheung, Tracy] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Oberoi, Snehlata] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, Div Orthodont, San Francisco, CA USA	University of California System; University of California Los Angeles; University of California System; University of California San Francisco	Cheung, T (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	sneha.oberoi@ucsf.edu						Aboudara C, 2009, AM J ORTHOD DENTOFAC, V135, P468, DOI 10.1016/j.ajodo.2007.04.043; Abramson Z, 2009, J CRANIOFAC SURG, V20, P657, DOI 10.1097/SCS.0b013e318193d521; ADUSS H, 1967, ARCHIV OTOLARYNGOL, V85, P53; Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294; Desalu I, 2010, Ghana Med J, V44, P16; DRAKE AF, 1993, LARYNGOSCOPE, V103, P915; DRETTNER B, 1960, Acta Otolaryngol, V52, P131; Enciso R, 2010, ORAL SURG ORAL MED O, V109, P285, DOI 10.1016/j.tripleo.2009.09.033; Fukushiro AP, 2005, CLEFT PALATE-CRAN J, V42, P396, DOI 10.1597/03-081.1; Gubisch W, 1995, Facial Plast Surg, V11, P159, DOI 10.1055/s-2008-1064531; HAIRFIELD WM, 1988, CLEFT PALATE J, V25, P135; Honein MA, 1999, TERATOLOGY, V60, P356, DOI 10.1002/(SICI)1096-9926(199912)60:6<356::AID-TERA8>3.0.CO;2-B; Imamura N, 2002, AM J ORTHOD DENTOFAC, V122, P189, DOI 10.1067/mod.2002.125234; ISONO S, 1993, J APPL PHYSIOL, V75, P148, DOI 10.1152/jappl.1993.75.1.148; Iwasaki T, 2009, AM J ORTHOD DENTOFAC, V136; Iwasaki T, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.04.010; Kim YJ, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.10.025; Ludlow JB, 2006, DENTOMAXILLOFAC RAD, V35, P219, DOI 10.1259/dmfr/14340323; Oberoi S, 2011, ORAL SURG ORAL MED O; Oberoi S, 2010, CLEFT PALATE-CRAN J, V47, P507, DOI 10.1597/08-171; Oberoi S, 2009, CLEFT PALATE-CRAN J, V46, P503, DOI 10.1597/08-153.1; Olszewska E, 2009, EUR ARCH OTO-RHINO-L, V266, P535, DOI 10.1007/s00405-008-0826-2; Ronen O, 2007, PEDIATRICS, V120, pE1028, DOI 10.1542/peds.2006-3433; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Schendel SA, 2010, J ORAL MAXIL SURG, V68, P696, DOI 10.1016/j.joms.2009.07.040; SMAHEL Z, 1991, J CRAN GENET DEV BIO, V11, P24; SMAHEL Z, 1992, CLEFT PALATE-CRAN J, V29, P282, DOI 10.1597/1545-1569(1992)029<0282:NCICWC>2.3.CO;2; TRINDADE IEK, 1992, CLEFT PALATE-CRAN J, V29, P429, DOI 10.1597/1545-1569(1992)029<0429:PFOIWC>2.3.CO;2; WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P112, DOI 10.1597/1545-1569(1992)029<0112:CSMBOC>2.3.CO;2; Warren D W, 1969, Cleft Palate J, V6, P134; WARREN DW, 1992, CLEFT PALATE-CRAN J, V29, P511, DOI 10.1597/1545-1569(1992)029<0511:NAIBAS>2.3.CO;2; WETMORE RF, 1992, CLEFT PALATE-CRAN J, V29, P498, DOI 10.1597/1545-1569(1992)029<0498:IOMNNF>2.3.CO;2	32	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43405	10.1371/journal.pone.0043405	http://dx.doi.org/10.1371/journal.pone.0043405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952677	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000034
J	Mazumdar, B; Meyer, K; Ray, R				Mazumdar, Budhaditya; Meyer, Keith; Ray, Ranjit			N-Terminal Region of Gelsolin Induces Apoptosis of Activated Hepatic Stellate Cells by a Caspase-Dependent Mechanism	PLOS ONE			English	Article							VIRUS CORE PROTEIN; FAMILIAL AMYLOIDOSIS; LIVER FIBROSIS; ACTIN; EXPRESSION; PLASMA; RESOLUTION; COMPLEXES; VARIANTS	Activated hepatic stellate cells (HSCs) are the major source for alteration of extracellular matrix in fibrosis and cirrhosis. Conditioned medium (CM) collected from immortalized human hepatocytes (IHH) have earlier been shown to be responsible for apoptosis of HSCs. In this study, we have shown that antibodies raised against a peptide derived from a linear B-cell epitope in the N-terminal region of gelsolin identified a gelsolin fragment in IHH CM. Analysis of activated stellate cell death by CM collected from Huh7 cells transfected with plasmids encoding gelsolin deletion mutants suggested that the N-terminal half of gelsolin contained sequences which were responsible for stellate cell death. Further analysis determined that this activity was restricted to a region encompassing amino acids 1-70 in the gelsolin sequence; antibody directed to an epitope within this region was able to neutralize stellate cell death. Gelsolin modulation of cell death using this fragment involved upregulation of TRAIL-R1 and TRAIL-R2, and involved caspase 3 activation by extrinsic pathway. The apoptotic activity of N-terminal gelsolin fragments was restricted to activated but not quiescent stellate cells indicating its potential application in therapeutic use as an anti-fibrotic agent. Gelsolin fragments encompassing N-terminal regions in polypeptides of different molecular sizes were detected by N-terminal peptide specific antiserum in IHH CM immunoprecipitated with chronically HCV infected patient sera, suggesting the presence of autoantibodies generated against N-terminal gelsolin fragments in patients with chronic liver disease.	[Mazumdar, Budhaditya; Meyer, Keith; Ray, Ranjit] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA; [Ray, Ranjit] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University	Mazumdar, B (corresponding author), St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA.	rayr@slu.edu			Saint Louis University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080812] Funding Source: NIH RePORTER	Saint Louis University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an internal research grant from Saint Louis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado R, 1997, CLIN SCI, V92, P103, DOI 10.1042/cs0920103; Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Arai M, 1999, DEV DYNAM, V215, P297, DOI 10.1002/(SICI)1097-0177(199908)215:4<297::AID-AJA2>3.3.CO;2-9; Arthur MJP, 2002, GASTROENTEROLOGY, V122, P1525, DOI 10.1053/gast.2002.33367; Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; Basu A, 2002, VIROLOGY, V298, P53, DOI 10.1006/viro.2002.1460; Basu A, 2006, APOPTOSIS, V11, P1391, DOI 10.1007/s10495-006-8312-z; Chen CD, 2001, EMBO J, V20, P6277, DOI 10.1093/emboj/20.22.6277; Fischer R, 2001, GASTROENTEROLOGY, V120, P1212, DOI 10.1053/gast.2001.23260; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; GRIFFITHS MR, 1991, J CLIN PATHOL, V44, P646, DOI 10.1136/jcp.44.8.646; Huff ME, 2003, J MOL BIOL, V334, P119, DOI 10.1016/j.jmb.2003.09.029; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; JANMEY PA, 1987, BLOOD, V70, P524; Kamada S, 1998, P NATL ACAD SCI USA, V95, P8532, DOI 10.1073/pnas.95.15.8532; Kangas H, 2002, AMYLOID, V9, P83, DOI 10.3109/13506120208995240; Khaitlina S, 2002, FEBS LETT, V521, P14, DOI 10.1016/S0014-5793(02)02657-1; Kiuru S, 1998, AMYLOID, V5, P55, DOI 10.3109/13506129809007291; Kiuru-Enari S, 2002, J NEUROPATH EXP NEUR, V61, P565, DOI 10.1093/jnen/61.6.565; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P8239; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; MARTINEZHERNANDEZ A, 1984, LAB INVEST, V51, P57; MISHRA VS, 1994, GENOMICS, V23, P560, DOI 10.1006/geno.1994.1543; Page LJ, 2005, EMBO J, V24, P4124, DOI 10.1038/sj.emboj.7600872; Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295; SMITH DB, 1988, AM J PATHOL, V130, P261; SMITH DB, 1987, J LAB CLIN MED, V110, P189; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Taimr P, 2003, HEPATOLOGY, V37, P87, DOI 10.1053/jhep.2003.50002; YIN HL, 1984, J BIOL CHEM, V259, P5271; Zapun A, 2000, BIOCHEM J, V350, P873, DOI 10.1042/0264-6021:3500873	34	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44461	10.1371/journal.pone.0044461	http://dx.doi.org/10.1371/journal.pone.0044461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952982	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000101
J	Wang, YJ; Zheng, Z; Wang, YC; Liu, JQ; Li, N; Hu, XL; Han, F; Liu, Y; Hu, DH				Wang, Yaojun; Zheng, Zhao; Wang, Yunchuan; Liu, Jiaqi; Li, Na; Hu, Xiaolong; Han, Fu; Liu, Yang; Hu, Dahai			Role of Donor-Specific Regulatory T Cells in Long-Term Acceptance of Rat Hind Limb Allograft	PLOS ONE			English	Article							COMPOSITE TISSUE ALLOTRANSPLANTATION; DOUBLE-HAND TRANSPLANTATION; IMMUNOSUPPRESSIVE DRUGS; HEMATOPOIETIC-CELLS; TOLERANCE; CHIMERISM; INDUCTION; REJECTION; SURVIVAL; THERAPY	Background: Vascularized bone marrow transplantation (VBMT) is widely accepted as an efficient means of establishing chimerism and inducing tolerance. However, the mechanism underlying is poorly understood. Recently, regulatory T cells (Tregs) have been shown to play an important role in regulating immune responses to allogeneic antigens. In this study, we explored the role of Tregs in the induction of tolerance in an allogeneic hind limb transplantation model. Methodology/Principal Findings: Forty-eight Lewis rats were divided into 6 groups. They received isografts and allografts from Brown-Norway hind limbs. Recipients in groups 1 and 2 received isografts and those in the other groups received allografts. The bone components of donor limbs were kept intact in groups 1, 3, and 5 but removed before transplantation into groups 2, 4, and 6. Tapered cyclosporin A (CsA) was administered to recipients in groups 5 and 6 after transplantation. During the 100-day observation period, all isografts survived, but the allografts in groups 3 and 4 were rejected within 8 to 12 days. CsA-treated intact allografts survived rejection-free for more than 100 days, and CsA-treated allografts lacking bone elements were rejected within 2 months. Stable peripheral chimerism and myeloid chimerism were observed in group 5. Declining peripheral chimerism and a lack of myeloid chimerism were observed in group 6. Donor-specific Tregs were exclusively detected in both peripheral blood and in the spleens of long-term recipient rats in group 5, with an increased FoxP3 mRNA expression in the allografts. This was further demonstrated to be responsible for donor-specific hyporeactivity by in vitro one-way mixed lymphocyte reaction (MLR). Conclusion/Significance: Bone components in the allogeneic hind limbs can induce myeloid chimerism and donor-specific Tregs may be essential to tolerance induction. The bone-removal hind limb model may be a suitable counterpart to the induction of tolerance in the study of limb transplantation.	[Wang, Yaojun; Zheng, Zhao; Wang, Yunchuan; Liu, Jiaqi; Li, Na; Hu, Xiaolong; Han, Fu; Liu, Yang; Hu, Dahai] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University	Wang, YJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi Provinc, Peoples R China.	burns@fmmu.edu.cn		Hu, Dahai/0000-0001-5543-092X	Academic Support Program Funds of Xijing Hospital, Fourth Military Medical University	Academic Support Program Funds of Xijing Hospital, Fourth Military Medical University	Research described in this article was supported by the Academic Support Program Funds of Xijing Hospital, Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsian E, 2007, MICROSURG, V27, P190; Bonde S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003212; Bozulic LD, 2011, TRANSPLANTATION, V91, P908, DOI 10.1097/TP.0b013e31820fafb4; Brandt C, 2009, ALLERGY, V64, P1588, DOI 10.1111/j.1398-9995.2009.02054.x; Brouha PCR, 2001, TRANSPLANTATION, V72, pS36; Cendales LC, 2006, TRANSPLANTATION, V81, P418, DOI 10.1097/01.tp.0000185304.49987.d8; Demirkiran A, 2008, TRANSPLANTATION, V85, P783, DOI 10.1097/TP.0b013e318166910b; Denecke C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009232; DOI K, 1979, PLAST RECONSTR SURG, V64, P613, DOI 10.1097/00006534-197964050-00003; Dubernard JM, 2003, ANN SURG, V238, P128, DOI 10.1097/01.SLA.0000078945.70869.82; Eljaafari A, 2006, TRANSPLANTATION, V82, P1764, DOI 10.1097/01.tp.0000250937.46187.ca; Foster RD, 2003, TRANSPLANTATION, V76, P988, DOI 10.1097/01.TP.0000079827.91675.A3; Hettiaratchy S, 2004, BRIT J PLAST SURG, V57, P381, DOI 10.1016/j.bjps.2004.02.012; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kreisel D, 2002, TRANSPLANTATION, V73, P1501, DOI 10.1097/00007890-200205150-00022; Kulahci Y, 2010, TRANSPLANTATION, V90, P843, DOI 10.1097/TP.0b013e3181f28bb0; Lanzetta M, 2005, TRANSPLANTATION, V79, P1210, DOI 10.1097/01.TP.0000157118.28394.FA; Levine E, 2005, ANN PLAS SURG, V54, P502, DOI 10.1097/01.sap.0000155282.48465.94; Piza-Katzer H, 2002, J HAND SURG-BRIT EUR, V27B, P385, DOI 10.1054/jhsb.2002.0759; Ravindra KV, 2008, TRANSPL P, V40, P1237, DOI 10.1016/j.transproceed.2008.04.003; Rifle G, 2003, TRANSPLANTATION, V75, p3S, DOI 10.1097/01.TP.0000067943.90241.73; Robinson E, 1996, BRIT J PLAST SURG, V49, P281, DOI 10.1016/S0007-1226(96)90156-3; Rossini AA, 1999, PHYSIOL REV, V79, P99, DOI 10.1152/physrev.1999.79.1.99; Santiago SF, 1999, MICROSURG, V19, P330; Siemionow M, 2002, J HAND SURG-AM, V27A, P1095, DOI 10.1053/jhsu.2002.36524; Starzl TE, 1998, NEW ENGL J MED, V339, P1905, DOI 10.1056/NEJM199812243392607; STEVENS HPJD, 1991, TRANSPLANT P, V23, P623; Tai CY, 2003, TRANSPLANTATION, V75, P1591, DOI 10.1097/01.TP.0000061490.85273.29; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Ye EM, 1998, BURNS, V24, P646, DOI 10.1016/S0305-4179(98)00081-3; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	31	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43825	10.1371/journal.pone.0043825	http://dx.doi.org/10.1371/journal.pone.0043825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952774	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000052
J	Fenoy, IM; Chiurazzi, R; Sanchez, VR; Argenziano, MA; Soto, A; Picchio, MS; Martin, V; Goldman, A				Fenoy, Ignacio M.; Chiurazzi, Romina; Sanchez, Vanesa R.; Argenziano, Mariana A.; Soto, Ariadna; Picchio, Mariano S.; Martin, Valentina; Goldman, Alejandra			Toxoplasma gondii Infection Induces Suppression in a Mouse Model of Allergic Airway Inflammation	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; HELMINTH INFECTION; IMMUNE-RESPONSES; MURINE MODEL; ASTHMA; IMMUNOSUPPRESSION; CYTOKINES; IL-10; MICE	Allergic asthma is an inflammatory disorder characterized by infiltration of the airway wall with inflammatory cells driven mostly by activation of Th2-lymphocytes, eosinophils and mast cells. There is a link between increased allergy and a reduction of some infections in Western countries. Epidemiological data also show that respiratory allergy is less frequent in people exposed to orofecal and foodborne microbes such as Toxoplasma gondii. We previously showed that both acute and chronic parasite T. gondii infection substantially blocked development of airway inflammation in adult BALB/c mice. Based on the high levels of IFN-gamma along with the reduction of Th2 phenotype, we hypothesized that the protective effect might be related to the strong Th1 immune response elicited against the parasite. However, other mechanisms could also be implicated. The possibility that regulatory T cells inhibit allergic diseases has received growing support from both animal and human studies. Here we investigated the cellular mechanisms involved in T. gondii induced protection against allergy. Our results show for the first time that thoracic lymph node cells from mice sensitized during chronic T. gondii infection have suppressor activity. Suppression was detected both in vitro, on allergen specific T cell proliferation and in vivo, on allergic lung inflammation after adoptive transference from infected/sensitized mice to previously sensitized animals. This ability was found to be contact-independent and correlated with high levels of TGF-beta and CD4(+) FoxP3(+) cells.	[Fenoy, Ignacio M.; Chiurazzi, Romina; Sanchez, Vanesa R.; Argenziano, Mariana A.; Soto, Ariadna; Picchio, Mariano S.; Martin, Valentina; Goldman, Alejandra] Univ Nacl San Martin, CESyMA, Escuela Ciencia & Tecnol, Buenos Aires, DF, Argentina		Fenoy, IM (corresponding author), Univ Nacl San Martin, CESyMA, Escuela Ciencia & Tecnol, Buenos Aires, DF, Argentina.	agoldman@unsam.edu.ar	Argenziano, Mariana/J-9692-2019; Picchio, Mariano/AAE-1114-2019; Argenziano, Mariana/J-5382-2019	Argenziano, Mariana/0000-0002-2825-581X; Argenziano, Mariana/0000-0002-2825-581X; Soto, Ariadna/0000-0002-7265-0956	National Agency for Scientific and Technological Promotion (ANPCyT, Argentina) [PICT 0562/08]; National Research Council (CONICET, Argentina) [PIP 0168]; UNSAM [SJ10/55]	National Agency for Scientific and Technological Promotion (ANPCyT, Argentina)(ANPCyT); National Research Council (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNSAM	This work was supported by PICT 0562/08 of the National Agency for Scientific and Technological Promotion (ANPCyT, Argentina), by PIP 0168 of the National Research Council (CONICET, Argentina) and by SJ10/55 of the UNSAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN IA, 1995, J IMMUNOL, V155, P3955; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Auffermann-Gratzinger S, 2001, BLOOD, V97, P3171, DOI 10.1182/blood.V97.10.3171; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Doetze A, 2000, INT IMMUNOL, V12, P623, DOI 10.1093/intimm/12.5.623; Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561; Fenoy I, 2009, CLIN EXP IMMUNOL, V155, P275, DOI 10.1111/j.1365-2249.2008.03813.x; Fernandes JFC, 2010, CLIN IMMUNOL, V136, P148, DOI 10.1016/j.clim.2010.02.019; Fonseca DM, 2012, CLIN EXP ALLERGY, V42, P131, DOI 10.1111/j.1365-2222.2011.03845.x; Gazzinelli RT, 1996, CURR TOP MICROBIOL, V219, P127; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Goni O, 2002, INT IMMUNOL, V14, P1125, DOI 10.1093/intimm/dxf076; Gredmark S, 2003, J VIROL, V77, P10943, DOI 10.1128/JVI.77.20.10943-10956.2003; Guilliams M, 2007, J IMMUNOL, V179, P2748, DOI 10.4049/jimmunol.179.5.2748; Hall BM, 2011, CURR OPIN IMMUNOL, V23, P641, DOI 10.1016/j.coi.2011.07.012; Hansen G, 2000, J CLIN INVEST, V105, P61, DOI 10.1172/JCI7589; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Kasper L, 2004, INT J PARASITOL, V34, P401, DOI 10.1016/j.ijpara.2003.11.023; KHAN IA, 1995, PARASITE IMMUNOL, V17, P185, DOI 10.1111/j.1365-3024.1995.tb00888.x; Kitagaki K, 2006, J IMMUNOL, V177, P1628, DOI 10.4049/jimmunol.177.3.1628; Kline JN, 2002, AM J PHYSIOL-LUNG C, V283, pL170, DOI 10.1152/ajplung.00402.2001; KuoLee R, 2008, CLIN EXP ALLERGY, V38, P1003, DOI 10.1111/j.1365-2222.2008.02956.x; Langermans JAM, 2001, PARASITE IMMUNOL, V23, P169, DOI 10.1046/j.1365-3024.2001.00371.x; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Matricardi PM, 2003, ALLERGY, V58, P461, DOI 10.1034/j.1398-9995.2003.00175.x; McGuirk P, 1998, EUR J IMMUNOL, V28, P153, DOI 10.1002/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.3.CO;2-R; McSorley HJ, 2008, J IMMUNOL, V181, P6456, DOI 10.4049/jimmunol.181.9.6456; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Morampudi V, 2011, MICROBES INFECT, V13, P394, DOI 10.1016/j.micinf.2011.01.006; Nakao A, 2000, J EXP MED, V192, P151, DOI 10.1084/jem.192.2.151; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Ozdemir C, 2009, CLIN EXP ALLERGY, V39, P626, DOI 10.1111/j.1365-2222.2009.03242.x; Tenorio EP, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/786078; Provoost S, 2009, ALLERGY, V64, P1539, DOI 10.1111/j.1398-9995.2009.02056.x; Qiu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022004; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Ring J, 2001, CURR OPIN IMMUNOL, V13, P701, DOI 10.1016/S0952-7915(01)00282-5; Robinson DS, 2010, J ALLERGY CLIN IMMUN, V126, P1081, DOI 10.1016/j.jaci.2010.06.025; Romagnani S, 2006, ALLERGY, V61, P3, DOI 10.1111/j.1398-9995.2006.01005; Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025; Sayers I, 2004, J ALLERGY CLIN IMMUN, V114, P302, DOI 10.1016/j.jaci.2004.03.057; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Smit JJ, 2003, EUR J PHARMACOL, V470, P193, DOI 10.1016/S0014-2999(03)01794-1; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Vigario AM, 2007, INT J PARASITOL, V37, P963, DOI 10.1016/j.ijpara.2007.01.004; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Wohlleben G, 2004, INT IMMUNOL, V16, P585, DOI 10.1093/intimm/dxh062; Wohlleben G, 2003, J IMMUNOL, V170, P4601, DOI 10.4049/jimmunol.170.9.4601; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	61	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43420	10.1371/journal.pone.0043420	http://dx.doi.org/10.1371/journal.pone.0043420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952678	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600023
J	Park, CS; Cha, H; Kwon, EJ; Jeong, D; Hajjar, RJ; Kranias, EG; Cho, C; Park, WJ; Kim, DH				Park, Chang Sik; Cha, Hyeseon; Kwon, Eun Jeong; Jeong, Dongtak; Hajjar, Roger J.; Kranias, Evangelia G.; Cho, Chunghee; Park, Woo Jin; Kim, Do Han			AAV-Mediated Knock-Down of HRC Exacerbates Transverse Aorta Constriction-Induced Heart Failure	PLOS ONE			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; INDUCED CARDIAC-HYPERTROPHY; CHANNEL RYANODINE RECEPTOR; CA-BINDING-PROTEIN; RICH CA2+-BINDING PROTEIN; HISTIDINE-RICH; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; DILATED CARDIOMYOPATHY; II PHOSPHORYLATION	Background: Histidine-rich calcium binding protein (HRC) is located in the lumen of sarcoplasmic reticulum (SR) that binds to both triadin (TRN) and SERCA affecting Ca2+ cycling in the SR. Chronic overexpression of HRC that may disrupt intracellular Ca2+ homeostasis is implicated in pathogenesis of cardiac hypertrophy. Ablation of HRC showed relatively normal phenotypes under basal condition, but exhibited a significantly increased susceptibility to isoproterenol-induced cardiac hypertrophy. In the present study, we characterized the functions of HRC related to Ca2+ cycling and pathogenesis of cardiac hypertrophy using the in vitro siRNA-and the in vivo adeno-associated virus (AAV)-mediated HRC knock-down (KD) systems, respectively. Methodology/Principal Findings: AAV-mediated HRC-KD system was used with or without C57BL/6 mouse model of transverse aortic constriction-induced failing heart (TAC-FH) to examine whether HRC-KD could enhance cardiac function in failing heart (FH). Initially we expected that HRC-KD could elicit cardiac functional recovery in failing heart (FH), since predesigned siRNA-mediated HRC-KD enhanced Ca2+ cycling and increased activities of RyR2 and SERCA2 without change in SR Ca2+ load in neonatal rat ventricular cells (NRVCs) and HL-1 cells. However, AAV9-mediated HRC-KD in TAC-FH was associated with decreased fractional shortening and increased cardiac fibrosis compared with control. We found that phospho-RyR2, phospho-CaMKII, phospho-p38 MAPK, and phospho-PLB were significantly upregulated by HRC-KD in TAC-FH. A significantly increased level of cleaved caspase-3, a cardiac cell death marker was also found, consistent with the result of TUNEL assay. Conclusions/Significance: Increased Ca2+ leak and cytosolic Ca2+ concentration due to a partial KD of HRC could enhance activity of CaMKII and phosphorylation of p38 MAPK, causing the mitochondrial death pathway observed in TAC-FH. Our results present evidence that down-regulation of HRC could deteriorate cardiac function in TAC-FH through perturbed SR-mediated Ca2+ cycling.	[Park, Chang Sik; Cha, Hyeseon; Kwon, Eun Jeong; Cho, Chunghee; Park, Woo Jin; Kim, Do Han] Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju, South Korea; [Park, Chang Sik; Cha, Hyeseon; Kwon, Eun Jeong; Cho, Chunghee; Park, Woo Jin; Kim, Do Han] Gwangju Inst Sci & Technol, Syst Biol Res Ctr, Kwangju, South Korea; [Jeong, Dongtak; Hajjar, Roger J.] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA; [Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Cincinnati	Park, CS (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju, South Korea.	dhkim@gist.ac.kr	Jeong, Dongtak/AAK-4194-2020; Jeong, Dongtak/ABA-7745-2020; Dongtak, Jeong/AGZ-5435-2022	Jeong, Dongtak/0000-0003-4153-3498; 	National Research Foundation (NRF) for the Ministry of Education, Science and Technology (MEST) [2011-0002144]; Gwangju Institute of Science and Technology.(GIST) [2011]	National Research Foundation (NRF) for the Ministry of Education, Science and Technology (MEST); Gwangju Institute of Science and Technology.(GIST)	This project was supported by: National Research Foundation (NRF) for the Ministry of Education, Science and Technology (MEST) grant (2011-0002144). Gwangju Institute of Science and Technology.(GIST) Systems Biology Infrastructure Establishment Grant (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Arvanitis DA, 2008, EUR HEART J, V29, P2514, DOI 10.1093/eurheartj/ehn328; Arvanitis DA, 2007, AM J PHYSIOL-HEART C, V293, pH1581, DOI 10.1152/ajpheart.00278.2007; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Cha H, 2010, EXP MOL MED, V42, P61, DOI 10.3858/emm.2010.42.1.006; CHEN SRW, 1993, BIOCHEMISTRY-US, V32, P3743, DOI 10.1021/bi00065a029; Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Diez J, 1998, CURR OPIN CARDIOL, V13, P317, DOI 10.1097/00001573-199809000-00005; Du GG, 2001, P NATL ACAD SCI USA, V98, P13625, DOI 10.1073/pnas.241516898; Fan GC, 2004, AM J PHYSIOL-HEART C, V287, pH1705, DOI 10.1152/ajpheart.01211.2003; Gregory KN, 2006, J MOL CELL CARDIOL, V40, P653, DOI 10.1016/j.yjmcc.2006.02.003; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Han PD, 2011, AM J PHYSIOL-HEART C, V301, pH1588, DOI 10.1152/ajpheart.01153.2010; Hang T, 2006, ANN CLIN LAB SCI, V36, P88; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; HOFMANN SL, 1989, J BIOL CHEM, V264, P18083; Jaehnig EJ, 2006, MOL CELL BIOL, V26, P9315, DOI 10.1128/MCB.00482-06; Jeong D, 2006, CIRC RES, V99, P307, DOI 10.1161/01.RES.0000234780.06115.2c; Jiang DW, 2002, CIRC RES, V91, P218, DOI 10.1161/01.RES.0000028455.36940.5E; KIM DH, 1994, J MOL CELL CARDIOL, V26, P1505, DOI 10.1006/jmcc.1994.1169; Kim E, 2003, BIOCHEM BIOPH RES CO, V300, P192, DOI 10.1016/S0006-291X(02)02829-2; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Lee HG, 2001, J BIOL CHEM, V276, P39533, DOI 10.1074/jbc.M010664200; Lee JM, 2004, J BIOL CHEM, V279, P6994, DOI 10.1074/jbc.M312446200; Lee SH, 2012, J MOL CELL CARDIOL, V52, P718, DOI 10.1016/j.yjmcc.2011.12.002; Linden RM, 2002, NAT BIOTECHNOL, V20, P987, DOI 10.1038/nbt1002-987; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Nguyen A, 2004, FEBS LETT, V572, P307, DOI 10.1016/j.febslet.2004.06.061; Palomeque J, 2009, CIRC RES, V105, P1204, DOI 10.1161/CIRCRESAHA.109.204172; PICELLO E, 1992, BIOCHEM BIOPH RES CO, V186, P659, DOI 10.1016/0006-291X(92)90797-O; Sahoo SK, 2009, J BIOL CHEM, V284, P31109, DOI 10.1074/jbc.M109.031989; Seo IR, 2006, BIOCHEM J, V399, P325, DOI 10.1042/BJ20060701; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Suk JY, 1999, BIOCHEM BIOPH RES CO, V263, P667, DOI 10.1006/bbrc.1999.1432; Terentyev D, 2005, CIRC RES, V96, P651, DOI 10.1161/01.RES.0000160609.98948.25; Ward P, 2003, J VIROL, V77, P11480, DOI 10.1128/JVI.77.21.11480-11490.2003; Ward P, 2000, J VIROL, V74, P744, DOI 10.1128/JVI.74.2.744-754.2000; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050; Zhou XY, 2007, CARDIOVASC RES, V75, P487, DOI 10.1016/j.cardiores.2007.04.005; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200	50	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43282	10.1371/journal.pone.0043282	http://dx.doi.org/10.1371/journal.pone.0043282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952658	Green Submitted, gold, Green Published			2022-12-27	WOS:000308213600019
J	Yamaguchi, A; Tanaka, S; Yamaguchi, S; Kuwahara, H; Takamura, C; Imajoh-Ohmi, S; Horikawa, DD; Toyoda, A; Katayama, T; Arakawa, K; Fujiyama, A; Kubo, T; Kunieda, T				Yamaguchi, Ayami; Tanaka, Sae; Yamaguchi, Shiho; Kuwahara, Hirokazu; Takamura, Chizuko; Imajoh-Ohmi, Shinobu; Horikawa, Daiki D.; Toyoda, Atsushi; Katayama, Toshiaki; Arakawa, Kazuharu; Fujiyama, Asao; Kubo, Takeo; Kunieda, Takekazu			Two Novel Heat-Soluble Protein Families Abundantly Expressed in an Anhydrobiotic Tardigrade	PLOS ONE			English	Article							LIFE-TARSE MISSION; TREHALOSE; SPACE; DESICCATION; SEQUENCE; MECHANISMS; RESISTANCE; TOLERANCE	Tardigrades are able to tolerate almost complete dehydration by reversibly switching to an ametabolic state. This ability is called anhydrobiosis. In the anhydrobiotic state, tardigrades can withstand various extreme environments including space, but their molecular basis remains largely unknown. Late embryogenesis abundant (LEA) proteins are heat-soluble proteins and can prevent protein-aggregation in dehydrated conditions in other anhydrobiotic organisms, but their relevance to tardigrade anhydrobiosis is not clarified. In this study, we focused on the heat-soluble property characteristic of LEA proteins and conducted heat-soluble proteomics using an anhydrobiotic tardigrade. Our heat-soluble proteomics identified five abundant heat-soluble proteins. All of them showed no sequence similarity with LEA proteins and formed two novel protein families with distinct subcellular localizations. We named them Cytoplasmic Abundant Heat Soluble (CAHS) and Secretory Abundant Heat Soluble (SAHS) protein families, according to their localization. Both protein families were conserved among tardigrades, but not found in other phyla. Although CAHS protein was intrinsically unstructured and SAHS protein was rich in beta-structure in the hydrated condition, proteins in both families changed their conformation to an alpha-helical structure in water-deficient conditions as LEA proteins do. Two conserved repeats of 19-mer motifs in CAHS proteins were capable to form amphiphilic stripes in alpha-helices, suggesting their roles as molecular shield in water-deficient condition, though charge distribution pattern in alpha-helices were different between CAHS and LEA proteins. Tardigrades might have evolved novel protein families with a heat-soluble property and this study revealed a novel repertoire of major heat-soluble proteins in these anhydrobiotic animals.	[Yamaguchi, Ayami; Tanaka, Sae; Yamaguchi, Shiho; Kuwahara, Hirokazu; Horikawa, Daiki D.; Kubo, Takeo; Kunieda, Takekazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Takamura, Chizuko; Imajoh-Ohmi, Shinobu] Univ Tokyo, Inst Med Sci, Tokyo 113, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Ctr Genet Resource Informat, Mishima, Shizuoka 411, Japan; [Katayama, Toshiaki] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo 113, Japan; [Arakawa, Kazuharu] Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa, Japan; [Fujiyama, Asao] Natl Inst Informat, Principles Informat Res Div, Tokyo, Japan	University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; Keio University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Yamaguchi, A (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	kunieda@biol.s.u-tokyo.ac.jp	KUBO, TAKEO/G-4951-2014; Kunieda, Takekazu/G-4946-2014	Arakawa, Kazuharu/0000-0002-2893-4919; Kunieda, Takekazu/0000-0002-6256-1335; Kubo, Takeo/0000-0002-5914-5269; Tanaka, Sae/0000-0002-3460-2777	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21710223, 20017010]; Grants-in-Aid for Scientific Research [21200043] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Young Scientists (B) 21710223, and a Grant-in-Aid for Scientific Research on Priority Areas, Comparative Genomics 20017010 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Dure L, 2001, PROTEIN PEPTIDE LETT, V8, P115, DOI 10.2174/0929866013409643; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Forster F, 2012, BIOINFORM BIOL INSIG, V6, P69, DOI 10.4137/BBI.S9150; Forster F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-469; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Horikawa DD, 2008, ASTROBIOLOGY, V8, P549, DOI 10.1089/ast.2007.0139; Jones BL, 2012, COMP BIOCHEM PHYS A, V162, P193, DOI 10.1016/j.cbpa.2012.02.020; Jonsson I., 2014, OPEN ZOOL J, V3, P1, DOI [10.2174/1874336601003010001, DOI 10.2174/1874336601003010001]; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Mali B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-168; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Persson D, 2011, J ZOOL SYST EVOL RES, V49, P90, DOI 10.1111/j.1439-0469.2010.00605.x; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rebecchi L, 2011, J ZOOL SYST EVOL RES, V49, P98, DOI 10.1111/j.1439-0469.2010.00606.x; Rebecchi L, 2009, ASTROBIOLOGY, V9, P581, DOI 10.1089/ast.2008.0305; SCHIEVANO E, 1994, BIOPOLYMERS, V34, P879, DOI 10.1002/bip.360340707; Schill RO, 2010, TOPICS CURRENT GENET, P133; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418; WESTH P, 1991, J EXP ZOOL, V258, P303, DOI 10.1002/jez.1402580305	32	68	76	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44209	10.1371/journal.pone.0044209	http://dx.doi.org/10.1371/journal.pone.0044209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937162	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600091
J	Islam, Z; Gilbert, M; Mohammad, QD; Klaij, K; Li, JJ; van Rijs, W; Tio-Gillen, AP; Talukder, KA; Willison, HJ; van Belkum, A; Endtz, HP; Jacobs, BC				Islam, Zhahirul; Gilbert, Michel; Mohammad, Quazi D.; Klaij, Kevin; Li, Jianjun; van Rijs, Wouter; Tio-Gillen, Anne P.; Talukder, Kaisar A.; Willison, Hugh J.; van Belkum, Alex; Endtz, Hubert P.; Jacobs, Bart C.			Guillain-Barre Syndrome-Related Campylobacter jejuni in Bangladesh: Ganglioside Mimicry and Cross-Reactive Antibodies	PLOS ONE			English	Article							CLINICAL-FEATURES; LIPOPOLYSACCHARIDES; INDUCTION; INFECTION; CHILDREN	Background: Campylobacter jejuni is the predominant antecedent infection in Guillain-Barre syndrome (GBS). Molecular mimicry and cross-reactive immune responses to C. jejuni lipo-oligosaccharides (LOS) precipitate the development of GBS, although this mechanism has not been established in patients from developing countries. We determined the carbohydrate mimicry between C. jejuni LOS and gangliosides, and the cross-reactive antibody response in patients with GBS in Bangladesh. Methodology: Sera from 97 GBS patients, and 120 neurological and family controls were tested for antibody reactivity against LOS from C. jejuni isolates from GBS patients in Bangladesh (BD-07, BD-39, BD-10, BD-67 and BD-94) by enzyme-linked immunosorbent assay (ELISA). Cross-reactivity to LOS was determined by ELISA. The LOS outer core structures of C. jejuni strains associated with GBS/MFS were determined by mass spectrometry. Principle Findings: IgG antibodies to LOS from C. jejuni BD-07, BD-39, BD-10, and BD-67 IgG antibodies were found in serum from 56%, 58%, 14% and 15% of GBS patients respectively, as compared to very low frequency (<3%) in controls (p<0.001). Monoclonal antibodies specific for GM1 and GD1a reacted strongly with LOS from the C. jejuni strains (BD-07 and BD-39). Mass spectrometry analysis confirmed the presence of GM1 and GD1a carbohydrate mimics in the LOS from C. jejuni BD-07 and BD-39. Both BD-10 and BD-67 express the same LOS outer core, which appears to be a novel structure displaying GA2 and GD3 mimicry. Up to 90-100% of serum reactivity to gangliosides in two patients (DK-07 and DK-39) was inhibited by 50 mu g/ml of LOS from the autologous C. jejuni isolates. However, patient DK-07 developed an anti-GD1a immune response while patient DK-39 developed an anti-GM1 immune response. Conclusion: Carbohydrate mimicry between C. jejuni LOS and gangliosides, and cross-reactive serum antibody precipitate the majority of GBS cases in Bangladesh.	[Islam, Zhahirul; Talukder, Kaisar A.; Endtz, Hubert P.] ICDDR B, Ctr Food & Waterborne Dis, Dhaka, Bangladesh; [Islam, Zhahirul; van Belkum, Alex; Endtz, Hubert P.] Univ Med Ctr, Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Gilbert, Michel; Li, Jianjun] Natl Res Council Canada, Ottawa, ON, Canada; [Mohammad, Quazi D.] Dhaka Med Coll Hosp, Dept Neurol, Dhaka, Bangladesh; [Willison, Hugh J.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	International Centre for Diarrhoeal Disease Research (ICDDR); Erasmus University Rotterdam; Erasmus MC; National Research Council Canada; Dhaka Medical College; University of Glasgow	Islam, Z (corresponding author), ICDDR B, Ctr Food & Waterborne Dis, Dhaka, Bangladesh.	zislam@icddrb.org	willison, hugh/HCI-7819-2022; Jacobs, Bart/ABE-2210-2021	Gilbert, Michel/0000-0002-0204-4408; Li, Jianjun/0000-0002-6531-3687; Islam, Dr. Zhahirul/0000-0003-0935-8079	Erasmus University Medical Centre, Rotterdam, The Netherlands; International Centre for Diarrhoeal Disease Research, Bangladesh's (icddr,b)	Erasmus University Medical Centre, Rotterdam, The Netherlands(Netherlands Government); International Centre for Diarrhoeal Disease Research, Bangladesh's (icddr,b)	This research study was funded by the Erasmus University Medical Centre, Rotterdam, The Netherlands and the International Centre for Diarrhoeal Disease Research, Bangladesh's (icddr,b) core donors which provide unrestricted support to icddr, b for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2002, INFECT IMMUN, V70, P1202, DOI 10.1128/IAI.70.3.1202-1208.2002; Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Ang CW, 1999, NEUROLOGY, V53, P2122, DOI 10.1212/WNL.53.9.2122; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; ASPINALL GO, 1995, EUR J BIOCHEM, V231, P570, DOI 10.1111/j.1432-1033.1995.0570d.x; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735; Islam Z, 2011, EMERG INFECT DIS, V17, P1317, DOI [10.3201/eid1707.101999, 10.3201/eid1707.102031]; Islam Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007257; Islam Z, 2009, EMERG INFECT DIS, V15, P1316, DOI 10.3201/eid1508.090120; Jacobs BC, 1997, J NEUROIMMUNOL, V79, P62, DOI 10.1016/S0165-5728(97)00110-0; Jacobs BC, 1997, J INFECT DIS, V175, P729, DOI 10.1093/infdis/175.3.729; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Jacobs BC, 1996, ANN NEUROL, V40, P181, DOI 10.1002/ana.410400209; Kaida K, 2004, ANN NEUROL, V56, P567, DOI 10.1002/ana.20222; Kaida K, 2009, GLYCOBIOLOGY, V19, P676, DOI 10.1093/glycob/cwp027; Kaida KI, 2006, J NEUROL NEUROSUR PS, DOI [10.1136/jnnp, DOI 10.1136/JNNP;087940]; Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; Kuijf ML, 2007, J NEUROIMMUNOL, V188, P69, DOI 10.1016/j.jneuroim.2007.05.014; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Kuijf ML, 2005, J NEUROL SCI, V239, P37, DOI 10.1016/j.jns.2005.07.009; Kusunoki S, 1999, MUSCLE NERVE, V22, P1071, DOI 10.1002/(SICI)1097-4598(199908)22:8<1071::AID-MUS10>3.0.CO;2-0; Li JJ, 2005, ELECTROPHORESIS, V26, P3360, DOI 10.1002/elps.200500145; Nachamkin I, 2007, NEUROLOGY, V69, P1665, DOI 10.1212/01.wnl.0000265396.87983.bd; Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002; PENNER JL, 1983, EUR J CLIN MICROBIOL, V2, P378, DOI 10.1007/BF02019474; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; Salloway S, 1996, INFECT IMMUN, V64, P2945, DOI 10.1128/IAI.64.8.2945-2949.1996; van Belkum A, 2001, NAT MED, V7, P752, DOI 10.1038/89831; Xiang SL, 2006, J NEUROIMMUNOL, V174, P126, DOI 10.1016/j.jneuroim.2006.02.009; Yuki N, 1997, J INFECT DIS, V176, pS150, DOI 10.1086/513800; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Yuki N, 2007, J PERIPHER NERV SYST, V12, P238, DOI 10.1111/j.1529-8027.2007.00153.x	37	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43976	10.1371/journal.pone.0043976	http://dx.doi.org/10.1371/journal.pone.0043976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952833	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000308044800083
J	Kong, SL; Liu, XY; Fu, LW; Yu, XC; An, CC				Kong, Shuanglei; Liu, Xinyao; Fu, Liwen; Yu, Xiangchun; An, Chengcai			I-PfoP3I: A Novel Nicking HNH Homing Endonuclease Encoded in the Group I Intron of the DNA Polymerase Gene in Phormidium foveolarum Phage Pf-WMP3	PLOS ONE			English	Article							COXIELLA-BURNETII; RNA; SEQUENCE; REGION; PSBA	Homing endonucleases encoded in a group I self-splicing intron in a protein-coding gene in cyanophage genomes have not been reported, apart from some free-standing homing edonucleases. In this study, a nicking DNA endonuclease, I-PfoP3I, encoded in a group IA2 intron in the DNA polymerase gene of a T7-like cyanophage Pf-WMP3, which infects the freshwater cyanobacterium Phormidium foveolarum is described. The Pf-WMP3 intron splices efficiently in vivo and self-splices in vitro simultaneously during transcription. I-PfoP3I belongs to the HNH family with an unconventional C-terminal HNH motif. I-PfoP3I nicks the intron-minus Pf-WMP3 DNA polymerase gene more efficiently than the Pf-WMP4 DNA polymerase gene that lacks any intervening sequence in vitro, indicating the variable capacity of I-PfoP3I. I-PfoP3I cleaves 4 nt upstream of the intron insertion site on the coding strand of EXON 1 on both intron-minus Pf-WMP3 and Pf-WMP4 DNA polymerase genes. Using an in vitro cleavage assay and scanning deletion mutants of the intronless target site, the minimal recognition site was determined to be a 14 bp region downstream of the cut site. I-PfoP3I requires Mg2+, Ca2+ or Mn2+ for nicking activity. Phylogenetic analysis suggests that the intron and homing endonuclease gene elements might be inserted in Pf-WMP3 genome individually after differentiation from Pf-WMP4. To our knowledge, this is the first report of the presence of a group I self-splicing intron encoding a functional homing endonuclease in a protein-coding gene in a cyanophage genome.	[Kong, Shuanglei; Liu, Xinyao; Fu, Liwen; Yu, Xiangchun; An, Chengcai] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Peking University	Kong, SL (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	chcaian@pku.edu.cn			National High Technology Research and Development Program of China [2006AA06Z341, 2004AA214072]; Beijing Natural Science Foundation [5062020]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National High Technology Research and Development Program of China [2006AA06Z341, 2004AA214072] (http://www.863.gov.cn/default.htm); and the Beijing Natural Science Foundation [5062020] (http://www.bjnsf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016825; BELFORT M, 1985, CELL, V41, P375, DOI 10.1016/S0092-8674(85)80010-6; BINISZKIEWICZ D, 1994, EMBO J, V13, P4629, DOI 10.1002/j.1460-2075.1994.tb06785.x; Bonocora RP, 2009, CURR BIOL, V19, P223, DOI 10.1016/j.cub.2009.01.033; Bonocora RP, 2004, J BACTERIOL, V186, P8153, DOI 10.1128/JB.186.23.8153-8155.2004; Bonocora RP, 2001, MOL MICROBIOL, V39, P1299, DOI 10.1111/j.1365-2958.2001.02318.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Edgell DR, 2000, J BACTERIOL, V182, P5281, DOI 10.1128/JB.182.19.5281-5289.2000; GoodrichBlair H, 1996, CELL, V84, P211, DOI 10.1016/S0092-8674(00)80976-9; Haugen P, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-159; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Johnson RM, 2009, CLIN CHIM ACTA, V400, P74, DOI 10.1016/j.cca.2008.10.006; Ko M, 2002, J BACTERIOL, V184, P3917, DOI 10.1128/JB.184.14.3917-3922.2002; Landthaler M, 2004, J BACTERIOL, V186, P4307, DOI 10.1128/JB.186.13.4307-4314.2004; Landthaler M, 2003, NUCLEIC ACIDS RES, V31, P3071, DOI 10.1093/nar/gkg433; Landthaler M, 2002, NUCLEIC ACIDS RES, V30, P1935, DOI 10.1093/nar/30.9.1935; Landthaler M, 2006, J MOL BIOL, V358, P1137, DOI 10.1016/J.JMB.2006.02.054; Lee CN, 2009, APPL ENVIRON MICROB, V75, P7828, DOI 10.1128/AEM.01214-09; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Liu XY, 2008, MICROB ECOL, V56, P671, DOI 10.1007/s00248-008-9386-7; Liu XY, 2007, VIROLOGY, V366, P28, DOI 10.1016/j.virol.2007.04.019; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Mehta P, 2004, PROTEIN SCI, V13, P295, DOI 10.1110/ps.03115604; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Millard AD, 2010, ISME J, V4, P1121, DOI 10.1038/ismej.2010.43; Nikolcheva T, 1997, RNA, V3, P1016; Nord D, 2007, J BACTERIOL, V189, P5293, DOI 10.1128/JB.00234-07; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Raghavan R, 2008, J BACTERIOL, V190, P5934, DOI 10.1128/JB.00602-08; Raghavan R, 2007, J BACTERIOL, V189, P6572, DOI 10.1128/JB.00812-07; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Shen BW, 2004, J MOL BIOL, V342, P43, DOI 10.1016/j.jmb.2004.07.032; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993; Zeng QL, 2009, CURR BIOL, V19, P218, DOI 10.1016/j.cub.2008.11.069; Zhao L, 2007, EMBO J, V26, P2432, DOI 10.1038/sj.emboj.7601672; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	2	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43738	10.1371/journal.pone.0043738	http://dx.doi.org/10.1371/journal.pone.0043738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952751	Green Submitted, gold, Green Published			2022-12-27	WOS:000308044800056
J	Pascalis, H; Temmam, S; Wilkinson, DA; Dsouli, N; Turpin, M; de Lamballerie, X; Dellagi, K				Pascalis, Herve; Temmam, Sarah; Wilkinson, David A.; Dsouli, Najla; Turpin, Magali; de lamballerie, Xavier; Dellagi, Koussay			Molecular Evolutionary Analysis of pH1N1 2009 Influenza Virus in Reunion Island, South West Indian Ocean Region: A Cohort Study	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; HEMAGGLUTININ; A(H1N1); TRANSMISSION; EMERGENCE; ORIGIN; INDIVIDUALS; INFECTION; SEVERITY	Background/Objectives: Molecular epidemiology is a powerful tool to decipher the dynamics of viral transmission, quasispecies temporal evolution and origins. Little is known about the pH1N1 molecular dynamics in general population. A prospective study (CoPanFlu-RUN) was carried out in Reunion Island to characterize pH1N1 genetic variability and molecular evolution occurring in population during the pH1N1 Influenza pandemic in 2009. Methodology: We directly amplified pH1N1 genomes from 28 different nasal swabs (26 individuals from 21 households). Fifteen strains were fully sequenced and 13 partially. This includes pairs of sequences from different members of 5 separate households; and two pairs from individuals, collected at different times. We assessed the molecular evolution of pH1N1 by genetic variability and phylogenetic analyses. Principal Findings: We found that i) Reunion pH1N1 sequences stemmed from global "clade 7'' but shaped two phylogenetic sub-clades; ii) D239E mutation was identified in the hemagglutinin protein of all Reunion sequences, a mutation which has been associated elsewhere with mild-, upper-respiratory tract pH1N1 infecting strains; iii) Date estimates from molecular phylogenies predicted clade emergence some time before the first detection of pH1N1 by the epidemiological surveillance system; iv) Phylogenetic relatedness was observed between Reunion pH1N1 viruses and those from other countries in South-western Indian Ocean area; v) Quasispecies populations were observed within households and individuals of the cohort-study. Conclusions: Surveillance and/or prevention systems presently based on Influenza virus sequence variation should take into account that the majority of studies of pH1N1 Influenza generate genetic data for the HA/NA viral segments obtained from hospitalized-patients, which is potentially non-representative of the overall viral diversity within whole populations. Our observations highlight the importance of collecting unbiased data at the community level and conducting whole genome analysis to accurately understand viral dynamics.	[Pascalis, Herve; Temmam, Sarah; Wilkinson, David A.; Dsouli, Najla; Turpin, Magali; Dellagi, Koussay] GIS CRVOI, Ctr Rech & Veille Malad Emergentes Ocean Indien, Plateforme Technol CYROI, St Denis, Reunion, France; [Temmam, Sarah] Univ Lyon, CNRS, Ecol Microbienne UMR 5557, Lyon, France; [Wilkinson, David A.] Univ Reunion, St Denis, Reunion, France; [de lamballerie, Xavier] Univ Mediterranee, IRD, Unite Virus Emergents UMR S 190, Marseille, France	Centre National de la Recherche Scientifique (CNRS); University of La Reunion; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Pascalis, H (corresponding author), GIS CRVOI, Ctr Rech & Veille Malad Emergentes Ocean Indien, Plateforme Technol CYROI, St Denis, Reunion, France.	herve.pascalis@ird.fr	Pascalis, Herve/F-5726-2014; Pascalis, Herve/M-9410-2019; TEMMAM, Sarah/AAX-3717-2021	Pascalis, Herve/0000-0002-6822-7311; Pascalis, Herve/0000-0002-6822-7311; TEMMAM, Sarah/0000-0003-3655-9220; Wilkinson, David/0000-0002-9986-6212; Abid, sayda/0000-0003-2488-1431	CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI; CRVOI; RUN-Emerge: European; European Commission under FP7 program; CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI; CRVOI; RUN-Emerge: European; European Commission under FP7 program	CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI(Institut National de la Sante et de la Recherche Medicale (Inserm)); CRVOI; RUN-Emerge: European; European Commission under FP7 program; CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund); INSERM/IMMI(Institut National de la Sante et de la Recherche Medicale (Inserm)); CRVOI; RUN-Emerge: European; European Commission under FP7 program	This study was supported by funds from CPER-ERDF (Contrat Programme Etat/Region and European Regional Development Fund), INSERM/IMMI and CRVOI. D.A. Wilkinson post-doctoral fellowships were funded by RUN-Emerge: European project funded by European Commission under FP7 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Barrero PR, 2011, J VIROL, V85, P1058, DOI 10.1128/JVI.00936-10; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Chan KH, 2011, CLIN VACCINE IMMUNOL, V18, P867, DOI 10.1128/CVI.00555-10; Chao DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014555; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x; Dellagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025738; Drummond AJ, 2010, GENEIOUS V5 3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Filleul L, 2010, LANCET INFECT DIS, V10, P294, DOI 10.1016/S1473-3099(10)70076-1; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Furuse Y, 2010, BIOINFORMATION, V5, P7, DOI 10.6026/97320630005007; Furuse Y, 2010, INFECT GENET EVOL, V10, P569, DOI 10.1016/j.meegid.2010.01.010; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Giria MT, 2011, J CLIN VIROLOGY OFFI; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Goni N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-215; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Gubareva LV, 2002, J INFECT DIS, V186, P1575, DOI 10.1086/345372; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ilyicheva T, 2011, INFECT GENET EVOL; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Koita OA, 2011, SEROEPIDEMIOLOGICAL; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Ninove L, 2010, VECTOR-BORNE ZOONOT, V10, P237, DOI 10.1089/vbz.2009.0110; Pariani E, 2011, J Prev Med Hyg, V52, P17; Parks D, 2009, PLOS CURRENTS, V1; Poon LLM, 2011, J CLIN VIROL, V52, P146, DOI 10.1016/j.jcv.2011.06.022; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; Tse H, 2011, EXP BIOL MED, V236, P915, DOI 10.1258/ebm.2011.010264; Zhang AJX, 2011, CLIN VACCINE IMMUNOL, V18, P1918, DOI 10.1128/CVI.05357-11; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43742	10.1371/journal.pone.0043742	http://dx.doi.org/10.1371/journal.pone.0043742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952752	Green Published, gold			2022-12-27	WOS:000308044800057
J	Potashkin, JA; Santiago, JA; Ravina, BM; Watts, A; Leontovich, AA				Potashkin, Judith A.; Santiago, Jose A.; Ravina, Bernard M.; Watts, Arthur; Leontovich, Alexey A.			Biosignatures for Parkinson's Disease and Atypical Parkinsonian Disorders Patients	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; PERIPHERAL-BLOOD LYMPHOCYTES; MITOCHONDRIAL COMPLEX-I; DIFFERENTIAL EXPRESSION; DOPAMINE-RECEPTOR; OXIDATIVE STRESS; GENE-EXPRESSION; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; IMMUNE CELLS	Diagnosis of Parkinson' disease (PD) carries a high misdiagnosis rate due to failure to recognize atypical parkinsonian disorders (APD). Usually by the time of diagnosis greater than 60% of the neurons in the substantia nigra are dead. Therefore, early detection would be beneficial so that therapeutic intervention may be initiated early in the disease process. We used splice variant-specific microarrays to identify mRNAs whose expression is altered in peripheral blood of early-stage PD patients compared to healthy and neurodegenerative disease controls. Quantitative polymerase chain reaction assays were used to validate splice variant transcripts in independent sample sets. Here we report a PD signature used to classify blinded samples with 90% sensitivity and 94% specificity and an APD signature that resulted in a diagnosis with 95% sensitivity and 94% specificity. This study provides the first discriminant functions with coherent diagnostic signatures for PD and APD. Analysis of the PD biomarkers identified a regulatory network with nodes centered on the transcription factors HNF4A and TNF, which have been implicated in insulin regulation.	[Potashkin, Judith A.; Santiago, Jose A.] Rosalind Franklin Univ Med & Sci, Cellular & Mol Pharmacol Dept, Chicago Med Sch, N Chicago, IL USA; [Ravina, Bernard M.] Univ Rochester, Dept Neurol, Sch Med, Rochester, NY USA; [Ravina, Bernard M.] Biogen Idec Inc, Cambridge, MA USA; [Watts, Arthur] Univ Rochester, Sch Med, Dept Biostat, Rochester, NY USA; [Leontovich, Alexey A.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA	Chicago Medical School; Rosalind Franklin University Medical & Science; University of Rochester; Biogen; University of Rochester; Mayo Clinic	Potashkin, JA (corresponding author), Rosalind Franklin Univ Med & Sci, Cellular & Mol Pharmacol Dept, Chicago Med Sch, N Chicago, IL USA.	judy.potashkin@rosalindfranklin.edu	Santiago, Jose A./CAJ-2999-2022	Santiago, Jose A./0000-0002-1431-5789	U.S. Army Medical Research and Materiel Command [W81XWH-09-0708, W23RRYX7022N606]	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the U.S. Army Medical Research and Materiel Command under awards number W81XWH-09-0708 to JAP and W23RRYX7022N606 to BMR [https://mrmc.amedd.army.mil/]. Opinions, conclusions, interpretations and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Barbanti P, 1999, MOVEMENT DISORD, V14, P764, DOI 10.1002/1531-8257(199909)14:5<764::AID-MDS1008>3.0.CO;2-W; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Ben-Shaul Y, 2006, EUR J NEUROSCI, V23, P2915, DOI 10.1111/j.1460-9568.2006.04812.x; Beyer K, 2008, NEUROGENETICS, V9, P163, DOI 10.1007/s10048-008-0124-6; Bieler S, 2012, J PROTEOME RES; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Caronti B, 1999, NEUROREPORT, V10, P2907, DOI 10.1097/00001756-199909290-00006; Caronti B, 2001, J NEURAL TRANSM, V108, P803, DOI 10.1007/s007020170030; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; D'Amelio M, 2009, PARKINSONISM RELAT D, V15, P660, DOI 10.1016/j.parkreldis.2009.02.013; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Fehlbaum-Beurdeley P, 2010, ALZHEIMERS DEMENT, V6, P25, DOI 10.1016/j.jalz.2009.07.001; Foti R, 2010, J BIOL CHEM, V285, P18565, DOI 10.1074/jbc.M109.088294; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gordon J, 2003, TRENDS IMMUNOL, V24, P438, DOI 10.1016/S1471-4906(03)00176-5; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ilani T, 2004, FASEB J, V18, DOI 10.1096/fj.04-1652fje; Kipnis J, 2004, J NEUROSCI, V24, P6133, DOI 10.1523/JNEUROSCI.0600-04.2004; Lines MA, 2012, AM J HUMAN GENETICS; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Maracchioni A, 2007, J NEUROCHEM, V100, P142, DOI 10.1111/j.1471-4159.2006.04204.x; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Meredith EJ, 2005, IMMUNOLOGY, V115, P289, DOI 10.1111/j.1365-2567.2005.02166.x; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Molochnikov L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-26; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Nagai Y, 1996, NEUROLOGY, V46, P791, DOI 10.1212/WNL.46.3.791; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Novikova SI, 2005, NEUROTOXICOL TERATOL, V27, P3, DOI 10.1016/j.ntt.2004.08.004; Petrozzi L, 2001, NEUROL SCI, V22, P83, DOI 10.1007/s100720170058; Poewe W, 2002, EUR J NEUROL, V9, P23, DOI 10.1046/j.1468-1331.9.s3.3.x; Potashkin JA, 2007, BRAIN RES, V1182, P1, DOI 10.1016/j.brainres.2007.08.080; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rasche A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-310; Ravina B, 2009, MOVEMENT DISORD, V24, P2081, DOI 10.1002/mds.22690; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sandyk R, 1993, Int J Neurosci, V69, P125; Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405; Savaskan NE, 2004, EUR J NEUROSCI, V19, P212, DOI 10.1046/j.1460-9568.2003.03078.x; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Scherzer CR, 2009, NEUROBIOL DIS, V35, P148, DOI 10.1016/j.nbd.2009.02.016; SCHULZ JB, 1994, CURR OPIN NEUROL, V7, P333, DOI 10.1097/00019052-199408000-00010; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; Soreq L, 2011, NEURODEGENERATIVE DI; Soreq L, 2008, J NEUROIMMUNOL, V201, P227, DOI 10.1016/j.jneuroim.2008.06.019; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Sunada Y, 1998, NEUROSCI LETT, V254, P180, DOI 10.1016/S0304-3940(98)00697-1; Taccioli C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar007; Takeo K, 2009, AM J PHYSIOL-CELL PH, V297, pC330, DOI 10.1152/ajpcell.00009.2009; Tan EK, 2005, NEUROGENETICS, V6, P179, DOI 10.1007/s10048-005-0001-5; Testa D, 2001, NEUROL SCI, V22, P247, DOI 10.1007/s100720100021; Turner L, 2011, METHODS MOL BIOL, V724, P269, DOI 10.1007/978-1-61779-055-3_17; ULITSKY I, 2010, PLOS ONE, V0005; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; Xu Q, 2011, DIABETES CARE, V34, P910, DOI 10.2337/dc10-1922; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	71	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43595	10.1371/journal.pone.0043595	http://dx.doi.org/10.1371/journal.pone.0043595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952715	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800042
J	Singh, VK; Das, K; Seshadri, K				Singh, Vivek K.; Das, Kaveri; Seshadri, Kothandaraman			Kinetic Modelling of GlmU Reactions - Prioritization of Reaction for Therapeutic Application	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRYPANOSOMA-BRUCEI; SYSTEMS BIOLOGY; ACETYLTRANSFERASE; REPRESENTATION; INHIBITORS; DRUGBANK; TOOLBOX; MATLAB; GENES	Mycobacterium tuberculosis(Mtu), a successful pathogen, has developed resistance against the existing anti-tubercular drugs necessitating discovery of drugs with novel action. Enzymes involved in peptidoglycan biosynthesis are attractive targets for antibacterial drug discovery. The bifunctional enzyme mycobacterial GlmU (Glucosamine 1-phosphate N-acetyltransferase/N-acetylglucosamine-1-phosphate uridyltransferase) has been a target enzyme for drug discovery. Its C-and N-terminal domains catalyze acetyltransferase (rxn-1) and uridyltransferase (rxn-2) activities respectively and the final product is involved in peptidoglycan synthesis. However, the bifunctional nature of GlmU poses difficulty in deciding which function to be intervened for therapeutic advantage. Genetic analysis showed this as an essential gene but it is still unclear whether any one or both of the activities are critical for cell survival. Often enzymatic activity with suitable high-throughput assay is chosen for random screening, which may not be the appropriate biological function inhibited for maximal effect. Prediction of rate-limiting function by dynamic network analysis of reactions could be an option to identify the appropriate function. With a view to provide insights into biochemical assays with appropriate activity for inhibitor screening, kinetic modelling studies on GlmU were undertaken. Kinetic model of Mtu GlmU-catalyzed reactions was built based on the available kinetic data on Mtu and deduction from Escherichia coli data. Several model variants were constructed including coupled/decoupled, varying metabolite concentrations and presence/absence of product inhibitions. This study demonstrates that in coupled model at low metabolite concentrations, inhibition of either of the GlmU reactions cause significant decrement in the overall GlmU rate. However at higher metabolite concentrations, rxn-2 showed higher decrement. Moreover, with available intracellular concentration of the metabolites and in vivo variant of model, uncompetitive inhibition of rxn-2 caused highest decrement. Thus, at physiologically relevant metabolite concentrations, targeting uridyltranferase activity of Mtu GlmU would be a better choice for therapeutic intervention.	[Singh, Vivek K.; Das, Kaveri; Seshadri, Kothandaraman] AstraZeneca India Pvt Ltd, Innovat Med Infect iMed Infect, Bangalore, Karnataka, India	AstraZeneca	Singh, VK (corresponding author), AstraZeneca India Pvt Ltd, Innovat Med Infect iMed Infect, Bangalore, Karnataka, India.	kothandaraman.seshadri@gmail.com			Astra Zeneca	Astra Zeneca(AstraZeneca)	The authors have read the journal's policy and have the following conflicts: This work was funded by Astra Zeneca, the employer of all authors. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bakker BM, 1997, J BIOL CHEM, V272, P3207, DOI 10.1074/jbc.272.6.3207; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Eisenthal R, 1998, J BIOL CHEM, V273, P5500, DOI 10.1074/jbc.273.10.5500; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Gehring AM, 1996, BIOCHEMISTRY-US, V35, P579, DOI 10.1021/bi952275a; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Irwin HS, 1993, ENZYME KINETICS BEHA; Jamshidi N, 2001, BIOINFORMATICS, V17, P286, DOI 10.1093/bioinformatics/17.3.286; Jamshidi N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.8; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keating SM, 2006, BIOINFORMATICS, V22, P1275, DOI 10.1093/bioinformatics/btl111; KUKKOKALSKE E, 1989, J BACTERIOL, V171, P4498, DOI 10.1128/JB.171.8.4498-4500.1989; Li YM, 2011, CARBOHYD RES, V346, P1714, DOI 10.1016/j.carres.2011.05.024; Marcellin Esteban, 2009, Biotechnology Journal, V4, P58, DOI 10.1002/biot.200800197; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; Mochalkin I, 2008, PROTEIN SCI, V17, P577, DOI 10.1110/ps.073271408; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Pereira MP, 2009, ANTIMICROB AGENTS CH, V53, P2306, DOI 10.1128/AAC.01572-08; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Singh VK, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-27; Smallbone K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-6; Vadali RV, 2004, METAB ENG, V6, P133, DOI 10.1016/j.ymben.2004.02.001; Who, 2010, TUB DAT; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Young JD, 2008, BIOTECHNOL BIOENG, V100, P542, DOI 10.1002/bit.21780; Zhang WL, 2008, INT J BIOCHEM CELL B, V40, P2560, DOI 10.1016/j.biocel.2008.05.003; Zhang Z, 2009, ACTA CRYSTALLOGR D, V65, P275, DOI 10.1107/S0907444909001036; Zhou Y, 2011, ARCH MICROBIOL, V193, P751, DOI 10.1007/s00203-011-0715-8	33	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43969	10.1371/journal.pone.0043969	http://dx.doi.org/10.1371/journal.pone.0043969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952829	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800080
J	Taniwaki, MH; Pitt, JI; Iamanaka, BT; Sartori, D; Copetti, MV; Balajee, A; Fungaro, MHP; Frisvad, JC				Taniwaki, Marta H.; Pitt, John I.; Iamanaka, Beatriz T.; Sartori, Daniele; Copetti, Marina V.; Balajee, Arun; Fungaro, Maria Helena P.; Frisvad, Jens C.			Aspergillus bertholletius sp. nov. from Brazil Nuts	PLOS ONE			English	Article							MYCOTOXINS	During a study on the mycobiota of brazil nuts (Bertholletia excelsa) in Brazil, a new Aspergillus species, A. bertholletius, was found, and is described here. A polyphasic approach was applied using morphological characters, extrolite data as well as partial beta-tubulin, calmodulin and ITS sequences to characterize this taxon. A. bertholletius is represented by nineteen isolates from samples of brazil nuts at various stages of production and soil close to Bertholletia excelsa trees. The following extrolites were produced by this species: aflavinin, cyclopiazonic acid, kojic acid, tenuazonic acid and ustilaginoidin C. Phylogenetic analysis using partial beta-tubulin and camodulin gene sequences showed that A. bertholletius represents a new phylogenetic clade in Aspergillus section Flavi. The type strain of A. bertholletius is CCT 7615 (=ITAL 270/06 = IBT 29228).	[Taniwaki, Marta H.; Iamanaka, Beatriz T.] Inst Tecnol Alimentos, Ctr Ciencia & Qualidade Alimentos, Sao Paulo, Brazil; [Pitt, John I.] CSIRO Anim Food & Hlth Sci, Sydney, NSW, Australia; [Sartori, Daniele; Fungaro, Maria Helena P.] Univ Estadual Londrina, Ctr Ciencias Biol, Londrina, Parana, Brazil; [Copetti, Marina V.] Univ Fed Santa Maria, Dept Tecnol & Ciencia Alimentos, BR-97119900 Santa Maria, RS, Brazil; [Balajee, Arun] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; [Frisvad, Jens C.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade Estadual de Londrina; Universidade Federal de Santa Maria (UFSM); Centers for Disease Control & Prevention - USA; Technical University of Denmark	Taniwaki, MH (corresponding author), Inst Tecnol Alimentos, Ctr Ciencia & Qualidade Alimentos, Sao Paulo, Brazil.	marta@ital.sp.gov.br	Frisvad, Jens C/K-2818-2017; Fapesp, Biota/F-8655-2017; Fungaro, Maria Helena P/H-7369-2014; Taniwaki, Marta/ABF-9849-2021; Copetti, Marina/ABG-3490-2020	Frisvad, Jens C/0000-0002-0573-4340; Fapesp, Biota/0000-0002-9887-8449; Fungaro, Maria Helena P/0000-0002-6199-7030; Taniwaki, Marta/0000-0002-1676-2101; Copetti, Marina/0000-0002-1419-9159	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministerio da Agricultura, Pecuaria e Abastecimento, (MAPA) Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Agricultura, Pecuaria e Abastecimento, (MAPA) Brazil	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Ministerio da Agricultura, Pecuaria e Abastecimento, (MAPA) Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo A. C. S., 2000, Scientia Agricola, V57, P729, DOI 10.1590/S0103-90162000000400021; Bayman P, 2002, MYCOPATHOLOGIA, V155, P161, DOI 10.1023/A:1020419226146; Freire FDO, 2000, MYCOPATHOLOGIA, V149, P13, DOI 10.1023/A:1007241827937; FRISVAD JC, 1987, J CHROMATOGR, V404, P195, DOI 10.1016/S0021-9673(01)86850-3; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Goncalves JS, 2012, WORLD J MICROB BIOT, V28, P1817, DOI 10.1007/s11274-011-0956-3; Hong SB, 2006, INT J SYST EVOL MICR, V56, P477, DOI 10.1099/ijs.0.63980-0; Houbraken J, 2012, ANTON LEEUW INT J G, V101, P403, DOI 10.1007/s10482-011-9647-1; Kornerup A., 1978, METHUEN HDB COLOUR; Olsen M, 2008, WORLD MYCOTOXIN J, V1, P123, DOI 10.3920/WMJ2008.1032; Pitt J. I., 2009, FUNGI FOOD SPOILAGE, DOI DOI 10.3114/sim.2007.59.13; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varga J, 2011, STUD MYCOL, P57, DOI 10.3114/sim.2011.69.05; Wadt LHO, 2005, FOREST ECOL MANAG, V211, P371, DOI 10.1016/j.foreco.2005.02.061; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	17	20	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42480	10.1371/journal.pone.0042480	http://dx.doi.org/10.1371/journal.pone.0042480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952594	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800008
J	Horakova, O; Medrikova, D; van Schothorst, EM; Bunschoten, A; Flachs, P; Kus, V; Kuda, O; Bardova, K; Janovska, P; Hensler, M; Rossmeisl, M; Wang-Sattler, R; Prehn, C; Adamski, J; Illig, T; Keijer, J; Kopecky, J				Horakova, Olga; Medrikova, Dasa; van Schothorst, Evert M.; Bunschoten, Annelies; Flachs, Pavel; Kus, Vladimir; Kuda, Ondrej; Bardova, Kristina; Janovska, Petra; Hensler, Michal; Rossmeisl, Martin; Wang-Sattler, Rui; Prehn, Cornelia; Adamski, Jerzy; Illig, Thomas; Keijer, Jaap; Kopecky, Jan			Preservation of Metabolic Flexibility in Skeletal Muscle by a Combined Use of n-3 PUFA and Rosiglitazone in Dietary Obese Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ACTIVATED-RECEPTOR-ALPHA; FISH-OIL; INSULIN SENSITIVITY; WEIGHT-LOSS; MARINE ORIGIN; EICOSAPENTAENOIC ACID; GLYCOGEN-SYNTHESIS; MALONYL-COA; FIBER TYPES	Insulin resistance, the key defect in type 2 diabetes (T2D), is associated with a low capacity to adapt fuel oxidation to fuel availability, i.e., metabolic inflexibility. This, in turn, contributes to a further damage of insulin signaling. Effectiveness of T2D treatment depends in large part on the improvement of insulin sensitivity and metabolic adaptability of the muscle, the main site of whole-body glucose utilization. We have shown previously in mice fed an obesogenic high-fat diet that a combined use of n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) and thiazolidinediones (TZDs), anti-diabetic drugs, preserved metabolic health and synergistically improved muscle insulin sensitivity. We investigated here whether n-3 LC-PUFA could elicit additive beneficial effects on metabolic flexibility when combined with a TZD drug rosiglitazone. Adult male C57BL/6N mice were fed an obesogenic corn oil-based high-fat diet (cHF) for 8 weeks, or randomly assigned to various interventions: cHF with n-3 LC-PUFA concentrate replacing 15% of dietary lipids (cHF+F), cHF with 10 mg rosiglitazone/kg diet (cHF+ROSI), cHF+F+ROSI, or chow-fed. Indirect calorimetry demonstrated superior preservation of metabolic flexibility to carbohydrates in response to the combined intervention. Metabolomic and gene expression analyses in the muscle suggested distinct and complementary effects of the interventions, with n-3 LC-PUFA supporting complete oxidation of fatty acids in mitochondria and the combination with n-3 LC-PUFA and rosiglitazone augmenting insulin sensitivity by the modulation of branched-chain amino acid metabolism. These beneficial metabolic effects were associated with the activation of the switch between glycolytic and oxidative muscle fibers, especially in the cHF+F+ROSI mice. Our results further support the idea that the combined use of n-3 LC-PUFA and TZDs could improve the efficacy of the therapy of obese and diabetic patients.	[Horakova, Olga; Medrikova, Dasa; Flachs, Pavel; Kus, Vladimir; Kuda, Ondrej; Bardova, Kristina; Janovska, Petra; Hensler, Michal; Rossmeisl, Martin; Kopecky, Jan] Acad Sci Czech Republ Vvi, Inst Physiol, Dept Adipose Tissue Biol, Prague, Czech Republic; [van Schothorst, Evert M.; Bunschoten, Annelies; Keijer, Jaap] Wageningen Univ, Dept Human & Anim Physiol, Wageningen, Netherlands; [Wang-Sattler, Rui; Illig, Thomas] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Prehn, Cornelia; Adamski, Jerzy] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Wageningen University & Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Horakova, O (corresponding author), Acad Sci Czech Republ Vvi, Inst Physiol, Dept Adipose Tissue Biol, Prague, Czech Republic.	kopecky@biomed.cas.cz	Janovska, Petra/E-7160-2013; Rossmeisl, Martin/C-1892-2012; Rossmeisl, Martin/CAF-0060-2022; Hensler, Michal/C-7986-2012; Flachs, Pavel/A-5341-2012; Horakova, Olga/C-8001-2012; Kopecky, Jan/B-8244-2012; Wang-Sattler, Rui/B-5354-2014; Kuda, Ondrej/B-7990-2012; Bardova, Kristina/C-3493-2015; Keijer, Jaap/J-8089-2013	Janovska, Petra/0000-0002-6154-2175; Rossmeisl, Martin/0000-0001-8534-4002; Rossmeisl, Martin/0000-0001-8534-4002; Horakova, Olga/0000-0003-0933-4616; Kopecky, Jan/0000-0001-8072-2035; Wang-Sattler, Rui/0000-0002-8794-8229; Kuda, Ondrej/0000-0001-7034-4536; Bardova, Kristina/0000-0002-2297-5066; Adamski, Jerzy/0000-0001-9259-0199; van Schothorst, Evert/0000-0002-3036-5903; Keijer, Jaap/0000-0002-9720-7491; Prehn, Cornelia/0000-0002-1274-4715	Czech Science Foundation [303/08/0664, RVO: 67985823]; EPAX AS (Norway); European Union's Seventh Framework Programme [244995]; EFSD New Horizons research grant; German Federal Ministry of Education and Research (BMBF)	Czech Science Foundation(Grant Agency of the Czech Republic); EPAX AS (Norway); European Union's Seventh Framework Programme; EFSD New Horizons research grant; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The research leading to these results has received funding from the Czech Science Foundation (303/08/0664), RVO: 67985823, EPAX AS (Norway), the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement no 244995 (BIOCLAIMS), and the EFSD New Horizons research grant. This project has been also in part supported by a Grant from the German Federal Ministry of Education and Research (BMBF) to the German Center Diabetes Research (DZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Baranowski M, 2007, PROSTAG OTH LIPID M, V83, P99, DOI 10.1016/j.prostaglandins.2006.10.004; Bays HE, 2010, CURR MED RES OPIN, V26, P907, DOI 10.1185/03007991003645318; BELZUNG F, 1993, AM J PHYSIOL, V264, pR1111, DOI 10.1152/ajpregu.1993.264.6.R1111; Blachnio-Zabielska A, 2011, LIPIDS, V46, P229, DOI 10.1007/s11745-010-3515-z; Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988; Corpeleijn E, 2008, OBESITY, V16, P1025, DOI 10.1038/oby.2008.24; Couet C, 1997, INT J OBESITY, V21, P637, DOI 10.1038/sj.ijo.0800451; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; ESSEN B, 1975, ACTA PHYSIOL SCAND, V95, P153, DOI 10.1111/j.1748-1716.1975.tb10038.x; FASCHING P, 1991, DIABETES, V40, P583, DOI 10.2337/diabetes.40.5.583; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HILL JO, 1993, INT J OBESITY, V17, P223; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Hunt MC, 2006, FASEB J, V20, P1855, DOI 10.1096/fj.06-6042com; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Jucker BM, 1999, DIABETES, V48, P134, DOI 10.2337/diabetes.48.1.134; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kim HG, 2008, TOXICOLOGY, V246, P166, DOI 10.1016/j.tox.2008.01.003; Kischel P, 2001, J APPL PHYSIOL, V90, P1095, DOI 10.1152/jappl.2001.90.3.1095; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krebs JD, 2006, INT J OBESITY, V30, P1535, DOI 10.1038/sj.ijo.0803309; Kromhout D, 2011, DIABETES CARE, V34, P2515, DOI 10.2337/dc11-0896; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Kunesova M, 2006, PHYSIOL RES, V55, P63, DOI 10.33549/physiolres.930770; Kus V, 2008, AM J PHYSIOL-ENDOC M, V295, pE356, DOI 10.1152/ajpendo.90256.2008; Kus V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027126; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MacLean CH, 2004, AHRQ PUBLICATION, V04-E012-2; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Mori TA, 1999, AM J CLIN NUTR, V70, P817; Munro IA, 2012, BR J NUTR, P1; Nathan DM, 2008, DIABETOLOGIA, V51, P8, DOI 10.1007/s00125-007-0873-z; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Nettleton JA, 2005, J AM DIET ASSOC, V105, P428, DOI 10.1016/j.jada.2004.11.029; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; PELIKANOVA T, 1993, ANN NY ACAD SCI, V683, P272; Punthakee Z, 2012, DIABETOLOGIA, V55, P36, DOI 10.1007/s00125-011-2357-4; Raclot T, 1997, J LIPID RES, V38, P1963; Reyes-Soffer G, 2011, EXPERT OPIN PHARMACO, V12, P1429, DOI 10.1517/14656566.2011.563506; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; RUSTAN AC, 1993, J LIPID RES, V34, P1299; Ruxton CH, 2007, J HUM NUTR DIET, V17, P449; Ruzickova J, 2004, LIPIDS, V39, P1177, DOI 10.1007/s11745-004-1345-9; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Szendroedi J, 2008, DIABETOLOGIA, V51, P2155, DOI 10.1007/s00125-008-1153-2; Thorsdottir I, 2007, INT J OBESITY, V31, P1560, DOI 10.1038/sj.ijo.0803643; Tillmann H, 2000, GENE, V247, P241, DOI 10.1016/S0378-1119(00)00079-2; Todd MK, 2007, AM J PHYSIOL-ENDOC M, V292, pE485, DOI 10.1152/ajpendo.00080.2006; van Helden YGJ, 2010, CARCINOGENESIS, V31, P1329, DOI 10.1093/carcin/bgq083; van Schothorst EM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-110; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zhou GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026589	76	50	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43764	10.1371/journal.pone.0043764	http://dx.doi.org/10.1371/journal.pone.0043764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952760	Green Published, gold			2022-12-27	WOS:000308221300026
J	Neirynck, N; Eloot, S; Glorieux, G; Barreto, DV; Barreto, FC; Liabeuf, S; Lenglet, A; Lemke, HD; Massy, ZA; Vanholder, R				Neirynck, Nathalie; Eloot, Sunny; Glorieux, Griet; Barreto, Daniela V.; Barreto, Fellype C.; Liabeuf, Sophie; Lenglet, Aurelie; Lemke, Horst D.; Massy, Ziad A.; Vanholder, Raymond			Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease	PLOS ONE			English	Article							GROWTH-FACTOR 23; CYSTATIN-C; CARDIOVASCULAR MORTALITY; CREATININE CLEARANCE; SERUM CREATININE; POOLED ANALYSIS; RENAL-DISEASE; ALL-CAUSE; HEMODIALYSIS; INTERLEUKIN-6	Background: Uremic solute concentration increases as Glomerular Filtration Rate (GFR) declines. Weak associations were demonstrated between estimated GFR (eGFR) and the concentrations of several small water-soluble and protein-bound uremic solutes (MW<500Da). Since also middle molecular weight proteins have been associated with mortality and cardiovascular damage in Chronic Kidney Disease (CKD), we investigated the association between several eGFR formulae and the concentration of Low Molecular Weight Proteins (LMWP) (MW>500Da). Materials and Methods: In 95 CKD-patients (CKD-stage 2-5 not on dialysis), associations between different eGFR-formulae (creatinine, CystatinC-based or both) and the natural logarithm of the concentration of several LMWP's were analyzed: i.e. parathyroid hormone (PTH), Cystatin C (CystC), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), leptin, retinol binding protein (RbP), immunoglobin light chains kappa and lambda (Ig-kappa and Ig-lambda), beta-2-microglobulin (beta M-2), myoglobin and fibroblast growth factor-23 (FGF-23)). Results: The regression coefficients (R-2) between eGFR, based on the CKD-EPI-Crea-CystC-formula as reference, and the examined LMWP's could be divided into three groups. Most of the LMWP's associated weakly (R-2 <0.2) (FGF-23, leptin, IL-6, TNF-alpha, Ig-kappa, Ig-lambda) or intermediately (R-2 0.2-0.7) (RbP, myoglobin, PTH). Only beta M-2 and CystC showed a strong association (R-2 >0.7). Almost identical R-2-values were found per LMWP for all eGFR-formulae, with exception of CystC and beta M-2 which showed weaker associations with creatinine-based than with CystC-based eGFR. Conclusion: The association between eGFR and the concentration of several LMWP's is inconsistent, with in general low R-2-values. Thus, the use of eGFR to evaluate kidney function does not reflect the concentration of several LMWP's with proven toxic impact in CKD.	[Neirynck, Nathalie; Eloot, Sunny; Glorieux, Griet; Vanholder, Raymond] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium; [Barreto, Daniela V.; Barreto, Fellype C.; Liabeuf, Sophie; Lenglet, Aurelie; Massy, Ziad A.] INSERM, U1088, Amiens, France; [Barreto, Daniela V.; Barreto, Fellype C.; Liabeuf, Sophie; Massy, Ziad A.] Amiens Univ Hosp, Div Clin Pharmacol, Clin Res Ctr, Amiens, France; [Barreto, Daniela V.; Barreto, Fellype C.; Liabeuf, Sophie; Massy, Ziad A.] Jules Verne Univ Picardy, Amiens, France; [Lenglet, Aurelie; Massy, Ziad A.] Amiens Univ Hosp, Div Nephrol, Amiens, France; [Lemke, Horst D.] EXcorLab GmbH, Obernburg, Germany	Ghent University; Ghent University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Neirynck, N (corresponding author), Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium.	n.neirynck@ugent.be	, liabeuf/AFB-7848-2022; Barreto, Fellype C/C-6517-2012	Barreto, Fellype C/0000-0002-6394-9227	Amiens University hospital [PHRC: 2006/0100]; European Uremic Toxin Workgroup (EUTox); Belgian Fund for research Flanders (FWO Vlaanderen); Picardy Regional Council/Jules Verne University of Picardy; National Council of Technological and Scientific Development (CNPq), Brazil	Amiens University hospital; European Uremic Toxin Workgroup (EUTox); Belgian Fund for research Flanders (FWO Vlaanderen); Picardy Regional Council/Jules Verne University of Picardy(Region Hauts-de-France); National Council of Technological and Scientific Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by a Grant of the Amiens University hospital [PHRC: 2006/0100 (27/03/2006)] and a Grant from European Uremic Toxin Workgroup (EUTox). SE received post-doctoral grant of the Belgian Fund for research Flanders (FWO Vlaanderen). DVB and FCB received postdoctoral grants from the Picardy Regional Council/Jules Verne University of Picardy and postdoctoral scolarships from the National Council of Technological and Scientific Development (CNPq), Brazil. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astor BC, 2012, AM J KIDNEY DIS, V59, P653, DOI 10.1053/j.ajkd.2011.11.042; Bacchetta J, 2010, J CLIN ENDOCR METAB, V95, P1741, DOI 10.1210/jc.2009-1576; Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Christensen EI, 2001, AM J PHYSIOL-RENAL, V280, pF562, DOI 10.1152/ajprenal.2001.280.4.F562; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Donadio C, 2001, J PHARMACEUT BIOMED, V24, P835, DOI 10.1016/S0731-7085(00)00550-1; Drueke TB, 2009, SEMIN DIALYSIS, V22, P378, DOI 10.1111/j.1525-139X.2009.00584.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eloot S, 2011, CLIN J AM SOC NEPHRO, V6, P1266, DOI 10.2215/CJN.09981110; Futh R, 2004, CYTOKINE, V27, P166, DOI 10.1016/j.cyto.2004.05.006; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; HALLGREN R, 1978, J LAB CLIN MED, V91, P246; Hutchison CA, 2008, CLIN J AM SOC NEPHRO, V3, P1684, DOI 10.2215/CJN.02290508; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Ix JH, 2010, NEPHROL DIAL TRANSPL, V25, P993, DOI 10.1093/ndt/gfp699; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Keller C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-9; Kimmel PL, 1998, KIDNEY INT, V54, P236, DOI 10.1046/j.1523-1755.1998.00981.x; Kuan Y, 2005, NEPHROL DIAL TRANSPL, V20, P2394, DOI 10.1093/ndt/gfi076; Le Bricon T, 2000, CLIN CHEM, V46, P1206; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lilitkarntakul P, 2011, ATHEROSCLEROSIS, V216, P217, DOI 10.1016/j.atherosclerosis.2011.01.045; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; Menon V, 2004, CLIN NEPHROL, V61, P163; Okuno S, 2009, NEPHROL DIAL TRANSPL, V24, P571, DOI 10.1093/ndt/gfn521; Panichi V, 2004, NEPHROL DIAL TRANSPL, V19, P1154, DOI 10.1093/ndt/gfh052; Pecoits R, 2003, AM J KIDNEY DIS, V41, P1212, DOI 10.1016/S0272-6386(03)00353-6; Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1684, DOI 10.1093/ndt/17.9.1684; Rule AD, 2006, KIDNEY INT, V69, P399, DOI 10.1038/sj.ki.5000073; Schepers E, 2011, CLIN J AM SOC NEPHRO, V6, P2374, DOI 10.2215/CJN.01720211; Sciarretta S, 2010, J HYPERTENS, V28, P251, DOI 10.1097/HJH.0b013e3283326718; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Tripepi G, 2005, J AM SOC NEPHROL, V16, pS83, DOI 10.1681/ASN.2004110972; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Vanholder R, 2012, SEMIN DIALYSIS, V25, P9, DOI 10.1111/j.1525-139X.2011.01003.x; Weiner DE, 2007, J AM COLL CARDIOL, V50, P217, DOI 10.1016/j.jacc.2007.03.037; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194	54	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44201	10.1371/journal.pone.0044201	http://dx.doi.org/10.1371/journal.pone.0044201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952928	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300063
J	Olsen, HH; Grunewald, J; Tornling, G; Skold, CM; Eklund, A				Olsen, Helga H.; Grunewald, Johan; Tornling, Goran; Skold, C. Magnus; Eklund, Anders			Bronchoalveolar Lavage Results Are Independent of Season, Age, Gender and Collection Site	PLOS ONE			English	Article							NORMAL VOLUNTEER SUBJECT; BRONCHIAL BIOPSIES; CELL COUNTS; FLUID; COPD	Background: Clinical interpretation of bronchoalveolar lavage fluid results is dependent on the availability of reference values for healthy individuals. Only a few studies have published such reference values and the applicability of results is restricted by small sample sizes and the limited representativeness of the study population. We aim to investigate the influence of age, gender, collection site and season on bronchoalveolar lavage fluid results and to establish reference values for use in clinical practice. Methodology/Principal Findings: Bronchoalveolar lavage fluid data from 295 healthy never-smoking volunteers, investigated during 1990-2009, were analyzed retrospectively. 47 volunteers had 2-5 repeat lavages during the course of several years. Fluid recovery, total number of cells, cell concentration, and differential cell counts on cytospin prepared slides were recorded. Reference values, as represented by the 5th to the 95th percentile, were 72-96% for macrophages, 2-26% for lymphocytes, 0-4% for neutrophils and 0-1% for eosinophils. Basophils and mast cells were rare. When repeat lavages were performed, there was a relatively large intra-individual variability, mainly for macrophages and lymphocytes. An age dependent decrease of lavage fluid return was present, but there was no age dependent correlation with any of the other BALF parameters. The BALF cell parameters were independent of gender, season and site (lingula vs. middle lobe). Conclusions/Significance: Our data show that bronchoalveolar lavage fluid cell differential count is independent of age, gender, season and collection site (RML or lingua). It therefore seems acceptable to use the same reference values for all never-smoking individuals.	[Olsen, Helga H.; Grunewald, Johan; Tornling, Goran; Skold, C. Magnus; Eklund, Anders] Karolinska Univ Hosp, Div Resp Med, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Olsen, HH (corresponding author), Karolinska Univ Hosp, Div Resp Med, Dept Med, Stockholm, Sweden.	helga.haugomolsen@mpa.se	Grunewald, Johan/GQZ-8122-2022	Grunewald, Johan/0000-0003-0473-3984	AstraZeneca; Swedish Heart and Lung Foundation; Swedish Medical Research Council; Stockholm County Council	AstraZeneca(AstraZeneca); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm County Council(Stockholm County Council)	JG and AE received financial support from AstraZeneca to be able to pay a statistician and a BMA for a shorter time helping in putting data together. Funding was also received from The Swedish Heart and Lung Foundation, The Swedish Medical Research Council and Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbi B, 2007, EUR RESPIR J, V30, P769, DOI 10.1183/09031936.00112306; BANKS DE, 1990, AM J MED SCI, V300, P275, DOI 10.1097/00000441-199011000-00001; BARBERS RG, 1987, AM REV RESPIR DIS, V135, P1271; Behndig AF, 2006, EUR RESPIR J, V27, P359, DOI 10.1183/09031936.06.00136904; DAVIS GS, 1982, AM REV RESPIR DIS, V126, P611; DRENT M, 1993, THORAX, V48, P835, DOI 10.1136/thx.48.8.835; Ekberg-Jansson A, 2000, RESP MED, V94, P264, DOI 10.1053/rmed.1999.0735; EKLUND A, 1986, THORAX, V41, P629, DOI 10.1136/thx.41.8.629; ETTENSOHN DB, 1988, CHEST, V94, P275, DOI 10.1378/chest.94.2.275; ETTENSOHN DB, 1988, CHEST, V94, P281, DOI 10.1378/chest.94.2.281; EVERSON RB, 1994, AM J RESP CRIT CARE, V149, P899, DOI 10.1164/ajrccm.149.4.8143053; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Haslam PL, 1999, EUR RESPIR REV, V9, P25; Karimi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034232; Larsson BM, 2007, EUR RESPIR J, V29, P699, DOI 10.1183/09031936.00035706; Larsson K, 1998, EUR RESPIR J, V12, P825, DOI 10.1183/09031936.98.12040825; LAVIOLETTE M, 1988, AM REV RESPIR DIS, V138, P451, DOI 10.1164/ajrccm/138.2.451; LAVIOLETTE M, 1985, THORAX, V40, P651, DOI 10.1136/thx.40.9.651; Lofdahl JM, 2005, EUR RESPIR J, V25, P275, DOI 10.1183/09031936.05.00033504; Medbo A, 2007, RESP MED, V101, P1097, DOI [10.1016/j.rmed.2006.11.019, 10.1016/j.rmed.2007.07.018]; MERCHANT RK, 1992, AM REV RESPIR DIS, V146, P448, DOI 10.1164/ajrccm/146.2.448; Meyer K, 2007, CLIN PULM MED, V141, P148; Meyer KC, 1999, THORAX, V54, P697, DOI 10.1136/thx.54.8.697; Meyer KC, 1996, AM J RESP CRIT CARE, V153, P1072, DOI 10.1164/ajrccm.153.3.8630547; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Ouellette DR, 2006, CHEST, V130, P1185, DOI 10.1378/chest.130.4.1185; Sehlstedt M, 2010, INHAL TOXICOL, V22, P1144, DOI 10.3109/08958378.2010.529181; SUTINEN S, 1995, RESP MED, V89, P85, DOI 10.1016/0954-6111(95)90189-2; The BAL Cooperative Group Steering Committee, 1990, AM REV RESPIR DIS, V141, pS169; Turcotte H, 2003, LUNG, V181, P9, DOI 10.1007/s00408-002-0110-y; Warr GA, 1978, AM REV RESPIR DIS, V113, P96	32	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43644	10.1371/journal.pone.0043644	http://dx.doi.org/10.1371/journal.pone.0043644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952729	gold, Green Published, Green Submitted			2022-12-27	WOS:000308221300020
J	Talishinsky, A; Rosen, GD				Talishinsky, Alexander; Rosen, Glenn D.			Systems Genetics of the Lateral Septal Nucleus in Mouse: Heritability, Genetic Control, and Covariation with Behavioral and Morphological Traits	PLOS ONE			English	Article							RECOMBINANT INBRED STRAINS; CORTICOTROPIN-RELEASING-FACTOR; SEIZURE SUSCEPTIBILITY; NATURAL VARIATION; INTELLECTUAL DISABILITY; MEMORY IMPAIRMENTS; NERVOUS-SYSTEM; LEIGH-SYNDROME; CHANNEL GENE; BRAIN VOLUME	The lateral septum has strong efferent projections to hypothalamic and midbrain regions, and has been associated with modulation of social behavior, anxiety, fear conditioning, memory-related behaviors, and the mesolimbic reward pathways. Understanding natural variation of lateral septal anatomy and function, as well as its genetic modulation, may provide important insights into individual differences in these evolutionarily important functions. Here we address these issues by using efficient and unbiased stereological probes to estimate the volume of the lateral septum in the BXD line of recombinant inbred mice. Lateral septum volume is a highly variable trait, with a 2.5-fold difference among animals. We find that this trait covaries with a number of behavioral and physiological phenotypes, many of which have already been associated with behaviors modulated by the lateral septum, such as spatial learning, anxiety, and reward-seeking. Heritability of lateral septal volume is moderate (h(2) = 0.52), and much of the heritable variation is caused by a locus on the distal portion of chromosome (Chr) 1. Composite interval analysis identified a secondary interval on Chr 2 that works additively with the Chr 1 locus to increase lateral septum volume. Using bioinformatic resources, we identified plausible candidate genes in both intervals that may influence the volume of this key nucleus, as well as associated behaviors.	[Talishinsky, Alexander; Rosen, Glenn D.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Talishinsky, A (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	grosen@bidmc.harvard.edu		Talishinsky, Aleksandr/0000-0002-7225-2130; Rosen, Glenn/0000-0001-8281-5446	National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01 NS052397]; National Institutes of Health, National Institute on Drug Abuse; National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health, National Institute of Mental Health [P20 DA021131]; National Institute on Alcohol Abuse and Alcoholism [U01AA014425, U01AA13499, R01 AA018776]; Mouse Models of Human Cancers Consortium from the National Cancer Institue [U01CA105417]; National Center for Research Resources [U24 RR021760]; NATIONAL CANCER INSTITUTE [U01CA105417] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018776, U01AA013499, U01AA014425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Mouse Models of Human Cancers Consortium from the National Cancer Institue; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part, by institutes of the National Institutes of Health, including the National Institute of Neurological Disorders and Stroke (grant number R01 NS052397) and by National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, and the National Institute of Mental Health (grant number P20 DA021131). GeneNetwork is supported by the National Institute on Alcohol Abuse and Alcoholism (grants U01AA014425 and U01AA13499), the Mouse Models of Human Cancers Consortium from the National Cancer Institue (grant number U01CA105417), and by the the National Center for Research Resources (grant number U24 RR021760). Gene Weaver is supported by the National Institute on Alcohol Abuse and Alcoholism (R01 AA018776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airey DC, 2001, J NEUROSCI, V21, P5099, DOI 10.1523/JNEUROSCI.21-14-05099.2001; ALBERT DJ, 1984, PHYSIOL BEHAV, V33, P517, DOI 10.1016/0031-9384(84)90364-0; Alberts R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-516; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Baker EJ, 2012, NUCLEIC ACIDS RES, V40, pD1067, DOI 10.1093/nar/gkr968; Bao JX, 1996, ONCOGENE, V12, P2171; Beatty J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-16; Boughter JD, 2007, GENES BRAIN BEHAV, V6, P619, DOI 10.1111/j.1601-183X.2006.00293.x; Boughter JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038169; BRADY JV, 1955, J COMP PHYSIOL PSYCH, V48, P412, DOI 10.1037/h0046406; Bulfone A, 2004, GENE EXPR PATTERNS, V4, P297, DOI 10.1016/j.modgep.2003.11.001; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Chen G, 2009, ALCOHOL, V43, P411, DOI 10.1016/j.alcohol.2009.05.003; Cheng YC, 2011, G3-GENES GENOM GENET, V1, P505, DOI 10.1534/g3.111.001164; Chesler EJ, 2003, NEUROINFORMATICS, V1, P343, DOI 10.1385/NI:1:4:343; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; CHROBAK JJ, 1991, BEHAV NEURAL BIOL, V55, P247, DOI 10.1016/0163-1047(91)80142-2; CHROBAK JJ, 1989, BEHAV NEURAL BIOL, V52, P357, DOI 10.1016/S0163-1047(89)90472-X; Chung BHY, 2012, EUR J HUM GENET, V20, P398, DOI 10.1038/ejhg.2011.199; Chung BHY, 2011, AM J MED GENET A, V155A, P424, DOI 10.1002/ajmg.a.33821; Dains K, 1996, J PHARMACOL EXP THER, V279, P1430; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; Degroot A, 2001, PHARMACOL BIOCHEM BE, V69, P391, DOI 10.1016/S0091-3057(01)00541-X; Di Curzio DL, 2011, MAMM GENOME, V22, P209, DOI 10.1007/s00335-011-9315-9; Dong H, 2007, HEREDITY, V99, P62, DOI 10.1038/sj.hdy.6800965; Dong XH, 2006, J BIOL CHEM, V281, P10610, DOI 10.1074/jbc.M513459200; Englot DJ, 2009, PROG BRAIN RES, V177, P147, DOI 10.1016/S0079-6123(09)17711-7; Escayg A, 1998, GENOMICS, V50, P14, DOI 10.1006/geno.1998.5311; Ferraro TN, 2007, EPILEPSIA, V48, P1667, DOI 10.1111/j.1528-1167.2007.01126.x; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gaglani SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-44; Garcia-Hernandez A, 2010, EXP NEUROL, V222, P86, DOI 10.1016/j.expneurol.2009.12.010; Gardberg M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-55; Gerards M, 2010, MITOCHONDRION, V10, P510, DOI 10.1016/j.mito.2010.05.008; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hamel MG, 2008, EXP NEUROL, V210, P428, DOI 10.1016/j.expneurol.2007.11.014; ISHIZAWA H, 1990, BRAIN RES, V507, P189, DOI 10.1016/0006-8993(90)90271-C; Jan TA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-3; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; Kozell LB, 2009, J NEUROSCI, V29, P11662, DOI 10.1523/JNEUROSCI.1413-09.2009; Le Merrer J, 2006, PHARMACOL BIOCHEM BE, V83, P465, DOI 10.1016/j.pbb.2006.03.008; Leader B, 2000, MECH DEVELOP, V93, P221, DOI 10.1016/S0925-4773(00)00276-8; Leranth C, 1999, NEUROSCIENCE, V88, P701, DOI 10.1016/S0306-4522(98)00245-0; Li YH, 2002, NEUROSCI LETT, V323, P60, DOI 10.1016/S0304-3940(01)02531-9; Lionikas A, 2003, PHYSIOL GENOMICS, V16, P141, DOI 10.1152/physiolgenomics.00103.2003; Lu L, 2001, J NEUROSCI, V21, P3503, DOI 10.1523/JNEUROSCI.21-10-03503.2001; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Martin MV, 2006, GENES BRAIN BEHAV, V5, P614, DOI 10.1111/j.1601-183X.2006.00215.x; Matsuyama N, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00026; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; Mohamed S, 2010, AM J MED GENET A, V152A, P2318, DOI 10.1002/ajmg.a.33560; MOORE RY, 1964, J COMP PHYSIOL PSYCH, V57, P65, DOI 10.1037/h0042989; MORTENSEN RF, 1985, IMMUNOGENETICS, V22, P367, DOI 10.1007/BF00430920; Mozhui K, 2007, BEHAV GENET, V37, P223, DOI 10.1007/s10519-006-9122-3; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Murdoch JN, 2003, MOL CELL NEUROSCI, V22, P62, DOI 10.1016/S1044-7431(02)00021-0; NAKAMURA Y, 1995, NEUROSCI RES, V23, P1, DOI 10.1016/0168-0102(95)00925-J; Ngu LH, 2012, BBA-MOL BASIS DIS, V1822, P168, DOI 10.1016/j.bbadis.2011.10.012; Ophir AG, 2009, BEHAV NEUROSCI, V123, P979, DOI 10.1037/a0016663; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Peirce JL, 2003, GENES BRAIN BEHAV, V2, P238, DOI 10.1034/j.1601-183X.2003.00030.x; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; PHILLIPS TJ, 1994, BEHAV NEUROSCI, V108, P789, DOI 10.1037/0735-7044.108.4.789; Price ML, 2001, J NEUROSCI, V21, P2833, DOI 10.1523/JNEUROSCI.21-08-02833.2001; Reis DG, 2010, LEARN MEMORY, V17, P134, DOI 10.1101/lm.1534710; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; Rosen GD, 2009, GENES BRAIN BEHAV, V8, P296, DOI 10.1111/j.1601-183X.2009.00473.x; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Rosen GD, 2003, CURRENT PROTOCOLS NE; Rosen Glenn D, 2007, Methods Mol Biol, V401, P287, DOI 10.1007/978-1-59745-520-6_16; Rosen GD, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-5; Ryabinin AE, 2008, NEUROSCIENCE, V151, P780, DOI 10.1016/j.neuroscience.2007.11.014; Sanabria ERG, 2006, NEUROSCIENCE, V142, P871, DOI 10.1016/j.neuroscience.2006.06.057; Seecharan DJ, 2003, J NEUROSCI, V23, P11178; Singewald GM, 2011, NEUROPSYCHOPHARMACOL, V36, P793, DOI 10.1038/npp.2010.213; Smith SB, 2008, PHARMACOGENET GENOM, V18, P231, DOI 10.1097/FPC.0b013e3282f55ab2; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Tang XF, 2010, BIOCHEM BIOPH RES CO, V399, P537, DOI 10.1016/j.bbrc.2010.07.105; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; Thifault S, 2008, HUM MOL GENET, V17, P331, DOI 10.1093/hmg/ddm277; Thomas E, 2003, BRAIN RES, V960, P201, DOI 10.1016/S0006-8993(02)03882-9; Torrecilla M, 2008, EUR J NEUROSCI, V28, P618, DOI 10.1111/j.1460-9568.2008.06348.x; Trent NL, 2011, PHARMACOL BIOCHEM BE, V99, P580, DOI 10.1016/j.pbb.2011.06.009; Trent NL, 2010, PHYSIOL BEHAV, V101, P141, DOI 10.1016/j.physbeh.2010.04.035; Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232; Waselus M, 2006, J CHEM NEUROANAT, V31, P233, DOI 10.1016/j.jchemneu.2006.01.007; Williams RW, 2001, BEHAV GENET, V31, P61, DOI 10.1023/A:1010209925783; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665; Zou SB, 2009, ALCOHOL CLIN EXP RES, V33, P394, DOI 10.1111/j.1530-0277.2008.00848.x	98	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44236	10.1371/journal.pone.0044236	http://dx.doi.org/10.1371/journal.pone.0044236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952935	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300067
J	Wright, MJ; Angrish, D; Aarde, SM; Barlow, DJ; Buczynski, MW; Creehan, KM; Vandewater, SA; Parsons, LH; Houseknecht, KL; Dickerson, TJ; Taffe, MA				Wright, M. Jerry, Jr.; Angrish, Deepshikha; Aarde, Shawn M.; Barlow, Deborah J.; Buczynski, Matthew W.; Creehan, Kevin M.; Vandewater, Sophia A.; Parsons, Loren H.; Houseknecht, Karen L.; Dickerson, Tobin J.; Taffe, Michael A.			Effect of Ambient Temperature on the Thermoregulatory and Locomotor Stimulant Effects of 4-Methylmethcathinone in Wistar and Sprague-Dawley Rats	PLOS ONE			English	Article							CORE BODY-TEMPERATURE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; NUCLEUS-ACCUMBENS; AMPHETAMINE; MEPHEDRONE; CATHINONE; ECSTASY; METHAMPHETAMINE; SEROTONIN; DOPAMINE	The drug 4-methylmethcathinone (4-MMC; aka, mephedrone, MMCAT, "plant food'', "bath salts'') is a recent addition to the list of popular recreational psychomotor-stimulant compounds. Relatively little information about this drug is available in the scientific literature, but popular media reports have driven recent drug control actions in the UK and several US States. Online user reports of subjective similarity to 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy'') prompted the current investigation of the thermoregulatory and locomotor effects of 4-MMC. Male Wistar and Sprague-Dawley rats were monitored after subcutaneous administration of 4-MMC (1-10 mg/kg) using an implantable radiotelemetry system under conditions of low (23 degrees C) and high (27 degrees C) ambient temperature. A reliable reduction of body temperature was produced by 4-MMC in Wistar rats at 23 degrees C or 27 degrees C with only minimal effect in Sprague-Dawley rats. Increased locomotor activity was observed after 4-MMC administration in both strains with significantly more activity produced in the Sprague-Dawley strain. The 10 mg/kg s.c. dose evoked greater increase in extracellular serotonin, compared with dopamine, in the nucleus accumbens. Follow-up studies confirmed that the degree of locomotor stimulation produced by 10 mg/kg 4-MMC was nearly identical to that produced by 1 mg/kg d-methamphetamine in each strain. Furthermore, hypothermia produced by the serotonin 1(A/7) receptor agonist 8-hydroxy-N,N-dipropyl-2-aminotetralin (8-OH-DPAT) was similar in each strain. These results show that the cathinone analog 4-MMC exhibits thermoregulatory and locomotor properties that are distinct from those established for methamphetamine or MDMA in prior work, despite recent evidence of neuropharmacological similarity with MDMA.	[Wright, M. Jerry, Jr.; Aarde, Shawn M.; Buczynski, Matthew W.; Creehan, Kevin M.; Vandewater, Sophia A.; Parsons, Loren H.; Taffe, Michael A.] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA; [Angrish, Deepshikha; Dickerson, Tobin J.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Barlow, Deborah J.; Houseknecht, Karen L.] Univ New England, Dept Pharmaceut Sci, Portland, ME USA	Scripps Research Institute; Scripps Research Institute; University of New England - Maine	Wright, MJ (corresponding author), Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA.	mtaffe@scripps.edu	Taffe, Michael A/A-3153-2008; Taffe, Michael/AAJ-8159-2021	Taffe, Michael A/0000-0001-9827-1738; Wright Jr, Mayo Jerry/0000-0003-4073-0991	United States Public Health Service [DA018418, DA024705, DA024105]; National Institutes of Health; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018418, R01DA024105, F32DA029994, R01DA024705] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by United States Public Health Service grants DA018418, DA024705 and DA024105. The funding agencies (National Institutes of Health/National Institute on Drug Abuse) had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banjaw MY, 2005, BEHAV BRAIN RES, V160, P365, DOI 10.1016/j.bbr.2005.01.002; Bankson MG, 2002, NEUROPSYCHOPHARMACOL, V26, P40, DOI 10.1016/S0893-133X(01)00345-1; BATTAGLIA G, 1988, EUR J PHARMACOL, V149, P159, DOI 10.1016/0014-2999(88)90056-8; Baumann MH, 2008, PHARMACOL BIOCHEM BE, V90, P208, DOI 10.1016/j.pbb.2008.02.018; Baumann MH, 2012, NEUROPSYCHOPHARMACOL, V37, P1192, DOI 10.1038/npp.2011.304; Bexis S, 2006, BR J PHARM; Blessing WW, 2003, J NEUROSCI, V23, P6385; Caille S, 2007, J NEUROSCI, V27, P3695, DOI 10.1523/JNEUROSCI.4403-06.2007; Camilleri A, 2010, FORENSIC SCI INT, V197, P59, DOI 10.1016/j.forsciint.2009.12.048; Clark J.D., 1996, GUIDE CARE USE LAB A; Cuoco J, 2010, KXXV NEWS CHANNEL; DAFTERS RI, 1994, PSYCHOPHARMACOLOGY, V114, P505, DOI 10.1007/BF02249342; DalCason TA, 1997, PHARMACOL BIOCHEM BE, V58, P1109, DOI 10.1016/S0091-3057(97)00323-7; DEA, 2009, MICROGRAM B, V4, P61; DEA, 2011, MICROGRAM B, V44, P31; Docherty JR, 2010, BRIT J PHARMACOL, V160, P1029, DOI 10.1111/j.1476-5381.2010.00722.x; Freedman RR, 2005, PSYCHOPHARMACOLOGY, V183, P248, DOI 10.1007/s00213-005-0149-6; Geezaman DF, 2009, SURPRISINGLY E EXPER; Gilpin NW, 2011, PHARMACOL BIOCHEM BE, V99, P295, DOI 10.1016/j.pbb.2011.05.006; GLENNON RA, 1987, PHARMACOL BIOCHEM BE, V26, P547, DOI 10.1016/0091-3057(87)90164-X; GOLD LH, 1988, J PHARMACOL EXP THER, V247, P547; GORDON TL, 1993, PHARMACOL BIOCHEM BE, V44, P657, DOI 10.1016/0091-3057(93)90182-S; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Hadlock GC, 2011, J PHARMACOL EXP THER, V339, P530, DOI 10.1124/jpet.111.184119; Hall DA, 2008, PSYCHOPHARMACOLOGY, V195, P469, DOI 10.1007/s00213-007-0923-8; Huang PK, 2012, DRUG ALCOHOL DEPEND; HUGHES RN, 1976, NEUROPHARMACOLOGY, V15, P673, DOI 10.1016/0028-3908(76)90035-6; ITOH K, 1984, LIFE SCI, V34, P827, DOI 10.1016/0024-3205(84)90199-1; Iversen L, 2010, CONSIDERATION CATHIN; JOHANSON CE, 1981, J PHARMACOL EXP THER, V219, P355; Kehr J, 2011, BRIT J PHARMACOL, V164, P1949, DOI 10.1111/j.1476-5381.2011.01499.x; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; Lopez-Arnau R, 2012, BR J PHARM; Malberg JE, 1998, J NEUROSCI, V18, P5086; Martinez-Clemente J, 2012, EUR NEUROPSYCHOPHARM, V22, P231, DOI 10.1016/j.euroneuro.2011.07.009; McDermott C, 2008, PROG NEURO-PSYCHOPH, V32, P1816, DOI 10.1016/j.pnpbp.2008.08.004; Meph_Test, 2009, GOOD ALTERNATIVE NDM; Michael J, 2010, BISMARCK TRIBUNE; Miller ML, 2012, DRUG ALCOHOL DEPEND; Motbey CP, 2012, ADDICT BIOL, V17, P409, DOI 10.1111/j.1369-1600.2011.00384.x; MUELLER K, 1989, PSYCHOPHARMACOLOGY, V99, P501, DOI 10.1007/BF00589899; Myles BJ, 2008, PSYCHOPHARMACOLOGY, V198, P301, DOI 10.1007/s00213-007-1061-z; NENCINI P, 1984, J ETHNOPHARMACOL, V11, P79, DOI 10.1016/0378-8741(84)90097-7; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pedersen NP, 2001, J NEUROSCI, V21, P8648, DOI 10.1523/JNEUROSCI.21-21-08648.2001; Psychonaut Webmapping Research Group, 2010, MEPH REP; Rockhold RW, 1997, ANN EMERG MED, V29, P383, DOI 10.1016/S0196-0644(97)70351-2; Rusyniak DE, 2007, J PHARMACOL EXP THER, V323, P477, DOI 10.1124/jpet.107.126169; Sedefov R, 2010, EUROPOL EMCDDA JOINT; TARIQ M, 1989, LIFE SCI, V44, P951, DOI 10.1016/0024-3205(89)90494-3; Von Huben SN, 2007, NEUROPSYCHOPHARMACOL, V32, P673, DOI 10.1038/sj.npp.1301078; Walker QD, 2007, PSYCHOPHARMACOLOGY, V189, P435, DOI 10.1007/s00213-006-0531-z; Winstock AR, 2011, ADDICTION, V106, P154, DOI 10.1111/j.1360-0443.2010.03130.x; Winstock AR, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1605; Wright Jr MJ, 2012, BR J PHARM, DOI 10.1111/j.1476-5381.2012.02091.x; ZELGER JL, 1980, B NARCOTICS, V32, P67	56	70	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44652	10.1371/journal.pone.0044652	http://dx.doi.org/10.1371/journal.pone.0044652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952999	gold, Green Published, Green Submitted			2022-12-27	WOS:000308221300103
J	Xu, L; Xu, CF; Yu, CH; Miao, M; Zhang, XQ; Zhu, ZW; Ding, XY; Li, YM				Xu, Lei; Xu, Chengfu; Yu, Chaohui; Miao, Min; Zhang, Xuequn; Zhu, Zhongwei; Ding, Xiaoyun; Li, Youming			Association between Serum Growth Hormone Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study	PLOS ONE			English	Article							HEPATIC STEATOSIS; VISCERAL ADIPOSITY; METABOLIC SYNDROME; RISK-FACTORS; PREVALENCE; DEFICIENCY; STEATOHEPATITIS; OVERWEIGHT; MARKERS	Growth hormone (GH) is an important regulator of metabolism and body composition. GH deficiency is associated with increased visceral body fat and other features of the metabolic syndrome. Here we performed a cross-sectional study to explore the association of GH levels with nonalcoholic fatty liver disease (NAFLD), which is considered to be the hepatic manifestation of the metabolic syndrome. A total of 1,667 subjects were diagnosed as NAFLD according the diagnostic criteria, and 5,479 subjects were defined as the controls. The subjects with NAFLD had significantly lower levels of serum GH than the controls. Those with low GH levels had a higher prevalence of NAFLD and the metabolic syndrome. A stepwise logistic regression analysis showed that GH levels were significantly associated with the risk factor for NAFLD (OR = 0.651, 95% CI = 0.574-0.738, P < 0.001). Our results showed a significant association between lower serum GH levels and NAFLD.	[Xu, Lei; Ding, Xiaoyun] Ningbo No 1 Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China; [Xu, Lei; Xu, Chengfu; Yu, Chaohui; Zhang, Xuequn; Li, Youming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Miao, Min; Zhu, Zhongwei] Zhenhai Lianhua Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China	Zhejiang University	Xu, L (corresponding author), Ningbo No 1 Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China.	xulei22@163.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Ma, Han/0000-0001-9985-3035; Ding, Xiaoyun/0000-0002-3731-3508	National Key Basic Research Development Program [2012CB524905]; National Science and Technology Support Plan Project [2012BAI06B04]; National Natural Science Foundation of China [31070315, 81100278, 81170378]; Zhejiang Provincial Natural Science Foundation of China [Y2090463]; Science Foundation of Health Bureau of Zhejiang Province [2012RCA026]; Medical Science & Technology Foundation in Ningbo City [2010B03]	National Key Basic Research Development Program(National Basic Research Program of China); National Science and Technology Support Plan Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Science Foundation of Health Bureau of Zhejiang Province; Medical Science & Technology Foundation in Ningbo City	This study was supported by National Key Basic Research Development Program (No. 2012CB524905), National Science and Technology Support Plan Project (No. 2012BAI06B04), National Natural Science Foundation of China (No. 31070315, No. 81100278, and No. 81170378), Zhejiang Provincial Natural Science Foundation of China (No. Y2090463), Science Foundation of Health Bureau of Zhejiang Province (No. 2012RCA026), and Medical Science & Technology Foundation in Ningbo City (No. 2010B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2004, HEPATOLOGY, V39, P909, DOI 10.1002/hep.20140; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Attanasio AF, 2010, J CLIN ENDOCR METAB, V95, P74, DOI 10.1210/jc.2009-1326; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Cerda C, 2007, J HEPATOL, V47, P412, DOI 10.1016/j.jhep.2007.04.012; Di Somma C, 2010, J ENDOCRINOL INVEST, V33, P171, DOI [10.1007/BF03346577, 10.3275/6519]; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Follin C, 2006, J CLIN ENDOCR METAB, V91, P1872, DOI 10.1210/jc.2005-2298; Fusco A, 2012, CLIN ENDOCRINOL, V77, P531, DOI 10.1111/j.1365-2265.2011.04291.x; Gambino R, 2011, ANTIOXID REDOX SIGN, V15, P1325, DOI 10.1089/ars.2009.3058; Gardner CJ, 2012, EUR J ENDOCRINOL, V166, P993, DOI 10.1530/EJE-12-0002; Hong JW, 2011, HORM METAB RES, V43, P48, DOI 10.1055/s-0030-1265217; Ichikawa T, 2003, GUT, V52, P914, DOI 10.1136/gut.52.6.914; Ichikawa T, 2007, HEPATOL INT, V1, P287, DOI 10.1007/s12072-007-9007-4; Johannsson G., 1999, Journal of Endocrinological Investigation, V22, P41; Lanes R, 2004, J PEDIATR-US, V145, P657, DOI 10.1016/j.jpeds.2004.07.037; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; MELMED S, 1984, J CLIN INVEST, V73, P1425, DOI 10.1172/JCI111347; Misra M, 2008, AM J PHYSIOL-ENDOC M, V295, pE385, DOI 10.1152/ajpendo.00052.2008; Pasarica M, 2007, J CLIN ENDOCR METAB, V92, P4265, DOI 10.1210/jc.2007-0786; Qin Y, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-78; Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024; Tarantino G, 2010, WORLD J GASTROENTERO, V16, P4773, DOI 10.3748/wjg.v16.i38.4773; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P501, DOI 10.1093/gerona/glr004; Utz AL, 2008, J CLIN ENDOCR METAB, V93, P2507, DOI 10.1210/jc.2008-0169	28	39	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44136	10.1371/journal.pone.0044136	http://dx.doi.org/10.1371/journal.pone.0044136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952901	gold, Green Submitted, Green Published			2022-12-27	WOS:000308221300054
J	Yang, J; Li, P				Yang, Jing; Li, Ping			Brain Networks of Explicit and Implicit Learning	PLOS ONE			English	Article							WORKING-MEMORY; LANGUAGE; SYSTEMS; DISSOCIATION; ACQUISITION; TASK; KNOWLEDGE; RULES; FMRI; AGE	Are explicit versus implicit learning mechanisms reflected in the brain as distinct neural structures, as previous research indicates, or are they distinguished by brain networks that involve overlapping systems with differential connectivity? In this functional MRI study we examined the neural correlates of explicit and implicit learning of artificial grammar sequences. Using effective connectivity analyses we found that brain networks of different connectivity underlie the two types of learning: while both processes involve activation in a set of cortical and subcortical structures, explicit learners engage a network that uses the insula as a key mediator whereas implicit learners evoke a direct frontal-striatal network. Individual differences in working memory also differentially impact the two types of sequence learning.	[Yang, Jing; Li, Ping] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Yang, Jing; Li, Ping] Penn State Univ, Ctr Brain Behav & Cognit, University Pk, PA 16802 USA; [Yang, Jing] Guangdong Univ Foreign Studies, Natl Key Res Ctr Linguist & Appl Linguist, Guangzhou, Guangdong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Guangdong University of Foreign Studies	Yang, J (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.	pul8@psu.edu		Li, Ping/0000-0002-3314-943X	U.S. National Science Foundation [BCS1057855]; Partnership for International Research and Education Program [OISE-0968369]; National Key Research Center for Linguistics and Applied Linguistics, Guangdong University of Foreign Studies	U.S. National Science Foundation(National Science Foundation (NSF)); Partnership for International Research and Education Program; National Key Research Center for Linguistics and Applied Linguistics, Guangdong University of Foreign Studies	This work was supported by the U.S. National Science Foundation's Perception, Action, and Cognition Program and the Linguistics Program (#BCS1057855), and in part by the Partnership for International Research and Education Program (#OISE-0968369). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Peter Molenaar, Lawrence Lo, and Benjamin Zinszer for constructive comments on the unified SEM analysis, and Patrick Clark and Holly Spain Watkins for additional assistance with the experiment. We also thank the Penn State Social, Life, and Engineering Sciences Imaging Center and its staff for making the fMRI facility available and for assistance with the experiment. Revision of the manuscript was conducted at and supported by the National Key Research Center for Linguistics and Applied Linguistics, Guangdong University of Foreign Studies, where the first author is currently affiliated.	Aizenstein HJ, 2004, CEREB CORTEX, V14, P199, DOI 10.1093/cercor/bhg119; [Anonymous], NEUROPSYCHOLOGY MEMO; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brett M., 2002, NEUROIMAGE, V16, P497; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; CHIARELLO C, 1988, PSYCHOL AGING, V3, P358, DOI 10.1037/0882-7974.3.4.358; Chomsky, 1957, SYNTACTIC STRUCTURES; Christiansen MH, 2012, LANG COGNITIVE PROC, V27, P231, DOI 10.1080/01690965.2011.606666; COHEN NJ, 1985, ANN NY ACAD SCI, V444, P54, DOI 10.1111/j.1749-6632.1985.tb37579.x; DeKeyser R. M., 2003, IMPLICIT EXPLICIT LE, P313, DOI DOI 10.1002/9780470756492.CH11; Dennis NA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.004; Destrebecqz A, 2005, LEARN MEMORY, V12, P480, DOI 10.1101/lm.95605; DIENES Z, 1991, J EXP PSYCHOL LEARN, V17, P875, DOI 10.1037/0278-7393.17.5.875; Dunn D.M., 2007, PEABODY PICTURE VOCA; Eichenbaum H, 1999, NAT NEUROSCI, V2, P775, DOI 10.1038/12137; ELLIS N, 1993, EUR J COGN PSYCHOL, V5, P289, DOI 10.1080/09541449308520120; Ellis NC, 2005, STUD SECOND LANG ACQ, V27, P305, DOI 10.1017/S027226310505014X; Ellis NC, 1996, Q J EXP PSYCHOL-A, V49, P234, DOI 10.1080/027249896392883; Forkstam C, 2005, CURR OPIN NEUROL, V18, P435, DOI 10.1097/01.wco.0000171951.82995.c4; Friederici AD, 2002, P NATL ACAD SCI USA, V99, P529, DOI 10.1073/pnas.012611199; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gates KM, 2010, NEUROIMAGE, V50, P1118, DOI 10.1016/j.neuroimage.2009.12.117; Havik E, 2009, LANG LEARN, V59, P73, DOI 10.1111/j.1467-9922.2009.00501.x; HEINDEL WC, 1989, J NEUROSCI, V9, P582; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; ISINGRINI M, 1995, MEM COGNITION, V23, P462, DOI 10.3758/BF03197247; Juffs A, 2011, LANG TEACHING, V44, P137, DOI 10.1017/S0261444810000509; Kim J, 2007, HUM BRAIN MAPP, V28, P85, DOI 10.1002/hbm.20259; Li P, 2012, ROUTLEGE ENCY 2 LANG; Lieberman MD, 2004, J COGNITIVE NEUROSCI, V16, P427, DOI 10.1162/089892904322926764; Luk G, 2010, BRAIN COGNITION, V74, P347, DOI 10.1016/j.bandc.2010.09.004; McIntosh A.R., 1994, HUM BRAIN MAPP, V2, P2, DOI DOI 10.1002/HBM.460020104; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 1998, FOREIGN LANGUAGE LEARNING, P339; Morgan-Short K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032974; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Poldrack RA, 2003, NEURON, V37, P891, DOI 10.1016/S0896-6273(03)00159-4; Poldrack RA, 2012, NEUROIMAGE, V62, P1216, DOI 10.1016/j.neuroimage.2011.08.007; Prior A, 2010, BILING-LANG COGN, V13, P253, DOI 10.1017/S1366728909990526; Rauch SL, 1997, HUM BRAIN MAPP, V5, P124, DOI 10.1002/(SICI)1097-0193(1997)5:2<124::AID-HBM6>3.3.CO;2-P; Raven JC., 1988, MILL HILL VOCABULARY; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1991, J EXP PSYCHOL LEARN, V17, P888, DOI 10.1037/0278-7393.17.5.888; REBER PJ, 1994, LEARN MEMORY, V1, P217; Rebuschat P., 2011, P ANN M COGNITIVE SC, V33, P2061; Reiss JP, 2005, NEUROREPORT, V16, P1291, DOI 10.1097/01.wnr.0000175615.93312.1a; Seger CA, 2000, PSYCHOBIOLOGY, V28, P283; Seger CA, 2005, J NEUROSCI, V25, P2941, DOI 10.1523/JNEUROSCI.3401-04.2005; SNYDER PJ, 1993, CORTEX, V29, P115, DOI 10.1016/S0010-9452(13)80216-X; Sporns O., 2010, NETWORKS BRAIN; Sun R, 2005, PSYCHOL REV, V112, P159, DOI 10.1037/0033-295X.112.1.159; Sun R, 2001, COGNITIVE SCI, V25, P203, DOI 10.1016/S0364-0213(01)00035-0; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Wechsler D., 1997, WECHSLER ADULT INTEL	58	73	75	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42993	10.1371/journal.pone.0042993	http://dx.doi.org/10.1371/journal.pone.0042993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998EY	22952624	gold, Green Published			2022-12-27	WOS:000308221300009
J	Gavvovidis, I; Rost, I; Trimborn, M; Kaiser, FJ; Purps, J; Wiek, C; Hanenberg, H; Neitzel, H; Schindler, D				Gavvovidis, Ioannis; Rost, Isabell; Trimborn, Marc; Kaiser, Frank J.; Purps, Josephine; Wiek, Constanze; Hanenberg, Helmut; Neitzel, Heidemarie; Schindler, Detlev			A Novel MCPH1 Isoform Complements the Defective Chromosome Condensation of Human MCPH1-Deficient Cells	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNALS; RECESSIVE MICROCEPHALY MAPS; DNA-DAMAGE RESPONSE; CENTROSOMAL PROTEIN; MENTAL-RETARDATION; MITOTIC ENTRY; MUTATIONS; LOCUS; BRAIN; CHECKPOINT	Biallelic mutations in MCPH1 cause primary microcephaly (MCPH) with the cellular phenotype of defective chromosome condensation. MCPH1 encodes a multifunctional protein that notably is involved in brain development, regulation of chromosome condensation, and DNA damage response. In the present studies, we detected that MCPH1 encodes several distinct transcripts, including two major forms: full-length MCPH1 (MCPH1-FL) and a second transcript lacking the six 3' exons (MCPH1 Delta e9-14). Both variants show comparable tissue-specific expression patterns, demonstrate nuclear localization that is mediated independently via separate NLS motifs, and are more abundant in certain fetal than adult organs. In addition, the expression of either isoform complements the chromosome condensation defect found in genetically MCPH1-deficient or MCPH1 siRNA-depleted cells, demonstrating a redundancy of both MCPH1 isoforms for the regulation of chromosome condensation. Strikingly however, both transcripts are regulated antagonistically during cell-cycle progression and there are functional differences between the isoforms with regard to the DNA damage response; MCPH1-FL localizes to phosphorylated H2AX repair foci following ionizing irradiation, while MCPH1 Delta e9-14 was evenly distributed in the nucleus. In summary, our results demonstrate here that MCPH1 encodes different isoforms that are differentially regulated at the transcript level and have different functions at the protein level.	[Gavvovidis, Ioannis; Rost, Isabell; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany; [Gavvovidis, Ioannis] Max Delbruck Ctr Mol Med, Berlin, Germany; [Trimborn, Marc] Charite, Dept Med Genet, D-13353 Berlin, Germany; [Kaiser, Frank J.] Univ Lubeck, Inst Humangenet, Lubeck, Germany; [Purps, Josephine; Neitzel, Heidemarie] Charite, Dept Human Genet, D-13353 Berlin, Germany; [Wiek, Constanze; Hanenberg, Helmut] Univ Dusseldorf, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, D-40225 Dusseldorf, Germany; [Hanenberg, Helmut] Indiana Univ, Riley Hosp Children, Sch Med, Dept Pediat, Indianapolis, IN 46204 USA; [Hanenberg, Helmut] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	University of Wurzburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heinrich Heine University Dusseldorf; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University-Purdue University Indianapolis	Gavvovidis, I (corresponding author), Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany.	ioannis.gavvovidis@mdc-berlin.de		Wiek, Constanze/0000-0003-2214-8148; Gavvovidis, Ioannis/0000-0001-5644-9788	Hofmann La Roche; Deutsche Forschungsgemeinschaft (DFG) [NE531/5-3]; University of Wuerzburg; BMBF network of 'Inherited bone marrow failure syndromes'; BMBF network of 'Foamyvirus-mediated genetic therapy for FNACA (FoneFA)'; National Institutes of Health [R01s CA138237-01, CA155294-01]; NATIONAL CANCER INSTITUTE [R01CA155294, R01CA138237] Funding Source: NIH RePORTER	Hofmann La Roche; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Wuerzburg; BMBF network of 'Inherited bone marrow failure syndromes'; BMBF network of 'Foamyvirus-mediated genetic therapy for FNACA (FoneFA)'; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by a grant from Hofmann La Roche to DS and, in part, by a grant of the Deutsche Forschungsgemeinschaft (DFG) (NE531/5-3) to HN. This publication was funded by the DFG and the University of Wuerzburg in the funding program Open Access Publishing to DS. This work was suppored by the BMBF networks of 'Inherited bone marrow failure syndromes' and 'Foamyvirus-mediated genetic therapy for FNACA (FoneFA)' and the National Institutes of Health R01s CA138237-01 and CA155294-01 to HH. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Marchal JA, 2011, CELL CYCLE, V10, P2967, DOI 10.4161/cc.10.17.16871; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Boue S, 2002, BIOINFORMATICS, V18, pS65, DOI 10.1093/bioinformatics/18.suppl_2.S65; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DWORETZKY SI, 1988, J CELL BIOL, V107, P1279, DOI 10.1083/jcb.107.4.1279; Garshasbi M, 2006, HUM GENET, V118, P708, DOI 10.1007/s00439-005-0104-y; Gavvovidis I, 2010, CELL CYCLE, V9, P4893, DOI 10.4161/cc.9.24.14157; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Le Texier V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-169; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; Pietschmann T, 1999, J VIROL, V73, P2613, DOI 10.1128/JVI.73.4.2613-2621.1999; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Richards MW, 2010, J MOL BIOL, V395, P908, DOI 10.1016/j.jmb.2009.11.029; Rickmyre JL, 2007, J CELL SCI, V120, P3565, DOI 10.1242/jcs.016626; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Trimborn Marc, 2005, Hum Mutat, V26, P496, DOI 10.1002/humu.9382; Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242; VANDROMME M, 1995, P NATL ACAD SCI USA, V92, P4646, DOI 10.1073/pnas.92.10.4646; Wilson KA, 2008, CELL CYCLE, V7, P3584, DOI 10.4161/cc.7.22.7102; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yamashita D, 2011, J CELL BIOL, V194, P841, DOI 10.1083/jcb.201106141; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang XY, 2004, J VIROL, V78, P1219, DOI 10.1128/JVI.78.3.1219-1229.2004	60	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e40387	10.1371/journal.pone.0040387	http://dx.doi.org/10.1371/journal.pone.0040387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952573	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000308206500001
J	Kuo, CY; Yuen, YS; Meng, PJ; Ho, PH; Wang, JT; Liu, PJ; Chang, YC; Dai, CF; Fan, TY; Lin, HJ; Baird, AH; Chen, CA				Kuo, Chao-Yang; Yuen, Yeong Shyan; Meng, Pei-Jie; Ho, Ping-Ho; Wang, Jih-Terng; Liu, Pi-Jen; Chang, Yang-Chi; Dai, Chang-Feng; Fan, Tung-Yung; Lin, Hsing-Juh; Baird, Andrew Hamilton; Chen, Chaolun Allen			Recurrent Disturbances and the Degradation of Hard Coral Communities in Taiwan	PLOS ONE			English	Article							KENTING NATIONAL-PARK; SOUTHERN TAIWAN; PHASE-SHIFTS; MASS MORTALITY; REEF; RESILIENCE; RECOVERY; IMPACTS; SEA; ASSEMBLAGES	Recurrent disturbances can have a critical effect on the structure and function of coral reef communities. In this study, long-term changes were examined in the hard coral community at Wanlitung, in southern Taiwan, between 1985 and 2010. In this 26 year interval, the reef has experienced repeated disturbances that include six typhoons and two coral-bleaching events. The frequency of disturbance has meant that species susceptible to disturbance, such as those in the genus Acropora and Montipora have almost disappeared from the reef. Indeed, almost all hard coral species have declined in abundance, with the result that total hard coral cover in 2010 (17.7%) was less than half what it was in 1985 (47.5%). In addition, macro-algal cover has increased from 11.3% in 2003 to 28.5% in 2010. The frequency of disturbance combined with possible chronic influence of a growing human population mean that a diverse reef assemblage is unlikely to persist on this reef into the future.	[Kuo, Chao-Yang; Yuen, Yeong Shyan; Chen, Chaolun Allen] Acad Sinica, TIGP, Biodivers Res Ctr, Taipei 115, Taiwan; [Kuo, Chao-Yang; Baird, Andrew Hamilton] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Yuen, Yeong Shyan] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Meng, Pei-Jie; Liu, Pi-Jen; Fan, Tung-Yung] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Meng, Pei-Jie; Liu, Pi-Jen; Fan, Tung-Yung] Natl Dong Hwa Univ, Grad Inst Marine Biodivers & Evolutionary Biol, Checheng, Pingtung, Taiwan; [Ho, Ping-Ho] Natl Taiwan Ocean Univ, Inst Fishery & Environm Biol, Keelung, Taiwan; [Wang, Jih-Terng] Tajen Univ, Inst Biotechnol, Yanpu, Pingtung, Taiwan; [Chang, Yang-Chi] Natl Sun Yat Sen Univ, Dept Marine Environm & Engn, Kaohsiung 80424, Taiwan; [Dai, Chang-Feng; Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Lin, Hsing-Juh] Natl Chung Hsing Univ, Inst Life Sci, Taichung 40227, Taiwan	Academia Sinica - Taiwan; James Cook University; Universiti Malaya; National Museum of Marine Biology & Aquarium; National Dong Hwa University; National Taiwan Ocean University; National Sun Yat Sen University; National Taiwan University; National Chung Hsing University	Kuo, CY (corresponding author), Acad Sinica, TIGP, Biodivers Res Ctr, Taipei 115, Taiwan.	cac@gate.sinica.edu.tw	Liu, Pi-Jen/ABC-6596-2021; Yuen, Yeong Shyan/K-1262-2012; Meng, PJ/AAC-3677-2021; Baird, Andrew Hamilton/C-8449-2009; Chang, Yang-Chi/M-8849-2016	Yuen, Yeong Shyan/0000-0002-2413-4156; Baird, Andrew Hamilton/0000-0001-8504-4077; DAI, CHANG-FENG/0000-0003-2242-5643; Lin, Hsing-Juh/0000-0001-8322-7195; Chang, Yang-Chi/0000-0002-1088-9427	National Science Council (NSC); Australian Endeavour Award; NSC-Australian Academy of Science (AAS); Kenting National Park; Academia Sinica [AS-97-TP-B01, AS-100-TP2-A02-SUB3]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Australian Endeavour Award(Australian GovernmentDepartment of Industry, Innovation and Science); NSC-Australian Academy of Science (AAS); Kenting National Park; Academia Sinica(Academia Sinica - Taiwan)	Many thanks go to Chieh Wei for field assistance, and to members of the Coral Reef Evolutionary Ecology and Genetics (CREEG) laboratory, Biodiversity Research Center, Academia Sinica (BRCAS), for constructive comments before submission and ARC Centre of Excellence for Coral Reef Studies at James Cook University for hosting the sabbatical of CAC. YSY is a recipient of a National Science Council (NSC) postdoctoral fellowship (2010-2011). CAC was a recipient of an Australian Endeavour Award (2010-2011) and an NSC-Australian Academy of Science (AAS) fellowship (2010). Permits for monitoring were granted by the Kenting National Park. This is CREEG contribution no. 71.; This study was supported by a long-term ecological research grant from the NSC (http://web1.nsc.gov.tw/mp.aspx?mp=7) and Kenting National Park (http://www.ktnp.gov.tw/eng/) from 2003 to 2010, and Academia Sinica (http://www.sinica.edu.tw/main_e.shtml) Thematic Grant (AS-97-TP-B01; AS-100-TP2-A02-SUB3) to CAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; CARPENTER RC, 1990, MAR BIOL, V104, P67, DOI 10.1007/BF01313159; Chang KH, 1985, ELLIPTIC FUNCTIONS, P1; Chen CA, 2004, CORAL REEFS, V23, P508, DOI 10.1007/s00338-004-0423-9; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Dai C.-F., 1991, ATOLL RES B, V354, P1, DOI [10.5479/si.00775630.354.1, DOI 10.5479/SI.00775630.354.1]; Dai C-F, 1999, J NATL PARK, V9, P112; Dai C-F, 1998, J NATL PARK, V8, P79; Dai CF, 2007, DISTRIBUTION SPECIE, P49; Dai CF, 1988, THESIS YALE U, P315; Dai CF, 2002, P IUCN WCPA EA4 TAIP, P265; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; KNOWLTON N, 1992, AM ZOOL, V32, P674; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kuo CY, 2011, ZOOL STUD, V50, P85; Kuo CY, 2007, THESIS NATL SUN YS U, P71; Kuo YM, 2010, ESTUAR COAST SHELF S, V86, P225, DOI 10.1016/j.ecss.2009.11.017; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; Littler MM, 2006, HARMFUL ALGAE, V5, P565, DOI 10.1016/j.hal.2005.11.003; Meng PJ, 2008, ENVIRON POLLUT, V156, P67, DOI 10.1016/j.envpol.2007.12.039; Meng PJ, 2004, J NATL PARK, V14, P43; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Nystrom M, 2001, TRENDS ECOL EVOL, V16, P127, DOI 10.1016/S0169-5347(00)02089-9; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Shao KT, 2002, P IUCN WCPA EA 4 TAI, P351; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Tsai CC, 2004, BOT MAR, V47, P439, DOI 10.1515/BOT.2004.061; Wielgus J, 2003, J EXP MAR BIOL ECOL, V297, P31, DOI 10.1016/S0022-0981(03)00354-X; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilkinson C., 2004, STATUS CORAL REEFS W; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	43	38	38	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44364	10.1371/journal.pone.0044364	http://dx.doi.org/10.1371/journal.pone.0044364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952967	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000308206500066
J	Zhao, YL; Verma, V; Belcheva, A; Singh, A; Fridman, M; Golemi-Kotra, D				Zhao, Yinglu; Verma, Vidhu; Belcheva, Antoaneta; Singh, Atul; Fridman, Michael; Golemi-Kotra, Dasantila			Staphylococcus aureus Methicillin-Resistance Factor fmtA Is Regulated by the Global Regulator SarA	PLOS ONE			English	Article							BETA-LACTAM RESISTANCE; VIRULENCE DETERMINANT PRODUCTION; PENICILLIN-BINDING PROTEINS; WALL-ACTIVE ANTIBIOTICS; CELL-WALL; RNA-POLYMERASE; PROMOTER RECOGNITION; SIGMA-FACTOR; MOLECULAR-CLONING; BIOFILM FORMATION	fmtA encodes a low-affinity penicillin binding protein in Staphylococcus aureus. It is part of the core cell wall stimulon and is involved in methicillin resistance in S. aureus. Here, we report that the transcription factor, SarA, a pleiotropic regulator of virulence genes in S. aureus, regulates the expression of fmtA. In vitro binding studies with purified SarA revealed that it binds to specific sites within the 541-bp promoter region of fmtA. Mutation of a key residue of the regulatory activity of SarA (Arg90) abolished binding of SarA to the fmtA promoter, suggesting that SarA binds specifically to the fmtA promoter region. In vivo analysis of the fmtA promoter using a lux operon reporter fusion show high level expression following oxacillin induction, which was abrogated in a sarA mutant strain. These data suggest that SarA is essential for the induction of fmtA expression by cell wall-specific antibiotics. Further, in vitro transcription studies show that SarA enhances fmtA transcription and suggest that regulation of fmtA could be via a SigA-dependent mechanism. Overall, our results show that SarA plays a direct role in the regulation of fmtA expression via binding to the fmtA promoter.	[Belcheva, Antoaneta; Fridman, Michael; Golemi-Kotra, Dasantila] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Zhao, Yinglu; Verma, Vidhu; Singh, Atul; Golemi-Kotra, Dasantila] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	Zhao, YL (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	dgkotra@yorku.ca	/N-6611-2013	/0000-0003-1299-6987; Belcheva, Antoaneta/0000-0001-5061-7533	Canadian Institutes of Health Research [93530]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors declare that there are no financial, personal, or professional interests that could be construed to have influenced the manuscript. This study was supported by a grant from Canadian Institutes of Health Research (http://www.cihr.ca/e/193.html) to DGK (Operating Grant nr. 93530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley Judene, 2002, Infect Control Hosp Epidemiol, V23, P480; Belcheva A, 2012, J BACTERIOL, V194, P61, DOI 10.1128/JB.06143-11; Belcheva A, 2009, BIOCHEMISTRY-US, V48, P5592, DOI 10.1021/bi900478b; BERGERBACHI B, 1992, ANTIMICROB AGENTS CH, V36, P1367, DOI 10.1128/AAC.36.7.1367; Bernal P, 2010, J BIOL CHEM, V285, P24055, DOI 10.1074/jbc.M110.114793; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Chan PF, 1998, J BACTERIOL, V180, P6232; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Cheung AL, 2008, J BACTERIOL, V190, P2239, DOI 10.1128/JB.01826-07; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Chien YT, 1998, J BIOL CHEM, V273, P2645, DOI 10.1074/jbc.273.5.2645; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; Deora R, 1996, J BIOL CHEM, V271, P21828, DOI 10.1074/jbc.271.36.21828; Didier JP, 2010, FEMS MICROBIOL LETT, V306, P30, DOI 10.1111/j.1574-6968.2010.01930.x; Duran SP, 1996, FEMS MICROBIOL LETT, V141, P255, DOI 10.1016/0378-1097(96)00231-5; Fan X, 2007, J BIOL CHEM, V282, P35143, DOI 10.1074/jbc.M706296200; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; GEORGOPAPADAKOU NH, 1993, ANTIMICROB AGENTS CH, V37, P2045, DOI 10.1128/AAC.37.10.2045; HENZE U, 1993, J BACTERIOL, V175, P1612, DOI 10.1128/JB.175.6.1612-1620.1993; Henze UU, 1996, MICROB DRUG RESIST, V2, P193, DOI 10.1089/mdr.1996.2.193; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Ingavale SS, 2003, MOL MICROBIOL, V48, P1451, DOI 10.1046/j.1365-2958.2003.03503.x; Jo DS, 2011, ANTIMICROB AGENTS CH, V55, P2818, DOI 10.1128/AAC.01704-10; Komatsuzawa H, 1999, ANTIMICROB AGENTS CH, V43, P2121, DOI 10.1128/AAC.43.9.2121; Komatsuzawa H, 1997, ANTIMICROB AGENTS CH, V41, P2355, DOI 10.1128/AAC.41.11.2355; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Lamichhane-Khadka R, 2009, INT J ANTIMICROB AG, V34, P136, DOI 10.1016/j.ijantimicag.2009.01.018; Lindsay JA, 1999, MOL GEN GENET, V262, P323, DOI 10.1007/s004380051090; Liu YF, 2006, P NATL ACAD SCI USA, V103, P2392, DOI 10.1073/pnas.0510439103; Livermore DM, 2000, INT J ANTIMICROB AG, V16, pS3; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MAKI H, 1994, J BACTERIOL, V176, P4993, DOI 10.1128/jb.176.16.4993-5000.1994; Manna AC, 2004, J BACTERIOL, V186, P5267, DOI 10.1128/JB.186.16.5267-5280.2004; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; McCallum N, 2006, BBA-GEN SUBJECTS, V1760, P1475, DOI 10.1016/j.bbagen.2006.06.008; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; RAO L, 1995, J BACTERIOL, V177, P2609, DOI 10.1128/jb.177.10.2609-2614.1995; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; Schumacher MA, 2001, NATURE, V409, P215, DOI 10.1038/35051623; Sengupta M, 2012, CAN J MICROBIOL, V58, P703, DOI [10.1139/W2012-043, 10.1139/w2012-043]; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; SMITH IM, 1960, LANCET, V1, P1318; Sobral RG, 2007, J BACTERIOL, V189, P2376, DOI 10.1128/JB.01439-06; Sterba KM, 2003, J BACTERIOL, V185, P4410, DOI 10.1128/JB.185.15.4410-4417.2003; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; Suzuki J, 1997, FEMS MICROBIOL LETT, V153, P327, DOI 10.1016/S0378-1097(97)00269-3; Suzuki T, 2011, INVEST OPHTH VIS SCI, V52, P3187, DOI 10.1167/iovs.10-6558; TATTI KM, 1995, J MOL BIOL, V253, P8, DOI 10.1006/jmbi.1995.0531; Trotonda MP, 2008, INFECT IMMUN, V76, P5645, DOI 10.1128/IAI.00735-08; Trotonda MP, 2009, J INFECT DIS, V199, P209, DOI 10.1086/595740; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6; Wolz C, 2000, MOL MICROBIOL, V36, P230, DOI 10.1046/j.1365-2958.2000.01853.x; Wu SW, 1996, J BACTERIOL, V178, P6036, DOI 10.1128/jb.178.20.6036-6042.1996; Wu SW, 1996, MICROB DRUG RESIST, V2, P277, DOI 10.1089/mdr.1996.2.277	69	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43998	10.1371/journal.pone.0043998	http://dx.doi.org/10.1371/journal.pone.0043998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952845	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206500038
J	Zhou, J; Yuan, WJ; Zhu, N; Zhou, Y; Wang, L				Zhou Jing; Yuan Wei-jie; Zhu Nan; Zhou Yi; Wang Ling			Hemoglobin Targets for Chronic Kidney Disease Patients with Anemia: A Systematic Review and Meta-analysis	PLOS ONE			English	Review							LEFT-VENTRICULAR MASS; QUALITY-OF-LIFE; HEMODIALYSIS-PATIENTS; EPOETIN-ALPHA; ERYTHROPOIETIN THERAPY; RANDOMIZED-TRIAL; CARDIAC-DISEASE; RENAL-FAILURE; NORMALIZATION; HEMATOCRIT	Background: Numerous studies have identified a relationship between hemoglobin (Hb) levels and mortality in patients with chronic kidney disease (CKD), which have raised concerns about the optimal Hb targets in correction of anemia. Our study is designed to investigate the potential effects of targeted Hb levels, aiming to give some evidence for therapy of renal anemia. Methodology/Principal Findings: A comprehensive search of Medline, Embase and the Cochrane Database of Systematic Reviews was performed in December 2011 and updated in February 2012 for any new trials. Randomized trials designed to evaluate effects of high (generally the Hb about 13.0 g/dL) and low Hb (generally the Hb about 10.0 g/dL) targets on clinical outcomes in CKD patients with anemia were collected. All statistical analysis was calculated using the RevMan software available free from the Cochrane Collaboration. 24 trials involving 10361 patients were identified. Our findings demonstrated a statistically significant increased risk of mortality in the high Hb levels (RR 1.18; 95% CI 1.02 to 1.37) while the high and low Hb groups were both treated with ESAs. Overall, compared with low Hb levels, high Hb levels are associated with increased risk of hypertension (RR 1.40; 95% CI 1.11 to 1.75), stroke (RR 1.73; 95% CI 1.31 to 2.29), and hospitalizations (RR 1.07; 95% CI 1.01 to 1.14). However, there are no significant differences in the risk of non-fatal myocardial infarction (RR 1. 13; 95% CI 0.79 to 1.61) and renal replacement therapy (RR 1. 00; 95% CI 0.85 to 1.18). Conclusions/Significances: Targeting low Hb levels are beneficial to CKD patients especially in the predialysis population. The optimal Hb targets to aim for in CKD patients and at what Hb level the risks of adverse events begin to increase remain elusive. Future studies are still needed to elucidate these questions.	[Zhou Jing; Yuan Wei-jie; Zhu Nan; Zhou Yi; Wang Ling] Shanghai Jiao Tong Univ, Peoples Hosp 1, Dept Nephrol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhou, J (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 1, Dept Nephrol, Shanghai 200030, Peoples R China.	YWJ4169@yahoo.com.cn						Akizawa T, 2011, THER APHER DIAL, V15, P431, DOI 10.1111/j.1744-9987.2011.00931.x; [Anonymous], 2001, Am J Kidney Dis, V37, pS182; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Berns JS, 1999, KIDNEY INT, V56, P253, DOI 10.1046/j.1523-1755.1999.00531.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Cianciaruso B, 2008, J NEPHROL, V21, P861; Conlon PJ, 2000, RENAL FAILURE, V22, P435, DOI 10.1081/JDI-100100885; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; FDA Drug Safety Communication, 2011, MOD DOS REC IMPR SAF; Foley RN, 2000, KIDNEY INT, V58, P1325, DOI 10.1046/j.1523-1755.2000.00289.x; Furuland H, 2003, NEPHROL DIAL TRANSPL, V18, P353, DOI 10.1093/ndt/18.2.353; Gouva C, 2004, KIDNEY INT, V66, P753, DOI 10.1111/j.1523-1755.2004.00797.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; KDOQI, 2006, Am J Kidney Dis, V47, pS16; Kuriyama S, 1997, NEPHRON, V77, P176, DOI 10.1159/000190270; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; Levin A, 2007, AM J KIDNEY DIS, V50, P471; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Mactier R, 2011, NEPHRON CLIN PRACT, V118, pC27, DOI 10.1159/000328060; McMahon LP, 2000, NEPHROL DIAL TRANSPL, V15, P1425, DOI 10.1093/ndt/15.9.1425; NISSENSON AR, 1995, J AM SOC NEPHROL, V5, P1517; Obrador GT, 2001, KIDNEY INT, V60, P1875, DOI 10.1046/j.1523-1755.2001.00002.x; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Pappas KD, 2008, CARDIOVASC DRUG THER, V22, P37, DOI 10.1007/s10557-007-6075-6; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Patel M, 2012, J AM MED DIR ASSOC, V13, P244, DOI 10.1016/j.jamda.2010.09.009; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Regidor D, 2011, NEPHROL DIAL TRANSPL, V26, P1583, DOI 10.1093/ndt/gfq573; REVICKI DA, 1995, AM J KIDNEY DIS, V25, P548, DOI 10.1016/0272-6386(95)90122-1; Ritz E, 2007, AM J KIDNEY DIS, V49, P194, DOI 10.1053/j.ajkd.2006.11.032; Roger SD, 2004, J AM SOC NEPHROL, V15, P148, DOI 10.1097/01.ASN.0000102471.89084.8B; SIKOLE A, 1993, ARTIF ORGANS, V17, P977, DOI 10.1111/j.1525-1594.1993.tb03179.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P3154, DOI 10.1097/01.ASN.0000145436.09176.A7; TEEHAN BP, 1990, SEMIN NEPHROL, V10, P28; Villar E, 2011, J DIABETES COMPLICAT, V25, P237, DOI 10.1016/j.jdiacomp.2011.03.003; WATSON AJ, 1989, SEMIN NEPHROL, V9, P30	41	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43655	10.1371/journal.pone.0043655	http://dx.doi.org/10.1371/journal.pone.0043655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952731	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500019
J	Friese, M; Smith, CT; Plischke, T; Bluemke, M; Nosek, BA				Friese, Malte; Smith, Colin Tucker; Plischke, Thomas; Bluemke, Matthias; Nosek, Brian A.			Do Implicit Attitudes Predict Actual Voting Behavior Particularly for Undecided Voters?	PLOS ONE			English	Article							ASSOCIATION TEST; SOCIAL COGNITION; EXPLICIT ATTITUDES; PLANNED BEHAVIOR; FUTURE BEHAVIOR; METAANALYSIS; VALIDITY; STEREOTYPES; ELECTION; MODEL	The prediction of voting behavior of undecided voters poses a challenge to psychologists and pollsters. Recently, researchers argued that implicit attitudes would predict voting behavior particularly for undecided voters whereas explicit attitudes would predict voting behavior particularly for decided voters. We tested this assumption in two studies in two countries with distinct political systems in the context of real political elections. Results revealed that (a) explicit attitudes predicted voting behavior better than implicit attitudes for both decided and undecided voters, and (b) implicit attitudes predicted voting behavior better for decided than undecided voters. We propose that greater elaboration of attitudes produces stronger convergence between implicit and explicit attitudes resulting in better predictive validity of both, and less incremental validity of implicit over explicit attitudes for the prediction of voting behavior. However, greater incremental predictive validity of implicit over explicit attitudes may be associated with less elaboration.	[Friese, Malte] Univ Basel, Dept Psychol, Basel, Switzerland; [Smith, Colin Tucker] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Plischke, Thomas] Univ Mannheim, Dept Polit Sci, Mannheim, Germany; [Bluemke, Matthias] Univ Heidelberg, Dept Psychol, Heidelberg, Germany; [Nosek, Brian A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	University of Basel; State University System of Florida; University of Florida; University of Mannheim; Ruprecht Karls University Heidelberg; University of Virginia	Friese, M (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	malte.friese@unibas.ch	Bluemke, Matthias/V-2057-2019; Friese, Malte/A-3788-2016	Bluemke, Matthias/0000-0003-1493-7462; Friese, Malte/0000-0003-0055-513X; Nosek, Brian/0000-0001-6797-5476	Project Implicit; Fritz Thyssen Foundation	Project Implicit; Fritz Thyssen Foundation	This research was supported by Project Implicit and the Fritz Thyssen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Arcuri L, 2008, POLIT PSYCHOL, V29, P369, DOI 10.1111/j.1467-9221.2008.00635.x; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bluemke M, 2008, EUR J SOC PSYCHOL, V38, P977, DOI 10.1002/ejsp.487; Cadinu M., 2011, SOCIAL PERCEPTION CO, P203; De Houwer J, 2009, PSYCHOL B, P135; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Friese M, 2007, EXP PSYCHOL, V54, P247, DOI 10.1027/1618-3169.54.4.247; Friese M, 2008, EUR REV SOC PSYCHOL, V19, P285, DOI 10.1080/10463280802556958; Galdi S, 2008, SCIENCE, V321, P1100, DOI 10.1126/science.1160769; Galdi S, 2012, PERS SOC PSYCHOL B, V38, P559, DOI 10.1177/0146167211435981; Gawronski B, 2006, PSYCHOL BULL, V132, P692, DOI 10.1037/0033-2909.132.5.692; Gawronski B, 2011, ADV EXP SOC PSYCHOL, V44, P59, DOI 10.1016/B978-0-12-385522-0.00002-0; Glasman LR, 2006, PSYCHOL BULL, V132, P778, DOI 10.1037/0033-2909.132.5.778; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hagger MS, 2002, J SPORT EXERCISE PSY, V24, P3, DOI 10.1123/jsep.24.1.3; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Hofmann Wilhelm, 2005, EUROPEAN REV SOCIAL, V16, P335, DOI [DOI 10.1080/10463280500443228, 10.1080/10463280500443228]; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Karpinski A, 2005, PERS SOC PSYCHOL B, V31, P949, DOI 10.1177/0146167204273007; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Nosek B. A., 2010, HDB IMPLICIT SOCIAL, P548; Nosek BA, 2005, J EXP PSYCHOL GEN, V134, P565, DOI 10.1037/0096-3445.134.4.565; Nosek BA, 2012, HDB SOCIAL COGNITION, P36; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Nosek BA, 2007, EXP PSYCHOL, V54, P14, DOI 10.1027/1618-3169.54.1.14; PERRY P, 1979, PUBLIC OPIN QUART, V43, P312, DOI 10.1086/268524; Perugini M., 2010, HDB IMPLICIT SOCIAL, P255; Ranganath KA, 2008, J EXP SOC PSYCHOL, V44, P386, DOI 10.1016/j.jesp.2006.12.008; Rattinger H., 2009, GERMAN LONGITUDINAL; Roccato M, 2010, POLIT PSYCHOL, V31, P249, DOI 10.1111/j.1467-9221.2009.00751.x; Smith CT, 2011, SOC PSYCHOL-GERMANY, V42, P300, DOI 10.1027/1864-9335/a000072; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322; Visser P., 2000, ELECTION POLLS NEWS, P224; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Wilson TD, 2000, PSYCHOL REV, V107, P101, DOI 10.1037/0033-295X.107.1.101	41	48	49	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44130	10.1371/journal.pone.0044130	http://dx.doi.org/10.1371/journal.pone.0044130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZC	22952898	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000087
J	Langer, M; Pacureanu, A; Suhonen, H; Grimal, Q; Cloetens, P; Peyrin, F				Langer, Max; Pacureanu, Alexandra; Suhonen, Heikki; Grimal, Quentin; Cloetens, Peter; Peyrin, Francoise			X-Ray Phase Nanotomography Resolves the 3D Human Bone Ultrastructure	PLOS ONE			English	Article							SYNCHROTRON-RADIATION; TRABECULAR BONE; COMPACT-BONE; SECONDARY OSTEONS; CORTICAL BONE; CEMENT LINE; COLLAGEN; DENSITY; MINERALIZATION; ORIENTATION	Bone strength and failure are increasingly thought to be due to ultrastructural properties, such as the morphology of the lacuno-canalicular network, the collagen fiber orientation and the mineralization on the nanoscale. However, these properties have not been studied in 3D so far. Here we report the investigation of the human bone ultrastructure with X-ray phase nanotomography, which now provides the required sensitivity, spatial resolution and field of view. The 3D organization of the lacuno-canalicular network is studied in detail over several cells in osteonal and interstitial tissue. Nanoscale density variations are revealed and show that the cement line separating these tissues is hypermineralized. Finally, we show that the collagen fibers are organized as a twisted plywood structure in 3D.	[Langer, Max; Pacureanu, Alexandra; Peyrin, Francoise] Univ Lyon 1, CNRS, UMR5220, Inserm,U1044, F-69365 Lyon, France; [Langer, Max; Pacureanu, Alexandra; Suhonen, Heikki; Cloetens, Peter; Peyrin, Francoise] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Pacureanu, Alexandra] Politeh Univ Bucharest, LAPI, Bucharest, Romania; [Grimal, Quentin] UPMC Univ Paris 06, CNRS, UMR7623, LIP, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; European Synchrotron Radiation Facility (ESRF); Polytechnic University of Bucharest; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Langer, M (corresponding author), Univ Lyon 1, CNRS, UMR5220, Inserm,U1044, F-69365 Lyon, France.	max.langer@esrf.fr	Cloetens, Peter/AAJ-6131-2020; Suhonen, Heikki/B-7851-2012; Peyrin, Francoise/G-2823-2013; Langer, Max/E-1408-2013; grimal, quentin/P-4758-2014	Cloetens, Peter/0000-0002-4129-9091; Suhonen, Heikki/0000-0002-0337-6308; Peyrin, Francoise/0000-0002-1988-3435; Langer, Max/0000-0002-5821-9617; grimal, quentin/0000-0001-9041-8176; Pacureanu, Alexandra/0000-0003-2306-7040	French Medical Research Foundation (FRM - Fondation pour la recherche medicale)	French Medical Research Foundation (FRM - Fondation pour la recherche medicale)	This work was funded by the French Medical Research Foundation (FRM - Fondation pour la recherche medicale, www.frm.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JC, 2010, MICROSC MICROANAL, V16, P327, DOI 10.1017/S1431927610000231; Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013; Bleuet P, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3117489; Bousson V, 2004, J BONE MINER RES, V19, P794, DOI 10.1359/JBMR.040124; Bromage Timothy G., 2003, Anatomical Record, V274B, P157, DOI 10.1002/ar.b.10031; BURR DB, 1988, J BIOMECH, V21, P939, DOI 10.1016/0021-9290(88)90132-7; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Giraud-Guille MM, 2003, J BIOMECH, V36, P1571, DOI 10.1016/S0021-9290(03)00134-9; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; Guinier A., 1994, XRAY DIFFRACTION CRY; Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024; Hignette O, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1928191; HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Kingsmill VJ, 1998, J ANAT, V192, P245, DOI 10.1046/j.1469-7580.1998.19220245.x; KIRKPATRICK P, 1948, J OPT SOC AM, V38, P766, DOI 10.1364/JOSA.38.000766; Lane NE, 2006, J BONE MINER RES, V21, P466, DOI 10.1359/JBMR.051103; MAROTTI G, 1995, BONE, V16, P125, DOI 10.1016/S8756-3282(94)00019-0; Martin T, 2009, IEEE T NUCL SCI, V56, P1412, DOI 10.1109/TNS.2009.2015878; Mokso R, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2719653; Muller R, 2009, NAT REV RHEUMATOL, V5, P373, DOI 10.1038/nrrheum.2009.107; Nuzzo S, 2002, J BONE MINER RES, V17, P1372, DOI 10.1359/jbmr.2002.17.8.1372; O'Brien FJ, 2003, J BIOMECH, V36, P973, DOI 10.1016/S0021-9290(03)00066-6; PANNARALE L, 1994, ACTA ANAT, V151, P36; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; SCHAFFLER MB, 1987, ANAT REC, V217, P223, DOI 10.1002/ar.1092170302; Schneider P, 2011, BONE, V49, P304, DOI 10.1016/j.bone.2011.04.005; Schneider P, 2010, BONE, V47, P848, DOI 10.1016/j.bone.2010.07.026; Skedros JG, 2005, ANAT REC PART A, V286A, P781, DOI 10.1002/ar.a.20214; Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017; van Hove RP, 2009, BONE, V45, P321, DOI 10.1016/j.bone.2009.04.238	37	121	122	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e35691	10.1371/journal.pone.0035691	http://dx.doi.org/10.1371/journal.pone.0035691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952569	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000001
J	Matsui, A; Yokoo, H; Negishi, Y; Endo-Takahashi, Y; Chun, NAL; Kadouchi, I; Suzuki, R; Maruyama, K; Aramaki, Y; Semba, K; Kobayashi, E; Takahashi, M; Murakami, T				Matsui, Aya; Yokoo, Hideaki; Negishi, Yoichi; Endo-Takahashi, Yoko; Chun, Nicole A. L.; Kadouchi, Ichiro; Suzuki, Ryo; Maruyama, Kazuo; Aramaki, Yukihiko; Semba, Kentaro; Kobayashi, Eiji; Takahashi, Masafumi; Murakami, Takashi			CXCL17 Expression by Tumor Cells Recruits CD11b(+)Gr1(high)F4/80(-) Cells and Promotes Tumor Progression	PLOS ONE			English	Article							MURINE B16 MELANOMA; ANGIOGENIC SWITCH; SUPPRESSOR-CELLS; MYELOID CELLS; CANCER; CHEMOKINE; MIGRATION; GROWTH; TRANSFORMATION; TUMORIGENESIS	Background: Chemokines are involved in multiple aspects of pathogenesis and cellular trafficking in tumorigenesis. In this study, we report that the latest member of the C-X-C-type chemokines, CXCL17 (DMC/VCC-1), recruits immature myeloid-derived cells and enhances early tumor progression. Methodology/Principal Findings: CXCL17 was preferentially expressed in some aggressive types of gastrointestinal, breast, and lung cancer cells. CXCL17 expression did not impart NIH3T3 cells with oncogenic potential in vitro, but CXCL17-expressing NIH3T3 cells could form vasculature-rich tumors in immunodeficient mice. Our data showed that CXCL17-expressing tumor cells increased immature CD11b(+)Gr1(+) myeloid-derived cells at tumor sites in mice and promoted CD31(+) tumor angiogenesis. Extensive chemotactic assays proved that CXCL17-responding cells were CD11b(+)Gr1(high)F4/80(-) cells (similar to 90%) with a neutrophil-like morphology in vitro. Although CXCL17 expression could not increase the number of CD11b(+)Gr1(+) cells in tumor-burdened SCID mice or promote metastases of low metastatic colon cancer cells, the existence of CXCL17-responding myeloid-derived cells caused a striking enhancement of xenograft tumor formation. Conclusions/Significance: These results suggest that aberrant expression of CXCL17 in tumor cells recruits immature myeloid-derived cells and promotes tumor progression through angiogenesis.	[Matsui, Aya; Murakami, Takashi] Takasaki Univ Hlth & Welf, Lab Tumor Biol, Takasaki, Gunma, Japan; [Matsui, Aya; Chun, Nicole A. L.; Kadouchi, Ichiro; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Bioimaging Sci, Shimotsuke, Tochigi, Japan; [Yokoo, Hideaki] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gunma 371, Japan; [Negishi, Yoichi; Endo-Takahashi, Yoko] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Drug & Gene Delivery Syst, Tokyo, Japan; [Suzuki, Ryo; Maruyama, Kazuo; Aramaki, Yukihiko] Teikyo Univ, Sch Pharmaceut Sci, Dept Biopharmaceut, Sagamihara, Kanagawa, Japan; [Semba, Kentaro] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Kobayashi, Eiji] Jichi Med Univ, Div Dev Adv Med Technol, Shimotsuke, Tochigi, Japan	Jichi Medical University; Gunma University; Tokyo University of Pharmacy & Life Sciences; Teikyo University; Waseda University; Jichi Medical University	Matsui, A (corresponding author), Takasaki Univ Hlth & Welf, Lab Tumor Biol, Takasaki, Gunma, Japan.	murakami@takasaki-u.ac.jp		Suzuki, Ryo/0000-0001-6614-4486; Takahashi, Yoko/0000-0002-6881-6044	Health and Labour Science Research Grants of the Ministry of Health, Labor, and Welfare (Research on Biological Resources); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [20591326, 2008-2010, 23591627, 2011]; Takeda Science Foundation; "Strategic Research Platform" for Private Universities: matching fund subsidy from MEXT	Health and Labour Science Research Grants of the Ministry of Health, Labor, and Welfare (Research on Biological Resources); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); "Strategic Research Platform" for Private Universities: matching fund subsidy from MEXT	This study was supported by a grant to T.M. from the Health and Labour Science Research Grants of the Ministry of Health, Labor, and Welfare (Research on Biological Resources), the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Project No. 20591326, 2008-2010 and Project No. 23591627, 2011), Takeda Science Foundation (2010), and a grant from the "Strategic Research Platform" for Private Universities: matching fund subsidy from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; COPELAND NG, 1979, CELL, V16, P347, DOI 10.1016/0092-8674(79)90011-4; Fridlender ZG, 2010, CANCER RES, V70, P109, DOI 10.1158/0008-5472.CAN-09-2326; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; FUJITA J, 1984, NATURE, V309, P464, DOI 10.1038/309464a0; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hiraoka N, 2011, GASTROENTEROLOGY, V140, P310, DOI 10.1053/j.gastro.2010.10.009; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2009, CANCER CELL, V16, P173, DOI 10.1016/j.ccr.2009.08.014; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Murakami T, 2002, CANCER RES, V62, P7328; Murakami T, 2008, J INVEST DERMATOL, V128, P1506, DOI 10.1038/sj.jid.5701216; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Negishi Y, 2008, J CONTROL RELEASE, V132, P124, DOI 10.1016/j.jconrel.2008.08.019; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Poole TJ, 2001, DEV DYNAM, V220, P1, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1087>3.0.CO;2-2; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Tadmor T, 2011, BRIT J HAEMATOL, V153, P557, DOI 10.1111/j.1365-2141.2011.08678.x; WANG JM, 1990, BIOCHEM BIOPH RES CO, V169, P165, DOI 10.1016/0006-291X(90)91449-3; Weinstein EJ, 2006, BIOCHEM BIOPH RES CO, V350, P74, DOI 10.1016/j.bbrc.2006.08.194; Whitehead IP, 2001, ONCOGENE, V20, P1547, DOI 10.1038/sj.onc.1204188; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558; Yanagisawa S, 2009, CLIN CANCER RES, V15, P3014, DOI 10.1158/1078-0432.CCR-08-2237	37	55	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44080	10.1371/journal.pone.0044080	http://dx.doi.org/10.1371/journal.pone.0044080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952881	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206000080
J	Tomar, A; Lawson, C; Ghassemian, M; Schlaepfer, DD				Tomar, Alok; Lawson, Christine; Ghassemian, Majid; Schlaepfer, David D.			Cortactin as a Target for FAK in the Regulation of Focal Adhesion Dynamics	PLOS ONE			English	Article							CELL MOTILITY; KINASE-ACTIVITY; N-WASP; TYROSINE PHOSPHORYLATION; SUBSTRATE P130(CAS); RHOA ACTIVITY; V-SRC; ACTIN; MIGRATION; DOMAIN	Background: Efficient cell movement requires the dynamic regulation of focal adhesion (FA) formation and turnover. FAs are integrin-associated sites of cell attachment and establish linkages to the cellular actin cytoskeleton. Cells without focal adhesion kinase (FAK), an integrin-activated tyrosine kinase, exhibit defects in FA turnover and cell motility. Cortactin is an actin binding adaptor protein that can influence FA dynamics. FAK and cortactin interact, but the cellular role of this complex remains unclear. Principal Findings: Using FAK-null fibroblasts stably reconstituted with green fluorescent protein (GFP) tagged FAK constructs, we find that FAK activity and FAK C-terminal proline-rich region 2 (PRR2) and PRR3 are required for FA turnover and cell motility. Cortactin binds directly to FAK PRR2 and PRR3 sites via its SH3 domain and cortactin expression is important in promoting FA turnover and GFP-FAK release from FAs. FAK-cortactin binding is negatively-regulated by FAK activity and associated with cortactin tyrosine phosphorylation. FAK directly phosphorylates cortactin at Y421 and Y466 and over-expression of cortactin Y421, Y466, and Y482 mutated to phenylalanine (3YF) prevented FAK-enhanced FA turnover and cell motility. However, phospho-mimetic cortactin mutated to glutamic acid (3YE) did not affect FA dynamics and did not rescue FA turnover defects in cells with inhibited FAK activity or with PRR2-mutated FAK that does not bind cortactin. Conclusions: Our results support a model whereby FAK-mediated FA remodeling may occur through the formation of a FAK-cortactin signaling complex. This involves a cycle of cortactin binding to FAK, cortactin tyrosine phosphorylation, and subsequent cortactin-FAK dissociation accompanied by FA turnover and cell movement.	[Tomar, Alok; Lawson, Christine; Schlaepfer, David D.] Univ Calif San Diego, Moores Univ Calif San Diego Canc Ctr, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Tomar, A (corresponding author), Aerotek, San Diego, CA USA.	dschlaepfer@ucsd.edu			National Institutes of Health [GM087400, CA102310]; AHA fellowship [0825166F]; CIHR fellowship [200810MFE-193594-139144]; NATIONAL CANCER INSTITUTE [R01CA102310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA fellowship(American Heart Association); CIHR fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM087400 and CA102310 to David Schlaepfer. Alok Tomar was supported by an AHA fellowship (0825166F) and Christine Lawson by CIHR fellowship (200810MFE-193594-139144) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Corsi JM, 2009, J BIOL CHEM, V284, P34769, DOI 10.1074/jbc.M109.067280; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Eke I, 2012, J CLIN INVEST, V122, P1529, DOI 10.1172/JCI61350; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Hauck CR, 2001, J BIOL CHEM, V276, P17653, DOI 10.1074/jbc.M009329200; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Kruchten AE, 2008, AM J PHYSIOL-CELL PH, V295, pC1113, DOI 10.1152/ajpcell.00238.2008; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P21526, DOI 10.1074/jbc.M110.129999; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Meiler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033662; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; OKAMURA H, 1995, J BIOL CHEM, V270, P26613, DOI 10.1074/jbc.270.44.26613; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Polte TR, 1997, J BIOL CHEM, V272, P5501, DOI 10.1074/jbc.272.9.5501; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Ren G, 2009, CELL MOTIL CYTOSKEL, V66, P865, DOI 10.1002/cm.20380; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 2007, J BIOL CHEM, V282, P17450, DOI 10.1074/jbc.M610672200; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sieg DJ, 1999, J CELL SCI, V112, P2677; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; Wang WQ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-49; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200	59	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44041	10.1371/journal.pone.0044041	http://dx.doi.org/10.1371/journal.pone.0044041			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952866	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206000072
J	Buscariollo, DL; Davidson, MA; Black, M; Russell, WE; Rothman, RL; Moore, DJ				Buscariollo, Daniela L.; Davidson, Mario A.; Black, Margo; Russell, William E.; Rothman, Russell L.; Moore, Daniel J.			Factors That Influence Parental Attitudes toward Enrollment in Type 1 Diabetes Trials	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; RECRUITMENT; PERCEPTIONS	Aims: To assess parental attitudes towards type 1 diabetes clinical trials (T1DCTs) and factors that impact willingness to enroll their children with and without diabetes. Methods: A cross-sectional survey of parents of children with type 1 diabetes was administered at an academic clinic and a diabetes educational event. Results: Survey response rate was 36%. Of 166 participating parents, 76% were aware of T1DCTs. More parents reported willingness to enroll children with diabetes (47%) than unaffected children (36%). Only 18% recalled being asked to enroll their children, and of these, 60% agreed to enroll at least some of those times. Less than 30% were comfortable with placebos. Factors predicting willingness to enroll children with diabetes included healthcare provider trust, comfort with consent by proxy, low fear of child being a "guinea pig," and comfort with placebo. Factors predicting willingness to enroll unaffected children were provider trust, comfort with consent by proxy, comfort with placebo, and perceived ease of understanding T1DCT information. Conclusions: Parents report moderate willingness to enroll children in T1DCTs. Willingness is diminished by common trial methodologies. Although most parents recalled receiving trial-related information, significantly fewer recalled being asked to participate. Efforts to optimize effective communication around identified areas of parental concern may increase T1DCT participation.	[Buscariollo, Daniela L.; Black, Margo; Russell, William E.; Moore, Daniel J.] Vanderbilt Univ, Med Ctr, Dept Pediat, Ian Burr Div Endocrinol & Diabet, Nashville, TN 37232 USA; [Davidson, Mario A.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Rothman, Russell L.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Buscariollo, DL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Ian Burr Div Endocrinol & Diabet, Nashville, TN 37232 USA.	daniel.moore@vanderbilt.edu	Davidson, Mario/AAX-1102-2021; Moore, Daniel/V-6145-2019; Moore, Daniel J/A-4924-2008	Moore, Daniel/0000-0002-6889-9345; Moore, Daniel J/0000-0002-6889-9345; Rothman, Russsell/0000-0002-1506-3990	United States National Institutes of Health [F32DK083161]; Vanderbilt Physician Scientist Development Program; Type 1 Diabetes TrialNet Clinical Center Award;  [U01DK085465]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085465, F32DK083161, P30DK092986] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Physician Scientist Development Program; Type 1 Diabetes TrialNet Clinical Center Award; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DJM was supported by United States National Institutes of Health F32DK083161 and the Vanderbilt Physician Scientist Development Program. WER was supported by U01DK085465, Type 1 Diabetes TrialNet Clinical Center Award to Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Caldwell PHY, 2003, J PEDIATR-US, V142, P554, DOI 10.1067/mpd.2003.192; Caldwell PHY, 2002, J PEDIATR-US, V141, P798, DOI 10.1067/mpd.2002.129173; Harrell FE, 2001, REGRESSION MODELING; Harth SC, 1995, SOC SCI MED, V41, P1647, DOI 10.1016/0277-9536(95)00058-F; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; Ludvigsson J, 2011, DIABETOLOGIA, V54, P634, DOI 10.1007/s00125-010-1988-1; McGuinness Claire, 2007, Paediatr Nurs, V19, P37; Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594; Smyth RL, 2001, BRIT MED J, V322, P1377, DOI 10.1136/bmj.322.7299.1377; Snowdon C, 1997, SOC SCI MED, V45, P1337, DOI 10.1016/S0277-9536(97)00063-4; Stolt UG, 2005, EUR J HUM GENET, V13, P376, DOI 10.1038/sj.ejhg.5201336; Tait AR, 2003, ANESTHESIOLOGY, V99, P819, DOI 10.1097/00000542-200310000-00012; Tait AR, 2003, ANESTHESIOLOGY, V98; Tercyak KP, 1998, DIABETES CARE, V21, P213, DOI 10.2337/diacare.21.2.213; Walson PD, 1999, PEDIATRICS, V104, P619; Welton AJ, 1999, BRIT MED J, V318, P1114, DOI 10.1136/bmj.318.7191.1114; Wiley FM, 1999, CANCER PRACT, V7, P248, DOI 10.1046/j.1523-5394.1999.75010.x; Zupancic JAF, 1997, PEDIATRICS, V99, pE61	19	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44341	10.1371/journal.pone.0044341	http://dx.doi.org/10.1371/journal.pone.0044341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22937171	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600102
J	Guo, WT; Hao, HH; Dai, MH; Wang, YL; Huang, LL; Peng, DP; Wang, X; Wang, HL; Yao, M; Sun, YW; Liu, ZL; Yuan, ZH				Guo, Wentao; Hao, Haihong; Dai, Menghong; Wang, Yulian; Huang, Lingli; Peng, Dapeng; Wang, Xu; Wang, Hailan; Yao, Min; Sun, Yawei; Liu, Zhenli; Yuan, Zonghui			Development of Quinoxaline 1, 4-Dioxides Resistance in Escherichia coli and Molecular Change under Resistance Selection	PLOS ONE			English	Article							TO-FINISH FARMS; CENTRAL CARBON METABOLISM; INDUCED OXIDATIVE STRESS; ELONGATION-FACTOR G; LIPOIC ACID; ANTIMICROBIAL RESISTANCE; CONFERRING RESISTANCE; SUBSTRATE-SPECIFICITY; SODIUM-SALICYLATE; BRITISH-COLUMBIA	Quinoxaline 1, 4-dioxides (QdNOs) has been used in animals as antimicrobial agents and growth promoters for decades. However, the resistance to QdNOs in pathogenic bacteria raises worldwide concern but it is barely known. To explore the molecular mechanism involved in development of QdNOs resistance in Escherichia coli, 6 strains selected by QdNOs in vitro and 21 strains isolated from QdNOs-used swine farm were subjected to MIC determination and PCR amplification of oqxA gene. A conjugative transfer was carried out to evaluate the transfer risk of QdNOs resistant determinant. Furthermore, the transcriptional profile of a QdNOs-resistant E. coli (79O4-2) selected in vitro with its parent strain 79-161 was assayed with a prokaryotic suppression subtractive hybridization (SSH) PCR cDNA subtraction. The result showed that more than 95% (20/21) clinical isolates were oqxA positive, while all the 6 induced QdNOs-resistant strains carried no oqxA gene and exhibited low frequency of conjugation. 44 fragments were identified by SSH PCR subtraction in the QdNOs-resistant strain 79O4-2. 18 cDNAs were involved in biosynthesis of Fe-S cluster (narH), protein (rpoA, trmD, truA, glyS, ileS, rplFCX, rpsH, fusA), lipoate (lipA), lipid A (lpxC), trehalose (otsA), CTP(pyrG) and others molecular. The 11 cDNAs were related to metabolism or degradation of glycolysis (gpmA and pgi) and proteins (clpX, clpA, pepN and fkpB). The atpADG and ubiB genes were associated with ATP biosynthesis and electron transport chain. The pathway of the functional genes revealed that E. coli may adapt the stress generated by QdNOs or develop specific QdNOs-resistance by activation of antioxidative agents biosynthesis (lipoate and trehalose), protein biosynthesis, glycolysis and oxidative phosphorylation. This study initially reveals the possible molecular mechanism involved in the development of QdNOs-resistance in E. coli, providing with novel insights in prediction and assessment of the emergency and horizontal transfer of QdNOs-resistance in E. coli.	[Guo, Wentao; Hao, Haihong; Dai, Menghong; Wang, Yulian; Huang, Lingli; Peng, Dapeng; Wang, Xu; Wang, Hailan; Yao, Min; Sun, Yawei; Liu, Zhenli; Yuan, Zonghui] Huazhong Agr Univ, Natl Reference Lab Vet Drug Residues, MOA Key Lab Detect Vet Drug Residues, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Guo, WT (corresponding author), Huazhong Agr Univ, Natl Reference Lab Vet Drug Residues, MOA Key Lab Detect Vet Drug Residues, Wuhan, Hubei, Peoples R China.	yuan5802@mail.hzau.edu.cn	DAI, M/GPS-8291-2022; yuan, zonghui/A-1158-2017; Hao, Haihong/E-2789-2019	Hao, Haihong/0000-0003-0199-5700	National Natural Science Foundation of China [31101856]; Fundamental Research Funds for the Central Universities [2011QC005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This article is supported by National Natural Science Foundation of China (31101856) and the Fundamental Research Funds for the Central Universities (2011QC005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwar HT, 2008, CAN J VET RES, V72, P202; Akwar HT, 2008, CAN J VET RES, V72, P195; Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; BEUTIN L, 1981, ANTIMICROB AGENTS CH, V20, P336, DOI 10.1128/AAC.20.3.336; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Carta A, 2005, CURR MED CHEM, V12, P2259, DOI 10.2174/0929867054864831; Chandu D, 2003, MICROBIOL-SGM, V149, P3437, DOI 10.1099/mic.0.26518-0; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; DAMERAU K, 1993, J BACTERIOL, V175, P53, DOI 10.1128/JB.175.1.53-63.1993; De Long SK, 2008, APPL ENVIRON MICROB, V74, P225, DOI 10.1128/AEM.01647-07; Ding MX, 2006, J ANIM SCI, V84, P2367, DOI 10.2527/jas.2005-564; Ding X, 2006, J ANIM PHYSIOL AN N, V90, P238, DOI 10.1111/j.1439-0396.2005.00593.x; Drago L, 2005, J CHEMOTHERAPY, V17, P161, DOI 10.1179/joc.2005.17.2.161; Dunlop RH, 1998, PREV VET MED, V34, P283, DOI 10.1016/S0167-5877(97)00095-0; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fang GJ, 2006, FOOD CHEM TOXICOL, V44, P36, DOI 10.1016/j.fct.2005.06.003; Ganley B, 2001, BIOORGAN MED CHEM, V9, P2395, DOI 10.1016/S0968-0896(01)00163-8; Goraca A, 2008, J PHYSIOL PHARMACOL, V59, P379; Goraca A, 2009, J PHYSIOL PHARMACOL, V60, P61; Hansen LH, 2007, J ANTIMICROB CHEMOTH, V60, P145, DOI 10.1093/jac/dkm167; Hansen LH, 2004, ANTIMICROB AGENTS CH, V48, P3332, DOI 10.1128/AAC.48.9.3332-3337.2004; He QH, 2006, PHOTODERMATOL PHOTO, V22, P100, DOI 10.1111/j.1600-0781.2006.00199.x; HEDGES AJ, 1988, J APPL BACTERIOL, V64, P429, DOI 10.1111/j.1365-2672.1988.tb05100.x; Huang LL, 2008, J CHROMATOGR B, V874, P7, DOI 10.1016/j.jchromb.2008.08.013; KAASEN I, 1994, GENE, V145, P9, DOI 10.1016/0378-1119(94)90316-6; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; Kim YR, 2008, J MICROBIOL BIOTECHN, V18, P1146; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Krehenbrink M, 2011, MOL MICROBIOL, V82, P164, DOI 10.1111/j.1365-2958.2011.07803.x; Kumar A, 2007, BIOCHEM BIOPH RES CO, V353, P706, DOI 10.1016/j.bbrc.2006.12.073; Laskowska E, 1996, MOL MICROBIOL, V22, P555, DOI 10.1046/j.1365-2958.1996.1231493.x; Lee C, 2008, APPL MICROBIOL BIOT, V78, P371, DOI 10.1007/s00253-007-1300-6; Liang XF, 2011, BIOORGAN MED CHEM, V19, P852, DOI 10.1016/j.bmc.2010.12.017; LINTON AH, 1988, J APPL BACTERIOL, V64, P311, DOI 10.1111/j.1365-2672.1988.tb01876.x; Martinez JL, 2011, CURR OPIN PHARMACOL, V11, P439, DOI 10.1016/j.coph.2011.07.005; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; Maciag M, 2012, MUTAT RES-FUND MOL M, V731, P99, DOI 10.1016/j.mrfmmm.2011.12.005; Maciag M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-19; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; Moreira PI, 2007, J ALZHEIMERS DIS, V12, P195, DOI 10.3233/jad-2007-12210; Narita S, 2003, MOL MICROBIOL, V49, P167, DOI 10.1046/j.1365-2958.2003.03569.x; Narita S, 2002, J BACTERIOL, V184, P1417, DOI 10.1128/JB.184.5.1417-1422.2002; OHMAE K, 1981, ANTIMICROB AGENTS CH, V19, P86, DOI 10.1128/AAC.19.1.86; Ollagnier-de Choudens S, 1999, FEBS LETT, V453, P25, DOI 10.1016/S0014-5793(99)00694-8; Peed L, 2010, J BACTERIOL, V192, P4643, DOI 10.1128/JB.00317-10; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rothery RA, 2001, BIOCHEMISTRY-US, V40, P5260, DOI 10.1021/bi002393k; Rudd KE, 2000, NUCLEIC ACIDS RES, V28, P60, DOI 10.1093/nar/28.1.60; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Segers K, 2011, CHEM BIOL, V18, P685, DOI 10.1016/j.chembiol.2011.04.007; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Sorensen AH, 2003, ANTIMICROB AGENTS CH, V47, P798, DOI 10.1128/AAC.47.2.798-799.2003; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; STYRVOLD OB, 1991, J BACTERIOL, V173, P1187, DOI 10.1128/jb.173.3.1187-1192.1991; Coelho MLV, 2009, J MICROBIOL, V47, P327, DOI 10.1007/s12275-009-0044-7; Vaughan S, 2010, CURR OPIN MICROBIOL, V13, P453, DOI 10.1016/j.mib.2010.05.006; Gomis-Ruth FX, 2006, CURR OPIN STRUC BIOL, V16, P744, DOI 10.1016/j.sbi.2006.10.004; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Yuan YM, 2007, ARCH MICROBIOL, V187, P425, DOI 10.1007/s00203-006-0206-5; ZENGEL JM, 1994, PROG NUCLEIC ACID RE, V47, P331, DOI 10.1016/S0079-6603(08)60256-1; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998; Zou JJ, 2009, MUTAT RES-GEN TOX EN, V676, P27, DOI 10.1016/j.mrgentox.2009.03.001	68	48	50	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43322	10.1371/journal.pone.0043322	http://dx.doi.org/10.1371/journal.pone.0043322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952665	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600021
J	Hu, SH; Whitten, AE; King, GJ; Jones, A; Rowland, AF; James, DE; Martin, JL				Hu, Shu-Hong; Whitten, Andrew E.; King, Gordon J.; Jones, Alun; Rowland, Alexander F.; James, David E.; Martin, Jennifer L.			The Weak Complex between RhoGAP Protein ARHGAP22 and Signal Regulatory Protein 14-3-3 Has 1:2 Stoichiometry and a Single Peptide Binding Mode	PLOS ONE			English	Article							STRUCTURAL BASIS; WIDE PREDICTION; PHOSPHORYLATION; IDENTIFICATION; RAC; AKT	ARHGAP22 is a RhoGAP protein comprising an N-terminal PH domain, a RhoGAP domain and a C-terminal coiled-coil domain. It has recently been identified as an Akt substrate that binds 14-3-3 proteins in response to treatment with growth factors involved in cell migration. We used a range of biophysical techniques to investigate the weak interaction between 14-3-3 and a truncated form of ARHGAP22 lacking the coiled-coil domain. This weak interaction could be stabilized by chemical cross-linking which we used to show that: a monomer of ARHGAP22 binds a dimer of 14-3-3; the ARHGAP22 PH domain is required for the 14-3-3 interaction; the RhoGAP domain is unlikely to participate in the interaction; Ser16 is the more important of two predicted 14-3-3 binding sites; and, phosphorylation of Ser16 may not be necessary for 14-3-3 interaction under the conditions we used. Small angle X-ray scattering and cross-link information were used to generate solution structures of the isolated proteins and of the cross-linked ARHGAP22: 14-3-3 complex, showing that no major rearrangement occurs in either protein upon binding, and supporting a role for the PH domain and N-terminal peptide of ARHGAP22 in the 14-3-3 interaction. Small-angle X-ray scattering measurements of mixtures of ARHGAP22 and 14-3-3 were used to establish that the affinity of the interaction is similar to 30 mu M.	[Hu, Shu-Hong; Whitten, Andrew E.; King, Gordon J.; Jones, Alun; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia; [Rowland, Alexander F.; James, David E.] Garvan Inst Med Res, Sydney, NSW, Australia	University of Queensland; Garvan Institute of Medical Research	Hu, SH (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia.	j.martin@imb.uq.edu.au	King, Gordon/J-8718-2014; Martin, Jennifer L./A-6039-2010	Whitten, Andrew/0000-0001-8856-3120; Martin, Jennifer L./0000-0002-9225-8863; James, David/0000-0001-5946-5257	Australian National Health and Medical Research Council (NHMRC) [535921]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council (NHMRC) program grant 535921. The contents of this paper are solely the responsibility of the University of Queensland, the Garvan Institute and the individual authors and do not reflect the views of the National Health and Medical Research Council (NHMRC). AEW is an NHMRC Peter Doherty Fellow (569864); DEJ is an NHMRC Senior Principal Research Fellow (1019680); JLM is an ARC Australian Laureate Fellow (FL0992138) and honorary NHMRC Fellow (455829). The authors also acknowledge access to the SAXS/WAXS beam-line at the Australian Synchrotron (AS111/SAXS3171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cookson D. J., 2007, SAXS15ID SOFTWARE AC; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Larance M, 2010, MOL CELL PROTEOMICS, V9, P682, DOI 10.1074/mcp.M900435-MCP200; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Rowland AF, 2011, MOL CELL BIOL, V31, P4789, DOI 10.1128/MCB.05583-11; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wurtele M, 2001, NAT STRUCT BIOL, V8, P23; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e41731	10.1371/journal.pone.0041731	http://dx.doi.org/10.1371/journal.pone.0041731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952583	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600003
J	Kanzaki, N; Giblin-Davis, RM; Scheffrahn, RH; Taki, H; Esquivel, A; Davies, KA; Herre, EA				Kanzaki, Natsumi; Giblin-Davis, Robin M.; Scheffrahn, Rudolf H.; Taki, Hisatomo; Esquivel, Alejandro; Davies, Kerrie A.; Allen Herre, E.			Reverse Taxonomy for Elucidating Diversity of Insect-Associated Nematodes: A Case Study with Termites	PLOS ONE			English	Article							N. SP; ENVIRONMENTAL DNA; APHELENCHOIDIDAE; DIPLOGASTRIDAE; BIODIVERSITY; MORPHOLOGY; PHYLOGENY; PRIMERS	Background: The molecular operational taxonomic unit (MOTU) has recently been applied to microbial and microscopic animal biodiversity surveys. However, in many cases, some of the MOTUs cannot be definitively tied to any of the taxonomic groups in current databases. To surmount these limitations, the concept of "reverse taxonomy" has been proposed, i.e. to primarily list the MOTUs with morphological information, and then identify and/ordescribe them at genus/species level using subsamples or by re-isolating the target organisms. Nevertheless, the application of "reverse taxonomy" has not been sufficiently evaluated. Therefore, the practical applicability of "reverse taxonomy" is tested using termite-associated nematodes as a model system for phoretic/parasitic organisms which have high habitat specificity and a potential handle (their termite host species) for re-isolation attempts. Methodology: Forty-eight species (from 298 colonies) of termites collected from the American tropics and subtropics were examined for their nematode associates using the reverse taxonomy method and culturing attempts (morphological identification and further sequencing efforts). The survey yielded 51 sequence types (= MOTUs) belonging to 19 tentatively identified genera. Within these, four were identified based on molecular data with preliminary morphological observation, and an additional seven were identified or characterized from successful culturing, leaving eight genera unidentified. Conclusions: That 1/3 of the genera were not successfully identified suggests deficiencies in the depth of available sequences in the database and biological characters, i.e. usually isolated as phoretic/parasitic stages which are not available for morphological identification, and too many undiscovered lineages of nematodes. Although there still is the issue of culturability of nematodes, culturing attempts could help to make reverse taxonomy methods more effective. However, expansion of the database, i.e., production of more DNA barcodes tied to biological information by finding and characterizing additional new and known lineages, is necessary for analyzing functional diversity.	[Kanzaki, Natsumi; Giblin-Davis, Robin M.; Scheffrahn, Rudolf H.] Univ Florida IFAS, Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Kanzaki, Natsumi; Taki, Hisatomo] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Esquivel, Alejandro] Univ Nacl, Escuela Ciencias Agr, Lab Nematol, Heredia, Costa Rica; [Davies, Kerrie A.] Univ Adelaide, Sch Agr Food & Wine, Ctr Evolutionary Biol & Biodivers, Glen Osmond, SA, Australia; [Allen Herre, E.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	State University System of Florida; University of Florida; Forestry & Forest Products Research Institute - Japan; Universidad Nacional Costa Rica; University of Adelaide; Smithsonian Institution; Smithsonian Tropical Research Institute	Kanzaki, N (corresponding author), Univ Florida IFAS, Ft Lauderdale Res & Educ Ctr, Davie, FL USA.	nkanzaki@affrc.go.jp		Giblin-Davis, Robin/0000-0002-8861-8678	National Science Foundation [DEB-0450537]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21770094]	National Science Foundation(National Science Foundation (NSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by the National Science Foundation (DEB-0450537) - Biodiversity Surveys and Inventories, and a Grant-in-Aid for Young Scientists (B) (#21770094) from The Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRASSY I, 1984, KLASSE NEMATODA ORDN; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; Carta LK, 2005, NEMATOLOGY, V7, P863, DOI 10.1163/156854105776186299; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Davies K, 2010, NEMATOLOGY, V12, P935, DOI 10.1163/138855410X498932; De Ley P, 2005, PHILOS T R SOC B, V360, P1945, DOI 10.1098/rstb.2005.1726; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; DeSantis TZ, 2005, FEMS MICROBIOL LETT, V245, P271, DOI 10.1016/j.femsle.2005.03.016; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Hazir C, 2010, NEMATOLOGY, V12, P65, DOI 10.1163/156854109X448348; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt D. J., 2007, Journal of Nematode Morphology and Systematics, V10, P99; Hunt DJ, 1993, APHELENCHIDA LONGIDO; Kanzaki N., 2008, PINE WILT DISEASE, P44; Kanzaki N, 2011, ENVIRON ENTOMOL, V40, P281, DOI 10.1603/EN10182; Kanzaki N, 2010, NEMATOLOGY, V12, P803, DOI 10.1163/138855410X499067; Kanzaki N, 2009, NEMATOLOGY, V11, P171, DOI 10.1163/156854109X429510; Kanzaki N, 2009, NEMATOLOGY, V11, P203, DOI 10.1163/156854109X429547; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; Mayer WE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-212; Moser JC, 2005, AGR FOREST ENTOMOL, V7, P169, DOI 10.1111/j.1461-9555.2005.00261.x; Padial JM, 2007, ZOOTAXA, P67, DOI 10.11646/zootaxa.1586.1.7; Poinar GO., 1975, ENTOMOGENOUS NEMATOD; Porazinska DL, 2010, ZOOTAXA, P55, DOI 10.11646/zootaxa.2427.1.6; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Powers TO, 2009, MOL ECOL, V18, P985, DOI 10.1111/j.1365-294X.2008.04075.x; Robeson Michael S. II, 2009, BMC Ecology, V9, P25, DOI 10.1186/1472-6785-9-25; Siddall ME, 2012, J PARASITOL IN PRESS, P98; Steel H, 2011, NEMATOLOGY, V13, P347, DOI 10.1163/138855410X523023; Sudhaus W., 2003, Journal of Nematode Morphology and Systematics, V6, P43; Sudhaus W, 2001, J NEMATOL, V33, P1; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Von Lieven AF, 2003, NEMATOLOGY, V5, P583, DOI 10.1163/156854103322683300; von Lieven AF, 2000, J ZOOL SYST EVOL RES, V38, P37, DOI 10.1046/j.1439-0469.2000.381125.x; VONLIEVEN AF, 2001, THESIS FREIE U BERLI; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; WILLIAMS BD, 1992, GENETICS, V131, P609; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006	49	29	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43865	10.1371/journal.pone.0043865	http://dx.doi.org/10.1371/journal.pone.0043865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952792	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600052
J	Wang, PH; Bai, FW; Zenewicz, LA; Dai, JF; Gate, D; Cheng, G; Yang, L; Qian, F; Yuan, XL; Montgomery, RR; Flavell, RA; Town, T; Fikrig, E				Wang, Penghua; Bai, Fengwei; Zenewicz, Lauren A.; Dai, Jianfeng; Gate, David; Cheng, Gong; Yang, Long; Qian, Feng; Yuan, Xiaoling; Montgomery, Ruth R.; Flavell, Richard A.; Town, Terrence; Fikrig, Erol			IL-22 Signaling Contributes to West Nile Encephalitis Pathogenesis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROINFLAMMATORY GENE-EXPRESSION; CD8(+) T-CELLS; VIRUS-INFECTION; HOST-DEFENSE; INTERLEUKIN-22; BRAIN; TRAFFICKING; ENTRY; SURVIVAL	The Th17 cytokine, IL-22, regulates host immune responses to extracellular pathogens. Whether IL-22 plays a role in viral infection, however, is poorly understood. We report here that Il22(-/-) mice were more resistant to lethal West Nile virus (WNV) encephalitis, but had similar viral loads in the periphery compared to wild type (WT) mice. Viral loads, leukocyte infiltrates, proinflammatory cytokines and apoptotic cells in the central nervous system (CNS) of Il22(-/-) mice were also strikingly reduced. Further examination showed that Cxcr2, a chemokine receptor that plays a non-redundant role in mediating neutrophil migration, was significantly reduced in Il22(-/-) compared to WT leukocytes. Expression of Cxcr2 ligands, cxcl1 and cxcl5, was lower in Il22(-/-) brains than wild type mice. Correspondingly, neutrophil migration from the blood into the brain was attenuated following lethal WNV infection of Il22(-/-) mice. Our results suggest that IL-22 signaling exacerbates lethal WNV encephalitis likely by promoting WNV neuroinvasion.	[Wang, Penghua; Bai, Fengwei; Dai, Jianfeng; Cheng, Gong; Yang, Long; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Qian, Feng; Yuan, Xiaoling; Montgomery, Ruth R.] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA; [Zenewicz, Lauren A.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Gate, David; Town, Terrence] Cedars Sinai Med Ctr, Regenerat Med Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Gate, David; Town, Terrence] Cedars Sinai Med Ctr, Regenerat Med Inst, Dept Neurosurg, Los Angeles, CA 90048 USA; [Town, Terrence] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Flavell, Richard A.; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bai, Fengwei] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA	Yale University; Yale University; Yale University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of Southern Mississippi	Wang, PH (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	penghua.wang@yale.edu	Qian, Feng/F-8186-2010; Dai, Jianfeng/ACP-1114-2022; wang, Penghua/AAL-4011-2020; Gate, David/AAM-5007-2021	Gate, David/0000-0003-0481-9657; Montgomery, Ruth/0000-0002-8661-4454; Zenewicz, Lauren/0000-0002-8787-5955	National Institutes of Health [AI-055749, AI-50031, HHSN272201100019C, AI-079348]; National Institutes of Health/National Institute on Aging [5R00AG029726-04, 3R00AG029726-04S1]; Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, N01AI050031, R01AI055749, R03AI079348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG029726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by National Institutes of Health grants AI-055749, AI-50031, HHSN272201100019C and AI-079348. EF and RAF are investigators of the Howard Hughes Medical Institute. TT is supported by National Institutes of Health/National Institute on Aging 'Pathway to Independence' awards (5R00AG029726-04 and 3R00AG029726-04S1) and is the inaugural holder of the Ben Winters Endowed Chair in Regenerative Medicine. PW is supported by a Career Development Award from Northeast Biodefense Center U54-AI057158-Lipkin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DM, 1999, J VIROL, V73, P8781, DOI 10.1128/JVI.73.10.8781-8790.1999; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; BenNathan D, 1996, ARCH VIROL, V141, P459, DOI 10.1007/BF01718310; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brehin AC, 2008, J IMMUNOL, V180, P6760, DOI 10.4049/jimmunol.180.10.6760; Dai JF, 2008, J VIROL, V82, P4164, DOI 10.1128/JVI.02621-07; Dambacher J, 2008, CYTOKINE, V41, P209, DOI 10.1016/j.cyto.2007.11.016; Diamond MS, 2004, NAT MED, V10, P1294, DOI 10.1038/nm1204-1294; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Hosking MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011340; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Larena M, 2011, J VIROL, V85, P5446, DOI 10.1128/JVI.02611-10; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Levillayer F, 2007, GENETICS, V176, P1835, DOI 10.1534/genetics.107.073536; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105; Misse D, 2007, J IMMUNOL, V178, P407, DOI 10.4049/jimmunol.178.1.407; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rawal A, 2006, DIAGN CYTOPATHOL, V34, P127, DOI 10.1002/dc.20410; Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Sitati E, 2007, J VIROL, V81, P9801, DOI 10.1128/JVI.00941-07; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Tyler KL, 2006, NEUROLOGY, V66, P361, DOI 10.1212/01.wnl.0000195890.70898.1f; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036; Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08; Wang PH, 2010, NAT IMMUNOL, V11, P912, DOI 10.1038/ni.1933; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wu ZH, 2003, J NEUROSCI METH, V130, P53, DOI 10.1016/S0165-0270(03)00206-1; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	36	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44153	10.1371/journal.pone.0044153	http://dx.doi.org/10.1371/journal.pone.0044153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952908	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600085
J	Nazer, E; Verdun, RE; Sanchez, DO				Nazer, Ezequiel; Verdun, Ramiro E.; Sanchez, Daniel O.			Severe Heat Shock Induces Nucleolar Accumulation of mRNAs in Trypanosoma cruzi	PLOS ONE			English	Article							TUBULIN GENE-EXPRESSION; POSTTRANSCRIPTIONAL CONTROL; ARABIDOPSIS NUCLEOLUS; PROTEOMIC ANALYSIS; STRESS GRANULES; NUCLEAR EXPORT; PROTEINS; BODIES; REGION; INTERFERENCE	Several lines of evidence have shown that, besides its traditional function in ribosome biogenesis, the nucleolus is also involved in regulating other cellular processes such as mRNA metabolism, and that it also plays an important role as a sensor and coordinator of the stress response. We have recently shown that a subset of RNA Binding Proteins and the poly(A)+ RNA are accumulated into the Trypanosoma cruzi nucleolus after inducing transcription inhibition with Actinomycin D. In this study, we investigated the behaviour of the T. cruzi mRNA population in parasites subjected to severe heat shock, an environmental stress that also decreases the rate of RNA synthesis. We found that the bulk of poly(A)+ RNA is reversibly accumulated into the nucleolus when exposing T. cruzi epimastigote forms to severe heat shock. However, the Hsp70 mRNA was able to bypass such nucleolar accumulation. Together, these data reinforce the idea about the involvement of the T. cruzi nucleolus in mRNA metabolism during an environmental stress response. Interestingly, T. brucei procyclic forms did not induce nucleolar accumulation of poly(A)+ RNA under such stress condition, suggesting that different trypanosomatids have adopted different responses to deal with the same stress conditions.	[Nazer, Ezequiel; Sanchez, Daniel O.] UNSAM, CONICET, Inst Invest Biotecnol, San Martin, Buenos Aires, Argentina; [Verdun, Ramiro E.] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Miami	Nazer, E (corresponding author), UNSAM, CONICET, Inst Invest Biotecnol, San Martin, Buenos Aires, Argentina.	dsanchez@unsam.edu.ar		sanchez, daniel/0000-0002-5427-7764	National Agency for Promotion of Science and Technology, (ANPCyT, Argentina [PICT 2007-00624]	National Agency for Promotion of Science and Technology, (ANPCyT, Argentina(ANPCyT)	This work was funded by the National Agency for Promotion of Science and Technology, (ANPCyT, Argentina. PICT 2007-00624 to DOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bartholomeu DC, 2002, EXP PARASITOL, V102, P123, DOI 10.1016/S0014-4894(03)00034-1; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boyne JR, 2006, P NATL ACAD SCI USA, V103, P15190, DOI 10.1073/pnas.0604890103; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Cuevas IC, 2005, MOL BIOCHEM PARASIT, V139, P15, DOI 10.1016/j.molbiopara.2004.11.002; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Ideue T, 2004, J CELL SCI, V117, P2887, DOI 10.1242/jcs.01155; Jager AV, 2007, P NATL ACAD SCI USA, V104, P2035, DOI 10.1073/pnas.0611125104; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim SH, 2009, PLANT CELL, V21, P2045, DOI 10.1105/tpc.109.067736; Koroleva OA, 2009, PLANT CELL, V21, P1592, DOI 10.1105/tpc.108.060434; Kramer S, 2012, J CELL SCI; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Lee MGS, 1998, NUCLEIC ACIDS RES, V26, P4025, DOI 10.1093/nar/26.17.4025; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Michienzi A, 2000, P NATL ACAD SCI USA, V97, P8955, DOI 10.1073/pnas.97.16.8955; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024184; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Okura M, 2005, J BIOL CHEM, V280, P16235, DOI 10.1074/jbc.M414535200; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; REQUENA JM, 1992, MOL BIOCHEM PARASIT, V53, P201, DOI 10.1016/0166-6851(92)90022-C; Rodrigues DC, 2010, EXP PARASITOL, V126, P245, DOI 10.1016/j.exppara.2010.05.009; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saavedra C, 1996, GENE DEV, V10, P1608, DOI 10.1101/gad.10.13.1608; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; TANI T, 1995, MOL BIOL CELL, V6, P1515, DOI 10.1091/mbc.6.11.1515; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; Urban I, 2011, BIOCHEM J, V438, P303, DOI 10.1042/BJ20110683; URMENYI TP, 1992, DNA CELL BIOL, V11, P101, DOI 10.1089/dna.1992.11.101	42	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43715	10.1371/journal.pone.0043715	http://dx.doi.org/10.1371/journal.pone.0043715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952745	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800053
J	Caron, NS; Munsie, LN; Keillor, JW; Truant, R				Caron, Nicholas S.; Munsie, Lise N.; Keillor, Jeffrey W.; Truant, Ray			Using FLIM-FRET to Measure Conformational Changes of Transglutaminase Type 2 in Live Cells	PLOS ONE			English	Article							LIFETIME IMAGING MICROSCOPY; TISSUE TRANSGLUTAMINASE; HEAT-SHOCK; PROTEIN; LOCALIZATION; MUTATION; DISEASE; SINGLE; CYAN	Transglutaminase type 2 (TG2) is a ubiquitously expressed member of the transglutaminase family, capable of mediating a transamidation reaction between a variety of protein substrates. TG2 also has a unique role as a G-protein with GTPase activity. In response to GDP/GTP binding and increases in intracellular calcium levels, TG2 can undergo a large conformational change that reciprocally modulates the enzymatic activities of TG2. We have generated a TG2 biosensor that allows for quantitative assessment of TG2 conformational changes in live cells using Forster resonance energy transfer (FRET), as measured by fluorescence lifetime imaging microscopy (FLIM). Quantifying FRET efficiency with this biosensor provides a robust assay to quickly measure the effects of cell stress, changes in calcium levels, point mutations and chemical inhibitors on the conformation and localization of TG2 in living cells. The TG2 FRET biosensor was validated using established TG2 conformational point mutants, as well as cell stress events known to elevate intracellular calcium levels. We demonstrate in live cells that inhibitors of TG2 transamidation activity can differentially influence the conformation of the enzyme. The irreversible inhibitor of TG2, NC9, forces the enzyme into an open conformation, whereas the reversible inhibitor CP4d traps TG2 in the closed conformation. Thus, this biosensor provides new mechanistic insights into the action of two TG2 inhibitors and defines two new classes based on ability to alter TG2 conformation in addition to inhibiting transamidation activity. Future applications of this biosensor could be to discover small molecules that specifically alter TG2 conformation to affect GDP/GTP or calcium binding.	[Caron, Nicholas S.; Munsie, Lise N.; Truant, Ray] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Keillor, Jeffrey W.] Univ Ottawa, Dept Chem, Ottawa, ON, Canada	McMaster University; University of Ottawa	Caron, NS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	truantr@mcmaster.ca		Caron, Nicholas/0000-0002-3877-455X	Canadian Institutes of Health Research [MOP-16574]; CHDI Inc. (Los Angeles); Krembil Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CHDI Inc. (Los Angeles); Krembil Foundation	This work was funded by the Canadian Institutes of Health Research, grant MOP-16574, support from CHDI Inc. (Los Angeles) and the Krembil Foundation to RT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcor Damien, 2009, V462, P307, DOI 10.1007/978-1-60327-115-8_21; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Chen Y, 2003, DIFFERENTIATION, V71, P528, DOI 10.1111/j.1432-0436.2003.07109007.x; Colak G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016665; Cooper AJL, 2002, NEUROCHEM INT, V40, P1, DOI 10.1016/S0197-0186(01)00055-9; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DRUMMOND IAS, 1986, MOL CELL BIOL, V6, P1767, DOI 10.1128/MCB.6.5.1767; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Gundemir S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006123; Jeitner TM, 2009, J NEUROCHEM, V109, P160, DOI 10.1111/j.1471-4159.2009.05843.x; Keillor JW, 2008, CAN J CHEM, V86, P271, DOI 10.1139/V08-024; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kim SY, 2002, NEUROCHEM INT, V40, P85, DOI 10.1016/S0197-0186(01)00064-X; LUNEC J, 1983, RADIAT RES, V93, P588, DOI 10.2307/3576038; Majoul Irina, 2002, J Biotechnol, V82, P267; Munsie L, 2011, HUM MOL GENET, V20, P1937, DOI 10.1093/hmg/ddr075; Murthy SNP, 2002, P NATL ACAD SCI USA, V99, P2738, DOI 10.1073/pnas.052715799; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Pardin C, 2008, CHEM BIOL DRUG DES, V72, P189, DOI 10.1111/j.1747-0285.2008.00696.x; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Ruan QM, 2008, INT J CLIN EXP MED, V1, P248; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wiemann M, 1998, CALCIFIED TISSUE INT, V63, P154, DOI 10.1007/s002239900507	31	49	49	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44159	10.1371/journal.pone.0044159	http://dx.doi.org/10.1371/journal.pone.0044159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952912	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300057
J	de Magny, GC; Thiaw, W; Kumar, V; Manga, NM; Diop, BM; Gueye, L; Kamara, M; Roche, B; Murtugudde, R; Colwell, RR				de Magny, Guillaume Constantin; Thiaw, Wassila; Kumar, Vadlamani; Manga, Noel M.; Diop, Bernard M.; Gueye, Lamine; Kamara, Mamina; Roche, Benjamin; Murtugudde, Raghu; Colwell, Rita R.			Cholera Outbreak in Senegal in 2005: Was Climate a Factor?	PLOS ONE			English	Article							GLOBAL CLIMATE; INFECTIOUS-DISEASE; TEMPERATURE; EPIDEMICS; VARIABILITY; RAINFALL	Cholera is an acute diarrheal illness caused by Vibrio cholerae and occurs as widespread epidemics in Africa. In 2005, there were 31,719 cholera cases, with 458 deaths in the Republic of Senegal. We retrospectively investigated the climate origin of the devastating floods in mid-August 2005, in the Dakar Region of Senegal and the subsequent outbreak of cholera along with the pattern of cholera outbreaks in three other regions of that country. We compared rainfall patterns between 2002 and 2005 and the relationship between the sea surface temperature (SST) gradient in the tropical Atlantic Ocean and precipitation over Senegal for 2005. Results showed a specific pattern of rainfall throughout the Dakar region during August, 2005, and the associated rainfall anomaly coincided with an exacerbation of the cholera epidemic. Comparison of rainfall and epidemiological patterns revealed that the temporal dynamics of precipitation, which was abrupt and heavy, was presumably the determining factor. Analysis of the SST gradient showed that the Atlantic Ocean SST variability in 2005 differed from that of 2002 to 2004, a result of a prominent Atlantic meridional mode. The influence of this intense precipitation on cholera transmission over a densely populated and crowded region was detectable for both Dakar and Thies, Senegal. Thus, high resolution rainfall forecasts at subseasonal time scales should provide a way forward for an early warning system in Africa for cholera and, thereby, trigger epidemic preparedness. Clearly, attention must be paid to both natural and human induced environmental factors to devise appropriate action to prevent cholera and other waterborne disease epidemics in the region.	[de Magny, Guillaume Constantin] Ctr Rech IRD, MIVEGEC, UMR CNRS IRD UM1&2 5290, Montpellier, France; [Thiaw, Wassila; Kumar, Vadlamani] Climate Predict Ctr, Natl Ctr Environm Predict, Camp Springs, MD USA; [Manga, Noel M.; Diop, Bernard M.] Ctr Natl & Univ Fann, Clin Malad Infect, Dakar, Senegal; [Gueye, Lamine] Univ Cheikh Anta Diop Dakar UCAD, Unite Mixte Int Rech Environm Sante Soc UMI 3189, Dakar, Senegal; [Kamara, Mamina] Agence Natl Meteorol Senegal, Aeroport Leopold Sedar SENGHOR, Direct Meteorol Natl, Dakar Yoff, Senegal; [Roche, Benjamin] Ctr IRD Bondy, UMI IRD UPMC UMMISCO 209, Bondy, France; [Murtugudde, Raghu] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Colwell, Rita R.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Colwell, Rita R.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Colwell, Rita R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth, Baltimore, MD USA	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; National Oceanic Atmospheric Admin (NOAA) - USA; University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	de Magny, GC (corresponding author), Ctr Rech IRD, MIVEGEC, UMR CNRS IRD UM1&2 5290, Montpellier, France.	guillaume.demagny@ird.fr	, Nobody/M-9571-2019; Constantin de Magny, Guillaume/L-6706-2017	Roche, Benjamin/0000-0001-7975-4232	National Oceanic and Atmospheric Administration (NOAA) [S0660009]; National Institutes of Health [R01A139129-01]; NASA PO; ONR DYNAMO	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA PO; ONR DYNAMO	GCdeM and RRC were funded by National Oceanic and Atmospheric Administration (NOAA) grant no. S0660009 and National Institutes of Health grant no. R01A139129-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RM gratefully acknowledges his NASA PO and ONR DYNAMO grants for partial support.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P297; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P309; Chang P, 1997, NATURE, V385, P516, DOI 10.1038/385516a0; Chiang JCH, 2002, J CLIMATE, V15, P2616, DOI 10.1175/1520-0442(2002)015<2616:TTTVCB>2.0.CO;2; Codeco CT, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-1; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; de Magny G.C., 2005, CEMRACS 2004 MATH AP, V14, P156, DOI [10.1051/proc:2005013, DOI 10.1051/PROC:200501, DOI 10.1051/PROC:2005013]; de Magny GC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-20; de Magny GC, 2006, ECOHEALTH, V3, P223, DOI 10.1007/s10393-006-0061-5; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Fall S, 2006, INT J CLIMATOL, V26, P2057, DOI 10.1002/joc.1355; Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145; Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; Giannini A, 2003, SCIENCE, V302, P1027, DOI 10.1126/science.1089357; Hashizume M, 2008, J WATER HEALTH, V6, P323, DOI 10.2166/wh.2008.062; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; IPCC, 2007, CLIM CHANG 2007; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Love TB, 2004, P 84 AMS ANN M SEATT, P54; Fernandez MAL, 2009, T ROY SOC TROP MED H, V103, P137, DOI 10.1016/j.trstmh.2008.07.017; Mendelsohn J, 2008, INT J HYG ENVIR HEAL, V211, P156, DOI 10.1016/j.ijheh.2006.12.002; Murtugudde RG, 2001, GEOPHYS RES LETT, V28, P4463, DOI 10.1029/2001GL013407; Ndiaye M, 2005, INONDATIONS DAKAR EC, P4; Ndour C T, 2006, Med Trop (Mars), V66, P33; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; Patz JA, 2002, P NATL ACAD SCI USA, V99, P12506, DOI 10.1073/pnas.212467899; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Service Regional de la Statistique et de la Demographie de Diourbel, 2006, SIT EC SOC REG DAK; Shumway RH, 2006, TIME SERIES ANAL ITS, pxiii; Sun Y, 2007, J CLIMATE, V20, P4801, DOI 10.1175/JCLI4263.1; Thiaw W, 2006, RECENT CLIMATE ANOMA; United Nations, 2009, FLOODS AFF 600000 PE; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; World Health Organization, 2008, CHOL COUNTR PROF SEN, P2; World Health Organization, 2009, CHOL SURV NUMB CAS; World Health Organization, 1993, GUID LUTT CHOL	42	39	39	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44577	10.1371/journal.pone.0044577	http://dx.doi.org/10.1371/journal.pone.0044577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952995	Green Submitted, gold, Green Published			2022-12-27	WOS:000308221300100
J	Gao, N; Luo, JL; Uray, K; Qian, AH; Yin, SJ; Wang, GD; Wang, XY; Xia, Y; Wood, JD; Hu, HZ				Gao, Na; Luo, Jialie; Uray, Karen; Qian, Aihua; Yin, Shijin; Wang, Guodu; Wang, Xiyu; Xia, Yun; Wood, Jackie D.; Hu, Hongzhen			CaMKII Is Essential for the Function of the Enteric Nervous System	PLOS ONE			English	Article							PIG SMALL-INTESTINE; DEPENDENT PROTEIN-KINASE; NK1 TACHYKININ RECEPTORS; GASTROINTESTINAL-TRACT; SYNAPTIC-TRANSMISSION; INTERSTITIAL-CELLS; MYENTERIC NEURONS; SUBMUCOUS PLEXUS; MUSCLE; AUTOPHOSPHORYLATION	Background: Ca2+/calmodulin-dependent protein kinases (CaMKs) are major downstream mediators of neuronal calcium signaling that regulate multiple neuronal functions. CaMKII, one of the key CaMKs, plays a significant role in mediating cellular responses to external signaling molecules. Although calcium signaling plays an essential role in the enteric nervous system (ENS), the role of CaMKII in neurogenic intestinal function has not been determined. In this study, we investigated the function and expression pattern of CaMKII in the ENS across several mammalian species. Methodology/Principal Findings: CaMKII expression was characterized by immunofluorescence analyses and Western Blot. CaMKII function was examined by intracellular recordings and by assays of colonic contractile activity. Immunoreactivity for CaMKII was detected in the ENS of guinea pig, mouse, rat and human preparations. In guinea pig ENS, CaMKII immunoreactivity was enriched in both nitric oxide synthase (NOS)- and calretinin-containing myenteric plexus neurons and non-cholinergic secretomotor/vasodilator neurons in the submucosal plexus. CaMKII immunoreactivity was also expressed in both cholinergic and non-cholinergic neurons in the ENS of mouse, rat and human. The selective CaMKII inhibitor, KN-62, suppressed stimulus-evoked purinergic slow EPSPs and ATP-induced slow EPSP-like response in guinea pig submucosal plexus, suggesting that CaMKII activity is required for some metabotropic synaptic transmissions in the ENS. More importantly, KN-62 significantly suppressed tetrodotoxin-induced contractile response in mouse colon, which suggests that CaMKII activity is a major determinant of the tonic neurogenic inhibition of this tissue. Conclusion: ENS neurons across multiple mammalian species express CaMKII. CaMKII signaling constitutes an important molecular mechanism for controlling intestinal motility and secretion by regulating the excitability of musculomotor and secretomotor neurons. These findings revealed a fundamental role of CaMKII in the ENS and provide clues for the treatment of intestinal dysfunctions.	[Gao, Na; Luo, Jialie; Qian, Aihua; Yin, Shijin; Hu, Hongzhen] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA; [Uray, Karen] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX USA; [Wang, Guodu; Wang, Xiyu; Wood, Jackie D.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Xia, Yun] Ohio State Univ, Coll Med, Dept Anesthesiol, Columbus, OH 43210 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gao, N (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA.	wood.13@osu.edu; Hongzhen.Hu@uth.tmc.edu	wang, xiyu/GYA-4086-2022	Uray, Karen/0000-0001-6997-459X; Hu, Hongzhen/0000-0002-8967-7522	United States National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [DK56338]; Texas Medical Center Digestive Diseases Center [0008355]; Mission Connect/The Institute for Rehabilitation and Research (TIRR) Foundation [011-101]; University of Texas Health Science Center; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK37238]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037238, P30DK056338] Funding Source: NIH RePORTER	United States National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Texas Medical Center Digestive Diseases Center; Mission Connect/The Institute for Rehabilitation and Research (TIRR) Foundation; University of Texas Health Science Center; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported partly by grants from the United States National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases grant DK56338, which supports the Texas Medical Center Digestive Diseases Center to HH (0008355) and Mission Connect/The Institute for Rehabilitation and Research (TIRR) Foundation to HH (011-101), the University of Texas Health Science Center to HH, and the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to JDW (R01 DK37238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaeser F, 2006, MOL CELL BIOL, V26, P9105, DOI 10.1128/MCB.01452-06; Bolton TB, 1999, ANNU REV PHYSIOL, V61, P85, DOI 10.1146/annurev.physiol.61.1.85; Costa M, 2008, EUR REV MED PHARMACO, V12, P3; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Fang XC, 2006, EUR J PHARMACOL, V536, P113, DOI 10.1016/j.ejphar.2006.02.040; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; Gwynne RM, 2007, CURR NEUROPHARMACOL, V5, P1, DOI 10.2174/157015907780077141; Gwynne RM, 2009, AM J PHYSIOL-GASTR L, V297, pG179, DOI 10.1152/ajpgi.90700.2008; Hu HZ, 2004, J PHARMACOL EXP THER, V309, P310, DOI 10.1124/jpet.103.059204; Hu HZ, 2003, J PHYSIOL-LONDON, V550, P493, DOI 10.1113/jphysiol.2003.041731; Hu HZ, 2002, J COMP NEUROL, V442, P189, DOI 10.1002/cne.1424; JEITNER TM, 1991, NEUROSCIENCE, V40, P555, DOI 10.1016/0306-4522(91)90141-A; Koh SD, 1999, J PHYSIOL-LONDON, V517, P75, DOI 10.1111/j.1469-7793.1999.0075z.x; Lin Z, 2002, NEUROGASTROENT MOTIL, V14, P197, DOI 10.1046/j.1365-2982.2002.00317.x; Lomax AEG, 1998, CELL TISSUE RES, V294, P27, DOI 10.1007/s004410051153; Lorenz JM, 2002, AM J PHYSIOL-CELL PH, V283, pC1399, DOI 10.1152/ajpcell.00020.2002; MATOVCIK LM, 1993, AM J PHYSIOL, V264, pC1029, DOI 10.1152/ajpcell.1993.264.4.C1029; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Monro RL, 2004, J PHYSIOL-LONDON, V556, P571, DOI 10.1113/jphysiol.2004.060848; Okuno Y., 2011, Autonomic & Autacoid Pharmacology, V31, P21, DOI 10.1111/j.1474-8673.2011.00462.x; Perrino BA, 2011, ARCH BIOCHEM BIOPHYS, V510, P174, DOI 10.1016/j.abb.2011.03.009; Poole DP, 2004, HISTOCHEM CELL BIOL, V121, P21, DOI 10.1007/s00418-003-0602-8; Poole DP, 2003, HISTOCHEM CELL BIOL, V120, P51, DOI 10.1007/s00418-003-0541-4; Portbury AL, 1996, J COMP NEUROL, V367, P342, DOI 10.1002/(SICI)1096-9861(19960408)367:3<342::AID-CNE2>3.0.CO;2-5; Qureshi S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01406.x; Qureshi S, 2010, NEUROGASTROENT MOTIL, V22, pe164; Sanders KM, 2010, J PHYSIOL-LONDON, V588, P4621, DOI 10.1113/jphysiol.2010.196030; Schneider J, 2001, NEUROGASTROENT MOTIL, V13, P255, DOI 10.1046/j.1365-2982.2001.00265.x; Schulman H, 2004, J NEUROSCI, V24, P8399, DOI 10.1523/JNEUROSCI.3606-04.2004; Tack J, 2004, NEUROGASTROENT MOTIL, V16, P86, DOI 10.1111/j.1743-3150.2004.00481.x; Thornton PDJ, 2002, J PHYSIOL-LONDON, V539, P589, DOI 10.1113/jphysiol.2001.013399; Turner D J, 1999, Int J Surg Investig, V1, P87; Uemura S, 1995, ARCH HISTOL CYTOL, V58, P523, DOI 10.1679/aohc.58.523; Uray KS, 2011, SURGERY, V149, P114, DOI 10.1016/j.surg.2010.04.001; Vincent KM, 2011, NEUROGASTROENT MOTIL, V23, pE282, DOI 10.1111/j.1365-2982.2011.01673.x; Vittone L, 2008, FRONT BIOSCI-LANDMRK, V13, P5988, DOI 10.2741/3131; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wood JD, 2008, CURR OPIN GASTROEN, V24, P149, DOI 10.1097/MOG.0b013e3282f56125; Wood JD, 2010, CURR OPIN GASTROEN, V26, P102, DOI 10.1097/MOG.0b013e328334df4f; Wood JD, 2004, NEUROGASTROENT MOTIL, V16, P71, DOI 10.1111/j.1743-3150.2004.00479.x; WOOD JD, 1972, AM J PHYSIOL, V222, P118, DOI 10.1152/ajplegacy.1972.222.1.118	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44426	10.1371/journal.pone.0044426	http://dx.doi.org/10.1371/journal.pone.0044426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952977	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300090
J	Hanberry, BB; He, HS; Palik, BJ				Hanberry, Brice B.; He, Hong S.; Palik, Brian J.			Pseudoabsence Generation Strategies for Species Distribution Models	PLOS ONE			English	Article							PRESENCE-ONLY DATA; CLASSIFIER PERFORMANCE; THRESHOLD CRITERIA; PSEUDO-ABSENCES; SAMPLE-SIZE; PREVALENCE; SELECTION; ACCURACY	Background: Species distribution models require selection of species, study extent and spatial unit, statistical methods, variables, and assessment metrics. If absence data are not available, another important consideration is pseudoabsence generation. Different strategies for pseudoabsence generation can produce varying spatial representation of species. Methodology: We considered model outcomes from four different strategies for generating pseudoabsences. We generating pseudoabsences randomly by 1) selection from the entire study extent, 2) a two-step process of selection first from the entire study extent, followed by selection for pseudoabsences from areas with predicted probability <25%, 3) selection from plots surveyed without detection of species presence, 4) a two-step process of selection first for pseudoabsences from plots surveyed without detection of species presence, followed by selection for pseudoabsences from the areas with predicted probability <25%. We used Random Forests as our statistical method and sixteen predictor variables to model tree species with at least 150 records from Forest Inventory and Analysis surveys in the Laurentian Mixed Forest province of Minnesota. Conclusions: Pseudoabsence generation strategy completely affected the area predicted as present for species distribution models and may be one of the most influential determinants of models. All the pseudoabsence strategies produced mean AUC values of at least 0.87. More importantly than accuracy metrics, the two-step strategies over-predicted species presence, due to too much environmental distance between the pseudoabsences and recorded presences, whereas models based on random pseudoabsences under-predicted species presence, due to too little environmental distance between the pseudoabsences and recorded presences. Models using pseudoabsences from surveyed plots produced a balance between areas with high and low predicted probabilities and the strongest relationship between density and area with predicted probabilities >= 75%. Because of imperfect accuracy assessment, the best assessment currently may be evaluation of whether the species has been sufficiently but not excessively predicted to occur.	[Hanberry, Brice B.; He, Hong S.] Univ Missouri, Dept Forestry, Columbia, MO 65211 USA; [Palik, Brian J.] US Forest Serv, USDA, No Res Stn, Grand Rapids, MN USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service	Hanberry, BB (corresponding author), Univ Missouri, Dept Forestry, Columbia, MO 65211 USA.	hanberryb@missouri.edu		Palik, Brian/0000-0003-0300-9644; Hanberry, Brice/0000-0001-8657-9540; He, Hong S./0000-0002-3983-2512	National Fire Plan of the USDA Forest Service, Northern Research Station	National Fire Plan of the USDA Forest Service, Northern Research Station	Funding was provided by the National Fire Plan of the USDA Forest Service, Northern Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; BEERS TW, 1966, J FOREST, V64, P691; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; ECOMAP, 1993, NAT HIER FRAM EC UN; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Gomez-Rodriguez C, 2012, DIVERS DISTRIB, V18, P260, DOI 10.1111/j.1472-4642.2011.00837.x; Hanczar B, 2010, BIOINFORMATICS, V26, P822, DOI 10.1093/bioinformatics/btq037; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2011, J NAT CONSERV, V19, P1, DOI 10.1016/j.jnc.2010.03.002; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lutolf M, 2006, J APPL ECOL, V43, P802, DOI 10.1111/j.1365-2664.2006.01191.x; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Santika T, 2011, GLOBAL ECOL BIOGEOGR, V20, P181, DOI 10.1111/j.1466-8238.2010.00581.x; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; VanDerWal J, 2009, ECOLOGICAL MODELLING, V220, P598; Ward G, 2009, BIOMETRICS, V65, P554, DOI 10.1111/j.1541-0420.2008.01116.x; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	28	23	24	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44486	10.1371/journal.pone.0044486	http://dx.doi.org/10.1371/journal.pone.0044486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952985	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300094
J	Zhu, YC; Hua, WQ; Xu, M; He, W; Wang, XT; Dai, Y; Zhao, S; Tang, JX; Wang, SX; Lu, S				Zhu, Yinchang; Hua, Wanquan; Xu, Ming; He, Wei; Wang, Xiaoting; Dai, Yang; Zhao, Song; Tang, Jianxia; Wang, Shixia; Lu, Shan			A Novel Immunodiagnostic Assay to Detect Serum Antibody Response against Selected Soluble Egg Antigen Fractions from Schistosoma japonicum	PLOS ONE			English	Article							DIPSTICK DYE IMMUNOASSAY	Background: Schistosomiasis japonica remains a real threat to public health in China. The currently used immunodiagnostic assays are sensitive and have a certain degree of specificity, however, they all use complex crude antigens, are based on detection of schistosome-specific antibodies, and have been shown to cross-react with other parasitic diseases. Therefore, these assays cannot be used to evaluate chemotherapy efficacy. The development of highly sensitive and highly specific immunodiagnostic techniques that can monitor the decline of antibodies specific for S. japonica will be extremely valuable as part of the ongoing strategy to control schistosomiasis in endemic areas. Here we report on the identification of unique fraction antigens of soluble egg antigen (SEA) to which the antibodies disappear 7 weeks after effective treatment. Furthermore, we use these SEA fractions to develop a modified assay with both high sensitivity and specificity. Methodology/Principal Findings: SEA of S. japonicum was fractionated by electrophoresis using 7.5% SDS-PAGE under non-reducing conditions. The SEA fraction antigens to which antibodies were decreased soon after treatment were collected and used as the detection antigens to establish the FA-ELISA. Sera from patients with acute and chronic schistosomiasis infection, healthy people, and those with other parasitic diseases, were used to evaluate their sensitivity and specificity. Furthermore, sera from patients with chronic schistosomiasis infection were evaluated before and after treatment at different time points to evaluate their chemotherapeutic efficacy. Conclusion/Significance: We demonstrated that this novel FA-ELISA provided high sensitivity and specificity, with very low cross-reactivity, and can serve as an effective tool to determine the efficacy of chemotherapy against S. japonicum.	[Zhu, Yinchang; Hua, Wanquan; Xu, Ming; He, Wei; Wang, Xiaoting; Dai, Yang; Zhao, Song; Tang, Jianxia] Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China; [Zhu, Yinchang; Hua, Wanquan; Xu, Ming; He, Wei; Wang, Xiaoting; Dai, Yang; Zhao, Song; Tang, Jianxia] Jiangsu Inst Parasit Dis, Jiangsu Prov Key Lab Mol Biol Parasites, Wuxi, Jiangsu, Peoples R China; [Zhu, Yinchang] Wuxi Hosp Maternal & Child Hlth Care, Wuxi, Jiangsu, Peoples R China; [Wang, Shixia; Lu, Shan] Jiangsu Prov Hosp, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccines, Worcester, MA USA	Nanjing Medical University; University of Massachusetts System; University of Massachusetts Worcester	Zhu, YC (corresponding author), Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China.	yczhu2006@yahoo.com.cn	Wang, Xiaoting/AAI-3159-2020		Ministry of Health/ the Special Programme for Research and Training in Tropical Diseases (MOH/TDR) Joint Research Management Committee part of the World Bank Loan Project in China [JRMC:5-26]; National Natural Science Foundation of China [81000749, 81000748]; Natural Science Foundation of Jiangsu Province [BK2010152]	Ministry of Health/ the Special Programme for Research and Training in Tropical Diseases (MOH/TDR) Joint Research Management Committee part of the World Bank Loan Project in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The project was funded by Ministry of Health/ the Special Programme for Research and Training in Tropical Diseases (MOH/TDR) Joint Research Management Committee (JRMC:5-26) as part of the World Bank Loan Project in China, National Natural Science Foundation of China (81000749, 81000748), Natural Science Foundation of Jiangsu Province (BK2010152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGQUIST NR, 1992, MEM I OSWALDO CRUZ, V87, P29, DOI 10.1590/S0074-02761992000800004; Department of Parasitology Hunan Medical University Hunan Institute of parasitic Diseases Hunan Expert Committee on schistosomiasis, 1995, CHIN J PARASITOL PAR, V13, P277; Guan XiaoHong, 1996, Chinese Journal of Schistosomiasis Control, V8, P72; Hao Yang, 2009, Chinese Journal of Schistosomiasis Control, V21, P451; Lei Zheng-long, 2011, Zhongguo Xuexichongbing Fangzhi Zazhi, V23, P599; LI Y, 1991, IMMUNOLOGY IMMUNODIA, P210; Lin Dan-Dan, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P642; Lin DanDan, 2009, Chinese Journal of Schistosomiasis Control, V21, P1; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Wang TianPing, 2009, Chinese Journal of Schistosomiasis Control, V21, P241; Wu GL, 2002, ACTA TROP, V82, P193, DOI 10.1016/S0001-706X(02)00010-4; ZHAO WX, 1993, CHINESE MED J-PEKING, V106, P623; Zhou Xiao-Nong, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P1; Zhu HongQing, 2005, Chinese Journal of Schistosomiasis Control, V17, P273; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007; Zhu YC, 2005, ACTA TROP, V96, P137, DOI 10.1016/j.actatropica.2005.07.008; Zhu YC, 2002, J IMMUNOL METHODS, V266, P1, DOI 10.1016/S0022-1759(02)00086-8; Zhu YC, 2008, IMMUNOLOGY SCHISTOSO, P158	19	15	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44032	10.1371/journal.pone.0044032	http://dx.doi.org/10.1371/journal.pone.0044032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952862	gold, Green Published, Green Submitted			2022-12-27	WOS:000308221300044
J	Limberger, R; Wickham, SA				Limberger, Romana; Wickham, Stephen A.			Transitory versus Persistent Effects of Connectivity in Environmentally Homogeneous Metacommunities	PLOS ONE			English	Article							SPECIES-DIVERSITY; DISPERSAL; BIODIVERSITY; COMPETITION; DISTURBANCE; STABILITY; RICHNESS	While the effect of habitat connectivity on local and regional diversity has been analysed in a number of studies, time-dependent dynamics in metacommunities have received comparatively little consideration. When local patches of a metacommunity are identical in environmental conditions but differ in initial community composition, dispersal among patches may result in homogenization of local communities. In a microcosm experiment with benthic ciliates, we tested the hypothesis that the effect of connectivity on diversity is time-dependent and only transitory, with the degree of connectivity affecting the time to homogenization but not the final outcome. Six microcosms were connected to a metacommunity with one of three levels of connectivity. The six patches differed in initial community composition but were identical in environmental conditions. We found a time-dependent and transitory effect of connectivity on local and regional richness and on local Shannon diversity, while Bray-Curtis dissimilarity and regional Shannon diversity were persistently affected by connectivity. Local richness increased and regional richness decreased with connectivity during the initial phase of the experiment but soon converged to similar values in all three connectivity treatments. Local Shannon diversity was unimodally related to time, with maximum diversity reached sooner with high than with medium or low connectivity. Eventually, however, local diversity converged to similar values irrespective of connectivity. At the regional scale, Shannon diversity was persistently lower with high than with low connectivity. While initial differences in community composition vanished with medium and high connectivity, they were maintained with low connectivity resulting in persistently high beta and regional diversity. The effect of connectivity on ciliate community composition translated down to the algal resource, as stronger dominance of the superior competitor with high and medium connectivity resulted in stronger depletion of the resource.	[Limberger, Romana] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Limberger, Romana; Wickham, Stephen A.] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria	McGill University; Salzburg University	Limberger, R (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	romana.limberger@mail.mcgill.ca		Limberger, Romana/0000-0002-9421-7520	Austrian Science Fund, FWF [P19117-B17]; University of Salzburg	Austrian Science Fund, FWF(Austrian Science Fund (FWF)); University of Salzburg	This study was funded by the Austrian Science Fund, FWF, grant P19117-B17 to S. Wickham and a Marie-Andessner scholarship of the University of Salzburg to R. Limberger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019525; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Cadotte MW, 2006, ECOLOGY, V87, P1008, DOI 10.1890/0012-9658(2006)87[1008:MIOCRA]2.0.CO;2; Cadotte MW, 2005, ECOL LETT, V8, P548, DOI 10.1111/j.1461-0248.2005.00750.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chisholm C, 2011, ECOGRAPHY, V34, P415, DOI 10.1111/j.1600-0587.2010.06588.x; Fukami Tadashi, 2010, P45; Gilbert F, 1998, P ROY SOC B-BIOL SCI, V265, P577, DOI 10.1098/rspb.1998.0333; Howeth JG, 2008, ECOL LETT, V11, P245, DOI 10.1111/j.1461-0248.2007.01143.x; Howeth JG, 2010, ECOLOGY, V91, P2727, DOI 10.1890/09-1004.1; Kunte K, 2008, OIKOS, V117, P69, DOI 10.1111/j.2007.0030-1299.16125.x; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; Limberger R, 2012, OECOLOGIA, V168, P785, DOI 10.1007/s00442-011-2140-8; Limberger R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029071; Limberger R, 2011, OECOLOGIA, V167, P723, DOI 10.1007/s00442-011-2013-1; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Marie D., 2005, ALGAL CULTURING TECH, P253, DOI DOI 10.1016/B978-012088426-1/50018-4; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; Matthiessen B, 2010, HYDROBIOLOGIA, V653, P65, DOI 10.1007/s10750-010-0349-x; Matthiessen B, 2010, ECOLOGY, V91, P2022, DOI 10.1890/09-1395.1; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2003, OIKOS, V103, P618, DOI 10.1034/j.1600-0706.2003.12772.x; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; Staddon P, 2010, ECOL LETT, V13, P543, DOI 10.1111/j.1461-0248.2010.01450.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Verreydt D, 2012, ECOL LETT, V15, P218, DOI 10.1111/j.1461-0248.2011.01728.x; Warren PH, 1996, OIKOS, V77, P317, DOI 10.2307/3546071; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449	34	10	10	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44555	10.1371/journal.pone.0044555	http://dx.doi.org/10.1371/journal.pone.0044555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952993	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206500077
J	Ouchida, M; Kanzaki, H; Ito, S; Hanafusa, H; Jitsumori, Y; Tamaru, S; Shimizu, K				Ouchida, Mamoru; Kanzaki, Hirotaka; Ito, Sachio; Hanafusa, Hiroko; Jitsumori, Yoshimi; Tamaru, Seiji; Shimizu, Kenji			Novel Direct Targets of miR-19a Identified in Breast Cancer Cells by a Quantitative Proteomic Approach	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; MIR-17-92 CLUSTER; MICROARRAY ANALYSIS; MICRORNAS; PROLIFERATION; EXPRESSION; PREDICTION; GENES; ESTABLISHMENT; MIR-20A	The miR-17-92 cluster encodes 7 miRNAs inside a single polycistronic transcript, and is known as a group of oncogenic miRNAs that contribute to tumorigenesis in several cancers. However, their direct targets remain unclear, and it has been suggested that a single miRNA is capable of reducing the production of hundreds of proteins. The majority of reports on the identification of miRNA targets are based on computational approaches or the detection of altered mRNA levels, despite the fact that most miRNAs are thought to regulate their targets primarily by translational inhibition in higher organisms. In this study, we examined the target profiles of miR-19a, miR-20a and miR-92-1 in MCF-7 breast cancer cells by a quantitative proteomic strategy to identify their direct targets. A total of 123 proteins were significantly increased after the endogenous miR-19a, miR-20a and miR-92-1 were knocked down, and were identified as potential targets by two-dimensional electrophoresis and a mass spectrometric analysis. Among the upregulated proteins, four (PPP2R2A, ARHGAP1, IMPDH1 and NPEPL1) were shown to have miR-19a or miR-20a binding sites on their mRNAs. The luciferase activity of the plasmids with each binding site was observed to decrease, and an increased luciferase activity was observed in the presence of the specific anti-miRNA-LNA. A Western blot analysis showed the expression levels of IMPDH1 and NPEPL1 to increase after treatment with anti-miR-19a, while the expression levels of PPP2R2A and ARHGAP1 did not change. The expression levels of IMPDH1 and NPEPL1 did not significantly change by anti-miR-19a-LNA at the mRNA level. These results suggest that the IMPDH1 and NPEPL1 genes are direct targets of miR-19a in breast cancer, while the exogenous expression of these genes is not associated with the growth suppression of MCF-7 cells. Furthermore, our proteomic approaches were shown to be valuable for identifying direct miRNA targets.	[Ouchida, Mamoru; Kanzaki, Hirotaka; Ito, Sachio; Hanafusa, Hiroko; Jitsumori, Yoshimi; Shimizu, Kenji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Genet, Okayama 7008530, Japan; [Tamaru, Seiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Cent Res Lab, Okayama 7008530, Japan; [Kanzaki, Hirotaka] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Okayama University; Okayama University; Cedars Sinai Medical Center	Ouchida, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Genet, Okayama 7008530, Japan.	ouchidam@md.okayama-u.ac.jp			New Energy and Industrial Technology Development Organization; Okayama University Budget for Centers of Excellence	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Okayama University Budget for Centers of Excellence	This work was supported by grants from the New Energy and Industrial Technology Development Organization (to KS), and from the Okayama University Budget for Centers of Excellence (to KS and MO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; COLLART FR, 1988, J BIOL CHEM, V263, P15769; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kanzaki H, 2011, PROTEOMICS, V11, P3531, DOI 10.1002/pmic.201000501; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Kennan A, 2002, HUM MOL GENET, V11, P547, DOI 10.1093/hmg/11.5.547; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Martin G, 2007, J BIOSCIENCES, V32, P1049, DOI 10.1007/s12038-007-0106-0; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; SONOBE H, 1992, LAB INVEST, V67, P498; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	44	37	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44095	10.1371/journal.pone.0044095	http://dx.doi.org/10.1371/journal.pone.0044095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952885	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206500045
J	Schmitt, C; Schultheis, C; Husson, SJ; Liewald, JF; Gottschalk, A				Schmitt, Cornelia; Schultheis, Christian; Husson, Steven J.; Liewald, Jana F.; Gottschalk, Alexander			Specific Expression of Channelrhodopsin-2 in Single Neurons of Caenorhabditis elegans	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; MULTIPLE SEQUENCE ALIGNMENT; GREEN FLUORESCENT PROTEIN; C-ELEGANS; NERVOUS-SYSTEM; CELLULAR CAMP; SPATIOTEMPORAL CONTROL; OPTOGENETIC ANALYSIS; GLUTAMATE-RECEPTOR; MAMMALIAN-CELLS	Optogenetic approaches using light-activated proteins like Channelrhodopsin-2 (ChR2) enable investigating the function of populations of neurons in live Caenorhabditis elegans (and other) animals, as ChR2 expression can be targeted to these cells using specific promoters. Sub-populations of these neurons, or even single cells, can be further addressed by restricting the illumination to the cell of interest. However, this is technically demanding, particularly in free moving animals. Thus, it would be helpful if expression of ChR2 could be restricted to single neurons or neuron pairs, as even wide-field illumination would photostimulate only this particular cell. To this end we adopted the use of Cre or FLP recombinases and conditional ChR2 expression at the intersection of two promoter expression domains, i.e. in the cell of interest only. Success of this method depends on precise knowledge of the individual promoters' expression patterns and on relative expression levels of recombinase and ChR2. A bicistronic expression cassette with GFP helps to identify the correct expression pattern. Here we show specific expression in the AVA reverse command neurons and the aversive polymodal sensory ASH neurons. This approach shall enable to generate strains for optogenetic manipulation of each of the 302 C. elegans neurons. This may eventually allow to model the C. elegans nervous system in its entirety, based on functional data for each neuron.	[Schmitt, Cornelia; Schultheis, Christian; Husson, Steven J.; Liewald, Jana F.; Gottschalk, Alexander] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Schmitt, Cornelia; Schultheis, Christian; Husson, Steven J.; Liewald, Jana F.; Gottschalk, Alexander] Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany; [Husson, Steven J.] Katholieke Univ Leuven, Louvain, Belgium	Goethe University Frankfurt; Goethe University Frankfurt; KU Leuven	Schmitt, C (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany.	a.gottschalk@em.uni-frankfurt.de	Gottschalk, Alexander/D-3155-2011; Pokala, Navin/AAH-5719-2019	Gottschalk, Alexander/0000-0002-1197-6119; Pokala, Navin/0000-0003-2323-6190	Schram Foundation [T287/18545/2008]; Deutsche Forschungsgemeinschaft [EXC114, SFB807-P11, GO1011/3-1]; Human Frontier Science Program Organization Long Term Fellowship LTF [548/2009-L]	Schram Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program Organization Long Term Fellowship LTF	This study was supported by Schram Foundation grant T287/18545/2008, Deutsche Forschungsgemeinschaft grants EXC114, SFB807-P11, GO1011/3-1, and Human Frontier Science Program Organization Long Term Fellowship LTF 548/2009-L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chao MY, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-45; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gerdes HH, 1996, FEBS LETT, V389, P44, DOI 10.1016/0014-5793(96)00586-8; Ghosh K, 2002, METHODS, V28, P374, DOI 10.1016/S1046-2023(02)00244-X; Hart AC, 1999, J NEUROSCI, V19, P1952; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOESS R, 1984, COLD SPRING HARB SYM, V49, P761, DOI 10.1101/SQB.1984.049.01.086; Husson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040937; Husson SJ, 2012, CURR BIOL, V22, P743, DOI 10.1016/j.cub.2012.02.066; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Marti T, 1998, J BIOL CHEM, V273, P9312, DOI 10.1074/jbc.273.15.9312; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; PINES J, 1995, TRENDS GENET, V11, P326, DOI 10.1016/S0168-9525(00)89092-7; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SCHERTLER GFX, 1993, J MOL BIOL, V234, P156, DOI 10.1006/jmbi.1993.1570; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Schwarz V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-13; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Stirman JN, 2012, NAT PROTOC, V7, P207, DOI 10.1038/nprot.2011.433; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treinin M, 1998, P NATL ACAD SCI USA, V95, P15492, DOI 10.1073/pnas.95.26.15492; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Weissenberger S, 2011, J NEUROCHEM, V116, P616, DOI 10.1111/j.1471-4159.2010.07148.x; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	66	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43164	10.1371/journal.pone.0043164	http://dx.doi.org/10.1371/journal.pone.0043164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952643	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206500009
J	Gray, KS; Collins, CM; Speck, SH				Gray, Kathleen S.; Collins, Christopher M.; Speck, Samuel H.			Characterization of Omental Immune Aggregates during Establishment of a Latent Gammaherpesvirus Infection	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; B-CELLS; MILKY SPOTS; MURINE GAMMAHERPESVIRUS-68; PERITONEAL-CAVITY; UP-REGULATION; IN-VIVO; MACROPHAGES; MIGRATION; LESSONS	Herpesviruses are characterized by their ability to establish lifelong latent infection. The gammaherpesvirus subfamily is distinguished by lymphotropism, establishing and maintaining latent infection predominantly in B lymphocytes. Consequently, gammaherpesvirus pathogenesis is closely linked to normal B cell physiology. Murine gammaherpesvirus 68 (MHV68) pathogenesis in laboratory mice has been extensively studied as a model system to gain insights into the nature of gammaherpesvirus infection in B cells and their associated lymphoid compartments. In addition to B cells, MHV68 infection of macrophages contributes significantly to the frequency of viral genome-positive cells in the peritoneal cavity throughout latency. The omentum, a sheet of richly-vascularized adipose tissue, resides in the peritoneal cavity and contains clusters of immune cell aggregates termed milky spots. Although the value of the omentum in surgical wound-healing has long been appreciated, the unique properties of this tissue and its contribution to both innate and adaptive immunity have only recently been recognized. To determine whether the omentum plays a role in gammaherpesvirus pathogenesis we examined this site during early MHV68 infection and long-term latency. Following intraperitoneal infection, immune aggregates within the omentum expanded in size and number and contained virus-infected cells. Notably, a germinal-center B cell population appeared in the omentum of infected animals with earlier kinetics and greater magnitude than that observed in the spleen. Furthermore, the omentum harbored a stable frequency of viral genome-positive cells through early and into long-term latency, while removal of the omentum prior to infection resulted in a slight decrease in the establishment of splenic latency following intraperitoneal infection. These data provide the first evidence that the omentum is a site of chronic MHV68 infection that may contribute to the maintenance of chronic infection.	[Gray, Kathleen S.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Emory University	Gray, KS (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	sspeck@emory.edu	Speck, Samuel/L-5893-2019		NIH [CA052004, CA095318]; NATIONAL CANCER INSTITUTE [R01CA052004, R01CA095318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058057] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH R01 grants CA052004 and CA095318 to SHS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Berberich S, 2008, J IMMUNOL, V180, P2196, DOI 10.4049/jimmunol.180.4.2196; Berberich S, 2007, BLOOD, V109, P4627, DOI 10.1182/blood-2006-12-064345; Cai QI, 2006, J VIROL, V80, P7965, DOI 10.1128/JVI.00689-06; Coleman CB, 2010, J VIROL, V84, P13045, DOI 10.1128/JVI.01455-10; Collins CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033230; Collins CM, 2009, J VIROL, V83, P6484, DOI 10.1128/JVI.00297-09; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Gerber SA, 2006, AM J PATHOL, V169, P1739, DOI 10.2353/ajpath.2006.051222; Gill MB, 2009, J GEN VIROL, V90, P1461, DOI 10.1099/vir.0.010603-0; Gray KS, 2009, J VIROL, V83, P314, DOI 10.1128/JVI.01444-08; Hwang S, 2008, J VIROL, V82, P12498, DOI 10.1128/JVI.01152-08; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Kearney J F, 1992, Int Rev Immunol, V8, P247, DOI 10.3109/08830189209055577; Krug LT, 2009, J VIROL, V83, P4732, DOI 10.1128/JVI.00111-09; Lee BJ, 2000, J VIROL, V74, P2786, DOI 10.1128/JVI.74.6.2786-2792.2000; Mebius RE, 2009, IMMUNITY, V30, P670, DOI 10.1016/j.immuni.2009.04.005; Moon H, 2012, J KOREAN MED SCI, V27, P27, DOI 10.3346/jkms.2012.27.1.27; Moser JA, 2006, J VIROL, V80, P1592, DOI 10.1128/JVI.80.3.1592-1598.2006; Peacock JW, 2000, J GEN VIROL, V81, P421, DOI 10.1099/0022-1317-81-2-421; Polcicova K, 2008, VIRUS RES, V132, P257, DOI 10.1016/j.virusres.2007.12.004; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; SOLVASON N, 1992, J EXP MED, V175, P397, DOI 10.1084/jem.175.2.397; SOLVASON N, 1992, ANN NY ACAD SCI, V651, P10; SORENSEN EW, 2009, IMMUNOL RES; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weck KE, 1999, J VIROL, V73, P4651, DOI 10.1128/JVI.73.6.4651-4661.1999; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003	31	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43196	10.1371/journal.pone.0043196	http://dx.doi.org/10.1371/journal.pone.0043196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952645	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206000022
J	Perumal, D; Singh, S; Yoder, SJ; Bloom, GC; Chellappan, SP				Perumal, Deepak; Singh, Sandeep; Yoder, Sean J.; Bloom, Gregory C.; Chellappan, Srikumar P.			A Novel Five Gene Signature Derived from Stem-Like Side Population Cells Predicts Overall and Recurrence-Free Survival in NSCLC	PLOS ONE			English	Article							TOPOISOMERASE-II-ALPHA; LUNG ADENOCARCINOMA; EXPRESSION DATA; TUMOR; PATHWAY; MODELS; DEATH; MICROARRAYS; CARCINOMAS; PROFILES	Gene expression profiling has been used to characterize prognosis in various cancers. Earlier studies had shown that side population cells isolated from Non-Small Cell Lung Cancer (NSCLC) cell lines exhibit cancer stem cell properties. In this study we apply a systems biology approach to gene expression profiling data from cancer stem like cells isolated from lung cancer cell lines to identify novel gene signatures that could predict prognosis. Microarray data from side population (SP) and main population (MP) cells isolated from 4 NSCLC lines (A549, H1650, H460, H1975) were used to examine gene expression profiles associated with stem like properties. Differentially expressed genes that were over or under-expressed at least two fold commonly in all 4 cell lines were identified. We found 354 were upregulated and 126 were downregulated in SP cells compared to MP cells; of these, 89 up and 62 downregulated genes (average 2 fold changes) were used for Principle Component Analysis (PCA) and MetaCore (TM) pathway analysis. The pathway analysis demonstrated representation of 4 up regulated genes (TOP2A, AURKB, BRRN1, CDK1) in chromosome condensation pathway and 1 down regulated gene FUS in chromosomal translocation. Microarray data was validated using qRT-PCR on the 5 selected genes and all showed robust correlation between microarray and qRT-PCR. Further, we analyzed two independent gene expression datasets that included 360 lung adenocarcinoma patients from NCI Director's Challenge Set for overall survival and 63 samples from Sungkyunkwan University (SKKU) for recurrence free survival. Kaplan-Meier and log-rank test analysis predicted poor survival of patients in both data sets. Our results suggest that genes involved in chromosome condensation are likely related with stem-like properties and might predict survival in lung adenocarcinoma. Our findings highlight a gene signature for effective identification of lung adenocarcinoma patients with poor prognosis and designing more aggressive therapies for such patients.	[Perumal, Deepak; Singh, Sandeep; Chellappan, Srikumar P.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Yoder, Sean J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Genom Core Facil, Tampa, FL 33612 USA; [Bloom, Gregory C.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Chellappan, SP (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA.	Srikumar.Chellappan@moffitt.org			NCI [CA127725]; Lung Cancer SPORE; National Functional Genomics Center at Moffitt Cancer Center; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA127725] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer SPORE; National Functional Genomics Center at Moffitt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by grant CA127725 from the NCI. Support of the Lung Cancer SPORE as well as the National Functional Genomics Center at Moffitt Cancer Center is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SG, 2002, BMC MED RES METHODOL, V2; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chekerov R, 2006, NEOPLASIA, V8, P38, DOI 10.1593/neo.05580; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chikaish Y, 2011, ANTICANCER RES, V31, P4451; Dalton WS, 2006, SCIENCE, V312, P1165, DOI 10.1126/science.1125948; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Fatoba ST, 2011, CELL CYCLE, V10, P2317, DOI 10.4161/cc.10.14.15913; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanta SY, 2006, HUM PATHOL, V37, P1333, DOI 10.1016/j.humpath.2006.05.008; Koren R, 2004, ONCOL REP, V12, P915; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Navab R, 2011, P NATL ACAD SCI; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; R Development Core Team, 2008, LANG ENV STAT COMP; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shuda K, 2009, MOL REPROD DEV, V76, P1094, DOI 10.1002/mrd.21075; Stevens JB, 2007, CANCER RES, V67, P7686, DOI 10.1158/0008-5472.CAN-07-0472; Stevens JB, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-20; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Tanaka T, 2004, INT J CANCER, V111, P617, DOI 10.1002/ijc.20289; Tinker AV, 2006, CANCER CELL, V9, P333, DOI 10.1016/j.ccr.2006.05.001; Varis A, 2004, INT J CANCER, V109, P548, DOI 10.1002/ijc.20001; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Xu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013696; Yang P, 2004, LUNG CANCER, V46, P215, DOI 10.1016/j.lungcan.2004.03.012; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	54	23	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43589	10.1371/journal.pone.0043589	http://dx.doi.org/10.1371/journal.pone.0043589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952714	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000043
J	Ross, A; Koepfli, C; Li, XH; Schoepflin, S; Siba, P; Mueller, I; Felger, I; Smith, T				Ross, Amanda; Koepfli, Cristian; Li, Xiaohong; Schoepflin, Sonja; Siba, Peter; Mueller, Ivo; Felger, Ingrid; Smith, Thomas			Estimating the Numbers of Malaria Infections in Blood Samples Using High-Resolution Genotyping Data	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANTIMALARIAL EFFICACY; TRIALS; VIVAX; DIVERSITY; IMPACT	People living in endemic areas often habour several malaria infections at once. High-resolution genotyping can distinguish between infections by detecting the presence of different alleles at a polymorphic locus. However the number of infections may not be accurately counted since parasites from multiple infections may carry the same allele. We use simulation to determine the circumstances under which the number of observed genotypes are likely to be substantially less than the number of infections present and investigate the performance of two methods for estimating the numbers of infections from high-resolution genotyping data. The simulations suggest that the problem is not substantial in most datasets: the disparity between the mean numbers of infections and of observed genotypes was small when there was 20 or more alleles, 20 or more blood samples, a mean number of infections of 6 or less and where the frequency of the most common allele was no greater than 20%. The issue of multiple infections carrying the same allele is unlikely to be a major component of the errors in PCR-based genotyping. Simulations also showed that, with heterogeneity in allele frequencies, the observed frequencies are not a good approximation of the true allele frequencies. The first method that we proposed to estimate the numbers of infections assumes that they are a good approximation and hence did poorly in the presence of heterogeneity. In contrast, the second method by Li et al estimates both the numbers of infections and the true allele frequencies simultaneously and produced accurate estimates of the mean number of infections.	[Ross, Amanda; Koepfli, Cristian; Schoepflin, Sonja; Felger, Ingrid; Smith, Thomas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ross, Amanda; Koepfli, Cristian; Schoepflin, Sonja; Felger, Ingrid; Smith, Thomas] Univ Basel, Basel, Switzerland; [Koepfli, Cristian; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic, Australia; [Li, Xiaohong] BG Med Inc, Waltham, MA USA; [Siba, Peter; Mueller, Ivo] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Mueller, Ivo] Barcelona Ctr Int Hlth Res, Barcelona, Spain	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Walter & Eliza Hall Institute; PNG Institute Of Medical Research; ISGlobal; CRESIB	Ross, A (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	amanda.ross@unibas.ch	Koepfli, Cristian/H-8772-2019; Smith, Thomas/B-5569-2015; Mueller, Ivo/C-7251-2013	Koepfli, Cristian/0000-0002-9354-0414; Smith, Thomas/0000-0002-3650-9381; Mueller, Ivo/0000-0001-6554-6889; Ross, Amanda/0000-0001-6027-5645; Felger, Ingrid/0000-0003-1255-2606	Swiss National Science Foundation [320030-125316, 31003A-112196]; National Institutes of Health [AI063135, AI46919, TW007872]; Australian Agency for International Development; Victorian State Government OIS grant; National Health and Medical Research Council (NHMRC) IRIISS grant; FOGARTY INTERNATIONAL CENTER [R01TW007872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI063135, R01AI046919] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Agency for International Development; Victorian State Government OIS grant; National Health and Medical Research Council (NHMRC) IRIISS grant(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Swiss National Science Foundation project number 320030-125316. The data used was additionally supported by the Swiss National Science Foundation project number 31003A-112196, the National Institutes of Health (AI063135, AI46919 and TW007872) and the Australian Agency for International Development. Infrastructure was supported by the Victorian State Government OIS and National Health and Medical Research Council (NHMRC) IRIISS grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, METHODS TECHNIQUES C; Antao T, 2011, P ROY SOC B-BIOL SCI, V278, P1705, DOI 10.1098/rspb.2010.1907; Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711; Bretscher MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-234; Bruce MC, 2000, PARASITOLOGY, V121, P257, DOI 10.1017/S0031182099006356; CARTER R, 1973, T ROY SOC TROP MED H, V67, P830, DOI 10.1016/0035-9203(73)90011-4; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Farnert A, 2001, T ROY SOC TROP MED H, V95, P225, DOI 10.1016/S0035-9203(01)90175-0; Gatton ML, 2008, TRENDS PARASITOL, V24, P68, DOI 10.1016/j.pt.2007.11.003; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; Gupta V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-19; Hastings IM, 2010, AM J TROP MED HYG, V83, P489, DOI 10.4269/ajtmh.2010.10-0072; Hastings IM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-130; Hill WG, 1995, P ROY SOC B-BIOL SCI, V262, P249, DOI 10.1098/rspb.1995.0203; Juliano JJ, 2010, TRENDS PARASITOL, V26, P119, DOI 10.1016/j.pt.2009.12.007; Juliano JJ, 2009, J INFECT DIS, V200, P5, DOI 10.1086/599379; Koepfli C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001424; Koepfli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019010; Kwiek JJ, 2007, ANTIMICROB AGENTS CH, V51, P521, DOI 10.1128/AAC.00902-06; Li X, 2009, J R STAT SOC C-APPL, V58, P663, DOI 10.1111/j.1467-9876.2009.00673.x; Li XH, 2007, STAT APPL GENET MOL, V6; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McNamara DT, 2006, AM J TROP MED HYG, V74, P413, DOI 10.4269/ajtmh.2006.74.413; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Slater M, 2005, AM J TROP MED HYG, V73, P256, DOI 10.4269/ajtmh.2005.73.256; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	28	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42496	10.1371/journal.pone.0042496	http://dx.doi.org/10.1371/journal.pone.0042496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952595	Green Published, gold, Green Accepted			2022-12-27	WOS:000308206000007
J	Walter, J; Hartung, HP; Dihne, M				Walter, Janine; Hartung, Hans-Peter; Dihne, Marcel			Interferon Gamma and Sonic Hedgehog Signaling Are Required to Dysregulate Murine Neural Stem/Precursor Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL CONTROL; NEURITE OUTGROWTH; IFN-GAMMA; DIFFERENTIATION; NEUROGENESIS; EXPRESSION; CYTOKINES; IMPACT; BRAIN; STATS	Background: The pro-inflammatory cytokine interferon gamma (IFN gamma), a key player in various neurological diseases, was recently shown to induce a dysregulated phenotype in neural stem/precursor cells (NSPCs) that is characterized by the simultaneous expression of glial and neuronal markers and irregular electrophysiological properties. Thus far, the mechanisms of this phenomenon have remained unclear. Methodology/Principal Findings: To determine if binding of the signal transducers and activators of transcription (Stat 1) to the sonic hedgehog (SHH) promoter is important for this phenomenon to occur, chromatin immunoprecipitation and pharmacological inhibition studies were performed. We report here that the activation of both the Stat 1 and SHH pathways is necessary to elicit the dysregulated phenotype. Conclusions/Significance: Thus, blocking these pathways might preserve functional differentiation of NSPCs under inflammatory conditions leading to more effective regeneration.	[Walter, Janine; Hartung, Hans-Peter; Dihne, Marcel] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, N Rhine Westpha, Germany; [Walter, Janine; Dihne, Marcel] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Baden Wurttembe, Germany	Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Walter, J (corresponding author), Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, N Rhine Westpha, Germany.	Janine.Walter@googlemail.com						Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Darnell JE, 2007, CURR TOP MICROBIOL, V316, P155; De Simone R, 1998, CYTOKINE, V10, P418, DOI 10.1006/cyto.1997.0314; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Griffin DE, 1997, J CLIN INVEST, V100, P2948, DOI 10.1172/JCI119847; Kim IJ, 2002, J NEUROSCI, V22, P4530, DOI 10.1523/JNEUROSCI.22-11-04530.2002; Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Makela J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011091; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; RADY PL, 1995, CYTOKINE, V7, P793, DOI 10.1006/cyto.1995.0095; Rottenberg M, 2002, VIRAL IMMUNOL, V15, P247, DOI 10.1089/08828240260066206; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun L, 2010, BRAIN BEHAV IMMUN, V24, P220, DOI 10.1016/j.bbi.2009.09.016; Sweeten TL, 2004, BIOL PSYCHIAT, V55, P434, DOI 10.1016/j.biopsych.2003.09.001; Todoric J, 2011, DIABETES, V60, P1668, DOI 10.2337/db10-1628; Walter J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-18; Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004; Wang Y, 2008, ANN NEUROL, V64, P417, DOI 10.1002/ana.21457; Wei YP, 2000, J INTERF CYTOK RES, V20, P403, DOI 10.1089/107999000312342; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; YONG VW, 1992, GLIA, V6, P269, DOI 10.1002/glia.440060405; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412	30	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43338	10.1371/journal.pone.0043338	http://dx.doi.org/10.1371/journal.pone.0043338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952668	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000032
J	Arunkumar, KP; Sahu, AK; Mohanty, AR; Awasthi, AK; Pradeep, AR; Urs, SR; Nagaraju, J				Arunkumar, Kallare P.; Sahu, Anup Kumar; Mohanty, Atish Ranjan; Awasthi, Arvind K.; Pradeep, Appukuttannair R.; Urs, S. Raje; Nagaraju, Javaregowda			Genetic Diversity and Population Structure of Indian Golden Silkmoth (Antheraea assama)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; LEPIDOPTERA; SOFTWARE; MARKERS; COMPLEX	Background: The Indian golden saturniid silkmoth (Antheraea assama), popularly known as muga silkmoth, is a semi-domesticated silk producing insect confined to a narrow habitat range of the northeastern region of India. Owing to the prevailing socio-political problems, the muga silkworm habitats in the northeastern region have not been accessible hampering the phylogeography studies of this rare silkmoth. Recently, we have been successful in our attempt to collect muga cocoon samples, although to a limited extent, from their natural habitats. Out of 87 microsatellite markers developed previously for A. assama, 13 informative markers were employed to genotype 97 individuals from six populations and analyzed their population structure and genetic variation. Methodology/Principal Findings: We observed highly significant genetic diversity in one of the populations (WWS-1, a population derived from West Garo Hills region of Meghalaya state). Further analysis with and without WWS-1 population revealed that dramatic genetic differentiation (global F-ST = 0.301) was due to high genetic diversity contributed by WWS-1 population. Analysis of the remaining five populations (excluding WWS-1) showed a marked reduction in the number of alleles at all the employed loci. Structure analysis showed the presence of only two clusters: one formed by WWS-1 population and the other included the remaining five populations, inferring that there is no significant genetic diversity within and between these five populations, and suggesting that these five populations are probably derived from a single population. Patterns of recent population bottlenecks were not evident in any of the six populations studied. Conclusions/Significance: A. assama inhabiting the WWS-1 region revealed very high genetic diversity, and was genetically divergent from the five populations studied. The efforts should be continued to identify and study such populations from this region as well as other muga silkworm habitats. The information generated will be very useful in conservation of dwindling muga culture in Northeast India.	[Arunkumar, Kallare P.; Nagaraju, Javaregowda] Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Ctr Excellence Genet & Genom Silkmoths, Hyderabad, Andhra Pradesh, India; [Sahu, Anup Kumar] Cent Muga Eri Res & Training Inst, Reg Muga Res Stn, Boko, India; [Mohanty, Atish Ranjan; Awasthi, Arvind K.; Pradeep, Appukuttannair R.; Urs, S. Raje] Cent Silk Board, Seribiotech Res Lab, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Arunkumar, KP (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Ctr Excellence Genet & Genom Silkmoths, Hyderabad, Andhra Pradesh, India.	jnagaraju@cdfd.org.in			Centre of Excellence from the Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR), India	Centre of Excellence from the Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	JN acknowledges Centre of Excellence grant from the Department of Biotechnology, Government of India. AKP is recipient of the fellowship from Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunkumar KP, 2009, MOL ECOL RESOUR, V9, P268, DOI 10.1111/j.1755-0998.2008.02414.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Coates Brad Steven, 2011, Frontiers in Genetics, V2, P38, DOI 10.3389/fgene.2011.00038; Cornuet JM, 1996, GENETICS, V144, P2001; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Endler J.A., 1986, Monographs in Population Biology, pviii; ERSTS PJ, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fuentes-Contreras E, 2008, J ECON ENTOMOL, V101, P190, DOI 10.1603/0022-0493(2008)101[190:PGSOCM]2.0.CO;2; Goel RK, 2004, OAK TASAR CULTURE AB; HALE LR, 1991, GENETICS, V129, P103; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jolly MS, 1981, FAO AGR SERVICES B N; Lewis PO, 2001, GENETIC DATA ANAL GD; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; MANTEL N, 1967, CANCER RES, V27, P209; Meglecz E, 1997, GENETICA, V101, P59, DOI 10.1023/A:1018368622549; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M., 1987, MOL EVOLUTIONARY GEN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Prasad MD, 2003, J BIOSCIENCES, V28, P443, DOI 10.1007/BF02705119; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Salvato P, 2002, MOL ECOL, V11, P2435, DOI 10.1046/j.1365-294X.2002.01631.x; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Slatkin M, 1994, GENE FLOW POPULATION; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila M, 2011, J ZOOL SYST EVOL RES, V49, P119, DOI 10.1111/j.1439-0469.2010.00587.x; YOON CK, 1994, J HERED, V85, P421, DOI 10.1093/oxfordjournals.jhered.a111495	34	13	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43716	10.1371/journal.pone.0043716	http://dx.doi.org/10.1371/journal.pone.0043716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952746	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600039
J	Chiem, JC; Macq, J; Speybroeck, N				Chiem, Jean-Christophe; Macq, Jean; Speybroeck, Niko			Rule-Based Modeling of Chronic Disease Epidemiology: Elderly Depression as an Illustration	PLOS ONE			English	Article							SOCIAL SUPPORT; LIFE EVENTS; OLD-AGE; PREVALENCE; PREDICTORS; SIMULATION; COMMUNITY; NETWORKS; ANXIETY	Background: Rule-based Modeling (RBM) is a computer simulation modeling methodology already used to model infectious diseases. Extending this technique to the assessment of chronic diseases, mixing quantitative and qualitative data appear to be a promising alternative to classical methods. Elderly depression reveals an important source of comorbidities. Yet, the intertwined relationship between late-life events and the social support of the elderly person remains difficult to capture. We illustrate the usefulness of RBM in modeling chronic diseases using the example of elderly depression in Belgium. Methods: We defined a conceptual framework of interactions between late-life events and social support impacting elderly depression. This conceptual framework was underpinned by experts' opinions elicited through a questionnaire. Several scenarios were implemented successively to better mimic the real population, and to explore a treatment effect and a socioeconomic distinction. The simulated patterns of depression by age were compared with empirical patterns retrieved from the Belgian Health Interview Survey. Results: Simulations were run using different groupings of experts' opinions on the parameters. The results indicate that the conceptual framework can reflect a realistic evolution of the prevalence of depression. Indeed, simulations combining the opinions of well-selected experts and a treatment effect showed no significant difference with the empirical pattern. Conclusions: Our conceptual framework together with a quantification of parameters through elicited expert opinions improves the insights into possible dynamics driving elderly depression. While RBM does not require high-level skill in mathematics or computer programming, the whole implementation process provides a powerful tool to learn about complex chronic diseases, combining advantages of both quantitative and qualitative approaches.	[Chiem, Jean-Christophe; Macq, Jean; Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium	Universite Catholique Louvain	Chiem, JC (corresponding author), Catholic Univ Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium.	jean-christophe.chiem@uclouvain.be		Speybroeck, Niko/0000-0003-3322-3502	Universite Catholique de Louvain (UCL)	Universite Catholique de Louvain (UCL)	One Phd student working on this study was paid under a Phd Scholarship granted by Universite Catholique de Louvain (UCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrino-Silva C, 2011, CLINICS, V66, P233, DOI 10.1590/S1807-59322011000200009; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Axelrod R., 1997, COMPLEXITY, V3, P16, DOI DOI 10.1002/(ISSN)1099-0526; Belgian Federal Government, 2009, TABL MORT; Berk L.E., 2009, DEV LIFESPAN, V5th; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Blazer DG, 2005, PSYCHOL MED, V35, P1241, DOI 10.1017/S0033291705004411; Boisson M, 2010, SANTE MENTALE AFFAIR; COLLOPY F, 1992, MANAGE SCI, V38, P1394, DOI 10.1287/mnsc.38.10.1394; Dalgard OS, 2009, SOCIAL SUPPORT DEFIN; DeBeauvoir S., 1970, COMING AGE; Demarest S DS, 1997, HLTH INTERVIEW SURVE; Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x; Edmonds B, 2005, J MATH SOCIOL, V29, P209, DOI 10.1080/00222500590921283; Edmonds B, 2001, LECT NOTES ARTIF INT, V1979, P15; Edmonds B, 2010, J ARTIFICIAL SOC SOC, V13; Epstein JM, 2009, NATURE, V460, P687, DOI 10.1038/460687a; Epstein JM, 2008, JASSS-J ARTIF SOC S, V11; Evans M., 2000, ADV PSYCHIAT TREAT, V6, P49, DOI [DOI 10.1192/APT.6.1.49, 10.1192/apt.6.1.49]; Galea S, 2009, INT J DRUG POLICY, V20, P209, DOI 10.1016/j.drugpo.2008.08.005; Gerstorf D, 2009, PSYCHOL AGING, V24, P296, DOI 10.1037/a0015069; Gisle L, 2008, SANTE MENTALE ENQUET; Golden J, 2009, INT J GERIATR PSYCH, V24, P694, DOI 10.1002/gps.2181; Green Carla A, 2004, Evid Based Ment Health, V7, P58; Guilbaut C, 2007, GERONTOLOGIE SOC, V121, P163; Hammond RA, 2009, PREV CHRONIC DIS, V6; Haworth JE, 2005, EUR J HEART FAIL, V7, P803, DOI 10.1016/j.ejheart.2005.03.001; Hollingworth SA, 2010, AUST NZ J PSYCHIAT, V44, P513, DOI 10.3109/00048670903555138; Holroyd S, 2000, MEDSCAPE GEN MED, V2; Hoppmann C, 2009, GERONTOLOGY, V55, P449, DOI 10.1159/000211948; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; Jones AP, 2006, AM J PUBLIC HEALTH, V96, P488, DOI 10.2105/AJPH.2005.063529; Kelley-Moore JA, 2006, J HEALTH SOC BEHAV, V47, P126, DOI 10.1177/002214650604700203; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lorant V, 2007, BRIT J PSYCHIAT, V190, P293, DOI 10.1192/bjp.bp.105.020040; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Moss S, 2005, AM J SOCIOL, V110, P1095, DOI 10.1086/427320; O'Malley AJ, 2011, STAT MED, V30, P950, DOI 10.1002/sim.4190; Population Reference Bureau, 2008, TOD RES AG, V11; Population Reference Bureau, 2009, TOD RES AG, V17; Reker GT, 1997, GERONTOLOGIST, V37, P709, DOI 10.1093/geront/37.6.709; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Smith JP, 2004, POPUL DEV REV, V30, P108; Subramanian SV, 2008, SOC SCI MED, V66, P873, DOI 10.1016/j.socscimed.2007.11.029; van Iersel MB, 2006, J AM GERIATR SOC, V54, P728, DOI 10.1111/j.1532-5415.2006.00668_14.x; Waite A, 2004, BRIT J CLIN PSYCHOL, V43, P313, DOI 10.1348/0144665031753005; WENGER GC, 1995, AGEING SOC, V15, P59, DOI 10.1017/S0144686X00002129; Wilson K, 2007, INT J GERIATR PSYCH, V22, P974, DOI 10.1002/gps.1773; Yang Y, 2007, J HEALTH SOC BEHAV, V48, P16, DOI 10.1177/002214650704800102; ZISOOK S, 1991, AM J PSYCHIAT, V148, P1346	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e41452	10.1371/journal.pone.0041452	http://dx.doi.org/10.1371/journal.pone.0041452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952581	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600002
J	Costa, GMJ; Avelar, GF; Rezende-Neto, JV; Campos, PHA; Lacerda, SMSN; Andrade, BSC; Thome, RG; Hofmann, MC; Franca, LR				Costa, Guilherme M. J.; Avelar, Gleide F.; Rezende-Neto, Jose V.; Campos-Junior, Paulo Henrique A.; Lacerda, Samyra M. S. N.; Andrade, Bruno S. C.; Thome, Ralph Gruppi; Hofmann, Marie-Claude; Franca, Luiz R.			Spermatogonial Stem Cell Markers and Niche in Equids	PLOS ONE			English	Article							DAILY SPERM PRODUCTION; SEMINIFEROUS TUBULES; NEUROTROPHIC FACTOR; GERM-CELLS; ADULT; MOUSE; SPERMATOGENESIS; TESTIS; GDNF; EXPRESSION	Spermatogonial stem cells (SSCs) are the foundation of spermatogenesis and are located in a highly dynamic microenvironment called "niche" that influences all aspects of stem cell function, including homing, self-renewal and differentiation. Several studies have recently identified specific proteins that regulate the fate of SSCs. These studies also aimed at identifying surface markers that would facilitate the isolation of these cells in different vertebrate species. The present study is the first to investigate SSC physiology and niche in stallions and to offer a comparative evaluation of undifferentiated type A spermatogonia (Aund) markers (GFRA1, PLZF and CSF1R) in three different domestic equid species (stallions, donkeys, and mules). Aund were first characterized according to their morphology and expression of the GFRA1 receptor. Our findings strongly suggest that in stallions these cells were preferentially located in the areas facing the interstitium, particularly those nearby blood vessels. This distribution is similar to what has been observed in other vertebrate species. In addition, all three Aund markers were expressed in the equid species evaluated in this study. These markers have been well characterized in other mammalian species, which suggests that the molecular mechanisms that maintain the niche and Aund/SSCs physiology are conserved among mammals. We hope that our findings will help future studies needing isolation and cryopreservation of equids SSCs. In addition, our data will be very useful for studies that aim at preserving the germplasm of valuable animals, and involve germ cell transplantation or xenografts of equids testis fragments/germ cells suspensions.	[Costa, Guilherme M. J.; Avelar, Gleide F.; Rezende-Neto, Jose V.; Campos-Junior, Paulo Henrique A.; Lacerda, Samyra M. S. N.; Andrade, Bruno S. C.; Thome, Ralph Gruppi; Franca, Luiz R.] Univ Fed Minas Gerais, Lab Cellular Biol, Dept Morphol, Belo Horizonte, MG, Brazil; [Hofmann, Marie-Claude] Univ Texas MD Anderson Canc Ctr, Unit 1105, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA	Universidade Federal de Minas Gerais; University of Texas System; UTMD Anderson Cancer Center	Franca, LR (corresponding author), Univ Fed Minas Gerais, Lab Cellular Biol, Dept Morphol, Belo Horizonte, MG, Brazil.	lrfranca@icb.ufmg.br	Campos-Junior, Paulo HA/H-5751-2015; Mattos Jardim Costa, Guilherme/A-7369-2016; Lacerda, Samyra/AAG-8948-2021; Lacerda, Samyra/A-7756-2016; Thomé, Ralph G/M-7997-2018; Nassif, Samyra/AAR-5947-2020; DE FRANCA, LUIZ/AAA-6923-2021	Campos-Junior, Paulo HA/0000-0003-2400-2548; Mattos Jardim Costa, Guilherme/0000-0002-2907-7760; Lacerda, Samyra/0000-0003-4577-6243; Lacerda, Samyra/0000-0003-4577-6243; Hofmann, Marie-Claude/0000-0002-4899-8039	CNPq; FAPEMIG; Experimental Farm of Pedro Leopoldo - UFMG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K02HD054607, R01HD044543] Funding Source: NIH RePORTER	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Experimental Farm of Pedro Leopoldo - UFMG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Technical help from Mara Livia Santos as well as the support provided by the Experimental Farm of Pedro Leopoldo - UFMG, are highly appreciated.	Aeckerle N, 2012, MOL HUM REP IN PRESS; Albert S, 2012, CELLS TISSU IN PRESS; Auharek SA, 2010, J ANAT, V216, P577, DOI 10.1111/j.1469-7580.2010.01219.x; Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; BERNDTSON WE, 1983, THERIOGENOLOGY, V20, P449, DOI 10.1016/0093-691X(83)90204-2; Borjigin U, 2010, REPROD FERT DEVELOP, V22, P733, DOI 10.1071/RD09237; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Caires K, 2010, J ENDOCRINOL, V205, P133, DOI 10.1677/JOE-09-0275; Campos PHA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095430; Chiarini-Garcia H, 2003, REPRODUCTION, V126, P669, DOI 10.1530/reprod/126.5.669; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; Chiarini-Garcia H, 2009, ANIM REPROD SCI, V116, P139, DOI 10.1016/j.anireprosci.2008.12.019; Costa GMJ, 2008, THERIOGENOLOGY, V70, P1136, DOI 10.1016/j.theriogenology.2008.06.035; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; De Rooij DG, 2000, J ANDROL, V21, P776; De Rooij DG, 2009, MICROSC RES TECHNIQ, V72, P580, DOI 10.1002/jemt.20699; Dettin L, 2003, BIOL REPROD, V69, P1565, DOI 10.1095/biolreprod.103.016394; do Nascimento HF, 2009, INT J ANDROL, V32, P486, DOI 10.1111/j.1365-2605.2008.00884.x; Ehmcke J, 2006, REPRODUCTION, V132, P673, DOI 10.1530/rep.1.01081; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Franca LR, 1998, MALE REPROD MULTIDIS, V197, P219; Gassei K, 2010, J MED PRIMATOL, V39, P83, DOI 10.1111/j.1600-0684.2009.00397.x; Grasso M, 2012, REPRODUCTION, V143, P325, DOI 10.1530/REP-11-0385; Grisanti L, 2009, STEM CELLS, V27, P3043, DOI 10.1002/stem.206; Ha Tae-young, 2003, J Vet Sci, V4, P21; He ZP, 2012, METHODS MOL BIOL, V825, P45, DOI 10.1007/978-1-61779-436-0_4; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Hermann BP, 2010, REPRODUCTION, V139, P479, DOI 10.1530/REP-09-0255; Hermann BP, 2009, HUM REPROD, V24, P1704, DOI 10.1093/humrep/dep073; Hess R. A., 2007, MOL MECH SPERMATOGEN, P1; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Honaramooz A, 2011, Vet Med Int, V2011, P915031, DOI 10.4061/2011/915031; Honaramooz A, 2011, VET MED INT, V4; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; HUCKINS C, 1978, ANAT REC, V192, P519, DOI 10.1002/ar.1091920406; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; JOHNSON L, 1987, J REPROD FERTIL, V81, P227, DOI 10.1530/jrf.0.0810227; JOHNSON L, 1985, BIOL REPROD, V32, P1181, DOI 10.1095/biolreprod32.5.1181; JOHNSON L, 1990, ANAT RECORD, V227, P167, DOI 10.1002/ar.1092270205; JOHNSON L, 1990, J REPROD FERTIL, V89, P689, DOI 10.1530/jrf.0.0890689; JOHNSON L, 1991, BIOL REPROD, V44, P284, DOI 10.1095/biolreprod44.2.284; Johnston DS, 2011, BIOL REPROD, V85, P763, DOI 10.1095/biolreprod.110.087676; Klisch K, 2011, REPRODUCTION, V142, P667, DOI 10.1530/REP-11-0007; Kokkinaki M, 2009, BIOL REPROD, V80, P707, DOI 10.1095/biolreprod.108.073809; Kolasa A, 2012, REPROD BIOL, V12, P5, DOI 10.1016/S1642-431X(12)60074-6; Kuijk EW, 2009, REPRODUCTION, V138, P721, DOI 10.1530/REP-09-0138; Maki CB, 2009, HUM REPROD, V24, P1480, DOI 10.1093/humrep/dep033; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Neves ES, 2002, BIOL REPROD, V67, P247, DOI 10.1095/biolreprod67.1.247; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Powell RH, 2012, REPROD FERT DEVELOP, V24, P221, DOI 10.1071/RDv24n1Ab219; Robertson K, 1997, TRENDS GENET, V13, P1, DOI 10.1016/S0168-9525(96)30113-3; Russell LD, 2002, BIOL REPROD, V66, P950, DOI 10.1095/biolreprod66.4.950; Silva RC, 2012, J ANDROL, V33, P264, DOI 10.2164/jandrol.110.012898; Simon L, 2007, EXP CELL RES, V313, P3090, DOI 10.1016/j.yexcr.2007.05.002; Simon L, 2009, STEM CELLS, V27, P1666, DOI 10.1002/stem.93; Spinnler K, 2010, HUM REPROD, V25, P2181, DOI 10.1093/humrep/deq170; SWIERSTRA EE, 1974, J REPROD FERTIL, V40, P113, DOI 10.1530/jrf.0.0400113; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Verini-Supplizi A, 2000, RES VET SCI, V69, P113, DOI 10.1053/rvsc.2000.0398; von Schonfeldt V, 2004, CYTOGENET GENOME RES, V105, P235, DOI 10.1159/000078194; Worby CA, 1996, J BIOL CHEM, V271, P23619, DOI 10.1074/jbc.271.39.23619; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	70	48	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44091	10.1371/journal.pone.0044091	http://dx.doi.org/10.1371/journal.pone.0044091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937157	Green Submitted, gold, Green Published			2022-12-27	WOS:000308213600077
J	Guo, SC; Liu, ML; Godwin, AK				Guo, Shanchun; Liu, Mingli; Godwin, Andrew K.			Transcriptional Regulation of hTREX84 in Human Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; MESSENGER-RNA EXPORT; HUMAN BREAST-CANCER; SYNUCLEIN-GAMMA-GENE; DOMAIN PROTEIN P84N5; CHROMATIN IMMUNOPRECIPITATION; SACCHAROMYCES-CEREVISIAE; OVARIAN-CARCINOMA; AP-1 ACTIVITY; TREX COMPLEX	TREX (transcription/export) is a multiprotein complex that plays a key role in the transcriptional elongation and transport of mRNA from the nucleus to the cytoplasm. We previously reported the purification of the human TREX protein and found that expression of a member of this complex, p84N5 (referred to as hTREX84 or hHPR1), a RB binding protein, correlated with breast tumor size and metastasis. Here we examine the mechanisms of aberrant expression of hTREX84 in breast and ovarian cancer cells and evaluate its role in tumorigenesis. We show that ovarian tumor cells over-express hTREX84 4-fold and 10-fold compared to immortal, non-tumorigenic and primary ovarian surface epithelial cells, respectively. Reduction of hTREX84 levels by small interfering RNA result in inhibition of cellular proliferation and G(2/M) arrest. Even though we observed that hTREX84 expression was induced by treatment with a demethylation agent, 5-aza-2'-deoxycytidine (5-aza-dC), sodium bisulfite DNA sequencing and methylation specific PCR found no evidence of changes in DNA methylation in the CpG islands in the regulator region of hTREX84. We subsequently identify several transcriptional factors, including NF-kappa B binding sites in the hTREX84 gene promoter and demonstrate by chromatin immunoprecipation (ChIP) and site directed mutagenesis that RelA/p65 binds the NF-kB binding sites and induces hTREX84 expression. Finally, we show by immunohistochemistry (IHC) that RelA/p65 is abundantly expressed in malignant cells that aberrantly express hTREX84 indicating that RelA/p65 might play a pivotal role in regulating hTREX84 expression in cancer. Our results indicate that overexpression of hTREX84 is associated with cancer cell transformation, proliferation and may be regulated by RelA/p65.	[Guo, Shanchun; Godwin, Andrew K.] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA; [Guo, Shanchun; Liu, Mingli] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	Fox Chase Cancer Center; Morehouse School of Medicine; University of Kansas; University of Kansas Medical Center	Guo, SC (corresponding author), Fox Chase Canc Ctr, Div Med Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	sguo@msm.edu; AGodwin@kumc.edu			National Institutes of Health [R01 CA140323, 5U01CA113916]; Department of Defense Breast Cancer Research Program of the US Army Medical Research [DAMD17-03-1-0312]; Ovarian Cancer Research Fund; Kansas Bioscience Authority Eminent Scholar Program; Chancellors Distinguished Chair in Biomedical Sciences endowment; NATIONAL CANCER INSTITUTE [U54CA118638, U01CA113916, R01CA140323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program of the US Army Medical Research; Ovarian Cancer Research Fund; Kansas Bioscience Authority Eminent Scholar Program; Chancellors Distinguished Chair in Biomedical Sciences endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health, R01 CA140323 and 5U01CA113916, the Department of Defense Breast Cancer Research Program of the US Army Medical Research, DAMD17-03-1-0312, and the Ovarian Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support of the Biosample Repository, Cell Imaging, DNA Sequencing, Flow Cytometry and Cell Sorting, and Histopathology facilities at FCCC. We would like to thank Dr. Paul Cairns for helpful advice regarding DNA methylation methods. The authors would also like to acknowledge support from the Kansas Bioscience Authority Eminent Scholar Program and the Chancellors Distinguished Chair in Biomedical Sciences endowment.	AUERSPERG N, 1994, LAB INVEST, V71, P510; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; CHEN CC, 1995, AGENT ACTION SUPPL, V47, P135; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Daschner PJ, 1999, BREAST CANCER RES TR, V53, P229, DOI 10.1023/A:1006138803392; Dobrovic A, 1997, CANCER RES, V57, P3347; Doostzadeh-Cizeron J, 2000, J BIOL CHEM, V275, P25336, DOI 10.1074/jbc.M000793200; DURFEE T, 1994, J CELL BIOL, V127, P609, DOI 10.1083/jcb.127.3.609; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Gasparri F, 2004, FEBS LETT, V574, P13, DOI 10.1016/j.febslet.2004.07.074; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Gozuacik D, 2001, ONCOGENE, V20, P6233, DOI 10.1038/sj.onc.1204835; GRAFF JR, 1995, CANCER RES, V55, P5195; Guo S, 2003, P AM ASSOC CANC RES, P548; Guo SC, 2005, CANCER RES, V65, P3011, DOI 10.1158/0008-5472.CAN-04-3624; Gupta A, 2003, CANCER RES, V63, P664; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HAAF T, 1995, PHARMACOL THERAPEUT, V65, P19, DOI 10.1016/0163-7258(94)00053-6; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hurt E, 2004, P NATL ACAD SCI USA, V101, P1858, DOI 10.1073/pnas.0308663100; Jackson K, 2004, CANCER BIOL THER, V3, P1225, DOI 10.4161/cbt.3.12.1222; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Johnston SRD, 1999, CLIN CANCER RES, V5, P251; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kwon Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018872; LANGDON SP, 1988, CANCER RES, V48, P6166; Li YP, 2005, MOL CELL BIOL, V25, P4023, DOI 10.1128/MCB.25.10.4023-4033.2005; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; LINARDOPOULOS S, 1990, ANTICANCER RES, V10, P1711; Liu HY, 2005, CANCER RES, V65, P7635, DOI 10.1158/0008-5472.CAN-05-1089; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; MICHALOWSKY LA, 1989, MOL CELL BIOL, V9, P885, DOI 10.1128/MCB.9.3.885; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pakneshan P, 2004, J BIOL CHEM, V279, P31735, DOI 10.1074/jbc.M401669200; Paredes J, 2005, CLIN CANCER RES, V11, P5869, DOI 10.1158/1078-0432.CCR-05-0059; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; SOULE HD, 1990, CANCER RES, V50, P6075; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; TAIT L, 1990, CANCER RES, V50, P6087; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Yang J, 2008, ANN CLIN LAB SCI, V38, P105; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	71	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43610	10.1371/journal.pone.0043610	http://dx.doi.org/10.1371/journal.pone.0043610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952718	gold, Green Published, Green Submitted			2022-12-27	WOS:000308044800043
J	Lowe, CB; Haussler, D				Lowe, Craig B.; Haussler, David			29 Mammalian Genomes Reveal Novel Exaptations of Mobile Elements for Likely Regulatory Functions in the Human Genome	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; ULTRACONSERVED ELEMENTS; PARALLEL EVOLUTION; SUBSTITUTION RATES; BINDING SITES; NONCODING DNA; VERTEBRATE; ENHANCER; IDENTIFICATION; DATABASE	Recent research supports the view that changes in gene regulation, as opposed to changes in the genes themselves, play a significant role in morphological evolution. Gene regulation is largely dependent on transcription factor binding sites. Researchers are now able to use the available 29 mammalian genomes to measure selective constraint at the level of binding sites. This detailed map of constraint suggests that mammalian genomes co-opt fragments of mobile elements to act as gene regulatory sequence on a large scale. In the human genome we detect over 280,000 putative regulatory elements, totaling approximately 7 Mb of sequence, that originated as mobile element insertions. These putative regulatory regions are conserved non-exonic elements (CNEEs), which show considerable cross-species constraint and signatures of continued negative selection in humans, yet do not appear in a known mature transcript. These putative regulatory elements were co-opted from SINE, LINE, LTR and DNA transposon insertions. We demonstrate that at least 11%, and an estimated 20%, of gene regulatory sequence in the human genome showing cross-species conservation was co-opted from mobile elements. The location in the genome of CNEEs co-opted from mobile elements closely resembles that of CNEEs in general, except in the centers of the largest gene deserts where recognizable co-option events are relatively rare. We find that regions of certain mobile element insertions are more likely to be held under purifying selection than others. In particular, we show 6 examples where paralogous instances of an often co-opted mobile element region define a sequence motif that closely matches a transcription factor's binding profile.	[Lowe, Craig B.; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Lowe, CB (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	haussler@soe.ucsc.edu			Howard Hughes Medical Institute; National Institutes of Health [5U01 HG004695-03]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004695] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the Howard Hughes Medical Institute and the National Institutes of Health (5U01 HG004695-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyev MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r117; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baertsch R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-466; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bi S, 1997, J BIOL CHEM, V272, P30583, DOI 10.1074/jbc.272.48.30583; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Britten RJ, 1997, GENE, V205, P177, DOI 10.1016/S0378-1119(97)00399-5; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chiaromonte F, 2003, COLD SPRING HARB SYM, V68, P245, DOI 10.1101/sqb.2003.68.245; Chung DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002111; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; de la Calle-Mustienes E, 2005, GENOME RES; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Franchini LF, 2011, P NATL ACAD SCI USA, V108, P15270, DOI 10.1073/pnas.1104997108; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; Glazko GV, 2003, TRENDS GENET, V19, P119, DOI 10.1016/S0168-9525(03)00016-7; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Haussler, 2004, P 8 ANN INT C RES CO, P177, DOI DOI 10.1145/974614.974638; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Imamura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-89; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lenasi T, 2006, RNA, V12, P498, DOI 10.1261/rna.7261206; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lowe CB, 2011, SCIENCE, V333, P1019, DOI 10.1126/science.1202702; Lowe CB, 2010, J HERED, V101, P437, DOI 10.1093/jhered/esq016; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MCCLINTOCK B, 1956, COLD SPRING HARB SYM, V21, P197, DOI 10.1101/SQB.1956.021.01.017; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Polavarapu N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-226; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Smith AM, 2008, GENOME RES, V18, P1422, DOI 10.1101/gr.077008.108; Smith NGC, 2004, GENOMICS, V84, P806, DOI 10.1016/j.ygeno.2004.07.012; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; Taher L, 2009, BIOINFORMATICS, V25, P578, DOI 10.1093/bioinformatics/btp043; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005; Zhu JC, 2007, PLOS COMPUT BIOL, V3, P2498, DOI 10.1371/journal.pcbi.0030247	84	55	60	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43128	10.1371/journal.pone.0043128	http://dx.doi.org/10.1371/journal.pone.0043128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952639	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800020
J	Pastorino, L; Pollio, A; Pellacani, G; Guarneri, C; Ghiorzo, P; Longo, C; Bruno, W; Giusti, F; Bassoli, S; Bianchi-Scarra, G; Ruini, C; Seidenari, S; Tomasi, A; Ponti, G				Pastorino, Lorenza; Pollio, Annamaria; Pellacani, Giovanni; Guarneri, Carmelo; Ghiorzo, Paola; Longo, Caterina; Bruno, William; Giusti, Francesca; Bassoli, Sara; Bianchi-Scarra, Giovanna; Ruini, Cristel; Seidenari, Stefania; Tomasi, Aldo; Ponti, Giovanni			Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome	PLOS ONE			English	Article							PROTEINS; DEFECTS; GENE	Keratocystic odontogenic tumors (KCOTs) are cystic tumors that arise sporadically or associated with nevoid basal cell carcinoma syndrome (NBCCS). NBCCS is a rare autosomal dominantly inherited disease mainly characterized by multiple basal cell carcinomas, KCOTs of the jaws and a variety of other tumors. PTCH1 mutation can be found both in sporadic or NBCCS associated KCOTs. The aim of the current study was to assess whether a combined clinical and bio-molecular approach could be suitable for the detection of NBCCS among patients with a diagnosis of keratocystic odontogenic tumors (KCOTs). The authors collected keratocystic odontogenic tumors recorded in the database of the Pathology Department of the University of Modena and Reggio Emilia during the period 1991-2011. Through interviews and examinations, family pedigrees were drawn for all patients affected by these odontogenic lesions. We found out that 18 of the 70 patients with KCOTs and/or multiple basal cell carcinomas actually met the clinical criteria for the diagnosis of NBCCS. A wide inter- and intra-familial phenotypic variability was evident in the families. Ameloblastomas (AMLs) were reported in two probands that are also carriers of the PCTH1 germline mutations. Nine germline mutations in the PTCH1 gene, 5 of them novel, were evident in 14 tested probands. The clinical evaluation of the keratocystic odontogenic tumors can be used as screening for the detection of families at risk of NBCCS. Keratocystic odontogenic lesions are uncommon, and their discovery deserves the search for associated cutaneous basal cell carcinomas and other benign and malignant tumors related to NBCCS.	[Pastorino, Lorenza; Ghiorzo, Paola; Bruno, William; Bianchi-Scarra, Giovanna] Univ Genoa, Dept Internal Med & Med Specialties DiMI, Genoa, Italy; [Pollio, Annamaria] Univ Naples Federico II, Sch Med & Surg, Dept Odontostomatol & Maxillofacial Sci, Oral Med Unit, Naples, Italy; [Pellacani, Giovanni; Guarneri, Carmelo; Giusti, Francesca; Bassoli, Sara; Ruini, Cristel; Seidenari, Stefania] Univ Modena & Reggio Emilia, Div Dermatol, Dept Head & Neck Surg, Modena, Italy; [Longo, Caterina] Arcispedale Santa Maria Nuova, Dept Med 1, Dermatol Unit, Reggio Emilia, Italy; [Ghiorzo, Paola; Bianchi-Scarra, Giovanna] IRCCS AOU San Martino IST, Lab Genet Rare Hereditary Canc, Genoa, Italy; [Tomasi, Aldo; Ponti, Giovanni] Univ Modena & Reggio Emilia, Univ Hosp Modena & Reggio Emilia, Dept Clin & Diagnost Med & Publ Hlth, Modena, Italy	University of Genoa; University of Naples Federico II; Universita di Modena e Reggio Emilia; IRCCS Arcispedale S. Maria Nuova; University of Genoa; IRCCS AOU San Martino IST; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital	Pastorino, L (corresponding author), Univ Genoa, Dept Internal Med & Med Specialties DiMI, Genoa, Italy.	giovanni.ponti@unimore.it	pellacani, giovanni/E-8573-2011; Ruini, Cristel/ABB-6493-2020; Bruno, William/N-7477-2013; Ghiorzo, Paola/CAG-0673-2022; Pastorino, Lorenza/E-6084-2018; Ponti, Giovanni/A-5565-2012; Tomasi, Aldo/F-8513-2017; Longo, Caterina/A-8046-2012; Scarrà, Giovanna Bianchi/G-8933-2014	pellacani, giovanni/0000-0002-7222-2951; Ruini, Cristel/0000-0002-9860-1095; Bruno, William/0000-0002-0337-0168; Ghiorzo, Paola/0000-0002-3651-8173; Pastorino, Lorenza/0000-0002-2575-8331; Ponti, Giovanni/0000-0002-1971-7306; Tomasi, Aldo/0000-0002-1356-3430; Longo, Caterina/0000-0002-8218-3896; Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Guarneri, Claudio/0000-0002-5892-0120				Altamura D, 2010, J AM ACAD DERMATOL, V62, P67, DOI 10.1016/j.jaad.2009.05.035; August M, 2000, J ORAL MAXIL SURG, V58, P935, DOI 10.1053/joms.2000.8731; Bale AE, 1997, CANCER INVEST, V15, P180, DOI 10.3109/07357909709115772; BROWNE RM, 1971, BRIT DENT J, V131, P249, DOI 10.1038/sj.bdj.4802732; Chow HT, 1998, ORAL SURG ORAL MED O, V86, P573; CROWLEY TE, 1992, J ORAL MAXIL SURG, V50, P22, DOI 10.1016/0278-2391(92)90187-5; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Endo M, 2012, AM J MED GENET A, V158A, P351, DOI 10.1002/ajmg.a.34421; Eslami B, 2008, ORAL SURG ORAL MED O, V105, pE10, DOI 10.1016/j.tripleo.2008.01.034; Evans DG, 2010, AM J MED GENET A, V152A, P327, DOI 10.1002/ajmg.a.33139; Go JW, 2011, ANN DERMATOL, V23, pS36, DOI 10.5021/ad.2011.23.S1.S36; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Kakarantza-Angelopoulou E, 1990, J ORAL MAXILLOFAC SU, V48, P599; KAKARANTZAANGELOPOULOU E, 1990, J ORAL MAXIL SURG, V48, P593, DOI 10.1016/S0278-2391(10)80472-0; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Lam KY, 2000, LARYNGOSCOPE, V110, P1328, DOI 10.1097/00005537-200008000-00020; Levanat S, 1996, NAT GENET, V12, P85, DOI 10.1038/ng0196-85; LI TJ, 1994, J ORAL PATHOL MED, V23, P184, DOI 10.1111/j.1600-0714.1994.tb01110.x; Lo Muzio L, 1999, J AM DENT ASSOC, V130, P669; Lo Muzio L, 2011, EUR J HUM G IN PRESS; Lo Muziol L, 1999, J DENT RES, V78, P1345, DOI 10.1177/00220345990780070901; MATTHEWS JB, 1988, J PATHOL, V156, P283, DOI 10.1002/path.1711560403; Pastorino L, 2005, CHILD CARE HLTH DEV, V31, P351, DOI 10.1111/j.1365-2214.2005.00514.x; Philipsen HP, 2006, J ORAL PATHOL MED, V35, P525; Ponti G, 2012, CANC GENETI IN PRESS; Ponti G, 2012, ONCOLOGY LE IN PRESS; SHULER CF, 1987, ORAL SURG ORAL MED O, V64, P439, DOI 10.1016/0030-4220(87)90149-6; Sidransky D, 1996, NAT GENET, V14, P7, DOI 10.1038/ng0996-7; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tom WL, 2011, AM J MED GENET A, V155A, P2098, DOI 10.1002/ajmg.a.34127; Wicking C, 1997, AM J MED GENET, V73, P304	32	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43827	10.1371/journal.pone.0043827	http://dx.doi.org/10.1371/journal.pone.0043827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952776	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800062
J	Astorga, G; Hartel, S; Sanhueza, M; Bacigalupo, J				Astorga, Guadalupe; Haertel, Steffen; Sanhueza, Magdalena; Bacigalupo, Juan			TRP, TRPL and Cacophony Channels Mediate Ca2+ Influx and Exocytosis in Photoreceptors Axons in Drosophila	PLOS ONE			English	Article							LIGHT-SENSITIVE CHANNELS; PHOSPHOLIPASE-C; CALCIUM-CHANNELS; INSP(3) RECEPTOR; SPIDER TOXINS; PROTEIN; ACTIVATION; SYNAPSES; MELANOGASTER; RELEASE	In Drosophila photoreceptors Ca2+-permeable channels TRP and TRPL are the targets of phototransduction, occurring in photosensitive microvilli and mediated by a phospholipase C (PLC) pathway. Using a novel Drosophila brain slice preparation, we studied the distribution and physiological properties of TRP and TRPL in the lamina of the visual system. Immunohistochemical images revealed considerable expression in photoreceptors axons at the lamina. Other phototransduction proteins are also present, mainly PLC and protein kinase C, while rhodopsin is absent. The voltage-dependent Ca2+ channel cacophony is also present there. Measurements in the lamina with the Ca2+ fluorescent protein G-CaMP ectopically expressed in photoreceptors, revealed depolarization-induced Ca2+ increments mediated by cacophony. Additional Ca2+ influx depends on TRP and TRPL, apparently functioning as store-operated channels. Single synaptic boutons resolved in the lamina by FM4-64 fluorescence revealed that vesicle exocytosis depends on cacophony, TRP and TRPL. In the PLC mutant norpA bouton labeling was also impaired, implicating an additional modulation by this enzyme. Internal Ca2+ also contributes to exocytosis, since this process was reduced after Ca2+-store depletion. Therefore, several Ca2+ pathways participate in photoreceptor neurotransmitter release: one is activated by depolarization and involves cacophony; this is complemented by internal Ca2+ release and the activation of TRP and TRPL coupled to Ca2+ depletion of internal reservoirs. PLC may regulate the last two processes. TRP and TRPL would participate in two different functions in distant cellular regions, where they are opened by different mechanisms. This work sheds new light on the mechanism of neurotransmitter release in tonic synapses of non-spiking neurons.	[Astorga, Guadalupe; Sanhueza, Magdalena; Bacigalupo, Juan] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile; [Astorga, Guadalupe; Sanhueza, Magdalena; Bacigalupo, Juan] Univ Chile, Millennium Inst Cell Dynam & Biotechnol, Fac Sci, Santiago, Chile; [Haertel, Steffen] Univ Chile, Fac Med, Program Anat & Dev Biol, Lab Sci Image Anal,SCIAN Lab,BNI,ICBM, Santiago 7, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Astorga, G (corresponding author), Univ Paris 05, Lab Physiol Cerebrale, Paris, France.	masanhue@uchile.cl; bacigalu@uchile.cl	Härtel, Steffen/AAA-2336-2020	Härtel, Steffen/0000-0002-8913-1757	Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN [ICM-P05-001-F]; Fondo Nacional de Ciencia y Tecnologia (FONDECYT) [1100730]; Consejo Nacional de Ciencia y Tecnologia (CONICYT); FONDECYT [1120579]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) [D07I1019]; German-Chilean Center of Excellence Initiative for Medical Informatics (DAAD); BNI [ICM P09-015-F]; Advanced Imaging & Bioinformatics Initiative AI.BI	Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN; Fondo Nacional de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Consejo Nacional de Ciencia y Tecnologia (CONICYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); German-Chilean Center of Excellence Initiative for Medical Informatics (DAAD); BNI; Advanced Imaging & Bioinformatics Initiative AI.BI	Supported by Ministerio de Planificacion Nacional, Iniciativa Cientifica Milenio MIDEPLAN ICM-P05-001-F (JB, MS), Fondo Nacional de Ciencia y Tecnologia (FONDECYT) 1100730 (RD, JB), Doctoral Fellowship and Thesis grant by the Consejo Nacional de Ciencia y Tecnologia (CONICYT) (GA). Research in SCIAN-Lab (SH) is funded by FONDECYT (1120579), Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) (D07I1019), the German-Chilean Center of Excellence Initiative for Medical Informatics (DAAD), BNI (ICM P09-015-F) and the Advanced Imaging & Bioinformatics Initiative AI.BI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Agrawal N, 2010, J NEUROSCI, V30, P1301, DOI 10.1523/JNEUROSCI.3668-09.2010; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Cadetti L, 2006, EUR J NEUROSCI, V23, P2983, DOI 10.1111/j.1460-9568.2006.04845.x; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; DEER JLR, 1995, J BIOL CHEM, V270, P12623, DOI 10.1074/jbc.270.21.12623; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Delgado R, 2009, J NEUROPHYSIOL, V101, P2372, DOI 10.1152/jn.90578.2008; Dickman DK, 2008, J NEUROSCI, V28, P31, DOI 10.1523/JNEUROSCI.4498-07.2008; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Gu H, 2009, J NEUROPHYSIOL, V101, P42, DOI 10.1152/jn.91103.2008; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; Hamanaka Y, 2010, J COMP NEUROL, V518, P1133, DOI 10.1002/cne.22268; Hardie R.C., 2008, SENSES COMPREHENSIVE, P77; Hardie RC, 2004, J BIOL CHEM, V279, P47773, DOI 10.1074/jbc.M407525200; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; King GF, 2007, TOXICON, V49, P513, DOI 10.1016/j.toxicon.2006.11.012; LEUNG HT, 1989, NEURON, V3, P767, DOI 10.1016/0896-6273(89)90245-6; Lev S, 2012, J BIOL CHEM, V287, P1436, DOI 10.1074/jbc.M111.266585; LoGiudice L, 2009, NEUROSCIENTIST, V15, P380, DOI 10.1177/1073858408331373; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Ortiz-Miranda SI, 2010, J CELL PHYSIOL, V225, P276, DOI 10.1002/jcp.22263; Peixoto AA, 1998, GENETICS, V148, P827; Peng IF, 2007, J NEUROSCI, V27, P1072, DOI 10.1523/JNEUROSCI.4746-06.2007; POLLOCK JA, 1995, J NEUROSCI, V15, P3747; Pyza E, 2002, MICROSC RES TECHNIQ, V58, P335, DOI 10.1002/jemt.10141; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; Ramirez O, 2010, J MICROSC-OXFORD, V239, P173, DOI 10.1111/j.1365-2818.2010.03369.x; Ramirez OA, 2009, J BIOL CHEM, V284, P13077, DOI 10.1074/jbc.M900575200; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Ryglewski S, 2007, PLOS BIOL, V5, P818, DOI 10.1371/journal.pbio.0050066; Salido GM, 2009, CELL SIGNAL, V21, P457, DOI 10.1016/j.cellsig.2008.11.005; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Smith L A, 1998, J Neurogenet, V12, P227; Smith LA, 1996, J NEUROSCI, V16, P7868; Stuart AE, 2007, PROG NEUROBIOL, V82, P202, DOI 10.1016/j.pneurobio.2007.03.006; Szikra T, 2008, J PHYSIOL-LONDON, V586, P4859, DOI 10.1113/jphysiol.2008.160051; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Vazquez-Martinez O, 2003, J CELL SCI, V116, P2483, DOI 10.1242/jcs.00455; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; WECKSTROM M, 1995, ANN BIOMED ENG, V23, P70, DOI 10.1007/BF02368302; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590	50	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44182	10.1371/journal.pone.0044182	http://dx.doi.org/10.1371/journal.pone.0044182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952921	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300060
J	Chang, CH; Wang, Y; Trisal, P; Li, RX; Rossi, DL; Nair, A; Gupta, P; Losman, M; Cardillo, TM; Rossi, EA; Goldenberg, DM				Chang, Chien-Hsing; Wang, Yang; Trisal, Preeti; Li, Rongxiu; Rossi, Diane L.; Nair, Anju; Gupta, Pankaj; Losman, Michele; Cardillo, Thomas M.; Rossi, Edmund A.; Goldenberg, David M.			Evaluation of a Novel Hexavalent Humanized Anti-IGF-1R Antibody and Its Bivalent Parental IgG in Diverse Cancer Cell Lines	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; ALANINE SCANNING MUTAGENESIS; INSULIN-RECEPTOR; BREAST-CANCER; MONOCLONAL-ANTIBODIES; BINDING-SITE; MULTIFUNCTIONAL STRUCTURES; SOMATOMEDIN RECEPTOR; LIGAND-BINDING	A major mechanism of monoclonal antibodies that selectively target the insulin-like growth factor type 1 receptor (IGF-1R) to inhibit tumor growth is by downregulating the receptor, regardless whether they are capable (antagonistic) or incapable (agonistic) of blocking the binding of cognate ligands. We have developed and characterized a novel agonistic anti-IGF-1R humanized antibody, hR1, and used the Dock-and-Lock (DNL) method to construct Hex-hR1, the first multivalent antibody comprising 6 functional Fabs of hR1, with the aim of enhancing potency of hR1. Based on cross-blocking experiments, hR1 recognizes a region of cysteine-rich domain on the alpha-subunit, different from the epitopes mapped for existing anti-IGF-1R antibodies, yet hR1 is similar to other anti-IGF-1R antibodies in downregulating IGF-1R and inhibiting proliferation, colony formation, or invasion of selected cancer cell lines in vitro, as well as suppressing growth of the RH-30 rhabdomyosarcoma xenograft in nude mice when combined with the mTOR inhibitor, rapamycin. Hex-hR1 and hR1 are generally comparable in their bioactivities under the in-intro and in-vivo conditions investigated. Nevertheless, in selective experiments involving a direct comparison of potency, Hex-hR1 demonstrated a stronger effect on inhibiting cell proliferation stimulated by IGF-1 and could effectively downregulate IGF-1R at a concentration as low as 20 pM.	[Chang, Chien-Hsing; Wang, Yang; Trisal, Preeti; Li, Rongxiu; Rossi, Diane L.; Nair, Anju; Gupta, Pankaj; Losman, Michele; Cardillo, Thomas M.; Goldenberg, David M.] Immunomedics Inc, Morris Plains, NJ USA; [Chang, Chien-Hsing; Rossi, Edmund A.; Goldenberg, David M.] IBC Pharmaceut Inc, Morris Plains, NJ USA; [Goldenberg, David M.] Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ USA	Immunomedics Inc	Chang, CH (corresponding author), Immunomedics Inc, Morris Plains, NJ USA.	kchang@Immunomedics.com; dmg.gscancer@att.net			National Cancer Institute, United States National Institutes of Health [1R 43CA150742-01]	National Cancer Institute, United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Cancer Institute grant 1R 43CA150742-01 from the United States National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; ARTEAGA CL, 1989, J CLIN INVEST, V84, P1418, DOI 10.1172/JCI114315; ARTEAGA CL, 1989, CANCER RES, V49, P6237; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bohula EA, 2003, ANTI-CANCER DRUG, V14, P669, DOI 10.1097/01.cad.0000092782.37568.04; Buck E, 2010, MOL CANCER THER, V9, P2652, DOI 10.1158/1535-7163.MCT-10-0318; Burtrum D, 2003, CANCER RES, V63, P8912; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Chakravarti A, 2002, CANCER RES, V62, P200; Chang CH, 2007, CLIN CANCER RES, V13, p5586S, DOI 10.1158/1078-0432.CCR-07-1217; Chang CH, 2011, BISPECIFIC ANTIBODIES, P199, DOI 10.1007/978-3-642-20910-9_12; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Croasdale R, 2012, ARCH BIOCH BIOPHYS; Desbois-Mouthon C, 2009, CLIN CANCER RES, V15, P5445, DOI 10.1158/1078-0432.CCR-08-2980; Dong JY, 2011, J BIOL CHEM, V286, P4703, DOI 10.1074/jbc.M110.184317; Dong JY, 2010, MOL CANCER THER, V9, P2593, DOI 10.1158/1535-7163.MCT-09-1018; Gao J, 2012, CANCER RES, V72, P3, DOI 10.1158/0008-5472.CAN-11-0550; Gao J, 2011, CANCER RES, V71, P1029, DOI 10.1158/0008-5472.CAN-10-2274; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Gualberto A, 2011, BRIT J CANCER, V104, P68, DOI 10.1038/sj.bjc.6605972; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Hailey J, 2002, MOL CANCER THER, V1, P1349; Hewish M, 2009, RECENT PAT ANTI-CANC, V4, P54, DOI 10.2174/157489209787002515; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Jassem J, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.7500; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; Kim SY, 2009, ONCOLOGIST, V14, P83, DOI 10.1634/theoncologist.2008-0189; KULL FC, 1983, J BIOL CHEM, V258, P6561; Li S-I, 1992, BICH BIOPHYS RES COM, V196, P92; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; Olmos D, 2010, CANCER J, V16, P183, DOI 10.1097/PPO.0b013e3181dbebf9; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Pollak M, 2012, CLIN CANCER RES, V18, P40, DOI 10.1158/1078-0432.CCR-11-0998; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Qu ZX, 2005, METHODS, V36, P84, DOI 10.1016/j.ymeth.2005.01.008; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Riedemann J, 2007, BIOCHEM BIOPH RES CO, V355, P700, DOI 10.1016/j.bbrc.2007.02.041; Robert G, 2010, J CLIN ONCOL, V28, P4985; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Rossi DL, 2011, BIOTECHNOL PROGR, V27, P766, DOI 10.1002/btpr.584; Rossi EA, 2008, CANCER RES, V68, P8384, DOI 10.1158/0008-5472.CAN-08-2033; Rossi EA, 2012, BIOCONJUGATE CHEM, V23, P309, DOI 10.1021/bc2004999; Rossi EA, 2009, BLOOD, V113, P6161, DOI 10.1182/blood-2008-10-187138; Sachdev D, 2006, CANCER RES, V66, P2391, DOI 10.1158/0008-5472.CAN-05-3126; Sachdev D, 2003, CANCER RES, V63, P627; Sachdev D, 2010, ONCOGENE, V29, P251, DOI 10.1038/onc.2009.316; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Shang YL, 2008, MOL CANCER THER, V7, P2599, DOI 10.1158/1535-7163.MCT-07-2401; SOOS MA, 1992, J BIOL CHEM, V267, P12955; Sorensen H, 2004, FEBS LETT, V565, P19, DOI 10.1016/j.febslet.2004.03.077; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Wang Y, 2012, AACR M; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Wilsbacher JL, 2008, J BIOL CHEM, V283, P23721, DOI 10.1074/jbc.M708360200; XIONG LM, 1992, P NATL ACAD SCI USA, V89, P5356, DOI 10.1073/pnas.89.12.5356; Zha JP, 2010, CLIN CANCER RES, V16, P2512, DOI 10.1158/1078-0432.CCR-09-2232; Zha JP, 2009, MOL CANCER THER, V8, P2110, DOI 10.1158/1535-7163.MCT-09-0381	66	5	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44235	10.1371/journal.pone.0044235	http://dx.doi.org/10.1371/journal.pone.0044235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952934	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300066
J	Lin, WH; Huang, XL; Zhang, LN; Chen, DM; Wang, DY; Peng, QL; Xu, L; Li, JY; Liu, XJ; Li, KA; Ding, K; Jin, SG; Li, J; Wu, DH				Lin, Wanhua; Huang, Xiaoli; Zhang, Lina; Chen, Dongmei; Wang, Dongye; Peng, Qilong; Xu, Lei; Li, Jingya; Liu, Xiujie; Li, Kuai; Ding, Ke; Jin, Shouguang; Li, Jia; Wu, Donghai			BMS309403 Stimulates Glucose Uptake in Myotubes through Activation of AMP-Activated Protein Kinase	PLOS ONE			English	Article							ACID-BINDING PROTEIN; SKELETAL-MUSCLE; CASCADE; GLUT4; ALPHA; CELLS	BMS309403 is a biphenyl azole inhibitor against fatty acid binding protein 4 (FABP4) and regarded as a lead compound for effective treatment of obesity related cardio-metabolic diseases. Here we discovered an off-target activity of BMS309403 in that it stimulates glucose uptake in C2C12 myotubes in a temporal and dose dependent manner via activation of AMP-activated protein kinase (AMPK) signaling pathway but independent of FABPs. Further analysis indicated that BMS309403 activates AMPK through increasing the ratio of intracellular AMP:ATP while decreasing mitochondrial membrane potential. These findings provide mechanistic insights on the action of BMS309403.	[Lin, Wanhua; Huang, Xiaoli; Wang, Dongye; Li, Kuai; Wu, Donghai] Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Zhang, Lina; Chen, Dongmei; Xu, Lei; Li, Jingya; Li, Jia] Chinese Acad Sci, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai Inst Mat Med, Guangzhou, Guangdong, Peoples R China; [Peng, Qilong; Liu, Xiujie; Ding, Ke] Chinese Acad Sci, Inst Biol Chem, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State University System of Florida; University of Florida	Lin, WH (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.	jli@mail.shcnc.ac.cn; wu_donghai@gibh.ac.cn	Jin, Shouguang/N-5548-2016; Li, Jia/F-9116-2011; li, jia/GVT-7587-2022; Ding, Ke/B-3257-2010	Ding, Ke/0000-0001-9016-812X; ding, ke/0000-0001-8167-0476	National Basic Research Program of China (973 Program) [2011CB504004, 2010CB945500]; strategic program of stem cell (Chinese Academy of Sciences) [XDA01020303]; National Science Foundation of China [30970637, 30810099, 90813033, 30811120429]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); strategic program of stem cell (Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was supported by the National Basic Research Program of China (973 Program) (2011CB504004 and 2010CB945500), the strategic program of stem cell (Chinese Academy of Sciences XDA01020303) and the National Science Foundation of China (30970637, 30810099, 90813033 and 30811120429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Fischer H, 2006, BIOCHEM BIOPH RES CO, V346, P125, DOI 10.1016/j.bbrc.2006.05.083; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Hallsten K, 2003, OBES RES, V11, P257, DOI 10.1038/oby.2003.39; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Lee MYK, 2011, BRIT J PHARMACOL, V162, P1564, DOI 10.1111/j.1476-5381.2010.01158.x; Lemieux K, 2003, FASEB J, V17, P1658, DOI 10.1096/fj.02-1125com; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Prinsen CFM, 1998, BIOCHEM J, V329, P265; Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223; Rump R, 1996, EUR J CELL BIOL, V69, P135; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; van den Berg SAA, 2011, CURR OPIN CLIN NUTR, V14, P243, DOI 10.1097/MCO.0b013e3283455d7a; Xie ZL, 2009, DIABETES, V58, pA492	18	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44570	10.1371/journal.pone.0044570	http://dx.doi.org/10.1371/journal.pone.0044570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952994	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300099
J	Olivas, AD; Shogan, BD; Valuckaite, V; Zaborin, A; Belogortseva, N; Musch, M; Meyer, F; Trimble, WL; An, G; Gilbert, J; Zaborina, O; Alverdy, JC				Olivas, Andrea D.; Shogan, Benjamin D.; Valuckaite, Vesta; Zaborin, Alexander; Belogortseva, Natalya; Musch, Mark; Meyer, Folker; Trimble, William L.; An, Gary; Gilbert, Jack; Zaborina, Olga; Alverdy, John C.			Intestinal Tissues Induce an SNP Mutation in Pseudomonas aeruginosa That Enhances Its Virulence: Possible Role in Anastomotic Leak	PLOS ONE			English	Article							MULTIDRUG EFFLUX SYSTEM; MEXT; REGULATOR; RESECTION; DECONTAMINATION; PREVENTION; PLACEBO; PAO1	The most feared complication following intestinal resection is anastomotic leakage. In high risk areas (esophagus/rectum) where neoadjuvant chemoradiation is used, the incidence of anastomotic leaks remains unacceptably high (similar to 10%) even when performed by specialist surgeons in high volume centers. The aims of this study were to test the hypothesis that anastomotic leakage develops when pathogens colonizing anastomotic sites become in vivo transformed to express a tissue destroying phenotype. We developed a novel model of anastomotic leak in which rats were exposed to pre-operative radiation as in cancer surgery, underwent distal colon resection and then were intestinally inoculated with Pseudomonas aeruginosa, a common colonizer of the radiated intestine. Results demonstrated that intestinal tissues exposed to preoperative radiation developed a significant incidence of anastomotic leak (>60%; p<0.01) when colonized by P. aeruginosa compared to radiated tissues alone (0%). Phenotype analysis comparing the original inoculating strain (MPAO1-termed P1) and the strain retrieved from leaking anastomotic tissues (termed P2) demonstrated that P2 was altered in pyocyanin production and displayed enhanced collagenase activity, high swarming motility, and a destructive phenotype against cultured intestinal epithelial cells (i.e. apoptosis, barrier function, cytolysis). Comparative genotype analysis between P1 and P2 revealed a single nucleotide polymorphism (SNP) mutation in the mexT gene that led to a stop codon resulting in a non-functional truncated protein. Replacement of the mutated mexT gene in P2 with mexT from the original parental strain P1 led to reversion of P2 to the P1 phenotype. No spontaneous transformation was detected during 20 passages in TSB media. Use of a novel virulence suppressing compound PEG/Pi prevented P. aeruginosa transformation to the tissue destructive phenotype and prevented anastomotic leak in rats. This work demonstrates that in vivo transformation of microbial pathogens to a tissue destroying phenotype may have important implications in the pathogenesis of anastomotic leak.	[Olivas, Andrea D.; Shogan, Benjamin D.; Valuckaite, Vesta; Zaborin, Alexander; Belogortseva, Natalya; An, Gary; Zaborina, Olga; Alverdy, John C.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Musch, Mark] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Meyer, Folker; Trimble, William L.; Gilbert, Jack] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Valuckaite, Vesta; Alverdy, John C.] Bioengn Inst Adv Surg & Endoscopy, Chicago, IL USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Olivas, AD (corresponding author), Univ Chicago, Dept Surg, Chicago, IL 60637 USA.	jalverdy@surgery.bsd.uchicago.edu	Zaborina, Olga/AAQ-6977-2021; Gilbert, Jack/AAF-3270-2019	Meyer, Folker/0000-0003-1112-2284; An, Gary/0000-0003-4549-9004; Trimble, William L./0000-0001-7029-2676	National Institute of Health [RO1-GM062344-12]; Digestive Disease Research Core Center of the University of Chicago [DK42086]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062344] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Research Core Center of the University of Chicago(University of Chicago); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institute of Health (RO1-GM062344-12), Digestive Disease Research Core Center of the University of Chicago (DK42086) and the United States Department of Energy under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2011, AM J SURG, V202, P259, DOI 10.1016/j.amjsurg.2010.11.014; Alanezi Khaled, 2004, Ann Thorac Cardiovasc Surg, V10, P71; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Blewett C J, 2001, Ann Thorac Cardiovasc Surg, V7, P75; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Choi Dong Hyun, 2010, J Korean Soc Coloproctol, V26, P265, DOI 10.3393/jksc.2010.26.4.265; COHEN SR, 1985, SURGERY, V97, P443; COHN I, 1955, ANN SURG, V141, P707, DOI 10.1097/00000658-195514150-00016; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Jin YX, 2011, J BACTERIOL, V193, P399, DOI 10.1128/JB.01079-10; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Kohler T, 1999, J BACTERIOL, V181, P6300; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Lin JK, 2011, J GASTROINTEST SURG, V15, P2251, DOI 10.1007/s11605-011-1721-5; Maseda H, 2000, FEMS MICROBIOL LETT, V192, P107, DOI 10.1016/S0378-1097(00)00419-5; Maseda H, 2010, FEMS MICROBIOL LETT, V311, P36, DOI 10.1111/j.1574-6968.2010.02063.x; Merkel S, 2001, Colorectal Dis, V3, P154, DOI 10.1046/j.1463-1318.2001.00232.x; Ricciardi R, 2009, ARCH SURG-CHICAGO, V144, P407, DOI 10.1001/archsurg.2009.43; Romanowski K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-212; Roos D, 2011, BRIT J SURG, V98, P1365, DOI 10.1002/bjs.7631; Schardey HM, 1997, ANN SURG, V225, P172, DOI 10.1097/00000658-199702000-00005; SCHARDEY HM, 1994, ANTIMICROB AGENTS CH, V38, P2564, DOI 10.1128/AAC.38.11.2564; Seal JB, 2010, SURGERY, V147, P757, DOI 10.1016/j.surg.2010.03.008; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tian ZX, 2009, MICROB PATHOGENESIS, V47, P237, DOI 10.1016/j.micpath.2009.08.003; Tian ZX, 2009, NUCLEIC ACIDS RES, V37, P7546, DOI 10.1093/nar/gkp828; Tremblay J, 2008, J BASIC MICROB, V48, P509, DOI 10.1002/jobm.200800030; Valuckaite V, 2009, AM J PHYSIOL-GASTR L, V297, pG1041, DOI 10.1152/ajpgi.00328.2009; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Zaborin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034883; Zaborin A, 2009, P NATL ACAD SCI USA, V106, P6327, DOI 10.1073/pnas.0813199106; Zaborina Olga, 2006, Ann Clin Microbiol Antimicrob, V5, P14, DOI 10.1186/1476-0711-5-14; Zaborina O, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030035; Zaoui C, 2012, MOL MICROBIOL, V83, P536, DOI 10.1111/j.1365-2958.2011.07947.x	35	116	119	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44326	10.1371/journal.pone.0044326	http://dx.doi.org/10.1371/journal.pone.0044326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952955	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300081
J	Bouzat, S; Levi, V; Bruno, L				Bouzat, Sebastian; Levi, Valeria; Bruno, Luciana			Transport Properties of Melanosomes along Microtubules Interpreted by a Tug-of-War Model with Loose Mechanical Coupling	PLOS ONE			English	Article							MOLECULAR MOTORS; XENOPUS MELANOPHORES; CYTOPLASMIC DYNEIN; CARGO TRANSPORT; INTRACELLULAR-TRANSPORT; BIDIRECTIONAL TRANSPORT; ORGANELLE TRANSPORT; AXONAL-TRANSPORT; KINESIN MOTORS; IN-VITRO	In this work, we explored theoretically the transport of organelles driven along microtubules by molecular motors of opposed polarities using a stochastic model that considers a Langevin dynamics for the cargo, independent cargo-motor linkers and stepping motion for the motors. It has been recently proposed that the stiffness of the motor plays an important role when multiple motors collectively transport a cargo. Therefore, we considered in our model the recently reported values for the stiffness of the cargo-motor linker determined in living cells (similar to 0.01 pN/nm, [1]) which is significantly lower than the motor stiffness obtained in in vitro assays and used in previous studies. Our model could reproduce the multimodal velocity distributions and typical trajectory characteristics including the properties of the reversions in the overall direction of motion observed during melanosome transport along microtubules in Xenopus laevis melanophores. Moreover, we explored the contribution of the different motility states of the cargo-motor system to the different modes of the velocity distributions and could identify the microscopic mechanisms of transport leading to trajectories compatible with those observed in living cells. Finally, by changing the attachment and detachment rates, the model could reproduce the different velocity distributions observed during melanosome transport along microtubules in Xenopus laevis melanophores stimulated for aggregation and dispersion. Our analysis suggests that active tug-of-war processes with loose mechanical coupling can account for several aspects of cargo transport along microtubules in living cells.	[Bouzat, Sebastian] Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Levi, Valeria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, Argentina; [Bruno, Luciana] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, Argentina	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; University of Buenos Aires; University of Buenos Aires	Bouzat, S (corresponding author), Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	lbruno@df.uba.ar		Levi, Valeria/0000-0002-1666-4675	ANPCyT -Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2008-1104]; CONICET - Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220080100076]; CNEA -Comision Nacional de Energia Atomica	ANPCyT -Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET - Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CNEA -Comision Nacional de Energia Atomica	This research was supported by ANPCyT -Agencia Nacional de Promocion Cientifica y Tecnologica (under grant number PICT 2008-1104), CONICET - Consejo Nacional de Investigaciones Cientificas y Tecnicas (under grant number PIP 11220080100076) and CNEA -Comision Nacional de Energia Atomica, all Argentinean agencies. The authors are members of CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2011, P NATL ACAD SCI USA, V108, pE535, DOI 10.1073/pnas.1104298108; Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Bouzat S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066010; Bouzat S, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046009; Bruno L, 2008, CELL BIOCHEM BIOPHYS, V52, P191, DOI 10.1007/s12013-008-9034-3; Bruno L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018332; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Courty S, 2006, NANO LETT, V6, P1491, DOI 10.1021/nl060921t; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Driver JW, PHYS CHEM CHEM PHYS, V12; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; GUERIN T, 2010, THEORY CURRENT OPINI, V22, P14, DOI DOI 10.1016/J.CEB.2009.12.012; Guo SL, 2008, PHOTOCHEM PHOTOBIOL, V84, P671, DOI 10.1111/j.1751-1097.2008.00331.x; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Higuchi H, 1997, P NATL ACAD SCI USA, V94, P4395, DOI 10.1073/pnas.94.9.4395; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Kunwar A, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016012; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Muller MJI, 2010, BIOPHYS J, V98, P2610, DOI 10.1016/j.bpj.2010.02.037; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; Nilsson H, 1997, CELL MOTIL CYTOSKEL, V38, P397, DOI 10.1002/(SICI)1097-0169(1997)38:4<397::AID-CM9>3.3.CO;2-5; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; ROZDZIAL MM, 1986, CELL, V47, P1061, DOI 10.1016/0092-8674(86)90821-4; SAMMAK PJ, 1992, J CELL BIOL, V117, P57, DOI 10.1083/jcb.117.1.57; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Sims PA, 2009, CHEMPHYSCHEM, V10, P1511, DOI 10.1002/cphc.200900113; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Zhang YX, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011909	48	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43599	10.1371/journal.pone.0043599	http://dx.doi.org/10.1371/journal.pone.0043599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952716	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206500014
J	Abeyasinghe, RR; Galappaththy, GNL; Gueye, CS; Kahn, JG; Feachem, RGA				Abeyasinghe, Rabindra R.; Galappaththy, Gawrie N. L.; Gueye, Cara Smith; Kahn, James G.; Feachem, Richard G. A.			Malaria Control and Elimination in Sri Lanka: Documenting Progress and Success Factors in a Conflict Setting	PLOS ONE			English	Article							PLASMODIUM-VIVAX; CULICIFACIES; TRANSMISSION; SUBPICTUS; SEEKING; COSTS	Background: Sri Lanka has a long history of malaria control, and over the past decade has had dramatic declines in cases amid a national conflict. A case study of Sri Lanka's malaria programme was conducted to characterize the programme and explain recent progress. Methods: The case study employed qualitative and quantitative methods. Data were collected from published and grey literature, district-level and national records, and thirty-three key informant interviews. Expenditures in two districts for two years - 2004 and 2009 - were compiled. Findings: Malaria incidence in Sri Lanka has declined by 99.9% since 1999. During this time, there were increases in the proportion of malaria infections due to Plasmodium vivax, and the proportion of infections occurring in adult males. Indoor residual spraying and distribution of long-lasting insecticide-treated nets have likely contributed to the low transmission. Entomological surveillance was maintained. A strong passive case detection system captures infections and active case detection was introduced. When comparing conflict and non-conflict districts, vector control and surveillance measures were maintained in conflict areas, often with higher coverage reported in conflict districts. One of two districts in the study reported a 48% decline in malaria programme expenditure per person at risk from 2004 to 2009. The other district had stable malaria spending. Conclusions/Significance: Malaria is now at low levels in Sri Lanka - 124 indigenous cases were found in 2011. The majority of infections occur in adult males and are due to P. vivax. Evidence-driven policy and an ability to adapt to new circumstances contributed to this decline. Malaria interventions were maintained in the conflict districts despite an ongoing war. Sri Lanka has set a goal of eliminating malaria by the end of 2014. Early identification and treatment of infections, especially imported ones, together with effective surveillance and response, will be critical to achieving this goal.	[Abeyasinghe, Rabindra R.] WHO, Country Off, Port Moresby, Natl Capital Di, Papua N Guinea; [Galappaththy, Gawrie N. L.] Minist Hlth, Colombo, Western Provinc, Sri Lanka; [Gueye, Cara Smith; Feachem, Richard G. A.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Kahn, James G.] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA USA	World Health Organization; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Abeyasinghe, RR (corresponding author), WHO, Country Off, Port Moresby, Natl Capital Di, Papua N Guinea.	smithc1@globalhealth.ucsf.edu			Bill & Melinda Gates Foundation; World Health Organization; ExxonMobil; Australian Agency for International Development (AusAID); Anti-Malaria Campaign, Ministry of Health, Sri Lanka	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); World Health Organization(World Health Organization); ExxonMobil(Exxon Mobil Corporation); Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Anti-Malaria Campaign, Ministry of Health, Sri Lanka	This case study was funded by a grant from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: RRA is currently supported by the World Health Organization. During the period of case study data collection and write up, RRA was supported by the Anti-Malaria Campaign, Ministry of Health, Sri Lanka. GNLG is supported by the Anti-Malaria Campaign, Ministry of Health, Sri Lanka. GNLG represents Sri Lanka in the Asia Pacific Malaria Elimination Network (APMEN) and RRA chaired the APMEN Advisory Board. RRA is a member of the Malaria Elimination Group. RGAF is the Director of the UCSF Global Health Group, chair of the Malaria Elimination Group and is also the Network Chair of APMEN. CSG is Program Coordinator at the UCSF Global Health Group and provides assistance to the APMEN Joint-Secretariat. The Global Health Group provides support to eliminating countries, such as Sri Lanka, and is funded by the Bill & Melinda Gates Foundation. The Global Health Group also received funding from ExxonMobil during the period of this study. APMEN is funded through a grant from the Australian Agency for International Development (AusAID). JGK is a professor of health policy at UCSF. This case study is a component of a collaboration between the UCSF Global Health Group and the WHO Global Malaria Programme to document country experience with malaria elimination.	Abeyasinghe RR, 2010, MONITORING IN PRESS; Amerasinghe PH, 1999, MED VET ENTOMOL, V13, P124, DOI 10.1046/j.1365-2915.1999.00160.x; AMERASINGHE PH, 1992, J MED ENTOMOL, V29, P577, DOI 10.1093/jmedent/29.4.577; [Anonymous], 2009, WORLD MAL REP 2009; Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Barik TK, 2009, ACTA TROP, V109, P87, DOI 10.1016/j.actatropica.2008.09.017; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Bouffard S., 2006, J S ASIAN DEV, V1, P151; Briet OJT, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-8; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-77; Briet OJT, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-42; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; COHN EJ, 1973, AM J PUBLIC HEALTH, V63, P1086, DOI 10.2105/AJPH.63.12.1086; Colombo Page News Desk, FERR SERV INT SRI LA; de Silva MWA, 2001, SOC SCI MED, V53, P1363, DOI 10.1016/S0277-9536(00)00425-1; Dunn CL, 1936, POSTGRAD MED J, V12, P483; Dutt AK, 2010, ADV ASIAN HUM-ENV RE, V1, P29, DOI 10.1007/978-90-481-3358-1_2; Feachem RGA, 2009, SHRINKING MALARIA MA; Feachem RGA, 2010, LANCET, V376, P1517, DOI 10.1016/S0140-6736(10)61500-0; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Fernando SD, 2008, T ROY SOC TROP MED H, V102, P1081, DOI 10.1016/j.trstmh.2008.06.007; Fernando SD, 2009, AM J TROP MED HYG, V81, P763, DOI 10.4269/ajtmh.2009.09-0042; Fernando V.N, 2020, INT J SCI RES, V9, P1310; Galappaththy GNL, 1999, J COLL COMMUNITY PHY, V4; Gill CA, 1936, ANN TROP MED PARASIT, V91, P428; GREEN CA, 1980, J TROP MED HYG, V83, P75; GUNARATNA L F, 1956, Bull World Health Organ, V15, P791; *IMF, WORLD EC OUTL DAT; IMF, 2009, IMF REPR EXCH RAT SE; International Crisis Group, 2011, 124 INT CRIS GROUP; Irin, SRI LANK OP TOUR BUS; KARUNARATNE W A, 1959, J Trop Med Hyg, V62, P79; Konradsen F, 1999, B WORLD HEALTH ORGAN, V77, P301; Konradsen F, 1997, T ROY SOC TROP MED H, V91, P127, DOI 10.1016/S0035-9203(97)90194-2; Martins JS, 2009, CONFLICT HLTH, V3, P1; Matthys B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-217; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; MENDIS C, 1990, AM J TROP MED HYG, V42, P298, DOI 10.4269/ajtmh.1990.42.298; Mills A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S11; Ministry of Health Anti-Malaria Campaign, 1998, CENTR BANK ANN REP; Najera J, 2010, MALARIA EPIDEMICS DE; Office of the Director General of Health Services, 2008, 01142008 OFF DIR GEN; Pinikahana Jayaratne, 1993, Indian Journal of Malariology, V30, P51; Rajakaruna RS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-25; RAJENDRAM S, 1951, Indian J Malariol, V5, P1; Ramos WM, 2010, BRAZ J INFECT DIS, V14, P410, DOI 10.1590/S1413-86702010000400017; RBM-MERG, 2009, RBM TECHN PAP SER; Reilley B, 2002, TROP MED INT HEALTH, V7, P744, DOI 10.1046/j.1365-3156.2002.00919.x; Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2; ROJAS W, 1992, PARASITOL TODAY, V8, P141, DOI 10.1016/0169-4758(92)90287-C; Ruberu PS, 1977, EC JUSTIFICATI UNPUB; Rutherford GW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-447; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Seo SNN, 2005, ENVIRON DEV ECON, V10, P581, DOI 10.1017/S1355770X05002044; Sri Lanka Ministry of Defense, SPAT TEMP DISTR TERR, P1; Sri Lanka Ministry of Health Anti-Malaria Campaign, 2002, ADM REP ANT CAMP 200; Sri Lanka Ministry of Health Anti-Malaria Campaign, 2008, STRAT PLAN PHAS EL M; Tatarsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023832; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; The Global Health Group and the Malaria Atlas Project, 2011, ATL AS PAC MAL EL NE; The Henry J. Kaiser Family Foundation US Global Health Policy News, GLOB FUND CANC ROUND; The World Health Organization DoME, 1961, WHOMAL289 DOME, P289; van den Berg H, 2007, B WORLD HEALTH ORGAN, V85, P561, DOI 10.2471/BLT.06.035600; van der Hoek W, 2003, INT J EPIDEMIOL, V32, P280, DOI 10.1093/ije/dyg055; van der Hoek W, 1997, ANN TROP MED PARASIT, V91, P945, DOI 10.1080/00034989760347; VANDENBERGH H, 2006, EVALUATION INTEGRATE; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2004, WHOCDSCPEPVC200410; WHO, 2010, GUID TREATM MAL, V2nd; WHOLIS, GEN WHO LIB DAT; WIJESUNDERA MD, 1988, PARASITOL TODAY, V4, P147, DOI 10.1016/0169-4758(88)90193-7; World Bank, 2002, IMPL COMPL REP IDA 2; World Health Organization, 2007, MAL EL FIELD MAN LOW; World Health Organization, 1993, GLOB STRAT MAL CONTR; Yangzom T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-9	78	88	90	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43162	10.1371/journal.pone.0043162	http://dx.doi.org/10.1371/journal.pone.0043162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952642	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000020
J	Carlsen, KCL; Roll, S; Carlsen, KH; Mowinckel, P; Wijga, AH; Brunekreef, B; Torrent, M; Roberts, G; Arshad, SH; Kull, I; Kramer, U; von Berg, A; Eller, E; Host, A; Kuehni, C; Spycher, B; Sunyer, J; Chen, CM; Reich, A; Asarnoj, A; Puig, C; Herbarth, O; John, JMM; Van Steen, K; Willich, SN; Wahn, U; Lau, S; Keil, T				Carlsen, Karin C. Lodrup; Roll, Stephanie; Carlsen, Kai-Hakon; Mowinckel, Petter; Wijga, Alet H.; Brunekreef, Bert; Torrent, Maties; Roberts, Graham; Arshad, S. Hasan; Kull, Inger; Kraemer, Ursula; von Berg, Andrea; Eller, Esben; Host, Arne; Kuehni, Claudia; Spycher, Ben; Sunyer, Jordi; Chen, Chih-Mei; Reich, Andreas; Asarnoj, Anna; Puig, Carmen; Herbarth, Olf; John, Jestinah M. Mahachie; Van Steen, Kristel; Willich, Stefan N.; Wahn, Ulrich; Lau, Susanne; Keil, Thomas		Birth Cohorts Working Grp	Does Pet Ownership in Infancy Lead to Asthma or Allergy at School Age? Pooled Analysis of Individual Participant Data from 11 European Birth Cohorts	PLOS ONE			English	Article							DOG OWNERSHIP; CAT ALLERGEN; PROPENSITY SCORE; ATOPIC DISEASES; EARLY EXPOSURE; SENSITIZATION; CHILDHOOD; RISK; SYMPTOMS; COMMUNITY	Objective: To examine the associations between pet keeping in early childhood and asthma and allergies in children aged 6-10 years. Design: Pooled analysis of individual participant data of 11 prospective European birth cohorts that recruited a total of over 22,000 children in the 1990s. Exposure definition: Ownership of only cats, dogs, birds, rodents, or cats/dogs combined during the first 2 years of life. Outcome definition: Current asthma (primary outcome), allergic asthma, allergic rhinitis and allergic sensitization during 610 years of age. Data synthesis: Three-step approach: (i) Common definition of outcome and exposure variables across cohorts; (ii) calculation of adjusted effect estimates for each cohort; (iii) pooling of effect estimates by using random effects meta-analysis models. Results: We found no association between furry and feathered pet keeping early in life and asthma in school age. For example, the odds ratio for asthma comparing cat ownership with "no pets" (10 studies, 11489 participants) was 1.00 (95% confidence interval 0.78 to 1.28) (I 2 = 9%; p = 0.36). The odds ratio for asthma comparing dog ownership with "no pets" (9 studies, 11433 participants) was 0.77 (0.58 to 1.03) (I-2 = 0%, p = 0.89). Owning both cat(s) and dog(s) compared to "no pets" resulted in an odds ratio of 1.04 (0.59 to 1.84) (I-2 = 33%, p = 0.18). Similarly, for allergic asthma and for allergic rhinitis we did not find associations regarding any type of pet ownership early in life. However, we found some evidence for an association between ownership of furry pets during the first 2 years of life and reduced likelihood of becoming sensitized to aero-allergens. Conclusions: Pet ownership in early life did not appear to either increase or reduce the risk of asthma or allergic rhinitis symptoms in children aged 6-10. Advice from health care practitioners to avoid or to specifically acquire pets for primary prevention of asthma or allergic rhinitis in children should not be given.	[Carlsen, Karin C. Lodrup; Mowinckel, Petter] Oslo Univ Hosp, Dept Paediat, Ulleval, Norway; [Carlsen, Karin C. Lodrup; Carlsen, Kai-Hakon] Univ Oslo, Fac Med, Oslo, Norway; [Roll, Stephanie; Reich, Andreas; Willich, Stefan N.; Keil, Thomas] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Carlsen, Kai-Hakon] Oslo Univ Hosp, Rikshosp, Oslo, Norway; [Wijga, Alet H.] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands; [Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Brunekreef, Bert] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Torrent, Maties] Ib Salut Menorca Hlth Area, Menorca, Spain; [Torrent, Maties] Fdn Caubet Cimera, Menorca, Spain; [Roberts, Graham; Arshad, S. Hasan] Univ Southampton, David Hide Asthma & Allergy Res Ctr, Southampton, Hants, England; [Kull, Inger; Asarnoj, Anna] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Kraemer, Ursula] Univ Dusseldorf, Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany; [von Berg, Andrea] Marien Hosp Wesel, Dept Pediat, Wesel, Germany; [Eller, Esben] Odense Univ Hosp, Allergyctr, Dept Dermatol, DK-5000 Odense, Denmark; [Host, Arne] Odense Univ, Dept Pediat, Odense, Denmark; [Kuehni, Claudia; Spycher, Ben] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Sunyer, Jordi] Environm Epidemiol Res Ctr, Barcelona, Spain; [Sunyer, Jordi] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Chen, Chih-Mei] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Asarnoj, Anna] Karolinska Univ Hosp, Astrid Lindgrens Childrens Hosp, Solna, Sweden; [Puig, Carmen] Inst Municipal Invest Med Hosp Mar, Unitat Recerca Infancia Entorn, Barcelona, Spain; [Herbarth, Olf] Univ Leipzig, Fac Med, Leipzig, Germany; [Herbarth, Olf] UFZ Ctr Environm Res Leipzig, Dept Human Exposure Res & Epidemiol, Leipzig, Germany; [John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Ghent, Dept Otorhinolaryngol, B-9000 Ghent, Belgium; [John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, Inst Montefiore, Syst & Modeling Unit, B-4000 Liege, Belgium; [John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, GIGA R, Liege, Belgium; [Wahn, Ulrich; Lau, Susanne] Charite, Dept Paediat Pneumol & Immunol, D-13353 Berlin, Germany	University of Oslo; University of Oslo; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Oslo; National Hospital Norway; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University; Utrecht University Medical Center; Atencio Primaria de Menorca; Atencio Primaria de Menorca; University of Southampton; Karolinska Institutet; Heinrich Heine University Dusseldorf; St. Marien Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Bern; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Karolinska Institutet; Karolinska University Hospital; Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Ghent University; University of Liege; University of Liege; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Carlsen, KCL (corresponding author), Oslo Univ Hosp, Dept Paediat, Ulleval, Norway.	stephanie.roll@charite.de	Spycher, Ben D/B-3308-2008; Porta, Daniela/J-9042-2016; Asarnoj, Anna/ABC-4112-2020; Custovic, Adnan/A-2435-2012; Sunyer, Jordi/G-6909-2014; Bindslev-Jensen, Carsten/H-1877-2011; Forastiere, Francesco/J-9067-2016; Reich, Andreas/B-1204-2016; Heinrich, Joachim/N-1720-2013	Spycher, Ben D/0000-0002-1430-5695; Porta, Daniela/0000-0002-3431-2729; Custovic, Adnan/0000-0001-5218-7071; Sunyer, Jordi/0000-0002-2602-4110; Bindslev-Jensen, Carsten/0000-0002-8940-038X; Forastiere, Francesco/0000-0002-9162-5684; Reich, Andreas/0000-0002-3729-0772; Kull, Inger/0000-0001-6096-3771; Roberts, Graham/0000-0003-2252-1248; Alm, Bernt/0000-0002-3557-2995; Roll, Stephanie/0000-0003-1191-3289; brunekreef, bert/0000-0001-9908-0060; Heinrich, Joachim/0000-0002-9620-1629; Van Steen, Kristel/0000-0001-9868-5033; Alm, Johan/0000-0002-9062-4479; Kuehni, Claudia E./0000-0001-8957-2002; Asarnoj, Anna/0000-0002-0797-2369; Thijs, Carel/0000-0001-6646-5458	Global Allergy and Asthma European Network (GA2LEN) under 6th framework programme of the European Commission [FOOD-CT-2004-506378]	Global Allergy and Asthma European Network (GA2LEN) under 6th framework programme of the European Commission	This collaborative project was initiated, supported and funded by the Global Allergy and Asthma European Network (GA2LEN; www.ga2len.net) under the 6th framework programme of the European Commission (project no. FOOD-CT-2004-506378). Sources of funding of the individual birth cohort studies are described in their publications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULRAZZAQ YM, 1995, J ASTHMA, V32, P117, DOI 10.3109/02770909509083232; Al-Mousawi MSH, 2004, J ALLERGY CLIN IMMUN, V114, P1389, DOI 10.1016/j.jaci.2004.09.005; Almqvist C, 2003, CLIN EXP ALLERGY, V33, P1190, DOI 10.1046/j.1365-2222.2003.01764.x; Anyo G, 2002, CLIN EXP ALLERGY, V32, P361, DOI 10.1046/j.1365-2222.2002.01254.x; Apelberg BJ, 2001, J ALLERGY CLIN IMMUN, V107, P455, DOI 10.1067/mai.2001.113240; Arif AA, 2004, J PAEDIATR CHILD H, V40, P189, DOI 10.1111/j.1440-1754.2004.00335.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bener A, 2004, Eur Ann Allergy Clin Immunol, V36, P306; Bornehag CG, 2003, ALLERGY, V58, P939, DOI 10.1034/j.1398-9995.2003.00050.x; Braback L, 2001, PEDIAT ALLERG IMM-UK, V12, P4, DOI 10.1034/j.1399-3038.2001.012001004.x; BRUNEKREEF B, 1992, INT J EPIDEMIOL, V21, P338, DOI 10.1093/ije/21.2.338; Brussee JE, 2005, J ALLERGY CLIN IMMUN, V115, P946, DOI 10.1016/j.jaci.2005.02.035; Campo P, 2006, J ALLERGY CLIN IMMUN, V118, P1271, DOI 10.1016/j.jaci.2006.08.008; Carlsen KCL, 2006, ALLERGY, V61, P454, DOI 10.1111/j.1398-9995.2005.00938.x; Celedon JC, 2002, LANCET, V360, P781, DOI 10.1016/S0140-6736(02)09906-3; Chen CM, 2008, EUR RESPIR J, V31, P963, DOI 10.1183/09031936.00092807; Chen CM, 2007, J ALLERGY CLIN IMMUN, V119, P1148, DOI 10.1016/j.jaci.2007.02.017; Custovic A, 2003, J ALLERGY CLIN IMMUN, V111, P402, DOI 10.1067/mai.2003.55; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eller E, 2008, ALLERGY, V63, P1491, DOI 10.1111/j.1398-9995.2008.01790.x; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Jaakkola JJK, 2002, J ALLERGY CLIN IMMUN, V109, P784, DOI 10.1067/mai.2002.123870; Keil T, 2006, ALLERGY, V61, P1104, DOI 10.1111/j.1398-9995.2006.01167.x; Keil T, 2006, ALLERGY, V61, P221, DOI 10.1111/j.1398-9995.2006.00989.x; Lau S, 2005, ALLERGY, V60, P766, DOI 10.1111/j.1398-9995.2005.00781.x; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Litonjua AA, 2002, J ALLERGY CLIN IMMUN, V110, P736, DOI 10.1067/mai.2002.128948; McConnell R, 2002, EPIDEMIOLOGY, V13, P288, DOI 10.1097/00001648-200205000-00009; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Perzanowski MS, 2002, AM J RESP CRIT CARE, V166, P696, DOI 10.1164/rccm.2201035; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sandin A, 2004, PEDIATR ALLERGY IMMU, V15, P316, DOI 10.1111/j.1399-3038.2004.00166.x; Simpson A, 2005, CURR ALLERGY ASTHM R, V5, P212, DOI 10.1007/s11882-005-0040-x; Svanes C, 2008, INDOOR AIR, V18, P84, DOI 10.1111/j.1600-0668.2008.00523.x; Svanes C, 2003, J ALLERGY CLIN IMMUN, V112, P289, DOI 10.1067/mai.2003.1596; Svanes C, 2006, J ALLERGY CLIN IMMUN, V118, P691, DOI 10.1016/j.jaci.2006.06.017; Takkouche B, 2008, ALLERGY, V63, P857, DOI 10.1111/j.1398-9995.2008.01732.x; Wegienka G, 2011, CLIN EXP ALLERGY, V41, P979, DOI 10.1111/j.1365-2222.2011.03747.x; Woodcock A, 2001, J ALLERGY CLIN IMMUN, V108, P463, DOI 10.1067/mai.2001.116859	42	155	157	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43214	10.1371/journal.pone.0043214	http://dx.doi.org/10.1371/journal.pone.0043214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952649	gold, Green Accepted, Green Published			2022-12-27	WOS:000308206000024
J	Flores-Martin, J; Rena, V; Marquez, S; Panzetta-Dutari, GM; Genti-Raimondi, S				Flores-Martin, Jesica; Rena, Viviana; Marquez, Sebastian; Panzetta-Dutari, Graciela M.; Genti-Raimondi, Susana			StarD7 Knockdown Modulates ABCG2 Expression, Cell Migration, Proliferation, and Differentiation of Human Choriocarcinoma JEG-3 Cells	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; STEM-LIKE CELLS; GENE-EXPRESSION; TROPHOBLAST DIFFERENTIATION; LIPID TRANSPORT; PHOSPHATIDYLCHOLINE; IDENTIFICATION; BCRP/ABCG2; PLAYS; BEWO	Background: StAR-related lipid transfer domain containing 7 (StarD7) is a member of the START-domain protein family whose function still remains unclear. Our data from an explorative microarray assay performed with mRNAs from StarD7 siRNA-transfected JEG-3 cells indicated that ABCG2 (ATP-binding cassette sub-family G member 2) was one of the most abundantly downregulated mRNAs. Methodology/Principal Findings: Here, we have confirmed that knocking down StarD7 mRNA lead to a decrease in the xenobiotic/lipid transporter ABCG2 at both the mRNA and protein levels (-26.4% and -41%, p<0.05, at 48 h of culture, respectively). Also a concomitant reduction in phospholipid synthesis, bromodeoxyuridine (BrdU) uptake and 3 H-thymidine incorporation was detected. Wound healing and transwell assays revealed that JEG-3 cell migration was significantly diminished (p<0.05). Conversely, biochemical differentiation markers such as human chorionic gonadotrophin beta-subunit (beta hCG) protein synthesis and secretion as well as bhCG and syncytin-1 mRNAs were increased approximately 2-fold. In addition, desmoplakin immunostaining suggested that there was a reduction of intercellular desmosomes between adjacent JEG-3 cells after knocking down StarD7. Conclusions/Significance: Altogether these findings provide evidence for a role of StarD7 in cell physiology indicating that StarD7 modulates ABCG2 multidrug transporter level, cell migration, proliferation, and biochemical and morphological differentiation marker expression in a human trophoblast cell model.	[Flores-Martin, Jesica; Rena, Viviana; Marquez, Sebastian; Panzetta-Dutari, Graciela M.; Genti-Raimondi, Susana] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol, Consejo Nacl Invest Cient & Tecn,Dept Bioquim Cli, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Flores-Martin, J (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol, Consejo Nacl Invest Cient & Tecn,Dept Bioquim Cli, RA-5000 Cordoba, Argentina.	sgenti@fcq.unc.edu.ar		Flores Martin, Jesica Belen/0000-0002-1619-399X	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET) [6352, 919]; Agencia Nacional de Promocion Ciencia y Tecnica [FONCYT: PICT 2006/00147]; Ministerio de Ciencia y de la Provincia de Cordoba; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba [SECyT-UNC: 05/C244]	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Ciencia y Tecnica(ANPCyT); Ministerio de Ciencia y de la Provincia de Cordoba; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT))	This work was granted by the Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET: PIP No 6352, PIP No 919), the Agencia Nacional de Promocion Ciencia y Tecnica (FONCYT: PICT 2006/00147), the Ministerio de Ciencia y de la Provincia de Cordoba and the Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyT-UNC: 05/C244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khan A, 2011, PLACENTA, V32, pS90, DOI 10.1016/j.placenta.2010.12.025; Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Angeletti S, 2008, PLACENTA, V29, P396, DOI 10.1016/j.placenta.2008.02.011; Angeletti S, 2004, BIOCHEM BIOPH RES CO, V314, P181, DOI 10.1016/j.bbrc.2003.12.076; Angeletti S, 2012, BBA-BIOMEMBRANES, V1818, P425, DOI 10.1016/j.bbamem.2011.10.024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burleigh DW, 2007, PLACENTA, V28, P383, DOI 10.1016/j.placenta.2006.05.001; Chen Z, 2010, INT J CANCER, V126, P841, DOI 10.1002/ijc.24796; Clark AG, 2003, COLD SPRING HARB SYM, V68, P471; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; COLEMAN RA, 1987, J LIPID RES, V28, P1335; Durand S, 2004, PLACENTA, V25, P37, DOI 10.1016/S0143-4004(03)00214-5; Ee PLR, 2004, MOL CANCER THER, V3, P1577; Evseenko DA, 2007, PLACENTA, V28, pS116, DOI 10.1016/j.placenta.2006.12.003; Evseenko DA, 2006, AM J PHYSIOL-REG I, V290, pR1357, DOI 10.1152/ajpregu.00630.2005; Evseenko DA, 2007, FASEB J, V21, P3592, DOI 10.1096/fj.07-8688com; GUIDO ME, 1990, J NEUROCHEM, V55, P1855, DOI 10.1111/j.1471-4159.1990.tb05768.x; Herzog M, 2010, N-S ARCH PHARMACOL, V383, P1; Higashikuni Y, 2010, ARTERIOSCL THROM VAS, V30, P2128, DOI 10.1161/ATVBAHA.110.211755; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; HSU CD, 1994, AM J OBSTET GYNECOL, V170, P1135, DOI 10.1016/S0002-9378(94)70108-3; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Jelinek DF, 2003, MOL CANCER RES, V1, P346; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; Kharfi A, 2005, CLIN BIOCHEM, V38, P717, DOI 10.1016/j.clinbiochem.2005.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao QC, 2008, PHARM RES-DORDR, V25, P1244, DOI 10.1007/s11095-008-9537-z; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; Ni ZL, 2011, CURR PHARM BIOTECHNO, V12, P674, DOI 10.2174/138920111795164057; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Prouillac C, 2010, DRUG METAB DISPOS, V38, P1623, DOI 10.1124/dmd.110.033571; Quazi F, 2011, ESSAYS BIOCHEM, V50, P265, DOI [10.1042/BSE0500265, 10.1042/bse0500265]; Rena V, 2009, PLACENTA, V30, P876, DOI 10.1016/j.placenta.2009.07.010; Rena V, 2011, MOL ENDOCRINOL, V25, P1364, DOI 10.1210/me.2010-0503; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Singh AT, 2012, REPROD BIOMED ONLINE, V24, P224, DOI 10.1016/j.rbmo.2011.10.012; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tang DZ, 2005, PLANT J, V44, P245, DOI 10.1111/j.1365-313X.2005.02523.x; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; VAITUKAITIS J L, 1976, Journal of Clinical Endocrinology and Metabolism, V42, P1048; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Wang F, 2010, BRIT J CANCER, V103, P567, DOI 10.1038/sj.bjc.6605724; WEISS SJ, 1982, BIOCHEM J, V204, P587, DOI 10.1042/bj2040587; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Woehlecke H, 2003, BIOCHEM J, V376, P489, DOI 10.1042/BJ20030886; Wu MK, 2005, AM J PHYSIOL-GASTR L, V289, pG1067, DOI 10.1152/ajpgi.00194.2005; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595	55	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44152	10.1371/journal.pone.0044152	http://dx.doi.org/10.1371/journal.pone.0044152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952907	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000089
J	Foote, AD; Thomsen, PF; Sveegaard, S; Wahlberg, M; Kielgast, J; Kyhn, LA; Salling, AB; Galatius, A; Orlando, L; Gilbert, MTP				Foote, Andrew D.; Thomsen, Philip Francis; Sveegaard, Signe; Wahlberg, Magnus; Kielgast, Jos; Kyhn, Line A.; Salling, Andreas B.; Galatius, Anders; Orlando, Ludovic; Gilbert, M. Thomas P.			Investigating the Potential Use of Environmental DNA (eDNA) for Genetic Monitoring of Marine Mammals	PLOS ONE			English	Article							ATLANTIC; OCEAN; ACID	The exploitation of non-invasive samples has been widely used in genetic monitoring of terrestrial species. In aquatic ecosystems, non-invasive samples such as feces, shed hair or skin, are less accessible. However, the use of environmental DNA (eDNA) has recently been shown to be an effective tool for genetic monitoring of species presence in freshwater ecosystems. Detecting species in the marine environment using eDNA potentially offers a greater challenge due to the greater dilution, amount of mixing and salinity compared with most freshwater ecosystems. To determine the potential use of eDNA for genetic monitoring we used specific primers that amplify short mitochondrial DNA sequences to detect the presence of a marine mammal, the harbor porpoise, Phocoena phocoena, in a controlled environment and in natural marine locations. The reliability of the genetic detections was investigated by comparing with detections of harbor porpoise echolocation clicks by static acoustic monitoring devices. While we were able to consistently genetically detect the target species under controlled conditions, the results from natural locations were less consistent and detection by eDNA was less successful than acoustic detections. However, at one site we detected long-finned pilot whale, Globicephala melas, a species rarely sighted in the Baltic. Therefore, with optimization aimed towards processing larger volumes of seawater this method has the potential to compliment current visual and acoustic methods of species detection of marine mammals.	[Foote, Andrew D.; Thomsen, Philip Francis; Kielgast, Jos; Salling, Andreas B.; Orlando, Ludovic; Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Sveegaard, Signe; Kyhn, Line A.; Galatius, Anders] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Wahlberg, Magnus] Fjord&Baelt, Kerteminde, Denmark; [Wahlberg, Magnus] Univ So Denmark, Marine Biol Lab, Kerteminde, Denmark	University of Copenhagen; Aarhus University; University of Southern Denmark	Foote, AD (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	footead@gmail.com	Galatius, Anders/J-4755-2013; Galatius, Anders/AAM-9028-2020; Thomsen, Philip Francis/AAE-9354-2019; sveegaard, signe/AAZ-7529-2021; Gilbert, Marcus TP/A-8936-2013; Sveegaard, Signe/K-2938-2013; Orlando, Ludovic/A-8932-2013; Galatius, Anders/AGG-7831-2022; Kyhn, Line Anker/AAY-9923-2021	Galatius, Anders/0000-0003-1237-2066; Thomsen, Philip Francis/0000-0002-9867-4366; Gilbert, Marcus TP/0000-0002-5805-7195; Sveegaard, Signe/0000-0002-8893-9842; Orlando, Ludovic/0000-0003-3936-1850; Foote, Andrew/0000-0001-7384-1634; Kyhn, Line/0000-0002-0926-6812	Marie Curie Intra-European Fellowship [272385]; EU [293845]	Marie Curie Intra-European Fellowship(European Commission); EU(European Commission)	A.D.F. was funded by a Marie Curie Intra-European Fellowship no. 272385. L.O. was supported by a EU Marie Curie Career Integration Grant (293845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Arnason U, 2004, GENE, V333, P27, DOI 10.1016/j.gene.2004.02.010; Bailey H, 2010, AQUAT CONSERV, V20, P150, DOI 10.1002/aqc.1060; Carstensen J, 2006, MAR ECOL PROG SER, V321, P295, DOI 10.3354/meps321295; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Frere CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012299; Gillett RM, 2010, MAR MAMMAL SCI, V26, P917, DOI 10.1111/j.1748-7692.2010.00380.x; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Gross M, 2012, CURR BIOL, V22, pR73, DOI 10.1016/j.cub.2012.01.036; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hofreiter M, 2003, CURR BIOL, V13, pR693, DOI 10.1016/j.cub.2003.08.039; HOLMHANS.O, 1968, LIMNOL OCEANOGR, V13, P507; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kinze CC, 2003, BIOL WRITINGS FISHER; Kyhn LA, 2008, J MAR BIOL ASSOC UK, V88, P1085, DOI 10.1017/S0025315408000416; Parsons KM, 2003, MAR MAMMAL SCI, V19, P224, DOI 10.1111/j.1748-7692.2003.tb01104.x; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Scheidat M., 2008, Endangered Species Research, V5, P215, DOI 10.3354/esr00161; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Thomsen PF, 2012, PLOS ONE; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verfuss UK, 2007, J MAR BIOL ASSOC UK, V87, P165, DOI 10.1017/S0025315407054938; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	30	209	226	9	257	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e41781	10.1371/journal.pone.0041781	http://dx.doi.org/10.1371/journal.pone.0041781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952587	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000006
J	Graff, JW; Powers, LS; Dickson, AM; Kim, J; Reisetter, AC; Hassan, IH; Kremens, K; Gross, TJ; Wilson, ME; Monick, MM				Graff, Joel W.; Powers, Linda S.; Dickson, Anne M.; Kim, Jongkwang; Reisetter, Anna C.; Hassan, Ihab H.; Kremens, Karol; Gross, Thomas J.; Wilson, Mary E.; Monick, Martha M.			Cigarette Smoking Decreases Global MicroRNA Expression in Human Alveolar Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; ACTIVATION; INDUCTION; SMOKERS; INFLAMMATION; POLARIZATION; EMPHYSEMA; PROFILES; MODEL	Human alveolar macrophages are critical components of the innate immune system. Cigarette smoking-induced changes in alveolar macrophage gene expression are linked to reduced resistance to pulmonary infections and to the development of emphysema/COPD. We hypothesized that microRNAs (miRNAs) could control, in part, the unique messenger RNA (mRNA) expression profiles found in alveolar macrophages of cigarette smokers. Activation of macrophages with different stimuli in vitro leads to a diverse range of M1 (inflammatory) and M2 (anti-inflammatory) polarized phenotypes that are thought to mimic activated macrophages in distinct tissue environments. Microarray mRNA data indicated that smoking promoted an "inverse" M1 mRNA expression program, defined by decreased expression of M1-induced transcripts and increased expression of M1-repressed transcripts with few changes in M2-regulated transcripts. RT-PCR arrays identified altered expression of many miRNAs in alveolar macrophages of smokers and a decrease in global miRNA abundance. Stratification of human subjects suggested that the magnitude of the global decrease in miRNA abundance was associated with smoking history. We found that many of the miRNAs with reduced expression in alveolar macrophages of smokers were predicted to target mRNAs upregulated in alveolar macrophages of smokers. For example, miR-452 is predicted to target the transcript encoding MMP12, an important effector of smoking-related diseases. Experimental antagonism of miR-452 in differentiated monocytic cells resulted in increased expression of MMP12. The comprehensive mRNA and miRNA expression profiles described here provide insight into gene expression regulation that may underlie the adverse effects cigarette smoking has on alveolar macrophages.	[Graff, Joel W.; Powers, Linda S.; Dickson, Anne M.; Kim, Jongkwang; Reisetter, Anna C.; Hassan, Ihab H.; Kremens, Karol; Gross, Thomas J.; Wilson, Mary E.; Monick, Martha M.] Univ Iowa, Dept Med, Iowa City, IA 52242 USA; [Graff, Joel W.; Wilson, Mary E.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Graff, JW (corresponding author), Univ Iowa, Dept Med, Iowa City, IA 52242 USA.	martha-monick@uiowa.edu	Gross, Thomas/AAO-9404-2021	Gross, Thomas/0000-0001-9617-6606; Kim, Jong K./0000-0001-9290-0820; Wilson, Mary/0000-0001-8680-7275	NIH [R01 HL079901, R21HL109589, R21 AI080801, R01 AI045540]; Department of Veteran's Affairs; National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH [P30 ES005605]; National Center for Research Resources (NCRR), Clinical and Translational Science Awards (CTSA) [UL1RR024979]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079901, R01HL096625, R21HL109589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080801, R01AI045540, R01AI032135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran's Affairs(US Department of Veterans Affairs); National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH; National Center for Research Resources (NCRR), Clinical and Translational Science Awards (CTSA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by NIH R01 HL079901 and NIH R21HL109589 to M.M., NIH R21 AI080801, NIH R01 AI045540 and a Merit Review Award from the Department of Veteran's Affairs to M.W., and CDA-1 award from the Department of Veterans' Affairs to J.G. This publication was also made possible by funding from the National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center, NIEHS/NIH P30 ES005605 and Grant Number UL1RR024979 from the National Center for Research Resources (NCRR), Clinical and Translational Science Awards (CTSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benjamini Y., 2001, 2 STAGED LINEAR STEP; Berenson CS, 2006, J INFECT DIS, V194, P1375, DOI 10.1086/508428; BITTERMAN PB, 1986, J CLIN INVEST, V77, P700, DOI 10.1172/JCI112364; BITTERMAN PB, 1982, J CLIN INVEST, V70, P806, DOI 10.1172/JCI110677; Chen H, 2007, J IMMUNOL, V179, P6097, DOI 10.4049/jimmunol.179.9.6097; D'hulst AI, 2006, EUR RESPIR J, V28, P102, DOI 10.1183/09031936.06.00059305; Dhillon NK, 2009, TOXICOL APPL PHARM, V237, P22, DOI 10.1016/j.taap.2009.02.021; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Gao CJ, 2007, J IMMUNOL, V178, P1870, DOI 10.4049/jimmunol.178.3.1870; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HT, 2008, SURGERY, V144, P182, DOI 10.1016/j.surg.2008.03.007; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; KING TE, 1988, J INFECT DIS, V158, P1309, DOI 10.1093/infdis/158.6.1309; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Modestou MA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-64; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Monick MM, 1998, AM J PHYSIOL-LUNG C, V275, pL389, DOI 10.1152/ajplung.1998.275.2.L389; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Russell REK, 2002, AM J PHYSIOL-LUNG C, V283, pL867, DOI 10.1152/ajplung.00020.2002; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Shapiro SD, 2005, NEW ENGL J MED, V352, P2016, DOI 10.1056/NEJMe058044; Shapiro SD, 2005, AM J RESP CELL MOL, V32, P367, DOI 10.1165/rcmb.F296; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; VENET A, 1985, J CLIN INVEST, V75, P293, DOI 10.1172/JCI111688; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC	65	88	91	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44066	10.1371/journal.pone.0044066	http://dx.doi.org/10.1371/journal.pone.0044066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952876	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206000077
J	Mane, M; Muller, M				Mane, Maria; Mueller, Michael			Temporo-Spectral Imaging of Intrinsic Optical Signals during Hypoxia-Induced Spreading Depression-Like Depolarization	PLOS ONE			English	Article							LIGHT-SCATTERING; SYNAPTIC-TRANSMISSION; EPILEPTIFORM ACTIVITY; SULFHYDRYL OXIDATION; HIPPOCAMPAL SLICES; BRAIN-STEM; INHIBITION; MITOCHONDRIAL; REDUCTION; MEMBRANE	Spreading depression (SD) is characterized by a sustained near-complete depolarization of neurons, a massive depolarization of glia, and a negative deflection of the extracellular DC potential. These electrophysiological signs are accompanied by an intrinsic optical signal (IOS) which arises from changes in light scattering and absorption. Even though the underlying mechanisms are unclear, the IOS serves as non-invasive tool to define the spatiotemporal dynamics of SD in brain slices. Usually the tissue is illuminated by white light, and light reflectance or transmittance is monitored. Using a polychromatic, fast-switchable light source we now performed temporo-spectral recordings of the IOS associated with hypoxia-induced SD-like depolarization (HSD) in rat hippocampal slices kept in an interface recording chamber. Recording full illumination spectra (320-680 nm) yielded distinct reflectance profiles for the different phases of HSD. Early during hypoxia tissue reflectance decreased within almost the entire spectrum due to cell swelling. HSD was accompanied by a reversible reflectance increase being most pronounced at 400 nm and 460 nm. At 440 nm massive porphyrin absorption (Soret band) was detected. Hypotonic solutions, Ca2+-withdrawal and glial poisoning intensified the reflectance increase during HSD, whereas hypertonic solutions dampened it. Replacement of Cl- inverted the reflectance increase. Inducing HSD by cyanide distorted the IOS and reflectance at 340-400 nm increased irreversibly. The pronounced changes at short wavelengths (380 nm, 460 nm) and their cyanide sensitivity suggest that block of mitochondrial metabolism contributes to the IOS during HSD. For stable and reliable IOS recordings during HSD wavelengths of 460-560 nm are recommended.	[Mane, Maria; Mueller, Michael] Univ Gottingen, Abt Neuro & Sinnesphysiol, Zentrum Physiol & Pathophysiol, DFG Res Ctr Mol Physiol Brain CMPB, Gottingen, Germany	German Research Foundation (DFG); University of Gottingen	Mane, M (corresponding author), Univ Gottingen, Abt Neuro & Sinnesphysiol, Zentrum Physiol & Pathophysiol, DFG Res Ctr Mol Physiol Brain CMPB, Gottingen, Germany.	mmuelle7@gwdg.de	Müller, Michael/F-7222-2010	Müller, Michael/0000-0002-5863-1994	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants of the Deutsche Forschungsgemeinschaft to M. Muller (Research Center "Molecular Physiology of the Brain" CMPB, and Cluster of Excellence EXC171, "Microscopy at the Nanometer Range"). The funders (Deutsche Forschungsgemeinschaft) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken PG, 1999, METHODS, V18, P91, DOI 10.1006/meth.1999.0762; Andrew RD, 1999, METHODS, V18, P185, DOI 10.1006/meth.1999.0771; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Bahar S, 2000, J NEUROPHYSIOL, V84, P311; Bailey N.T., 1992, STAT METHODS BIOL; Basarsky TA, 1998, J NEUROSCI, V18, P7189; BURES J, 1956, J NEUROCHEM, V1, P153, DOI 10.1111/j.1471-4159.1956.tb12067.x; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; CHEBABO SR, 1995, BRAIN RES, V695, P203, DOI 10.1016/0006-8993(95)00778-O; CLARKE DD, 1970, BIOCHEM J, V120, P345, DOI 10.1042/bj1200345; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; ECCLES J, 1977, PROC R SOC SER B-BIO, V198, P345, DOI 10.1098/rspb.1977.0102; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Fayuk D, 2002, J NEUROPHYSIOL, V87, P1924, DOI 10.1152/jn.00231.2001; Fischer M, 2009, J NEUROPHYSIOL, V101, P1016, DOI 10.1152/jn.91124.2008; Foster KA, 2005, NEUROSCIENCE, V132, P645, DOI 10.1016/j.neuroscience.2005.01.040; Foster KA, 2006, PROG NEUROBIOL, V79, P136, DOI 10.1016/j.pneurobio.2006.07.001; Fujii F, 2004, BRAIN RES, V999, P29, DOI 10.1016/j.brainres.2003.11.017; Funke F, 2009, J NEUROPHYSIOL, V101, P2395, DOI 10.1152/jn.91260.2008; Gerich FJ, 2006, J NEUROPHYSIOL, V96, P492, DOI 10.1152/jn.01015.2005; Gorji A, 2004, EUR J NEUROSCI, V19, P3371, DOI 10.1111/j.0953-816X.2004.03436.x; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Haglund MM, 2004, EPILEPSIA, V45, P43, DOI 10.1111/j.0013-9580.2004.04010.x; Haglund MM, 1997, NEUROSURG CLIN N AM, V8, P413; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Hepp S, 2008, NEUROSCIENCE, V152, P903, DOI 10.1016/j.neuroscience.2008.01.029; Hepp S, 2005, J NEUROPHYSIOL, V94, P1091, DOI 10.1152/jn.00291.2005; Holthoff K, 1996, J NEUROSCI, V16, P2740, DOI 10.1523/jneurosci.16-08-02740.1996; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Huang R, 1996, J CEREBR BLOOD F MET, V16, P462, DOI 10.1097/00004647-199605000-00012; JOBSIS FF, 1977, J APPL PHYSIOL, V43, P858; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Kawauchi S, 2008, APPL OPTICS, V47, P4164, DOI 10.1364/AO.47.004164; Kohl M, 1998, OPT LETT, V23, P555, DOI 10.1364/OL.23.000555; Kron M, 2011, J NEUROPHYSIOL, V105, P3067, DOI 10.1152/jn.00822.2010; Largo C, 1997, J NEUROPHYSIOL, V78, P295, DOI 10.1152/jn.1997.78.1.295; Largo C, 1996, J NEUROSCI, V16, P1219; LAURITZEN M, 1984, BRAIN, V107, P447, DOI 10.1093/brain/107.2.447; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LIPTON P, 1973, J PHYSIOL-LONDON, V231, P365, DOI 10.1113/jphysiol.1973.sp010238; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MARTINSF.H, 1966, J NEUROPHYSIOL, V29, P715, DOI 10.1152/jn.1966.29.4.715; Maslarova A, 2011, STROKE, V42, P2917, DOI 10.1161/STROKEAHA.111.621581; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1982, SCIENCE, V217, P537, DOI 10.1126/science.7201167; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; Muller M, 2000, NEUROSCIENCE, V97, P33, DOI 10.1016/S0306-4522(00)00025-7; Muller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9; Muller M, 1999, J NEUROPHYSIOL, V82, P1818, DOI 10.1152/jn.1999.82.4.1818; Muller M, 2000, J NEUROPHYSIOL, V83, P735, DOI 10.1152/jn.2000.83.2.735; Risher WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022351; Shkirman S. F., 1999, Journal of Applied Spectroscopy, V66, P68, DOI 10.1007/BF02679221; Sick TJ, 1999, METHODS, V18, P104, DOI 10.1006/meth.1999.0763; SNOW RW, 1983, J NEUROPHYSIOL, V50, P561, DOI 10.1152/jn.1983.50.3.561; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Somjen GG, 2004, IONS BRAIN; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; VANDERKOOI JM, 1976, EUR J BIOCHEM, V64, P381, DOI 10.1111/j.1432-1033.1976.tb10312.x; VANHARREVELD A, 1953, J NEUROPHYSIOL, V16, P352, DOI 10.1152/jn.1953.16.4.352; VANHARREVELD A, 1958, AM J PHYSIOL, V192, P457, DOI 10.1152/ajplegacy.1958.192.3.457; Vasil'ev AS, 2000, J EVOL BIOCHEM PHYS+, V36, P5, DOI 10.1007/BF02890658	65	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43981	10.1371/journal.pone.0043981	http://dx.doi.org/10.1371/journal.pone.0043981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952835	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206000065
J	Marchewka, A; Jednorog, K; Falkiewicz, M; Szeszkowski, W; Grabowska, A; Szatkowska, I				Marchewka, Artur; Jednorog, Katarzyna; Falkiewicz, Marcel; Szeszkowski, Wojciech; Grabowska, Anna; Szatkowska, Iwona			Sex, Lies and fMRI-Gender Differences in Neural Basis of Deception	PLOS ONE			English	Article							PREFRONTAL CORTEX; WORKING-MEMORY; BRAIN ACTIVATION; INHIBITION; CEREBELLUM; CONFLICT; ROLES; TASK	Deception has always been a part of human communication as it helps to promote self-presentation. Although both men and women are equally prone to try to manage their appearance, their strategies, motivation and eagerness may be different. Here, we asked if lying could be influenced by gender on both the behavioral and neural levels. To test whether the hypothesized gender differences in brain activity related to deceptive responses were caused by differential socialization in men and women, we administrated the Gender Identify Inventory probing the participants' subjective social sex role. In an fMRI session, personal information. Only for personal information, we found differences in neural responses during instructed deception in men and women. The women vs. men direct contrast revealed no significant differences in areas of activation, but men showed higher BOLD signal compared to women in the left middle front gyrus (MFG). Moreover, this effect remained unchanged when self-reported psycholoigical gender was controlled for. Thus, ourstudy showed that gender differences in the neural processes engaged during falsifying personal information might be independent from socialization.	[Marchewka, Artur; Jednorog, Katarzyna; Falkiewicz, Marcel; Grabowska, Anna; Szatkowska, Iwona] M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland; [Marchewka, Artur] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Szeszkowski, Wojciech] Warsan Med Univ, Dept Radiol, Warsaw, Poland; [Grabowska, Anna] Warsan Sch Social Sci & Humanities, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Warsaw	Marchewka, A (corresponding author), M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland.	i.szatkowska@nencki.gov.pl	Jednoróg, Katarzyna/AFO-8052-2022; Szatkowska, Iwona/R-4152-2016; Marchewka, Artur/ABF-5174-2021	Jednoróg, Katarzyna/0000-0003-3072-6956; Grabowska, Anna/0000-0003-2156-350X; Szatkowska, Iwona/0000-0002-3185-7336; Marchewka, Artur/0000-0002-1982-3299	Polish Ministry of Science and Higher Education [NN 106 042 034]; Polish National Science Center [2011/01/B/HS6/04611]; European Social Fund; Human Capital Operational Programme for the execution of the project "Support for bio tech med scientists in technology transfer" [UDA-POKL.08.01-14-041/09-00]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Center; European Social Fund(European Social Fund (ESF)); Human Capital Operational Programme for the execution of the project "Support for bio tech med scientists in technology transfer"	This study was supported by grants from the Polish Ministry of Science and Higher Education (grant number: NN 106 042 034) and from the Polish National Science Center (grant number 2011/01/B/HS6/04611). Marcel Falkiewicz has been supported with scholarship from the European Social Fund, Human Capital Operational Programme for the execution of the project "Support for bio tech med scientists in technology transfer" (UDA-POKL.08.01-14-041/09-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2006, CEREB CORTEX, V16, P192, DOI 10.1093/cercor/bhi097; Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Abe N, 2011, NEUROSCIENTIST, V17, P560, DOI 10.1177/1073858410393359; Abe N, 2009, CURR OPIN NEUROL, V22, P594, DOI 10.1097/WCO.0b013e328332c3cf; Abe N, 2009, BRAIN, V132, P1386, DOI 10.1093/brain/awp052; Andreasen NC, 1999, HUM BRAIN MAPP, V8, P226, DOI 10.1002/(SICI)1097-0193(1999)8:4<226::AID-HBM6>3.3.CO;2-W; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bauer K, 2008, GENDER DIFFERENCES E; Bell EC, 2006, NEUROIMAGE, V30, P529, DOI 10.1016/j.neuroimage.2005.09.049; Bem S. L., 1981, J PERS SOC PSYCHOL; Bjorklund DF, 1996, PSYCHOL BULL, V120, P163, DOI 10.1037/0033-2909.120.2.163; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brett M, 2002, NEUROIMAGE, V16; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; DePaulo B., 1993, LYING DECEPTION EVER, P126; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dreber A, 2008, ECON LETT, V99, P197, DOI 10.1016/j.econlet.2007.06.027; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Feldman RS, 2002, BASIC APPL SOC PSYCH, V24, P163, DOI 10.1207/S15324834BASP2402_8; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Ganis G, 2009, SOC NEUROSCI, V4, P465, DOI 10.1080/17470910802507660; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Greely HT, 2007, AM J LAW MED, V33, P377, DOI 10.1177/009885880703300211; Herman-Jeglinska A, 2002, ARCH SEX BEHAV, V31, P527, DOI 10.1023/A:1020611416035; Hines TM, 1996, ACTA NEUROBIOL EXP, V56, P263; HUSELID RF, 1992, J HEALTH SOC BEHAV, V33, P348, DOI 10.2307/2137313; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; Kaylor-Hughes CJ, 2011, CRIM BEHAV MENT HEAL, V21, P8, DOI 10.1002/cbm.785; Kenner NM, 2010, J NEUROSCI, V30, P8512, DOI 10.1523/JNEUROSCI.1096-10.2010; Kuczynska A., 1992, INWENTARZ OCENY PLCI; Lee TMC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012291; Lee TMC, 2002, HUM BRAIN MAPP, V15, P157, DOI 10.1002/hbm.10020; Li CSR, 2006, NEUROIMAGE, V32, P1918, DOI 10.1016/j.neuroimage.2006.05.017; Marvel CL, 2010, NEUROPSYCHOL REV, V20, P271, DOI 10.1007/s11065-010-9137-7; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Nunez JM, 2005, NEUROIMAGE, V25, P267, DOI 10.1016/j.neuroimage.2004.10.041; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Rosenblitt JC, 2001, HORM BEHAV, V40, P396, DOI 10.1006/hbeh.2001.1704; Ross M, 1990, SELF INFERENCE PROCE, V6, P135; Silverman IW, 2003, DEV REV, V23, P219, DOI 10.1016/S0273-2297(03)00012-1; Sip KE, 2008, TRENDS COGN SCI, V12, P48, DOI 10.1016/j.tics.2007.11.008; Sip KE, 2010, NEUROPSYCHOLOGIA, V48, P3619, DOI 10.1016/j.neuropsychologia.2010.08.013; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Staunton C, 2011, J CRIM PSYCHOL, V1, P1, DOI 10.1108/20093829201100001; Szatkowska I, 2008, NEUROBIOL LEARN MEM, V90, P475, DOI 10.1016/j.nlm.2008.06.001; Szatkowska I, 2011, NEUROBIOL LEARN MEM, V96, P385, DOI 10.1016/j.nlm.2011.06.014; THOMAS BS, 1995, J ADOLESCENT HEALTH, V17, P91, DOI 10.1016/1054-139X(94)00104-M; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; TOOKE W, 1991, ETHOL SOCIOBIOL, V12, P345, DOI 10.1016/0162-3095(91)90030-T; Tyler JM, 2004, J APPL SOC PSYCHOL, V34, P2602, DOI 10.1111/j.1559-1816.2004.tb01994.x; Whiteside SP, 2003, EXP CLIN PSYCHOPHARM, V11, P210, DOI 10.1037/1064-1297.11.3.210; Whitley BE, 1999, SEX ROLES, V41, P657, DOI 10.1023/A:1018863909149	60	34	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43076	10.1371/journal.pone.0043076	http://dx.doi.org/10.1371/journal.pone.0043076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952631	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000017
J	Sellam, A; Tebbji, F; Whiteway, M; Nantel, A				Sellam, Adnane; Tebbji, Faiza; Whiteway, Malcolm; Nantel, Andre			A Novel Role for the Transcription Factor Cwt1p as a Negative Regulator of Nitrosative Stress in Candida albicans	PLOS ONE			English	Article							WALL DAMAGE RESPONSE; NITRIC-OXIDE; SACCHAROMYCES-CEREVISIAE; CICLOPIROX OLAMINE; GENE; EXPRESSION; RESISTANCE; VIRULENCE; LIBRARY	The ability of Candida albicans to survive in the presence of nitrosative stress during the initial contact with the host immune system is crucial for its ability to colonize mammalian hosts. Thus, this fungus must activate robust mechanisms to neutralize and repair nitrosative-induced damage. Until now, very little was known regarding the regulatory circuits associated with reactive nitrogen species detoxification in fungi. To gain insight into the transcriptional regulatory networks controlling nitrosative stress response (NRS) in C. albicans a compilation of transcriptional regulator-defective mutants were screened. This led to the identification of Cwt1p as a negative regulator of NSR. By combining genome-wide location and expression analyses, we have characterized the Cwt1p regulon and demonstrated that Cwt1p is directly required for proper repression of the flavohemoglobin Yhb1p, a key NO-detoxification enzyme. Furthermore, Cwt1p operates both by activating and repressing genes of specific functions solicited upon NSR. Additionally, we used Gene Set Enrichment Analysis to reinvestigate the C. albicans NSR-transcriptome and demonstrate a significant similarity with the transcriptional profiles of C. albicans interacting with phagocytic host-cells. In summary, we have characterized a novel negative regulator of NSR and bring new insights into the transcriptional regulatory network governing fungal NSR.	[Sellam, Adnane] Univ Montreal, IRIC, Montreal, PQ, Canada; [Tebbji, Faiza; Whiteway, Malcolm; Nantel, Andre] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Tebbji, Faiza; Whiteway, Malcolm] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Nantel, Andre] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	Universite de Montreal; National Research Council Canada; McGill University; McGill University	Sellam, A (corresponding author), Univ Montreal, IRIC, Montreal, PQ, Canada.	adnane.sellam@gmail.com; andre.nantel@nrc-cnrc.gc.ca	Sellam, Adnane/H-9765-2013	Sellam, Adnane/0000-0002-0506-7752; Tebbji, Faiza/0000-0002-7359-727X	Canadian Institutes of Health Research (CIHR) [MOP-84341]; Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT)	This work was supported by grant MOP-84341 from the Canadian Institutes of Health Research (CIHR) to AN and MW. FT is supported by a postdoctoral fellowship from the Fonds quebecois de la recherche sur la nature et les technologies (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS BB, 1991, CLIN DERMATOL, V9, P471, DOI 10.1016/0738-081X(91)90075-V; Bachewich C, 2005, MOL MICROBIOL, V57, P942, DOI 10.1111/j.1365-2958.2005.04727.x; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Bruno VM, 2006, PLOS PATHOG, V2, P204, DOI 10.1371/journal.ppat.0020021; Chiranand W, 2008, EUKARYOT CELL, V7, P268, DOI 10.1128/EC.00240-07; Cote P, 2009, MOL BIOL CELL, V20, P3363, DOI 10.1091/mbc.E09-03-0210; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Elahi S, 2001, IMMUNOLOGY, V104, P447, DOI 10.1046/j.1365-2567.2001.01331.x; Epp E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000753; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Fung Man-Lung, 2007, Open Biochem J, V1, P1, DOI 10.2174/1874091X00701010001; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Guillemette T, 2004, CURR GENET, V45, P214, DOI 10.1007/s00294-003-0479-z; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; Lavoie H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-578; Lee REB, 2005, J ANTIMICROB CHEMOTH, V55, P655, DOI 10.1093/jac/dki105; Moreno I, 2003, FEMS MICROBIOL LETT, V226, P159, DOI 10.1016/S0378-1097(03)00588-3; Moreno I, 2010, YEAST, V27, P77, DOI 10.1002/yea.1733; Nantel A, 2006, MED MYCOLOGY; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Navarathna DH, 2012, 11 ASM C CAND CAND, P61; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Rauceo JM, 2008, MOL BIOL CELL, V19, P2741, DOI 10.1091/mbc.E08-02-0191; Sellam A, 2009, EUKARYOT CELL, V8, P1174, DOI 10.1128/EC.00074-09; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Soontorngun N, 2007, MOL CELL BIOL, V27, P7895, DOI 10.1128/MCB.01055-07; Spiering MJ, 2010, EUKARYOT CELL, V9, P251, DOI 10.1128/EC.00291-09; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ullmann BD, 2004, EUKARYOT CELL, V3, P715, DOI 10.1128/EC.3.3.715-723.2004	35	20	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43956	10.1371/journal.pone.0043956	http://dx.doi.org/10.1371/journal.pone.0043956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952822	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000063
J	Ujvari, B; Pearse, AM; Taylor, R; Pyecroft, S; Flanagan, C; Gombert, S; Papenfuss, AT; Madsen, T; Belov, K				Ujvari, Beata; Pearse, Anne-Maree; Taylor, Robyn; Pyecroft, Stephen; Flanagan, Cassandra; Gombert, Sara; Papenfuss, Anthony T.; Madsen, Thomas; Belov, Katherine			Telomere Dynamics and Homeostasis in a Transmissible Cancer	PLOS ONE			English	Article							FACIAL-TUMOR DISEASE; TASMANIAN DEVIL; CONSERVATION; INSTABILITY; LENGTH; TRF2; TIN2; EXPRESSION; SHELTERIN; ROLES	Background: Devil Facial Tumour Disease (DFTD) is a unique clonal cancer that threatens the world's largest carnivorous marsupial, the Tasmanian devil (Sarcophilus harrisii) with extinction. This transmissible cancer is passed between individual devils by cell implantation during social interactions. The tumour arose in a Schwann cell of a single devil over 15 years ago and since then has expanded clonally, without showing signs of replicative senescence; in stark contrast to a somatic cell that displays a finite capacity for replication, known as the "Hayflick limit". Methodology/Principal Findings: In the present study we investigate the role of telomere length, measured as Telomere Copy Number (TCN), and telomerase and shelterin gene expression, as well as telomerase activity in maintaining hyperproliferation of Devil Facial Tumour (DFT) cells. Our results show that DFT cells have short telomeres. DFTD TCN does not differ between geographic regions or between strains. However, TCN has increased over time. Unlimited cell proliferation is likely to have been achieved through the observed up-regulation of the catalytic subunit of telomerase (TERT) and concomitant activation of telomerase. Up-regulation of the central component of shelterin, the TRF1-intercating nuclear factor 2 (TINF2) provides DFT a mechanism for telomere length homeostasis. The higher expression of both TERT and TINF2 may also protect DFT cells from genomic instability and enhance tumour proliferation. Conclusions/Significance: DFT cells appear to monitor and regulate the length of individual telomeres: i.e. shorter telomeres are elongated by up-regulation of telomerase-related genes; longer telomeres are protected from further elongation by members of the shelterin complex, which may explain the lack of spatial and strain variation in DFT telomere copy number. The observed longitudinal increase in gene expression in DFT tissue samples and telomerase activity in DFT cell lines might indicate a selection for more stable tumours with higher proliferative potential.	[Ujvari, Beata; Flanagan, Cassandra; Gombert, Sara; Belov, Katherine] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Pearse, Anne-Maree; Taylor, Robyn; Pyecroft, Stephen] Devil Facial Tumour Project, Diagnost Serv, Hlth Anim Lab, Dept Primary Ind Water & Environm, Launceston, Tas, Australia; [Madsen, Thomas] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Papenfuss, Anthony T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Papenfuss, Anthony T.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia	University of Sydney; University of Wollongong; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Ujvari, B (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	kathy.belov@sydney.edu.au	Ujvari, Beata/L-7541-2019; Papenfuss, Anthony T/C-6297-2008; Ujvari, Beata/K-8722-2012	Ujvari, Beata/0000-0003-2391-2988; Papenfuss, Anthony T/0000-0002-1102-8506; Ujvari, Beata/0000-0003-2391-2988; Madsen, Thomas/0000-0002-0998-8372; Belov, Katherine/0000-0002-9762-5554	Eric Guiler Fund [F3F98304778C800ECA2576CB007D1E6B]; Australian Research Council; ARC Future Fellowship; NHMRC Career Development Fellowship	Eric Guiler Fund; Australian Research Council(Australian Research Council); ARC Future Fellowship(Australian Research Council); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by the Eric Guiler Fund (Save the Tasmanian Devil Appeal): http://www.tassiedevil.com.au/tasdevil.nsf/Grants-&-scholarships/F3F98304778C800ECA2576CB007D1E6B, and the Australian Research Council: http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Kate Swift, Pamela Hodson and Bobby Hua for providing the lysed tumour cell line samples. We thank the Save the Tasmanian Devil Program and researchers from the School of Zoology at the University of Tasmania for collecting samples. We are grateful to Dr. Gabriele Saretzki and two anonymous reviewers for their comments, which have led to substantial improvements to this manuscript. KB is supported by an ARC Future Fellowship. ATP is supported by an NHMRC Career Development Fellowship. ATP's contribution was made possible through Victorian State Government Operational Infrastructure Support and NHMRC IRIISS.	[Anonymous], 1989, JMP VERS 7; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Bellon M, 2006, INT J CANCER, V119, P2090, DOI 10.1002/ijc.22026; Belov K, 2011, MAMM GENOME, V22, P83, DOI 10.1007/s00335-010-9294-2; Blackburn, 2006, TELOMERES; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; De Lange T, 2005, COLD SH Q B, V70, P197, DOI 10.1101/sqb.2005.70.032; Deakin JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002483; Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; Hamede R, 2012, CONSERV BIOL, V26, P124, DOI 10.1111/j.1523-1739.2011.01747.x; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; IUCN IUfCoN, 2011, RED LIST THREAT SPEC; Jones ME, 2008, P NATL ACAD SCI USA, V105, P10023, DOI 10.1073/pnas.0711236105; Jones ME, 2007, ECOHEALTH, V4, P326, DOI 10.1007/s10393-007-0120-6; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Loh R, 2006, VET PATHOL, V43, P896, DOI 10.1354/vp.43-6-896; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Murchison E P, 2008, Oncogene, V27 Suppl 2, pS19, DOI 10.1038/onc.2009.350; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pearse AM, 2012, CANCER GENET-NY, V205, P101, DOI 10.1016/j.cancergen.2011.12.001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Savre-Train I, 2000, P SOC EXP BIOL MED, V223, P379, DOI 10.1046/j.1525-1373.2000.22354.x; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; *STATSDIRECT LTD, 2008, STATSDIRECT STAT SOF; Xu Yucheng, 2011, Clin Adv Hematol Oncol, V9, P442; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200	47	20	21	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44085	10.1371/journal.pone.0044085	http://dx.doi.org/10.1371/journal.pone.0044085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952882	Green Published, gold			2022-12-27	WOS:000308206000081
J	Wang, TG; Lee, MH; Choi, E; Pardo-Villamizar, CA; Lee, SB; Yang, IH; Calabresi, PA; Nath, A				Wang, Tongguang; Lee, Myoung-Hwa; Choi, Elliot; Pardo-Villamizar, Carlos A.; Lee, Sung Bin; Yang, In Hong; Calabresi, Peter A.; Nath, Avindra			Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel	PLOS ONE			English	Article							POTASSIUM CHANNELS; T-CELLS; NOTCH-1 ACTIVATION; THERAPEUTIC TARGET; ADENYLYL-CYCLASE; NEURONAL DAMAGE; OLFACTORY-BULB; LATE-PHASE; BRAIN; EXPRESSION	Increasing evidence supports a critical role of T cells in neurodegeneration associated with acute and subacute brain inflammatory disorders. Granzyme B (GrB), released by activated T cells, is a cytotoxic proteinase which may induce perforin-independent neurotoxicity. Here, we studied the mechanism of perforin-independent GrB toxicity by treating primary cultured human neuronal cells with recombinant GrB. GrBactivated the protease-activated receptor (PAR)-1 receptor on the neuronal cell surface leading to decreased intracellular cyclic AMP levels. This was followed by increased expression and translocation of the voltage gated potassium channel, Kv1.3 to the neuronal cell membrane. Similar expression of Kv1.3 was also seen in neurons of the cerebral cortex adjacent to active inflammatory lesions in patients with multiple sclerosis. Kv1.3 expression was followed by activation of Notch-1 resulting in neurotoxicity. Blocking PAR-1, Kv1.3 or Notch-1 activation using specific pharmacological inhibitors or siRNAs prevented GrB-induced neurotoxicity. Furthermore, clofazimine protected against GrB-induced neurotoxicity in rat hippocampus, in vivo. These observations indicate that GrB released from T cells induced neurotoxicity by interacting with the membrane bound Gi-coupled PAR-1 receptor and subsequently activated Kv1.3 and Notch-1. These pathways provide novel targets to treat T cell-mediated neuroinflammatory disorders. Kv1.3 is of particular interest since it is expressed on the cell surface, only under pathological circumstances, and early in the cascade of events making it an attractive therapeutic target.	[Wang, Tongguang; Lee, Myoung-Hwa; Choi, Elliot; Nath, Avindra] NINDS, Sect Infect Nervous Syst, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Pardo-Villamizar, Carlos A.; Calabresi, Peter A.; Nath, Avindra] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Lee, Sung Bin; Yang, In Hong] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Yang, In Hong] Natl Univ Singapore, Singapore Inst Nanotechnol, Singapore 117548, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johns Hopkins University; Johns Hopkins University; National University of Singapore	Wang, TG (corresponding author), NINDS, Sect Infect Nervous Syst, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	natha@ninds.nih.gov	Pardo, Carlos A./A-5192-2008; Yang, In Hong/F-9125-2015; Calabresi, Peter A./AAF-2288-2019	Pardo, Carlos A./0000-0002-4128-5335; Yang, In Hong/0000-0002-1020-0538	National Multiple Sclerosis Society; National Institutes of Health (NIH) [NS41435]; NIH intramural funds; Project Restore-Bart Mclean Fund for Neuroimmunology Research; Maryland Stem Cell Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041435, ZIANS003130, ZIANS003134] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH intramural funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project Restore-Bart Mclean Fund for Neuroimmunology Research; Maryland Stem Cell Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by grants from the National Multiple Sclerosis Society, the National Institutes of Health (NIH) (NS41435, PAC), NIH intramural funds, Project Restore-Bart Mclean Fund for Neuroimmunology Research, and the Maryland Stem Cell Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Baliko F, 2007, AM J PATHOL, V170, P1686, DOI 10.2353/ajpath.2007.060971; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Biju KC, 2008, J COMP NEUROL, V506, P161, DOI 10.1002/cne.21540; Bock J, 2002, BIOCHEM BIOPH RES CO, V295, P526, DOI 10.1016/S0006-291X(02)00695-2; Chaitanya GV, 2009, NEUROPATHOLOGY, V29, P270, DOI 10.1111/j.1440-1789.2008.00980.x; Clayberger C, 2009, CURR OPIN ORGAN TRAN, V14, P30, DOI 10.1097/MOT.0b013e32831c8462; Colley B, 2004, RECEPTOR CHANNEL, V10, P25, DOI 10.1080/10606820490270870; Colley BS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-8; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Doczi MA, 2008, AM J PHYSIOL-REG I, V295, pR733, DOI 10.1152/ajpregu.00077.2008; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Ganor Y, 2007, J IMMUNOL, V178, P683, DOI 10.4049/jimmunol.178.2.683; Giuliani F, 2003, J IMMUNOL, V171, P368, DOI 10.4049/jimmunol.171.1.368; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hamill CE, 2007, MOL PHARMACOL, V72, P653, DOI 10.1124/mol.107.038158; Hu DH, 2009, GLIA, V57, P1492, DOI 10.1002/glia.20865; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Jurynczyk M, 2010, J NEUROIMMUNOL, V218, P3, DOI 10.1016/j.jneuroim.2009.08.010; Kessler CB, 2007, ENDOCRINOLOGY, V148, P1666, DOI 10.1210/en.2006-0443; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Kurschus FC, 2005, BLOOD, V105, P2049, DOI 10.1182/blood-2004-06-2180; Kurschus FC, 2008, P NATL ACAD SCI USA, V105, P13799, DOI 10.1073/pnas.0801724105; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Liu D, 2003, J NEUROCHEM, V86, P966, DOI 10.1046/j.1471-4159.2003.01913.x; Loeb CRK, 2006, J BIOL CHEM, V281, P28326, DOI 10.1074/jbc.M604544200; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; Marks DR, 2009, J NEUROSCI, V29, P6734, DOI 10.1523/JNEUROSCI.1350-09.2009; Mullen KM, 2006, ANN NEUROL, V60, P118, DOI 10.1002/ana.20884; Nagarsheth MH, 2006, J NEUROL SCI, V244, P111, DOI 10.1016/j.jns.2006.01.007; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; OhnoShosaku T, 1996, NEUROSCI LETT, V207, P195, DOI 10.1016/0304-3940(96)12518-0; Olianas MC, 2007, NEUROSCIENCE, V146, P1289, DOI 10.1016/j.neuroscience.2007.02.059; Olson EE, 2004, J CEREBR BLOOD F MET, V24, P964, DOI 10.1097/01.WCB.0000128266.87474.BF; Petito CK, 2006, J NEUROVIROL, V12, P272, DOI 10.1080/13550280600879204; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schwab N, 2009, BRAIN, V132, P1236, DOI 10.1093/brain/awp003; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Soto I, 2006, J NEUROCHEM, V96, P82, DOI 10.1111/j.1471-4159.2005.03510.x; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Taniguchi N, 2006, NEUROSCI LETT, V406, P38, DOI 10.1016/j.neulet.2006.06.071; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Turgeon VL, 1998, J NEUROSCI, V18, P6882; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Wang T, 2006, FASEB J, V20, P1209, DOI 10.1096/fj.05-5022fje; Wang TG, 2010, J NEUROSCI, V30, P5020, DOI 10.1523/JNEUROSCI.0311-10.2010; Warny M, 1999, AM J PHYSIOL-CELL PH, V276, pC717, DOI 10.1152/ajpcell.1999.276.3.C717; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yu SP, 1999, J NEUROCHEM, V73, P933, DOI 10.1046/j.1471-4159.1999.0730933.x	56	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43950	10.1371/journal.pone.0043950	http://dx.doi.org/10.1371/journal.pone.0043950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952817	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000062
J	Maltha, J; Gamboa, D; Bendezu, J; Sanchez, L; Cnops, L; Gillet, P; Jacobs, J				Maltha, Jessica; Gamboa, Dionicia; Bendezu, Jorge; Sanchez, Luis; Cnops, Lieselotte; Gillet, Philippe; Jacobs, Jan			Rapid Diagnostic Tests for Malaria Diagnosis in the Peruvian Amazon: Impact of pfhrp2 Gene Deletions and Cross-Reactions	PLOS ONE			English	Article							PLASMODIUM-VIVAX; FALCIPARUM-MALARIA; PLDH; INSTRUCTIONS; PERFORMANCE; REGION; ASSAYS	Background: In the Peruvian Amazon, Plasmodium falciparum and Plasmodium vivax malaria are endemic in rural areas, where microscopy is not available. Malaria rapid diagnostic tests (RDTs) provide quick and accurate diagnosis. However, pfhrp2 gene deletions may limit the use of histidine-rich protein-2 (PfHRP2) detecting RDTs. Further, cross-reactions of P. falciparum with P. vivax-specific test lines and vice versa may impair diagnostic specificity. Methods: Thirteen RDT products were evaluated on 179 prospectively collected malaria positive samples. Species diagnosis was performed by microscopy and confirmed by PCR. Pfhrp2 gene deletions were assessed by PCR. Results: Sensitivity for P. falciparum diagnosis was lower for PfHRP2 compared to P. falciparum-specific Plasmodium lactate dehydrogenase (Pf-pLDH)-detecting RDTs (71.6% vs. 98.7%, p<0.001). Most (19/21) false negative PfHRP2 results were associated with pfhrp2 gene deletions (25.7% of 74 P. falciparum samples). Diagnostic sensitivity for P. vivax (101 samples) was excellent, except for two products. In 10/12 P. vivax-detecting RDT products, cross-reactions with the PfHRP2 or Pf-pLDH line occurred at a median frequency of 2.5% (range 0%-10.9%) of P. vivax samples assessed. In two RDT products, two and one P. falciparum samples respectively cross-reacted with the Pv-pLDH line. Two Pf-pLDH/pan-pLDH-detecting RDTs showed excellent sensitivity with few (1.0%) cross-reactions but showed faint Pf-pLDH lines in 24.7% and 38.9% of P. falciparum samples. Conclusion: PfHRP2-detecting RDTs are not suitable in the Peruvian Amazon due to pfhrp2 gene deletions. Two Pf-pLDH-detecting RDTs performed excellently and are promising RDTs for this region although faint test lines are of concern.	[Maltha, Jessica; Cnops, Lieselotte; Gillet, Philippe; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Gamboa, Dionicia; Bendezu, Jorge; Sanchez, Luis] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Dept Ciencias Celulares & Mol, Fac Ciencias & Filosofia, Lima, Peru	Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Maltha, J (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jmaltha@itg.be	Gamboa, Dionicia/CAF-2097-2022; Jacobs, Jan/GRX-7316-2022; Bendezu, Jorge/L-6597-2019	Gamboa, Dionicia/0000-0002-1420-7729; Bendezu, Jorge/0000-0001-7102-3144; gillet, philippe/0000-0001-5878-6446; Cnops, Lieselotte/0000-0003-0658-1291	Steunfonds Marguerite-Marie Delacroix; National Institute of Health [U19 AI089681]; Directorate General for Development Cooperation (DGCD) of the Belgian Government [95502]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089681] Funding Source: NIH RePORTER	Steunfonds Marguerite-Marie Delacroix; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directorate General for Development Cooperation (DGCD) of the Belgian Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Part of the work performed by JM was funded by the "Steunfonds Marguerite-Marie Delacroix". Part of the work performed by DG and JB was funded by a National Institute of Health grant (U19 AI089681) and by Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 3, project 95502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MAL RAP DIAGN TEST P; [Anonymous], 2009, MAL RAP DIAGN TEST P; Arrospide N, 2006, REV PERU MED EXP SAL, P23; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022593; Bendezu J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-154; Cho D, 2001, PARASITOL RES, V87, P445, DOI 10.1007/s004360000360; Cnops L, 2010, CLIN MICROBIOL INFEC; Durand V Salomón, 2005, Rev. perú. med. exp. salud publica, V22, P47; Forney JR, 2003, J CLIN MICROBIOL, V41, P2358, DOI 10.1128/JCM.41.6.2358-2366.2003; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Gobierno regional de Loreto, 2011, AN SIT SAL REG LOR A; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Maltha J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-7; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-198; Mayxay M, 2004, TROP MED INT HEALTH, V9, P325, DOI 10.1111/j.1365-3156.2004.01199.x; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; Minesterio de Salud, 2011, BOL EP AN 2011; Piper RC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-213; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Aguirre AMR, 2009, REV PANAM SALUD PUBL, V25, P377, DOI 10.1590/S1020-49892009000500001; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2018, MAL RAP DIAGN TEST P; World Health Organization, 2010, BAS MAL MICR 1	27	83	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43094	10.1371/journal.pone.0043094	http://dx.doi.org/10.1371/journal.pone.0043094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952633	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600014
J	Meinen, S; Lin, S; Ruegg, MA; Punga, AR				Meinen, Sarina; Lin, Shuo; Rueegg, Markus A.; Punga, Anna Rostedt			Fatigue and Muscle Atrophy in a Mouse Model of Myasthenia Gravis Is Paralleled by Loss of Sarcolemmal nNOS	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; ACETYLCHOLINE-RECEPTOR; NO PRODUCTION; NEURONAL NOS; MDX MICE; MUSK; ANTIBODIES; VASOMODULATION	Myasthenia Gravis (MG) patients suffer from chronic fatigue of skeletal muscles, even after initiation of proper immunosuppressive medication. Since the localization of neuronal nitric oxide synthase (nNOS) at the muscle membrane is important for sustained muscle contraction, we here study the localization of nNOS in muscles from mice with acetylcholine receptor antibody seropositive (AChR+) experimental autoimmune MG (EAMG). EAMG was induced in 8 week-old male mice by immunization with AChRs purified from torpedo californica. Sham-injected wild type mice and mdx mice, a model for Duchenne muscular dystrophy, were used for comparison. At EAMG disease grade 3 (severe myasthenic weakness), the triceps, sternomastoid and masseter muscles were collected for analysis. Unlike in mdx muscles, total nNOS expression as well as the presence of its binding partner syntrophin alpha-1, were not altered in EAMG. Immunohistological and biochemical analysis showed that nNOS was lost from the muscle membrane and accumulated in the cytosol, which is likely the consequence of blocked neuromuscular transmission. Atrophy of all examined EAMG muscles were supported by upregulated transcript levels of the atrogenes atrogin-1 and MuRF1, as well as MuRF1 protein, in combination with reduced muscle fiber diameters. We propose that loss of sarcolemmal nNOS provides an additional mechanism for the chronic muscle fatigue and secondary muscle atrophy in EAMG and MG.	[Meinen, Sarina; Lin, Shuo; Rueegg, Markus A.; Punga, Anna Rostedt] Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, Basel, Switzerland	University of Basel	Meinen, S (corresponding author), Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, Basel, Switzerland.	annarostedtpunga@gmail.com	Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Punga, Anna/0000-0002-2178-9413; Lin, Shuo/0000-0003-2317-0339	Canton of Basel-Stadt; Canton of Baselland; Swiss Foundation for Research on Muscle Disease; European Union [242210]	Canton of Basel-Stadt; Canton of Baselland; Swiss Foundation for Research on Muscle Disease; European Union(European Commission)	The work was supported by the Cantons of Basel-Stadt and Baselland, The Swiss Foundation for Research on Muscle Disease and the European Union through FP7 project number 242210 "FIGHT-MG". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aricha R, 2006, FASEB J, V20, P374, DOI 10.1096/fj.05-4909fje; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Christadoss P, 2002, J NEUROIMMUNOL, V122, P186, DOI 10.1016/S0165-5728(01)00473-8; Fadel PJ, 2003, J PHYSIOL-LONDON, V549, P243, DOI 10.1113/jphysiol.2003.038828; Farrugia ME, 2007, CLIN NEUROPHYSIOL, V118, P269, DOI 10.1016/j.clinph.2006.10.004; Figueroa XF, 2009, AM J PHYSIOL-HEART C, V297, pH134, DOI 10.1152/ajpheart.00023.2009; Ghedini PC, 2008, MUSCLE NERVE, V38, P1585, DOI 10.1002/mus.21183; GRAVES J, 1993, BRIT J PHARMACOL, V108, P631, DOI 10.1111/j.1476-5381.1993.tb12853.x; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HALVORSEN SW, 1987, J NEUROSCI, V7, P2547; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; KOLTGEN D, 1994, NEUROSCI LETT, V173, P79, DOI 10.1016/0304-3940(94)90154-6; Lau T, 2000, J CLIN INVEST, V105, P1217, DOI 10.1172/JCI7199; Liewluck T, 2011, MUSCLE NERVE, V44, P789, DOI 10.1002/mus.22176; Martignago S, 2009, NEUROPATH APPL NEURO, V35, P103, DOI 10.1111/j.1365-2990.2008.00965.x; Matell G, 1998, ANN NY ACAD SCI, V841, P785, DOI 10.1111/j.1749-6632.1998.tb11019.x; Mizrachi K, 2010, J NEUROIMMUNOL, V220, P43, DOI 10.1016/j.jneuroim.2009.12.012; Nakayashiki N, 2000, J NEUROIMMUNOL, V105, P131, DOI 10.1016/S0165-5728(00)00199-5; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; Percival JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003387; Punga AR, 2006, CLIN NEUROPHYSIOL, V117, P1434, DOI 10.1016/j.clinph.2006.03.028; Punga AR, 2011, EXP NEUROL, V230, P207, DOI 10.1016/j.expneurol.2011.04.018; SCHMID A, 1985, J BIOL CHEM, V260, P3041; Soliven B, 2009, J NEUROL SCI, V277, P150, DOI 10.1016/j.jns.2008.09.033; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Suzuki N, 2010, J NEUROL SCI, V294, P95, DOI 10.1016/j.jns.2010.03.022; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246	34	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44148	10.1371/journal.pone.0044148	http://dx.doi.org/10.1371/journal.pone.0044148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952904	Green Accepted, gold, Green Published			2022-12-27	WOS:000308213600083
J	Li, ZY; Yi, YZ; Yin, XP; Zhang, Y; Liu, M; Liu, H; Li, XR; Li, YN; Zhang, ZF; Liu, JX				Li, Zhiyong; Yi, Yongzhu; Yin, Xiangping; Zhang, Yun; Liu, Ming; Liu, Hang; Li, Xuerui; Li, Yinu; Zhang, Zhifang; Liu, Jixing			Development of a Foot-and-Mouth Disease Virus Serotype A Empty Capsid Subunit Vaccine Using Silkworm (Bombyx mori) Pupae	PLOS ONE			English	Article							IMMUNE-RESPONSES; ANTIBODY-RESPONSE; FMDV; EXPRESSION; PROTECTION; SWINE; BACULOVIRUS; CHALLENGE; INDUCTION; SYSTEM	Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals that inflicts severe economic losses in the livestock industry. In 2009, FMDV serotype A caused outbreaks of FMD in cattle in China. Although an inactivated virus vaccine has proven effective to control FMD, its use may lead to new disease outbreaks due to a possible incomplete inactivation of the virus during the manufacturing process. Here, we expressed the P1-2A and the 3C coding regions of a serotype A FMDV field isolate in silkworm pupae (Bombyx mori) and evaluated the immunogenicity of the expression products. Four of five cattle vaccinated with these proteins developed high titers of FMDV-specific antibody and were completely protected against virulent homologous virus challenge with 10,000 50% bovine infectious doses (BID50). Furthermore, the 50% bovine protective dose (PD50) test was performed to assess the bovine potency of the empty capsid subunit vaccine and was shown to achieve 4.33 PD50 per dose. These data provide evidence that silkworm pupae can be used to express immunogenic FMDV proteins. This strategy might be used to develop a new generation of empty capsid subunit vaccines against a variety of diseases.	[Li, Zhiyong; Yin, Xiangping; Zhang, Yun; Liu, Ming; Liu, Hang; Li, Xuerui; Liu, Jixing] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Grazing Anim Dis, State Key Lab Vet Etiol Biol,Minist Agr, Lanzhou, Gansu, Peoples R China; [Yi, Yongzhu; Li, Yinu; Zhang, Zhifang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Li, ZY (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Grazing Anim Dis, State Key Lab Vet Etiol Biol,Minist Agr, Lanzhou, Gansu, Peoples R China.	zhifangzhang@yahoo.com; liujixing@hotmail.com		Li, Yinu/0000-0002-9310-8381	National 863 Project of China [2011AA10A211-3, 2006AA02Z440]; International Science & Technology Cooperation Program of China [2011DFA31830]; National Natural Science Foundation of China [3107139]; Chinese Funding for Social Public Interests [2005DIB4J041]	National 863 Project of China(National High Technology Research and Development Program of China); International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Funding for Social Public Interests	This work was supported by grants from National 863 Project of China (Grant No. 2011AA10A211-3, 2006AA02Z440), International Science & Technology Cooperation Program of China (Grant No. 2011DFA31830), National Natural Science Foundation of China (Grant No. 3107139), and Chinese Funding for Social Public Interests (No. 2005DIB4J041). The funders had no role in the study design and conduct, data collection and analysis, decision to publish, or in the preparation of the manuscript.	Cao YM, 2009, VET MICROBIOL, V137, P10, DOI 10.1016/j.vetmic.2008.12.007; Chen WZ, 2004, J VIROL, V78, P6900, DOI 10.1128/JVI.78.13.6900-6907.2004; De Clercq K, 2008, TRANSBOUND EMERG DIS, V55, P46, DOI 10.1111/j.1865-1682.2007.01012.x; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Domingo E, 2003, VIRUS RES, V91, P47, DOI 10.1016/S0168-1702(02)00259-9; FERRIS NP, 1990, J VIROL METHODS, V29, P33, DOI 10.1016/0166-0934(90)90005-Z; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; HAMBLIN C, 1986, J IMMUNOL METHODS, V93, P115, DOI 10.1016/0022-1759(86)90441-2; Jin RZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003933; Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2; LEWIS SA, 1991, J VIROL, V65, P6572, DOI 10.1128/JVI.65.12.6572-6580.1991; Li XM, 2008, VACCINE, V26, P2714, DOI 10.1016/j.vaccine.2008.03.020; Li YM, 2006, VACCINE, V24, P4602, DOI 10.1016/j.vaccine.2005.08.032; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002273; Lin XA, 2006, Z NATURFORSCH C, V61, P595; Ma MX, 2008, VET IMMUNOL IMMUNOP, V121, P1, DOI 10.1016/j.vetimm.2007.06.029; Mayr GA, 2001, VACCINE, V19, P2152, DOI 10.1016/S0264-410X(00)00384-4; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; Moraes MP, 2002, VACCINE, V20, P1631, DOI 10.1016/S0264-410X(01)00483-2; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Pacheco JM, 2005, VIROLOGY, V337, P205, DOI 10.1016/j.virol.2005.04.014; Rodriguez LL, 2009, VACCINE, V27, pD90, DOI 10.1016/j.vaccine.2009.08.039; Santos MJD, 2005, VACCINE, V23, P1838, DOI 10.1016/j.vaccine.2004.11.014; Su BW, 2008, VACCINE, V26, P5111, DOI 10.1016/j.vaccine.2008.03.089; Wang CY, 2001, BIOLOGICALS, V29, P221, DOI 10.1006/biol.2001.0302; Wang CY, 2002, VACCINE, V20, P2603, DOI 10.1016/S0264-410X(02)00148-2; Wang DM, 2008, TRANSGENIC RES, V17, P1163, DOI 10.1007/s11248-008-9188-1; Wang YZ, 2005, APPL MICROBIOL BIOT, V69, P385, DOI 10.1007/s00253-005-1998-y; Wu XF, 2001, GENE EXPRESSION TECH, P135	29	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43849	10.1371/journal.pone.0043849	http://dx.doi.org/10.1371/journal.pone.0043849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952788	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800066
J	Miret, M; Caballero, FF; Mathur, A; Naidoo, N; Kowal, P; Ayuso-Mateos, JL; Chatterji, S				Miret, Marta; Felix Caballero, Francisco; Mathur, Arvind; Naidoo, Nirmala; Kowal, Paul; Luis Ayuso-Mateos, Jose; Chatterji, Somnath			Validation of a Measure of Subjective Well-Being: An Abbreviated Version of the Day Reconstruction Method	PLOS ONE			English	Article							RELIABILITY; AGREEMENT; EXPERIENCE; VALIDITY	Background: The study of well-being is becoming a priority in social sciences. The Day Reconstruction Method (DRM) was developed to assess affective states. The aim of the present study was to validate an abbreviated version of the DRM designed for administration in population studies, and to assess its test-retest properties. Principal Findings: 1560 adults from Jodhpur (India) were interviewed using an abbreviated version of the DRM, and a week later they were re-interviewed using the original long version of the DRM, after which the abbreviated version of the DRM was compared with the original version. A regression model considering interaction terms was employed to analyse the impact of sociodemographic characteristics on net affect. Test-retest reliability was assessed, and found to be moderate. Positive affect showed more test-retest reliability than negative affect, while net affect had more temporal stability than U-index. The affect of sets A, B, and C, taken together, had a moderate predictive ability compared with the affect obtained using the full version of the DRM: AUC = 0.67 for positive affect; 0.66 for net affect; 0.61 for negative affect; and 0.60 for the U-index. Household income, gender, and setting all had a significant impact on net affect. Conclusions: Net affect and positive affect showed moderate temporal stability, whereas negative affect and the U-index showed fair temporal stability. Evaluating the affective state using the abbreviated version of the DRM provides a profile of the population similar to that of the full version. The results provide considerable support for using the short version of the DRM as an instrument to measure subjective well-being in large population surveys.	[Miret, Marta; Felix Caballero, Francisco; Luis Ayuso-Mateos, Jose] CIBERSAM, Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Miret, Marta; Felix Caballero, Francisco; Luis Ayuso-Mateos, Jose] Hosp Univ La Princesa, Dept Psychiat, Inst Invest Sanitaria Princesa, Madrid, Spain; [Miret, Marta; Felix Caballero, Francisco; Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Mathur, Arvind] Dr Sampurnanand Med Coll, Jodhpur, Rajasthan, India; [Naidoo, Nirmala; Kowal, Paul; Chatterji, Somnath] World Hlth Org, Dept Hlth Stat & Informat Syst, Geneva, Switzerland; [Kowal, Paul] Univ Newcastle, Fac Hlth, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Madrid; World Health Organization; University of Newcastle	Miret, M (corresponding author), CIBERSAM, Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, Madrid, Spain.	chatterjis@who.int	CHATTERJI, Somnath/ABE-6832-2020; Miret, Marta/C-6103-2019; Mathur, Arvind/AAH-5736-2019	Miret, Marta/0000-0003-3252-854X; Mathur, Arvind/0000-0001-9520-0571; Kowal, Paul/0000-0002-6314-8753; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X	United States National Institute on Aging through Interagency Agreements [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01-AG034479]; Instituto de Salud Carlos III-FIS [PS09/00295]; Spanish Ministry of Science and Innovation: ACI-Promociona [ACI2009-1010]; Centro de Investigacion Biomedica Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III; NATIONAL INSTITUTE ON AGING [R01AG034479] Funding Source: NIH RePORTER	United States National Institute on Aging through Interagency Agreements; Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation: ACI-Promociona(Ministry of Science and Innovation, Spain (MICINN)); Centro de Investigacion Biomedica Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This paper uses data from WHO SAGE. WHO's Study on Global Ageing and Adult Health is supported by the US National Institute on Aging through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01) and through a research grant (R01-AG034479). The research leading to these results received also funding from the Spanish Ministry of Science and Innovation ACI-Promociona (ACI2009-1010) and was supported by the Centro de Investigacion Biomedica Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III.; This paper uses data from World Health Organization (WHO) Study on global AGEing and adult health (SAGE). WHO's SAGE is supported by the United States National Institute on Aging through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01) and through a research grant (R01-AG034479). The paper was supported by the Instituto de Salud Carlos III-FIS research grant number PS09/00295, the Spanish Ministry of Science and Innovation: ACI-Promociona (ACI2009-1010), and the Centro de Investigacion Biomedica Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres AM, 2004, BRIT J MATH STAT PSY, V57, P1, DOI 10.1348/000711004849268; Andres AM, 2008, COMMUN STAT-THEOR M, V37, P760, DOI 10.1080/03610920701669884; Bylsma LM, 2011, J ABNORM PSYCHOL, V120, P155, DOI 10.1037/a0021662; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; DEYO RA, 1991, CONTROL CLIN TRIALS, V12, pS142, DOI 10.1016/S0197-2456(05)80019-4; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E, 2010, J PERS SOC PSYCHOL, V99, P52, DOI 10.1037/a0018066; Dockray S, 2010, SOC INDIC RES, V99, P269, DOI 10.1007/s11205-010-9578-7; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Krueger AB, 2008, J PUBLIC ECON, V92, P1833, DOI 10.1016/j.jpubeco.2007.12.015; Krueger AB, 2008, LANCET, V371, P1519, DOI 10.1016/S0140-6736(08)60656-X; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Layard R, 2010, SCIENCE, V327, P534, DOI 10.1126/science.1186315; Nguyen P, 2007, J STAT SOFTW, V21, P1; Obuchowski NA, 2006, STAT MED, V25, P481, DOI 10.1002/sim.2228; Prieto L, 1998, MED CLIN-BARCELONA, V110, P142; R Core Team, 2018, R LANG ENV STAT COMP; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; StataCorp, 2010, STAT STAT SOFTW REL; Stiglitz E., 2009, REPORT COMMISSION ME; White MP, 2009, PSYCHOL SCI, V20, P1000, DOI 10.1111/j.1467-9280.2009.02392.x	25	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43887	10.1371/journal.pone.0043887	http://dx.doi.org/10.1371/journal.pone.0043887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952801	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800073
J	Elias, RM; Correa-Costa, M; Barreto, CR; Silva, RC; Hayashida, CY; Castoldi, A; Goncalves, GM; Braga, TT; Barboza, R; Rios, FJ; Keller, AC; Cenedeze, MA; Hyane, MI; D'Imperio-Lima, MR; Figueiredo-Neto, AM; Reis, MA; Marinho, CRF; Pacheco-Silva, A; Camara, NOS				Elias, Rosa Maria; Correa-Costa, Matheus; Barreto, Claudiene Rodrigues; Silva, Reinaldo Correia; Hayashida, Caroline Y.; Castoldi, Angela; Goncalves, Giselle Martins; Braga, Tarcio Teodoro; Barboza, Renato; Rios, Francisco Jose; Keller, Alexandre Castro; Cenedeze, Marcos Antonio; Hyane, Meire Ioshie; D'Imperio-Lima, Maria Regina; Figueiredo-Neto, Antonio Martins; Reis, Marlene Antonia; Farias Marinho, Claudio Romero; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen			Oxidative Stress and Modification of Renal Vascular Permeability Are Associated with Acute Kidney Injury during P. berghei ANKA Infection	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HEME OXYGENASE-1; ADHESION MOLECULES; FALCIPARUM-MALARIA; REPERFUSION INJURY; KAPPA-B; FAILURE; SEQUESTRATION; CYTOADHERENCE; DYSFUNCTION	Malaria associated-acute kidney injury (AKI) is associated with 45% of mortality in adult patients hospitalized with severe form of the disease. However, the causes that lead to a framework of malaria-associated AKI are still poorly characterized. Some clinical studies speculate that oxidative stress products, a characteristic of Plasmodium infection, as well as proinflammatory response induced by the parasite are involved in its pathophysiology. Therefore, we aimed to investigate the development of malaria-associated AKI during infection by P. berghei ANKA, with special attention to the role played by the inflammatory response and the involvement of oxidative stress. For that, we took advantage of an experimental model of severe malaria that showed significant changes in the renal pathophysiology to investigate the role of malaria infection in the renal microvascular permeability and tissue injury. Therefore, BALB/c mice were infected with P. berghei ANKA. To assess renal function, creatinine, blood urea nitrogen, and ratio of proteinuria and creatininuria were evaluated. The products of oxidative stress, as well as cytokine profile were quantified in plasma and renal tissue. The change of renal microvascular permeability, tissue hypoxia and cellular apoptosis were also evaluated. Parasite infection resulted in renal dysfunction. Furthermore, we observed increased expression of adhesion molecule, proinflammatory cytokines and products of oxidative stress, associated with a decrease mRNA expression of HO-1 in kidney tissue of infected mice. The measurement of lipoprotein oxidizability also showed a significant increase in plasma of infected animals. Together, our findings support the idea that products of oxidative stress, as well as the immune response against the parasite are crucial to changes in kidney architecture and microvascular endothelial permeability of BALB/c mice infected with P. berghei ANKA.	[Elias, Rosa Maria; Barreto, Claudiene Rodrigues; Silva, Reinaldo Correia; Castoldi, Angela; Cenedeze, Marcos Antonio; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Dept Med, Disciplina Nefrol, Sao Paulo, Brazil; [Correa-Costa, Matheus; Hayashida, Caroline Y.; Goncalves, Giselle Martins; Braga, Tarcio Teodoro; Rios, Francisco Jose; Hyane, Meire Ioshie; D'Imperio-Lima, Maria Regina; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Dept Imunol, Lab Imunobiol Transplantes, Sao Paulo, Brazil; [Keller, Alexandre Castro] Univ Fed Sao Paulo, Dept Imunol, Sao Paulo, Brazil; [Figueiredo-Neto, Antonio Martins] Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, Brazil; [Reis, Marlene Antonia] Univ Fed Triangulo Mineiro, Div Patol, Uberaba, Brazil; [Barboza, Renato; Farias Marinho, Claudio Romero] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Pacheco-Silva, Alvaro] Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro; Universidade de Sao Paulo; Hospital Israelita Albert Einstein	Elias, RM (corresponding author), Univ Fed Sao Paulo, Dept Med, Disciplina Nefrol, Sao Paulo, Brazil.	niels@icb.usp.br	Complexos, INCT Fluidos/H-9172-2013; D'Império Lima, Maria Regina/I-4747-2012; Barboza, Renato/G-5833-2012; Marinho, Claudio Romero Farias/F-7507-2012; Pacheco-Silva, Alvaro/K-3583-2013; Castoldi, Angela/K-1889-2015; Keller, Alexandre C/E-4621-2012; Rios, Francisco J./C-6059-2012; Braga, Tarcio/AAG-4475-2020; Camara, Niels OS/G-8336-2011; camara, niels olsen saraiva/AAX-3269-2020; Correa-Costa, Matheus/B-2006-2014; Silva, Reinaldo/C-6285-2013; Braga, Tarcio T/E-4827-2014; Neto, Antonio Martins Figueiredo/ABA-5229-2020; Neto, Antonio MF/A-5222-2009	D'Império Lima, Maria Regina/0000-0002-4683-7709; Barboza, Renato/0000-0002-6441-7513; Marinho, Claudio Romero Farias/0000-0002-1227-3845; Keller, Alexandre C/0000-0002-7827-0292; Camara, Niels OS/0000-0001-5436-1248; camara, niels olsen saraiva/0000-0001-5436-1248; Braga, Tarcio T/0000-0002-2989-1076; Neto, Antonio Martins Figueiredo/0000-0002-6339-8699; Neto, Antonio MF/0000-0002-6339-8699; Rios, Francisco/0000-0002-8194-0787; Castoldi, Angela/0000-0002-8434-7989	State of Sao Paulo Foundation for Research Support (FAPESP) [07/07139-3, 10/52180-4, 12/02270-2]; CAPES; Brazilian Council of Scientific and Technologic Development (International Associated Laboratory of Renal Immunopathology, CNPq/Inserm); Complex Fluids INCT (FAPESP/CNPq)	State of Sao Paulo Foundation for Research Support (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Council of Scientific and Technologic Development (International Associated Laboratory of Renal Immunopathology, CNPq/Inserm); Complex Fluids INCT (FAPESP/CNPq)	This study was supported by grants 07/07139-3, 10/52180-4 and 12/02270-2 from the State of Sao Paulo Foundation for Research Support (FAPESP), CAPES (PRODOC grant), Brazilian Council of Scientific and Technologic Development (International Associated Laboratory of Renal Immunopathology, CNPq/Inserm) and Complex Fluids INCT (FAPESP/CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rohani M, SAUDI J KIDNEY DIS T, V22, P829; Andrade BB, J IMMUNOL, V185, P1196; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barsoum RS, 2000, J AM SOC NEPHROL, V11, P2147, DOI 10.1681/ASN.V11112147; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Chen XP, 2007, CHINESE MED J-PEKING, V120, P421, DOI 10.1097/00029330-200703010-00015; Cojean S, 2008, PARASITE, V15, P163, DOI 10.1051/parasite/2008152163; Correa-Costa M, PLOS ONE, V5; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; Dear JW, 2006, KIDNEY INT, V69, P832, DOI 10.1038/sj.ki.5000165; Eiam-Ong S, 2003, SEMIN NEPHROL, V23, P21, DOI 10.1053/snep.2003.50002; Eiam-Ong S, 1998, AM J KIDNEY DIS, V32, P361, DOI 10.1053/ajkd.1998.v32.pm9740151; Epiphanio S, 2008, CELL HOST MICROBE, V3, P331, DOI 10.1016/j.chom.2008.04.003; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Furuichi K, NEPHRON EXTRA, V2, P27; Goncalves GM, 2006, KIDNEY INT, V70, P1742, DOI 10.1038/sj.ki.5001893; Goncalves GM, 2006, INT IMMUNOPHARMACOL, V6, P1966, DOI 10.1016/j.intimp.2006.07.009; Heyman SN, CONTRIB NEPHROL, V174, P138; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kanodia KV, SAUDI J KIDNEY DIS T, V21, P1088; Kaur D, 2007, J TROP PEDIATRICS, V53, P210, DOI 10.1093/tropej/fml092; Kontush A, 1997, BIOFACTORS, V6, P99, DOI 10.1002/biof.5520060203; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; LAWRENCE C, 1986, AM J CLIN PATHOL, V86, P360, DOI 10.1093/ajcp/86.3.360; Lee HS, 2009, AM J NEPHROL, V29, P62, DOI 10.1159/000151277; Liu MC, 2009, MICROVASC RES, V77, P340, DOI 10.1016/j.mvr.2009.01.011; Mishra SK, 2008, SEMIN NEPHROL, V28, P395, DOI 10.1016/j.semnephrol.2008.04.007; Mshana R N, 1991, J Clin Lab Immunol, V34, P131; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Rabb H, 1997, KIDNEY INT, V51, P1463, DOI 10.1038/ki.1997.200; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shibahara S, 2003, TOHOKU J EXP MED, V200, P167, DOI 10.1620/tjem.200.167; Sibmooh Nathawut, 2004, Lipids Health Dis, V3, P15, DOI 10.1186/1476-511X-3-15; Sinniah R, 1999, INT J EXP PATHOL, V80, P87, DOI 10.1046/j.1365-2613.1999.00101.x; Siqueira AM, AM J TROP MED HYG, V83, P271; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; Tristao VR, J FLUORESC, V20, P665; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; Weiser S, 2007, CYTOKINE, V37, P84, DOI 10.1016/j.cyto.2007.02.021; William T, EMERG INFECT DIS, V17, P1248; Xu Y, INT J MOL MED, V26, P679; Yasuda H, 2006, KIDNEY INT, V69, P1535, DOI 10.1038/sj.ki.5000300; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; Yurdakan G, KAOHSIUNG J MED SCI, V28, P16	50	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44004	10.1371/journal.pone.0044004	http://dx.doi.org/10.1371/journal.pone.0044004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952850	gold, Green Submitted, Green Published			2022-12-27	WOS:000308221300041
J	Hamlyn, E; Ewings, FM; Porter, K; Cooper, DA; Tambussi, G; Schechter, M; Pedersen, C; Okulicz, JF; McClure, M; Babiker, A; Weber, J; Fidler, S				Hamlyn, Elizabeth; Ewings, Fiona M.; Porter, Kholoud; Cooper, David A.; Tambussi, Giuseppe; Schechter, Mauro; Pedersen, Court; Okulicz, Jason F.; McClure, Myra; Babiker, Abdel; Weber, Jonathan; Fidler, Sarah		INSIGHT SMART Investigator; SPARTAC Investigator	Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV Infection	PLOS ONE			English	Article							EARLY ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; TRANSMISSION; INTERRUPTION; RESERVOIR; ERADICATION; INITIATION; TRIAL; VIRUS; TREAT	Objectives: The magnitude of HIV viral rebound following ART cessation has consequences for clinical outcome and onward transmission. We compared plasma viral load (pVL) rebound after stopping ART initiated in primary (PHI) and chronic HIV infection (CHI). Design: Two populations with protocol-indicated ART cessation from SPARTAC (PHI, n = 182) and SMART (CHI, n = 1450) trials. Methods: Time for pVL to reach pre-ART levels after stopping ART was assessed in PHI using survival analysis. Differences in pVL between PHI and CHI populations 4 weeks after stopping ART were examined using linear and logistic regression. Differences in pVL slopes up to 48 weeks were examined using linear mixed models and viral burden was estimated through a time-averaged area-under-pVL curve. CHI participants were categorised by nadir CD4 at ART stop. Results: Of 171 PHI participants, 71 (41.5%) rebounded to pre-ART pVL levels, at a median of 50 (95% CI 48-51) weeks after stopping ART. Four weeks after stopping treatment, although the proportion with pVL >= 400 copies/ml was similar (78% PHI versus 79% CHI), levels were 0.45 (95% CI 0.26-0.64) log10 copies/ml lower for PHI versus CHI, and remained lower up to 48 weeks. Lower CD4 nadir in CHI was associated with higher pVL after ART stop. Rebound for CHI participants with CD4 nadir >500 cells/mm(3) was comparable to that experienced by PHI participants. Conclusions: Stopping ART initiated in PHI and CHI was associated with viral rebound to levels conferring increased transmission risk, although the level of rebound was significantly lower and sustained in PHI compared to CHI.	[Hamlyn, Elizabeth] Kings Coll Hosp Natl Hlth Serv Fdn Trust, London, England; [Ewings, Fiona M.; Porter, Kholoud; Babiker, Abdel] Med Res Council Clin Trials Unit, London, England; [Cooper, David A.] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Cooper, David A.] Univ New S Wales, Sydney, NSW, Australia; [Tambussi, Giuseppe] Ist Sci San Raffaele, Vaccine & Immunotherapy Res Ctr, I-20132 Milan, Italy; [Schechter, Mauro] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Pedersen, Court] Odense Univ Hosp, DK-5000 Odense, Denmark; [Okulicz, Jason F.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Okulicz, Jason F.] San Antonio Mil Med Ctr, Ft Sam Houston, TX USA; [Hamlyn, Elizabeth; McClure, Myra; Weber, Jonathan; Fidler, Sarah] Univ London Imperial Coll Sci Technol & Med, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital; Medical Research Council Clinical Trials Unit; University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universidade Federal do Rio de Janeiro; University of Southern Denmark; Odense University Hospital; Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; Imperial College London	Hamlyn, E (corresponding author), Kings Coll Hosp Natl Hlth Serv Fdn Trust, London, England.	e.hamlyn@nhs.net	Suñe, Tomàs Pumarola/F-7583-2017; Emery, Sean/O-9122-2019; Schechter, Mauro/AAG-7445-2020; Pumarola, Tomàs/AAB-5532-2019; Emery, Sean/J-3825-2017	Suñe, Tomàs Pumarola/0000-0002-5171-7461; Emery, Sean/0000-0001-6072-8309; Pumarola, Tomàs/0000-0002-5171-7461; Emery, Sean/0000-0001-6072-8309; Frater, John/0000-0001-7163-7277; Arenas-Pinto, Alejandro/0000-0002-3368-5005; Fidler, Sarah/0000-0003-1676-7583; Tambussi, Giuseppe/0000-0002-0604-2960; McClure, Myra/0000-0002-5494-407X; Porter, Kholoud/0000-0002-9226-6206; Leen, Clifford/0000-0001-8439-7719; Ohm-Laursen, Line/0000-0003-3105-3888; Tuset, Montse/0000-0002-9153-6956; fox, Julie/0000-0002-0583-8019; Thomason, Margaret/0000-0003-3590-0140	Wellcome Trust [WT069598MA, 069598/Z/02/B]; National Institute of Health [U01-AI068641, U01-AI046362, U01-AI042170]; MRC [G108/626, MC_U122886352] Funding Source: UKRI; Medical Research Council [MC_U122886352, G108/626] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042170, R01AI046995, U01AI046362, U01AI068641] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by Wellcome Trust grants WT069598MA and 069598/Z/02/B. The Biomedical Research Centre provided staff and infrastructure support in the United Kingdom. The SMART trial was funded by National Institute of Health Grants U01-AI068641, U01-AI046362 and U01-AI042170. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2006, LANCET, V368, P459, DOI 10.1016/S0140-6736(06)69153-8; Burman W, 2008, JAIDS-J ACQ IMM DEF, V49, P142, DOI 10.1097/QAI.0b013e318183a9ad; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fidler S, 2011, 6 IAS C HIV PATH TRE; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hamlyn E, 2010, CURR OPIN HIV AIDS, V5, P283, DOI 10.1097/COH.0b013e32833a6b11; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Lillo F, 2002, J BIOL REG HOMEOS AG, V16, P49; Oxenius A, 2002, P NATL ACAD SCI USA, V99, P13747, DOI 10.1073/pnas.202372199; Pires A, 2004, JAIDS-J ACQ IMM DEF, V36, P783, DOI 10.1097/00126334-200407010-00004; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Siliciano JD, 2006, CURR OPIN HIV AIDS, V1, P121, DOI 10.1097/01.COH.0000209582.82328.b8; Steingrover R, 2008, AIDS, V22, P1583, DOI 10.1097/QAD.0b013e328305bd77; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Wagner BG, 2010, AIDS, V24, P775, DOI 10.1097/QAD.0b013e3283366782; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wit FW, 2000, AIDS S4, V19, P345	23	51	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43754	10.1371/journal.pone.0043754	http://dx.doi.org/10.1371/journal.pone.0043754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952756	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000308221300025
J	Parthasarathy, G; Lun, SC; Guo, HD; Ammerman, NC; Geiman, DE; Bishai, WR				Parthasarathy, Geetha; Lun, Shichun; Guo, Haidan; Ammerman, Nicole C.; Geiman, Deborah E.; Bishai, William R.			Rv2190c, an NlpC/P60 Family Protein, Is Required for Full Virulence of Mycobacterium tuberculosis	PLOS ONE			English	Article							RESUSCITATION-PROMOTING FACTORS; GROWTH IN-VITRO; LISTERIA-MONOCYTOGENES; CELL-SEPARATION; BACILLUS-SUBTILIS; GENE; VIVO; P60; MUTAGENESIS; DIVISION	Mycobacterium tuberculosis, the etiologic agent of tuberculosis (TB) possesses at least five genes predicted to encode proteins with NlpC/P60 hydrolase domains, including the relatively uncharacterized Rv2190c. As NlpC/P60 domain-containingdomain-containing proteins are associated with diverse roles in bacterial physiology, our objective was to characterize Rv2190c in M. tuberculosis growth and virulence. Our data indicate that lack of Rv2190c is associated with impaired growth, both in vitro and during an in vivo mouse model of TB. These growth defects are associated with altered colony morphology and phthiocerol dimycocerosate levels, indicating that Rv2190c is involved in cell wall maintenance and composition. In addition, we have demonstrated that Rv2190c is expressed during active growth phase and that its protein product is immunogenic during infection. Our findings have significant implications, both for better understanding the role of Rv2190c in M. tuberculosis biology and also for translational developments.	[Parthasarathy, Geetha; Lun, Shichun; Guo, Haidan; Ammerman, Nicole C.; Geiman, Deborah E.; Bishai, William R.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Bishai, William R.] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Howard Hughes Medical Institute	Parthasarathy, G (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	wbishai1@jhmi.edu		Ammerman, Nicole C./0000-0001-9359-9144	HHMI; NIH [AI36973, AI37856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036973, R01AI037856, R29AI036973] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge the support of HHMI and NIH grants AI36973 and AI37856. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Gao LY, 2006, INFECT IMMUN, V74, P1757, DOI 10.1128/IAI.74.3.1757-1767.2006; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; HESS J, 1995, INFECT IMMUN, V63, P2047, DOI 10.1128/IAI.63.5.2047-2053.1995; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Hett EC, 2007, MOL MICROBIOL, V66, P658, DOI 10.1111/j.1365-2958.2007.05945.x; Hett EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001020; Ishikawa S, 1998, J BACTERIOL, V180, P2549, DOI 10.1128/JB.180.9.2549-2555.1998; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lee JH, 2008, J BACTERIOL, V190, P699, DOI 10.1128/JB.01273-07; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Nedeltchev GG, 2009, INFECT IMMUN, V77, P598, DOI 10.1128/IAI.01132-08; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Pilgrim S, 2003, INFECT IMMUN, V71, P3473, DOI 10.1128/IAI.71.6.3473-3484.2003; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Thayil SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028076; Tsuge Y, 2008, J BACTERIOL, V190, P8204, DOI 10.1128/JB.00752-08; Tufariello JM, 2004, INFECT IMMUN, V72, P515, DOI 10.1128/IAI.72.1.515-526.2004; WHO, 2008, 2008 TUB FACTS; WHO, 2011, WHO GLOBAL TUBERCULO; WUENSCHER MD, 1993, J BACTERIOL, V175, P3491, DOI 10.1128/jb.175.11.3491-3501.1993	28	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43429	10.1371/journal.pone.0043429	http://dx.doi.org/10.1371/journal.pone.0043429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952680	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300015
J	Wu, CC; D'Argenio, D; Asgharzadeh, S; Triche, T				Wu, Chia-Chin; D'Argenio, David; Asgharzadeh, Shahab; Triche, Timothy			TARGETgene: A Tool for Identification of Potential Therapeutic Targets in Cancer	PLOS ONE			English	Article							PHASE-II TRIAL; METASTATIC BREAST-CANCER; D-RECEPTOR VDR; VITAMIN-D; CELL-CYCLE; KINASE INHIBITORS; ARSENIC TRIOXIDE; NETWORK; PATHWAYS; TRASTUZUMAB	The vast array of in silico resources and data of high throughput profiling currently available in life sciences research offer the possibility of aiding cancer gene and drug discovery process. Here we propose to take advantage of these resources to develop a tool, TARGETgene, for efficiently identifying mutation drivers, possible therapeutic targets, and drug candidates in cancer. The simple graphical user interface enables rapid, intuitive mapping and analysis at the systems level. Users can find, select, and explore identified target genes and compounds of interest (e. g., novel cancer genes and their enriched biological processes), and validate predictions using user-defined benchmark genes (e. g., target genes detected in RNAi screens) and curated cancer genes via TARGETgene. The high-level capabilities of TARGETgene are also demonstrated through two applications in this paper. The predictions in these two applications were then satisfactorily validated by several ways, including known cancer genes, results of RNAi screens, gene function annotations, and target genes of drugs that have been used or in clinical trial in cancer treatments. TARGETgene is freely available from the Biomedical Simulations Resource web site (http://bmsr.usc.edu/Software/TARGET/TARGET.html).	[Wu, Chia-Chin] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [D'Argenio, David] Univ So Calif, Dept Biomed Engn & Biomed Simulat Resource, Los Angeles, CA USA; [Asgharzadeh, Shahab; Triche, Timothy] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Asgharzadeh, Shahab; Triche, Timothy] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	University of Texas System; UTMD Anderson Cancer Center; University of Southern California; University of Southern California; Children's Hospital Los Angeles	Wu, CC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	perwu777@gmail.com	Wu, Chia-Chin/ABD-5516-2021	Wu, Chia-Chin/0000-0002-5208-6016; Asgharzadeh, Shahab/0000-0002-0510-3848; D'Argenio, David/0000-0003-3658-7088	National Institutes of Health (NIH) [P41-EB001978]; U.S. Department of Defence [W81XWH-07-1-0580]; NIH Child Health Research Career Development Award Program [K12-CA60104]; NATIONAL CANCER INSTITUTE [U01CA060104, R01CA060104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001978] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defence(United States Department of Defense); NIH Child Health Research Career Development Award Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health (NIH) grant P41-EB001978 (to DD), U.S. Department of Defence grant W81XWH-07-1-0580 (to TT), and NIH Child Health Research Career Development Award Program K12-CA60104 (to SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; BURAS RR, 1994, BREAST CANCER RES TR, V31, P191, DOI 10.1007/BF00666153; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costa JL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-499; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Diesing D, 2006, ANTICANCER RES, V26, P2755; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Farina AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004797; Fornier MN, 2007, CLIN CANCER RES, V13, P5841, DOI 10.1158/1078-0432.CCR-07-1218; Fornier MN, 2011, ANN ONCOL, V22, P2575, DOI 10.1093/annonc/mdr018; Frampton JE, 2009, DRUGS, V69, P2125, DOI 10.2165/11203240-000000000-00000; Frank DA, 2009, IDRUGS, V12, P29; Friedrich M, 2002, HISTOCHEM J, V34, P35, DOI 10.1023/A:1021343825552; Fujii T, 2008, CURR MED CHEM, V15, P528, DOI 10.2174/092986708783769759; Gilsdorf M, 2010, NUCLEIC ACIDS RES, V38, pD448, DOI 10.1093/nar/gkp1038; Gligorov J, 2008, BREAST CANCER RES TR, V112, P53, DOI 10.1007/s10549-008-0232-x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawkins W, 2005, CANCER BIOL THER, V4, P1275, DOI 10.4161/cbt.4.11.2286; Herold CI, 2011, CLIN CANCER RES, V17, P6061, DOI 10.1158/1078-0432.CCR-11-1071; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hodge AE, 2007, CLIN PHARMACOL THER, V81, P21, DOI 10.1038/sj.clpt.6100048; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaufman B, 2009, J CLIN ONCOL, V27, P5529, DOI 10.1200/JCO.2008.20.6847; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kostner K, 2009, ANTICANCER RES, V29, P3511; Kohfeld S, 2007, EUR J MED CHEM, V42, P1317, DOI 10.1016/j.ejmech.2007.02.007; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee SK, 2009, ADV DRUG DELIVER REV, V61, P650, DOI 10.1016/j.addr.2009.03.016; Li XQ, 2004, CANCER INVEST, V22, P389, DOI 10.1081/CNV-200029068; Liu HF, 2003, J BIOL CHEM, V278, P2541, DOI 10.1074/jbc.M210391200; Loging W, 2007, NAT REV DRUG DISCOV, V6, P220, DOI 10.1038/nrd2265; Luu TH, 2008, CLIN CANCER RES, V14, P7138, DOI 10.1158/1078-0432.CCR-08-0122; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mills E, 2005, J PINEAL RES, V39, P360, DOI 10.1111/j.1600-079X.2005.00258.x; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Perotti C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2193; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Srougi MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017108; Stears RL, 2003, NAT MED, V9, P140, DOI 10.1038/nm0103-140; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Torkamani A, 2009, GENOME RES, V19, P1570, DOI 10.1101/gr.092833.109; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang Q, 2002, CANCER LETT, V179, P71, DOI 10.1016/S0304-3835(01)00846-1; Wardley AM, 2010, J CLIN ONCOL, V28, P976, DOI 10.1200/JCO.2008.21.6531; Wesierska-Gqdek J, 2004, POL J PHARMACOL, V56, P635; Witters LM, 2004, ONCOL REP, V11, P693; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu CC, 2010, BIOINFORMATICS, V26, P807, DOI 10.1093/bioinformatics/btq044; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Ye JA, 2005, CLIN EXP PHARMACOL P, V32, P1042, DOI 10.1111/j.1440-1681.2005.04302.x; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014	72	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43305	10.1371/journal.pone.0043305	http://dx.doi.org/10.1371/journal.pone.0043305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952662	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300011
J	Alba, A; Bicout, DJ; Vidal, F; Curco, A; Allepuz, A; Napp, S; Garcia-Bocanegra, I; Costa, T; Casal, J				Alba, Anna; Bicout, Dominique J.; Vidal, Francesc; Curco, Antoni; Allepuz, Alberto; Napp, Sebastian; Garcia-Bocanegra, Ignacio; Costa, Taiana; Casal, Jordi			Model to Track Wild Birds for Avian Influenza by Means of Population Dynamics and Surveillance Information	PLOS ONE			English	Article							A-VIRUS; SHEDDING PATTERNS; SENTINEL DUCKS; INFECTION; EPIZOOTIOLOGY; PERPETUATION; TRANSMISSION; MALLARDS; TURKEYS; GULLS	Design, sampling and data interpretation constitute an important challenge for wildlife surveillance of avian influenza viruses (AIV). The aim of this study was to construct a model to improve and enhance identification in both different periods and locations of avian species likely at high risk of contact with AIV in a specific wetland. This study presents an individual-based stochastic model for the Ebre Delta as an example of this appliance. Based on the Monte-Carlo method, the model simulates the dynamics of the spread of AIV among wild birds in a natural park following introduction of an infected bird. Data on wild bird species population, apparent AIV prevalence recorded in wild birds during the period of study, and ecological information on factors such as behaviour, contact rates or patterns of movements of waterfowl were incorporated as inputs of the model. From these inputs, the model predicted those species that would introduce most of AIV in different periods and those species and areas that would be at high risk as a consequence of the spread of these AIV incursions. This method can serve as a complementary tool to previous studies to optimize the allocation of the limited AI surveillance resources in a local complex ecosystem. However, this study indicates that in order to predict the evolution of the spread of AIV at the local scale, there is a need for further research on the identification of host factors involved in the interspecies transmission of AIV.	[Alba, Anna; Allepuz, Alberto; Napp, Sebastian; Garcia-Bocanegra, Ignacio; Casal, Jordi] Univ Autonoma Barcelona IRTA, Ctr Recerca Sanitat Anim, Barcelona, Spain; [Bicout, Dominique J.] Ctr Natl Rech Sci VetAgro Sup, Unite Biomath & Epidemiol, Environm & Predict Sante Populat TIMC, Marcy Letoile, France; [Vidal, Francesc; Curco, Antoni] Parc Nat Delta Ebre, Dept Medi Ambient & Habitatge, Tarragona, Spain; [Allepuz, Alberto; Costa, Taiana; Casal, Jordi] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Garcia-Bocanegra, Ignacio] Univ Cordoba, Fac Vet, Dept Sanidad Anim, Cordoba, Spain	IRTA; VetAgro Sup; Autonomous University of Barcelona; Universidad de Cordoba	Alba, A (corresponding author), Univ Autonoma Barcelona IRTA, Ctr Recerca Sanitat Anim, Campus Univ Autonoma Barcelona, Barcelona, Spain.	ana.alba@cresa.uab.es	Bocanegra, Ignacio Garcia/G-1443-2016; Costa, Taiana/HHS-5800-2022; Costa, Taiana/O-9469-2019; Casal, Jordi/F-3020-2016; Napp, Sebastian/F-3331-2016; Allepuz, Alberto/N-2398-2014	Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Costa, Taiana/0000-0002-5010-4188; Costa, Taiana/0000-0002-5010-4188; Casal, Jordi/0000-0002-6909-9366; Napp, Sebastian/0000-0001-5813-7286; Allepuz, Alberto/0000-0003-3518-1991	Department of Agriculture, Livestock, Fisheries, Food and Environment (DAAM) of the Catalan Government (Spain)	Department of Agriculture, Livestock, Fisheries, Food and Environment (DAAM) of the Catalan Government (Spain)	This work has been supported by the Department of Agriculture, Livestock, Fisheries, Food and Environment (DAAM) of the Catalan Government (Spain) as part of Surveillance Program for Avian Influenza in Catalonia, financing the expenses of technical personnel. URL: http://www20.gencat.cat/portal/site/DAR. The funders accepted the publication of this work and had no role in its design, data analysis, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Atkinson P.W., 2006, URGENT PRELIMINARY A; Brown JD, 2008, AVIAN PATHOL, V37, P393, DOI 10.1080/03079450802216595; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Busquets N, 2010, VIRUS RES, V149, P10, DOI 10.1016/j.virusres.2009.12.005; Caron A, 2011, ECOHEALTH, V8, P109, DOI 10.1007/s10393-010-0356-4; Cebolla M, 1999, GENERALITAT CATALUNY, P86; Costa TP, 2011, AVIAN PATHOL, V40, P119, DOI 10.1080/03079457.2010.540002; Costa TP, 2010, AVIAN DIS, V54, P1286, DOI 10.1637/9480-072210-Reg.1; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; EC, 2007, EUR COMM AN DIS NOT; EC, 2009, EUR COMM AN DIS NOT; EC, 2008, EUR COMM AN DIS NOT; EC, 2006, EUR COMM AN DIS NOT; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; HALVORSON D, 1983, AVIAN DIS, V27, P77, DOI 10.2307/1590374; HALVORSON DA, 1985, APPL ENVIRON MICROB, V49, P914, DOI 10.1128/AEM.49.4.914-919.1985; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Henaux V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010997; Hesterberg U, 2007, ANN REPORT SURVEILLA; Hesterberg U., 2008, ANN REPORT SURVEILLA; Hesterberg U, 2009, INFLUENZA OTHER RESP, V3, P1, DOI 10.1111/j.1750-2659.2008.00058.x; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Krauss S, 2010, AVIAN DIS, V54, P394, DOI 10.1637/8703-031609-Review.1; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; SINNECKER R, 1983, ACTA VIROL, V27, P75; Stallknecht D. E., 2008, ECOLOGY AVIAN INFLUE, P43; Vandegrift KJ, 2010, ANN NY ACAD SCI, V1195, P113, DOI 10.1111/j.1749-6632.2010.05451.x	35	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44354	10.1371/journal.pone.0044354	http://dx.doi.org/10.1371/journal.pone.0044354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952962	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500063
J	Raafat, A; Strizzi, L; Lashin, K; Ginsburg, E; McCurdy, D; Salomon, D; Smith, GH; Medina, D; Callahan, R				Raafat, Ahmed; Strizzi, Luigi; Lashin, Karim; Ginsburg, Erika; McCurdy, David; Salomon, David; Smith, Gilbert H.; Medina, Daniel; Callahan, Robert			Effects of Age and Parity on Mammary Gland Lesions and Progenitor Cells in the FVB/N-RC Mice	PLOS ONE			English	Article							RECEPTOR-ALPHA EXPRESSION; BREAST-CANCER RISK; EPITHELIAL-CELLS; STEM-CELLS; MOUSE; GROWTH; HYPERPLASIA; PREGNANCY; HORMONE	The FVB/N mouse strain is extensively used in the development of animal models for breast cancer research. Recently it has been reported that the aging FVB/N mice develop spontaneous mammary lesions and tumors accompanied with abnormalities in the pituitary glands. These observations have a great impact on the mouse models of human breast cancer. We have developed a population of inbred FVB/N mice (designated FVB/N-RC) that have been genetically isolated for 20 years. To study the effects of age and parity on abnormalities of the mammary glands of FVB/N-RC mice, twenty-five nulliparous and multiparous (3-4 pregnancies) females were euthanized at 16-22 months of age. Examination of the mammary glands did not reveal macroscopic evidence of mammary gland tumors in either aged-nulliparous or multiparous FVB/N-RC mice (0/25). However, histological analysis of the mammary glands showed rare focal nodules of squamous changes in 2 of the aged multiparous mice. Mammary gland hyperplasia was detected in 8% and 71% of the aged-nulliparous and aged-multiparous mice, respectively. Epithelial contents and serum levels of triiodothyronine were significantly higher in the experimental groups than the 14-wk-old control mice. Immuno-histochemical staining of the pituitary gland pars distalis showed no difference in prolactin staining between the control and the aged mice. Tissue transplant and dilution studies showed no effect of age and/or parity on the ability of putative progenitor cells present among the injected mammary cells to repopulate a cleared fat pad and develop a full mammary gland outgrowth. This FVB/N-RC mouse substrain is suitable to develop mouse models for breast cancer.	[Raafat, Ahmed; Lashin, Karim; McCurdy, David; Smith, Gilbert H.; Callahan, Robert] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; [Strizzi, Luigi] Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA; [Ginsburg, Erika] NCI, Off Director, NIH, Bethesda, MD 20892 USA; [Salomon, David] NCI, Lab Canc Prevent, NIH, Bethesda, MD 20892 USA; [Medina, Daniel] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine	Raafat, A (corresponding author), NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA.	rc54d@nih.gov			NCI's Center for Cancer Research Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC005148, ZIABC010021] Funding Source: NIH RePORTER	NCI's Center for Cancer Research Intramural Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The NCI's Center for Cancer Research Intramural Research Program funded this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2003, REPRODUCTION, V125, P165, DOI 10.1530/reprod/125.2.165; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Fendrick JL, 1998, J MAMMARY GLAND BIOL, V3, P7, DOI 10.1023/A:1018766000275; Frech MS, 2005, CANCER RES, V65, P681; Gonzalez-Sancho JM, 2002, MOL CARCINOGEN, V34, P25, DOI 10.1002/mc.10046; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; Lawson JS, 1999, LANCET, V354, P1787, DOI 10.1016/S0140-6736(99)04936-3; Mahler JF, 1996, TOXICOL PATHOL, V24, P710, DOI 10.1177/019262339602400606; Neville M. C., 1987, MAMMARY GLAND DEV RE; Nieto AI, 2003, COMPARATIVE MED, V53, P433; Potter M, 1985, CURR TOP MICROBIOL, P234; Raafat A, 2004, ONCOGENE, V23, P9401, DOI 10.1038/sj.onc.1208187; Radaelli E, 2009, VET PATHOL, V46, P736, DOI 10.1354/vp.08-VP-0280-R-FL; Siwko SK, 2008, STEM CELLS, V26, P3205, DOI 10.1634/stemcells.2008-0103; SMITH GH, 1988, J CELL SCI, V90, P173; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; TANAKA T, 1980, J CLIN ENDOCR METAB, V51, P1058, DOI 10.1210/jcem-51-5-1058; Tosovic A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2587; Visvader JE, 2006, CANCER RES, V66, P9798, DOI 10.1158/0008-5472.CAN-06-2254; VONDERHAAR BK, 1982, CANCER RES, V42, P4553; Wagner KU, 2004, BREAST CANCER RES, V6, P31, DOI 10.1186/bcr723; Wakefield LM, 2003, COMPARATIVE MED, V53, P424; YOUNG LJT, 1971, EXP GERONTOL, V6, P49, DOI 10.1016/0531-5565(71)90048-9	26	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43624	10.1371/journal.pone.0043624	http://dx.doi.org/10.1371/journal.pone.0043624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952723	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500018
J	Wang, LB; Su, LF; Shen, H; Hu, DW				Wang, Lubin; Su, Longfei; Shen, Hui; Hu, Dewen			Decoding Lifespan Changes of the Human Brain Using Resting-State Functional Connectivity MRI	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DEFAULT NETWORK; QUANTITATIVE METAANALYSIS; DIMENSIONALITY REDUCTION; MOTOR-PERFORMANCE; FACE RECOGNITION; WHITE-MATTER; GRAY-MATTER; FMRI; REGRESSION	The development of large-scale functional brain networks is a complex, lifelong process that can be investigated using resting-state functional connectivity MRI (rs-fcMRI). In this study, we aimed to decode the developmental dynamics of the whole-brain functional network in seven decades (8-79 years) of the human lifespan. We first used parametric curve fitting to examine linear and nonlinear age effect on the resting human brain, and then combined manifold learning and support vector machine methods to predict individuals' "brain ages" from rs-fcMRI data. We found that age-related changes in interregional functional connectivity exhibited spatially and temporally specific patterns. During brain development from childhood to senescence, functional connections tended to linearly increase in the emotion system and decrease in the sensorimotor system; while quadratic trajectories were observed in functional connections related to higher-order cognitive functions. The complex patterns of age effect on the whole-brain functional network could be effectively represented by a low-dimensional, nonlinear manifold embedded in the functional connectivity space, which uncovered the inherent structure of brain maturation and aging. Regression of manifold coordinates with age further showed that the manifold representation extracted sufficient information from rs-fcMRI data to make prediction about individual brains' functional development levels. Our study not only gives insights into the neural substrates that underlie behavioral and cognitive changes over age, but also provides a possible way to quantitatively describe the typical and atypical developmental progression of human brain function using rs-fcMRI.	[Wang, Lubin; Su, Longfei; Shen, Hui; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Wang, LB (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn	Hu, Dewen/AAN-8511-2020; Hu, Dewen/D-1978-2015	Su, Longfei/0000-0003-0573-2756	National Basic Research Program of China [2011CB707802]; National High-Tech Program of China [2012AA011601]; National Science Foundation of China [90820304, 61003202]	National Basic Research Program of China(National Basic Research Program of China); National High-Tech Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB707802), the National High-Tech Program of China (2012AA011601), and the National Science Foundation of China (90820304, 61003202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brodersen KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002079; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fu Y, 2008, IEEE T MULTIMEDIA, V10, P578, DOI 10.1109/TMM.2008.921847; Gerber S, 2010, MED IMAGE ANAL, V14, P643, DOI 10.1016/j.media.2010.05.008; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guo GD, 2008, IEEE T IMAGE PROCESS, V17, P1178, DOI 10.1109/TIP.2008.924280; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hasan KM, 2007, NEUROREPORT, V18, P1735, DOI 10.1097/WNR.0b013e3282f0d40c; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Hasan KM, 2009, BRAIN RES, V1249, P91, DOI 10.1016/j.brainres.2008.10.026; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; He XF, 2005, IEEE T PATTERN ANAL, V27, P328, DOI 10.1109/TPAMI.2005.55; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jacques PS, 2010, NEUROBIOL AGING, V31, P315, DOI 10.1016/j.neurobiolaging.2008.03.012; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kochunov P, 2011, NEUROIMAGE, V58, P41, DOI 10.1016/j.neuroimage.2011.05.050; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; Lebel C, 2010, NEUROIMAGE, V52, P20, DOI 10.1016/j.neuroimage.2010.03.072; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Shen XL, 2008, NEUROIMAGE, V41, P886, DOI 10.1016/j.neuroimage.2008.02.051; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Su LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036147; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Williams LM, 2006, J NEUROSCI, V26, P6422, DOI 10.1523/JNEUROSCI.0022-06.2006; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	72	35	37	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44530	10.1371/journal.pone.0044530	http://dx.doi.org/10.1371/journal.pone.0044530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952990	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206500076
J	Ek, CJ; Habgood, MD; Dennis, R; Dziegielewska, KM; Mallard, C; Wheaton, B; Saunders, NR				Ek, C. Joakim; Habgood, Mark D.; Dennis, Ross; Dziegielewska, Katarzyna M.; Mallard, Carina; Wheaton, Benjamin; Saunders, Norman R.			Pathological Changes in the White Matter after Spinal Contusion Injury in the Rat	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CORD-INJURY; INFLAMMATORY RESPONSE; CHRONIC DEMYELINATION; AXONAL DAMAGE; SPARED AXONS; REGENERATION; MYELIN; IDENTIFICATION; REMYELINATION	It has been shown previously that after spinal cord injury, the loss of grey matter is relatively faster than loss of white matter suggesting interventions to save white matter tracts offer better therapeutic possibilities. Loss of white matter in and around the injury site is believed to be the main underlying cause for the subsequent loss of neurological functions. In this study we used a series of techniques, including estimations of the number of axons with pathology, immunohistochemistry and mapping of distribution of pathological axons, to better understand the temporal and spatial pathological events in white matter following contusion injury to the rat spinal cord. There was an initial rapid loss of axons with no detectable further loss beyond 1 week after injury. Immunoreactivity for CNPase indicated that changes to oligodendrocytes are rapid, extending to several millimetres away from injury site and preceding much of the axonal loss, giving early prediction of the final volume of white matter that survived. It seems that in juvenile rats the myelination of axons in white matter tracts continues for some time, which has an important bearing on interpretation of our, and previous, studies. The amount of myelin debris and axon pathology progressively decreased with time but could still be observed at 10 weeks after injury, especially at more distant rostral and caudal levels from the injury site. This study provides new methods to assess injuries to spinal cord and indicates that early interventions are needed for the successful sparing of white matter tracts following injury.	[Ek, C. Joakim; Habgood, Mark D.; Dennis, Ross; Dziegielewska, Katarzyna M.; Wheaton, Benjamin; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Ek, C. Joakim; Mallard, Carina] Univ Gothenburg, Sahlgrenska Acad, Dept Neurosci & Physiol, Gothenburg, Sweden	University of Melbourne; University of Gothenburg	Ek, CJ (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	cjek@unimelb.edu.au	Wheaton, Ben/AAC-7037-2021	Saunders, Norman/0000-0001-6660-7639; Wheaton, Benjamin/0000-0003-0619-4777; Mallard, Carina/0000-0001-8953-919X	Victorian Neurotrauma Initiative [DP048]	Victorian Neurotrauma Initiative	This work was supported by the Victorian Neurotrauma Initiative (Grant #DP048). For more information about this research fund, go to http://www.vni.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MSR, 2008, TISSUE CELL, V40, P143, DOI 10.1016/j.tice.2007.11.002; BACKE HA, 1991, PARAPLEGIA, V29, P607, DOI 10.1038/sc.1991.89; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; Cheng S, 2012, J BIOMECH, V45, P1186, DOI 10.1016/j.jbiomech.2012.01.050; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Gomes-Leal W, 2005, BRAIN RES, V1066, P57, DOI 10.1016/j.brainres.2005.10.069; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GRIFFITHS IR, 1983, J NEUROL SCI, V58, P335, DOI 10.1016/0022-510X(83)90093-X; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; HIRSCHBERG DL, 1994, J NEUROIMMUNOL, V50, P9, DOI 10.1016/0165-5728(94)90209-7; Illis LS, 2012, SPINAL CORD, V50, P259, DOI 10.1038/sc.2011.132; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Koopmans G.C., 2009, EXP NEUROL; LAMPERT P, 1967, J NEUROPATH EXP NEUR, V26, P156; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; LOTAN M, 1994, EXP NEUROL, V126, P284, DOI 10.1006/exnr.1994.1066; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Mills LR, 2004, NEUROIMAGE, V21, P1069, DOI 10.1016/j.neuroimage.2003.10.041; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Olby NJ, 1996, J NEUROCYTOL, V25, P465, DOI 10.1007/BF02284816; Plemel JR, 2011, GLIA, V59, P1891, DOI 10.1002/glia.21232; Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; Rosenberg LJ, 1997, J NEUROTRAUM, V14, P823, DOI 10.1089/neu.1997.14.823; Smith PM, 2006, BRAIN PATHOL, V16, P99, DOI 10.1111/j.1750-3639.2006.00001.x; Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Wang L, 2009, NEUROPATHOLOGY, V29, P230, DOI 10.1111/j.1440-1789.2008.00969.x; Wu B, 2009, J NEUROTRAUM, V26, P1847, DOI 10.1089/neu.2008.0551	35	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43484	10.1371/journal.pone.0043484	http://dx.doi.org/10.1371/journal.pone.0043484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952690	Green Published, gold			2022-12-27	WOS:000308206000039
J	Feng, S; Tian, EB; Zhang, L; Wang, QT; Deng, HT				Feng, Shan; Tian, Enbing; Zhang, Lei; Wang, Qingtao; Deng, Haiteng			Development of the Fc-III Tagged Protein Expression System for Protein Purification and Detection	PLOS ONE			English	Article							RECOMBINANT PROTEINS; FUSION PROTEINS; BINDING	In the present work, we developed the Fc-III tagged protein expression system for protein purification and detection. The Fc-III sequence encodes for a 13 residue peptide and this peptide is cyclized by disulfide bond formation when the fusion protein is expressed. The Fc-III-fusion proteins selectively bind to immunoglobulin Fc domains (IgG-Fc) expressed from E. coli. We showed the efficient purification of Fc-III tagged proteins by immobilized non-native IgG-Fc and the detection of the cellular locations of fusion proteins by fluorescent-conjugated IgG-Fc. Our results prove that Fc-III tagged protein expression system is a simple and efficient tool for protein purification and detection and is a useful addition to the biochemistry and proteomics toolbox.	[Feng, Shan; Zhang, Lei; Deng, Haiteng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Tian, Enbing; Wang, Qingtao] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China	Tsinghua University; Capital Medical University	Feng, S (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	dht@mail.tsinghua.edu.cn		Deng, Haiteng/0000-0001-9496-1280	Center for Life Sciences (Tsinghua University); National Natural Science Foundation of China [30872391]; U.S. National Institutes of Health [U19 DE018385]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U19DE018385] Funding Source: NIH RePORTER	Center for Life Sciences (Tsinghua University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the Center for Life Sciences (Tsinghua University), the National Natural Science Foundation of China (No.30872391), and U.S. National Institutes of Health grants (U19 DE018385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonyarattanakalin S, 2006, J AM CHEM SOC, V128, P11463, DOI 10.1021/ja062377w; Byers HL, 2009, J PROTEOMICS, V73, P231, DOI 10.1016/j.jprot.2009.09.002; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dias RLA, 2006, J AM CHEM SOC, V128, P2726, DOI 10.1021/ja057513w; HENGEN PN, 1995, TRENDS BIOCHEM SCI, V20, P285, DOI 10.1016/S0968-0004(00)89045-3; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; KARLSSON R, 1995, J IMMUNOL METHODS, V183, P43, DOI 10.1016/0022-1759(95)00030-E; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; POCKER Y, 1967, BIOCHEMISTRY-US, V6, P668, DOI 10.1021/bi00855a005; Sakamoto K, 2009, J BIOL CHEM, V284, P9986, DOI 10.1074/jbc.M807618200; Strambio-de-Castillia C, 2005, J PROTEOME RES, V4, P2250, DOI 10.1021/pr0501517; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; UHLEN M, 1992, Current Opinion in Biotechnology, V3, P363, DOI 10.1016/0958-1669(92)90164-E	14	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44208	10.1371/journal.pone.0044208	http://dx.doi.org/10.1371/journal.pone.0044208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952929	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000093
J	Lu, L; Chesters, D; Zhang, W; Li, GC; Ma, Y; Ma, HL; Song, XP; Wu, HX; Meng, FX; Zhu, CD; Liu, QY				Lu, Liang; Chesters, Douglas; Zhang, Wen; Li, Guichang; Ma, Ying; Ma, Huailei; Song, Xiuping; Wu, Haixia; Meng, Fengxia; Zhu, Chaodong; Liu, Qiyong			Small Mammal Investigation in Spotted Fever Focus with DNA-Barcoding and Taxonomic Implications on Rodents Species from Hainan of China	PLOS ONE			English	Article							DELIMITATION; MITOCHONDRIAL; PHYLOGENY; EVOLUTION; IDENTIFICATION; DIVERGENCE; AUSTRALIA; MURIDAE; GENE	Although mammals are a well-studied group of animals, making accurate field identification of small mammals is still complex because of morphological variation across developmental stages, color variation of pelages, and often damaged osteological and dental characteristics. In 2008, small mammals were collected for an epidemiological study of a spotted fever outbreak in Hainan, China. Ten species of small mammals were identified by morphological characters in the field, most using pelage color characters only. The study is extended here, in order to assess whether DNA barcoding would be suitable as an identification tool in these small mammals. Barcode clusters showed some incongruence with morphospecies, especially for some species of Rattus and Niviventer, so molecular delineation was carried out with an expanded dataset of combined cytochrome b (Cyt-b) and cytochrome c oxidase subunit I (COI) sequences. COI sequences were successfully amplified from 83% of collected mammals, but failed in all specimens of Suncus murinus, which were thus excluded in DNA barcoding analysis. Of note, ten molecular taxonomic units were found from samples of nine morphologically identified species. Accordingly, 11 species of small mammals were present in the investigated areas, including four Rattus species, three Niviventer species, Callosciurus erythraeus, Neohylomys hainanensis, Tupaia belangeri, and Suncus murinus. Based on the results of the phylogenetic and molecular delineation analyses, the systematic status of some rodent species should be redefined. R. rattus hainanicus and R. rattus sladeni are synonyms of R. andamanensis. R. losea from China and Southeast Asia comprises two independent species: R. losea and R. sakeratensis. Finally, the taxonomic status of three putative species of Niviventer should be further confirmed according to morphological, molecular and ecological characters.	[Lu, Liang; Li, Guichang; Ma, Ying; Ma, Huailei; Song, Xiuping; Wu, Haixia; Meng, Fengxia; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Vector Biol & Control, Beijing, Peoples R China; [Zhang, Wen] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Bioinformat, Beijing, Peoples R China; [Lu, Liang; Zhang, Wen; Li, Guichang; Ma, Ying; Ma, Huailei; Song, Xiuping; Wu, Haixia; Meng, Fengxia; Liu, Qiyong] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Chesters, Douglas; Zhu, Chaodong] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Ma, Ying] QingHai Inst Endem Dis Prevent & Control, Xining, Qinghai, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Zoology, CAS	Lu, L (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Vector Biol & Control, Beijing, Peoples R China.	liuqiyong@icdc.cn	Chesters, Douglas/AAF-7926-2019; ZHU, Chao-Dong/E-5961-2011	ZHU, Chao-Dong/0000-0002-9347-3178	Special Infectious Disease Program [2008ZX10004-010]; National Science and Technology Pillar Program of the Ministry of Science and Technology, China [2008BAI56B02]	Special Infectious Disease Program; National Science and Technology Pillar Program of the Ministry of Science and Technology, China	This work was supported by the Special Infectious Disease Program (Grant No. 2008ZX10004-010) and the National Science and Technology Pillar Program (2008BAI56B02) of the Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin Ken P., 2003, ACIAR Monograph Series, V100, P1; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Balakirev A.E., 2010, MOSCOW U BIOL SCI B, V65, P171, DOI [10.3103/S0096392510040139, DOI 10.3103/S0096392510040139]; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Chen W, 2011, J ZOOL, V284, P215, DOI 10.1111/j.1469-7998.2011.00797.x; Chen WC, 2010, ZOOL SCI, V27, P487, DOI 10.2108/zsj.27.487; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Fontaneto D, 2008, J EVOLUTION BIOL, V21, P580, DOI 10.1111/j.1420-9101.2007.01472.x; GOLDMAN N, 1993, J MOL EVOL, V36, P182, DOI 10.1007/BF00166252; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huang WJ, 1995, GLIRES CHINA; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jin Y, 2011, DIS SURVEIL, V26, P18; Jing MD, 2007, MOL PHYLOGENET EVOL, V44, P521, DOI 10.1016/j.ympev.2007.04.003; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Li YC, 2008, ZOOL SCI, V25, P686, DOI 10.2108/zsj.25.686; Lorenz JG, 2005, PHILOS T R SOC B, V360, P1869, DOI 10.1098/rstb.2005.1718; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Meredith RW, 2010, J MAMM EVOL, V17, P75, DOI 10.1007/s10914-010-9129-7; Meredith RW, 2009, MOL PHYLOGENET EVOL, V51, P554, DOI 10.1016/j.ympev.2009.02.009; Mills JN, 1998, EMERG INFECT DIS, V4, P529, DOI 10.3201/eid0404.980403; Monroe MC, 1999, EMERG INFECT DIS, V5, P75, DOI 10.3201/eid0501.990109; Montgelard C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-321; Musser G.G., 1973, American Museum Novitates, VNo. 2525, P1; Musser G. G., 1970, Am. Mus. Novit., VNo. 2406, P1; Musser G.G., 1981, B AM MUS NAT HIST, V168, P225; Musser Guy G., 1993, P501; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quicke DLJ, 2012, MOL ECOLOGY RESOURCE; Rambaut A., 2007, TRACER V1 4; Rivera PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022199; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Siler CD, 2010, HERPETOL MONOGR, V24, P1, DOI 10.1655/HERPMONOGRAPHS-D-10-00003.1; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Swofford DL., 2003, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang Y. X., 2003, COMPLETE CHECKLIST M; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yu HT, 1996, ZOOL STUD, V35, P195; Zhang LJ, 2009, CLIN MICROBIOL INFEC, V15, P338, DOI 10.1111/j.1469-0691.2008.02266.x; Zwickl D. J, 2006, GENETIC ALGORITHM AP	57	15	20	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43479	10.1371/journal.pone.0043479	http://dx.doi.org/10.1371/journal.pone.0043479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952689	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000038
J	Rao, VG; Bhat, J; Yadav, R; Gopalan, GP; Nagamiah, S; Bhondeley, MK; Anjinappa, SM; Ramchandra, J; Chadha, VK; Wares, F				Rao, Vikas G.; Bhat, Jyothi; Yadav, Rajiv; Gopalan, Gopi Punnathanathu; Nagamiah, Selvakumar; Bhondeley, Manoj Kumar; Anjinappa, Sharada M.; Ramchandra, Jitendra; Chadha, Vineet K.; Wares, Fraser			Prevalence of Pulmonary Tuberculosis - A Baseline Survey In Central India	PLOS ONE			English	Article							TRIBAL POPULATION; MADHYA-PRADESH; IMPLEMENTATION	Background: The present study provides an estimate of the prevalence of bacteriologially positive pulmonary tuberculosis in Jabalpur, a district in central India. Methodology/Principal Findings: A community based cross-sectional survey was undertaken in Jabalpur District of the central Indian state of Madhya Pradesh. A stratified cluster sampling design was adopted to select the sample. All eligible individuals were questioned for pulmonary symptoms suggestive of TB disease. Two sputum samples were collected from all eligible individuals and were examined by Ziehl-Neelsen smear microscopy and solid media culture methods. Of the 99,918 individuals eligible for screening, 95,071 (95.1%) individuals were screened. Of these, 7,916 (8.3%) were found to have symptoms and sputum was collected from 7,533 (95.2%) individuals. Overall prevalence of bacteriologically positive PTB was found to be 255.3 per 100,000 population (95% C. I: 195.3-315.4). Prevalence was significantly higher (p < 0.001) amongst males (355.8; 95% C. I: 304.4-413.4) compared with females (109.0; 95% C. I: 81.2-143.3). Prevalence was also significantly higher in rural areas (348.9; 95% C. I: 292.6-412.8) as compared to the urban (153.9; 95% C. I: 123.2-190.1). Conclusions/Significance: The TB situation in Jabalpur district, central India, is observed to be comparable to the TB situation at the national level (255.3 versus 249). There is however, a need to maintain and further strengthen TB control measures on a sustained and long term basis in the area to have a significant impact on the disease prevalence in the community.	[Rao, Vikas G.; Bhat, Jyothi; Yadav, Rajiv; Bhondeley, Manoj Kumar] Indian Council Med Res, Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India; [Gopalan, Gopi Punnathanathu; Nagamiah, Selvakumar] Indian Council Med Res, Natl Inst Res TB, Madras, Tamil Nadu, India; [Anjinappa, Sharada M.; Ramchandra, Jitendra; Chadha, Vineet K.] Natl TB Inst, Bangalore, Karnataka, India; [Wares, Fraser] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization	Rao, VG (corresponding author), Indian Council Med Res, Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India.	drvgrao@rediffmail.com		, Jyothi/0000-0001-8788-2250	WHO; United States Agency for International Development under WHO/TRC (NIRT) Collaborative Model DOTS Project; Indian Council of Medical Research, New Delhi	WHO(World Health Organization); United States Agency for International Development under WHO/TRC (NIRT) Collaborative Model DOTS Project(United States Agency for International Development (USAID)); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	The study was supported in part by the WHO, with financial assistance provided by the United States Agency for International Development under the WHO/TRC (NIRT) Collaborative Model DOTS Project and the Indian Council of Medical Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1974, Bull World Health Organ, V51, P473; [Anonymous], 2001, REV NAT TUB CONTR PR; [Anonymous], 2011, REV NAT TUB CONTR PR; Bhat J, 2009, INT J EPIDEMIOL, V38, P1026, DOI 10.1093/ije/dyp222; Chakma T., 1996, Indian Journal of Tuberculosis, V43, P85; Datta M, 2001, INT J TUBERC LUNG D, V5, P240; Gopi P. G., 1997, Indian Journal of Tuberculosis, V44, P171; Gopi PG, 2006, INT J TUBERC LUNG D, V10, P343; GOTHI G. D., 1979, Indian Journal of Tuberculosis, V26, P121; GOTHI GD, 1976, INDIAN J MED RES, V64, P1150; Indian Council of Medical Research, 1959, IND COUNC MED RES SP; International Institute for Population Sciences (IIPS) and Macro International, 2007, INT I POP SCI IIPS M, VI; Manjula Datta, 2000, Indian Journal of Tuberculosis, V47, P147; MAYURNATH S, 1984, INDIAN J MED RES, V80, P129; Module for Laboratory technicians, 2005, REV NAT TUB CONTR PR; Murhekar MV, 2004, B WORLD HEALTH ORGAN, V82, P836; Narang P, 1999, INT J TUBERC LUNG D, V3, P478; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Pamra SP, 1973, INDIAN J TUBERC, P20; Rao VG, 2010, INT J TUBERC LUNG D, V14, P368; Rao VG, 2010, INT J INFECT DIS, V14, pE713, DOI 10.1016/j.ijid.2010.02.2243; Subramani R, 2008, INT J TUBERC LUNG D, V12, P916; Tupasi TE, 1999, INT J TUBERC LUNG D, V3, P471; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2010, WHOHTMTB20107; World Health Organization, 1994, WHOTB94179; Yadav R, 2010, Indian J Tuberc, V57, P114	27	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43225	10.1371/journal.pone.0043225	http://dx.doi.org/10.1371/journal.pone.0043225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952651	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308206000025
J	Hastie, KM; King, LB; Zandonatti, MA; Saphire, EO				Hastie, Kathryn M.; King, Liam B.; Zandonatti, Michelle A.; Saphire, Erica Ollmann			Structural Basis for the dsRNA Specificity of the Lassa Virus NP Exonuclease	PLOS ONE			English	Article							I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; DNA SUBSTRATE; HUMAN TREX2; BINDING; MECHANISM; REVEALS; SITE; RNA	Lassa virus causes hemorrhagic fever characterized by immunosuppression. The nucleoprotein of Lassa virus, termed NP, binds the viral genome. It also has an additional enzymatic activity as an exonuclease that specifically digests double-stranded RNA (dsRNA). dsRNA is a strong signal to the innate immune system of viral infection. Digestion of dsRNA by the NP exonuclease activity appears to cause suppression of innate immune signaling in the infected cell. Although the fold of the NP enzyme is conserved and the active site completely conserved with other exonucleases in its DEDDh family, NP is atypical among exonucleases in its preference for dsRNA and its strict specificity for one substrate. Here, we present the crystal structure of Lassa virus NP in complex with dsRNA. We find that unlike the exonuclease in Klenow fragment, the double-stranded nucleic acid in complex with Lassa NP remains base-paired instead of splitting, and that binding of the paired complementary strand is achieved by "relocation" of a basic loop motif from its typical exonuclease position. Further, we find that just one single glycine that contacts the substrate strand and one single tyrosine that stacks with a base of the complementary, non-substrate strand are responsible for the unique substrate specificity. This work thus provides templates for development of antiviral drugs that would be specific for viral, rather than host exonucleases of similar fold and active site, and illustrates how a very few amino acid changes confer alternate specificity and biological phenotype to an enzyme.	[Hastie, Kathryn M.; King, Liam B.; Zandonatti, Michelle A.; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Hastie, KM (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	erica@scripps.edu		Saphire, Erica Ollmann/0000-0002-1206-7451	NIAID [HHSN27220090049C]; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NIAID grant HHSN27220090049C and The Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award and the Skaggs Institute for Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; BRENOWITZ S, 1991, J BIOL CHEM, V266, P7888; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; COWART M, 1989, BIOCHEMISTRY-US, V28, P1975, DOI 10.1021/bi00431a004; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; de Silva U, 2009, NUCLEIC ACIDS RES, V37, P2411, DOI 10.1093/nar/gkp025; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISHERHOCH SP, 1987, J INFECT DIS, V155, P465, DOI 10.1093/infdis/155.3.465; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Horio T, 2004, FEBS LETT, V577, P111, DOI 10.1016/j.febslet.2004.09.074; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kukreti P, 2008, J BIOL CHEM, V283, P17979, DOI 10.1074/jbc.M801053200; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Nguyen LH, 2001, BIOCHEMISTRY-US, V40, P7174, DOI 10.1021/bi010141t; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605	23	38	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44211	10.1371/journal.pone.0044211	http://dx.doi.org/10.1371/journal.pone.0044211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937163	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600092
J	Huang, XL; Wang, L; Zhang, H; Wang, HB; Zhao, XP; Qian, GX; Hu, JF; Ge, SF; Fan, XQ				Huang, Xiaolin; Wang, Li; Zhang, He; Wang, Haibo; Zhao, Xiaoping; Qian, Guanxiang; Hu, Jifan; Ge, Shengfang; Fan, Xianqun			Therapeutic Efficacy by Targeting Correction of Notch1-Induced Aberrants in Uveal Tumors	PLOS ONE			English	Article							ONCOLYTIC ADENOVIRUS; GENE-THERAPY; MELANOMA-CELLS; BREAST-CANCER; NOTCH1; INHIBITION; EXPRESSION; GROWTH; P53; SUPPRESSION	There is a need for more effective treatments for uveal melanoma. The recombinant oncolytic adenovirus H101 replicates specifically in p53-depleted tumor cells, and has been approved for use by the Chinese State Food and Drug Administration. However, this treatment is associated with subsequent remission. Transfection of uveal melanoma cells with a small interfering RNA against Notch1 (siNotch1) effectively suppressed Notch1 expression, resulting in significant cell growth inhibition when combined with H101 treatment. Combined treatment with siNotch1 and H101 (H101-Notch1-siRNA) greatly enhanced apoptosis and cell cycle arrest in vitro as compared to treatment with H101 or siNotch1 alone. For in vivo treatments, the combined treatment of siNotch1 and H101 showed remarkable tumor growth inhibition and prolonged mouse survival in the OCM1 xenograft model. We predict that Notch pathway deregulation could be a feature of uveal melanoma, and could be a therapeutic target, especially if p53 is concurrently targeted.	[Huang, Xiaolin; Zhao, Xiaoping; Ge, Shengfang; Fan, Xianqun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhang, He; Wang, Haibo; Hu, Jifan] Stanford Univ, Sch Med, Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Wang, Li; Zhang, He; Wang, Haibo; Zhao, Xiaoping; Qian, Guanxiang; Ge, Shengfang] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Shanghai Jiao Tong University	Fan, XQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Ophthalmol, Shanghai 200030, Peoples R China.	geshengfang@sjtu.edu.cn; fanxq@sh163.net	WANG, LI/K-2495-2014	WANG, LI/0000-0002-3784-8828	National Key Program for Basic Research of China [2010CB529902]; National Natural Science Foundation of China [10979034]; Shanghai Leading Academic Discipline Project [S30205]	National Key Program for Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by a National Key Program for Basic Research of China grant (2010CB529902) to GXQ, a National Natural Science Foundation of China grant (10979034) to SFG, and a Shanghai Leading Academic Discipline Project grant (S30205) to XQF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT DM, 1984, INVEST OPHTH VIS SCI, V25, P1284; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asnaghi L, 2012, CLIN CANCER RES, V18, P654, DOI 10.1158/1078-0432.CCR-11-1406; Aster JC, 2001, CURR OPIN HEMATOL, V8, P237, DOI 10.1097/00062752-200107000-00010; Bergelson JM, 1997, J INFECT DIS, V175, P697, DOI 10.1093/infdis/175.3.697; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Brennan K, 2003, BREAST CANCER RES, V5, P69, DOI 10.1186/bcr559; Cherubini G, 2006, CELL CYCLE, V5, P2244, DOI 10.4161/cc.5.19.3263; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Cun BY, 2012, CANCER BIOL THER, V13, P77, DOI 10.4161/cbt.13.2.18436; Damato B, 2009, ARCH OPHTHALMOL-CHIC, V127, P113, DOI 10.1001/archophthalmol.2008.529; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; Fukazawa T, 2010, INT J MOL MED, V25, P3, DOI 10.3892/ijmm_00000306; Harper JA, 2003, CLIN GENET, V64, P461, DOI 10.1046/j.1399-0004.2003.00194.x; Hu Fang, 2006, Ai Zheng, V25, P919; Huang X, 2012, BR J OPHTHALMOL; Inskip PD, 2003, CANCER CAUSE CONTROL, V14, P251, DOI 10.1023/A:1023684502638; Jia RB, 2011, MOL MED REP, V4, P163, DOI 10.3892/mmr.2010.397; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; Kasuya H, 2007, CURR CANCER DRUG TAR, V7, P123, DOI 10.2174/156800907780058826; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kujala E, 2009, ACTA OPHTHALMOL, V87, P149, DOI 10.1111/j.1755-3768.2008.01369.x; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Laws AM, 2004, EUR J IMMUNOL, V34, P726, DOI 10.1002/eji.200324772; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Masuda S, 2005, CANCER SCI, V96, P274, DOI 10.1111/j.1349-7006.2005.00048.x; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Oh JY, 2010, INT J MOL MED, V25, P369, DOI 10.3892/ijmm_00000354; Qian CF, 2009, INT J MOL MED, V24, P445, DOI 10.3892/ijmm_00000251; Rae FK, 2000, INT J CANCER, V88, P726, DOI 10.1002/1097-0215(20001201)88:5<726::AID-IJC7>3.0.CO;2-H; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Song X, 2010, INVEST OPHTH VIS SCI, V51, P2626, DOI 10.1167/iovs.09-3516; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Suzuki T, 2000, INT J ONCOL, V17, P1131; Triozzi PL, 2008, CANCER TREAT REV, V34, P247, DOI 10.1016/j.ctrv.2007.12.002; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Xu Rui-Hua, 2005, Ai Zheng, V24, P975; Yu H, 2007, INT J GYNECOL CANCER, V17, P511, DOI 10.1111/j.1525-1438.2007.00813.x; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414; Zerp SF, 1999, BRIT J CANCER, V79, P921, DOI 10.1038/sj.bjc.6690147; Zhang H, 2009, MOL THER, V17, P57, DOI 10.1038/mt.2008.236; Zhou YX, 2010, PIGM CELL MELANOMA R, V23, P661, DOI 10.1111/j.1755-148X.2010.00729.x	47	21	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44301	10.1371/journal.pone.0044301	http://dx.doi.org/10.1371/journal.pone.0044301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937170	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600101
J	Bernard, B; Thorsson, V; Rovira, H; Shmulevich, I				Bernard, Brady; Thorsson, Vesteinn; Rovira, Hector; Shmulevich, Ilya			Increasing Coverage of Transcription Factor Position Weight Matrices through Domain-level Homology	PLOS ONE			English	Article							DNA-BINDING SITES; DATABASE; IDENTIFICATION; EXPRESSION; SMART	Transcription factor-DNA interactions, central to cellular regulation and control, are commonly described by position weight matrices (PWMs). These matrices are frequently used to predict transcription factor binding sites in regulatory regions of DNA to complement and guide further experimental investigation. The DNA sequence preferences of transcription factors, encoded in PWMs, are dictated primarily by select residues within the DNA binding domain(s) that interact directly with DNA. Therefore, the DNA binding properties of homologous transcription factors with identical DNA binding domains may be characterized by PWMs derived from different species. Accordingly, we have implemented a fully automated domain-level homology searching method for identical DNA binding sequences. By applying the domain-level homology search to transcription factors with existing PWMs in the JASPAR and TRANSFAC databases, we were able to significantly increase coverage in terms of the total number of PWMs associated with a given species, assign PWMs to transcription factors that did not previously have any associations, and increase the number of represented species with PWMs over an order of magnitude. Additionally, using protein binding microarray (PBM) data, we have validated the domain-level method by demonstrating that transcription factor pairs with matching DNA binding domains exhibit comparable DNA binding specificity predictions to transcription factor pairs with completely identical sequences. The increased coverage achieved herein demonstrates the potential for more thorough species-associated investigation of protein-DNA interactions using existing resources. The PWM scanning results highlight the challenging nature of transcription factors that contain multiple DNA binding domains, as well as the impact of motif discovery on the ability to predict DNA binding properties. The method is additionally suitable for identifying domain-level homology mappings to enable utilization of additional information sources in the study of transcription factors. The domain-level homology search method, resulting PWM mappings, web-based user interface, and web API are publicly available at http://dodoma.systemsbiology.netdodoma.systemsbiology.net.	[Bernard, Brady; Thorsson, Vesteinn; Rovira, Hector; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA	Institute for Systems Biology (ISB)	Bernard, B (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	ilya.shmulevich@systemsbiology.org			National Cancer Institute [U24CA143835]; NATIONAL CANCER INSTITUTE [U24CA143835] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute [U24CA143835]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleyne TM, 2009, BIOINFORMATICS, V25, P1012, DOI 10.1093/bioinformatics/btn645; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Annala M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020059; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Lahdesmaki H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001820; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Thijs G, 2002, BIOINFORMATICS, V18, P331, DOI 10.1093/bioinformatics/18.2.331; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wagner A, 1999, BIOINFORMATICS, V15, P776, DOI 10.1093/bioinformatics/15.10.776; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42779	10.1371/journal.pone.0042779	http://dx.doi.org/10.1371/journal.pone.0042779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952610	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800012
J	Ekouevi, D; Abrams, EJ; Schlesinger, M; Myer, L; Phanuphak, N; Carter, RJ				Ekouevi, Didier; Abrams, Elaine J.; Schlesinger, Malka; Myer, Landon; Phanuphak, Nittaya; Carter, Rosalind J.		MTCT-Plus Initiative	Maternal CD4+Cell Count Decline after Interruption of Antiretroviral Prophylaxis for the Prevention of Mother-to-Child Transmission of HIV	PLOS ONE			English	Article							THERAPY	Background: We evaluated maternal CD4+ cell count (CD4+) decline after PMTCT prophylaxis in a multi-country HIV care program. Methods: Analysis was restricted to antiretroviral therapy (ART)-naive, HIV-infected pregnant women with CD4+ >= 250 cells/mm(3) at enrollment. Single-dose nevirapine (sd-NVP) or short-course antiretroviral prophylaxis (sc-ARVp) with zidovudine (AZT) or AZT + lamivudine (3TC) was initiated in 11 programs while 2 programs offered triple-drug antiretroviral prophylaxis (tARVp) (AZT+3TC+ NVP or nelfinavir). All regimens were stopped at delivery. CD4+ decline was defined as proportion of women who declined to CD4+ <350 cells/mm(3) or <200 cells/mm(3) at 24 months. Weibull regression was used for multivariable analysis. Findings: A total of 1,393 women with enrollment CD4+ >= 250 cells/mm(3) initiated tARVp (172; 12%) or sc-ARVp (532; 38%) during pregnancy or received intrapartum sd-NVP (689; 50%). At enrollment, maternal median age was 27 years (interquartile range (IQR) 23-30), median CD4+ was 469 cells/mm(3) (IQR: 363-613). At 24 months post-delivery, the cumulative probability of CD4+ decline to <200 cells/mm(3) was 12% (95% CI: 10-14). Among a subgroup of 903 women with CD4+ >= 400 cells at enrollment, the 24 month cumulative probability of decline to CD4+ <350 cells/mm(3) was 28%; (95% CI: 25-32). Lower antepartum CD4+ was associated with higher probability of CD4+ decline to <350 cells/mm(3): 46% (CD4+400-499 cells/mm(3)) vs. 19% (CD4+ >= 500 cells/mm(3)). After adjusting for age, enrollment CD4+ and WHO stage, women who received tARVp or sd-NVP were twice as likely to experience CD4+ decline to <350 cells/mm(3) within 24 months than women receiving sc-ARVp (adjusted hazard ratio: 2.2; 95% CI: 1.5-3.2, p<0.0001). Conclusion: Decline in CD4+ cell count to ART eligibility thresholds by 24 months postpartum was common among women receiving PMTCT prophylaxis during pregnancy and/or delivery.	[Ekouevi, Didier] PACCI, MTCT Plus Initiat Programme, Abidjan, Cote Ivoire; [Ekouevi, Didier] Univ Victor Segalen, ISPED, INSERM, U893, Bordeaux, France; [Abrams, Elaine J.; Carter, Rosalind J.] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs ICAP, New York, NY USA; [Abrams, Elaine J.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Schlesinger, Malka] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Phanuphak, Nittaya] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Columbia University; Columbia University; Columbia University; University of Cape Town; Thai Red Cross Society	Ekouevi, D (corresponding author), PACCI, MTCT Plus Initiat Programme, Abidjan, Cote Ivoire.	didier.ekouevi@gmail.com	Phanuphak, Nittaya/AAA-8579-2019; EKOUEVI, Didier K/E-7960-2014		Bill and Melinda Gates Foundation; William and Flora Hewlett Foundation; Robert Wood Johnson Foundation; Henry J. Kaiser Family Foundation; John D. and Catherine T. MacArthur Foundation; David and Lucille Packard Foundation; Rockefeller Foundation; Starr Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); William and Flora Hewlett Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Henry J. Kaiser Family Foundation; John D. and Catherine T. MacArthur Foundation; David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Rockefeller Foundation; Starr Foundation	Funding for the MTCT-Plus Initiative was provided by the Bill and Melinda Gates Foundation, the William and Flora Hewlett Foundation, the Robert Wood Johnson Foundation, the Henry J. Kaiser Family Foundation, the John D. and Catherine T. MacArthur Foundation, the David and Lucille Packard Foundation, the Rockefeller Foundation, and the Starr Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, HIGH POSS COST COVID; Arrive E, 2010, AIDS, V24, P2478, DOI 10.1097/QAD.0b013e32833e1659; Cavallo IK, 2010, INT J GYNECOL OBSTET, V108, P111, DOI 10.1016/j.ijgo.2009.09.014; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dabis F, 2009, AIDS, V23, P825, DOI 10.1097/QAD.0b013e32832949d5; Danel C, 2006, LANCET, V367, P1981, DOI 10.1016/S0140-6736(06)68887-9; deJong MD, 1997, AIDS, V11, pF79, DOI 10.1097/00002030-199711000-00002; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fao P, 2012, CLIN INFECT DIS, V55, P449, DOI 10.1093/cid/cis461; Fowler M, 2012, 19 C RETR OPP INF 20; Koyanagi A, 2010, AIDS RES HUM RETROV, V26, P547, DOI 10.1089/aid.2009.0138; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Palacios R, 2009, HIV MED, V10, P157, DOI 10.1111/j.1468-1293.2008.00665.x; Rabkin M, 2004, SAVING MOTHER SAVING; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Skiest DJ, 2007, J INFECT DIS, V195, P1426, DOI 10.1086/512681; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; Toro PL, 2010, AIDS, V24, P515, DOI 10.1097/QAD.0b013e3283350ecd; Watts DH, 2009, INFECT DIS OBSTET GY, V2009; WHO, 2006, ANT DRUGS TREAT PREG; WHO, 2010, REC US ANT DRUGS TRE; World Health Organization, 2012, PROGR UPD US ANT DRU	22	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43750	10.1371/journal.pone.0043750	http://dx.doi.org/10.1371/journal.pone.0043750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952754	gold, Green Published, Green Submitted			2022-12-27	WOS:000308044800058
J	Kovacevic, S; Azma, S; Irimia, A; Sherfey, J; Halgren, E; Marinkovic, K				Kovacevic, Sanja; Azma, Sheeva; Irimia, Andrei; Sherfey, Jason; Halgren, Eric; Marinkovic, Ksenija			Theta Oscillations Are Sensitive to Both Early and Late Conflict Processing Stages: Effects of Alcohol Intoxication	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FRONTAL-MIDLINE THETA; EVENT-RELATED POTENTIALS; SURFACE-BASED ANALYSIS; WORKING-MEMORY; EEG DYNAMICS; PREFRONTAL CORTEX; RESPONSE CONFLICT; DELTA-OSCILLATION; COGNITIVE CONTROL	Prior neuroimaging evidence indicates that decision conflict activates medial and lateral prefrontal and parietal cortices. Theoretical accounts of cognitive control highlight anterior cingulate cortex (ACC) as a central node in this network. However, a better understanding of the relative primacy and functional contributions of these areas to decision conflict requires insight into the neural dynamics of successive processing stages including conflict detection, response selection and execution. Moderate alcohol intoxication impairs cognitive control as it interferes with the ability to inhibit dominant, prepotent responses when they are no longer correct. To examine the effects of moderate intoxication on successive processing stages during cognitive control, spatio-temporal changes in total event-related theta power were measured during Stroop-induced conflict. Healthy social drinkers served as their own controls by participating in both alcohol (0.6 g/kg ethanol for men, 0.55 g/kg women) and placebo conditions in a counterbalanced design. Anatomically-constrained magnetoencephalography (aMEG) approach was applied to complex power spectra for theta (4-7 Hz) frequencies. The principal generator of event-related theta power to conflict was estimated to ACC, with contributions from fronto-parietal areas. The ACC was uniquely sensitive to conflict during both early conflict detection, and later response selection and execution stages. Alcohol attenuated theta power to conflict across successive processing stages, suggesting that alcohol-induced deficits in cognitive control may result from theta suppression in the executive network. Slower RTs were associated with attenuated theta power estimated to ACC, indicating that alcohol impairs motor preparation and execution subserved by the ACC. In addition to their relevance for the currently prevailing accounts of cognitive control, our results suggest that alcohol-induced impairment of top-down strategic processing underlies poor self-control and inability to refrain from drinking.	[Kovacevic, Sanja; Halgren, Eric; Marinkovic, Ksenija] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Azma, Sheeva] Georgetown Univ, Interdisciplinary Program Neurosci, Washington, DC USA; [Irimia, Andrei] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Sherfey, Jason] Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA	University of California System; University of California San Diego; Georgetown University; University of California System; University of California Los Angeles; Boston University	Kovacevic, S (corresponding author), Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA.	xenia@ucsd.edu	Marinkovic, Ksenija/AAD-4701-2020; Irimia, Andrei/B-8275-2008	Marinkovic, Ksenija/0000-0003-1658-4496; Irimia, Andrei/0000-0002-9254-9388; Sherfey, Jason/0000-0001-8467-0025; Azma, Sheeva/0000-0003-4648-3717	National Institutes of Health [AA016624, RR031599]; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Investigation of Neurodevelopmental Disorders (MIND) Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by funds from the National Institutes of Health (AA016624 and RR031599) and Medical Investigation of Neurodevelopmental Disorders (MIND) Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew C, 2010, ALCOHOL CLIN EXP RES, V34, P669, DOI 10.1111/j.1530-0277.2009.01136.x; Asada H, 1999, NEUROSCI LETT, V274, P29, DOI 10.1016/S0304-3940(99)00679-5; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Bartholow BD, 2003, BIOL PSYCHOL, V64, P167, DOI 10.1016/S0301-0511(03)00108-X; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Brier MR, 2010, INT J PSYCHOPHYSIOL, V78, P215, DOI 10.1016/j.ijpsycho.2010.07.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Buxton R., 2002, INTRO FUNCTIONAL MAG; Cahalan D., 1969, MONOGRAPH RUTGERS CT, V6; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; CHANDLER BC, 1977, J STUD ALCOHOL, V38, P381, DOI 10.15288/jsa.1977.38.381; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; EYSENCK SBG, 1978, PSYCHOL REP, V43, P1247, DOI 10.2466/pr0.1978.43.3f.1247; Field M, 2010, ALCOHOL CLIN EXP RES, V34, P1346, DOI 10.1111/j.1530-0277.2010.01218.x; Fillmore Mark T, 2003, Behav Cogn Neurosci Rev, V2, P179, DOI 10.1177/1534582303257007; Finn P, 2000, REV NIAAAS NEUROSCIE, P337; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FRANCIS WN, 1982, FREQUENCY ANAL ENGLI; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gramfort A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/923703; Halgren E, 2002, CEREB CORTEX, V12, P710, DOI 10.1093/cercor/12.7.710; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Iannetti GD, 2007, MAGN RESON IMAGING, V25, P978, DOI 10.1016/j.mri.2007.03.018; Ishii R, 1999, NEUROREPORT, V10, P675, DOI 10.1097/00001756-199903170-00003; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kirmizi-Alsan E, 2006, BRAIN RES, V1104, P114, DOI 10.1016/j.brainres.2006.03.010; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krause CM, 2002, ALCOHOL, V26, P145, DOI 10.1016/S0741-8329(01)00204-X; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Lin FH, 2004, NEUROIMAGE, V23, P582, DOI 10.1016/j.neuroimage.2004.04.027; Lyvers M, 2000, EXP CLIN PSYCHOPHARM, V8, P225, DOI 10.1037/1064-1297.8.2.225; Maltzman I., 1996, PHARM ALCOHOL ALCOHO, P248; Marinkovic K, 2004, NEUROSCIENTIST, V10, P142, DOI 10.1177/1073858403261018; Marinkovic K, 2012, HUM BRAIN MAPP, V33, P319, DOI 10.1002/hbm.21213; MARTIN CS, 1993, ALCOHOL CLIN EXP RES, V17, P140, DOI 10.1111/j.1530-0277.1993.tb00739.x; McEvoy LK, 2001, COGNITIVE BRAIN RES, V11, P363, DOI 10.1016/S0926-6410(01)00009-X; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Porjesz B, 2005, CLIN NEUROPHYSIOL, V116, P993, DOI 10.1016/j.clinph.2004.12.016; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rangaswamy M, 2008, BRAIN RES, V1235, P153, DOI 10.1016/j.brainres.2008.06.053; Rangaswamy M, 2007, INT J PSYCHOPHYSIOL, V63, P3, DOI 10.1016/j.ijpsycho.2006.10.003; Repovs G, 2004, HORIZONS PSYCHOL, V13, P105; RHODES LE, 1975, ELECTROEN CLIN NEURO, V38, P561, DOI 10.1016/0013-4694(75)90156-X; Rickenbacher E, 2011, ALCOHOL IN PRESS; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Roelofs A, 2006, P NATL ACAD SCI USA, V103, P13884, DOI 10.1073/pnas.0606265103; Sammer G, 2007, HUM BRAIN MAPP, V28, P793, DOI 10.1002/hbm.20309; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Schuckit MA, 1997, ADDICTION, V92, P979, DOI 10.1046/j.1360-0443.1997.9289797.x; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Trujillo LT, 2007, CLIN NEUROPHYSIOL, V118, P645, DOI 10.1016/j.clinph.2006.11.009; Uchida S, 2003, J CLIN NEUROSCI, V10, P371, DOI 10.1016/S0967-5868(03)00025-0; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wang CM, 2005, J NEUROSCI, V25, P604, DOI 10.1523/JNEUROSCI.4151-04.2005; Yamanaka K, 2010, J COGNITIVE NEUROSCI, V22, P714, DOI 10.1162/jocn.2009.21258; ZUCKERMAN M, 1971, J CONSULT CLIN PSYCH, V36, P45, DOI 10.1037/h0030478	84	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43957	10.1371/journal.pone.0043957	http://dx.doi.org/10.1371/journal.pone.0043957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952823	gold, Green Published			2022-12-27	WOS:000308044800076
J	Ponsuksili, S; Murani, E; Schwerin, M; Schellander, K; Tesfaye, D; Wimmers, K				Ponsuksili, Siriluck; Murani, Eduard; Schwerin, Manfred; Schellander, Karl; Tesfaye, Dawit; Wimmers, Klaus			Gene Expression and DNA-Methylation of Bovine Pretransfer Endometrium Depending on Its Receptivity after In Vitro-Produced Embryo Transfer	PLOS ONE			English	Article							ADHESION MOLECULES; GROWTH-FACTORS; ESTROUS-CYCLE; IMPLANTATION; P53; WOMEN; CYTOKINES; EZH2; REPRODUCTION; PROFILES	Embryonic implantation to establish a pregnancy is a complex process that requires appropriate communication between the embryo and the maternal endometrium. Inadequate uterine receptivity may contribute to the majority of implantation failures. To provide a comprehensive inventory of genes and functional networks that represent the maternal input of the embryo-maternal cross-talk, a longitudinal, holistic study of the endometrial transcriptome in relation to the days of estrous and to the receptivity of the endometrium was performed in bovine. At day 3 of estrous, genes related to cell communication and mitochondrial energy metabolism were differentially expressed among high-and low-receptive endometria (HR, LR); at day 7, transcripts functioning in immune and inflammatory pathways, oxidative stress, and angiogenesis had different abundances. Additionally, temporal transcriptional changes between days 3 and 7 differed considerably among HR and LR. Further, several transcription factors were predicted as relevant for receptivity because they were either differentially expressed among HR and LR animals or are known to be associated with genes we detected to have differential expression. Finally, global DNA methylation varied according to the interaction of receptivity group and day of estrous, and a divergent trend, which correlated with abundance of DNMT1 transcript, was observed in LR and HR along the estrous cycle days. The study revealed that, even in early estrous, transcripts related to cell communication and response to exogenous stimuli, vascularization, and energy supply show divergent expression and longitudinal temporal regulation in HR and LR. Key components of these molecular pathways are known to be dependent on ovarian hormones that promote uterine receptivity.	[Ponsuksili, Siriluck; Schwerin, Manfred] Leibniz Inst Farm Anim Biol, Res Grp Funct Genome Anal, Dummerstorf, Germany; [Murani, Eduard; Wimmers, Klaus] Leibniz Inst Farm Anim Biol, Res Unit Mol Biol, Dummerstorf, Germany; [Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, Bonn, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Bonn	Ponsuksili, S (corresponding author), Leibniz Inst Farm Anim Biol, Res Grp Funct Genome Anal, Dummerstorf, Germany.	wimmers@fbn-dummerstorf.de	Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG PO753/6-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This research was supported by German Research Foundation (Deutsche Forschungsgemeinschaft, DFG PO753/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Aplin JD, 2000, BEST PRACT RES CL OB, V14, P757, DOI 10.1053/beog.2000.0116; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bagot CN, 2001, DEV DYNAM, V222, P538, DOI 10.1002/dvdy.1209; Bauersachs S, 2005, J MOL ENDOCRINOL, V34, P889, DOI 10.1677/jme.1.01799; Bowen JA, 2000, P SOC EXP BIOL MED, V223, P331, DOI 10.1046/j.1525-1373.2000.22348.x; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Furst RW, 2012, MOL CELL ENDOCRINOL, V348, P67, DOI 10.1016/j.mce.2011.07.032; Hastings JM, 2006, BIOL REPROD, V75, P176, DOI 10.1095/biolreprod.106.052852; HINTERMAIR V, 2007, THESIS TU MUNICH; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Hu WW, 2008, CELL CYCLE, V7, P848, DOI 10.4161/cc.7.7.5658; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hu WW, 2009, CELL CYCLE, V8, P3621, DOI 10.4161/cc.8.22.9938; Hung TH, 2011, TAIWAN J OBSTET GYNE, V45, P189; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Kammerer U, 2004, IMMUNOBIOLOGY, V209, P569, DOI 10.1016/j.imbio.2004.04.009; Kane MT, 1997, HUM REPROD UPDATE, V3, P137, DOI 10.1093/humupd/3.2.137; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; King AE, 2010, J STEROID BIOCHEM, V120, P116, DOI 10.1016/j.jsbmb.2010.01.003; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu AX, 2011, J CLIN ENDOCR METAB, V96, pE493, DOI 10.1210/jc.2010-2192; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Makker A, 2006, MED RES REV, V26, P699, DOI 10.1002/med.20061; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; Mitko K, 2008, REPRODUCTION, V135, P225, DOI 10.1530/REP-07-0415; Morsch DM, 2009, J MOL HISTOL, V40, P53, DOI 10.1007/s10735-009-9212-7; Nakamura H, 2004, AM J REPROD IMMUNOL, V51, P16, DOI 10.1046/j.8755-8920.2003.00116.x; Pafilis J, 2007, CELL TISSUE RES, V329, P1, DOI 10.1007/s00441-007-0406-6; Raaphorst FM, 2003, NEOPLASIA, V5, P481, DOI 10.1016/S1476-5586(03)80032-5; Revel A, 2005, FERTIL STERIL, V83, P580, DOI 10.1016/j.fertnstert.2004.11.008; Saino M, 2004, ONCOL REP, V12, P47; Salilew-Wondim D, 2010, PHYSIOL GENOMICS, V42, P201, DOI 10.1152/physiolgenomics.00047.2010; Simon C, 2000, BEST PRACT RES CL OB, V14, P815, DOI 10.1053/beog.2000.0121; Simon C, 1998, J REPROD IMMUNOL, V39, P117, DOI 10.1016/S0165-0378(98)00017-5; Sohr S, 2011, CELL CYCLE, V10, P3758, DOI 10.4161/cc.10.21.17946; Spell AR, 2001, THERIOGENOLOGY, V56, P287, DOI 10.1016/S0093-691X(01)00563-5; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Sugino N, 2002, REPRODUCTION, V123, P379, DOI 10.1530/reprod/123.3.379; Szczepanska M, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-1; TABIBZADEH S, 1995, HUM REPROD, V10, P1579, DOI 10.1093/HUMREP/10.6.1579; Tan YF, 2003, REPRODUCTION, V126, P171, DOI 10.1530/rep.0.1260171; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Taylor HS, 2000, HUM REPROD UPDATE, V6, P75, DOI 10.1093/humupd/6.1.75; Thomas K, 2003, FERTIL STERIL, V80, P502, DOI 10.1016/S0015-0282(03)00792-1; van Kaam KJAF, 2011, FERTIL STERIL, V95, P1421, DOI 10.1016/j.fertnstert.2011.01.031; van Mourik MSM, 2009, J LEUKOCYTE BIOL, V85, P4, DOI 10.1189/jlb.0708395; Van Vaerenbergh I, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.08.057; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Walker CG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-100; Wolf E, 2003, REPROD DOMEST ANIM, V38, P276, DOI 10.1046/j.1439-0531.2003.00435.x; Wu Y, 2007, FERTIL STERIL, V87, P24, DOI 10.1016/j.fertnstert.2006.05.077; Yamagata Y, 2009, HUM REPROD, V24, P1126, DOI 10.1093/humrep/dep015; Zanatta A, 2010, J ASSIST REPROD GEN, V27, P701, DOI 10.1007/s10815-010-9471-y; Zhai PY, 2000, AM J PHYSIOL-HEART C, V278, pH1640, DOI 10.1152/ajpheart.2000.278.5.H1640; Zhai PY, 2000, AM J PHYSIOL-HEART C, V279, pH2766, DOI 10.1152/ajpheart.2000.279.6.H2766	60	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42402	10.1371/journal.pone.0042402	http://dx.doi.org/10.1371/journal.pone.0042402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952593	Green Submitted, gold, Green Published			2022-12-27	WOS:000308044800007
J	Liu, JN; Hettmer, S; Milsom, MD; Hofmann, I; Hua, F; Miller, C; Bronson, RT; Wagers, AJ				Liu, Jianing; Hettmer, Simone; Milsom, Michael D.; Hofmann, Inga; Hua, Frederic; Miller, Christine; Bronson, Roderick T.; Wagers, Amy J.			Induction of Histiocytic Sarcoma in Mouse Skeletal Muscle	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; GRANULOCYTIC SARCOMA; ONCOGENIC KRAS; EXTRAMEDULLARY LEUKEMIA; TUMOR SUPPRESSION; MICE; INK4A/ARF; CANCER; CD47	Myeloid sarcomas are extramedullary accumulations of immature myeloid cells that may present with or without evidence of pathologic involvement of the bone marrow or peripheral blood, and often coincide with or precede a diagnosis of acute myeloid leukemia (AML). A dearth of experimental models has hampered the study of myeloid sarcomas and led us to establish a new system in which tumor induction can be evaluated in an easily accessible non-hematopoietic tissue compartment. Using ex-vivo transduction of oncogenic Kras(G12V) into p16/p19(-/-) bone marrow cells, we generated transplantable leukemia-initiating cells that rapidly induced tumor formation in the skeletal muscle of immunocompromised NOD. SCID mice. In this model, murine histiocytic sarcomas, equivalent to human myeloid sarcomas, emerged at the injection site 30-50 days after cell implantation and consisted of tightly packed monotypic cells that were CD48+, CD47+ and Mac1+, with low or absent expression of other hematopoietic lineage markers. Tumor cells also infiltrated the bone marrow, spleen and other non-hematopoietic organs of tumor-bearing animals, leading to systemic illness (leukemia) within two weeks of tumor detection. P16/p19(-/-); Kras(G12V) myeloid sarcomas were multi-clonal, with dominant clones selected during secondary transplantation. The systemic leukemic phenotypes exhibited by histiocytic sarcoma-bearing mice were nearly identical to those of animals in which leukemia was introduced by intravenous transplantation of the same donor cells. Moreover, murine histiocytic sarcoma could be similarly induced by intramuscular injection of MLL-AF9 leukemia cells. This study establishes a novel, transplantable model of murine histiocytic/myeloid sarcoma that recapitulates the natural progression of these malignancies to systemic disease and indicates a cell autonomous leukemogenic mechanism.	[Liu, Jianing; Hettmer, Simone; Hua, Frederic; Miller, Christine; Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Liu, Jianing; Hettmer, Simone; Hua, Frederic; Miller, Christine; Wagers, Amy J.] Joslin Diabet Ctr, Cambridge, MA USA; [Hettmer, Simone; Hofmann, Inga] Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hettmer, Simone; Hofmann, Inga] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Milsom, Michael D.] HI STEM Heidelberg Inst Stem Cell Technol & Expt, Heidelberg, Germany; [Milsom, Michael D.] DKFZ German Canc Res Ctr, Heidelberg, Germany; [Bronson, Roderick T.] Tufts Univ, Sch Vet Med, Cumming Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Tufts University	Liu, JN (corresponding author), Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	amy_wagers@harvard.edu	Milsom, Michael/AAK-4600-2020	/0000-0002-3567-254X; Hettmer, Simone/0000-0003-1709-4448	Harvard Stem Cell Institute; National Institutes of Health (NIH) [1RO1 HL088582, HL088582-01S1]; Hope Street Kids; P.A.L.S. Bermuda/St. Baldrick's; ALSF; Bear Necessities; Spitzencluster "Molecular and Cell Based Medicine"; German Bundesministerium fur Bildung and Forschung (BMBF); Dietmar Hopp Stiftung; NIH [K08 5K08CA140723]; NATIONAL CANCER INSTITUTE [K08CA140723] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Street Kids; P.A.L.S. Bermuda/St. Baldrick's; ALSF; Bear Necessities; Spitzencluster "Molecular and Cell Based Medicine"; German Bundesministerium fur Bildung and Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Dietmar Hopp Stiftung; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by grants from the Harvard Stem Cell Institute, and National Institutes of Health (NIH) (1RO1 HL088582 and HL088582-01S1) to AJW, by Hope Street Kids, P.A.L.S. Bermuda/St. Baldrick's, ALSF and Bear Necessities to SH, grant of Spitzencluster "Molecular and Cell Based Medicine" funded by the German Bundesministerium fur Bildung and Forschung (BMBF) and the Dietmar Hopp Stiftung to MM, and NIH (K08 5K08CA140723) to IH. Content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Askmyr M, 2011, BONE, V48, P115, DOI 10.1016/j.bone.2010.06.003; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Braun BS, 2008, CLIN CANCER RES, V14, P2249, DOI 10.1158/1078-0432.CCR-07-1005; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Byrd JC, 1997, J CLIN ONCOL, V15, P466, DOI 10.1200/JCO.1997.15.2.466; Campidelli C, 2009, AM J CLIN PATHOL, V132, P426, DOI 10.1309/AJCP1ZA7HYZKAZHS; Carrasco DR, 2006, CANCER CELL, V9, P379, DOI 10.1016/j.ccr.2006.03.028; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Dai SM, 2000, NAT BIOTECHNOL, V18, P1108, DOI 10.1038/80323; de Vries NA, 2010, CLIN CANCER RES, V16, P3431, DOI 10.1158/1078-0432.CCR-09-3414; DOUAY L, 1991, BRIT J HAEMATOL, V79, P27, DOI 10.1111/j.1365-2141.1991.tb08002.x; Dusenbery KE, 2003, J PEDIAT HEMATOL ONC, V25, P760, DOI 10.1097/00043426-200310000-00004; Fatrai S, 2011, J BIOL CHEM, V286, P6061, DOI 10.1074/jbc.M110.201848; Frisch BJ, 2011, BLOOD; Fritz J, 2007, SKELETAL RADIOL, V36, P985, DOI 10.1007/s00256-007-0314-6; Ginsberg JP, 2002, MED PEDIATR ONCOL, V38, P387, DOI 10.1002/mpo.10069; Harris N. L., 2000, Histopathology (Oxford), V36, P69; HAUPT Y, 1992, ONCOGENE, V7, P981; Hettmer S, 2011, P NATL ACAD SCI USA, V108, P20002, DOI 10.1073/pnas.1111733108; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Johnston DL, 2012, PEDIATR BLOOD CANCER, V58, P519, DOI 10.1002/pbc.23201; Kikuchi Y, 2005, LEUKEMIA RES, V29, P445, DOI 10.1016/j.leukres.2004.09.005; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Koc Y, 1999, CANCER-AM CANCER SOC, V85, P608, DOI 10.1002/(SICI)1097-0142(19990201)85:3<608::AID-CNCR11>3.0.CO;2-5; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Koo S, 2010, HAEMATOL-HEMATOL J, V95, P1642, DOI 10.3324/haematol.2010.023168; Lane SW, 2011, BLOOD; LEMISCHKA IR, 1993, CURR OPIN GENET DEV, V3, P115, DOI 10.1016/S0959-437X(05)80351-X; LIU PI, 1973, CANCER, V31, P948, DOI 10.1002/1097-0142(197304)31:4<948::AID-CNCR2820310428>3.0.CO;2-N; Mashima R, 2010, LAB INVEST, V90, P1357, DOI 10.1038/labinvest.2010.121; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; NEIMAN RS, 1981, CANCER-AM CANCER SOC, V48, P1426, DOI 10.1002/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; Puri P, 1999, EUR J CANCER CARE, V8, P113; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; SEARS HF, 1976, CANCER-AM CANCER SOC, V37, P1808, DOI 10.1002/1097-0142(197604)37:4<1808::AID-CNCR2820370427>3.0.CO;2-U; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shank-Calvo JA, 2006, ONCOGENE, V25, P3023, DOI 10.1038/sj.onc.1209326; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sisack MJ, 1997, J AM ACAD DERMATOL, V37, P308; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tyner JW, 2009, BLOOD, V113, P1749, DOI 10.1182/blood-2008-04-152157; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588; Uhrbom L, 2002, CANCER RES, V62, P5551; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262	60	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44044	10.1371/journal.pone.0044044	http://dx.doi.org/10.1371/journal.pone.0044044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952867	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300046
J	Martins, GM; Arenas, F; Neto, AI; Jenkins, SR				Martins, Gustavo M.; Arenas, Francisco; Neto, Ana I.; Jenkins, Stuart R.			Effects of Fishing and Regional Species Pool on the Functional Diversity of Fish Communities	PLOS ONE			English	Article							BIODIVERSITY LOSS; ECOSYSTEM; BIOGEOGRAPHY; RICHNESS; PRODUCTIVITY; EXTINCTION; RESILIENCE; INSURANCE; SELECTION; PATTERNS	The potential population and community level impacts of fishing have received considerable attention, but little is known about how fishing influences communities' functional diversity at regional scales. We examined how estimates of functional diversity differed among 25 regions of variable richness and investigated the functional consequences of removing species targeted by commercial fisheries. Our study shows that fishing leads to substantial losses in functional diversity. The magnitude of such loss was, however, reduced in the more speciose regions. Moreover, the removal of commercially targeted species caused a much larger reduction in functional diversity than expected by random species deletions, which was a consequence of the selective nature of fishing for particular species traits. Results suggest that functional redundancy is spatially variable, that richer biotas provide some degree of insurance against the impact of fishing on communities' functional diversity and that fishing predominantly selects for particular species traits. Understanding how fishing impacts community functional diversity is key to predict its effects for biodiversity as well as ecosystem functioning.	[Martins, Gustavo M.; Arenas, Francisco; Neto, Ana I.] Ctr Interdisciplinar Invest Marinha & Ambiental C, Oporto, Portugal; [Martins, Gustavo M.; Neto, Ana I.] Univ Acores, Grp Biol Marina, CIRN, Ponta Delgada, Portugal; [Martins, Gustavo M.; Neto, Ana I.] Univ Acores, Dept Biol, Ponta Delgada, Portugal; [Jenkins, Stuart R.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Jenkins, Stuart R.] Marine Biol Assoc UK, Plymouth, Devon, England	Universidade do Porto; Universidade dos Acores; Universidade dos Acores; Bangor University; Marine Biological Association United Kingdom	Martins, GM (corresponding author), Ctr Interdisciplinar Invest Marinha & Ambiental C, Oporto, Portugal.	gmartins@uac.pt	de Melo Azevedo Neto, Ana Isabel/C-1505-2010; Arenas, Francisco/M-7095-2015; Jenkins, Stuart R/D-2032-2010; Martins, Gustavo M./A-8857-2008; Arenas, Francisco/M-6367-2013	de Melo Azevedo Neto, Ana Isabel/0000-0003-0708-5636; Arenas, Francisco/0000-0001-6925-3805; Jenkins, Stuart R/0000-0002-2299-6318; Martins, Gustavo M./0000-0001-5051-2221; Arenas, Francisco/0000-0001-6925-3805	Foundation for Science and Technology, Portugal [SFRH/BDP/63040/2009]; Natural Environment Research Council [NE/B504649/1] Funding Source: researchfish	Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	GMM was supported by a post-doctoral grant awarded by the Foundation for Science and Technology, Portugal (SFRH/BDP/63040/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Cardinale BJ, 2004, OIKOS, V104, P437, DOI 10.1111/j.0030-1299.2004.13254.x; Carlton JT, 1999, ANNU REV ECOL SYST, V30, P515, DOI 10.1146/annurev.ecolsys.30.1.515; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Downing AL, 2005, ECOLOGY, V86, P701, DOI 10.1890/03-0239; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Fisher JAD, 2010, MAR ECOL PROG SER, V405, P1, DOI 10.3354/meps08601; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Floeter SR, 2005, MAR BIOL, V147, P1435, DOI 10.1007/s00227-005-0027-0; Fox JW, 2005, ECOL LETT, V8, P846, DOI 10.1111/j.1461-0248.2005.00795.x; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; FROESE R, 2000, FISHBASE 2000 CONCEP; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Halpern BS, 2008, MAR ECOL PROG SER, V364, P147, DOI 10.3354/meps07553; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Ingram T, 2009, ECOLOGY, V90, P2444, DOI 10.1890/08-1841.1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Leibold MA, 2004, LIMNOL OCEANOGR, V49, P1278, DOI 10.4319/lo.2004.49.4_part_2.1278; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; LOMOLINO MV, 1984, OECOLOGIA, V61, P376, DOI 10.1007/BF00379638; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Miller TE, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P122; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Naeslund B, 2006, OIKOS, V115, P504, DOI 10.1111/j.2006.0030-1299.14782.x; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; O'Connor NE, 2005, ECOLOGY, V86, P1783, DOI 10.1890/04-1172; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Poos MS, 2009, ECOLOGY, V90, P341, DOI 10.1890/08-1638.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; Scott BE, 2006, ECOL MODEL, V191, P383, DOI 10.1016/j.ecolmodel.2005.05.015; Tegner MJ, 1996, TRENDS ECOL EVOL, V11, P278, DOI 10.1016/0169-5347(96)30029-3; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	55	22	23	8	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44297	10.1371/journal.pone.0044297	http://dx.doi.org/10.1371/journal.pone.0044297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952950	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300076
J	Giacopuzzi, E; Bresciani, R; Schauer, R; Monti, E; Borsani, G				Giacopuzzi, Edoardo; Bresciani, Roberto; Schauer, Roland; Monti, Eugenio; Borsani, Giuseppe			New Insights on the Sialidase Protein Family Revealed by a Phylogenetic Analysis in Metazoa	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; TRANS-SIALIDASE; SEQUENCE; ACID; EVOLUTION; BINDING; IDENTIFICATION; GANGLIOSIDES	Sialidases are glycohydrolytic enzymes present from virus to mammals that remove sialic acid from oligosaccharide chains. Four different sialidase forms are known in vertebrates: the lysosomal NEU1, the cytosolic NEU2 and the membrane-associated NEU3 and NEU4. These enzymes modulate the cell sialic acid content and are involved in several cellular processes and pathological conditions. Molecular defects in NEU1 are responsible for sialidosis, an inherited disease characterized by lysosomal storage disorder and neurodegeneration. The studies on the biology of sialic acids and sialyltransferases, the anabolic counterparts of sialidases, have revealed a complex picture with more than 50 sialic acid variants selectively present in the different branches of the tree of life. The gain/loss of specific sialoconjugates have been proposed as key events in the evolution of deuterostomes and Homo sapiens, as well as in the host-pathogen interactions. To date, less attention has been paid to the evolution of sialidases. Thus we have conducted a survey on the state of the sialidase family in metazoan. Using an in silico approach, we identified and characterized sialidase orthologs from 21 different organisms distributed among the evolutionary tree: Metazoa relative (Monosiga brevicollis), early Deuterostomia, precursor of Chordata and Vertebrata (teleost fishes, amphibians, reptiles, avians and early and recent mammals). We were able to reconstruct the evolution of the sialidase protein family from the ancestral sialidase NEU1 and identify a new form of the enzyme, NEU5, representing an intermediate step in the evolution leading to the modern NEU3, NEU4 and NEU2. Our study provides new insights on the mechanisms that shaped the substrate specificity and other peculiar properties of the modern mammalian sialidases. Moreover, we further confirm findings on the catalytic residues and identified enzyme loop portions that behave as rapidly diverging regions and may be involved in the evolution of specific properties of sialidases.	[Giacopuzzi, Edoardo; Borsani, Giuseppe] Univ Brescia, Unit Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Bresciani, Roberto; Monti, Eugenio] Univ Brescia, Unit Biochem & Clin Chem, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Schauer, Roland] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany	University of Brescia; University of Brescia; University of Kiel	Giacopuzzi, E (corresponding author), Univ Brescia, Unit Biol & Genet, Dept Biomed Sci & Biotechnol, Brescia, Italy.	monti@med.unibs.it	Bresciani, Roberto/AAA-9728-2020; Borsani, Giuseppe/B-1709-2010	Bresciani, Roberto/0000-0002-7881-7550; Borsani, Giuseppe/0000-0003-0110-1148; MONTI, Eugenio/0000-0002-4742-7445; Giacopuzzi, Edoardo/0000-0002-5692-366X	Fondazione Cariplo; ZEBRAGENE grant; Regione Lombardia; Network Enable Drug Discovery (NEDD) grant	Fondazione Cariplo(Fondazione Cariplo); ZEBRAGENE grant; Regione Lombardia(Regione Lombardia); Network Enable Drug Discovery (NEDD) grant	This work was supported by Fondazione Cariplo (http://www.fondazionecariplo.it), ZEBRAGENE grant to G. B. and E. M. and by the Regione Lombardia (http://www.regione.lombardia.it), and Network Enable Drug Discovery (NEDD) grant to E. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Amino R, 1998, J BIOL CHEM, V273, P24575, DOI 10.1074/jbc.273.38.24575; AMINO R, 1995, GLYCOBIOLOGY, V5, P625, DOI 10.1093/glycob/5.6.625; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bao Y, 2010, MICROBES INFECT, V12, P716, DOI 10.1016/j.micinf.2010.04.014; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Beitz E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-313; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blouin C, 2004, PROTEIN SCI, V13, P608, DOI 10.1110/ps.03299804; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Buschiazzo A, 2008, CURR OPIN CHEM BIOL, V12, P565, DOI 10.1016/j.cbpa.2008.06.017; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; CHUANG NN, 1990, COMP BIOCHEM PHYS C, V97, P353, DOI 10.1016/0742-8413(90)90153-Z; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; d'Azzo A., 2001, METABOLIC MOL BASES, V3, P3811; Dell A, 1999, BBA-GEN SUBJECTS, V1473, P196, DOI 10.1016/S0304-4165(99)00179-8; Giacopuzzi E, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-45; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hollister J, 2003, GLYCOBIOLOGY, V13, P487, DOI 10.1093/glycob/cwg053; Jiang H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-444; Koles K, 2009, GLYCOCONJUGATE J, V26, P313, DOI 10.1007/s10719-008-9154-4; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Lukong KE, 2001, J BIOL CHEM, V276, P17286, DOI 10.1074/jbc.M100460200; Maddison W., 2018, MESQUITE MODULAR SYS; Manzoni M, 2007, BIOCHEM J, V408, P395, DOI 10.1042/BJ20070627; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyata S, 2011, GLYCOBIOLOGY, V21, P1596, DOI 10.1093/glycob/cwr081; Monti E, 2004, GENOMICS, V83, P445, DOI 10.1016/j.ygeno.2003.08.019; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Mozzi A, 2012, PROTEINS, V80, P1123, DOI 10.1002/prot.24013; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saito M, 2001, BBA-BIOMEMBRANES, V1511, P271, DOI 10.1016/S0005-2736(01)00282-6; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Schauer R, 1997, N COMP BIOC B, V29, P243; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schwerdtfeger SM, 2010, PHARMAZIE, V65, P551, DOI 10.1691/ph.2010.0546; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tollis Marc, 2011, Mob Genet Elements, V1, P107; Tsuji S, 1996, GLYCOBIOLOGY, V6, pR5; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	55	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44193	10.1371/journal.pone.0044193	http://dx.doi.org/10.1371/journal.pone.0044193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952925	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206500054
J	Keller, AA; Garner, K; Miller, RJ; Lenihan, HS				Keller, Arturo A.; Garner, Kendra; Miller, Robert J.; Lenihan, Hunter S.			Toxicity of Nano-Zero Valent Iron to Freshwater and Marine Organisms	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; ZEROVALENT IRON; REACTIVITY; MOBILITY	We tested whether three commercial forms (uncoated, organic coating, and iron oxide coating) of nano zero-valent iron (nZVI) are toxic to freshwater and marine organisms, specifically three species of marine phytoplankton, one species of freshwater phytoplankton, and a freshwater zooplankton species (Daphnia magna), because these organisms may be exposed downstream of where nZVI is applied to remediate polluted soil. The aggregation and reactivity of the three types of nZVI varied considerably, which was reflected in their toxicity. Since levels of Fe2+ and Fe3+ increase as the nZVI react, we also evaluated their toxicity independently. All four phytoplankton species displayed decreasing population growth rates, and Daphnia magna showed increasing mortality, in response to increasing levels of nZVI, and to a lesser degree with increasing Fe2+ and Fe3+. All forms of nZVI aggregated in soil and water, especially in the presence of a high concentration of calcium ions in groundwater, thus reducing their transports through the environment. However, uncoated nZVI aggregated extremely rapidly, thus vastly reducing the probability of environmental transport and potential for toxicity. This information can be used to design a risk management strategy to arrest the transport of injected nZVI beyond the intended remediation area, by injecting inert calcium salts as a barrier to transport.	[Keller, Arturo A.; Garner, Kendra; Miller, Robert J.; Lenihan, Hunter S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Univ Calif Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Keller, AA (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Univ Calif Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA.	keller@bren.ucsb.edu		Miller, Robert/0000-0002-8350-3759	National Science Foundation; U.S. Environmental Protection Agency [NSF-EF0830117]; National Science Foundation Grant [EF-0742521]; AECOM Environment; AECOM; Directorate For Geosciences [0962306] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); National Science Foundation Grant(National Science Foundation (NSF)); AECOM Environment; AECOM; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation and the U.S. Environmental Protection Agency under Cooperative Agreement # NSF-EF0830117, and by National Science Foundation Grant EF-0742521. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or the U.S. Environmental Protection Agency. The work was also supported by a grant from AECOM Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The authors received a $86,000 grant from AECOM to study the toxicity, mobility and persistence of nZVI, to inform their risk assessment. Arturo Keller is member of the Advisory Board of AECOM and receives a small ($3,000/yr) honorarium from AECOM. None of the authors have been employed by AECOM, and there are no patents, or conflicts with products in development or marketed products. In particular, the authors have no commercial or other conflict of interest with the manufacturer of the nano-scale zero valent iron particles used in this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barbouti A, 2001, FREE RADICAL BIO MED, V31, P490, DOI 10.1016/S0891-5849(01)00608-6; Bennett P, 2010, J CONTAM HYDROL, V116, P35, DOI 10.1016/j.jconhyd.2010.05.006; Comba S, 2009, WATER RES, V43, P3717, DOI 10.1016/j.watres.2009.05.046; Diao MH, 2009, WATER RES, V43, P5243, DOI 10.1016/j.watres.2009.08.051; EPA United States Environmental Protection Agency, 2002, 821R02012 EPA; Gavaskar A., 2005, COST PERFORMANCE REP; He F, 2007, ENVIRON SCI TECHNOL, V41, P6216, DOI 10.1021/es0705543; He F, 2010, WATER RES, V44, P2360, DOI 10.1016/j.watres.2009.12.041; He F, 2009, J COLLOID INTERF SCI, V334, P96, DOI 10.1016/j.jcis.2009.02.058; Kadar E, 2010, ENVIRON POLLUT, V158, P3490, DOI 10.1016/j.envpol.2010.03.025; Karn B, 2009, ENVIRON HEALTH PERSP, V117, P1823, DOI 10.1289/ehp.0900793; Keenan CR, 2009, ENVIRON SCI TECHNOL, V43, P4555, DOI 10.1021/es9006383; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Lee C, 2008, ENVIRON SCI TECHNOL, V42, P4927, DOI 10.1021/es800408u; Li HC, 2009, ECOTOX ENVIRON SAFE, V72, P684, DOI 10.1016/j.ecoenv.2008.09.027; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Lin YH, 2010, SCI TOTAL ENVIRON, V408, P2260, DOI 10.1016/j.scitotenv.2010.01.039; Miller RJ, 2010, ENVIRON SCI TECHNOL, V44, P7329, DOI 10.1021/es100247x; Phenrat T, 2009, ENVIRON SCI TECHNOL, V43, P195, DOI 10.1021/es801955n; Phenrat T, 2009, ENVIRON SCI TECHNOL, V43, P1507, DOI 10.1021/es802187d; Puzyn T, 2011, NAT NANOTECHNOL, V6, P175, DOI [10.1038/nnano.2011.10, 10.1038/NNANO.2011.10]; Saleh N, 2008, ENVIRON SCI TECHNOL, V42, P3349, DOI 10.1021/es071936b; Shin MC, 2008, DESALINATION, V223, P299, DOI 10.1016/j.desal.2007.01.223; Wang W, 2010, J HAZARD MATER, V173, P724, DOI 10.1016/j.jhazmat.2009.08.145; Xiu ZM, 2010, ENVIRON SCI TECHNOL, V44, P7647, DOI 10.1021/es101786y; Zhang WX, 2003, J NANOPART RES, V5, P323, DOI 10.1023/A:1025520116015	27	112	120	0	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43983	10.1371/journal.pone.0043983	http://dx.doi.org/10.1371/journal.pone.0043983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952836	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500034
J	Khan, N; Kazmi, RH; Willems, LAJ; van Heusden, AW; Ligterink, W; Hilhorst, HWM				Khan, Noorullah; Kazmi, Rashid H.; Willems, Leo A. J.; van Heusden, Adriaan W.; Ligterink, Wilco; Hilhorst, Henk W. M.			Exploring the Natural Variation for Seedling Traits and Their Link with Seed Dimensions in Tomato	PLOS ONE			English	Article							LYCOPERSICON-PIMPINELLIFOLIUM; INTERSPECIFIC CROSS; QUANTITATIVE TRAITS; SALT TOLERANCE; WATER-STRESS; QTL ANALYSIS; SIZE; GROWTH; GERMINATION; WEIGHT	The success of germination, growth and final yield of every crop depends to a large extent on the quality of the seeds used to grow the crop. Seed quality is defined as the viability and vigor attribute of a seed that enables the emergence and establishment of normal seedlings under a wide range of environments. We attempt to dissect the mechanisms involved in the acquisition of seed quality, through a combined approach of physiology and genetics. To achieve this goal we explored the genetic variation found in a RIL population of Solanum lycopersicum (cv. Moneymaker) x Solanum pimpinellifolium through extensive phenotyping of seed and seedling traits under both normal and nutrient stress conditions and root system architecture (RSA) traits under optimal conditions. We have identified 62 major QTLs on 21 different positions for seed, seedling and RSA traits in this population. We identified QTLs that were common across both conditions, as well as specific to stress conditions. Most of the QTLs identified for seedling traits co-located with seed size and seed weight QTLs and the positive alleles were mostly contributed by the S. lycopersicum parent. Co-location of QTLs for different traits might suggest that the same locus has pleiotropic effects on multiple traits due to a common mechanistic basis. We show that seed weight has a strong effect on seedling vigor and these results are of great importance for the isolation of the corresponding genes and elucidation of the underlying mechanisms.	[Khan, Noorullah; Kazmi, Rashid H.; Willems, Leo A. J.; Ligterink, Wilco; Hilhorst, Henk W. M.] Wageningen Univ, Lab Plant Physiol, Wageningen Seed Lab, Wageningen, Netherlands; [van Heusden, Adriaan W.] Wageningen Univ & Res Ctr Plant Breeding, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Khan, N (corresponding author), Wageningen Univ, Lab Plant Physiol, Wageningen Seed Lab, Wageningen, Netherlands.	wilco.ligterink@wur.nl	Ligterink, Wilco/C-8103-2009; Hilhorst, Henk/K-1658-2013	Ligterink, Wilco/0000-0002-0228-169X; hilhorst, henk/0000-0002-6743-583X	Higher Education Commission, Pakistan; Technology Foundation STW	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan); Technology Foundation STW(Technologiestichting STW)	This work was supported by the Higher Education Commission, Pakistan (NK) and by the Technology Foundation STW (RHK, LAJW, WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Armengaud P, 2009, PLANT J, V57, P945, DOI 10.1111/j.1365-313X.2008.03739.x; BAKER HG, 1972, ECOLOGY, V53, P997, DOI 10.2307/1935413; Bettey M, 2000, NEW PHYTOL, V148, P277, DOI 10.1046/j.1469-8137.2000.00760.x; BLEASDALE JK, 1967, J HORTIC SCI BIOTECH, V42, P51, DOI 10.1080/00221589.1967.11514192; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CANNON O S, 1973, Hortscience, V8, P404; Castro J., 2006, Handbook of seed science and technology, P397; CHAMBERS JC, 1995, ECOLOGY, V76, P2124, DOI 10.2307/1941687; Clerkx EJM, 2004, PLANT PHYSIOL, V135, P432, DOI 10.1104/pp.103.036814; Coolbear P, 1995, SEED QUALITY BASIC M, P223; Cornelissen JHC, 1999, OECOLOGIA, V118, P248, DOI 10.1007/s004420050725; DEVICENTE MC, 1993, GENETICS, V134, P585; DICKSON MH, 1980, HORTSCIENCE, V15, P771; Doerge RW, 1996, GENETICS, V142, P285; Doganlar S, 2000, THEOR APPL GENET, V100, P1267, DOI 10.1007/s001220051433; Doganlar S, 2002, GENOME, V45, P1189, DOI 10.1139/G02-091; DOLAN RW, 1984, AM J BOT, V71, P1302, DOI 10.2307/2443655; ELLIS RH, 1992, PLANT GROWTH REGUL, V11, P249, DOI 10.1007/BF00024563; Epstein E, 2004, NATURE, V430, P829, DOI 10.1038/430829c; Fenner M., 1991, Seed Science Research, V1, P75, DOI 10.1017/S0960258500000696; Finch-Savage W, 2010, PLANT SCI; Finch -Savage W., 1995, SEED QUALITY BASIC M, P361; Fita A, 2008, J AM SOC HORTIC SCI, V133, P448, DOI 10.21273/JASHS.133.3.448; Foolad Majid R, 2007, Int J Plant Genomics, V2007, P97386, DOI [10.1155/2007/64358, 10.1155/2007/97386]; Foolad MR, 1998, MOL BREEDING, V4, P519, DOI 10.1023/A:1009648112491; Foolad MR, 1997, MOL BREEDING, V3, P269, DOI 10.1023/A:1009668325331; GOLDMAN IL, 1995, THEOR APPL GENET, V90, P925, DOI 10.1007/BF00222905; Grandillo S, 1996, THEOR APPL GENET, V92, P935, DOI 10.1007/BF00224033; Greene DF, 1998, CAN J FOREST RES, V28, P1307, DOI 10.1139/cjfr-28-9-1307; HARPER J. L., 1970, Annual review of ecology and systematics., V1, P327, DOI 10.1146/annurev.es.01.110170.001551; Hilhorst H, 2007, ENCY LIFE SCI, P1; Hilhorst HWM, 1997, ADV AGRON, V61, P111, DOI 10.1016/S0065-2113(08)60663-X; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; JANZEN DH, 1969, EVOLUTION, V23, P1, DOI [10.2307/2406478, 10.1111/j.1558-5646.1969.tb03489.x]; JONES RA, 1986, EUPHYTICA, V35, P575, DOI 10.1007/BF00021866; Joosen RVL, 2009, CURR GENOMICS, V10, P540, DOI 10.2174/138920209789503914; Joosen RVL, 2010, PLANT J, V62, P148, DOI 10.1111/j.1365-313X.2009.04116.x; JURADO E, 1992, J ECOL, V80, P407, DOI 10.2307/2260686; Kazmi RH, 2012, PLANT CELL ENVIRON, V35, P929, DOI 10.1111/j.1365-3040.2011.02463.x; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Koller DL, 2009, MAMM GENOME, V20, P180, DOI 10.1007/s00335-008-9161-6; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; LEE WG, 1989, J ECOL, V77, P704, DOI 10.2307/2260980; Ligterink W, 2012, SEED SCI RES, V22, pS45, DOI 10.1017/S0960258511000328; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Malamy JE, 1997, TRENDS PLANT SCI, V2, P390, DOI 10.1016/S1360-1385(97)90054-6; MARSHALL DL, 1986, AM J BOT, V73, P457, DOI 10.2307/2444249; McDonald MB, 1998, SEED SCI RES, V8, P265, DOI 10.1017/S0960258500004165; Moegenburg SM, 1996, OECOLOGIA, V106, P539, DOI 10.1007/BF00329713; MORSE DH, 1985, OECOLOGIA, V67, P372, DOI 10.1007/BF00384943; NIEUWHOF M, 1989, PLANT BREEDING, V102, P248, DOI 10.1111/j.1439-0523.1989.tb00343.x; Orsi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000347; Pijl van der L., 1972, PRINCIPLES DISPERSAL; Rick C M, 1973, Basic Life Sci, V2, P255; Rick C. M., 1982, Plant improvement and somatic cell genetics, P1; RICK CHARLES M., 1958, ECON BOT, V12, P346, DOI 10.1007/BF02860023; RICK CM, 1977, PLANT SYST EVOL, V127, P139, DOI 10.1007/BF00984147; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; SCOTT SJ, 1982, EUPHYTICA, V31, P869, DOI 10.1007/BF00039227; SEIWA K, 1991, CAN J BOT, V69, P532, DOI 10.1139/b91-072; Seiwa K, 1996, VEGETATIO, V123, P51, DOI 10.1007/BF00044887; SORENSEN K, 1986, EXPERIENTIA, V42, P161, DOI 10.1007/BF01952446; STANTON ML, 1984, ECOLOGY, V65, P1105, DOI 10.2307/1938318; STEBBINS GL, 1976, OECOLOG PLANTAR, V11, P321; Stubbe H, 1960, GENET RESOUR CROP EV, V8, P110; Stubbe H, 1965, GENET RESOUR CROP EV, V13, P517; TANKSLEY SD, 1982, HEREDITY, V49, P11, DOI 10.1038/hdy.1982.61; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Teng W, 2009, HEREDITY, V102, P372, DOI 10.1038/hdy.2008.108; TRIPATHI RS, 1990, OIKOS, V57, P289, DOI 10.2307/3565956; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Voorrips RE, 2000, ACTA PHYSIOL PLANT, V22, P259, DOI 10.1007/s11738-000-0026-1; WELLER JI, 1988, GENETICS, V118, P329; Whalley WR, 1999, PLANT CELL ENVIRON, V22, P229, DOI 10.1046/j.1365-3040.1999.00412.x; Whittington W., 1973, SEED ECOLOGY, P5; Willson M.F., 1983, PLANT REPROD ECOLOGY; WINN AA, 1988, ECOLOGY, V69, P1537, DOI 10.2307/1941651; WOLF S, 1986, J AM SOC HORTIC SCI, V111, P960; WOOD DM, 1990, AM J BOT, V77, P1411, DOI 10.2307/2444751; Wothke J.L, 1999, AMOS 4 0 USERS GUIDE; Wright IJ, 1999, J ECOL, V87, P85, DOI 10.1046/j.1365-2745.1999.00330.x; WUDIRI BB, 1985, SCI HORTIC-AMSTERDAM, V27, P189, DOI 10.1016/0304-4238(85)90022-6; WULFF RD, 1986, J ECOL, V74, P99, DOI 10.2307/2260351; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529; ZHANG JH, 1991, B TORREY BOT CLUB, V118, P141, DOI 10.2307/2996855	86	40	41	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43991	10.1371/journal.pone.0043991	http://dx.doi.org/10.1371/journal.pone.0043991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952841	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206500037
J	Kudo, Y; Iizuka, S; Yoshida, M; Nguyen, PT; Siriwardena, SBSM; Tsunematsu, T; Ohbayashi, M; Ando, T; Hatakeyama, D; Shibata, T; Koizumi, K; Maeda, M; Ishimaru, N; Ogawa, I; Takata, T				Kudo, Yasusei; Iizuka, Shinji; Yoshida, Maki; Phuong Thao Nguyen; Siriwardena, Samadarani B. S. M.; Tsunematsu, Takaaki; Ohbayashi, Mariko; Ando, Toshinori; Hatakeyama, Daijiro; Shibata, Toshiyuki; Koizumi, Keiichi; Maeda, Masahiro; Ishimaru, Naozumi; Ogawa, Ikuko; Takata, Takashi			Periostin Directly and Indirectly Promotes Tumor Lymphangiogenesis of Head and Neck Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; VEGF-C; CELL-SURVIVAL; ORAL-CANCER; RECEPTOR-BINDING; GENE-EXPRESSION; LUNG-CANCER; IN-VIVO; ANGIOGENESIS	Background: Metastasis to regional lymph nodes via lymphatic vessels plays a key role in cancer progression. Tumor lymphangiogenesis is known to promote lymphatic metastasis, and vascular endothelial growth factor C (VEGF-C) is a critical activator of tumor lymphangiogenesis during the process of metastasis. We previously identified periostin as an invasion-and angiogenesis-promoting factor in head and neck squamous cell carcinoma (HNSCC). In this study, we discovered a novel role for periostin in tumor lymphangiogenesis. Methods and Findings: Periostin overexpression upregulated VEGF-C mRNA expression in HNSCC cells. By using conditioned media from periostin-overexpressing HNSCC cells, we examined tube formation of lymphatic endothelial cells. Conditioned media from periostin-overexpressing cells promoted tube formation. To know the correlation between periostin and VEGF-C, we compared Periostin expression with VEGF-C expression in 54 HNSCC cases by immunohistochemistry. Periostin expression was correlated well with VEGF-C expression in HNSCC cases. Moreover, correlation between periostin and VEGF-C secretion was observed in serum from HNSCC patients. Interestingly, periostin itself promoted tube formation of lymphatic endothelial cells independently of VEGF-C. Periostin-promoted lymphangiogenesis was mediated by Src and Akt activity. Indeed possible correlation between periostin and lymphatic status in periostin-overexpressing xenograft tumors and HNSCC cases was observed. Conclusions: Our findings suggest that periostin itself as well as periostin-induced upregulation of VEGF-C may promote lymphangiogenesis. We suggest that periostin may be a marker for prediction of malignant behaviors in HNSCC and a potential target for future therapeutic intervention to obstruct tumoral lymphatic invasion and lymphangiogenesis in HNSCC patients.	[Kudo, Yasusei; Iizuka, Shinji; Yoshida, Maki; Phuong Thao Nguyen; Siriwardena, Samadarani B. S. M.; Tsunematsu, Takaaki; Ohbayashi, Mariko; Ando, Toshinori; Takata, Takashi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan; [Hatakeyama, Daijiro; Shibata, Toshiyuki] Gifu Univ, Grad Sch Med, Dept Oral & Maxillofacial Sci, Gifu, Japan; [Koizumi, Keiichi] Toyama Univ, Inst Nat Med, Dept Kampo Diagnost, Toyama 930, Japan; [Maeda, Masahiro] Immuno Biol Labs Co Ltd, Dept Res & Dev, Fujioka, Gunma, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan; [Kudo, Yasusei; Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan	Hiroshima University; Gifu University; University of Toyama; Hiroshima University; Tokushima University	Kudo, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan.	yasusei@tokushima-u.ac.jp; ttakata@hiroshima-u.ac.jp	Ando, Toshinori/AAA-6401-2021; Koizumi, Keiichi/AAG-6915-2019; Ando, Toshinori/AAG-4033-2021; Nguyen, Thao/AAH-7394-2019	Ando, Toshinori/0000-0002-3141-8173; Ando, Toshinori/0000-0002-3141-8173; Nguyen, Thao/0000-0003-4651-5168; Kudo, Yasusei/0000-0002-0392-7720	Ministry of Education, Science, and Culture of Japan; Japan Society for the Promotion of Science; Kurozumi Memorial Foundation; Grants-in-Aid for Scientific Research [23659858] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kurozumi Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Science, and Culture of Japan (Y. Kudo and T. Takata), a Research Fellowship for Young Scientists and the Excellent Young Researchers Overseas Visit Program from the Japan Society for the Promotion of Science (S. Iizuka), and a Kurozumi Memorial Foundation grant (Y. Kudo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YH, 2009, CANCER LETT, V281, P188, DOI 10.1016/j.canlet.2009.02.043; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Beasley NJP, 2002, CANCER RES, V62, P1315; Ben QW, 2011, ONCOL REP, V25, P709, DOI 10.3892/or.2011.1140; Ben QW, 2009, INT J ONCOL, V34, P821, DOI 10.3892/ijo_00000208; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Eriksson U, 1999, CURR TOP MICROBIOL, V237, P41; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; FIDLER IJ, 1997, PRINCIPLES PRACTICE, P135; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Fujimoto K, 2011, ONCOL REP, V25, P1211, DOI 10.3892/or.2011.1194; Galvagni F, 2010, CIRC RES, V106, P1839, DOI 10.1161/CIRCRESAHA.109.206326; Hamada K, 2000, BLOOD, V96, P3793, DOI 10.1182/blood.V96.12.3793.h8003793_3793_3800; Hong LZ, 2010, MOL BIOL REP, V37, P2285, DOI 10.1007/s11033-009-9721-1; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Ischenko I, 2010, CURR CANCER DRUG TAR, V10, P546, DOI 10.2174/156800910791517181; Joukov V, 1996, EMBO J, V15, P290; Li JS, 2007, WORLD J GASTROENTERO, V13, P5261, DOI 10.3748/wjg.v13.i39.5261; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Kudo Y, 2003, ORAL ONCOL, V39, P515, DOI 10.1016/S1368-8375(03)00015-0; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Kukk E, 1996, DEVELOPMENT, V122, P3829; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; Lymboussaki A, 1999, CIRC RES, V85, P992; Lymboussaki A, 1997, SCIENCE, V276, P1423; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Matsuo M, 2006, CELL TISSUE RES, V326, P749, DOI 10.1007/s00441-006-0229-x; Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639; Regezi J. A., 1989, ORAL PATHOLOGY CLIN, P70; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Scatena MT, 2002, TRENDS CARDIOVAS MED, V12, P83, DOI 10.1016/S1050-1738(01)00151-7; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Siriwardena BSMS, 2008, J CLIN PATHOL, V61, P103, DOI 10.1136/jcp.2007.047662; Siriwardena BSMS, 2006, BRIT J CANCER, V95, P1396, DOI 10.1038/sj.bjc.6603431; Stetler-Stevenson WG, 2001, PRINCIPLES PRACTICE, P123; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; Takanami I, 2008, INT J BIOL MARKER, V23, P182, DOI 10.1177/172460080802300308; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tilman G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-80; Utispan K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-13; Wen PY, 2001, PRINCIPLES PRACTICE, P2655; Zhou F, 2010, AM J PATHOL, V177, P2124, DOI 10.2353/ajpath.2010.091301	54	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44488	10.1371/journal.pone.0044488	http://dx.doi.org/10.1371/journal.pone.0044488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952986	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206500074
J	Hosseinpoor, AR; Parker, LA; d'Espaignet, ET; Chatterji, S				Hosseinpoor, Ahmad Reza; Anne Parker, Lucy; d'Espaignet, Edouard Tursan; Chatterji, Somnath			Socioeconomic Inequality in Smoking in Low-Income and Middle-Income Countries: Results from the World Health Survey	PLOS ONE			English	Article							SOCIAL INEQUALITIES; PATERNAL SMOKING; CHILD-MORTALITY; TOBACCO CONTROL; INCREASED RISK; POOR; INTERVENTIONS; MALNUTRITION; INDONESIA; ENGLAND	Objectives: To assess the magnitude and pattern of socioeconomic inequality in current smoking in low and middle income countries. Methods: We used data from the World Health Survey [WHS] in 48 low-income and middle-income countries to estimate the crude prevalence of current smoking according to household wealth quintile. A Poisson regression model with a robust variance was used to generate the Relative Index of Inequality [RII] according to wealth within each of the countries studied. Results: In males, smoking was disproportionately prevalent in the poor in the majority of countries. In numerous countries the poorest men were over 2.5 times more likely to smoke than the richest men. Socioeconomic inequality in women was more varied showing patterns of both pro-rich and pro-poor inequality. In 20 countries pro-rich relative socioeconomic inequality was statistically significant: the poorest women had a higher prevalence of smoking compared to the richest women. Conversely, in 9 countries women in the richest population groups had a statistically significant greater risk of smoking compared to the poorest groups. Conclusion: Both the pattern and magnitude of relative inequality may vary greatly between countries. Prevention measures should address the specific pattern of smoking inequality observed within a population.	[Hosseinpoor, Ahmad Reza; Chatterji, Somnath] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [Anne Parker, Lucy] Univ Miguel Hernandez Elche, Dept Publ Hlth, Alicante, Spain; [Anne Parker, Lucy] CIBER Epidemiol & Salud Publ, Madrid, Spain; [d'Espaignet, Edouard Tursan] WHO, Tobacco Free Initiat, CH-1211 Geneva, Switzerland	World Health Organization; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; World Health Organization	Hosseinpoor, AR (corresponding author), WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland.	hosseinpoora@who.int	d'Espaignet, Edouard Tursan/V-3857-2019; Hosseinpoor, Ahmad Reza/AFP-8422-2022; CHATTERJI, Somnath/ABE-6832-2020; Parker, Lucy Anne/R-3622-2017	Hosseinpoor, Ahmad Reza/0000-0001-7322-672X; Parker, Lucy Anne/0000-0002-2362-4057	WHO	WHO(World Health Organization)	This study was funded by WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, PROJ TOB PROD CONS T; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bauld L, 2007, TOB CONTROL, V16, P400, DOI 10.1136/tc.2007.021626; Doku D, 2010, AFR HEALTH SCI, V10, P201; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Gakidou E, 2007, JAMA-J AM MED ASSOC, V298, P1876, DOI 10.1001/jama.298.16.1876; Guindond GE, 2003, CURRENT FUTURE TREND; Harper S, 2006, METHODS SOCIAL EPIDE; Hosseinpoor AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020331; Hosseinpoor AR, 2005, B WORLD HEALTH ORGAN, V83, P837; Hu TW, 2005, TOB CONTROL, V14, P247, DOI 10.1136/tc.2004.010777; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Main C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-178; Mathur C, 2008, NICOTINE TOB RES, V10, P109, DOI 10.1080/14622200701767779; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Murray C., 2003, HLTH SYSTEMS PERFORM, P115; Peretti-Watel P, 2009, INT J DRUG POLICY, V20, P230, DOI 10.1016/j.drugpo.2008.10.001; Rose G., 2008, ROSES STRATEGY PREVE; Semba RD, 2008, AM J PUBLIC HEALTH, V98, P1824, DOI 10.2105/AJPH.2007.119289; Semba RD, 2007, PUBLIC HEALTH NUTR, V10, P7, DOI 10.1017/S136898000722292X; Toll BA, 2005, TOB CONTROL, V14, P172, DOI 10.1136/tc.2004.008953; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Van der Heydena JHA, 2009, LUNG CANCER, V63, P322, DOI 10.1016/j.lungcan.2008.06.006; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; Warren CW, 2000, B WORLD HEALTH ORGAN, V78, P868; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; Word Bank, 2004, WORLD DEV REP 2005 B	30	98	100	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42843	10.1371/journal.pone.0042843	http://dx.doi.org/10.1371/journal.pone.0042843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZC	22952617	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000012
J	Hubo, M; Jonuleit, H				Hubo, Mario; Jonuleit, Helmut			Plasmacytoid Dendritic Cells Are Inefficient in Activation of Human Regulatory T Cells	PLOS ONE			English	Article							IN-VITRO; INTERFERON; EXPANSION; INDUCE; INTERLEUKIN-2; STIMULATION; INITIATION; EXPRESSION; IMMUNITY; DISEASE	Background: Dendritic cells (DC) play a key role in initiation and regulation of immune responses. Plasmacytoid DC (pDC), a small subset of DC, characterized as type-I interferon producing cells, are critically involved in anti-viral immune responses, but also mediate tolerance by induction of regulatory T cells (Treg). In this study, we compared the capacity of human pDC and conventional DC (cDC) to modulate T cell activity in presence of Foxp3(+) Treg. Principal Findings: In coculture of T effector cells (Teff) and Treg, activated cDC overcome Treg anergy, abrogate their suppressive function and induce Teff proliferation. In contrast, pDC do not break Treg anergy but induce Teff proliferation even in coculture with Treg. Lack of Treg-mediated suppression is independent of proinflammatory cytokines like IFN-alpha, IL-1, IL-6 and TNF-alpha. Phenotyping of pDC-stimulated Treg reveals a reduced expression of Treg activation markers GARP and CTLA-4. Additional stimulation by anti-CD3 antibodies enhances surface expression of GARP and CTLA-4 on Treg and consequently reconstitutes their suppressive function, while increased costimulation with anti-CD28 antibodies is ineffective. Conclusions/Significance: Our data show that activated pDC induce Teff proliferation, but are insufficient for functional Treg activation and, therefore, allow expansion of Teff also in presence of Treg.	[Hubo, Mario; Jonuleit, Helmut] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, Mainz, Germany	Johannes Gutenberg University of Mainz	Hubo, M (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, Mainz, Germany.	mario.hubo@unimedizin-mainz.de	Jonuleit, Helmut/D-8059-2011	Jonuleit, Helmut/0000-0002-5672-9365	German Research Foundation [Transregio52]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (Transregio52, http://gepris.dfg.de/gepris/OCTOPUS/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Becker C, 2009, BLOOD, V114, P1263, DOI 10.1182/blood-2009-02-206730; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Boor PPC, 2011, EUR J IMMUNOL, V41, P1663, DOI 10.1002/eji.201041229; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Chen SC, 2010, ARCH DERMATOL RES, V302, P113, DOI 10.1007/s00403-009-0966-2; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Han GM, 2003, GENES IMMUN, V4, P177, DOI 10.1038/sj.gene.6363966; Hanabuchi S, 2010, J IMMUNOL, V184, P2999, DOI 10.4049/jimmunol.0804106; Houot R, 2006, J IMMUNOL, V176, P5293, DOI 10.4049/jimmunol.176.9.5293; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Martin-Gayo E, 2010, BLOOD, V115, P5366, DOI 10.1182/blood-2009-10-248260; Matta BM, 2010, EUR J IMMUNOL, V40, P2667, DOI 10.1002/eji.201040839; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Noel G, 2009, INT IMMUNOL, V21, P1025, DOI 10.1093/intimm/dxp068; Ouabed A, 2008, J IMMUNOL, V180, P5862, DOI 10.4049/jimmunol.180.9.5862; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Salio M, 2003, EUR J IMMUNOL, V33, P1052, DOI 10.1002/eji.200323676; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; Swiecki M, 2010, EUR J IMMUNOL, V40, P2094, DOI 10.1002/eji.201040602; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103	41	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44056	10.1371/journal.pone.0044056	http://dx.doi.org/10.1371/journal.pone.0044056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952871	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000075
J	Mazzotti, DR; Guindalini, C; de Souza, AAL; Sato, JR; Santos-Silva, R; Bittencourt, LRA; Tufik, S				Mazzotti, Diego Robles; Guindalini, Camila; Lino de Souza, Altay Alves; Sato, Joao Ricardo; Santos-Silva, Rogerio; Azeredo Bittencourt, Lia Rita; Tufik, Sergio			Adenosine Deaminase Polymorphism Affects Sleep EEG Spectral Power in a Large Epidemiological Sample	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; POPULATION; HUMANS	Slow wave oscillations in the electroencephalogram (EEG) during sleep may reflect both sleep need and intensity, which are implied in homeostatic regulation. Adenosine is strongly implicated in sleep homeostasis, and a single nucleotide polymorphism in the adenosine deaminase gene (ADA G22A) has been associated with deeper and more efficient sleep. The present study verified the association between the ADA G22A polymorphism and changes in sleep EEG spectral power (from C3-A2, C4-A1, O1-A2, and O2-A1 derivations) in the Epidemiologic Sleep Study (EPISONO) sample from Sao Paulo, Brazil. Eight-hundred individuals were subjected to full-night polysomnography and ADA G22A genotyping. Spectral analysis of the EEG was carried out in all individuals using fast Fourier transformation of the signals from each EEG electrode. The genotype groups were compared in the whole sample and in a subsample of 120 individuals matched according to ADA genotype for age, gender, body mass index, caffeine intake status, presence of sleep disturbance, and sleep-disturbing medication. When compared with homozygous GG genotype carriers, A allele carriers showed higher delta spectral power in Stage 1 and Stages 3+4 of sleep, and increased theta spectral power in Stages 1, 2 and REM sleep. These changes were seen both in the whole sample and in the matched subset. The higher EEG spectral power indicates that the sleep of individuals carrying the A allele may be more intense. Therefore, this polymorphism may be an important source of variation in sleep homeostasis in humans, through modulation of specific components of the sleep EEG.	[Mazzotti, Diego Robles; Guindalini, Camila; Lino de Souza, Altay Alves; Santos-Silva, Rogerio; Azeredo Bittencourt, Lia Rita; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil; [Guindalini, Camila] Univ Fed Sao Paulo, Dept Psiquiatria, Lab Neurociencias Clin LiNC, Sao Paulo, Brazil; [Sato, Joao Ricardo] Univ Fed ABC, Ctr Matemat Comp & Cognicao, Santo Andre, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC)	Mazzotti, DR (corresponding author), Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil.	camilascg@googlemail.com	Seguranca Publica, Inct/I-2423-2013; Sono, Cepid/I-5371-2013; Mazzotti, Diego/C-3968-2012; Mazzotti, Diego R./S-1886-2019; de Souza, Altay A Lino/K-7797-2012; Bittencourt, Lia/C-6551-2012; Santos-Silva, Rogerio/E-4630-2013	Mazzotti, Diego R./0000-0003-3924-9199; de Souza, Altay A Lino/0000-0002-3331-4087; Bittencourt, Lia/0000-0001-7738-0927; Sato, Joao Ricardo/0000-0002-7503-9781; Guindalini, Camila/0000-0002-6278-5881	Associacao Fundo de Incentivo a Psicofarmacologia (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID) [98/14303-3]	Associacao Fundo de Incentivo a Psicofarmacologia (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Associacao Fundo de Incentivo a Psicofarmacologia (AFIP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID #98/14303-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Ambrosius U, 2008, BIOL PSYCHIAT, V64, P344, DOI 10.1016/j.biopsych.2008.03.002; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BATTISTUZZI G, 1981, ANN HUM GENET, V45, P15, DOI 10.1111/j.1469-1809.1981.tb00301.x; Borbely A A, 1982, Hum Neurobiol, V1, P195; Chikahisa Sachiko, 2011, Front Neurol, V2, P87, DOI 10.3389/fneur.2011.00087; De Gennaro L, 2008, ANN NEUROL, V64, P455, DOI 10.1002/ana.21434; Diamond A, 2006, GENETIC MATCHING EST; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; HIRSCHHORN R, 1994, ANN HUM GENET, V58, P1, DOI 10.1111/j.1469-1809.1994.tb00720.x; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Iber C., 2007, RULES TERMINOL TECH, V176, P2012; Kalinchuk AV, 2011, J NEUROCHEM, V116, P260, DOI 10.1111/j.1471-4159.2010.07100.x; Landolt HP, 2008, BIOCHEM PHARMACOL, V75, P2070, DOI 10.1016/j.bcp.2008.02.024; Landolt HP, 2011, PROG BRAIN RES, V193, P51, DOI 10.1016/B978-0-444-53839-0.00004-1; Mazzotti DR, 2011, SLEEP, V34, P399, DOI 10.1093/sleep/34.3.399; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Retey JV, 2005, P NATL ACAD SCI USA, V102, P15676, DOI 10.1073/pnas.0505414102; Santos-Silva R, 2009, SLEEP MED, V10, P679, DOI 10.1016/j.sleep.2008.11.001; Tafti M, 2009, SLEEP MED, V10, pS17, DOI 10.1016/j.sleep.2009.07.002; Vyazovskiy VV, 2005, J SLEEP RES, V14, P299, DOI 10.1111/j.1365-2869.2005.00456.x; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7	24	26	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44154	10.1371/journal.pone.0044154	http://dx.doi.org/10.1371/journal.pone.0044154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952909	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206000090
J	Meganathan, K; Jagtap, S; Wagh, V; Winkler, J; Gaspar, JA; Hildebrand, D; Trusch, M; Lehmann, K; Hescheler, J; Schluter, H; Sachinidis, A				Meganathan, Kesavan; Jagtap, Smita; Wagh, Vilas; Winkler, Johannes; Gaspar, John Antonydas; Hildebrand, Diana; Trusch, Maria; Lehmann, Karola; Hescheler, Juergen; Schlueter, Hartmut; Sachinidis, Agapios			Identification of Thalidomide-Specific Transcriptomics and Proteomics Signatures during Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							VERTEBRATE LIMB DEVELOPMENT; DEVELOPMENTAL TOXICITY TEST; IN-VITRO; MULTIPLE-MYELOMA; EXPRESSION; MICE; RABBITS; TERATOGENICITY; TRANSFORMATION; MALFORMATIONS	Embryonic development can be partially recapitulated in vitro by differentiating human embryonic stem cells (hESCs). Thalidomide is a developmental toxicant in vivo and acts in a species-dependent manner. Besides its therapeutic value, thalidomide also serves as a prototypical model to study teratogenecity. Although many in vivo and in vitro platforms have demonstrated its toxicity, only a few test systems accurately reflect human physiology. We used global gene expression and proteomics profiling (two dimensional electrophoresis (2DE) coupled with Tandem Mass spectrometry) to demonstrate hESC differentiation and thalidomide embryotoxicity/teratogenecity with clinically relevant dose(s). Proteome analysis showed loss of POU5F1 regulatory proteins PKM2 and RBM14 and an over expression of proteins involved in neuronal development (such as PAK2, PAFAH1B2 and PAFAH1B3) after 14 days of differentiation. The genomic and proteomic expression pattern demonstrated differential expression of limb, heart and embryonic development related transcription factors and biological processes. Moreover, this study uncovered novel possible mechanisms, such as the inhibition of RANBP1, that participate in the nucleocytoplasmic trafficking of proteins and inhibition of glutathione transferases (GSTA1, GSTA2), that protect the cell from secondary oxidative stress. As a proof of principle, we demonstrated that a combination of transcriptomics and proteomics, along with consistent differentiation of hESCs, enabled the detection of canonical and novel teratogenic intracellular mechanisms of thalidomide.	[Meganathan, Kesavan; Jagtap, Smita; Wagh, Vilas; Winkler, Johannes; Gaspar, John Antonydas; Hescheler, Juergen; Sachinidis, Agapios] Ctr Physiol & Pathophysiol, Inst Neurophysiol, Cologne, Germany; [Hildebrand, Diana; Schlueter, Hartmut] Univ Med Ctr, Inst Clin Chem, Hamburg, Germany; [Trusch, Maria] Univ Hamburg, Inst Organ Chem, Mass Spectrometry Grp, D-2000 Hamburg, Germany; [Lehmann, Karola] Proteome Factory AG, Berlin, Germany	University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg	Meganathan, K (corresponding author), Ctr Physiol & Pathophysiol, Inst Neurophysiol, Cologne, Germany.	a.sachinidis@uni-koeln.de	Wagh, Vilas/B-3267-2009; Schluter, Hartmut/D-1371-2015; Wagh, Vilas/A-9522-2010; Sachinidis, Agapios/AAD-4178-2020; Sachinidis, Agapios/AAM-7988-2020; Riedner, Maria/W-5546-2019	Schluter, Hartmut/0000-0002-9358-7036; Winkler, Johannes/0000-0001-7309-8342	EU	EU(European Commission)	This work was supported by the EU FP7 project Embryonic Stem cell-based Novel Alterntaive Testing Strategies (ESNATS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler S, 2008, TOXICOL IN VITRO, V22, P200, DOI 10.1016/j.tiv.2007.07.013; Assadi AH, 2008, NEUROSCI LETT, V439, P100, DOI 10.1016/j.neulet.2008.04.096; Augustine-Rauch K, 2010, BIRTH DEFECTS RES C, V90, P87, DOI 10.1002/bdrc.20175; Breckenridge RA, 2010, INT J DEV BIOL, V54, P215, DOI 10.1387/ijdb.072356rb; CHARITE J, 1994, CELL, V78, P589, DOI 10.1016/0092-8674(94)90524-X; CHERNOFF N, 1982, J TOXICOL ENV HEALTH, V10, P541, DOI 10.1080/15287398209530275; Chung F, 2004, CLIN CANCER RES, V10, P5949, DOI 10.1158/1078-0432.CCR-04-0421; Church VL, 2002, INT J DEV BIOL, V46, P927; DELAHUNT CS, 1964, SCIENCE, V146, P1300, DOI 10.1126/science.146.3649.1300; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ema M, 2010, REPROD TOXICOL, V29, P49, DOI 10.1016/j.reprotox.2009.09.003; FRATTA ID, 1965, TOXICOL APPL PHARM, V7, P268, DOI 10.1016/0041-008X(65)90095-5; Gove C, 1997, EMBO J, V16, P1806; Hansen JM, 2004, ANTIOXID REDOX SIGN, V6, P1, DOI 10.1089/152308604771978291; Hansen JM, 1999, REPROD TOXICOL, V13, P547, DOI 10.1016/S0890-6238(99)00053-2; HARDIN BD, 1987, TERATOGEN CARCIN MUT, V7, P29, DOI 10.1002/tcm.1770070106; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HOAR RM, 1995, J AM COLL TOXICOL, V14, P11, DOI 10.3109/10915819509008677; Ito T, 2011, CELL MOL LIFE SCI, V68, P1569, DOI 10.1007/s00018-010-0619-9; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jagtap S, 2011, BRIT J PHARMACOL, V162, P1743, DOI 10.1111/j.1476-5381.2010.01197.x; KAJII T, 1963, LANCET, V2, P151; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Knobloch J, 2008, MOL CELL BIOL, V28, P529, DOI 10.1128/MCB.00533-07; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; Knobloch J, 2008, MOL PHARMACEUT, V5, P1138, DOI 10.1021/mp8001232; Kodama T, 2009, CLIN LYMPHOMA MYELOM, V9, P154, DOI 10.3816/CLM.2009.n.037; Kodiha M., 2012, J SIGNAL TRANSDUCT, P18; Kraljevic S, 2004, EMBO REP, V5, P837, DOI 10.1038/sj.embor.7400236; Lu HC, 1997, DEVELOPMENT, V124, P1643; Mayshar Y, 2011, J CELL MOL MED, V15, P1393, DOI 10.1111/j.1582-4934.2010.01105.x; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Miller MT, 1999, TERATOLOGY, V60, P306, DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Parman T, 1999, NAT MED, V5, P582, DOI 10.1038/8466; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SAWIN PB, 1965, EXPERIENTIA, V21, P672, DOI 10.1007/BF02144076; Scholz G, 1999, TOXICOL IN VITRO, V13, P675, DOI 10.1016/S0887-2333(99)00046-6; SCHUMACHER H, 1968, J PHARMACOL EXP THER, V160, P189; SEIDENBERG JM, 1986, TERATOGEN CARCIN MUT, V6, P361, DOI 10.1002/tcm.1770060503; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; SMITHELLS RW, 1973, BMJ-BRIT MED J, V1, P269, DOI 10.1136/bmj.1.5848.269; Stephens TD, 2009, BIRTH DEFECTS RES A, V85, P725, DOI 10.1002/bdra.20597; Teo SK, 2004, TOXICOL SCI, V81, P379, DOI 10.1093/toxsci/kfh207; Teo SK, 2001, TOXICOL SCI, V59, P160, DOI 10.1093/toxsci/59.1.160; Tumpel S, 2002, DEV BIOL, V250, P251, DOI 10.1006/dbio.2002.0762; Winkler J, 2009, CURR MED CHEM, V16, P4814, DOI 10.2174/092986709789909657; WOBUS AM, 1984, EXP CELL RES, V152, P212, DOI 10.1016/0014-4827(84)90246-5; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zimny-Arndt Ursula, 2009, V492, P65, DOI 10.1007/978-1-59745-493-3_4	54	72	74	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44228	10.1371/journal.pone.0044228	http://dx.doi.org/10.1371/journal.pone.0044228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952932	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600094
J	Niederer, SA; Lamata, P; Plank, G; Chinchapatnam, P; Ginks, M; Rhode, K; Rinaldi, CA; Razavi, R; Smith, NP				Niederer, Steven Alexander; Lamata, Pablo; Plank, Gernot; Chinchapatnam, Phani; Ginks, Matt; Rhode, Kawal; Rinaldi, Christopher Aldo; Razavi, Reza; Smith, Nicolas Peter			Analyses of the Redistribution of Work following Cardiac Resynchronisation Therapy in a Patient Specific Model	PLOS ONE			English	Article							BUNDLE-BRANCH BLOCK; RESYNCHRONIZATION THERAPY; DILATED CARDIOMYOPATHY; OXYGEN-CONSUMPTION; BLOOD-FLOW; OXIDATIVE-METABOLISM; HEART; EFFICIENCY; PERFUSION; STRAIN	Regulation of regional work is essential for efficient cardiac function. In patients with heart failure and electrical dysfunction such as left branch bundle block regional work is often depressed in the septum. Following cardiac resynchronisation therapy (CRT) this heterogeneous distribution of work can be rebalanced by altering the pattern of electrical activation. To investigate the changes in regional work in these patients and the mechanisms underpinning the improved function following CRT we have developed a personalised computational model. Simulations of electromechanical cardiac function in the model estimate the regional stress, strain and work pre- and post-CRT. These simulations predict that the increase in observed work performed by the septum following CRT is not due to an increase in the volume of myocardial tissue recruited during contraction but rather that the volume of recruited myocardium remains the same and the average peak work rate per unit volume increases. These increases in the peak average rate of work is is attributed to slower and more effective contraction in the septum, as opposed to a change in active tension. Model results predict that this improved septal work rate following CRT is a result of resistance to septal contraction provided by the LV free wall. This resistance results in septal shortening over a longer period which, in turn, allows the septum to contract while generating higher levels of active tension to produce a higher work rate.	[Niederer, Steven Alexander; Chinchapatnam, Phani; Ginks, Matt; Rhode, Kawal; Rinaldi, Christopher Aldo; Razavi, Reza; Smith, Nicolas Peter] Kings Coll London, Imaging Sci & Biomed Engn Div, London WC2R 2LS, England; [Lamata, Pablo; Smith, Nicolas Peter] Univ Oxford, Comp Lab, Oxford OX1 3QD, England; [Plank, Gernot] Med Univ Graz, Inst Biophys, Graz, Austria; [Ginks, Matt; Rinaldi, Christopher Aldo; Razavi, Reza] St Thomas Hosp, Dept Cardiol, London, England	University of London; King's College London; University of Oxford; Medical University of Graz; Guy's & St Thomas' NHS Foundation Trust	Niederer, SA (corresponding author), Kings Coll London, Imaging Sci & Biomed Engn Div, London WC2R 2LS, England.	Nicolas.smith@kcl.ox.ac.uk	Plank, Gernot/C-9498-2011; Lamata, Pablo/E-3251-2010; Lamata, Pablo/AAE-7884-2020; Plank, Gernot/O-3791-2019; Rinaldi, Claudia/GSD-6821-2022	Plank, Gernot/0000-0002-7380-6908; Lamata, Pablo/0000-0002-3097-4928; Lamata, Pablo/0000-0002-3097-4928; Plank, Gernot/0000-0002-7380-6908; Rinaldi, christopher/0000-0002-3930-1957; Rhode, Kawal/0000-0002-4707-7318; Niederer, Steven/0000-0002-4612-6982; Razavi, Reza/0000-0003-1065-3008	U.K. Engineering and Physical Sciences Research Council; St Jude Medical educational grant; Austrian Science Fund (FWF) [F 3201] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H019898/1] Funding Source: researchfish; Medical Research Council [MR/J006742/1] Funding Source: researchfish	U.K. Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); St Jude Medical educational grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the U.K. Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Matthew Ginks receives a St Jude Medical educational grant and Christopher Rinaldi receives St Jude educational support and is on advisory boards for St Jude Medical and Medtronic. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bassingthwaighte JB, 1999, AM J CARDIOL, V83, P7; Bogaard MD, 2011, EUR J HEART FAIL, V13, P1126, DOI 10.1093/eurjhf/hfr094; DELHAAS T, 1994, J PHYSIOL-LONDON, V477, P481, DOI 10.1113/jphysiol.1994.sp020209; Deussen A, 1997, PFLUG ARCH EUR J PHY, V433, P488, DOI 10.1007/s004240050304; Dokos S, 2002, AM J PHYSIOL-HEART C, V283, pH2650, DOI 10.1152/ajpheart.00111.2002; Duckett SG, 2011, J AM COLL CARDIOL, V58, P1128, DOI 10.1016/j.jacc.2011.04.042; Durrer D, 1970, TOTAL EXCITATION ISO, P899; GROVER M, 1983, CIRC RES, V53, P72, DOI 10.1161/01.RES.53.1.72; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HISANO R, 1987, CIRC RES, V61, P318, DOI 10.1161/01.RES.61.3.318; Kass DA, 1999, CIRCULATION, V99, P1567, DOI 10.1161/01.CIR.99.12.1567; Lindner O, 2005, EUR HEART J, V26, P70, DOI 10.1093/eurheartj/ehi046; Lindner O, 2006, J NUCL MED, V47, P378; Nelson GS, 2000, CIRCULATION, V102, P3053; Niederer SA, 2011, CARDIOVASC RES, V89, P336, DOI 10.1093/cvr/cvq318; Nowak B, 2003, J AM COLL CARDIOL, V41, P1523, DOI 10.1016/S0735-1097(03)00257-2; OPIE LH, 1965, J PHYSIOL-LONDON, V180, P529, DOI 10.1113/jphysiol.1965.sp007715; Prinzen FW, 1999, J AM COLL CARDIOL, V33, P1735, DOI 10.1016/S0735-1097(99)00068-6; Suga H, 1979, AM J PHYSIOL, P498; Sundell J, 2004, J AM COLL CARDIOL, V43, P1027, DOI 10.1016/j.jacc.2003.10.044; Ten Tusscher KHWJ, 2006, PROG BIOPHYS MOL BIO, V90, P326, DOI 10.1016/j.pbiomolbio.2005.05.015; Ukkonen H, 2003, CIRCULATION, V107, P28, DOI 10.1161/01.CIR.0000047068.02226.95	22	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43504	10.1371/journal.pone.0043504	http://dx.doi.org/10.1371/journal.pone.0043504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952697	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600029
J	Wang, JP; Rudzinski, JF; Gong, Q; Soh, HT; Atzberger, PJ				Wang, Jinpeng; Rudzinski, Joseph F.; Gong, Qiang; Soh, H. Tom; Atzberger, Paul J.			Influence of Target Concentration and Background Binding on In Vitro Selection of Affinity Reagents	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; MATHEMATICAL-ANALYSIS; RNA MOLECULES; LIGANDS; APTAMERS; SELEX	Nucleic acid-based aptamers possess many useful features that make them a promising alternative to antibodies and other affinity reagents, including well-established chemical synthesis, reversible folding, thermal stability and low cost. However, the selection process typically used to generate aptamers (SELEX) often requires significant resources and can fail to yield aptamers with sufficient affinity and specificity. A number of seminal theoretical models and numerical simulations have been reported in the literature offering insights into experimental factors that govern the effectiveness of the selection process. Though useful, these previous models have not considered the full spectrum of experimental factors or the potential impact of tuning these parameters at each round over the course of a multi-round selection process. We have developed an improved mathematical model to address this important question, and report that both target concentration and the degree of non-specific background binding are critical determinants of SELEX efficiency. Although smaller target concentrations should theoretically offer superior selection outcome, we show that the level of background binding dramatically affect the target concentration that will yield maximum enrichment at each round of selection. Thus, our model enables experimentalists to determine appropriate target concentrations as a means for protocol optimization. Finally, we perform a comparative analysis of two different selection methods over multiple rounds of selection, and show that methods with inherently lower background binding offer dramatic advantages in selection efficiency.	[Wang, Jinpeng; Gong, Qiang; Soh, H. Tom; Atzberger, Paul J.] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Rudzinski, Joseph F.; Atzberger, Paul J.] Univ Calif Santa Barbara, Dept Math, Santa Barbara, CA 93106 USA; [Gong, Qiang; Soh, H. Tom] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Wang, JP (corresponding author), Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA.	tsoh@engr.ucsb.edu; atzberg@math.ucsb.edu	Wang, Jinpeng/P-4015-2019; Gong, Qiang/H-3234-2014; Gong, Qiang/D-5337-2009; Wang, Jinpeng/H-6542-2014; Rudzinski, Joseph F./AAR-7971-2020; Atzberger, Paul/B-2799-2016	Wang, Jinpeng/0000-0002-3739-2015; Wang, Jinpeng/0000-0002-3739-2015; Rudzinski, Joseph F./0000-0003-3403-640X; Atzberger, Paul/0000-0001-6806-8069	National Science Foundation [0956210]; ARO Institute for Collaborative Biotechnologies; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); ARO Institute for Collaborative Biotechnologies; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by National Science Foundation CAREER Award 0956210, ARO Institute for Collaborative Biotechnologies, and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027051; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Djordjevic M, 2006, PHYS BIOL, V3, P13, DOI 10.1088/1478-3975/3/1/002; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; Haller AA, 1997, P NATL ACAD SCI USA, V94, P8521, DOI 10.1073/pnas.94.16.8521; IRVINE D, 1991, J MOL BIOL, V222, P739, DOI 10.1016/0022-2836(91)90509-5; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Levine HA, 2007, COMPUT BIOL CHEM, V31, P11, DOI 10.1016/j.compbiolchem.2006.10.002; Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106; Plaxco KW, 2011, TRENDS BIOTECHNOL, V29, P1, DOI 10.1016/j.tibtech.2010.10.005; Seo YJ, 2010, B MATH BIOL, V72, P1623, DOI 10.1007/s11538-009-9491-x; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Sun FZ, 1996, J MOL BIOL, V258, P650, DOI 10.1006/jmbi.1996.0276; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vant-Hull B, 1998, J MOL BIOL, V278, P579, DOI 10.1006/jmbi.1998.1727; Vant-Hull B., 2000, CURR PROTOC NUCL ACI; Willis MC, 1998, BIOCONJUGATE CHEM, V9, P573, DOI 10.1021/bc980002x; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590	20	44	46	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43940	10.1371/journal.pone.0043940	http://dx.doi.org/10.1371/journal.pone.0043940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952815	Green Published, gold			2022-12-27	WOS:000308213600061
J	Gabrielli, E; Pericolini, E; Cenci, E; Monari, C; Magliani, W; Ciociola, T; Conti, S; Gatti, R; Bistoni, F; Polonelli, L; Vecchiarelli, A				Gabrielli, Elena; Pericolini, Eva; Cenci, Elio; Monari, Claudia; Magliani, Walter; Ciociola, Tecla; Conti, Stefania; Gatti, Rita; Bistoni, Francesco; Polonelli, Luciano; Vecchiarelli, Anna			Antibody Constant Region Peptides Can Display Immunomodulatory Activity through Activation of the Dectin-1 Signalling Pathway	PLOS ONE			English	Article							BETA-GLUCAN RECOGNITION; HUMAN DENDRITIC CELLS; CANDIDA-ALBICANS; THERAPEUTIC ACTIVITY; INNATE IMMUNITY; CRYPTOCOCCUS-NEOFORMANS; LIGHT-CHAINS; HOST-DEFENSE; KAPPA-B; MONOCYTES	We previously reported that a synthetic peptide with sequence identical to a CDR of a mouse monoclonal antibody specific for difucosyl human blood group A exerted an immunomodulatory activity on murine macrophages. It was therapeutic against systemic candidiasis without possessing direct candidacidal properties. Here we demonstrate that a selected peptide, N10K, putatively deriving from the enzymatic cleavage of the constant region (Fc) of human IgG(1), is able to induce IL-6 secretion and pIkB-alpha activation. More importantly, it causes an up-regulation of Dectin-1 expression. This leads to an increased activation of beta-glucan-induced pSyk, CARD9 and pIkB-alpha, and an increase in the production of pro-inflammatory cytokines such as IL-6, IL-12, IL-1 beta and TNF-alpha. The increased activation of this pathway coincides with an augmented phagocytosis of non opsonized Candida albicans cells by monocytes. The findings suggest that some Fc-peptides, potentially deriving from the proteolysis of immunoglobulins, may cause an unexpected immunoregulation in a way reminiscent of innate immunity molecules.	[Gabrielli, Elena; Pericolini, Eva; Cenci, Elio; Monari, Claudia; Bistoni, Francesco; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Magliani, Walter; Ciociola, Tecla; Conti, Stefania; Polonelli, Luciano] Univ Parma, Dept Pathol & Lab Med, Microbiol Sect, I-43100 Parma, Italy; [Gatti, Rita] Univ Parma, Dept Expt Med, Histol Sect, I-43100 Parma, Italy	University of Perugia; University of Parma; University Hospital of Parma; University of Parma	Gabrielli, E (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy.	vecchiar@unipg.it	Conti, Stefania/N-3558-2015; MONARI, Claudia/AAY-3848-2020; Ciociola, Tecla/AFN-5212-2022; Pericolini, Eva/AAZ-5848-2021; Ciociola, Tecla/HCH-2453-2022; monari, claudia/O-4563-2018	Conti, Stefania/0000-0001-9973-8352; MONARI, Claudia/0000-0002-5027-9367; Ciociola, Tecla/0000-0001-6499-2545; monari, claudia/0000-0002-5027-9367; CENCI, ELIO/0000-0003-0752-7262; Vecchiarelli, Anna/0000-0002-3185-6720; Pericolini, Eva/0000-0002-5299-8197	Italian Ministry of Health [40H39]	Italian Ministry of Health(Ministry of Health, Italy)	The work was supported by funding from Italian Ministry of Health for the National AIDS Research Program (Grant number 40H39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda DC, 2012, J BIOL CHEM, V287, P14912, DOI 10.1074/jbc.M111.322362; BISTONI F, 1986, INFECT IMMUN, V51, P668, DOI 10.1128/IAI.51.2.668-674.1986; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Busetto S, 2004, CYTOM PART A, V58A, P201, DOI 10.1002/cyto.a.20014; Casoli C, 2006, AIDS, V20, P975, DOI 10.1097/01.aids.0000222068.14878.0d; Cenci E, 2006, J LEUKOCYTE BIOL, V79, P40, DOI 10.1189/jlb.0205113; CHAKA W, 1995, CLIN DIAGN LAB IMMUN, V2, P753, DOI 10.1128/CDLI.2.6.753-759.1995; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; COHEN S, 1964, ADV IMMUNOL, V4, P287, DOI 10.1016/S0065-2776(08)60710-5; Conti G, 2008, ANTIMICROB AGENTS CH, V52, P4331, DOI 10.1128/AAC.00506-08; Dennehy KM, 2007, J LEUKOCYTE BIOL, V82, P253, DOI 10.1189/jlb.1206753; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Gabrielli E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008187; Gaffen SL, 2011, IMMUNOL RES, V50, P181, DOI 10.1007/s12026-011-8226-x; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Haas A, 2008, CYTOM PART A, V73A, P799, DOI 10.1002/cyto.a.20598; Hot A, 2011, ANN RHEUM DIS, V70, P727, DOI 10.1136/ard.2010.143768; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Lee YG, 2009, INT J BIOCHEM CELL B, V41, P811, DOI 10.1016/j.biocel.2008.08.011; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li M, 2009, CHINESE MED J-PEKING, V122, P496, DOI 10.3760/cma.j.issn.0366-6999.2009.05.003; Magliani W, 2009, CURR MED CHEM, V16, P2305, DOI 10.2174/092986709788453104; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Monari C, 2003, EUR J IMMUNOL, V33, P1041, DOI 10.1002/eji.200323388; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pietrella D, 2008, INFECT IMMUN, V76, P4359, DOI 10.1128/IAI.00669-08; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; Polonelli L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034105; Polonelli L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002371; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sengul S, 2002, KIDNEY INT, V62, P1977, DOI 10.1046/j.1523-1755.2002.00660.x; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Skrzypek F, 2009, MICROBES INFECT, V11, P661, DOI 10.1016/j.micinf.2009.03.010; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tsoni SV, 2008, ANN NY ACAD SCI, V1143, P45, DOI 10.1196/annals.1443.019; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Yang Z, 2009, IMMUNOBIOLOGY, V214, P321, DOI 10.1016/j.imbio.2008.09.002	44	16	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43972	10.1371/journal.pone.0043972	http://dx.doi.org/10.1371/journal.pone.0043972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952831	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800081
J	Mishra, NN; Bayer, AS; Tran, TT; Shamoo, Y; Mileykovskaya, E; Dowhan, W; Guan, ZQ; Arias, CA				Mishra, Nagendra N.; Bayer, Arnold S.; Tran, Truc T.; Shamoo, Yousif; Mileykovskaya, Eugenia; Dowhan, William; Guan, Ziqiang; Arias, Cesar A.			Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-FAECALIS; DIGLUCOSYL DIGLYCERIDE; ATCC 9790; VANCOMYCIN; ACID; SUSCEPTIBILITY; STRAINS; FAECIUM; PROTEIN	Background: The lipopeptide antibiotic, daptomycin (DAP) interacts with the bacterial cell membrane (CM). Development of DAP resistance during therapy in a clinical strain of Enterococcus faecalis was associated with mutations in genes encoding enzymes involved in cell envelope homeostasis and phospholipid metabolism. Here we characterized changes in CM phospholipid profiles associated with development of DAP resistance in clinical enterococcal strains. Methodology: Using two clinical strain-pairs of DAP-susceptible and DAP-resistant E. faecalis (S613 vs. R712) and E. faecium (S447 vs. R446) recovered before and after DAP therapy, we compared four distinct CM profiles: phospholipid content, fatty acid composition, membrane fluidity and capacity to be permeabilized and/or depolarized by DAP. Additionally, we characterized the cell envelope of the E. faecium strain-pair by transmission electron microscopy and determined the relative cell surface charge of both strain-pairs. Principal Findings: Both E. faecalis and E. faecium mainly contained four major CM PLs: phosphatidylglycerol (PG), cardiolipin, lysyl-phosphatidylglycerol (L-PG) and glycerolphospho-diglycodiacylglycerol (GP-DGDAG). In addition, E. faecalis CMs (but not E. faecium) also contained: i) phosphatidic acid; and ii) two other unknown species of amino-containing PLs. Development of DAP resistance in both enterococcal species was associated with a significant decrease in CM fluidity and PG content, with a concomitant increase in GP-DGDAG. The strain-pairs did not differ in their outer CM translocation (flipping) of amino-containing PLs. Fatty acid content did not change in the E. faecalis strain-pair, whereas a significant decrease in unsaturated fatty acids was observed in the DAP-resistant E. faecium isolate R446 (vs S447). Resistance to DAP in E. faecium was associated with distinct structural alterations of the cell envelope and cell wall thickening, as well as a decreased ability of DAP to depolarize and permeabilize the CM. Conclusion: Distinct alterations in PL content and fatty acid composition are associated with development of enterococcal DAP resistance.	[Mishra, Nagendra N.; Bayer, Arnold S.] Harbor Univ Calif Los Angeles Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA USA; [Bayer, Arnold S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Tran, Truc T.; Arias, Cesar A.] Univ Texas Med Sch Houston, Lab Antimicrobial Res, Div Infect Dis, Houston, TX USA; [Tran, Truc T.] Univ Houston Coll Pharm, Houston, TX USA; [Shamoo, Yousif] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA; [Shamoo, Yousif] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Mileykovskaya, Eugenia; Dowhan, William] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Guan, Ziqiang] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Arias, Cesar A.] Univ Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; Rice University; Rice University; University of Texas System; University of Texas Health Science Center Houston; Duke University; Universidad El Bosque	Mishra, NN (corresponding author), Harbor Univ Calif Los Angeles Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA USA.	cesar.arias@uth.tmc.edu	Guan, Ziqiang/AAE-5110-2019	Shamoo, Yousif/0000-0001-9241-8962; Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health (NIH) from the National Institute of Allergy and Infectious Diseases (NIAID) [R00 AI72961, R01 AI093749]; NIH [R01 AI39108, R01 AI080714]; NIAID; John S. Dunn Foundation Collaborative Research Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039108, R01AI080714, R00AI072961, R01AI093749] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Institute of Allergy and Infectious Diseases (NIAID); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); John S. Dunn Foundation Collaborative Research Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CAA is supported by National Institutes of Health (NIH) grants R00 AI72961 and R01 AI093749 to CAA from the National Institute of Allergy and Infectious Diseases (NIAID). ASB and YS are supported by NIH grants R01 AI39108 and R01 AI080714 also from NIAID. This work was also supported in part by a John S. Dunn Foundation Collaborative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBRON RT, 1971, J BIOL CHEM, V246, P4216; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Bao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038458; Bayer AS, 2000, INFECT IMMUN, V68, P3548, DOI 10.1128/IAI.68.6.3548-3553.2000; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; CARSON DD, 1981, J BACTERIOL, V146, P590, DOI 10.1128/JB.146.2.590-604.1981; Cui LZ, 2010, ANTIMICROB AGENTS CH, V54, P5222, DOI 10.1128/AAC.00437-10; Dixit BL, 1998, EUR J BIOCHEM, V254, P202, DOI 10.1046/j.1432-1327.1998.2540202.x; DOSSANTO.JM, 1970, J BACTERIOL, V104, P611, DOI 10.1128/JB.104.2.611-619.1970; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P1434, DOI 10.1128/JCM.33.5.1434-1434.1995; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; FISCHER W, 1973, BIOCHIM BIOPHYS ACTA, V296, P527, DOI 10.1016/0005-2760(73)90113-6; FISCHER W, 1975, BIOCHIM BIOPHYS ACTA, V380, P227, DOI 10.1016/0005-2760(75)90009-0; FISCHER W, 1973, BIOCHIM BIOPHYS ACTA, V306, P353, DOI 10.1016/0005-2760(73)90174-4; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; GANFIELD MCW, 1980, J BIOL CHEM, V255, P5164; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; GOLDBERG DE, 1981, P NATL ACAD SCI-BIOL, V78, P5513, DOI 10.1073/pnas.78.9.5513; Green Myke R, 2006, J Oncol Pharm Pract, V12, P179, DOI 10.1177/1078155206069165; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Higgins DL, 2005, ANTIMICROB AGENTS CH, V49, P1127, DOI 10.1128/AAC.49.3.1127-1134.2005; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Leuko S, 2004, APPL ENVIRON MICROB, V70, P6884, DOI 10.1128/AEM.70.11.6884-6886.2004; Mave V, 2009, J ANTIMICROB CHEMOTH, V64, P175, DOI 10.1093/jac/dkp154; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Mukhopadhyay K, 2007, MICROBIOL-SGM, V153, P1187, DOI 10.1099/mic.0.2006/003111-0; Munoz-Price LS, 2005, CLIN INFECT DIS, V41, P565, DOI 10.1086/432121; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Panesso D, 2010, J CLIN MICROBIOL, V48, P1562, DOI 10.1128/JCM.02526-09; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028316; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Pogliano J, 2012, J BACTERIOL IN PRESS; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Rubio A, 2012, MOL MEMBR BIOL, V29, P1, DOI 10.3109/09687688.2011.640948; Sabol K, 2005, ANTIMICROB AGENTS CH, V49, P1664, DOI 10.1128/AAC.49.4.1664-1665.2005; Sader HS, 2009, DIAGN MICR INFEC DIS, V65, P158, DOI 10.1016/j.diagmicrobio.2009.06.016; Sakayori Y, 2003, MICROBIOL-SGM, V149, P2901, DOI 10.1099/mic.0.26435-0; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Tsai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-13; Twilla JD, 2012, J HOSP MED, V7, P243, DOI 10.1002/jhm.994; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P3114, DOI 10.1128/AAC.49.8.3114-3121.2005; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	49	96	99	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43958	10.1371/journal.pone.0043958	http://dx.doi.org/10.1371/journal.pone.0043958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952824	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800077
J	Mora-Lee, S; Sirerol-Piquer, MS; Gutierrez-Perez, M; Gomez-Pinedo, U; Roobrouck, VD; Lopez, T; Casado-Nieto, M; Abizanda, G; Rabena, MT; Verfaille, C; Prosper, F; Garcia-Verdugo, JM				Mora-Lee, Silvia; Salome Sirerol-Piquer, Ma; Gutierrez-Perez, Maria; Gomez-Pinedo, Ulises; Roobrouck, Valerie D.; Lopez, Tania; Casado-Nieto, Mayte; Abizanda, Gloria; Teresa Rabena, Maria; Verfaille, Catherine; Prosper, Felipe; Manuel Garcia-Verdugo, Jose			Therapeutic Effects of hMAPC and hMSC Transplantation after Stroke in Mice	PLOS ONE			English	Article							MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; ADULT PROGENITOR CELLS; ISCHEMIC RAT-BRAIN; BONE-MARROW; MYOCARDIAL-INFARCTION; ARTERIAL THROMBOSIS; FUNCTIONAL RECOVERY; FERRIC-CHLORIDE; FOLLOW-UP	Stroke represents an attractive target for stem cell therapy. Although different types of cells have been employed in animal models, a direct comparison between cell sources has not been performed. The aim of our study was to assess the effect of human multipotent adult progenitor cells (hMAPCs) and human mesenchymal stem cells (hMSCs) on endogenous neurogenesis, angiogenesis and inflammation following stroke. BALB/Ca-RAG 2(-/-) gamma C-/- mice subjected to FeCl3 thrombosis mediated stroke were intracranially injected with 2x10(5) hMAPCs or hMSCs 2 days after stroke and followed for up to 28 days. We could not detect long-term engraftment of either cell population. However, in comparison with PBS-treated animals, hMSC and hMAPC grafted animals demonstrated significantly decreased loss of brain tissue. This was associated with increased angiogenesis, diminished inflammation and a glial-scar inhibitory effect. Moreover, enhanced proliferation of cells in the subventricular zone (SVZ) and survival of newly generated neuroblasts was observed. Interestingly, these neuroprotective effects were more pronounced in the group of animals treated with hMAPCs in comparison with hMSCs. Our results establish cell therapy with hMAPCs and hMSCs as a promising strategy for the treatment of stroke.	[Mora-Lee, Silvia; Gutierrez-Perez, Maria; Lopez, Tania; Abizanda, Gloria; Prosper, Felipe] Univ Navarra, Ctr Appl Med Res, Univ Navarra Clin, Hematol & Cell Therapy Area, E-31080 Pamplona, Spain; [Mora-Lee, Silvia; Gutierrez-Perez, Maria; Lopez, Tania; Abizanda, Gloria; Prosper, Felipe] Univ Navarra, Ctr Appl Med Res, Div Canc, E-31080 Pamplona, Spain; [Salome Sirerol-Piquer, Ma; Casado-Nieto, Mayte; Manuel Garcia-Verdugo, Jose] Univ Valencia, Cavanilles Inst Biodivers & Evolut Biol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Comparat Neurobiol, Valencia, Spain; [Gomez-Pinedo, Ulises] Hosp Clin San Carlos, Lab Med Regenerat, Madrid, Spain; [Roobrouck, Valerie D.; Verfaille, Catherine] Katholieke Univ Leuven, Stem Cell Inst, Louvain, Belgium; [Teresa Rabena, Maria] Univ Valencia, Dept Stat, Valencia, Spain	University of Navarra; University of Navarra; CIBERNED; University of Valencia; Hospital Clinico San Carlos; KU Leuven; University of Valencia	Mora-Lee, S (corresponding author), Univ Navarra, Ctr Appl Med Res, Univ Navarra Clin, Hematol & Cell Therapy Area, E-31080 Pamplona, Spain.	fprosper@unav.es; J.Manuel.Garcia@uv.es	, ulises.gomez-pinedo/C-3414-2016; Prosper, Felipe/H-6859-2017; Sirerol, Salome/K-6141-2012; García-Verdugo, José Manuel/L-8421-2017; Verfaillie, Catherine/H-5148-2013	, ulises.gomez-pinedo/0000-0003-3097-5557; Prosper, Felipe/0000-0001-6115-8790; Sirerol, Salome/0000-0002-9678-4502; García-Verdugo, José Manuel/0000-0001-9872-6499; Verfaillie, Catherine/0000-0001-7564-4079; Abizanda, Gloria/0000-0002-2504-5163	Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion (ISCIII) [RD06/0014, RD06/0010]; "UTE project CIMA", Centro de Investigacion Biomedica en Red, Enfermedades Neurodegenerativas; Spanish Plan Nacional (Ministerio de Ciencia e Innovacion); Consejo Nacional de Ciencia y Tecnologia fellowship [205970]	Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion (ISCIII); "UTE project CIMA", Centro de Investigacion Biomedica en Red, Enfermedades Neurodegenerativas; Spanish Plan Nacional (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Nacional de Ciencia y Tecnologia fellowship	This work was supported by FP6 STREP Project (STROKEMAP), Comunidad de Trabajo de los Pirineos and FEDER Funds, Red de Terapia Celular TERCEL (RETICS) from Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion (ISCIII) RD06/0014 and RD06/0010, PSE SINBAD, and funds from the "UTE project CIMA", Centro de Investigacion Biomedica en Red, Enfermedades Neurodegenerativas, and Spanish Plan Nacional (Ministerio de Ciencia e Innovacion). SML is funded by a Consejo Nacional de Ciencia y Tecnologia fellowship (205970). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranguren XL, 2008, J CLIN INVEST, V118, P505, DOI [10.1172/JC131153, 10.1172/JCI31153]; Aranguren XL, 2007, BLOOD, V109, P2634, DOI 10.1182/blood-2006-06-030411; Aranguren XL, 2011, CELL TRANSPLANT, V20, P259, DOI 10.3727/096368910X516592; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bin Deng Y, 2010, NEUROL RES, V32, P148, DOI 10.1179/174313209X414434; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chen JL, 2004, BRAIN RES, V1005, P21, DOI 10.1016/j.brainres.2003.11.080; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Eglitis MA, 1999, NEUROREPORT, V10, P1289, DOI 10.1097/00001756-199904260-00025; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Gonzalez-Perez O, 2002, NEUROSCI LETT, V321, P100, DOI 10.1016/S0304-3940(02)00056-3; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Janssens S, 2010, ANNU REV MED, V61, P287, DOI 10.1146/annurev.med.051508.215152; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Kovacsovics-Bankowski M, 2009, CELL IMMUNOL, V255, P55, DOI 10.1016/j.cellimm.2008.10.004; Krupinski J, 2003, NEUROREPORT, V14, P1171, DOI 10.1097/00001756-200306110-00014; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2001, CELL TRANSPLANT, V10, P31; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Mazo M, 2010, J CARDIOVASC TRANSL, V3, P79, DOI 10.1007/s12265-009-9159-9; Mora-Lee S, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-28; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pelacho B, 2007, J TISSUE ENG REGEN M, V1, P51, DOI 10.1002/term.7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2000, BIOCHEM SOC T, V28, P341, DOI 10.1042/0300-5127:0280341; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Senior K, 2001, LANCET, V358, P817, DOI 10.1016/S0140-6736(05)71790-6; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Suarez-Monteagudo C, 2009, RESTOR NEUROL NEUROS, V27, P151, DOI 10.3233/RNN-2009-0483; Walker PA, 2010, EXP NEUROL; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yu GL, 2009, RESTOR NEUROL NEUROS, V27, P41, DOI 10.3233/RNN-2009-0460; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	53	56	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43683	10.1371/journal.pone.0043683	http://dx.doi.org/10.1371/journal.pone.0043683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952736	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300021
J	Rai, A; Surolia, A; Panda, D				Rai, Ankit; Surolia, Avadhesha; Panda, Dulal			An Antitubulin Agent BCFMT Inhibits Proliferation of Cancer Cells and Induces Cell Death by Inhibiting Microtubule Dynamics	PLOS ONE			English	Article							INDIVIDUAL MICROTUBULES; KINETIC STABILIZATION; INTRACELLULAR-TRANSPORT; SUPPRESSES DYNAMICS; ASSEMBLY DYNAMICS; DRUG DISCOVERY; TUBULIN; RHODANINE; BINDING; APOPTOSIS	Using cell based screening assay, we identified a novel anti-tubulin agent (Z)-5-((5-(4-bromo-3-chlorophenyl)furan-2-yl)methylene)-2-thioxothiazolidin-4-one (BCFMT) that inhibited proliferation of human cervical carcinoma (HeLa) (IC50, 7.2 +/- 1.8 mu M), human breast adenocarcinoma (MCF-7) (IC50, 10.0 +/- 0.5 mu M), highly metastatic breast adenocarcinoma (MDA-MB-231) (IC50, 6.0 +/- 1 mu M), cisplatin-resistant human ovarian carcinoma (A2780-cis) (IC50, 5.8 +/- 0.3 mu M) and multi-drug resistant mouse mammary tumor (EMT6/AR1) (IC50, 6.5 +/- 1 mu M) cells. Using several complimentary strategies, BCFMT was found to inhibit cancer cell proliferation at G2/M phase of the cell cycle apparently by targeting microtubules. In addition, BCFMT strongly suppressed the dynamics of individual microtubules in live MCF-7 cells. At its half maximal proliferation inhibitory concentration (10 mu M), BCFMT reduced the rates of growing and shortening phases of microtubules in MCF-7 cells by 37 and 40%, respectively. Further, it increased the time microtubules spent in the pause (neither growing nor shortening detectably) state by 135% and reduced the dynamicity (dimer exchange per unit time) of microtubules by 70%. In vitro, BCFMT bound to tubulin with a dissociation constant of 8.3 +/- 1.8 mu M, inhibited tubulin assembly and suppressed GTPase activity of microtubules. BCFMT competitively inhibited the binding of BODIPY FL-vinblastine to tubulin with an inhibitory concentration (K-i) of 5.2 +/- 1.5 mu M suggesting that it binds to tubulin at the vinblastine site. In cultured cells, BCFMT-treatment depolymerized interphase microtubules, perturbed the spindle organization and accumulated checkpoint proteins (BubR1 and Mad2) at the kinetochores. BCFMT-treated MCF-7 cells showed enhanced nuclear accumulation of p53 and its downstream p21, which consequently activated apoptosis in these cells. The results suggested that BCFMT inhibits proliferation of several types of cancer cells including drug resistance cells by suppressing microtubule dynamics and indicated that the compound may have chemotherapeutic potential.	[Rai, Ankit; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India; [Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Science (IISC) - Bangalore	Rai, A (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India.	surolia@mbu.iisc.ernet.in; panda@iitb.ac.in		Rai, Ankit/0000-0002-3732-3597	DAE-SRC fellowship, Department of Atomic energy; J.C. Bose fellowship, Government of India	DAE-SRC fellowship, Department of Atomic energy; J.C. Bose fellowship, Government of India	D.P. is supported by a DAE-SRC fellowship, Department of Atomic energy. A. S. is supported by a J.C. Bose fellowship, Government of India. A. R. is a CSIR (Council of Scientific & Industrial Research) fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Balis FM, 2002, J NATL CANCER I, V94, P78, DOI 10.1093/jnci/94.2.78; Beuria TK, 2009, BIOCHEM J, V423, P61, DOI 10.1042/BJ20090817; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; BHATTACH.B, 1974, P NATL ACAD SCI USA, V71, P2627, DOI 10.1073/pnas.71.7.2627; Bhattacharyya B, 2010, METHOD CELL BIOL, V95, P301, DOI 10.1016/S0091-679X(10)95017-6; Chatterji BP, 2011, EXPERT OPIN THER PAT, V21, P167, DOI 10.1517/13543776.2011.545349; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cruz-Monserrate Z, 2003, EUR J BIOCHEM, V270, P3822, DOI 10.1046/j.1432-1033.2003.03776.x; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; DHAMODHARAN R, 1995, MOL BIOL CELL, V6, P1215, DOI 10.1091/mbc.6.9.1215; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Drake DM, 2008, J PHARM SCI-US, V97, P1399, DOI 10.1002/jps.21106; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Dziadyk JM, 2004, ANTICANCER RES, V24, P27; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gerdes JM, 2005, HUM MOL GENET, V14, pR291, DOI 10.1093/hmg/ddi269; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Gupta K, 2002, BIOCHEMISTRY-US, V41, P13029, DOI 10.1021/bi025952r; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hernandes MZ, 2010, CURR DRUG TARGETS, V11, P303, DOI 10.2174/138945010790711996; Kamath K, 2003, CANCER RES, V63, P6026; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kumar G, 2007, J MED CHEM, V50, P2665, DOI 10.1021/jm061257w; Lam JKW, 2011, J DRUG TARGET, V19, P56, DOI 10.3109/10611861003733938; LEE JC, 1975, J BIOL CHEM, V250, P9276; Mohan R, 2006, BIOCHEMISTRY-US, V45, P5440, DOI 10.1021/bi0523409; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; O'Connor R, 2007, EXPERT OPIN DRUG MET, V3, P805, DOI 10.1517/17425255.3.6.805; PANDA D, 1992, BIOCHEMISTRY-US, V31, P9709, DOI 10.1021/bi00155a026; Panda D, 1997, P NATL ACAD SCI USA, V94, P10560, DOI 10.1073/pnas.94.20.10560; Panda D, 1998, P NATL ACAD SCI USA, V95, P9313, DOI 10.1073/pnas.95.16.9313; Pourroy B, 2004, MOL PHARMACOL, V66, P580; Ramkumar K, 2010, MOLECULES, V15, P3958, DOI 10.3390/molecules15063958; Rathinasamy K, 2006, FEBS J, V273, P4114, DOI 10.1111/j.1742-4658.2006.05413.x; Rathinasamy K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-213; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; Sharma SV, 2008, NAT REV CANCER, V10, P241; Sing WT, 2001, BIOORG MED CHEM LETT, V11, P91, DOI 10.1016/S0960-894X(00)00610-7; Singh P, 2008, IUBMB LIFE, V60, P368, DOI 10.1002/iub.42; Singh P, 2012, BIOCHEMISTRY-US, V51, P5434, DOI 10.1021/bi201813u; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Srivastava P, 2007, FEBS J, V274, P4788, DOI 10.1111/j.1742-4658.2007.06004.x; Tomasic T, 2009, CURR MED CHEM, V16, P1596, DOI 10.2174/092986709788186200; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799	54	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44311	10.1371/journal.pone.0044311	http://dx.doi.org/10.1371/journal.pone.0044311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952952	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300078
J	Rocha-Rego, V; Pereira, MG; Oliveira, L; Mendlowicz, MV; Fiszman, A; Marques-Portella, C; Berger, W; Chu, C; Joffily, M; Moll, J; Mari, JJ; Figueira, I; Volchan, E				Rocha-Rego, Vanessa; Pereira, Mirtes G.; Oliveira, Leticia; Mendlowicz, Mauro V.; Fiszman, Adriana; Marques-Portella, Carla; Berger, William; Chu, Carlton; Joffily, Mateus; Moll, Jorge; Mari, Jair J.; Figueira, Ivan; Volchan, Eliane			Decreased Premotor Cortex Volume in Victims of Urban Violence with Posttraumatic Stress Disorder	PLOS ONE			English	Article							CHILDHOOD SEXUAL-ABUSE; STRUCTURAL BRAIN ABNORMALITIES; SELF-INDUCED SADNESS; GRAY-MATTER VOLUME; ANTERIOR CINGULATE; HIPPOCAMPAL VOLUME; PREFRONTAL CORTEX; PERSONAL-SPACE; PTSD; MRI	Background: Studies addressing posttraumatic stress disorder (PTSD) have demonstrated that PTSD patients exhibit structural abnormalities in brain regions that relate to stress regulation and fear responses, such as the hippocampus, amygdala, anterior cingulate cortex, and ventromedial prefrontal cortex. Premotor cortical areas are involved in preparing to respond to a threatening situation and in representing the peripersonal space. Urban violence is an important and pervasive cause of human suffering, especially in large urban centers in the developing world. Violent events, such as armed robbery, are very frequent in certain cities, and these episodes increase the risk of PTSD. Assaultive trauma is characterized by forceful invasion of the peripersonal space; therefore, could this traumatic event be associated with structural alteration of premotor areas in PTSD? Methodology/Principal Findings: Structural magnetic resonance imaging scans were acquired from a sample of individuals that had been exposed to urban violence. This sample consisted of 16 PTSD patients and 16 age-and gender-matched controls. Psychometric questionnaires differentiated PTSD patients from trauma-exposed controls with regard to PTSD symptoms, affective, and resilience predispositions. Voxel-based morphometric analysis revealed that, compared with controls, the PTSD patients presented significant reductions in gray matter volume in the ventral premotor cortex and in the pregenual anterior cingulate cortex. Conclusions: Volume reduction in the premotor cortex that is observed in victims of urban violence with PTSD may be associated with a disruption in the dynamical modulation of the safe space around the body. The finding that PTSD patients presented a smaller volume of pregenual anterior cingulate cortex is consistent with the results of other PTSD neuroimaging studies that investigated different types of traumatic events.	[Rocha-Rego, Vanessa; Joffily, Mateus; Volchan, Eliane] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Pereira, Mirtes G.; Oliveira, Leticia; Mendlowicz, Mauro V.; Berger, William] Univ Fed Fluminense, Niteroi, RJ, Brazil; [Fiszman, Adriana; Marques-Portella, Carla; Figueira, Ivan] Univ Fed Rio de Janeiro, Inst Psiquiatria, Rio De Janeiro, Brazil; [Chu, Carlton] UCL, London, England; [Moll, Jorge] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Mari, Jair J.] Univ Fed Sao Paulo, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; University of London; University College London; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal de Sao Paulo (UNIFESP)	Rocha-Rego, V (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	rochavr@biof.ufrj.br	Berger, William/K-3258-2012; Oliveira, Leticia/P-1159-2019; Neurociencia, Inct/I-1011-2013; Moll, Jorge/B-2654-2013; figueira, ivan/B-4577-2008; Joffily, Mateus/H-7457-2017; Volchan, Eliane/C-5792-2013; Pereira, Mirtes Garcia/J-6222-2016; de Jesus Mari, Jair/A-7309-2008; Moll, Jorge/AAF-8388-2021	Berger, William/0000-0001-7656-4548; Oliveira, Leticia/0000-0002-8450-2264; Joffily, Mateus/0000-0003-4073-4562; Pereira, Mirtes Garcia/0000-0003-4682-223X; de Jesus Mari, Jair/0000-0002-5403-0112; Moll, Jorge/0000-0002-4297-591X	National Council for Scientific and Technological Development (CNPq); Carlos Chagas Filho Foundation for Research Support in Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support in Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the National Council for Scientific and Technological Development (CNPq) and the Carlos Chagas Filho Foundation for Research Support in Rio de Janeiro (FAPERJ). Currently, Vanessa Rocha-Rego is funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Berger William, 2004, Rev. psiquiatr. Rio Gd. Sul, V26, P167, DOI 10.1590/S0101-81082004000200006; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; Bremner JD, 2001, HIPPOCAMPUS, V11, P75, DOI 10.1002/hipo.1023; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Cohn MA, 2009, EMOTION, V9, P361, DOI 10.1037/a0015952; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; Eckart C, 2011, J PSYCHIATR NEUROSCI, V36, P176, DOI 10.1503/jpn.100010; Falconer E, 2008, J PSYCHIATR NEUROSCI, V33, P413; Figueira I, 2007, J TRAUMA STRESS, V20, P89, DOI 10.1002/jts.20183; First M. B., 1997, STRUCTURED CLIN INTE; Francati V, 2007, DEPRESS ANXIETY, V24, P202, DOI 10.1002/da.20208; Friedman M.J., 2008, PSYCHOPHARMACOLOGY A, P245; George MS, 1996, BIOL PSYCHIAT, V40, P859, DOI 10.1016/0006-3223(95)00572-2; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P2621, DOI 10.1016/j.neuropsychologia.2005.09.011; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; Hakamata Y, 2007, NEUROSCI RES, V59, P383, DOI 10.1016/j.neures.2007.08.012; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1978, PSYCHOL BULL, V85, P117, DOI 10.1037/0033-2909.85.1.117; Hidalgo RB, 2000, J CLIN PSYCHIAT, V61, P5; HOROWITZ MJ, 1964, ARCH GEN PSYCHIAT, V11, P651; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI 10.1586/ERN.10.198; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Jatzko A, 2006, J AFFECT DISORDERS, V94, P121, DOI 10.1016/j.jad.2006.03.010; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kesler ML, 2001, COGNITIVE BRAIN RES, V11, P213, DOI 10.1016/S0926-6410(00)00073-2; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Killgore WDS, 2004, NEUROIMAGE, V21, P1215, DOI 10.1016/j.neuroimage.2003.12.033; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Kroes MCW, 2011, J PSYCHIATR NEUROSCI, V36, P256, DOI 10.1503/jpn.100077; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Litz BT, 2000, J ABNORM PSYCHOL, V109, P26, DOI 10.1037/0021-843X.109.1.26; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Lobo Isabela, 2011, Psychol. Neurosci., V4, P191, DOI 10.3922/j.psns.2011.2.004; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Mari JD, 2008, REV BRAS PSIQUIATR, V30, P183, DOI 10.1590/S1516-44462008000300002; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; Pelletier M, 2003, NEUROREPORT, V14, P1111, DOI 10.1097/00001756-200306110-00003; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phillips ML, 1998, PSYCHIAT RES-NEUROIM, V83, P127, DOI 10.1016/S0925-4927(98)00036-5; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Robinson BL, 2011, CURR OPIN PSYCHIATR, V24, P29, DOI 10.1097/YCO.0b013e3283413519; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2009, J TRAUMA STRESS, V22, P409, DOI 10.1002/jts.20442; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Vogt B. A., 2009, CINGULATE NEUROBIOLO; Volchan E, 2011, BIOL PSYCHOL, V88, P13, DOI 10.1016/j.biopsycho.2011.06.002; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weathers F.W., 1994, PTSD CHECKLIST CIVIL; Wieser MJ, 2010, CYBERPSYCH BEH SOC N, V13, P547, DOI 10.1089/cyber.2009.0432; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Woon FL, 2009, J NEUROPSYCH CLIN N, V21, P5, DOI 10.1176/appi.neuropsych.21.1.5; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001	76	36	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42560	10.1371/journal.pone.0042560	http://dx.doi.org/10.1371/journal.pone.0042560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998EY	22952599	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300007
J	Clarke, M; Pentz, R; Bobyn, J; Hayley, S				Clarke, Melanie; Pentz, Rowan; Bobyn, Jessica; Hayley, Shawn			Stressor-Like Effects of c-Jun N-Terminal Kinase (JNK) Inhibition	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLUCOCORTICOID-RECEPTOR; PARKINSONS-DISEASE; HIPPOCAMPAL CA1; LOCUS-COERULEUS; BRAIN-INJURY; DEPRESSION; CORTICOSTERONE; RESPONSES; NEURONS	There is an urgent need for novel treatment strategies for stressor related disorders, particularly depression and anxiety disorders. Indeed, existing drug treatments are only clinically successful in a subset of patients and relapse is common. This likely stems from the fact that stressor disorders are heterogeneous with multiple biological pathways being affected. To this end, the present investigation sought to assess in mice the contribution of the c-Jun N terminal kinase (JNK) pathway to the behavioral, hormonal and neurochemical effects of an acute stressor. Indeed, although JNK has been shown to modulate glucocorticoid receptors in vitro, virtually nothing is known of the role for JNK in affecting stressor induced pathology. We presently found that the JNK antagonist, SP600125, (but not the p38 antagonist, SB203580) increased plasma corticosterone levels under resting conditions and in the context of an acute stressor (wet bedding + restraint). SP600125 also reduced exploration in an open field arena, but prevented the stressor induced increase in open arm exploration in an elevated plus maze. Finally, SP600125 affected noradrenergic activity in the central amygdala and locus coruleus under resting condition, but prevented the noradrenergic effects within the paraventricular nucleus of the hypothalamus that were induced by the acute stressor exposure. These data suggest inhibiting endogenous JNK can have stressor-like corticoid, behavioral and central monoamine effects under basal conditions, but can actually reverse some behavioral and neurochemical effects of an acute stressor. Thus, endogenous JNK appears to affect stress relevant processes in a context-dependent manner.	[Clarke, Melanie; Pentz, Rowan; Bobyn, Jessica; Hayley, Shawn] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada	Carleton University	Clarke, M (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	shawn_hayley@carleton.ca			CIHR (Canadian Institutes of Health Research); NSERC (Natural Sciences and Engineering Research Council of Canada); NSERC scholarship	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by grants to S.H. from the CIHR (Canadian Institutes of Health Research) and NSERC (Natural Sciences and Engineering Research Council of Canada). M.C. was supported, in part, by an NSERC scholarship. S.H. is a Canada Research Chair in Neuroscience (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1988, BRAIN RES, V441, P362, DOI 10.1016/0006-8993(88)91415-1; Adzic M, 2009, J ENDOCRINOL, V202, P87, DOI 10.1677/JOE-08-0509; Anisman H, 2009, J PSYCHIATR NEUROSCI, V34, P4; Bevilaqua LRM, 2003, EUR J NEUROSCI, V17, P897, DOI 10.1046/j.1460-9568.2003.02524.x; Bland ST, 2006, NEUROREPORT, V17, P593, DOI 10.1097/00001756-200604240-00008; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Bruna A, 2003, EMBO J, V22, P6035, DOI 10.1093/emboj/cdg590; Budziszewska B, 2010, J PHYSIOL PHARMACOL, V61, P207; CHANPALAY V, 1993, ADV NEUROL, V60, P438; Choi DC, 2008, PSYCHONEUROENDOCRINO, V33, P659, DOI 10.1016/j.psyneuen.2008.02.006; Colombo A, 2007, CELL DEATH DIFFER, V14, P1845, DOI 10.1038/sj.cdd.4402202; Curran BP, 2003, NEUROSCIENCE, V118, P347, DOI 10.1016/S0306-4522(02)00941-7; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; De Oliveira ACP, 2008, GLIA, V56, P844, DOI 10.1002/glia.20658; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; FELDMAN S, 1994, BRAIN RES, V658, P21, DOI 10.1016/S0006-8993(09)90005-1; Frodl T, 2012, NEUROBIOL D IN PRESS; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Guan QH, 2006, NEUROSCIENCE, V139, P609, DOI 10.1016/j.neuroscience.2005.11.067; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Haeusgen W, 2009, NEUROSCIENCE, V161, P951, DOI 10.1016/j.neuroscience.2009.04.014; Harvey BH, 2006, PHYSIOL BEHAV, V87, P881, DOI 10.1016/j.physbeh.2006.01.033; Hayley S, 2005, NEUROSCIENCE, V135, P659, DOI 10.1016/j.neuroscience.2005.03.051; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; JOHNSON RW, 1993, PHYSIOL BEHAV, V53, P127, DOI 10.1016/0031-9384(93)90020-G; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Karten YJG, 1999, P NATL ACAD SCI USA, V96, P13456, DOI 10.1073/pnas.96.23.13456; Li HH, 2009, BEHAV BRAIN RES, V205, P32, DOI 10.1016/j.bbr.2009.06.036; Li XM, 2007, EUR J NEUROSCI, V25, P391, DOI 10.1111/j.1460-9568.2006.05300.x; Ma S, 2008, NEUROSCIENCE, V154, P1639, DOI 10.1016/j.neuroscience.2008.04.068; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Meller E, 2003, BRAIN RES, V979, P57, DOI 10.1016/S0006-8993(03)02866-X; Niimi K, 2011, BIOCHEM BIOPH RES CO, V406, P524, DOI 10.1016/j.bbrc.2011.02.071; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Roy V, 2007, BEHAV BRAIN RES, V185, P49, DOI 10.1016/j.bbr.2007.07.008; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Szumlinski KK, 2001, PHARMACOL BIOCHEM BE, V69, P485, DOI 10.1016/S0091-3057(01)00564-0; Tanaka M, 1983, PHARM BIOCH BEHAV, V19, P287; Unger EK, 2010, ENDOCRINOLOGY, V151, P671, DOI 10.1210/en.2009-0711; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Wang WY, 2004, NEUROSCI RES, V48, P195, DOI 10.1016/j.neures.2003.10.012; Wang XH, 2005, NEUROPSYCHOPHARMACOL, V30, P242, DOI 10.1038/sj.npp.1300606; Watanabe G, 1997, J BIOL CHEM, V272, P20063, DOI 10.1074/jbc.272.32.20063; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281; Yoshimura K, 2011, NEUROSCI RES, V71, P266, DOI 10.1016/j.neures.2011.07.1830; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	51	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44073	10.1371/journal.pone.0044073	http://dx.doi.org/10.1371/journal.pone.0044073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952879	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206000079
J	Souza, JP; Cecatti, JG; Haddad, SM; Parpinelli, MA; Costa, ML; Katz, L; Say, L				Souza, Joao Paulo; Cecatti, Jose Guilherme; Haddad, Samira M.; Parpinelli, Mary Angela; Costa, Maria Laura; Katz, Leila; Say, Lale		Severe Maternal Morbidity Grp	The WHO Maternal Near-Miss Approach and the Maternal Severity Index Model (MSI): Tools for Assessing the Management of Severe Maternal Morbidity	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; MORTALITY; DEATH; ICU	Objectives: To validate the WHO maternal near-miss criteria and develop a benchmark tool for severe maternal morbidity assessments. Methods: In a multicenter cross-sectional study implemented in 27 referral maternity hospitals in Brazil, a one-year prospective surveillance on severe maternal morbidity and data collection was carried out. Diagnostic accuracy tests were used to assess the validity of the WHO maternal near-miss criteria. Binary logistic regression was used to model the death probability among women with severe maternal complications and benchmark the management of severe maternal morbidity. Results: Of the 82,388 women having deliveries in the participating health facilities, 9,555 women presented pregnancy-related complications, including 140 maternal deaths and 770 maternal near misses. The WHO maternal near-miss criteria were found to be accurate and highly associated with maternal deaths (Positive likelihood ratio 106.8 (95% CI 99.56-114.6)). The maternal severity index (MSI) model was developed and found to able to describe the relationship between life-threatening conditions and mortality (Area under the ROC curve: 0.951 (95% CI 0.909-0.993)). Conclusion: The identification of maternal near-miss cases using the WHO list of pregnancy-related life-threatening conditions was validated. The MSI model can be used as a tool for benchmarking the performance of health services managing women with severe maternal complications and provide case-mix adjustment.	[Souza, Joao Paulo; Say, Lale] World Hlth Org, UNDP UNFPA WHO World Bank Special Programme Res, Dept Reprod Hlth & Res, Geneva, Switzerland; [Cecatti, Jose Guilherme; Haddad, Samira M.; Parpinelli, Mary Angela; Costa, Maria Laura] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil; [Katz, Leila] Inst Med Integral Prof Fernando Figueira IMIP, Dept Obstet, Recife, PE, Brazil	The World Bank; United Nations Population Fund; World Health Organization; Universidade Estadual de Campinas; Instituto de Medicina Integral Professor Fernando Figueira (IMIP)	Souza, JP (corresponding author), World Hlth Org, UNDP UNFPA WHO World Bank Special Programme Res, Dept Reprod Hlth & Res, Geneva, Switzerland.	souzaj@who.int	Souza, João Paulo/G-1982-2010; Moisés, Elaine C/A-5708-2015; Nakamura-Pereira, Marcos/X-1107-2019; Amorim, Melania/C-5807-2013; Pacagnella, Rodolfo/H-6247-2012; Andreucci, Carla B/J-4845-2015; Moisés, Elaine Christine Dantas/N-9522-2019; Katz, Leila/M-5291-2013; Rudge, Marilza V C/C-8338-2012; CORDIOLI, EDUARDO/AAR-6100-2020; Costa, Maria Laura/I-4980-2019; Cecatti, Jose Guilherme/M-5945-2013; Surita, Fernanda Garanhani/H-9575-2012; de Carvalho Pacagnella, Rodolfo/H-9390-2019; Calderon, Iracema/W-4336-2019; , lalesay/AAG-1912-2021; Leite, Debora F B/D-7299-2018; Peracoli, Jose Carlos/G-4923-2012	Souza, João Paulo/0000-0002-2288-4244; Moisés, Elaine C/0000-0001-9099-4544; Nakamura-Pereira, Marcos/0000-0002-4231-0205; Amorim, Melania/0000-0003-1047-2514; Pacagnella, Rodolfo/0000-0002-5739-0009; Andreucci, Carla B/0000-0002-5590-108X; Moisés, Elaine Christine Dantas/0000-0001-9099-4544; Katz, Leila/0000-0001-9854-7917; Rudge, Marilza V C/0000-0002-9227-832X; Costa, Maria Laura/0000-0001-8280-3234; Cecatti, Jose Guilherme/0000-0003-1285-8445; Surita, Fernanda Garanhani/0000-0003-4335-0337; de Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Calderon, Iracema/0000-0003-4761-4336; Leite, Debora F B/0000-0001-8839-3934; Santana, Danielly/0000-0001-8912-2626; Peracoli, Jose Carlos/0000-0002-3273-3001; Rocha Filho, Edilberto/0000-0002-6434-2654; CORDIOLI, EDUARDO/0000-0001-5405-9380	CNPq/DECIT (The Brazilian National Research Council and the Department of Science and Technology of the Brazilian Ministry of Health) [402702/2008-5]	CNPq/DECIT (The Brazilian National Research Council and the Department of Science and Technology of the Brazilian Ministry of Health)	The Brazilian Network for Surveillance of Severe Maternal Morbidity was financially supported by CNPq/DECIT (The Brazilian National Research Council and the Department of Science and Technology of the Brazilian Ministry of Health), grant number 402702/2008-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22; Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283; Haddad SM, 2011, INTRACLASS COR UNPUB; Higgins Thomas L, 2007, J Intensive Care Med, V22, P141, DOI 10.1177/0885066607299520; Knaus WA, 2002, ARCH SURG-CHICAGO, V137, P37, DOI 10.1001/archsurg.137.1.37; Lapinsky SE, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.10.003; Lewis G, 2007, CONF ENQ MAT CHILD H; Maine D, 2007, LANCET, V370, P1380, DOI 10.1016/S0140-6736(07)61580-3; Muench MV, 2008, J REPROD MED, V53, P914; Neto AFO, 2009, INT J GYNECOL OBSTET, V105, P252, DOI 10.1016/j.ijgo.2009.01.025; Parpinelli, 2009, REPROD HLTH, V24, P15, DOI [DOI 10.1186/1742-4755-6-15, 10.1186/1742-4755-6-15]; Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001; Pattinson R, 2009, BEST PRACT RES CL OB, V23, P285, DOI 10.1016/j.bpobgyn.2009.01.013; Price LC, 2008, BEST PRACT RES CL OB, V22, P775, DOI 10.1016/j.bpobgyn.2008.06.001; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828; Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x; Tempe Anjali, 2007, Indian J Med Sci, V61, P179; Togal T, 2010, J CRIT CARE, V25, P628, DOI 10.1016/j.jcrc.2010.02.015; United Nations, 2010, GLOB STRAT WOM CHILD; Vasquez DN, 2007, CHEST, V131, P718, DOI 10.1378/chest.06-2388; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; WHO U. UNFPA The World Bank, 2012, TRENDS MAT MORT 1990; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	30	108	115	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44129	10.1371/journal.pone.0044129	http://dx.doi.org/10.1371/journal.pone.0044129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952897	gold, Green Published			2022-12-27	WOS:000308206000086
J	Squirrell, JM; Fong, JJ; Ariza, CA; Mael, A; Meyer, K; Shevde, NK; Roopra, A; Lyons, GE; Kamp, TJ; Eliceiri, KW; Ogle, BM				Squirrell, Jayne M.; Fong, Jimmy J.; Ariza, Carlos A.; Mael, Amber; Meyer, Kassondra; Shevde, Nirupama K.; Roopra, Avtar; Lyons, Gary E.; Kamp, Timothy J.; Eliceiri, Kevin W.; Ogle, Brenda M.			Endogenous Fluorescence Signatures in Living Pluripotent Stem Cells Change with Loss of Potency	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; OXIDATIVE-PHOSPHORYLATION; NEURAL DIFFERENTIATION; EMBRYOID BODIES; MICROSCOPY; MOUSE; NADH; ACTIVATION; DEPENDENCE; NAD(P)H	The therapeutic potential of stem cells is limited by the non-uniformity of their phenotypic state. Thus it would be advantageous to noninvasively monitor stem cell status. Driven by this challenge, we employed multidimensional multiphoton microscopy to quantify changes in endogenous fluorescence occurring with pluripotent stem cell differentiation. We found that global and cellular-scale fluorescence lifetime of human embryonic stem cells (hESC) and murine embryonic stem cells (mESC) consistently decreased with differentiation. Less consistent were trends in endogenous fluorescence intensity with differentiation, suggesting intensity is more readily impacted by nuances of species and scale of analysis. What emerges is a practical and accessible approach to evaluate, and ultimately enrich, living stem cell populations based on changes in metabolism that could be exploited for both research and clinical applications.	[Squirrell, Jayne M.; Fong, Jimmy J.; Lyons, Gary E.; Kamp, Timothy J.; Eliceiri, Kevin W.; Ogle, Brenda M.] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53715 USA; [Mael, Amber; Shevde, Nirupama K.] WiCell Res Inst, Madison, WI USA; [Ogle, Brenda M.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison	Squirrell, JM (corresponding author), Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53715 USA.	ogle@wisc.edu	Kamp, Timothy/ABD-1343-2020; Eliceiri, Kevin/ABD-4516-2020	Kamp, Timothy/0000-0003-2103-7876; Eliceiri, Kevin/0000-0001-8678-670X	National Institutes of Health [1K18HL092218, HL100014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K18HL092218, RC1HL100014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by grants from National Institutes of Health (1K18HL092218), (HL100014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi S, 2012, J BIOPHOTONICS, V5, P57, DOI 10.1002/jbio.201100077; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Beres M, 2010, CULT HEALTH SEX, V12, P1, DOI 10.1080/13691050903075226; Bieberich E, 2004, J CELL BIOL, V167, P723, DOI 10.1083/jcb.200405144; Bird DK, 2004, APPL OPTICS, V43, P5173, DOI 10.1364/AO.43.005173; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Buschke DG, 2011, MICROSC MICROANAL, V17, P540, DOI 10.1017/S1431927610000280; Centonze VE, 1998, BIOPHYS J, V75, P2015, DOI 10.1016/S0006-3495(98)77643-X; CHANCE B, 1958, J BIOL CHEM, V233, P736; Chen AA, 2010, INTEGR BIOL-UK, V2, P517, DOI 10.1039/c0ib00054j; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Conklin MW, 2009, CELL BIOCHEM BIOPHYS, V53, P145, DOI 10.1007/s12013-009-9046-7; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Feraud O, 2007, CELL DEATH DIFFER, V14, P385, DOI 10.1038/sj.cdd.4402041; Fernandez LA, 2005, TRANSPLANTATION, V80, P729, DOI 10.1097/01.tp.0000179105.95770.cd; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; GALLAS JM, 1987, PHOTOCHEM PHOTOBIOL, V45, P595, DOI 10.1111/j.1751-1097.1987.tb07385.x; Gaspers LD, 2008, METHODS, V46, P224, DOI 10.1016/j.ymeth.2008.09.012; Georgakoudi I, 2002, CANCER RES, V62, P682; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Hernandez-Garcia D, 2008, EXP CELL RES, V314, P2090, DOI 10.1016/j.yexcr.2008.03.005; Hronik-Tupaj M, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-9; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Iyer V, 2006, J NEUROPHYSIOL, V95, P535, DOI 10.1152/jn.00865.2005; King MA, 2000, J IMMUNOL METHODS, V243, P155, DOI 10.1016/S0022-1759(00)00232-5; Konig K, 2011, MICROSC RES TECHNIQ, V74, P9, DOI 10.1002/jemt.20866; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; KORETSKY AP, 1987, BIOCHIM BIOPHYS ACTA, V893, P398, DOI 10.1016/0005-2728(87)90092-2; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Lakowicz JR, 1999, J BIOMOL SCREEN, V4, P355, DOI 10.1177/108705719900400610; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lee ER, 2006, J BIOL CHEM, V281, P21162, DOI 10.1074/jbc.M602734200; Levitt JM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2401149; Liang J, 2007, SPECTROCHIM ACTA A, V67, P355, DOI 10.1016/j.saa.2006.07.035; Lim HJ, 2011, MOL CELLS, V31, P123, DOI 10.1007/s10059-011-0016-8; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Menter JM, 2006, PHOTOCH PHOTOBIO SCI, V5, P403, DOI 10.1039/b516429j; Mohr JC, 2010, BIOMATERIALS, V31, P1885, DOI 10.1016/j.biomaterials.2009.11.033; Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Pachernik J, 2002, REPROD NUTR DEV, V42, P317, DOI 10.1051/rnd:2002028; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rice WL, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2823019; Rice WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010075; Skala MC, 2005, CANCER RES, V65, P1180, DOI 10.1158/0008-5472.CAN-04-3031; Skala MC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717503; Squirrell JM, 1999, NAT BIOTECHNOL, V17, P763, DOI 10.1038/11698; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; Stringari C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.046012; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Tadrous PJ, 2003, J PATHOL, V199, P309, DOI 10.1002/path.1286; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Uchugonova A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3002370; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200; Wang HW, 2009, ANTI-CANCER AGENT ME, V9, P1012, DOI 10.2174/187152009789377718; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wu Tom Y H, 2006, Drug Discov Today Technol, V3, P255, DOI 10.1016/j.ddtec.2006.09.001; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JC, 1997, LASER SURG MED, V20, P319, DOI 10.1002/(SICI)1096-9101(1997)20:3<319::AID-LSM11>3.0.CO;2-8; Zhang QH, 2002, SCIENCE, V295, P1895; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	71	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43708	10.1371/journal.pone.0043708	http://dx.doi.org/10.1371/journal.pone.0043708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952742	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206000046
J	Xing, LD; Bell, PR; Persons, WS; Ji, SA; Miyashita, T; Burns, ME; Ji, Q; Currie, PJ				Xing, Lida; Bell, Phil R.; Persons, W. Scott; Ji, Shuan; Miyashita, Tetsuto; Burns, Michael E.; Ji, Qiang; Currie, Philip J.			Abdominal Contents from Two Large Early Cretaceous Compsognathids (Dinosauria: Theropoda) Demonstrate Feeding on Confuciusornithids and Dromaeosaurids	PLOS ONE			English	Article							FEATHERED DINOSAURS; YIXIAN FORMATION; BIRD; DIET; TISSUE; PRESERVATION; VERTEBRATES; EVOLUTION; PATTERNS; ANATOMY	Two skeletons of the large compsognathid Sinocalliopteryx gigas include intact abdominal contents. Both specimens come from the Jianshangou Beds of the lower Yixian Formation (Neocomian), Liaoning, China. The holotype of S. gigas preserves a partial dromaeosaurid leg in the abdominal cavity, here attributed to Sinornithosaurus. A second, newly-discovered specimen preserves the remains of at least two individuals of the primitive avialan, Confuciusornis sanctus, in addition to acid-etched bones from a possible ornithischian. Although it cannot be stated whether such prey items were scavenged or actively hunted, the presence of two Confuciusornis in a grossly similar state of digestion suggests they were consumed in rapid succession. Given the lack of clear arboreal adaptations in Sinocalliopteryx, we suggest it may have been an adept stealth hunter.	[Xing, Lida; Persons, W. Scott; Miyashita, Tetsuto; Burns, Michael E.; Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Bell, Phil R.] Pipestone Creek Dinosaur Initiat, Clairmont, AB, Canada; [Ji, Shuan; Ji, Qiang] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China	University of Alberta; Chinese Academy of Geological Sciences	Xing, LD (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	philbyb@gmail.com	Burns, Michael E/GPC-8311-2022	Xing, Lida/0000-0003-3923-9206; Burns, Michael/0000-0002-9587-563X				[Anonymous], HOWE RANCH DINOSAURS; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Chen PJ, 2005, SCI CHINA SER D, V48, P298, DOI 10.1360/04yd0038; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe LM, 2010, NEUES JAHRB GEOL P-A, V258, P257, DOI 10.1127/0077-7749/2010/0125; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Chin K, 2003, PALAIOS, V18, P286, DOI 10.1669/0883-1351(2003)018<0286:RPOUMT>2.0.CO;2; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Dal Sasso C, 1998, NATURE, V392, P383; Dal Sasso Cristiano, 2011, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V37, P1; Dalsatt J, 2006, NATURWISSENSCHAFTEN, V93, P444, DOI 10.1007/s00114-006-0125-y; De Klerk WJ, 2000, J VERTEBR PALEONTOL, V20, P324, DOI 10.1671/0272-4634(2000)020[0324:ANCDFT]2.0.CO;2; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dong Z., 2000, VERTEBRATA PALASIA S, V38, P10; Farmer CG, 2008, PHYSIOL BIOCHEM ZOOL, V81, P125, DOI 10.1086/524150; Fursich FT, 2007, PALAEOGEOGR PALAEOCL, V253, P434, DOI 10.1016/j.palaeo.2007.06.012; Gishlick AD, 2007, ZOOL J LINN SOC-LOND, V149, P569, DOI 10.1111/j.1096-3642.2007.00269.x; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; HOU LH, 1995, NATURE, V377, P616, DOI 10.1038/377616a0; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Huchzermeyer F.W., 2003, CROCODILES BIOL HUSB; Hunter Luke, 2005, CATS AFRICA BEHAV EC; Hurum JH, 2006, ACTA PALAEONTOL POL, V51, P1; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji S, 2007, ACTA GEOL SIN-ENGL, V81, P8; Kingdon J., 1977, E AFRICAN MAMMALS A; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; LOSOS JB, 1988, BIOL J LINN SOC, V35, P379, DOI 10.1111/j.1095-8312.1988.tb00477.x; Martin LD, 1998, NATURWISSENSCHAFTEN, V85, P286, DOI 10.1007/s001140050501; Marugan-Lobon J, 2011, J SYST PALAEONTOL, V9, P91, DOI 10.1080/14772019.2010.517786; Mateus Isabel, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P101; Norell Mark A., 1999, American Museum Novitates, V3282, P1; O'Connor J, 2011, P NATL ACAD SCI USA, V108, P19662, DOI 10.1073/pnas.1117727108; OSTROM J H, 1978, Zitteliana, V4, P73; Peyer K, 2006, J VERTEBR PALEONTOL, V26, P879, DOI 10.1671/0272-4634(2006)26[879:AROCFT]2.0.CO;2; Qiang J, 1999, J VERTEBR PALEONTOL, V19, P1, DOI 10.1080/02724634.1999.10011117; RICHARDS DF, 1977, J ZOOL, V183, P495, DOI 10.1111/j.1469-7998.1977.tb04201.x; Rodriguez-Robles JA, 1999, J ZOOL, V248, P49; SARGEANT AB, 1984, WILDLIFE MONOGR, P1; SLIP DJ, 1988, J HERPETOL, V22, P323, DOI 10.2307/1564156; Smithers R. H. N., 1971, MUS MEM NAT MUS MONU, V4, P1; Stevens CE., 1995, COMP PHYSL VERTEBRAT, DOI 10.1086/416640; Sturkie P., 2000, AVIAN PHYSL; Sunquist ME, 2002, WILD CATS WORLD; Suzuki S, 2000, HAYASHIBARA MUS NAT, V1, P83; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Uriona TJ, 2005, J EXP BIOL, V208, P3047, DOI 10.1242/jeb.01746; Vestjens WJM, 1976, EMU, V77, P36; Whittle Christopher H., 2000, Bulletin of the New Mexico Museum of Natural History and Science, V17, P75; Whittow GC, 2000, STURKIES AVIAN PHYSL; Wings O, 2007, ACTA PALAEONTOL POL, V52, P1; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu X., 2000, SPECIAL PUBLICATION, V2000, P179; Xu Xing, 2004, Vertebrata Palasiatica, V42, P111; Xu Xing, 1998, Vertebrata Palasiatica, V36, P147; [袁崇喜 Yuan Chongxi], 2004, [地质学报, Acta Geologica Sinica], V78, P464; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zheng WJ, 2012, CRETACEOUS RES, V34, P208, DOI 10.1016/j.cretres.2011.11.001; Zheng X, 2010, P ROY SOC B, V22, P211; Zheng XT, 2011, P NATL ACAD SCI USA, V108, P15904, DOI 10.1073/pnas.1112694108; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P571, DOI 10.1007/s00114-004-0567-z; Zhou Zhong-He, 2009, Vertebrata Palasiatica, V47, P299; Zhou ZH, 2010, SCI CHINA EARTH SCI, V53, P1894, DOI 10.1007/s11430-010-4094-9	71	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44012	10.1371/journal.pone.0044012	http://dx.doi.org/10.1371/journal.pone.0044012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952855	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206000069
J	Campos, F; Perez-Mato, M; Agulla, J; Blanco, M; Barral, D; Almeida, A; Brea, D; Waeber, C; Castillo, J; Ramos-Cabrer, P				Campos, Francisco; Perez-Mato, Maria; Agulla, Jesus; Blanco, Miguel; Barral, David; Almeida, Angeles; Brea, David; Waeber, Christian; Castillo, Jose; Ramos-Cabrer, Pedro			Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; MILD HYPOTHERMIA; BLOOD-FLOW; OXALOACETATE; LACTATE; SPECTROSCOPY; COMBINATION; METABOLISM; GLUCOSE; DEATH	Glutamate excitotoxicity, metabolic rate and inflammatory response have been associated to the deleterious effects of temperature during the acute phase of stroke. So far, the association of temperature with these mechanisms has been studied individually. However, the simultaneous study of the influence of temperature on these mechanisms is necessary to clarify their contributions to temperature-mediated ischemic damage. We used non-invasive Magnetic Resonance Spectroscopy to simultaneously measure temperature, glutamate excitotoxicity and metabolic rate in the brain in animal models of ischemia. The immune response to ischemia was measured through molecular serum markers in peripheral blood. We submitted groups of animals to different experimental conditions (hypothermia at 33 degrees C, normothermia at 37 degrees C and hyperthermia at 39 degrees C), and combined these conditions with pharmacological modulation of glutamate levels in the brain through systemic injections of glutamate and oxaloacetate. We show that pharmacological modulation of glutamate levels can neutralize the deleterious effects of hyperthermia and the beneficial effects of hypothermia, however the analysis of the inflammatory response and metabolic rate, demonstrated that their effects on ischemic damage are less critical than glutamate excitotoxity. We conclude that glutamate excitotoxicity is the key molecular mechanism which is influenced by body temperature during the acute phase of brain stroke.	[Campos, Francisco; Perez-Mato, Maria; Agulla, Jesus; Blanco, Miguel; Barral, David; Brea, David; Castillo, Jose; Ramos-Cabrer, Pedro] Univ Santiago de Compostela, IDIS, Hosp Univ Santiago, Clin Neurosci Res Lab,Dept Neurol, Santiago De Compostela, Spain; [Almeida, Angeles] Hosp Univ Salamanca, Res Unit, Salamanca, Spain; [Almeida, Angeles] Inst Hlth Sci Castilla & Leon, Salamanca, Spain; [Almeida, Angeles] Univ Salamanca, Dept Biochem & Mol Biol, E-37008 Salamanca, Spain; [Waeber, Christian] Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA USA	Universidade de Santiago de Compostela; University of Salamanca; University of Salamanca; Harvard University; Massachusetts General Hospital	Campos, F (corresponding author), Univ Santiago de Compostela, IDIS, Hosp Univ Santiago, Clin Neurosci Res Lab,Dept Neurol, Santiago De Compostela, Spain.	francampos@linc-stg.eu; pedro.ramos@usc.es	ALMEIDA, ANGELES/B-4727-2017; Waeber, Christian/B-3171-2016; Ramos-Cabrer, Pedro/J-5306-2014; Agulla, Jesus/E-2326-2018; Brea López, David/M-1128-2015; Ramos-Cabrer, Pedro/AAF-1467-2020; Barral, David/AAA-3314-2020; Waeber, Christian/A-8333-2009	ALMEIDA, ANGELES/0000-0003-0485-8904; Waeber, Christian/0000-0001-6078-0027; Ramos-Cabrer, Pedro/0000-0003-0368-7031; Agulla, Jesus/0000-0001-9574-2549; Brea López, David/0000-0003-2365-7374; Ramos-Cabrer, Pedro/0000-0003-0368-7031; Barral, David/0000-0001-6658-4684; Waeber, Christian/0000-0001-6078-0027; Castillo, Jose/0000-0002-6685-3001	Spanish Ministry of Science and Innovation [SAF2011-30517]; Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III [RETICS-RD06/0026]; Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio) [09CSA057918PR]; Xunta de Galicia (Conselleria de Sanidade) [PS09/32]; Xunta de Galicia (Fundacion Mutua Madrilena); Red de Investigacion Cooperativa Neurovascular	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III(Instituto de Salud Carlos III); Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio)(Xunta de Galicia); Xunta de Galicia (Conselleria de Sanidade)(Xunta de Galicia); Xunta de Galicia (Fundacion Mutua Madrilena)(Xunta de Galicia); Red de Investigacion Cooperativa Neurovascular	This project has been partially supported by grants from the Spanish Ministry of Science and Innovation SAF2011-30517 and Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III, RETICS-RD06/0026; Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio: 09CSA057918PR; Conselleria de Sanidade: PS09/32 and; Fundacion Mutua Madrilena and by Red de Investigacion Cooperativa Neurovascular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruscato TJ, 1999, J PHARMACOL EXP THER, V289, P668; Antonelli T, 2008, CEREB CORTEX, V18, P1748, DOI 10.1093/cercor/bhm217; Berger R, 1998, DEV BRAIN RES, V105, P67, DOI 10.1016/S0165-3806(97)00165-X; Blanco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030700; Brea D, 2011, REV NEUROLOGIA, V52, P12, DOI 10.33588/rn.5201.2010494; Brea D, 2011, CLIN IMMUNOL, V139, P193, DOI 10.1016/j.clim.2011.02.001; Brea D, 2009, CEREBROVASC DIS, V27, P48, DOI 10.1159/000200441; Campos F, 2012, NEUROCHEM INT, V60, P495, DOI 10.1016/j.neuint.2012.02.003; Campos F, 2012, INT J BIOCHEM CELL B, V44, P262, DOI 10.1016/j.biocel.2011.11.003; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Castellanos M, 2008, NEUROLOGY, V71, P1862, DOI 10.1212/01.wnl.0000326064.42186.7e; Castellanos Mar, 2007, Cerebrovasc Dis, V24 Suppl 1, P7, DOI 10.1159/000107374; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1999, CEREBROVASC DIS, V9, P1, DOI 10.1159/000047548; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Clark DL, 2008, EXP NEUROL, V212, P386, DOI 10.1016/j.expneurol.2008.04.016; Davalos A, 1997, CEREBROVASC DIS, V7, P64, DOI 10.1159/000108169; Fillenz M, 2005, NEUROCHEM INT, V47, P413, DOI 10.1016/j.neuint.2005.05.011; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Germain D, 2001, MAGN RESON MATER PHY, V13, P47, DOI 10.1016/S1352-8661(01)00123-5; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; Higuchi T, 1997, MAGNET RESON MED, V37, P851, DOI 10.1002/mrm.1910370608; Karaszewski B, 2006, ANN NEUROL, V60, P438, DOI 10.1002/ana.20957; Karaszewski B, 2009, BRAIN, V132, P955, DOI 10.1093/brain/awp010; LO EH, 1992, STROKE, V23, P889, DOI 10.1161/01.STR.23.6.889; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Paxinos G, 2008, RAT BRAIN STEREOTAXI; Rodriguez-Yanez M, 2008, CURR OPIN NEUROL, V21, P353, DOI 10.1097/WCO.0b013e3282ffafbf; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; STILLMAN AE, 1993, JMRI-J MAGN RESON IM, V3, P682, DOI 10.1002/jmri.1880030421; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tomsick TA, 2010, NEUROLOGY, V74, P1069, DOI 10.1212/WNL.0b013e3181d76b8f; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; WHITE JA, 1986, J AUTOM CHEM, V8, P170, DOI 10.1155/S1463924686000330; Winfree CJ, 1996, NEUROSURGERY, V38, P1216, DOI 10.1097/00006123-199606000-00034; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zaremba J, 2004, MED SCI MONITOR, V10, pRA148; Zausinger S, 2003, STROKE, V34, P1526, DOI 10.1161/01.STR.0000070841.31224.29; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540; Zhu HD, 2005, EXP NEUROL, V193, P361, DOI 10.1016/j.expneurol.2005.01.022; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731; Zlotnik A, 2010, ANESTH ANALG, V111, P1497, DOI 10.1213/ANE.0b013e3181fc0112	45	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44191	10.1371/journal.pone.0044191	http://dx.doi.org/10.1371/journal.pone.0044191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952923	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600090
J	Kwok, YH; Hutchinson, MR; Gentgall, MG; Rolan, PE				Kwok, Yuen H.; Hutchinson, Mark R.; Gentgall, Melanie G.; Rolan, Paul E.			Increased Responsiveness of Peripheral Blood Mononuclear Cells to In Vitro TLR 2, 4 and 7 Ligand Stimulation in Chronic Pain Patients	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; NEUROPATHIC PAIN; RAT MODEL; ACTIVATION; IMMUNE; EXPRESSION; HYPERSENSITIVITY; MAINTENANCE; MACROPHAGES; TOLERANCE	Glial activation via Toll-like receptor (TLR) signaling has been shown in animals to play an important role in the initiation and establishment of chronic pain. However, our ability to assess this central immune reactivity in clinical pain populations is currently lacking. Peripheral blood mononuclear cells (PBMCs) are an accessible source of TLR expressing cells that may mirror similarities in TLR responsiveness of the central nervous system. The aim of this study was to characterize the IL-1 beta response to various TLR agonists in isolated PBMCs from chronic pain sufferers (on and not on opioids) and pain-free controls. Venous blood was collected from 11 chronic pain sufferers on opioids (>= 20 mg of morphine / day), 8 chronic pain sufferers not on opioids and 11 pain-free controls. PBMCs were isolated and stimulated in vitro with a TLR2 (Pam3CSK4), TLR4 (LPS) or TLR7 (imiquimod) agonist. IL-1 beta released into the supernatant was measured with ELISA. Significantly increased IL-1 beta expression was found in PBMCs from chronic pain sufferers (on and not on opioids) compared with pain-free controls for TLR2 (F ((6, 277)) = 15, P<0.0001), TLR4 (F ((8, 263)) = 3, P = 0.002) and TLR7 (F ((2,201)) = 5, P = 0.005) agonists. These data demonstrate that PBMCs from chronic pain sufferers were more responsive to TLR agonists compared with controls, suggesting peripheral cells may have the potential to become a source of biomarkers for chronic pain.	[Kwok, Yuen H.; Rolan, Paul E.] Univ Adelaide, Sch Med Sci, Discipline Pharmacol, Adelaide, SA, Australia; [Hutchinson, Mark R.] Univ Adelaide, Sch Med Sci, Discipline Physiol, Adelaide, SA, Australia; [Gentgall, Melanie G.; Rolan, Paul E.] Univ Adelaide, Pain & Anaesthesia Res Clin, Adelaide, SA, Australia; [Rolan, Paul E.] Royal Adelaide Hosp, Pain Management Unit, Adelaide, SA 5000, Australia	University of Adelaide; University of Adelaide; University of Adelaide; Royal Adelaide Hospital	Kwok, YH (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Pharmacol, Adelaide, SA, Australia.	yuen.kwok@adelaide.edu.au	Hutchinson, Mark/N-1815-2019; Hutchinson, Mark R/G-4147-2014	Hutchinson, Mark/0000-0003-2154-5950; Hutchinson, Mark R/0000-0003-2154-5950; Kwok, Yuen/0000-0002-5336-9544	Pain and Anaesthesia Research Clinic, University of Adelaide; Australian Research Council (ARC) [DP110100297]	Pain and Anaesthesia Research Clinic, University of Adelaide; Australian Research Council (ARC)(Australian Research Council)	The study was funded by the Pain and Anaesthesia Research Clinic, University of Adelaide and was supported by Grant Number [DP110100297] from Australian Research Council (ARC). Its contents are solely the responsibility of the authors and the funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	2010 National Opioid Use Guideline Group, 2010, CANADIAN GUIDELINE S; Akira S, 2003, SCAND J INFECT DIS, V35, P555, DOI 10.1080/00365540310015683; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Budd K, 2006, BIOMED PHARMACOTHER, V60, P310, DOI 10.1016/j.biopha.2006.06.015; CHAO CC, 1991, CYTOKINE, V3, P292, DOI 10.1016/1043-4666(91)90497-2; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Chu LF, 2006, J PAIN, V7, P43, DOI 10.1016/j.jpain.2005.08.001; Davis JM, 2010, J IMMUNOL, V184, P7297, DOI 10.4049/jimmunol.0904180; de Leo JA, 2006, PAIN, V122, P17, DOI 10.1016/j.pain.2006.02.034; DEFORGE LE, 1991, BIOCHEM BIOPH RES CO, V174, P18, DOI 10.1016/0006-291X(91)90478-P; Doverty M, 2001, PAIN, V90, P91, DOI 10.1016/S0304-3959(00)00391-2; Dunne DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011343; Grace PM, 2011, BRAIN BEHAV IMMUN, V25, P1322, DOI 10.1016/j.bbi.2011.04.003; Guo LH, 2007, CELL MOL LIFE SCI, V64, P1128, DOI 10.1007/s00018-007-6494-3; Hutchinson Mark R, 2007, ScientificWorldJournal, V7, P98; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Hutchinson MR, 2004, PAIN, V110, P751, DOI 10.1016/j.pain.2004.05.017; Hutchinson MR, 2008, BRAIN BEHAV IMMUN; Hutchinson MR, 2009, BRAIN BEHAV IMMUN; Jang Y, 2012, ANESTH ANALG; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kovarik JJ, 2011, EUR J CLIN INVEST, V41, P291, DOI 10.1111/j.1365-2362.2010.02407.x; Kowalski ML, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/132732; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Mao TK, 2005, HEPATOLOGY, V42, P802, DOI 10.1002/hep.20859; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; Menzebach A, 2004, ANASTH INTENSIV NOTF, V39, P204, DOI 10.1055/s-2004-814389; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nicotra L, 2012, EXP NEUROL, V234, P316, DOI 10.1016/j.expneurol.2011.09.038; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Risdahl JM, 1998, J NEUROIMMUNOL, V83, P4, DOI 10.1016/S0165-5728(97)00216-6; Rossi S., 2011, AUSTR MED HDB 2011; Sacerdote P, 1997, BRIT J PHARMACOL, V121, P834, DOI 10.1038/sj.bjp.0701138; Shi XQ, 2011, GLIA, V59, P231, DOI 10.1002/glia.21093; Sutterwala FS, 2006, J ENDOTOXIN RES, V12, P251, DOI 10.1179/096805106X118771; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tanga FY, 2004, NEUROCHEM INT, V45, P397, DOI 10.1016/j.neuint.2003.06.002; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Tsujimoto H, 2006, CLIN IMMUNOL, V119, P180, DOI 10.1016/j.clim.2006.01.004; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251	50	40	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44232	10.1371/journal.pone.0044232	http://dx.doi.org/10.1371/journal.pone.0044232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937165	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600095
J	Reperant, LA; Kuiken, T; Grenfell, BT; Osterhaus, ADME; Dobson, AP				Reperant, Leslie A.; Kuiken, Thijs; Grenfell, Bryan T.; Osterhaus, Albert D. M. E.; Dobson, Andrew P.			Linking Influenza Virus Tissue Tropism to Population-Level Reproductive Fitness	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSE; RESPIRATORY-TRACT; WITHIN-HOST; METABOLIC PROPERTIES; TRANSMISSION; INFECTION; DYNAMICS; MODEL; EVOLUTION; CLEARANCE	Influenza virus tissue tropism defines the host cells and tissues that support viral replication and contributes to determining which regions of the respiratory tract are infected in humans. The location of influenza virus infection along the respiratory tract is a key determinant of virus pathogenicity and transmissibility, which are at the basis of influenza burdens in the human population. As the pathogenicity and transmissibility of influenza virus ultimately determine its reproductive fitness at the population level, strong selective pressures will shape influenza virus tissue tropisms that maximize fitness. At present, the relationships between influenza virus tissue tropism within hosts and reproductive fitness at the population level are poorly understood. The selective pressures and constraints that shape tissue tropism and thereby influence the location of influenza virus infection along the respiratory tract are not well characterized. We use mathematical models that link within-host infection dynamics in a spatially-structured human respiratory tract to between-host transmission dynamics, with the aim of characterizing the possible selective pressures on influenza virus tissue tropism. The results indicate that spatial heterogeneities in virus clearance, virus pathogenicity or both, resulting from the unique structure of the respiratory tract, may drive optimal receptor binding affinity-that maximizes influenza virus reproductive fitness at the population level-towards sialic acids with alpha 2,6 linkage to galactose. The expanding cell pool deeper down the respiratory tract, in association with lower clearance rates, may result in optimal infectivity rates-that likewise maximize influenza virus reproductive fitness at the population level-to exhibit a decreasing trend towards deeper regions of the respiratory tract. Lastly, pre-existing immunity may drive influenza virus tissue tropism towards upper regions of the respiratory tract. The proposed framework provides a new template for the cross-scale study of influenza virus evolutionary and epidemiological dynamics in humans.	[Reperant, Leslie A.; Kuiken, Thijs; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Reperant, Leslie A.; Grenfell, Bryan T.; Dobson, Andrew P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Reperant, LA (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	l.reperant@erasmusmc.nl		Osterhaus, Albert/0000-0002-6074-1172; Kuiken, Thijs/0000-0001-5501-9049; Reperant, Leslie/0000-0002-7212-1595	Dutch Ministry of Economic Affairs; VIRGO Consortium; Dutch government [BSIK03012]; European Commission [044490, 258084]; Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; NSF [0742373]; NIH [R01 GM083983-01]; ERC [250136]; EU [223498]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083983] Funding Source: NIH RePORTER	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); VIRGO Consortium; Dutch government; European Commission(European CommissionEuropean Commission Joint Research Centre); Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); EU(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LAR, ADMEO and TK were supported by the Dutch Ministry of Economic Affairs grant "Impuls Veterinair Influenza Onderzoek Nederland". ADMEO and TK were supported by the VIRGO Consortium, an innovative cluster approved by the Netherlands Genomics Initiative, and partially funded by the Dutch government (grant number BSIK03012); European Commission grant no. 044490 "New-FluBird", and European Commission grant no. 258084 "Flupig". BTG was supported by the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health, and by grants NSF 0742373, and NIH R01 GM083983-01. ADMEO was supported by the ERC advanced grant no. 250136 "FluPlan", and EU FP7 grant no. 223498 "Emperie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Almeida ARM, 2005, SEMIN IMMUNOL, V17, P239, DOI 10.1016/j.smim.2005.02.002; ANDERSON R M, 1991; [Anonymous], WKLY EPIDEMIOL REC; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Bajaria SH, 2002, J ACQ IMMUN DEF SYND, V30, P41, DOI 10.1097/00042560-200205010-00006; BARTH WF, 1964, J CLIN INVEST, V43, P1036, DOI 10.1172/JCI104987; Beauchemin C, 2005, J THEOR BIOL, V232, P223, DOI 10.1016/j.jtbi.2004.08.001; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; BROWN GC, 1973, J IMMUNOL, V110, P889; Brydon EWA, 2003, J GEN VIROL, V84, P2389, DOI 10.1099/vir.0.18913-0; Canini L, 2011, J VIROL, V85, P2764, DOI 10.1128/JVI.01318-10; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dahari H, 2005, J HEPATOL, V42, P491, DOI 10.1016/j.jhep.2004.12.017; Dobrovolny HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013811; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Falk R, 1997, EXP LUNG RES, V23, P495, DOI 10.3109/01902149709039240; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; GREEN GM, 1973, ARCH INTERN MED, V131, P109, DOI 10.1001/archinte.131.1.109; Guarner J, 2000, AM J CLIN PATHOL, V114, P227, DOI 10.1309/HV74-N24T-2K2C-3E8Q; Guarner J, 2006, CLIN INFECT DIS, V43, P132, DOI 10.1086/505122; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Ito R, 2003, VACCINE, V21, P2362, DOI 10.1016/S0264-410X(03)00078-1; Jackson C, 2010, AM J EPIDEMIOL, V171, P465, DOI 10.1093/aje/kwp394; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Lee HY, 2009, J VIROL, V83, P7151, DOI 10.1128/JVI.00098-09; Memoli MJ, 2009, J INFECT DIS, V200, P1232, DOI 10.1086/605893; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Moller W, 2004, J APPL PHYSIOL, V97, P2200, DOI 10.1152/japplphysiol.00970.2003; MORELL A, 1973, CLIN EXP IMMUNOL, V13, P521; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Park AW, 2009, SCIENCE, V326, P726, DOI 10.1126/science.1175980; Pepin KM, 2010, J THEOR BIOL, V265, P501, DOI 10.1016/j.jtbi.2010.05.036; PLOPPER CG, 1989, AM J ANAT, V184, P31, DOI 10.1002/aja.1001840104; R Core Team, 2020, R LANG ENV STAT COMP; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; REYNOLDS HY, 1991, PHYSIOL REV, V71, P1117, DOI 10.1152/physrev.1991.71.4.1117; Saenz RA, 2010, J VIROL; Shechter Y, 2001, P NATL ACAD SCI USA, V98, P1212, DOI 10.1073/pnas.98.3.1212; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; SIM GK, 1995, ADV IMMUNOL, V58, P297, DOI 10.1016/S0065-2776(08)60622-7; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; SMITH H, 1988, REV INFECT DIS, V10, P56; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; Stahlhofen W., 1989, J AEROSOL MED, V2, P285, DOI [10.1089/jam.1989.2.285, DOI 10.1089/JAM.1989.2.285]; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P1; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Turner D, 2011, J IMMUNOL; van den Brand JMA, PLOS ONE IN PRESS; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Volkov I, 2010, J R SOC INTERFACE, V7, P1311, DOI 10.1098/rsif.2009.0560; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; WEIBEL ER, 1979, B EUR PHYSIOPATH RES, V15, P999; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	86	29	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43115	10.1371/journal.pone.0043115	http://dx.doi.org/10.1371/journal.pone.0043115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952637	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600016
J	Shiao, CC; Ko, WJ; Wu, VC; Huang, TM; Lai, CF; Lin, YF; Chao, CT; Chu, TS; Tsai, HB; Wu, PC; Young, GH; Kao, TW; Huang, JW; Chen, YM; Lin, SL; Wu, MS; Tsai, PR; Wu, KD; Wang, MJ				Shiao, Chih-Chung; Ko, Wen-Je; Wu, Vin-Cent; Huang, Tao-Min; Lai, Chun-Fu; Lin, Yu-Feng; Chao, Chia-Ter; Chu, Tzong-Shinn; Tsai, Hung-Bin; Wu, Pei-Chen; Young, Guang-Huar; Kao, Tze-Wah; Huang, Jenq-Wen; Chen, Yung-Ming; Lin, Shuei-Liong; Wu, Ming-Shou; Tsai, Pi-Ru; Wu, Kwan-Dun; Wang, Ming-Jiuh		Natl Taiwan Univ Hosp Study Grp	U-Curve Association between Timing of Renal Replacement Therapy Initiation and In-Hospital Mortality in Postoperative Acute Kidney Injury	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; EXTRACORPOREAL MEMBRANE-OXYGENATION; FAILURE ASSESSMENT SCORE; CARDIAC-SURGERY; RISK-FACTORS; DIALYSIS; HEMOFILTRATION; EPIDEMIOLOGY; SURVIVAL; OUTCOMES	Background: Postoperative acute kidney injury (AKI) is associated with poor outcomes in surgical patients. This study aims to evaluate whether the timing of renal replacement therapy (RRT) initiation affects the in-hospital mortality of patients with postoperative AKI. Methodology: This multicenter retrospective observational study, which was conducted in the intensive care units (ICUs) in a tertiary hospital (National Taiwan University Hospital) and its branch hospitals in Taiwan between January, 2002, and April, 2009, included adult patients with postoperative AKI who underwent RRT for predefined indications. The demographic data, comorbid diseases, types of surgery and RRT, and the indications for RRT were documented. Patients were categorized according to the period of time between the ICU admission and RRT initiation as the early (EG, <= 1 day), intermediate (IG, 2-3 days), and late (LG, >= 4 days) groups. The in-hospital mortality rate censored at 180 day was defined as the endpoint. Results: Six hundred forty-eight patients (418 men, mean age 63.0 +/- 15.9 years) were enrolled, and 379 patients (58.5%) died during the hospitalization. Both the estimated probability of death and the in-hospital mortality rates of the three groups represented U-curves. According to the Cox proportional hazard method, LG (hazard ratio, 1.527; 95% confidence interval, 1.152-2.024; P=0.003, compared with IG group), age (1.014; 1.006-1.021), diabetes (1.279; 1.022-1.601; P=0.031), cirrhosis (2.147; 1.421-3.242), extracorporeal membrane oxygenation support (1.811; 1.391-2.359), initial neurological dysfunction (1.448; 1.107-1.894; P = 0.007), pre-RRT mean arterial pressure (0.988; 0.981-0.995), inotropic equivalent (1.006; 1.001-1.012; P = 0.013), APACHE II scores (1.055; 1.037-1.073), and sepsis (1.939; 1.536-2.449) were independent predictors of the inhospital mortality (All P < 0.001 except otherwise stated). Conclusions: The current study found a U-curve association between the timing of the RRT initiation after the ICU admission and patients' in-hospital mortalities, and alerts physicians of certain factors affecting the outcome after the RRT initiation.	[Shiao, Chih-Chung] St Marys Hosp Luodong, Div Nephrol, Dept Internal Med, Yilan, Taiwan; [Shiao, Chih-Chung] St Marys Med Nursing & Management Coll, Yilan, Taiwan; [Ko, Wen-Je; Lin, Yu-Feng; Tsai, Hung-Bin] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Ko, Wen-Je; Young, Guang-Huar; Tsai, Pi-Ru] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Wu, Vin-Cent; Lai, Chun-Fu; Chao, Chia-Ter; Chu, Tzong-Shinn; Wu, Pei-Chen; Kao, Tze-Wah; Huang, Jenq-Wen; Chen, Yung-Ming; Lin, Shuei-Liong; Wu, Ming-Shou; Wu, Kwan-Dun] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Huang, Tao-Min] Natl Taiwan Univ Hosp, Yun Lin Branch, Div Nephrol, Dept Internal Med, Douliu City, Yunlin County, Taiwan; [Wang, Ming-Jiuh] Natl Taiwan Univ Hosp, Dept Anesthesiol & Forens Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Shiao, CC (corresponding author), St Marys Hosp Luodong, Div Nephrol, Dept Internal Med, Yilan, Taiwan.	canon@ntuh.gov.tw	Shiao, Chih-Chung/AAM-2716-2020; Huang, Tao Min/C-5379-2011; Tsai, Hung-Bin/G-3761-2011; Chao, Chia-Ter/H-7994-2019; Lin, Shuei-Liong/AGR-2002-2022	Shiao, Chih-Chung/0000-0003-2220-7574; Huang, Tao Min/0000-0002-9387-0798; Chao, Chia-Ter/0000-0003-2892-7986; Lin, Shuei-Liong/0000-0002-1041-5571; LIN, YU-FENG/0000-0002-4350-7755; WU, MING-SHIOU/0000-0002-1674-443X; HUANG, JENQ-WEN/0000-0001-8011-2317; WU, KWAN-DUN/0000-0002-3339-1509; WU, VIN-CENT/0000-0001-7935-0991; LAI, CHUN-FU/0000-0003-2109-1522; CHU, TZONG-SHINN/0000-0002-5291-2509; Tsai, Hung-Bin/0000-0002-0689-8339; CHEN, YUNG-MING/0000-0002-9241-1258	Ta-Tung Kidney Foundation; Taiwan National Science Council [NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4]; NTUH [098-001177, 100-001667]	Ta-Tung Kidney Foundation; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NTUH	This study was financially supported by The Ta-Tung Kidney Foundation, Taiwan National Science Council (grant NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4), and NTUH 098-001177, NTUH 100-001667. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelha FJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7894; Andrade L, 2007, CLIN J AM SOC NEPHRO, V2, P739, DOI 10.2215/CJN.00680207; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bagshaw SM, 2009, J CRIT CARE, V24, P129, DOI 10.1016/j.jcrc.2007.12.017; Balk RA, 2000, CRIT CARE CLIN, V16, P179, DOI 10.1016/S0749-0704(05)70106-8; Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/00003246-200210000-00005; Brienza N, 2010, CURR OPIN CRIT CARE, V16, P353, DOI 10.1097/MCC.0b013e32833a9ef5; Chen YS, 2001, J HEART LUNG TRANSPL, V20, P850, DOI 10.1016/S1053-2498(01)00267-4; Clark E, 2012, NEPHROL DIAL TRANSPL, V27, P2761, DOI 10.1093/ndt/gfr740; Coca SG, 2010, KIDNEY INT, V78, P926, DOI 10.1038/ki.2010.259; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; Eachempati SR, 2007, J TRAUMA, V63, P987, DOI 10.1097/TA.0b013e3181574930; Elahi M, 2009, EUR J CARDIO-THORAC, V35, P854, DOI 10.1016/j.ejcts.2008.12.019; Garcia-Fernandez N, 2011, BLOOD PURIFICAT, V32, P104, DOI 10.1159/000324195; Gill N, 2005, CHEST, V128, P2847, DOI 10.1378/chest.128.4.2847; Glance LG, 2011, ARCH SURG; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Iyem H, 2009, HEMODIAL INT, V13, P55, DOI 10.1111/j.1542-4758.2009.00347.x; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Kheterpal S, 2007, ANESTHESIOLOGY, V107, P892, DOI 10.1097/01.anes.0000290588.29668.38; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kolhe Nitin V, 2008, Crit Care, V12 Suppl 1, pS2, DOI 10.1186/cc7003; Lafrance JP, 2010, AM J KIDNEY DIS, V56, P651, DOI 10.1053/j.ajkd.2010.05.011; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lin YF, 2008, BLOOD PURIFICAT, V26, P547, DOI 10.1159/000178771; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Ng KP, 2012, QJM-INT J MED, V105, P33, DOI 10.1093/qjmed/hcr133; Ostermann M, 2009, CRIT CARE, V13, DOI 10.1186/cc8154; Ostermann M, 2008, CRIT CARE, V12, DOI 10.1186/cc7123; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Piccinni P, 2006, INTENS CARE MED, V32, P80, DOI 10.1007/s00134-005-2815-x; Rondon-Berrios H, 2007, CURR OPIN NEPHROL HY, V16, P64, DOI 10.1097/MNH.0b013e32802ef4a5; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Seabra VF, 2008, AM J KIDNEY DIS, V52, P272, DOI 10.1053/j.ajkd.2008.02.371; Shiao CC, 2009, CRIT CARE, V13, DOI 10.1186/cc8147; Tsai CW, 2008, EUR J CARDIO-THORAC, V34, P1158, DOI 10.1016/j.ejcts.2008.07.025; Uchino S, 2007, INT J ARTIF ORGANS, V30, P281, DOI 10.1177/039139880703000402; Uchino S, 2008, NEPHRON CLIN PRACT, V109, pC216, DOI 10.1159/000142931; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Wu VC, 2006, CLIN INFECT DIS, V42, P66, DOI 10.1086/498509; Wu VC, 2008, INTENS CARE MED, V34, P101, DOI 10.1007/s00134-007-0813-x; Wu VC, 2007, J AM COLL SURGEONS, V205, P266, DOI 10.1016/j.jamcollsurg.2007.04.006; Wu VC, 2011, KIDNEY INT, V80, P1222, DOI 10.1038/ki.2011.259	49	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42952	10.1371/journal.pone.0042952	http://dx.doi.org/10.1371/journal.pone.0042952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952623	gold, Green Submitted, Green Published			2022-12-27	WOS:000308213600011
J	Lee, WC; Kan, D; Chen, YY; Han, SK; Lu, KS; Chien, CL				Lee, Wen-Ching; Kan, Daphne; Chen, Yun-Yu; Han, Shan-Kuo; Lu, Kuo-Shyan; Chien, Chung-Liang			Suppression of Extensive Neurofilament Phosphorylation Rescues alpha-Internexin/Peripherin-Overexpressing PC12 Cells from Neuronal Cell Death	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; AMYOTROPHIC-LATERAL-SCLEROSIS; INTERMEDIATE-FILAMENT PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; NF-H; INCLUSION DISEASE; MOTOR-NEURONS; NEURODEGENERATIVE DISEASES; TRIPLET PROTEINS; TAIL DOMAINS	Intermediate filament (IF) overproduction induces abnormal accumulation of neuronal IF, which is a pathological indicator of some neurodegenerative disorders. In our study, alpha-Internexin-and peripherin-overexpressing PC12 cells (pINT-EGFP and pEGFP-peripherin) were used as models to study neuropathological pathways responsible for neurodegenerative diseases. Microarray data revealed that Cdk5-related genes were downregulated and Cdk5 regulatory subunit-associated protein 3 (GSK-3 alpha and GSK-3 beta) were upregulated in pINT-EGFP cells. Increased expression of phosphorylated neurofilament and aberrant activation of Cdk5 and GSK-3 beta were detected in both pEGFP-peripherin and pINT-EGFP cells by Western blotting. In addition, pharmacological approaches to retaining viability of pINT-EGFP and pEGFP-peripherin cells were examined. Treatment with Cdk5 inhibitor and GSK-3 beta inhibitor significantly suppressed neuronal death. Dynamic changes of disaggregation of EGFP-peripherin and decrease in green fluorescence intensity were observed in pEGFP-peripherin and pINT-EGFP cells by confocal microscopy after GSK-3 beta inhibitor treatment. We conclude that inhibition of Cdk5 and GSK-3 beta suppresses neurofilament phosphorylation, slows down the accumulation of neuronal IF in the cytoplasm, and subsequently avoids damages to cell organelles. The results suggest that suppression of extensive neurofilament phosphorylation may be a potential strategy for ameliorating neuron death. The suppression of hyperphosphorylation of neuronal cytoskeletons with kinase inhibitors could be one of potential therapeutic treatments for neurodegenerative diseases.	[Lee, Wen-Ching; Chen, Yun-Yu; Han, Shan-Kuo; Lu, Kuo-Shyan; Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan; [Kan, Daphne; Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Ctr Genom Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lee, WC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan.	chien@ntu.edu.tw		CHIEN, CHUNG-LIANG/0000-0001-9806-486X	National Science Council, Taiwan [NSC NSC-97-2628-B-002-043-MY3, NSC-98-3111-B-002-004]; Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by grants to C.-L. Chien (NSC NSC-97-2628-B-002-043-MY3 and NSC-98-3111-B-002-004) from the National Science Council, Taiwan. Facilities provided by grants from the Ministry of Education, Taiwan to the Center of Genomic Medicine in National Taiwan University are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Bajaj NPS, 1999, PROG NEURO-PSYCHOPH, V23, P833, DOI 10.1016/S0278-5846(99)00044-5; Bajaj NPS, 2000, AMYOTROPH LATERAL SC, V1, P319, DOI 10.1080/146608200300079563; Bajaj NPS, 1997, J NEUROCHEM, V69, P737; Beaulieu JM, 1999, BIOCHEM CELL BIOL, V77, P41, DOI 10.1139/bcb-77-1-41; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Bhatta H, 2009, J MICROBIOL METH, V77, P77, DOI 10.1016/j.mimet.2009.01.011; Cairns NJ, 2004, ACTA NEUROPATHOL, V108, P213, DOI 10.1007/s00401-004-0882-7; Cairns NJ, 2004, AM J PATHOL, V164, P2153, DOI 10.1016/S0002-9440(10)63773-X; Cairns NJ, 2004, J PATHOL, V204, P438, DOI 10.1002/path.1650; Chen J, 2005, J HUAZHONG U SCI TEC, V25, P403; Chen Juan, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P375; Chien CL, 2005, J NEUROSCI RES, V80, P693, DOI 10.1002/jnr.20506; CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323; Ching GY, 1998, J CELL SCI, V111, P321; CORBO M, 1992, J NEUROPATH EXP NEUR, V51, P531, DOI 10.1097/00005072-199209000-00008; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; ESCURAT M, 1990, J NEUROSCI, V10, P764; FLIEGNER KH, 1994, J COMP NEUROL, V342, P161, DOI 10.1002/cne.903420202; FLIEGNER KH, 1991, INT REV CYTOL, V131, P109, DOI 10.1016/S0074-7696(08)62018-5; Grant P, 2000, J NEUROCYTOL, V29, P843, DOI 10.1023/A:1010999509251; GUAN RJ, 1991, J BIOL CHEM, V266, P8262; Guidato S, 1996, NEUROSCI LETT, V217, P157, DOI 10.1016/0304-3940(96)13098-6; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; He CZ, 2004, J NEUROL SCI, V217, P47, DOI 10.1016/j.jns.2003.08.016; Helfand BT, 2003, J CELL SCI, V116, P2345, DOI 10.1242/jcs.00526; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; Kesavapany S, 2003, NEUROSIGNALS, V12, P252, DOI 10.1159/000074627; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P7384, DOI 10.1073/pnas.85.19.7384; Lee WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-8; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Liu HL, 2003, J NEUROCHEM, V86, P1553, DOI 10.1046/j.1471-4159.2003.01978.x; Lobsiger CS, 2005, P NATL ACAD SCI USA, V102, P10351, DOI 10.1073/pnas.0503862102; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; MIGHELI A, 1993, LAB INVEST, V68, P185; Millecamps S, 2006, J NEUROCHEM, V98, P926, DOI 10.1111/j.1471-4159.2006.03932.x; Molina-Porcel L, 2008, ARCH NEUROL-CHICAGO, V65, P272, DOI 10.1001/archneurol.2007.37; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; PARYSEK LM, 1987, J NEUROSCI, V7, P781; PARYSEK LM, 1991, J NEUROSCI RES, V30, P80, DOI 10.1002/jnr.490300110; Portier Marie-Madeleine, 1993, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V316, P1124; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; Robertson J, 2001, J CELL BIOL, V155, P217, DOI 10.1083/jcb.200107058; Rudrabhatla P, 2011, FASEB J, V25, P3896, DOI 10.1096/fj.11-181297; Sasaki T, 2002, J BIOL CHEM, V277, P36032, DOI 10.1074/jbc.M206674200; Sharma M, 1999, J NEUROCHEM, V73, P79, DOI 10.1046/j.1471-4159.1999.0730079.x; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Sun DM, 1996, J BIOL CHEM, V271, P14245, DOI 10.1074/jbc.271.24.14245; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Veeranna, 2008, J NEUROCHEM, V107, P35, DOI 10.1111/j.1471-4159.2008.05547.x; WONG PC, 1995, J CELL BIOL, V130, P1413, DOI 10.1083/jcb.130.6.1413; Yokota O, 2008, ACTA NEUROPATHOL, V115, P561, DOI 10.1007/s00401-007-0329-z; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006	57	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43883	10.1371/journal.pone.0043883	http://dx.doi.org/10.1371/journal.pone.0043883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952800	gold, Green Submitted, Green Published			2022-12-27	WOS:000308044800072
J	Lertpiriyapong, K; Gamazon, ER; Feng, Y; Park, DS; Pang, J; Botka, G; Graffam, ME; Ge, ZM; Fox, JG				Lertpiriyapong, Kvin; Gamazon, Eric R.; Feng, Yan; Park, Danny S.; Pang, Jassia; Botka, Georgina; Graffam, Michelle E.; Ge, Zhongming; Fox, James G.			Campylobacter jejuni Type VI Secretion System: Roles in Adaptation to Deoxycholic Acid, Host Cell Adherence, Invasion, and In Vivo Colonization	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; BILE-ACIDS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; VIBRIO-CHOLERAE; GENE; IDENTIFICATION; GENOME; EXPRESSION; INFECTION	The recently identified type VI secretion system (T6SS) of proteobacteria has been shown to promote pathogenicity, competitive advantage over competing microorganisms, and adaptation to environmental perturbation. By detailed phenotypic characterization of loss-of-function mutants, in silico, in vitro and in vivo analyses, we provide evidence that the enteric pathogen, Campylobacter jejuni, possesses a functional T6SS and that the secretion system exerts pleiotropic effects on two crucial processes - survival in a bile salt, deoxycholic acid (DCA), and host cell adherence and invasion. The expression of T6SS during initial exposure to the upper range of physiological levels of DCA (0.075%-0.2%) was detrimental to C. jejuni proliferation, whereas down-regulation or inactivation of T6SS enabled C. jejuni to resist this effect. The C. jejuni multidrug efflux transporter gene, cmeA, was significantly up-regulated during the initial exposure to DCA in the wild type C. jejuni relative to the T6SS-deficient strains, suggesting that inhibition of proliferation is the consequence of T6SS-mediated DCA influx. A sequential modulation of the efflux transporter activity and the T6SS represents, in part, an adaptive mechanism for C. jejuni to overcome this inhibitory effect, thereby ensuring its survival. C. jejuni T6SS plays important roles in host cell adhesion and invasion as T6SS inactivation resulted in a reduction of adherence to and invasion of in vitro cell lines, while over-expression of a hemolysin co-regulated protein, which encodes a secreted T6SS component, greatly enhanced these processes. When inoculated into B6.129P2-IL-10(tm1Cgn) mice, the T6SS-deficient C. jejuni strains did not effectively establish persistent colonization, indicating that T6SS contributes to colonization in vivo. Taken together, our data demonstrate the importance of bacterial T6SS in host cell adhesion, invasion, colonization and, for the first time to our knowledge, adaptation to DCA, providing new insights into the role of T6SS in C. jejuni pathogenesis.	[Lertpiriyapong, Kvin; Feng, Yan; Pang, Jassia; Botka, Georgina; Graffam, Michelle E.; Ge, Zhongming; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Gamazon, Eric R.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Park, Danny S.] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA	Massachusetts Institute of Technology (MIT); University of Chicago; Columbia University	Lertpiriyapong, K (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.	zge@mit.edu; jgfox@mit.edu	Gamazon, Eric/I-6873-2018	Gamazon, Eric/0000-0003-4204-8734; Ge, Zhongming/0000-0003-0924-7563	National Institutes of Health [R01CH067529, R01DK05413, T32RR007036, P30ES002109]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants R01CH067529, R01DK05413, T32RR007036 and P30ES002109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Bidlack JE, 2004, J BACTERIOL, V186, P5202, DOI 10.1128/JB.186.16.5202-5209.2004; BJORKHEM I, 1989, J LIPID RES, V30, P1033; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Blondel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011724; Bodhidatta L, 2010, AM J TROP MED HYG, V83, P1106, DOI 10.4269/ajtmh.2010.10-0367; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; BRODEY PA, 1982, AM J ROENTGENOL, V139, P1199, DOI 10.2214/ajr.139.6.1199; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034639; Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440; Chen ML, 2006, INFECT IMMUN, V74, P6581, DOI 10.1128/IAI.00958-06; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Das S, 2002, BIOCHEM BIOPH RES CO, V295, P922, DOI 10.1016/S0006-291X(02)00782-9; de Pace F, 2011, MICROBIOL-SGM, V157, P2954, DOI 10.1099/mic.0.050005-0; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Ge ZM, 2005, INFECT IMMUN, V73, P3559, DOI 10.1128/IAI.73.6.3559-3567.2005; Gustafsson U, 2003, WORLD J GASTROENTERO, V9, P1576, DOI 10.3748/wjg.v9.i7.1576; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Hofmann AF, 2006, P NATL ACAD SCI USA, V103, P4333, DOI 10.1073/pnas.0600780103; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Kaakoush NO, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-15; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; LAMBERT ME, 1979, BRIT MED J, V1, P857, DOI 10.1136/bmj.1.6167.857; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lin J, 2005, J BACTERIOL, V187, P7417, DOI 10.1128/JB.187.21.7417-7424.2005; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Malik-Kale P, 2008, J BACTERIOL, V190, P2286, DOI 10.1128/JB.01736-07; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; NORTHFIE.TC, 1973, GUT, V14, P513, DOI 10.1136/gut.14.7.513; Poly F, 2004, J BACTERIOL, V186, P4781, DOI 10.1128/JB.186.14.4781-4795.2004; Poly F, 2008, INFECT IMMUN, V76, P5655, DOI 10.1128/IAI.00780-08; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; ROLLINS DM, 1983, APPL ENVIRON MICROB, V45, P284, DOI 10.1128/AEM.45.1.284-289.1983; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2012, J BIOL CHEM; Sarris PF, 2011, INFECT GENET EVOL, V11, P157, DOI 10.1016/j.meegid.2010.09.006; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; SHERIHA GM, 1968, LIPIDS, V3, P72, DOI 10.1007/BF02530972; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Vertzoni M, 2008, J LIPID RES, V49, P2690, DOI 10.1194/jlr.D800039-JLR200; Weber B, 2009, ENVIRON MICROBIOL, V11, P3018, DOI 10.1111/j.1462-2920.2009.02005.x; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0; Zheng J, 2008, INFECT IMMUN, V76, P4498, DOI 10.1128/IAI.01317-07; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876; Zhou Y, 2012, INFECT IMMUN, V80, P1243, DOI 10.1128/IAI.05994-11	55	90	93	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42842	10.1371/journal.pone.0042842	http://dx.doi.org/10.1371/journal.pone.0042842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952616	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800015
J	Zhao, TS; Gao, S; Wang, XC; Liu, JC; Duan, YT; Yuan, ZN; Sheng, J; Li, SS; Wang, F; Yu, M; Ren, H; Hao, JH				Zhao, Tiansuo; Gao, Song; Wang, Xiuchao; Liu, Jingcheng; Duan, Yitao; Yuan, Zhanna; Sheng, Jun; Li, Shasha; Wang, Feng; Yu, Ming; Ren, He; Hao, Jihui			Hypoxia-Inducible Factor-1 alpha Regulates Chemotactic Migration of Pancreatic Ductal Adenocarcinoma Cells through Directly Transactivating the CX3CR1 Gene	PLOS ONE			English	Article							NEUROPATHIC PAIN; RECEPTOR CX3CR1; CHEMOKINE; FRACTALKINE; EXPRESSION; CANCER; ADHESION; IDENTIFICATION	CX3CR1 is an important chemokine receptor and regulates the chemotactic migration of pancreatic ductal adenocarcinoma (PDAC) cells. Up to now, its regulatory mechanism remains largely undefined. Here, we report that hypoxia upregulates the expression of CX3CR1 in pancreatic cancer cells. When hypoxia-inducible factor (HIF)-1 alpha expression was knocked down in vitro and in vivo, the expression of CX3CR1 was significantly decreased. Chromatin immunoprecipitation assay demonstrated that HIF-1 alpha bound to the hypoxia-response element (HRE; 5'-A/GCGTG-3') of CX3CR1 promoter under normoxia, and this binding was significantly enhanced under hypoxia. Overexpression of HIF-1 alpha significantly upregulated the expression of luciferase reporter gene under the control of the CX3CR1 promoter in pancreatic cancer cells. Importantly, we demonstrated that HIF-1 alpha may regulate cancer cell migration through CX3CR1. The HIF-1 alpha/CX3CR1 pathway might represent a valuable therapeutic target to prevent invasion and distant metastasis in PDAC.	[Zhao, Tiansuo; Gao, Song; Wang, Xiuchao; Liu, Jingcheng; Yuan, Zhanna; Sheng, Jun; Li, Shasha; Yu, Ming; Ren, He; Hao, Jihui] Tianjin Med Univ Canc Inst & Hosp, Dept Pancreat Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Duan, Yitao] Tianjin Univ, Sch Chem Engn & Technol, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Wang, Feng] Tianjin Med Univ Nankai Hosp, Inst Chinese & Modern Med Acute Abdominal Dis, Tianjin, Peoples R China	Tianjin Medical University; Tianjin University; Tianjin Medical University	Zhao, TS (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Pancreat Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	herenrh@yahoo.com.cn; jihuihao@yahoo.com	wu, ping/AAP-9449-2020		National Natural Science Foundation of China [81172355 30973490, 30900596, 30901448]; New Century Excellent Talents Programme of the Ministry of Education [NCET-07-0614]; Natural Science Foundation of Tianjin [10JCZDJC20200]; China Postdoctoral Science Foundation [20090450773]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Programme of the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (81172355 30973490, 30900596, 30901448), the New Century Excellent Talents Programme of the Ministry of Education (NCET-07-0614), the Natural Science Foundation of Tianjin (10JCZDJC20200) and the China Postdoctoral Science Foundation (20090450773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; ELSASSER HP, 1992, VIRCHOWS ARCH B, V61, P295, DOI 10.1007/BF02890431; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Garin A, 2002, BIOCHEM J, V368, P753, DOI 10.1042/BJ20020951; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Liu M, 2010, J PATHOL, V221, P221, DOI 10.1002/path.2706; Marchesi F, 2008, CANCER RES, V68, P9060, DOI 10.1158/0008-5472.CAN-08-1810; Mimura L, 2011, J PHARMACOL SCI, V115, P453, DOI 10.1254/jphs.10R19FM; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pour PM, 2003, PANCREAS, V26, P322, DOI 10.1097/00006676-200305000-00002; Ryu J, 2008, CARDIOVASC RES, V78, P333, DOI 10.1093/cvr/cvm067; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x	22	45	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43399	10.1371/journal.pone.0043399	http://dx.doi.org/10.1371/journal.pone.0043399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952674	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800030
J	Huang, GL; Li, BK; Zhang, MY; Wei, RR; Yuan, YF; Shi, M; Chen, XQ; Huang, L; Zhang, HZ; Liu, WQ; Huang, BJ; Li, HH; Zheng, XF; Luo, XR; Wang, HY				Huang, Guo-Liang; Li, Bin-Kui; Zhang, Mei-Yin; Wei, Rong-Rong; Yuan, Yun-Fei; Shi, Ming; Chen, Xiao-Qian; Huang, Long; Zhang, Hui-Zhong; Liu, Wanqing; Huang, Bi-Jun; Li, Honghua; Zheng, Xiao-Feng; Luo, Xian-Rong; Wang, Hui-Yun			Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; TUMOR PROGRESSION; CIRRHOTIC LIVER; INHIBITOR PI-88; PHASE-II; EXPRESSION; CANCER; GROWTH; PHOSPHORYLATION; RECEPTOR	Objectives: The role of heparanase (HPSE) gene in cancers including hepatocellular carcinoma (HCC) is currently controversial. This study was aimed at investigating the impact of genetic alteration and expression change of HPSE on the progression and prognosis of HCC. Methods: The HPSE gene was studied in three different aspects: (1) loss of heterozygosity (LOH) by a custom SNP microarray and DNA copy number by real-time PCR; (2) mRNA level by qRT-PCR; and (3) protein expression by immunohistochemistry. The clinical significances of allele loss and expression change of HPSE were analyzed. Results: Microarray analysis showed that the average LOH frequency for 10 SNPs located within HPSE gene was 31.6%, three of which were significantly correlated with tumor grade, serum HBV-DNA level, and AFP concentration. In agreement with SNP LOH data, DNA copy number loss of HPSE was observed in 38.74% (43/111) of HCC cases. HPSE mRNA level was notably reduced in 74.1% (83/112) of tumor tissues compared with non-tumor liver tissues, which was significantly associated with DNA copy number loss, increased tumor size, and post-operative metastasis. HPSE protein level was also remarkably reduced in 66.3% (53/80) of tumor tissues, which was correlated with tumor grade. Patients with lower expression level of HPSE mRNA or protein had a significantly lower survival rate than those with higher expression. Cox regression analysis suggested that HPSE protein was an independent predictor of overall survival in HCC patients. Conclusions: The results in this study demonstrate that genetic alteration and reduction of HPSE expression are associated with tumor progression and poor prognosis of HCCs, suggesting that HPSE behaves like a tumor suppressor gene and is a potential prognostic marker for HCC patients.	[Huang, Guo-Liang; Zhang, Mei-Yin; Wei, Rong-Rong; Chen, Xiao-Qian; Huang, Long; Huang, Bi-Jun; Wang, Hui-Yun] Sun Yat Sen Univ, Ctr Canc, Natl Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Guo-Liang] Guangdong Med Coll, Sino Amer Canc Res Inst, Dongguan, Guangdong, Peoples R China; [Li, Bin-Kui; Yuan, Yun-Fei; Shi, Ming] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Hui-Zhong] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Wanqing] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Li, Honghua; Zheng, Xiao-Feng; Wang, Hui-Yun] UMDNJ, Robert W Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA; [Luo, Xian-Rong] PLA, Hosp 458, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Sun Yat Sen University; Sun Yat Sen University; University of Chicago; Rutgers State University New Brunswick; Rutgers State University Medical Center	Huang, GL (corresponding author), Sun Yat Sen Univ, Ctr Canc, Natl Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	wanghyun@mail.sysu.edu.cn	Huang, Bi-Jun/GSD-2430-2022; Huang, Guoliang/H-1625-2011	Huang, Guoliang/0000-0002-8902-8100; Shi, Ming/0000-0002-4051-4474; Yuan, Yunfei/0000-0003-2467-3683; Li, Binkui/0000-0003-3201-2914; Liu, Wanqing/0000-0001-7727-6900	National Natural Science Foundation of China [30772491]; Research Fund of National Key Laboratory of Oncology in South China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of National Key Laboratory of Oncology in South China	This work was supported by a grant (No: 30772491) from the National Natural Science Foundation of China (to H-YW) and partially supported by the Research Fund of National Key Laboratory of Oncology in South China (to H-YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bando K, 1999, GENE CHROMOSOME CANC, V25, P284, DOI 10.1002/(SICI)1098-2264(199907)25:3<284::AID-GCC11>3.0.CO;2-I; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Dong SO, 2010, WORLD J GASTROENTERO, V16, P306, DOI 10.3748/wjg.v16.i3.306; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; El-Assal ON, 2001, CLIN CANCER RES, V7, P1299; Esti C, 2008, CANCER, V113, P1004; Hu GH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl601; Huang GL, 2010, WORLD J GASTROENTERO, V16, P2046, DOI 10.3748/wjg.v16.i16.2046; Huang SF, 1999, CANCER GENET CYTOGEN, V111, P21, DOI 10.1016/S0165-4608(98)00215-5; Ikeguchi M, 2003, ANN SURG ONCOL, V10, P297, DOI 10.1245/ASO.2003.05.022; Ikeguchi M, 2003, EUR J CANCER, V39, P86, DOI 10.1016/S0959-8049(02)00558-0; Ikeguchi M, 2002, J SURG ONCOL, V81, P148, DOI 10.1002/jso.10163; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Khasraw M, 2010, ANN ONCOL, V21, P1302, DOI 10.1093/annonc/mdp524; Koliopanos A, 2001, CANCER RES, V61, P4655; Lewis KD, 2008, INVEST NEW DRUG, V26, P89, DOI 10.1007/s10637-007-9080-5; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; Liu CJ, 2009, J HEPATOL, V50, P958, DOI 10.1016/j.jhep.2008.12.023; Liu WQ, 2009, CLIN CANCER RES, V15, P7602, DOI 10.1158/1078-0432.CCR-09-0890; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Nasser NJ, 2009, P NATL ACAD SCI USA, V106, P2253, DOI 10.1073/pnas.0812846106; Nasser NJ, 2005, P NATL ACAD SCI USA, V102, P15161, DOI 10.1073/pnas.0507279102; Nishimura T, 2006, CANCER GENET CYTOGEN, V167, P57, DOI 10.1016/j.cancergencyto.2005.09.002; Nobuhisa T, 2007, CANCER SCI, V98, P535, DOI 10.1111/j.1349-7006.2007.00420.x; Ohkawa T, 2004, LAB INVEST, V84, P1289, DOI 10.1038/labinvest.3700159; Takaoka M, 2003, LAB INVEST, V83, P613, DOI 10.1097/01.LAB.0000067482.84946.BD; Wang HY, 2005, GENOME RES, V15, P276, DOI 10.1101/gr.2885205; Xiao Y, 2003, HEPATOL RES, V26, P192, DOI 10.1016/S1386-6346(03)00107-4; Yeh SH, 2004, HEPATOLOGY, V40, P847, DOI 10.1002/hep.20409; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2003, CANCER RES, V63, P7733	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44061	10.1371/journal.pone.0044061	http://dx.doi.org/10.1371/journal.pone.0044061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952874	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300047
J	Isaac, NJB; Redding, DW; Meredith, HM; Safi, K				Isaac, Nick J. B.; Redding, David W.; Meredith, Helen M.; Safi, Kamran			Phylogenetically-Informed Priorities for Amphibian Conservation	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; POPULATION DECLINES; SPECIES CATEGORIES; EXTINCTION RISK; PHYLOGENY; DIVERSITY; BIODIVERSITY; MODELS; FROGS; DIVERSIFICATION	The amphibian decline and extinction crisis demands urgent action to prevent further large numbers of species extinctions. Lists of priority species for conservation, based on a combination of species' threat status and unique contribution to phylogenetic diversity, are one tool for the direction and catalyzation of conservation action. We describe the construction of a near-complete species-level phylogeny of 5713 amphibian species, which we use to create a list of evolutionarily distinct and globally endangered species (EDGE list) for the entire class Amphibia. We present sensitivity analyses to test the robustness of our priority list to uncertainty in species' phylogenetic position and threat status. We find that both sources of uncertainty have only minor impacts on our 'top 100' list of priority species, indicating the robustness of the approach. By contrast, our analyses suggest that a large number of Data Deficient species are likely to be high priorities for conservation action from the perspective of their contribution to the evolutionary history.	[Isaac, Nick J. B.] Nat Environm Res Council Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Redding, David W.] UCL, London, England; [Meredith, Helen M.] Durrell Inst Conservat & Ecol, London, England; [Meredith, Helen M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Safi, Kamran] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Safi, Kamran] Univ Konstanz, Dept Biol, Constance, Germany	UK Centre for Ecology & Hydrology (UKCEH); University of London; University College London; Zoological Society of London; Max Planck Society; University of Konstanz	Isaac, NJB (corresponding author), Nat Environm Res Council Ctr Ecol & Hydrol, Maclean Bldg, Wallingford, Oxon, England.	ksafi@orn.mpg.de	Isaac, Nick/C-2716-2011; Safi, Kamran/B-2079-2008; Redding, David/M-1766-2019	Isaac, Nick/0000-0002-4869-8052; Safi, Kamran/0000-0002-8418-6759; Redding, David/0000-0001-8615-1798	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adams MJ, 1999, J WILDLIFE MANAGE, V63, P1162, DOI 10.2307/3802834; Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Alford RA, 2011, NATURE, V480, P461, DOI 10.1038/480461a; [Anonymous], 2008, EDG EX PROGR; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Bininda-Emonds ORP, 2002, ANNU REV ECOL SYST, V33, P265, DOI 10.1146/annurev.ecolsys.33.010802.150511; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Carpenter SR, 2000, ECOSYSTEMS, V3, P1, DOI 10.1007/s100210000001; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Collen B, 2011, PHILOS T R SOC B, V366, P2577, DOI 10.1098/rstb.2011.0015; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Diniz JAF, 2004, CONSERV BIOL, V18, P698; Emerson SB, 2000, MOL PHYLOGENET EVOL, V16, P131, DOI 10.1006/mpev.2000.0778; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faith DP, 1996, CONSERV BIOL, V10, P1286, DOI 10.1046/j.1523-1739.1996.10041286.x; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Frost DR, 2007, AMPHIBIAN SPECIES WO; Gower DJ, 2005, CONSERV BIOL, V19, P45, DOI 10.1111/j.1523-1739.2005.00589.x; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; Mendelson II J, 2007, AMPHIBIAN CONSERVATI, P32; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Mooers AO, 2003, ANIM CONSERV, V6, P183, DOI 10.1017/S1367943003003226; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; Nee S, 2001, EVOLUTION, V55, P661, DOI 10.1554/0014-3820(2001)055[0661:ISRFP]2.0.CO;2; Orme C.D.L., 2011, CAPER COMP ANAL PHYL; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Safi K, 2010, GLOBAL ECOL BIOGEOGR, V19, P352, DOI 10.1111/j.1466-8238.2010.00523.x; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Sitas N, 2009, ANIM CONSERV, V12, P231, DOI 10.1111/j.1469-1795.2009.00244.x; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Stuart SN, 2004, SCIENCE, V10, P1; Team R. D. C, 2011, R LANG ENV STAT COMP; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N; Zhang P, 2006, P NATL ACAD SCI USA, V103, P7360, DOI 10.1073/pnas.0602325103	57	101	106	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43912	10.1371/journal.pone.0043912	http://dx.doi.org/10.1371/journal.pone.0043912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952807	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000308206500028
J	Nakayama, S; Johnstone, RA; Manica, A				Nakayama, Shinnosuke; Johnstone, Rufus A.; Manica, Andrea			Temperament and Hunger Interact to Determine the Emergence of Leaders in Pairs of Foraging Fish	PLOS ONE			English	Article							DECISION-MAKING; PERSONALITY-DIFFERENCES; INDIVIDUAL-DIFFERENCES; SOCIAL FACILITATION; BARNACLE GEESE; ZEBRA FINCHES; EVOLUTION; MOVEMENTS; BOLDNESS; DOMINANCE	Studies on leadership have focused either on physiological state as the key predictor (i.e. "leading according to need"), or else on temperamental asymmetries among group members (i.e. intrinsic leadership). In this paper, we explore how both factors interact in determining the emergence of leaders. We observed pairs of sticklebacks with varying degrees of temperamental difference, and recorded their movements back and forth between a safe covered area and a risky foraging area, both before and after satiating one of the two pair members (but not the other). Before satiation, when the fish had similar hunger levels, temperament was a good predictor of social roles, with the bolder member of a pair leading and the shyer member following. The effect of satiation depended on which fish received the additional food. When the shyer member of a pair was fed, and consequently became less active, the bolder fish did not change its behaviour but continued to lead. By contrast, when the bolder member of a pair was fed, and consequently initiated fewer trips out of cover, the shyer partner compensated by initiating trips more frequently itself. In pairs that differed only a little in temperament, feeding the bolder fish actually led to a role reversal, with the shyer fish emerging as a leader in the majority of joint trips out of cover. Our results show that leadership emerges as the consequence of multiple factors, and that their interaction can be complex.	[Nakayama, Shinnosuke; Johnstone, Rufus A.; Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Nakayama, S (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	shinn407@gmail.com	Manica, Andrea/B-5497-2008; Manica, Andrea/N-9013-2019	Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X	Association for the Study of Animal Behaviour; Japan Society of the Promotion of Science	Association for the Study of Animal Behaviour; Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by a grant from the Association for the Study of Animal Behaviour to AM and a fellowship from the Japan Society of the Promotion of Science to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barelli C, 2008, BEHAVIOUR, V145, P965, DOI 10.1163/156853908784089243; Beauchamp G, 2000, BEHAVIOUR, V137, P301, DOI 10.1163/156853900502097; Borg B, 2004, BEHAVIOUR, V141, P1521, DOI 10.1163/1568539042948213; Conradt L, 2007, P ROY SOC B-BIOL SCI, V274, P2317, DOI 10.1098/rspb.2007.0186; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Conradt L, 2009, PHILOS T R SOC B, V364, P807, DOI 10.1098/rstb.2008.0257; Dahlbom SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023565; Erhart EM, 1999, INT J PRIMATOL, V20, P927, DOI 10.1023/A:1020830703012; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Flack A, 2012, ANIM BEHAV, V83, P703, DOI 10.1016/j.anbehav.2011.12.018; FOSSEY D, 1972, ANIM BEHAV, V20, P36, DOI 10.1016/S0003-3472(72)80171-4; Freeman R, 2011, BIOL LETTERS, V7, P63, DOI 10.1098/rsbl.2010.0627; Glickman SE, 1997, ANN NY ACAD SCI, V807, P175, DOI 10.1111/j.1749-6632.1997.tb51919.x; Harcourt JL, 2010, ETHOLOGY, V116, P440, DOI 10.1111/j.1439-0310.2010.01757.x; Harcourt JL, 2010, CURR BIOL, V20, P156, DOI 10.1016/j.cub.2009.11.045; Harcourt JL, 2009, ANIM BEHAV, V77, P1501, DOI 10.1016/j.anbehav.2009.03.004; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; JAMES WT, 1953, J COMP PHYSIOL PSYCH, V46, P427, DOI 10.1037/h0056028; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Krause J, 2002, LIVING GROUPS; Kurvers RHJM, 2011, P ROY SOC B-BIOL SCI, V278, P2018, DOI 10.1098/rspb.2010.2266; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Laland KN, 2004, LEARN BEHAV, V32, P4; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; McClure M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1573, DOI 10.1007/s00265-011-1167-5; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P605, DOI 10.1098/rspb.2008.1182; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nakayama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036606; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Pike TW, 2008, P ROY SOC B-BIOL SCI, V275, P2515, DOI 10.1098/rspb.2008.0744; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Scheid C, 2010, ANIM COGN, V13, P545, DOI 10.1007/s10071-009-0305-1; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wolf M, 2011, P ROY SOC B-BIOL SCI, V278, P440, DOI 10.1098/rspb.2010.1051	44	34	35	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43747	10.1371/journal.pone.0043747	http://dx.doi.org/10.1371/journal.pone.0043747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952753	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000049
J	Behanzin, L; Diabate, S; Minani, I; Lowndes, CM; Boily, MC; Labbe, AC; Anagonou, S; Zannou, DM; Buve, A; Alary, M				Behanzin, Luc; Diabate, Souleymane; Minani, Isaac; Lowndes, Catherine M.; Boily, Marie-Claude; Labbe, Annie-Claude; Anagonou, Severin; Zannou, Djimon Marcel; Buve, Anne; Alary, Michel			Decline in HIV Prevalence among Young Men in the General Population of Cotonou, Benin, 1998-2008	PLOS ONE			English	Article							REDUCING HETEROSEXUAL TRANSMISSION; SIMPLEX-VIRUS TYPE-2; FEMALE SEX WORKERS; INFECTION; INTERVENTIONS; EPIDEMIC; CONDOMS; SEROPREVALENCE; PERFORMANCE; ANTIBODIES	Objective: To assess changes in the prevalence of HIV and other sexually transmitted infections, as well as in different proximal and distal factors related to HIV infection, in the general population of Cotonou between 1998 and 2008, while an intensive preventive intervention targeting the sex work milieu was ongoing. Methods: A two-stage cluster sampling procedure was used to select the participants in each study. Subjects aged 15-49 who agreed to participate were interviewed and tested for HIV, syphilis, HSV-2, gonorrhoea and chlamydia. We used the Roa-Scott Chi-square test (proportions) and the Student's t test (means) for bivariate comparisons, and adjusted logistic regression models taking into account the cluster effect for multivariate analyses. Results: HIV prevalence decreased significantly in men (3.4% in 1998 versus 2.0% in 2008, p = 0.048), especially in those aged 15-29 (3.0% to 0.5%, p = 0.002). Among men, the prevalence of gonorrhoea decreased significantly (1.1% to 0.3%, p = 0.046) while HSV-2 prevalence increased from 12.0% to 18.1% (p = 0.0003). The proportion of men who reported condom use at least once (29.3% to 61.0%, p<0.0001) and of those having attained a secondary educational level or more (17.1% to 61.3%, p<0.0001) also increased significantly. There was an overall decrease in the prevalence of syphilis (1.5% to 0.6%, p = 0.0003). Conclusion: This is the first population-based study reporting a significant decline in HIV prevalence among young men in an African setting where overall prevalence has never reached 5%. The decline occurred while preventive interventions targeting the sex work milieu were ongoing and the educational level was increasing.	[Behanzin, Luc; Diabate, Souleymane; Lowndes, Catherine M.; Boily, Marie-Claude; Alary, Michel] Univ Quebec, Ctr Rech FRSQ CHA, URESP, Quebec City, PQ, Canada; [Behanzin, Luc; Diabate, Souleymane; Alary, Michel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Minani, Isaac] Dispensaire IST, Cotonou, Benin; [Lowndes, Catherine M.] Hlth Protect Agcy, London, England; [Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Labbe, Annie-Claude] Hop Maison Neuve Rosemont, Dept Microbiol, Montreal, PQ, Canada; [Anagonou, Severin; Zannou, Djimon Marcel] Univ Abomey Calavi, Fac Sci Sante, Cotonou, Benin; [Anagonou, Severin; Zannou, Djimon Marcel] Ctr Natl Hosp Univ, Cotonou, Benin; [Buve, Anne] Inst Trop Med, Unit Epidemiol & Control HIV STD, B-2000 Antwerp, Belgium; [Alary, Michel] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada	Laval University; University of Quebec; Laval University; Health Protection Agency; Imperial College London; Universite de Montreal; University of Abomey Calavi; Institute of Tropical Medicine (ITM); Institut national de sante publique du Quebec (INSPQ)	Behanzin, L (corresponding author), Univ Quebec, Ctr Rech FRSQ CHA, URESP, Quebec City, PQ, Canada.	malary@uresp.ulaval.ca		Boily, Marie-Claude/0000-0003-3919-006X	Canadian Institutes of Health Research [HCB-82159]; UNAIDS; Canadian International Development Agency	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UNAIDS; Canadian International Development Agency	Funding provided by Canadian Institutes of Health Research (grant no. HCB-82159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Canadian Institutes of Health Research (grant no. HCB-82159) for funding the 2008 survey, UNAIDS for funding the 1998 survey, the Canadian International Development Agency for funding the intervention in the sex work milieu, the Programme national de lutte contre le Sida et les IST and the Ministry of Health of Benin for their involvement at all levels. We also thank the participants as well as the personnel of Projet Sida 1/2/3 and of Dispensaire IST (Benin), the Institute of Tropical Medicine (Antwerp, Belgium) and the Centre hospitalier affilie universitaire de Quebec (Canada) for their contribution.	Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; [Anonymous], PROGR REP 2011 GLOB; [Anonymous], 2006, RAPP DEUX ENQ SURV 2; Banandur P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S13; BENOIT SN, 1990, J ACQ IMMUN DEF SYND, V3, P1193; Biraro S, 2011, SEX TRANSM DIS, V38, P140, DOI 10.1097/OLQ.0b013e3181f0bafb; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Buve A, 2001, AIDS, V15, pS117, DOI 10.1097/00002030-200108004-00013; Carael M, 2006, SEX TRANSM INFECT, V82, pIII26, DOI 10.1136/sti.2006.021196; Cayley WE, 2004, AM FAM PHYSICIAN, V70, P1268; [Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS) Direction Nationale de la Statistique et de l'Informatique Ministere du plan et de. l'amenagement du territoire (DNSI/MPAT) ORC Macro International Inc], 2006, ENQ DEM SANT EDSM 4; [Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS) Direction Nationale de la Statistique et de l'Informatique Ministere du plan et de. l'amenagement du territoire (DNSI/MPAT) ORC Macro International Inc], 2002, ENQ DEM SANT EDSM 3; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; Gaydos CA, 2010, J CLIN MICROBIOL, V48, P3236, DOI 10.1128/JCM.01019-10; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Ghys PD, 2010, SEX TRANSM INFECT, V86, pI1, DOI [10.1136/sti.2010.047852, 10.1136/sti.2010.044933]; Glynn JR, 2001, AIDS, V15, P1717, DOI 10.1097/00002030-200109070-00016; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Institut National de la Statistique et de l'Analyse Economique (INSAE) du Benin, 2008, PROJ DEP POP 2002 20; Institut National de la Statistique et de l'Analyse Economique (INSAE) du Benin/Macro International Inc, 2007, ENQ DEM SANT EDSB 3; [Institut national de la statistique (INS) Ministere de la lutte contre le SIDA (MLS) ORC Macro], 2005, ENQ IND SIDA COT IV; [Institut national de la Statistique (INS) du Niger Macro International Inc], 2007, ENQ DEM SANT IND MUL; Joint United Nations Programme on HIV/AIDS, 1998, LOOK DEEP HIV EP QUE; Lagarde E, 2001, AIDS, V15, P1399, DOI 10.1097/00002030-200107270-00009; Lowndes CM, 2007, SEX TRANSM INFECT, V83, P577, DOI 10.1136/sti.2007.027441; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; Lowndes CM, 2008, CHARACTERISATION HIV; Martin ET, 2009, ARCH INTERN MED, V169, P1233, DOI 10.1001/archinternmed.2009.177; [Ministere de la Sante Publique et de la lutte contre les Endemies du Niger CARESM Centre de la la Recherche Medicale et sanitaires du Niger], 2002, ENQ NAT SER INF VIH; MULDER D, 1995, BRIT MED J, V311, P833, DOI 10.1136/bmj.311.7009.833; Oelemann WMR, 2002, J CLIN MICROBIOL, V40, P881, DOI 10.1128/JCM.40.3.881-885.2002; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; RENTON AM, 1994, SOC SCI MED, V38, P1153, DOI 10.1016/0277-9536(94)90230-5; Strick LB, 2006, CLIN INFECT DIS, V43, P347, DOI 10.1086/505496; Temmerman M, 1999, INT J STD AIDS, V10, P405, DOI 10.1258/0956462991914339; UNAIDS, 2010, REP GLOB AIDS EP; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; [World Health Organization (WHO) UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; [World Health Organization (WHO) USAID DELIVER], 2003, CAP HIV 1 HIV 2 RAPI; World Health Organization (WHO) UNAIDS/WHO, 1997, WKLY EPIDEMIOL REC, V12, P81; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020	48	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43818	10.1371/journal.pone.0043818	http://dx.doi.org/10.1371/journal.pone.0043818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952773	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600047
J	Dumon, S; Walton, DS; Volpe, G; Wilson, N; Dasse, E; Del Pozzo, W; Landry, JR; Turner, B; O'Neill, LP; Gottgens, B; Frampton, J				Dumon, Stephanie; Walton, David S.; Volpe, Giacomo; Wilson, Nicola; Dasse, Emilie; Del Pozzo, Walter; Landry, Josette-Renee; Turner, Bryan; O'Neill, Laura P.; Goettgens, Berthold; Frampton, Jon			Itga2b Regulation at the Onset of Definitive Hematopoiesis and Commitment to Differentiation	PLOS ONE			English	Article							GENE-EXPRESSION; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; DEMETHYLASE JMJD3; MPL RECEPTOR; STEM-CELLS; THROMBOPOIETIN; PROGENITORS; INHIBITION; TISSUE	Product of the Itga2b gene, CD41 contributes to hematopoietic stem cell (HSC) and megakaryocyte/platelet functions. CD41 expression marks the onset of definitive hematopoiesis in the embryo where it participates in regulating the numbers of multipotential progenitors. Key to platelet aggregation, CD41 expression also characterises their precursor, the megakaryocyte, and is specifically up regulated during megakaryopoiesis. Though phenotypically unique, megakaryocytes and HSC share numerous features, including key transcription factors, which could indicate common sub-regulatory networks. In these respects, Itga2b can serve as a paradigm to study features of both developmental-stage and HSC-versus megakaryocyte-specific regulations. By comparing different cellular contexts, we highlight a mechanism by which internal promoters participate in Itga2b regulation. A developmental process connects epigenetic regulation and promoter switching leading to CD41 expression in HSC. Interestingly, a similar process can be observed at the Mpl locus, which codes for another receptor that defines both HSC and megakaryocyte identities. Our study shows that Itga2b expression is controlled by lineage-specific networks and associates with H4K8ac in megakaryocyte or H3K27me3 in the multipotential hematopoietic cell line HPC7. Correlating with the decrease in H3K27me3 at the Itga2b Iocus, we find that following commitment to megakaryocyte differentiation, the H3K27 demethylase Jmjd3 up-regulation influences both Itga2b and Mpl expression.	[Dumon, Stephanie; Walton, David S.; Volpe, Giacomo; Dasse, Emilie; Turner, Bryan; O'Neill, Laura P.; Frampton, Jon] Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Wilson, Nicola; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; [Landry, Josette-Renee] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Del Pozzo, Walter] Nikhef, Amsterdam, Netherlands	University of Birmingham; University of Cambridge; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; FOM National Institute for Subatomic Physics	Dumon, S (corresponding author), Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Birmingham, W Midlands, England.	s.dumon@bham.ac.uk	Volpe, Giacomo/AAQ-5235-2021; Volpe, Giacomo/AAT-2783-2020; Volpe, Giacomo/GSI-6601-2022	Volpe, Giacomo/0000-0001-5000-6951; Del Pozzo, Walter/0000-0003-3978-2030; Gottgens, Berthold/0000-0001-6302-5705	Leukemia and Lymphoma Research [06062, 09022]; Wellcome Trust [08433/Z/07/Z]; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [G0800784, G9818340B, G0900951, G0800784B] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0800784, G0900951] Funding Source: UKRI	Leukemia and Lymphoma Research; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Leukemia and Lymphoma Research (grant number 06062 and 09022) http://leukaemialymphomaresearch.org.uk/ and the Wellcome Trust (grant number 08433/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; do O PP, 2002, BLOOD, V99, P3939, DOI 10.1182/blood.V99.11.3939; Dumon S, 2006, EXP HEMATOL, V34, P654, DOI 10.1016/j.exphem.2006.01.014; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fleury M, 2010, INT J DEV BIOL, V54, P1067, DOI 10.1387/ijdb.103104mf; Follows GA, 2006, GENOME RES, V16, P1310, DOI 10.1101/gr.5373606; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Garcia P, 1996, ONCOGENE, V13, P695; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Hong W, 2002, MOL CELL BIOL, V22, P3729, DOI 10.1128/MCB.22.11.3729-3743.2002; Huang H, 2009, J CELL BIOCHEM, V107, P857, DOI 10.1002/jcb.22184; Jackers P, 2004, J BIOL CHEM, V279, P52183, DOI 10.1074/jbc.M407489200; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Lorvellec M, 2010, STEM CELLS, V28, P1751, DOI 10.1002/stem.496; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Ninos JM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-9; Perlingeiro RCR, 2003, STEM CELLS, V21, P272, DOI 10.1634/stemcells.21-3-272; Petit-Cocault L, 2007, DEVELOPMENT, V134, P3031, DOI 10.1242/dev.001818; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Pozner A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-84; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Tober J, 2007, BLOOD, V109, P1433, DOI 10.1182/blood-2006-06-031898; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Vincent A, 2009, DIFFERENTIATION, V78, P99, DOI 10.1016/j.diff.2009.07.002; White DA, 1999, METHODS, V19, P417, DOI 10.1006/meth.1999.0878; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316	44	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43300	10.1371/journal.pone.0043300	http://dx.doi.org/10.1371/journal.pone.0043300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952660	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600020
J	Leikoski, N; Fewer, DP; Jokela, J; Alakoski, P; Wahlsten, M; Sivonen, K				Leikoski, Niina; Fewer, David P.; Jokela, Jouni; Alakoski, Pirita; Wahlsten, Matti; Sivonen, Kaarina			Analysis of an Inactive Cyanobactin Biosynthetic Gene Cluster Leads to Discovery of New Natural Products from Strains of the Genus Microcystis	PLOS ONE			English	Article							FRESH-WATER CYANOBACTERIUM; LISSOCLINUM-PATELLA; CYCLIC-PEPTIDES; AERUGINOSA PCC-7806; MARINE TUNICATE; BLOOM; ULITHIACYCLAMIDE; UNDECAPEPTIDE; PRENYLATION; ANABAENA	Cyanobactins are cyclic peptides assembled through the cleavage and modification of short precursor proteins. An inactive cyanobactin gene cluster has been described from the genome Microcystis aeruginosa NIES843. Here we report the discovery of active counterparts in strains of the genus Microcystis guided by this silent cyanobactin gene cluster. The end products of the gene clusters were structurally diverse cyclic peptides, which we named piricyclamides. Some of the piricyclamides consisted solely of proteinogenic amino acids while others contained disulfide bridges and some were prenylated or geranylated. The piricyclamide gene clusters encoded between 1 and 4 precursor genes. They encoded highly diverse core peptides ranging in length from 7-17 amino acids with just a single conserved amino acid. Heterologous expression of the pir gene cluster from Microcystis aeruginosa PCC7005 in Escherichia coli confirmed that this gene cluster is responsible for the biosynthesis of piricyclamides. Chemical analysis demonstrated that Microcystis strains could produce an array of piricyclamides some of which are geranylated or prenylated. The genetic diversity of piricyclamides in a bloom sample was explored and 19 different piricyclamide precursor genes were found. This study provides evidence for a stunning array of piricyclamides in Microcystis, a worldwide occurring bloom forming cyanobacteria.	[Leikoski, Niina; Fewer, David P.; Jokela, Jouni; Alakoski, Pirita; Wahlsten, Matti; Sivonen, Kaarina] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland	University of Helsinki	Leikoski, N (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	kaarina.sivonen@helsinki.fi	Fewer, David P/A-8704-2008	Fewer, David P/0000-0003-3978-4845; Sivonen, Kaarina/0000-0002-2904-0458; Jokela, Jouni/0000-0001-5096-3575; Wahlsten, Matti/0000-0002-4107-1695	Academy of Finland (Research Center of Excellence) [118637]	Academy of Finland (Research Center of Excellence)(Academy of FinlandFinnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by the grant from the Academy of Finland to KS (Research Center of Excellence 118637). NL is a student at Viikki Doctoral Programme in Molecular Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann HI, 2007, J NAT PROD, V70, P1611, DOI 10.1021/np0700873; Burja AM, 2001, TETRAHEDRON, V57, P9347, DOI 10.1016/S0040-4020(01)00931-0; Cascales L, 2010, ORG BIOMOL CHEM, V8, P5035, DOI 10.1039/c0ob00139b; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; Donia MS, 2011, CHEM BIOL, V18, P508, DOI 10.1016/j.chembiol.2011.01.019; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fewer DP, 2011, ENV MICROBIOL REP, V3, P189, DOI 10.1111/j.1758-2229.2010.00207.x; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Fu X, 1998, J NAT PROD, V61, P1547, DOI 10.1021/np9802872; Gelb MH, 1997, SCIENCE, V275, P1750, DOI 10.1126/science.275.5307.1750; IRELAND C, 1980, J AM CHEM SOC, V102, P5688, DOI 10.1021/ja00537a053; IRELAND CM, 1982, J ORG CHEM, V47, P1807, DOI 10.1021/jo00349a002; Ishida K, 1996, TETRAHEDRON, V52, P9025, DOI 10.1016/0040-4020(96)00452-8; Ishida K, 1997, J NAT PROD, V60, P724, DOI 10.1021/np970146k; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kotai J, 1972, 1169 NORW I WAT RES; Lagerwerf FM, 1996, RAPID COMMUN MASS SP, V10, P1905, DOI 10.1002/(SICI)1097-0231(199612)10:15<1905::AID-RCM755>3.0.CO;2-9; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Leet JE, 2008, J NAT PROD, V71, P460, DOI 10.1021/np070523l; Leikoski N, 2010, APPL ENVIRON MICROB, V76, P701, DOI 10.1128/AEM.01061-09; Leikoski N, 2009, APPL ENVIRON MICROB, V75, P853, DOI 10.1128/AEM.02134-08; Lin S, 2011, GENE, V473, P139, DOI 10.1016/j.gene.2010.11.011; McIntosh JA, 2011, J AM CHEM SOC, V133, P13698, DOI 10.1021/ja205458h; McIntosh JA, 2010, J AM CHEM SOC, V132, P15499, DOI 10.1021/ja1067806; McIntosh JA, 2010, CHEMBIOCHEM, V11, P1413, DOI 10.1002/cbic.201000196; Neitz S, 2001, RAPID COMMUN MASS SP, V15, P1586, DOI 10.1002/rcm.413; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Portmann C, 2008, J NAT PROD, V71, P1891, DOI 10.1021/np800409z; Portmann C, 2008, J NAT PROD, V71, P1193, DOI 10.1021/np800118g; Raveh A, 2010, TETRAHEDRON, V66, P2705, DOI 10.1016/j.tet.2010.02.008; Schmidt EW, 2009, METHOD ENZYMOL, V458, P575, DOI 10.1016/S0076-6879(09)04823-X; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x; Sudek S, 2006, APPL ENVIRON MICROB, V72, P4382, DOI 10.1128/AEM.00380-06; Van Wagoner RM, 2007, ADV APPL MICROBIOL, V61, P89, DOI 10.1016/S0065-2164(06)61004-6; WILLIAMS DE, 1989, J NAT PROD, V52, P732, DOI 10.1021/np50064a011; Zafrir-Ilan E, 2010, TETRAHEDRON LETT, V51, P6602, DOI 10.1016/j.tetlet.2010.10.051; Ziemert N, 2008, APPL ENVIRON MICROB, V74, P1791, DOI 10.1128/AEM.02392-07	40	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43002	10.1371/journal.pone.0043002	http://dx.doi.org/10.1371/journal.pone.0043002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952627	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800017
J	Stocks, T; Angquist, L; Banasik, K; Harder, MN; Taylor, MA; Hager, J; Arner, P; Oppert, JM; Martinez, JA; Polak, J; Rousseau, F; Langin, D; Rossner, S; Holst, C; MacDonald, IA; Kamatani, Y; Pfeiffer, AFH; Kunesova, M; Saris, WHM; Hansen, T; Pedersen, O; Astrup, A; Sorensen, TIA				Stocks, Tanja; Angquist, Lars; Banasik, Karina; Harder, Marie N.; Taylor, Moira A.; Hager, Joerg; Arner, Peter; Oppert, Jean-Michel; Alfredo Martinez, J.; Polak, Jan; Rousseau, Francis; Langin, Dominique; Rossner, Stephan; Holst, Claus; MacDonald, Ian A.; Kamatani, Yoichiro; Pfeiffer, Andreas F. H.; Kunesova, Marie; Saris, Wim H. M.; Hansen, Torben; Pedersen, Oluf; Astrup, Arne; Sorensen, Thorkild I. A.			TFAP2B Influences the Effect of Dietary Fat on Weight Loss under Energy Restriction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBESITY-RELATED TRAITS; BODY-MASS INDEX; LOW-CARBOHYDRATE; FTO GENE; INSULIN-RESISTANCE; RANDOMIZED-TRIAL; IDENTICAL-TWINS; ADULT OBESITY; LOCI	Background: Numerous gene loci are related to single measures of body weight and shape. We investigated if 55 SNPs previously associated with BMI or waist measures, modify the effects of fat intake on weight loss and waist reduction under energy restriction. Methods and Findings: Randomized controlled trial of 771 obese adults. (Registration: ISRCTN25867281.) One SNP was selected for replication in another weight loss intervention study of 934 obese adults. The original trial was a 10-week 600 kcal/d energy-deficient diet with energy percentage from fat (fat%) in range of 20-25 or 40-45. The replication study used an 8-weeks diet of 880 kcal/d and 20 fat%; change in fat% intake was used for estimation of interaction effects. The main outcomes were intervention weight loss and waist reduction. In the trial, mean change in fat% intake was -12/+4 in the low/high-fat groups. In the replication study, it was -23/-12 among those reducing fat% more/less than the median. TFAP2B-rs987237 genotype AA was associated with 1.0 kg (95% CI, 0.4; 1.6) greater weight loss on the low-fat, and GG genotype with 2.6 kg (1.1; 4.1) greater weight loss on the high-fat (interaction p-value; p=0.00007). The replication study showed a similar (non-significant) interaction pattern. Waist reduction results generally were similar. Study-strengths include (i) the discovery study randomised trial design combined with the replication opportunity (ii) the strict dietary intake control in both studies (iii) the large sample sizes of both studies. Limitations are (i) the low minor allele frequency of the TFAP2B polymorphism, making it hard to investigate non-additive genetic effects (ii) the different interventions preventing identical replication-discovery study designs (iii) some missing data for non-completers and dietary intake. No adverse effects/outcomes or side-effects were observed. Conclusions: Under energy restriction, TFAP2B may modify the effect of dietary fat intake on weight loss and waist reduction.	[Stocks, Tanja; Angquist, Lars; Holst, Claus; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Stocks, Tanja] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Banasik, Karina; Harder, Marie N.; Hansen, Torben; Pedersen, Oluf; Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark; [Taylor, Moira A.; MacDonald, Ian A.] Univ Nottingham, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2RD, England; [Hager, Joerg] CEA Genom Inst, Dept Human Genet, Evry, France; [Arner, Peter] Karolinska Inst, Dept Med, Karolinska Univ Hosp, Stockholm, Sweden; [Oppert, Jean-Michel] Univ Paris 06, Dept Nutr, Pitie Salpetriere Hosp, AP HP,Human Nutr Res Ctr Ile de France, Paris, France; [Alfredo Martinez, J.] Univ Navarra, Dept Physiol & Nutr, E-31080 Pamplona, Spain; [Polak, Jan] Charles Univ Prague, Dept Sports Med, Ctr Prevent Med, Fac Med 1, Prague, Czech Republic; [Rousseau, Francis] IntegraGen SA, Evry, France; [Langin, Dominique] Univ Toulouse 3, Obes Res Lab, Inst Metab & Cardiovasc Dis, Inserm UPS UMR1048,Toulouse Univ Hosp, F-31062 Toulouse, France; [Rossner, Stephan] Karolinska Inst, Obes Unit, Dept Med, Karolinska Univ Hosp, Huddinge, Sweden; [Kamatani, Yoichiro] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France; [Pfeiffer, Andreas F. H.] German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany; [Pfeiffer, Andreas F. H.] Charite, Dept Diabet Endocrinol & Metab, D-13353 Berlin, Germany; [Kunesova, Marie] Obes Management Ctr, Inst Endocrinol, Prague, Czech Republic; [Saris, Wim H. M.] DSM Nutr Prod Ltd, DSM Corp, Kaiseraugst, Switzerland; [Saris, Wim H. M.] Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht, Maastricht, Netherlands; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Fac Hlth Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Astrup, Arne] Univ Copenhagen, Dept Human Nutr, Fac Life Sci, Frederiksberg, Denmark	University of Copenhagen; Umea University; Novo Nordisk Foundation; University of Copenhagen; University of Nottingham; CEA; UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Karolinska University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Navarra; Charles University Prague; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Karolinska Institutet; Karolinska University Hospital; Foundation Jean Dausset-CEPH; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institute of Endocrinology - Prague; DSM NV; Maastricht University; Maastricht University Medical Centre (MUMC); University of Southern Denmark; University of Copenhagen; Aarhus University; University of Copenhagen	Stocks, T (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Frederiksberg, Denmark.	tst@ipm.regionh.dk; la@ipm.regionh.dk	Banasik, Karina/G-1728-2013; Polak, Jan/J-3404-2014; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Kamatani, Yoichiro/N-5513-2015; Oppert, Jean-Michel/F-2810-2017; Banasik, Karina/S-3475-2019; Pedersen, Oluf/AAG-8015-2020; Pfeiffer, Andreas F.H./AAJ-2311-2020; Pedersen, Oluf/Z-1731-2019; Astrup, Arne/B-1407-2015; Martinez Hernandez, J Alfredo/K-8709-2014	Polak, Jan/0000-0001-9964-652X; Banasik, Karina/0000-0003-2489-2499; Pfeiffer, Andreas F.H./0000-0002-6887-0016; Pedersen, Oluf/0000-0002-3321-3972; Angquist, Lars/0000-0002-9516-4424; Hansen, Torben/0000-0001-8748-3831; Astrup, Arne/0000-0001-8968-8996; Arner, Peter/0000-0002-6208-6220; Taylor, Moira/0000-0003-4100-8343; Macdonald, Ian/0000-0002-7540-9850; Langin, Dominique/0000-0002-2669-7825; Martinez Hernandez, J Alfredo/0000-0001-5218-6941	European Community [QLK1-CT-2000-00618]; European Commission [FP6-2005-513946]; DSM, Innovation centre, Urmond, The Netherlands; Danish Council for Strategic Research	European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); DSM, Innovation centre, Urmond, The Netherlands; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was funded by the European Community (Contract no. QLK1-CT-2000-00618, NUGENOB project), the European Commission Food Quality and Safety Priority of the Sixth Framework Program (Contract no. FP6-2005-513946, DiOGenes project), DSM, Innovation centre, Urmond, The Netherlands (genotyping), and the Danish Council for Strategic Research (GENDINOB project, TS and LA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Bouchard C, 1994, Obes Res, V2, P400; Bountziouka V, 2011, NUTR METAB CARDIOVAS; Busetto L, 2011, DIABETES-METAB RES, V27, P230, DOI 10.1002/dmrr.1171; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Croteau-Chonka DC, 2011, OBESITY, V19, P1019, DOI 10.1038/oby.2010.256; Franks PW, 2008, DIABETOLOGIA, V51, P2214, DOI 10.1007/s00125-008-1158-x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Grau K, 2009, INT J OBESITY, V33, P1227, DOI 10.1038/ijo.2009.159; Grau K, 2010, AM J CLIN NUTR, V91, P472, DOI 10.3945/ajcn.2009.27947; Hainer V, 2000, INT J OBESITY, V24, P1051, DOI 10.1038/sj.ijo.0801358; Haupt A, 2008, OBESITY, V16, P1969, DOI 10.1038/oby.2008.283; Haupt A, 2009, OBESITY, V17, P1942, DOI 10.1038/oby.2009.233; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hession M, 2009, OBES REV, V10, P36, DOI 10.1111/j.1467-789X.2008.00518.x; Larsen TM, 2010, OBES REV, V11, P76, DOI 10.1111/j.1467-789X.2009.00603.x; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nilsson L, 2011, MOL GENET METAB, V102, P78, DOI 10.1016/j.ymgme.2010.08.017; Petersen M, 2006, INT J OBESITY, V30, P552, DOI 10.1038/sj.ijo.0803186; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Santos JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019934; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867; Sorensen TIA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010012; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STILL CD, 2011, OBESITY SILVER SPRIN; Tao Y, 2006, ENDOCRINOLOGY, V147, P1685, DOI 10.1210/en.2005-1304; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tsukada S, 2006, MOL ENDOCRINOL, V20, P1104, DOI 10.1210/me.2005-0311; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	39	29	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43212	10.1371/journal.pone.0043212	http://dx.doi.org/10.1371/journal.pone.0043212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952648	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800023
J	Vittecoq, M; Grandhomme, V; Champagnon, J; Guillemain, M; Crescenzo-Chaigne, B; Renaud, F; Thomas, F; Gauthier-Clerc, M; van der Werf, S				Vittecoq, Marion; Grandhomme, Viviane; Champagnon, Jocelyn; Guillemain, Matthieu; Crescenzo-Chaigne, Bernadette; Renaud, Francois; Thomas, Frederic; Gauthier-Clerc, Michel; van der Werf, Sylvie			High Influenza A Virus Infection Rates in Mallards Bred for Hunting in the Camargue, South of France	PLOS ONE			English	Article							AVIAN INFLUENZA; AMINO-ACID; WILD BIRDS; DISEASE; RESTOCKING; PATHOGEN; ORIGINS; HOST; CONSERVATION; REPLICATION	During the last decade, the role of wildlife in emerging pathogen transmission to domestic animals has often been pointed out. Conversely, far less attention has been paid to pathogen transmission from domestic animals to wildlife. Here, we focus on the case of game restocking, which implies the release of millions of animals worldwide each year. We conducted a 2-year study in the Camargue (Southern France) to investigate the influence of hand-reared Mallard releases on avain influenza virus dynamics in surrounding wildlife. We sampled Mallards (cloacal swabs) from several game duck facilities in 2009 and 2010 before their release. A very high (99%) infection rate caused by an H10N7 strain was detected in the game bird facility we sampled in 2009. We did not detect this strain in shot ducks we sampled, neither during the 2008/2009 nor the 2009/2010 hunting seasons. In 2010 infection rates ranged from 0 to 24% in hand-reared ducks. The 2009 H10N7 strain was fully sequenced. It results from multiple reassortment events between Eurasian low pathogenic strains. Interestingly, H10N7 strains had previously caused human infection in Egypt and Australia. The H10 and N7 segments we sequenced were clearly distinct from the Australian ones but they belonged to the same large cluster as the Egyptian ones. We did not observe any mutation linked to increased virulence, transmission to mammals, or antiviral resistence in the H10N7 strain we identified. Our results indicate that the potential role of hand-reared Mallards in influenza virus epizootics must be taken into account given the likely risk of viral exchange between game bird facilities and wild habitats, owing to duck rearing conditions. Measures implemented to limit transmission from wildlife to domestic animals as well as measures to control transmission from domestic animals to wild ones need to be equally reinforced.	[Vittecoq, Marion; Champagnon, Jocelyn; Gauthier-Clerc, Michel] Ctr Rech Tour du Valat, Arles, France; [Vittecoq, Marion; Grandhomme, Viviane; Renaud, Francois; Thomas, Frederic] Univ Montpellier, CNRS, Inst Rech Dev, Malad Infect & Vecteurs Ecol Genet Evolut & Contr, Montpellier, France; [Vittecoq, Marion; Grandhomme, Viviane; Crescenzo-Chaigne, Bernadette; van der Werf, Sylvie] Inst Pasteur, Unite Genet Mol Virus ARN, Dept Virol, Paris, France; [Grandhomme, Viviane; van der Werf, Sylvie] CNRS, Unite Rech Assoc 3015, Paris, France; [Champagnon, Jocelyn; Guillemain, Matthieu] Ctr Natl Etud & Rech Appl Avifaune Migratrice, Off Natl Chasse & Faune Sauvage, Arles, France; [Grandhomme, Viviane; van der Werf, Sylvie] Univ Paris Diderot Sorbonne Paris Cite, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Vittecoq, M (corresponding author), Ctr Rech Tour du Valat, Arles, France.	vittecoq@tourduvalat.org	Champagnon, Jocelyn/AAM-4028-2020	THOMAS, Frederic/0000-0003-2238-1978; van der WERF, Sylvie/0000-0002-1148-4456; Champagnon, Jocelyn/0000-0003-4850-8033	French "Agence Inter-etablissement pour la Recherche et le Developpement"; Centre National de la Recherche Scientifique; MAVA foundation	French "Agence Inter-etablissement pour la Recherche et le Developpement"; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); MAVA foundation	M. Vittecoq was supported by an axa. Ph.D research fellowship. The authors thank the French "Agence Inter-etablissement pour la Recherche et le Developpement", the Centre National de la Recherche Scientifique, and the MAVA foundation for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bell D, 2004, PHILOS T R SOC B, V359, P1107, DOI 10.1098/rstb.2004.1492; BYERS SM, 1991, J WILDLIFE MANAGE, V55, P580, DOI 10.2307/3809502; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Campitelli L, 2008, J GEN VIROL, V89, P48, DOI 10.1099/vir.0.83111-0; Champagnon J, 2011, CONSEQUENCES MASSIVE; Champagnon J, 2012, J NAT CONSERV, V20, P231, DOI 10.1016/j.jnc.2012.02.002; Champagnon J, 2012, EUR J WILDLIFE RES, V58, P255, DOI 10.1007/s10344-011-0573-3; Champagnon Jocelyn, 2009, Wildfowl, P184; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Crescenzo-Chaigne B, 2002, VIROLOGY, V303, P240, DOI 10.1006/viro.2002.1637; de la Barrera CA, 2005, ARCH MED RES, V36, P628, DOI 10.1016/j.arcmed.2005.05.002; Deceuninck (B.), 2010, ORNITHOS, V17, P266; Diaz-Sanchez S, 2012, EUR J WILDLIFE RES, V58, P99, DOI 10.1007/s10344-011-0547-5; Dobson A, 1996, ECOLOGY, V77, P1026, DOI 10.2307/2265573; Duval X, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000362; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; French ministry of agriculture and fisheries, 2006, DGALSDSPAN20068163 F; Gall A, 2008, J CLIN MICROBIOL, V46, P2561, DOI 10.1128/JCM.00466-08; Gog J, 2002, P ROY SOC B-BIOL SCI, V269, P671, DOI 10.1098/rspb.2001.1667; Greger M, 2007, CRIT REV MICROBIOL, V33, P243, DOI 10.1080/10408410701647594; Gunnarsson G, 2006, OECOLOGIA, V149, P203, DOI 10.1007/s00442-006-0446-8; Handberg KJ, 2010, AVIAN DIS, V54, P420, DOI 10.1637/8746-032709-Reg.1; HATTA M, 2001, AIDS RES HUM RETRO S, V293, P1840; Hedrick RP, 1998, IMMUNOL REV, V166, P365, DOI 10.1111/j.1600-065X.1998.tb01276.x; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Huang YY, 2009, VIRUS GENES, V38, P398, DOI 10.1007/s11262-009-0339-0; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kiesecker JM, 2001, CONSERV BIOL, V15, P1064, DOI 10.1046/j.1523-1739.2001.0150041064.x; Kobasa D, 1997, J VIROL, V71, P6706, DOI 10.1128/JVI.71.9.6706-6713.1997; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lebarbenchon C, 2007, INFECT GENET EVOL, V7, P604, DOI 10.1016/j.meegid.2007.05.009; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Lebarbenchon C, 2010, AVIAN DIS, V54, P446, DOI 10.1637/8665-022509-ResNote.1; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lu HG, 2004, AVIAN DIS, V48, P263, DOI 10.1637/7064; Mathevet R, 2002, LAND USE POLICY, V19, P277, DOI 10.1016/S0264-8377(02)00025-X; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Mondain-Monval J-Y, 2000, FAUNE SAUVAGE, V251, P124; Mondain-Monval Jean-Yves, 2009, Wildfowl, P192; Navarro-Gonzalez N, 2010, ANIM CONSERV, V13, P586, DOI 10.1111/j.1469-1795.2010.00390.x; OBENAUER JC, 2006, AIDS RES HUM RETRO S, V311, P1576, DOI DOI 10.1126/SCIENCE.1121586; OIE, 2012, UPD HIGHL PATH AV IN; OIE, 2011, TERR COD OIE WORLD O; OLSEN B, 2006, AIDS RES HUM RETRO S, V312, P384, DOI DOI 10.1126/SCIENCE.1122438; Orozovic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016028; Scholtissek C, 1998, ANTIVIR RES, V37, P83, DOI 10.1016/S0166-3542(97)00061-2; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Siembieda JL, 2010, VECTOR-BORNE ZOONOT, V10, P793, DOI 10.1089/vbz.2009.0095; Slota KE, 2011, VECTOR-BORNE ZOONOT, V11, P1115, DOI 10.1089/vbz.2010.0114; Stailknecht DE, 2007, J WILDLIFE DIS, V43, pS15; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Szeleczky Z, 2010, VET MICROBIOL, V145, P142, DOI 10.1016/j.vetmic.2010.03.008; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Varghese JN, 1997, P NATL ACAD SCI USA, V94, P11808, DOI 10.1073/pnas.94.22.11808; Velarde R, 2010, AVIAN DIS, V54, P411, DOI 10.1637/8808-040109-Reg.1; VIGGERS KL, 1993, WILDLIFE RES, V20, P687, DOI 10.1071/WR9930687; Villanua D, 2008, EUR J WILDLIFE RES, V54, P199, DOI 10.1007/s10344-007-0130-2; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 1998, EMERG INFECT DIS, V4, P436, DOI 10.3201/eid0403.980325; WHO, 2012, WHO CUM NUMB CONF HU; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560	74	11	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43974	10.1371/journal.pone.0043974	http://dx.doi.org/10.1371/journal.pone.0043974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952832	gold, Green Submitted, Green Published			2022-12-27	WOS:000308044800082
J	Alkawareek, MY; Algwari, QT; Laverty, G; Gorman, SP; Graham, WG; O'Connell, D; Gilmore, BF				Alkawareek, Mahmoud Y.; Algwari, Qais Th.; Laverty, Garry; Gorman, Sean P.; Graham, William G.; O'Connell, Deborah; Gilmore, Brendan F.			Eradication of Pseudomonas aeruginosa Biofilms by Atmospheric Pressure Non-Thermal Plasma	PLOS ONE			English	Article							BARRIER DISCHARGE PLASMA; BACTERIAL BIOFILMS; NOSOCOMIAL INFECTIONS; PERSISTER CELLS; IN-VITRO; INACTIVATION; MECHANISMS; DISEASE; JET; STERILIZATION	Bacteria exist, in most environments, as complex, organised communities of sessile cells embedded within a matrix of self-produced, hydrated extracellular polymeric substances known as biofilms. Bacterial biofilms represent a ubiquitous and predominant cause of both chronic infections and infections associated with the use of indwelling medical devices such as catheters and prostheses. Such infections typically exhibit significantly enhanced tolerance to antimicrobial, biocidal and immunological challenge. This renders them difficult, sometimes impossible, to treat using conventional chemotherapeutic agents. Effective alternative approaches for prevention and eradication of biofilm associated chronic and device-associated infections are therefore urgently required. Atmospheric pressure non-thermal plasmas are gaining increasing attention as a potential approach for the eradication and control of bacterial infection and contamination. To date, however, the majority of studies have been conducted with reference to planktonic bacteria and rather less attention has been directed towards bacteria in the biofilm mode of growth. In this study, the activity of a kilohertz-driven atmospheric pressure non-thermal plasma jet, operated in a helium oxygen mixture, against Pseudomonas aeruginosa in vitro biofilms was evaluated. Pseudomonas aeruginosa biofilms exhibit marked susceptibility to exposure of the plasma jet effluent, following even relatively short (similar to 10's s) exposure times. Manipulation of plasma operating conditions, for example, plasma operating frequency, had a significant effect on the bacterial inactivation rate. Survival curves exhibit a rapid decline in the number of surviving cells in the first 60 seconds followed by slower rate of cell number reduction. Excellent anti-biofilm activity of the plasma jet was also demonstrated by both confocal scanning laser microscopy and metabolism of the tetrazolium salt, XTT, a measure of bactericidal activity.	[Alkawareek, Mahmoud Y.; Laverty, Garry; Gorman, Sean P.; Gilmore, Brendan F.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Algwari, Qais Th.; Graham, William G.; O'Connell, Deborah] Queens Univ Belfast, Ctr Plasma Phys, Belfast, Antrim, North Ireland; [O'Connell, Deborah] Univ York, Dept Phys, York Plasma Inst, York YO10 5DD, N Yorkshire, England; [Algwari, Qais Th.] Univ Mosul, Coll Elect Engn, Dept Elect, Mosul, Iraq	Queens University Belfast; Queens University Belfast; University of York - UK; University of Mosul	Alkawareek, MY (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	b.gilmore@qub.ac.uk	O'Connell, Deborah/N-2782-2019; Alkawareek, Mahmoud Y/H-5871-2012; O'Connell, Deborah/D-7967-2018	O'Connell, Deborah/0000-0002-1457-9004; Alkawareek, Mahmoud Y/0000-0002-4852-0617; O'Connell, Deborah/0000-0002-1457-9004; Algwari, Qais/0000-0002-6524-946X; Laverty, Garry/0000-0002-1435-2942; Graham, William/0000-0003-2759-4657	The University of Jordan; EPSRC [EP/H003797/1]; EPSRC [EP/H003797/2, EP/I500987/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H003797/1, EP/I500987/1, EP/H003797/2] Funding Source: researchfish	The University of Jordan; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors would like to thank The University of Jordan for supporting Mahmoud Alkawareek in his PhD study, as well as EPSRC for supporting Deborah O'Connell through a Career Acceleration Fellowship (Grant No. EP/H003797/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramzon N, 2006, IEEE T PLASMA SCI, V34, P1304, DOI 10.1109/TPS.2006.877515; Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014; Algwari QT, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3628455; Alkawareek MY, 2012, FEMS IMMUNOL MED MIC, V65, P381, DOI 10.1111/j.1574-695X.2012.00942.x; Aslam S, 2008, AM J INFECT CONTROL, V36; Berthelot P, 2001, INTENS CARE MED, V27, P503, DOI 10.1007/s001340100870; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chaieb K, 2011, MICROB PATHOGENESIS, V50, P1, DOI 10.1016/j.micpath.2010.11.004; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dongari-Bagtzoglou A, 2008, EXPERT REV ANTI-INFE, V6, P141, DOI 10.1586/14787210.6.2.141; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002; ELIASSON B, 1987, J PHYS D APPL PHYS, V20, P1421, DOI 10.1088/0022-3727/20/11/010; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Georgescu N, 2010, IEEE T PLASMA SCI, V38, P3156, DOI 10.1109/TPS.2010.2070811; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Harris A, 1999, CLIN INFECT DIS, V28, P1128, DOI 10.1086/514760; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koban I, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073039; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220; Lee MH, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115022; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lu X, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349475; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Ma Y, 2008, IEEE T PLASMA SCI, V36, P1615, DOI 10.1109/TPS.2008.917165; MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339; Mericam-Bourdet N, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/055207; Moisan M, 2002, PURE APPL CHEM, V74, P349, DOI 10.1351/pac200274030349; Nwankire CE, 2010, PLASMA CHEM PLASMA P, V30, P537, DOI 10.1007/s11090-010-9236-5; Obritsch MD, 2005, PHARMACOTHERAPY, V25, P1353, DOI 10.1592/phco.2005.25.10.1353; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Pitts B, 2003, J MICROBIOL METH, V54, P269, DOI 10.1016/S0167-7012(03)00034-4; Reid G, 1999, INT J ANTIMICROB AG, V11, P223, DOI 10.1016/S0924-8579(99)00020-5; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Rossi F, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115017; Rupf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025893; Salamitou S., 2009, BIOTECHNOLOGY, V8, P228, DOI DOI 10.1186/1475-2875-8-228; Shi JJ, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2828551; Sladek REJ, 2007, LETT APPL MICROBIOL, V45, P318, DOI 10.1111/j.1472-765X.2007.02194.x; Sousa JS, 2011, J APPL PHYS, V109, DOI 10.1063/1.3601347; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Walsh JL, 2008, IEEE T PLASMA SCI, V36, P954, DOI 10.1109/TPS.2008.924495; Wei GD, 2011, IEEE T PLASMA SCI, V39, P1842, DOI 10.1109/TPS.2011.2159810; Xu L, 2011, EUR J CLIN MICROBIOL, V30, P25, DOI 10.1007/s10096-010-1047-3; Yardimci O, 2010, IEEE T PLASMA SCI, V38, P973, DOI 10.1109/TPS.2010.2041674	60	133	138	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44289	10.1371/journal.pone.0044289	http://dx.doi.org/10.1371/journal.pone.0044289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952948	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300074
J	Hofmann, I; Weiss, A; Elain, G; Schwaederle, M; Sterker, D; Romanet, V; Schmelzle, T; Lai, A; Brachmann, SM; Bentires-Alj, M; Roberts, TM; Sellers, WR; Hofmann, F; Maira, SM				Hofmann, Irmgard; Weiss, Andreas; Elain, Gaelle; Schwaederle, Maria; Sterker, Dario; Romanet, Vincent; Schmelzle, Tobias; Lai, Albert; Brachmann, Saskia M.; Bentires-Alj, Mohamed; Roberts, Thomas M.; Sellers, William R.; Hofmann, Francesco; Maira, Sauveur-Michel			K-RAS Mutant Pancreatic Tumors Show Higher Sensitivity to MEK than to PI3K Inhibition In Vivo	PLOS ONE			English	Article							CANCER CELLS; ANTITUMOR-ACTIVITY; DRUG DISCOVERY; BREAST-CANCER; DUCTAL ADENOCARCINOMA; SIGNALING PATHWAYS; ONCOGENIC RAS; KINASE; GROWTH; VASCULATURE	Activating K-RAS mutations occur at a frequency of 90% in pancreatic cancer, and to date no therapies exist targeting this oncogene. K-RAS signals via downstream effector pathways such as the MAPK and the PI3K signaling pathways, and much effort has been focused on developing drugs targeting components of these pathways. To better understand the requirements for K-RAS and its downstream signaling pathways MAPK and PI3K in pancreatic tumor maintenance, we established an inducible K-RAS knock down system that allowed us to ablate K-RAS in established tumors. Knock down of K-RAS resulted in impaired tumor growth in all pancreatic xenograft models tested, demonstrating that K-RAS expression is indeed required for tumor maintenance of K-RAS mutant pancreatic tumors. We further examined signaling downstream of K-RAS, and detected a robust reduction of pERK levels upon K-RAS knock down. In contrast, no effect on pAKT levels could be observed due to almost undetectable basal expression levels. To investigate the requirement of the MAPK and the PI3K pathways on tumor maintenance, three selected pancreatic xenograft models were tested for their response to MEK or PI3K inhibition. Tumors of all three models regressed upon MEK inhibition, but showed less pronounced response to PI3K inhibition. The effect of MEK inhibition on pancreatic xenografts could be enhanced further by combined application of a PI3K inhibitor. These data provide further rationale for testing combinations of MEK and PI3K inhibitors in clinical trials comprising a patient population with pancreatic cancer harboring mutations in K-RAS.	[Hofmann, Irmgard; Weiss, Andreas; Elain, Gaelle; Schwaederle, Maria; Sterker, Dario; Romanet, Vincent; Schmelzle, Tobias; Brachmann, Saskia M.; Hofmann, Francesco; Maira, Sauveur-Michel] Novartis Inst Biomed Res, Oncol Dis Area, Basel, Switzerland; [Lai, Albert] Novartis Inst Biomed Res, Oncol Dis Area, Emeryville, CA USA; [Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Roberts, Thomas M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sellers, William R.] Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA USA	Novartis; Novartis; Friedrich Miescher Institute for Biomedical Research; Harvard University; Dana-Farber Cancer Institute; Novartis	Hofmann, I (corresponding author), Novartis Inst Biomed Res, Oncol Dis Area, Basel, Switzerland.	irmgard.hofmann@novartis.com	Mohamed, Bentires-Alj/F-4484-2015	Mohamed, Bentires-Alj/0000-0001-6344-1127	Novartis AG	Novartis AG	All research costs were covered by Novartis AG. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bodoky G, 2012, INVEST NEW DRUG, V30, P1216, DOI 10.1007/s10637-011-9687-4; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Chang Q, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-515; Chang Q, 2009, CANCER BIOL THER, V8, P1893, DOI 10.4161/cbt.8.20.9430; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Clarke R, 1997, BREAST CANCER RES TR, V46, P255, DOI 10.1023/A:1005938428456; Cleary JM, 2010, CURR ONCOL REP, V12, P87, DOI 10.1007/s11912-010-0091-6; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fleming JB, 2005, MOL CANCER RES, V3, P413, DOI 10.1158/1541-7786.MCR-04-0206; Fokas E, 2012, CANCER RES, V72, P239, DOI 10.1158/0008-5472.CAN-11-2263; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Markman B, 2010, ONCOTARGET, V1, P530, DOI 10.18632/oncotarget.188; Matsuo Y, 2009, MOL CANCER RES, V7, P799, DOI 10.1158/1541-7786.MCR-08-0577; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Qayum N, 2012, CLIN CANCER RES, V18, P161, DOI 10.1158/1078-0432.CCR-11-1413; Qayum N, 2009, CANCER RES, V69, P6347, DOI 10.1158/0008-5472.CAN-09-0657; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Sheikh R, 2010, EXPERT REV ANTICANC, V10, P1647, DOI [10.1586/era.10.148, 10.1586/ERA.10.148]; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Yu K, 2008, CANCER BIOL THER, V7, P307; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao YP, 2006, J SURG RES, V136, P325, DOI 10.1016/j.jss.2006.06.031; Zhu H, 2006, CANCER BIOL THER, V5, P1693, DOI 10.4161/cbt.5.12.3466	53	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44146	10.1371/journal.pone.0044146	http://dx.doi.org/10.1371/journal.pone.0044146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952903	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300055
J	Mahmood, S; Kanwar, N; Tran, J; Zhang, ML; Kung, SKP				Mahmood, Sajid; Kanwar, Namita; Tran, Jimmy; Zhang, Man-li; Kung, Sam K. P.			SHP-1 Phosphatase Is a Critical Regulator in Preventing Natural Killer Cell Self-Killing	PLOS ONE			English	Article							INHIBITORY LY49 RECEPTORS; NK CELLS; MEDIATED CYTOTOXICITY; TYROSINE PHOSPHATASE; NKG2D RECEPTOR; NK1.1 ANTIGEN; MOTH-EATEN; IN-VITRO; T-CELL; ACTIVATION	Balance of signals generated from the engaged activating and inhibitory surface receptors regulates mature NK cell activities. The inhibitory receptors signal through immunoreceptor tyrosine based inhibitory motifs (ITIM), and recruit phosphatases such as SHP-1 to inhibit NK cell activation. To directly examine the importance of SHP-1 in regulating activities and cell fate of mature NK cells, we used our established lentiviral-based engineering protocol to knock down the SHP-1 protein expression in primary C57BL/6NCrl cells. Gene silencing of the SHP-1 in primary NK cells abrogated the ability of ITIM-containing NK inhibitory receptors to suppress the activation signals induced by NK1.1 activating receptors. We followed the fates of stably transduced SHP-1 silenced primary NK cells over a longer period of time in IL-2 containing cultures. We observed an impaired IL-2 induced proliferation in the SHP-1 knockdown NK cells. More interestingly, these "de-regulated'' SHP-1 knockdown NK cells mediated specific self-killing in a real-time live cell microscopic imaging system we developed to study NK cell cytotoxicity in vitro. Selective target recognition of the SHP-1 knockdown NK cells revealed also possible involvement of the SHP-1 phosphatase in regulating other NK functions in mature NK cells.	[Mahmood, Sajid; Tran, Jimmy; Zhang, Man-li; Kung, Sam K. P.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Kanwar, Namita] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, John Buhler Res Ctr, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Mahmood, S (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	kung@cc.umanitoba.ca			Manitoba Health Research Council; Natural Sciences and Engineering Research Council [RGPIN/355727-2008]; Manitoba Institute of Child Health; CIHR IID; Global Health Training Program; Manitoba Medical Service Foundation; Manitoba Blue Cross	Manitoba Health Research Council; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Institute of Child Health; CIHR IID(Canadian Institutes of Health Research (CIHR)); Global Health Training Program; Manitoba Medical Service Foundation; Manitoba Blue Cross	This work was supported by Establishment and Operating Grants from the Manitoba Health Research Council, and Natural Sciences and Engineering Research Council (RGPIN/355727-2008 to S. K. P. K.). J.T. was supported by a fellowship provided by Manitoba Health Research Council. S. M. has been supported by a graduate fellowship provided by Manitoba Institute of Child Health, Manitoba Health Research Council and CIHR IID and Global Health Training Program. S. K. P. K. was a Basic Science Career Development Research Awardee of the Manitoba Medical Service Foundation supported with funds provided by the Manitoba Blue Cross. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyweera TP, 2011, J CELL BIOL, V192, P675, DOI 10.1083/jcb.201009135; Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Babic M, 2010, J EXP MED, V207, P2663, DOI 10.1084/jem.20100921; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; Biassoni Roberto, 2010, Self Nonself, V1, P103; Binstadt BA, 1997, IMMUNOL REV, V155, P197, DOI 10.1111/j.1600-065X.1997.tb00952.x; Gunturi A, 2003, J IMMUNOL, V170, P1737, DOI 10.4049/jimmunol.170.4.1737; KARLHOFER FM, 1991, J IMMUNOL, V146, P3662; Koh CY, 2001, BLOOD, V97, P3132, DOI 10.1182/blood.V97.10.3132; KOO GC, 1991, J IMMUNOL, V147, P1194; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; Kung SKP, 2010, METHODS MOL BIOL, V612, P233, DOI 10.1007/978-1-60761-362-6_16; Kung SKP, 2000, J VIROL, V74, P3668, DOI 10.1128/JVI.74.8.3668-3681.2000; KUNG SKP, 1995, J IMMUNOL, V154, P1624; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Ljutic B, 2005, J IMMUNOL, V174, P4789, DOI 10.4049/jimmunol.174.8.4789; Long EO, 2001, IMMUNOL REV, V181, P223, DOI 10.1034/j.1600-065X.2001.1810119.x; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Lowin-Kropf B, 2000, J IMMUNOL, V165, P1314, DOI 10.4049/jimmunol.165.3.1314; Lunemann A, 2011, INT IMMUNOL, V23, P139, DOI 10.1093/intimm/dxq463; Moretta Lorenzo, 2001, Current Opinion in Pharmacology, V1, P387, DOI 10.1016/S1471-4892(01)00067-4; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Olson JA, 2009, J IMMUNOL, V183, P3219, DOI 10.4049/jimmunol.0804268; Orr MT, 2011, CURR TOP MICROBIOL, V350, P67, DOI 10.1007/82_2010_85; Ortaldo JR, 2005, MOL IMMUNOL, V42, P445, DOI 10.1016/j.molimm.2004.07.024; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Purdy AK, 2009, J IMMUNOL, V183, P7234, DOI 10.4049/jimmunol.0900088; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Sentman CL, 2006, ADV CANCER RES, V95, P249, DOI 10.1016/S0065-230X(06)95007-6; Tran J, 2007, MOL THER, V15, P1331, DOI 10.1038/sj.mt.6300184; Tran J, 2010, VACCINE, V28, P3767, DOI 10.1016/j.vaccine.2010.03.013; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang LL, 1999, J IMMUNOL, V162, P1318; Whittaker GC, 2008, BLOOD, V112, P2869, DOI 10.1182/blood-2007-11-121590; Yadav PK, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/348530; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Yu YYL, 1996, IMMUNITY, V4, P67, DOI 10.1016/S1074-7613(00)80299-X; Yusa S, 2002, J IMMUNOL, V168, P5047, DOI 10.4049/jimmunol.168.10.5047; Zafirova B, 2011, CELL MOL LIFE SCI, V68, P3519, DOI 10.1007/s00018-011-0797-0; Zaritskaya L, 2010, EXPERT REV VACCINES, V9, P601, DOI [10.1586/erv.10.49, 10.1586/ERV.10.49]	46	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44244	10.1371/journal.pone.0044244	http://dx.doi.org/10.1371/journal.pone.0044244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952938	gold, Green Published, Green Submitted			2022-12-27	WOS:000308221300068
J	Nagel, CH; Dohner, K; Binz, A; Bauerfeind, R; Sodeik, B				Nagel, Claus-Henning; Doehner, Katinka; Binz, Anne; Bauerfeind, Rudolf; Sodeik, Beate			Improper Tagging of the Non-Essential Small Capsid Protein VP26 Impairs Nuclear Capsid Egress of Herpes Simplex Virus	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; LARGE TEGUMENT PROTEIN; 3-DIMENSIONAL LOCALIZATION; MUTANT VIRUS; CELL-CULTURE; VIRAL GROWTH; UL36 GENE; TYPE-1; TRANSPORT; DNA	To analyze the subcellular trafficking of herpesvirus capsids, the small capsid protein has been labeled with different fluorescent proteins. Here, we analyzed the infectivity of several HSV1(17(+)) strains in which the N-terminal region of the non-essential small capsid protein VP26 had been tagged at different positions. While some variants replicated with similar kinetics as their parental wild type strain, others were not infectious at all. Improper tagging resulted in the aggregation of VP26 in the nucleus, prevented efficient nuclear egress of viral capsids, and thus virion formation. Correlative fluorescence and electron microscopy showed that these aggregates had sequestered several other viral proteins, but often did not contain viral capsids. The propensity for aggregate formation was influenced by the type of the fluorescent protein domain, the position of the inserted tag, the cell type, and the progression of infection. Among the tags that we have tested, mRFPVP26 had the lowest tendency to induce nuclear aggregates, and showed the least reduction in replication when compared to wild type. Our data suggest that bona fide monomeric fluorescent protein tags have less impact on proper assembly of HSV1 capsids and nuclear capsid egress than tags that tend to dimerize. Small chemical compounds capable of inducing aggregate formation of VP26 may lead to new antiviral drugs against HSV infections.	[Nagel, Claus-Henning; Doehner, Katinka; Binz, Anne; Sodeik, Beate] Hannover Med Sch, Inst Virol, Hannover, Germany; [Bauerfeind, Rudolf] Hannover Med Sch, Inst Cell Biol, Hannover, Germany	Hannover Medical School; Hannover Medical School	Nagel, CH (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	sodeik.beate@mh-hannover.de	Sodeik, Beate/C-9732-2010	Sodeik, Beate/0000-0003-4650-3036	German Research Council [DFG-SPP1175, DFG-SFP900]; European Union [12702]; Research Core Unit for Laser Microscopy at Hannover Medical School; Research Core Unit for Electron Microscopy at Hannover Medical School	German Research Council(German Research Foundation (DFG)); European Union(European Commission); Research Core Unit for Laser Microscopy at Hannover Medical School; Research Core Unit for Electron Microscopy at Hannover Medical School	This study was supported by the German Research Council (DFG-SPP1175 to BS and RB; DFG-SFP900 to BS), and the European Union 6th Framework Program (EU-NEST AXON SUPPORT, contract number 12702 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Anja Pohlmann, Anna Buch, Daniela Kieneke, Deepika Devadas, Eva Borst, Fenja Anderson, Randi Diestel and Malte Sandbaumhuter for their comments on the manuscript, and Christof Bohnen and Julia Schipke for support with BAC-mutagenesis (Institute of Virology, Hannover Medical School) as well as Joel Baines (Cornell University, USA) and Prashant Desai (Johns Hopkins University, Baltimore, MD) for helpful discussions. We are grateful to John Subak-Sharpe (MRC Virology Unit, Glasgow, UK) and Prashant Desai for providing HSV1 strains. We thank Susanne Bailer (Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany), Jay Brown and Bill Newcomb (University of Virginia, Charlottesville, VA), Edouard Cantin (City of Hope National Medical Center, Duarte,; California), Richard J. Courtney (Pennsylvania State University College of Medicine, Hershey, PA), Prashant Desai, Roselyn Eisenberg and Gary Cohen (University of Pennsylvania, Philadelphia, PA), Regine Heilbronn (Charite-Universit Delta tsmedizin, Berlin, Germany), Ari Helenius (Eidgenossische Technische Hochschule Zurich, Switzerland), Helena Browne and Anthony Minson (University of Cambridge, UK), Valerie Preston (MRC Virology Unit, Glasgow, UK), Bernard Roizman (University of Chicago, Chicago, Illinois), and Dan Tenney (Bristol-Myers Squibb, Wallingford, CT) for donating invaluable antibodies. We furthermore acknowledge the support of the Research Core Units for Laser Microscopy and Electron Microscopy at Hannover Medical School.	Ali MA, 1996, VIROLOGY, V216, P278, DOI 10.1006/viro.1996.0061; Antinone SE, 2006, J VIROL, V80, P5494, DOI 10.1128/JVI.00026-06; Antinone SE, 2010, J VIROL, V84, P13019, DOI 10.1128/JVI.01296-10; Apcarian A, 2010, J GEN VIROL, V91, P2659, DOI 10.1099/vir.0.019984-0; Baines JD, 2011, TRENDS MICROBIOL, V19, P606, DOI 10.1016/j.tim.2011.09.001; Baker ML, 2006, PLOS COMPUT BIOL, V2, P1313, DOI 10.1371/journal.pcbi.0020146; Bohannon KP, 2012, J GEN VIROL, V93, P124, DOI 10.1099/vir.0.036145-0; BOOY FP, 1994, P NATL ACAD SCI USA, V91, P5652, DOI 10.1073/pnas.91.12.5652; Borst EM, 2001, J VIROL, V75, P1450, DOI 10.1128/JVI.75.3.1450-1458.2001; Bosse JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040585; Bowman BR, 2003, EMBO J, V22, P757, DOI 10.1093/emboj/cdg086; BROWN SM, 1973, J GEN VIROL, V18, P329, DOI 10.1099/0022-1317-18-3-329; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cardone G, 2012, J VIROL; Chaudhuri V, 2008, J VIROL, V82, P10231, DOI 10.1128/JVI.01890-07; Chen DH, 2001, J VIROL, V75, P11863, DOI 10.1128/JVI.75.23.11863-11867.2001; Cheng SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017966; Chi JHI, 2000, J VIROL, V74, P1468, DOI 10.1128/JVI.74.3.1468-1476.2000; Church GA, 1997, J VIROL, V71, P3603, DOI 10.1128/JVI.71.5.3603-3612.1997; COHEN GH, 1980, J VIROL, V34, P521, DOI 10.1128/JVI.34.2.521-531.1980; Dasgupta A, 1999, J VIROL, V73, P2006, DOI 10.1128/JVI.73.3.2006-2015.1999; de Oliveira AP, 2008, J VIROL, V82, P4974, DOI 10.1128/JVI.02431-07; Desai P, 2003, J VIROL, V77, P391, DOI 10.1128/JVI.77.1.391-404.2003; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Desai P, 1998, VIROLOGY, V247, P115, DOI 10.1006/viro.1998.9230; Desai PJ, 2000, J VIROL, V74, P11608, DOI 10.1128/JVI.74.24.11608-11618.2000; Dohner K, 2006, J VIROL, V80, P8211, DOI 10.1128/JVI.02528-05; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Espagne A, 2011, BIOCHEMISTRY-US, V50, P437, DOI 10.1021/bi1015875; Everett RD, 2011, ALPHAHERPESVIRUSES: MOLECULAR VIROLOGY, P51; Forest T, 2005, NAT CELL BIOL, V7, P429, DOI 10.1038/ncb1243; Fuchs W, 2004, J VIROL, V78, P11879, DOI 10.1128/JVI.78.21.11879-11889.2004; GAO M, 1994, J VIROL, V68, P3702, DOI 10.1128/JVI.68.6.3702-3712.1994; Henson BW, 2009, J VIROL, V83, P3877, DOI 10.1128/JVI.01733-08; Homa FL, 1997, REV MED VIROL, V7, P107, DOI 10.1002/(SICI)1099-1654(199707)7:2<107::AID-RMV191>3.0.CO;2-M; HUANG AS, 1964, P SOC EXP BIOL MED, V116, P863, DOI 10.3181/00379727-116-29392; Jirmo AC, 2009, J IMMUNOL, V182, P283, DOI 10.4049/jimmunol.182.1.283; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Kim DB, 2002, J VIROL, V76, P1548, DOI 10.1128/JVI.76.4.1548-1558.2002; Ko DH, 2010, J VIROL, V84, P1397, DOI 10.1128/JVI.01721-09; Kobiler O, 2011, MBIO, V2, DOI 10.1128/mBio.00278-11; Kops AD, 1998, VIROLOGY, V252, P162, DOI 10.1006/viro.1998.9450; Koslowski KM, 1997, J VIROL, V71, P9118, DOI 10.1128/JVI.71.12.9118-9123.1997; Krautwald M, 2008, J GEN VIROL, V89, P1346, DOI 10.1099/vir.0.83652-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamberti C, 1998, J VIROL, V72, P2463, DOI 10.1128/JVI.72.3.2463-2473.1998; Lee JH, 2008, VIROLOGY, V378, P347, DOI 10.1016/j.virol.2008.05.035; Leelawong M, 2012, J VIROL, V86, P6303, DOI 10.1128/JVI.07051-11; Livingston CM, 2008, J VIROL, V82, P6324, DOI 10.1128/JVI.00455-08; Lo P, 2003, J VIROL, V77, P4291, DOI 10.1128/JVI.77.7.4291-4297.2003; Luxton GWG, 2006, J VIROL, V80, P201, DOI 10.1128/JVI.80.1.201-209.2006; MATUSICKKUMAR L, 1994, J VIROL, V68, P5384, DOI 10.1128/JVI.68.9.5384-5394.1994; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; MCNABB DS, 1992, J VIROL, V66, P7581, DOI 10.1128/JVI.66.12.7581-7584.1992; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Munger J, 2001, J VIROL, V75, P5491, DOI 10.1128/JVI.75.12.5491-5497.2001; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; Newcomb WW, 2000, J VIROL, V74, P1663, DOI 10.1128/JVI.74.4.1663-1673.2000; Nijman SMB, 2011, FEBS LETT, V585, P1, DOI 10.1016/j.febslet.2010.11.024; Ott M, 2011, J GEN VIROL, V92, P2734, DOI 10.1099/vir.0.032730-0; Perkins EM, 2008, J VIROL, V82, P7201, DOI 10.1128/JVI.00423-08; Phelan A, 1997, J VIROL, V71, P1124, DOI 10.1128/JVI.71.2.1124-1132.1997; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Reichelt M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002740; Reichelt M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001266; Rixon FJ, 1996, J GEN VIROL, V77, P2251, DOI 10.1099/0022-1317-77-9-2251; Roberts APE, 2009, J VIROL, V83, P105, DOI 10.1128/JVI.01032-08; Rode K, 2011, J VIROL, V85, P4271, DOI 10.1128/JVI.02067-10; Schipke J, 2012, J VIROL, V86, P3682, DOI 10.1128/JVI.06432-11; Shanda SK, 2008, J VIROL, V82, P7388, DOI 10.1128/JVI.00225-08; Simpson-Holley M, 2005, J VIROL, V79, P12840, DOI 10.1128/JVI.79.20.12840-12851.2005; Smith GA, 2004, P NATL ACAD SCI USA, V101, P16034, DOI 10.1073/pnas.0404686101; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Snyder A, 2006, J VIROL, V80, P11165, DOI 10.1128/JVI.01107-06; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Sugimoto K, 2008, J VIROL, V82, P5198, DOI 10.1128/JVI.02681-07; Thurlow JK, 2005, J VIROL, V79, P150, DOI 10.1128/JVI.79.1.150-158.2005; TRUS BL, 1992, P NATL ACAD SCI USA, V89, P11508, DOI 10.1073/pnas.89.23.11508; TRUS BL, 1995, J VIROL, V69, P7362, DOI 10.1128/JVI.69.11.7362-7366.1995; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tucker CL, 2003, NAT GENET, V35, P204, DOI 10.1038/ng1103-204; Wang L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-156; Ward PL, 1996, J VIROL, V70, P4623, DOI 10.1128/JVI.70.7.4623-4631.1996; Ward SA, 2011, ALPHAHERPESVIRUSES: MOLECULAR VIROLOGY, P89; Wingfield PT, 1997, J VIROL, V71, P8955, DOI 10.1128/JVI.71.12.8955-8961.1997; Wisner TW, 2011, J VIROL, V85, P5919, DOI 10.1128/JVI.00116-11; Wolfstein A, 2006, TRAFFIC, V7, P227, DOI 10.1111/j.1600-0854.2005.00379.x; Yu XK, 2005, J VIROL, V79, P1327, DOI 10.1128/JVI.79.2.1327-1332.2005; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeng W, 2006, BIOCHEMISTRY-US, V45, P10482, DOI 10.1021/bi060943u; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; ZHOU ZH, 1995, NAT STRUCT BIOL, V2, P1026, DOI 10.1038/nsb1195-1026	94	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44177	10.1371/journal.pone.0044177	http://dx.doi.org/10.1371/journal.pone.0044177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952920	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300059
J	Tuncalp, O; Hindin, MJ; Adu-Bonsaffoh, K; Adanu, R				Tuncalp, Oezge; Hindin, Michelle J.; Adu-Bonsaffoh, Kwame; Adanu, Richard			Listening to Women's Voices: The Quality of Care of Women Experiencing Severe Maternal Morbidity, in Accra, Ghana	PLOS ONE			English	Article							SEVERE OBSTETRIC COMPLICATIONS; BURKINA-FASO; HEALTH; MISS; DELIVERY; SERVICES; ACCOUNTS; BENIN	Background: Women who survive severe obstetric complications can provide insight into risk factors and potential strategies for prevention of maternal morbidity as well as maternal mortality. We interviewed 32 women, in an urban facility in Ghana, who had experienced severe morbidity defined using a standardized WHO near-miss definition and identification criteria. Women provided personal accounts of their experiences of severe maternal morbidity and perceptions of the care they received. Methods and Findings: The study took place in a referral facility in urban Accra, and semi-structured interviews were conducted with women who had either a maternal near miss (n = 17) or a potentially life-threatening complication (n = 15). The most common themes surrounding the traumatic delivery were the fear of dying and concern over the potential (or actual) loss of the baby. For many women, the loss of a baby negatively influenced how they viewed and coped with this experience. Women's perceptions of the quality of the care highlighted several key factors such as the importance of information, good communication and attitudes, and availability of human (i.e., more doctors) and physical resources (i.e., more beds, water) at the facility. Conclusions: Our results suggest that experiences of women with severe maternal morbidity may inform different aspects of quality improvement in the facilities, which in turn have a positive impact on future health seeking behavior, service utilization and reduction in maternal morbidity and mortality.	[Tuncalp, Oezge; Hindin, Michelle J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Adu-Bonsaffoh, Kwame] Univ Ghana, Sch Med, Coll Hlth Sci, Dept Obstet & Gynecol,Korle Bu Teaching Hosp, Accra, Ghana; [Adanu, Richard] Univ Ghana, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Accra, Ghana	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Ghana; University of Ghana	Tuncalp, O (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA.	otuncalp@jhsph.edu	Tunçalp, Ӧzge/Y-2724-2018; Adu-Bonsaffoh, Kwame/AAH-5560-2020	Tunçalp, Ӧzge/0000-0002-5370-682X; Hindin, Michelle/0000-0001-9941-7639; ADU-BONSAFFOH, KWAME/0000-0002-3741-6646	Bill and Melinda Gates Institute for Population and Reproductive Health Dissertation Research Award, Johns Hopkins Bloomberg School of Public Health	Bill and Melinda Gates Institute for Population and Reproductive Health Dissertation Research Award, Johns Hopkins Bloomberg School of Public Health	The study was funded by Bill and Melinda Gates Institute for Population and Reproductive Health Dissertation Research Award, Johns Hopkins Bloomberg School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers S, 2007, BIRTH-ISS PERINAT C, V34, P253, DOI 10.1111/j.1523-536X.2007.00178.x; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; D'Ambruoso L, 2010, SOC SCI MED, V71, P1728, DOI 10.1016/j.socscimed.2010.05.023; Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8; Fottrell E, 2010, BRIT J PSYCHIAT, V196, P18, DOI 10.1192/bjp.bp.108.062489; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; GILSON L, 1994, SOC SCI MED, V39, P767, DOI 10.1016/0277-9536(94)90038-8; Gulmezoglu AM, 2003, BRIT MED BULL, V67, P73, DOI 10.1093/bmb/ldg001; Hulton L, 2000, FRAMEWORK EVALUATION; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Keenan KF, 2005, J FAM PLAN REPROD H, V31, P40, DOI 10.1783/0000000052972825; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007; Saurel-Cubizolles MJ, 2000, BRIT J OBSTET GYNAEC, V107, P1202, DOI 10.1111/j.1471-0528.2000.tb11608.x; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Schwandt H, 2012, UNSAFE ABORTION GHAN; Souza JP, 2009, BIRTH-ISS PERINAT C, V36, P149, DOI 10.1111/j.1523-536X.2009.00313.x; Storeng KT, 2010, SOC SCI MED, V71, P1749, DOI 10.1016/j.socscimed.2010.03.056; Tuncalp O, 2012, SEVERE MATERNAL COMP; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; Wang W, 2011, LEVELS TRENDS USE MA; Weeks A, 2005, BJOG-INT J OBSTET GY, V112, P1302, DOI 10.1111/j.1471-0528.2005.00703.x; Witter S, 2007, REPROD HEALTH MATTER, V15, P61, DOI 10.1016/S0968-8080(07)30325-X; Witter S, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-20; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	29	39	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44536	10.1371/journal.pone.0044536	http://dx.doi.org/10.1371/journal.pone.0044536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998EY	22952992	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300098
J	Cande, J; Andolfatto, P; Prud'homme, B; Stern, DL; Gompel, N				Cande, Jessica; Andolfatto, Peter; Prud'homme, Benjamin; Stern, David L.; Gompel, Nicolas			Evolution of Multiple Additive Loci Caused Divergence between Drosophila yakuba and D-santomea in Wing Rowing during Male Courtship	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MELANOGASTER SPECIES SUBGROUP; SEXUAL ISOLATION; MORPHOLOGICAL EVOLUTION; REPRODUCTIVE ISOLATION; GENUS DROSOPHILA; GENETIC-BASIS; BEHAVIOR; SONG; QTL	In Drosophila, male flies perform innate, stereotyped courtship behavior. This innate behavior evolves rapidly between fly species, and is likely to have contributed to reproductive isolation and species divergence. We currently understand little about the neurobiological and genetic mechanisms that contributed to the evolution of courtship behavior. Here we describe a novel behavioral difference between the two closely related species D. yakuba and D. santomea: the frequency of wing rowing during courtship. During courtship, D. santomea males repeatedly rotate their wing blades to face forward and then back (rowing), while D. yakuba males rarely row their wings. We found little intraspecific variation in the frequency of wing rowing for both species. We exploited multiplexed shotgun genotyping (MSG) to genotype two backcross populations with a single lane of Illumina sequencing. We performed quantitative trait locus (QTL) mapping using the ancestry information estimated by MSG and found that the species difference in wing rowing mapped to four or five genetically separable regions. We found no evidence that these loci display epistasis. The identified loci all act in the same direction and can account for most of the species difference.	[Cande, Jessica; Prud'homme, Benjamin; Gompel, Nicolas] Aix Marseille Univ, Inst Biol Dev Marseille Luminy, Marseille, France; [Andolfatto, Peter; Stern, David L.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Andolfatto, Peter] Princeton Univ, Lewis Sigler Inst Integrat Biol, Princeton, NJ 08544 USA; [Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	UDICE-French Research Universities; Aix-Marseille Universite; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Cande, J (corresponding author), Aix Marseille Univ, Inst Biol Dev Marseille Luminy, Marseille, France.	benjamin.prudhomme@univ-amu.fr; sternd@janelia.hhmi.org; nicolas.gompel@univ-amu.fr		Andolfatto, Peter/0000-0003-3393-4574; Stern, David/0000-0002-1847-6483; Gompel, Nicolas/0000-0003-3358-7963	Human Frontiers Long Term Fellowship [LT000708/2010-L]; EURYI award; Human Frontier Science Program Career and Development Award; ANR grant; Centre National de la Recherche Scientifique	Human Frontiers Long Term Fellowship; EURYI award(European Science Foundation (ESF)); Human Frontier Science Program Career and Development Award; ANR grant(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by a Human Frontiers Long Term Fellowship (LT000708/2010-L), a EURYI award, a Human Frontier Science Program Career and Development Award, an ANR grant, and the Centre National de la Recherche Scientifique. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Ashburner M., 1989, DROSOPHILA LAB HDB; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Beavis W.D., 1994, P 49 ANN CORN SORGH, P250; Blyth JE, 2008, ETHOLOGY, V114, P728, DOI 10.1111/j.1439-0310.2008.01519.x; Bock IR, 1972, U TEXAS PUBLS, V7, P1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Carbone MA, 2005, GENETICS, V171, P211, DOI 10.1534/genetics.105.044412; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; COBB M, 1989, J INSECT BEHAV, V2, P63, DOI 10.1007/BF01053619; COBB M, 1985, BEHAVIOUR, V95, P203, DOI 10.1163/156853985X00136; COWLING DE, 1981, ANIM BEHAV, V29, P924, DOI 10.1016/S0003-3472(81)80030-9; Edwards AC, 2009, GENETICS, V182, P889, DOI 10.1534/genetics.109.101691; Ellison CK, 2011, J EVOLUTION BIOL, V24, P1110, DOI 10.1111/j.1420-9101.2011.02244.x; Feder JL, 2003, GENETICS, V163, P939; Gleason JM, 2009, HEREDITY, V103, P416, DOI 10.1038/hdy.2009.79; Gleason JM, 2002, HEREDITY, V89, P1, DOI 10.1038/sj.hdy.6800099; Gleason JM, 2004, GENETICS, V166, P1303, DOI 10.1534/genetics.166.3.1303; Gould F, 2010, P NATL ACAD SCI USA, V107, P8660, DOI 10.1073/pnas.0910945107; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Holtzman S, 2010, FLY, V4, P349, DOI 10.4161/fly.4.4.13304; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lagisz M, 2012, HEREDITY, V108, P602, DOI 10.1038/hdy.2011.129; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; LEMEUNIER F, 1976, PROC R SOC SER B-BIO, V193, P275, DOI 10.1098/rspb.1976.0046; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Llopart A, 2002, EVOLUTION, V56, P2262; Lynch M., 1998, GENETICS ANAL QUANTI; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Martins E. P., 1996, PHYLOGENIES COMP MET; Mas F, 2005, J CHEM ECOL, V31, P2747, DOI 10.1007/s10886-005-7570-5; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Moehring AJ, 2006, GENETICS, V173, P225, DOI 10.1534/genetics.105.052985; Moehring AJ, 2004, GENETICS, V167, P1265, DOI 10.1534/genetics.103.024364; Moehring AJ, 2006, GENETICS, V173, P215, DOI 10.1534/genetics.105.052993; Noor MAF, 2001, GENETICS, V159, P581; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Orgogozo V, 2006, GENETICS, V173, P197, DOI 10.1534/genetics.105.054098; Orgogozo V, 2009, FLY, V3, P117, DOI 10.4161/fly.8836; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rebeiz M, 2009, CELL, V139, P1189, DOI 10.1016/j.cell.2009.11.004; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rueppell O, 2009, BEHAV GENET, V39, P541, DOI 10.1007/s10519-009-9278-8; Schafer MA, 2010, J EVOLUTION BIOL, V23, P518, DOI 10.1111/j.1420-9101.2009.01916.x; Shaw KL, 2009, P NATL ACAD SCI USA, V106, P9737, DOI 10.1073/pnas.0900229106; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Spieth H.T., 1952, B AM MUS NAT HIST, V99, P399; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Williams MA, 2001, HEREDITY, V86, P68, DOI 10.1046/j.1365-2540.2001.00811.x; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	55	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43888	10.1371/journal.pone.0043888	http://dx.doi.org/10.1371/journal.pone.0043888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952802	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206500026
J	Han, EH; Rha, GB; Chi, YI				Han, Eun Hee; Rha, Geun Bae; Chi, Young-In			MED25 Is a Mediator Component of HNF4 alpha-Driven Transcription Leading to Insulin Secretion in Pancreatic Beta-Cells	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-4; PROTEIN-PROTEIN INTERACTIONS; VITAMIN-D-RECEPTOR; COACTIVATOR COMPLEX; GLUCOSE-METABOLISM; STRUCTURAL BASIS; GENE-EXPRESSION; YOUNG MODY1; ACTIVATION; INHIBITORS	Unique nuclear receptor Hepatocyte Nuclear Factor 4 alpha (HNF4 alpha) is an essential transcriptional regulator for early development and proper function of pancreatic beta-cells, and its mutations are monogenic causes of a dominant inherited form of diabetes referred to as Maturity Onset Diabetes of the Young 1 (MODY1). As a gene-specific transcription factor, HNF4 alpha exerts its function through various molecular interactions, but its protein recruiting network has not been fully characterized. Here we report the identification of MED25 as one of the HNF4 alpha binding partners in pancreatic beta-cells leading to insulin secretion which is impaired in MODY patients. MED25 is one of the subunits of the Mediator complex that is required for induction of RNA polymerase II transcription by various transcription factors including nuclear receptors. This HNF4 alpha-MED25 interaction was initially identified by a yeast-two-hybrid method, confirmed by in vivo and in vitro analyses, and proven to be mediated through the MED25-LXXLL motif in a ligand-independent manner. Reporter-gene based transcription assays and siRNA/shRNA-based gene silencing approaches revealed that this interaction is crucial for full activation of HNF4 alpha-mediated transcription, especially expression of target genes implicated in glucose-stimulated insulin secretion. Selected MODY mutations at the LXXLL motif binding pocket disrupt these interactions and cause impaired insulin secretion through a 'loss-of-function' mechanism.	[Han, Eun Hee; Rha, Geun Bae; Chi, Young-In] Univ Minnesota, Hormel Inst, Sect Struct Biol, Austin, MN 55912 USA	University of Minnesota System	Han, EH (corresponding author), Univ Minnesota, Hormel Inst, Sect Struct Biol, 801 16th Ave NE, Austin, MN 55912 USA.	ychi@hi.umn.edu	Han, Eun Hee/X-8570-2019		American Diabetes Association [7-08-CD-03]; Commonwealth of Kentucky Diabetes Research Trust Fund [KDR-PP09-09]	American Diabetes Association(American Diabetes Association); Commonwealth of Kentucky Diabetes Research Trust Fund	This work was funded by the American Diabetes Association (7-08-CD-03) and the Commonwealth of Kentucky Diabetes Research Trust Fund (KDR-PP09-09) to YIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Belakavadi M, 2006, REV PHYSIOL BIOCH P, V156, P23, DOI 10.1007/s10254-005-0002-7; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Dell H, 1999, J BIOL CHEM, V274, P9013, DOI 10.1074/jbc.274.13.9013; Ding N, 2009, J BIOL CHEM, V284, P2648, DOI 10.1074/jbc.M806514200; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Galande AK, 2005, CHEMBIOCHEM, V6, P1991, DOI 10.1002/cbic.200500083; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Haider S, 2005, J MOL CELL CARDIOL, V38, P927, DOI 10.1016/j.yjmcc.2005.01.007; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; Hsia EY, 2010, ADV DRUG DELIVER REV, V62, P1227, DOI 10.1016/j.addr.2010.09.016; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Kim TW, 2004, P NATL ACAD SCI USA, V101, P12153, DOI 10.1073/pnas.0401985101; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Lu P, 2008, J BIOL CHEM, V283, P33685, DOI 10.1074/jbc.M806213200; Maeda Y, 2002, MOL ENDOCRINOL, V16, P1502, DOI 10.1210/me.16.7.1502; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; McKenna NJ, 1999, J STEROID BIOCHEM, V69, P3, DOI 10.1016/S0960-0760(98)00144-7; Mita Y, 2010, BIOORG MED CHEM LETT, V20, P1712, DOI 10.1016/j.bmcl.2010.01.079; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mukherjee S, 2010, PHARM RES-DORDR, V27, P1439, DOI 10.1007/s11095-010-0117-7; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Owen K, 2001, BEST PRACT RES CL EN, V15, P309, DOI 10.1053/beem.2001.0148; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Rana R, 2011, MOL CELL BIOL, V31, P466, DOI 10.1128/MCB.00847-10; Rha GB, 2009, J BIOL CHEM; Rha GB, 2011, BIOSCIENCE REP, V31, P411, DOI 10.1042/BSR20110013; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Rosano C, 2011, CURR MED CHEM, V18, P1188, DOI 10.2174/092986711795029645; Shanle EK, 2010, ADV DRUG DELIVER REV, V62, P1265, DOI 10.1016/j.addr.2010.08.001; Shih David Q, 2002, Curr Diab Rep, V2, P125, DOI 10.1007/s11892-002-0071-9; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Sladek FM, 2001, NUCL RECEPTORS GENET; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Sun AM, 2011, CHEMMEDCHEM, V6, P654, DOI 10.1002/cmdc.201000507; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wang JC, 1998, J BIOL CHEM, V273, P30847, DOI 10.1074/jbc.273.47.30847; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	52	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44007	10.1371/journal.pone.0044007	http://dx.doi.org/10.1371/journal.pone.0044007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952853	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500040
J	Noguchi, C; Rapp, JB; Skorobogatko, YV; Bailey, LD; Noguchi, E				Noguchi, Chiaki; Rapp, Jordan B.; Skorobogatko, Yuliya V.; Bailey, Lauren D.; Noguchi, Eishi			Swi1 Associates with Chromatin through the DDT Domain and Recruits Swi3 to Preserve Genomic Integrity	PLOS ONE			English	Article							DNA-REPLICATION CHECKPOINT; FORK PROTECTION COMPLEX; XENOPUS EGG EXTRACTS; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; RESPONSE PATHWAY; STRAND BREAKS; DAMAGED DNA; TIPIN	Swi1 and Swi3 form the replication fork protection complex and play critical roles in proper activation of the replication checkpoint and stabilization of replication forks in the fission yeast Schizosaccharomyces pombe. However, the mechanisms by which the Swi1-Swi3 complex regulates these processes are not well understood. Here, we report functional analyses of the Swi1-Swi3 complex in fission yeast. Swi1 possesses the DDT domain, a putative DNA binding domain found in a variety of chromatin remodeling factors. Consistently, the DDT domain-containing region of Swi1 interacts with DNA in vitro, and mutations in the DDT domain eliminate the association of Swi1 with chromatin in S. pombe cells. DDT domain mutations also render cells highly sensitive to S-phase stressing agents and induce strong accumulation of Rad22-DNA repair foci, indicating that the DDT domain is involved in the activity of the Swi1-Swi3 complex. Interestingly, DDT domain mutations also abolish Swi1's ability to interact with Swi3 in cells. Furthermore, we show that Swi1 is required for efficient chromatin association of Swi3 and that the Swi1 C-terminal domain directly interacts with Swi3. These results indicate that Swi1 associates with chromatin through its DDT domain and recruits Swi3 to function together as the replication fork protection complex.	[Noguchi, Chiaki; Rapp, Jordan B.; Skorobogatko, Yuliya V.; Bailey, Lauren D.; Noguchi, Eishi] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	Drexel University	Noguchi, C (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA.	enoguchi@drexelmed.edu	Noguchi, Eishi/AAF-3986-2021; Noguchi, Eishi/E-7283-2013	Noguchi, Eishi/0000-0001-5470-5127	Leukemia Research Foundation; National Institutes of Health [GM077604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077604] Funding Source: NIH RePORTER	Leukemia Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by funds from Leukemia Research Foundation (to EN) and National Institutes of Health (GM077604, to EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alfa C., 1993, EXPT FISSION YEAST; Ansbach AB, 2008, MOL BIOL CELL, V19, P595, DOI 10.1091/mbc.E07-06-0618; Aravind L, 2012, CELL CYCLE, V11, P119, DOI 10.4161/cc.11.1.18475; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Carr AM, 2002, DNA REPAIR, V1, P983, DOI 10.1016/S1568-7864(02)00165-9; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Doerks T, 2001, TRENDS BIOCHEM SCI, V26, P145, DOI 10.1016/S0968-0004(00)01769-2; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KEENEY JB, 1994, GENETICS, V136, P849; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lee BS, 2004, MOL CELL BIOL, V24, P9813, DOI 10.1128/MCB.24.22.9813-9822.2004; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Matsumoto S, 2005, J BIOL CHEM, V280, P42536, DOI 10.1074/jbc.M510575200; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Noguchi C, 2007, GENETICS, V175, P553, DOI 10.1534/genetics.106.065334; Noguchi Chiaki, 2008, Biotechnology Journal, V3, P1280, DOI 10.1002/biot.200800140; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Noguchi E., 2010, NATURE ED, V3, P46; Noguchi Eishi, 2009, V521, P493, DOI [10.1007/978-1-60327-817-5_28, 10.1007/978-1-60327-815-7_28]; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; Rapp JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013379; Rapp Jordan B., 2009, V521, P191, DOI [10.1007/978-1-60327-815-7_10, 10.1007/978-1-60327-817-5_10]; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sabatinos SA., 2010, NAT ED, V3, P40; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Shiozaki K, 1997, METHOD ENZYMOL, V283, P506; Shiozaki K, 1997, FOREIGN GENE EXPRESS, P133; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Tanaka T, 2010, J BIOL CHEM, V285, P39609, DOI 10.1074/jbc.M110.173344; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200	56	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43988	10.1371/journal.pone.0043988	http://dx.doi.org/10.1371/journal.pone.0043988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952839	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206500035
J	Dempere-Marco, L; Melcher, DP; Deco, G				Dempere-Marco, Laura; Melcher, David P.; Deco, Gustavo			Effective Visual Working Memory Capacity: An Emergent Effect from the Neural Dynamics in an Attractor Network	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; OBJECT; MODEL; MECHANISMS; SHIFTS; LOAD; OSCILLATIONS; ATTENTION; SALIENCE	The study of working memory capacity is of outmost importance in cognitive psychology as working memory is at the basis of general cognitive function. Although the working memory capacity limit has been thoroughly studied, its origin still remains a matter of strong debate. Only recently has the role of visual saliency in modulating working memory storage capacity been assessed experimentally and proved to provide valuable insights into working memory function. In the computational arena, attractor networks have successfully accounted for psychophysical and neurophysiological data in numerous working memory tasks given their ability to produce a sustained elevated firing rate during a delay period. Here we investigate the mechanisms underlying working memory capacity by means of a biophysically-realistic attractor network with spiking neurons while accounting for two recent experimental observations: 1) the presence of a visually salient item reduces the number of items that can be held in working memory, and 2) visually salient items are commonly kept in memory at the cost of not keeping as many non-salient items. Our model suggests that working memory capacity is determined by two fundamental processes: encoding of visual items into working memory and maintenance of the encoded items upon their removal from the visual display. While maintenance critically depends on the constraints that lateral inhibition imposes to the mnemonic activity, encoding is limited by the ability of the stimulated neural assemblies to reach a sufficiently high level of excitation, a process governed by the dynamics of competition and cooperation among neuronal pools. Encoding is therefore contingent upon the visual working memory task and has led us to introduce the concept of effective working memory capacity (eWMC) in contrast to the maximal upper capacity limit only reached under ideal conditions.	[Dempere-Marco, Laura; Deco, Gustavo] Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain; [Melcher, David P.] Univ Trento, Ctr Mind Brain Sci, Dept Psychol, Rovereto, Italy; [Deco, Gustavo] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Pompeu Fabra University; University of Barcelona; University of Trento; ICREA	Dempere-Marco, L (corresponding author), Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain.	laura.dempere@upf.edu	DECO, GUSTAVO/A-6341-2008; Dempere-Marco, Laura/ABH-5264-2020; Melcher, David/D-1775-2010	DECO, GUSTAVO/0000-0002-8995-7583; Melcher, David/0000-0003-0926-585X; Dempere-Marco, Laura/0000-0003-2602-1902	Ministry of Science and Innovation through Ramon y Cajal programme [TIN2010-21771-C02-02]; ICREA Funding Source: Custom	Ministry of Science and Innovation through Ramon y Cajal programme; ICREA(ICREA)	Funding from the Ministry of Science and Innovation through the Ramon y Cajal programme and research project TIN2010-21771-C02-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R, 2011, BMC NEURSOCI, V12, P45; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Amit DJ, 2003, CEREB CORTEX, V13, P435, DOI 10.1093/cercor/13.5.435; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Berg D, 2008, J VISION, V8, P1164, DOI DOI 10.1167/8.6.1164.[; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Fine MS, 2009, J NEUROSCI, V29, P8016, DOI 10.1523/JNEUROSCI.5503-08.2009; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; GEGENFURTNER KR, 1993, J EXP PSYCHOL HUMAN, V19, P845, DOI 10.1037/0096-1523.19.4.845; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; KOCH C, 1985, HUM NEUROBIOL, V4, P219; KOCH KW, 1989, EXP BRAIN RES, V76, P292; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lundqvist M, 2011, J COGNITIVE NEUROSCI, V23, P3008, DOI 10.1162/jocn_a_00029; Macoveanu J, 2006, NEUROSCIENCE, V141, P1611, DOI 10.1016/j.neuroscience.2006.04.080; Melcher D, 2001, NATURE, V412, P401, DOI 10.1038/35086646; Melcher D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029296; Miller EK, 1996, J NEUROSCI, V16, P5154; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; Palomares M, 2010, VISION RES, V50, P2000, DOI 10.1016/j.visres.2010.07.011; Piazza M, 2011, COGNITION, V121, P147, DOI 10.1016/j.cognition.2011.05.007; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Rainer G, 2002, EUR J NEUROSCI, V15, P1244, DOI 10.1046/j.1460-9568.2002.01958.x; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Stetter M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031903; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Warden MR, 2007, CEREB CORTEX, V17, pI41, DOI 10.1093/cercor/bhm070; Yakovlev V, 2005, CEREB CORTEX, V15, P602, DOI 10.1093/cercor/bhh161; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	49	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42719	10.1371/journal.pone.0042719	http://dx.doi.org/10.1371/journal.pone.0042719			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952608	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000010
J	Steffen, MM; Li, Z; Effler, TC; Hauser, LJ; Boyer, GL; Wilhelm, SW				Steffen, Morgan M.; Li, Zhou; Effler, T. Chad; Hauser, Loren J.; Boyer, Gregory L.; Wilhelm, Steven W.			Comparative Metagenomics of Toxic Freshwater Cyanobacteria Bloom Communities on Two Continents	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; LAKE TAIHU; MICROBIAL COMMUNITY; ENZYME-ACTIVITIES; NITROGEN; GROWTH; GENES; EUTROPHICATION; MICROCYSTINS; NUTRIENTS	Toxic cyanobacterial blooms have persisted in freshwater systems around the world for centuries and appear to be globally increasing in frequency and severity. Toxins produced by bloom-associated cyanobacteria can have drastic impacts on the ecosystem and surrounding communities, and bloom biomass can disrupt aquatic food webs and act as a driver for hypoxia. Little is currently known regarding the genomic content of the Microcystis strains that form blooms or the companion heterotrophic community associated with bloom events. To address these issues, we examined the bloom-associated microbial communities in single samples from Lake Erie (North America), Lake Tai (Taihu, China), and Grand Lakes St. Marys (OH, USA) using comparative metagenomics. Together the Cyanobacteria and Proteobacteria comprised >90% of each bloom bacterial community sample, although the dominant phylum varied between systems. Relative to the existing Microcystis aeruginosa NIES 843 genome, sequences from Lake Erie and Taihu revealed a number of metagenomic islands that were absent in the environmental samples. Moreover, despite variation in the phylogenetic assignments of bloom-associated organisms, the functional potential of bloom members remained relatively constant between systems. This pattern was particularly noticeable in the genomic contribution of nitrogen assimilation genes. In Taihu, the genetic elements associated with the assimilation and metabolism of nitrogen were predominantly associated with Proteobacteria, while these functions in the North American lakes were primarily contributed to by the Cyanobacteria. Our observations build on an emerging body of metagenomic surveys describing the functional potential of microbial communities as more highly conserved than that of their phylogenetic makeup within natural systems.	[Steffen, Morgan M.; Effler, T. Chad; Hauser, Loren J.; Wilhelm, Steven W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Li, Zhou; Hauser, Loren J.] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN USA; [Hauser, Loren J.] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Boyer, Gregory L.] SUNY Syracuse, Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Steffen, MM (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	wilhelm@utk.edu	Wilhelm, Steven W/B-8963-2008; Li, Zhou/L-7976-2015	Wilhelm, Steven W/0000-0001-6283-8077; Boyer, Gregory/0000-0003-4490-5461	National Science Foundation [IOS 0841918, CBET 0826838]; Wallace-Dean Graduate Fellowship through the University of Tennessee; Directorate For Engineering [0826838] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Wallace-Dean Graduate Fellowship through the University of Tennessee; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation grants IOS 0841918 and CBET 0826838 to SWW and a Wallace-Dean Graduate Fellowship through the University of Tennessee to MMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2; Boyer GL, 2008, ADV EXP MED BIOL, V619, P153, DOI 10.1007/978-0-387-75865-7_7; Brittain SM, 2000, J GREAT LAKES RES, V26, P241, DOI 10.1016/S0380-1330(00)70690-3; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; CHARLTON MN, 1993, J GREAT LAKES RES, V19, P291, DOI 10.1016/S0380-1330(93)71218-6; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Conroy JD, 2005, J GREAT LAKES RES, V31, P89, DOI 10.1016/S0380-1330(05)70307-5; Davis TW, 2010, AQUAT MICROB ECOL, V61, P149, DOI 10.3354/ame01445; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Dole VS, 2010, COMPARATIVE MED, V60, P427; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1213, DOI 10.4319/lo.2010.55.3.1213; Frossard A, 2012, ISME J, V6, P680, DOI 10.1038/ismej.2011.134; Hernandez JM, 2009, MED HYPOTHESES, V72, P539, DOI 10.1016/j.mehy.2008.11.041; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ichimura T., 1971, P 7 INT SEAW S, P208; Joung SH, 2011, HARMFUL ALGAE, V10, P188, DOI 10.1016/j.hal.2010.09.005; Kandeler E, 2000, BIOL FERT SOILS, V32, P390, DOI 10.1007/s003740000268; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lehman RM, 2002, APPL ENVIRON MICROB, V68, P1569, DOI 10.1128/AEM.68.4.1569-1575.2002; Li HB, 2011, WATER RES, V45, P1702, DOI 10.1016/j.watres.2010.11.011; Li N, 2011, CHIN J OCEANOL LIMN, V29, P505, DOI 10.1007/s00343-011-0056-0; Mankiewicz-Boczek J, 2011, HARMFUL ALGAE, V10, P356, DOI 10.1016/j.hal.2011.01.001; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Otten TG, 2012, ENVIRON SCI TECHNOL, V46, P3480, DOI 10.1021/es2041288; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Pasic L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-570; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P385, DOI 10.1016/j.hal.2008.08.026; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rogers ED, 2011, ENVIRON SCI TECHNOL, V45, P1962, DOI 10.1021/es103538b; Saxton MA, 2011, J GREAT LAKES RES, V37, P683, DOI 10.1016/j.jglr.2011.07.004; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Scott JT, 2010, LIMNOL OCEANOGR, V55, P1265, DOI 10.4319/lo.2010.55.3.1265; Shimizu Kazuya, 2011, Lakes & Reservoirs Research and Management, V16, P169, DOI 10.1111/j.1440-1770.2011.00480.x; Stone R, 2011, SCIENCE, V333, P1210, DOI 10.1126/science.333.6047.1210; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Watanabe MM., 2000, NIES COLLECTION LIST; Wilhelm SW, 2011, HARMFUL ALGAE, V10, P207, DOI 10.1016/j.hal.2010.10.001; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Ye C, 2011, J ENVIRON SCI, V23, P222, DOI 10.1016/S1001-0742(10)60396-8; Ye WJ, 2011, HARMFUL ALGAE, V10, P472, DOI 10.1016/j.hal.2011.03.002; Yoshida T, 2008, J BACTERIOL, V190, P1762, DOI 10.1128/JB.01534-07	53	96	97	7	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44002	10.1371/journal.pone.0044002	http://dx.doi.org/10.1371/journal.pone.0044002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952848	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000067
J	Zhu, YY; Su, Y; Li, ZG; Zhang, Y				Zhu, Yun-Yan; Su, Yin; Li, Zhan-Guo; Zhang, Yu			The Largely Normal Response to Toll-Like Receptor 7 and 9 Stimulation and the Enhanced Expression of SIGIRR by B Cells in Systemic Lupus Erythematosus	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; MURINE LUPUS; IMMUNE-RESPONSES; EPITHELIAL-CELLS; FAMILY-MEMBER; UP-REGULATION; INFLAMMATION; TIR8/SIGIRR; TLR7	Background: Altered Toll-like receptor (TLR) signaling has been implicated in the pathogenesis of systemic lupus erythematosus (SLE). The present study was undertaken to characterize responses of B cells from SLE patients to TLR7 and TLR9 stimulation and to explore the potential role of single immunoglobulin interleukin-1 receptor related molecule (SIGIRR) in the regulation of TLR-mediated responses of SLE B cells. Methodology/Principal Findings: Peripheral blood mononuclear cells (PBMC) were isolated from 64 patients with SLE and 37 healthy donors. CD19+ B cells purified using microbeads were cultured with TLR7 or TLR9 agonists. Cell proliferation was measured by thymine incorporation and the frequency of antibody-secreting cells was determined by ELISPOT assay. SIGIRR expression in PBMCs and B cells was analyzed using flow cytometry analysis. In contrast to the enhanced proliferation following B cell receptor (BCR) engagement, B cells from SLE patients exhibited a virtually normal proliferative response to TLR7 or TLR9 stimulation. Moreover, B cells from SLE patients and healthy donors were almost equally competent to differentiate into antibody-secreting cells upon TLR engagement except for a reduction in the generation of IgG-secreting cells by TLR9-stimulated lupus B cells. In line with these somehow unexpected observations, SLE B cells were found to express a significantly higher level of SIGIRR than normal B cells. Conclusions/Significance: Despite the reported upregulation of TLR7 and TLR9 expression in B cell from SLE patients, their responses to TLR stimulation were largely normal. The increased expression of the negative regulator SIGIRR may be partly responsible for the "balance of terror".	[Zhu, Yun-Yan; Zhang, Yu] Peking Univ, Hlth Sci Ctr, Dept Immunol, Minist Hlth, Beijing 100871, Peoples R China; [Zhu, Yun-Yan; Zhang, Yu] Peking Univ, Hlth Sci Ctr, Minist Hlth, Key Lab Med Immunol, Beijing 100871, Peoples R China; [Su, Yin; Li, Zhan-Guo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Zhu, YY (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, Minist Hlth, Beijing 100871, Peoples R China.	zhangyu007@hsc.pku.edu.cn; zgli@yahoo.cn			National Science Foundation of China [30830091, 81172844]; Ministry of Science and Technology of China [2011CB946100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the Ministry of Science and Technology of China (2011CB946100) and the National Science Foundation of China (30830091) to Y.Z. 1, National Science Foundation of China (81172844) to Z.G.L.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; ANDERSON CC, 1994, IMMUNOL RES, V13, P10, DOI 10.1007/BF02918220; Avalos AM, 2010, AUTOIMMUNITY, V43, P76, DOI 10.3109/08916930903374618; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Drexler SK, 2010, ARTHRITIS RHEUM-US, V62, P2249, DOI 10.1002/art.27517; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Hanten JA, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-39; Huang X, 2006, J IMMUNOL, V177, P548, DOI 10.4049/jimmunol.177.1.548; KLINMAN DM, 1991, ARTHRITIS RHEUM, V34, P1404; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lech M, 2007, KIDNEY INT, V72, P182, DOI 10.1038/sj.ki.5002293; Lech M, 2008, J EXP MED, V205, P1879, DOI 10.1084/jem.20072646; Lech M, 2010, J PATHOL, V220, P596, DOI 10.1002/path.2678; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Meyer-Bahlburg A, 2008, AUTOIMMUN REV, V7, P313, DOI 10.1016/j.autrev.2007.11.027; Migita K, 2007, J RHEUMATOL, V34, P493; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Muzio M, 2009, BRIT J HAEMATOL, V144, P507, DOI 10.1111/j.1365-2141.2008.07475.x; Nakano S, 2008, RHEUMATOLOGY, V47, P145, DOI 10.1093/rheumatology/kem327; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Polentarutti N, 2003, EUR CYTOKINE NETW, V14, P211; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; SALATA M, 1988, CLIN EXP IMMUNOL, V71, P439; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Thomassen E, 1999, CYTOKINE, V11, P389, DOI 10.1006/cyto.1998.0452; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wu O, 2009, IMMUNOBIOLOGY, V214, P392, DOI 10.1016/j.imbio.2008.10.004; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Zeuner RA, 2003, RHEUMATOLOGY, V42, P563, DOI 10.1093/rheumatology/keg191; Zhang C, 2011, MOL BIOL REP, V38, P601, DOI 10.1007/s11033-010-0146-7	43	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44131	10.1371/journal.pone.0044131	http://dx.doi.org/10.1371/journal.pone.0044131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952899	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206000088
J	Castagneyrol, B; Lagache, L; Giffard, B; Kremer, A; Jactel, H				Castagneyrol, Bastien; Lagache, Lelia; Giffard, Brice; Kremer, Antoine; Jactel, Herve			Genetic Diversity Increases Insect Herbivory on Oak Saplings	PLOS ONE			English	Article							PLANT GENOTYPIC DIVERSITY; ARTHROPOD COMMUNITY; ASSOCIATIONAL SUSCEPTIBILITY; TREE; BIODIVERSITY; RESISTANCE; DAMAGE; METAANALYSIS; SELECTION; COMPLEMENTARITY	A growing body of evidence from community genetics studies suggests that ecosystem functions supported by plant species richness can also be provided by genetic diversity within plant species. This is not yet true for the diversity-resistance relationship as it is still unclear whether damage by insect herbivores responds to genetic diversity in host plant populations. We developed a manipulative field experiment based on a synthetic community approach, with 15 mixtures of one to four oak (Quercus robur) half-sib families. We quantified genetic diversity at the plot level by genotyping all oak saplings and assessed overall damage caused by ectophagous and endophagous herbivores along a gradient of increasing genetic diversity. Damage due to ectophagous herbivores increased with the genetic diversity in oak sapling populations as a result of higher levels of damage in mixtures than in monocultures for all families (complementarity effect) rather than because of the presence of more susceptible oak genotypes in mixtures (selection effect). Assemblages of different oak genotypes would benefit polyphagous herbivores via improved host patch location, spill over among neighbouring saplings and diet mixing. By contrast, genetic diversity was a poor predictor of the abundance of endophagous herbivores, which increased with individual sapling apparency. Plant genetic diversity may not provide sufficient functional contrast to prevent tree sapling colonization by specialist herbivores while enhancing the foraging of generalist herbivores. Long term studies are nevertheless required to test whether the effect of genetic diversity on herbivory change with the ontogeny of trees and local adaptation of specialist herbivores.	[Castagneyrol, Bastien; Lagache, Lelia; Giffard, Brice; Kremer, Antoine; Jactel, Herve] Univ Bordeaux, BIOGECO, UMR1202, Talence, France; [Castagneyrol, Bastien; Lagache, Lelia; Giffard, Brice; Kremer, Antoine; Jactel, Herve] INRA, BIOGECO, UMR1202, Cestas, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE	Castagneyrol, B (corresponding author), Univ Bordeaux, BIOGECO, UMR1202, Talence, France.	bastien.castagneyrol@gmail.com	Kremer, Antoine/G-2272-2018	Kremer, Antoine/0000-0002-3372-3235; Giffard, Brice/0000-0003-4367-1245; Castagneyrol, Bastien/0000-0001-8795-7806	EVOLTREE Network of Excellence (EU) [016322]; European Commission [226299]; LinkTree project (ANR BIODIVERSA); EU Network of Excellence EvolTree	EVOLTREE Network of Excellence (EU)(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); LinkTree project (ANR BIODIVERSA)(French National Research Agency (ANR)); EU Network of Excellence EvolTree	This study was founded by the EVOLTREE Network of Excellence (EU FP7 project 016322). BC was funded by a grant for the BACCARA project, which received funding from the European Commission's Seventh Framework Programme (FP7/2007-2013), under grant agreement no. 226299. LL received funding from the LinkTree project (ANR BIODIVERSA) and the EU Network of Excellence EvolTree. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLAN IN PRESS; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; [Anonymous], 2010, R LANG ENV STAT COMP; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bangert RK, 2006, MOL ECOL, V15, P4215, DOI 10.1111/j.1365-294X.2006.03092.x; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Barbour RC, 2009, ECOLOGY, V90, P1762, DOI 10.1890/08-0951.1; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BERNAYS EA, 1994, ECOLOGY, V75, P1997, DOI 10.2307/1941604; Bertheau C, 2010, ECOL LETT, V13, P506, DOI 10.1111/j.1461-0248.2010.01445.x; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Castagneyrol B, 2012, ECOLOGY IN PRESS; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Crawford KM, 2007, ECOLOGY, V88, P2114, DOI 10.1890/06-1441.1; Crutsinger GM, 2008, OECOLOGIA, V158, P65, DOI 10.1007/s00442-008-1130-y; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dungey HS, 2000, EVOLUTION, V54, P1938, DOI 10.1111/j.0014-3820.2000.tb01238.x; Finch S, 2000, ENTOMOL EXP APPL, V96, P91, DOI 10.1023/A:1004058518179; Floater GJ, 2000, J APPL ECOL, V37, P87, DOI 10.1046/j.1365-2664.2000.00468.x; Gamfeldt L, 2007, OIKOS, V116, P700, DOI 10.1111/j.2007.0030-1299.15382.x; Genung MA, 2012, OECOLOGIA, V168, P167, DOI 10.1007/s00442-011-2080-3; Giffard B, 2012, OECOLOGIA, V168, P415, DOI 10.1007/s00442-011-2089-7; Glinwood R, 2009, ARTHROPOD-PLANT INTE, V3, P215, DOI 10.1007/s11829-009-9072-9; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Guichoux E, 2011, MOL ECOL RESOUR, V11, P578, DOI 10.1111/j.1755-0998.2011.02983.x; Hajjar R, 2008, AGR ECOSYST ENVIRON, V123, P261, DOI 10.1016/j.agee.2007.08.003; Hamback PA, 2000, ECOLOGY, V81, P1784, DOI 10.1890/0012-9658(2000)081[1784:ARIDTP]2.0.CO;2; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Hochwender CG, 2004, OECOLOGIA, V138, P547, DOI 10.1007/s00442-003-1472-4; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Ito M, 2005, ACTA OECOL, V27, P17, DOI 10.1016/j.actao.2004.08.005; Jactel H, 2006, CAN J FOREST RES, V36, P314, DOI 10.1139/x05-251; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Jactel H, 2012, GLOBAL CHANGE BIOL, V18, P267, DOI 10.1111/j.1365-2486.2011.02512.x; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Karban R, 2010, ECOL ENTOMOL, V35, P92, DOI 10.1111/j.1365-2311.2009.01162.x; Kotowska AM, 2010, J ECOL, V98, P237, DOI 10.1111/j.1365-2745.2009.01606.x; Kramer M., 2005, R2 STAT MIXED MODELS; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Madritch MD, 2005, SOIL BIOL BIOCHEM, V37, P319, DOI 10.1016/j.soilbio.2004.08.002; Madritch MD, 2002, ECOLOGY, V83, P2084, DOI 10.1890/0012-9658(2002)083[2084:PDIEFI]2.0.CO;2; Milligan BG, 2003, GENETICS, V163, P1153; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; Otway SJ, 2005, J ANIM ECOL, V74, P234, DOI 10.1111/j.1365-2656.2005.00913.x; Peacock L, 2000, J APPL ECOL, V37, P821, DOI 10.1046/j.1365-2664.2000.00528.x; Peacock L, 2001, J APPL ECOL, V38, P1070, DOI 10.1046/j.1365-2664.2001.00655.x; Pinheiro J., 2011, NLME LINEAR NONLINEA; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Riihimaki J, 2005, OECOLOGIA, V142, P90, DOI 10.1007/s00442-004-1696-y; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Silfver T, 2009, FOREST ECOL MANAG, V257, P2145, DOI 10.1016/j.foreco.2009.02.020; Smith DS, 2011, J EVOLUTION BIOL, V24, P422, DOI 10.1111/j.1420-9101.2010.02178.x; Sobek S, 2009, OECOLOGIA, V160, P279, DOI 10.1007/s00442-009-1304-2; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tack AJM, 2011, ECOLOGY, V92, P1594, DOI 10.1890/10-2006.1; Tack AJM, 2010, ECOLOGY, V91, P2660, DOI 10.1890/09-1027.1; Tikkanen OP, 2003, FOREST ECOL MANAG, V177, P587, DOI 10.1016/S0378-1127(02)00330-4; TONHASCA A, 1994, ECOL ENTOMOL, V19, P239, DOI 10.1111/j.1365-2311.1994.tb00415.x; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; Utsumi S, 2011, P ROYAL SOC B; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; White JA, 2000, ECOLOGY, V81, P1795, DOI 10.1890/0012-9658(2000)081[1795:ASOCTA]2.0.CO;2; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wimp GM, 2007, MOL ECOL, V16, P5057, DOI 10.1111/j.1365-294X.2007.03544.x	76	51	51	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44247	10.1371/journal.pone.0044247	http://dx.doi.org/10.1371/journal.pone.0044247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937168	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600098
J	Lian, M; Struthers, J; Schootman, M				Lian, Min; Struthers, James; Schootman, Mario			Comparing GIS-Based Measures in Access to Mammography and Their Validity in Predicting Neighborhood Risk of Late-Stage Breast Cancer	PLOS ONE			English	Article							MEASURING SPATIAL ACCESSIBILITY; ALCOHOL OUTLET DENSITY; LOS-ANGELES; GEOGRAPHIC ACCESS; PHYSICAL-ACTIVITY; TRAVEL DISTANCE; SOCIOECONOMIC DEPRIVATION; SOCIODEMOGRAPHIC FACTORS; RECREATIONAL RESOURCES; FOOD ENVIRONMENT	Background: Assessing neighborhood environment in access to mammography remains a challenge when investigating its contextual effect on breast cancer-related outcomes. Studies using different Geographic Information Systems (GIS)-based measures reported inconsistent findings. Methods: We compared GIS-based measures (travel time, service density, and a two-Step Floating Catchment Area method [2SFCA]) of access to FDA-accredited mammography facilities in terms of their Spearman correlation, agreement (Kappa) and spatial patterns. As an indicator of predictive validity, we examined their association with the odds of late-stage breast cancer using cancer registry data. Results: The accessibility measures indicated considerable variation in correlation, Kappa and spatial pattern. Measures using shortest travel time (or average) and service density showed low correlations, no agreement, and different spatial patterns. Both types of measures showed low correlations and little agreement with the 2SFCA measures. Of all measures, only the two measures using 6-timezone-weighted 2SFCA method were associated with increased odds of late-stage breast cancer (quick-distance-decay: odds ratio [OR] = 1.15, 95% confidence interval [CI] = 1.01-1.32; slow-distance-decay: OR = 1.19, 95% CI = 1.03-1.37) after controlling for demographics and neighborhood socioeconomic deprivation. Conclusions: Various GIS-based measures of access to mammography facilities exist and are not identical in principle and their association with late-stage breast cancer risk. Only the two measures using the 2SFCA method with 6-timezone weighting were associated with increased odds of late-stage breast cancer. These measures incorporate both travel barriers and service competition. Studies may observe different results depending on the measure of accessibility used.	[Lian, Min; Struthers, James; Schootman, Mario] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Lian, M (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	mlian@dom.wustl.edu	Schootman, Mario/AAF-3941-2019	Schootman, Mario/0000-0003-1162-8824	National Cancer Institute at the National Institutes of Health [R01 CA109675]; CDC; Missouri Department of Health and Senior Services (DHSS) [U58/DP000820-05]; DHSS; University of Missouri; NATIONAL CANCER INSTITUTE [R01CA109675] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000820] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Missouri Department of Health and Senior Services (DHSS); DHSS; University of Missouri; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported in part by a grant (R01 CA109675) from the National Cancer Institute at the National Institutes of Health. Cancer incidence data are collected by the Missouri Cancer Registry and Research Center (MCR-ARC) participating in the National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC). MCR-ARC is supported in part by a cooperative agreement between the CDC and the Missouri Department of Health and Senior Services (DHSS) (# U58/DP000820-05) and a Surveillance Contract between DHSS and the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Ann Intern Med, V151, pI, DOI 10.7326/0003-4819-151-9-200911030-00002; [Anonymous], 2009, ARCGIS DESKT HELP VE; Arndt V, 2002, BRIT J CANCER, V86, P1034, DOI 10.1038/sj.bjc.6600209; Arndt V, 2001, J CLIN EPIDEMIOL, V54, P719, DOI 10.1016/S0895-4356(00)00351-6; Astell-Burt T, 2011, SOC SCI MED; Athas WF, 2000, J NATL CANCER I, V92, P269, DOI 10.1093/jnci/92.3.269; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Bell S, ANN ASS AM IN PRESS; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bissonnette L, 2012, HEALTH PLACE, V18, P841, DOI 10.1016/j.healthplace.2012.03.007; Bluthenthal RN, 2008, J URBAN HEALTH, V85, P191, DOI 10.1007/s11524-008-9255-1; Burns CM, 2007, HEALTH PLACE, V13, P877, DOI 10.1016/j.healthplace.2007.02.005; Campbell CA, 2009, AM J PREV MED, V37, P556, DOI 10.1016/j.amepre.2009.09.028; Catalano RA, 1998, AM J PUBLIC HEALTH, V88, P586, DOI 10.2105/AJPH.88.4.586; Celaya MO, 2010, RURAL REMOTE HEALTH, V10; Celaya MO, 2006, CANCER CAUSE CONTROL, V17, P851, DOI 10.1007/s10552-006-0025-7; Cerin E, 2011, APPETITE, V56, P693, DOI 10.1016/j.appet.2011.02.006; Cohen DA, 2006, SOC SCI MED, V62, P3062, DOI 10.1016/j.socscimed.2005.11.060; Cummins SCJ, 2005, AM J PREV MED, V29, P308, DOI 10.1016/j.amepre.2005.06.011; Dai DJ, 2010, HEALTH PLACE, V16, P1038, DOI 10.1016/j.healthplace.2010.06.012; Elkin EB, 2010, MED CARE, V48, P349, DOI 10.1097/MLR.0b013e3181ca3ecb; Elting LS, 2009, AM J PREV MED, V37, P102, DOI 10.1016/j.amepre.2009.03.017; Engelman KK, 2002, J AM GERIATR SOC, V50, P62, DOI 10.1046/j.1532-5415.2002.50009.x; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fu LY, 2009, PEDIATRICS, V124, P1579, DOI 10.1542/peds.2009-0233; Gatrell AC, 2012, HEALTH PLACE, V18, P832, DOI 10.1016/j.healthplace.2012.03.009; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Gumpertz ML, 2006, CANCER CAUSE CONTROL, V17, P325, DOI 10.1007/s10552-005-0513-1; Hyndman JCG, 2000, J MED SCREEN, V7, P141, DOI 10.1136/jms.7.3.141; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jennings A, 2011, AM J PREV MED, V40, P405, DOI 10.1016/j.amepre.2010.12.014; Kwate NOA, 2010, PREV MED, V51, P153, DOI 10.1016/j.ypmed.2010.04.020; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lian M, 2011, AM J EPIDEMIOL, V174, P828, DOI 10.1093/aje/kwr162; Lovett A, 2002, SOC SCI MED, V55, P97, DOI 10.1016/S0277-9536(01)00212-X; Luo W, 2012, HEALTH PLACE, V18, P789, DOI 10.1016/j.healthplace.2012.04.002; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; Malqvist M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-762; Marchick J, 2005, CANCER-AM CANCER SOC, V103, P1571, DOI 10.1002/cncr.20915; Maroko AR, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-34; McLafferty S, 2009, CANCER-AM CANCER SOC, V115, P2755, DOI 10.1002/cncr.24306; Meden T, 2002, JAMA-J AM MED ASSOC, V287, P111, DOI 10.1001/jama.287.1.111; Meersman SC, 2009, CANCER CAUSE CONTROL, V20, P1469, DOI 10.1007/s10552-009-9373-4; Mobley LR, 2009, CANCER CAUSE CONTROL, V20, P1017, DOI 10.1007/s10552-009-9295-1; Moore LV, 2008, AM J PREV MED, V34, P16, DOI 10.1016/j.amepre.2007.09.021; Moore LV, 2008, J URBAN HEALTH, V85, P206, DOI 10.1007/s11524-008-9259-x; Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040; Nattinger AB, 2001, J NATL CANCER I, V93, P1344, DOI 10.1093/jnci/93.17.1344; NAYERI K, 1992, NEW YORK STATE J MED, V92, P8; Pearce J, 2008, J EPIDEMIOL COMMUN H, V62, P862, DOI 10.1136/jech.2007.068114; Pearce J, 2008, J EPIDEMIOL COMMUN H, V62, P198, DOI 10.1136/jech.2006.059196; Pearce JMS, 2009, EUR NEUROL, V61, P63, DOI 10.1159/000175125; Pearce J, 2007, AM J PREV MED, V32, P375, DOI 10.1016/j.amepre.2007.01.009; Peipins LA, 2011, J COMMUNITY HLTH; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Schonlau M, 2008, GEOSPATIAL HEALTH, V3, P91, DOI 10.4081/gh.2008.235; Schootman M, 2006, J EPIDEMIOL COMMUN H, V60, P202, DOI 10.1136/jech.2005.041020; Schootman M, 2007, ANN EPIDEMIOL, V17, P704, DOI 10.1016/j.annepidem.2007.03.017; Scribner RA, 1998, SEX TRANSM DIS, V25, P544, DOI 10.1097/00007435-199811000-00009; Scribner R, 2007, J STUD ALCOHOL DRUGS, V68, P934, DOI 10.15288/jsad.2007.68.934; Sharkey JR, 2008, J NUTR, V138, P620, DOI 10.1093/jn/138.3.620; Smith DM, 2010, INT J EPIDEMIOL, V39, P277, DOI 10.1093/ije/dyp221; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Teach SJ, 2006, PEDIATRICS, V117, pS78, DOI 10.1542/peds.2005-2000E; Theall KP, 2009, GEOSPATIAL HEALTH, V3, P241, DOI 10.4081/gh.2009.224; Wang FH, 2005, HEALTH PLACE, V11, P131, DOI 10.1016/j.healthplace.2004.02.003; Wang L, 2007, HEALTH PLACE, V13, P656, DOI 10.1016/j.healthplace.2006.10.001; Witten K, 2008, PREV MED, V47, P299, DOI 10.1016/j.ypmed.2008.04.010; Wong LY, 2010, INT J HLTH PLANN MAN; Yang Duck-Hye, 2006, J Med Syst, V30, P23, DOI 10.1007/s10916-006-7400-5; Zenk SN, 2008, HEALTH PLACE, V14, P336, DOI 10.1016/j.healthplace.2007.08.003; Zenk SN, 2006, J URBAN HEALTH, V83, P195, DOI 10.1007/s11524-005-9023-4; Zenk SN, 2005, AM J PUBLIC HEALTH, V95, P660, DOI 10.2105/AJPH.2004.042150	73	37	37	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43000	10.1371/journal.pone.0043000	http://dx.doi.org/10.1371/journal.pone.0043000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952626	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600012
J	Cai, X; Li, L; Krumholz, A; Guo, ZJ; Erpelding, TN; Zhang, C; Zhang, Y; Xi, YN; Wang, LHV				Cai, Xin; Li, Li; Krumholz, Arie; Guo, Zijian; Erpelding, Todd N.; Zhang, Chi; Zhang, Yu; Xi, Younan; Wang, Lihong V.			Multi-Scale Molecular Photoacoustic Tomography of Gene Expression	PLOS ONE			English	Article							IN-VIVO; MICROSCOPY; SYSTEM; PROBE	Photoacoustic tomography (PAT) is a molecular imaging technology. Unlike conventional reporter gene imaging, which is usually based on fluorescence, photoacoustic reporter gene imaging relies only on optical absorption. This work demonstrates several key merits of PAT using lacZ, one of the most widely used reporter genes in biology. We show that the expression of lacZ can be imaged by PAT as deep as 5.0 cm in biological tissue, with resolutions of similar to 1.0 mm and similar to 0.4 mm in the lateral and axial directions, respectively. We further demonstrate non-invasive, simultaneous imaging of a lacZ-expressing tumor and its surrounding microvasculature in vivo by dual-wavelength acoustic-resolution photoacoustic microscopy (AR-PAM), with a lateral resolution of 45 mu m and an axial resolution of 15 mu m. Finally, using optical-resolution photoacoustic microscopy (OR-PAM), we show intra-cellular localization of lacZ expression, with a lateral resolution of a fraction of a micron. These results suggest that PAT is a complementary tool to conventional optical fluorescence imaging of reporter genes for linking biological studies from the microscopic to the macroscopic scales.	[Cai, Xin; Li, Li; Krumholz, Arie; Guo, Zijian; Zhang, Chi; Zhang, Yu; Xi, Younan; Wang, Lihong V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Erpelding, Todd N.] Philips Res N Amer, Briarcliff Manor, NY USA	Washington University (WUSTL); Philips; Philips Research	Cai, X (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	lhwang@biomed.wustl.edu	Wang, Lihong V./A-7147-2009; Zhang, Yu Shrike/H-4885-2013; Xia, Younan/E-8499-2011; Guo, Zijian/D-8652-2012	Wang, Lihong V./0000-0001-9783-4383; Zhang, Yu Shrike/0000-0002-0045-0808; 	National Institutes of Health [R01 EB000712, R01 EB008085, R01 CA134539, U54 CA136398]; NATIONAL CANCER INSTITUTE [U54CA136398, R01CA134539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000712, R01EB008085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by National Institutes of Health Grant Nos. R01 EB000712, R01 EB008085, R01 CA134539, and U54 CA136398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Beard P, 2009, QUANTITATIVE PHOTOAC, P121; CEPKO C, 1998, CELLS LAB MANUAL, V3; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Filonov GS, 2012, ANGEW CHEM INT EDIT, V51, P1448, DOI 10.1002/anie.201107026; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; Kim C, 2011, PHILOS T R SOC A, V369, P4644, DOI 10.1098/rsta.2010.0353; Kim C, 2010, BIOMED OPT EXPRESS, V1, P278, DOI 10.1364/BOE.1.000278; Kostli KP, 2001, PHYS MED BIOL, V46, P1863, DOI 10.1088/0031-9155/46/7/309; Laufer JG, 2010, PROC SPIE, V7564, DOI 10.1117/12.842204; Li L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717531; Li L, 2008, J INNOV OPT HEAL SCI, V1, P207, DOI 10.1142/S1793545808000212; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566; Song KH, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2818045; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	19	43	43	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43999	10.1371/journal.pone.0043999	http://dx.doi.org/10.1371/journal.pone.0043999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952846	Green Published, gold, Green Accepted			2022-12-27	WOS:000308044800087
J	Andrabi, R; Bala, M; Kumar, R; Wig, N; Hazarika, A; Luthra, K				Andrabi, Raiees; Bala, Manju; Kumar, Rajesh; Wig, Naveet; Hazarika, Anjali; Luthra, Kalpana			Neutralization of Tier-2 Viruses and Epitope Profiling of Plasma Antibodies from Human Immunodeficiency Virus Type 1 Infected Donors from India	PLOS ONE			English	Article							PROXIMAL EXTERNAL REGION; HUMAN MONOCLONAL-ANTIBODIES; SUBTYPE-C INFECTION; VACCINE DESIGN; HIV VACCINES; TRANSMEMBRANE GLYCOPROTEIN; ENVELOPE GLYCOPROTEINS; GP120 GLYCOPROTEIN; CRYSTAL-STRUCTURE; GP41 ANTIBODIES	Broadly cross neutralizing antibodies (NAbs) are generated in a group of HIV-1 infected individuals during the natural infection, but little is known about their prevalence in patients infected with viral subtypes from different geographical regions. We tested here the neutralizing efficiency of plasma antibodies from 80 HIV-1 infected antiretroviral drug naive patients against a panel of subtype-B and C tier 2 viruses. We detected cross-neutralizing antibodies in approximately 19-27% of the plasma, however the subtype-C specific neutralization efficiency predominated (p = 0.004). The neutralizing activity was shown to be exclusively mediated by the immunoglobulin G (IgG) fraction in the representative plasma samples. Epitope mapping of three, the most cross-neutralizing plasma (CNP) AIIMS206, AIIMS239 and AIIMS249 with consensus-C overlapping envelope peptides revealed ten different binding specificities with only V3 and IDR being common. The V3 and IDR were highly antigenic regions but no correlation between their reciprocal Max50 binding titers and neutralization was observed. In addition, the neutralizing activity of CNP was not substantially reduced by V3 and gp41 peptides except a modest contribution of MPER peptide. The MPER was rarely recognized by plasma antibodies though antibody depletion and competition experiments demonstrated MPER dependent neutralization in two out of three CNP. Interestingly, the binding specificity of one of the CNP (AIIMS206) overlapped with broadly neutralizing mAb 2F5 epitope. Overall, the data suggest that, despite the low immunogenicity of HIV-1 MPER, the antibodies directed to this region may serve as crucial reagents for HIV-1 vaccine design.	[Andrabi, Raiees; Kumar, Rajesh; Luthra, Kalpana] All India Inst Med Sci, Dept Biochem, CN Ctr, New Delhi 110029, India; [Wig, Naveet] All India Inst Med Sci, Dept Med, CN Ctr, New Delhi 110029, India; [Hazarika, Anjali] All India Inst Med Sci, Blood Bank, CN Ctr, New Delhi, India; [Bala, Manju] Safdarjang Hosp, Reg STD Teaching Training & Res Ctr, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Vardhman Mahavir Medical College & Safdarjung Hospital	Andrabi, R (corresponding author), All India Inst Med Sci, Dept Biochem, CN Ctr, New Delhi 110029, India.	kalpanaluthra@gmail.com		Bala, Manju/0000-0002-1934-8272; Singh, Vikram/0000-0003-2737-8102	Department of Biotechnology India (DBT) [BT/PR 10511/MED/29/66/2008]; Indian Council of Medical Research (ICMR) [61/7/2008-BMS]; Indian Council of Medical Research (ICMR)	Department of Biotechnology India (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This work was funded by Department of Biotechnology India (DBT) (BT/PR 10511/MED/29/66/2008) and Indian Council of Medical Research (ICMR) (61/7/2008-BMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We profoundly thank all the study participants. We acknowledge Prof. Miroslaw K. Gorny for critically reviewing the manuscript and Prof. Susan Zolla Pazner for constant technical advice and support. The Fogarty AIDS International Training & Research Program (AITRP) fellowship (USA), RF/SRF fellowship provided by Indian Council of Medical Research (ICMR) to Raiees Andrabi is highly acknowledged.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Andrabi R, 2011, ARCH VIROL, V156, P1787, DOI 10.1007/s00705-011-1053-5; Balla-Jhagjhoorsingh SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025488; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Braibant M, 2006, AIDS, V20, P1923, DOI 10.1097/01.aids.0000247113.43714.5e; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Bures R, 2002, J VIROL, V76, P2233, DOI 10.1128/JVI.76.5.2233-2244.2002; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; CHIODI F, 1987, J MED VIROL, V23, P1, DOI 10.1002/jmv.1890230102; Choudhary AK, 2012, J MICROBIOL, V50, P149, DOI 10.1007/s12275-012-1246-y; Cleveland SM, 2000, VIROLOGY, V266, P66, DOI 10.1006/viro.1999.0041; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; GABUZDA DH, 1992, J VIROL, V66, P3306, DOI 10.1128/JVI.66.6.3306-3315.1992; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haynes BF, 2006, EXPERT REV VACCINES, V5, P347, DOI 10.1586/14760584.5.3.347; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Jere A, 2004, MICROBES INFECT, V6, P279, DOI 10.1016/j.micinf.2003.11.012; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Koff WC, 2011, VACCINE; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Lakhashe S, 2008, J BIOSCIENCES, V33, P515, DOI 10.1007/s12038-008-0070-3; Lakhashe SK, 2007, VIROLOGY, V359, P295, DOI 10.1016/j.virol.2006.09.019; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liu PH, 2011, J VIROL, V85, P11196, DOI 10.1128/JVI.05601-11; Louisirirotchanakul S, 1998, J ACQ IMMUN DEF SYND, V19, P315, DOI 10.1097/00042560-199812010-00001; Lynch RM, 2009, AIDS RES HUM RETROV, V25, P237, DOI 10.1089/aid.2008.0219; Lynch RM, 2012, J VIROLOGY; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MOORE JP, 1994, J VIROL, V68, P5142, DOI 10.1128/JVI.68.8.5142-5155.1994; MOORE JP, 1993, J VIROL, V67, P863, DOI 10.1128/JVI.67.2.863-875.1993; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 1997, IMMUNOL LETT, V57, P105, DOI 10.1016/S0165-2478(97)00043-6; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; POUMBOURIOS P, 1992, AIDS RES HUM RETROV, V8, P2055, DOI 10.1089/aid.1992.8.2055; Rademeyer C, 2007, VIROLOGY, V368, P172, DOI 10.1016/j.virol.2007.06.013; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Spenlehauer C, 1998, J VIROL, V72, P9855, DOI 10.1128/JVI.72.12.9855-9864.1998; Spurrier B, 2011, STRUCTURE, V19, P691, DOI 10.1016/j.str.2011.02.012; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	85	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43704	10.1371/journal.pone.0043704	http://dx.doi.org/10.1371/journal.pone.0043704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952740	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300024
J	Reijmer, YD; Leemans, A; Heringa, SM; Wielaard, I; Jeurissen, B; Koek, HL; Biessels, GJ				Reijmer, Yael D.; Leemans, Alexander; Heringa, Sophie M.; Wielaard, Ilse; Jeurissen, Ben; Koek, Huiberdina L.; Biessels, Geert Jan		Vasc Cognitive Impairment Study Gr	Improved Sensitivity to Cerebral White Matter Abnormalities in Alzheimer's Disease with Spherical Deconvolution Based Tractography	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; TENSOR IMAGING TRACTOGRAPHY; IN-VIVO; HUMAN BRAIN; DIFFUSION TRACTOGRAPHY; CORPUS-CALLOSUM; MRI DATA; RESOLUTION; ANISOTROPY; INTEGRITY	Diffusion tensor imaging (DTI) based fiber tractography (FT) is the most popular approach for investigating white matter tracts in vivo, despite its inability to reconstruct fiber pathways in regions with "crossing fibers." Recently, constrained spherical deconvolution (CSD) has been developed to mitigate the adverse effects of "crossing fibers" on DTI based FT. Notwithstanding the methodological benefit, the clinical relevance of CSD based FT for the assessment of white matter abnormalities remains unclear. In this work, we evaluated the applicability of a hybrid framework, in which CSD based FT is combined with conventional DTI metrics to assess white matter abnormalities in 25 patients with early Alzheimer's disease. Both CSD and DTI based FT were used to reconstruct two white matter tracts: one with regions of "crossing fibers," i.e., the superior longitudinal fasciculus (SLF) and one which contains only one fiber orientation, i.e. the midsagittal section of the corpus callosum (CC). The DTI metrics, fractional anisotropy (FA) and mean diffusivity (MD), obtained from these tracts were related to memory function. Our results show that in the tract with "crossing fibers" the relation between FA/MD and memory was stronger with CSD than with DTI based FT. By contrast, in the fiber bundle where one fiber population predominates, the relation between FA/MD and memory was comparable between both tractography methods. Importantly, these associations were most pronounced after adjustment for the planar diffusion coefficient, a measure reflecting the degree of fiber organization complexity. These findings indicate that compared to conventionally applied DTI based FT, CSD based FT combined with DTI metrics can increase the sensitivity to detect functionally significant white matter abnormalities in tracts with complex white matter architecture.	[Reijmer, Yael D.; Heringa, Sophie M.; Wielaard, Ilse; Biessels, Geert Jan] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Jeurissen, Ben] Univ Antwerp, Dept Phys, Vis Lab, B-2020 Antwerp, Belgium; [Koek, Huiberdina L.] Univ Med Ctr Utrecht, Dept Geriatr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Antwerp; Utrecht University; Utrecht University Medical Center	Reijmer, YD (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands.	y.d.reijmer@umcutrecht.nl	Leemans, Alexander/A-1784-2011; Jeurissen, Ben/C-3246-2011	Leemans, Alexander/0000-0002-9306-6126; Jeurissen, Ben/0000-0002-3488-9819	Utrecht University; VIDI from ZonMw, The Netherlands Organisation for Health Research and Development [91711384]; project Care4Me (Cooperative Advanced REsearch for Medical Efficiency) in the framework of the EU research programme ITEA (Information Technology for European Advancement)	Utrecht University; VIDI from ZonMw, The Netherlands Organisation for Health Research and Development; project Care4Me (Cooperative Advanced REsearch for Medical Efficiency) in the framework of the EU research programme ITEA (Information Technology for European Advancement)	The research of GJB is supported by a high potential grant from Utrecht University and VIDI grant 91711384 from ZonMw, The Netherlands Organisation for Health Research and Development. The research of AL is supported by the project Care4Me (Cooperative Advanced REsearch for Medical Efficiency) in the framework of the EU research programme ITEA (Information Technology for European Advancement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Anderson AW, 2005, MAGN RESON MED, V54, P1194, DOI 10.1002/mrm.20667; Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chang LC, 2012, MAGN RESON IN PRESS; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Jansons KM, 2003, LECT NOTES COMPUT SC, V2732, P672; Jeurissen B, 2012, HUM BRAIN M IN PRESS; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Kavcic V, 2008, ALZHEIMERS DEMENT, V4, P381, DOI 10.1016/j.jalz.2008.07.001; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Leemans A, 2011, DIFFUSION MRI, P354; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Reisberg B, 1999, EUR ARCH PSY CLIN N, V249, P28; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Serra L, 2010, J ALZHEIMERS DIS, V19, P147, DOI 10.3233/JAD-2010-1223; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; Van Hecke W, 2008, NEUROIMAGE, V43, P69, DOI 10.1016/j.neuroimage.2008.07.006; Van Hecke W, 2011, NEUROIMAGE, V55, P566, DOI 10.1016/j.neuroimage.2010.12.005; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Virta A, 1999, MAGN RESON IMAGING, V17, P1121, DOI 10.1016/S0730-725X(99)00048-X; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897	62	67	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44074	10.1371/journal.pone.0044074	http://dx.doi.org/10.1371/journal.pone.0044074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952880	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300048
J	Scott, MM; Perello, M; Chuang, JC; Sakata, I; Gautron, L; Lee, CE; Lauzon, D; Elmquist, JK; Zigman, JM				Scott, Michael M.; Perello, Mario; Chuang, Jen-Chieh; Sakata, Ichiro; Gautron, Laurent; Lee, Charlotte E.; Lauzon, Danielle; Elmquist, Joel K.; Zigman, Jeffrey M.			Hindbrain Ghrelin Receptor Signaling Is Sufficient to Maintain Fasting Glucose	PLOS ONE			English	Article							ENERGY-BALANCE; INSULIN SENSITIVITY; PANCREATIC-ISLETS; ARCUATE NUCLEUS; MOUSE-BRAIN; FOOD-INTAKE; MICE; HORMONE; EXPRESSION; NEURONS	The neuronal coordination of metabolic homeostasis requires the integration of hormonal signals with multiple interrelated central neuronal circuits to produce appropriate levels of food intake, energy expenditure and fuel availability. Ghrelin, a peripherally produced peptide hormone, circulates at high concentrations during nutrient scarcity. Ghrelin promotes food intake, an action lost in ghrelin receptor null mice and also helps maintain fasting blood glucose levels, ensuring an adequate supply of nutrients to the central nervous system. To better understand mechanisms of ghrelin action, we have examined the roles of ghrelin receptor (GHSR) expression in the mouse hindbrain. Notably, selective hindbrain ghrelin receptor expression was not sufficient to restore ghrelin-stimulated food intake. In contrast, the lowered fasting blood glucose levels observed in ghrelin receptor-deficient mice were returned to wild-type levels by selective re-expression of the ghrelin receptor in the hindbrain. Our results demonstrate the distributed nature of the neurons mediating ghrelin action.	[Scott, Michael M.; Perello, Mario; Chuang, Jen-Chieh; Sakata, Ichiro; Gautron, Laurent; Lee, Charlotte E.; Lauzon, Danielle; Elmquist, Joel K.; Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Scott, Michael M.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Elmquist, Joel K.; Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA; [Elmquist, Joel K.; Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Virginia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Scott, MM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA.	joel.elmquist@utsouthwestern.edu; jeffrey.zigman@utsouthwestern.edu	gautron, laurent/AAQ-5983-2021; Sakata, Ichiro/F-9194-2012	Sakata, Ichiro/0000-0002-6067-0407; Zigman, Jeffrey/0000-0003-3477-1295; Perello, Mario/0000-0003-2114-6765	National Institutes of Health; NIDA; NIMH; NIDDK;  [5K99DA024719-02];  [1R01DA024680];  [1R01MH085298];  [1K08DK068069];  [R01DK071320];  [RL1DK081185]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071320, RL1DK081185, K08DK068069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024680, K99DA024719, R00DA024719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funds used to conduct this study were provided by the National Institutes of Health, specifically, NIDA, NIMH, and NIDDK. The relevant grants are listed below: 5K99DA024719-02 to M. S., 1R01DA024680, 1R01MH085298, and 1K08DK068069 to J.M.Z., and R01DK071320 and RL1DK081185 to J.K.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Arnold M, 2006, J NEUROSCI, V26, P11052, DOI 10.1523/JNEUROSCI.2606-06.2006; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Bailey ART, 2000, J NEUROENDOCRINOL, V12, P191; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Chuang JC, 2011, MOL ENDOCRINOL, V25, P1600, DOI 10.1210/me.2011-1001; Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Date Y, 2001, BIOCHEM BIOPH RES CO, V280, P904, DOI 10.1006/bbrc.2000.4212; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; Dezaki K, 2008, PHARMACOL THERAPEUT, V118, P239, DOI 10.1016/j.pharmthera.2008.02.008; Faulconbridge LF, 2003, DIABETES, V52, P2260, DOI 10.2337/diabetes.52.9.2260; Faulconbridge LF, 2008, BRAIN RES, V1218, P151, DOI 10.1016/j.brainres.2008.04.068; Hashimoto H, 2007, ENDOCRINOLOGY, V148, P1638, DOI 10.1210/en.2006-0993; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P4521, DOI 10.1210/jc.2004-2537; Li RL, 2012, J BIOL CHEM; Longo KA, 2008, REGUL PEPTIDES, V150, P55, DOI 10.1016/j.regpep.2008.03.011; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; Olszewski PK, 2003, PEPTIDES, V24, P919, DOI 10.1016/S0196-9781(03)00159-1; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Qi Yong, 2011, BMC Physiology, V11, P1, DOI 10.1186/1472-6793-11-1; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Scott V, 2007, PHYSIOL BEHAV, V90, P180, DOI 10.1016/j.physbeh.2006.09.026; Takayama K, 2007, NEUROSCI LETT, V417, P292, DOI 10.1016/j.neulet.2007.02.089; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yi CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032100; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	37	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44089	10.1371/journal.pone.0044089	http://dx.doi.org/10.1371/journal.pone.0044089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952883	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300049
J	Shi, DB; Guo, W; Chen, WB; Fu, LY; Wang, JS; Tian, Y; Xiao, XS; Kang, TB; Huang, WL; Deng, WG				Shi, Dingbo; Guo, Wei; Chen, Wangbin; Fu, Lingyi; Wang, Jingshu; Tian, Yung; Xiao, Xiangsheng; Kang, Tiebang; Huang, Wenlin; Deng, Wuguo			Nicotine Promotes Proliferation of Human Nasopharyngeal Carcinoma Cells by Regulating alpha 7AChR, ERK, HIF-1 alpha and VEGF/PEDF Signaling	PLOS ONE			English	Article							LUNG-CANCER CELLS; ACETYLCHOLINE-RECEPTORS; TUMOR-GROWTH; ANGIOGENESIS; HYPOXIA; EXPRESSION; PATHWAY; ACTIVATION; KINASE; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA	Nicotine, the major component in cigarette smoke, can promote tumor growth and angiogenesis, but the precise mechanisms involved remain largely unknown. Here, we investigated the mechanism of action of nicotine in human nasopharyngeal carcinoma (NPC) cells. Nicotine significantly promoted cell proliferation in a dose and time-dependent manner in human NPC cells. The mechanism studies showed that the observed stimulation of proliferation was accompanied by the nicotine-mediated simultaneous modulation of alpha 7AChR, HIF-1 alpha, ERK and VEGF/PEDF signaling. Treatment of NPC cells with nicotine markedly upregulated the expression of alpha 7AChR and HIF-1 alpha proteins. Transfection with a alpha 7AChR or HIF-1 alpha-specific siRNA or a alpha 7AChR-selective inhibitor significantly attenuated the nicotine-mediated promotion of NPC cell proliferation. Nicotine also promoted the phosphorylation of ERK1/2 but not JNK and p38 proteins, thereby induced the activation of ERK/MAPK signaling pathway. Pretreatment with an ERK-selective inhibitor effectively reduced the nicotine-induced proliferation of NPC cells. Moreover, nicotine upregulated the expression of VEGF but suppressed the expression of PEDF at mRNA and protein levels, leading to a significant increase of the ratio of VEGF/PEDF in NPC cells. Pretreatment with a alpha 7AChR or ERK-selective inhibitor or transfection with a HIF-1 alpha-specific siRNA in NPC cells significantly inhibited the nicotine-induced HIF-1 alpha expression and VEGF/PEDF ratio. These results therefore indicate that nicotine promotes proliferation of human NPC cells in vitro through simultaneous modulation of alpha 7AChR, HIF-1 alpha, ERK and VEGF/PEDF signaling and suggest that the related molecules such as HIF-1 alpha might be the potential therapeutic targets for tobacco-associated diseases such as nasopharyngeal carcinomas.	[Shi, Dingbo; Chen, Wangbin; Fu, Lingyi; Wang, Jingshu; Tian, Yung; Xiao, Xiangsheng; Kang, Tiebang; Huang, Wenlin; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Wenlin; Deng, Wuguo] State Key Lab Targeted Therapy Drug Guangdong, Guangzhou, Guangdong, Peoples R China; [Guo, Wei] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China	Sun Yat Sen University; Dalian Medical University	Shi, DB (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	dengwg@sysucc.org.cn	xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81071687]; Ph.D. Programs Foundation of Ministry of Education of China; State Key Laboratory of Oncology in Southern China; "985 Program" of Sun Yat-Sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); State Key Laboratory of Oncology in Southern China; "985 Program" of Sun Yat-Sen University	This work was supported from the National Natural Science Foundation of China (No. 81071687), the Ph.D. Programs Foundation of Ministry of Education of China, the State Key Laboratory of Oncology in Southern China, and the "985 Program" of Sun Yat-Sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2005, BIOCHEM BIOPH RES CO, V326, P387, DOI 10.1016/j.bbrc.2004.11.041; Arias HR, 2009, INT J BIOCHEM CELL B, V41, P1441, DOI 10.1016/j.biocel.2009.01.013; Bose C, 2005, AM J PHYSIOL-GASTR L, V289, pG926, DOI 10.1152/ajpgi.00138.2005; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Cardinale A, 2012, CRIT REV TOXICOL, V42, P68, DOI 10.3109/10408444.2011.623150; Carlisle DL, 2007, PULM PHARMACOL THER, V20, P629, DOI 10.1016/j.pupt.2006.07.001; Cheeseman MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002336; Chowdhury P, 2007, CELL PROLIFERAT, V40, P125; Davis R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007524; Fan W, 2011, DIFFERENTIATION, V81, P181, DOI 10.1016/j.diff.2010.12.003; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Lane D, 2005, AM J REPROD IMMUNOL, V53, P153, DOI 10.1111/j.1600-0897.2005.00259.x; Li Q, 2011, CELL PHYSIOL BIOCHEM, V27, P605, DOI 10.1159/000329982; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Lopez-Lazaro M, 2009, P NATL ACAD SCI USA, V106, pE26, DOI 10.1073/pnas.0813047106; Nishioka T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3055; Oshima M, 2005, AUTOIMMUNITY, V38, P161, DOI 10.1080/08916930500050491; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rathinavelu A, 2011, J CELL MOL IN PRESS; Riljak V, 2011, NEUROENDOCRINOL LETT, V32, P816; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sebolt-Leopold Judith S., 2007, V172, P155; Shi D, 2012, J PINEAL RE IN PRESS; Shin VY, 2005, MOL CANCER RES, V3, P607, DOI 10.1158/1541-7786.MCR-05-0106; Shin VY, 2004, CARCINOGENESIS, V25, P2487, DOI 10.1093/carcin/bgh266; Shou Z, 2012, J CANCER RES CLIN, V138, P585, DOI 10.1007/s00432-011-1125-7; Tanaka H, 2006, CANCER RES, V66, P11263, DOI 10.1158/0008-5472.CAN-06-1699; Taslim N, 2011, ALCOHOL CLIN EXP RES, V35, P540, DOI 10.1111/j.1530-0277.2010.01371.x; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Wan XB, 2012, CANC SCI IN PRESS; Wang JS, 2012, J PINEAL RES, V53, P77, DOI 10.1111/j.1600-079X.2012.00973.x; Xiao XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022934; Ye YN, 2004, J PHARMACOL EXP THER, V308, P66, DOI 10.1124/jpet.103.058321; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-0051OC	41	54	61	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43898	10.1371/journal.pone.0043898	http://dx.doi.org/10.1371/journal.pone.0043898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952803	gold, Green Published, Green Submitted			2022-12-27	WOS:000308221300031
J	Tang, YP; Wade, J				Tang, Yu Ping; Wade, Juli			17 beta-Estradiol Regulates the Sexually Dimorphic Expression of BDNF and TrkB Proteins in the Song System of Juvenile Zebra Finches	PLOS ONE			English	Article							FACTOR MESSENGER-RNA; NERVE GROWTH-FACTOR; ANDROGEN RECEPTOR PROTEIN; EARLY ESTROGEN-TREATMENT; NEUROTROPHIC FACTOR; SEX-DIFFERENCES; NEURONAL CONNECTIVITY; BRAIN; DIFFERENTIATION; SURVIVAL	Mature brain derived neurotrophic factor (BDNF) plays critical roles in development of brain structure and function, including neurogenesis, axon growth, cell survival and processes associated with learning. Expression of this peptide is regulated by estradiol (E2). The zebra finch song system is sexually dimorphic - only males sing and the brain regions controlling song are larger and have more cells in males compared to females. Masculinization of this system is partially mediated by E2, and earlier work suggests that BDNF with its high affinity receptor TrkB may also influence this development. The present study evaluated expression of multiple forms of both BDNF and TrkB in the developing song system in juvenile males and females treated with E2 or a vehicle control. Using immunohistochemistry and Western blot analysis, BDNF was detected across the song nuclei of 25-day-old birds. Westerns allowed the pro-and mature forms of BDNF to be individually identified, and proBDNF to be quantified. Several statistically significant effects of sex existed in both the estimated total number of BDNF+ cells and relative concentration of proBDNF, varying across the regions and methodologies. E2 modulated BDNF expression, although the specific nature of the regulation depended on brain region, sex and the technique used. Similarly, TrkB (both truncated and full-length isoforms) was detected by Western blot in the song system of juveniles of both sexes, and expression was regulated by E2. In the context of earlier research on these molecules in the developing song system, this work provides a critical step in describing specific forms of BDNF and TrkB, and how they can be mediated by sex and E2. As individual isoforms of each can have opposing effects on mechanisms, such as cell survival, it will now be important to investigate in depth their specific functions in song system maturation.	[Tang, Yu Ping] Michigan State Univ, Neurosci Program, Dept Psychol, E Lansing, MI 48824 USA; Michigan State Univ, Neurosci Program, Dept Zool, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Tang, YP (corresponding author), Michigan State Univ, Neurosci Program, Dept Psychol, E Lansing, MI 48824 USA.	tangyupi@msu.edu	wade, juli/F-4993-2012		NIH [RO1-MH55488]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055488, R01MH096705] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH RO1-MH55488. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINSREGAN E, 1990, HORM BEHAV, V24, P114, DOI 10.1016/0018-506X(90)90031-R; Agate RJ, 2003, P NATL ACAD SCI USA, V100, P4873, DOI 10.1073/pnas.0636925100; Aguirre CC, 2009, EUR J NEUROSCI, V29, P447, DOI 10.1111/j.1460-9568.2008.06591.x; Akutagawa E, 1998, P NATL ACAD SCI USA, V95, P11429, DOI 10.1073/pnas.95.19.11429; ARNOLD AP, 1975, J EXP ZOOL, V191, P309, DOI 10.1002/jez.1401910302; Arnold AP, 1997, J NEUROBIOL, V33, P572, DOI 10.1002/(SICI)1097-4695(19971105)33:5<572::AID-NEU6>3.3.CO;2-6; BALTHAZART J, 1995, BEHAVIOUR, V120, P225; Barker PA, 2009, NAT NEUROSCI, V12, P105, DOI 10.1038/nn0209-105; BOTTJER SW, 1985, J NEUROSCI, V5, P1556, DOI 10.1523/jneurosci.05-06-01556.1985; Cambiasso MJ, 2000, EUR J NEUROSCI, V12, P2291, DOI 10.1046/j.1460-9568.2000.00120.x; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chen XQ, 2005, P NATL ACAD SCI USA, V102, P7730, DOI 10.1073/pnas.0408350102; CLAYTON NS, 1988, ANIM BEHAV, V36, P1016, DOI 10.1016/S0003-3472(88)80061-7; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; De Vries GJ, 2004, ENDOCRINOLOGY, V145, P1063, DOI 10.1210/en.2003-1504; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; Fenner BM, 2012, CYTOKINE GROWTH FACT; Gibbs RB, 1999, BRAIN RES, V844, P20, DOI 10.1016/S0006-8993(99)01880-6; GRISHAM W, 1995, J NEUROBIOL, V26, P163, DOI 10.1002/neu.480260202; GRISHAM W, 1994, J NEUROBIOL, V25, P185, DOI 10.1002/neu.480250209; Grisham W, 2007, NEUROSCI LETT, V418, P92, DOI 10.1016/j.neulet.2007.03.002; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Itoh Y, 2010, GENOME RES, V20, P512, DOI 10.1101/gr.102343.109; Johnson F, 1997, J NEUROSCI, V17, P2101; Johnson F, 2000, DEV BRAIN RES, V120, P113, DOI 10.1016/S0165-3806(00)00002-X; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KIRN JR, 1989, J NEUROSCI, V9, P3176; Kittelberger JM, 2005, J NEUROBIOL, V62, P406, DOI 10.1002/neu.20109; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Lessmann V, 2009, NEUROSCI RES, V65, P11, DOI 10.1016/j.neures.2009.06.004; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; MATHEWS GA, 1988, HORM BEHAV, V22, P540, DOI 10.1016/0018-506X(88)90057-8; MATHEWS GA, 1991, J NEUROBIOL, V22, P970, DOI 10.1002/neu.480220908; MATHEWS GA, 1990, GEN COMP ENDOCR, V80, P48, DOI 10.1016/0016-6480(90)90147-E; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MIRANDA RC, 1993, MOL CELL NEUROSCI, V4, P510, DOI 10.1006/mcne.1993.1063; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; Nixdorf-Bergweiler BE, 2001, MICROSC RES TECHNIQ, V54, P335, DOI 10.1002/jemt.1147; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Qi LM, 2012, DEV NEUROBIOL, V72, P199, DOI 10.1002/dneu.20956; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; SIMPSON HB, 1991, J NEUROBIOL, V22, P755, DOI 10.1002/neu.480220710; SIMPSON HB, 1991, J NEUROBIOL, V22, P777, DOI 10.1002/neu.480220711; Sohrabji F, 2006, FRONT NEUROENDOCRIN, V27, P404, DOI 10.1016/j.yfrne.2006.09.003; Solum DT, 2002, J NEUROSCI, V22, P2650, DOI 10.1523/JNEUROSCI.22-07-02650.2002; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Tang YP, 2011, J NEUROENDOCRINOL, V23, P584, DOI 10.1111/j.1365-2826.2011.02146.x; Tang YP, 2010, NEUROSCIENCE, V171, P1131, DOI 10.1016/j.neuroscience.2010.10.014; Tang YP, 2007, DEV NEUROBIOL, V67, P474, DOI 10.1002/dneu.20354; Tang YP, 2006, BRAIN RES, V1126, P102, DOI 10.1016/j.brainres.2006.08.002; Tang YP, 2009, DEV NEUROBIOL, V69, P462, DOI 10.1002/dneu.20721; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tomaszycki ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-24; TORANALLERAND CD, 1992, P NATL ACAD SCI USA, V89, P4668, DOI 10.1073/pnas.89.10.4668; Wade J, 1999, HORM BEHAV, V36, P141, DOI 10.1006/hbeh.1999.1537; Wade J, 1996, P NATL ACAD SCI USA, V93, P5264, DOI 10.1073/pnas.93.11.5264; Wade J, 2000, J CHEM NEUROANAT, V19, P33, DOI 10.1016/S0891-0618(00)00051-X; WADE J, 1994, GEN COMP ENDOCR, V94, P53, DOI 10.1006/gcen.1994.1059; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; Wade J, 2001, MICROSC RES TECHNIQ, V54, P354, DOI 10.1002/jemt.1148; Wissman AM, 2009, J NEUROSCI, V29, P6461, DOI 10.1523/JNEUROSCI.0638-09.2009; Wu D, 2010, BRAIN RES, V1343, P104, DOI 10.1016/j.brainres.2010.04.084; Xu ZQ, 2011, EUR J NEUROSCI, V33, P1376, DOI 10.1111/j.1460-9568.2011.07635.x; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	71	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43687	10.1371/journal.pone.0043687	http://dx.doi.org/10.1371/journal.pone.0043687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952738	gold, Green Published			2022-12-27	WOS:000308221300023
J	Rogalski, MA; Skelly, DK				Rogalski, Mary Alta; Skelly, David Kiernan			Positive Effects of Nonnative Invasive Phragmites australis on Larval Bullfrogs	PLOS ONE			English	Article							COMMON REED; TYPHA-ANGUSTIFOLIA; EXPERIMENTAL VENUE; TIDAL MARSHES; PLANT; FISH; CONSERVATION; RESTORATION; PERFORMANCE; RESPONSES	Background: Nonnative Phragmites australis (common reed) is one of the most intensively researched and managed invasive plant species in the United States, yet as with many invasive species, our ability to predict, control or understand the consequences of invasions is limited. Rapid spread of dense Phragmites monocultures has prompted efforts to limit its expansion and remove existing stands. Motivation for large-scale Phragmites eradication programs includes purported negative impacts on native wildlife, a view based primarily on observational results. We took an experimental approach to test this assumption, estimating the effects of nonnative Phragmites australis on a native amphibian. Methodology/Principal Findings: Concurrent common garden and reciprocal transplant field experiments revealed consistently strong positive influences of Phragmites on Rana catesbeiana (North American bullfrog) larval performance. Decomposing Phragmites litter appears to contribute to the effect. Conclusions/Significance: Positive effects of Phragmites merit further research, particularly in regions where both Phragmites and R. catesbeiana are invasive. More broadly, the findings of this study reinforce the importance of experimental evaluations of the effects of biological invasion to make informed conservation and restoration decisions.	[Rogalski, Mary Alta; Skelly, David Kiernan] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Yale University	Rogalski, MA (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	mary.rogalski@yale.edu	Skelly, David/D-3878-2013	Rogalski, Mary/0000-0003-1728-3409	Norcross Wildlife Foundation A.V. Stout Fund; Yale School of Forestry & Environmental Studies Carpenter/Sperry Fund	Norcross Wildlife Foundation A.V. Stout Fund; Yale School of Forestry & Environmental Studies Carpenter/Sperry Fund	Norcross Wildlife Foundation A.V. Stout Fund (http://www.norcrossws.org/Grants/Andystout.htm) and the Yale School of Forestry & Environmental Studies Carpenter/Sperry Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Michael J., 2007, V2, P679; Adams MJ, 2000, ECOL APPL, V10, P559, DOI 10.1890/1051-0761(2000)010[0559:PPATEO]2.0.CO;2; Ailstock MS, 2001, RESTOR ECOL, V9, P49, DOI 10.1046/j.1526-100x.2001.009001049.x; Alford RA, 1999, TADPOLES, P240; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Brown CJ, 2006, BIOL INVASIONS, V8, P327, DOI 10.1007/s10530-004-8244-x; Brown JH, 2004, AUSTRAL ECOL, V29, P530, DOI 10.1111/j.1442-9993.2004.01340.x; Bruno JF, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P13; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; CLARKSON RW, 1986, J HERPETOL, V20, P42, DOI 10.2307/1564123; Cohen JS, 2012, ECOL APPL, V22, P218, DOI 10.1890/11-0078.1; Fell PE, 2003, ESTUARIES, V26, P534, DOI 10.1007/BF02823729; Freidenburg LK, 2004, ECOL LETT, V7, P369, DOI 10.1111/j.1461-0248.2004.00587.x; Gosner K. L., 1960, Herpetologica, V16, P183; Gratton C, 2006, ECOL APPL, V16, P622, DOI 10.1890/1051-0761(2006)016[0622:AFWRFR]2.0.CO;2; HANSEN RM, 1978, PALEOBIOLOGY, V4, P302, DOI 10.1017/S0094837300006011; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hunter KL, 2006, ESTUAR COAST, V29, P487, DOI 10.1007/BF02784996; Jivoff PR, 2003, ESTUARIES, V26, P587, DOI 10.1007/BF02823733; KAY SH, 1995, J AQUAT PLANT MANAGE, V33, P25; Kennedy TA, 2004, FRESHWATER BIOL, V49, P65, DOI 10.1046/j.1365-2426.2003.01166.x; Kulesza AE, 2006, WETLANDS, V26, P1079, DOI 10.1672/0277-5212(2006)26[1079:APRTDL]2.0.CO;2; Larson BMH, 2007, BIOL INVASIONS, V9, P947, DOI 10.1007/s10530-007-9095-z; Lawler SP, 1999, CONSERV BIOL, V13, P613, DOI 10.1046/j.1523-1739.1999.98075.x; Maerz JC, 2005, FUNCT ECOL, V19, P970, DOI 10.1111/j.1365-2435.2005.01054.x; Maerz JC, 2010, FRESHWATER BIOL, V55, P1694, DOI 10.1111/j.1365-2427.2010.02404.x; Maret TJ, 2006, BIOL CONSERV, V127, P129, DOI 10.1016/j.biocon.2005.08.003; MARKS M, 1994, NAT AREA J, V14, P285; Marris E, 2005, NATURE, V438, P272, DOI 10.1038/438272a; Meyerson L.A., 2009, HUMAN IMPACTS SALT M, P57; Meyerson LA, 2000, WETLANDS ECOLOGY MAN, V8, P89, DOI DOI 10.1023/A:1008432200133; Miller JR, 2007, RESTOR ECOL, V15, P382, DOI 10.1111/j.1526-100X.2007.00234.x; Osgood DT, 2003, ESTUARIES, V26, P522, DOI 10.1007/BF02823728; Parsons KC, 2003, ESTUARIES, V26, P596, DOI 10.1007/BF02823734; Paxton BJ., 2006, CTR CONSERVATION BIO; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Robertson TL, 2005, WETLANDS, V25, P1, DOI 10.1672/0277-5212(2005)025[0001:ACOECA]2.0.CO;2; ROMAN CT, 1984, ENVIRON MANAGE, V8, P141, DOI 10.1007/BF01866935; Rudrappa T, 2007, J CHEM ECOL, V33, P1898, DOI 10.1007/s10886-007-9353-7; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Saltonstall Kristin, 2004, SIDA Contributions to Botany, V21, P683; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Skelly DK, 2000, ECOL LETT, V3, P483, DOI 10.1046/j.1461-0248.2000.00186.x; Skelly DK, 2003, HERPETOLOGICA, V59, P37, DOI 10.1655/0018-0831(2003)059[0037:AONBSB]2.0.CO;2; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Townsend CR, 2003, CONSERV BIOL, V17, P38, DOI 10.1046/j.1523-1739.2003.02017.x; WEBSTER JR, 1986, ANNU REV ECOL SYST, V17, P567, DOI 10.1146/annurev.es.17.110186.003031; Weinstein MP, 1999, ESTUARIES, V22, P793, DOI 10.2307/1353112; Weis JS, 2003, MAR POLLUT BULL, V46, P816, DOI 10.1016/S0025-326X(03)00036-5; Weis Judith S., 2002, Wetlands Ecology and Management, V10, P71, DOI 10.1023/A:1014311521708; Windham L, 2003, ESTUARIES, V26, P452, DOI 10.1007/BF02823722	54	24	24	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44420	10.1371/journal.pone.0044420	http://dx.doi.org/10.1371/journal.pone.0044420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952976	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206500070
J	Yaseen, ZS; Fisher, K; Morales, E; Galynker, II				Yaseen, Zimri S.; Fisher, Karin; Morales, Esperanza; Galynker, Igor I.			Love and Suicide: The Structure of the Affective Intensity Rating Scale (AIRS) and Its Relation to Suicidal Behavior	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; CIRCUMPLEX MODEL; AFFECTIVE STATES; RISK-FACTORS; DSM-IV; RELIABILITY; VALIDITY; BIPOLAR; SCHIZOPHRENIA; PREDICTORS	Background: Suicide has been linked to intense negative affect. However, little is known about the range of affects experienced by suicidal persons, or the separate effects of affect valence and intensity. We examine a novel self-report scale, the 17-item Affective Intensity Rating Scale (AIRS), and its relation to suicidality in a high-risk sample. Methodology/Principal Findings: Patients presenting with suicidality were recruited from the Emergency Department in a large urban hospital, and completed a battery of assessments there. Structure of the AIRS was assessed using Maximum Likelihood Factor Analysis with Oblimin rotation. Convergent and divergent validity were assessed by regressing AIRS subscales against Brief Symptom Inventory subscales. Relation to suicidality was assessed by regression of suicide attempt status against scale and subscale scores, and individual items and two-way item interactions, along with significant clinical and demographic factors. 176 subjects were included in analyses. Three reliable subscales were identified within the AIRS measure: positive feelings towards self, negative feelings towards self, and negative feelings towards other. Only individual AIRS items associated significantly with suicide attempt status; strong 'feelings of love' associated positively with actual suicide attempt, while 'feelings of calm' and 'positive feelings towards self' associated negatively. Interaction analyses suggest 'calm' moderates the association of 'love' with suicide attempt. Conclusions/Significance: Factor analysis of the AIRS is consistent with a circumplex model of affect. Affective dimensions did not predict suicidal behavior, but intense feelings of love, particularly in the absence of protective feelings of calm or positive self-view associated with current attempt.	[Yaseen, Zimri S.; Fisher, Karin; Morales, Esperanza; Galynker, Igor I.] Beth Israel Deaconess Med Ctr, Dept Psychiat & Behav Sci, New York, NY 10003 USA	Harvard University; Beth Israel Deaconess Medical Center	Yaseen, ZS (corresponding author), Beth Israel Deaconess Med Ctr, Dept Psychiat & Behav Sci, New York, NY 10003 USA.	zsyaseen@gmail.com	Galynker, Igor/AAC-9629-2021	Yaseen, Zimri/0000-0003-4103-2511	American Foundation for Suicide Prevention [AFSP 1-SRG-xxxx-00139]	American Foundation for Suicide Prevention	This study was supported by grant AFSP 1-SRG-xxxx-00139 from the American Foundation for Suicide Prevention awarded to IIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2005, PROG NEUROBIOL, V77, P283, DOI 10.1016/j.pneurobio.2005.11.005; BACHOROWSKI JA, 1994, PERS INDIV DIFFER, V17, P191, DOI 10.1016/0191-8869(94)90025-6; Bolton JM, 2010, J PSYCHIATR RES, V44, P817, DOI 10.1016/j.jpsychires.2010.01.003; Buunk BP, 1996, PSYCHOL SCI, V7, P359, DOI 10.1111/j.1467-9280.1996.tb00389.x; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Canetto SS, 2002, J PSYCHOL, V136, P573, DOI 10.1080/00223980209605552; Chatard A, 2011, J PERS SOC PSYCHOL, V100, P587, DOI 10.1037/a0022461; Chen YW, 1996, BIOL PSYCHIAT, V39, P896, DOI 10.1016/0006-3223(95)00295-2; Cheniaux E, 2009, PSYCHOPATHOLOGY, V42, P293, DOI 10.1159/000228838; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; COYNE JC, 1976, J ABNORM PSYCHOL, V85, P186, DOI 10.1037/0021-843X.85.2.186; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Fisher HE, 2010, J NEUROPHYSIOL, V104, P51, DOI 10.1152/jn.00784.2009; FLETT GL, 1995, PERS INDIV DIFFER, V19, P585, DOI 10.1016/0191-8869(95)00089-O; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; G Atlanta, 2008, GA CTR DIS CONTR PRE; Galynker II, 2011, SOC COGN AFFECT NEUR; Hall RCW, 1999, PSYCHOSOMATICS, V40, P18, DOI 10.1016/S0033-3182(99)71267-3; Hendin H, 2004, SUICIDE LIFE-THREAT, V34, P386, DOI 10.1521/suli.34.4.386.53734; Hendin H, 2007, J NERV MENT DIS, V195, P363, DOI 10.1097/NMD.0b013e318052264d; Hendin H, 2010, J NERV MENT DIS, V198, P220, DOI 10.1097/NMD.0b013e3181d13d14; Hirsch JK, 2007, PSYCHOL AGING, V22, P380, DOI 10.1037/0882-7974.22.2.380; Holma KM, 2010, AM J PSYCHIAT, V167, P801, DOI 10.1176/appi.ajp.2010.09050627; KAHN J, 1985, J SOC PERS RELAT, V2, P447, DOI 10.1177/0265407585024005; Katz C, 2011, J CLIN PSYCHIAT, V72, P1628, DOI 10.4088/JCP.10m06186blu; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Kring AM, 2008, SCHIZOPHRENIA BULL, V34, P819, DOI 10.1093/schbul/sbn071; LARSEN RJ, 1987, J RES PERS, V21, P1, DOI 10.1016/0092-6566(87)90023-7; LARSEN RJ, 1985, PERS INDIV DIFFER, V6, P631, DOI 10.1016/0191-8869(85)90013-3; LIEBERMAN PB, 1985, HOSP COMMUNITY PSYCH, V36, P291; Lizardi D, 2011, ACTA PSYCHIAT SCAND, V124, P295, DOI 10.1111/j.1600-0447.2011.01724.x; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Meadows LA, 2005, AM J COMMUN PSYCHOL, V36, P109, DOI 10.1007/s10464-005-6236-3; Mikulincer M, 2002, J PERS SOC PSYCHOL, V83, P881, DOI 10.1037//0022-3514.83.4.881; Mundt JC, 2010, J PSYCHIATR RES, V44, P1224, DOI 10.1016/j.jpsychires.2010.04.025; Oquendo MA, 2004, AM J PSYCHIAT, V161, P1433, DOI 10.1176/appi.ajp.161.8.1433; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Rude SS, 2002, COGNITION EMOTION, V16, P423, DOI 10.1080/02699930143000554; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sanger S, 2008, ARCH SUICIDE RES, V12, P352, DOI 10.1080/13811110802325232; Siegel K, 1999, AIDS EDUC PREV, V11, P53; Simon RI, 2006, SUICIDE LIFE-THREAT, V36, P296, DOI 10.1521/suli.2006.36.3.296; Spiliotopoulou G, 2009, AUST OCCUP THER J, V56, P150, DOI 10.1111/j.1440-1630.2009.00785.x; STRACK S, 1983, J PERS SOC PSYCHOL, V44, P798, DOI 10.1037/0022-3514.44.4.798; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027092; WARNER MD, 1995, PSYCHIATR SERV, V46, P1284; Weiner B, 2000, EDUC PSYCHOL REV, V12, P1, DOI 10.1023/A:1009017532121; Yaseen Z, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-110; Zouk H, 2006, J AFFECT DISORDERS, V92, P195, DOI 10.1016/j.jad.2006.01.016	50	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44069	10.1371/journal.pone.0044069	http://dx.doi.org/10.1371/journal.pone.0044069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZC	22952877	Green Published, gold			2022-12-27	WOS:000308206000078
J	Zheng, BB; Wu, XM; Ge, XX; Deng, XX; Grosser, JW; Guo, WW				Zheng, Bei-Bei; Wu, Xiao-Meng; Ge, Xiao-Xia; Deng, Xiu-Xin; Grosser, Jude W.; Guo, Wen-Wu			Comparative Transcript Profiling of a Male Sterile Cybrid Pummelo and Its Fertile Type Revealed Altered Gene Expression Related to Flower Development	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; CITRUS-UNSHIU MARC.; SATSUMA MANDARIN; BRASSICA-NAPUS; MOLECULAR CHARACTERIZATION; HOMEOTIC GENES; SWEET ORANGE; RNA-SEQ; MITOCHONDRIAL GENOMES; POLLEN DEVELOPMENT	Male sterile and seedless characters are highly desired for citrus cultivar improvement. In our breeding program, a male sterile cybrid pummelo, which could be considered as a variant of male fertile pummelo, was produced by protoplast fusion. Herein, ecotopic stamen primordia initiation and development were detected in this male sterile cybrid pummelo. Histological studies revealed that the cybrid showed reduced petal development in size and width, and retarded stamen primordia development. Additionally, disorganized cell proliferation was also detected in stamen-like structures (fused to petals and/or carpel). To gain new insight into the underlying mechanism, we compared, by RNA-Seq analysis, the nuclear gene expression profiles of floral buds of the cybrid with that of fertile pummelo. Gene expression profiles which identified a large number of differentially expressed genes (DEGs) between the two lines were captured at both petal primordia and stamen primordia distinguishable stages. For example, nuclear genes involved in nucleic acid binding and response to hormone synthesis and metabolism, genes required for floral bud identification and expressed in particular floral whorls. Furthermore, in accordance with flower morphology of the cybrid, expression of PISTILLATA (PI) was reduced in stamen-like structures, even though it was restricted to correct floral whorls. Down-regulated expression of APETALA3 (AP3) coincided with that of PI. These finding indicated that, due to their whorl specific effects in flower development, citrus class-B MADS-box genes likely constituted 'perfect targets' for CMS retrograde signaling, and that dysfunctional mitochondria seemed to cause male sterile phenotype in the cybrid pummelo.	[Zheng, Bei-Bei; Wu, Xiao-Meng; Ge, Xiao-Xia; Deng, Xiu-Xin; Guo, Wen-Wu] Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China; [Zheng, Bei-Bei; Wu, Xiao-Meng; Ge, Xiao-Xia; Deng, Xiu-Xin; Guo, Wen-Wu] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Grosser, Jude W.] Univ Florida, Citrus Res & Educ Ctr, Lake Alfred, FL USA	Huazhong Agricultural University; State University System of Florida; University of Florida	Zheng, BB (corresponding author), Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	guoww@mail.hzau.edu.cn		Xiuxin, Deng/0000-0003-4490-4514	Ministry of Science and Technology of China [2011CB100606, 2011AA100205]; National NSF of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National NSF of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the Ministry of Science and Technology of China (2011CB100606, 2011AA100205) and the National NSF of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, J EXP BOT, V60, P1085, DOI 10.1093/jxb/ern301; [Anonymous], 2011, HAPL CLEM GEN; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bassene JB, 2011, PLANT CELL REP, V30, P1077, DOI 10.1007/s00299-011-1014-1; Benjamini Y, 2001, ANN STAT, V29, P1165; Bentolila S, 2012, PLANT PHYSIOL, V158, P996, DOI 10.1104/pp.111.190231; Cabasson CM, 2001, PLANT CELL REP, V20, P604; Cai XD, 2007, PLANT CELL TISS ORG, V90, P275, DOI 10.1007/s11240-007-9266-8; Cai XD, 2009, SCI HORTIC-AMSTERDAM, V122, P323, DOI 10.1016/j.scienta.2009.05.017; Carlsson J, 2008, MITOCHONDRION, V8, P74, DOI 10.1016/j.mito.2007.09.006; Carlsson J, 2007, PLANT J, V49, P452, DOI 10.1111/j.1365-313X.2006.02975.x; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Dambier D, 2011, PLANT CELL REP, V30, P883, DOI 10.1007/s00299-010-1000-z; Desgagne-Penix I, 2008, J EXP BOT, V59, P2057, DOI 10.1093/jxb/ern063; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Fu J, 2011, PLANT BREEDING, V130, P287, DOI 10.1111/j.1439-0523.2010.01773.x; Ge XX, 2010, ACTA PHYSIOL PLANT, V32, P1197, DOI 10.1007/s11738-010-0515-9; Grosser J. W., 1990, Plant Breeding Reviews, V8, P339; Grosser JW, 2011, PLANT CELL TISS ORG, V104, P343, DOI 10.1007/s11240-010-9823-4; Grosser JW, 1996, PLANT CELL REP, V15, P672, DOI 10.1007/BF00231922; Guo WenWu, 2000, Acta Horticulturae Sinica, V27, P487; Guo WW, 2004, PLANT CELL REP, V22, P752, DOI 10.1007/s00299-003-0747-x; Hama E, 2004, PLANTA, V218, P712, DOI 10.1007/s00425-003-1157-6; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hu JH, 2008, PLANT CELL, V20, P320, DOI 10.1105/tpc.107.057752; Huerta L, 2009, TREE PHYSIOL, V29, P569, DOI 10.1093/treephys/tpn049; Jing B, 2012, J EXP BOT, V63, P1285, DOI 10.1093/jxb/err355; Koshita Y, 2004, SCI HORTIC-AMSTERDAM, V99, P301, DOI 10.1016/S0304-4238(03)00113-4; Koshita Y, 1999, SCI HORTIC-AMSTERDAM, V79, P185, DOI 10.1016/S0304-4238(98)00209-X; Lamb RS, 2002, DEVELOPMENT, V129, P2079; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Linke B, 2005, MITOCHONDRION, V5, P389, DOI 10.1016/j.mito.2005.10.001; Linke B, 2003, PLANT J, V34, P27, DOI 10.1046/j.1365-313X.2003.01703.x; Liu GY, 2009, PLANT CELL, V21, P2672, DOI 10.1105/tpc.108.060079; Liu Q, 2007, J EXP BOT, V58, P4161, DOI 10.1093/jxb/erm273; Moreira CD, 2000, MOL BREEDING, V6, P401, DOI 10.1023/A:1009632223708; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murai K, 2002, PLANT J, V29, P169, DOI 10.1046/j.0960-7412.2001.01203.x; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ng M, 2001, PLANT CELL, V13, P739, DOI 10.1105/tpc.13.4.739; Olimpieri I, 2011, PLANT SCI, V180, P496, DOI 10.1016/j.plantsci.2010.11.004; Pfluger J, 2004, DEVELOPMENT, V131, P4697, DOI 10.1242/dev.01306; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; Teixeira RT, 2005, PLANT J, V42, P731, DOI 10.1111/j.1365-313X.2005.02407.x; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Vidal AM, 2003, PLANTA, V217, P442, DOI 10.1007/s00425-003-0999-2; Wang L, 2010, PLANT CELL TISS ORG, V103, P165, DOI 10.1007/s11240-010-9764-y; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Yamamoto M, 1997, SCI HORTIC-AMSTERDAM, V70, P9, DOI 10.1016/S0304-4238(97)00017-4; Yang JH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-231; Yang XY, 2007, PLANT CELL REP, V26, P219, DOI 10.1007/s00299-006-0229-z; Yi B, 2010, PLANT J, V63, P925, DOI 10.1111/j.1365-313X.2010.04289.x; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zsigmond L, 2008, PLANT PHYSIOL, V146, P1721, DOI 10.1104/pp.107.111260; Zubko MK, 1996, J EXP BOT, V47, P1101, DOI 10.1093/jxb/47.8.1101	66	53	56	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43758	10.1371/journal.pone.0043758	http://dx.doi.org/10.1371/journal.pone.0043758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952758	gold, Green Submitted, Green Published			2022-12-27	WOS:000308213600041
J	Lechene, CP; Lee, GY; Poczatek, JC; Toner, M; Biggers, JD				Lechene, Claude P.; Lee, Gloria Y.; Poczatek, J. Collin; Toner, Mehmet; Biggers, John D.			3D Multi-isotope Imaging Mass Spectrometry Reveals Penetration of O-18-Trehalose in Mouse Sperm Nucleus	PLOS ONE			English	Article							SPERMATOZOA; PORE; CELLS	The prevalence of genetically engineered mice in medical research has led to ever increasing storage costs. Trehalose has a significant beneficial effect in preserving the developmental potential of mouse sperm following partial desiccation and storage at temperatures above freezing. Using multi-isotope imaging mass spectrometry, we are able to image and measure trehalose in individual spermatozoa. We provide the first evidence that trehalose penetrates the nucleus of a mammalian cell, permitting tolerance to desiccation. These results have broad implications for long-term storage of mammalian cells.	[Lechene, Claude P.; Poczatek, J. Collin] Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Cambridge, MA 02138 USA; [Lee, Gloria Y.; Toner, Mehmet] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Biggers, John D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lechene, CP (corresponding author), Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Cambridge, MA 02138 USA.	cpl@harvard.edu			NIH/NIBIB [5P41 EB001974-10]; NIH/NIA [1R21AG034641-01]; NIH/NCRR [5 R24 RR018934]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR018934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034641] Funding Source: NIH RePORTER	NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded through the following grants: NIH/NIBIB 5P41 EB001974-10, NIH/NIA 1R21AG034641-01 and NIH/NCRR 5 R24 RR018934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 1996, MOL REPROD DEV, V45, P87, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;87::AID-MRD12&gt;3.0.CO;2-U; Bagchi B, 2005, CHEM REV, V105, P3197, DOI 10.1021/cr020661+; Cheng J, 2006, J PHYS CHEM B, V110, P8329, DOI 10.1021/jp0573341; Cheng J, 2005, ANAL CHEM, V77, P3651, DOI 10.1021/ac048131w; Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353; Elmoazzen HY, 2009, CRYOBIOLOGY, V59, P113, DOI 10.1016/j.cryobiol.2009.03.005; FAWCETT DW, 1965, AM J ANAT, V116, P567, DOI 10.1002/aja.1001160306; Ho HC, 2010, J ANAT, V216, P525, DOI 10.1111/j.1469-7580.2009.01204.x; Hochi S, 2011, J REPROD DEVELOP, V57, P557, DOI 10.1262/jrd.11-061O; Knight J, 2002, NATURE, V417, P785, DOI 10.1038/417785a; Kusakabe H, 2001, P NATL ACAD SCI USA, V98, P13501, DOI 10.1073/pnas.241517598; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Lelong G, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2753841; Li MW, 2007, REPRODUCTION, V133, P919, DOI 10.1530/REP-06-0096; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029924; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Russo MJ, 1997, NAT BIOTECHNOL, V15, P278, DOI 10.1038/nbt0397-278; Shaman JA, 2007, ARCH ANDROLOGY, V53, P135, DOI 10.1080/01485010701329378; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745	23	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42267	10.1371/journal.pone.0042267	http://dx.doi.org/10.1371/journal.pone.0042267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952592	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800006
J	Li, YF; Wang, DD; Zhao, BW; Wang, W; Yuan, SQ; Huang, CY; Chen, YM; Zheng, Y; Keshari, RP; Xia, JC; Zhou, ZW				Li, Yuan-fang; Wang, Dan-dan; Zhao, Bai-wei; Wang, Wei; Yuan, Shu-qiang; Huang, Chun-yu; Chen, Yong-ming; Zheng, Yan; Keshari, Rajiv Prasad; Xia, Jian-chuan; Zhou, Zhi-wei			Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR	PLOS ONE			English	Article							HYDROCARBON RECEPTOR REPRESSOR; GENE-EXPRESSION; CANCER; IDENTIFICATION; SURVIVAL; PROFILE	Background: The aryl hydrocarbon receptor (AHR) repressor (AHRR), a member of growing superfamily, is a basic-helix-loop-helix/Per-AHR nuclear translocator (ARNT)-Sim (bHLH-PAS) protein. Recently, AHRR has been proposed to function as a putative new tumor suppressor gene based on some relevant studies in multiple types of human cancers. This current study aims to investigate AHHR expression and its prognostic significance in primary gastric adenocarcinoma. Methodology/Principal Findings: The expression level of AHRR was analyzed using real-time quantitative PCR (RT-qPCR), western blotting, and immunohistochemical staining. It was clearly showed that the expression status of AHRR was reduced in tumor tissue samples compared with that in matched adjacent non-tumor tissue samples by RT-qPCR (P = 0.0423) and western blotting analysis (P = 0.004). Moreover, data revealed that AHRR without exon 8 (the active isoform) was the predominant form either in tumor tissues (66.7%, 8/12) or in matched adjacent non-tumor tissues (100.0%, 12/12), and the mRNA level of this isoform was significantly reduced in tumor tissues (P = 0.006). Immunohistochemistry analysis indicated that AHRR expression was significantly decreased in 175 of 410 (42.7%) gastric adenocarcinoma cases. Kaplan-Meier survival curves and Multivariate Cox analysis revealed that decreased expression of AHRR was significantly associated with poor prognosis in gastric adenocarcinoma patients. Conclusions/Significance: Our data suggests that, in primary gastric adenocarcinoma, AHRR may play as a suppressor gene and its expression status has the potential to be an independent prognostic factor.	[Li, Yuan-fang; Wang, Dan-dan; Zhao, Bai-wei; Wang, Wei; Yuan, Shu-qiang; Huang, Chun-yu; Chen, Yong-ming; Zheng, Yan; Keshari, Rajiv Prasad; Xia, Jian-chuan; Zhou, Zhi-wei] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuan-fang; Wang, Dan-dan; Zhao, Bai-wei; Wang, Wei; Yuan, Shu-qiang; Huang, Chun-yu; Chen, Yong-ming; Zheng, Yan; Keshari, Rajiv Prasad; Xia, Jian-chuan; Zhou, Zhi-wei] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuan-fang; Zhao, Bai-wei; Wang, Wei; Yuan, Shu-qiang; Huang, Chun-yu; Chen, Yong-ming; Zheng, Yan; Keshari, Rajiv Prasad; Zhou, Zhi-wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, YF (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	xiajch@sysucc.org.cn; zhouzhw@sysucc.org.cn	Li, Yuan/GXV-1310-2022; Chen, Yongming/E-3656-2015	Chen, Yongming/0000-0003-2843-5543	Guangdong Province Science and Technology Project [2009B080701006]	Guangdong Province Science and Technology Project	This work was supported by the Guangdong Province Science and Technology Project (2009B080701006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila MA, 2000, BRIT J CANCER, V82, P1974; Cauchi S, 2003, PHARMACOGENETICS, V13, P339, DOI 10.1097/00008571-200306000-00005; Chen CN, 2005, J CLIN ONCOL, V23, P7286, DOI 10.1200/JCO.2004.00.2253; Currier N, 2005, TOXICOL PATHOL, V33, P726, DOI 10.1080/01926230500352226; Evans BR, 2005, ARCH BIOCHEM BIOPHYS, V441, P151, DOI 10.1016/j.abb.2005.07.008; Fujita H, 2002, TERATOLOGY, V65, P10, DOI 10.1002/tera.1093; Haarmann-Stemmann T, 2007, DRUG METAB DISPOS, V35, P2262, DOI 10.1124/dmd.107.016253; Haarmann-Stemmann T, 2006, BIOL CHEM, V387, P1195, DOI 10.1515/BC.2006.147; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hippo Y, 2002, CANCER RES, V62, P233; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karchner SI, 2009, MOL CELL BIOL, V29, P3465, DOI 10.1128/MCB.00206-09; Lee HS, 2007, CLIN CANCER RES, V13, P4154, DOI 10.1158/1078-0432.CCR-07-0173; Lee JS, 2011, TOXICOL SCI, V119, P319, DOI 10.1093/toxsci/kfq336; Liang Y, 2012, INT J CANCER, V130, P1745, DOI 10.1002/ijc.26166; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Monick MM, 2012, AM J MED GENET B, V159B, P141, DOI 10.1002/ajmg.b.32021; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Pellikainen J, 2002, CLIN CANCER RES, V8, P3487; Sanada N, 2009, J PHARMACOL SCI, V109, P380, DOI 10.1254/jphs.08328FP; STANBRIDGE EJ, 1990, SCIENCE, V247, P12, DOI 10.1126/science.2403692; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024897; Yasui Wataru, 2005, Gastric Cancer, V8, P86, DOI 10.1007/s10120-005-0320-0; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	29	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43555	10.1371/journal.pone.0043555	http://dx.doi.org/10.1371/journal.pone.0043555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952704	gold, Green Submitted, Green Published			2022-12-27	WOS:000308044800038
J	Su, HM; Tsai, WC; Lin, TH; Hsu, PC; Lee, WH; Lin, MY; Chen, SC; Lee, CS; Voon, WC; Lai, WT; Sheu, SH				Su, Ho-Ming; Tsai, Wei-Chung; Lin, Tsung-Hsien; Hsu, Po-Chao; Lee, Wen-Hsien; Lin, Ming-Yen; Chen, Szu-Chia; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			P Wave Dispersion and Maximum P Wave Duration Are Independently Associated with Rapid Renal Function Decline	PLOS ONE			English	Article							LEFT ATRIAL ENLARGEMENT; CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; BRACHIAL PREEJECTION PERIOD; GLOMERULAR-FILTRATION-RATE; EJECTION TIME PREDICTS; SERUM URIC-ACID; ELECTROCARDIOGRAPHIC DIAGNOSIS; ECHOCARDIOGRAPHIC ASSESSMENT; DIASTOLIC DYSFUNCTION	The P wave parameters measured by 12-lead electrocardiogram (ECG) are commonly used as noninvasive tools to assess for left atrial enlargement. There are limited studies to evaluate whether P wave parameters are independently associated with decline in renal function. Accordingly, the aim of this study is to assess whether P wave parameters are independently associated with progression to renal end point of >= 25% decline in estimated glomerular filtration rate (eGFR). This longitudinal study included 166 patients. The renal end point was defined as >= 25% decline in eGFR. We measured two ECG P wave parameters corrected by heart rate, i.e. corrected P wave dispersion (PWdisperC) and corrected P wave maximum duration (PWdurMaxC). Heart function and structure were measured from echocardiography. Clinical data, P wave parameters, and echocardiographic measurements were compared and analyzed. Forty-three patients (25.9%) reached renal end point. Kaplan-Meier curves for renal end point-free survival showed PWdisperC > median (63.0 ms) (log-rank P = 0.004) and PWdurMaxC > median (117.9 ms) (log-rank P < 0.001) were associated with progression to renal end point. Multivariate forward Cox-regression analysis identified increased PWdisperC (hazard ratio [HR], 1.024; P = 0.001) and PWdurMaxC (HR, 1.029; P = 0.001) were independently associated with progression to renal end point. Our results demonstrate that increased PWdisperC and PWdurMaxC were independently associated with progression to renal end point. Screening patients by means of PWdisperC and PWdurMaxC on 12 lead ECG may help identify a high risk group of rapid renal function decline.	[Su, Ho-Ming; Tsai, Wei-Chung; Lin, Tsung-Hsien; Hsu, Po-Chao; Lee, Wen-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Div Cardiol, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Lin, Ming-Yen; Chen, Szu-Chia] Kaohsiung Med Univ, Div Nephrol, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Su, Ho-Ming; Chen, Szu-Chia] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung Municipal Hsiaokang Hosp, Kaohsiung, Taiwan; [Su, Ho-Ming; Lin, Tsung-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Fac Med, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Su, HM (corresponding author), Kaohsiung Med Univ, Div Cardiol, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.	scarchenone@yahoo.com.tw	Lin, Ming Yen/A-8637-2010; 蘇, 河名/AAE-9843-2019	Lin, Ming Yen/0000-0002-8194-4833; Lin, Tsung-Hsien/0000-0002-7226-8730; Su, Ho-Ming/0000-0003-0247-3250				ALPERT MA, 1989, ARCH INTERN MED, V149, P1161, DOI 10.1001/archinte.149.5.1161; Bazett HC, 1920, J PHYSIOL-LONDON, V53, P320, DOI 10.1113/jphysiol.1920.sp001881; Birkbeck JP, 2006, J ELECTROCARDIOL, V39, P225, DOI 10.1016/j.jelectrocard.2005.06.109; Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; BUXTON AE, 1981, CHEST, V80, P68, DOI 10.1378/chest.80.1.68; Chen SC, 2012, HYPERTENS R IN PRESS; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P2750, DOI 10.2215/CJN.04660511; Chen SC, 2011, HYPERTENS RES, V34, P1052, DOI 10.1038/hr.2011.95; Chen SC, 2010, CIRC J, V74, P2206, DOI 10.1253/circj.CJ-10-0273; Chen SC, 2010, HYPERTENS RES, V33, P492, DOI 10.1038/hr.2010.24; Cicoira M, 2002, AM HEART J, V143, P1107, DOI 10.1067/mhj.2002.122122; Dagli N, 2008, CLIN RES CARDIOL, V97, P98, DOI 10.1007/s00392-007-0587-8; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Faramawi MF, 2011, EUR J EPIDEMIOL, V26, P101, DOI 10.1007/s10654-010-9534-5; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Ford ML, 2010, HYPERTENSION, V55, P1110, DOI 10.1161/HYPERTENSIONAHA.109.143024; Furukawa M, 2011, NEPHRON CLIN PRACT, V117, pC341, DOI 10.1159/000321512; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gunduz H, 2005, TEX HEART I J, V32, P163; HAZEN MS, 1991, AM HEART J, V122, P823, DOI 10.1016/0002-8703(91)90531-L; JIN L, 1988, ARCH INTERN MED, V148, P1545, DOI 10.1001/archinte.148.7.1545; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; Khan NA, 2006, J AM SOC NEPHROL, V17, P244, DOI 10.1681/ASN.2005030270; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Koz C, 2008, SOUTH MED J, V101, P246, DOI 10.1097/SMJ.0b013e3181647071; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Magnani JW, 2011, AM J CARDIOL, V107, P917, DOI 10.1016/j.amjcard.2010.10.075; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Nakagawa T, 2006, BLOOD PURIFICAT, V24, P67, DOI 10.1159/000089440; Paoletti E, 2011, NEPHROL DIAL TRANSPL, V26, P670, DOI 10.1093/ndt/gfq409; Patane S, 2011, INT J CARDIOL, V149, P241, DOI 10.1016/j.ijcard.2010.10.126; Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447; Ronco C, 2010, CONTRIB NEPHROL, V164, P33, DOI 10.1159/000313718; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Su HM, 2012, AM J HYPERT IN PRESS; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Truong QA, 2011, J ELECTROCARDIOL, V44, P257, DOI 10.1016/j.jelectrocard.2010.04.011; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; WAGGONER AD, 1976, CIRCULATION, V54, P553, DOI 10.1161/01.CIR.54.4.553; Yilmaz R, 2004, ANN NONINVAS ELECTRO, V9, P330, DOI 10.1111/j.1542-474X.2004.94568.x; Yjrn DH, 2007, YONSEI MED J, V48, P810, DOI 10.3349/ymj.2007.48.5.810; Zeng CL, 2003, ACTA CARDIOL, V58, P139, DOI 10.2143/AC.58.2.2005266	47	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42815	10.1371/journal.pone.0042815	http://dx.doi.org/10.1371/journal.pone.0042815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952614	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800014
J	Yoon, JA; Han, DH; Noh, JY; Kim, MH; Son, GH; Kim, K; Kim, CJ; Pak, YK; Cho, S				Yoon, Ji-Ae; Han, Dong-Hee; Noh, Jong-Yun; Kim, Mi-Hee; Son, Gi Hoon; Kim, Kyungjin; Kim, Chang-Ju; Pak, Youngmi Kim; Cho, Sehyung			Meal Time Shift Disturbs Circadian Rhythmicity along with Metabolic and Behavioral Alterations in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; CENTRAL PACEMAKER; FOOD-INTAKE; JET-LAG; CLOCK; WORK; OBESITY; GENE; EXPRESSION; GLUCOSE	In modern society, growing numbers of people are engaged in various forms of shift works or trans-meridian travels. Such circadian misalignment is known to disturb endogenous diurnal rhythms, which may lead to harmful physiological consequences including metabolic syndrome, obesity, cancer, cardiovascular disorders, and gastric disorders as well as other physical and mental disorders. However, the precise mechanism(s) underlying these changes are yet unclear. The present work, therefore examined the effects of 6 h advance or delay of usual meal time on diurnal rhythmicities in home cage activity (HCA), body temperature (BT), blood metabolic markers, glucose homeostasis, and expression of genes that are involved in cholesterol homeostasis by feeding young adult male mice in a time-restrictive manner. Delay of meal time caused locomotive hyperactivity in a significant portion (42%) of subjects, while 6 h advance caused a torpor-like symptom during the late scotophase. Accordingly, daily rhythms of blood glucose and triglyceride were differentially affected by time-restrictive feeding regimen with concurrent metabolic alterations. Along with these physiological changes, time-restrictive feeding also influenced the circadian expression patterns of low density lipoprotein receptor (LDLR) as well as most LDLR regulatory factors. Strikingly, chronic advance of meal time induced insulin resistance, while chronic delay significantly elevated blood glucose levels. Taken together, our findings indicate that persistent shifts in usual meal time impact the diurnal rhythms of carbohydrate and lipid metabolisms in addition to HCA and BT, thereby posing critical implications for the health and diseases of shift workers.	[Yoon, Ji-Ae; Han, Dong-Hee; Noh, Jong-Yun; Kim, Mi-Hee; Pak, Youngmi Kim; Cho, Sehyung] Kyung Hee Univ, Dept Neurosci, Seoul, South Korea; [Yoon, Ji-Ae; Han, Dong-Hee; Noh, Jong-Yun; Kim, Mi-Hee; Pak, Youngmi Kim; Cho, Sehyung] Kyung Hee Univ, Neurodegenerat Control Res Ctr, Seoul, South Korea; [Son, Gi Hoon] Korea Univ, Coll Med, Dept Legal Med, Seoul 136705, South Korea; [Kim, Kyungjin] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Kim, Chang-Ju; Pak, Youngmi Kim; Cho, Sehyung] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Kyung Hee University	Yoon, JA (corresponding author), Kyung Hee Univ, Dept Neurosci, Seoul, South Korea.	sehyung@khu.ac.kr	Pak, Youngmi Kim/AAI-1091-2020; Kim, Chang Ju/M-4216-2017	Pak, Youngmi Kim/0000-0001-7424-3484; Kim, Chang Ju/0000-0003-4749-5795; Son, Gi Hoon/0000-0001-9758-5903	Korea Research Foundation (KRF); Korea government (MEST) [331-2006-1-C00212, 313-2007-2-C00625, 2008-0062417, 2009-0088886]	Korea Research Foundation (KRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Research Foundation (KRF) grants funded by Korea government (MEST) (Nos. 331-2006-1-C00212, 313-2007-2-C00625, 2008-0062417, 2009-0088886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Arble DM, 2010, BEST PRACT RES CL EN, V24, P785, DOI 10.1016/j.beem.2010.08.003; BALASUBRAMANIAM S, 1994, BIOCHEM J, V298, P39, DOI 10.1042/bj2980039; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cho S, 1998, MOL BRAIN RES, V54, P74, DOI 10.1016/S0169-328X(97)00325-2; Crispim CA, 2011, METABOLISM, V60, P1726, DOI 10.1016/j.metabol.2011.04.014; Culpepper L, 2010, J FAM PRACTICE, V59, pS3; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; DESIR D, 1981, J CLIN ENDOCR METAB, V52, P628, DOI 10.1210/jcem-52-4-628; Doi M, 2007, J BIOL RHYTHM, V22, P127, DOI 10.1177/0748730406298332; Dong XY, 2010, PEPTIDES, V31, P2145, DOI 10.1016/j.peptides.2010.07.020; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; Fortes PC, 2009, PERITON DIALYSIS INT, V29, pS145; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gluck EF, 2006, AM J PHYSIOL-REG I, V291, pR1303, DOI 10.1152/ajpregu.00232.2006; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gutman R, 2012, INT J OBESITY, V36, P1131, DOI 10.1038/ijo.2011.215; Habbal OA, 2009, INT REV IMMUNOL, V28, P93, DOI 10.1080/08830180802645050; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kalra SP, 2003, REGUL PEPTIDES, V111, P1, DOI 10.1016/S0167-0115(02)00305-1; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Matsumoto E, 2010, J BIOL CHEM, V285, P33028, DOI 10.1074/jbc.M109.089391; Mieda M, 2011, J NEUROSCI, V31, P15391, DOI 10.1523/JNEUROSCI.2801-11.2011; Murray G, 2010, BIPOLAR DISORD, V12, P459, DOI 10.1111/j.1399-5618.2010.00843.x; Nelson RJ, 2004, AM J PHYSIOL-REG I, V287, pR6, DOI 10.1152/ajpregu.00164.2004; Novakova M, 2011, CHRONOBIOL INT, V28, P630, DOI 10.3109/07420528.2011.596983; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Park N, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.005; Refinetti R., 2006, CIRCADIAN PHYSL, V2nd; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanchez-Alavez M, 2007, P NATL ACAD SCI USA, V104, P3009, DOI 10.1073/pnas.0611209104; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Sookoian S, 2007, WORLD J GASTROENTERO, V13, P4242, DOI 10.3748/wjg.v13.i31.4242; Swoap SJ, 2008, BIOCHEM PHARMACOL, V76, P817, DOI 10.1016/j.bcp.2008.06.017; Szosland D, 2010, INT J OCCUP MED ENV, V23, P287, DOI 10.2478/v10001-010-0032-5; Treuer T, 2010, EUR PSYCHIAT, V25, P328, DOI 10.1016/j.eurpsy.2009.11.012; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Van Cauter E, 2007, HORM RES, V67, P2, DOI 10.1159/000097543; Van Veen MM, 2010, BIOL PSYCHIAT, V67, P1091, DOI 10.1016/j.biopsych.2009.12.032; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Walters AS, 2008, J CLIN SLEEP MED, V4, P591; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	56	37	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44053	10.1371/journal.pone.0044053	http://dx.doi.org/10.1371/journal.pone.0044053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952870	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800091
J	Christensen, EA; Kulatunga, P; Lagerholm, BC				Christensen, Eva Arnspang; Kulatunga, Pasad; Lagerholm, B. Christoffer			A Single Molecule Investigation of the Photostability of Quantum Dots	PLOS ONE			English	Article							BLINKING; SUPERRESOLUTION; INTERMITTENCY; NANOCRYSTALS; DIFFUSION; TRACKING; PROTEIN	Quantum dots (QDs) are very attractive probes for multi-color fluorescence imaging in biological applications because of their immense brightness and reported extended photostability. We report here however that single QDs, suitable for biological applications, that are subject to continuous blue excitation from a conventional 100 W mercury arc lamp will undergo a continuous blue-switching of the emission wavelength eventually reaching a permanent dark, photobleached state. We further show that beta-mercaptoethanol has a dual stabilizing effect on the fluorescence emission of QDs: 1) by increasing the frequency of time that a QD is in its fluorescent state, and 2) by decreasing the photobleaching rate. The observed QD color spectral switching is especially detrimental for multi-color single molecule applications, as we regularly observe spectral blue-shifts of 50 nm, or more even after only ten seconds of illumination. However, of significant importance for biological applications, we find that even small, biologically compatible, concentrations (25 mu M) of beta-mercaptoethanol has a significant stabilizing effect on the emission color of QDs, but that greater amounts are required to completely abolish the spectral blue shifting or to minimize the emission intermittency of QDs.	[Christensen, Eva Arnspang; Lagerholm, B. Christoffer] Univ So Denmark, Dept Chem & Phys, Odense M, Denmark; [Christensen, Eva Arnspang; Lagerholm, B. Christoffer] Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, Odense M, Denmark; [Kulatunga, Pasad] Hobart & William Smith Coll, Dept Phys, Geneva, NY 14456 USA	University of Southern Denmark; University of Southern Denmark	Christensen, EA (corresponding author), Univ So Denmark, Dept Chem & Phys, Odense M, Denmark.	lagerholm@memphys.sdu.dk	Arnspang, Eva C/Y-1132-2018	Arnspang, Eva C/0000-0002-3095-4070; Lagerholm, Christoffer/0000-0003-4678-5168	Villum Kann Rasmussen Foundation; Leo Pharma Forskningsfond; Novo Nordisk Fonden; Danish Natural Research Foundation; Danish Ministry of Science; Lundbeckfonden	Villum Kann Rasmussen Foundation(Villum Fonden); Leo Pharma Forskningsfond(LEO Pharma); Novo Nordisk Fonden(Novo Nordisk Foundation); Danish Natural Research Foundation(Danish Natural Science Research Council); Danish Ministry of Science; Lundbeckfonden(Lundbeckfonden)	This work was supported with grants from the Villum Kann Rasmussen Foundation to BioNET - Danish Center for Biophysics, and grants from Leo Pharma Forskningsfond, Lundbeckfonden and Novo Nordisk Fonden to BCL. This work was carried out in the laboratories of MEMPHYS - Center for Biomembrane Physics which is funded by the Danish Natural Research Foundation and using microscopy equipment at the Danish Molecular Biomedical Imaging Center (DaMBIC) which is funded by the Danish Ministry of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y; Biebricher A, 2006, J PHYS CHEM B, V110, P5174, DOI 10.1021/jp060660b; Chen HP, 2009, CHEM COMMUN, P1676, DOI 10.1039/b819356h; Chen Y, 2008, J AM CHEM SOC, V130, P5026, DOI 10.1021/ja711379k; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Durisic N, 2007, BIOPHYS J, V93, P1338, DOI 10.1529/biophysj.107.106864; Durisic N, 2009, ACS NANO, V3, P1167, DOI 10.1021/nn800684z; Fomenko V, 2008, NANO LETT, V8, P287, DOI 10.1021/nl0726609; Hohng S, 2004, J AM CHEM SOC, V126, P1324, DOI 10.1021/ja039686w; Hoyer P, 2011, NANO LETT, V11, P245, DOI 10.1021/nl103639f; Inui K, 1997, CELL BIOL INT, V21, P419, DOI 10.1006/cbir.1997.0165; Jones M, 2003, J PHYS CHEM B, V107, P11346, DOI 10.1021/jp035598m; KATARI JEB, 1994, J PHYS CHEM-US, V98, P4109, DOI 10.1021/j100066a034; Lagerholm BC, 2006, BIOPHYS J, V91, P3050, DOI 10.1529/biophysj.105.079178; Lee SF, 2007, J AM CHEM SOC, V129, P8936, DOI 10.1021/ja071876+; Lee SF, 2009, CHEMPHYSCHEM, V10, P2174, DOI 10.1002/cphc.200900200; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Mahler B, 2008, NAT MATER, V7, P659, DOI 10.1038/nmat2222; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Pinaud F, 2006, BIOMATERIALS, V27, P1679, DOI 10.1016/j.biomaterials.2005.11.018; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Sark WGJHM, 2001, J PHYS CHEM B, V105, P8281, DOI 10.1021/jp012018h; Wang XY, 2009, NATURE, V459, P686, DOI 10.1038/nature08072; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; You CJ, 2010, ANGEW CHEM INT EDIT, V49, P4108, DOI 10.1002/anie.200907032	30	20	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44355	10.1371/journal.pone.0044355	http://dx.doi.org/10.1371/journal.pone.0044355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952963	gold, Green Published, Green Submitted			2022-12-27	WOS:000308221300085
J	Parmalee, NL; Schubert, C; Figueroa, M; Bird, AC; Peto, T; Gillies, MC; Bernstein, PS; Kiryluk, K; Terwilliger, JD; Allikmets, R				Parmalee, Nancy L.; Schubert, Carl; Figueroa, Maria; Bird, Alan C.; Peto, Tunde; Gillies, Mark C.; Bernstein, Paul S.; Kiryluk, Krzysztof; Terwilliger, Joseph D.; Allikmets, Rando		MacTel Project	Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2	PLOS ONE			English	Article							JUXTAFOVEOLAR RETINAL TELANGIECTASIS; MONOZYGOTIC TWINS; CLASSIFICATION; ASSOCIATION; PREVALENCE	Macular Telangiectasia type 2 (MacTel) is a relatively rare macular disease of adult onset presenting with distortions in the visual field and leading to progressive loss of visual acuity. For the purpose of a gene mapping study, several pedigrees were ascertained with multiple affected family members. Seventeen families with a total of 71 individuals (including 45 affected or possibly affected) were recruited at clinical centers in 7 countries under the auspices of the MacTel Project. The disease inheritance was consistent with autosomal dominant segregation with reduced penetrance. Genome-wide linkage analysis was performed, followed by analysis of recombination breakpoints. Linkage analysis identified a single peak with multi-point LOD score of 3.45 on chromosome 1 at 1q41-42 under a dominant model. Recombination mapping defined a minimal candidate region of 15.6 Mb, from 214.32 (rs1579634; 219.96 cM) to 229.92 Mb (rs7542797; 235.07 cM), encompassing the 1q41-42 linkage peak. Sanger sequencing of the top 14 positional candidates genes under the linkage peak revealed no causal variants in these pedigrees.	[Parmalee, Nancy L.; Schubert, Carl; Allikmets, Rando] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Parmalee, Nancy L.; Terwilliger, Joseph D.] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Kiryluk, Krzysztof] Columbia Univ, Dept Med, New York, NY USA; [Terwilliger, Joseph D.] Columbia Univ, Dept Psychiat, New York, NY USA; [Terwilliger, Joseph D.] Columbia Univ, Columbia Genome Ctr, New York, NY USA; [Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Figueroa, Maria] EMMES Corp, Rockville, MD USA; [Bird, Alan C.; Peto, Tunde] Moorfields Eye Hosp, London, England; [Gillies, Mark C.] Univ Sydney, Dept Clin Ophthalmol & Eye Hlth, Save Sight Inst, Sydney, NSW 2006, Australia; [Bernstein, Paul S.] Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Emmes Corporation; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Sydney; Utah System of Higher Education; University of Utah	Parmalee, NL (corresponding author), Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA.	rla22@columbia.edu	gillies, mark c/B-3242-2012; Peto, Tunde/G-8812-2018; Allikmets, Rando/ABD-4533-2021	Peto, Tunde/0000-0001-6265-0381; 	Lowy Medical Research Foundation through the MacTel Project; NEI Vision Training Grant; DoH NIHR BMRC MEH funding; NATIONAL EYE INSTITUTE [P30EY014800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK090207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084995] Funding Source: NIH RePORTER	Lowy Medical Research Foundation through the MacTel Project; NEI Vision Training Grant; DoH NIHR BMRC MEH funding; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was funded by the Lowy Medical Research Foundation, through the MacTel Project. https://web.emmes.com/study/mactel/about/about.htm. N.L.P. has received a portion of her funding from the NEI Vision Training Grant. T. P. has received part of her funding from DoH NIHR BMRC MEH funding. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maria Figueroa is an employee of The EMMES Corporation. The EMMES Corporation was contracted by the MacTel Project to provide data management services regarding patient enrollment.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aung KZ, 2010, RETINA-J RET VIT DIS, V30, P473, DOI 10.1097/IAE.0b013e3181bd2c71; Chew E, 2006, ARCH OPHTHALMOL-CHIC, V124, P573, DOI 10.1001/archopht.124.4.573; CHEW EY, 1986, ARCH OPHTHALMOL-CHIC, V104, P71; Clemons TE, 2010, OPHTHAL EPIDEMIOL, V17, P66, DOI 10.3109/09286580903450361; Finger RP, 2009, INVEST OPHTH VIS SCI, V50, P1366, DOI 10.1167/iovs.08-2032; GASS JDM, 1993, OPHTHALMOLOGY, V100, P1536; Gillies MC, 2009, OPHTHALMOLOGY, V116, P2422, DOI 10.1016/j.ophtha.2009.05.010; Hannan SR, 2007, BRIT J OPHTHALMOL, V91, P1729, DOI 10.1136/bjo.2007.115675; HUTTON WL, 1978, ARCH OPHTHALMOL-CHIC, V96, P1362; Issa PC, 2009, EYE, V23, P435, DOI 10.1038/sj.eye.6703003; Issa PC, 2008, ACTA OPHTHALMOL, V86, P464, DOI 10.1111/j.1600-0420.2007.01041.x; Issa PC, 2008, INVEST OPHTH VIS SCI, V49, P1172, DOI 10.1167/iovs.07-0636; Issa PC, 2007, INVEST OPHTH VIS SCI, V48, P3788, DOI 10.1167/iovs.06-1272; Issa PC, 2009, DOC OPHTHALMOL, V119, P133, DOI 10.1007/s10633-009-9190-9; Issa PC, 2009, EXP EYE RES, V89, P25, DOI 10.1016/j.exer.2009.02.006; Klein R, 2010, AM J OPHTHALMOL, V150, P55, DOI 10.1016/j.ajo.2010.02.013; Menchini U, 2000, AM J OPHTHALMOL, V129, P401, DOI 10.1016/S0002-9394(99)00380-3; Oh KT, 1999, RETINA-J RET VIT DIS, V19, P246, DOI 10.1097/00006982-199903000-00012; Parmalee NL, 2010, MOL VIS, V16, P2718; Purcell S, PLINK WHOLE GENOME D; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Siddiqui N, 2005, AM J OPHTHALMOL, V139, P568, DOI 10.1016/j.ajo.2004.09.030; Yannuzzi LA, 2006, ARCH OPHTHALMOL-CHIC, V124, P450, DOI 10.1001/archopht.124.4.450	24	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e24268	10.1371/journal.pone.0024268	http://dx.doi.org/10.1371/journal.pone.0024268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952568	gold, Green Published			2022-12-27	WOS:000308221300001
J	Pircs, K; Nagy, P; Varga, A; Venkei, Z; Erdi, B; Hegedus, K; Juhasz, G				Pircs, Karolina; Nagy, Peter; Varga, Agnes; Venkei, Zsolt; Erdi, Balazs; Hegedus, Krisztina; Juhasz, Gabor			Advantages and Limitations of Different p62-Based Assays for Estimating Autophagic Activity in Drosophila	PLOS ONE			English	Article							P62; LONGEVITY; REF(2)P	Levels of the selective autophagy substrate p62 have been established in recent years as a specific readout for basal autophagic activity. Here we compared different experimental approaches for using this assay in Drosophila larvae. Similar to the more commonly used western blots, quantifying p62 dots in immunostained fat body cells of L3 stage larvae detected a strong accumulation of endogenous p62 aggregates in null mutants for Atg genes and S6K. Importantly, genes whose mutation or silencing results in early stage lethality can only be analyzed by microscopy using clonal analysis. The loss of numerous general housekeeping genes show a phenotype in large-scale screens including autophagy, and the p62 assay was potentially suitable for distinguishing bona fide autophagy regulators from silencing of a DNA polymerase subunit or a ribosomal gene that likely has a non-specific effect on autophagy. p62 accumulation upon RNAi silencing of known autophagy regulators was dependent on the duration of the knockdown effect, unlike in the case of starvation-induced autophagy. The endogenous p62 assay was more sensitive than a constitutively overexpressed p62-GFP reporter, which showed self-aggregation and large-scale accumulation even in control cells. We recommend western blots for following the conversion of overexpressed p62-GFP reporters to estimate autophagic activity if sample collection from mutant larvae or adults is possible. In addition, we also showed that overexpressed p62 or Atg8 reporters can strongly influence the phenotypes of each other, potentially giving rise to false or contradicting results. Overexpressed p62 aggregates also incorporated Atg8 reporter molecules that might lead to a wrong conclusion of strongly enhanced autophagy, whereas expression of an Atg8 reporter transgene rescued the inhibitory effect of a dominant-negative Atg4 mutant on basal and starvation-induced autophagy.	[Pircs, Karolina; Nagy, Peter; Varga, Agnes; Venkei, Zsolt; Erdi, Balazs; Hegedus, Krisztina; Juhasz, Gabor] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary	Eotvos Lorand University	Pircs, K (corresponding author), Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary.	szmrt@elte.hu	Juhasz, Gabor/G-5622-2013; Nagy, Peter/AFT-0238-2022; Pircs, Karolina/O-2016-2017	Juhasz, Gabor/0000-0001-8548-8874; Nagy, Peter/0000-0002-5053-0646; Pircs, Karolina/0000-0001-8281-4785; Varga, Agnes/0000-0002-2120-1499; Venkei, Zsolt G/0000-0003-1282-849X	Wellcome Trust [087518/Z/08/Z]; Hungarian Academy of Sciences [BO/00552/11]; European Union; European Social Fund [TAMOP 4.2.1./B-09/1/KMR-2010-0003]	Wellcome Trust(Wellcome TrustEuropean Commission); Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by the Wellcome Trust (087518/Z/08/Z), the Hungarian Academy of Sciences (BO/00552/11), and the European Union and the European Social Fund contributed to the purchase of the electron microscope (TAMOP 4.2.1./B-09/1/KMR-2010-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; DEZELEE S, 1989, EMBO J, V8, P3437, DOI 10.1002/j.1460-2075.1989.tb08508.x; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Erdi B, 2012, AUTOPHAGY, V8, P1124, DOI 10.4161/auto.20069; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Juhasz Gabor, 2008, V445, P125, DOI 10.1007/978-1-59745-157-4_8; Klionsky DJ, 2005, AUTOPHAGY, V1, P59, DOI 10.4161/auto.1.1.1536; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608	19	101	102	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44214	10.1371/journal.pone.0044214	http://dx.doi.org/10.1371/journal.pone.0044214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952930	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000308221300064
J	Ulas, T; Riemer, SA; Zaparty, M; Siebers, B; Schomburg, D				Ulas, Thomas; Riemer, S. Alexander; Zaparty, Melanie; Siebers, Bettina; Schomburg, Dietmar			Genome-Scale Reconstruction and Analysis of the Metabolic Network in the Hyperthermophilic Archaeon Sulfolobus Solfataricus	PLOS ONE			English	Article							GENUS SULFOLOBUS; CARBON FIXATION; BINDING-PROTEIN; BACTERIA; PATHWAY; TRANSPORT; MODELS; P2; ACIDOCALDARIUS; DEHYDROGENASE	We describe the reconstruction of a genome-scale metabolic model of the crenarchaeon Sulfolobus solfataricus, a hyperthermoacidophilic microorganism. It grows in terrestrial volcanic hot springs with growth occurring at pH 2-4 (optimum 3.5) and a temperature of 75-80 degrees C (optimum 80 degrees C). The genome of Sulfolobus solfataricus P2 contains 2,992,245 bp on a single circular chromosome and encodes 2,977 proteins and a number of RNAs. The network comprises 718 metabolic and 58 transport/exchange reactions and 705 unique metabolites, based on the annotated genome and available biochemical data. Using the model in conjunction with constraint-based methods, we simulated the metabolic fluxes induced by different environmental and genetic conditions. The predictions were compared to experimental measurements and phenotypes of S. solfataricus. Furthermore, the performance of the network for 35 different carbon sources known for S. solfataricus from the literature was simulated. Comparing the growth on different carbon sources revealed that glycerol is the carbon source with the highest biomass flux per imported carbon atom (75% higher than glucose). Experimental data was also used to fit the model to phenotypic observations. In addition to the commonly known heterotrophic growth of S. solfataricus, the crenarchaeon is also able to grow autotrophically using the hydroxypropionate-hydroxybutyrate cycle for bicarbonate fixation. We integrated this pathway into our model and compared bicarbonate fixation with growth on glucose as sole carbon source. Finally, we tested the robustness of the metabolism with respect to gene deletions using the method of Minimization of Metabolic Adjustment (MOMA), which predicted that 18% of all possible single gene deletions would be lethal for the organism.	[Ulas, Thomas; Riemer, S. Alexander; Schomburg, Dietmar] Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, D-38106 Braunschweig, Germany; [Zaparty, Melanie] Univ Regensburg, Inst Mol & Cellular Anat, Regensburg, Germany; [Siebers, Bettina] Univ Duisburg Essen, Fac Chem, Biofilm Ctr, Essen, Germany	Braunschweig University of Technology; University of Regensburg; University of Duisburg Essen	Ulas, T (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinformat & Biochem, D-38106 Braunschweig, Germany.	d.schomburg@tu-bs.de		Schomburg, Dietmar/0000-0002-3354-822X; Siebers, Bettina/0000-0002-9905-541X	BMBF [0315004B, 0315004A]	BMBF(Federal Ministry of Education & Research (BMBF))	The project was performed in the course of the transnational SysMO initiative within the Sulfolobus Systemsbiology "SulfoSYS" project. Thomas Ulas was supported by the BMBF (0315004B) and Melanie Zaparty was supported by the BMBF (0315004A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 1999, J BACTERIOL, V181, P4285, DOI 10.1128/JB.181.14.4285-4291.1999; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ates O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-12; Bannert C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-589; Bar-Even A, 2012, J EXP BOT, V63, P2325, DOI 10.1093/jxb/err417; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Boyle NR, 2011, METAB ENG, V13, P150, DOI 10.1016/j.ymben.2011.01.005; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chong PK, 2007, J PROTEOME RES, V6, P3985, DOI 10.1021/pr070232y; Christen P, 2011, BIODEGRADATION, V22, P475, DOI 10.1007/s10532-010-9420-6; Chung BKS, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-50; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; Daniel RM, 2000, CELL MOL LIFE SCI, V57, P250, DOI 10.1007/PL00000688; Duggin IG, 2006, J BIOL CHEM, V281, P15029, DOI 10.1074/jbc.R500029200; Elferink MGL, 2001, MOL MICROBIOL, V39, P1494, DOI 10.1046/j.1365-2958.2001.02336.x; Esser D, 2012, J PROTEOME RES, V11, P4823, DOI 10.1021/pr300190k; Esser D, 2011, EXTREMOPHILES, V15, P711, DOI 10.1007/s00792-011-0392-1; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; GROGAN DW, 1989, J BACTERIOL, V171, P6710, DOI 10.1128/jb.171.12.6710-6719.1989; Han L, 2003, BIOPROC BIOSYST ENG, V25, P205, DOI 10.1007/s00449-002-0300-2; Hucka M., 2008, NAT PRECED, V58, DOI [10.1038/npre.2008.2715.1, DOI 10.1038/NPRE.2008.2715.1]; Izzo V, 2005, RES MICROBIOL, V156, P677, DOI 10.1016/j.resmic.2005.04.001; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Janssen P, 2005, EMBO REP, V6, P397, DOI 10.1038/sj.embor.7400412; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kieldsen KR, 2009, BIOTECHNOL BIOENG, V102, P583, DOI 10.1002/bit.22067; Koerdt A, 2012, EXTREMOPHILES, V16, P115, DOI 10.1007/s00792-011-0411-2; Kumar VS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-28; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; LUBBEN M, 1995, BBA-BIOENERGETICS, V1229, P1, DOI 10.1016/0005-2728(94)00174-4; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; NICOLAUS B, 1991, BIOTECHNOL LETT, V13, P667, DOI 10.1007/BF01086324; NICOLAUS B, 1992, SYST APPL MICROBIOL, V15, P18, DOI 10.1016/S0723-2020(11)80131-1; NICOLAUS B, 1993, FEMS MICROBIOL LETT, V109, P203, DOI 10.1111/j.1574-6968.1993.tb06168.x; Nunn CEM, 2010, J BIOL CHEM, V285, P33701, DOI 10.1074/jbc.M110.146332; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Pfeifer F, 1994, MOL BIOL ARCH BAS S; PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Quester S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-376; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Schafer G, 1999, MICROBIOL MOL BIOL R, V63, P570; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; SCHONHEIT P, 1995, WORLD J MICROB BIOT, V11, P26, DOI 10.1007/BF00339135; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Simon G, 2009, FEMS MICROBIOL LETT, V299, P255, DOI 10.1111/j.1574-6968.2009.01759.x; Snijders APL, 2006, PROTEOMICS, V6, P1518, DOI 10.1002/pmic.200402070; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; WHITE RH, 1988, J BACTERIOL, V170, P4608, DOI 10.1128/jb.170.10.4608-4612.1988; Wieloch P, 2012, THESIS U BRAUNSCHWEI; YU JP, 1994, J BACTERIOL, V176, P325, DOI 10.1128/JB.176.2.325-332.1994; Zaparty M, 2010, EXTREMOPHILES, V14, P119, DOI 10.1007/s00792-009-0280-0; ZHOU D, 1989, J BACTERIOL, V171, P6610, DOI 10.1128/jb.171.12.6610-6616.1989; ZILLIG W, 1980, ARCH MICROBIOL, V125, P259, DOI 10.1007/BF00446886; Zillig W, 1991, CURR OPIN GENET DEV, V1, P544, DOI 10.1016/S0959-437X(05)80206-0; Zolghadr B, 2010, J BACTERIOL, V192, P104, DOI 10.1128/JB.01061-09	70	32	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43401	10.1371/journal.pone.0043401	http://dx.doi.org/10.1371/journal.pone.0043401			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952675	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300014
J	Javanbakht, M; Abolhasani, F; Mashayekhi, A; Baradaran, HR; Noudeh, YJ				Javanbakht, Mehdi; Abolhasani, Farid; Mashayekhi, Atefeh; Baradaran, Hamid R.; noudeh, Younes Jahangiri			Health Related Quality of Life in Patients with Type 2 Diabetes Mellitus in Iran: A National Survey	PLOS ONE			English	Article							PRIMARY-CARE; EQ-5D; COMPLICATIONS; PREVALENCE; ADULTS; QUESTIONNAIRE; POPULATION; SYMPTOMS; TURKEY; JAPAN	Introduction: The aim of this study was to measure health-related quality of life (HRQoL) in Iranian people with Type 2 Diabetes Mellitus using two different measures and examines which socio-demographic and diabetes-related characteristics are associated with better quality of life based on a nationally distributed sample. Methods: A multi-stage cluster sampling method was used to select 3472 subjects as a part of Iranian surveillance of risk factors of non-communicable disease (ISRFNCD). EuroQol-5 Dimensions questionnaire (EQ-5D) and Visual Analog Scale (VAS) were employed to measure HRQoL. Binary logistic and Tobit regression models were used to investigate factors associated with EQ-5D results. Results: The mean age of subjects was 59.4 years (SD = 11.7), 61.3% were female and had 8.08 years (SD = 6.7) known duration of diabetes. The patients reported "some or extreme problems" most frequently in Pain/Discomfort (69.3%) and Anxiety/Depression (56.6%) dimensions of EQ-5D. The mean EQ-5D and VAS score were 0.70 (95% CI 0.69-0.71) and 56.8 (95% CI 56.15-57.5) respectively. Female gender, lower education, unemployment, long duration of diabetes, diabetes-related hospitalization in past years and having nephropathy and lower extremity lesions were associated with higher probabilities of reporting "some or extreme problems" in most dimensions of EQ-5D in binary logistic regression models. The same factors in addition to retinopathy were significantly associated with lower levels of HRQoL in Tobit regression analysis too. Conclusions: The study findings indicate that patients with diabetes in Iran suffer from relatively poor HRQoL. Therefore much more attention should be paid to main determinants of HRQoL to identify and implement appropriate policies for achieving better management of diabetes and ultimately improving the quality of life of diabetic patients in this region.	[Javanbakht, Mehdi; Mashayekhi, Atefeh] Univ Tehran Med Sci, Sch Hlth Care Management, Hlth Care Management & Econ Res Ctr, Tehran, Iran; [Javanbakht, Mehdi] Shiraz Univ Med Sci, Sch Hlth Care Management & Informat Sci, Shiraz, Iran; [Abolhasani, Farid] Univ Tehran Med Sci, Endocrinol & Meolism Res Inst, Tehran, Iran; [Baradaran, Hamid R.] Univ Tehran Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr Firouzgar, Tehran, Iran; [noudeh, Younes Jahangiri] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Shiraz University of Medical Science; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Javanbakht, M (corresponding author), Univ Tehran Med Sci, Sch Hlth Care Management, Hlth Care Management & Econ Res Ctr, Tehran, Iran.	javanbakhtm@gmail.com	Baradaran, Hamid R/N-2577-2019; Baradaran, Hamid Reza/C-1556-2017	Baradaran, Hamid R/0000-0002-5070-5864; Baradaran, Hamid Reza/0000-0002-5070-5864; Jahangiri, Younes/0000-0002-3328-2919; Javanbakht, Mehdi/0000-0002-8661-8439	Endocrine Research Center affiliated with Tehran University of Medical Sciences [1213]	Endocrine Research Center affiliated with Tehran University of Medical Sciences	This study was supported by a grant (number 1213) from the Endocrine Research Center affiliated with Tehran University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci F, 2008, DIABETES RES CLIN PR, V79, P117, DOI 10.1016/j.diabres.2007.07.003; Al-Maskari MY, 2011, SAUDI MED J, V32, P1285; Ardito SQ, 2011, INT J CARDIOL, V152, P133, DOI 10.1016/j.ijcard.2011.07.060; Blumenschein K, 1996, HEALTH POLICY, V36, P155, DOI 10.1016/0168-8510(95)00809-8; Brown DW, 2004, DIABETES RES CLIN PR, V65, P105, DOI 10.1016/j.diabres.2003.11.014; Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1; Choi YJ, 2011, DIABETES METAB J, V35, P587, DOI 10.4093/dmj.2011.35.6.587; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Devlin NJ, 2007, EQ 5D VALUE SETS INV, DOI 10.1007/1-4020-5511-0; Esteghamati A, 2009, DIABETOLOGIA, V52, P1520, DOI 10.1007/s00125-009-1398-4; Hahl J, 2002, QUAL LIFE RES, V11, P427, DOI 10.1023/A:1015684100227; Hanninen J, 1998, DIABETES RES CLIN PR, V42, P17, DOI 10.1016/S0168-8227(98)00085-0; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; Joshi VD, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-36; Kapur A, 2007, INDIAN J MED RES, V125, P473; KeinanenKiukaanniemi S, 1996, DIABETIC MED, V13, P382, DOI 10.1002/(SICI)1096-9136(199604)13:4<382::AID-DIA14>3.0.CO;2-Y; Lee WJ, 2012, J KOREAN MED SCI, V27, P255, DOI 10.3346/jkms.2012.27.3.255; Lloyd A, 2001, Value Health, V4, P392, DOI 10.1046/j.1524-4733.2001.45029.x; Murphy, 2000, VALUE HEALTH, V3, pS47, DOI [10.1046/j.1524-4733.2000.36028.x, DOI 10.1046/J.1524-4733.2000.36028.X]; O'Reilly DJ, 2011, QUAL LIFE RES, V20, P939, DOI 10.1007/s11136-010-9828-9; Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448; Quah JHM, 2011, ANN ACAD MED SINGAP, V40, P276; Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458; Roglic G, 2011, MORTALITY ATTRIBUTAB; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Saito I, 2006, DIABETES RES CLIN PR, V73, P51, DOI 10.1016/j.diabres.2005.11.015; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Sanjari M, 2011, INT J LOW EXTR WOUND, V10, P200, DOI 10.1177/1534734611428728; Sobocki P, 2007, VALUE HEALTH, V10, P153, DOI 10.1111/j.1524-4733.2006.00162.x; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x; Taghdisi MH, 2012, HEALTH EDUC J, V71, P229, DOI 10.1177/0017896911398812; Ucan O, 2010, J CLIN NURS, V19, P2511, DOI 10.1111/j.1365-2702.2010.03295.x; Varghese RT, 2007, DIABETES METAB SYND, V1, P173, DOI 10.1016/j.dsx.2007.05.005; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	36	67	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44526	10.1371/journal.pone.0044526	http://dx.doi.org/10.1371/journal.pone.0044526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZH	22952989	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206500075
J	Kostyuk, V; Potapovich, A; Stancato, A; De Luca, C; Lulli, D; Pastore, S; Korkina, L				Kostyuk, Vladimir; Potapovich, Alla; Stancato, Andrea; De Luca, Chiara; Lulli, Daniela; Pastore, Saveria; Korkina, Liudmila			Photo-Oxidation Products of Skin Surface Squalene Mediate Metabolic and Inflammatory Responses to Solar UV in Human Keratinocytes	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; GROWTH-FACTOR RECEPTOR; OXIDATIVE STRESS; CHEMOKINE EXPRESSION; EGF RECEPTOR; ACTIVATION; TRANSCRIPTION; PATHWAY; KAPPA; AHR	The study aimed to identify endogenous lipid mediators of metabolic and inflammatory responses of human keratinocytes to solar UV irradiation. Physiologically relevant doses of solar simulated UVA+UVB were applied to human skin surface lipids (SSL) or to primary cultures of normal human epidermal keratinocytes (NHEK). The decay of photo-sensitive lipid-soluble components, alpha-tocopherol, squalene (Sq), and cholesterol in SSL was analysed and products of squalene photo-oxidation (SqPx) were quantitatively isolated from irradiated SSL. When administered directly to NHEK, low-dose solar UVA+UVB induced time-dependent inflammatory and metabolic responses. To mimic UVA+UVB action, NHEK were exposed to intact or photo-oxidised SSL, Sq or SqPx, 4-hydroxy-2-nonenal (4-HNE), and the product of tryptophan photo-oxidation 6-formylindolo[3,2-b]carbazole (FICZ). FICZ activated exclusively metabolic responses characteristic for UV, i.e. the aryl hydrocarbon receptor (AhR) machinery and downstream CYP1A1/CYP1B1 gene expression, while 4-HNE slightly stimulated inflammatory UV markers IL-6, COX-2, and iNOS genes. On contrast, SqPx induced the majority of metabolic and inflammatory responses characteristic for UVA+UVB, acting via AhR, EGFR, and G-protein-coupled arachidonic acid receptor (G2A). Conclusions/Significance: Our findings indicate that Sq could be a primary sensor of solar UV irradiation in human SSL, and products of its photo-oxidation mediate/induce metabolic and inflammatory responses of keratinocytes to UVA+UVB, which could be relevant for skin inflammation in the sun-exposed oily skin.	[Kostyuk, Vladimir; Potapovich, Alla; Stancato, Andrea; De Luca, Chiara; Lulli, Daniela; Pastore, Saveria; Korkina, Liudmila] Ist Dermopat Immacolata IDI IRCCS, Lab Tissue Engn & Skin Pathophysiol, Rome, Italy; [Kostyuk, Vladimir; Potapovich, Alla] Belarusian State Univ, Dept Biol, Minsk, BELARUS	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Belarusian State University	Kostyuk, V (corresponding author), Ist Dermopat Immacolata IDI IRCCS, Lab Tissue Engn & Skin Pathophysiol, Rome, Italy.	l.korkina@idi.it	Kostyuk, Vladimir A./AAB-6601-2021; Lulli, Daniela/AAA-2165-2019; Lulli, Daniela/K-6363-2016	Lulli, Daniela/0000-0002-6314-4699; Kostyuk, Vladimir/0000-0002-1246-4131	Italian Ministry for Health [IDI IRCCS-2010]	Italian Ministry for Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry for Health (Grant IDI IRCCS-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; De Luca C, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/321494; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; Ekanayake-Mudiyanselage S, 2003, J INVEST DERMATOL, V120, P915, DOI 10.1046/j.1523-1747.2003.12233.x; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Hattori T, 2008, J INVEST DERMATOL, V128, P1123, DOI 10.1038/sj.jid.5701172; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Katiyar SK, 2000, J INVEST DERMATOL, V114, P328, DOI 10.1046/j.1523-1747.2000.00876.x; KOHNO Y, 1995, BBA-LIPID LIPID MET, V1256, P52, DOI 10.1016/0005-2760(95)00005-W; Lamore SD, 2010, J PHOTOCH PHOTOBIO B, V101, P251, DOI 10.1016/j.jphotobiol.2010.07.010; Leonarduzzi G, 2004, FREE RADICAL BIO MED, V37, P1694, DOI 10.1016/j.freeradbiomed.2004.08.027; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu W, 1999, J CELL SCI, V112, P2409; Liu W, 2010, NITRIC OXIDE-BIOL CH, V23, P199, DOI 10.1016/j.niox.2010.06.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luecke S, 2010, CHEM-BIOL INTERACT, V184, P466, DOI 10.1016/j.cbi.2010.01.038; Luecke S, 2010, PIGM CELL MELANOMA R, V23, P828, DOI 10.1111/j.1755-148X.2010.00762.x; Martinez-Carpio PA, 2010, PHOTODERMATOL PHOTO, V26, P250, DOI 10.1111/j.1600-0781.2010.00534.x; McInturff JE, 2005, J INVEST DERMATOL, V125, P1, DOI 10.1111/j.0022-202X.2004.23459.x; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; NICOLAIDES N, 1968, J INVEST DERMATOL, V51, P83, DOI 10.1038/jid.1968.96; Oesch-Bartlomowicz B, 2009, BIOCHEM PHARMACOL, V77, P627, DOI 10.1016/j.bcp.2008.10.017; Ottaviani M, 2006, J INVEST DERMATOL, V126, P2430, DOI 10.1038/sj.jid.5700434; PASSI S, 1991, Journal of Dermatological Science, V2, P84, DOI 10.1016/0923-1811(91)90016-Q; Pastore S, 2005, J IMMUNOL, V174, P5047, DOI 10.4049/jimmunol.174.8.5047; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Pastore S, 2012, ANTIOXID REDOX SIGN, V16, P314, DOI 10.1089/ars.2011.4053; Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814; PICARDO M, 1991, PHOTODERMATOL PHOTO, V8, P105; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Potapovich AI, 2011, TOXICOL APPL PHARM, V255, P138, DOI 10.1016/j.taap.2011.06.007; Rannug A, 2006, BIOL CHEM, V387, P1149, DOI 10.1515/BC.2006.143; Rannug A, 2010, P NATL ACAD SCI USA, V107, P18239, DOI 10.1073/pnas.1013653107; Ryu A, 2009, BIOL PHARM BULL, V32, P1504, DOI 10.1248/bpb.32.1504; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seidel SD, 2001, J BIOCHEM MOL TOXIC, V15, P187; Sottero B, 2009, CURR MED CHEM, V16, P685, DOI 10.2174/092986709787458353; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Sutter CH, 2009, P NATL ACAD SCI USA, V106, P4266, DOI 10.1073/pnas.0900874106; Thiele J, 2005, SKIN AGING, P65; Thiele JJ, 1998, J INVEST DERMATOL, V110, P756, DOI 10.1046/j.1523-1747.1998.00169.x; Tsuji G, 2011, J DERMATOL SCI, V62, P42, DOI 10.1016/j.jdermsci.2010.10.017; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Vondracek J, 2011, CURR DRUG METAB, V12, P89, DOI 10.2174/138920011795016827; Xu YR, 2006, J BIOL CHEM, V281, P27389, DOI 10.1074/jbc.M602355200; Xu YR, 2009, J CELL BIOCHEM, V107, P873, DOI 10.1002/jcb.22195; Zouboulis CC, 2008, EXP DERMATOL, V17, P542, DOI 10.1111/j.1600-0625.2008.00725.x	47	57	58	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44472	10.1371/journal.pone.0044472	http://dx.doi.org/10.1371/journal.pone.0044472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952984	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500073
J	Abcejo, AJ; Sathish, V; Smelter, DF; Aravamudan, B; Thompson, MA; Hartman, WR; Pabelick, CM; Prakash, YS				Abcejo, Amard J.; Sathish, Venkatachalem; Smelter, Dan F.; Aravamudan, Bharathi; Thompson, Michael A.; Hartman, William R.; Pabelick, Christina M.; Prakash, Y. S.			Brain-Derived Neurotrophic Factor Enhances Calcium Regulatory Mechanisms in Human Airway Smooth Muscle	PLOS ONE			English	Article							OPERATED CA2+ INFLUX; TNF-ALPHA; INTRACELLULAR CA2+; PROTEIN EXPRESSION; TRKB RECEPTOR; BDNF; DYSFUNCTION; ACTIVATION; CHANNELS; AGONIST	Neurotrophins (NTs), which play an integral role in neuronal development and function, have been found in non-neuronal tissue (including lung), but their role is still under investigation. Recent reports show that NTs such as brain-derived neurotrophic factor (BDNF) as well as NT receptors are expressed in human airway smooth muscle (ASM). However, their function is still under investigation. We hypothesized that NTs regulate ASM intracellular Ca2+ ([Ca2+](i)) by altered expression of Ca2+ regulatory proteins. Human ASM cells isolated from lung samples incidental to patient surgery were incubated for 24 h (overnight) in medium (control) or 1 nM BDNF in the presence vs. absence of inhibitors of signaling cascades (MAP kinases; PI3/Akt; NF kappa B). Measurement of [Ca2+](i) responses to acetylcholine (ACh) and histamine using the Ca2+ indicator fluo-4 showed significantly greater responses following BDNF exposure: effects that were blunted by pathway inhibitors. Western analysis of whole cell lysates showed significantly higher expression of CD38, Orai1, STIM1, IP3 and RyR receptors, and SERCA following BDNF exposure, effects inhibited by inhibitors of the above cascades. The functional significance of BDNF effects were verified by siRNA or pharmacological inhibition of proteins that were altered by this NT. Overall, these data demonstrate that NTs activate signaling pathways in human ASM that lead to enhanced [Ca2+](i) responses via increased regulatory protein expression, thus enhancing airway contractility.	[Abcejo, Amard J.; Sathish, Venkatachalem; Smelter, Dan F.; Aravamudan, Bharathi; Thompson, Michael A.; Hartman, William R.; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Sathish, Venkatachalem; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Abcejo, AJ (corresponding author), Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA.	prakash.ys@mayo.edu		venkatachalem, sathish/0000-0001-9770-8299; Prakash, Y S/0000-0002-2968-224X	National Institutes of Health [HL088029, HL090595]; Flight Attendants Medical Research Institute (FAMRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088029, R01HL056470, R01HL090595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute (FAMRI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants HL088029 (Prakash) and HL090595 (Pabelick) from the National Institutes of Health, and the Flight Attendants Medical Research Institute (FAMRI; Prakash). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani Y, 2000, Respir Res, V1, P49, DOI 10.1186/rr12; Amrani Y, 2007, AM J RESP CELL MOL, V36, P387, DOI 10.1165/ajrcmb.36.3.387; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; Braun A, 2004, BRIT J PHARMACOL, V141, P431, DOI 10.1038/sj.bjp.0705638; Canossa M, 1997, P NATL ACAD SCI USA, V94, P13279, DOI 10.1073/pnas.94.24.13279; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; COBURN RF, 1990, AM J PHYSIOL, V258, pL119, DOI 10.1152/ajplung.1990.258.4.L119; Damera G, 2009, PULM PHARMACOL THER, V22, P353, DOI 10.1016/j.pupt.2008.12.006; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; Hotta K, 1999, AM J PHYSIOL-LUNG C, V276, pL405, DOI 10.1152/ajplung.1999.276.3.L405; Hoyle GW, 2003, CYTOKINE GROWTH F R, V14, P551, DOI 10.1016/S1359-6101(03)00061-3; ITO Y, 1995, BRIT J PHARMACOL, V116, P2738, DOI 10.1111/j.1476-5381.1995.tb17235.x; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jude JA, 2011, ADV EXP MED BIOL, V691, P449, DOI 10.1007/978-1-4419-6612-4_46; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Kannan MS, 1997, AM J PHYSIOL-LUNG C, V272, pL659, DOI 10.1152/ajplung.1997.272.4.L659; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kovalchuk Y, 2004, CURR OPIN NEUROBIOL, V14, P558, DOI 10.1016/j.conb.2004.08.014; Lahiri T, 2002, AM J PHYSIOL-LUNG C, V283, pL1239, DOI 10.1152/ajplung.00231.2001; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Lommatzsch M, 2005, INT J DEV NEUROSCI, V23, P495, DOI 10.1016/j.ijdevneu.2005.05.009; Lommatzsch M, 2003, ANN NY ACAD SCI, V992, P241, DOI 10.1111/j.1749-6632.2003.tb03154.x; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Luther JA, 2009, AUTON NEUROSCI-BASIC, V151, P46, DOI 10.1016/j.autneu.2009.08.009; Mantilla CB, 2012, MUSCLE NERVE, V45, P274, DOI 10.1002/mus.22295; Meuchel LW, 2011, AM J PHYSIOL-LUNG C, V301, pL91, DOI 10.1152/ajplung.00320.2010; MURRAY RK, 1991, J PHYSIOL-LONDON, V435, P123, DOI 10.1113/jphysiol.1991.sp018501; Pabelick CM, 2004, ANESTHESIOLOGY, V101, P373, DOI 10.1097/00000542-200408000-00018; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Prakash YS, 2006, AM J PHYSIOL-LUNG C, V291, pL447, DOI 10.1152/ajplung.00501.2005; Prakash YS, 2009, AM J RESP CELL MOL, V41, P603, DOI 10.1165/rcmb.2008-0151OC; Prakash Ys, 2010, Expert Rev Respir Med, V4, P395, DOI 10.1586/ers.10.29; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ricci A, 2004, AM J RESP CELL MOL, V30, P12, DOI 10.1165/rcmb.2002-0110OC; Ricci A, 2000, GROWTH FACTORS, V18, P193, DOI 10.3109/08977190009003244; Rochlitzer S, 2006, BIOCHEM SOC T, V34, P594, DOI 10.1042/BST0340594; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Sathish V, 2012, EUR RESPIR J, V40, P470, DOI 10.1183/09031936.00090511; Scuri Mario, 2010, Inflammation & Allergy Drug Targets, V9, P173; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; UNDEM BJ, 1994, HOSP PRACT, V29, P59, DOI 10.1080/21548331.1994.11442974; Undem BJ, 1994, HOSP PRACT OFF ED, V29, P69; Wang XH, 1998, J NEUROSCI, V18, P4985; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; WORLEY JF, 1990, AM J PHYSIOL, V259, pL468, DOI 10.1152/ajplung.1990.259.6.L468; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	53	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44343	10.1371/journal.pone.0044343	http://dx.doi.org/10.1371/journal.pone.0044343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952960	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206000098
J	Afonso, JM; Bello, G; Guimaraes, ML; Sojka, M; Morgado, MG				Afonso, Joana Morais; Bello, Gonzalo; Guimaraes, Monick L.; Sojka, Marta; Morgado, Mariza G.			HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations among Patients from the North, Central and South Regions of Angola	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CIRCULATING RECOMBINANT; SURVEILLANCE; VARIABILITY; PREVENTION; AFRICA; ORIGIN	Background: Angola presents a very complex HIV-1 epidemic characterized by the co-circulation of several HIV-1 group M subtypes, intersubtype recombinants and unclassified (U) variants. The viral diversity outside the major metropolitan regions (Luanda and Cabinda) and the prevalence of transmitted drug resistance mutations (DRM) since the introduction of HAART in 2004, however, has been barely studied. Methods: One hundred and one individuals from the Central (n = 44), North (n = 35), and South (n = 22) regions of Angola were diagnosed as HIV-1 positive and had their blood collected between 2008 and 2010, at one of the National Referral Centers for HIV diagnosis, the Kifangondo Medical Center, located in the border between the Luanda and Bengo provinces. Angolan samples were genotyped based on phylogenetic and bootscanning analyses of the pol (PR/RT) gene and their drug resistance profile was analyzed. Results: Among the 101 samples analyzed, 51% clustered within a pure group M subtype, 42% were classified as intersubtype recombinants, and 7% were denoted as U. We observed an important variation in the prevalence of different HIV-1 genetic variants among country regions, with high frequency of subtype F1 in the North (20%), intersubtype recombinants in the Central (42%), and subtype C in the South (45%). Statistically significant difference in HIV-1 clade distribution was only observed in subtype C prevalence between North vs South (p = 0.0005) and Central vs South (p = 0.0012) regions. DRM to NRTI and/or NNRTI were detected in 16.3% of patients analyzed. Conclusions: These results demonstrate a heterogeneous distribution of HIV-1 genetic variants across different regions in Angola and also revealed an unexpected high frequency of DRM to RT inhibitors in patients that have reported no antiretroviral usage, which may decrease the efficiency of the standard first-line antiretroviral regimens currently used in the country.	[Afonso, Joana Morais; Bello, Gonzalo; Guimaraes, Monick L.; Morgado, Mariza G.] Inst Oswaldo Cruz FIOCRUZ, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil; [Afonso, Joana Morais] Univ Agostinho Neto, Fac Med, Luanda, Angola; [Sojka, Marta] Sao Lucas Med Ctr, Kifangondo, Angola	Fundacao Oswaldo Cruz; University Agostinho Neto	Afonso, JM (corresponding author), Inst Oswaldo Cruz FIOCRUZ, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil.	jmafonso.7@gmail.com; mmorgado@ioc.fiocruz.br	Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Machado de Morais, Joana Filipa/0000-0002-4524-4055	Laboratory of Aids and Molecular Immunology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation; OWSDW (Organization for Women in Science for the Developing World), Faculty of Medicine - University Agostinho Neto, Angola	Laboratory of Aids and Molecular Immunology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation; OWSDW (Organization for Women in Science for the Developing World), Faculty of Medicine - University Agostinho Neto, Angola	The present study received the following financial support: Laboratory of Aids and Molecular Immunology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation; OWSDW (Organization for Women in Science for the Developing World), Faculty of Medicine - University Agostinho Neto, Angola. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis A., 2005, Infection Genetics and Evolution, V5, P231, DOI 10.1016/j.meegid.2004.07.007; Castelbranco EPAF, 2010, AIDS RES HUM RETROV, V26, P1313, DOI 10.1089/aid.2010.0111; [Anonymous], 1998, HIV DRUG RES DAT; Bartolo I, 2005, AIDS RES HUM RETROV, V21, P306, DOI 10.1089/aid.2005.21.306; Bartolo I, 2009, ANTIMICROB AGENTS CH, V53, P3156, DOI 10.1128/AAC.00110-09; Bartolo I, 2009, INFECT GENET EVOL, V9, P672, DOI 10.1016/j.meegid.2008.05.003; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Jordan MR, 2008, ANTIVIR THER, V13, P15; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Ministry of Health-Republic of Angola, UNGASS REP 2010; Ministry of Health-Republic of Angola, GUID ANT TREATM ANG; Niama FR, 2009, AIDS RES HUM RETROV, V25, P1345, DOI 10.1089/aid.2009.0169; Nkengasong JN, 2004, AIDS REV, V6, P4; Peeters M, 2003, AIDS, V17, P2547, DOI 10.1097/00002030-200312050-00002; RAY S, SIMPLOT V2 5 0; SANTOSFERREIRA MO, 1990, J ACQ IMMUN DEF SYND, V3, P780; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomson MA, 2005, AIDS, V19, P1155, DOI 10.1097/01.aids.0000176215.95119.1d; UNAIDS, 2010, EP FACT SHEET HIV AI; USAID, 2011, HIV AIDS HLTH PROF A; van de Vijver D, 2007, EPIDEMIOLOGY TRANSMI; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000	26	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42996	10.1371/journal.pone.0042996	http://dx.doi.org/10.1371/journal.pone.0042996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952625	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000015
J	Attar, H; Bedard, K; Migliavacca, E; Gagnebin, M; Dupre, Y; Descombes, P; Borel, C; Deutsch, S; Prokisch, H; Meitinger, T; Mehta, D; Wichmann, E; Delabar, JM; Dermitzakis, ET; Krause, KH; Antonarakis, SE				Attar, Homa; Bedard, Karen; Migliavacca, Eugenia; Gagnebin, Maryline; Dupre, Yann; Descombes, Patrick; Borel, Christelle; Deutsch, Samuel; Prokisch, Holger; Meitinger, Thomas; Mehta, Divya; Wichmann, Erich; Delabar, Jean Maurice; Dermitzakis, Emmanouil T.; Krause, Karl-Heinz; Antonarakis, Stylianos E.			Extensive Natural Variation for Cellular Hydrogen Peroxide Release Is Genetically Controlled	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; NADPH OXIDASE; DOWNS-SYNDROME; STEM-CELLS; NOX FAMILY; MUTATION; LINKAGE; IDENTIFICATION; MITOCHONDRIAL	Natural variation in DNA sequence contributes to individual differences in quantitative traits. While multiple studies have shown genetic control over gene expression variation, few additional cellular traits have been investigated. Here, we investigated the natural variation of NADPH oxidase-dependent hydrogen peroxide (H2O2 release), which is the joint effect of reactive oxygen species (ROS) production, superoxide metabolism and degradation, and is related to a number of human disorders. We assessed the normal variation of H2O2 release in lymphoblastoid cell lines (LCL) in a family-based 3-generation cohort (CEPH-HapMap), and in 3 population-based cohorts (KORA, GenCord, HapMap). Substantial individual variation was observed, 45% of which were associated with heritability in the CEPH-HapMap cohort. We identified 2 genome-wide significant loci of Hsa12 and Hsa15 in genome-wide linkage analysis. Next, we performed genome-wide association study (GWAS) for the combined KORA-GenCord cohorts (n = 279) using enhanced marker resolution by imputation (>1.4 million SNPs). We found 5 significant associations (p<5.00x10(-)8) and 54 suggestive associations (p<1.00x10-5), one of which confirmed the linked region on Hsa15. To replicate our findings, we performed GWAS using 58 HapMap individuals and similar to 2.1 million SNPs. We identified 40 genome-wide significant and 302 suggestive SNPs, and confirmed genome signals on Hsa1, Hsa12, and Hsa15. Genetic loci within 900 kb from the known candidate gene p67phox on Hsa1 were identified in GWAS in both cohorts. We did not find replication of SNPs across all cohorts, but replication within the same genomic region. Finally, a highly significant decrease in H2O2 release was observed in Down Syndrome (DS) individuals (p<2.88x10-12). Taken together, our results show strong evidence of genetic control of H2O2 in LCL of healthy and DS cohorts and suggest that cellular phenotypes, which themselves are also complex, may be used as proxies for dissection of complex disorders.	[Attar, Homa; Migliavacca, Eugenia; Gagnebin, Maryline; Dupre, Yann; Borel, Christelle; Deutsch, Samuel; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Bedard, Karen; Krause, Karl-Heinz] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Bedard, Karen; Krause, Karl-Heinz] Univ Hosp, Geneva, Switzerland; [Migliavacca, Eugenia] Univ Lausanne, Swiss Inst Bioinformat, Dorigny, Switzerland; [Descombes, Patrick] Univ Geneva, Sch Med, NCCR Frontiers Genet, Geneva, Switzerland; [Prokisch, Holger; Meitinger, Thomas; Mehta, Divya; Wichmann, Erich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Delabar, Jean Maurice] Univ Paris 07, Paris, France; [Delabar, Jean Maurice] CNRS, Paris, France	University of Geneva; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; University of Lausanne; University of Geneva; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Attar, H (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	homa.attar@gmail.com; Stylianos.Antonarakis@unige.ch	Krause, Karl-Heinz/E-8030-2011; Mehta, Divya/ABD-4551-2021; borel, christelle/AAC-9645-2019; Meitinger, Thomas/O-1318-2015; Antonarakis, Stylianos E/N-8866-2014; Prokisch, Holger/N-8964-2013; Dermitzakis, Emmanouil/B-7687-2013	Krause, Karl-Heinz/0000-0002-9033-6768; Antonarakis, Stylianos E/0000-0001-8907-5823; Prokisch, Holger/0000-0003-2379-6286; Deutsch, Samuel/0000-0001-9456-7101; Meitinger, Thomas/0000-0002-8838-8403; Bedard, Karen/0000-0001-5864-5344; Mehta, Divya Deepak/0000-0002-7359-348X; Mehta, Divya/0000-0001-7971-7255	Swiss National Science Foundation; National Center for Competence in Research (NCCR) "Frontiers in Genetics"; European Union FP6 "AnEUploidy" integrated project	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research (NCCR) "Frontiers in Genetics"(Swiss National Science Foundation (SNSF)); European Union FP6 "AnEUploidy" integrated project	The work was supported by grants from the Swiss National Science Foundation, the National Center for Competence in Research (NCCR) "Frontiers in Genetics," and the European Union FP6 "AnEUploidy" integrated project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Antonarakis SE, 2006, TRENDS MOL MED, V12, P473, DOI 10.1016/j.molmed.2006.08.005; Antonarakis SE, 2010, NAT REV GENET, V11, P380, DOI 10.1038/nrg2793; Arca M, 2008, ARTERIOSCL THROM VAS, V28, P752, DOI 10.1161/ATVBAHA.107.154823; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedard K, 2009, HUM MUTAT, V30, P1123, DOI 10.1002/humu.21029; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Del Campo M, 2006, AM J HUM GENET, V78, P533, DOI 10.1086/501073; Deng AY, 2007, HUM MOL GENET, V16, pR195, DOI 10.1093/hmg/ddm126; Dermitzakis ET, 2009, SCIENCE, V326, P239, DOI 10.1126/science.1182009; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; DINAUER MC, 1989, J CLIN INVEST, V84, P2012, DOI 10.1172/JCI114393; Dominiczak AF, 2004, CLIN EXP HYPERTENS, V26, P611, DOI 10.1081/CEH-200031939; ELROYSTEIN O, 1988, CELL, V52, P259, DOI 10.1016/0092-8674(88)90515-6; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Helguera P, 2005, J NEUROSCI, V25, P2295, DOI 10.1523/JNEUROSCI.5107-04.2005; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Hultqvist M, 2007, J IMMUNOL, V179, P1431, DOI 10.4049/jimmunol.179.3.1431; Jose GS, 2008, CLIN SCI, V114, P173, DOI 10.1042/CS20070130; KEDZIORA J, 1988, FREE RADICAL BIO MED, V4, P317, DOI 10.1016/0891-5849(88)90052-4; KOBAYASHI S, 1995, J BIOCHEM, V117, P758, DOI 10.1093/oxfordjournals.jbchem.a124773; Krause KH, 2007, EXP GERONTOL, V42, P256, DOI 10.1016/j.exger.2006.10.011; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Mein CA, 2004, HUM MOL GENET, V13, pR169, DOI 10.1093/hmg/ddh078; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Moreno MU, 2006, J HYPERTENS, V24, P1299, DOI 10.1097/01.hjh.0000234110.54110.56; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Noack D, 1999, HUM GENET, V105, P460, DOI 10.1007/s004390051131; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Pellegrini-Calace M, 2006, BIOINFORMATICS, V22, P775, DOI 10.1093/bioinformatics/btl006; Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Romito A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009029; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stearns SC, 2010, NAT REV GENET, V11, P611, DOI 10.1038/nrg2831; Stephenson A, 2004, GENOMICS, V83, P1105, DOI 10.1016/j.ygeno.2003.12.007; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85	64	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43566	10.1371/journal.pone.0043566	http://dx.doi.org/10.1371/journal.pone.0043566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952707	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000041
J	Gerus, P; Rao, G; Berton, E				Gerus, Pauline; Rao, Guillaume; Berton, Eric			Subject-Specific Tendon-Aponeurosis Definition in Hill-Type Model Predicts Higher Muscle Forces in Dynamic Tasks	PLOS ONE			English	Article							HUMAN MEDIAL GASTROCNEMIUS; HUMAN TENDINOUS TISSUE; IN-VIVO; MECHANICAL-PROPERTIES; ACHILLES-TENDON; JOINT MOMENTS; FASCICLE; ELONGATION; ULTRASOUND; BEHAVIOR	Neuromusculoskeletal models are a common method to estimate muscle forces. Developing accurate neuromusculoskeletal models is a challenging task due to the complexity of the system and large inter-subject variability. The estimation of muscles force is based on the mechanical properties of tendon-aponeurosis complex. Most neuromusculoskeletal models use a generic definition of the tendon-aponeurosis complex based on in vitro test, perhaps limiting their validity. Ultrasonography allows subject-specific estimates of the tendon-aponeurosis complex's mechanical properties. The aim of this study was to investigate the influence of subject-specific mechanical properties of the tendon-aponeurosis complex on a neuromusculoskeletal model of the ankle joint. Seven subjects performed isometric contractions from which the tendon-aponeurosis force-strain relationship was estimated. Hopping and running tasks were performed and muscle forces were estimated using subject-specific tendon-aponeurosis and generic tendon properties. Two ultrasound probes positioned over the muscle-tendon junction and the mid-belly were combined with motion capture to estimate the in vivo tendon and aponeurosis strain of the medial head of gastrocnemius muscle. The tendon-aponeurosis force-strain relationship was scaled for the other ankle muscles based on tendon and aponeurosis length of each muscle measured by ultrasonography. The EMG-driven model was calibrated twice - using the generic tendon definition and a subject-specific tendon-aponeurosis force-strain definition. The use of subject-specific tendon-aponeurosis definition leads to a higher muscle force estimate for the soleus muscle and the plantar-flexor group, and to a better model prediction of the ankle joint moment compared to the model estimate which used a generic definition. Furthermore, the subject-specific tendon-aponeurosis definition leads to a decoupling behaviour between the muscle fibre and muscle-tendon unit in agreement with previous experiments using ultrasonography. These results indicate the use of subject-specific tendon-aponeurosis definitions in a neuromusculoskeletal model produce better agreement with measured external loads and more physiological model behaviour.	[Gerus, Pauline] Griffith Univ, Griffith Hlth Inst, Ctr Musculoskeletal Res, Gold Coast, Australia; [Rao, Guillaume; Berton, Eric] Aix Marseille Univ, Inst Movement Sci EJ Marey, Marseille, France	Griffith University; Menzies Health Institute Queensland; UDICE-French Research Universities; Aix-Marseille Universite	Gerus, P (corresponding author), Griffith Univ, Griffith Hlth Inst, Ctr Musculoskeletal Res, Gold Coast, Australia.	pauline@gerus.fr	RAO, Guillaume/A-3971-2010	RAO, Guillaume/0000-0002-7751-6959; Pauline, Gerus/0000-0003-3266-1578				Bobbert MF, 2001, J EXP BIOL, V204, P533; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; Burgess KE, 2009, J ORTHOP RES, V27, P820, DOI 10.1002/jor.20811; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Domire Zachary J., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P337, DOI 10.1080/10255840701379562; Duclay J, 2009, MUSCLE NERVE, V39, P819, DOI 10.1002/mus.21297; Finni T, 2002, J APPL BIOMECH, V18, P180, DOI 10.1123/jab.18.2.180; Fukashiro S, 2006, INT J SPORT HLTH SCI, V4, P298; Gao F, 2011, CLIN BIOMECH, V26, P516, DOI 10.1016/j.clinbiomech.2010.12.003; Gerus P, 2011, J BIOMECH, V44, P2333, DOI 10.1016/j.jbiomech.2011.05.021; GRIFFITHS RI, 1991, J PHYSIOL-LONDON, V436, P219, DOI 10.1113/jphysiol.1991.sp018547; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Ishikawa M, 2005, J APPL PHYSIOL, V99, P217, DOI 10.1152/japplphysiol.01352.2004; Karamanidis K, 2005, J EXP BIOL, V208, P3907, DOI 10.1242/jeb.01830; Korstanje JWH, 2010, J BIOMECH, V43, P1373, DOI 10.1016/j.jbiomech.2010.01.001; Kubo K, 2003, INT J SPORTS MED, V24, P125, DOI 10.1055/s-2003-38204; Kubo K, 2001, EUR J APPL PHYSIOL, V84, P162; Li L, 2009, CLIN BIOMECH, V24, P101, DOI 10.1016/j.clinbiomech.2008.08.008; Lichtwark GA, 2007, J BIOMECH, V40, P157, DOI 10.1016/j.jbiomech.2005.10.035; Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950; LIEBER RL, 1992, J BIOMECH, V25, P421, DOI 10.1016/0021-9290(92)90261-X; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; Maganaris CN, 2000, J EXP BIOL, V203, P751; Maganaris CN, 2000, J BIOMECH, V33, P1453, DOI 10.1016/S0021-9290(00)00099-3; Maganaris CN, 2002, J BIOMECH, V35, P1019, DOI 10.1016/S0021-9290(02)00047-7; Magnusson SP, 2003, ACTA PHYSIOL SCAND, V177, P185, DOI 10.1046/j.1365-201X.2003.01048.x; Manal K, 2003, J BIOMECH, V36, P1197, DOI 10.1016/S0021-9290(03)00152-0; Manal K, 2010, J APPL BIOMECH, V26, P224, DOI 10.1123/jab.26.2.224; Muramatsu T, 2001, J APPL PHYSIOL, V90, P1671, DOI 10.1152/jappl.2001.90.5.1671; Muramatsu T, 2002, J APPL PHYSIOL, V92, P129, DOI 10.1152/jappl.2002.92.1.129; Oda T, 2007, J ELECTROMYOGR KINES, V17, P587, DOI 10.1016/j.jelekin.2006.04.013; Pearson SJ, 2007, CLIN BIOMECH, V22, P712, DOI 10.1016/j.clinbiomech.2007.02.006; Shin DD, 2009, J APPL PHYSIOL, V107, P1276, DOI 10.1152/japplphysiol.91598.2008; Sousa F, 2007, J APPL PHYSIOL, V102, P382, DOI 10.1152/japplphysiol.00274.2006; Stafilidis S, 2005, EUR J APPL PHYSIOL, V94, P317, DOI 10.1007/s00421-004-1301-4; Sugisaki N, 2005, INT J SPORT HLTH SCI, V3, P100; Tilp M, 2012, EUR J APPL PHYSIOL, V112, P1485, DOI 10.1007/s00421-011-2111-0; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zhao H, 2009, J APPL PHYSIOL, V106, P843, DOI 10.1152/japplphysiol.91212.2008	39	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44406	10.1371/journal.pone.0044406	http://dx.doi.org/10.1371/journal.pone.0044406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952973	Green Published, gold			2022-12-27	WOS:000308206000100
J	McClanahan, TR; Donner, SD; Maynard, JA; MacNeil, MA; Graham, NAJ; Maina, J; Baker, AC; Alemu, IJB; Beger, M; Campbell, SJ; Darling, ES; Eakin, CM; Heron, SF; Jupiter, SD; Lundquist, CJ; McLeod, E; Mumby, PJ; Paddack, MJ; Selig, ER; van Woesik, R				McClanahan, Tim R.; Donner, Simon D.; Maynard, Jeffrey A.; MacNeil, M. Aaron; Graham, Nicholas A. J.; Maina, Joseph; Baker, Andrew C.; Alemu, Jahson B. I.; Beger, Maria; Campbell, Stuart J.; Darling, Emily S.; Eakin, C. Mark; Heron, Scott F.; Jupiter, Stacy D.; Lundquist, Carolyn J.; McLeod, Elizabeth; Mumby, Peter J.; Paddack, Michelle J.; Selig, Elizabeth R.; van Woesik, Robert			Prioritizing Key Resilience Indicators to Support Coral Reef Management in a Changing Climate	PLOS ONE			English	Article							MORTALITY; DEGRADATION; DIVERSITY; STABILITY; RESPONSES; STRESS; FISHES; SHIFTS	Managing coral reefs for resilience to climate change is a popular concept but has been difficult to implement because the empirical scientific evidence has either not been evaluated or is sometimes unsupportive of theory, which leads to uncertainty when considering methods and identifying priority reefs. We asked experts and reviewed the scientific literature for guidance on the multiple physical and biological factors that affect the ability of coral reefs to resist and recover from climate disturbance. Eleven key factors to inform decisions based on scaling scientific evidence and the achievability of quantifying the factors were identified. Factors important to resistance and recovery, which are important components of resilience, were not strongly related, and should be assessed independently. The abundance of resistant (heat-tolerant) coral species and past temperature variability were perceived to provide the greatest resistance to climate change, while coral recruitment rates, and macroalgae abundance were most influential in the recovery process. Based on the 11 key factors, we tested an evidence-based framework for climate change resilience in an Indonesian marine protected area. The results suggest our evidence-weighted framework improved upon existing un-weighted methods in terms of characterizing resilience and distinguishing priority sites. The evaluation supports the concept that, despite high ecological complexity, relatively few strong variables can be important in influencing ecosystem dynamics. This is the first rigorous assessment of factors promoting coral reef resilience based on their perceived importance, empirical evidence, and feasibility of measurement. There were few differences between scientists' perceptions of factor importance and the scientific evidence found in journal publications but more before and after impact studies will be required to fully test the validity of all the factors. The methods here will increase the feasibility and defensibility of including key resilience metrics in evaluations of coral reefs, as well as reduce costs. Adaptation, marine protected areas, priority setting, resistance, recovery.	[McClanahan, Tim R.] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA; [Donner, Simon D.] Univ British Columbia, Dept Geog, Vancouver, BC V5Z 1M9, Canada; [MacNeil, M. Aaron] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Graham, Nicholas A. J.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Maina, Joseph] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Baker, Andrew C.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA; [Alemu, Jahson B. I.] Inst Marine Affairs, Chaguaramas, Trinidad Tobago; [Beger, Maria] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Campbell, Stuart J.] Wildlife Conservat Soc, Indonesian Program, Bogor, Java, Indonesia; [Darling, Emily S.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Eakin, C. Mark] Natl Ocean & Atmospher Adm, Silver Spring, MD USA; [Heron, Scott F.] Natl Ocean & Atmospher Adm, Townsville, Qld, Australia; [Heron, Scott F.] James Cook Univ, Sch Engn & Phys Sci, Marine Geophys Lab, Townsville, Qld 4811, Australia; [Jupiter, Stacy D.] Wildlife Conservat Soc, Fiji Country Program, Suva, Fiji; [Lundquist, Carolyn J.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand; [McLeod, Elizabeth] Nature Conservancy, Honolulu, HI USA; [Mumby, Peter J.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia, Qld, Australia; [Paddack, Michelle J.] Santa Barbara City Coll, Dept Biol Sci, Santa Barbara, CA USA; [Selig, Elizabeth R.] Conservat Int, Sci Knowledge Div, Arlington, VA USA; [van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Wildlife Conservation Society; University of British Columbia; Australian Institute of Marine Science; James Cook University; Macquarie University; University of Miami; University of Queensland; Wildlife Conservation Society - Indonesia; Simon Fraser University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Nature Conservancy; University of Queensland; Conservation International; Florida Institute of Technology	McClanahan, TR (corresponding author), Wildlife Conservat Soc, Marine Programs, Bronx, NY USA.	tmcclanahan@wcs.org	McClanahan, Tim/K-4998-2019; MacNeil, M. Aaron/ABD-6444-2021; Graham, Nicholas AJ/C-8360-2014; McLean, Laurence JA/C-7367-2014; Beger, Maria/ABC-5975-2022; Heron, Scott F/E-7928-2011; MacNeil, Aaron/E-8196-2017; Mumby, Peter/F-9914-2010; Beger, Maria/F-9049-2013; Eakin, C. Mark/F-5585-2010	MacNeil, M. Aaron/0000-0001-8406-325X; Graham, Nicholas AJ/0000-0002-0304-7467; Beger, Maria/0000-0003-1363-3571; MacNeil, Aaron/0000-0001-8406-325X; Mumby, Peter/0000-0002-6297-9053; Beger, Maria/0000-0003-1363-3571; Eakin, C. Mark/0000-0002-5987-0858; McClanahan, Timothy/0000-0001-5821-3584; Maina, Joseph/0000-0003-1268-6137; Alemu I, Jahson/0000-0002-6936-2857; Campbell, Stuart/0000-0002-1158-3200; Baker, Andrew/0000-0002-7866-2587; Darling, Emily/0000-0002-1048-2838; Maynard, Dr Jeffrey/0000-0002-6444-6373; Lundquist, Carolyn/0000-0002-2101-7237; Heron, Scott/0000-0001-5262-6978; Jupiter, Stacy/0000-0001-9742-1677	John D. and Catherine T. MacArthur Foundation; Wildlife Conservation Society (Karimunjawa surveys); NERC [NE/G017344/1] Funding Source: UKRI; Natural Environment Research Council [NE/G017344/1] Funding Source: researchfish	John D. and Catherine T. MacArthur Foundation; Wildlife Conservation Society (Karimunjawa surveys); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by grants from the John D. and Catherine T. MacArthur Foundation to the lead author and benefited from support from the Wildlife Conservation Society (Karimunjawa surveys) and The Nature Conservancy for partial support of conference attendance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2011, GLOBAL CHANGE BIOL, V17, P2023, DOI 10.1111/j.1365-2486.2011.02395.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Obura D, 2009, RESILIENCE ASSESSMEN; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Sale PF, 2011, OUR DYING PLANET: AN ECOLOGIST'S VIEW OF THE CRISIS WE FACE, P1; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Victor S, 2008, ESTUAR COAST SHELF S, V77, P175, DOI 10.1016/j.ecss.2007.09.009; West J, 2003, COMMENTARY, V115, P17; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	32	160	166	8	167	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42884	10.1371/journal.pone.0042884	http://dx.doi.org/10.1371/journal.pone.0042884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952618	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000308206000013
J	Ubertini, M; Lefebvre, S; Gangnery, A; Grangere, K; Le Gendre, R; Orvain, F				Ubertini, Martin; Lefebvre, Sebastien; Gangnery, Aline; Grangere, Karine; Le Gendre, Romain; Orvain, Francis			Spatial Variability of Benthic-Pelagic Coupling in an Estuary Ecosystem: Consequences for Microphytobenthos Resuspension Phenomenon	PLOS ONE			English	Article							INTERTIDAL SEDIMENTS; CHLOROPHYLL-A; MICROALGAL BIOMASS; STABLE-ISOTOPES; HYDROBIA-ULVAE; CASSINO BEACH; TAGUS ESTUARY; DYNAMICS; COASTAL; ERODIBILITY	The high degree of physical factors in intertidal estuarine ecosystem increases material processing between benthic and pelagic compartments. In these ecosystems, microphytobenthos resuspension is a major phenomenon since its contribution to higher trophic levels can be highly significant. Understanding the sediment and associated microphytobenthos resuspension and its fate in the water column is indispensable for measuring the food available to benthic and pelagic food webs. To identify and hierarchize the physical/biological factors potentially involved in MPB resuspension, the entire intertidal area and surrounding water column of an estuarine ecosystem, the Bay des Veys, was sampled during ebb tide. A wide range of physical parameters (hydrodynamic regime, grain size of the sediment, and suspended matter) and biological parameters (flora and fauna assemblages, chlorophyll) were analyzed to characterize benthic-pelagic coupling at the bay scale. Samples were collected in two contrasted periods, spring and late summer, to assess the impact of forcing variables on benthic-pelagic coupling. A mapping approach using kriging interpolation enabled us to overlay benthic and pelagic maps of physical and biological variables, for both hydrological conditions and trophic indicators. Pelagic Chl a concentration was the best predictor explaining the suspension-feeders spatial distribution. Our results also suggest a perennial spatio-temporal structure of both benthic and pelagic compartments in the ecosystem, at least when the system is not imposed to intense wind, with MPB distribution controlled by both grain size and bathymetry. The benthic component appeared to control the pelagic one via resuspension phenomena at the scale of the bay. Co-inertia analysis showed closer benthic-pelagic coupling between the variables in spring. The higher MPB biomass observed in summer suggests a higher contribution to filter-feeders diets, indicating a higher resuspension effect in summer than in spring, in turn suggesting an important role of macrofauna bioturbation and filter feeding (Cerastoderma edule).	[Ubertini, Martin; Grangere, Karine; Orvain, Francis] Univ Caen Basse Normandie, FRE3484, BioMEA, Caen, France; [Ubertini, Martin; Grangere, Karine; Orvain, Francis] CNRS, INEE, FRE3484, BioMEA, Caen, France; [Gangnery, Aline; Le Gendre, Romain] IFREMER, LERN, Port En Bessin, France; [Lefebvre, Sebastien] Univ Lille 1, CNRS, UMR 8187, Stn Marine Wimereux,LOG, Wimereux, France; [Orvain, Francis] CNRS, UMR 7208, BOREA, Museum Hist Nat,CRESCO, Dinard, France	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Ubertini, M (corresponding author), Univ Caen Basse Normandie, FRE3484, BioMEA, Caen, France.	francis.orvain@unicaen.fr	Ubertini, Martin/AAH-3898-2020; Lefebvre, Sébastien/G-8562-2011	Lefebvre, Sébastien/0000-0002-7152-5897; Le Gendre, Romain/0000-0001-7015-8290	Regional council of Basse-Normandie	Regional council of Basse-Normandie(Region Normandie)	This work was funded by the Regional council of Basse-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CL, 1997, ESTUAR COAST SHELF S, V45, P507, DOI 10.1006/ecss.1996.0193; Austen I, 1999, ESTUAR COAST SHELF S, V49, P99, DOI 10.1006/ecss.1998.0491; Blanchard GF, 2001, J EXP MAR BIOL ECOL, V264, P85, DOI 10.1016/S0022-0981(01)00312-4; BOUGRIER S, 1995, AQUACULTURE, V134, P143, DOI 10.1016/0044-8486(95)00036-2; BROTAS V, 1995, HYDROBIOLOGIA, V300, P93, DOI 10.1007/BF00024451; Callier MD, 2009, MAR POLLUT BULL, V58, P1544, DOI 10.1016/j.marpolbul.2009.05.010; CARPENTER SR, 1986, LIMNOL OCEANOGR, V31, P112, DOI 10.4319/lo.1986.31.1.0112; Cartaxana P, 2006, ESTUAR COAST SHELF S, V66, P225, DOI 10.1016/j.ecss.2005.08.011; Choy EJ, 2009, J EXP MAR BIOL ECOL, V382, P18, DOI 10.1016/j.jembe.2009.10.002; Cibic T, 2007, ESTUAR COAST SHELF S, V75, P50, DOI 10.1016/j.ecss.2007.01.020; Ciutat A, 2006, MAR ECOL-PROG SER, V346, P114; Cognie B, 1999, OCEANOL ACTA, V22, P441, DOI 10.1016/S0399-1784(00)88727-7; COLIJN F, 1984, MAR ECOL PROG SER, V14, P185, DOI 10.3354/meps014185; Consalvey M, 2004, PHOTOSYNTH RES, V81, P91, DOI 10.1023/B:PRES.0000028397.86495.b5; DEJONGE VN, 1995, LIMNOL OCEANOGR, V40, P766; Deroin JP, 2012, INT J APPL EARTH OBS, V18, P183, DOI 10.1016/j.jag.2012.01.019; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Dubois S, 2007, J EXP MAR BIOL ECOL, V351, P121, DOI 10.1016/j.jembe.2007.06.020; Dubois S, 2007, AQUACULTURE, V271, P336, DOI 10.1016/j.aquaculture.2007.03.023; Dubois S, 2007, MAR ECOL PROG SER, V336, P151, DOI 10.3354/meps336151; Eleftheriou A., 1984, METHODS STUDY MARINE, P140; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Grangere K, 2010, MAR ECOL PROG SER, V415, P141, DOI 10.3354/meps08659; Guarini JM, 2008, ECOL MODEL, V211, P267, DOI 10.1016/j.ecolmodel.2007.09.011; Guarini JM, 2004, J SEA RES, V52, P241, DOI 10.1016/j.seares.2004.04.003; Hammerstrom KK, 2010, INTEGR ENVIRON ASSES, P1; Hansen K, 1996, AQUAT MICROB ECOL, V10, P181, DOI 10.3354/ame010181; Hayward P.J., 1990, MARINE FAUNA BRIT IS, V1; Honkoop PJC, 2006, J SEA RES, V55, P278, DOI 10.1016/j.seares.2005.11.001; Huot Y, 2007, BIOGEOSCIENCES, V4, P853, DOI 10.5194/bg-4-853-2007; Kang CK, 2006, MAR ECOL PROG SER, V315, P113, DOI 10.3354/meps315113; Kasim M, 2006, J OCEANOGR, V62, P267, DOI 10.1007/s10872-006-0051-9; Koh CH, 2007, ESTUAR COAST SHELF S, V72, P42, DOI 10.1016/j.ecss.2006.10.005; Kon K, 2012, ESTUAR COAST SHELF S, V96, P236, DOI 10.1016/j.ecss.2011.11.015; Lazure P, 2008, ADV WATER RESOUR, V31, P233, DOI 10.1016/j.advwatres.2007.06.010; Lefebvre S, 2009, ESTUAR COAST SHELF S, V82, P415, DOI 10.1016/j.ecss.2009.02.002; Longphuirt SN, 2007, ESTUAR COAST SHELF S, V74, P367, DOI 10.1016/j.ecss.2007.04.025; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Lucas CH, 2000, MAR ECOL PROG SER, V196, P59, DOI 10.3354/meps196059; Lucas CH, 2003, ESTUARIES, V26, P885, DOI 10.1007/BF02803347; Lund-Hansen LC, 1999, ESTUARIES, V22, P39, DOI 10.2307/1352925; Malet N, 2008, ESTUAR COAST SHELF S, V78, P576, DOI 10.1016/j.ecss.2007.11.001; Newell RIE, 2002, LIMNOL OCEANOGR, V47, P1367, DOI 10.4319/lo.2002.47.5.1367; Odebrecht C, 2003, J COASTAL RES, P486; Orvain F, 2006, J SEA RES, V55, P54, DOI 10.1016/j.seares.2005.10.002; Orvain F, 2004, MAR ECOL PROG SER, V278, P205, DOI 10.3354/meps278205; Orvain F, 2012, MAR ECOL PROG SER, V458, P53, DOI 10.3354/meps09698; Pannard A, 2008, CAN J FISH AQUAT SCI, V65, P47, DOI 10.1139/F07-149; Perissinotto R, 2003, ACTA OECOL, V24, pS307, DOI 10.1016/S1146-609X(03)00028-6; Perkins RG, 2003, CONT SHELF RES, V23, P575, DOI 10.1016/S0278-4343(03)00006-2; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pillay D, 2007, MAR ECOL PROG SER, V347, P1, DOI 10.3354/meps07054; Porter ET, 2010, MAR ECOL PROG SER, V413, P33, DOI 10.3354/meps08709; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Rorig LR, 2003, J COASTAL RES, P167; Saburova MA, 1995, MAR ECOL PROG SER, V129, P229, DOI 10.3354/meps129229; Safi KA, 2003, MAR ECOL PROG SER, V259, P67, DOI 10.3354/meps259067; Schelske C.L., 1962, P GULF CARIBBEAN FIS, P75; Serodio J, 2006, ESTUAR COAST SHELF S, V68, P547, DOI 10.1016/j.ecss.2006.03.005; Snoeijs P, 2002, J PHYCOL, V38, P265, DOI 10.1046/j.1529-8817.2002.01105.x; Spears BM, 2008, MAR FRESHWATER RES, V59, P313, DOI 10.1071/MF07164; SPOONER N, 1994, ORG GEOCHEM, V22, P773, DOI 10.1016/0146-6380(94)90138-4; Tolhurst TJ, 2003, HYDROBIOLOGIA, V503, P183, DOI 10.1023/B:HYDR.0000008474.33782.8d; Tolhurst TJ, 2002, PROCEED MARINE SCI, V5, P409; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood G. J. C., 2006, FUNCTIONING MICROPHY, P121; Underwood GJC, 1999, ADV ECOL RES, V29, P93; Utermohl V. H., 1931, VERH INT VEREIN THEO, V5, P567, DOI DOI 10.1080/03680770.1931.11898492; van der Wal D, 2008, MAR ECOL PROG SER, V367, P57, DOI 10.3354/meps07535; van der Wal D, 2010, ECOSYSTEMS, V13, P338, DOI 10.1007/s10021-010-9322-9; WAITE AM, 1992, LIMNOL OCEANOGR, V37, P468, DOI 10.4319/lo.1992.37.3.0468; Webster R, 2006, COMPUT GEOSCI-UK, V32, P1320, DOI 10.1016/j.cageo.2005.12.002; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985	73	73	74	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44155	10.1371/journal.pone.0044155	http://dx.doi.org/10.1371/journal.pone.0044155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952910	gold, Green Published			2022-12-27	WOS:000308206000091
J	Heinrich, S; Valentin, K; Frickenhaus, S; John, U; Wiencke, C				Heinrich, Sandra; Valentin, Klaus; Frickenhaus, Stephan; John, Uwe; Wiencke, Christian			Transcriptomic Analysis of Acclimation to Temperature and Light Stress in Saccharina latissima (Phaeophyceae)	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SUPEROXIDE-DISMUTASE ACTIVITY; ASCORBATE-GLUTATHIONE CYCLE; REACTIVE OXYGEN-METABOLISM; KELP LAMINARIA-SACCHARINA; INDUCED OXIDATIVE STRESS; PROGRAMMED CELL-DEATH; GENE-EXPRESSION; COLD-ACCLIMATION; ECOTYPIC DIFFERENTIATION	Kelps, brown algae of the order Laminariales, dominate rocky shores and form huge kelp beds which provide habitat and nurseries for various marine organisms. Whereas the basic physiological and ecophysiological characteristics of kelps are well studied, the molecular processes underlying acclimation to different light and temperature conditions are still poorly understood. Therefore we investigated the molecular mechanisms underlying the physiological acclimation to light and temperature stress. Sporophytes of S. latissima were exposed to combinations of light intensities and temperatures, and microarray hybridizations were performed to determine changes in gene expression patterns. This first large-scale transcriptomic study of a kelp species shows that S. latissima responds to temperature and light stress with a multitude of transcriptional changes: up to 32% of genes showed an altered expression after the exposure experiments. High temperature had stronger effects on gene expression in S. latissima than low temperature, reflected by the higher number of temperature-responsive genes. We gained insights into underlying molecular processes of acclimation, which includes adjustment of the primary metabolism as well as induction of several ROS scavengers and a sophisticated regulation of Hsps. We show that S. latissima, as a cold adapted species, must make stronger efforts for acclimating to high than to low temperatures. The strongest response was caused by the combination of high temperatures with high light intensities, which proved most harmful for the alga.	[Heinrich, Sandra; Wiencke, Christian] Alfred Wegener Inst Polar & Marine Res, Dept Funct Ecol, Bremerhaven, Germany; [Valentin, Klaus] Alfred Wegener Inst Polar & Marine Res, Dept Polar Biol Oceanog, Bremerhaven, Germany; [Frickenhaus, Stephan] Hsch Bremerhaven, Dept Biotechnol, Bremerhaven, Germany; [John, Uwe] Alfred Wegener Inst Polar & Marine Res, Dept Ecol Chem, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Heinrich, S (corresponding author), Alfred Wegener Inst Polar & Marine Res, Dept Funct Ecol, Bremerhaven, Germany.	Sandra.Heinrich@awi.de	Valentin, Klaus/G-5862-2014; john, uwe/S-3009-2016	Valentin, Klaus/0000-0001-7401-9423; john, uwe/0000-0002-1297-4086; Frickenhaus, Stephan/0000-0002-0356-9791	PACES (Coastal and Polar Systems: Polar Regions and Coasts in a changing Earth System) research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment	PACES (Coastal and Polar Systems: Polar Regions and Coasts in a changing Earth System) research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment	Financial support was provided by the PACES (Coastal and Polar Systems: Polar Regions and Coasts in a changing Earth System) research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WW, 2004, BIOSCIENCE, V54, P41, DOI 10.1641/0006-3568(2004)054[0041:PSOOE]2.0.CO;2; ADAMS WW, 1987, PLANT PHYSIOL, V83, P213, DOI 10.1104/pp.83.1.213; Aguilera J, 2002, POLAR BIOL, V25, P432, DOI 10.1007/s00300-002-0362-2; Aguilera J, 2002, MAR BIOL, V140, P1087, DOI 10.1007/s00227-002-0792-y; Alexieva V., 2003, BULG J PLANT PHYSL, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JM., 2001, PHOTOINHIBITION, P1; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K., 1997, OXIDATIVE STRESS MOL; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; Bischof K, 2006, MAR ECOL PROG SER, V306, P165, DOI 10.3354/meps306165; Bischof K, 2003, SCI MAR, V67, P353, DOI 10.3989/scimar.2003.67n3353; Bischof K., 2012, RECENT ADV SEAWEED B; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; BOLTON JJ, 1983, PHYCOLOGIA, V22, P133, DOI 10.2216/i0031-8884-22-2-133.1; Borum J, 2002, MAR BIOL, V141, P11, DOI 10.1007/s00227-002-0806-9; Bruhn J, 1996, MAR BIOL, V125, P639, DOI 10.1007/BF00349245; Burritt DJ, 2002, PLANTA, V215, P829, DOI 10.1007/s00425-002-0805-6; Carlsen BP, 2007, POLAR BIOL, V30, P939, DOI 10.1007/s00300-007-0272-4; CHARPY-ROUBAUD C, 1990, Marine Microbial Food Webs, V4, P31; Chaves I, 2011, BIOL PLANTARUM, V55, P153, DOI 10.1007/s10535-011-0021-y; Collen J, 1999, PLANT CELL ENVIRON, V22, P1143, DOI 10.1046/j.1365-3040.1999.00477.x; Collen J, 1999, J PHYCOL, V35, P54, DOI 10.1046/j.1529-8817.1999.3510054.x; Collen J, 2001, J PHYCOL, V37, P474, DOI 10.1046/j.1529-8817.2001.037004474.x; Collen J, 2007, NEW PHYTOL, V176, P45, DOI 10.1111/j.1469-8137.2007.02152.x; Collen J, 2006, J EXP BOT, V57, P3869, DOI 10.1093/jxb/erl171; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Contreras L, 2009, AQUAT TOXICOL, V94, P94, DOI 10.1016/j.aquatox.2009.06.004; Cosse A, 2009, NEW PHYTOL, V182, P239, DOI 10.1111/j.1469-8137.2008.02745.x; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Crepineau F, 2000, PLANT MOL BIOL, V43, P503, DOI 10.1023/A:1006489920808; DAVISON IR, 1991, MAR BIOL, V110, P449, DOI 10.1007/BF01344363; DAVISON IR, 1987, BRIT PHYCOL J, V22, P77, DOI 10.1080/00071618700650101; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dittami S., 2009, GENOME BIOL, V10, P51; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Dring MJ, 2006, ADV BOT RES, V43, P175, DOI 10.1016/S0065-2296(05)43004-9; DUNTON KH, 1985, J EXP MAR BIOL ECOL, V94, P181, DOI 10.1016/0022-0981(85)90057-7; Ensminger I, 2006, PHYSIOL PLANTARUM, V126, P28, DOI 10.1111/j.1399-3054.2006.00627.x; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Franklin LA, 1997, EUR J PHYCOL, V32, P207, DOI 10.1080/09670269710001737149; Fu WD, 2011, J APPL PHYCOL, V23, P681, DOI 10.1007/s10811-010-9561-3; Fu WD, 2009, MAR BIOTECHNOL, V11, P738, DOI 10.1007/s10126-009-9188-z; GERARD VA, 1988, MAR BIOL, V97, P575, DOI 10.1007/BF00391054; GERARD VA, 1988, MAR BIOL, V97, P25, DOI 10.1007/BF00391242; GERARD VA, 1990, MAR BIOL, V107, P519, DOI 10.1007/BF01313437; Gevaert F, 2003, MAR ECOL PROG SER, V247, P43, DOI 10.3354/meps247043; Gomez I, 2009, BOT MAR, V52, P593, DOI 10.1515/BOT.2009.073; Graham MH, 2007, P NATL ACAD SCI USA, V104, P16576, DOI 10.1073/pnas.0704778104; Grant CM, 2000, BBA-GENE STRUCT EXPR, V1490, P33, DOI 10.1016/S0167-4781(99)00234-1; Gravot A, 2010, NEW PHYTOL, V188, P98, DOI 10.1111/j.1469-8137.2010.03400.x; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Hader DP, 1997, PHOTOCHEM PHOTOBIOL, V66, P1, DOI 10.1111/j.1751-1097.1997.tb03132.x; Haghjou MM, 2009, PHYSIOL PLANTARUM, V135, P272, DOI 10.1111/j.1399-3054.2008.01193.x; Han TJ, 1996, EUR J PHYCOL, V31, P233, DOI 10.1080/09670269600651431; Hanelt D, 1997, J PHYCOL, V33, P387, DOI 10.1111/j.0022-3646.1997.00387.x; Hanelt D, 1998, MAR BIOL, V131, P361, DOI 10.1007/s002270050329; Heinrich S, 2012, EUR J PHYCOL, V47, P83, DOI 10.1080/09670262.2012.660639; Huner NPA, 1996, PHYSIOL PLANTARUM, V98, P358, DOI 10.1034/j.1399-3054.1996.980218.x; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Janknegt PJ, 2008, J PHYCOL, V44, P957, DOI 10.1111/j.1529-8817.2008.00553.x; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Keren N, 2005, PLANT CELL, V17, P2768, DOI 10.1105/tpc.105.035048; KIRST GO, 1995, J PHYCOL, V31, P181, DOI 10.1111/j.0022-3646.1995.00181.x; Kumar M, 2010, J EXP MAR BIOL ECOL, V391, P27, DOI 10.1016/j.jembe.2010.06.001; Lehmann M, 2009, MOL PLANT, V2, P390, DOI 10.1093/mp/ssn080; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Li R, 2004, MAR BIOL, V144, P205, DOI 10.1007/s00227-003-1190-9; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lu IF, 2006, MAR BIOL, V150, P1, DOI 10.1007/s00227-006-0323-3; Ludlow MM, 1987, PHOTOINHIBITION, P89; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; Luning K, 1990, SEAWEEDS THEIR ENV B; Machalek KM, 1996, PLANT CELL ENVIRON, V19, P1005, DOI 10.1111/j.1365-3040.1996.tb00207.x; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; Moharikar S, 2006, J PHYCOL, V42, P423, DOI 10.1111/j.1529-8817.2006.00207.x; Muller R, 2008, CLIM RES, V37, P203, DOI 10.3354/cr00762; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; NAGAHISA E, 1995, BIOSCI BIOTECH BIOCH, V59, P2176, DOI 10.1271/bbb.59.2176; Nagao M, 2008, PLANT CELL ENVIRON, V31, P872, DOI 10.1111/j.1365-3040.2008.01804.x; Noctor G, 1998, PLANT PHYSIOL, V118, P471, DOI 10.1104/pp.118.2.471; Noctor G, 1997, PHYSIOL PLANTARUM, V100, P255, DOI 10.1034/j.1399-3054.1997.1000206.x; Noctor G, 2006, PLANT CELL ENVIRON, V29, P409, DOI 10.1111/j.1365-3040.2005.01476.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pearson GA, 2010, MAR BIOTECHNOL, V12, P195, DOI 10.1007/s10126-009-9208-z; Perelman A, 2006, J EXP MAR BIOL ECOL, V334, P229, DOI 10.1016/j.jembe.2006.02.009; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qureshi MI, 2007, J PLANT PHYSIOL, V164, P1239, DOI 10.1016/j.jplph.2007.01.013; Roeder V, 2005, J PHYCOL, V41, P1227, DOI 10.1111/j.1529-8817.2005.00150.x; Roleda MY, 2007, PHOTOCHEM PHOTOBIOL, V83, P851, DOI 10.1562/2006-08-17-IR-1005; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Sakamoto T, 2011, BIOSCI BIOTECH BIOCH, V75, P561, DOI 10.1271/bbb.100794; SEEMANN JR, 1987, PLANT PHYSIOL, V84, P796, DOI 10.1104/pp.84.3.796; Segovia M, 2003, PLANT PHYSIOL, V132, P99, DOI 10.1104/pp.102.017129; Shiu CT, 2005, J EXP BOT, V56, P2851, DOI 10.1093/jxb/eri277; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Sundaram S, 2010, PLANTA, V231, P361, DOI 10.1007/s00425-009-1055-7; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tanahashi N, 1999, MOL BIOL REP, V26, P3, DOI 10.1023/A:1006909522731; Tanaka K, 1997, MOL BIOL REP, V24, P3, DOI 10.1023/A:1006876904158; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Valles D, 2008, PROTEIN J, V27, P267, DOI 10.1007/s10930-008-9133-4; Vardi A, 1999, CURR BIOL, V9, P1061, DOI 10.1016/S0960-9822(99)80459-X; VAYDA ME, 1994, PLANT MOL BIOL, V24, P229, DOI 10.1007/BF00040590; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; WEIS E, 1981, PLANTA, V151, P33, DOI 10.1007/BF00384234; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Wiencke C, 2006, J ECOL, V94, P455, DOI 10.1111/j.1365-2745.2006.01102.x; Wolfe-Simon F, 2005, J PHYCOL, V41, P453, DOI 10.1111/j.1529-8817.2005.00086.x; Wu TM, 2008, PHYCOLOGIA, V47, P346, DOI 10.2216/PH07-77.1	122	61	65	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44342	10.1371/journal.pone.0044342	http://dx.doi.org/10.1371/journal.pone.0044342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937172	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600103
J	Winkler, M; Bertram, S; Gnirss, K; Nehlmeier, I; Gawanbacht, A; Kirchhoff, F; Ehrhardt, C; Ludwig, S; Kiene, M; Moldenhauer, AS; Goedecke, U; Karsten, CB; Kuhl, A; Pohlmann, S				Winkler, Michael; Bertram, Stephanie; Gnirss, Kerstin; Nehlmeier, Inga; Gawanbacht, Ali; Kirchhoff, Frank; Ehrhardt, Christina; Ludwig, Stephan; Kiene, Miriam; Moldenhauer, Anna-Sophie; Goedecke, Ulrike; Karsten, Christina B.; Kuehl, Annika; Poehlmann, Stefan			Influenza A Virus Does Not Encode a Tetherin Antagonist with Vpu-Like Activity and Induces IFN-Dependent Tetherin Expression in Infected Cells	PLOS ONE			English	Article							HIV-1 RELEASE; RESTRICTION; GLYCOPROTEIN; PROTEIN; TYPE-1; RESPONSES; ANTIGEN; SURFACE; CD317	The interferon-induced host cell factor tetherin inhibits release of human immunodeficiency virus (HIV) from the plasma membrane of infected cells and is counteracted by the HIV-1 protein Vpu. Influenza A virus (FLUAV) also buds from the plasma membrane and is not inhibited by tetherin. Here, we investigated if FLUAV encodes a functional equivalent of Vpu for tetherin antagonism. We found that expression of the FLUAV protein NS1, which antagonizes the interferon (IFN) response, did not block the tetherin-mediated restriction of HIV release, which was rescued by Vpu. Similarly, tetherin-mediated inhibition of HIV release was not rescued by FLUAV infection. In contrast, FLUAV infection induced tetherin expression on target cells in an IFN-dependent manner. These results suggest that FLUAV escapes the antiviral effects of tetherin without encoding a tetherin antagonist with Vpu-like activity.	[Winkler, Michael; Bertram, Stephanie; Gnirss, Kerstin; Nehlmeier, Inga; Moldenhauer, Anna-Sophie; Goedecke, Ulrike; Karsten, Christina B.; Kuehl, Annika; Poehlmann, Stefan] German Primate Ctr, Gottingen, Germany; [Gnirss, Kerstin; Kiene, Miriam; Karsten, Christina B.; Kuehl, Annika; Poehlmann, Stefan] Hannover Med Sch, Inst Virol, D-3000 Hannover, Germany; [Gawanbacht, Ali; Kirchhoff, Frank] Univ Ulm, Med Ctr, Inst Mol Virol, Ulm, Germany; [Ehrhardt, Christina; Ludwig, Stephan] Univ Munster, Inst Mol Virol, Munster, Germany; [Karsten, Christina B.] Hannover Med Sch, Inst Cellular Chem, D-3000 Hannover, Germany	Deutsches Primatenzentrum (DPZ); Hannover Medical School; Ulm University; University of Munster; Hannover Medical School	Winkler, M (corresponding author), German Primate Ctr, Gottingen, Germany.	s.poehlmann@dpz.eu	Karsten, Christina B./GNH-2673-2022; Kirchhoff, Frank/O-8367-2018; Karsten, Christina B./J-8689-2019; Pöhlmann, Stefan/H-2395-2011	Kirchhoff, Frank/0000-0002-7052-2360; Karsten, Christina B./0000-0003-1934-6442; Pöhlmann, Stefan/0000-0001-6086-9136; Winkler, Michael/0000-0002-6198-554X; Ludwig, Stephan/0000-0003-4490-3052	Leibniz Association; International Research Training Group [1273]; Center for Infection Biology of Hannover Medical School;  [Sonderforschungsbereich 900]	Leibniz Association; International Research Training Group; Center for Infection Biology of Hannover Medical School; 	The study was supported by the Leibniz Association (MW SB IN ASM UG AK and SP), Sonderforschungsbereich 900 (CK SP), International Research Training Group 1273 (MK) and Center for Infection Biology of Hannover Medical School (KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bruce EA, 2012, J GEN VIROL, V93, P963, DOI 10.1099/vir.0.038778-0; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kawai S, 2006, ONCOL REP, V15, P361; Khurana S, 2007, J VIROL, V81, P12630, DOI 10.1128/JVI.01255-07; Kuhl A, 2011, J INFECT DIS, V204, pS850, DOI 10.1093/infdis/jir378; Kuhl A, 2010, NAT MED, V16, P155, DOI 10.1038/nm0210-155; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lopez LA, 2012, J VIROL, V86, P5467, DOI 10.1128/JVI.06280-11; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; Mangeat B, 2012, J BIOL CHEM, V287, P22015, DOI 10.1074/jbc.M111.319996; Marzi A, 2006, J VIROL, V80, P6305, DOI 10.1128/JVI.02545-05; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Radoshitzky SR, 2010, J VIROL, V84, P10569, DOI 10.1128/JVI.00103-10; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Watanabe R, 2011, VIROLOGY, V417, P50, DOI 10.1016/j.virol.2011.05.006; Yondola MA, 2011, J VIROL, V85, P2480, DOI 10.1128/JVI.02188-10; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	46	24	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43337	10.1371/journal.pone.0043337	http://dx.doi.org/10.1371/journal.pone.0043337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952667	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800026
J	Frost, CJ; Nyamdari, B; Tsai, CJ; Harding, SA				Frost, Christopher J.; Nyamdari, Batbayar; Tsai, Chung-Jui; Harding, Scott A.			The Tonoplast-Localized Sucrose Transporter in Populus (PtaSUT4) Regulates Whole-Plant Water Relations, Responses to Water Stress, and Photosynthesis	PLOS ONE			English	Article							GALACTINOL-SYNTHASE GENE; INDUCED TREE MORTALITY; POPLAR POPULUS; DROUGHT; ARABIDOPSIS; TOLERANCE; BARLEY; MECHANISMS; RESISTANCE; EXPRESSION	The Populus sucrose (Suc) transporter 4 (PtaSUT4), like its orthologs in other plant taxa, is tonoplast localized and thought to mediate Suc export from the vacuole into the cytosol. In source leaves of Populus, SUT4 is the predominantly expressed gene family member, with transcript levels several times higher than those of plasma membrane SUTs. A hypothesis is advanced that SUT4-mediated tonoplast sucrose fluxes contribute to the regulation of osmotic gradients between cellular compartments, with the potential to mediate both sink provisioning and drought tolerance in Populus. Here, we describe the effects of PtaSUT4-RNA interference (RNAi) on sucrose levels and raffinose family oligosaccharides (RFO) induction, photosynthesis, and water uptake, retention and loss during acute and chronic drought stresses. Under normal water-replete growing conditions, SUT4-RNAi plants had generally higher shoot water contents than wild-type plants. In response to soil drying during a short-term, acute drought, RNAi plants exhibited reduced rates of water uptake and delayed wilting relative to wild-type plants. SUT4-RNAi plants had larger leaf areas and lower photosynthesis rates than wild-type plants under well-watered, but not under chronic water-limiting conditions. Moreover, the magnitude of shoot water content, height growth, and photosynthesis responses to contrasting soil moisture regimes was greater in RNAi than wild-type plants. The concentrations of stress-responsive RFOs increased in wild-type plants but were unaffected in SUT4-RNAi plants under chronically dry conditions. We discuss a model in which the subcellular compartmentalization of sucrose mediated by PtaSUT4 is regulated in response to both sink demand and plant water status in Populus.	[Frost, Christopher J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Frost, CJ (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	sharding@uga.edu	Tsai, CJ/C-2450-2009; Frost, Christopher/A-4506-2012	Tsai, CJ/0000-0002-9282-7704; Frost, Christopher/0000-0001-5986-8646	Office of Science (BER), U.S. Department of Energy [DE-SC0005140]	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by the Office of Science (BER), U.S. Department of Energy, award no. DE-SC0005140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Babushok VI, 2007, J CHROMATOGR A, V1157, P414, DOI 10.1016/j.chroma.2007.05.044; Baigorria GA, 2007, INT J CLIMATOL, V27, P749, DOI 10.1002/joc.1435; Bento dos Santos T, 2011, PLANT PHYSIOL BIOCH, V49, P441, DOI 10.1016/j.plaphy.2011.01.023; Berthier A, 2009, PLANT CELL PHYSIOL, V50, P1329, DOI 10.1093/pcp/pcp081; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Bradshaw HD, 2000, J PLANT GROWTH REGUL, V19, P306, DOI 10.1007/s003440000030; CEULEMANS R, 1988, CAN J BOT, V66, P1404, DOI 10.1139/b88-196; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Cho SM, 2010, BOTANY, V88, P452, DOI 10.1139/B10-009; Cong L, 2008, PLANT SCI, V174, P156, DOI 10.1016/j.plantsci.2007.11.002; Drozdova IS, 2004, RUSS J PLANT PHYSL+, V51, P668, DOI 10.1023/B:RUPP.0000040755.53233.a5; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Eom JS, 2011, PLANT PHYSIOL, V157, P109, DOI 10.1104/pp.111.176982; ERICKSON RO, 1957, AM J BOT, V44, P297, DOI 10.2307/2438380; Fu QS, 2011, PLANT PHYSIOL, V157, P1518, DOI 10.1104/pp.111.184820; GIAQUINTA RT, 1983, ANNU REV PLANT PHYS, V34, P347, DOI 10.1146/annurev.pp.34.060183.002023; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; HO LC, 1982, PHYSIOL PLANTARUM, V56, P225, DOI 10.1111/j.1399-3054.1982.tb00330.x; Hogg EH, 2002, CAN J FOREST RES, V32, P823, DOI [10.1139/x01-152, 10.1139/X01-152]; Jeong ML, 2004, PLANT PHYSIOL, V136, P3364, DOI 10.1104/pp.104.044776; KABAT EA, 1953, J AM CHEM SOC, V75, P4507, DOI 10.1021/ja01114a034; KAISER G, 1984, PLANTA, V161, P562, DOI 10.1007/BF00407090; Kim MS, 2008, MOL PLANT MICROBE IN, V21, P1643, DOI 10.1094/MPMI-21-12-1643; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; KOVATS E, 1958, HELV CHIM ACTA, V41, P1915, DOI 10.1002/hlca.19580410703; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Lalonde S, 2003, PLANT CELL ENVIRON, V26, P37, DOI 10.1046/j.1365-3040.2003.00847.x; Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393; Li X, 2011, J PLANT PHYSIOL, V168, P1761, DOI 10.1016/j.jplph.2011.04.006; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Neuhaus HE, 2007, FEBS LETT, V581, P2223, DOI 10.1016/j.febslet.2007.02.003; Okubo-Kurihara E, 2011, J PLANT RES, V124, P395, DOI 10.1007/s10265-010-0377-7; Payyavula RS, 2011, PLANT J, V65, P757, DOI 10.1111/j.1365-313X.2010.04463.x; Penna S, 2003, TRENDS PLANT SCI, V8, P355, DOI 10.1016/S1360-1385(03)00159-6; Philippe RN, 2010, NEW PHYTOL, V188, P787, DOI 10.1111/j.1469-8137.2010.03392.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Possen BJHM, 2011, FOREST ECOL MANAG, V262, P1387, DOI 10.1016/j.foreco.2011.06.035; Reinders A, 2008, PLANT MOL BIOL, V68, P289, DOI 10.1007/s11103-008-9370-0; Reinders A, 2006, PLANT CELL ENVIRON, V29, P1871, DOI 10.1111/j.1365-3040.2006.01563.x; Rennie EA, 2009, P NATL ACAD SCI USA, V106, P14162, DOI 10.1073/pnas.0902279106; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sala A, 2010, NEW PHYTOL, V186, P274, DOI 10.1111/j.1469-8137.2009.03167.x; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Schneider S, 2012, PLANT BIOLOGY, V14, P325, DOI 10.1111/j.1438-8677.2011.00506.x; Schneider T, 2009, PLANT CELL PHYSIOL, V50, P2174, DOI 10.1093/pcp/pcp151; SCHULTE PJ, 1988, CAN J BOT, V66, P1073, DOI 10.1139/b88-153; Schulz A, 2011, PLANT J, V68, P129, DOI 10.1111/j.1365-313X.2011.04672.x; Silim S, 2009, TREES-STRUCT FUNCT, V23, P959, DOI 10.1007/s00468-009-0338-8; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; TARDIEU F, 1993, PHILOS T R SOC B, V341, P57, DOI 10.1098/rstb.1993.0091; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; TSCHAPLINSKI TJ, 1994, CAN J FOREST RES, V24, P681, DOI 10.1139/x94-091; Tschaplinski TJ, 1998, TREE PHYSIOL, V18, P653; Turgeon R, 1998, P NATL ACAD SCI USA, V95, P12055, DOI 10.1073/pnas.95.20.12055; Turgeon R, 2004, PLANT PHYSIOL, V136, P3795, DOI 10.1104/pp.104.042036; Unda F, 2012, J EXP BOT, V63, P2059, DOI 10.1093/jxb/err411; Valluru R, 2011, PLANT SCI, V181, P387, DOI 10.1016/j.plantsci.2011.07.009; van Heerden PDR, 2010, J EXP BOT, V61, P2877, DOI 10.1093/jxb/erq144; VOGELMANN TC, 1993, ANNU REV PLANT PHYS, V44, P231, DOI 10.1146/annurev.pp.44.060193.001311; Vogelmann TC, 2002, PLANT CELL ENVIRON, V25, P1313, DOI 10.1046/j.1365-3040.2002.00910.x; Wang Z, 2009, PLANTA, V230, P1155, DOI 10.1007/s00425-009-1014-3; Weise A, 2000, PLANT CELL, V12, P1345, DOI 10.1105/tpc.12.8.1345; Weschke W, 2000, PLANT J, V21, P455, DOI 10.1046/j.1365-313x.2000.00695.x; Weschke W, 2003, PLANT J, V33, P395, DOI 10.1046/j.1365-313X.2003.01633.x; Wingenter K, 2010, PLANT PHYSIOL, V154, P665, DOI 10.1104/pp.110.162040	70	53	59	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44467	10.1371/journal.pone.0044467	http://dx.doi.org/10.1371/journal.pone.0044467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952983	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300092
J	Madalena, CRG; Diez, JL; Gorab, E				Gutierrez Madalena, Christiane Rodriguez; Luis Diez, Jose; Gorab, Eduardo			Chromatin Structure of Ribosomal RNA Genes in Dipterans and Its Relationship to the Location of Nucleolar Organizers	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; POLYTENE CHROMOSOMES; SCIARA-COPROPHILA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION UNITS; CHIRONOMUS-TENTANS; DNA-SEQUENCES; CROSS-LINKING; POLYMERASE-I; RDNA	Nucleoli, nuclear organelles in which ribosomal RNA is synthesized and processed, emerge from nucleolar organizers (NORs) located in distinct chromosomal regions. In polytene nuclei of dipterans, nucleoli of some species can be observed under light microscopy exhibiting distinctive morphology: Drosophila and chironomid species display well-formed nucleoli in contrast to the fragmented and dispersed nucleoli seen in sciarid flies. The available data show no apparent relationship between nucleolar morphology and location of NORs in Diptera. The regulation of rRNA transcription involves controlling both the transcription rate per gene as well as the proportion of rRNA genes adopting a proper chromatin structure for transcription, since active and inactive rRNA gene copies coexist in NORs. Transcription units organized in nucleosomes and those lacking canonical nucleosomes can be analyzed by the method termed psoralen gel retarding assay (PGRA), allowing inferences on the ratio of active to inactive rRNA gene copies. In this work, possible connections between chromosomal location of NORs and proportion of active rRNA genes were studied in Drosophila melanogaster, and in chironomid and sciarid species. The data suggested a link between location of NORs and proportion of active rRNA genes since the copy number showing nucleosomal organization predominates when NORs are located in the pericentric heterochromatin. The results presented in this work are in agreement with previous data on the chromatin structure of rRNA genes from distantly related eukaryotes, as assessed by the PGRA.	[Gutierrez Madalena, Christiane Rodriguez; Gorab, Eduardo] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Luis Diez, Jose] CSIC, Ctr Invest Biol, Dept Biol Celular & Desarrollo, Madrid, Spain	Universidade de Sao Paulo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Madalena, CRG (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil.	egorab@usp.br			Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMELIN HA, 1969, GENETICS, V61, P351; BARR HJ, 1966, J CELL BIOL, V31, pC17, DOI 10.1083/jcb.31.3.C17; BEERMANN W, 1952, CHROMOSOMA, V5, P139; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; CHOOI WY, 1979, CHROMOSOMA, V74, P57, DOI 10.1007/BF00344483; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; CONCONI A, 1992, P NATL ACAD SCI USA, V89, P5256, DOI 10.1073/pnas.89.12.5256; DAMMANN R, 1995, MOL CELL BIOL, V15, P5294; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; DEGELMANN A, 1979, CHROMOSOMA, V71, P263, DOI 10.1007/BF00287136; EASTMAN EM, 1980, CHROMOSOMA, V79, P293, DOI 10.1007/BF00327321; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Fuchs J, 2004, CHROMOSOME RES, V12, P427, DOI 10.1023/B:CHRO.0000034726.05374.db; GABRUSEW.N, 1972, CHROMOSOMA, V38, P237, DOI 10.1007/BF00290924; GABRUSEW.N, 1966, J CELL BIOL, V29, P347, DOI 10.1083/jcb.29.2.347; GAMBARINI AG, 1974, J CELL BIOL, V62, P215, DOI 10.1083/jcb.62.1.215; Gorab E, 1995, J MOL EVOL, V41, P1016, DOI 10.1007/BF00173183; Greciano PG, 2009, CHROMOSOMA, V118, P361, DOI 10.1007/s00412-009-0203-y; Madalena CRG, 2007, CHROMOSOME RES, V15, P409, DOI 10.1007/s10577-007-1127-0; Madalena CRG, 2008, CHROMOSOME RES, V16, P1233, DOI 10.1007/s10577-008-1271-1; HAMMOND MP, 1985, CHROMOSOMA, V91, P279, DOI 10.1007/BF00328223; HENNIG W, 1971, NATURE-NEW BIOL, V233, P70, DOI 10.1038/newbio233070a0; HOLLENBERG CP, 1976, CHROMOSOMA, V57, P185, DOI 10.1007/BF00292917; Jones HS, 2007, NAT STRUCT MOL BIOL, V14, P123, DOI 10.1038/nsmb1199; KAHN J, 1962, Q J MICROSC SCI, V103, P407; KARPEN GH, 1988, GENE DEV, V2, P1745, DOI 10.1101/gad.2.12b.1745; KERREBROCK AW, 1989, J MOL BIOL, V210, P1, DOI 10.1016/0022-2836(89)90286-6; KEYL HG, 1957, CHROMOSOMA, V8, P739; LAIRD CD, 1976, CHROMOSOMA, V58, P193, DOI 10.1007/BF00701359; LUCCHINI R, 1992, MOL CELL BIOL, V12, P4288, DOI 10.1128/MCB.12.10.4288; MCKNIGHT SL, 1976, CELL, V8, P305, DOI 10.1016/0092-8674(76)90014-3; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nanda I, 2008, CYTOGENET GENOME RES, V122, P396, DOI 10.1159/000167828; PARDUE ML, 1970, CHROMOSOMA, V29, P268, DOI 10.1007/BF00325943; PARDUE ML, 1973, COLD SPRING HARB SYM, V38, P475, DOI 10.1101/SQB.1974.038.01.051; PAVAN C, 1965, BROOKHAVEN SYM BIOL, P222; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; RENKAWITZ R, 1979, MOL GEN GENET, V173, P1, DOI 10.1007/BF00267685; RITOSSA FM, 1966, GENETICS, V54, P819; ROIHA H, 1981, NATURE, V290, P749, DOI 10.1038/290749a0; Sanz C, 2007, CHROMOSOME RES, V15, P429, DOI 10.1007/s10577-007-1134-1; SPEAR BB, 1973, P NATL ACAD SCI USA, V70, P1359, DOI 10.1073/pnas.70.5.1359; Stancheva I, 1997, NUCLEIC ACIDS RES, V25, P1727, DOI 10.1093/nar/25.9.1727; Toussaint M, 2005, BIOCHEM CELL BIOL, V83, P449, DOI 10.1139/O05-141; Xu J, 1996, CHROMOSOMA, V104, P545, DOI 10.1007/BF00352294; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008; Ye JQ, 2006, MOL CELL BIOL, V26, P8781, DOI 10.1128/MCB.01409-06; Yosida TH, 1980, CYTOGENETICS BLACK R, P173; ZAHA A, 1982, CHROMOSOMA, V87, P103, DOI 10.1007/BF00333512	51	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44006	10.1371/journal.pone.0044006	http://dx.doi.org/10.1371/journal.pone.0044006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952852	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500039
J	Thessen, AE; Patterson, DJ; Murray, SA				Thessen, Anne E.; Patterson, David J.; Murray, Shauna A.			The Taxonomic Significance of Species That Have Only Been Observed Once: The Genus Gymnodinium (Dinoflagellata) as an Example	PLOS ONE			English	Article							SP-NOV DINOPHYCEAE; NEOBURSARIDIUM-GIGAS BALECH; COMB. NOV; PHYTOPLANKTON COMPOSITION; GEOGRAPHIC-DISTRIBUTION; PHYLOGENETIC ANALYSIS; WATER DINOFLAGELLATE; ELECTRON-MICROSCOPY; RDNA SEQUENCES; CHESAPEAKE BAY	Taxonomists have been tasked with cataloguing and quantifying the Earth's biodiversity. Their progress is measured in code-compliant species descriptions that include text, images, type material and molecular sequences. It is from this material that other researchers are to identify individuals of the same species in future observations. It has been estimated that 13% to 22% (depending on taxonomic group) of described species have only ever been observed once. Species that have only been observed at the time and place of their original description are referred to as oncers. Oncers are important to our current understanding of biodiversity. They may be validly described species that are members of a rare biosphere, or they may indicate endemism, or that these species are limited to very constrained niches. Alternatively, they may reflect that taxonomic practices are too poor to allow the organism to be re-identified or that the descriptions are unknown to other researchers. If the latter are true, our current tally of species will not be an accurate indication of what we know. In order to investigate this phenomenon and its potential causes, we examined the microbial eukaryote genus Gymnodinium. This genus contains 268 extant species, 103 (38%) of which have not been observed since their original description. We report traits of the original descriptions and interpret them in respect to the status of the species. We conclude that the majority of oncers were poorly described and their identity is ambiguous. As a result, we argue that the genus Gymnodinium contains only 234 identifiable species. Species that have been observed multiple times tend to have longer descriptions, written in English. The styles of individual authors have a major effect, with a few authors describing a disproportionate number of oncers. The information about the taxonomy of Gymnodinium that is available via the internet is incomplete, and reliance on it will not give access to all necessary knowledge. Six new names are presented - Gymnodinium campbelli for the homonymous name Gymnodinium translucens Campbell 1973, Gymnodinium antarcticum for the homonymous name Gymnodinium frigidum Balech 1965, Gymnodinium manchuriensis for the homonymous name Gymnodinium autumnale Skvortzov 1968, Gymnodinium christenum for the homonymous name Gymnodinium irregulare Christen 1959, Gymnodinium conkufferi for the homonymous name Gymnodinium irregulare Conrad & Kufferath 1954 and Gymnodinium chinensis for the homonymous name Gymnodinium frigidum Skvortzov 1968.	[Thessen, Anne E.; Patterson, David J.] Marine Biol Lab, Ctr Lib & Informat, Woods Hole, MA 02543 USA; [Murray, Shauna A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Murray, Shauna A.] Sydney Inst Marine Sci, Mosman, Australia	Marine Biological Laboratory - Woods Hole; University of New South Wales Sydney; Sydney Institute of Marine Science	Thessen, AE (corresponding author), Marine Biol Lab, Ctr Lib & Informat, Woods Hole, MA 02543 USA.	annethessen@gmail.com	Thessen, Anne/J-6449-2012; Murray, Shauna/K-5781-2015	Thessen, Anne/0000-0002-2908-3327; Murray, Shauna/0000-0001-7096-1307; Patterson, David J./0000-0003-2645-7335	John D and Catherine T MacArthur Foundation; Alfred P Sloan Foundation [0830976, DBI-1062387]	John D and Catherine T MacArthur Foundation; Alfred P Sloan Foundation(Alfred P. Sloan Foundation)	This work was funded by grants from the John D and Catherine T MacArthur Foundation and the Alfred P Sloan Foundation to the Encyclopedia of Life and the National Science Foundation Data Net Program 0830976 and Global Names Project DBI-1062387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti Donat, 2009, BMC Res Notes, V2, P53, DOI 10.1186/1756-0500-2-53; Akatsuka K, 1952, REP FAC FISH PREF U, V2, P19; AKSELMAN R, 1985, Physis Seccion A los Oceanos y sus Organismos, V43, P39; Al-Qassab S, 2002, ACTA PROTOZOOL, V41, P91; Allman GJ, 1854, P ROYAL IR AC, V6, P115; Alonso-Rodriguez R, 2003, AQUACULTURE, V219, P317, DOI 10.1016/S0044-8486(02)00509-4; Alroy J, 2002, P NATL ACAD SCI USA, V99, P3706, DOI 10.1073/pnas.062691099; Alvarez C. M., 1984, ACTA BOT MALACITANA, V9, P27; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Amorim A, 2001, PHYCOLOGIA, V40, P572, DOI 10.2216/i0031-8884-40-6-572.1; Annenkova N V, 2009, Dokl Biol Sci, V426, P253; [Anonymous], 1929, BOT GAZ, V87, P556; [Anonymous], 1997, ENGLISH GLOBAL LANGU; Antipova N, 1955, REP ACAD SCI USSR, V103, P325; Arzul G, 2001, EFFECTS MARINE ANIMA, P115; Attaran-Fariman G, 2007, PHYCOLOGIA, V46, P644, DOI 10.2216/07-05.1; Bachmann H, 1924, VERH SCHWEIZ NATURF, V105, P15; Balech E., 1971, Revista Mus argent Cienc nat Bernardino Rivadavia Inst nac Invest Cienc nac (Hydrobiol), V3, P1; Balech E., 1965, Antarctic Research Series, V5, P107; Balech E., 1976, PUBL I ANTARTICO ARG, V11, P1; BALLANTINE D, 1961, J PROTOZOOL, V8, P217, DOI 10.1111/j.1550-7408.1961.tb01207.x; Baumeister W, 1943, ARCH PROTISTENKD, V96, P332; Berard-Therriault L., 1999, GUIDE IDENTIFICATION; Bergh RS, 1881, BIDRAG CILIOFLAGLATE, P60; Beszteri B, 2005, PROTIST, V156, P317, DOI 10.1016/j.protis.2005.07.002; Bickel DJ, 1999, TRZS NSW, P174; BICUDO C E M, 1970, Rickia, V5, P5; Biecheler B, 1939, B SOC ZOOL FRANCE, V64, P1; Bolch CJS, 1999, PHYCOLOGIA, V38, P301, DOI 10.2216/i0031-8884-38-4-301.1; Bondarenko Nina A., 2002, Limnology, V3, P127, DOI 10.1007/s102010200015; Bourquin Lindt E, 1918, CONTRIBUTION ETUDE P; Braarud T, 1953, RAPP PV REUN CONS PE, V133, P1; Bujak JP, 1983, MODERN FOSSIL PERINI; BURSA ADAM, 1963, ARCTIC JOUR ARCTIC INST N AMER, V16, P239; BURSA AS, 1961, J FISH RES BOARD CAN, V18, P563, DOI 10.1139/f61-046; BUSCH WERNER, 1927, ARCH PROTISTENK, V58, P456; Butschli O., 1885, BRONNS KLASSEN ORDNU, P906; Cachon J., 1967, PROTISTOLOGICA, V3, P427; Calado AJ, 2005, PHYCOLOGIA, V44, P112, DOI 10.2216/0031-8884(2005)44[112:OTFDPI]2.0.CO;2; Calkins GN., 1902, B US FISH COMM, V21, P413; Calliari D, 2006, STUD TRENTINI SCI S2, V81, P351; Campbell P. H., 1973, THESIS U N CAROLINA; Caraus I, 2002, THESIS U BACAU BACAU; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; CARTY S, 1993, OHIO J SCI, V93, P140; Carty S, FRESHWATER DINOFLAGE; Celekli Abuzer, 2007, Turkish Journal of Botany, V31, P49; Chapman A, 2009, NUMBERS LIVING SPECI; Charubhun Bawpit, 2000, Kasetsart Journal Natural Sciences, V34, P486; Chatton uU., 1912, B SOC ZOOLOGIQUE FRA, V37, P85; Chen GF, 2008, CHINESE SCI BULL, V53, P561, DOI 10.1007/s11434-008-0108-9; Christen H. R., 1959, Mitteilungen der Naturwissenschaftlichen Gesellschaft in Winterthur, VNo. 27, P167; Churilova TY, 1992, THESIS UKRANIAN AKAD; Claparede E., 1858, ETUDES INFUSOIRES RH; Cleary DFR, 2007, ECOL APPL, V17, P1184, DOI 10.1890/05-0878; Coats DW, 2002, J PHYCOL, V38, P520, DOI 10.1046/j.1529-8817.2002.t01-1-01200.x; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; CONRAD W., 1926, ARCH PROTISTENK, V55, P63; Conrad W., 1954, MEM I R SCI NAT BELG, V127, P1; CORLISS JO, 1979, AM ZOOL, V19, P573; Cridland AA, 1958, NEW PHYTOL, V57, P285, DOI [10.1111/j.1469-8137.1958.tb05317.x, DOI 10.1111/J.1469-8137.1958.TB05317.X]; CULLEN JJ, 1982, J EXP MAR BIOL ECOL, V63, P67, DOI 10.1016/0022-0981(82)90051-X; Danysz MJ, 1886, COMPTES RENDUS, V105, P238; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; Day S.A., 1995, FLORA AUSTR SUPPLEME; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Salas MF, 2003, J PHYCOL, V39, P1233, DOI 10.1111/j.0022-3646.2003.03-019.x; Diesing KM, 1886, SB KGL AKAD WISS MN, V52, P287; Diesing KM, 1850, SYSTEMA HELMINTHUM; DODGE J.D., 1982, MARINE DINOFLAGELLAT; DODGE JD, 1975, BOT J LINN SOC, V71, P103, DOI 10.1111/j.1095-8339.1975.tb02449.x; DODGE JD, 1981, BRIT PHYCOL J, V16, P273, DOI 10.1080/00071618100650291; DODGE JOHN D., 1967, BRIT PHYCOL BULL, V3, P327; Dogiel V., 1906, Mitteilungen aus der Zoologischen Station zu Neapel Berlin, V18, P1; DRAGESCO J, 1965, CAH BIOL MAR, V6, P83; DREBES G., 1974, MARINES PHYTOPLANKTO; Drira Z, 2009, J MAR BIOL ASSOC UK, V89, P1559, DOI 10.1017/S002531540900023X; DRUART JC, 1983, SCHWEIZ Z HYDROL, V45, P430, DOI 10.1007/BF02538133; Ehrenberg CG., 1838, INFUSIONSTHIERCHEN A, DOI [10.5962/bhl.title.58475, DOI 10.5962/BHL.TITLE.58475]; ELBRACHTER M, 1994, HELGOLANDER MEERESUN, V48, P359, DOI 10.1007/BF02366252; Elbrachter M., 1979, METEOR FORSCHUNGS D, V30, P1; Ellegaard M, 1999, PHYCOLOGIA, V38, P289, DOI 10.2216/i0031-8884-38-4-289.1; Entz G xEza jun., 1910, Allattani Kozlemenyek Budapest, V9; Entz GJ, 1902, NOVEN KOZLEM, V1, P83; EPA, 2007, COMPR LIST CHES BAY; Evitt W., 1967, GEOLOGICAL SCI, V10, P1; Figueroa RI, 2006, J PHYCOL, V42, P350, DOI 10.1111/j.1529-8817.2006.00191.x; Finlay BJ, 2004, PROTIST, V155, P15, DOI 10.1078/1434461000160; Finlay BJ, 1996, Q REV BIOL, V71, P221, DOI 10.1086/419370; Foissner Wilhelm, 2002, Bulletin of Zoological Nomenclature, V59, P165; Fontaneto D, 2012, ROTIFEROLOGIST EFFEC; Foote M, 1982, PHYTOLOGIA, V52, P1; Forzza R.C, 2010, CATALOGO PLANTAS FUN, V1, P366; Fraga S, 1995, PHYCOLOGIA, V34, P514, DOI 10.2216/i0031-8884-34-6-514.1; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; FREUDENTHAL HD, 1963, J PROTOZOOL, V10, P182, DOI 10.1111/j.1550-7408.1963.tb01659.x; FRILIGOS N, 1989, TOXICOL ENVIRON CHEM, V24, P171, DOI 10.1080/02772248909357487; Ghinaglia LT, 2004, HYDROBIOLOGIA, V519, P85; Gil-Rodriguez M.C., 2003, LISTA ESPECIES MARIN, P5; Gomez F, 2006, J BIOGEOGR, V33, P261, DOI 10.1111/j.1365-2699.2005.01373.x; Gomez F, 2004, HYDROBIOLOGIA, V517, P43, DOI 10.1023/B:HYDR.0000027336.05452.07; Gomez F, 2003, BOT MAR, V46, P215, DOI 10.1515/BOT.2003.021; Gomez Fernando, 2005, Acta Botanica Croatica, V64, P129; Gomez Fernando, 2007, Algae, V22, P273; Gotelli NJ, 2004, PHILOS T R SOC B, V359, P585, DOI 10.1098/rstb.2003.1443; Gotsis-Skretas O, 2008, MICROPLANKTON ABUNDA, DOI [10.1594/PANGAEA.692046, DOI 10.1594/PANGAEA.692046]; Graham Herbert W, 1943, TRANS AMER MICROSC SOC, V62, P259, DOI 10.2307/3223028; Graham JM, 2004, MICROBIAL ECOL, V48, P528, DOI 10.1007/s00248-004-0223-3; Grasse PP, 1952, PHYLOGENIE PROTOZOAI; Guedon JC, 1994, DIRECTORY ELECT J NE, P17; Guo Feng, 2002, Journal of Oceanography in Taiwan Strait, V21, P469; HADA Y, 1974, Bulletin of Plankton Society of Japan, V20, P112; Hada Y., 1967, B SUZUGAMINE WOMENS, V13, P1; Hada Y, 1966, SCI REP JAPANESE ANT, V1, P209; Hada Y., 1968, B SUZUGAMINE WOMENS, V14, P1; Hada Y, 1970, BIOLOGY E, V31, P1; Hallegraeff G.M., 2003, Monographs on Oceanographic Methodology, V11, P25; Hallegraeff G. M., 2002, AQUACULTURISTS GUIDE; HALLEGRAEFF GM, 2010, ALGAE AUSTR PHYTOPLA; Hansen G, 2000, J PHYCOL, V36, P394, DOI 10.1046/j.1529-8817.2000.99172.x; HANSEN G, 1995, PHYCOLOGIA, V34, P166, DOI 10.2216/i0031-8884-34-2-166.1; Hansen G, 2000, PHYCOLOGIA, V39, P365, DOI 10.2216/i0031-8884-39-5-365.1; Hansen G, 2004, KARENIA SELLIFORMIS; Hansen G, 1992, PLANKTON INDRE DANSK, V11; Hansen G, 2007, J LIMNOL, V66, P107, DOI 10.4081/jlimnol.2007.107; Hansen G, 2007, PHYCOL RES, V55, P25, DOI 10.1111/j.1440-1835.2006.00442.x; Harris T. M., 1940, Proceedings of the Linnean Society of London, V152, P4; Harvey M, 1997, CAN J FISH AQUAT SCI, V54, P1937, DOI 10.1139/f97-099; Hasle GR, 1960, OSLO I MN, V2, P1; Herdman E. C., 1922, Proceedings and Transactions of the Liverpool Biological Society, V36, P15; Herdman E. C., 1924, P T LIVERPOOL BIOL S, V38, P75; HOPE BRIGT, 1954, NYTT MAG BOT, V2, P149; HORIGUCHI T, 1994, EUR J PHYCOL, V29, P237, DOI 10.1080/09670269400650691; HORIGUCHI T, 1988, J PLANT RES, V101, P255; Hu H., 2006, FRESHWATER ALGAE CHI; Hu H., 1980, KEXUE TONGBAO, V25, P882; Hu H.J., 1983, Chinese Journal of Oceanology and Limnology, V1, P198; HUANG R, 1988, ESTUAR COAST SHELF S, V26, P643, DOI 10.1016/0272-7714(88)90040-6; Huber-Pestalozzi, 1950, PHYTOPLANKTON SUSSWA; HULBURT EM, 1957, BIOL BULL, V112, P196, DOI 10.2307/1539198; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; Jakobsen HH, 2000, MAR ECOL PROG SER, V201, P121, DOI 10.3354/meps201121; Javornicky P, 1965, PHYCOLOGIA, V5, P53; Jorgensen E, 1912, UR SVENSKA HYDROGRAF, V4, P1; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Kang Wei, 2009, China Environmental Science, V29, P1285; Kim SY, 2009, ESTUAR COAST, V32, P1225, DOI 10.1007/s12237-009-9212-6; Kiselev IA, 1954, OPREDELITEL PRESNOVO, V6, P1; Klebs G, 1912, VERH NAT VER HEIDELB, V11, P367; Kobanova GI, 2009, CONTEMP PROBL ECOL, V2, P581, DOI 10.1134/S1995425509060150; Kofoid C. A., 1921, MEMOIRS U CALIFORNIA, DOI [10.5962/bhl.title.24995, DOI 10.5962/BHL.TITLE.24995]; KOFOID CHARLES A., 1931, SCI REPT TOHOKU IMP UNIV SER 4 BIOL, V6, P1; Konovalova G.V., 2001, Asian Marine Biology, V17, P1; Konovalova H, 1998, DINOFLAGELLATES DINO; Kopczynska EE, 1998, POLAR BIOL, V20, P342, DOI 10.1007/s003000050312; Labour MV, 1925, DINOFLAGELLATES NO S; LACKEY JAMES B., 1965, TRANS SAN DIEGO SOC NAT HIST, V14, P9; Lackey JB, 1936, BIOL BULL-US, V70, P264, DOI 10.2307/1537471; LACKEY JB, 1963, J MAR BIOL ASSOC UK, V43, P797, DOI 10.1017/S0025315400025698; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Lantzsch K, 1914, Z WISS ZOOL, V108, P631; Largaiolli V, 1907, STEIN NUOVA NOTARISI, V18, P1; LARSEN J, 1990, J NAT HIST, V24, P801, DOI 10.1080/00222939000770571; Larsen J, 1994, PHYCOLOGIA; Larsen J, 1996, PHYCOLOGIA, V35, P342, DOI 10.2216/i0031-8884-35-4-342.1; Lebour M. V., 1917, J MAR BIOL ASS UK, V11, P183; Lee W.J., 1999, Protistology, V1, P10; Lee WJ, 1998, PROTIST, V149, P229, DOI 10.1016/S1434-4610(98)70031-8; Lee WJ, 1999, TRZS NSW, P232; Lemmermann E, 1903, FORSCHUNGSBER BIOL S, V10, P116; Lemmermann E., 1899, ABHANDLUNGEN HERAUSG, V16, P313, DOI DOI 10.1038/SJ.NPP.1300597; Lemmermann E., 1907, BOT JB, V38, P343; Lemmermann E., 1900, HEDWIGIA, V39, P115; Lemmermann EJ., 1905, FORSCHUNGSBERICHTE B, V12, P154; Lewis JM, 2002, PHYLUM PYRROPHYTA DI; Liebetanz B, 1925, B INT ACAD POLON S B, P116; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Lindberg K, 2005, PHYCOLOGIA, V44, P416, DOI 10.2216/0031-8884(2005)44[416:SOWDIW]2.0.CO;2; Lindemann E, 1928, NATURLICHEN PFLANZEN, P3; LOEBLICH ALFRED R. III, 1965, TAXON, V14, P15, DOI 10.2307/1216704; Lohmann H., 1908, Wissenschaftliche Meeresuntersuchungen Kiel N F, V10; Maggi L, 1880, B SCI PAVIA, V2, P7; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; MARGALEF R, 1969, Pubblicazioni della Stazione Zoologica di Napoli, V37, P40; Marshall HG, 2009, J COASTAL RES, P59; MARSHALL HG, 1980, ESTUARIES, V3, P207, DOI 10.2307/1352071; Marshall HG, 2005, J PLANKTON RES, V27, P1083, DOI 10.1093/plankt/fbi079; MARSHALL HG, 1976, MAR BIOL, V38, P81, DOI 10.1007/BF00391488; Maskell WM, 1887, T P NZ I, V20, P3; Massart J, 1920, B CL SCI AC ROY BELG, V35, P437; Massart J, 1901, RECHERCHES ORG INFER; MATZENAUER LOTHAR, 1933, BOT ARCH [LEIPZIG], V35, P437; May F.E., 1977, PALYNOLOGY, V1, P103; McLaughlin F., 2009, Canadian Data Report of Hydrography and Ocean Sciences, V180, P1; Mcmanus GB, 2009, J PLANKTON RES, V31, P1119, DOI 10.1093/plankt/fbp061; McMinn Andrew, 2005, P202; Michev T, 1998, BIODIVERSITY SREBARN; Mitchell EAD, 2005, PROTIST, V156, P263, DOI 10.1016/j.protis.2005.07.001; Moestrup O, 2008, PHYCOLOGIA, V47, P54, DOI 10.2216/07-32.1; Moestrup O, 2009, PHYCOL RES, V57, P203, DOI 10.1111/j.1440-1835.2009.00540.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Morris S., 1937, Archiv fuer Protistenkunde Jena, V89, P405; Murray S.A., 2003, THESIS U SYDNEY SYDN; Murray S, 2007, PHYCOL RES, V55, P176, DOI 10.1111/j.1440-1835.2007.00460.x; Murray S, 2009, PROTIST, V160, P245, DOI 10.1016/j.protis.2008.12.004; Nentwich M, 2004, CYBERSCIENCE RES AGE; Nesterova D.A., 2006, NW PART BLACK SEA BI, P557; NGO HM, 1990, T AM MICROSC SOC, V109, P380, DOI 10.2307/3226692; NIKOLAIDES G, 1990, HELGOLANDER MEERESUN, V44, P487, DOI 10.1007/BF02365482; NILSSON JR, 1962, J PROTOZOOL, V9, P273, DOI 10.1111/j.1550-7408.1962.tb02619.x; Nordli O., 1954, Nyt Magazin for Naturvidenskaberne, V88, P49; NORRIS RICHARD E., 1961, NEW ZEALAND JOUR SCI, V4, P162; Novarino G, 1997, J PLANKTON RES, V19, P1081, DOI 10.1093/plankt/19.8.1081; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Nygaard G, 1945, DANSK PLANTE PLANKTO; OCHOA JL, 2002, HARMFUL ALGAL BLOOMS, P119; Ohno N, 1911, J COLL SCI IMP U TOK, V32, P78; Okolodkov YB, 1998, SARSIA, V83, P267, DOI 10.1080/00364827.1998.10413687; Okolodkov YB, 2000, SARSIA, V85, P345, DOI 10.1080/00364827.2000.10414585; Okolodkov YB, 1997, BOTANICHESKIY ZH ROS, V82, P97; Okolodkov Yuri B., 2006, Act. Bot. Mex, P1; Orlova T.Y., 2004, RUSS J MAR BIOL+, V30, P77, DOI [10.1023/B:RUMB.0000025983.20298.9a, DOI 10.1023/B:RUMB.0000025983.20298.9A]; Orlova TY, 2009, RUSS J MAR BIOL +, V35, P60, DOI 10.1134/S106307400901009X; Ostenfeld CH, 1913, VID SKRIF MATH NAT, V9, P113; PANT MC, 1985, INT REV GES HYDROBIO, V70, P269, DOI 10.1002/iroh.19850700215; PARKE M, 1976, J MAR BIOL ASSOC UK, V56, P527, DOI 10.1017/S002531540002066X; PARKE M, 1964, J MAR BIOL ASSOC UK, V44, P499, DOI 10.1017/S0025315400024954; PARSON M J, 1989, Castanea, V54, P79; Patterson DJ, 2010, TRENDS ECOL EVOL, V25, P686, DOI 10.1016/j.tree.2010.09.004; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; Patterson DJ, 2000, SYST ASSOC SPEC VOL, V59, P269; Paulmier G, 1992, CATALOGUE ILLUSTRE M; PAULSEN O, 1908, NORDISCHES PLANKTON, P1; Paulsen O., 1907, MEDDELELSER KOMMISSI, V1, P1; Pawlowski J., 2009, PROTIST DIVERSITY GE, P83, DOI 10.1007/978-90-481-2801-3_7; Penard E., 1891, B TRAV SOC BOT GENEV, V6, P1; Perty M, 1852, KENNTNIS KLEINSTER L; Petersen J. B., 1956, Biologiske Meddelelser, V23, P1; Pfandl K, 2009, LIMNOL OCEANOGR, V54, P171, DOI 10.4319/lo.2009.54.1.0171; Phillips JA, 2002, ALGAE NAMES DISTRIBU; Piontkovsky S, 2011, PHYTOPLANKTON ABUNDA; Pitzik GK, 1967, NOVITATES SYSTEMATIC, P68; Playfair G. I., 1920, Proceedings of the Linnean Society of New South Wales, V44; Popovskaya GI, 2011, GEOGR NAT RESOUR, V32, P344, DOI 10.1134/S187537281104007X; Popovskaya G.I., 2000, Aquatic Ecosystem Health & Management, V3, P215, DOI 10.1016/S1463-4988(00)00021-X; POPOVSKY J, 1971, Archiv fuer Protistenkunde, V113, P277; POPOVSKY J, 1968, Preslia (Prague), V40, P251; POPOVSKY J, 1990, ARCH HYDROBIOL, P1; Popovsky J., 1990, SUSSWASSERFLORA MITT; Pouchet G., 1887, Journal de l'Anatomie et de la Physiologie, Vxxiii, P87; Pouchet M, 1894, NOUVELLES ARCH MISSI, V5, P155; Pylyshyn Z.W., 2003, SEEING VISUALIZING I; Raup D.M., 1992, EXTINCTION BAD GENES; Redeke H. C., 1919, Bijdragen tot de Dierkunde, V21; Rene A, 2011, HARMFUL ALGAE, V12, P11, DOI 10.1016/j.hal.2011.08.008; Revilla M, 2009, J SEA RES, V61, P60, DOI 10.1016/j.seares.2008.05.009; Riding James B., 2002, Palynology, V26, P5, DOI 10.2113/0260005; Ros M., 1985, Anales de Biologia (Murcia), V2, P169; Rouchijanen MI, 1968, NOVITATES SYSTEMATIC, P25; RUINEN JAKOBA, 1938, ARCH PRO TISTENK, V90, P210; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Saburova Maria, 2009, BioRisk, V3, P97; Saldarriaga JF, 2003, J PHYCOL, V39, P368, DOI 10.1046/j.1529-8817.2003.02113.x; SARMA Y S R K, 1974, British Phycological Journal, V9, P21; Saville-Kent W, 1880, MANUAL INFUSORIA; Scharff N, 2003, J ARACHNOL, V31, P246, DOI 10.1636/0161-8202(2003)031[0246:WTQESS]2.0.CO;2; Schiller J, 1954, PLANT SYST EVOL, V101, P236; Schiller J, 1957, WISSENSCHAFTLICHE AR, V9, P1; Schiller J, 1933, DINOFLAGELLATAE PERI, P617; SCHILLER JOS, 1928, ARCH PROTISTENK, V62, P119; Schilling AJ, 1891, FLORA ODER ALLGEMEIN, V3, P1; Schmarda L.K., 1846, KLEINE BEITRAGE NATU; Schmarda L.K., 1854, DENKSCH K AKAD WISS, VVII, P1; SCHNEPF E, 1989, PLANT SYST EVOL, V164, P75, DOI 10.1007/BF00940431; Schroder B, 1900, ABDRUCK MITTHEILUNGE, V14, P1; SCHUTT F, 1895, PERIDINEEN PLANKTONE; Seaborn David W., 1997, Virginia Journal of Science, V48, P265; Segers H, 2012, ZOOTAXA, P61; Senicheva MI, 2008, SPECIES DIVERSITY SE, P5; Senzaki Satoshi, 1994, Japanese Journal of Phycology, V42, P29; Shao P, 2004, MAR BIOL, V144, P215, DOI 10.1007/s00227-003-1157-x; Shen Y.F., 1990, MODERN BIOMONITORING; SHYAM R, 1975, PLANT SYST EVOL, V124, P205, DOI 10.1007/BF00992726; SHYAM R, 1980, NOVA HEDWIGIA, V32, P133; Siano R, 2010, PROTIST, V161, P385, DOI 10.1016/j.protis.2010.01.002; Simpson AGB, 1997, ARCH PROTISTENKD, V147, P213, DOI 10.1016/S0003-9365(97)80049-8; Skolka V.H., 1989, CERCETARI MARINE, V22, P147; SKUJA H., 1939, ACTA HORTI BOT UNIV LATVIENSIS, V11/12, P41; SKUJA H, 1956, NOVA ACTA R SOC SC 4, V16, P1; SKUJA H, 1948, SYMB BOT UPSAL, V9, P1, DOI DOI 10.1016/J.HAL.2015.12.001; Skuja H., 1964, NOVA ACTA R SOC SC 4, V18, P1; Skvortzov B. V., 1968, Q J TAIWAN MUSEUM, V21, P79; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Steidinger K.A., 1996, Nova Hedwigia Beiheft, V112, P415; Steidinger Karen A., 2009, P131; Stein F., 1878, ORG FLAGELLATEN; Stein F, 1883, ORG INFUSIONSTTHIERE; Stein R, 1997, BER POLARFORSCH, V255, P98; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Struder-Kypke MC, 2002, AQUAT MICROB ECOL, V27, P203, DOI 10.3354/ame027203; Subrahmanyan R., 1961, Indian Journal of Fisheries, V7, P307; Sukhanova IN, 2010, OCEANOLOGY+, V50, P743, DOI 10.1134/S0001437010050115; Sundstrom AM, 2009, J PHYCOL, V45, P938, DOI 10.1111/j.1529-8817.2009.00712.x; TAFT CLARENCE E., 1964, OHIO J SCI, V64, P43; Takano Y, 2004, PHYCOL RES, V52, P107, DOI 10.1111/j.1440-183.2004.00332.x; Tang YZ, 2008, J EUKARYOT MICROBIOL, V55, P91, DOI 10.1111/j.1550-7408.2008.00305.x; Taylor F.J.R., 1976, BIBLIOTHECA BOT, V132, P1; TAYLOR FJR, 1982, MAR BIOL, V67, P323, DOI 10.1007/BF00397673; Taylor WR, 1968, BIOL TRACE ELEMENTS; Thessen AE, 2011, ZOOKEYS, P15, DOI 10.3897/zookeys.150.1766; Thompson RH, 1947, CHESAPEAKE BIOL LAB, V67, P1; Throndsen J, 1983, WORKING PARTY TAXONO, P62; THURSTON JP, 1964, J PROTOZOOL, V11, P307, DOI 10.1111/j.1550-7408.1964.tb01759.x; Tiffany MA, 2007, LAKE RESERV MANAGE, V23, P582, DOI 10.1080/07438140709354039; Tilstone GH, 2000, MAR ECOL PROG SER, V205, P23, DOI 10.3354/meps205023; TILSTONE GH, 1994, MAR ECOL PROG SER, V112, P241, DOI 10.3354/meps112241; TSUJI T, 1979, Journal of the Oceanographical Society of Japan, V35, P173, DOI 10.1007/BF02114310; Utermohl H., 1925, Archiv Hydrobiol Stuttgart Suppl Bd, V5, P1; van Goor ACJ, 1925, REV TRAV BOT NEERL, V22, P275; van Meel L, 1969, B I R SCI NAT BELG, V45, P1; Ventsel MV, 1992, RESULTS 3 JOINT US U; Villeret S, 1953, B SOC BOT FRANCE, V100, P71; Wailes G. H., 1939, Canadian Pacific Fauna, V1, P1; Waters RE, 1992, PHYTOPLANKTON ESQUIM; Wawrik F., 1956, PLANT SYST EVOL, V103, P291, DOI DOI 10.1007/BF01279237; WEDEMAYER GJ, 1982, J PHYCOL, V18, P13, DOI 10.1111/j.1529-8817.1982.tb03152.x; West W., 1906, Dublin Transactions of the Royal Irish Academy, V33, P77; West W, 1909, P R SOC LOND B-CONTA, V81, P165, DOI 10.1098/rspb.1909.0016; Wiktor Jozef, 2005, Polish Polar Research, V26, P259; Williams G. L., 1978, INITIAL REPORTS DEEP, P783; Wolgar S., 2000, SCI PUBL POLICY, V27, P165, DOI [DOI 10.3152/147154300781782039, 10.3152/147154300781782039]; WOLOSZYNSKA JADWIGA, 1952, ACTA SOC BOT POLON, V21, P311; WOOD E. J. F., 1954, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V5, P171; Wulff A., 1919, Wissenschaftliche Meeresuntersuchungen Kiel Abt Helgoland N F, V13, P95; Yamaguchi H, 2011, PROTIST, V162, P650, DOI 10.1016/j.protis.2011.01.002; Zacharias O., 1899, BIOL CENTRALBLATT, V19, P141; Zenetos A, 2005, MEDITERR MAR SCI, V6, P63, DOI 10.12681/mms.186	337	35	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44015	10.1371/journal.pone.0044015	http://dx.doi.org/10.1371/journal.pone.0044015			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952856	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206500041
J	Timaru-Kast, R; Luh, C; Gotthardt, P; Huang, CS; Schafer, MK; Engelhard, K; Thal, SC				Timaru-Kast, Ralph; Luh, Clara; Gotthardt, Philipp; Huang, Changsheng; Schaefer, Michael K.; Engelhard, Kristin; Thal, Serge C.			Influence of Age on Brain Edema Formation, Secondary Brain Damage and Inflammatory Response after Brain Trauma in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; TUMOR-NECROSIS-FACTOR; PROSPECTIVE MULTICENTER TRIAL; NF-KAPPA-B; OXIDATIVE STRESS; GENE-EXPRESSION; OLDER-ADULTS; HEAD-INJURY; ENVIRONMENTAL ENRICHMENT; NEURONAL DEATH	After traumatic brain injury (TBI) elderly patients suffer from higher mortality rate and worse functional outcome compared to young patients. However, experimental TBI research is primarily performed in young animals. Aim of the present study was to clarify whether age affects functional outcome, neuroinflammation and secondary brain damage after brain trauma in mice. Young (2 months) and old (21 months) male C57Bl6N mice were anesthetized and subjected to a controlled cortical impact injury (CCI) on the right parietal cortex. Animals of both ages were randomly assigned to 15 min, 24 h, and 72 h survival. At the end of the observation periods, contusion volume, brain water content, neurologic function, cerebral and systemic inflammation (CD3+ T cell migration, inflammatory cytokine expression in brain and lung, blood differential cell count) were determined. Old animals showed worse neurological function 72 h after CCI and a high mortality rate (19.2%) compared to young (0%). This did not correlate with histopathological damage, as contusion volumes were equal in both age groups. Although a more pronounced brain edema formation was detected in old mice 24 hours after TBI, lack of correlation between brain water content and neurological deficit indicated that brain edema formation is not solely responsible for age-dependent differences in neurological outcome. Brains of old naive mice were about 8% smaller compared to young naive brains, suggesting age-related brain atrophy with possible decline in plasticity. Onset of cerebral inflammation started earlier and primarily ipsilateral to damage in old mice, whereas in young mice inflammation was delayed and present in both hemispheres with a characteristic T cell migration pattern. Pulmonary interleukin 1 beta expression was up-regulated after cerebral injury only in young, not aged mice. The results therefore indicate that old animals are prone to functional deficits and strong ipsilateral cerebral inflammation without major differences in morphological brain damage compared to young.	[Timaru-Kast, Ralph; Luh, Clara; Gotthardt, Philipp; Huang, Changsheng; Schaefer, Michael K.; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anaesthesiol, Mainz, Germany; [Huang, Changsheng; Schaefer, Michael K.; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Timaru-Kast, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anaesthesiol, Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Huang, Changsheng/0000-0003-0535-1865	Focus Program Translational Neurosciences of the Johannes Gutenberg-University	Focus Program Translational Neurosciences of the Johannes Gutenberg-University	This work was supported by grants from the Focus Program Translational Neurosciences of the Johannes Gutenberg-University to SCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PLOS ONE; Arnett HA, 2003, J NEUROSCI, V23, P9824; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; Barnes CJ, 1998, AGING-CLIN EXP RES, V10, P455, DOI 10.1007/BF03340159; Barreto G, 2010, J NEUROSURG ANESTH, V22, P214, DOI 10.1097/ANA.0b013e3181d56c98; Bieber AJ, 2003, ANN NEUROL, V53, P680, DOI 10.1002/ana.10578; Buchhold B, 2007, RESTOR NEUROL NEUROS, V25, P467; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Campbell SJ, 2007, NEUROPATH APPL NEURO, V33, P108, DOI 10.1111/j.1365-2990.2006.00773.x; Castillo-Ruiz MM, 2007, EXP GERONTOL, V42, P343, DOI 10.1016/j.exger.2006.10.008; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; COTMAN CW, 1979, MECH AGEING DEV, V9, P103, DOI 10.1016/0047-6374(79)90124-6; Felzien LK, 2001, BRAIN RES, V890, P137, DOI 10.1016/S0006-8993(00)03090-0; Ferger B, 2004, J NEUROCHEM, V89, P822, DOI 10.1111/j.1471-4159.2004.02399.x; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; GRIFFIN WST, 1994, NEUROSCI LETT, V176, P133, DOI 10.1016/0304-3940(94)90066-3; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Johnstone B, 1998, BRAIN INJURY, V12, P569, DOI 10.1080/026990598122331; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Popa-Wagner A, 2007, ACTA NEUROPATHOL, V113, P277, DOI 10.1007/s00401-006-0164-7; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Popa-Wagner A, 2010, CURR NEUROVASC RES, V7, P251, DOI 10.2174/156720210792231813; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Sandhu SK, 2002, BIOGERONTOLOGY, V3, P161, DOI 10.1023/A:1015643107449; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Sharman KG, 2002, NEUROBIOL AGING, V23, P633, DOI 10.1016/S0197-4580(01)00329-3; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Thal SC, 2009, CRIT CARE MED, V37, P2228, DOI 10.1097/CCM.0b013e3181a068fc; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; UNTERBERG A, 1994, ACTA NEUROCHIR, P431; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; Williams B, 2007, NEUROSCI LETT, V413, P110, DOI 10.1016/j.neulet.2006.11.040; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	79	65	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43829	10.1371/journal.pone.0043829	http://dx.doi.org/10.1371/journal.pone.0043829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952778	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500024
J	Bahlmann, J; Korb, FM; Gratton, C; Friederici, AD				Bahlmann, Joerg; Korb, Franziska M.; Gratton, Caterina; Friederici, Angela D.			Levels of Integration in Cognitive Control and Sequence Processing in the Prefrontal Cortex	PLOS ONE			English	Article							FRONTAL-CORTEX; HIERARCHICAL ORGANIZATION; SYNTACTIC STRUCTURE; WORKING-MEMORY; LANGUAGE; LEARNABILITY; INVOLVEMENT; FMRI	Cognitive control is necessary to flexibly act in changing environments. Sequence processing is needed in language comprehension to build the syntactic structure in sentences. Functional imaging studies suggest that sequence processing engages the left ventrolateral prefrontal cortex (PFC). In contrast, cognitive control processes additionally recruit bilateral rostral lateral PFC regions. The present study aimed to investigate these two types of processes in one experimental paradigm. Sequence processing was manipulated using two different sequencing rules varying in complexity. Cognitive control was varied with different cue-sets that determined the choice of a sequencing rule. Univariate analyses revealed distinct PFC regions for the two types of processing (i.e. sequence processing: left ventrolateral PFC and cognitive control processing: bilateral dorsolateral and rostral PFC). Moreover, in a common brain network (including left lateral PFC and intraparietal sulcus) no interaction between sequence and cognitive control processing was observed. In contrast, a multivariate pattern analysis revealed an interaction of sequence and cognitive control processing, such that voxels in left lateral PFC and parietal cortex showed different tuning functions for tasks involving different sequencing and cognitive control demands. These results suggest that the difference between the process of rule selection (i.e. cognitive control) and the process of rule-based sequencing (i.e. sequence processing) find their neuronal underpinnings in distinct activation patterns in lateral PFC. Moreover, the combination of rule selection and rule sequencing can shape the response of neurons in lateral PFC and parietal cortex.	[Bahlmann, Joerg; Gratton, Caterina] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Korb, Franziska M.; Friederici, Angela D.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Korb, Franziska M.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	University of California System; University of California Berkeley; Max Planck Society; Duke University	Bahlmann, J (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	bahlmann@berkeley.edu		Korb, Franziska/0000-0002-1005-0090	Leopoldina - National Academy of Science Grant [LPDS 2009-20]	Leopoldina - National Academy of Science Grant	This research was supported by the Leopoldina - National Academy of Science Grant (LPDS 2009-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bahlmann J, 2009, BRAIN RES, V1298, P161, DOI 10.1016/j.brainres.2009.08.017; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Christoff K, 2009, BRAIN RES, V1286, P94, DOI 10.1016/j.brainres.2009.05.096; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; D'Esposito Mark, 2008, Handb Clin Neurol, V88, P237, DOI 10.1016/S0072-9752(07)88011-0; Danielmeier C, 2011, J NEUROSCI, V31, P1780, DOI 10.1523/JNEUROSCI.4299-10.2011; de Vries MH, 2008, COGNITION, V107, P763, DOI 10.1016/j.cognition.2007.09.002; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Forkstam C, 2006, NEUROIMAGE, V32, P956, DOI 10.1016/j.neuroimage.2006.03.057; Forstmann BU, 2005, NEUROPSYCHOLOGIA, V43, P943, DOI 10.1016/j.neuropsychologia.2004.08.008; Friederici AD, 2006, CEREB CORTEX, V16, P1709, DOI 10.1093/cercor/bhj106; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Gazzaley Adam, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P580, DOI 10.3758/CABN.4.4.580; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Krawczyk DC, 2011, CORTEX, V47, P588, DOI 10.1016/j.cortex.2010.04.008; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Makuuchi M, 2009, P NATL ACAD SCI USA, V106, P8362, DOI 10.1073/pnas.0810928106; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mohr HM, 2006, J NEUROSCI, V26, P4465, DOI 10.1523/JNEUROSCI.5232-05.2006; Mueller JL, 2010, COGNITIVE SCI, V34, P338, DOI 10.1111/j.1551-6709.2009.01093.x; Newell A, 1994, UNIFIED THEORIES COG; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Opitz B, 2004, J NEUROSCI, V24, P8436, DOI 10.1523/JNEUROSCI.2220-04.2004; Perruchet P, 2005, PSYCHON B REV, V12, P307, DOI 10.3758/BF03196377; Petrides M, 2000, J NEUROSCI, V20, P7496; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Roder B, 2002, NEUROIMAGE, V15, P1003, DOI 10.1006/nimg.2001.1026; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Santi A, 2010, NEUROIMAGE, V51, P1285, DOI 10.1016/j.neuroimage.2010.03.034; Serences JT, 2009, NEUROIMAGE, V44, P223, DOI 10.1016/j.neuroimage.2008.07.043; Tettamanti M, 2009, CORTEX, V45, P825, DOI 10.1016/j.cortex.2008.11.014; Udden J, 2008, BRAIN RES, V1224, P69, DOI 10.1016/j.brainres.2008.05.070; Woolgar A, 2011, J NEUROSCI, V31, P14592, DOI 10.1523/JNEUROSCI.2616-11.2011; Yee LTS, 2010, J NEUROPHYSIOL, V103, P557, DOI 10.1152/jn.91299.2008	45	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43774	10.1371/journal.pone.0043774	http://dx.doi.org/10.1371/journal.pone.0043774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZC	22952762	Green Published, gold			2022-12-27	WOS:000308206000050
J	Chen, CC; Wang, SH; Wang, HJ; Mao, XY; Zhang, TC; Ji, GH; Shi, X; Xia, T; Lu, WJ; Zhang, DP; Dai, JX; Guo, YJ				Chen, Changchun; Wang, Shuhui; Wang, Huajing; Mao, Xiaoyan; Zhang, Tiancheng; Ji, Guanghui; Shi, Xin; Xia, Tian; Lu, Weijia; Zhang, Dapeng; Dai, Jianxin; Guo, Yajun			Potent Neutralization of Botulinum Neurotoxin/B by Synergistic Action of Antibodies Recognizing Protein and Ganglioside Receptor Binding Domain	PLOS ONE			English	Article							CLOSTRIDIUM-BOTULINUM; MONOCLONAL-ANTIBODIES; HIGH-AFFINITY; B RECOGNIZES; HEAVY-CHAIN; SEROTYPE-A; IDENTIFICATION; SYNAPTOTAGMIN; TOXIN; SITES	Background: Botulinum neurotoxins (BoNTs), the causative agents for life-threatening human disease botulism, have been recognized as biological warfare agents. Monoclonal antibody (mAb) therapeutics hold considerable promise as BoNT therapeutics, but the potencies of mAbs against BoNTs are usually less than that of polyclonal antibodies (or oligoclonal antibodies). The confirmation of key epitopes with development of effective mAb is urgently needed. Methods and Findings: We selected 3 neutralizing mAbs which recognize different non-overlapping epitopes of BoNT/B from a panel of neutralizing antibodies against BoNT/B. By comparing the neutralizing effects among different combination groups, we found that 8E10, response to ganglioside receptor binding site, could synergy with 5G10 and 2F4, recognizing non-overlapping epitopes within Syt II binding sites. However, the combination of 5G10 with 2F4 blocking protein receptor binding sites did not achieve synergistical effects. Moreover, we found that the binding epitope of 8E10 was conserved among BoNT A, B, E, and F, which might cross-protect the challenge of different serotypes of BoNTs in vivo. Conclusions: The combination of two mAbs recognizing different receptors' binding domain in BoNTs has a synergistic effect. 8E10 is a potential universal partner for the synergistical combination with other mAb against protein receptor binding domain in BoNTs of other serotypes.	[Chen, Changchun; Wang, Shuhui] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200030, Peoples R China; [Wang, Huajing; Zhang, Tiancheng; Ji, Guanghui; Shi, Xin; Xia, Tian; Zhang, Dapeng; Dai, Jianxin; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China; [Wang, Huajing; Zhang, Tiancheng; Ji, Guanghui; Shi, Xin; Xia, Tian; Zhang, Dapeng; Dai, Jianxin; Guo, Yajun] Natl Engn Res Ctr Antibody Med, State Key Lab Antibody Med & Targeting Therapy, Shanghai, Peoples R China; [Wang, Huajing; Zhang, Tiancheng; Ji, Guanghui; Shi, Xin; Xia, Tian; Zhang, Dapeng; Dai, Jianxin; Guo, Yajun] Shanghai Key Lab Cell Engn, Shanghai, Peoples R China; [Mao, Xiaoyan; Lu, Weijia] Lanzhou Inst Biol Prod, Lanzhou, Gansu, Peoples R China; [Dai, Jianxin; Guo, Yajun] Peoples Liberat Army Gen Hosp, Ctr Canc, Beijing, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Chinese People's Liberation Army General Hospital	Chen, CC (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200030, Peoples R China.	jxdai@smmu.edu.cn; yjguo@smmu.edu.cn		xia, tian/0000-0002-1527-2194; Ji, Guanghui/0000-0003-3763-2311	National Nature Science Foundation for China; Ministry of Science & Technology of China; Shanghai Commission of Science Technology; Ministry of Science & Technology of China [2010ZX09401-407]; Shanghai Commission of Education	National Nature Science Foundation for China(National Natural Science Foundation of China (NSFC)); Ministry of Science & Technology of China(Ministry of Science and Technology, China); Shanghai Commission of Science Technology(Shanghai Science & Technology Committee); Ministry of Science & Technology of China(Ministry of Science and Technology, China); Shanghai Commission of Education	This work was supported by grants from National Nature Science Foundation for China, Ministry of Science & Technology of China (973 and 863 Program Projects), Shanghai Commission of Science & Technology (Key Laboratory and projects) as well as special program projects for infectious diseases and new drug development from Ministry of Science & Technology of China (2010ZX09401-407). Dr. Jianxin Dai is recipient of Pujiang Scholar Award from Shanghai Commission of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amersdorfer P, 2002, VACCINE, V20, P1640, DOI 10.1016/S0264-410X(01)00482-0; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Darios F, 2010, P NATL ACAD SCI USA, V107, P18197, DOI 10.1073/pnas.1007125107; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; Hicks RP, 2005, CURR MED CHEM, V12, P667, DOI 10.2174/0929867053202223; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Johnson EA, 2001, TOXICON, V39, P1703, DOI 10.1016/S0041-0101(01)00157-X; KIENLE E, 1989, MED MICROBIOL IMMUN, V178, P127, DOI 10.1007/BF00198011; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; LOMNETH R, 1991, J NEUROCHEM, V57, P1413, DOI 10.1111/j.1471-4159.1991.tb08308.x; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Muraro L, 2009, BIOCHEM BIOPH RES CO, V380, P76, DOI 10.1016/j.bbrc.2009.01.037; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Perosa F, 2003, J IMMUNOL, V171, P1918, DOI 10.4049/jimmunol.171.4.1918; Rossetto Ornella, 2008, V184, P129; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Sharma S, 2006, PROTEIN EXPRES PURIF, V45, P288, DOI 10.1016/j.pep.2005.07.020; SIMPSON LL, 1971, J NEUROCHEM, V18, P1751, DOI 10.1111/j.1471-4159.1971.tb03750.x; Singh BR, 2000, NAT STRUCT BIOL, V7, P617, DOI 10.1038/77900; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Wang H, 2010, MICROBES INFECT, V12, P1012, DOI 10.1016/j.micinf.2010.07.002; West M, 2005, DATE ISSUE 02 02 200	37	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43845	10.1371/journal.pone.0043845	http://dx.doi.org/10.1371/journal.pone.0043845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952786	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206000054
J	Li, CG; Yang, PH; Zhang, YL; Sun, Y; Wang, W; Zou, Z; Xing, L; Chen, ZW; Tang, C; Guo, F; Deng, JJ; Zhao, Y; Yan, YW; Tang, J; Wang, XL; Jiang, CY				Li, Chenggang; Yang, Penghui; Zhang, Yanli; Sun, Yang; Wang, Wei; Zou, Zhen; Xing, Li; Chen, Zhongwei; Tang, Chong; Guo, Feng; Deng, Jiejie; Zhao, Yan; Yan, Yiwu; Tang, Jun; Wang, Xiliang; Jiang, Chengyu			Corticosteroid Treatment Ameliorates Acute Lung Injury Induced by 2009 Swine Origin Influenza A (H1N1) Virus in Mice	PLOS ONE			English	Article							CYTOKINE RESPONSE; CLINICAL-ASPECTS; VIRAL LOAD; HOSPITALIZATION; INHIBITION; DISEASE; DEATH	Background: The 2009 influenza pandemic affected people in almost all countries in the world, especially in younger age groups. During this time, the debate over whether to use corticosteroid treatment in severe influenza H1N1 infections patients resurfaced and was disputed by clinicians. There is an urgent need for a susceptible animal model of 2009 H1N1 infection that can be used to evaluate the pathogenesis and the therapeutic effect of corticosteroid treatment during infection. Methodology/Principal Findings: We intranasally inoculated two groups of C57BL/6 and BALB/c mice (using 4- or 6-to 8-week-old mice) to compare the pathogenesis of several different H1N1 strains in mice of different ages. Based on the results, a very susceptible 4-week-old C57BL/6 mouse model of Beijing 501 strain of 2009 H1N1 virus infection was established, showing significantly elevated lung edema and cytokine levels compared to controls. Using our established animal model, the cytokine production profile and lung histology were assessed at different times post-infection, revealing increased lung lesions in a time-dependent manner. In additional, the mice were also treated with dexamethasone, which significantly improved survival rate and lung lesions in infected mice compared to those in control mice. Our data showed that corticosteroid treatment ameliorated acute lung injury induced by the 2009 A/H1N1 virus in mice and suggested that corticosteroids are valid drugs for treating 2009 A/H1N1 infection. Conclusions/Significance: Using the established, very susceptible 2009 Pandemic Influenza A (H1N1) mouse model, our studies indicate that corticosteroids are a potential therapeutic remedy that may address the increasing concerns over future 2009 A/H1N1pandemics.	[Li, Chenggang; Zhang, Yanli; Sun, Yang; Wang, Wei; Zou, Zhen; Guo, Feng; Deng, Jiejie; Zhao, Yan; Yan, Yiwu; Tang, Jun; Jiang, Chengyu] Tsinghua Univ, Peking Union Med Coll, Dept Biochem & Mol Biol,Inst Basic Med Sci, State Key Lab Med Mol Biol,Chinese Acad Med Sci, Beijing 100084, Peoples R China; [Yang, Penghui; Xing, Li; Chen, Zhongwei; Tang, Chong; Wang, Xiliang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University; Beijing Institute of Microbiology & Epidemiology	Li, CG (corresponding author), Tsinghua Univ, Peking Union Med Coll, Dept Biochem & Mol Biol,Inst Basic Med Sci, State Key Lab Med Mol Biol,Chinese Acad Med Sci, Beijing 100084, Peoples R China.	xiliangw@126.com; jiang@pumc.edu.cn	Yan, Yiwu/P-5499-2017; , 孙阳/B-2495-2016; Zou, Zhen/ABB-3301-2021; Wang, Wei/N-9423-2019	Yan, Yiwu/0000-0001-8289-7277; , 孙阳/0000-0002-1463-689X; Zou, Zhen/0000-0002-1651-591X; Wang, Wei/0000-0001-9243-8672; Tang, Jun/0000-0003-3177-8926; Guo, Feng/0000-0002-4506-7618	National Natural Scientific Foundation [30800977, 30972614]; Beijing Natural Science Foundation [7112105]; Ministry of Science and Technology of China [2009CB522102, 2009CB522105]; 111project [B08007]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 111project(Ministry of Education, China - 111 Project)	Funding provided by National Natural Scientific Foundation (30800977 and 30972614) (http://www.nsfc.gov.cn/Portal0/default106.htm), Beijing Natural Science Foundation (7112105) (http://www.bjnsf.org/) and Ministry of Science and Technology of China (2009CB522102 and 2009CB522105) (http://www.973.gov.cn/Default_3.aspx) 111project (B08007) (http://www.safea.gov.cn/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2006, CURR DRUG TARGETS, V7, P649, DOI 10.2174/138945006777435344; Annane D, 2011, AM J RESP CRIT CARE, V183, P1125, DOI 10.1164/rccm.201102-0345ED; [Anonymous], 2009, MMWR MORB MORTAL WKL, P913; ASHBAUGH DG, 1967, LANCET, V2, P319; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Confalonieri M, 2010, INTENS CARE MED, V36, P1780, DOI 10.1007/s00134-010-1964-8; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344; Kim Sangsoo, 2011, Genomics & Informatics, V9, P1; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Martin-Loeches I, 2011, INTENS CARE MED, V37, P272, DOI 10.1007/s00134-010-2078-z; Matthay MA, 2011, AM J RESP CRIT CARE, V183, P1127, DOI 10.1164/rccm.201103-0395ED; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Quispe-Laime AM, 2010, INTENS CARE MED, V36, P33, DOI 10.1007/s00134-009-1727-6; Nencioni L, 2009, J BIOL CHEM, V284, P16004, DOI 10.1074/jbc.M900146200; Salluh JIF, 2010, INTENS CARE MED, V36, P1098, DOI 10.1007/s00134-010-1815-7; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sauerzapf V, 2009, J EPIDEMIOL COMMUN H, V63, P324, DOI 10.1136/jech.2008.077024; Sun Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001931; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tyburski JG, 2001, SURGERY, V130, P748, DOI 10.1067/msy.2001.118094; World Health Organization, 2009, CLIN MAN HUM INF PAN; Yang N, 2011, J MOL CELL BIOL, V3, P221, DOI 10.1093/jmcb/mjr017; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029347	32	27	32	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44110	10.1371/journal.pone.0044110	http://dx.doi.org/10.1371/journal.pone.0044110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952892	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000084
J	Paunic, V; Gragert, L; Madbouly, A; Freeman, J; Maiers, M				Paunic, Vanja; Gragert, Loren; Madbouly, Abeer; Freeman, John; Maiers, Martin			Measuring Ambiguity in HLA Typing Methods	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; HIGH-RESOLUTION HLA; HIGHLY ACCURATE; HIGH-THROUGHPUT; HAPLOTYPE MAP; ASSOCIATION; GENERATION; ALLELES; INFORMATION; EXPRESSION	In hematopoietic stem cell transplantation, donor selection is based primarily on matching donor and patient HLA genes. These genes are highly polymorphic and their typing can result in exact allele assignment at each gene (the resolution at which patients and donors are matched), but it can also result in a set of ambiguous assignments, depending on the typing methodology used. To facilitate rapid identification of matched donors, registries employ statistical algorithms to infer HLA alleles from ambiguous genotypes. Linkage disequilibrium information encapsulated in haplotype frequencies is used to facilitate prediction of the most likely haplotype assignment. An HLA typing with less ambiguity produces fewer high-probability haplotypes and a more reliable prediction. We estimated ambiguity for several HLA typing methods across four continental populations using an information theory-based measure, Shannon's entropy. We used allele and haplotype frequencies to calculate entropy for different sets of 1,000 subjects with simulated HLA typing. Using allele frequencies we calculated an average entropy in Caucasians of 1.65 for serology, 1.06 for allele family level, 0.49 for a 2002-era SSO kit, and 0.076 for single-pass SBT. When using haplotype frequencies in entropy calculations, we found average entropies of 0.72 for serology, 0.73 for allele family level, 0.05 for SSO, and 0.002 for single-pass SBT. Application of haplotype frequencies further reduces HLA typing ambiguity. We also estimated expected confirmatory typing mismatch rates for simulated subjects. In a hypothetical registry with all donors typed using the same method, the entropy values based on haplotype frequencies correspond to confirmatory typing mismatch rates of 1.31% for SSO versus only 0.08% for SBT. Intermediate-resolution single-pass SBT contains the least ambiguity of the methods we evaluated and therefore the most certainty in allele prediction. The presented measure objectively evaluates HLA typing methods and can help define acceptable HLA typing for donor recruitment.	[Paunic, Vanja; Gragert, Loren; Madbouly, Abeer; Freeman, John; Maiers, Martin] Natl Marrow Donor Program, Bioinformat Res, Minneapolis, MN USA; [Paunic, Vanja] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA	National Marrow Donor Program; University of Minnesota System; University of Minnesota Twin Cities	Gragert, L (corresponding author), Natl Marrow Donor Program, Bioinformat Res, Minneapolis, MN USA.	lgragert@nmdp.org		Maiers, Martin/0000-0002-0198-2064	Office of Naval Research [N00014-11-1-0339]	Office of Naval Research(Office of Naval Research)	This work has been funded by Office of Naval Research grant N00014-11-1-0339. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; Bochtler W, 2007, BONE MARROW TRANSPL, V39, P737, DOI 10.1038/sj.bmt.1705672; Cano P, 2011, HUM IMMUNOL, V72, pS149; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Ghodke Y, 2005, EUR J EPIDEMIOL, V20, P475, DOI 10.1007/s10654-005-5081-x; Gourraud PA, 2005, HUM IMMUNOL, V66, P563, DOI 10.1016/j.humimm.2005.01.011; Helmberg W, 2000, TISSUE ANTIGENS, V56, P99, DOI 10.1034/j.1399-0039.2000.560115.x; Helmberg W, 2005, HUM IMMUNOL, V66, pS36; Hertz T, 2007, BIOINFORMATICS, V23, pE148, DOI 10.1093/Bioinformatics/btl324; Holdsworth R, 2009, TISSUE ANTIGENS, V73, P95, DOI 10.1111/j.1399-0039.2008.01183.x; Hurley CK, 2000, TISSUE ANTIGENS, V55, P352, DOI 10.1034/j.1399-0039.2000.550409.x; Hurley CK, 2004, BONE MARROW TRANSPL, V33, P443, DOI 10.1038/sj.bmt.1704365; Hurley CK, 1993, DNA METHODS HLA TYPI, P41; Kollman C, 2007, HUM IMMUNOL, V68, P950, DOI 10.1016/j.humimm.2007.10.009; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lazaro A. M., 1996, Human Immunology, V47, P43, DOI 10.1016/0198-8859(96)84910-X; Lezon TR, 2006, P NATL ACAD SCI USA, V103, P19033, DOI 10.1073/pnas.0609152103; Listgarten J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000016; Maiers M, 2000, Rev Immunogenet, V2, P449; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Marsh S G E, 2005, Int J Immunogenet, V32, P107, DOI 10.1111/j.1744-313X.2005.00509.x; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Morishima Y, 2002, BLOOD, V99, P4200, DOI 10.1182/blood.V99.11.4200; NG J, 1993, TISSUE ANTIGENS, V42, P473, DOI 10.1111/j.1399-0039.1993.tb02191.x; Ng J, 1996, TISSUE ANTIGENS, V47, P21, DOI 10.1111/j.1399-0039.1996.tb02510.x; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Nunes E, 2011, BLOOD, V118, pE180, DOI 10.1182/blood-2011-05-353490; Petersdorf EW, 2007, PLOS MED, V4, P59, DOI 10.1371/journal.pmed.0040008; PETERSDORF EW, 1995, BLOOD, V86, P1606, DOI 10.1182/blood.V86.4.1606.bloodjournal8641606; Robinson J, 2000, TISSUE ANTIGENS, V55, P280, DOI 10.1034/j.1399-0039.2000.550314.x; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Rozemuller EH, 1996, HUM IMMUNOL, V46, P27, DOI 10.1016/0198-8859(95)00075-5; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; Schneider Thomas D, 2010, Nano Commun Netw, V1, P173, DOI 10.1016/j.nancom.2010.09.002; Schuster S. C., 2007, NATURE, V200; Sen D, 2009, IEEE T SYST MAN CY B, V39, P117, DOI 10.1109/TSMCB.2008.2005527; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Skibola C, 2012, TISSUE ANTIGENS; Tan P., 2006, INTRO DATA MINING; Thorsby E, 2005, TRANSPL IMMUNOL, V14, P175, DOI 10.1016/j.trim.2005.03.021; Walsh EC, 2003, AM J HUM GENET, V73, P580, DOI 10.1086/378101; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Zhang XC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-6	45	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43585	10.1371/journal.pone.0043585	http://dx.doi.org/10.1371/journal.pone.0043585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952712	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000042
J	Vacquie-Garcia, J; Royer, F; Dragon, AC; Viviant, M; Bailleul, F; Guinet, C				Vacquie-Garcia, Jade; Royer, Francois; Dragon, Anne-Cecile; Viviant, Morgane; Bailleul, Frederic; Guinet, Christophe			Foraging in the Darkness of the Southern Ocean: Influence of Bioluminescence on a Deep Diving Predator	PLOS ONE			English	Article							SEALS MIROUNGA-LEONINA; ELEPHANT SEALS; KING PENGUINS; MESOPELAGIC SQUID; STABLE-ISOTOPES; PREY; STRATEGIES; BEHAVIOR; DIVE; DIET	How non-echolocating deep diving marine predators locate their prey while foraging remains mostly unknown. Female southern elephant seals (SES) (Mirounga leonina) have vision adapted to low intensity light with a peak sensitivity at 485 nm. This matches the wavelength of bioluminescence produced by a large range of marine organisms including myctophid fish, SES's main prey. In this study, we investigated whether bioluminescence provides an accurate estimate of prey occurrence for SES. To do so, four SES were satellite-tracked during their post-breeding foraging trip and were equipped with Time-Depth-Recorders that also recorded light levels every two seconds. A total of 3386 dives were processed through a light-treatment model that detected light events higher than ambient level, i.e. bioluminescence events. The number of bioluminescence events was related to an index of foraging intensity for SES dives deep enough to avoid the influence of natural ambient light. The occurrence of bioluminescence was found to be negatively related to depth both at night and day. Foraging intensity was also positively related to bioluminescence both during day and night. This result suggests that bioluminescence likely provides SES with valuable indications of prey occurrence and might be a key element in predator-prey interactions in deep-dark marine environments.	[Vacquie-Garcia, Jade; Dragon, Anne-Cecile; Viviant, Morgane; Bailleul, Frederic; Guinet, Christophe] Ctr Etud Biol Chize, CNRS UPR 1934, Villiers En Bois, France; [Royer, Francois] Collecte Localisat Satellites, Ramonville St Agne, France	Centre National de la Recherche Scientifique (CNRS)	Vacquie-Garcia, J (corresponding author), Ctr Etud Biol Chize, CNRS UPR 1934, Villiers En Bois, France.	jadevacquiegarcia@gmail.com	Guinet, Christophe/AAR-8457-2020	Bailleul, Frederic/0000-0002-4186-4708; VACQUIE GARCIA, Jade/0000-0002-3126-3423	French Polar Institute (Institut Paul Emile Victor, IPEV) [109]; Territoire des Terres Australes et Antarctiques Francaises (TAAF); Total Foundation	French Polar Institute (Institut Paul Emile Victor, IPEV); Territoire des Terres Australes et Antarctiques Francaises (TAAF); Total Foundation(Total SA)	This study is part of the national research program (no. 109, H. Weimerskirch and the observatory Mammiferes Explorateurs du Milieu Oceanique, MEMO SOERE CTD 02) supported by the French Polar Institute (Institut Paul Emile Victor, IPEV) and the Territoire des Terres Australes et Antarctiques Francaises (TAAF). This work was carried out in the framework of IPSOS-SEAL (ANR VMC 07), TOPP-PATCHES and CNES-TOSCA programs. This work is supported by the Total Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Authier M, 2012, METHODS ECOL EVOL, V3, P281, DOI 10.1111/j.2041-210X.2011.00162.x; Bailleul F, 2010, ECOGRAPHY, V33, P709, DOI 10.1111/j.1600-0587.2009.06034.x; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; BERRYMAN AA, 1992, ECOLOGY, V73, P1530, DOI 10.2307/1940005; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Bost CA, 2002, MAR ECOL PROG SER, V227, P51, DOI 10.3354/meps227051; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Campagna C, 2001, MAR MAMMAL SCI, V17, P402, DOI 10.1111/j.1748-7692.2001.tb01283.x; Cezilly F, 1996, REV ECOL-TERRE VIE, V51, P43; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; Culik B, 2000, J EXP BIOL, V203, P2311; Culik B, 2001, ZOOL-ANAL COMPLEX SY, V104, P327, DOI 10.1078/0944-2006-00038; Daneri GA, 2002, POLAR BIOL, V25, P739, DOI 10.1007/s00300-002-0408-5; Dewael Y, 2002, J EXP BIOL, V205, P799; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Fauchald P, 1999, AM NAT, V153, P603, DOI 10.1086/303203; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Fossette S, 2008, J ANIM ECOL, V77, P236, DOI 10.1111/j.1365-2656.2007.01344.x; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; HERRING PJ, 1992, MAR BIOL, V112, P293, DOI 10.1007/BF00702474; Hooker SK, 2002, MAR MAMMAL SCI, V18, P680, DOI 10.1111/j.1748-7692.2002.tb01066.x; Kastak D, 1999, CAN J ZOOL, V77, P1751, DOI 10.1139/cjz-77-11-1751; Kastak D, 1998, J ACOUST SOC AM, V103, P2216, DOI 10.1121/1.421367; Kuhn CE, 2009, J ANIM ECOL, V78, P513, DOI 10.1111/j.1365-2656.2008.01509.x; LANCRAFT TM, 1989, POLAR BIOL, V9, P225, DOI 10.1007/BF00263770; Levenson DH, 1999, MAR MAMMAL SCI, V15, P1303, DOI 10.1111/j.1748-7692.1999.tb00892.x; Levenson DH, 1997, CAN J ZOOL, V75, P2050, DOI 10.1139/z97-838; Lubimova TG, 1987, SPECIFIC FEATURES EC, P320; LYTHGOE JN, 1970, NATURE, V227, P955, DOI 10.1038/227955a0; Mackie GO, 2004, HYDROBIOLOGIA, V530, P73, DOI 10.1007/s10750-004-2644-x; MACKIE GO, 1991, HYDROBIOLOGIA, V216, P581, DOI 10.1007/BF00026516; Martin GR, 1999, IBIS, V141, P444, DOI 10.1111/j.1474-919X.1999.tb04413.x; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; MCNAMARA J, 1982, THEOR POPUL BIOL, V21, P269, DOI 10.1016/0040-5809(82)90018-1; MORIN JG, 1975, SCIENCE, V190, P74, DOI 10.1126/science.190.4209.74; OATEN A, 1977, THEOR POPUL BIOL, V12, P263, DOI 10.1016/0040-5809(77)90046-6; PAKHOMOV EA, 1994, MAR ECOL PROG SER, V111, P155, DOI 10.3354/meps111155; PIELOU E C, 1969, P286; Robison BH, 2003, BIOL BULL-US, V205, P102, DOI 10.2307/1543231; RODHOUSE PG, 1992, CAN J ZOOL, V70, P1007, DOI 10.1139/z92-143; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2001, POLAR BIOL, V24, P467, DOI 10.1007/s003000100235; Schulte-Pelkum N, 2007, J EXP BIOL, V210, P781, DOI 10.1242/jeb.02708; Schusterman RJ, 2000, J ACOUST SOC AM, V107, P2256, DOI 10.1121/1.428506; SLIP DJ, 1995, CAN J ZOOL, V73, P1519, DOI 10.1139/z95-180; Suzuki I, 2009, POLAR BIOL, V32, P667, DOI 10.1007/s00300-009-0596-3; Thompson D., 1993, Symposia of the Zoological Society of London, V66, P349; Tseitlin VB, 1982, REP SOVIET UNION ACA, V264, P1018; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; Viviant M, 2011, THESIS U P M CURRIE; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; White CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000639; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Williams A, 1999, MAR BIOL, V130, P259; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; YOUNG RE, 1980, SCIENCE, V208, P1286, DOI 10.1126/science.208.4449.1286; Zuur Alain F., 2009, P1; [No title captured]	64	32	32	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43565	10.1371/journal.pone.0043565	http://dx.doi.org/10.1371/journal.pone.0043565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952706	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000040
J	Almeida, OP; Yeap, BB; Alfonso, H; Hankey, GJ; Flicker, L; Norman, PE				Almeida, Osvaldo P.; Yeap, Bu B.; Alfonso, Helman; Hankey, Graeme J.; Flicker, Leon; Norman, Paul E.			Older Men Who Use Computers Have Lower Risk of Dementia	PLOS ONE			English	Article							LEISURE ACTIVITIES; WESTERN-AUSTRALIA; ALZHEIMER-DISEASE; STATE-EXAMINATION; INTERNET USAGE; PREVALENCE; ADULTS; POPULATION; LINKAGE; PREVENTION	Objective: To determine if older men who use computers have lower risk of developing dementia. Methods: Cohort study of 5506 community-dwelling men aged 69 to 87 years followed for up to 8.5 years. Use of computers measured as daily, weekly, less than weekly and never. Participants also reported their use of email, internet, word processors, games or other computer activities. The primary outcome was the incidence of ICD-10 diagnosis of dementia as recorded by the Western Australian Data Linkage System. Results: 1857/5506 (33.7%) men reported using computers and 347 (6.3%) received a diagnosis of dementia during an average follow up of 6.0 years (range: 6 months to 8.5 years). The hazard ratio (HR) of dementia was lower among computer users than non-users (HR = 0.62, 95%CI = 0.47-0.81, after adjustment for age, educational attainment, size of social network, and presence of depression or of significant clinical morbidity). The HR of dementia appeared to decrease with increasing frequency of computer use: 0.68 (95%CI = 0.41-1.13), 0.61 (95%CI = 0.39-0.94) and 0.59 (95%CI = 0.40-0.87) for less than weekly, at least weekly and daily. The HR of dementia was 0.66 (95%CI = 0.50-0.86) after the analysis was further adjusted for baseline cognitive function, as measured by the Mini-Mental State Examination. Conclusion: Older men who use computers have lower risk of receiving a diagnosis of dementia up to 8.5 years later. Randomised trials are required to determine if the observed associations are causal.	[Almeida, Osvaldo P.; Alfonso, Helman] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Almeida, Osvaldo P.; Alfonso, Helman; Flicker, Leon] Univ Western Australia, Med Res Ctr, Western Australian Ctr Hlth & Ageing, Perth, WA 6009, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia; [Yeap, Bu B.; Hankey, Graeme J.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol & Diabet, Fremantle, WA, Australia; [Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Perth, WA, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA, Australia; [Norman, Paul E.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Almeida, OP (corresponding author), Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia.	osvaldo.almeida@uwa.edu.au	Flicker, Leon/AAE-1530-2022; Norman, Paul E/C-5485-2013; Hankey, Graeme J/H-4968-2014; Almeida, Osvaldo P./A-4925-2008	Flicker, Leon/0000-0002-3650-0475; Norman, Paul E/0000-0003-3406-0506; Hankey, Graeme J/0000-0002-6044-7328; Almeida, Osvaldo P./0000-0002-8689-6199	National Health and Medical Research Council of Australia [279408, 379600, 403963, 513823]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by National Health and Medical Research Council of Australia project grant numbers 279408, 379600, 403963 and 513823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2011, HOUS US INF TECHN AU; Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P283, DOI 10.1001/archgenpsychiatry.2007.33; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Beasley R, 2003, EUR RESPIR J, V21, P374, DOI 10.1183/09031936.03.00039403; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Hyde Z, 2010, ANN INTERN MED, V153, P693, DOI 10.7326/0003-4819-153-11-201012070-00002; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lobo A, 2007, ACTA PSYCHIAT SCAND, V116, P299, DOI 10.1111/j.1600-0447.2007.01006.x; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Pink B, 2008, INTRO SOCIO EC INDEX; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ritchie K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3885; Slegers K, 2008, J GERONTOL B-PSYCHOL, V63, pP176, DOI 10.1093/geronb/63.3.P176; Slegers K, 2009, AGING CLIN EXP RES, V21, P43, DOI 10.1007/BF03324898; Small GW, 2009, AM J GERIAT PSYCHIAT, V17, P116, DOI 10.1097/JGP.0b013e3181953a02; Tun PA, 2010, PSYCHOL AGING, V25, P560, DOI 10.1037/a0019543; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Zilkens RR, 2009, NEUROEPIDEMIOLOGY, V32, P61, DOI 10.1159/000170908	34	43	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44239	10.1371/journal.pone.0044239	http://dx.doi.org/10.1371/journal.pone.0044239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22937167	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600097
J	Green, CJ; Henriksen, TI; Pedersen, BK; Solomon, TPJ				Green, Charlotte J.; Henriksen, Tora I.; Pedersen, Bente K.; Solomon, Thomas P. J.			Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia	PLOS ONE			English	Article							PROTEIN-KINASE-C; RAT SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASE; HUMAN MYOCYTES; DIABETES-MELLITUS; POTENT INHIBITORS; 3T3-L1 ADIPOCYTES; DOWN-REGULATION; C2C12 MYOTUBES; L6 MYOTUBES	Background: Glucagon like peptide-1 (GLP-1) stimulates insulin secretion from the pancreas but also has extra-pancreatic effects. GLP-1 may stimulate glucose uptake in cultured muscle cells but the mechanism is not clearly defined. Furthermore, while the pancreatic effects of GLP-1 are glucose-dependent, the glucose-dependency of its extra-pancreatic effects has not been examined. Methods: Skeletal muscle satellite cells isolated from young (22.5+/-0.97 yr), lean (BMI 22.5+/-0.6 kg/m(2)), healthy males were differentiated in media containing either 22.5 mM (high) or 5 mM (normal) glucose for 7 days in the absence or presence of insulin and/or various GLP-1 concentrations. Myocellular effects of GLP-1, insulin and glucose were assessed by western-blot, glucose uptake and glycogen synthesis. Results: We firstly show that the GLP-1 receptor protein is expressed in differentiated human muscle satellite cells (myocytes). Secondly, we show that in 5 mM glucose media, exposure of myocytes to GLP-1 results in a dose dependent increase in glucose uptake, GLUT4 amount and subsequently glycogen synthesis in a PI3K dependent manner, independent of the insulin signaling cascade. Importantly, we provide evidence that differentiation of human satellite cells in hyperglycemic (22.5 mM glucose) conditions increases GLUT1 expression, and renders the cells insulin resistant and interestingly GLP-1 resistant in terms of glucose uptake and glycogen synthesis. Hyperglycemic conditions did not affect the ability of insulin to phosphorylate downstream targets, PKB or GSK3. Interestingly we show that at 5 mM glucose, GLP-1 increases GLUT4 protein levels and that this effect is abolished by hyperglycemia. Conclusions: GLP-1 increases glucose uptake and glycogen synthesis into fully-differentiated human satellite cells in a PI3-K dependent mechanism potentially through increased GLUT4 protein levels. The latter occurs independently of the insulin signaling pathway. Attenuation of both GLP-1 and insulin-induced glucose metabolism by hyperglycemia is likely to occur downstream of PI3K.	[Green, Charlotte J.] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Ctr Inflammat & Metab,Dept Infect Dis, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Rigshosp, Fac Hlth Sci, Copenhagen Muscle Res Ctr, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Green, CJ (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Ctr Inflammat & Metab,Dept Infect Dis, DK-1168 Copenhagen, Denmark.	cgreen@inflammation-metabolism.dk	GREEN, Charlotte/B-9742-2014; Henriksen, Tora/AGK-6018-2022; Pedersen, Bente Klarlund/AGR-3217-2022; Solomon, Thomas PJ/I-4476-2019	GREEN, Charlotte/0000-0003-1631-3186; Henriksen, Tora/0000-0003-1568-8920; Pedersen, Bente Klarlund/0000-0001-6508-6288; Solomon, Thomas PJ/0000-0002-0579-284X	Danish National Research Foundation [02-512-55]; European Foundation for the Study of Diabetes/Amylin; Amylin Phamaceuticals, Inc, European Foundation for the Study of Diabetes	Danish National Research Foundation(Danmarks Grundforskningsfond); European Foundation for the Study of Diabetes/Amylin; Amylin Phamaceuticals, Inc, European Foundation for the Study of Diabetes	The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (no.02-512-55). This study was also partially supported by a Paul Langerhans program grant from the European Foundation for the Study of Diabetes/Amylin (TPJS). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; This project was partially funded by Amylin Phamaceuticals, Inc as part of the Paul Langerhans program grant from the European Foundation for the Study of Diabetes. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aas V, 2011, BBA-MOL BASIS DIS, V1812, P94, DOI 10.1016/j.bbadis.2010.09.014; Acitores A, 2004, J ENDOCRINOL, V180, P389, DOI 10.1677/joe.0.1800389; Alcantara AI, 1997, ARCH BIOCHEM BIOPHYS, V341, P1, DOI 10.1006/abbi.1997.9951; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Arnes L, 2008, INT J MOL MED, V22, P127; Ayala JE, 2009, ENDOCRINOLOGY, V150, P1155, DOI 10.1210/en.2008-0945; Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broholm C, 2012, AM J PHYSIOL-ENDOC M, V303, pE283, DOI 10.1152/ajpendo.00586.2011; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Chai WD, 2012, DIABETES, V61, P888, DOI 10.2337/db11-1073; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; DELGADO E, 1995, PEPTIDES, V16, P225, DOI 10.1016/0196-9781(94)00175-8; Esguerra JL, 2011, PLOS ONE, V6; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; GALANTE P, 1995, DIABETES, V44, P646, DOI 10.2337/diabetes.44.6.646; Gao H, 2007, ENDOCRINE, V32, P90, DOI 10.1007/s12020-007-9011-4; Giralt M, 1999, DIGEST DIS SCI, V44, P322, DOI 10.1023/A:1026654417697; Gonzalez N, 2005, REGUL PEPTIDES, V126, P203, DOI 10.1016/j.regpep.2004.10.002; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; Gromada J, 1997, PFLUG ARCH EUR J PHY, V434, P515, DOI 10.1007/s004240050431; Gutzwiller JP, 1999, AM J PHYSIOL-REG I, V276, pR1541, DOI 10.1152/ajpregu.1999.276.5.R1541; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Kanzaki M, 2004, J CELL BIOL, V164, P279, DOI 10.1083/jcb.200306152; Kawano Y, 1999, DIABETOLOGIA, V42, P1071, DOI 10.1007/s001250051273; Luque MA, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730465; Moreno P, 2012, J MOL ENDOCRINOL, V48, P37, DOI 10.1530/JME-11-0127; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Standaert ML, 1996, BIOCHEM J, V313, P1039, DOI 10.1042/bj3131039; Tolessa T, 1998, J CLIN INVEST, V102, P764, DOI 10.1172/JCI942; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tsuchiya Y, 2010, J BIOL CHEM, V285, P34371, DOI 10.1074/jbc.M110.128520; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; XIA P, 1994, DIABETES, V43, P1122, DOI 10.2337/diabetes.43.9.1122; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033; Yang H, 1998, AM J PHYSIOL-CELL PH, V275, pC675, DOI 10.1152/ajpcell.1998.275.3.C675	42	44	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44284	10.1371/journal.pone.0044284	http://dx.doi.org/10.1371/journal.pone.0044284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937169	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600100
J	Keow, JY; Pond, ED; Cisar, JS; Cravatt, BF; Crawford, BD				Keow, Jonathan Y.; Pond, Eric D.; Cisar, Justin S.; Cravatt, Benjamin F.; Crawford, Bryan D.			Activity-Based Labeling of Matrix Metalloproteinases in Living Vertebrate Embryos	PLOS ONE			English	Article							ZEBRAFISH; EXPRESSION; FISH; MATRIX-METALLOPROTEINASE-9; PROTEASES; BIOLOGY; TARGET; CANCER; CELLS; GENE	Extracellular matrix (ECM) remodeling is a physiologically and developmentally essential process mediated by a family of zinc-dependent extracellular proteases called matrix metalloproteinases (MMPs). In addition to complex transcriptional control, MMPs are subject to extensive post-translational regulation. Because of this, classical biochemical, molecular and histological techniques that detect the expression of specific gene products provide useful but limited data regarding the biologically relevant activity of MMPs. Using benzophenone-bearing hydroxamate-based probes that interact with the catalytic zinc ion in MMPs, active proteases can be covalently 'tagged' by UV cross-linking. This approach has been successfully used to tag MMP-2 in vitro in tissue culture supernatants, and we show here that this probe tags proteins with mobilities consistent with known MMPs and detectable gelatinolytic activity in homogenates of zebrafish embryos. Furthermore, because of the transparency of the zebrafish embryo, UV-photocroslinking can be accomplished in vivo, and rhodamated benzophenone probe is detected in striking spatial patterns consistent with known distributions of active matrix remodeling in embryos. Finally, in metamorphosing Xenopus tadpoles, this probe can be used to biotinylate active MMP-2 by injecting it and cross-linking it in vivo, allowing the protein to be subsequently extracted and biochemically identified.	[Keow, Jonathan Y.; Pond, Eric D.; Crawford, Bryan D.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada; [Cisar, Justin S.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of New Brunswick; Scripps Research Institute	Keow, JY (corresponding author), Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada.	bryanc@unb.ca		Crawford, Bryan/0000-0002-0512-4649; Keow, Jonathan/0000-0001-5985-4770	National Sciences and Engineering Research Council (NSERC) of Canada [341540-07]; NSERC; Michael J. Smith Foundation; NATIONAL CANCER INSTITUTE [R37CA087660] Funding Source: NIH RePORTER	National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael J. Smith Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant (341540-07) to BDC. JYK was supported by scholarships from NSERC and a travel grant from the Michael J. Smith Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Ali MAM, 2012, J CELL PHYSIOL, V227, P3397, DOI 10.1002/jcp.24040; Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Burrage PS, 2007, CURR DRUG TARGETS, V8, P293, DOI 10.2174/138945007779940098; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Cavallo-Medved D, 2009, EXP CELL RES, V315, P1234, DOI 10.1016/j.yexcr.2009.01.021; Chen CH, 2005, BIOSCI BIOTECH BIOCH, V72, P1586; Crawford BD, 2005, DEV BIOL, V286, P405, DOI 10.1016/j.ydbio.2005.06.035; Crawford BD, 2003, MOL BIOL CELL, V14, P3065, DOI 10.1091/mbc.E02-08-0537; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Duchossoy Y, 2001, MOL CELL NEUROSCI, V17, P945, DOI 10.1006/mcne.2001.0986; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Franz-Odendaal TA, 2008, DEV DYNAM, V237, P3240, DOI 10.1002/dvdy.21754; Hillegass JM, 2007, TOXICOL SCI, V100, P168, DOI 10.1093/toxsci/kfm192; Inohaya K, 1997, DEV GROWTH DIFFER, V39, P191; Jung JC, 2002, DEV DYNAM, V223, P402, DOI 10.1002/dvdy.10069; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Kawaguchi M, 2005, FEBS J, V272, P4315, DOI 10.1111/j.1742-4658.2005.04845.x; Keow JY, 2011, MATRIX BIOL, V30, P169, DOI 10.1016/j.matbio.2011.01.003; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Kudo N, 2004, ACTA CRYSTALLOGR D, V60, P725, DOI 10.1107/S0907444904001866; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Lombard C, 2005, BIOCHIMIE, V87, P265, DOI 10.1016/j.biochi.2005.01.007; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagy V, 2007, LEARN MEMORY, V14, P655, DOI 10.1101/lm.678307; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Packard BZ, 2009, MATRIX BIOL, V28, P3, DOI 10.1016/j.matbio.2008.10.001; Qi F, 2010, HEPATOLOGY, V52, P2158, DOI 10.1002/hep.23945; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; van Hinsbergh VWM, 2008, CARDIOVASC RES, V78, P203, DOI 10.1093/cvr/cvm102; VanSaun Michael N., 2006, Birth Defects Research, V78, P69, DOI 10.1002/bdrc.20061; von Burstin J, 2008, INT J CANCER, V123, P2138, DOI 10.1002/ijc.23780; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wlodarczyk J, 2011, DEV NEUROBIOLOGY; Wyatt RA, 2009, ZEBRAFISH, V6, P347, DOI 10.1089/zeb.2009.0609; Yoong S, 2007, GENE EXPR PATTERNS, V7, P39, DOI 10.1016/j.modgep.2006.05.005; Zhang JS, 2003, MATRIX BIOL, V22, P279, DOI 10.1016/S0945-053X(03)00020-9; Zhang JS, 2003, DEV GENES EVOL, V213, P456, DOI 10.1007/s00427-003-0346-4	46	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43434	10.1371/journal.pone.0043434	http://dx.doi.org/10.1371/journal.pone.0043434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952682	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600024
J	Liu, KY; Shu, DY; Song, N; Gai, ZC; Yuan, Y; Li, J; Li, M; Guo, SY; Peng, JX; Hong, HZ				Liu, Kaiyu; Shu, Duanyang; Song, Na; Gai, Zhongchao; Yuan, Yuan; Li, Juan; Li, Min; Guo, Shuying; Peng, Jianxin; Hong, Huazhu			The Role of Cytochrome c on Apoptosis Induced by Anagrapha falcifera Multiple Nuclear Polyhedrosis Virus in Insect Spodoptera litura Cells	PLOS ONE			English	Article							CASPASE ACTIVATION; RELEASE; DEATH; MITOCHONDRIA; INVOLVEMENT; STARVATION; INDUCTION; PATHWAY; LINE; DATP	There are conflicting reports on the role of cytochrome c during insect apoptosis. Our previous studies have showed that cytochrome c released from the mitochondria was an early event by western blot analysis and caspase-3 activation was closely related to cytochrome c release during apoptosis induced by baculovirus in Spodoptera litura cells (Sl-1 cell line). In the present study, alteration in mitochondrial morphology was observed by transmission electron microscopy, and cytochrome c release from mitochondria in apoptotic Sl-1 cells induced with Anagrapha falcifera multiple nuclear polyhedrosis virus (AfMNPV) has further been confirmed by immunofluoresence staining protocol, suggesting that structural disruption of mitochondria and the release of cytochrome c are important events during Lepidoptera insect cell apoptosis. We also used Sl-1 cell-free extract system and the technique of RNA interference to further investigate the role of cytochrome c in apoptotic Sl-1 cells induced by AfMNPV. Caspase-3 activity in cell-free extracts supplemented with exogenous cytochrome c was determined and showed an increase with the extension of incubation time. DsRNA-mediated silencing of cytochrome c resulted in the inhibition of apoptosis and protected the cells from AfMNPV-induced cell death. Silencing of expression of cytochrome c had a remarkable effect on pro-caspase-3 and pro-caspase-9 activation and resulted in the reduction of caspase-3 and caspase-9 activity in Sl-1 cells undergoing apoptosis. Caspase-9 inhibitor could inhibit activation of pro-caspase-3, and the inhibition of the function of Apaf-1 with FSBA blocked apoptosis, hinting that Apaf-1 could be involved in Sl-1 cell apoptosis induced by AfMNPV. Taken together, these results strongly demonstrate that cytochrome c plays an important role in apoptotic signaling pathways in Lepidopteran insect cells.	[Liu, Kaiyu; Shu, Duanyang; Song, Na; Gai, Zhongchao; Yuan, Yuan; Li, Juan; Li, Min; Guo, Shuying; Peng, Jianxin; Hong, Huazhu] Cent China Normal Univ, Inst Entomol, Wuhan, Peoples R China; [Liu, Kaiyu; Peng, Jianxin; Hong, Huazhu] Cent China Normal Univ, Key Lab Pesticide & Chem Biol, Minist Educ, Wuhan, Peoples R China	Central China Normal University; Central China Normal University	Liu, KY (corresponding author), Cent China Normal Univ, Inst Entomol, Wuhan, Peoples R China.	jxpeng@mail.ccnu.edu.cn	Gai, Zhongchao/GON-5469-2022	Gai, Zhongchao/0000-0003-3367-3378	National Natural Science Foundation of China [30470073, 30970136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this work was provided by the National Natural Science Foundation of China (30470073; 30970136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Abdelwahid E, 2011, BBA-MOL CELL RES, V1813, P597, DOI 10.1016/j.bbamcr.2010.10.008; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Beem E, 2004, AM J PHYSIOL-CELL PH, V287, pC664, DOI 10.1152/ajpcell.00232.2003; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chen CJ, 1996, J GEN VIROL, V77, P167, DOI 10.1099/0022-1317-77-2-167; Dorstyn L, 2004, J CELL BIOL, V167, P405, DOI 10.1083/jcb.200408054; Dorstyn L, 2006, CELL DEATH DIFFER, V13, P1049, DOI 10.1038/sj.cdd.4401918; He JL, 2000, J PHARMACOL EXP THER, V295, P896; Huang JF, 2011, PESTIC BIOCHEM PHYS, V100, P256, DOI 10.1016/j.pestbp.2011.04.010; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kumarswamy R, 2009, INT J BIOCHEM CELL B, V41, P1430, DOI 10.1016/j.biocel.2008.12.009; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu KY, 2007, CYTOTECHNOLOGY, V54, P97, DOI 10.1007/s10616-007-9080-5; Liu LJ, 2007, CELL BIOL INT, V31, P996, DOI 10.1016/j.cellbi.2007.03.011; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Malagoli D, 2005, CELL TISSUE RES, V320, P337, DOI 10.1007/s00441-004-1050-z; Means JC, 2007, CELL DEATH DIFFER, V14, P383, DOI 10.1038/sj.cdd.4402036; Means J, 2006, CELL DEATH DIFFER, V13, P1222, DOI 10.1038/sj.cdd.4401821; Mohan M, 2003, CELL BIOL INT, V27, P483, DOI 10.1016/S1065-6995(03)00071-4; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Sahdev S, 2003, BIOCHEM BIOPH RES CO, V307, P483, DOI 10.1016/S0006-291X(03)01224-5; Shan SG, 2009, INSECT SCI, V16, P485, DOI 10.1111/j.1744-7917.2009.01278.x; Tian L, 2012, ARCH INSECT BIOCHEM, V79, P207, DOI 10.1002/arch.20457; Varkey J, 1999, J CELL BIOL, V144, P701, DOI 10.1083/jcb.144.4.701; Wei W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037457; Wu WX, 2011, J INSECT PHYSIOL, V57, P723, DOI 10.1016/j.jinsphys.2011.02.008; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	34	29	34	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e40877	10.1371/journal.pone.0040877	http://dx.doi.org/10.1371/journal.pone.0040877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952575	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600001
J	Ottestad, I; Hassani, S; Borge, GI; Kohler, A; Vogt, G; Hyotylainen, T; Oresic, M; Bronner, KW; Holven, KB; Ulven, SM; Myhrstad, MCW				Ottestad, Inger; Hassani, Sahar; Borge, Grethe I.; Kohler, Achim; Vogt, Gjermund; Hyotylainen, Tuulia; Oresic, Matej; Bronner, Kirsti W.; Holven, Kirsten B.; Ulven, Stine M.; Myhrstad, Mari C. W.			Fish Oil Supplementation Alters the Plasma Lipidomic Profile and Increases Long-Chain PUFAs of Phospholipids and Triglycerides in Healthy Subjects	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; DIETARY-FAT; INFLAMMATION; METABOLISM; HUMANS; PPAR	Background: While beneficial health effects of fish and fish oil consumption are well documented, the incorporation of n-3 polyunsaturated fatty acids in plasma lipid classes is not completely understood. The aim of this study was to investigate the effect of fish oil supplementation on the plasma lipidomic profile in healthy subjects. Methodology/Principal Findings: In a double-blinded randomized controlled parallel-group study, healthy subjects received capsules containing either 8 g/d of fish oil (FO) (1.6 g/d EPA+DHA) (n = 16) or 8 g/d of high oleic sunflower oil (HOSO) (n = 17) for seven weeks. During the first three weeks of intervention, the subjects completed a fully controlled diet period. BMI and total serum triglycerides, total-, LDL- and HDL-cholesterol were unchanged during the intervention period. Lipidomic analyses were performed using Ultra Performance Liquid Chromatography (UPLC) coupled to electrospray ionization quadrupole time-of-flight mass spectrometry (QTOFMS), where 568 lipids were detected and 260 identified. Both t-tests and Multi-Block Partial Least Square Regression (MBPLSR) analysis were performed for analysing differences between the intervention groups. The intervention groups were well separated by the lipidomic data after three weeks of intervention. Several lipid classes such as phosphatidylcholine, phosphatidylethanolamine, lysophosphatidylcholine, sphingomyelin, phosphatidylserine, phosphatidylglycerol, and triglycerides contributed strongly to this separation. Twenty-three lipids were significantly decreased (FDR<0.05) in the FO group after three weeks compared with the HOSO group, whereas fifty-one were increased including selected phospholipids and triglycerides of long-chain polyunsaturated fatty acids. After seven weeks of intervention the two intervention groups showed similar grouping. Conclusions/Significance: In healthy subjects, fish oil supplementation alters lipid metabolism and increases the proportion of phospholipids and triglycerides containing long-chain polyunsaturated fatty acids. Whether the beneficial effects of fish oil supplementation may be explained by a remodeling of the plasma lipids into phospholipids and triglycerides of long-chain polyunsaturated fatty acids needs to be further investigated. Trial Registration: ClinicalTrials.govNCT01034423	[Ottestad, Inger; Ulven, Stine M.; Myhrstad, Mari C. W.] Fac Hlth Sci, Dept Hlth Nutr & Management, Oslo, Norway; [Ottestad, Inger; Ulven, Stine M.; Myhrstad, Mari C. W.] Akershus Univ, Coll Appl Sci, Oslo, Norway; [Ottestad, Inger; Holven, Kirsten B.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Hassani, Sahar; Borge, Grethe I.; Kohler, Achim; Vogt, Gjermund] Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway; [Hassani, Sahar; Kohler, Achim] Norwegian Univ Life Sci, Ctr Integrat Genet CIGENE, Dept Math Sci & Technol, As, Norway; [Hyotylainen, Tuulia; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Bronner, Kirsti W.] Ctr Res & Dev, TINE SA, Oslo, Norway	Oslo Metropolitan University (OsloMet); University of Oslo; Nofima; Norwegian University of Life Sciences; VTT Technical Research Center Finland	Ottestad, I (corresponding author), Fac Hlth Sci, Dept Hlth Nutr & Management, Oslo, Norway.	mari.myhrstad@hioa.no	Ulven, Stine Marie/ABD-7140-2020; Oresic, Matej/K-7673-2016; Hyötyläinen, Tuulia/AAP-6266-2020; Oresic, Matej/AAV-3978-2020; Myhrstad, Mari/ABE-7132-2021	Oresic, Matej/0000-0002-2856-9165; Borge, Grethe Iren A./0000-0003-0086-4434; Kohler, Achim/0000-0001-5759-1989; Hyotylainen, Tuulia/0000-0002-1389-8302; Myhrstad, Mari/0000-0003-1982-1792	Norwegian Research Council [184813/110]; Nordic Centre of Excellence on Food, Nutrition and Health [070014]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Nordic Centre of Excellence on Food, Nutrition and Health	This study was supported by the Norwegian Research Council (184813/110) http://www.forskningsradet.no and the Nordic Centre of Excellence on Food, Nutrition and Health "Systems biology in controlled dietary interventions and cohort studies" (SYSDIET nr.070014) http://www.sysdiet.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block RC, 2010, PROSTAG LEUKOTR ESS, V82, P87, DOI 10.1016/j.plefa.2009.12.005; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Christensen J H, 1997, Ugeskr Laeger, V159, P5525; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Fekete K, 2009, AM J CLIN NUTR, V89, p2070S, DOI 10.3945/ajcn.2009.27230I; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; Gross RW, 2011, CHEM BIOL, V18, P284, DOI 10.1016/j.chembiol.2011.01.014; Hammad SM, 2011, ADV EXP MED BIOL, V721, P57, DOI 10.1007/978-1-4614-0650-1_4; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; HARRIS WS, 1989, J LIPID RES, V30, P785; Hartweg J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003205.pub2; Hassani S, 2011, CHEMOMETRICS INTELLI, DOI [10.1016/j.chemo lab.2011.06.001, DOI 10.1016/J.CHEM0-LAB.2011.06.001]; Hodge AM, 2007, NUTR METAB CARDIOVAS, V17, P415, DOI 10.1016/j.numecd.2006.04.005; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hornstra G, 2001, J Nutr Health Aging, V5, P160; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Knapp HR, 1997, AM J CLIN NUTR, V65, P1687; Kontush A, 2010, CURR ATHEROSCLER REP, V12, P194, DOI 10.1007/s11883-010-0100-0; Kowalski B., 1989, J CHEMOMETR, V3, P3; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; Lankinen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022646; Lankinen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005258; McCombie G, 2009, METABOLOMICS, V5, P363, DOI 10.1007/s11306-009-0161-7; Nodari S, 2009, CARDIOVASC DRUG THER, V23, P5, DOI 10.1007/s10557-008-6142-7; Ottestad I, 2012, BRIT J NUTR, V108, P315, DOI 10.1017/S0007114511005484; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Seppanen-Laakso T, 2009, J MOL ENDOCRINOL, V42, P185, DOI 10.1677/JME-08-0150; Shearer GC, 2012, BBA-MOL CELL BIOL L, V1821, P843, DOI 10.1016/j.bbalip.2011.10.011; Sijben JWC, 2007, P NUTR SOC, V66, P237, DOI 10.1017/S0029665107005472; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Yetukuri L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023589; Yetukuri L, 2010, J LIPID RES, V51, P2341, DOI 10.1194/jlr.M006494; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	42	49	50	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42550	10.1371/journal.pone.0042550	http://dx.doi.org/10.1371/journal.pone.0042550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952598	Green Published, gold			2022-12-27	WOS:000308213600005
J	Diez-Rivero, CM; Reche, PA				Diez-Rivero, Carmen M.; Reche, Pedro A.			CD8 T Cell Epitope Distribution in Viruses Reveals Patterns of Protein Biosynthesis	PLOS ONE			English	Article							DEFECTIVE RIBOSOMAL PRODUCTS; CLASS-I BINDING; PEPTIDE BINDING; WEB SERVER; ANTIGEN; PREDICTION; IMMUNODOMINANCE; DEGRADATION; INFLUENZA; DISCOVERY	Distinguishing T cell epitope distribution patterns is relevant for epitope- vaccine design. To that end, we invest0069gated the distribution of known CD8 T cell epitopes from Hepatitis C Virus, Human Immunodeficiency Virus-1 and Influenza A Virus using x 2 statistics. We found that epitopes are not distributed in the viral proteomes proportionally to the size of the source proteins. Specifically, capsid and matrix proteins pack significantly more epitopes than those expected by their size. Such non-homogeneous distribution cannot be accounted by underlying MHC I-peptide binding preferences nor it is related to sequence variability. Instead, we propose that it might be related to preferential protein translation/biosynthesis. Overall, these results support the prioritization of structural antigens for epitope identification and vaccine design.	[Diez-Rivero, Carmen M.; Reche, Pedro A.] Univ Complutense Madrid, Fac Med, Dept Immunol, Lab Immunomed, Madrid, Spain	Complutense University of Madrid	Diez-Rivero, CM (corresponding author), Univ Complutense Madrid, Fac Med, Dept Immunol, Lab Immunomed, Madrid, Spain.	parecheg@med.ucm.es	Reche, Pedro A/B-1881-2013	Reche, Pedro A/0000-0003-3966-5838	Ministerio de Ciencia e Innovacion of Spain [SAF2009-08103]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Ministerio de Ciencia e Innovacion of Spain (SAF2009-08103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CXL, 2011, FRONT BIOSCI-LANDMRK, V16, P3014, DOI 10.2741/3895; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Diez-Rivero CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-479; Diez-Rivero CM, 2010, PROTEINS, V78, P63, DOI 10.1002/prot.22535; Donnes P, 2005, PROTEIN SCI, V14, P2132, DOI 10.1110/ps.051352405; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Eberl G, 1996, EUR J IMMUNOL, V26, P2709, DOI 10.1002/eji.1830261124; Flower Darren R, 2010, Immunome Res, V6 Suppl 2, pS1, DOI 10.1186/1745-7580-6-S2-S1; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Reche PA, 2005, BIOINFORMATICS, V21, P2140, DOI 10.1093/bioinformatics/bti269; Reche PA, 2005, NUCLEIC ACIDS RES, V33, pW138, DOI 10.1093/nar/gki357; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; Reche Pedro A, 2006, Med Immunol, V5, P1, DOI 10.1186/1476-9433-5-1; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Sandberg JK, 1998, J IMMUNOL, V160, P3163; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; VILLARREAL LP, 1976, BIOCHEMISTRY-US, V15, P1663, DOI 10.1021/bi00653a012; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	34	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43674	10.1371/journal.pone.0043674	http://dx.doi.org/10.1371/journal.pone.0043674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952734	Green Submitted, gold, Green Published			2022-12-27	WOS:000308044800051
J	Ding, MZ; Wang, X; Liu, W; Cheng, JS; Yang, Y; Yuan, YJ				Ding, Ming-Zhu; Wang, Xin; Liu, Wei; Cheng, Jing-Sheng; Yang, Yang; Yuan, Ying-Jin			Proteomic Research Reveals the Stress Response and Detoxification of Yeast to Combined Inhibitors	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; ALCOHOL-DEHYDROGENASE; ALDEHYDE REDUCTION; GROWTH; ACID; FERMENTATION; ADAPTATION; TOLERANCE	The tolerant mechanism of yeast to the combination of three inhibitors (furfural, phenol and acetic acid) was investigated using 2-DE combined with MALDI-TOF/TOF-MS. The stress response and detoxification related proteins (e.g., Ahp1p, Hsp26p) were expressed higher in the tolerant yeast than in the parental yeast. The expressions of most nitrogen metabolism related proteins (e.g. Gdh1p, Met1p) were higher in the parental yeast, indicating that the tolerant yeast decreases its nitrogen metabolism rate to reserve energy, and possesses high resistance to the stress of combined inhibitors. Furthermore, upon exposure to the inhibitors, the proteins related to protein folding, degradation and translation (e.g., Ssc1p, Ubp14p, Efb1p) were all significantly affected and the oxidative stress related proteins (e.g., Ahp1p, Grx1p) were increased. Knockdown of genes related to the oxidative stress and unfolded protein response (Grx1, Gre2, Asc1) significantly decreased the tolerance of yeast to inhibitors, which further suggested that yeast responded to the inhibitors mainly by inducing unfolded protein response. This study reveals that increasing the detoxification and tolerating oxidative stress, and/or decreasing the nitrogen metabolism would be promising strategies in developing more tolerant strains to the multiple inhibitors in lignocellulose hydrolysates.	[Ding, Ming-Zhu] Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; Tianjin Univ, Sch Chem Engn & Technol, Dept Pharmaceut Engn, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Ding, MZ (corresponding author), Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn			National Natural Science Foundation of China [20736006, 21020102040]; National Basic Research Program of China ("973" Program) [2011CBA00802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China ("973" Program)(National Basic Research Program of China)	The authors are grateful for the financial support from the National Natural Science Foundation of China (Key Program: 20736006, Major International Joint Research Project: 21020102040), and the National Basic Research Program of China ("973" Program: 2011CBA00802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers E, 1996, APPL ENVIRON MICROB, V62, P3187, DOI 10.1128/AEM.62.9.3187-3195.1996; Allen SA, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-2; Almeida B, 2009, PROTEOMICS, V9, P720, DOI 10.1002/pmic.200700816; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Alvarez-Ordonez A, 2010, INT J FOOD MICROBIOL, V136, P278, DOI 10.1016/j.ijfoodmicro.2009.09.024; AXE DD, 1995, BIOTECHNOL BIOENG, V47, P8, DOI 10.1002/bit.260470103; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng JS, 2009, PROTEOMICS, V9, P4704, DOI 10.1002/pmic.200900249; Diaz De Villegas ME, 1992, ACTA BIOTECHNOL, V12, P351; Ding MZ, 2012, METABOLOMICS, V8, P232, DOI 10.1007/s11306-011-0303-6; HEIPIEPER HJ, 1994, TRENDS BIOTECHNOL, V12, P409, DOI 10.1016/0167-7799(94)90029-9; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Horvath IS, 2003, APPL ENVIRON MICROB, V69, P4076, DOI 10.1128/AEM.69.7.4076-4086.2003; Larroy C, 2002, BIOCHEM J, V361, P163, DOI 10.1042/0264-6021:3610163; Li BZ, 2010, APPL MICROBIOL BIOT, V86, P1915, DOI 10.1007/s00253-010-2518-2; Lin FM, 2009, PROTEOMICS, V9, P5471, DOI 10.1002/pmic.200900100; Lin FM, 2009, APPL ENVIRON MICROB, V75, P3765, DOI 10.1128/AEM.02594-08; Liu ZL, 2006, APPL MICROBIOL BIOT, V73, P27, DOI 10.1007/s00253-006-0567-3; Liu ZL, 2008, APPL MICROBIOL BIOT, V81, P743, DOI 10.1007/s00253-008-1702-0; Ma Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026108; Martinez A, 2001, BIOTECHNOL PROGR, V17, P287, DOI 10.1021/bp0001720; Miller EN, 2009, APPL ENVIRON MICROB, V75, P6132, DOI 10.1128/AEM.01187-09; Modig T, 2002, BIOCHEM J, V363, P769, DOI 10.1042/0264-6021:3630769; Mollapour M, 2008, YEAST, V25, P169, DOI 10.1002/yea.1576; OURA E, 1977, PROCESS BIOCHEM, V12, P19; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 1999, BIOTECHNOL BIOENG, V62, P447, DOI 10.1002/(SICI)1097-0290(19990220)62:4<447::AID-BIT7>3.3.CO;2-S; Petersson A, 2006, YEAST, V23, P455, DOI 10.1002/yea.1370; Piper P, 2001, MICROBIOL-SGM, V147, P2635, DOI 10.1099/00221287-147-10-2635; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; VERDUYN C, 1990, J GEN MICROBIOL, V136, P405, DOI 10.1099/00221287-136-3-405; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Weeks ME, 2006, PROTEOMICS, V6, P2772, DOI 10.1002/pmic.200500741; WEIGERT B, 1988, BIOTECHNOL LETT, V10, P895, DOI 10.1007/BF01027002; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200	38	38	41	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43474	10.1371/journal.pone.0043474	http://dx.doi.org/10.1371/journal.pone.0043474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952687	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800032
J	Kato, Y; Nozaki, M				Kato, Yuzuru; Nozaki, Masami			Distinct DNA Methylation Dynamics of Spermatogenic Cell-Specific Intronless Genes Is Associated with CpG Content	PLOS ONE			English	Article							DE-NOVO METHYLATION; MALE GERM-CELLS; HISTONE DEACETYLASE COMPLEX; BINDING-PROTEIN; MOUSE SPERMATOGENESIS; TRANSCRIPTIONAL REPRESSION; MAMMALIAN DEVELOPMENT; CYTOSINE METHYLATION; RESPONSIVE ELEMENT; MEIOTIC PROPHASE	In mammals, DNA methylation is restricted to cytosines of CpG dinucleotides, which are frequently found in short genomic regions including gene promoters. Methylation within CpG-rich regions around promoters tends to repress gene expression; thus, the CpG islands of housekeeping genes are normally unmethylated. We previously described a testis-specific single-exon gene containing a CpG-rich sequence that is methylated and thus repressed in somatic cells, whereas its expression in spermatogenic cells requires that it be hypomethylated. However, the relationship among the specific expression of spermatogenic genes, their methylation dynamics, and their CpG frequencies are poorly understood. Here, we analyzed the methylation patterns of the sphort genomic region around the transcription start site in spermatogenic cell-specific single-exon genes of various CpG contents. By using UniGene and Ensembl database analyses of the mouse genome and reverse transcription-PCR, we identified 39 single-exon genes that are exclusively expressed in spermatogeniccells. Regardless of their specific expression characteristics, genes containing higher (7 to 14 CpGs in 200 bp; mean = 12) and lower (2 to 6 CpGs in 200 bp; mean = 3.1) number of CpG were hypo-and hyper-methylated, respectively, in all cell types examined, including spermatogeniccells. We found that genes with intermediate number of CpG (2 to 11 CpGs in 200 bp; mean = 6.9) are methylated in somatic cells, but not in male germ cells. These results suggest that DNA methylation dynamics of spermatogenic cell-specific single-exon genes are associated with CpG content, and the methylation status are stably maintained throughout male germ cell development.	[Kato, Yuzuru; Nozaki, Masami] Osaka Univ, Microbial Dis Res Inst, Dept Cell Biol, Suita, Osaka 565, Japan	Osaka University	Kato, Y (corresponding author), Natl Inst Genet, Div Mammalian Dev, Genet Strains Res Ctr, Mishima, Sizuoka, Japan.	mnozaki@biken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology Japan	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Choi E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-256; Choi YC, 1997, MAMM GENOME, V8, P317, DOI 10.1007/s003359900431; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Geyer CB, 2004, BIOL REPROD, V71, P837, DOI 10.1095/biolreprod.104.028969; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hata K, 2002, DEVELOPMENT, V129, P1983; Hata K, 2006, MOL REPROD DEV, V73, P116, DOI 10.1002/mrd.20387; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hickox DM, 2002, BIOL REPROD, V67, P917, DOI 10.1095/biolreprod.101.001446; Hisano M, 2003, NUCLEIC ACIDS RES, V31, P4797, DOI 10.1093/nar/gkg670; Hisano M, 2003, MOL REPROD DEV, V65, P148, DOI 10.1002/mrd.10276; Hong S, 2005, J BIOL CHEM, V280, P7685, DOI 10.1074/jbc.M412444200; IANNELLO RC, 1992, BIOL REPROD, V47, P48, DOI 10.1095/biolreprod47.1.48; Iannello RC, 2000, J BIOL CHEM, V275, P19603, DOI 10.1074/jbc.M001867200; Iannello RC, 1997, MOL CELL BIOL, V17, P612, DOI 10.1128/MCB.17.2.612; Ike A, 2004, FEBS LETT, V559, P159, DOI 10.1016/S0014-5793(04)00065-1; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kleene KC, 1998, J MOL EVOL, V47, P275, DOI 10.1007/PL00006385; Lecuyer C, 2000, BIOL REPROD, V63, P1801, DOI 10.1095/biolreprod63.6.1801; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Martins RP, 2007, P NATL ACAD SCI USA, V104, P8340, DOI 10.1073/pnas.0700076104; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Oakes CC, 2007, DEV BIOL, V307, P368, DOI 10.1016/j.ydbio.2007.05.002; Oakes CC, 2007, P NATL ACAD SCI USA, V104, P228, DOI 10.1073/pnas.0607521104; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Onishi M, 2004, GENOMICS, V83, P647, DOI 10.1016/j.ygeno.2003.09.018; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Santambrogio P, 2007, J HISTOCHEM CYTOCHEM, V55, P1129, DOI 10.1369/jhc.7A7273.2007; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singal R, 2000, BIOL REPROD, V63, P1237, DOI 10.1095/biolreprod63.5.1237; Somboonthum P, 2005, NUCLEIC ACIDS RES, V33, P3401, DOI 10.1093/nar/gki652; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Suetake I, 2006, J BIOCHEM, V140, P553, DOI 10.1093/jb/mvj185; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tanaka H, 2005, MOL CELL BIOL, V25, P7107, DOI 10.1128/MCB.25.16.7107-7119.2005; Tanaka H, 2003, BIOL REPROD, V69, P475, DOI 10.1095/biolreprod.103.015867; Tang HH, 2008, BIOL REPROD, V78, P455, DOI 10.1095/biolreprod.107.064964; THOMAS KH, 1989, BIOL REPROD, V41, P729, DOI 10.1095/biolreprod41.4.729; TRASLER JM, 1990, MOL CELL BIOL, V10, P1828, DOI 10.1128/MCB.10.4.1828; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang PJ, 2007, CHROMOSOME RES, V15, P623, DOI 10.1007/s10577-007-1141-2; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; WEBER J, 1994, CANCER RES, V54, P1766; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Yang F, 2007, GENE EXPR PATTERNS, V7, P131, DOI 10.1016/j.modgep.2006.06.002; Yoshimura Y, 1999, GENE, V237, P193, DOI 10.1016/S0378-1119(99)00287-5; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	73	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43658	10.1371/journal.pone.0043658	http://dx.doi.org/10.1371/journal.pone.0043658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952732	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800050
J	Molnar, F; Caraco, T; Korniss, G				Molnar, Ferenc, Jr.; Caraco, Thomas; Korniss, Gyorgy			Extraordinary Sex Ratios: Cultural Effects on Ecological Consequences	PLOS ONE			English	Article							DEMOGRAPHIC STOCHASTICITY; SELECTION; DYNAMICS; EVOLUTION; INVASION; REPRODUCTION; POPULATIONS; INVESTMENT; NUCLEATION; EXTINCTION	We model sex-structured population dynamics to analyze pairwise competition between groups differing both genetically and culturally. A sex-ratio allele is expressed in the heterogametic sex only, so that assumptions of Fisher's analysis do not apply. Sex-ratio evolution drives cultural evolution of a group-associated trait governing mortality in the homogametic sex. The two-sex dynamics under resource limitation induces a strong Allee effect that depends on both sex ratio and cultural trait values. We describe the resulting threshold, separating extinction from positive growth, as a function of female and male densities. When initial conditions avoid extinction due to the Allee effect, different sex ratios cannot coexist; in our model, greater female allocation always invades and excludes a lesser allocation. But the culturally transmitted trait interacts with the sex ratio to determine the ecological consequences of successful invasion. The invading female allocation may permit population persistence at self-regulated equilibrium. For this case, the resident culture may be excluded, or may coexist with the invader culture. That is, a single sex-ratio allele in females and a cultural dimorphism in male mortality can persist; a low-mortality resident trait is maintained by father-to-son cultural transmission. Otherwise, the successfully invading female allocation excludes the resident allele and culture and then drives the population to extinction via a shortage of males. Finally, we show that the results obtained under homogeneous mixing hold, with caveats, in a spatially explicit model with local mating and diffusive dispersal in both sexes.	[Molnar, Ferenc, Jr.; Korniss, Gyorgy] Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12181 USA; [Caraco, Thomas] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Molnar, F (corresponding author), Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12181 USA.	korniss@rpi.edu	Korniss, Gyorgy/A-7360-2011	Caraco, Thomas/0000-0002-8538-6007; Molnar, Ferenc/0000-0002-5614-3989	National Science Foundation [DEB-0918413, DEB-0918392]; Division Of Environmental Biology [0918413] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation under grant numbers DEB-0918413 and DEB-0918392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allstadt A, 2007, EVOL ECOL RES, V9, P375; Allstadt A, 2009, J THEOR BIOL, V258, P537, DOI 10.1016/j.jtbi.2009.02.012; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; [Anonymous], 1984, NATURE SELECTION EVO; Appleby BM, 1997, P ROY SOC B-BIOL SCI, V264, P1111, DOI 10.1098/rspb.1997.0153; Ashih AC, 2001, THEOR POPUL BIOL, V60, P93, DOI 10.1006/tpbi.2001.1527; Berec L, 2001, AM NAT, V157, P217, DOI 10.1086/318626; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; CHARNOV E L, 1982; DIAMOND JM, 1987, NATURE, V330, P16, DOI 10.1038/330016a0; DICKEMAN M, 1975, ANNU REV ECOL SYST, V6, P107, DOI 10.1146/annurev.es.06.110175.000543; DIJKSTRA C, 1990, FUNCT ECOL, V4, P143, DOI 10.2307/2389333; Engen S, 2003, ECOLOGY, V84, P2378, DOI 10.1890/02-0123; ESHEL I, 1975, HEREDITY, V34, P351, DOI 10.1038/hdy.1975.44; Fisher RA, 1930, GENETICAL THEORY NAT; FRANK SA, 1986, THEOR POPUL BIOL, V29, P312, DOI 10.1016/0040-5809(86)90013-4; Gandhi A, 1999, J THEOR BIOL, V200, P121, DOI 10.1006/jtbi.1999.0978; Going BM, 2009, OECOLOGIA, V159, P839, DOI 10.1007/s00442-008-1264-y; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HARRIS TE, 1974, ANN PROBAB, V2, P969, DOI 10.1214/aop/1176996493; HASTINGS IM, 1994, P ROY SOC B-BIOL SCI, V258, P83, DOI 10.1098/rspb.1994.0146; Hinrichsen H, 2000, ADV PHYS, V49, P815, DOI 10.1080/00018730050198152; Hrdy S.B., 1984, INFANTICIDE COMP EVO; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Karlin S., 1986, THEORETICAL STUDIES; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; Korniss G, 2005, J THEOR BIOL, V233, P137, DOI 10.1016/j.jtbi.2004.09.018; Korniss G, 1997, PHYS REV E, V56, P4072, DOI 10.1103/PhysRevE.56.4072; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; KUMM J, 1994, THEOR POPUL BIOL, V46, P249, DOI 10.1006/tpbi.1994.1027; LALAND KN, 1995, CURR ANTHROPOL, V36, P131, DOI 10.1086/204346; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; LIGGETT TM, 1999, STOCHASTIC INTERACTI; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Marro J., 1999, NONEQUILIBRIUM PHASE, DOI 10.1017/CBO9780511524288; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; Miller TEX, 2011, AM NAT, V177, P549, DOI 10.1086/659628; Murray JD, 2003, MATH BIOL, V3; Nitta T, 2008, LECT NOTES COMPUT SC, V5191, P368, DOI 10.1007/978-3-540-79992-4_47; O'Malley L, 2006, THEOR POPUL BIOL, V70, P464, DOI 10.1016/j.tpb.2006.06.006; Oborny B, 2005, OIKOS, V109, P291; Press WH., 1992, NUMERICAL RECIPIES C, V2nd edn; Schiesser W. E., 1991, NUMERICAL METHOD LIN; SHAW RF, 1953, AM NAT, V87, P337, DOI 10.1086/281794; Shelton AO, 2010, AM NAT, V175, P302, DOI 10.1086/650374; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Tainaka K, 2006, EUROPHYS LETT, V74, P554, DOI 10.1209/epl/i2005-10558-3; UYENOYAMA MK, 1982, THEOR POPUL BIOL, V22, P43, DOI 10.1016/0040-5809(82)90035-1; van Kampen N. G., 1981, STOCHASTIC PROCESSES; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Wolfram Research Inc., 2010, MATH VERS 8 0	55	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43364	10.1371/journal.pone.0043364	http://dx.doi.org/10.1371/journal.pone.0043364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952669	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800027
J	Monteiro, NM; Lyons, DO				Monteiro, Nuno M.; Lyons, David O.			Stronger Sexual Selection in Warmer Waters: The Case of a Sex Role Reversed Pipefish	PLOS ONE			English	Article							NEROPHIS-LUMBRICIFORMIS PISCES; SIZE DIMORPHISM; ECOLOGY; TEMPERATURE; POPULATION; SYNGNATHIDAE; REPRODUCTION; RECRUITMENT; COMPETITION; DYNAMICS	In order to answer broader questions about sexual selection, one needs to measure selection on a wide array of phenotypic traits, simultaneously through space and time. Nevertheless, studies that simultaneously address temporal and spatial variation in reproduction are scarce. Here, we aimed to investigate the reproductive dynamics of a cold-water pipefish simultaneously through time (encompassing variation within each breeding cycle and as individuals grow) and space (by contrasting populations experiencing distinct water temperature regimes) in order to test hypothesized differences in sexual selection. Even though the sampled populations inhabited locations with very different water temperature regimes, they exhibited considerable similarities in reproductive parameters. The most striking was the existence of a well-defined substructure in reproductive activity, where larger individuals reproduce for longer periods, which seemed dependent on a high temperature threshold for breeding rather than on the low temperatures that vary heavily according to latitude. Furthermore, the perceived disparities among populations, such as size at first reproduction, female reproductive investment, or degree of sexual size dimorphism, seemed dependent on the interplay between seawater temperature and the operational sex ratio (OSR). Contrary to our expectations of an enhanced opportunity for sexual selection in the north, we found the opposite: higher female reproductive investment coupled with increased sexual size dimorphism in warmer waters, implying that a prolonged breeding season does not necessarily translate into reduced sexual selection pressure. In fact, if the limited sex has the ability to reproduce either continuously or recurrently during the entire breeding season, an increased opportunity for sexual selection might arise from the need to compete for available partners under strongly biased OSRs across protracted breeding seasons. A more general discussion on the effects of climate change in the pressure of sexual selection is also presented.	[Monteiro, Nuno M.] Ctr Invest Biodiversdade & Recursos Genet, Vairao, Portugal; [Monteiro, Nuno M.] Univ Fernando Pessoa, Fac Ciencias Saude, CEBIMED, Oporto, Portugal; [Lyons, David O.] Natl Pk & Wildlife Serv, Galway, Ireland	Universidade Fernando Pessoa	Monteiro, NM (corresponding author), Ctr Invest Biodiversdade & Recursos Genet, Vairao, Portugal.	nmonteir@fc.up.pt	Monteiro, Nuno/A-2900-2009	Monteiro, Nuno/0000-0001-6994-4673	Portuguese Foundation for Science and Technology (FCT) [PTDC/AAC-CLI/112936/2009]; FCT (Programa Ciencia)	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT (Programa Ciencia)	The Portuguese Foundation for Science and Technology (FCT) partially funded this study through the R&D project PTDC/AAC-CLI/112936/2009. NM was funded by FCT (Programa Ciencia 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNESJO I, 1995, BEHAV ECOL, V6, P229, DOI 10.1093/beheco/6.2.229; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Berglund A, 2003, ADV STUD BEHAV, V32, P131, DOI 10.1016/S0065-3454(03)01003-9; BERGLUND A, 1990, BEHAV ECOL SOCIOBIOL, V27, P129, DOI 10.1007/BF00168456; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Dawson C.E., 1986, P628; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Klug H, 2010, J EVOLUTION BIOL, V23, P447, DOI 10.1111/j.1420-9101.2009.01921.x; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Laptikhovsky V., 2006, RUSSIAN J MARINE BIO, V32, P201; Lester SE, 2007, ECOLOGY, V88, P2229, DOI 10.1890/06-1784.1; LEWIS JR, 1986, HYDROBIOLOGIA, V142, P1, DOI 10.1007/BF00026742; Lindman HR., 1974, ANAL VARIANCE COMPLE; Lyons David O., 2005, Biology and Environment, V105B, P9, DOI 10.3318/BIOE.2005.105.1.9; Lyons DO, 2004, J MAR BIOL ASSOC UK, V84, P461, DOI 10.1017/S0025315404009452h; McCoy EE, 2001, MOL ECOL, V10, P1793, DOI 10.1046/j.0962-1083.2001.01320.x; Mills SC, 2007, P ROY SOC B-BIOL SCI, V274, P143, DOI 10.1098/rspb.2006.3639; Monteiro N, 2001, J MAR BIOL ASSOC UK, V81, P1031, DOI 10.1017/S002531540100501X; Monteiro NM, 2006, J FISH BIOL, V69, P66, DOI 10.1111/j.0022-1112.2006.01064.x; Monteiro N.M., 2002, Acta Ethologica, V5, P39, DOI 10.1007/s10211-002-0060-7; Monteiro NM, 2005, ESTUAR COAST SHELF S, V63, P93, DOI 10.1016/j.ecss.2004.10.012; Monteiro NM, 2005, J FISH BIOL, V67, P1475, DOI 10.1111/j.0022-1112.2005.00818.x; Monteiro NM, 2003, J MAR BIOL ASSOC UK, V83, P1179, DOI 10.1017/S0025315403008452h; Monteiro Nuno, 2002, Acta Ethologica, V4, P109; Reaney LT, 2007, BEHAV ECOL SOCIOBIOL, V61, P1515, DOI 10.1007/s00265-007-0383-5; Rispoli VF, 2008, J EVOLUTION BIOL, V21, P30, DOI 10.1111/j.1420-9101.2007.01470.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Silva K, 2008, J ANIM ECOL, V77, P390, DOI 10.1111/j.1365-2656.2007.01346.x; Silva K, 2007, ANIM BEHAV, V74, P1525, DOI 10.1016/j.anbehav.2007.03.008; Silva K, 2010, ANIM BEHAV, V79, P885, DOI 10.1016/j.anbehav.2010.01.001; Silva K, 2009, BEHAV ECOL, V20, P768, DOI 10.1093/beheco/arp058; Sogabe A, 2011, J FISH BIOL, V78, P1833, DOI 10.1111/j.1095-8649.2011.02973.x; Spottiswoode CN, 2006, P ROY SOC B-BIOL SCI, V273, P3023, DOI 10.1098/rspb.2006.3688; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Twiss SD, 2007, BIOL LETTERS, V3, P12, DOI 10.1098/rsbl.2006.0559; Vincent A, 1994, BEHAV ECOL SOCIOBIOL, V34, P142; Weir LK, 2011, AM NAT, V177, P167, DOI 10.1086/657918; West PM, 2002, SCIENCE, V297, P1339, DOI 10.1126/science.1073257; Wilson AB, 2009, MOL ECOL, V18, P1263, DOI 10.1111/j.1365-294X.2009.04084.x; Zuo WY, 2012, P ROY SOC B-BIOL SCI, V279, P1840, DOI 10.1098/rspb.2011.2000	42	16	16	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44251	10.1371/journal.pone.0044251	http://dx.doi.org/10.1371/journal.pone.0044251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952940	gold, Green Published, Green Submitted			2022-12-27	WOS:000308044800101
J	Rolfe, PA; Bernstein, DA; Grisafi, P; Fink, GR; Gifford, DK				Rolfe, P. Alexander; Bernstein, Douglas A.; Grisafi, Paula; Fink, Gerald R.; Gifford, David K.			Ruler Arrays Reveal Haploid Genomic Structural Variation	PLOS ONE			English	Article							COPY NUMBER; DNA; POLYMORPHISMS; HYBRIDIZATION; DELETIONS; REPEATS; DISEASE; GENE	Despite the known relevance of genomic structural variants to pathogen behavior, cancer, development, and evolution, certain repeat based structural variants may evade detection by existing high-throughput techniques. Here, we present ruler arrays, a technique to detect genomic structural variants including insertions and deletions (indels), duplications, and translocations. A ruler array exploits DNA polymerase's processivity to detect physical distances between defined genomic sequences regardless of the intervening sequence. The method combines a sample preparation protocol, tiling genomic microarrays, and a new computational analysis. The analysis of ruler array data from two genomic samples enables the identification of structural variation between the samples. In an empirical test between two closely related haploid strains of yeast ruler arrays detected 78% of the structural variants larger than 100 bp.	[Rolfe, P. Alexander; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Bernstein, Douglas A.; Grisafi, Paula; Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Rolfe, PA (corresponding author), Pathogenica Inc, Boston, MA 02109 USA.	gfink@wi.mit.edu; gifford@mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	American Cancer Society [PF-09-072-01-MBC]; United States National Institutes of Health [R01GM069676]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069676] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DAB is funded by the American Cancer Society grant PF-09-072-01-MBC. PAR and DKG were funded by United States National Institutes of Health grant R01GM069676 to DKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aradhya S, 2007, AM J MED GENET A, V143A, P1431, DOI 10.1002/ajmg.a.31773; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Brandstrom M, 2007, GENETICS, V176, P1691, DOI 10.1534/genetics.107.070805; CHA JHJ, 1994, LIFE SCI, V54, P1459, DOI 10.1016/0024-3205(94)90012-4; Chen XN, 1998, AM J HUM GENET, V63, P625, DOI 10.1086/301973; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Engert JC, 2007, EUR J HUM GENET; FEENER CA, 1991, AM J HUM GENET, V48, P621; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Johnston M, 1997, NATURE, V387, P87, DOI 10.1038/387s087; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kraus J, 1997, HUM GENET, V99, P374, DOI 10.1007/s004390050375; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Rouchleau E, 2007, CLIN GENET, V72, P199; Salathia N, 2007, PLANT J, V51, P727, DOI 10.1111/j.1365-313X.2007.03194.x; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Shen MH, 2007, CLIN GENET, V72, P238, DOI 10.1111/j.1399-0004.2007.00858.x; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vogler AJ, 2006, J BACTERIOL, V188, P4253, DOI 10.1128/JB.00001-06; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Williams RM, 2002, J IND MICROBIOL BIOT, V28, P186, DOI 10.1038/sj/jim/7000200	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43210	10.1371/journal.pone.0043210	http://dx.doi.org/10.1371/journal.pone.0043210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952647	gold, Green Published, Green Submitted			2022-12-27	WOS:000308044800022
J	Su, XY; Zhang, J; Mackie, RI; Cann, IKO				Su, Xiaoyun; Zhang, Jing; Mackie, Roderick I.; Cann, Isaac K. O.			Supplementing with Non-Glycoside Hydrolase Proteins Enhances Enzymatic Deconstruction of Plant Biomass	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; CALDICELLULOSIRUPTOR-BESCII; HYDROLYSIS; ENZYMES; CELLULASE; THERMOPHILUM; BINDING	The glycoside hydrolases (GH) of Caldicellulosiruptor bescii are thermophilic enzymes, and therefore they can hydrolyze plant cell wall polysaccharides at high temperatures. Analyses of two C. bescii glycoside hydrolases, CbCelA-TM1 and CbXyn10A with cellulase and endoxylanase activity, respectively, demonstrated that each enzyme is highly thermostable under static incubation at 70 degrees C. Both enzymes, however, rapidly lost their enzymatic activities when incubated at 70 degrees C with end-over-end shaking. Since crowding conditions, even at low protein concentrations, seem to influence enzymatic properties, three non-glycoside hydrolase proteins were tested for their capacity to stabilize the thermophilic proteins at high temperatures. The three proteins investigated were a small heat shock protein CbHsp18 from C. bescii, a histone MkHistone1 from Methanopyrus kandleri, and bovine RNase A, from a commercial source. Fascinatingly, each of these proteins increased the thermostability of the glycoside hydrolases at 70 degrees C during end-over-end shaking incubation, and this property translated into increases in hydrolysis of several substrates including the bioenergy feedstock Miscanthus. Furthermore, MkHistone1 and RNase A also altered the initial products released from the cello-oligosaccharide cellopentaose during hydrolysis with the cellodextrinase CbCdx1A, which further demonstrated the capacity of the three non-GH proteins to influence hydrolysis of substrates by the thermophilic glycoside hydrolases. The non-GH proteins used in the present report were small proteins derived from each of the three lineages of life, and therefore expand the space from which different polypeptides can be tested for their influence on plant cell wall hydrolysis, a critical step in the emerging biofuel industry.	[Su, Xiaoyun; Zhang, Jing; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Su, Xiaoyun; Zhang, Jing; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Zhang, Jing; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Su, XY (corresponding author), Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA.	icann@illinois.edu			Energy Biosciences Institute	Energy Biosciences Institute	This work was funded by the Energy Biosciences Institute, Discovery and Characterization of Hydrolytic Enzymes to Improve Biocatalysis and Conversion of Plant Cell Wall Polysaccharides to Biofuels Program at the University of Illinois, Urbana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; Borjesson J, 2007, ENZYME MICROB TECH, V41, P186, DOI 10.1016/j.enzmictec.2007.01.003; CavacoPaulo A, 1996, TEXT RES J, V66, P287, DOI 10.1177/004051759606600501; CAVACOPAULO A, 1994, BIOCATALYSIS, V10, P353, DOI 10.3109/10242429409065244; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Han YJ, 2007, ENZYME MICROB TECH, V41, P638, DOI 10.1016/j.enzmictec.2007.05.012; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Han YJ, 2010, BIOCHEM ENG J, V48, P218, DOI 10.1016/j.bej.2009.10.013; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hu ZH, 2008, BIOCHEM ENG J, V38, P369, DOI 10.1016/j.bej.2007.08.001; Iakiviak M, 2011, APPL ENVIRON MICROB, V77, P7541, DOI 10.1128/AEM.06088-11; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kim R, 1998, P NATL ACAD SCI USA, V95, P9129, DOI 10.1073/pnas.95.16.9129; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; KURR M, 1991, ARCH MICROBIOL, V156, P239, DOI 10.1007/BF00262992; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Lochner A, 2011, APPL ENVIRON MICROB, V77, P4042, DOI 10.1128/AEM.02811-10; Ma H, 2009, BIORESOURCE TECHNOL, V100, P1279, DOI 10.1016/j.biortech.2008.08.045; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; REESE ET, 1980, BIOTECHNOL BIOENG, V22, P323, DOI 10.1002/bit.260220207; Reeve JN, 1997, CELL, V89, P999, DOI 10.1016/S0092-8674(00)80286-X; Samaniuk JR, 2011, BIORESOURCE TECHNOL, V102, P4489, DOI 10.1016/j.biortech.2010.11.117; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Su X, 2012, APPL ENV MICROBIOL, DOI 101128/AEM06814-11; Tarasov SG, 2011, P NATL ACAD SCI USA, V108, P9798, DOI 10.1073/pnas.1014598108; Te'o VSJ, 2000, FEMS MICROBIOL LETT, V190, P13, DOI 10.1016/S0378-1097(00)00308-6; Tengborg C, 2001, BIOTECHNOL PROGR, V17, P110, DOI 10.1021/bp000145+; Totani K, 2008, J AM CHEM SOC, V130, P2101, DOI 10.1021/ja077570k; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Yang B, 2006, BIOTECHNOL BIOENG, V94, P611, DOI 10.1002/bit.20750; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871; Zverlov V, 1998, MICROBIOL-SGM, V144, P457, DOI 10.1099/00221287-144-2-457	39	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43828	10.1371/journal.pone.0043828	http://dx.doi.org/10.1371/journal.pone.0043828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952777	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800063
J	Tamaru, A; Nakajima, C; Wada, T; Wang, YJ; Inoue, M; Kawahara, R; Maekura, R; Ozeki, Y; Ogura, H; Kobayashi, K; Suzuki, Y; Matsumoto, S				Tamaru, Aki; Nakajima, Chie; Wada, Takayuki; Wang, Yajun; Inoue, Manabu; Kawahara, Ryuji; Maekura, Ryoji; Ozeki, Yuriko; Ogura, Hisashi; Kobayashi, Kazuo; Suzuki, Yasuhiko; Matsumoto, Sohkichi			Dominant Incidence of Multidrug and Extensively Drug-Resistant Specific Mycobacterium tuberculosis Clones in Osaka Prefecture, Japan	PLOS ONE			English	Article							RIFAMPIN RESISTANCE; BEIJING FAMILY; EAST-ASIA; GENOTYPE; TRANSMISSION; FITNESS; STRAINS	Infection and transmission of multidrug-resistant Mycobacterium tuberculosis (MDR-Mtb) and extensively drug-resistant M. tuberculosis (XDR-Mtb) is a serious health problem. We analyzed a total of 1,110 Mtb isolates in Osaka Prefecture and neighboring areas from April 2000 to March 2009. A total of 89 MDR-Mtb were identified, 36 (48.5%) of which were determined to be XDR-Mtb. Among the 89 MDR-Mtb isolates, 24 (27.0%) phylogenetically distributed into six clusters based on mycobacterial interspersed repetitive units-various number of tandem repeats (MIRU-VNTR) typing. Among these six clusters, the MIRU-VNTR patterns of four (OM-V02, OM-V03, OM-V04, and OM-V06) were only found for MDR-Mtb. Further analysis revealed that all isolates belonging to OM-V02 and OM-V03, and two isolates from OM-V04 were clonal. Importantly such genotypes were not observed for drug-sensitive isolates. These suggest that few but transmissible clones can transmit after acquiring multidrug resistance and colonize even in a country with a developed, well-organized healthcare system.	[Tamaru, Aki; Kawahara, Ryuji] Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka 537, Japan; [Tamaru, Aki; Wang, Yajun; Inoue, Manabu; Matsumoto, Sohkichi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 558, Japan; [Nakajima, Chie; Suzuki, Yasuhiko] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan; [Wada, Takayuki] Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Osaka 543, Japan; [Maekura, Ryoji] Natl Toneyama Hosp, Natl Hosp Org, Dept Internal Med, Toyonaka, Osaka, Japan; [Ozeki, Yuriko] Sonoda Womens Univ, Dept Food & Nutr, Amagasaki, Hyogo, Japan; [Ogura, Hisashi] Osaka City Univ, Grad Sch Med, Dept Virol, Osaka 558, Japan; [Kobayashi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Shinjyuku Ku, Tokyo, Japan; [Suzuki, Yasuhiko] Japan Int Cooperat Agcy Sci & Technol Res Partner, Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo, Japan	Osaka Prefectural Institute of Public Health; Osaka Metropolitan University; Hokkaido University; Osaka Metropolitan University; National Institute of Infectious Diseases (NIID); Japan Science & Technology Agency (JST)	Tamaru, A (corresponding author), Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka 537, Japan.	tamaru@iph.pref.osaka.jp	Nakajima, Chie/A-5020-2012; Suzuki, Yasuhiko/F-6890-2012	Matsumoto, Sohkichi/0000-0002-6106-7538	Ministry of Health, Labour and Welfare (Research on Emerging and Reemerging Infectious Diseases, Health Sciences Research Grants); Osaka City University; United States-Japan Cooperative Medical Science Programs; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24590651] Funding Source: KAKEN	Ministry of Health, Labour and Welfare (Research on Emerging and Reemerging Infectious Diseases, Health Sciences Research Grants); Osaka City University; United States-Japan Cooperative Medical Science Programs; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Health, Labour and Welfare (Research on Emerging and Reemerging Infectious Diseases, Health Sciences Research Grants) to AT, TW, KK and SM, and a grant from Osaka City University to SM, RM and AT, by a grant from United States-Japan Cooperative Medical Science Programs, by the Global Center of Excellence Program, "Establishment of International Collaboration Centers for Zoonosis Control", Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, by Grants-in-Aid for the Program of Founding Research Center for Emerging and Re-emerging Infectious Diseases from MEXT to YS as well as by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science to YS and CN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Jain A, 2008, J BIOSCIENCES, V33, P605, DOI 10.1007/s12038-008-0078-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Kubica T, 2004, INT J TUBERC LUNG D, V8, P1107; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Masjedi MR, 2006, CLIN INFECT DIS, V43, P841, DOI 10.1086/507542; Ministry of Health Labour and Welfare, 2011, STAT AIDS 2010; Ministry of Health Labour and Welfare, 2011, STAT TUB 2010; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Murase Y, 2010, EMERG INFECT DIS, V16, P948, DOI 10.3201/eid1606.091844; O'Sullivan DM, 2010, J MED MICROBIOL, V59, P1533, DOI 10.1099/jmm.0.019091-0; PLIKAYTIS BB, 1994, J CLIN MICROBIOL, V32, P1542, DOI 10.1128/JCM.32.6.1542-1546.1994; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shah NS, 2009, JAMA-J AM MED ASSOC, V300, P2153; Sun YJ, 2007, INT J TUBERC LUNG D, V11, P436; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Ti T, 2006, INT J TUBERC LUNG D, V10, P1111; Tuberculosis Research Committee (Ryoken), 2002, KEKKAKU, V82, P155; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Vazquez-Gallardo R, 2007, INT J TUBERC LUNG D, V11, P429; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC	31	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42505	10.1371/journal.pone.0042505	http://dx.doi.org/10.1371/journal.pone.0042505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952596	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300006
J	Wang, JJ; Chen, SZ; Zhang, C; Stegeman, S; Pfaff-Amesse, T; Zhang, Y; Zhang, WF; Amesse, L; Chen, YF				Wang, Jinju; Chen, Shuzhen; Zhang, Cheng; Stegeman, Samantha; Pfaff-Amesse, Teresa; Zhang, Ying; Zhang, Wenfeng; Amesse, Lawrence; Chen, Yanfang			Human Endometrial Stromal Stem Cells Differentiate into Megakaryocytes with the Ability to Produce Functional Platelets	PLOS ONE			English	Article							BLOOD CD34(+) CELLS; IN-VITRO; GENERATION; TRANSFUSION; THROMBOCYTOPENIA; CONCENTRATE; PROGENITORS; MECHANISMS; EXPRESSION; SURVIVAL	Human endometrium is a high dynamic tissue that contains endometrial stromal stem cells (hESSCs). The hESSCs have been differentiated into a number of cell lineages. However, differentiation of hESSCs into megakaryocytes (MKs) has not yet been investigated. The aim of this study was to investigate the feasibility of MK generation from hESSCs and subsequent production of functional platelets (PLTs). In our study, hESSCs were cultured from endometrial stromal cells as confirmed by positive stromal cell specific markers (CD90 and CD29) and negative hematopoietic stem cell markers (CD45 and CD34) expression. Then, hESSCs were differentiated in a medium supplemented with thrombopoietin (TPO) for 18 days. The MK differentiation was analyzed by flow cytometry and confocal microscopy. The differentiation medium was collected for PLT production analysis by flow cytometry, transmission electron microscopy and functional measurements. Our results show: 1) MKs were successfully generated from hESSCs as identified by expression of specific markers (CD41a: 1 +/- 0.09% and 39 +/- 3.0%; CD42b: 1.2 +/- 0.06% and 28 +/- 2.0%, control vs. differentiation) accompanied with reduction of pluripotent transcription factors (Oct4 and Sox2) expression; 2) The level of PLTs in the differentiation medium was 16 +/- 1 number/mu l as determined by size (2-4 mu m) and CD41a expression (CD41a: 1 +/- 0.4% and 90 +/- 2.0%, control vs. differentiation); 3) Generated PLTs were functional as evidenced by the up-regulation of CD62p expression and fibrinogen binding following thrombin stimulation; 4) Released PLTs showed similar ultra-structure characteristics (alpha granules, vacuoles and dense tubular system) as PLTs from peripheral blood determined by electron microscopic analysis. Data demonstrate the feasibility of generating MKs from hESSCs, and that the generated MKs release functional PLTs. Therefore, hESSCs could be a potential new stem cell source for in vitro MK/PLT production.	[Wang, Jinju; Chen, Shuzhen; Zhang, Cheng; Stegeman, Samantha; Zhang, Wenfeng; Chen, Yanfang] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Pfaff-Amesse, Teresa; Amesse, Lawrence] Wright State Univ, Boonshoft Sch Med, Dept Obstet & Gynecol, Dayton, OH USA; [Zhang, Ying] Guangdong Med Coll, Affiliated Hosp, Dept Obstet & Gynecol, Zhanjiang, Guangdong, Peoples R China	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton; Guangdong Medical University	Wang, JJ (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA.	yanfang.chen@wright.edu		chen, shuzhen/0000-0001-5709-9978; Wang, Jinju/0000-0003-1210-7676	National Institutes of Health (NIH) [HL098637]; Wright State University Boonshoft School of Medicine Emerging Science Seed Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098637] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wright State University Boonshoft School of Medicine Emerging Science Seed Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) HL098637 (YC) and Wright State University Boonshoft School of Medicine Emerging Science Seed Grant (LA and YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumberg N, 2008, LEUKEMIA, V22, P631, DOI 10.1038/sj.leu.2404920; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; CHOI ES, 1995, BLOOD, V85, P402; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fujimoto TT, 2003, BLOOD, V102, P4044, DOI 10.1182/blood-2003-06-1773; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Gaur M, 2006, J THROMB HAEMOST, V4, P436, DOI 10.1111/j.1538-7836.2006.01744.x; Kanbur Nuray O, 2003, Int J Adolesc Med Health, V15, P161; Kaushansky Kenneth, 2009, Hematology Am Soc Hematol Educ Program, P147, DOI 10.1182/asheducation-2009.1.147; Matsubara Y, 2009, BIOCHEM BIOPH RES CO, V378, P716, DOI 10.1016/j.bbrc.2008.11.117; Matsunaga T, 2006, STEM CELLS, V24, P2877, DOI 10.1634/stemcells.2006-0309; Matthai C, 2006, MOL HUM REPROD, V12, P7, DOI 10.1093/molehr/gah254; Mattia G, 2002, BLOOD, V99, P888, DOI 10.1182/blood.V99.3.888; Nevo S, 2007, TRANSFUSION, V47, P1700, DOI 10.1111/j.1537-2995.2007.01345.x; Nishikii H, 2008, J EXP MED, V205, P1917, DOI 10.1084/jem.20071482; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Proulx C, 2003, J HEMATOTH STEM CELL, V12, P179, DOI 10.1089/152581603321628322; Santamaria X, 2011, MOL THER, V19, P2065, DOI 10.1038/mt.2011.173; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Shim MH, 2004, EXP HEMATOL, V32, P638, DOI 10.1016/j.exphem.2004.04.002; Stephan F, 1999, CHEST, V115, P1363, DOI 10.1378/chest.115.5.1363; Stevens WT, 2006, TRANSFUSION, V46, P649, DOI 10.1111/j.1537-2995.2006.00760.x; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Ungerer M, 2004, CIRC RES, V95, pE36, DOI 10.1161/01.RES.0000141700.96085.2e; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Wolff EF, 2007, REPROD SCI, V14, P524, DOI 10.1177/1933719107306896; Wolff EF, 2011, J CELL MOL MED, V15, P747, DOI 10.1111/j.1582-4934.2010.01068.x	30	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44300	10.1371/journal.pone.0044300	http://dx.doi.org/10.1371/journal.pone.0044300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952951	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300077
J	Fogli, A; Merle, C; Roussel, V; Schiffmann, R; Ughetto, S; Theisen, M; Boespflug-Tanguy, O				Fogli, Anne; Merle, Christine; Roussel, Veronique; Schiffmann, Raphael; Ughetto, Sylvie; Theisen, Manfred; Boespflug-Tanguy, Odile			CSF N-Glycan Profiles to Investigate Biomarkers in Brain Developmental Disorders: Application to Leukodystrophies Related to eIF2B Mutations	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; CONGENITAL DISORDERS; SERUM; GLYCOSYLATION; ASIALOTRANSFERRIN; IDENTIFICATION; PROTEINS; ATAXIA	Background: Primary or secondary abnormalities of glycosylation have been reported in various brain diseases. Decreased asialotransferrin to sialotransferrin ratio in cerebrospinal fluid (CSF) is a diagnostic marker of leukodystrophies related to mutations of genes encoding translation initiation factor, EIF2B. We investigated the CSF glycome of eIF2B-mutated patients and age-matched normal individuals in order to further characterize the glycosylation defect for possible use as a biomarker. Methodology/Principal Findings: We conducted a differential N-glycan analysis using MALDI-TOF/MS of permethylated N-glycans in CSF and plasma of controls and eIF2B-mutated patients. We found in control CSF that tri-antennary/bisecting and high mannose structures were highly represented in samples obtained between 1 to 5 years of age, whereas fucosylated, sialylated structures were predominant at later age. In CSF, but not in plasma, of eIF2B-mutated patient samples, we found increased relative intensity of bi-antennary structures and decreased tri-antennary/bisecting structures in N-glycan profiles. Four of these structures appeared to be biomarker candidates of glycomic profiles of eIF2B-related disorders. Conclusion: Our results suggest a dynamic development of normal CSF N-glycan profiles from high mannose type structures to complex sialylated structures that could be correlated with postnatal brain maturation. CSF N-glycome analysis shows relevant quantitative changes associated with eIF2B related disorders. This approach could be applied to other neurological disorders involving developmental gliogenesis/synaptogenesis abnormalities.	[Fogli, Anne; Boespflug-Tanguy, Odile] CNRS 6247, Lab GReD, Fac Med, UMR,INSERM,U931, Clermont Ferrand, France; [Fogli, Anne] CHU Clermont Ferrand, Serv Biochim Med, Clermont Ferrand, France; [Merle, Christine; Roussel, Veronique; Theisen, Manfred] Biopole Clermont Limagne, Proteodynamics, St Beauzire, France; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Ughetto, Sylvie] CHU Clermont Ferrand, Dept Med Informat, Clermont Ferrand, France; [Boespflug-Tanguy, Odile] Hop Robert Debre, AP HP, Serv Neuropediat & Malad Metab, Ctr Reference Leucodystrophies, F-75019 Paris, France; [Boespflug-Tanguy, Odile] Univ Paris Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; Baylor Scott & White Health; Baylor University Medical Center; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fogli, A (corresponding author), CNRS 6247, Lab GReD, Fac Med, UMR,INSERM,U931, Clermont Ferrand, France.	anne.fogli@inserm.u-clermont1.fr	Fogli, Anne/AAL-6640-2020	Fogli, Anne/0000-0002-2651-7441	European Leukodystrophy Association (ELA) research foundation; "Leukotreat" European consortium, FP7-Heath program [241622]	European Leukodystrophy Association (ELA) research foundation; "Leukotreat" European consortium, FP7-Heath program	This work was supported by grants of the European Leukodystrophy Association (ELA) research foundation and the "Leukotreat" European consortium supported by the FP7-Heath program (FP7#241622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2006, J PROTEOME RES, V5, P1626, DOI 10.1021/pr060010k; Boespflug-Tanguy O, 2008, CURR NEUROL NEUROSCI, V8, P217, DOI 10.1007/s11910-008-0034-x; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; Dastych M, 2010, SCAND J CLIN LAB INV, V70, P87, DOI 10.3109/00365510903521559; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Geva M, 2010, BRAIN, V133, P2448, DOI 10.1093/brain/awq180; Goetz JA, 2009, GLYCOCONJUGATE J, V26, P117, DOI 10.1007/s10719-008-9170-4; Goldman R, 2009, CLIN CANCER RES, V15, P1808, DOI 10.1158/1078-0432.CCR-07-5261; Guillard M, 2011, CLIN CHEM, V57, P593, DOI 10.1373/clinchem.2010.153635; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kyselova Z, 2008, CLIN CHEM, V54, P1166, DOI 10.1373/clinchem.2007.087148; Kyselova Z, 2007, J PROTEOME RES, V6, P1822, DOI 10.1021/pr060664t; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Mechref Y, 2009, J PROTEOME RES, V8, P2656, DOI 10.1021/pr8008385; Morelle W, 2007, NAT PROTOC, V2, P1585, DOI 10.1038/nprot.2007.227; PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731; Quarles RH, 1997, J MOL NEUROSCI, V8, P1, DOI 10.1007/BF02736858; Rakotomalala R., 2005, ACTES EGC 2005 RNTI; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Sinha A, 2009, CLIN CHIM ACTA, V400, P14, DOI 10.1016/j.cca.2008.09.026; Stanta JL, 2010, J PROTEOME RES, V9, P4476, DOI 10.1021/pr1002356; Tang ZQ, 2010, J PROTEOME RES, V9, P104, DOI 10.1021/pr900397n; Taniguchi M, 2008, DEMENT GERIATR COGN, V26, P117, DOI 10.1159/000147479; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; Vanderver A, 2008, NEUROLOGY, V70, P2226, DOI 10.1212/01.wnl.0000313857.54398.0e; Vanderver A, 2005, CLIN CHEM, V51, P2031, DOI 10.1373/clinchem.2005.055053; Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556; Vanhooren V, 2010, EXP GERONTOL, V45, P738, DOI 10.1016/j.exger.2010.08.009; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086	33	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42688	10.1371/journal.pone.0042688	http://dx.doi.org/10.1371/journal.pone.0042688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952606	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000009
J	Krawetz, RJ; Wu, YE; Martin, L; Rattner, JB; Matyas, JR; Hart, DA				Krawetz, Roman J.; Wu, Yiru Elizabeth; Martin, Liam; Rattner, Jerome B.; Matyas, John R.; Hart, David A.			Synovial Fluid Progenitors Expressing CD90+from Normal but Not Osteoarthritic Joints Undergo Chondrogenic Differentiation without Micro-Mass Culture	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PARTIAL-THICKNESS DEFECTS; STROMAL CELLS; AGGREGATION; CLUSTERS; CRITERIA; THERAPY; REPAIR	Objective: Mesenchymal progenitor cells (MPCs) can differentiate into osteoblasts, adipocytes, and chondrocytes, and are in part responsible for maintaining tissue integrity. Recently, a progenitor cell population has been found within the synovial fluid that shares many similarities with bone marrow MPCs. These synovial fluid MPCs (sfMPCs) share the ability to differentiate into bone and fat, with a bias for cartilage differentiation. In this study, sfMPCs were isolated from human and canine synovial fluid collected from normal individuals and those with osteoarthritis (human: clinician-diagnosed, canine: experimental) to compare the differentiation potential of CD90+ vs. CD90- sfMPCs, and to determine if CD90 (Thy-1) is a predictive marker of synovial fluid progenitors with chondrogenic capacity in vitro. Methods: sfMPCs were derived from synovial fluid from normal and OA knee joints. These cells were induced to differentiate into chondrocytes and analyzed using quantitative PCR, immunofluorescence, and electron microscopy. Results: The CD90+ subpopulation of sfMPCs had increased chondrogenic potential compared to the CD90- population. Furthermore, sfMPCs derived from healthy joints did not require a micro-mass step for efficient chondrogenesis. Whereas sfMPCs from OA synovial fluid retain the ability to undergo chondrogenic differentiation, they require micro-mass culture conditions. Conclusions: Overall, this study has demonstrated an increased chondrogenic potential within the CD90+ fraction of human and canine sfMPCs and that this population of cells derived from healthy normal joints do not require a micro-mass step for efficient chondrogenesis, while sfMPCs obtained from OA knee joints do not differentiate efficiently into chondrocytes without the micro-mass procedure. These results reveal a fundamental shift in the chondrogenic ability of cells isolated from arthritic joint fluids, and we speculate that the mechanism behind this change of cell behavior is exposure to the altered milieu of the OA joint fluid, which will be examined in further studies.	[Krawetz, Roman J.; Wu, Yiru Elizabeth; Hart, David A.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Krawetz, Roman J.; Rattner, Jerome B.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada; [Martin, Liam] Univ Calgary, Dept Med, Calgary, AB, Canada; [Matyas, John R.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Krawetz, RJ (corresponding author), Univ Calgary, Dept Surg, Calgary, AB, Canada.	rkrawetz@ucalgary.ca		Wu, Elizabeth/0000-0002-0660-9306	Pfizer; Alberta Innovates-Health Solutions; Canadian Institutes for Health Research [MOP 79384]; Pfizer Inc.	Pfizer(Pfizer); Alberta Innovates-Health Solutions; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer Inc.(Pfizer)	This study was supported by research grants from Pfizer, Alberta Innovates-Health Solutions team grant in osteoarthritis, and Canadian Institutes for Health Research (MOP 79384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interest: This study was partly funded by Pfizer Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030; Ando W, 2008, TISSUE ENG PT A, V14, P2041, DOI 10.1089/ten.tea.2008.0015; Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015; Barker TH, 2009, BBA-MOL CELL RES, V1793, P921, DOI 10.1016/j.bbamcr.2008.10.004; Bradley EW, 2011, J CELL PHYSIOL, V226, P1683, DOI 10.1002/jcp.22499; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fan JB, 2009, TISSUE ENG PART B-RE, V15, P75, DOI 10.1089/ten.teb.2008.0586; Gao F, 2008, TRANSL RES, V151, P293, DOI 10.1016/j.trsl.2008.03.003; Gigout A, 2008, J BIOL CHEM, V283, P31522, DOI 10.1074/jbc.M804234200; Han HS, 2010, J ORTHOP RES, V28, P1283, DOI 10.1002/jor.21129; Heng B, 2008, CYTOTECHNOLOGY, V58, P69, DOI 10.1007/s10616-008-9174-8; Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616; Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Jones E, 2010, ANN RHEUM DIS, V69, P450, DOI 10.1136/ard.2008.106435; Jones EA, 2008, ARTHRITIS RHEUM-US, V58, P1731, DOI 10.1002/art.23485; Kanamoto Takashi, 2008, Clin Calcium, V18, P1744, DOI CliCa081217441749; Koelling S, 2009, EXPERT OPIN BIOL TH, V9, P1399, DOI 10.1517/14712590903246370; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460; Kurth TB, 2011, ARTHRITIS RHEUM-US, V63, P1289, DOI 10.1002/art.30234; Lim JJ, 2011, BIOTECHNOL BIOENG, V108, P151, DOI 10.1002/bit.22909; Lorda-Diez CI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024546; Luo WJ, 2008, EXP CELL RES, V314, P3382, DOI 10.1016/j.yexcr.2008.07.003; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; McGonagle D, 2008, RHEUMATOLOGY, V47, P1114, DOI 10.1093/rheumatology/ken236; Morito T, 2008, RHEUMATOLOGY, V47, P1137, DOI 10.1093/rheumatology/ken114; Nagase T, 2008, ARTHRITIS RHEUM, V58, P1389, DOI 10.1002/art.23418; Okura H, 2010, TISSUE ENG PART C-ME, V16, P761, DOI [10.1089/ten.tec.2009.0208, 10.1089/ten.TEC.2009.0208]; P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Wei CJ, 2006, J CELL PHYSIOL, V206, P322, DOI 10.1002/jcp.20459	34	46	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43616	10.1371/journal.pone.0043616	http://dx.doi.org/10.1371/journal.pone.0043616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952721	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206000044
J	Schurgers, LJ; Joosen, IA; Laufer, EM; Chatrou, MLL; Herfs, M; Winkens, MHM; Westenfeld, R; Veulemans, V; Krueger, T; Shanahan, CM; Jahnen-Dechent, W; Biessen, E; Narula, J; Vermeer, C; Hofstra, L; Reutelingsperger, CP				Schurgers, Leon J.; Joosen, Ivo A.; Laufer, Eduard M.; Chatrou, Martijn L. L.; Herfs, Marjolein; Winkens, Mark H. M.; Westenfeld, Ralf; Veulemans, Verena; Krueger, Thilo; Shanahan, Catherine M.; Jahnen-Dechent, Willi; Biessen, Erik; Narula, Jagat; Vermeer, Cees; Hofstra, Leonard; Reutelingsperger, Chris P.			Vitamin K-Antagonists Accelerate Atherosclerotic Calcification and Induce a Vulnerable Plaque Phenotype	PLOS ONE			English	Article							MATRIX GLA-PROTEIN; SMOOTH-MUSCLE-CELLS; CORONARY-ARTERY CALCIUM; BONE MORPHOGENETIC PROTEINS; VASCULAR CALCIFICATION; INTIMAL CALCIFICATION; MYOCARDIAL-INFARCTION; PHOSPHATE CRYSTALS; ENDOTHELIAL-CELLS; PROGNOSTIC VALUE	Background: Vitamin K-antagonists (VKA) are treatment of choice and standard care for patients with venous thrombosis and thromboembolic risk. In experimental animal models as well as humans, VKA have been shown to promote medial elastocalcinosis. As vascular calcification is considered an independent risk factor for plaque instability, we here investigated the effect of VKA on coronary calcification in patients and on calcification of atherosclerotic plaques in the ApoE(-/-) model of atherosclerosis. Methodology/Principal Findings: A total of 266 patients (133 VKA users and 133 gender and Framingham Risk Score matched non-VKA users) underwent 64-slice MDCT to assess the degree of coronary artery disease (CAD). VKA-users developed significantly more calcified coronary plaques as compared to non-VKA users. ApoE(-/-) mice (10 weeks) received a Western type diet (WTD) for 12 weeks, after which mice were fed a WTD supplemented with vitamin K-1 (VK1, 1.5 mg/g) or vitamin K-1 and warfarin (VK1 & W; 1.5 mg/g & 3.0 mg/g) for 1 or 4 weeks, after which mice were sacrificed. Warfarin significantly increased frequency and extent of vascular calcification. Also, plaque calcification comprised microcalcification of the intimal layer. Furthermore, warfarin treatment decreased plaque expression of calcification regulatory protein carboxylated matrix Gla-protein, increased apoptosis and, surprisingly outward plaque remodeling, without affecting overall plaque burden. Conclusions/Significance: VKA use is associated with coronary artery plaque calcification in patients with suspected CAD and causes changes in plaque morphology with features of plaque vulnerability in ApoE(-/-) mice. Our findings underscore the need for alternative anticoagulants that do not interfere with the vitamin K cycle.	[Schurgers, Leon J.; Chatrou, Martijn L. L.; Reutelingsperger, Chris P.] Maastricht Univ, Med Ctr, Dept Biochem, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Joosen, Ivo A.; Laufer, Eduard M.; Winkens, Mark H. M.; Hofstra, Leonard] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands; [Herfs, Marjolein; Vermeer, Cees] Maastricht Univ, VitaK, Maastricht, Netherlands; [Westenfeld, Ralf; Veulemans, Verena] Univ Hosp Dusseldorf, Div Cardiol, Dusseldorf, Germany; [Krueger, Thilo] Rhein Westfal TH Aachen, Div Nephrol & Clin Immunol, Aachen, Germany; [Shanahan, Catherine M.] Kings Coll London, Div Cardiovasc, London, England; [Jahnen-Dechent, Willi] Rhein Westfal TH Aachen, Dept Biomed Engn, Aachen, Germany; [Biessen, Erik] Maastricht Univ, Med Ctr, Dept Pathol, Maastricht, Netherlands; [Narula, Jagat] Mt Sinai Sch Med, Dept Cardiol, New York, NY USA; [Hofstra, Leonard] Cardiol Ctr Netherlands, Utrecht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; RWTH Aachen University; University of London; King's College London; RWTH Aachen University; Maastricht University; Icahn School of Medicine at Mount Sinai	Schurgers, LJ (corresponding author), Maastricht Univ, Med Ctr, Dept Biochem, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.	l.schurgers@maastrichtuniversity.nl	Schurgers, Leon/AAT-7100-2021; Jahnen-Dechent, Willi/A-7608-2011	Biessen, Erik/0000-0002-6454-8548; Shanahan, Catherine/0000-0002-8352-8171; Jahnen-Dechent, Willi/0000-0003-1315-4407; Schurgers, Leon/0000-0001-7867-6957; Vermeer, Cees/0000-0002-2300-8561	European Interreg program IVA-VLANED-2.1; British Heart Foundation [RG/11/14/29056] Funding Source: researchfish	European Interreg program IVA-VLANED-2.1; British Heart Foundation(British Heart Foundation)	European research grant as principal investigator from the European Interreg program IVA-VLANED-2.1 was granted to Dr. C. Reutelingsperger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Bouvet C, 2008, ARTERIOSCL THROM VAS, V28, P856, DOI 10.1161/ATVBAHA.107.153056; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Chatrou MLL, 2011, HAMOSTASEOLOGIE, V31, P251, DOI 10.5482/ha-1157; Chatrou MLL, 2012, BLOOD REV, V26, P155, DOI 10.1016/j.blre.2012.03.002; Chen NX, 2010, KIDNEY INT, V77, P436, DOI 10.1038/ki.2009.481; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; D'Andrea G, 2008, BLOOD REV, V22, P127, DOI 10.1016/j.blre.2007.11.004; Detrano R, 1996, J AM COLL CARDIOL, V27, P285, DOI 10.1016/0735-1097(95)00460-2; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Doherty TM, 2004, ENDOCR REV, V25, P629, DOI 10.1210/er.2003-0015; Dumont EAWJ, 2000, CIRCULATION, V102, P1564, DOI 10.1161/01.CIR.102.13.1564; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; El-Maadawy S, 2003, CONNECT TISSUE RES, V44, P272, DOI 10.1080/03008200390181762; Essalihi R, 2003, AM J HYPERTENS, V16, P103, DOI 10.1016/S0895-7061(02)03204-1; Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305; Fujii K, 2005, AM J CARDIOL, V96, P352, DOI 10.1016/j.amjcard.2005.03.074; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Kolodgie Frank D., 2001, Cardiology Clinics, V19, P127, DOI 10.1016/S0733-8651(05)70199-5; Koos R, 2005, AM J CARDIOL, V96, P747, DOI 10.1016/j.amjcard.2005.05.014; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Lutgens E, 1999, CIRCULATION, V99, P276, DOI 10.1161/01.CIR.99.2.276; McCollough CH, 2007, RADIOLOGY, V243, P527, DOI 10.1148/radiol.2432050808; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; Naik V, 2012, CARDIOVASC RES, V94, P545, DOI 10.1093/cvr/cvs126; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; PRICE PA, 1985, J BIOL CHEM, V260, P4971; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185; Rennenberg RJMW, 2010, BLOOD, V115, P5121, DOI 10.1182/blood-2010-01-264598; Roijers RB, 2011, AM J PATHOL, V178, P2879, DOI 10.1016/j.ajpath.2011.02.004; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; Schurgers LJ, 2008, THROMB HAEMOSTASIS, V100, P593, DOI 10.1160/TH08-02-0087; Schurgers LJ, 2007, BLOOD, V109, P2823, DOI 10.1182/blood-2006-07-035345; Schurgers LJ, 2004, BLOOD, V104, P3231, DOI 10.1182/blood-2004-04-1277; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Spronk HMH, 2003, J VASC RES, V40, P531, DOI 10.1159/000075344; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; Weijs B, 2011, EUR HEART J, V32, P2555, DOI 10.1093/eurheartj/ehr226; Yao YC, 2006, J BIOL CHEM, V281, P33921, DOI 10.1074/jbc.M604239200; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200	55	113	115	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43229	10.1371/journal.pone.0043229	http://dx.doi.org/10.1371/journal.pone.0043229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952653	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000027
J	Xu, YQ; Zhang, D; Jin, T; Cai, DJ; Wu, Q; Lu, YF; Liu, J; Klaassen, CD				Xu, Yi-Qiao; Zhang, Dan; Jin, Tao; Cai, Ding-Jun; Wu, Qin; Lu, Yuanfu; Liu, Jie; Klaassen, Curtis D.			Diurnal Variation of Hepatic Antioxidant Gene Expression in Mice	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; MOLECULAR-MECHANISM; CLOCK; GLUTATHIONE; METALLOTHIONEIN; CADMIUM; TIME; TRANSCRIPTION; INFLAMMATION; STRESS	Background: This study was aimed to examine circadian variations of hepatic antioxidant components, including the Nrf2-pathway, the glutathione (GSH) system, antioxidant enzymes and metallothionein in mouse liver. Methods and Results: Adult mice were housed in light-and temperature-controlled facilities for 2 weeks, and livers were collected every 4 h during the 24 h period. Total RNA was isolated, purified, and subjected to real-time RT-PCR analysis. Hepatic mRNA levels of Nrf2, Keap1, Nqo1 and Gclc were higher in the light-phase than the dark-phase, and were female-predominant. Hepatic GSH presented marked circadian fluctuations, along with glutathione S-transferases (GST-alpha 1, GST-mu, GST-pi) and glutathione peroxidase (GPx1). The expressions of GPx1, GST-mu and GST-pi mRNA were also higher in females. Antioxidant enzymes Cu/Zn superoxide dismutase (Sod1), catalase (CAT), cyclooxygenase-2 (Cox-2) and heme oxygenase-1 (Ho-1) showed circadian rhythms, with higher expressions of Cox-2 and CAT in females. Metallothionein, a small nonenzymatic antioxidant protein, showed dramatic circadian variation in males, but higher expression in females. The circadian variations of the clock gene Brain and Muscle Arnt-like Protein-1(Bmal1), albumin site D-binding protein (Dbp), nuclear receptor Rev-Erb alpha (Nr1d1), period protein (Per1 and Per2) and cryptochrome 1(Cry1) were in agreement with the literature. Furthermore, acetaminophen hepatotoxicity is more severe when administered in the afternoon when hepatic GSH was lowest. Conclusions: Circadian variations and gender differences in transcript levels of antioxidant genes exist in mouse liver, which could affect body responses to oxidative stress at different times of the day.	[Xu, Yi-Qiao; Zhang, Dan; Jin, Tao; Wu, Qin; Lu, Yuanfu; Liu, Jie] Zunyi Med Coll, Zunyi, Peoples R China; [Cai, Ding-Jun] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China; [Liu, Jie; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	Zunyi Medical University; Chengdu University of Traditional Chinese Medicine; University of Kansas; University of Kansas Medical Center	Xu, YQ (corresponding author), Zunyi Med Coll, Zunyi, Peoples R China.	JLiu@kumc.edu			National Natural Science Foundation of China [81160415]; Science and Technology Foundation of Guizhou Province [TZJF2009-41, 2010-5, C-453]; Foundation of Zunyi Medical College	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Guizhou Province; Foundation of Zunyi Medical College	This study was supported by National Natural Science Foundation of China (No. 81160415), Science and Technology Foundation of Guizhou Province (No. TZJF2009-41, 2010-5 and C-453) and Foundation of Zunyi Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Bass J, 2011, NATURE, V469, P476, DOI 10.1038/469476a; BellPedersen D, 1996, P NATL ACAD SCI USA, V93, P13096, DOI 10.1073/pnas.93.23.13096; Blanco RA, 2007, AM J CLIN NUTR, V86, P1016, DOI 10.1093/ajcn/86.4.1016; Bozek K, 2010, BIOSYSTEMS, V102, P61, DOI 10.1016/j.biosystems.2010.07.010; Bruckner JV, 2002, J PHARMACOL EXP THER, V300, P273, DOI 10.1124/jpet.300.1.273; Bur IM, 2009, J BIOL CHEM, V284, P9066, DOI 10.1074/jbc.M808360200; CAHILL AL, 1983, ENVIRON RES, V31, P54, DOI 10.1016/0013-9351(83)90061-0; Chen P, 2009, AM J PATHOL, V174, P63, DOI 10.2353/ajpath.2009.080430; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Gachon F, 2011, EXPERT OPIN DRUG MET, V7, P147, DOI 10.1517/17425255.2011.544251; Gadacha W, 2009, REDOX REP, V14, P154, DOI 10.1179/135100009X466131; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; Immenschuh S, 2010, CURR DRUG TARGETS, V11, P1541, DOI 10.2174/1389450111009011541; Inoue N, 1999, XENOBIOTICA, V29, P43, DOI 10.1080/004982599238803; JAESCHKE H, 1985, BIOCHEM PHARMACOL, V34, P1029, DOI 10.1016/0006-2952(85)90606-9; Jang YS, 2011, BIOCHEM BIOPH RES CO, V409, P22, DOI 10.1016/j.bbrc.2011.04.099; Kakan X, 2011, EXP TOXICOL PATHOL, V63, P581, DOI 10.1016/j.etp.2010.04.011; Kang YJ, 2006, EXP BIOL MED, V231, P1459, DOI 10.1177/153537020623100903; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Lim FL, 2006, XENOBIOTICA, V36, P1140, DOI 10.1080/00498250600861819; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Luo C, 2011, MED HYPOTHESES, V77, P174, DOI 10.1016/j.mehy.2011.04.002; Matsunaga N, 2008, HEPATOLOGY, V48, P240, DOI 10.1002/hep.22304; Matsunaga N, 2011, TOXICOLOGY, V280, P144, DOI 10.1016/j.tox.2010.12.005; Matsunaga N, 2009, YAKUGAKU ZASSHI, V129, P1357, DOI 10.1248/yakushi.129.1357; Miura N, 2012, J TOXICOL SCI, V37, P191, DOI 10.2131/jts.37.191; Paschos GK, 2010, ANNU REV PHARMACOL, V50, P187, DOI 10.1146/annurev.pharmtox.010909.105621; Sani M, 2006, COMP BIOCHEM PHYS B, V145, P331, DOI 10.1016/j.cbpb.2006.08.005; SCHNELL RC, 1984, PHARMACOLOGY, V29, P149; Skrzypinska-Gawrysiak M, 2000, Int J Occup Med Environ Health, V13, P165; Skrzypinska-Gawrysiak M, 1995, Int J Occup Med Environ Health, V8, P115; Vina J, 2011, CURR PHARM DESIGN, V17, P3959, DOI 10.2174/138161211798764942; Yamamura Y, 2010, CHRONOBIOL INT, V27, P213, DOI 10.3109/07420521003769111; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003; Zhang YKJ, 2009, DRUG METAB DISPOS, V37, P106, DOI 10.1124/dmd.108.024174	41	73	78	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44237	10.1371/journal.pone.0044237	http://dx.doi.org/10.1371/journal.pone.0044237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952936	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000095
J	Arora, R; del Alcazar, CM; Morrisey, EE; Naiche, LA; Papaioannou, VE				Arora, Ripla; del Alcazar, Chelsea M.; Morrisey, Edward E.; Naiche, L. A.; Papaioannou, Virginia E.			Candidate Gene Approach Identifies Multiple Genes and Signaling Pathways Downstream of Tbx4 in the Developing Allantois	PLOS ONE			English	Article							BETA-CATENIN GENE; EMBRYONIC LETHALITY; MURINE ALLANTOIS; MOUSE EMBRYOS; VASCULAR DEVELOPMENT; DEFECTS; VASCULOGENESIS; HYALURONAN; MESODERM; GROWTH	Loss of Tbx4 results in absence of chorio-allantoic fusion and failure of formation of the primary vascular plexus of the allantois leading to embryonic death at E10.5. We reviewed the literature for genes implicated in chorio-allantoic fusion, cavitation and vascular plexus formation, processes affected in Tbx4 mutant allantoises. Using this candidate gene approach, we identified a number of genes downstream of Tbx4 in the allantois including extracellular matrix molecules Vcan, Has2, and Itga5, transcription factors Snai1 and Twist, and signaling molecules Bmp2, Bmp7, Notch2, Jag1 and Wnt2. In addition, we show that the canonical Wnt signaling pathway contributes to the vessel-forming potential of the allantois. Ex vivo, the Tbx4 mutant phenotype can be rescued using agonists of the Wnt signaling pathway and, in wildtype allantoises, an inhibitor of the canonical Wnt signaling pathway disrupts vascular plexus formation. In vivo, Tbx4 and Wnt2 double heterozygous placentas show decreased vasculature suggesting interactions between Tbx4 and the canonical Wnt signaling pathway in the process of allantois-derived blood vessel formation.	[Arora, Ripla; del Alcazar, Chelsea M.; Papaioannou, Virginia E.] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA; [Morrisey, Edward E.] Univ Penn, Dept Med & Cell & Dev Biol, Philadelphia, PA 19104 USA; [Naiche, L. A.] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA	Columbia University; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Arora, R (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA.	vep1@columbia.edu		Naiche, L. A./0000-0002-5031-4804; Papaioannou, Virginia/0000-0001-7558-8601	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R37HD033082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD033082] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project was supported by grant number R37HD033082 (V. E. P.) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICHD or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Argraves WS, 2005, ANAT REC PART A, V286A, P875, DOI 10.1002/ar.a.20232; Brault V, 2001, DEVELOPMENT, V128, P1253; BROWN JJG, 1993, DEVELOPMENT, V117, P483; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; DAVIS CA, 1993, METHOD ENZYMOL, V225, P502; Downs KM, 2000, ANAT EMBRYOL, V202, P323, DOI 10.1007/s004290000118; Downs KM, 1998, DEVELOPMENT, V125, P4507; Downs KM, 2004, DEVELOPMENT, V131, P37, DOI 10.1242/dev.00906; Downs KM, 2001, DEV BIOL, V233, P347, DOI 10.1006/dbio.2001.0227; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; FENDERSON BA, 1993, DIFFERENTIATION, V54, P85; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Giros A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022002; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; Inman KE, 2007, GENESIS, V45, P237, DOI 10.1002/dvg.20281; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; Karner CM, 2010, DEV DYNAM, V239, P2014, DOI 10.1002/dvdy.22340; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; Lomeli Hilda, 2009, BMC Res Notes, V2, P22, DOI 10.1186/1756-0500-2-22; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Naiche LA, 2011, DEV DYNAM, V240, P2290, DOI 10.1002/dvdy.22731; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; Ouimette JF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1036; PAPAIOANNOU VE, 2008, INBORN ERRORS DEV MO, P852; Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855; Rao AS, 2005, EUR J ENDOCRINOL, V153, P929, DOI 10.1530/eje.1.02038; Scotti M, 2012, DEVELOPMENT, V139, P731, DOI 10.1242/dev.075408; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Wang H, 2007, J BIOL CHEM, V282, P782, DOI 10.1074/jbc.M606610200; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1006/dbio.1997.8559; Zhang HB, 1996, DEVELOPMENT, V122, P2977	46	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43581	10.1371/journal.pone.0043581	http://dx.doi.org/10.1371/journal.pone.0043581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952711	Green Submitted, gold, Green Published			2022-12-27	WOS:000308213600033
J	Hermanson, SB; Carlson, CB; Riddle, SM; Zhao, J; Vogel, KW; Nichols, RJ; Bi, K				Hermanson, Spencer B.; Carlson, Coby B.; Riddle, Steven M.; Zhao, Jing; Vogel, Kurt W.; Nichols, R. Jeremy; Bi, Kun			Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; KINASE 2 LRRK2; PARKINSONS-DISEASE; 14-3-3 BINDING; GTP-BINDING; PROTEIN	Background: Mutations in the leucine-rich repeat kinase-2 (LRRK2) have been linked to Parkinson's disease. Recent studies show that inhibition of LRRK2 kinase activity decreased the level of phosphorylation at its own Ser910 and Ser935, indicating that these sites are prime targets for cellular readouts of LRRK2 inhibition. Methodology/Principal Findings: Using Time-Resolved Forster Resonance Energy Transfer (TR-FRET) technology, we developed a high-throughput cellular assay for monitoring LRRK2 phosphorylation at Ser935. LRRK2-Green Fluorescence Protein (GFP) fusions were expressed in cells via BacMam. Phosphorylation at Ser935 in these cells is detected using a terbium labeled anti-phospho-Ser935 antibody that generates a TR-FRET signal between terbium and GFP. LRRK2 wild-type and G2019S are constitutively phosphorylated at Ser935 in cells as measured by TR-FRET. The phosphorylation level is reduced for the R1441C mutant and little could be detected for the kinase-dead mutant D1994A. The TR-FRET cellular assay was further validated using reported LRRK2 inhibitors including LRRK2-IN-1 and our results confirmed that inhibition of LRRK2 can reduce the phosphorylation level at Ser935. To demonstrate the utility of this assay for screening, we profiled a small library of 1120 compounds. Three known LRRK2 inhibitors were identified and 16 hits were followed up in the TR-FRET and a cytotoxicity assay. Interestingly, out of the top 16 hits, five are known inhibitors of I kappa B phosphorylation, two CHK1 and two CDC25 inhibitors. Thirteen hits were further tested in a biochemical LRRK2 kinase activity assay and Western blot analysis for their effects on the phosphorylation of Ser910, Ser935, Ser955 and Ser973. Conclusions/Significance: We developed a TR-FRET cellular assay for LRRK2 Ser935 phosphorylation that can be applied to the screening for LRRK2 inhibitors. We report for the first time that several compounds such as IKK16, CHK1 inhibitors and GW441756 can inhibit LRRK2 Ser935 phosphorylation in cells and LRRK2 kinase activity in vitro.	[Hermanson, Spencer B.; Carlson, Coby B.; Riddle, Steven M.; Vogel, Kurt W.; Bi, Kun] Life Technol Corp, Primary & Stem Cell Syst, Madison, WI USA; [Zhao, Jing; Nichols, R. Jeremy] Parkinsons Inst, Sunnyvale, CA USA	Thermo Fisher Scientific	Hermanson, SB (corresponding author), Life Technol Corp, Primary & Stem Cell Syst, Madison, WI USA.	Kun.Bi@lifetech.com	Zhao, Jing/C-7359-2016	Zhao, Jing/0000-0002-8575-8181; Nichols, R Jeremy/0000-0002-5228-7571	Michael J. Fox Foundation for Parkinson's Research; Brin/Wojciki foundation	Michael J. Fox Foundation for Parkinson's Research; Brin/Wojciki foundation	Support for this work by R. Jeremy Nichols was from grants from the Michael J. Fox Foundation for Parkinson's Research and the benevolence of the Brin/Wojciki foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Azorsa DO, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-43; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Doggett EA, 2012, J NEUROCHEM, V120, P37, DOI 10.1111/j.1471-4159.2011.07537.x; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Han YS, 2004, J PHARMACOL EXP THER, V309, P64, DOI 10.1124/jpet.103.059477; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Lebakken CS, 2009, J BIOMOL SCREEN, V14, P924, DOI 10.1177/1087057109339207; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Looyenga BD, 2011, P NATL ACAD SCI USA, V108, P1439, DOI 10.1073/pnas.1012500108; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Reichling LJ, 2009, BIOCHEM BIOPH RES CO, V384, P255, DOI 10.1016/j.bbrc.2009.04.098; Robers MB, 2008, ANAL BIOCHEM, V372, P189, DOI 10.1016/j.ab.2007.09.012; Saunders-Pullman R, 2010, MOVEMENT DISORD, V25, P2536, DOI 10.1002/mds.23314; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Swinney DC, 2002, J BIOL CHEM, V277, P23573, DOI 10.1074/jbc.M200842200; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Wood ER, 2004, BIOORG MED CHEM LETT, V14, P953, DOI 10.1016/j.bmcl.2003.12.002; Zhang JW, 2012, BIOORG MED CHEM LETT, V22, P1864, DOI 10.1016/j.bmcl.2012.01.084	38	32	34	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43580	10.1371/journal.pone.0043580	http://dx.doi.org/10.1371/journal.pone.0043580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952710	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600032
J	Jing, YY; Han, ZP; Liu, Y; Sun, K; Zhang, SS; Jiang, GC; Li, R; Gao, L; Zhao, X; Wu, D; Cai, X; Wu, MC; Wei, LX				Jing, Yingying; Han, Zhipeng; Liu, Yan; Sun, Kai; Zhang, Shanshan; Jiang, Guocheng; Li, Rong; Gao, Lu; Zhao, Xue; Wu, Dong; Cai, Xiong; Wu, Mengchao; Wei, Lixin			Mesenchymal Stem Cells in Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							T-LYMPHOCYTE PROLIFERATION; BONE-MARROW; STROMAL CELLS; TGF-BETA; EXPRESSION; CANCER; GROWTH; TRANSPLANTATION; PROGRESSION	In response to inflammation, mesenchymal stem cells (MSCs) are known to migrate to tissue injury sites to participate in immune modulation, tissue remodeling and wound healing. Tumors apply persistent mechanical and pathological stress to tissues and causes continual infiltration of MSCs. Here, we demonstrate that MSCs promote human hepatocellular carcinoma (HCC) metastasis under the influence of inflammation. The metastasis promoting effect could be imitated with the supernatant of MSCs pretreated with IFN gamma and TNF alpha. Interestingly, treatment of HCC cells with the supernatant leads to epithelial-mesenchymal transition (EMT), an effect related to the production of TGF beta by cytokines stimulated MSCs. Importantly, the levels of MSCs expressing SSEA4 in clinical HCC samples significantly correlated with poor prognosis of HCC, and EMT of HCC was strongly associated with a shorter cancer-free interval (CFI) and a worse overall survival (OS). Therefore, our results suggest that MSCs in tumor inflammatory microenvironment could promote tumor metastasis through TGF beta-induced EMT.	[Jing, Yingying; Han, Zhipeng; Liu, Yan; Sun, Kai; Zhang, Shanshan; Jiang, Guocheng; Li, Rong; Gao, Lu; Zhao, Xue; Wu, Mengchao; Wei, Lixin] Second Mil Med Univ, Tumor Immunol & Gene Therapy Ctr, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Wu, Dong; Cai, Xiong] Second Mil Med Univ, Dept Combined Treatment, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Jing, YY (corresponding author), Second Mil Med Univ, Tumor Immunol & Gene Therapy Ctr, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.	weilixin@yahoo.com		Wei, Lixin/0000-0002-9526-5348	National Natural Science Foundation of China [81030041, 30901722, 31171321, 81000970, 81101622]; Key Basic Research Project of China [2010CB945600, 2011CB966200]; Special Funds for National key Sci-Tech Special Project of China [2008ZX10002-019, 2008ZX10002-025]; Shanghai Science and Technology Committee [10ZR1439600, 11ZR1449500, 10411963100, 10ZR1439900]; NSFC, China [30921006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Basic Research Project of China; Special Funds for National key Sci-Tech Special Project of China; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); NSFC, China(National Natural Science Foundation of China (NSFC))	This project was supported by Key project of National Natural Science Foundation of China (grant no: 81030041); Key Basic Research Project of China (grant no: 2010CB945600, 2011CB966200); National Natural Science Foundation of China (grant no: 30901722, 31171321, 81000970,81101622); Special Funds for National key Sci-Tech Special Project of China (grant no: 2008ZX10002-019, 2008ZX10002-025); Shanghai Science and Technology Committee (grant no: 10ZR1439600, 11ZR1449500, 10411963100, 10ZR1439900) and Science Fund for Creative Research Groups, NSFC, China (grant no: 30921006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Hall B., 2007, V180, P263; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Jin H, 2010, BIOMED RES-TOKYO, V31, P105, DOI 10.2220/biomedres.31.105; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li GC, 2010, CANCER SCI, V101, P2546, DOI 10.1111/j.1349-7006.2010.01738.x; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin FT, 2010, BREAST CANCER RES TR, V124, P317, DOI 10.1007/s10549-010-0734-1; Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291; Nasef A, 2007, GENE EXPRESSION, V13, P217; Niess H, 2011, ANN SURG, V254, P767, DOI 10.1097/SLA.0b013e3182368c4f; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poon RTP, 2007, ANN SURG, V245, P51, DOI 10.1097/01.sla.0000225255.01668.65; Popp FC, 2009, LIVER TRANSPLANT, V15, P1192, DOI 10.1002/lt.21862; Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075; Quintavalla J, 2002, BIOMATERIALS, V23, P109, DOI 10.1016/S0142-9612(01)00086-2; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Sun T, 2010, HEPATOLOGY, V51, P545, DOI 10.1002/hep.23311; Wu F, 2009, HEPATOLOGY, V50, P1839, DOI 10.1002/hep.23197; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Xu WR, 2004, EXP BIOL MED, V229, P623, DOI 10.1177/153537020422900706; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	34	82	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43272	10.1371/journal.pone.0043272	http://dx.doi.org/10.1371/journal.pone.0043272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952657	gold, Green Submitted, Green Published			2022-12-27	WOS:000308213600018
J	Mahler, A; Steiniger, J; Bock, M; Brandt, AU; Haas, V; Boschmann, M; Paul, F				Maehler, Anja; Steiniger, Jochen; Bock, Markus; Brandt, Alexander U.; Haas, Verena; Boschmann, Michael; Paul, Friedemann			Is Metabolic Flexibility Altered in Multiple Sclerosis Patients?	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MICRODIALYSIS ETHANOL TECHNIQUE; SKELETAL-MUSCLE; HUNTINGTONS-DISEASE; ADIPOSE-TISSUE; BLOOD-FLOW; MITOCHONDRIAL DYSFUNCTION; AUTONOMIC DYSFUNCTION; INSULIN-RESISTANCE; PROGRESSION	Objectives: Metabolic flexibility is defined as ability to adjust fuel oxidation to fuel availability. Multiple sclerosis (MS) results in reduced muscle strength and exercise intolerance. We tested the hypothesis that altered metabolic flexibility contributes to exercise intolerance in MS patients. Methods: We studied 16 patients (all on glatiramer) and 16 matched healthy controls. Energy expenditure (EE), and carbohydrate (COX) and lipid oxidation (LOX) rates were determined by calorimetry, before and after an oral glucose load. We made measurements either at rest (canopy device) or during 40 min low-grade (0.5 W/kg) exercise (metabolic chamber). We also obtained plasma, and adipose tissue and skeletal muscle dialysate samples by microdialysis to study tissue-level metabolism under resting conditions. Results: At rest, fasting and postprandial plasma glucose, insulin, and free fatty acid levels did not differ between patients and controls. Fasting and postprandial COX was higher and LOX lower in patients. In adipose, fasting and postprandial dialysate glucose, lactate, and glycerol levels were higher in patients vs. controls. In muscle, fasting and postprandial dialysate metabolite levels did not differ significantly between the groups. During exercise, EE did not differ between the groups. However, COX increased sharply over 20 min in patients, without reaching a steady state, followed by an immediate decrease within the next 20 min and fell even below basal levels after exercise in patients, compared to controls. Conclusions: Glucose tolerance is not impaired in MS patients. At rest, there is no indication for metabolic inflexibility or mitochondrial dysfunction in skeletal muscle. The increased adipose tissue lipolytic activity might result from glatiramer treatment. Autonomic dysfunction might cause dysregulation of postprandial thermogenesis at rest and lipid mobilization during exercise.	[Maehler, Anja; Steiniger, Jochen; Bock, Markus; Haas, Verena; Boschmann, Michael; Paul, Friedemann] Expt & Clin Res Ctr, Berlin, Germany; [Maehler, Anja; Steiniger, Jochen; Bock, Markus; Haas, Verena; Boschmann, Michael; Paul, Friedemann] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Maehler, Anja; Bock, Markus; Brandt, Alexander U.; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mahler, A (corresponding author), Expt & Clin Res Ctr, Berlin, Germany.	michael.boschmann@charite.de	Paul, Friedemann/ABF-9415-2020	Haas, Verena/0000-0001-8841-2381; Mahler, Anja/0000-0002-3904-5789; paul, friedemann/0000-0002-6378-0070	Deutsche Forschungsgemeinschaft [DFG KFO 192/2, DFG Exc 257]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Michael Boschmann is supported by Deutsche Forschungsgemeinschaft (DFG KFO 192/2), as is Friedemann Paul (DFG Exc 257). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2001, HUMAN ENERGY REQUIRE; Arenas J, 1998, ANN NEUROL, V43, P397, DOI 10.1002/ana.410430321; Argov Z, 1998, EUR NEUROL, V39, P65, DOI 10.1159/000007912; Aziz NA, 2010, J NEUROL NEUROSUR PS, V81, P1233, DOI 10.1136/jnnp.2009.191833; Boschmann M, 2005, HYPERTENSION, V46, P130, DOI 10.1161/01.HYP.0000171477.63859.b2; Boschmann M, 2010, J CLIN ENDOCR METAB, V95, P1634, DOI 10.1210/jc.2009-1293; Brunner E, 2002, NONPARAMETRIC ANAL L; Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109; Carroll CC, 2005, ARCH PHYS MED REHAB, V86, P224, DOI 10.1016/j.apmr.2004.03.035; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Corpeleijn E, 2010, AM J PHYSIOL-ENDOC M, V299, pE14, DOI 10.1152/ajpendo.00187.2010; Damian MS, 2001, MUSCLE NERVE, V24, P648, DOI 10.1002/mus.1050; ENOKSSON S, 1995, INT J OBESITY, V19, P350; Fellander G, 1996, INT J OBESITY, V20, P220; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Flachenecker P, 2003, NEUROLOGY, V61, P851, DOI 10.1212/01.WNL.0000080365.95436.B8; Flachenecker P, 2001, MULT SCLER, V7, P327, DOI 10.1177/135245850100700509; Formica CA, 1997, CALCIFIED TISSUE INT, V61, P129; Frayn F N., 2003, METABOLIC REGULATION; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Garner DJP, 2003, MUSCLE NERVE, V27, P456, DOI 10.1002/mus.10346; Gaster M, 2011, BIOCHEM BIOPH RES CO, V404, P1023, DOI 10.1016/j.bbrc.2010.12.102; Haensch CA, 2006, J NEUROL, V253, P3, DOI 10.1007/s00415-006-1102-2; HICKNER RC, 1995, J APPL PHYSIOL, V79, P638, DOI 10.1152/jappl.1995.79.2.638; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KentBraun JA, 1997, J APPL PHYSIOL, V83, P1998, DOI 10.1152/jappl.1997.83.6.1998; Kumleh HH, 2006, J NEUROL SCI, V243, P65, DOI 10.1016/j.jns.2005.11.030; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lodi R, 2000, ANN NEUROL, V48, P72; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Mancardi GL, 2000, J NEUROL, V247, P220, DOI 10.1007/s004150050568; Muller MJ, 2004, AM J CLIN NUTR, V80, P1379; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; RANDLE PJ, 1963, LANCET, V1, P785; Regenold WT, 2008, J NEUROL SCI, V275, P106, DOI 10.1016/j.jns.2008.07.032; Rossi P, 1998, J NEUROL SCI, V161, P148, DOI 10.1016/S0022-510X(98)00276-7; Shelton RC, 2010, PROG NEUROBIOL, V91, P275, DOI 10.1016/j.pneurobio.2010.04.004; STAHLE L, 1991, J PHARMACOL METHOD, V25, P41, DOI 10.1016/0160-5402(91)90021-V; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; White LJ, 2004, SPORTS MED, V34, P1077, DOI 10.2165/00007256-200434150-00005; Witte ME, 2010, MITOCHONDRION, V10, P411, DOI 10.1016/j.mito.2010.05.014	43	41	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43675	10.1371/journal.pone.0043675	http://dx.doi.org/10.1371/journal.pone.0043675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952735	Green Accepted, Green Published, gold			2022-12-27	WOS:000308213600036
J	Sanchez-Martinez, A; Calleja, M; Peralta, S; Matsushima, Y; Hernandez-Sierra, R; Whitworth, AJ; Kaguni, LS; Garesse, R				Sanchez-Martinez, Alvaro; Calleja, Manuel; Peralta, Susana; Matsushima, Yuichi; Hernandez-Sierra, Rosana; Whitworth, Alexander J.; Kaguni, Laurie S.; Garesse, Rafael			Modeling Pathogenic Mutations of Human Twinkle in Drosophila Suggests an Apoptosis Role in Response to Mitochondrial Defects	PLOS ONE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DNA-POLYMERASE-GAMMA; MULTIPLE DELETIONS; THYMIDINE PHOSPHORYLASE; LINKER REGION; HELICASE; MUTANT; REPLICATION; DISORDERS; PROTEINS	The human gene C10orf2 encodes the mitochondrial replicative DNA helicase Twinkle, mutations of which are responsible for a significant fraction of cases of autosomal dominant progressive external ophthalmoplegia (adPEO), a human mitochondrial disease caused by defects in intergenomic communication. We report the analysis of orthologous mutations in the Drosophila melanogaster mitochondrial DNA (mtDNA) helicase gene, d-mtDNA helicase. Increased expression of wild type d-mtDNA helicase using the UAS-GAL4 system leads to an increase in mtDNA copy number throughout adult life without any noteworthy phenotype, whereas overexpression of d-mtDNA helicase containing the K388A mutation in the helicase active site results in a severe depletion of mtDNA and a lethal phenotype. Overexpression of two d-mtDNA helicase variants equivalent to two human adPEO mutations shows differential effects. The A442P mutation exhibits a dominant negative effect similar to that of the active site mutant. In contrast, overexpression of d-mtDNA helicase containing the W441C mutation results in a slight decrease in mtDNA copy number during the third instar larval stage, and a moderate decrease in life span in the adult population. Overexpression of d-mtDNA helicase containing either the K388A or A442P mutations causes a mitochondrial oxidative phosphorylation (OXPHOS) defect that significantly reduces cell proliferation. The mitochondrial impairment caused by these mutations promotes apoptosis, arguing that mitochondria regulate programmed cell death in Drosophila. Our study of d-mtDNA helicase overexpression provides a tractable Drosophila model for understanding the cellular and molecular effects of human adPEO mutations.	[Sanchez-Martinez, Alvaro; Peralta, Susana; Hernandez-Sierra, Rosana; Garesse, Rafael] Univ Autonoma Madrid, Fac Med, Dept Bioquim,Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Sanchez-Martinez, Alvaro; Peralta, Susana; Hernandez-Sierra, Rosana; Garesse, Rafael] Univ Autonoma Madrid, Fac Med, Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Sanchez-Martinez, Alvaro; Peralta, Susana; Hernandez-Sierra, Rosana; Garesse, Rafael] Hosp 12 Octubre I 12, Inst Invest Santitaria, Madrid, Spain; [Calleja, Manuel] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain; [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA; [Whitworth, Alexander J.] Univ Sheffield, Dept Biomed Sci, MRC Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Michigan State University; Michigan State University; University of Sheffield	Sanchez-Martinez, A (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim,Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid, Spain.	rafael.garesse@uam.es	Garesse, Rafael/F-3836-2012; Sanchez-Martinez, Alvaro/L-3851-2019; Sanchez-Martinez, Alvaro/L-1395-2013	Sanchez-Martinez, Alvaro/0000-0002-2728-6251; Whitworth, Alexander/0000-0002-1154-6629; Garesse, Rafael/0000-0002-0338-2281	Centre for Biomedical Research on Rare Diseases, Instituto de Salud Carlos III [PI 07/0167]; Comunidad de Madrid [GEN-0269/2006]; National Institutes of Health [GM45295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER; Medical Research Council [MC_G1000735] Funding Source: researchfish; MRC [MC_G1000735] Funding Source: UKRI	Centre for Biomedical Research on Rare Diseases, Instituto de Salud Carlos III; Comunidad de Madrid(Comunidad de Madrid); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Centre for Biomedical Research on Rare Diseases, Instituto de Salud Carlos III (grant number PI 07/0167), and the Comunidad de Madrid (grant number GEN-0269/2006) to RG, and the National Institutes of Health (grant number GM45295) to LSK. ASM was a Fellow from the Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Abdelwahid E, 2011, BBA-MOL CELL RES, V1813, P597, DOI 10.1016/j.bbamcr.2010.10.008; Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Arama E, 2006, EMBO J, V25, P232, DOI 10.1038/sj.emboj.7600920; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; El-Khoury R, 2009, GENETICS, V183, P861, DOI 10.1534/genetics.109.107813; Frangini M, 2009, FEBS J, V276, P1104, DOI 10.1111/j.1742-4658.2008.06853.x; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002; Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Krieser RJ, 2009, APOPTOSIS; Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301; Lopez LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401; Martinez-Azorin F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200; Mendes CS, 2006, EMBO REP, V7, P933, DOI 10.1038/sj.embor.7400773; Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; Pickrell AM, 2009, J BIOENERG BIOMEMBR, V41, P453, DOI 10.1007/s10863-009-9245-3; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Umate Pavan, 2011, Commun Integr Biol, V4, P118, DOI 10.4161/cib.4.1.13844; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Walker DW, 2004, P NATL ACAD SCI USA, V101, P10290, DOI 10.1073/pnas.0403767101; Wanrooij S, BIOCH BIOPHYS ACTA, V1797, P1378; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Ziviani E, AUTOPHAGY, V6; Ziviani E, 2010, AUTOPHAGY, V6, P660, DOI 10.4161/auto.6.5.12242	46	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43954	10.1371/journal.pone.0043954	http://dx.doi.org/10.1371/journal.pone.0043954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952820	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600064
J	Bao, B; Ahmad, A; Kong, DJ; Ali, S; Azmi, AS; Li, YW; Banerjee, S; Padhye, S; Sarkar, FH				Bao, Bin; Ahmad, Aamir; Kong, Dejuan; Ali, Shadan; Azmi, Asfar S.; Li, Yiwei; Banerjee, Sanjeev; Padhye, Subhash; Sarkar, Fazlul H.			Hypoxia Induced Aggressiveness of Prostate Cancer Cells Is Linked with Deregulated Expression of VEGF, IL-6 and miRNAs That Are Attenuated by CDF	PLOS ONE			English	Article							PANCREATIC-CANCER; STEM-CELLS; TUMOR HYPOXIA; LUNG-CANCER; PROGNOSTIC-FACTOR; DRUG-RESISTANCE; BREAST-CANCER; ANALOG CDF; MICRORNAS; INTERLEUKIN-6	Tumor hypoxia with deregulated expression of hypoxia inducing factor (HIF) and its biological consequence leads to poor prognosis of patients diagnosed with solid tumors, resulting in higher mortality, suggesting that understanding of the molecular relationship of hypoxia with other cellular features of tumor aggressiveness would be invaluable for developing newer targeted therapy for solid tumors. emerging evidence also suggest that hypoxia and HIF signaling pathways contributes to the acquisition of epithelial-to-mesenchymal transition (EMT), maintenance of cancer stem cell (CSC) functions, and also maintains the vicious cycle of inflammation, all of which contribute to radiation therapy and chemotherapy resistance. however, the detailed mechanism by which hypoxia/HIF drive these events are not fully understood. Here, we have shown that hypoxia leads to increased expression of VEGF, IL-6, and CSC marker genes such as Nanog, OCt4 and EZH2, and also increased the expression of miR-21, an oncogenic miRNA, in prostate cancer (PCa) cells (PC-3 and LNCaP). The treatment of PCa cell with CDF, a novel Curcumin-derived synthetic analogue previously showed anti-tumor activity in vivo, inhibited the productions of VEGF and IL-6, and down-regulated the expression of Nanog, Oct4, EZH2 mrNAs, as well as miR-21 under hypoxic condition. Moreover, CDF treatment of PCa cells led to decreased cell migration under hypoxic condition. taken together, these result suggest that the anti-tumor effect of CDF is in part mediated through deregulation of tumor hypoxic pathways, and thus CDF could become useful for cancer therapy.	[Bao, Bin; Ahmad, Aamir; Kong, Dejuan; Azmi, Asfar S.; Li, Yiwei; Banerjee, Sanjeev; Sarkar, Fazlul H.] Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48202 USA; [Ali, Shadan; Sarkar, Fazlul H.] Wayne State Univ, Dept Oncol, Karmanos Canc Inst, Detroit, MI 48202 USA; [Padhye, Subhash] ISTRA, Dept Chem, MCE Soc Abeda Inamdar Senior Coll Arts Sci & Comm, Pune, Maharashtra, India	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Bao, B (corresponding author), Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48202 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723; AZMI, ASFAR/0000-0003-1178-9505	Puschelberg and Guido Foundations; National Cancer Institute, National Institutes of Health grants [5R01CA131151, 5R01CA132794, 1R01CA154321]; Department of Defense Exploration-Hypothesis Development Award [PC101482]; NATIONAL CANCER INSTITUTE [R01CA132794, R01CA131151, R01CA154321] Funding Source: NIH RePORTER	Puschelberg and Guido Foundations; National Cancer Institute, National Institutes of Health grants; Department of Defense Exploration-Hypothesis Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Puschelberg and Guido Foundations for their generous financial contribution, Grant support from the National Cancer Institute, National Institutes of Health grants 5R01CA131151, 5R01CA132794 and 1R01CA154321 (FHS), and the Department of Defense Exploration-Hypothesis Development Award PC101482 (BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, CANCER LETT, V319, P173, DOI 10.1016/j.canlet.2012.01.013; Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Conze D, 2001, CANCER RES, V61, P8851; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jiang JA, 2011, CANCER BIOL THER, V11, P714, DOI 10.4161/cbt.11.8.15274; Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x; Kong Bo, 2009, World J Stem Cells, V1, P8, DOI 10.4252/wjsc.v1.i1.8; Kong D, 2008, CANCER RES, V68, P1927, DOI 10.1158/0008-5472.CAN-07-3241; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Michaud DS, 2006, CANCER RES, V66, P4525, DOI 10.1158/0008-5472.CAN-05-3987; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; MOULDER JE, 1987, CANCER METAST REV, V5, P313, DOI 10.1007/BF00055376; Nie Y, 2011, INT J BIOL SCI, V7, P762, DOI 10.7150/ijbs.7.762; Nilsson CL, 2010, J PROTEOME RES, V9, P430, DOI 10.1021/pr9007927; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Padhye S, 2010, MINI-REV MED CHEM, V10, P372, DOI 10.2174/138955710791330891; Padhye S, 2009, PHARM RES-DORDR, V26, P2438, DOI 10.1007/s11095-009-9955-6; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; Pietras A, 2010, CURR TOP MICROBIOL, V345, P1, DOI 10.1007/82_2010_72; Pocock R, 2011, PFLUG ARCH EUR J PHY, V461, P307, DOI 10.1007/s00424-010-0910-5; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Quero L, 2011, RADIOTHER ONCOL; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Wang Z, 2007, CANCER RES, V67, P11377; Wertz K, 2009, NUTR CANCER, V61, P775, DOI 10.1080/01635580903285023; Yi H, 2012, KOREAN J PHYSIOL PHA, V16, P11, DOI 10.4196/kjpp.2012.16.1.11; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	57	89	90	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43726	10.1371/journal.pone.0043726	http://dx.doi.org/10.1371/journal.pone.0043726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952749	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800055
J	Cardenas-Valladolid, J; Salinero-Fort, MA; Gomez-Campelo, P; de Burgos-Lunar, C; Abanades-Herranz, JC; Arnal-Selfa, R; Lopez-Andres, A				Cardenas-Valladolid, Juan; Salinero-Fort, Miguel A.; Gomez-Campelo, Paloma; de Burgos-Lunar, Carmen; Abanades-Herranz, Juan C.; Arnal-Selfa, Rosa; Lopez-Andres, Ana			Effectiveness of Standardized Nursing Care Plans in Health Outcomes in Patients with Type 2 Diabetes Mellitus: A Two-Year Prospective Follow-Up Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PREVALENCE; DIAGNOSES; INTERVENTIONS; HYPERTENSION; VALIDATION	Background: Implementation of a standardized language in Nursing Care Plans (SNCP) allows for increased efficiency in nursing data management. However, the potential relationship with patients health outcomes remains uncertain. The aim of this study was to evaluate the effectiveness of SNCP implementation, based on North American Nursing Diagnosis Association (NANDA) and Nursing Interventions Classification (NIC), in the improvement of metabolic, weight, and blood pressure control of Type 2 Diabetes Mellitus (T2DM) patients. Methods: A two-year prospective follow-up study, in routine clinical practice conditions. 31 primary health care centers (Spain) participated with 24,124 T2DM outpatients. Data was collected from Computerized Clinical Records; SNCP were identified using NANDA and NIC taxonomies. Descriptive and ANCOVA analyses were conducted. Results: 18,320 patients were identified in the Usual Nursing Care (UNC) group and 5,168 in the SNCP group. At the two-year follow-up, the SNCP group improved all parameters except LDL cholesterol and diastolic blood pressure. We analyzed data adjustming by the baseline value for these variables and variables with statistically significant differences between groups at baseline visit. Results indicated a lowering of all parameters except HbA1c, but a statistically significant reduction was only observed with diastolic blood pressure results. However, the adjusted reduction of diastolic blood pressure is of little clinical relevance. Greater differences of control values for diastolic blood pressure, HbA1c, LDL-cholesterol and Body Mass Index were found in the SNCP group, but only reached statistical significance for HbA1c. A greater proportion of patients with baseline HbA1c >= 7 decreased to <7% at the two-year follow-up in the SNCP group than in the UNC group (16.9% vs. 15%; respectively; p = 0.01). Conclusions: Utilization of SNCP was helpful in achieving glycemic control targets in poorly controlled patients with T2DM (HbA1c >= 7%). Diastolic blood pressure results were slightly improved in the SNCP group compared to the UNC group.	[Cardenas-Valladolid, Juan] Serv Madrileno Salud, Unidad Apoyo Tecn Gerencia Adjunta Planificac & C, Madrid, Spain; [Salinero-Fort, Miguel A.; Gomez-Campelo, Paloma] Hosp Carlos III, Fdn Invest Biomed, Madrid, Spain; [de Burgos-Lunar, Carmen] Hosp Carlos III, Unidad Epidemiol Clin, Madrid, Spain; [Abanades-Herranz, Juan C.] Serv Madrileno Salud, Direcc Tecn Formac & Invest, Madrid, Spain; [Arnal-Selfa, Rosa] Serv Madrileno Salud, Direcc Enfermeria, Direcc Asistencial N, Madrid, Spain; [Lopez-Andres, Ana] Univ Rey Juan Carlos, Fac Ciencias Salud, Dept Med Prevent & Salud Publ, Madrid, Spain	Hospital Carlos III; Hospital Carlos III; Universidad Rey Juan Carlos	Cardenas-Valladolid, J (corresponding author), Serv Madrileno Salud, Unidad Apoyo Tecn Gerencia Adjunta Planificac & C, Madrid, Spain.	jcardenas.gapm04@salud.madrid.org	SALINERO-FORT, MIGUEL A./GOP-2536-2022	SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Gomez Campelo, Paloma/0000-0003-2299-1741; Cardenas Valladolid, Juan/0000-0002-3321-7316	Instituto de la Salud Carlos III [PI07/0865]	Instituto de la Salud Carlos III(Instituto de Salud Carlos III)	Funding for the study was supplied by the "Instituto de la Salud Carlos III" (PI07/0865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ESTR DIAB SIST NAC S; Bianchi C, 2008, DIABETES CARE, V31, pS208, DOI 10.2337/dc08-s256; Bulechek GM, 2009, NURSING INTERVENTION; Carpenito L. J, 2000, NURSING DIAGNOSIS AP, V8th; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; de Burgos-Lunar C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-146; Gravalos GJD, 2006, REV ESP SALUD PUBLIC, V80, P67, DOI 10.1590/S1135-57272006000100007; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Montalban EG, 2010, GAC SANIT, V24, P233, DOI 10.1016/j.gaceta.2010.01.010; Gonzalez-Jurado MA, 2006, THESIS U COMPLUTENSE; Gordon M., 1994, NURSING DIAGNOSIS PR; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Lavin Mary Ann, 2004, Int J Nurs Terminol Classif, V15, P39, DOI 10.1111/j.1744-618X.2004.00039.x; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Muller-Staub M, 2006, J ADV NURS, V56, P514, DOI 10.1111/j.1365-2648.2006.04012.x; NANDA International, 2011, NURS DIAGN DEF CLASS; Paans W, 2011, J CLIN NURS, V20, P2386, DOI 10.1111/j.1365-2702.2010.03573.x; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389; ROSENTHAL GE, 1992, MED CARE, V30, P1127, DOI 10.1097/00005650-199212000-00005; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Urquhart C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002099.pub2; Valdes S, 2007, MED CLIN-BARCELONA, V129, P352, DOI 10.1157/13109554; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Welton JM, 1999, J AM MED INFORM ASSN, P171	28	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43870	10.1371/journal.pone.0043870	http://dx.doi.org/10.1371/journal.pone.0043870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952794	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800070
J	Hammett, TM; Jarlais, DCD; Kling, R; Kieu, BT; McNicholl, JM; Wasinrapee, P; McDougal, JS; Liu, W; Chen, Y; Meng, DH; Doan, N; Nguyen, TH; Hoang, QN; Hoang, TV				Hammett, Theodore M.; Jarlais, Don C. Des; Kling, Ryan; Binh Thanh Kieu; McNicholl, Janet M.; Wasinrapee, Punneeporn; McDougal, J. Stephen; Liu, Wei; Chen, Yi; Meng, Donghua; Ngu Doan; Tho Huu Nguyen; Quyen Ngoc Hoang; Tren Van Hoang			Controlling HIV Epidemics among Injection Drug Users: Eight Years of Cross-Border HIV Prevention Interventions in Vietnam and China	PLOS ONE			English	Article							CAPTURE ENZYME-IMMUNOASSAY; TYPE-1 INCIDENCE; HARM REDUCTION; PREVALENCE; INFECTION; PATTERNS; PROVINCE; LAW	Introduction: HIV in Vietnam and Southern China is driven by injection drug use. We have implemented HIV prevention interventions for IDUs since 2002-2003 in Lang Son and Ha Giang Provinces, Vietnam and Ning Ming County (Guangxi), China. Methods: Interventions provide peer education and needle/syringe distribution. Evaluation employed serial cross-sectional surveys of IDUs 26 waves from 2002 to 2011, including interviews and HIV testing. Outcomes were HIV risk behaviors, HIV prevalence and incidence. HIV incidence estimation used two methods: 1) among new injectors from prevalence data; and 2) a capture enzyme immunoassay (BED testing) on all HIV+ samples. Results: We found significant declines in drug-related risk behaviors and sharp reductions in HIV prevalence among IDUs (Lang Son from 46% to 23% [p<0.001], Ning Ming: from 17% to 11% [p=0.003], and Ha Giang: from 51% to 18% [p<0.001]), reductions not experienced in other provinces without such interventions. There were significant declines in HIV incidence to low levels among new injectors through 36-48 months, then some rebound, particularly in Ning Ming, but BED-based estimates revealed significant reductions in incidence through 96 months. Discussion: This is one of the longest studies of HIV prevention among IDUs in Asia. The rebound in incidence among new injectors may reflect sexual transmission. BED-based estimates may overstate incidence (because of false-recent results in patients with long-term infection or on ARV treatment) but adjustment for false-recent results and survey responses on duration of infection generally confirm BED-based incidence trends. Combined trends from the two estimation methods show sharp declines in incidence to low levels. The significant downward trends in all primary outcome measures indicate that the Cross-Border interventions played an important role in bringing HIV epidemics among IDUs under control. The Cross-Border project offers a model of HIV prevention for IDUs that should be considered for large-scale replication.	[Hammett, Theodore M.; Kling, Ryan] ABT Associates Inc, Cambridge, MA 02138 USA; [Jarlais, Don C. Des] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Binh Thanh Kieu] ABT Associates Inc, Hanoi, Vietnam; [McNicholl, Janet M.] Ctr Dis Control & Prevent, DHAP, Branch Lab, Atlanta, GA USA; [Wasinrapee, Punneeporn] Thai Minist Publ Hlth US CDC Collaborat, Nonthaburi, Thailand; [McDougal, J. Stephen] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS STDs & TB Prevent, Atlanta, GA USA; [Liu, Wei; Chen, Yi] Guangxi Ctr Dis Control, Nanning, Peoples R China; [Meng, Donghua] Ning Ming Cty Hlth Dept, Ning Ming City, Guangxi, Peoples R China; [Ngu Doan] ABT Associates Inc, Ho Chi Minh City, Vietnam; [Tho Huu Nguyen] Lang Son Prov HIV AIDS Ctr, Lang Son City, Vietnam; [Quyen Ngoc Hoang; Tren Van Hoang] Ha Giang Prov Hlth Serv, Ha Giang City, Vietnam	ABT Associates; Harvard University; Beth Israel Deaconess Medical Center; ABT Associates; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; ABT Associates	Hammett, TM (corresponding author), ABT Associates Inc, Cambridge, MA 02138 USA.	ted_hammett@abtassoc.com			National Institute on Drug Abuse, U.S. National Institutes of Health: NIDA [1 R01 DA-14703]; Ford Foundation (Hanoi office); United Kingdom Department for International Development; World Bank; Global Fund to Fight AIDS, Tuberculosis, and Malaria; AusAID HAARP Cross-Border Program; Ford Foundation (Beijing office); NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014703] Funding Source: NIH RePORTER	National Institute on Drug Abuse, U.S. National Institutes of Health: NIDA; Ford Foundation (Hanoi office); United Kingdom Department for International Development; World Bank(The World Bank India); Global Fund to Fight AIDS, Tuberculosis, and Malaria(United States Agency for International Development (USAID)); AusAID HAARP Cross-Border Program; Ford Foundation (Beijing office); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by: National Institute on Drug Abuse, U.S. National Institutes of Health: NIDA grant no. 1 R01 DA-14703 (www.nida.nih.gov); Ford Foundation (Hanoi and Beijing offices) (www.fordfound.org); United Kingdom Department for International Development (www.dfid.gov.uk); World Bank (www.worldbank.org); Global Fund to Fight AIDS, Tuberculosis, and Malaria (www.theglobalfund.org); AusAID HAARP Cross-Border Program (www.haarp-online.org); Anonymous Donor, New York City (see comments). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt Associates Inc. Beth Israel Medical Center, 2010, CROSS BORD PROJ IMPL; [Anonymous], 2007, PREV HIV INF INJ DRU; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Broadhead RS, 2009, J DRUG ISSUES, V39, P829, DOI 10.1177/002204260903900403; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Cameron AC, 2003, MICROECONOMETRICS ME; Cohen DA, 2000, AIDS PATIENT CARE ST, V14, P37, DOI 10.1089/108729100318118; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Des Jarlais DC, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-89; Des Jarlais DC, 2000, AIDS, V14, pS41, DOI 10.1097/00002030-200006001-00006; Greene W.H., 2007, ECONOMETRIC ANAL; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hammett TM, 2008, ADDICTION, V103, P137, DOI 10.1111/j.1360-0443.2007.02053.x; Hammett TM, 2010, AIDS CARE, V22, P1466, DOI 10.1080/09540121003758580; Hammett TM, 2006, AIDS EDUC PREV, V18, P97, DOI 10.1521/aeap.2006.18.2.97; Hammett TM, 2005, INT J DRUG POLICY, V16, P235, DOI 10.1016/j.drugpo.2005.05.009; Hammett TM, 2005, J URBAN HEALTH, V82, pIV34, DOI 10.1093/jurban/jti106; Hammett TM, 2005, JAIDS-J ACQ IMM DEF, V38, P228, DOI 10.1097/00126334-200502010-00016; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Havashida T, 2008, AIDS RES HUM RETROV, V24, P495; Human Rights Watch, 2010, HUMAN RIGHTS WATCH; Human Rights Watch, 2011, HUMAN RIGHTS WATCH; Jarlais DC, 2005, AM J PUBLIC HEALTH, V95, P1439, DOI 10.2105/AJPH.2003.036517; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Laeyendecker O, 2012, AIDS RES HUM RETROVI; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014748; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; National Institute on Drug Abuse, 1994, OUTR RISK RED STRAT; Needle RH, 2005, INT J DRUG POLICY, V16, pS45, DOI 10.1016/j.drugpo.2005.02.009; Needle RH, 2003, EVIDENCE ACTION EFFE; Ngo AD, 2009, INT J DRUG POLICY, V20, P179, DOI 10.1016/j.drugpo.2007.12.009; Office of Global AIDS Coordinator, 2010, UPD HIV 1 INC EST SU; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Quan VM, 2010, ADDICTION, V106, P583, DOI DOI 10.1111/J.1360-0443.2010.03175.X; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Semaan S, 2002, J ACQ IMMUN DEF SYND, V30, pS73, DOI 10.1097/01.QAI.0000017613.32101.90; Stimson G., 1998, DRUG INJECTING HIV I; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Vietnam Administration for HIV/AIDS Control (Ministry of Health) and Family Health International, 2009, 2007 HIV AIDS EST PR; Wasinrapee P, 2004, 15 INT AIDS C BANGK; Weibel W, 1993, INDIGENOUS LEADER OU; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; Welte A, 2009, AIDS RES HUM RETROV, V25, P125, DOI 10.1089/aid.2008.0150; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; World Health Organization, 2009, ASS COMP TREATM PEOP; Wu ZY, 2007, AIDS, V21, pS115, DOI 10.1097/01.aids.0000304706.79541.ef; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8	58	34	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43141	10.1371/journal.pone.0043141	http://dx.doi.org/10.1371/journal.pone.0043141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952640	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800021
J	Jin, XX; Abbot, S; Zhang, XK; Kang, L; Voskinarian-Berse, V; Zhao, R; Kameneva, MV; Moore, LR; Chalmers, JJ; Zborowski, M				Jin, Xiaoxia; Abbot, Stewart; Zhang, Xiaokui; Kang, Lin; Voskinarian-Berse, Vanessa; Zhao, Rui; Kameneva, Marina V.; Moore, Lee R.; Chalmers, Jeffrey J.; Zborowski, Maciej			Erythrocyte Enrichment in Hematopoietic Progenitor Cell Cultures Based on Magnetic Susceptibility of the Hemoglobin	PLOS ONE			English	Article							RED-BLOOD-CELLS; EX-VIVO; MAGNETOPHORETIC SEPARATION; TRACKING VELOCIMETRY; IN-VIVO	Using novel media formulations, it has been demonstrated that human placenta and umbilical cord blood-derived CD34+ cells can be expanded and differentiated into erythroid cells with high efficiency. However, obtaining mature and functional erythrocytes from the immature cell cultures with high purity and in an efficient manner remains a significant challenge. A distinguishing feature of a reticulocyte and maturing erythrocyte is the increasing concentration of hemoglobin and decreasing cell volume that results in increased cell magnetophoretic mobility (MM) when exposed to high magnetic fields and gradients, under anoxic conditions. Taking advantage of these initial observations, we studied a noninvasive (label-free) magnetic separation and analysis process to enrich and identify cultured functional erythrocytes. In addition to the magnetic cell separation and cell motion analysis in the magnetic field, the cell cultures were characterized for cell sedimentation rate, cell volume distributions using differential interference microscopy, immunophenotyping (glycophorin A), hemoglobin concentration and shear-induced deformability (elongation index, EI, by ektacytometry) to test for mature erythrocyte attributes. A commercial, packed column high-gradient magnetic separator (HGMS) was used for magnetic separation. The magnetically enriched fraction comprised 80% of the maturing cells (predominantly reticulocytes) that showed near 70% overlap of EI with the reference cord blood-derived RBC and over 50% overlap with the adult donor RBCs. The results demonstrate feasibility of label-free magnetic enrichment of erythrocyte fraction of CD34+ progenitor-derived cultures based on the presence of paramagnetic hemoglobin in the maturing erythrocytes.	[Jin, Xiaoxia; Moore, Lee R.; Zborowski, Maciej] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Jin, Xiaoxia; Chalmers, Jeffrey J.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Abbot, Stewart; Zhang, Xiaokui; Kang, Lin; Voskinarian-Berse, Vanessa] Celgene Cellular Therapeut, Warren, NJ USA; [Zhao, Rui; Kameneva, Marina V.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Cleveland Clinic Foundation; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jin, XX (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.	zborowm@ccf.org	Chalmers, Jeffrey J/D-2305-2009		Defence Advanced Research Agency (DARPA) [BAA07-21]; National Health Institutes (NIH) [CA062349]; National Science Foundation (NSF) [BES-0124897]; Defence Advanced Research Projects Agency (DARPA); NATIONAL CANCER INSTITUTE [R01CA062349] Funding Source: NIH RePORTER	Defence Advanced Research Agency (DARPA); National Health Institutes (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Defence Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by funding from Defence Advanced Research Agency (DARPA) Projects, BAA07-21 "Continuous RBC Production" to SA; the National Health Institutes (NIH), CA062349 to MZ; and the National Science Foundation (NSF), BES-0124897 to JJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JJC, LRM and MZ are co-authors of patents assigned to Cleveland Clinic and The Ohio State University, issued, licensed and pending that are related to certain aspects of equipment and methods developed for the purpose of this study. SA, XZ, LK and VV-B are employees of Celgene Cellular Therapeutics, Inc. (CCT) who collaborate and share materials with the rest of co-authors as supported by Defence Advanced Research Projects Agency (DARPA) funding (see Financial Disclosure). This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.	Chalmers JJ, 1999, J MAGN MAGN MATER, V194, P231, DOI 10.1016/S0304-8853(98)00557-5; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Furlani EP, 2007, J PHYS D APPL PHYS, V40, P1313, DOI 10.1088/0022-3727/40/5/001; Gerlach JC, 2010, TISSUE ENG PART C-ME, V16, P115, DOI [10.1089/ten.tec.2008.0654, 10.1089/ten.TEC.2008.0654]; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Han KH, 2006, IEE P-NANOBIOTECHNOL, V153, P67, DOI 10.1049/ip-nbt:20050019; Han KH, 2004, J APPL PHYS, V96, P5797, DOI 10.1063/1.1803628; Jin X, 2008, ANALYST, V133, P1767, DOI 10.1039/b802113a; Jing Y, 2007, BIOTECHNOL BIOENG, V96, P1139, DOI 10.1002/bit.21202; Lee SS, 2007, ARTIF ORGANS, V31, P80, DOI 10.1111/j.1525-1594.2007.00344.x; Lichtman MA., 2006, WILLIAMS HEMATOLOGY, V7th, P1183; Magnani M, 2003, ERYTHROCYTE ENG DRUG; Nakamura M, 2001, EXP FLUIDS, V30, P371, DOI 10.1007/s003480000211; Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467; Pauling L, 1936, P NATL ACAD SCI USA, V22, P210, DOI 10.1073/pnas.22.4.210; Salmon ED, 2001, CURRENT PROTOCOLS CE; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Sullivan MT, 2007, TRANSFUSION, V47, P385, DOI 10.1111/j.1537-2995.2007.01128.x; TAKAYASU M, 1982, IEEE T MAGN, V18, P1520, DOI 10.1109/TMAG.1982.1062072; Takayasu M, 2000, IEEE T APPL SUPERCON, V10, P927, DOI 10.1109/77.828383; Zborowski M, 2003, BIOPHYS J, V84, P2638, DOI 10.1016/S0006-3495(03)75069-3	21	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e39491	10.1371/journal.pone.0039491	http://dx.doi.org/10.1371/journal.pone.0039491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952572	Green Published, gold, Green Accepted			2022-12-27	WOS:000308044800002
J	Gaugler-Senden, IPM; Tamsma, JT; van der Bent, C; Kusters, R; Steegers, EAP; de Groot, CJM				Gaugler-Senden, Ingrid P. M.; Tamsma, Jouke T.; van der Bent, Chris; Kusters, Ron; Steegers, Eric A. P.; de Groot, Christianne J. M.			Angiogenic Factors in Women Ten Years after Severe Very Early Onset Preeclampsia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ISCHEMIC-HEART-DISEASE; TYROSINE KINASE 1; ADHESION MOLECULES; POTENTIAL ROLE; SERUM-LEVELS; RISK; HISTORY; HYPERTENSION; PROTEINURIA	Background: Women with a history of mainly severe and early onset preeclampsia have an increased risk of future cardiovascular disease. During these complicated pregnancies increased levels of anti-angiogenic factors can be found. We hypothesize that women with a history of severe very early onset preeclampsia still have increased levels of these biomarkers years after this pregnancy, resulting in increased risk for cardiovascular disease. Methods: Twenty women with severe early onset preeclampsia before 24 weeks' gestation, who delivered between 1993-2003 in a tertiary referral centre and twenty matched controls with uncomplicated pregnancies and healthy term infants, were addressed for participation in the study. Venous plasma samples were analyzed for basic fibroblast growth factor (bFGF), placental growth factor (PLGF), soluble fms-like tyrosine kinase-1 (sFlt-1), vascular endothelial growth factor (VEGF), E-and P-selectin, soluble intercellular adhesion molecule-3 (sICAM-3) and thrombomodulin by ELISA. Results: Sixteen case subjects and 18 control subjects consented participation. The median time interval index pregnancy to study was 9.4 and 9.7 years for cases and controls, respectively. Median levels for cases-controls (p-value) were not different; bFGF: 17.43-11.11 pg/mL (0.33), sFlt-1: 102.98-101.92 pg/ml (0.84), PLGF: 3.57-4.20 pg/mL (0.38), VEGF: 64.05-45.72 pg/mL (0.73), E-selectin: 5.11-4.68 ng/mL (0.20), P-selectin: 85.35-71.69 ng/mL (0.69), sICAM-3: 0.42-0.63 ng/mL (0.41) and Thrombomodulin: 0.92-0.93 ng/mL (0.59). Conclusion: There were no differences in angiogenic biomarkers between women with a history of severe early onset preeclampsia versus uncomplicated pregnancy almost 10 years later, suggesting that these angiogenic factors will not contribute to the early detection of women at risk for future cardiovascular disease.	[Gaugler-Senden, Ingrid P. M.] Jeroen Bosch Hosp, Dept Obstet & Gynecol, Shertogenbosch, Netherlands; [Tamsma, Jouke T.; van der Bent, Chris] Leiden Univ, Med Ctr, Dept Endocrinol & Gastro Intestinal Med, Leiden, Netherlands; [Kusters, Ron] Jeroen Bosch Hosp, Dept Clin Chem, Shertogenbosch, Netherlands; [Steegers, Eric A. P.] Univ Med Ctr Rotterdam, Erasmus MC, Div Obstet & Prenatal Med, Dept Obstet & Gynecol, Rotterdam, Netherlands; [de Groot, Christianne J. M.] Vrije Univ Amsterdam Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands	Jeroen Bosch Ziekenhuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Jeroen Bosch Ziekenhuis; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Gaugler-Senden, IPM (corresponding author), Jeroen Bosch Hosp, Dept Obstet & Gynecol, Shertogenbosch, Netherlands.	i.gaugler@jbz.nl		de Groot, Christianne/0000-0003-3277-2542				Alber HF, 2005, HEART, V91, P365, DOI 10.1136/hrt.2003.021311; Belgore FM, 2001, AM J CARDIOL, V87, P805, DOI 10.1016/S0002-9149(00)01512-5; Berks D, 2009, OBSTET GYNECOL, V114, P1307, DOI 10.1097/AOG.0b013e3181c14e3e; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Cassidy A, 2009, ARTERIOSCL THROM VAS, V29, P134, DOI 10.1161/ATVBAHA.108.171066; Chedraui P, 2009, J MATERN-FETAL NEO M, V22, P565, DOI 10.1080/14767050902801769; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Gaugler-Senden IPM, 2008, EUR J OBSTET GYN R B, V140, P171, DOI 10.1016/j.ejogrb.2008.03.004; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Khurana R, 2005, CIRCULATION, V111, P2828, DOI 10.1161/CIRCULATIONAHA.104.495887; Kim SY, 2011, ANGIOLOGY, V62, P176, DOI 10.1177/0003319710370963; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Livingston JC, 2000, AM J OBSTET GYNECOL, V183, P1554, DOI 10.1067/mob.2000.108022; Malik I, 2001, LANCET, V358, P971, DOI 10.1016/S0140-6736(01)06104-9; Masuyama H, 2010, BJOG-INT J OBSTET GY, V117, P314, DOI 10.1111/j.1471-0528.2009.02453.x; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Nakajima K, 2004, CLIN CARDIOL, V27, P281, DOI 10.1002/clc.4960270509; Noori M, 2005, NY TIMES        1026, V122, P478; Ong CYT, 2001, OBSTET GYNECOL, V98, P608, DOI 10.1016/S0029-7844(01)01528-9; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Salahuddin S, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.010; Sattar N, 2003, HYPERTENSION, V42, P39, DOI 10.1161/01.HYP.0000074428.11168.EE; Saxena AR, 2010, HYPERTENSION, V55, P1239, DOI 10.1161/HYPERTENSIONAHA.109.147595; Simas TAM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.030; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Su YN, 2001, OBSTET GYNECOL, V97, P898, DOI 10.1016/S0029-7844(01)01341-2; Torry DS, 1998, AM J OBSTET GYNECOL, V179, P1539, DOI 10.1016/S0002-9378(98)70021-3; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548; Yinon Y, 2010, CIRCULATION, V122, P1846, DOI 10.1161/CIRCULATIONAHA.110.948455	36	15	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43637	10.1371/journal.pone.0043637	http://dx.doi.org/10.1371/journal.pone.0043637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952728	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300019
J	Kverka, M; Ulcova-Gallova, Z; Bartova, J; Cibulka, J; Bibkova, K; Micanova, Z; Tlaskalova-Hogenova, H				Kverka, Miloslav; Ulcova-Gallova, Zdenka; Bartova, Jirina; Cibulka, Jan; Bibkova, Katarina; Micanova, Zdenka; Tlaskalova-Hogenova, Helena			Sperm Cells Induce Distinct Cytokine Response in Peripheral Mononuclear Cells from Infertile Women with Serum Anti-Sperm Antibodies	PLOS ONE			English	Article							IMMUNE-RESPONSES; GROWTH-FACTOR; ENDOMETRIOSIS; ABORTION; SYSTEM; FLUID	Background and Aims: Anti-sperm antibodies in can markedly reduce the likelihood of natural conception. The etiology of this anti-sperm immunity in human females is unknown. We compared the cytokine response of peripheral blood mononuclear cells (PBMCs) from infertile patients with or without anti-sperm antibodies (ASA) and fertile women. Methodology/Principal Findings: We cultivated the PBMCs together with sperm antigens (whole cells or cell lysate), and screened the supernatants for 40 cytokines by antibody array. When stimulated with whole sperm cells, the PBMCs from patients with ASA produce less IL-3, IL-11, IL-13, ICAM-1, GCSF and more IL-2, IL-4 and IL-12p70 as compared to healthy women. PBMCs from patients with ASA produce typically less IL-13, IL-7, IL-17 and MIG, and more MIP-1 beta and IL-8, as compared to PBMCs from patients without ASA. In response to sperm cell lysate, PBMCs from infertile women without ASA respond initially by increase in production of growth factors (GCSF, GM-CSF and PDGF-BB) followed by increase in chemokines (e.g. IL-8, MCP-1 and MIP-1 beta). Conclusions: Cellular immune responses to sperm antigens, measured by production of cytokines, differ among infertile women with ASA, infertile women without ASA and healthy women. This difference could play an important role in the initial steps of the infertility pathogenesis.	[Kverka, Miloslav; Tlaskalova-Hogenova, Helena] Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic; [Ulcova-Gallova, Zdenka; Cibulka, Jan; Bibkova, Katarina; Micanova, Zdenka] Charles Univ Prague, Dept Gynecol & Obstet, Plzen, Czech Republic; [Ulcova-Gallova, Zdenka; Cibulka, Jan; Bibkova, Katarina; Micanova, Zdenka] Fac Hosp, Plzen, Czech Republic; [Bartova, Jirina] Charles Univ Prague, Fac Med 1, Gen Univ Hosp, Inst Dent Res, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; General University Hospital Prague	Kverka, M (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic.	ulcova@fnplzen.cz	Tlaskalová-Hogenová, Helena/J-8008-2014; Kverka, Miloslav/H-2507-2014	Kverka, Miloslav/0000-0002-1335-5252	Ministry of Education, Youth and Sports of the Czech Republic [MSM 002 1620812]; Institutional Research Concept [RVO: 61388971]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concept	This work was supported by a grant of the Ministry of Education, Youth and Sports of the Czech Republic (MSM 002 1620812) and by Institutional Research Concept (RVO: 61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaouat G, 2004, INT ARCH ALLERGY IMM, V134, P93, DOI 10.1159/000074300; CHAOUAT G, 1990, J REPROD FERTIL, V89, P447; Chaouat G, 2007, J ASSIST REPROD GEN, V24, P491, DOI 10.1007/s10815-007-9142-9; CZERKINSKY C, 1987, P NATL ACAD SCI USA, V84, P2449, DOI 10.1073/pnas.84.8.2449; Friberg J, 1974, Acta Obstet Gynecol Scand Suppl, V36, P31; Fukushi J, 2000, J IMMUNOL, V165, P2818, DOI 10.4049/jimmunol.165.5.2818; Gallinelli A, 2004, GYNECOL ENDOCRINOL, V18, P144, DOI 10.1080/09513590310001653044; Hammadeh ME, 2003, AM J REPROD IMMUNOL, V50, P124, DOI 10.1034/j.1600-0897.2003.00056.x; HILL JA, 1987, J IMMUNOL, V139, P2250; HJORT T, 1988, HUM REPROD, V3, P59, DOI 10.1093/oxfordjournals.humrep.a136652; Kamada Masaharu, 1999, Journal of Medical Investigation, V46, P19; Koumantaki Y, 2001, EUR J OBSTET GYN R B, V98, P66, DOI 10.1016/S0301-2115(01)00289-5; Kverka M, 2007, CLIN CHEM, V53, P955, DOI 10.1373/clinchem.2006.077107; MCDERMOTT MR, 1979, J IMMUNOL, V122, P1892; MCSHANE PM, 1985, JAMA-J AM MED ASSOC, V253, P3555, DOI 10.1001/jama.253.24.3555; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; NAZ RK, 1989, BIOL REPROD, V41, P533, DOI 10.1095/biolreprod41.3.533; Ostanin AA, 2007, B EXP BIOL MED+, V143, P75, DOI 10.1007/s10517-007-0021-2; PAUL WE, 1989, CELL, V57, P521, DOI 10.1016/0092-8674(89)90121-9; Robertson SA, 2000, REV REPROD, V5, P164, DOI 10.1530/revreprod/5.3.164; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Somigliana E, 1996, HUM REPROD, V11, P1190; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulcova-Gallova Z, 2010, J REPROD IMMUNOL, V86, P115, DOI 10.1016/j.jri.2010.07.002; Ulcova-Gallova Z, 2000, Zentralbl Gynakol, V122, P495, DOI 10.1055/s-2000-10611; WELCH PA, 1989, J IMMUNOL, V143, P3562; WHO, 1999, WHO LAB MAN EX HUM S, P1; Wira CR, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1661, DOI 10.1016/B978-012491543-5/50101-7; Zdenka U-G., 2005, J REPROD CONTRACEPT, V16, P35; Zhao Ying, 2003, Methods Mol Biol, V224, P183	31	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44172	10.1371/journal.pone.0044172	http://dx.doi.org/10.1371/journal.pone.0044172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952917	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300058
J	Song, GL; Li, Q; Long, Y; Gu, QL; Hackett, PB; Cui, ZB				Song, Guili; Li, Qing; Long, Yong; Gu, Qilin; Hackett, Perry B.; Cui, Zongbin			Effective Gene Trapping Mediated by Sleeping Beauty Transposon	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MESSENGER-RNA DECAY; INSERTIONAL MUTAGENESIS; FUNCTIONAL-ANALYSIS; GENOME-WIDE; LARGE-SCALE; MOUSE; ZEBRAFISH; EXPRESSION; MICE	Gene trapping is a high-throughput approach to elucidate gene functions by disrupting and recapitulating expression of genes in a target genome. A number of transposon-based gene-trapping systems are developed for mutagenesis in cells and model organisms, but there is still much room for the improvement of their efficiency in gene disruption and mutation. Herein, a gene-trapping system mediated by Sleeping Beauty (SB) transposon was developed by inclusion of three functional cassettes. The mutation cassette can abrogate the splice of trapped genes and terminate their translation. Once an endogenous gene is captured, the finding cassette independently drives the translation of reporter gene in HeLa cells and zebrafish embryos. The efficiency cassette controls the remobilization of integrated traps through inducible expression of SB gene. Analysis of transposon-genome junctions indicate that most of trap cassettes are integrated into an intron without an obvious 39 bias. The transcription of trapped genes was abrogated by alternative splicing of the mutation cassette. In addition, integrated transposons can be induced to excise from their original insertion sites. Furthermore, the Cre/LoxP system was introduced to delete the efficiency cassette for stabilization of gene interruption and bio-safety. Thus, this gene-trap vector is an alternative and effective tool for the capture and disruption of endogenous genes in vitro and in vivo.	[Song, Guili; Li, Qing; Long, Yong; Gu, Qilin; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Song, Guili; Gu, Qilin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hackett, Perry B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Minnesota System; University of Minnesota Twin Cities	Song, GL (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zbcui@ihb.ac.cn	Gu, Qilin/H-3911-2017	Gu, Qilin/0000-0001-9193-077X	National Basic Research Program of China [2012CB944500]; National Natural Science Foundation of China [30871442]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (#2012CB944500) and the National Natural Science Foundation of China (#30871442 to Z. Cui). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Amsterdam A, 2006, TRENDS GENET, V22, P473, DOI 10.1016/j.tig.2006.06.011; Amsterdam A, 2011, METHOD CELL BIOL, V104, P59, DOI 10.1016/B978-0-12-374814-0.00004-5; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Balciunas D, 2005, ZEBRAFISH, V1, P335, DOI 10.1089/zeb.2005.1.335; Bjarnadottir H, 2005, J BIOTECHNOL, V117, P173, DOI 10.1016/j.jbiotec.2005.01.016; Boeuf P, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-5; Bonaldo P, 1998, EXP CELL RES, V244, P125, DOI 10.1006/excr.1998.4208; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Carlson CM, 2005, NAT REV GENET, V6, P568, DOI 10.1038/nrg1638; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Clark KJ, 2004, GENESIS, V39, P225, DOI 10.1002/gene.20049; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; De-Zolt Silke, 2009, V530, P29, DOI 10.1007/978-1-59745-471-1_3; Driever W, 1996, DEVELOPMENT, V123, P37; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Fahrenkrug SC, 1999, MAR BIOTECHNOL, V1, P552, DOI 10.1007/PL00011810; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; Galla M, NUCL ACIDS RES; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Geurts AM, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-30; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Hackett PB, 2005, ADV GENET, V54, P189, DOI 10.1016/S0065-2660(05)54009-4; Haffter P, 1996, DEVELOPMENT, V123, P1; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; Izsvak Z, 2005, NAT METHODS, V2, P735, DOI 10.1038/nmeth1005-735; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Largaespada David A., 2009, V530, P379, DOI 10.1007/978-1-59745-471-1_20; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YY, 2011, J BIOL CHEM, V286, P45116, DOI 10.1074/jbc.M111.267328; Liu GY, 2004, J GENE MED, V6, P574, DOI 10.1002/jgm.486; Liu Z J, 1990, DNA Seq, V1, P125, DOI 10.3109/10425179009016040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClive P, 1998, DEV DYNAM, V212, P267, DOI 10.1002/(SICI)1097-0177(199806)212:2<267::AID-AJA11>3.0.CO;2-1; Medico E, 2001, NAT BIOTECHNOL, V19, P579, DOI 10.1038/89343; Mikkola HKA, 2004, METH MOLEC MED, V105, P3; Miskey C, 2005, CELL MOL LIFE SCI, V62, P629, DOI 10.1007/s00018-004-4232-7; Misra RP, 2002, ENDOCRINE, V19, P229, DOI 10.1385/ENDO:19:3:229; Molina A, 2001, BIOCHEM J, V356, P353, DOI 10.1042/0264-6021:3560353; Ni Jun, 2008, Briefings in Functional Genomics & Proteomics, V7, P444, DOI 10.1093/bfgp/eln049; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Schnuetgen F, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn603; Shigeoka T, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni022; Sinzelle L, 2008, P NATL ACAD SCI USA, V105, P4715, DOI 10.1073/pnas.0707746105; Sivasubbu S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S9; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Talbot WS, 2000, GENE DEV, V14, P755; Thorey IS, 1998, MOL CELL BIOL, V18, P3081, DOI 10.1128/MCB.18.5.3081; Tsakiridis A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp640; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang XQ, 2005, CLIN CANCER RES, V11, P483; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Xin HB, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni016; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Yant SR, 2003, MOL CELL BIOL, V23, P8505, DOI 10.1128/MCB.23.23.8505-8518.2003; Yergeau DA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-11; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024	81	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44123	10.1371/journal.pone.0044123	http://dx.doi.org/10.1371/journal.pone.0044123			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952894	gold, Green Submitted, Green Published			2022-12-27	WOS:000308221300053
J	Bakker, MG; Tu, ZJ; Bradeen, JM; Kinkel, LL				Bakker, Matthew G.; Tu, Zheng J.; Bradeen, James M.; Kinkel, Linda L.			Implications of Pyrosequencing Error Correction for Biological Data Interpretation	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; QUALITY; READS; SOIL	There has been a rapid proliferation of approaches for processing and manipulating second generation DNA sequence data. However, users are often left with uncertainties about how the choice of processing methods may impact biological interpretation of data. In this report, we probe differences in output between two different processing pipelines: a de-noising approach using the AmpliconNoise algorithm for error correction, and a standard approach using quality filtering and preclustering to reduce error. There was a large overlap in reads culled by each method, although AmpliconNoise removed a greater net number of reads. Most OTUs produced by one method had a clearly corresponding partner in the other. Although each method resulted in OTUs consisting entirely of reads that were culled by the other method, there were many more such OTUs formed in the standard pipeline. Total OTU richness was reduced by AmpliconNoise processing, but per-sample OTU richness, diversity and evenness were increased. Increases in per-sample richness and diversity may be a result of AmpliconNoise processing producing a more even OTU rank-abundance distribution. Because communities were randomly subsampled to equalize sample size across communities, and because rare sequence variants are less likely to be selected during subsampling, fewer OTUs were lost from individual communities when subsampling AmpliconNoise-processed data. In contrast to taxon-based diversity estimates, phylogenetic diversity was reduced even on a per-sample basis by de-noising, and samples switched widely in diversity rankings. This work illustrates the significant impacts of processing pipelines on the biological interpretations that can be made from pyrosequencing surveys. This study provides important cautions for analyses of contemporary data, for requisite data archiving (processed vs. non-processed data), and for drawing comparisons among studies performed using distinct data processing pipelines.	[Bakker, Matthew G.; Bradeen, James M.; Kinkel, Linda L.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Tu, Zheng J.] Univ Minnesota, Inst Supercomp, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bakker, MG (corresponding author), Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA.	matt.g.bakker@gmail.com	Bakker, Matthew/B-8610-2013	Bakker, Matthew/0000-0003-0345-0587; Bradeen, James/0000-0003-1930-4728	National Science Foundation; Mustard Seed Foundation; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, through the Microbial Observatories program [2006-04464]	National Science Foundation(National Science Foundation (NSF)); Mustard Seed Foundation; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, through the Microbial Observatories program	MGB gratefully acknowledges support from the National Science Foundation (Graduate Research Fellowship) and the Mustard Seed Foundation (Harvey Fellows program). Funding was provided by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, through the Microbial Observatories program (grant number 2006-04464 to LLK and JMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McVeigh HP, 1996, J IND MICROBIOL, V17, P197, DOI 10.1007/BF01574693; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rintala H, 2001, MOL CELL PROBE, V15, P337, DOI 10.1006/mcpr.2001.0379; Schlatter DC, 2010, APPL ENVIRON MICROB, V76, P2009, DOI 10.1128/AEM.02320-09; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	24	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44357	10.1371/journal.pone.0044357	http://dx.doi.org/10.1371/journal.pone.0044357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952965	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500064
J	Kowalczykiewicz, D; Pawlak, P; Lechniak, D; Wrzesinski, J				Kowalczykiewicz, Dorota; Pawlak, Piotr; Lechniak, Dorota; Wrzesinski, Jan			Altered Expression of Porcine Piwi Genes and piRNA during Development	PLOS ONE			English	Article							SMALL RNAS; ARGONAUTE FAMILY; DNA METHYLATION; BIOGENESIS; PROTEINS; PATHWAY; MILI; RETROTRANSPOSON; IDENTIFICATION; AMPLIFICATION	Three Sus scrofa Piwi genes (Piwil1, Piwil2 and Piwil4) encoding proteins of 861, 985 and 853 aminoacids, respectively, were cloned and sequenced. Alignment of the Piwi proteins showed the high identity between Sus scrofa and Homo sapiens. Relative transcript abundance of porcine Piwil1, Piwil2 and Piwil4 genes in testes, ovaries and oocytes derived from sexually immature and mature animals was examined using Real-Time PCR. Expression of the three Piwi mRNAs was proved to be tissue specific and restricted exclusively to the gonads. In testes of adult pigs the highest relative transcript abundance was observed for the Sus scrofa Piwil1 gene. On the other hand, in testes of neonatal pigs the Piwil1 transcript level was over 2-fold reduced while the level of Piwil2 transcript was higher. As regards the expression of the Piwil4 transcript, its level was 34-fold elevated in testes of neonatal piglet when compared to adult male. In ovaries of prepubertal and pubertal female pigs transcript abundance of the three Piwi genes was significantly reduced in comparison with testes. However, similarly to testes, in ovaries of neonatal pigs the Piwil2 gene was characterized by the highest relative transcript abundance among the three Piwi genes analysed. In prepubertal and pubertal oocytes Piwil1 transcript was the most abundant whereas the expression of Piwil4 was undetectable. We also demonstrated that expression of piRNA occurs preferentially in the gonads of adult male and female pigs. Moreover, a piRNA subset isolated from ovaries was 2-3 nucleotides longer than the piRNA from testes.	[Kowalczykiewicz, Dorota; Wrzesinski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Pawlak, Piotr; Lechniak, Dorota] Univ Life Sci, Dept Genet & Anim Breeding, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Life Sciences	Kowalczykiewicz, D (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	wrzesinj@ibch.poznan.pl	Pawlak, Piotr/AAX-7094-2020	Pawlak, Piotr/0000-0003-3489-1684; Wrzesinski, Jan/0000-0002-3777-4320; LECHNIAK, DOROTA Marta/0000-0001-8543-0752	Polish Ministry of Science and Higher Education [N N303 414237, DPN/N103/COST/2009]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish Ministry of Science and Higher Education (N N303 414237 and DPN/N103/COST/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Gu AH, 2010, HUM REPROD, V25, P2955, DOI 10.1093/humrep/deq274; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Gunawardane LS, 2002, GENE DEV, V16, P2733; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hunter MG, 2000, REV REPROD, V5, P122, DOI 10.1530/revreprod/5.2.122; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kawaoka S, 2008, BIOCHEM BIOPH RES CO, V367, P755, DOI 10.1016/j.bbrc.2008.01.013; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Liu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034770; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Ohnishi Y, 2010, NUCLEIC ACIDS RES, V38, P5141, DOI 10.1093/nar/gkq229; Pillai RS, 2012, DEV GROWTH DIFFER, V54, P78, DOI 10.1111/j.1440-169X.2011.01320.x; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Simon B, 2011, STRUCTURE, V19, P172, DOI 10.1016/j.str.2010.11.015; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Siomi MC, 2010, GENE DEV, V24, P636, DOI 10.1101/gad.1899210; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Tian YA, 2011, P NATL ACAD SCI USA, V108, P903, DOI 10.1073/pnas.1017762108; Warzych E, 2007, MOL REPROD DEV, V74, P280, DOI 10.1002/mrd.20610; Wei KF, 2012, J CELL BIOCHEM, V113, P2576, DOI 10.1002/jcb.24133; Wilczynska A, 2009, RNA, V15, P337, DOI 10.1261/rna.1422509; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Zhou X, 2010, GENETICA, V138, P805, DOI 10.1007/s10709-010-9462-z	50	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43816	10.1371/journal.pone.0043816	http://dx.doi.org/10.1371/journal.pone.0043816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952772	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500023
J	Pan, LT; Wang, XX; Yang, SY; Wu, X; Lee, I; Zhang, XZ; Rupp, RA; Xu, JJ				Pan, Leiting; Wang, Xiaoxu; Yang, Shuying; Wu, Xian; Lee, Imshik; Zhang, Xinzheng; Rupp, Romano A.; Xu, Jingjun			Ultraviolet Irradiation-Dependent Fluorescence Enhancement of Hemoglobin Catalyzed by Reactive Oxygen Species	PLOS ONE			English	Article							VITAMIN-C; PHOTODYNAMIC THERAPY; HEME DEGRADATION; VISIBLE-LIGHT; RADIATION; ERYTHROCYTES; PEROXIDE; BLOOD; SKIN	Ultraviolet (UV) light has a potent effect on biological organisms. Hemoglobin, an oxygen-transport protein, plays an irreplaceable role in sustaining life of all vertebrates. In this study we scrutinize the effects of ultraviolet irradiation (UVI) as well as visible irradiation on the flourescence characteristics of bovine hemoglobin (BHb) in vitro. Data show that UVI results in flourescence enhancement of BHb in a dose-dependent manner. Furthermore, UVI-induced flourencence enhancement is significantly increased when BHb is pretreated with hydrogen peroxide (H2O2), a tye of reactive oxygen species (ROS). Meanwhile, The water-soluble antioxidant vitamin C suppresses this UVI-induced flourescence enhancement. In contrast, green light irradiation does not lead to flourescence enhancement of BHb no matter whether H2O2 is acting on the BHb solution or not. Taken together, these results indicate that catalysis of ROS and UVI-dependent irradiation play two key roles in the process of UVI-induced flourescence enhancement of BHb.	[Pan, Leiting; Wang, Xiaoxu; Yang, Shuying; Wu, Xian; Lee, Imshik; Zhang, Xinzheng; Rupp, Romano A.; Xu, Jingjun] Nankai Univ, TEDA Appl Phys Sch, Minist Educ, Key Lab Weak Light Nonlinear Photon, Tianjin 300071, Peoples R China; [Pan, Leiting; Wang, Xiaoxu; Yang, Shuying; Wu, Xian; Lee, Imshik; Zhang, Xinzheng; Rupp, Romano A.; Xu, Jingjun] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China; [Rupp, Romano A.] Univ Vienna, Fac Phys, Vienna, Austria	Nankai University; Nankai University; University of Vienna	Pan, LT (corresponding author), Nankai Univ, TEDA Appl Phys Sch, Minist Educ, Key Lab Weak Light Nonlinear Photon, Tianjin 300071, Peoples R China.	plt@nankai.edu.cn; jjxu@nankai.edu.cn	Lee, Imshik/G-6129-2010; xu, jing/GRR-8698-2022; Jingjun, Xu/A-1282-2010; Zhang, Xinzheng/C-5703-2009; Pan, Leiting/F-5001-2010	Lee, Imshik/0000-0002-0098-392X; Zhang, Xinzheng/0000-0001-8128-3273; 	Specialized Research Fund for the Doctoral Program of Higher Education (New Teachers) [20110031120004]; Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China [11074133]; National Basic Research Program of China [2007CB307002, 2010CB934101]; 111 project [B07013]; International S&T cooperation program of China [2011DFA52870]	Specialized Research Fund for the Doctoral Program of Higher Education (New Teachers)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); 111 project(Ministry of Education, China - 111 Project); International S&T cooperation program of China	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (New Teachers) (No. 20110031120004), the Fundamental Research Funds for the Central Universities, the National Natural Science Foundation of China (No. 11074133), the National Basic Research Program of China (Nos. 2007CB307002, 2010CB934101), 111 project (No. B07013) and International S&T cooperation program of China (2011DFA52870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CU A, 1975, J AM CHEM SOC, V97, P2579, DOI 10.1021/ja00842a066; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Farris PK, 2005, DERMATOL SURG, V31, P814; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; HEITZER T, 1996, NY TIMES        1026, V94, P6; Hussein MR, 2005, J CUTAN PATHOL, V32, P191, DOI 10.1111/j.0303-6987.2005.00281.x; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Kaestner L, 2006, CELL CALCIUM, V39, P13, DOI 10.1016/j.ceca.2005.09.004; Kaestner L, 2004, PHOTOCH PHOTOBIO SCI, V3, P981, DOI 10.1039/b403127j; Krukoski DW, 2009, HEMATOLOGY, V14, P168, DOI 10.1179/102453309X402296; Lavi R, 2003, J BIOL CHEM, V278, P40917, DOI 10.1074/jbc.M303034200; Lavi R, 2010, LASER SURG MED, V42, P473, DOI 10.1002/lsm.20919; Lin JY, 2003, J AM ACAD DERMATOL, V48, P866, DOI 10.1067/mjd.2003.425; Longstreth J, 1998, J PHOTOCH PHOTOBIO B, V46, P20, DOI 10.1016/S1011-1344(98)00183-3; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Nagababu E, 1998, BIOCHEM BIOPH RES CO, V247, P592, DOI 10.1006/bbrc.1998.8846; Nghiem DX, 2001, J INVEST DERMATOL, V117, P1193, DOI 10.1046/j.0022-202x.2001.01503.x; Pamphilon DH, 1998, VOX SANG, V74, P15, DOI 10.1111/j.1423-0410.1998.tb05395.x; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Rowen RJ, 1996, INT J BIOSOCIAL MED, V14, P115; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Svobodova AR, 2011, BIOL PHARM BULL, V34, P471; Valencia A, 2006, FREE RADICAL BIO MED, V40, P641, DOI 10.1016/j.freeradbiomed.2005.09.036; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Yu L, 1997, CHINESE J MED PHYS, V14, P136; Zhao J, 2008, INT J MOL SCI, V9, P145, DOI 10.3390/ijms9020145	27	12	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44142	10.1371/journal.pone.0044142	http://dx.doi.org/10.1371/journal.pone.0044142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952902	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206500049
J	Taylor, WR; Nguyen, K; Nguyen, D; Nguyen, H; Horby, P; Nguyen, HL; Lien, T; Tran, G; Tran, N; Nguyen, HM; Nguyen, T; Nguyen, HH; Nguyen, T; Tran, G; Farrar, J; de Jong, M; Schultsz, C; Tran, H; Nguyen, D; Vu, B; Le, H; Dao, T; Nguyen, T; Wertheim, H				Taylor, Walter R.; Nguyen, Kinh; Nguyen, Duc; Nguyen, Huyen; Horby, Peter; Nguyen, Ha L.; Lien, Trinh; Tran, Giang; Tran, Ninh; Nguyen, Ha M.; Nguyen, Thai; Nguyen, Ha H.; Nguyen, Thanh; Tran, Giap; Farrar, Jeremy; de Jong, Menno; Schultsz, Constance; Tran, Huong; Nguyen, Diep; Vu, Bich; Le, Hoa; Dao, Trinh; Nguyen, Trung; Wertheim, Heiman			The Spectrum of Central Nervous System Infections in an Adult Referral Hospital in Hanoi, Vietnam	PLOS ONE			English	Article							ACUTE BACTERIAL-MENINGITIS; TUBERCULOUS MENINGITIS; CEREBROSPINAL-FLUID; JAPANESE ENCEPHALITIS; BACTERIOLOGICAL DIAGNOSIS; MENINGOCOCCAL DISEASE; ANTIBIOTIC THERAPY; CHILDREN; PCR; FEATURES	Objectives: To determine prospectively the causative pathogens of central nervous system (CNS) infections in patients admitted to a tertiary referral hospital in Hanoi, Vietnam. Methods: From May 2007 to December 2008, cerebrospinal fluid (CSF) samples from 352 adults with suspected meningitis or encephalitis underwent routine testing, staining (Gram, Ziehl-Nielsen, India ink), bacterial culture and polymerase chain reaction targeting Neisseria meningitidis, Streptococcus pneumoniae, S. suis, Haemophilus influenzae type b, Herpes simplex virus (HSV), Varicella Zoster virus (VZV), enterovirus, and 16S ribosomal RNA. Blood cultures and clinically indicated radiology were also performed. Patients were classified as having confirmed or suspected bacterial (BM), tuberculous (TBM), cryptococcal (CRM), eosinophilic (EOM) meningitis, aseptic encephalitis/meningitis (AEM), neurocysticercosis and others. Results: 352 (male: 66%) patients were recruited: median age 34 years (range 13-85). 95/352 (27.3%) diagnoses were laboratory confirmed and one by cranial radiology: BM (n = 62), TBM (n = 9), AEM (n = 19), CRM (n = 5), and neurocysticercosis (n = 1, cranial radiology). S. suis predominated as the cause of BM [48/62 (77.4%)]; Listeria monocytogenese (n = 1), S. pasteurianus (n = 1) and N. meningitidis (n = 2) were infrequent. AEM viruses were: HSV (n = 12), VZV (n = 5) and enterovirus (n = 2). 5 patients had EOM. Of 262/352 (74.4%) patients with full clinical data, 209 (79.8%) were hospital referrals and 186 (71%) had been on antimicrobials. 21 (8%) patients died: TBM (15.2%), AEM (10%), and BM (2.8%). Conclusions: Most infections lacked microbiological confirmation. S. suis was the most common cause of BM in this setting. Improved diagnostics are needed for meningoencephalitic syndromes to inform treatment and prevention strategies.	[Taylor, Walter R.; Horby, Peter; Wertheim, Heiman] Univ Oxford, Clin Res Unit, Hanoi, Vietnam; [Taylor, Walter R.; Horby, Peter; Farrar, Jeremy; de Jong, Menno; Schultsz, Constance; Wertheim, Heiman] Churchill Hosp, Ctr Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Nguyen, Kinh; Nguyen, Duc; Nguyen, Huyen; Nguyen, Ha L.; Lien, Trinh; Tran, Giang; Tran, Ninh; Nguyen, Ha M.; Nguyen, Thai; Nguyen, Ha H.; Nguyen, Thanh; Tran, Giap; Tran, Huong; Nguyen, Diep; Vu, Bich; Le, Hoa; Dao, Trinh; Nguyen, Trung] Natl Hosp Trop Dis, Hanoi, Vietnam; [Farrar, Jeremy; de Jong, Menno; Schultsz, Constance] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford; National Hospital of Tropical Diseases; University of Oxford	Taylor, WR (corresponding author), Univ Oxford, Clin Res Unit, Hanoi, Vietnam.	bob@tropmedres.ac	Horby, Peter/D-1585-2013; Farrar, Jeremy J./HGA-7610-2022; Wertheim, Heiman FL/F-3338-2016	Wertheim, Heiman FL/0000-0002-5003-5565; Horby, Peter/0000-0002-9822-1586; Farrar, Jeremy/0000-0002-2700-623X; Tran Thi Hai, Ninh/0000-0003-4350-9985	Wellcome Trust of Grat Britain	Wellcome Trust of Grat Britain	The funding for this study came from core funds, provided mostly by the Wellcome Trust of Grat Britain. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrab A, 2010, JPN J INFECT DIS, V63, P128; BECK RW, 1984, NEUROLOGY, V34, P105, DOI 10.1212/WNL.34.1.105; Beld M, 2004, J CLIN MICROBIOL, V42, P3059, DOI 10.1128/JCM.42.7.3059-3064.2004; Cardosa MJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-9; Chan YC, 2001, ANN ACAD MED SINGAP, V30, P659; CHAU TTH, 2010, PLOS MED, V0007; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; CUTLER RWP, 1968, BRAIN, V91, P707, DOI 10.1093/brain/91.4.707; DAVIS SD, 1975, AM J DIS CHILD, V129, P802, DOI 10.1001/archpedi.1975.02120440028007; de Jong MD, 2000, J CLIN MICROBIOL, V38, P2568, DOI 10.1128/JCM.38.7.2568-2573.2000; FEELEY EJ, 1965, J AMER MED ASSOC, V191, P412, DOI 10.1001/jama.1965.03080050058021; FELDMAN WE, 1978, AM J DIS CHILD, V132, P672, DOI 10.1001/archpedi.1978.02120320032006; GEISELER PJ, 1980, REV INFECT DIS, V2, P725; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018; HO DTN, 2011, PLOS ONE, V0006; Hosoglu S, 2003, EUR J EPIDEMIOL, V18, P337, DOI 10.1023/A:1023673532656; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Le-Van-Hoa, 1965, Bull Soc Pathol Exot Filiales, V58, P236; Lowry PW, 1998, AM J TROP MED HYG, V58, P324, DOI 10.4269/ajtmh.1998.58.324; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; MARTON KI, 1986, ANN INTERN MED, V104, P840, DOI 10.7326/0003-4819-104-6-840; Michael B, 2010, EMERG MED J, V27, P433, DOI 10.1136/emj.2009.075598; Moon SY, 2010, EUR J CLIN MICROBIOL, V29, P793, DOI 10.1007/s10096-010-0929-8; Nair D, 2009, EPIDEMIOL INFECT, V137, P570, DOI 10.1017/S0950268808001398; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nguyen THM, 2009, CLIN INFECT DIS, V49, P1387, DOI 10.1086/630207; Nigrovic LE, 2008, PEDIATRICS, V122, P726, DOI 10.1542/peds.2007-3275; OBERTI J, 1981, B WORLD HEALTH ORGAN, V59, P585; Ooi MH, 2008, CLIN INFECT DIS, V47, P458, DOI 10.1086/590008; PICKENS S, 1978, SCAND J INFECT DIS, V10, P183, DOI 10.3109/inf.1978.10.issue-3.05; Poyart C, 2002, INT J SYST EVOL MICR, V52, P1247, DOI 10.1099/00207713-52-4-1247; PUNYAGUPTA S, 1990, J NEUROL SCI, V96, P241, DOI 10.1016/0022-510X(90)90136-B; Queuche F, 1997, Sante, V7, P155; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; RANKIN J, 1957, Scott Med J, V2, P200; Ray P, 2007, AM J EMERG MED, V25, P179, DOI 10.1016/j.ajem.2006.07.012; SCIARRA D, 1952, JAMA-J AM MED ASSOC, V148, P841, DOI 10.1001/jama.1952.02930100059013; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; STEWART SM, 1953, J CLIN PATHOL, V6, P241, DOI 10.1136/jcp.6.3.241; Sturt AS, 2010, J CLIN MICROBIOL, V48, P2247, DOI 10.1128/JCM.00081-10; Sun W, 2008, ORAL SURG ORAL MED O, V105, P566, DOI 10.1016/j.tripleo.2007.08.015; Taylor WRJ, 2009, CLIN INFECT DIS, V49, pE79, DOI 10.1086/605533; THE P H, 1989, Acta Leidensia, V57, P229; Thomas KE, 2002, CLIN INFECT DIS, V35, P46, DOI 10.1086/340979; Thomson RB, 2001, INFECT DIS CLIN N AM, V15, P1047, DOI 10.1016/S0891-5520(05)70186-0; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P996, DOI 10.1128/JCM.42.3.996-1002.2004; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P378, DOI 10.1128/JCM.42.1.378-379.2004; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; Torok ME, 2007, AM J TROP MED HYG, V77, P555, DOI 10.4269/ajtmh.2007.77.555; Torok ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001772; Trinh P., 1974, Bulletin Soc Path Exot, V67, P298; TUGWELL P, 1976, Q J MED, V45, P583; Uga S, 2009, Nepal Med Coll J, V11, P75; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; WENGER JD, 1990, J INFECT DIS, V162, P1316, DOI 10.1093/infdis/162.6.1316; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Yaramis A, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.5.e49	62	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e42099	10.1371/journal.pone.0042099	http://dx.doi.org/10.1371/journal.pone.0042099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952590	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500003
J	Zhao, M; Sun, JC; Zhao, ZM				Zhao, Min; Sun, Jingchun; Zhao, Zhongming			Distinct and Competitive Regulatory Patterns of Tumor Suppressor Genes and Oncogenes in Ovarian Cancer	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; SIGNALING INDUCES APOPTOSIS; CELL-CYCLE; REPRODUCTIVE FACTORS; HMGA2 GENE; EXPRESSION; BIOLOGY; NETWORK; OVEREXPRESSION; SUSCEPTIBILITY	Background: So far, investigators have found numerous tumor suppressor genes (TSGs) and oncogenes (OCGs) that control cell proliferation and apoptosis during cancer development. Furthermore, TSGs and OCGs may act as modulators of transcription factors (TFs) to influence gene regulation. A comprehensive investigation of TSGs, OCGs, TFs, and their joint target genes at the network level may provide a deeper understanding of the post-translational modulation of TSGs and OCGs to TF gene regulation. Methodology/Principal Findings: In this study, we developed a novel computational framework for identifying target genes of TSGs and OCGs using TFs as bridges through the integration of protein-protein interactions and gene expression data. We applied this pipeline to ovarian cancer and constructed a three-layer regulatory network. In the network, the top layer was comprised of modulators (TSGs and OCGs), the middle layer included TFs, and the bottom layer contained target genes. Based on regulatory relationships in the network, we compiled TSG and OCG profiles and performed clustering analyses. Interestingly, we found TSGs and OCGs formed two distinct branches. The genes in the TSG branch were significantly enriched in DNA damage and repair, regulating macromolecule metabolism, cell cycle and apoptosis, while the genes in the OCG branch were significantly enriched in the ErbB signaling pathway. Remarkably, their specific targets showed a reversed functional enrichment in terms of apoptosis and the ErbB signaling pathway: the target genes regulated by OCGs only were enriched in anti-apoptosis and the target genes regulated by TSGs only were enriched in the ErbB signaling pathway. Conclusions/Significance: This study provides the first comprehensive investigation of the interplay of TSGs and OCGs in a regulatory network modulated by TFs. Our application in ovarian cancer revealed distinct regulatory patterns of TSGs and OCGs, suggesting a competitive regulatory mechanism acting upon apoptosis and the ErbB signaling pathway through their specific target genes.	[Zhao, Min; Sun, Jingchun; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Ctr Quantitat Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zhao, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Zhao, Min/J-6588-2019	Zhao, Min/0000-0001-5498-3434	National Institutes of Health [R01LM011177]; National Institutes of Health (VICC Cancer Center Core grant) [P30CA68485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (VICC Cancer Center Core grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was partially supported by grants from National Institutes of Health (R01LM011177 and the VICC Cancer Center Core grant P30CA68485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Aronson AR, 2004, STUD HEALTH TECHNOL, V107, P268; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Beleza-Meireles A, 2008, EUR J ENDOCRINOL, V158, P729, DOI 10.1530/EJE-07-0793; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bignone PA, 2007, ONCOGENE, V26, P683, DOI 10.1038/sj.onc.1209827; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Campan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028141; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Dwyer J, 2007, ANN NY ACAD SCI, V1114, P36, DOI 10.1196/annals.1396.022; Everett L, 2010, METHODS MOL BIOL, V674, P297, DOI 10.1007/978-1-60761-854-6_19; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Guler G, 2011, BREAST CANCER RES TR, V129, P421, DOI 10.1007/s10549-010-1248-6; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; HANKINSON SE, 1995, CANCER, V76, P284, DOI 10.1002/1097-0142(19950715)76:2<284::AID-CNCR2820760219>3.0.CO;2-5; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Holmes KA, 2008, CANCER RES, V68, P7380, DOI 10.1158/0008-5472.CAN-08-0133; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang Y, 2011, J LEUKOCYTE BIOL, V90, P87, DOI 10.1189/jlb.1210674; Hunter DS, 2002, CANCER RES, V62, P3766; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jia P, 2010, MOL PSYCHIATR, V15, P453, DOI 10.1038/mp.2009.93; Jia PL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S12; Kaur M, 2009, NUCLEIC ACIDS RES, V37, pD820, DOI 10.1093/nar/gkn593; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Khanna A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017979; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Klein G, 2002, TUMOR SUPPRESSOR GEN, P491; Konnikova L, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-23; KVALE G, 1988, INT J CANCER, V42, P246, DOI 10.1002/ijc.2910420217; Leung PCK, 2007, HUM REPROD UPDATE, V13, P143, DOI 10.1093/humupd/dml002; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Mahajan A, 2010, MODERN PATHOL, V23, P673, DOI 10.1038/modpathol.2010.49; Malek A, 2008, INT J CANCER, V123, P348, DOI 10.1002/ijc.23491; Martinez LA, 2010, MOL CELL BIOL, V30, P524, DOI 10.1128/MCB.00938-09; Osborne C, 2004, ONCOLOGIST, V9, P361, DOI 10.1634/theoncologist.9-4-361; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Park C, 2006, INT J MOL MED, V17, P715; R Development Core Team, 2008, R LANG ENV STAT COMP; Rebbeck TR, 2004, NAT REV GENET, V5, P589, DOI 10.1038/nrg1403; Riddick G, 2011, NAT REV NEUROL, V7, P439, DOI 10.1038/nrneurol.2011.100; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Santos SDM, 2008, NATURE, V454, P288, DOI 10.1038/454288a; SCHWAB M, 1989, BIOCHIM BIOPHYS ACTA, V989, P49, DOI 10.1016/0304-419X(89)90034-6; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shelton DN, 2011, P OBST GYN, V2, P16; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shimada M, 2003, MOL CELL BIOL, V23, P4107, DOI 10.1128/MCB.23.12.4107-4120.2003; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Takai N, 2002, INT J MOL MED, V9, P287; Tang MJ, 2007, J BIOL CHEM, V282, P34457, DOI 10.1074/jbc.M704459200; Teng CB, 2004, REPRODUCTION, V128, P197, DOI 10.1530/rep.1.00053; Trinh XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022469; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Xu DK, 2002, EMBO J, V21, P4081, DOI 10.1093/emboj/cdf413	76	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44175	10.1371/journal.pone.0044175	http://dx.doi.org/10.1371/journal.pone.0044175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952919	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206500052
J	Bezerra, GA; Dobrovetsky, E; Dong, AP; Seitova, A; Crombett, L; Shewchuk, LM; Hassell, AM; Sweitzer, SM; Sweitzer, TD; McDevitt, PJ; Johanson, KO; Kennedy-Wilson, KM; Cossar, D; Bochkarev, A; Gruber, K; Dhe-Paganon, S				Bezerra, Gustavo Arruda; Dobrovetsky, Elena; Dong, Aiping; Seitova, Almagul; Crombett, Lissete; Shewchuk, Lisa M.; Hassell, Annie M.; Sweitzer, Sharon M.; Sweitzer, Thomas D.; McDevitt, Patrick J.; Johanson, Kyung O.; Kennedy-Wilson, Karen M.; Cossar, Doug; Bochkarev, Alexey; Gruber, Karl; Dhe-Paganon, Sirano			Structures of Human DPP7 Reveal the Molecular Basis of Specific Inhibition and the Architectural Diversity of Proline-Specific Peptidases	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROLYL OLIGOPEPTIDASE; SUBSTRATE-SPECIFICITY; SERINE-PROTEASE; DIPEPTIDYL; PURIFICATION; IV; AMINOPEPTIDASE; POTENT; MODEL	Proline-specific dipeptidyl peptidases (DPPs) are emerging targets for drug development. DPP4 inhibitors are approved in many countries, and other dipeptidyl peptidases are often referred to as DPP4 activity-and/or structure-homologues (DASH). Members of the DASH family have overlapping substrate specificities, and, even though they share low sequence identity, therapeutic or clinical cross-reactivity is a concern. Here, we report the structure of human DPP7 and its complex with a selective inhibitor Dab-Pip (L-2,4-diaminobutyryl-piperidinamide) and compare it with that of DPP4. Both enzymes share a common catalytic domain (alpha/beta-hydrolase). The catalytic pocket is located in the interior of DPP7, deep inside the cleft between the two domains. Substrates might access the active site via a narrow tunnel. The DPP7 catalytic triad is completely conserved and comprises Ser162, Asp418 and His443 (corresponding to Ser630, Asp708 and His740 in DPP4), while other residues lining the catalytic pockets differ considerably. The "specificity domains" are structurally also completely different exhibiting a b-propeller fold in DPP4 compared to a rare, completely helical fold in DPP7. Comparing the structures of DPP7 and DPP4 allows the design of specific inhibitors and thus the development of less cross-reactive drugs. Furthermore, the reported DPP7 structures shed some light onto the evolutionary relationship of prolyl-specific peptidases through the analysis of the architectural organization of their domains.	[Bezerra, Gustavo Arruda; Gruber, Karl] Graz Univ, Inst Mol Biosci, Graz, Austria; [Dobrovetsky, Elena; Dong, Aiping; Seitova, Almagul; Crombett, Lissete; Cossar, Doug; Bochkarev, Alexey; Dhe-Paganon, Sirano] Univ Toronto, MaRS Ctr, Struct Genom Consortium, Toronto, ON, Canada; [Dhe-Paganon, Sirano] Univ Toronto, MaRS Ctr, Dept Physiol, Toronto, ON, Canada; [Sweitzer, Sharon M.; Sweitzer, Thomas D.; McDevitt, Patrick J.; Johanson, Kyung O.; Kennedy-Wilson, Karen M.] GlaxoSmithKline, Collegeville, PA USA	University of Graz; University of Toronto; Structural Genomics Consortium; University of Toronto; GlaxoSmithKline	Bezerra, GA (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	karl.gruber@uni-graz.at; sirano.dhepaganon@utoronto.ca	Gruber, Karl/GPP-6706-2022	Gruber, Karl/0000-0002-3485-9740; Arruda Bezerra, Gustavo/0000-0003-4471-821X	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Doktoratskolleg "Molecular Enzymology" from Austrian Science Fund; UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Doktoratskolleg "Molecular Enzymology" from Austrian Science Fund; UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. Additional funding was provided by the Doktoratskolleg "Molecular Enzymology" Grant W901-B05 from the Austrian Science Fund (to KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. We thank Curt Haffner (GlaxoSmithKline) for synthesizing Dab-Pip.	Adams PD, 2011, METHODS; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Ahn JH, 2008, BIOORG MED CHEM LETT, V18, P6525, DOI 10.1016/j.bmcl.2008.10.076; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Araki H, 2001, J BIOCHEM-TOKYO, V129, P279, DOI 10.1093/oxfordjournals.jbchem.a002855; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bricogne G, 2009, BUSTER 2 8 0; Busek P, 2004, INT J BIOCHEM CELL B, V36, P408, DOI 10.1016/S1357-2725(03)00262-0; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Chiravuri M, 2000, J IMMUNOL, V165, P5695, DOI 10.4049/jimmunol.165.10.5695; Chiravuri M, 2000, J BIOL CHEM, V275, P26994; CUMMINS P, 1992, Biochemical Society Transactions, V20, p56S; Danilova O, 2007, BIOORG MED CHEM LETT, V17, P507, DOI 10.1016/j.bmcl.2006.10.012; Danilova OV, 2009, ENDOCRINOLOGY, V150, P5240, DOI 10.1210/en.2009-0386; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Goettig P, 2002, EMBO J, V21, P5343, DOI 10.1093/emboj/cdf552; Goldstone DC, 2010, PROTEINS, V78, P1457, DOI 10.1002/prot.22662; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Hiramatsu H, 2004, BIOL CHEM, V385, P561, DOI 10.1515/BC.2004.068; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kozarich JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-87; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leiting B, 2003, BIOCHEM J, V371, P525, DOI 10.1042/BJ20021643; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; Medrano FJ, 1998, EMBO J, V17, P1, DOI 10.1093/emboj/17.1.1; Mele DA, 2009, CELL CYCLE, V8, P2425, DOI 10.4161/cc.8.15.9144; MENTLEIN R, 1989, J NEUROCHEM, V52, P1284, DOI 10.1111/j.1471-4159.1989.tb01877.x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Renault L, 2005, CHEM-BIOL INTERACT, V157, P339, DOI 10.1016/j.cbi.2005.10.100; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sentandreu MA, 2000, J AGR FOOD CHEM, V48, P5014, DOI 10.1021/jf990892q; Senten K, 2003, J MED CHEM, V46, P5005, DOI 10.1021/jm0308803; Soisson SM, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-16; Stockel-Maschek A, 2000, BBA-PROTEIN STRUCT M, V1479, P15, DOI 10.1016/S0167-4838(00)00054-6; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; Underwood R, 1999, J BIOL CHEM, V274, P34053, DOI 10.1074/jbc.274.48.34053; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xu ZJ, 2011, J MED CHEM, V54, P5607, DOI 10.1021/jm200644r; Yamada H, 2007, PROTEIN SCI, V16, P1389, DOI 10.1110/ps.072851407; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Yoshimoto T, 1999, J BIOCHEM, V126, P559, DOI 10.1093/oxfordjournals.jbchem.a022486	60	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43019	10.1371/journal.pone.0043019	http://dx.doi.org/10.1371/journal.pone.0043019			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952628	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206000016
J	Blas, MM; Alva, IE; Garcia, PJ; Carcamo, C; Montano, SM; Munante, R; Zunt, JR				Blas, Magaly M.; Alva, Isaac E.; Garcia, Patricia J.; Carcamo, Cesar; Montano, Silvia M.; Munante, Ricardo; Zunt, Joseph R.			Association between Human Papillomavirus and Human T-Lymphotropic Virus in Indigenous Women from the Peruvian Amazon	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FEMALE SEX WORKERS; RISK-FACTORS; CERVICAL NEOPLASIA; HUMAN RETROVIRUSES; I INFECTION; HTLV-I/II; PREVALENCE; GRADE; ABNORMALITIES	Background: No association between the Human T-cell lymphotropic virus (HTLV), an oncogenic virus that alters host immunity, and the Human Papillomavirus (HPV) has previously been reported. Examining the association between these two viruses may permit the identification of a population at increased risk for developing cervical cancer. Methods and Findings: Between July 2010 and February 2011, we conducted a cross-sectional study among indigenous Amazonian Peruvian women from the Shipibo-Konibo ethnic group, a group with endemic HTLV infection. We recruited women between 15 and 39 years of age who were living in the cities of Lima and Ucayali. Our objectives were to determine the association between HTLV and: (i) HPV infection of any type, and (ii) high-risk HPV type infection. Sexually active Shipibo-Konibo women were screened for HTLV-1 and HTLV-2 infections. All HTLV-1 or -2 positive women, along with two community-matched HTLV negative sexually active Shipibo-Konibo controls were later tested for the presence of HPV DNA, conventional cytology, and HIV. We screened 1,253 Shipibo-Konibo women, observing a prevalence of 5.9% (n = 74) for HTLV-1 and 3.8% (n = 47) for HTLV-2 infections. We enrolled 62 (60.8%) HTLV-1 positive women, 40 (39.2%) HTLV-2 positive women, and 205 community-matched HTLV negative controls. HTLV-1 infection was strongly associated with HPV infection of any type (43.6% vs. 29.3%; Prevalence Ratio (PR): 2.10, 95% CI: 1.53-2.87), and with high-risk HPV infection (32.3% vs. 22.4%; PR: 1.93, 95% CI: 1.04-3.59). HTLV-2 was not significantly associated with either of these HPV infections. Conclusions: HTLV-1 infection was associated with HPV infection of any type and with high-risk HPV infection. Future longitudinal studies are needed to evaluate the incidence of high-risk HPV infection as well as the incidence of cervical neoplasia among HTLV-1 positive women.	[Blas, Magaly M.; Alva, Isaac E.; Garcia, Patricia J.; Carcamo, Cesar] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol STD & HIV Unit, Lima, Peru; [Montano, Silvia M.] US Naval Med Res Unit 6 NAMRU 6, Lima, Peru; [Munante, Ricardo] Minist Hlth, Ucayali Reg Hlth Directorate, Ucayali, Peru; [Zunt, Joseph R.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Zunt, Joseph R.] Univ Washington, Sch Med, Dept Neurol Global Hlth & Med, Seattle, WA USA	Universidad Peruana Cayetano Heredia; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Blas, MM (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol STD & HIV Unit, Lima, Peru.	magaly.blas.b@upch.pe	Zunt, Joseph/ABD-2886-2021		International Clinical Research Fellows Program at Vanderbilt University [R24 TW007988]; Fogarty International Center/National Institutes of Health (FIC/NIH) [R01 TW008398, RO1 NS055627]; Merck Co., Inc.; indigenous health program; regional organization (ORAU) of the Interethnic Association for the Development of the Peruvian Rainforest (AIDESEP); regional organization (FECONAU) of the Interethnic Association for the Development of the Peruvian Rainforest (AIDESEP); FOGARTY INTERNATIONAL CENTER [R01TW008398, R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055627] Funding Source: NIH RePORTER	International Clinical Research Fellows Program at Vanderbilt University; Fogarty International Center/National Institutes of Health (FIC/NIH); Merck Co., Inc.(Merck & Company); indigenous health program; regional organization (ORAU) of the Interethnic Association for the Development of the Peruvian Rainforest (AIDESEP); regional organization (FECONAU) of the Interethnic Association for the Development of the Peruvian Rainforest (AIDESEP); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the International Clinical Research Fellows Program at Vanderbilt University (R24 TW007988), by the Fogarty International Center/National Institutes of Health (FIC/NIH) grant R01 TW008398 to Magaly Blas, RO1 NS055627 to Joseph R. Zunt and supported in part by a research grant from the Merck Investigator-Initiated Studies Program of Merck & Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the indigenous health program and the regional organizations (ORAU and FECONAU) of the Interethnic Association for the Development of the Peruvian Rainforest (AIDESEP) for their support in the development of this study. We also want to thank the indigenous leaders who helped us conduct this study, and the personnel of this project, especially Yolanda Nunta, Jeiser Suarez, Greti Trigoso, Neylar Morales, Rosario Trujillo, Janet Soto, and Maybee Terrones. We also want to thank Monica Nieto and Ada Romero for conducting the HTLV testing, Donna Kenney for conducting the HPV testing, Martin Gutierrez for conducting the HIV testing and Dr. Jaime Caceres for evaluating the Pap smears.	Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165; Almonte M, 2011, INT J GYNECOL CANCER, V21, P1654, DOI 10.1097/IGC.0b013e3182288104; Alva IE, 2012, AM J TROP M IN PRESS; Beutner Karl R., 1997, American Journal of Medicine, V102, P9; Blattner WA, 1999, P ASSOC AM PHYSICIAN, V111, P563, DOI 10.1046/j.1525-1381.1999.99210.x; Brown B, 2012, INT J STD AIDS, V23, P242, DOI 10.1258/ijsa.2011.011193; Carneiro-Proietti ABF, 2002, J BIOMED SCI, V9, P587, DOI 10.1007/BF02254986; Castle PE, 2003, SEX TRANSM DIS, V30, P575, DOI 10.1097/00007435-200307000-00009; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Davey DD, 2003, CANCER J, V9, P327, DOI 10.1097/00130404-200309000-00002; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Duerr A, 2001, AM J OBSTET GYNECOL, V184, P584, DOI 10.1067/mob.2001.111791; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Fujiyoshi T, 1999, AIDS RES HUM RETROV, V15, P1235, DOI 10.1089/088922299310124; Gallo RC, 2002, IMMUNOL REV, V185, P236, DOI 10.1034/j.1600-065X.2002.18520.x; Gongora-Biachi R A, 1997, Ginecol Obstet Mex, V65, P141; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; MIYAZAKI K, 1991, OBSTET GYNECOL, V77, P107; Montano SM, 2011, SEX TRANSM INFECT, V87, P81, DOI 10.1136/sti.2010.043315; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Proietti FA, 2006, REV PANAM SALUD PUBL, V19, P7, DOI 10.1590/S1020-49892006000100002; Radja N, 2004, INT J STD AIDS, V15, P202, DOI 10.1258/095646204322916687; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; SPALTON DJ, 1991, BRIT J OPHTHALMOL, V75, P174, DOI 10.1136/bjo.75.3.174; STRICKLER HD, 1995, INT J CANCER, V61, P23, DOI 10.1002/ijc.2910610105; Vrielink H, 2004, TRANSFUS MED REV, V18, P46, DOI 10.1016/j.tmrv.2003.10.004; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization (WHO)/Institute Catala` d'Oncologia (ICO) Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2010, SUMM REP HPV CERV CA; WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591; Zunt JR, 2002, J INFECT DIS, V186, P1669, DOI 10.1086/345364	31	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44240	10.1371/journal.pone.0044240	http://dx.doi.org/10.1371/journal.pone.0044240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952937	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000096
J	Ge, XJ; Hsu, TW; Hung, KH; Lin, CJ; Huang, CC; Huang, CC; Chiang, YC; Chiang, TY				Ge, Xue-Jun; Hsu, Tsai-Wen; Hung, Kuo-Hsiang; Lin, Chung-Jian; Huang, Chi-Chung; Huang, Chao-Ching; Chiang, Yu-Chung; Chiang, Tzen-Yuh			Inferring Multiple Refugia and Phylogeographical Patterns in Pinus massoniana Based on Nucleotide Sequence Variation and DNA Fingerprinting	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MICROSATELLITE LOCI; SOFTWARE; PINACEAE; FLOW; NUMBER; SPACER; LIMITS; RANGE; TESTS	Background: Pinus massoniana, an ecologically and economically important conifer, is widespread across central and southern mainland China and Taiwan. In this study, we tested the central-marginal paradigm that predicts that the marginal populations tend to be less polymorphic than the central ones in their genetic composition, and examined a founders' effect in the island population. Methodology/Principal Findings: We examined the phylogeography and population structuring of the P. massoniana based on nucleotide sequences of cpDNA atpB-rbcL intergenic spacer, intron regions of the AdhC2 locus, and microsatellite fingerprints. SAMOVA analysis of nucleotide sequences indicated that most genetic variants resided among geographical regions. High levels of genetic diversity in the marginal populations in the south region, a pattern seemingly contradicting the central-marginal paradigm, and the fixation of private haplotypes in most populations indicate that multiple refugia may have existed over the glacial maxima. STRUCTURE analyses on microsatellites revealed that genetic structure of mainland populations was mediated with recent genetic exchanges mostly via pollen flow, and that the genetic composition in east region was intermixed between south and west regions, a pattern likely shaped by gene introgression and maintenance of ancestral polymorphisms. As expected, the small island population in Taiwan was genetically differentiated from mainland populations. Conclusions/Significance: The marginal populations in south region possessed divergent gene pools, suggesting that the past glaciations might have low impacts on these populations at low latitudes. Estimates of ancestral population sizes interestingly reflect a recent expansion in mainland from a rather smaller population, a pattern that seemingly agrees with the pollen record.	[Ge, Xue-Jun] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Hsu, Tsai-Wen; Huang, Chao-Ching] Endem Species Res Inst, Nantou, Taiwan; [Hung, Kuo-Hsiang] Pingtung Univ Sci & Technol, Grad Inst Bioresources, Pingtung, Taiwan; [Lin, Chung-Jian; Huang, Chi-Chung; Chiang, Tzen-Yuh] Cheng Kung Univ, Dept Life Sci, Tainan, Taiwan; [Chiang, Yu-Chung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	Chinese Academy of Sciences; South China Botanical Garden, CAS; National Pingtung University Science & Technology; National Cheng Kung University; National Sun Yat Sen University	Ge, XJ (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	yuchung@mail.npust.edu.tw; tychiang@mail.ncku.edu.tw	Chiang, Yu-Chung/E-9143-2011; Chiang, Tzen-Yuh/F-7383-2014; Ge, Xue-Jun/AAP-5967-2020	Ge, Xue-Jun/0000-0002-5008-9475; Huang, Chao-Ching/0000-0003-2799-7181	National Basic Research Program of China (973 Program) [2007CB411600]; Council of Agriculture (COA) of Taiwan	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Council of Agriculture (COA) of Taiwan	This work was financially supported by the National Basic Research Program of China (973 Program) (2007CB411600) and a grant from the Council of Agriculture (COA) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod D., 1996, FLORISTIC CHARACTERI, P43; Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; BENNETT KD, 1990, PALEOBIOLOGY, V16, P11, DOI 10.1017/S0094837300009684; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Chiang TY, 1998, BOT BULL ACAD SINICA, V39, P245; Chiang TY, 2004, ANN MO BOT GARD, V91, P207; Chiang YC, 2006, MOL ECOL, V15, P765, DOI 10.1111/j.1365-294X.2005.02833.x; Chiang YC, 2003, AM J BOT, V90, P561, DOI 10.3732/ajb.90.4.561; Chiang YC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-161; CRANDALL KA, 1993, GENETICS, V134, P959; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1994, GENETICS, V136, P343; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FU YX, 1993, GENETICS, V133, P693; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Huang S, 2001, MOL ECOL, V10, P2669, DOI 10.1046/j.0962-1083.2001.01395.x; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hung KH, 2012, BOT STUD, V53, P191; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Karhu A, 2006, J EVOLUTION BIOL, V19, P167, DOI 10.1111/j.1420-9101.2005.00982.x; KLIMAN RM, 1993, GENETICS, V133, P375; Kremenetski CV, 1998, ARCTIC ALPINE RES, V30, P317, DOI 10.2307/1552004; Laurance WF, 2008, SCIENCE, V319, P1184, DOI 10.1126/science.319.5867.1184b; Le Maitre D. C., 1998, P407; Lei Zuo-Qi, 1993, Acta Botanica Sinica, V35, P128; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 1977, ACTA PALAEONTOL, V16, P10; LIU KB, 1992, QUATERNARY RES, V38, P32, DOI 10.1016/0033-5894(92)90028-H; Lu SY, 2001, GENOME, V44, P797, DOI 10.1139/gen-44-5-797; Lusk C, 2008, NEW PHYTOL, V178, P1, DOI 10.1111/j.1469-8137.2008.02371.x; Muir G, 2005, MOL ECOL, V14, P549, DOI 10.1111/j.1365-294X.2004.02418.x; Naydenov K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-233; Ohsako T, 2008, GENES GENET SYST, V83, P89, DOI 10.1266/ggs.83.89; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Parchman TL, 2011, AM J BOT, V98, P669, DOI 10.3732/ajb.1000378; Perry DJ, 1996, P NATL ACAD SCI USA, V93, P13020, DOI 10.1073/pnas.93.23.13020; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Richardson David M., 1998, P3; Salim K, 2010, HEREDITAS, V147, P165, DOI 10.1111/j.1601-5223.2010.02176.x; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Schaal BA, 2000, P NATL ACAD SCI USA, V97, P7024, DOI 10.1073/pnas.97.13.7024; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1991, GENETICS, V129, P555; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Templeton Alan R., 2000, Plant Species Biology, V15, P211, DOI 10.1046/j.1442-1984.2000.00041.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Wachowiak W, 2011, HEREDITY, V106, P775, DOI 10.1038/hdy.2010.118; Wang XR, 1999, AM J BOT, V86, P1742, DOI 10.2307/2656672; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xu XW, 2008, THEOR APPL GENET, V116, P835, DOI 10.1007/s00122-008-0717-3; Zhou YF, 2010, EVOLUTION, V64, P2342, DOI 10.1111/j.1558-5646.2010.00988.x	62	24	26	9	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43717	10.1371/journal.pone.0043717	http://dx.doi.org/10.1371/journal.pone.0043717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952747	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206000047
J	Negishi, T; Oshima, K; Hattori, M; Kanai, M; Mano, S; Nishimura, M; Yoshida, K				Negishi, Takashi; Oshima, Kenshiro; Hattori, Masahira; Kanai, Masatake; Mano, Shoji; Nishimura, Mikio; Yoshida, Kumi			Tonoplast- and Plasma Membrane-Localized Aquaporin-Family Transporters in Blue Hydrangea Sepals of Aluminum Hyperaccumulating Plant	PLOS ONE			English	Article							FULL-LENGTH CDNA; INTRINSIC PROTEINS; COLOR DEVELOPMENT; TOLERANCE; FACILITATE; CLONING; DIFFUSION; TOXICITY; SYSTEM; GENES	Hydrangea (Hydrangea macrophylla) is tolerant of acidic soils in which toxicity generally arises from the presence of the soluble aluminum (Al) ion. When hydrangea is cultivated in acidic soil, its resulting blue sepal color is caused by the Al complex formation of anthocyanin. The concentration of vacuolar Al in blue sepal cells can reach levels in excess of approximately 15 mM, suggesting the existence of an Al-transport and/or storage system. However, until now, no Al transporter has been identified in Al hyperaccumulating plants, animals or microorganisms. To identify the transporter being responsible for Al hyperaccumulation, we prepared a cDNA library from blue sepals according to the sepal maturation stage, and then selected candidate genes using a microarray analysis and an in silico study. Here, we identified the vacuolar and plasma membrane-localized Al transporters genes vacuolar Al transporter (VALT) and plasma membrane Al transporter 1 (PALT1), respectively, which are both members of the aquaporin family. The localization of each protein was confirmed by the transient co-expression of the genes. Reverse transcription-PCR and immunoblotting results indicated that VALT and PALT1 are highly expressed in sepal tissue. The overexpression of VALT and PALT1 in Arabidopsis thaliana conferred Al-tolerance and Al-sensitivity, respectively.	[Negishi, Takashi; Yoshida, Kumi] Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Negishi, Takashi; Yoshida, Kumi] Nagoya Univ, G COE Chem, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Oshima, Kenshiro; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Kanai, Masatake; Mano, Shoji; Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 444, Japan; [Mano, Shoji; Nishimura, Mikio] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan	Nagoya University; Nagoya University; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Negishi, T (corresponding author), Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	yoshidak@is.nagoya-u.ac.jp	Hattori, Masahira/AAD-3785-2019; Hattori, Masahira/C-6958-2016; Yoshida, Kumi/AAJ-2078-2020	Hattori, Masahira/0000-0001-9467-0344; Mano, Shoji/0000-0003-1323-3308; Nishimura, Mikio/0000-0001-7960-9721; Kanai, Masatake/0000-0001-7808-8258	Global Centers of Excellence Program in Chemistry, Nagoya University, Creative Scientific Research in Priority Areas [16GS0206]; Ministry of Education, Culture, Sports, Science and Technology, Japan [16370021, 24380062]; National Institute for Basic Biology Cooperative Research Program [10-301, 11-301]; Japan Advanced Plant Science Network; Grants-in-Aid for Scientific Research [22112523] Funding Source: KAKEN	Global Centers of Excellence Program in Chemistry, Nagoya University, Creative Scientific Research in Priority Areas; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Basic Biology Cooperative Research Program; Japan Advanced Plant Science Network; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant in aid for scientific research by the Global Centers of Excellence Program in Chemistry, Nagoya University, Creative Scientific Research in Priority Areas (No. 16GS0206), (B) (No. 16370021 and 24380062) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the National Institute for Basic Biology Cooperative Research Program (No. 10-301 and 11-301), and Japan Advanced Plant Science Network. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	'ALLEN R. C., 1943, Contributions. Boyce Thompson Institute for Plant Research, V13, P221; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Cerbah M, 2001, THEOR APPL GENET, V103, P45, DOI 10.1007/s001220000529; Chenery E.M., 1937, J ROY HORTIC SOC, V62, P604; Delhaize E, 2004, P NATL ACAD SCI USA, V101, P15249, DOI 10.1073/pnas.0406258101; Ezaki B, 1998, FEMS MICROBIOL LETT, V159, P99, DOI 10.1016/S0378-1097(97)00554-5; Famoso AN, 2010, PLANT PHYSIOL, V153, P1678, DOI 10.1104/pp.110.156794; Foy CD, 1962, SOIL SCI SOC AM J, V27, P403; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Hanikenne M, 2011, CURR OPIN PLANT BIOL, V14, P252, DOI 10.1016/j.pbi.2011.04.003; Hayashi K., 1953, MISC REP RES I NAT R, V29, P1; Hedfalk K, 2006, CURR OPIN STRUC BIOL, V16, P447, DOI 10.1016/j.sbi.2006.06.009; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Ito D, 2009, BIOSCI BIOTECH BIOCH, V73, P1054, DOI 10.1271/bbb.80831; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Kakimoto M, 2005, BIOMETALS, V18, P467, DOI 10.1007/s10534-005-4663-0; KAMMERLOHER W, 1994, PLANT J, V6, P187, DOI 10.1046/j.1365-313X.1994.6020187.x; KINRAIDE TB, 1991, PLANT SOIL, V134, P167, DOI 10.1007/BF00010729; Kondo T, 2005, TETRAHEDRON LETT, V46, P6645, DOI 10.1016/j.tetlet.2005.07.146; Lawrence WJC, 1938, BIOCHEM J, V32, P1661, DOI 10.1042/bj0321661; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; Ma JF, 1997, NATURE, V390, P569, DOI 10.1038/37518; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Matsumoto H, 2000, INT REV CYTOL, V200, P1, DOI 10.1016/S0074-7696(00)00001-2; MATSUMOTO H, 1976, PLANT CELL PHYSIOL, V17, P627; Maurel C, 2009, CURR OPIN PLANT BIOL, V12, P690, DOI 10.1016/j.pbi.2009.09.002; Mitsuhashi N, 2000, PLANT CELL PHYSIOL, V41, P993, DOI 10.1093/pcp/pcd040; Morita A, 2004, PHYTOCHEMISTRY, V65, P2775, DOI 10.1016/j.phytochem.2004.08.043; Robinson GM, 1939, J AM CHEM SOC, V61, P1606, DOI 10.1021/ja01875a510; Rouge P, 2008, BIOCHEM BIOPH RES CO, V367, P60, DOI 10.1016/j.bbrc.2007.12.079; Ryan PR, 2011, J EXP BOT, V62, P9, DOI 10.1093/jxb/erq272; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Schott EJ, 1997, MOL GEN GENET, V254, P63, DOI 10.1007/s004380050391; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; SUHAYDA CG, 1986, PHYSIOL PLANTARUM, V68, P189, DOI 10.1111/j.1399-3054.1986.tb01913.x; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; TAKEDA K, 1990, PHYTOCHEMISTRY, V29, P1089, DOI 10.1016/0031-9422(90)85409-9; TAKEDA K, 1985, PHYTOCHEMISTRY, V24, P2251, DOI 10.1016/S0031-9422(00)83019-8; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; Tanaka Y, 2009, INT J MOL SCI, V10, P5350, DOI 10.3390/ijms10125350; Toyama-Kato Y, 2003, BIOCHEM ENG J, V14, P237, DOI 10.1016/S1369-703X(02)00220-6; Vert G, 2009, PLANTA, V229, P1171, DOI 10.1007/s00425-009-0904-8; Wudick MM, 2009, NEW PHYTOL, V184, P289, DOI 10.1111/j.1469-8137.2009.02985.x; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yang JL, 2008, PLANT PHYSIOL, V146, P602, DOI 10.1104/pp.107.111989; Yoshida K, 2003, PLANT CELL PHYSIOL, V44, P262, DOI 10.1093/pcp/pcg033; Yoshida K, 2009, NAT PROD REP, V26, P884, DOI 10.1039/b800165k	53	74	86	9	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43189	10.1371/journal.pone.0043189	http://dx.doi.org/10.1371/journal.pone.0043189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952644	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206000021
J	Waldbauer, JR; Rodrigue, S; Coleman, ML; Chisholm, SW				Waldbauer, Jacob R.; Rodrigue, Sebastien; Coleman, Maureen L.; Chisholm, Sallie W.			Transcriptome and Proteome Dynamics of a Light-Dark Synchronized Bacterial Cell Cycle	PLOS ONE			English	Article							MESSENGER-RNA; GENE-EXPRESSION; STATISTICAL-MODEL; GENOMIC ANALYSIS; PROCHLOROCOCCUS; TANDEM; CYANOTHECE; GROWTH; SYNECHOCOCCUS; CYANOBACTERIA	Background: Growth of the ocean's most abundant primary producer, the cyanobacterium Prochlorococcus, is tightly synchronized to the natural 24-hour light-dark cycle. We sought to quantify the relationship between transcriptome and proteome dynamics that underlie this obligate photoautotroph's highly choreographed response to the daily oscillation in energy supply. Methodology/Principal Findings: Using RNA-sequencing transcriptomics and mass spectrometry-based quantitative proteomics, we measured timecourses of paired mRNA-protein abundances for 312 genes every 2 hours over a light-dark cycle. These temporal expression patterns reveal strong oscillations in transcript abundance that are broadly damped at the protein level, with mRNA levels varying on average 2.3 times more than the corresponding protein. The single strongest observed protein-level oscillation is in a ribonucleotide reductase, which may reflect a defense strategy against phage infection. The peak in abundance of most proteins also lags that of their transcript by 2-8 hours, and the two are completely antiphase for some genes. While abundant antisense RNA was detected, it apparently does not account for the observed divergences between expression levels. The redirection of flux through central carbon metabolism from daytime carbon fixation to nighttime respiration is associated with quite small changes in relative enzyme abundances. Conclusions/Significance: Our results indicate that expression responses to periodic stimuli that are common in natural ecosystems (such as the diel cycle) can diverge significantly between the mRNA and protein levels. Protein expression patterns that are distinct from those of cognate mRNA have implications for the interpretation of transcriptome and metatranscriptome data in terms of cellular metabolism and its biogeochemical impact.	[Waldbauer, Jacob R.; Rodrigue, Sebastien; Coleman, Maureen L.; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Waldbauer, Jacob R.] Woods Hole Oceanog Inst, Joint Program Chem Oceanog, Cambridge, MA USA; [Coleman, Maureen L.; Chisholm, Sallie W.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT)	Waldbauer, JR (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	chisholm@mit.edu		Chisholm, Sallie/0000-0003-1480-2445; Coleman, Maureen/0000-0001-5065-0106	Gordon and Betty Moore Foundation Marine Microbiology Initiative; MIT Energy Initiative, Department of Energy Genomics:GtL program; NSF Center for Microbial Oceanography: Research and Education (C-MORE); Office of Naval Research NDSEG Fellowship; NSF Graduate Research Fellowship; NSERC; FQRNT	Gordon and Betty Moore Foundation Marine Microbiology Initiative(Gordon and Betty Moore Foundation); MIT Energy Initiative, Department of Energy Genomics:GtL program; NSF Center for Microbial Oceanography: Research and Education (C-MORE)(National Science Foundation (NSF)); Office of Naval Research NDSEG Fellowship(Office of Naval Research); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT(FQRNT)	This work was supported in large part by a grant from the Gordon and Betty Moore Foundation Marine Microbiology Initiative. Additional funding support was from the MIT Energy Initiative, Department of Energy Genomics:GtL program, and the NSF Center for Microbial Oceanography: Research and Education (C-MORE). JRW was supported by an Office of Naval Research NDSEG Fellowship and an NSF Graduate Research Fellowship. SR was supported by postdoctoral fellowships from NSERC and FQRNT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Aryal UK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-194; Axmann IM, 2009, J BACTERIOL, V191, P5342, DOI 10.1128/JB.00419-09; Bandyopadhyay A, 2011, MBIO, V2, DOI 10.1128/mBio.00214-11; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Britos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018179; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Doherty MK, 2006, EXPERT REV PROTEOMIC, V3, P97, DOI 10.1586/14789450.3.1.97; Evguenieva-Hackenberg E, 2011, CURR OPIN MICROBIOL, V14, P587, DOI 10.1016/j.mib.2011.07.025; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Futschik ME, 2008, BIOINFORMATICS, V24, P1063, DOI 10.1093/bioinformatics/btn072; Garcia-Pichel F, 2003, ALGOLOGICAL STUDIES, V109, P15; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098; GURLAND J, 1971, AM STAT, V25, P30, DOI 10.2307/2682923; Halbeisen RE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000105; Helbling DE, 2012, ISME J, V6, P902, DOI [10.1038/ISMEJ.2011.158, 10.1038/ismej.2011.158]; Holtzendorff J, 2001, J BACTERIOL, V183, P915, DOI 10.1128/JB.183.3.915-920.2001; Hsiao CA, 2009, CLASSIFICATION OUTLI; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Jacquet S, 2001, APPL ENVIRON MICROB, V67, P782, DOI 10.1128/AEM.67.2.782-790.2001; Jayapal KP, 2010, J PROTEOME RES, V9, P2087, DOI 10.1021/pr9007738; Jayapal KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002097; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly L, 2012, NUCLEIC ACIDS RES, V40, pD632, DOI 10.1093/nar/gkr1022; Kielbasa SM, 2007, GENOME INFORM SER, V18, P1; Kramer G, 2010, MOL CELL PROTEOMICS, V9, P2508, DOI 10.1074/mcp.M110.001826; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Lee PS, 2003, BIOTECHNOL BIOENG, V84, P834, DOI 10.1002/bit.10841; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Mary I, 2003, FEMS MICROBIOL LETT, V226, P135, DOI 10.1016/S0378-1097(03)00587-1; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Picard F, 2009, CR BIOL, V332, P958, DOI 10.1016/j.crvi.2009.09.005; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; Richter JD, 2011, CURR OPIN GENET DEV, V21, P363, DOI 10.1016/j.gde.2011.06.001; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Rust MJ, 2011, SCIENCE, V331, P220, DOI 10.1126/science.1197243; Shalapyonok A, 1998, APPL ENVIRON MICROB, V64, P1066; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sherman LA, 2010, ADV EXP MED BIOL, V675, P275, DOI 10.1007/978-1-4419-1528-3_16; Shi T, 2010, ISME J, V4, P621, DOI 10.1038/ismej.2009.148; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Smith DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010487; Steglich C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r54; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Stockel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016680; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Straub C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016208; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P2890, DOI 10.1093/nar/gkg398; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	70	100	102	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43432	10.1371/journal.pone.0043432	http://dx.doi.org/10.1371/journal.pone.0043432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952681	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000035
J	Anderson, J; Mizgalewicz, A; Illes, J				Anderson, James; Mizgalewicz, Ania; Illes, Judy			Reviews of Functional MRI: The Ethical Dimensions of Methodological Critique	PLOS ONE			English	Review							IMAGING RESEARCH; RISKS; SCHIZOPHRENIA; DISCLOSURE; PSYCHOSIS; DISORDER	Neuroimaging studies involving human subjects raise a range of ethics issues. Many of these issues are heightened in the context of neuroimaging research involving persons with mental health disorders. There has been growing interest in these issues among legal scholars, philosophers, social scientists, and as well as neuroimagers over the last decade. Less clear, however, is the extent to which members of the neuroimaging community are engaged with these issues when they undertake their research and report results. In this study, we analyze the peer-reviewed review literature involving fMRI as applied to the study of mental health disorders. Our hypothesis is that, due to the critical orientation of reviews, and the vulnerability of mental health population, the penetrance of neuroethics will be higher in the review literature in this area than it is in the primary fMRI research literature more generally. We find that while authors of reviews do focus a great deal of attention on the methodological limitations of the studies they discussed, contrary to our hypothesis, they do not frame concerns in ethical terms despite their ethical significance. We argue that an ethics lens on such discussion would increase the knowledge-value of this scholarly work.	[Anderson, James; Mizgalewicz, Ania; Illes, Judy] Univ British Columbia, Natl Core Neuroeth, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Anderson, J (corresponding author), Univ British Columbia, Natl Core Neuroeth, Vancouver, BC V5Z 1M9, Canada.	jilles@mail.ubc.ca			NIH/NIMH [9R01MH84282-06]; CIHR CNE [85117]; British Columbia Knowledge Development Fund; Canada Foundation for Innovation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084282] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CIHR CNE(Canadian Institutes of Health Research (CIHR)); British Columbia Knowledge Development Fund; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from NIH/NIMH 9R01MH84282-06 (J. Illes), CIHR CNE #85117, British Columbia Knowledge Development Fund, and the Canada Foundation for Innovation. Judy Illes is the Canada Research Chair in Neuroethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano B, 1997, Ann Ist Super Sanita, V33, P483; Apold VS, 2011, ACCOUNT RES, V18, P31, DOI 10.1080/08989621.2011.542681; Appiah K. A., 2008, EXPT ETHICS; Borgelt E, 2011, J BIOETHIC INQ, V8, P15, DOI 10.1007/s11673-010-9271-1; Boyce AC, 2009, BIOETHICS, V23, P349, DOI 10.1111/j.1467-8519.2009.01724.x; BUCHSBAUM MS, 1990, SCHIZOPHRENIA BULL, V16, P379, DOI 10.1093/schbul/16.3.379; Canli T, 2002, BRAIN COGNITION, V50, P414, DOI 10.1016/S0278-2626(02)00517-1; Canli T, 2007, AM J BIOETHICS, V7, P3, DOI 10.1080/15265160701290249; Cerullo MA, 2009, INT REV PSYCHIATR, V21, P314, DOI 10.1080/09540260902962107; Eijkholt M, 2012, INT J LAW PSYCHIAT, V35, P146, DOI 10.1016/j.ijlp.2011.12.003; Francati V, 2007, DEPRESS ANXIETY, V24, P202, DOI 10.1002/da.20208; Franck N, 2002, J NEUROPSYCH CLIN N, V14, P277, DOI 10.1176/appi.neuropsych.14.3.277; Fusar-Poli P, 2008, EUR PSYCHIAT, V23, P237, DOI 10.1016/j.eurpsy.2008.03.008; Fusar-Poli P, 2007, NEUROSCI BIOBEHAV R, V31, P465, DOI 10.1016/j.neubiorev.2006.11.006; Garnett A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018537; Gunsalus CK, 2006, SCIENCE, V312, P1441, DOI 10.1126/science.1121479; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; Kelly A M Clare, 2007, Curr Psychiatry Rep, V9, P401, DOI 10.1007/s11920-007-0052-4; Kulynych J, 2002, BRAIN COGNITION, V50, P345, DOI 10.1016/S0278-2626(02)00518-3; Marshall J, 2007, CAN J NEUROL SCI, V34, P11, DOI 10.1017/S0317167100005734; Marshall Jennifer, 2009, IRB, V31, P9; Mobbs D, 2007, PLOS BIOL, V5, P693, DOI 10.1371/journal.pbio.0050103; Moll J, 2008, ANN NY ACAD SCI, V1124, P161, DOI 10.1196/annals.1440.005; Schmidt MH, 2009, ACCOUNT RES, V16, P153, DOI 10.1080/08989620902984106	24	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42836	10.1371/journal.pone.0042836	http://dx.doi.org/10.1371/journal.pone.0042836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952615	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600009
J	Cox, JL; Wilder, PJ; Desler, M; Rizzino, A				Cox, Jesse L.; Wilder, Phillip J.; Desler, Michelle; Rizzino, Angie			Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TUMOR-INITIATING CELLS; LARGE GENE LISTS; TRANSCRIPTIONAL REGULATION; BRAIN-TUMORS; MOUSE; EXPRESSION; CANCER; PHOSPHORYLATION; DIFFERENTIATION	Medulloblastomas and glioblastomas are devastating tumors that respond poorly to treatment. These tumors have been shown to express SOX2 and overexpression of SOX2 has been correlated with poor prognosis. Although knockdown of SOX2 impairs the growth and tumorigenicity of brain tumor cells, it was unclear how elevating SOX2 levels would affect their fate. Interestingly, studies conducted with neural stem cells have shown that small increases or decreases in the level of this transcription factor significantly alter their fate. Here, we report that elevating SOX2 3-fold above endogenous levels in U87 and U118 glioblastoma, and DAOY medulloblastoma cells significantly impairs their ability to proliferate. We extended these findings and determined that elevating SOX2 in DAOY cells remodels their cell-cycle profile by increasing the proportion of cells in the G1-compartment, and induces the expression of genes associated with differentiation. Furthermore, we show that elevating SOX2 leads to a dramatic induction of CD133 expression in DAOY cells, yet inhibits the ability of both CD133(+) and CD133(-) cells to form neurospheres. Together, these findings argue that SOX2 levels must be carefully controlled in glioblastomas and medulloblastomas to maintain their fate. Equally important, our data suggests that increases in the expression of SOX2 during brain tumor progression are likely to be linked closely with changes in other critical genes that work in concert with SOX2 to enhance the tumorigenicity of brain tumors. Importantly, we demonstrate that this is also likely to be true for other cancers that express SOX2. Moreover, these studies demonstrate the advantage of using inducible promoters to study the effects of SOX2 elevation, as compared to gene expression systems that rely on constitutive expression.	[Cox, Jesse L.; Wilder, Phillip J.; Desler, Michelle; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Cox, JL (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	arizzino@unmc.edu			Nebraska Department of Health [2011 29, 2012 33]	Nebraska Department of Health	This work was supported by the Nebraska Department of Health; Contract grant number: (2011 29; 2012 33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Annovazzi L, 2011, CANCER GENOM PROTEOM, V8, P139; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Christensen K, 2011, J NEURO-ONCOL, V104, P129, DOI 10.1007/s11060-010-0488-y; Cox JL, 2011, J CELL SCI, V124, P2654, DOI 10.1242/jcs.083238; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Xi, 2010, J Vis Exp, DOI 10.3791/2086; Jenkin D, 1998, MED PEDIATR ONCOL, V31, P506, DOI 10.1002/(SICI)1096-911X(199812)31:6<506::AID-MPO7>3.0.CO;2-X; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Kingsley-Kallesen M, 2001, IN VITRO CELL DEV-AN, V37, P684; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Perek D, 1998, CHILD NERV SYST, V14, P582, DOI 10.1007/s003810050276; RIEDERER BM, 1995, J HISTOCHEM CYTOCHEM, V43, P1269, DOI 10.1177/43.12.8537643; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Zhao HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027026	41	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44087	10.1371/journal.pone.0044087	http://dx.doi.org/10.1371/journal.pone.0044087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937156	gold, Green Submitted, Green Published			2022-12-27	WOS:000308213600076
J	Matzer, F; Wisiak, UV; Graninger, M; Sollner, W; Stilling, HP; Glawischnig-Goschnik, M; Lueger, A; Fazekas, C				Matzer, Franziska; Wisiak, Ursula V.; Graninger, Monika; Soellner, Wolfgang; Stilling, Hans Peter; Glawischnig-Goschnik, Monika; Lueger, Andreas; Fazekas, Christian			Biopsychosocial Health Care Needs at the Emergency Room: Challenge of Complexity	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS PATIENTS; EXTENDED HOSPITAL STAY; INTERMED PROJECT; TRIAGE; RELIABILITY; INPATIENTS; MEDICINE; SYSTEMS; MODEL; RISK	Background: In an emergency room of internal medicine, triage and treatment of patients deserve first priority. However, biopsychosocial case complexity may also affect patient health outcome but has not yet been explored in this setting. Therefore, the aims of the study are (1) to estimate prevalence rates of complex patients in the emergency room (ER), (2) to describe biopsychosocial complexity in this population and (3) to evaluate possible correlations between patient profiles regarding case complexity and further clinical treatment. Methods: During a study period of one week, all patients of an emergency room of internal medicine who were triaged to Manchester levels three to five were invited to participate in the study. Biopsychosocial case complexity was assessed by the INTERMED method. Psychosocial interventions were evaluated based on all documented interventions and recommendations given at the emergency room and during inpatient treatment. Results: Study participants consisted of 167 patients with a subgroup of 19% (n = 32) receiving subsequent inpatient-treatment at the department. High biopsychosocial case complexity was found in 12% (n = 20) of the total sample (INTERMED score > 20). This finding was paralleled by a cluster analysis suggesting three clusters with one highly complex patient group of 14%. These highly complex patients differed significantly from the other clusters as they had visited the emergency room more often within the last year and lived alone more frequently. In addition, admission rates were highest in this group. During ER treatment and subsequent inpatient treatment, 21% of highly complex patients received interventions addressing psychosocial factors as compared to 6% and 7%, respectively, in the other clusters. Conclusions: A standardized screening of biopsychosocial case complexity among 'frequent utilizers' of the ER would be helpful to detect specific multidisciplinary health care needs among this particularly burdened patient group.	[Matzer, Franziska; Wisiak, Ursula V.; Graninger, Monika; Stilling, Hans Peter; Glawischnig-Goschnik, Monika; Fazekas, Christian] Med Univ Graz, Dept Med Psychol & Psychotherapy, Graz, Austria; [Soellner, Wolfgang] Gen Hosp Nuremberg, Dept Psychosomat & Psychotherapy, Nurnberg, Germany; [Lueger, Andreas] Med Univ Graz, Dept Internal Med, Graz, Austria	Medical University of Graz; Medical University of Graz	Matzer, F (corresponding author), Med Univ Graz, Dept Med Psychol & Psychotherapy, Graz, Austria.	christian.fazekas@medunigraz.at	Fazekas, Christian/O-3074-2017	Fazekas, Christian/0000-0002-0943-648X				Auerbach C, 2010, SOC WORK HEALTH CARE, V49, P314, DOI 10.1080/00981380903426772; Belleville G., 2010, PRIMARY PSYCHIAT, V17, P35; Bonk A, 2009, UNFALLCHIRURG, V112, P445, DOI 10.1007/s00113-009-1617-y; Cooke MW, 1999, J ACCID EMERG MED, V16, P179; Curran GM, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-17; de Jonge P, 2005, AUST NZ J PSYCHIAT, V39, P795, DOI 10.1111/j.1440-1614.2005.01684.x; de Jonge P, 2004, GEN HOSP PSYCHIAT, V26, P147, DOI 10.1016/j.genhosppsych.2003.09.001; de Jonge P, 2003, J PSYCHOSOM RES, V54, P497, DOI 10.1016/S0022-3999(02)00441-5; de Jonge P, 2002, J PSYCHOSOM RES, V52, P25, DOI 10.1016/S0022-3999(01)00309-9; de Jonge P, 2003, PSYCHOSOM MED, V65, P534, DOI 10.1097/01.PSY.0000077504.01963.1B; Esler JL, 2004, J PSYCHOSOM RES, V56, P263, DOI 10.1016/S0022-3999(03)00515-4; Fischer CJ, 2000, DIABETES METAB, V26, P295; Ford JD, 2004, SOC SCI MED, V58, P2145, DOI 10.1016/j.socscimed.2003.08.017; Hamer Helen P, 2006, Nurs Health Sci, V8, P224, DOI 10.1111/j.1442-2018.2006.00287.x; Herms AMRD, 2003, PSYCHOSOMATICS, V44, P196, DOI 10.1176/appi.psy.44.3.196; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hoogervorst ELJ, 2003, J NEUROL NEUROSUR PS, V74, P20, DOI 10.1136/jnnp.74.1.20; Huyse FJ, 1999, GEN HOSP PSYCHIAT, V21, P39, DOI 10.1016/S0163-8343(98)00057-7; Kathol RG, 2005, AUST NZ J PSYCHIAT, V39, P816, DOI 10.1111/j.1440-1614.2005.01687.x; Koch N, 2001, ARTHRIT RHEUM-ARTHR, V45, P216, DOI 10.1002/1529-0131(200106)45:3<216::AID-ART251>3.3.CO;2-6; Larkin GL, 2009, ACAD EMERG MED, V16, P1110, DOI 10.1111/j.1553-2712.2009.00545.x; Lemke KW, 2012, MED CARE, V50, P131, DOI 10.1097/MLR.0b013e3182353ceb; Lobo E, 2007, PSYCHOSOM MED, V69, P99, DOI 10.1097/PSY.0b013e31802e46da; Luthy C, 2007, J PSYCHOSOM RES, V62, P513, DOI 10.1016/j.jpsychores.2006.11.016; Mazzocato C, 2000, J PAIN SYMPTOM MANAG, V19, P83, DOI 10.1016/S0885-3924(99)00156-6; Rutschmann OT, 2005, SWISS MED WKLY, V135, P145; Stephenson DT, 2006, EMERG MED J, V23, P595, DOI 10.1136/emj.2005.032854; Stiefel FC, 1999, SPINE, V24, P378, DOI 10.1097/00007632-199902150-00017; Stiefel FC, 2006, MED CLIN N AM, V90, P713, DOI 10.1016/j.mcna.2006.05.006; Tandjung R, 2011, INT J GEN MED, V4, P773, DOI 10.2147/IJGM.S25338; Wade D, 2011, CLIN REHABIL, V25, P387, DOI 10.1177/0269215511400282	31	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e41775	10.1371/journal.pone.0041775	http://dx.doi.org/10.1371/journal.pone.0041775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952586	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600004
J	Adekeye, OA; Heiman, HJ; Onyeabor, OS; Hyacinth, HI				Adekeye, Oluwatoyosi A.; Heiman, Harry J.; Onyeabor, Onyekachi S.; Hyacinth, Hyacinth I.			The New Invincibles: HIV Screening among Older Adults in the US	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS RISK BEHAVIORS; AGED 50; INFECTION; TUBERCULOSIS; POPULATION; PREVENTION; DIAGNOSES; KNOWLEDGE; COLLEGE	Background: Thirteen percent of the U.S. population is ages 65 and older, a number projected to reach 20% by 2030. By 2015, 50% of Human Immunodeficiency Virus (HIV)-infected individuals in the U. S. are expected to be ages 50 and older. Current Centers for Disease Control and Prevention guidelines recommend "opt-out" HIV screening for individuals ages 13-64. The purpose of this study was to assess the occurrence and barriers to HIV screening in older adults, and to evaluate the rationale for expanding routine HIV screening to this population. Methods: The study used 2009 National Health Interview Survey (NHIS) data. A total of 12,366 (unweighted) adults, ages 50 and older, participated in the adult section of the NHIS and answered questions on the HIV/AIDS, Sexually Transmitted Diseases, and Tuberculosis components. Associations between HIV screening, socio-demographic variables, and knowledge of HIV-related disease were examined using logistic regression models. Results: The HIV screening rate within this population was 25.4%. Race had no statistically significant effect. Low risk perception of HIV exposure (84.1%) accounted for low likelihood of planned screening (3.5%) within 12 months post survey. A routine medical check-up was the single most common reason for HIV screening (37.6%), with only about half (52.7%) of the tests suggested by a health care provider. Conclusion: It is imperative that practices and policies are developed and implemented to increase HIV awareness and screening in the older adult population. Increased health care provider awareness of the importance of HIV screening, especially for those 65 and older, is critical. Health policies and clinical guidelines should be revised to promote and support screening of all adults.	[Adekeye, Oluwatoyosi A.] Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA; [Heiman, Harry J.; Onyeabor, Onyekachi S.] Morehouse Sch Med, Satcher Hlth Leadership Inst, Atlanta, GA 30310 USA; [Hyacinth, Hyacinth I.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA	Morehouse School of Medicine; Morehouse School of Medicine; Morehouse School of Medicine	Adekeye, OA (corresponding author), Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA.	oadekeye@msm.edu	Hyacinth, Hyacinth/U-5722-2017	Hyacinth, Hyacinth/0000-0002-1991-7463	Department of Health and Human Services, Public Health Service [MPCMP101051-01-01]; Office of Minority Health [MPCMP061011, OMH-MSM-1-06]; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) [R21HL092358, NIH/NCRR-5P20RR0111044]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092358] Funding Source: NIH RePORTER	Department of Health and Human Services, Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Office of Minority Health(United States Department of Health & Human Services); National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors were supported in part by the following grants: MPCMP101051-01-01, from the Department of Health and Human Services, Public Health Service, a grant from the Office of Minority Health, Cooperative Agreement Number: MPCMP061011 and Project Number: OMH-MSM-1-06, National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) - R21HL092358 and NIH/NCRR-5P20RR0111044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Its content are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services.	Ajuluchukwu DC, 2003, NAT HIV PREV C JUL A; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; [Anonymous], 2008, CLIN INTERV AGING; [Anonymous], 2009, HIV TEST IMPL GUID C; Beckwith CG, 2010, JAIDS-J ACQ IMM DEF, V55, pS49, DOI 10.1097/QAI.0b013e3181f9c0f7; Braithwaite RL, 2003, AM J PUBLIC HEALTH, V93, P759, DOI 10.2105/AJPH.93.5.759; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2010, HIV US FACT SHEET; Centers for Disease Control and Prevention, 2010, HIV AIDS AFR AM YOUT; Centers for Disease Control and Prevention (CDC), 2005, HIV PREV 3 DEC; DeHertogh DA, 1994, INFECT MED, V11, P361; DeHertogh DA, 1994, INFECT MED, V11, P370; FITTERLING JM, 1993, ADDICTION, V88, P1257, DOI 10.1111/j.1360-0443.1993.tb02148.x; Gott CM, 2001, HEALTH SOC CARE COMM, V9, P72, DOI 10.1046/j.1365-2524.2001.00285.x; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; Jittimanee SX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006360; Kirk JB, 2009, J AM GERIATR SOC, V57, P2129, DOI 10.1111/j.1532-5415.2009.02494.x; LEIGH BC, 1993, AM J PUBLIC HEALTH, V83, P1400, DOI 10.2105/AJPH.83.10.1400; Linley L, 2007, NAT HIV PREV C ATL G, P136; Longo B, 2008, AIDS PATIENT CARE ST, V22, P365, DOI 10.1089/apc.2007.0168; Mahendradhata Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-385; Malhotra S., 2008, J AM PHYS SURG, V13, P88; McNair LD, 1998, J SEX MARITAL THER, V24, P29, DOI 10.1080/00926239808414666; Moody HR, 2009, AGING CONCEPTS CONTR, pxxi; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Orchi N, 2008, AIDS CARE, V20, P419, DOI 10.1080/09540120701867073; Paul SM, 2007, J AM GERIATR SOC, V55, P1393, DOI 10.1111/j.1532-5415.2007.01295.x; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Shisana O, 2004, SAMJ S AFR MED J, V94, P537; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; STALL R, 1994, ARCH INTERN MED, V154, P57, DOI 10.1001/archinte.154.1.57; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vance DE, 2011, CLIN INTERV AGING, V6, P181, DOI 10.2147/CIA.S14726; REPORT GLOBAL HIV AI	37	39	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43618	10.1371/journal.pone.0043618	http://dx.doi.org/10.1371/journal.pone.0043618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952722	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800044
J	Kisand, V; Valente, A; Lahm, A; Tanet, G; Lettieri, T				Kisand, Veljo; Valente, Angelica; Lahm, Armin; Tanet, Gerard; Lettieri, Teresa			Phylogenetic and Functional Metagenomic Profiling for Assessing Microbial Biodiversity in Environmental Monitoring	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; NEW-GENERATION; DATABASE; SERVER; SOIL; IDENTIFICATION; COMMUNITIES; ANNOTATION; ABUNDANCE; PATHWAYS	Decisions guiding environmental management need to be based on a broad and comprehensive understanding of the biodiversity and functional capability within ecosystems. Microbes are of particular importance since they drive biogeochemical cycles, being both producers and decomposers. Their quick and direct responses to changes in environmental conditions modulate the ecosystem accordingly, thus providing a sensitive readout. Here we have used direct sequencing of total DNA from water samples to compare the microbial communities of two distinct coastal regions exposed to different anthropogenic pressures: the highly polluted Port of Genoa and the protected area of Montecristo Island in the Mediterranean Sea. Analysis of the metagenomes revealed significant differences in both microbial diversity and abundance between the two areas, reflecting their distinct ecological habitats and anthropogenic stress conditions. Our results indicate that the combination of next generation sequencing (NGS) technologies and bioinformatics tools presents a new approach to monitor the diversity and the ecological status of aquatic ecosystems. Integration of metagenomics into environmental monitoring campaigns should enable the impact of the anthropogenic pressure on microbial biodiversity in various ecosystems to be better assessed and also predicted.	[Kisand, Veljo] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Kisand, Veljo; Valente, Angelica; Tanet, Gerard; Lettieri, Teresa] European Commiss Joint Res Ctr, Inst Environm & Sustainabil, Ispra, VA, Italy; [Lahm, Armin] Bioinformat Project Support, Rome, Italy	University of Tartu; European Commission Joint Research Centre; EC JRC ISPRA Site	Kisand, V (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	teresa.lettieri@jrc.ec.europa.eu	Kisand, Veljo/H-2466-2012	Kisand, Veljo/0000-0002-5535-1639; Lettieri, Teresa/0000-0002-3363-9666	European Commission; European Regional Development Fund through the Center of Excellence in Chemical Biology, Estonia	European Commission(European CommissionEuropean Commission Joint Research Centre); European Regional Development Fund through the Center of Excellence in Chemical Biology, Estonia	This work was funded by the European Commission and partly funded by the European Regional Development Fund through the Center of Excellence in Chemical Biology, Estonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bertolotto RM, 2005, MAR POLLUT BULL, V50, P348, DOI 10.1016/j.marpolbul.2004.12.002; Bodour AA, 2003, ENVIRON MICROBIOL, V5, P888, DOI 10.1046/j.1462-2920.2003.00481.x; Brennerova MV, 2009, ENVIRON MICROBIOL, V11, P2216, DOI 10.1111/j.1462-2920.2009.01943.x; Brochier-Armanet C, 2011, ISME J, V5, P1291, DOI 10.1038/ismej.2011.16; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Falciani R, 2000, J ANAL ATOM SPECTROM, V15, P561, DOI 10.1039/b000742k; Feingersch R, 2010, ISME J, V4, P78, DOI 10.1038/ismej.2009.92; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Golubiewsk N, 2010, ENCY EARTH; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Jeon S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-222; Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-359; Lingner T, 2011, NUCLEIC ACIDS RES, V39, pW518, DOI 10.1093/nar/gkr388; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Metzger KJ, 2011, ECOL INFORM, V6, P4, DOI 10.1016/j.ecoinf.2010.11.003; Niemi G, 2004, ENVIRON HEALTH PERSP, V112, P979, DOI 10.1289/ehp.6903; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pavan M, 1989, ISOLA MONTECRISTO RI, V77, P125; Raffaelli D.G., 2010, ECOSYSTEM ECOLOGY NE; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Sinigalliano CD, 2010, WATER RES, V44, P3763, DOI 10.1016/j.watres.2010.04.026; Spellerberg I. F., 2005, MONITORING ECOLOGICA, DOI DOI 10.1017/CBO9780511614699; Sumpter JP, 2009, PHILOS T R SOC A, V367, P3877, DOI 10.1098/rsta.2009.0106; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vaughan H, 2001, ENVIRON MONIT ASSESS, V67, P3, DOI 10.1023/A:1006423432114; Wade TJ, 2003, ENVIRON HEALTH PERSP, V111, P1102, DOI 10.1289/ehp.6241	50	35	36	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43630	10.1371/journal.pone.0043630	http://dx.doi.org/10.1371/journal.pone.0043630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952724	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800046
J	Mitchell, JD; McKellar, QA; McKeever, DJ				Mitchell, John D.; McKellar, Quintin A.; McKeever, Declan J.			Pharmacodynamics of Antimicrobials against Mycoplasma mycoides mycoides Small Colony, the Causative Agent of Contagious Bovine Pleuropneumonia	PLOS ONE			English	Article							IN-VITRO; INOCULUM SIZE; COMPARATIVE PHARMACOKINETICS; STAPHYLOCOCCUS-AUREUS; BACTERICIDAL ACTIVITY; ANTIBACTERIAL AGENTS; ESCHERICHIA-COLI; PENICILLIN-G; DANOFLOXACIN; OXYTETRACYCLINE	Background: Mycoplasma mycoides subspecies mycoides Small Colony (MmmSC) is the causative agent of Contagious Bovine Pleuropneumonia (CBPP), a disease of substantial economic importance in sub-Saharan Africa. Failure of vaccination to curtail spread of this disease has led to calls for evaluation of the role of antimicrobials in CBPP control. Three major classes of antimicrobial are effective against mycoplasmas, namely tetracyclines, fluoroquinolones and macrolides. Therefore, the objectives of this study were to determine the effector kinetics of oxytetracycline, danofloxacin and tulathromycin against two MmmSC field strains in artificial medium and adult bovine serum. Methods: Minimum inhibitory concentrations (MIC) were determined for oxytetracycline, danofloxacin and tulathromycin against MmmSC strains B237 and Tan8 using a macrodilution technique, and time-kill curves were constructed for various multiples of the MIC over a 24 hour period in artificial medium and serum. Data were fitted to sigmoid E-max models to obtain 24 hour-area under curve/MIC ratios for mycoplasmastasis and, where appropriate, for mycoplasmacidal activity and virtual mycoplasmal elimination. Results: Minimum inhibitory concentrations against B237 were 20-fold higher, 2-fold higher and approximately 330-fold lower in serum than in artificial medium for oxytetracycline, danofloxacin and tulathromycin, respectively. Such differences were mirrored in experiments using Tan8. Oxytetracycline was mycoplasmastatic against both strains in both matrices. Danofloxacin elicited mycoplasmacidal activity against B237 and virtual elimination of Tan8; similar maximum antimycoplasmal effects were observed in artificial medium and serum. Tulathromycin effected virtual elimination of B237 but was mycoplasmastatic against Tan8 in artificial medium. However, this drug was mycoplasmastatic against both strains in the more physiologically relevant matrix of serum. Conclusions: Oxytetracycline, danofloxacin and tulathromycin are all suitable candidates for further investigation as potential treatments for CBPP. This study also highlights the importance of testing drug activity in biological matrices as well as artificial media.	[Mitchell, John D.; McKeever, Declan J.] Royal Vet Coll, Hatfield, Herts, England; [McKellar, Quintin A.] Univ Hertfordshire, Hatfield AL10 9AB, Herts, England	University of London; University of London Royal Veterinary College; University of Hertfordshire	Mitchell, JD (corresponding author), Royal Vet Coll, Hatfield, Herts, England.	jdmitchell@rvc.ac.uk			Biotechnology and Biological Sciences Research Council [BB/H009450/1]; BBSRC [BB/H009450/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Biotechnology and Biological Sciences Research Council (grant reference BB/H009450/1, http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi FS, 2003, RES VET SCI, V74, P247, DOI 10.1016/S0034-5288(03)00005-5; Ayling RD, 2005, ANTIMICROB AGENTS CH, V49, P5162, DOI 10.1128/AAC.49.12.5162-5165.2005; Ayling RD, 2000, VET REC, V146, P243, DOI 10.1136/vr.146.9.243; Bengtsson B, 1997, J VET PHARMACOL THER, V20, P258, DOI 10.1046/j.1365-2885.1997.00066.x; BROOK I, 1989, REV INFECT DIS, V11, P361; BURROWS GE, 1987, J VET PHARMACOL THER, V10, P54, DOI 10.1111/j.1365-2885.1987.tb00077.x; COOPER AC, 1993, RES VET SCI, V54, P329, DOI 10.1016/0034-5288(93)90130-8; Cottew, 1987, REV SCI TECH OIE, V6, P625; Craig WA, 2004, DIAGN MICR INFEC DIS, V50, P229, DOI 10.1016/j.diagmicrobio.2004.07.006; Craigmill AL, 2004, J VET PHARMACOL THER, V27, P343, DOI 10.1111/j.1365-2885.2004.00606.x; DAVEY LA, 1985, VET REC, V117, P426, DOI 10.1136/vr.117.17.426; DEVINE LF, 1970, APPL MICROBIOL, V19, P329, DOI 10.1128/AEM.19.2.329-334.1970; Evans NA, 2005, VET THER, V6, P83; Firsov AA, 1999, ANTIMICROB AGENTS CH, V43, P498, DOI 10.1128/AAC.43.3.498; FRIIS C, 1993, AM J VET RES, V54, P1122; Frimodt-Moller N, 2002, INT J ANTIMICROB AG, V19, P333, DOI 10.1016/S0924-8579(02)00029-8; GILES CJ, 1991, J VET PHARMACOL THER, V14, P400, DOI 10.1111/j.1365-2885.1991.tb00854.x; Gloede J, 2010, J ANTIMICROB CHEMOTH, V65, P186, DOI 10.1093/jac/dkp434; Godinho KS, 2008, VET MICROBIOL, V129, P426, DOI 10.1016/j.vetmic.2007.11.033; GUARD CL, 1986, CAN J VET RES, V50, P342; Hannan PCT, 2000, VET RES, V31, P373, DOI 10.1051/vetres:2000100; Huebschle OJB, 2006, RES VET SCI, V81, P304, DOI 10.1016/j.rvsc.2006.02.005; Jores J, 2008, VET IMMUNOL IMMUNOP, V124, P192, DOI 10.1016/j.vetimm.2008.02.019; Konig C, 1998, J ANTIMICROB CHEMOTH, V42, P227, DOI 10.1093/jac/42.2.227; Lees P, 2006, ANTIMICROBIAL RESIST, P49; Lees P, 2004, J REGULATORY AFFAIRS, V15, P175; Levison ME, 2004, INFECT DIS CLIN N AM, V18, P451, DOI 10.1016/j.idc.2004.04.012; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; March JB, 2000, J CLIN MICROBIOL, V38, P1419, DOI 10.1128/JCM.38.4.1419-1425.2000; MARCHANT CD, 1992, J PEDIATR-US, V120, P72, DOI 10.1016/S0022-3476(05)80601-8; Mariner JC, 2006, PREV VET MED, V73, P75, DOI 10.1016/j.prevetmed.2005.09.002; MARTIN SR, 1979, BIOPHYS CHEM, V10, P319, DOI 10.1016/0301-4622(79)85019-X; Martinez M., 2006, ANTIMICROBIAL THERAP, P81; Mckellar OA, 2004, J VET PHARMACOL THER, V27, P503, DOI 10.1111/j.1365-2885.2004.00603.x; Mizunaga S, 2005, J ANTIMICROB CHEMOTH, V56, P91, DOI 10.1093/jac/dki163; Morrissey I, 1999, J ANTIMICROB CHEMOTH, V43, P423; Niang M., 2010, Journal of Veterinary Medicine and Animal Health, V2, P35; Niang M, 2006, FAO OIE AU IBAR IAEA, P25; NOUWS JFM, 1985, VET QUART, V7, P306, DOI 10.1080/01652176.1985.9694004; Nowakowski MA, 2004, VET THER, V5, P60; Regalla J, 1996, REV SCI TECH OIE, V15, P1309, DOI 10.20506/rst.15.4.979; RWEYEMAMU MM, 1995, REV SCI TECH OIE, V14, P593, DOI 10.20506/rst.14.3.856; Sallovitz J, 2002, VET J, V164, P47, DOI 10.1053/tvjl.2002.0715; Sarasola P, 2002, ANTIMICROB AGENTS CH, V46, P3013, DOI 10.1128/AAC.46.9.3013-3019.2002; SORIANO F, 1990, J ANTIMICROB CHEMOTH, V25, P621, DOI 10.1093/jac/25.4.621; Thomson GR, 2005, T410 CYB; Toutain PL, 2002, RES VET SCI, V73, P105, DOI 10.1016/S0034-5288(02)00039-5; WITKAMP RF, 1992, AM J VET RES, V53, P1830; Yaya A, 2004, FAO OIE AU IBAR IAEA	49	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44158	10.1371/journal.pone.0044158	http://dx.doi.org/10.1371/journal.pone.0044158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952911	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800098
J	Patra, R; Chattopadhyay, S; De, R; Ghosh, P; Ganguly, M; Chowdhury, A; Ramamurthy, T; Nair, GB; Mukhopadhyay, AK				Patra, Rajashree; Chattopadhyay, Santanu; De, Ronita; Ghosh, Prachetash; Ganguly, Mou; Chowdhury, Abhijit; Ramamurthy, T.; Nair, G. B.; Mukhopadhyay, Asish K.			Multiple Infection and Microdiversity among Helicobacter pylori Isolates in a Single Host in India	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION-STRUCTURE; LENGTH-POLYMORPHISM; ALLELIC DIVERSITY; GENOME DIVERSITY; GASTRIC-CANCER; STRAINS; SEQUENCE; VACA; RECOMBINATION	Helicobacter pylori is one of the most diverse bacterial species that chronically infects more than 70% of Indian population. Interestingly, data showing microdiversity of the H. pylori strains within a particular gastric niche remained scarce. To understand the extent of genetic diversity among H. pylori strains within a given host, 30 patients with gastro-duodenal problems were subjected to endoscopy and from each patient 10 single colonies were isolated. Characterization of each of these 10 single colonies by DNA fingerprinting as well as genotyping of several important genetic markers viz. cagA, vacA, iceA, vapD, cag PAI empty site, IS605, RFLP and two other genetic segments within cag PAI revealed that all of the 30 patients were infected with more than one strain and sometimes strains with 5 to 6 types of genetic variants. Analyses of certain genetic loci showed the microdiversity among the colonies from single patient, which may be due to the recombination events during long-term carriage of the pathogen. These results suggest that most of the patients have acquired H. pylori due to repeated exposure to this pathogen with different genetic make-up, which may increase the possibility of super infections. Genetic exchanges between these unrelated H. pylori strains may support certain H. pylori variant to grow better in a given host than the parental strain and thereby increasing the possibility for the severity of the infection.	[Patra, Rajashree; Chattopadhyay, Santanu; De, Ronita; Ghosh, Prachetash; Ganguly, Mou; Ramamurthy, T.; Nair, G. B.; Mukhopadhyay, Asish K.] Natl Inst Cholera & Enter Dis, Kolkata, India; [Chowdhury, Abhijit] Inst Post Grad Med Educ & Res, Liver Res Ctr, Sch Digest & Liver Dis, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Patra, R (corresponding author), Natl Inst Cholera & Enter Dis, Kolkata, India.	asish_mukhopadhyay@yahoo.com	Mukhopadhyay, Asish/ABE-7697-2020; DE, RONITA/HDM-7066-2022; Das, Rajashree/AAS-4747-2020; Das, Rajashree/D-1755-2017	Das, Rajashree/0000-0003-1202-4942; De, Ronita/0000-0002-1469-6139; Chattopadhyay, Santanu/0000-0002-6275-8568	Indian Council of Medical Research and Department of Biotechnology, India [BT/PR10407/BRB/10/604/2008]	Indian Council of Medical Research and Department of Biotechnology, India(Indian Council of Medical Research (ICMR))	The work was supported in part by the Indian Council of Medical Research and Department of Biotechnology, India (Sanction No. BT/PR10407/BRB/10/604/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Azuma T, 2004, J GASTROENTEROL, V39, P97, DOI 10.1007/s00535-003-1279-4; Berg DE, 1997, TRENDS MICROBIOL, V5, P468, DOI 10.1016/S0966-842X(97)01164-5; Berg Douglas E., 1994, Methods in Molecular and Cellular Biology, V5, P13; Burucoa C, 1999, J CLIN MICROBIOL, V37, P4071, DOI 10.1128/JCM.37.12.4071-4080.1999; Cao P, 1997, J BACTERIOL, V179, P2852, DOI 10.1128/jb.179.9.2852-2856.1997; Chattopadhyay S, 2004, J CLIN MICROBIOL, V42, P2821, DOI 10.1128/JCM.42.6.2821-2824.2004; Cooke CL, 2005, FEMS IMMUNOL MED MIC, V45, P11, DOI 10.1016/j.femsim.2005.04.002; Correa P, 1997, J Physiol Pharmacol, V48 Suppl 4, P19; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; GARNER JA, 1995, J INFECT DIS, V172, P290, DOI 10.1093/infdis/172.1.290; Gill H H, 1993, Indian J Gastroenterol, V12, P9; Go MF, 1996, J BACTERIOL, V178, P3934, DOI 10.1128/jb.178.13.3934-3938.1996; GRAHAM DY, 1991, DIGEST DIS SCI, V36, P1084, DOI 10.1007/BF01297451; Han SR, 2000, J CLIN MICROBIOL, V38, P3646, DOI 10.1128/JCM.38.10.3646-3651.2000; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Ito Y, 1998, J INFECT DIS, V178, P1391, DOI 10.1086/314435; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jiang Q, 1996, MOL MICROBIOL, V20, P833, DOI 10.1111/j.1365-2958.1996.tb02521.x; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kitamoto N, 1998, HELICOBACTER, V3, P152, DOI 10.1046/j.1523-5378.1998.08703.x; Kuo CH, 1999, J INFECT DIS, V180, P2064, DOI 10.1086/315130; LOPEZ CR, 1993, FEMS MICROBIOL LETT, V110, P37, DOI 10.1111/j.1574-6968.1993.tb06292.x; Marshall DG, 1996, J APPL BACTERIOL, V81, P509; Miehlke S, 1999, J CLIN MICROBIOL, V37, P245, DOI 10.1128/JCM.37.1.245-247.1999; Morales-Espinosa R, 2008, BIOQUIMIA, V33, P43; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; NEALE KR, 1995, ALIMENT PHARM THER, V9, P77; OWEN RJ, 1994, J CLIN MICROBIOL, V32, P1203, DOI 10.1128/JCM.32.5.1203-1210.1994; Parsonnet J, 1998, INFECT DIS CLIN N AM, V12, P185, DOI 10.1016/S0891-5520(05)70417-7; PARSONNET J, 1995, ALIMENT PHARM THERAP, V9, P45; PRASAD S, 1994, J GASTROEN HEPATOL, V9, P501, DOI 10.1111/j.1440-1746.1994.tb01281.x; Shortridge VD, 1997, J CLIN MICROBIOL, V35, P471, DOI 10.1128/JCM.35.2.471-473.1997; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; TAYLOR DE, 1992, J BACTERIOL, V174, P6800, DOI 10.1128/JB.174.21.6800-6806.1992; TAYLOR NS, 1995, J CLIN MICROBIOL, V33, P918, DOI 10.1128/JCM.33.4.918-923.1995; TEE W, 1992, J CLIN MICROBIOL, V30, P1562, DOI 10.1128/JCM.30.6.1562-1567.1992; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Doorn LJ, 1998, J CLIN MICROBIOL, V36, P2597, DOI 10.1128/JCM.36.9.2597-2603.1998; Yakoob J, 2001, CLIN MICROBIOL INFEC, V7, P187, DOI 10.1046/j.1198-743x.2001.00226.x; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yamaoka Y, 1998, J CLIN MICROBIOL, V36, P2258, DOI 10.1128/JCM.36.8.2258-2263.1998	47	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43370	10.1371/journal.pone.0043370	http://dx.doi.org/10.1371/journal.pone.0043370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952670	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800028
J	Richerioux, N; Blondeau, C; Wiedemann, A; Remy, S; Vautherot, JF; Denesvre, C				Richerioux, Nicolas; Blondeau, Caroline; Wiedemann, Agnes; Remy, Sylvie; Vautherot, Jean-Francois; Denesvre, Caroline			Rho-ROCK and Rac-PAK Signaling Pathways Have Opposing Effects on the Cell-to-Cell Spread of Marek's Disease Virus	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SMALL-MOLECULE INHIBITOR; SARCOMA-ASSOCIATED HERPESVIRUS; ACTIN CYTOSKELETON; PROTEIN-KINASE; GENE-PRODUCT; VIRAL SPREAD; MYOSIN-II; ADP-RIBOSYLTRANSFERASE; P21-ACTIVATED KINASE	Marek's Disease Virus (MDV) is an avian alpha-herpesvirus that only spreads from cell-to-cell in cell culture. While its cell-to-cell spread has been shown to be dependent on actin filament dynamics, the mechanisms regulating this spread remain largely unknown. Using a recombinant BAC20 virus expressing an EGFPVP22 tegument protein, we found that the actin cytoskeleton arrangements and cell-cell contacts differ in the center and periphery of MDV infection plaques, with cells in the latter areas showing stress fibers and rare cellular projections. Using specific inhibitors and activators, we determined that Rho-ROCK pathway, known to regulate stress fiber formation, and Rac-PAK, known to promote lamellipodia formation and destabilize stress fibers, had strong contrasting effects on MDV cell-to-cell spread in primary chicken embryo skin cells (CESCs). Inhibition of Rho and its ROCKs effectors led to reduced plaque sizes whereas inhibition of Rac or its group I-PAKs effectors had the adverse effect. Importantly, we observed that the shape of MDV plaques is related to the semi-ordered arrangement of the elongated cells, at the monolayer level in the vicinity of the plaques. Inhibition of Rho-ROCK signaling also resulted in a perturbation of the cell arrangement and a rounding of plaques. These opposing effects of Rho and Rac pathways in MDV cell-to-cell spread were validated for two parental MDV recombinant viruses with different ex vivo spread efficiencies. Finally, we demonstrated that Rho/Rac pathways have opposing effects on the accumulation of N-cadherin at cell-cell contact regions between CESCs, and defined these contacts as adherens junctions. Considering the importance of adherens junctions in HSV-1 cell-to-cell spread in some cell types, this result makes of adherens junctions maintenance one potential and attractive hypothesis to explain the Rho/Rac effects on MDV cell-to-cell spread. Our study provides the first evidence that MDV cell-to-cell spread is regulated by Rho/Rac signaling.	[Richerioux, Nicolas; Blondeau, Caroline; Remy, Sylvie; Vautherot, Jean-Francois; Denesvre, Caroline] INRA, Infect Dis & Publ Hlth UMR1282, ISP, BIOVA Team, F-37380 Nouzilly, France; [Wiedemann, Agnes] INRA, Infect Dis & Publ Hlth UMR1282, ISP, SPVB Team, F-37380 Nouzilly, France; [Richerioux, Nicolas; Blondeau, Caroline; Wiedemann, Agnes; Remy, Sylvie; Vautherot, Jean-Francois; Denesvre, Caroline] Univ Tours, Infect Dis & Publ Hlth UMR1282, ISP, Tours, France	INRAE; INRAE; Universite de Tours	Richerioux, N (corresponding author), INRA, Infect Dis & Publ Hlth UMR1282, ISP, BIOVA Team, F-37380 Nouzilly, France.	denesvre@tours.inra.fr	Blondeau, Caroline/D-4269-2017	Wiedemann, Agnes/0000-0001-8237-3545	INRA/(National Institute for Agricultural Research) Region Centre fellowship	INRA/(National Institute for Agricultural Research) Region Centre fellowship	Nicolas Richerioux is a PhD student supported by an INRA/(National Institute for Agricultural Research) Region Centre fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; Albertinazzi C, 1999, J CELL SCI, V112, P3821; Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x; Aubert M, 2009, J VIROL, V83, P6171, DOI 10.1128/JVI.02163-08; BIGGS PM, 1967, J NATL CANCER I, V39, P267; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Blondeau C, 2008, J VIROL, V82, P9278, DOI 10.1128/JVI.00598-08; Blondeau C, 2007, VET RES, V38, P419, DOI 10.1051/vetres:2007009; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chan MWC, 2004, J BIOL CHEM, V279, P41047, DOI 10.1074/jbc.M406631200; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Comunale F, 2007, BIOL CELL, V99, P503, DOI 10.1042/BC20070011; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Denesvre C, 2007, J VIROL, V81, P12348, DOI 10.1128/JVI.01177-07; Dixit R, 2008, NEUROSCI LETT, V440, P113, DOI 10.1016/j.neulet.2008.05.031; Dorange F, 2000, J GEN VIROL, V81, P2219, DOI 10.1099/0022-1317-81-9-2219; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Favoreel HW, 2007, TRENDS MICROBIOL, V15, P426, DOI 10.1016/j.tim.2007.08.003; Favoreel HW, 2010, VET MICROBIOL, V143, P2, DOI 10.1016/j.vetmic.2010.02.007; Favoreel HW, 2005, P NATL ACAD SCI USA, V102, P8990, DOI 10.1073/pnas.0409099102; Frampton AR, 2007, J VIROL, V81, P10879, DOI 10.1128/JVI.00504-07; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gill MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001808; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hase H, 1996, CELL STRUCT FUNCT, V21, P17, DOI 10.1247/csf.21.17; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Jarosinski KW, 2007, J VIROL, V81, P10575, DOI 10.1128/JVI.01065-07; Johnson DC, 2001, J VIROL, V75, P821, DOI 10.1128/JVI.75.2.821-833.2001; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Keyser J, 2007, FEBS LETT, V581, P5349, DOI 10.1016/j.febslet.2007.10.030; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Lazaro-Dieguez F, 2008, J CELL SCI, V121, P1415, DOI 10.1242/jcs.017665; Loubery S, 2008, CELL MOL LIFE SCI, V65, P2790, DOI 10.1007/s00018-008-8350-5; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; May JS, 2005, J VIROL, V79, P5059, DOI 10.1128/JVI.79.8.5059-5068.2005; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; NAZERIAN K, 1968, CANCER RES, V28, P2454; Oh MJ, 2010, BIOCHEM BIOPH RES CO, V391, P176, DOI 10.1016/j.bbrc.2009.11.027; Ostap EM, 2002, J MUSCLE RES CELL M, V23, P305, DOI 10.1023/A:1022047102064; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Petherbridge L, 2004, J VIROL, V78, P13376, DOI 10.1128/JVI.78.23.13376-13380.2004; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rosselin M, 2010, CELL RES, V20, P647, DOI 10.1038/cr.2010.45; Sahai E, 2006, METHOD ENZYMOL, V406, P128, DOI 10.1016/S0076-6879(06)06011-3; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schauer K, 2010, NAT METHODS, V7, P560, DOI [10.1038/NMETH.1462, 10.1038/nmeth.1462]; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schumacher D, 2005, J VIROL, V79, P3987, DOI 10.1128/JVI.79.7.3987-3997.2005; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Schumacher D, 2008, VIROLOGY, V375, P37, DOI 10.1016/j.virol.2008.01.026; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sward K, 2000, J PHYSIOL-LONDON, V522, P33, DOI 10.1111/j.1469-7793.2000.0033m.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Van den Broeke C, 2011, VIRUSES-BASEL, V3, P278, DOI 10.3390/v3040278; Van den Broeke C, 2009, P NATL ACAD SCI USA, V106, P8707, DOI 10.1073/pnas.0900436106; van Leeuwen H, 2002, J VIROL, V76, P3471, DOI 10.1128/JVI.76.7.3471-3481.2002; Veettil MV, 2006, J VIROL, V80, P11432, DOI 10.1128/JVI.01342-06; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237; YONEMURA S, 1995, J CELL SCI, V108, P127; Yoon M, 2002, J VIROL, V76, P7203, DOI 10.1128/JVI.76.14.7203-7208.2002; Zelnik V, 2004, MAREKS DIS EVOLVING	88	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44072	10.1371/journal.pone.0044072	http://dx.doi.org/10.1371/journal.pone.0044072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952878	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800094
J	Marchand, A; Proust, C; Morange, PE; Lompre, AM; Tregouet, DA				Marchand, Alexandre; Proust, Carole; Morange, Pierre-Emmanuel; Lompre, Anne-Marie; Tregouet, David-Alexandre			miR-421 and miR-30c Inhibit SERPINE 1 Gene Expression in Human Endothelial Cells	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; RISK; ASSOCIATION; BINDING; BIOMARKERS; CARCINOMA; SEQUENCE; RECEPTOR	In this work, we assessed whether SERPINE1 expression could be under the influence of microRNAs (miRNAs) predicted to bind the SERPINE1 3'UTR region. We specifically focused on the 3'UTR region harboring a common polymorphism, rs1050955, that have been found associated to SERPINE1 monocyte expression, and investigated whether the presence of different alleles at rs1050955 could modify the miRNAs binding efficiency and affect PAI-1 protein levels. We demonstrated that, in human umbilical vein endothelial cells, both miR-421 and miR-30c directly interacted with PAI-1 mRNA to inhibit the expression of the associated protein. However, these inhibitory mechanisms were independent on the allele present at the rs1050955 locus. We further showed that miR-421 levels correlated with PAI-1 activity in the plasma sample of 40 patients with venous thrombosis. Our results strongly suggest that the regulation of PAI-1 molecule could be under the influence of several miRNAs whose measurement in the plasma of patients could be envisaged as a biomarker for inflammatory and thrombotic disorders.	[Marchand, Alexandre; Lompre, Anne-Marie] INSERM, UMR S 956, Paris, France; [Marchand, Alexandre; Proust, Carole; Lompre, Anne-Marie; Tregouet, David-Alexandre] Univ Paris 06, Fac Med, Paris, France; [Marchand, Alexandre; Proust, Carole; Lompre, Anne-Marie; Tregouet, David-Alexandre] ICAN Inst Cardiometab & Nutr, Paris, France; [Proust, Carole; Tregouet, David-Alexandre] INSERM, UMR S 937, Paris, France; [Morange, Pierre-Emmanuel] INSERM, UMR S 1062, Marseille, France; [Morange, Pierre-Emmanuel] Univ Mediterranee, Fac Med, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Marchand, A (corresponding author), INSERM, UMR S 956, Paris, France.	david.tregouet@upmc.fr	Trégouët, David-Alexandre/P-9210-2019; Morange, Pierre/T-9070-2019; LOMPRE, Anne-Marie/H-2872-2013; Tregouet, David-Alexandre/E-3961-2016	Trégouët, David-Alexandre/0000-0001-9084-7800; Morange, Pierre/0000-0002-9065-722X; Marchand, Alexandre/0000-0002-2670-6939	Association Francaise contre les Myopathies (AFM); Leducq Foundation (Caerus network); Program Hospitalier de Recherche Clinique [PHRC2099 RENOVA-TV]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Leducq Foundation (Caerus network)(Leducq Foundation); Program Hospitalier de Recherche Clinique	A. Marchand and A-M. Lompre were supported by Association Francaise contre les Myopathies (AFM), and by the Leducq Foundation (Caerus network). This works also benefitted from financial support from the Program Hospitalier de Recherche Clinique (PHRC2099 RENOVA-TV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 2011, THROMB HAEMOSTASIS, V106, P416, DOI 10.1160/TH11-03-0179; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dupuis M, 2004, CIRCULATION, V110, P867, DOI 10.1161/01.CIR.0000138850.72900.FE; Haas U, 2012, RNA BIOL, V9, P924, DOI 10.4161/rna.20497; Hao J, 2011, BIOCHEM BIOPH RES CO, V406, P552, DOI 10.1016/j.bbrc.2011.02.086; Hitti E, 2012, FRONT BIOSCI-LANDMRK, V17, P1846, DOI 10.2741/4023; Iwaki T, 2012, BRIT J HAEMATOL, V157, P291, DOI 10.1111/j.1365-2141.2012.09074.x; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jiang Z, 2010, J GASTROENTEROL, V45, P17, DOI 10.1007/s00535-009-0135-6; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Juhan-Vague I, 2003, J THROMB HAEMOST, V1, P2322, DOI 10.1046/j.1538-7836.2003.00458.x; JuhanVague I, 1996, CIRCULATION, V94, P2057, DOI 10.1161/01.CIR.94.9.2057; Karbiener M, 2011, RNA BIOL, V8, P850, DOI 10.4161/rna.8.5.16153; Lanktree MB, 2010, BLOOD, V116, P2160, DOI 10.1182/blood-2010-02-269902; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Meltzer ME, 2009, SEMIN THROMB HEMOST, V35, P468, DOI 10.1055/s-0029-1234142; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morange PE, 2007, ARTERIOSCL THROM VAS, V27, P2250, DOI 10.1161/ATVBAHA.107.149468; Nossent AY, 2011, AM J HYPERTENS, V24, P999, DOI 10.1038/ajh.2011.92; Perez MP, 2012, MOL MED REP, V5, P1135, DOI 10.3892/mmr.2012.785; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Su SY, 2006, ARTERIOSCL THROM VAS, V26, P948, DOI 10.1161/01.ATV.0000204731.17646.f2; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zhang Y, 2012, MOL CANCER RES, V10, P516, DOI 10.1158/1541-7786.MCR-11-0473	37	52	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44532	10.1371/journal.pone.0044532	http://dx.doi.org/10.1371/journal.pone.0044532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952991	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300097
J	Pedrazzi, M; Averna, M; Sparatore, B; Patrone, M; Salamino, F; Marcoli, M; Maura, G; Cervetto, C; Frattaroli, D; Pontremoli, S; Melloni, E				Pedrazzi, Marco; Averna, Monica; Sparatore, Bianca; Patrone, Mauro; Salamino, Franca; Marcoli, Manuela; Maura, Guido; Cervetto, Chiara; Frattaroli, Daniela; Pontremoli, Sandro; Melloni, Edon			Potentiation of NMDA Receptor-Dependent Cell Responses by Extracellular High Mobility Group Box 1 Protein	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INDUCED-DIFFERENTIATION; NEURITE OUTGROWTH; ACTIVATION; AMPHOTERIN; RELEASE; GLUTAMATE; CALPAIN; BINDING; HMGB1	Background: Extracellular high mobility group box 1 (HMGB1) protein can operate in a synergistic fashion with different signal molecules promoting an increase of cell Ca2+ influx. However, the mechanisms responsible for this effect of HMGB1 are still unknown. Principal Findings: Here we demonstrate that, at concentrations of agonist per se ineffective, HMGB1 potentiates the activation of the ionotropic glutamate N-methyl-D-aspartate receptor (NMDAR) in isolated hippocampal nerve terminals and in a neuroblastoma cell line. This effect was abolished by the NMDA channel blocker MK-801. The HMGB1-facilitated NMDAR opening was followed by activation of the Ca2+-dependent enzymes calpain and nitric oxide synthase in neuroblastoma cells, resulting in an increased production of NO, a consequent enhanced cell motility, and onset of morphological differentiation. We have also identified NMDAR as the mediator of HMGB1-stimulated murine erythroleukemia cell differentiation, induced by hexamethylenebisacetamide. The potentiation of NMDAR activation involved a peptide of HMGB1 located in the B box at the amino acids 130-139. This HMGB1 fragment did not overlap with binding sites for other cell surface receptors of HMGB1, such as the advanced glycation end products or the Toll-like receptor 4. Moreover, in a competition assay, the HMGB1(130-139) peptide displaced the NMDAR/HMGB1 interaction, suggesting that it comprised the molecular and functional site of HMGB1 regulating the NMDA receptor complex. Conclusion: We propose that the multifunctional cytokine-like molecule HMGB1 released by activated, stressed, and damaged or necrotic cells can facilitate NMDAR-mediated cell responses, both in the central nervous system and in peripheral tissues, independently of other known cell surface receptors for HMGB1.	[Pedrazzi, Marco; Averna, Monica; Sparatore, Bianca; Salamino, Franca; Marcoli, Manuela; Maura, Guido; Cervetto, Chiara; Frattaroli, Daniela; Pontremoli, Sandro; Melloni, Edon] Univ Genoa, Dept Expt Med DIMES, Genoa, Italy; [Pedrazzi, Marco; Averna, Monica; Sparatore, Bianca; Salamino, Franca; Marcoli, Manuela; Maura, Guido; Melloni, Edon] Univ Genoa, CEBR, Genoa, Italy; [Patrone, Mauro] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci & Innovaz Tecnol, DiSIT, Alessandria, Italy	University of Genoa; University of Genoa; University of Eastern Piedmont Amedeo Avogadro	Pedrazzi, M (corresponding author), Univ Genoa, Dept Expt Med DIMES, Genoa, Italy.	monica.averna@unige.it	Averna, Maurizio/U-9527-2017; Cervetto, Chiara/G-6404-2010; AVERNA, MONICA/R-5719-2019	Cervetto, Chiara/0000-0001-8290-3008; AVERNA, MONICA/0000-0002-9463-7533; marcoli, manuela/0000-0003-3261-5264; PATRONE, Mauro/0000-0002-7740-2396	Italian Ministry of Education, University and Research (PRIN); University "A. Avogadro"; University of Genoa	Italian Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University "A. Avogadro"; University of Genoa	This work was supported by the Italian Ministry of Education, University and Research (PRIN 2008), the University "A. Avogadro" and the University of Genoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2009, LAB INVEST, V89, P278, DOI 10.1038/labinvest.2008.165; Averna M, 2009, J NEUROCHEM, V110, P412, DOI 10.1111/j.1471-4159.2009.06149.x; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Cervetto C, 2010, J PHARMACOL EXP THER, V332, P210, DOI 10.1124/jpet.109.154955; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Contestabile A, 2004, NEUROCHEM INT, V45, P903, DOI 10.1016/j.neuint.2004.03.021; Corasaniti MT, 1996, BIOCHEM BIOPH RES CO, V229, P299, DOI 10.1006/bbrc.1996.1796; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Evangelopoulos ME, 2010, NEUROSCI LETT, V468, P28, DOI 10.1016/j.neulet.2009.10.054; Fages C, 2000, J CELL SCI, V113, P611; GILLO B, 1993, BLOOD, V81, P783; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Hinoi E, 2004, EUR J BIOCHEM, V271, P1, DOI 10.1046/j.1432-1033.2003.03907.x; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2004, J INTERN MED, V255, P351, DOI 10.1111/j.1365-2796.2003.01301.x; Huttunen HJ, 2002, CANCER RES, V62, P4805; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Marcoli M, 2008, J NEUROCHEM, V105, P2330, DOI 10.1111/j.1471-4159.2008.05322.x; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; MELLONI E, 1988, P NATL ACAD SCI USA, V85, P3835, DOI 10.1073/pnas.85.11.3835; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Musante V, 2011, J NEUROCHEM, V117, P516, DOI 10.1111/j.1471-4159.2011.07223.x; NAKAMURA Y, 1993, GLIA, V9, P48, DOI 10.1002/glia.440090107; North WG, 1997, MOL CHEM NEUROPATHOL, V30, P77, DOI 10.1007/BF02815151; Passalacqua M, 2009, ARCH BIOCHEM BIOPHYS, V481, P202, DOI 10.1016/j.abb.2008.11.013; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; Pedrazzi M, 2006, J NEUROCHEM, V99, P827, DOI 10.1111/j.1471-4159.2006.04120.x; RAITERI M, 1974, EUR J PHARMACOL, V25, P411, DOI 10.1016/0014-2999(74)90272-6; Ranzato E, 2009, MOL CELL BIOCHEM, V332, P199, DOI 10.1007/s11010-009-0192-4; Schelman WR, 1997, MOL BRAIN RES, V48, P197, DOI 10.1016/S0169-328X(97)00093-4; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Sparatore B, 2005, BIOCHEM J, V389, P215, DOI 10.1042/BJ20050053; Sparatore B, 1996, BIOCHEM J, V320, P253, DOI 10.1042/bj3200253; Sparatore B, 2002, BIOCHEM J, V363, P529, DOI 10.1042/0264-6021:3630529; Sparatore B, 2001, BIOCHEM J, V357, P569, DOI 10.1042/0264-6021:3570569; Tagami K, 2006, BRIT J HAEMATOL, V135, P567, DOI 10.1111/j.1365-2141.2006.06335.x; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tzeng HP, 2008, AM J PHYSIOL-HEART C, V294, pH1490, DOI 10.1152/ajpheart.00910.2007; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107	47	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44518	10.1371/journal.pone.0044518	http://dx.doi.org/10.1371/journal.pone.0044518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952988	gold, Green Submitted, Green Published			2022-12-27	WOS:000308221300096
J	Asati, A; Kachurina, O; Kachurin, A				Asati, Atul; Kachurina, Olga; Kachurin, Anatoly			Simultaneous Measurements of Auto-Immune and Infectious Disease Specific Antibodies Using a High Throughput Multiplexing Tool	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; ANTI-GM1 ANTIBODIES; GANGLIOSIDE COMPLEXES; NEUROPATHY; GM1; AUTOANTIBODIES; CERAMIDASE; VACCINE	Considering importance of ganglioside antibodies as biomarkers in various immune-mediated neuropathies and neurological disorders, we developed a high throughput multiplexing tool for the assessment of gangliosides-specific antibodies based on Biolpex/Luminex platform. In this report, we demonstrate that the ganglioside high throughput multiplexing tool is robust, highly specific and demonstrating, similar to 100-fold higher concentration sensitivity for IgG detection than ELISA. In addition to the ganglioside-coated array, the high throughput multiplexing tool contains beads coated with influenza hemagglutinins derived from H1N1 A/Brisbane/59/07 and H1N1 A/California/07/09 strains. Influenza beads provided an added advantage of simultaneous detection of ganglioside-and influenza-specific antibodies, a capacity important for the assay of both infectious antigen-specific and autoimmune antibodies following vaccination or disease. Taken together, these results support the potential adoption of the ganglioside high throughput multiplexing tool for measuring ganglioside antibodies in various neuropathic and neurological disorders.	[Asati, Atul; Kachurina, Olga; Kachurin, Anatoly] Sanofi Pasteur, Orlando, FL USA	Sanofi-Aventis	Asati, A (corresponding author), Sanofi Pasteur, VaxDesign Campus, Orlando, FL USA.	Anatoly.Kachurin@sanofipasteur.com			Biomedical Advanced Research and Development Authority, Department of Health and Human Services [HHSO100201000035C]	Biomedical Advanced Research and Development Authority, Department of Health and Human Services	This project has been funded in whole or in part with Federal funds from Biomedical Advanced Research and Development Authority, Department of Health and Human Services, under Contract No. HHSO100201000035C. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alaedini A, 2002, J NEUROIMMUNOL, V127, P145, DOI 10.1016/S0165-5728(02)00102-9; Alaedini A, 2002, J NEUROL SCI, V196, P41, DOI 10.1016/S0022-510X(02)00022-9; Alaedini A, 2001, J CLIN LAB ANAL, V15, P96, DOI 10.1002/jcla.8; Cats EA, 2010, NEUROLOGY, V75, P1961, DOI 10.1212/WNL.0b013e3181ff94c2; Colasanti T, 2010, AUTOIMMUN REV, V9, P807, DOI 10.1016/j.autrev.2010.07.008; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hartung HP, 2001, CURR OPIN NEUROL, V14, P597, DOI 10.1097/00019052-200110000-00008; Kaida K, 2010, J NEUROIMMUNOL, V223, P5, DOI 10.1016/j.jneuroim.2010.02.001; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; KARPIAK SE, 1976, SCIENCE, V194, P735, DOI 10.1126/science.982041; KARPIAK SE, 1981, EPILEPSIA, V22, P189, DOI 10.1111/j.1528-1157.1981.tb04101.x; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; Kita K, 2000, BBA-MOL CELL BIOL L, V1485, P111, DOI 10.1016/S1388-1981(00)00029-9; Koga M, 2001, J NEUROL NEUROSUR PS, V71, P123, DOI 10.1136/jnnp.71.1.123; KORNBERG AJ, 1994, MUSCLE NERVE, V17, P100, DOI 10.1002/mus.880170115; Kusunoki S, 1996, ANN NEUROL, V39, P424, DOI 10.1002/ana.410390404; Kusunoki S, 2011, J NEUROCHEM, V116, P828, DOI 10.1111/j.1471-4159.2010.07029.x; Lardone RD, 2010, J NEUROL NEUROSUR PS, V81, P629, DOI 10.1136/jnnp.2009.183665; LEDEEN RW, 1982, METHOD ENZYMOL, V83, P139; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; Liljeblad A, 2010, ORG BIOMOL CHEM, V8, P886, DOI 10.1039/b920939p; Lopez PHH, 2002, J NEUROIMMUNOL, V128, P69, DOI 10.1016/S0165-5728(02)00139-X; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Meinl E., 2010, CLIN EXP NEUROIMMUNO, V1, P47; Mudrak B, 2010, TOXINS, V2, P1445, DOI 10.3390/toxins2061445; Nachamkin I, 2008, J INFECT DIS, V198, P226, DOI 10.1086/589624; O'Hanlon GM, 2000, AUTOIMMUNITY, V32, P133, DOI 10.3109/08916930008994083; Ogawa G, 2009, J NEUROIMMUNOL, V214, P125, DOI 10.1016/j.jneuroim.2009.06.017; REES JH, 1995, ANN NEUROL, V38, P809, DOI 10.1002/ana.410380516; Sadatipour BT, 1998, ANN NEUROL, V44, P980, DOI 10.1002/ana.410440621; SADIQ SA, 1990, NEUROLOGY, V40, P1067, DOI 10.1212/WNL.40.7.1067; Tani M, 2000, J BIOL CHEM, V275, P3462, DOI 10.1074/jbc.275.5.3462; VANDENBERG LH, 1992, J NEUROL NEUROSUR PS, V55, P8, DOI 10.1136/jnnp.55.1.8; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; VANSCHAIK IN, 1994, J NEUROIMMUNOL, V54, P109, DOI 10.1016/0165-5728(94)90237-2; Wang DJ, 2011, INFLUENZA O IN PRESS	37	1	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e42681	10.1371/journal.pone.0042681	http://dx.doi.org/10.1371/journal.pone.0042681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952605	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206500006
J	Deng, YM; Jiang, JF; Chen, SM; Teng, NJ; Song, AP; Guan, ZY; Fang, WM; Chen, FD				Deng, Yanming; Jiang, Jiafu; Chen, Sumei; Teng, Nianjun; Song, Aiping; Guan, Zhiyong; Fang, Weimin; Chen, Fadi			Combination of Multiple Resistance Traits from Wild Relative Species in Chrysanthemum via Trigeneric Hybridization	PLOS ONE			English	Article							ARTEMISIA-VULGARIS; SALT-TOLERANCE; MECHANISMS; HYBRID	Background: With the objective of combining multiple resistant traits from wild relative species in florist's chrysanthemums, trigeneric hybridization was conducted by crossing two intergeneric F-1 hybrids Chrysanthemum grandiflorum X Artemisia vulgaris and Chrysanthemum crassum X Crossostephium chinense. Methodology/Principal Findings: To assess post-pollination phenomena, we investigated pollen germination on the stigma and embryo development, using fluorescence and scanning electron microscopy and paraffin-embedded sections, respectively. We selected eight putative trigeneric hybrid lines that showed the greatest morphological differences from the parents from among the progeny derived via embryo rescue. The hybridity of one trigeneric hybrid was further confirmed by fluorescent genomic in situ hybridization; in addition, the aphid resistance and salt tolerance of this hybrid were higher than those of the chrysanthemum parent and the C. grandiflorum X A. vulgaris F-1 hybrid, respectively. Conclusions/Significance: The enhanced aphid resistance of the hybrid line reflects the inheritance of chromosomes from A. vulgaris, which carries genes that encode bioactive components. The enhanced salt tolerance of the trigeneric hybrid is attributable to inheritance of genetic materials from Chrysanthemum crassum and Crossostephium chinense, which act to maintain the compartmentation of Na+ and K+ ions and their selective transportation among different organs to avert deleterious effects and protect the photosynthetic apparatus. The results indicate that trigeneric hybridization between different bigeneric hybrids is a promising method for combination of multiple stress-resistance traits for improvement of chrysanthemum.	[Deng, Yanming; Jiang, Jiafu; Chen, Sumei; Teng, Nianjun; Song, Aiping; Guan, Zhiyong; Fang, Weimin; Chen, Fadi] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Deng, Yanming] Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences	Deng, YM (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chenfd@njau.edu.cn		Deng, Yanming/0000-0001-7978-1417	Fundamental Research Funds for the Central Universities [KYJ 200907, KYZ201112]; Ministry of Science and Technology of the People's Republic of China [2011AA100208]; Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [CX(10)114]; Science and Technology Program of Jiangsu Province [BE2011325]; Program for New Century Excellent Talents in University of Chinese Ministry of Education [NCET-10-0492]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province; Science and Technology Program of Jiangsu Province; Program for New Century Excellent Talents in University of Chinese Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Fundamental Research Funds for the Central Universities (KYJ 200907, KYZ201112), 863 project of Ministry of Science and Technology of the People's Republic of China (2011AA100208), Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province (CX(10)114), the Science and Technology Program of Jiangsu Province (BE2011325), the Program for New Century Excellent Talents in University of Chinese Ministry of Education (Grant No. NCET-10-0492), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkenar AA, 2007, SCI HORTIC-AMSTERDAM, V114, P74, DOI 10.1016/j.scienta.2007.06.022; Anderson NO, 2006, FLOWER BREEDING AND GENETICS: ISSUES, CHALLENGES AND OPPORTUNITIES FOR THE 21ST CENTURY, P389; Bremer K., 1993, B NAT HIST MUS LOND, V23, P71; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Cheng X, 2011, EUPHYTICA, V177, P45, DOI 10.1007/s10681-010-0248-2; Deng YM, 2012, PLANT PHYSIOL BIOCH, V55, P93, DOI 10.1016/j.plaphy.2012.03.006; Deng YM, 2012, SCI HORTIC-AMSTERDAM, V134, P185, DOI 10.1016/j.scienta.2011.11.012; Deng YM, 2011, PLANT CELL REP, V30, P2177, DOI 10.1007/s00299-011-1123-x; Deng YM, 2010, EUPHYTICA, V174, P41, DOI 10.1007/s10681-009-0113-3; Deng YM, 2010, SCI HORTIC-AMSTERDAM, V124, P500, DOI 10.1016/j.scienta.2010.02.009; Deng YM, 2010, PLANTA, V231, P693, DOI 10.1007/s00425-009-1081-5; DUMAS C, 1983, THEOR APPL GENET, V67, P1, DOI 10.1007/BF00303914; FEDAK G, 1980, THEOR APPL GENET, V56, P221, DOI 10.1007/BF00295452; Fukai S, 2003, ACTA HORTIC, P223, DOI 10.17660/ActaHortic.2003.620.26; Ge XH, 2007, CHROMOSOME RES, V15, P849, DOI 10.1007/s10577-007-1168-4; Guan Zhi-yong, 2010, Shengtaixue Zazhi, V29, P467; Jauhar PP, 2010, NUCLEUS CALCUTTA, V53, P3, DOI 10.1007/s13237-010-0010-0; Jenczewski E, 2004, CRIT REV PLANT SCI, V23, P21, DOI 10.1080/07352680490273239; Kang HY, 2012, GENET RESOUR CROP EV, V59, P445, DOI 10.1007/s10722-011-9694-5; Kasha K J, 1970, Nature, V225, P874, DOI 10.1038/225874a0; Kondo Katsuhiko, 2002, Chromosome Science, V6, P87; Kosina R, 1996, ANN BOT-LONDON, V78, P583, DOI 10.1006/anbo.1996.0164; Lee YH, 1996, EUPHYTICA, V89, P235, DOI 10.1007/BF00034611; Li J, 2008, EUPHYTICA, V164, P293, DOI 10.1007/s10681-008-9734-1; Li XF, 2006, EUPHYTICA, V150, P117, DOI 10.1007/s10681-006-9099-2; McClure BA, 2006, PLANTA, V224, P233, DOI 10.1007/s00425-006-0284-2; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; SIDDIQUI KA, 1971, HEREDITAS-GENETISK A, V69, P263; Sun CQ, 2010, EUPHYTICA, V174, P51, DOI 10.1007/s10681-009-0117-z; Tang FP, 2009, EUPHYTICA, V169, P133, DOI 10.1007/s10681-009-9956-x; Wang B., 1995, PLANT PHYSL COMMUN, V31, P50; Wang J, 2006, J STORED PROD RES, V42, P339, DOI 10.1016/j.jspr.2005.06.001; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Zhao HE, 2009, GENET RESOUR CROP EV, V56, P937, DOI 10.1007/s10722-009-9412-8; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	38	10	11	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44337	10.1371/journal.pone.0044337	http://dx.doi.org/10.1371/journal.pone.0044337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952958	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500061
J	Ford, N; Hargreaves, S; Shanks, L				Ford, Nathan; Hargreaves, Sally; Shanks, Leslie			Mortality after Fluid Bolus in Children with Shock Due to Sepsis or Severe Infection: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PHASE-II TRIAL; AFRICAN CHILDREN; SEPTIC SHOCK; VOLUME EXPANSION; KENYAN CHILDREN; SEVERE MALARIA; RESUSCITATION; MANAGEMENT; ALBUMIN; SALINE	Introduction: Sepsis is one of the leading causes of childhood mortality, yet controversy surrounds the current treatment approach. We conducted a systematic review to assess the evidence base for fluid resuscitation in the treatment of children with shock due to sepsis or severe infection. Methods: We searched 3 databases for randomized trials, quasi-randomized trials, and controlled before-after studies assessing children with septic shock in which at least one group was treated with bolus fluids. The primary outcome was mortality at 48 hours. Assessment of methodological quality followed the GRADE criteria. Relative risks (RRs) and 95% confidence intervals (CI) were calculated and data pooled using fixed-effects method. Results: 13 studies met our inclusion criteria. No bolus has significantly better mortality outcomes at 48 hours for children with general septic shock (RR 0.69; 95% CI 0.54-0.89), and children with malaria (RR 0.64; 95% CI 0.45-0.91) when compared to giving any bolus. This result is largely driven by a single, high quality trial (the FEAST trial). There is no evidence investigating bolus vs no bolus in children with Dengue fever or severe malnutrition. Colloid and crystalloid boluses were found to have similar effects on mortality across all sub-groups (general septic shock, malaria, Dengue fever, and severe malnutrition). Conclusions: The majority of all randomized evidence to date comes from the FEAST trial, which found that fluid boluses were harmful compared to no bolus. Simple algorithms are needed to support health-care providers in the triage of patients to determine who could potentially be harmed by the provision of bolus fluids, and who will benefit.	[Ford, Nathan] Med Sans Frontieres, Geneva, Switzerland; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Hargreaves, Sally] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Infect Dis & Immun, Int Hlth Unit, London, England; [Shanks, Leslie] Med Sans Frontieres, Amsterdam, Netherlands	Doctors Without Borders; University of Cape Town; Imperial College London; Doctors Without Borders	Ford, N (corresponding author), Med Sans Frontieres, Geneva, Switzerland.	Nathan.ford@msf.org		Hargreaves, Sally/0000-0003-2974-4348				Akech S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010021; Akech S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4416; Akech SO, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-71; Akech SO, 2010, CRIT CARE MED, V38, P1630, DOI 10.1097/CCM.0b013e3181e81165; Berend K, 2011, NEW ENGL J MED, V365, P1349, DOI 10.1056/NEJMc1108712; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Chopra A, 2011, INDIAN J PEDIATR, V78, P833, DOI 10.1007/s12098-011-0366-4; Cifra H, 2003, CRIT CARE SHOCK, V6, P95; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Duke T, 2011, LANCET, V378, P1685, DOI 10.1016/S0140-6736(11)60881-7; Dung NM, 1999, CLIN INFECT DIS, V29, P787, DOI 10.1086/520435; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Ford SR, 2011, NEW ENGL J MED, V365, P1348, DOI 10.1056/NEJMc1108712; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; Hicks Peter, 2008, Crit Care Resusc, V10, P8; Kissoon N, 2011, NEW ENGL J MED, V365, P1350, DOI 10.1056/NEJMc1108712; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Maitland K, 2005, CLIN INFECT DIS, V40, P538, DOI 10.1086/427505; Maitland K, 2005, BRIT J HAEMATOL, V128, P393, DOI 10.1111/j.1365-2141.2004.05312.x; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Nhan NT, 2001, CLIN INFECT DIS, V32, P204, DOI 10.1086/318479; Ribeiro CT, 2011, NEW ENGL J MED, V365, P1348, DOI 10.1056/NEJMc1108712; Santhanam I, 2008, PEDIATR EMERG CARE, V24, P647, DOI 10.1097/PEC.0b013e31818844cf; Scott H, 2011, NEW ENGL J MED, V365, P1350, DOI 10.1056/NEJMc1108712; Upadhyay M, 2005, INDIAN PEDIATR, V42, P223; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; WILSON RF, 1971, ANN SURG, V174, P939, DOI 10.1097/00000658-197112000-00009	29	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43953	10.1371/journal.pone.0043953	http://dx.doi.org/10.1371/journal.pone.0043953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952819	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500030
J	Buckle, CH; De Leenheer, E; Lawson, MA; Yong, K; Rabin, N; Perry, M; Vanderkerken, K; Croucher, PI				Buckle, Clive Henry; De Leenheer, Evy; Lawson, Michelle Anne; Yong, Kwee; Rabin, Neil; Perry, Mark; Vanderkerken, Karen; Croucher, Peter Ian			Soluble Rank Ligand Produced by Myeloma Cells Causes Generalised Bone Loss in Multiple Myeloma	PLOS ONE			English	Article							KAPPA-B LIGAND; SERUM OSTEOPROTEGERIN LEVELS; RECEPTOR ACTIVATOR; OSTEOCLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; FRACTURE RISK; MURINE MODEL; EXPRESSION; DENOSUMAB; DISEASE	Patients with multiple myeloma commonly develop focal osteolytic bone disease, as well as generalised osteoporosis. The mechanisms underlying the development of osteoporosis in patients with myeloma are poorly understood. Although disruption of the RANKL/OPG pathway has been shown to underlie formation of focal osteolytic lesions, its role in the development of osteoporosis in myeloma remains unclear. Increased soluble RANKL in serum from patients with myeloma raises the possibility that this molecule plays a key role. The aim of the present study was to establish whether sRANKL produced by myeloma cells contributes directly to osteoporosis. C57BL/KaLwRij mice were injected with either 5T2MM or 5T33MM murine myeloma cells. 5T2MM-bearing mice developed osteolytic bone lesions (p<0.05) with increased osteoclast surface (p<0.01) and reduced trabecular bone volume (p<0.05). Bone volume was also reduced at sites where 5T2MM cells were not present (p<0.05). In 5T2MM-bearing mice soluble mRANKL was increased (p<0.05), whereas OPG was not altered. In contrast, 5T33MM-bearing mice had no changes in osteoclast surface or trabecular bone volume and did not develop osteolytic lesions. Soluble mRANKL was undetectable in serum from 5T33MM-bearing mice. In separate experiments, RPMI-8226 human myeloma cells were transduced with an human RANKL/eGFP construct, or eGFP alone. RPMI-8226/hRANKL/eGFP cells, but not RPMI-8226/eGFP cells, stimulated osteoclastic bone resorption (p<0.05) in vitro. Sub-cutaneous injection of NOD/SCID mice with RPMI-8226/hRANKL/eGFP or RPMI-8226/eGFP cells resulted in tumour development in all mice. RPMI-8226/hRANKL/eGFP-bearing mice exhibited increased serum soluble hRANKL (p<0.05) and a three-fold increase in osteoclast number (p<0.05) compared to RPMI-8226/eGFP-bearing mice. This was associated with reduced trabecular bone volume (27%, p<0.05), decreased trabecular number (29%, p<0.05) and increased trabecular thickness (8%, p<0.05). Our findings demonstrate that soluble RANKL produced by myeloma cells causes generalised bone loss, suggesting that targeting RANKL may prevent osteoporosis in patients with myeloma.	[Buckle, Clive Henry; De Leenheer, Evy; Lawson, Michelle Anne; Croucher, Peter Ian] Univ Sheffield, Fac Med Dent & Hlth, Dept Human Metab, Sheffield, S Yorkshire, England; [Yong, Kwee; Rabin, Neil] UCL, Dept Haematol, London, England; [Perry, Mark] Univ Bristol, Dept Anat, Bristol, Avon, England; [Vanderkerken, Karen] Vrije Univ Brussel, Dept Haematol & Immunol, Brussels, Belgium; [Croucher, Peter Ian] Garvan Inst Med Res, Sydney, NSW, Australia	University of Sheffield; University of London; University College London; University of Bristol; Vrije Universiteit Brussel; Garvan Institute of Medical Research	Buckle, CH (corresponding author), Univ Sheffield, Fac Med Dent & Hlth, Dept Human Metab, Sheffield, S Yorkshire, England.	p.croucher@garvan.org.au	Lawson, Michelle/M-6095-2019; Vanderkerken, Karin/I-3513-2013	Lawson, Michelle/0000-0002-5446-923X; Croucher, Peter/0000-0002-7102-2413; Vanderkerken, Karin/0000-0002-2137-7179	Leukaemia and Lymphoma Research [09021]; Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen; Onderzoeksraad-VUB; The Multiple Myeloma Research Foundation [10/2003]	Leukaemia and Lymphoma Research; Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen(FWO); Onderzoeksraad-VUB; The Multiple Myeloma Research Foundation	These studies were supported by grants from the following organisations: Leukaemia and Lymphoma Research - (no 09021) (leukaemialymphomaresearch.org.uk) - provided support for staff and recurrent costs to support the project; the Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen, Onderzoeksraad-VUB (www.fwo.be) - provided support for staff and recurrent costs to support the project; The Multiple Myeloma Research Foundation - contract 10/2003 (www.themmrf.org) -provided support for maintaining the mouse models of myeloma used in this project; and the Ernest Heine Family Foundation and Mrs Janice Gibson (no url or number) provide support for PIC. The authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Body JJ, 2010, J BONE MINER RES, V25, P440, DOI 10.1359/jbmr.090810; Body JJ, 2006, CLIN CANCER RES, V12, P1221, DOI 10.1158/1078-0432.CCR-05-1933; Croucher PI, 2001, BLOOD, V98, P3534, DOI 10.1182/blood.V98.13.3534; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3; Farrugia AN, 2003, CANCER RES, V63, P5438; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Giuliani N, 2001, BLOOD, V98, P3527, DOI 10.1182/blood.V98.13.3527; Giuliani N, 2002, BLOOD, V100, P4615, DOI 10.1182/blood-2002-04-1121; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Hargreaves PG, 1998, BRIT J HAEMATOL, V101, P694, DOI 10.1046/j.1365-2141.1998.00754.x; Heath DJ, 2007, CANCER RES, V67, P202, DOI 10.1158/0008-5472.CAN-06-1287; Heider U, 2003, CLIN CANCER RES, V9, P1436; Holen I, 2001, BRIT J HAEMATOL, V114, P414, DOI 10.1046/j.1365-2141.2001.02963.x; Ikeda T, 2001, ENDOCRINOLOGY, V142, P1419, DOI 10.1210/en.142.4.1419; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lipton A, 2002, CLIN CANCER RES, V8, P2306; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; McCloskey EV, 2004, MULTIPLE MYELOMA REL; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Melton LJ, 2005, J BONE MINER RES, V20, P487, DOI 10.1359/JBMR.041131; Melton LJ, 2004, J BONE MINER RES, V19, P25, DOI 10.1359/JBMR.0301212; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; RADL J, 1979, J IMMUNOL, V122, P609; RADL J, 1988, AM J PATHOL, V132, P593; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Seidel C, 2001, BLOOD, V98, P2269, DOI 10.1182/blood.V98.7.2269; Sezer O, 2002, BLOOD, V99, P4646, DOI 10.1182/blood-2002-01-0148; Shipman CM, 2003, CANCER RES, V63, P912; SHIPMAN CM, 2000, BLOOD, V96, P1552; Terpos E, 2003, INT J CANCER, V106, P455, DOI 10.1002/ijc.11247; Terpos E, 2003, BLOOD, V102, P1064, DOI 10.1182/blood-2003-02-0380; Vanderkerken K, 1999, BLOOD, V93, P235, DOI 10.1182/blood.V93.1.235.401k17_235_241; Vanderkerken Karin, 2005, V113, P191, DOI 10.1385/1-59259-916-8:191; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x	40	27	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e41127	10.1371/journal.pone.0041127	http://dx.doi.org/10.1371/journal.pone.0041127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952578	Green Accepted, Green Published, gold			2022-12-27	WOS:000308206000003
J	Kanngiesser, P; Warneken, F				Kanngiesser, Patricia; Warneken, Felix			Young Children Consider Merit when Sharing Resources with Others	PLOS ONE			English	Article							EQUITY; ALLOCATION; INEQUALITY; FAIRNESS; REWARD	Merit is a key principle of fairness: rewards should be distributed according to how much someone contributed to a task. Previous research suggests that children have an early ability to take merit into account in third-party situations but that merit-based sharing in first-party contexts does not emerge until school-age. Here we provide evidence that three-and five-year-old children already use merit to share resources with others, even when sharing is costly for the child. In Study 1, a child and a puppet-partner collected coins that were later exchanged for rewards. We varied the work-contribution of both partners by manipulating how many coins each partner collected. Children kept fewer stickers in trials in which they had contributed less than in trials in which they had contributed more than the partner, showing that they took merit into account. Few children, however, gave away more than half of the stickers when the partner had worked more. Study 2 confirmed that children related their own work-contribution to their partner's, rather than simply focusing on their own contribution. Taken together, these studies show that merit-based sharing is apparent in young children; however it remains constrained by a self-serving bias.	[Kanngiesser, Patricia] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Warneken, Felix] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Bristol; Harvard University	Kanngiesser, P (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.	patricia.kanngiesser@bris.ac.uk		Kanngiesser, Patricia/0000-0003-1068-3725	Science of Generosity Initiative; Cusanuswerk fellowship	Science of Generosity Initiative; Cusanuswerk fellowship	This work was funded by a grant of the Science of Generosity Initiative to FW, and a Cusanuswerk fellowship to PK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almas I, 2010, SCIENCE, V328, P1176, DOI 10.1126/science.1187300; Baumard N, 2012, DEV PSYCHOL, V48, P492, DOI 10.1037/a0026598; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Damon W., 1977, SOCIAL WORLD CHILD; Frohlich N, 2004, PUBLIC CHOICE, V119, P91, DOI 10.1023/B:PUCH.0000024169.08329.eb; Gummerum M, 2008, HUM DEV, V51, P235, DOI 10.1159/000151494; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; HOOK J, 1978, CHILD DEV, V49, P1035, DOI 10.1111/j.1467-8624.1978.tb04072.x; HOOK JG, 1979, PSYCHOL BULL, V86, P429, DOI 10.1037/0033-2909.86.3.429; LEVENTHAL GS, 1973, CHILD DEV, V44, P753, DOI 10.2307/1127720; LEVENTHAL GS, 1970, J PERS SOC PSYCHOL, V15, P57, DOI 10.1037/h0029173; LoBue V, 2011, SOC DEV, V20, P154, DOI 10.1111/j.1467-9507.2009.00560.x; NELSON SA, 1977, DEV PSYCHOL, V13, P192, DOI 10.1037/0012-1649.13.3.192; Ng R, 2011, DEV PSYCHOL, V47, P1230, DOI 10.1037/a0024923; Sandel M.J, 2010, JUSTICE WHAT IS RIGH; Singer-Freeman KE, 2001, COGNITIVE DEV, V16, P811, DOI 10.1016/S0885-2014(01)00066-1; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; Warneken F, 2011, PSYCHOL SCI, V22, P267, DOI 10.1177/0956797610395392	20	112	118	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43979	10.1371/journal.pone.0043979	http://dx.doi.org/10.1371/journal.pone.0043979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZC	22952834	gold, Green Published			2022-12-27	WOS:000308206000064
J	Li, TT; Chen, JH; Qiu, SA; Zhang, YJ; Wang, PK; Yang, LW; Lu, Y; Shi, JS				Li, Tingting; Chen, Jinhui; Qiu, Shuai; Zhang, Yanjuan; Wang, Pengkai; Yang, Liwei; Lu, Ye; Shi, Jisen			Deep Sequencing and Microarray Hybridization Identify Conserved and Species-Specific MicroRNAs during Somatic Embryogenesis in Hybrid Yellow Poplar	PLOS ONE			English	Article							CELL-WALL; COMPARATIVE GENOMICS; GENE-EXPRESSION; SMALL RNAS; IDENTIFICATION; PREDICTION; TARGETS; EVOLUTION; RESOURCE; DIVERSE	Background: To date, several studies have indicated a major role for microRNAs (miRNAs) in regulating plant development, but miRNA-mediated regulation of the developing somatic embryo is poorly understood, especially during early stages of somatic embryogenesis in hardwood plants. In this study, Solexa sequencing and miRNA microfluidic chips were used to discover conserved and species-specific miRNAs during somatic embryogenesis of hybrid yellow poplar (Liriodendron tulipiferaxL. chinense). Methodology/Principal Findings: A total of 17,214,153 reads representing 7,421,623 distinct sequences were obtained from a short RNA library generated from small RNAs extracted from all stages of somatic embryos. Through a combination of deep sequencing and bioinformatic analyses, we discovered 83 sequences with perfect matches to known miRNAs from 33 conserved miRNA families and 273 species-specific candidate miRNAs. MicroRNA microarray results demonstrated that many conserved and species-specific miRNAs were expressed in hybrid yellow poplar embryos. In addition, the microarray also detected another 149 potential miRNAs, belonging to 29 conserved families, which were not discovered by deep sequencing analysis. The biological processes and molecular functions of the targets of these miRNAs were predicted by carrying out BLAST search against Arabidopsis thaliana GenBank sequences and then analyzing the results with Gene Ontology. Conclusions: Solexa sequencing and microarray hybridization were used to discover 232 candidate conserved miRNAs from 61 miRNA families and 273 candidate species-specific miRNAs in hybrid yellow poplar. In these predicted miRNAs, 64 conserved miRNAs and 177 species-specific miRNAs were detected by both sequencing and microarray hybridization. Our results suggest that miRNAs have wide-ranging characteristics and important roles during all stages of somatic embryogenesis in this economically important species.	[Li, Tingting; Chen, Jinhui; Qiu, Shuai; Zhang, Yanjuan; Wang, Pengkai; Yang, Liwei; Lu, Ye; Shi, Jisen] Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Gene Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Li, TT (corresponding author), Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Gene Engn, Nanjing, Jiangsu, Peoples R China.	jshi@njfu.edu.cn			National Key Basic Research Program of China [2012CB114500]; National Science Foundation of China [30930077, 30901156, 31170619]; Natural Science Foundation of Jiangsu University [09KJA220001]; Doctorate Fellowship Foundation of Nanjing Forestry University [163010107]; Priority Academic Program Development of Jiangsu Higher Education Institutions fund	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu University(Natural Science Foundation of Jiangsu Province); Doctorate Fellowship Foundation of Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions fund	This work was supported by National Key Basic Research Program of China grant 2012CB114500; National Science Foundation of China grants 30930077, 30901156 and 31170619; Natural Science Foundation of Jiangsu University grant 09KJA220001; Doctorate Fellowship Foundation of Nanjing Forestry University grant 163010107; and Priority Academic Program Development of Jiangsu Higher Education Institutions fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert VA, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-5; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Barozai MYK, 2008, PLANT PHYSIOL BIOCH, V46, P739, DOI 10.1016/j.plaphy.2008.05.009; Barozai MYK, 2012, GENE, V499, P163, DOI 10.1016/j.gene.2012.03.006; BERGER F, 1994, SCIENCE, V263, P1421, DOI 10.1126/science.263.5152.1421; Bilban M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-19; Bisgrove SR, 2001, PLANTA, V212, P648, DOI 10.1007/s004250000434; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bonnet E, 2010, BIOINFORMATICS, V26, P1566, DOI 10.1093/bioinformatics/btq233; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai JL, 2004, IN VITRO CELL DEV-PL, V40, P376, DOI 10.1079/IVP2004538; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; De Craene LPR, 2003, INT J PLANT SCI, V164, pS329, DOI 10.1086/377063; Dudits D., 1995, In vitro embryogenesis in plants., P267; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Grigg SP, 2009, CURR BIOL, V19, P1485, DOI 10.1016/j.cub.2009.06.070; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Hunt D, 1998, MAGNOLIAS THEIR ALLI, P304; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim KD, 2005, ENVIRON MANAGE, V36, P1, DOI 10.1007/s00267-004-1089-3; Li HY, 2011, PLANTA, V233, P611, DOI 10.1007/s00425-010-1327-2; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Liang HY, 2011, TREE GENET GENOMES, V7, P941, DOI 10.1007/s11295-011-0386-2; Lu David P, 2005, J RNAi Gene Silencing, V1, P44; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mariani TJ, 2002, FASEB J, V16, P321, DOI 10.1096/fj.02-0351fje; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MERKLE SA, 1993, PLANT CELL TISS ORG, V34, P191, DOI 10.1007/BF00036101; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; Oh TJ, 2008, NEW PHYTOL, V179, P67, DOI 10.1111/j.1469-8137.2008.02448.x; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ranocha P, 2002, PLANT PHYSIOL, V129, P145, DOI 10.1104/pp.010988; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Shi J, 2011, Patent No. [CN 102037896 A, 102037896]; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wei Zhong-Xin, 1993, Acta Botanica Yunnanica, V15, P163; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Wu XM, 2011, PLANTA, V233, P495, DOI 10.1007/s00425-010-1312-9; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3	65	50	55	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43451	10.1371/journal.pone.0043451	http://dx.doi.org/10.1371/journal.pone.0043451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952685	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206000036
J	Budulac, SE; Boezen, HM; Hiemstra, PS; Lapperre, TS; Vonk, JM; Timens, W; Postma, DS				Budulac, Simona E.; Boezen, H. Marike; Hiemstra, Pieter S.; Lapperre, Therese S.; Vonk, Judith M.; Timens, Wim; Postma, Dirkje S.		GLUCOLD Study Grp	Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							TOLL-LIKE-RECEPTOR-2 EXPRESSION; COPD; SALMETEROL; SMOKERS; CELLS	Toll-like receptors (TLRs) participate in the defence against bacterial infections that are common in patients with Chronic Obstructive Pulmonary Disease (COPD). We studied all tagging SNPs in TLR2 and TLR4 and their associations with the level and change over time of both FEV1 and sputum inflammatory cells in moderate-to-severe COPD. Nine TLR2 SNPs and 17 TLR4 SNPs were genotyped in 110 COPD patients. Associations of SNPs with lung function and inflammatory cells in induced sputum were analyzed cross-sectionally with linear regression and longitudinally with linear mixed-effect models. Two SNPs in TLR2 (rs1898830 and rs11938228) were associated with a lower level of FEV1 and accelerated decline of FEV1 and higher numbers of sputum inflammatory cells. None of the TLR4 SNPs was associated with FEV1 level. Eleven out of 17 SNPs were associated with FEV1 decline, including rs12377632 and rs10759931, which were additionally associated with higher numbers of sputum inflammatory cells at baseline and with increase over time. This is the first longitudinal study showing that tagging SNPs in TLR2 and TLR4 are associated with the level and decline of lung function as well as with inflammatory cell numbers in induced sputum in COPD patients, suggesting a role in the severity and progression of COPD.	[Budulac, Simona E.; Boezen, H. Marike; Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Hiemstra, Pieter S.; Lapperre, Therese S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Timens, Wim] Univ Groningen, Dept Pathol, Univ Med Ctr Groningen, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Dept Pulmonol, Univ Med Ctr Groningen, Groningen, Netherlands; [Budulac, Simona E.; Boezen, H. Marike; Vonk, Judith M.; Timens, Wim; Postma, Dirkje S.] Univ Groningen, GRIAC, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen; University of Groningen	Budulac, SE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	s.budulac@umcg.nl	Rabe, Klaus F./AAW-6296-2021; Vonk, Judith M/ABA-3009-2020; Vonk, Judith/K-8477-2019; Sont, Jacob K/J-8071-2015; Mauad, Thais/G-1254-2012; /V-8478-2019; Hiemstra, Pieter S/K-8587-2018; Timens, Wim/K-5570-2013	Rabe, Klaus F./0000-0002-7020-1401; Vonk, Judith M/0000-0001-7531-4547; Vonk, Judith/0000-0001-7531-4547; Sont, Jacob K/0000-0002-5840-0651; Mauad, Thais/0000-0002-3354-1466; Hiemstra, Pieter S/0000-0002-0238-5982; Timens, Wim/0000-0002-4146-6363; Lapperre, Therese/0000-0002-5176-0101; Kerstjens, Huib/0000-0001-7705-7927	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands; Netherlands Organization for Scientific Research (NWO) [940-35-033]; Netherlands Asthma Foundation (NAF) [37.97.74, 3.2.02.51]; GlaxoSmithKline (NL); Leiden University Medical Center (LUMC); University of Groningen (RUG); AstraZeneca; GSK; Nycomed; Chiesi; Amgen; Boehringer Ingelheim; Centocor; Galapagos; GlaxoSmithKline; Glaxo-SmithKline; Netherlands Asthma Funds	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands(Netherlands Government); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Foundation (NAF); GlaxoSmithKline (NL); Leiden University Medical Center (LUMC); University of Groningen (RUG); AstraZeneca(AstraZeneca); GSK(GlaxoSmithKline); Nycomed; Chiesi(Chiesi Pharmaceuticals Inc); Amgen(Amgen); Boehringer Ingelheim(Boehringer Ingelheim); Centocor; Galapagos(Galapagos NV); GlaxoSmithKline(GlaxoSmithKline); Glaxo-SmithKline(GlaxoSmithKline); Netherlands Asthma Funds	This work was supported by the Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands; The GLUCOLD study was supported by unrestricted grants of the Netherlands Organization for Scientific Research (NWO; 940-35-033), the Netherlands Asthma Foundation (NAF; 37.97.74 and 3.2.02.51), GlaxoSmithKline (NL), Leiden University Medical Center (LUMC), and University of Groningen (RUG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: SEB has no competing interests. DSP received funding for research from AstraZeneca, GSK, Nycomed. Travel to ERS or ATS has been partially funded by AstraZeneca, GSK, Chiesi, Nycomed. DSP has been consultant to AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Nycomed, TEVA. PSH has received unrestricted research grants for the Department of Pulmonology (Leiden University Medical Center) from Amgen, Boehringer Ingelheim, Centocor, Galapagos and GlaxoSmithKline. TSL has no competing interests. JMV has no competing interests. HMB has no competing interests. WT has received an unrestricted grant from Glaxo-SmithKline and a sponsored grant from Netherlands Asthma Funds. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2010, GLOBAL STRATEGY DIAG; Baines KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018426; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Budulac SE, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-60; Chen KH, 2011, SHOCK, V35, P35, DOI 10.1097/SHK.0b013e3181eb45b3; Doss CGP, 2008, FUNCT INTEGR GENOMIC, V8, P309, DOI 10.1007/s10142-008-0086-7; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-68; Homma T, 2004, AM J RESP CELL MOL, V31, P463, DOI 10.1165/rcmb.2004-0161OC; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kerkhof M, 2010, THORAX, V65, P690, DOI 10.1136/thx.2009.119636; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Lapperre TS, 2004, AM J RESP CRIT CARE, V170, P499, DOI 10.1164/rccm.200401-112OC; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nadigel J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-149; Pabst S, 2009, LUNG, V187, P173, DOI 10.1007/s00408-009-9144-8; Pace E, 2011, HUM IMMUNOL, V72, P54, DOI 10.1016/j.humimm.2010.09.009; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pons J, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-64; Rohde G, 2006, RESP MED, V100, P892, DOI 10.1016/j.rmed.2005.08.018; Sabroe I, 2004, THORAX, V59, P81; Sarir H, 2008, EUR J PHARMACOL, V585, P346, DOI 10.1016/j.ejphar.2008.03.009; Schleimer Robert P, 2005, Proc Am Thorac Soc, V2, P342, DOI 10.1513/pats.200504-030SR; Schmitt C, 2002, CLIN CHEM, V48, P1661; Speletas M, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/260286; Veen JCCMI, 1996, EUR RESPIR J, V9, P2441, DOI 10.1183/09031936.96.09122441; von Scheele I, 2011, RESP MED, V105, P1222, DOI 10.1016/j.rmed.2011.02.012; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914	33	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43124	10.1371/journal.pone.0043124	http://dx.doi.org/10.1371/journal.pone.0043124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952638	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600017
J	Doetsch, M; Gluch, A; Poznanovic, G; Bode, J; Vidakovic, M				Doetsch, Martina; Gluch, Angela; Poznanovic, Goran; Bode, Juergen; Vidakovic, Melita			YY1-Binding Sites Provide Central Switch Functions in the PARP-1 Gene Expression Network	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE PROMOTER; TRANSCRIPTION FACTOR YY1; AUG INITIATOR CODON; BINDING PROTEIN; CELL-DEATH; NUCLEAR; ELEMENT; METHYLATION; REPRESSION; CLEAVAGE	Evidence is presented for the involvement of the interplay between transcription factor Yin Yang 1 (YY1) and poly(ADP-ribose) polymerase-1 (PARP-1) in the regulation of mouse PARP-1 gene (muPARP-1) promoter activity. We identified potential YY1 binding motifs (BM) at seven positions in the muPARP-1 core-promoter (-574/+200). Binding of YY1 was observed by the electrophoretic supershift assay using anti-YY1 antibody and linearized or supercoiled forms of plasmids bearing the core promoter, as well as with 30 bp oligonucleotide probes containing the individual YY1 binding motifs and four muPARP-1 promoter fragments. We detected YY1 binding to BM1 (-587/-558), BM4 (-348/-319) and a very prominent association with BM7 (+86/+115). Inspection of BM7 reveals overlap of the muPARP-1 translation start site with the Kozak sequence and YY1 and PARP-1 recognition sites. Site-directed mutagenesis of the YY1 and PARP-1 core motifs eliminated protein binding and showed that YY1 mediates PARP-1 binding next to the Kozak sequence. Transfection experiments with a reporter gene under the control of the muPARP-1 promoter revealed that YY1 binding to BM1 and BM4 independently repressed the promoter. Mutations at these sites prevented YY1 binding, allowing for increased reporter gene activity. In PARP-1 knockout cells subjected to PARP-1 overexpression, effects similar to YY1 became apparent; over expression of YY1 and PARP-1 revealed their synergistic action. Together with our previous findings these results expand the PARP-1 autoregulatory loop principle by YY1 actions, implying rigid limitation of muPARP-1 expression. The joint actions of PARP-1 and YY1 emerge as important contributions to cell homeostasis.	[Doetsch, Martina; Gluch, Angela; Bode, Juergen; Vidakovic, Melita] Helmholtz Ctr Infect Res Epigenet Regulat, Braunschweig, Germany; [Doetsch, Martina] Univ Vienna, Max F Perutz Labs, Dept Biochem & Mol Cell Biol, Vienna, Austria; [Gluch, Angela] BIOBASE GmbH, Wolfenbuettel, Germany; [Poznanovic, Goran; Vidakovic, Melita] Univ Belgrade, Inst Biol Res, Dept Mol Biol, Belgrade, Serbia; [Bode, Juergen] Hannover Med Sch MHH, Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Belgrade; Hannover Medical School	Doetsch, M (corresponding author), Helmholtz Ctr Infect Res Epigenet Regulat, Braunschweig, Germany.	melita@ibiss.bg.ac.rs	Poznanovic, Goran/E-6349-2015; Vidaković, Melita/G-6747-2016	Poznanovic, Goran/0000-0003-0839-7017; Vidaković, Melita/0000-0001-8410-6264	Ministry of Education, Science and Technological Development of the Republic of Serbia [173020]; Excellence Initiative REBIRTH (Regenerative Biology to Reconstructive Therapy); ReGene (Regenerative Medicine and Biology) Grant from the Bundesministerium fur Bildung und Forschung; Alexander von Humboldt Foundation [IV-SER/1121681 STP];  [SFB 738]	Ministry of Education, Science and Technological Development of the Republic of Serbia; Excellence Initiative REBIRTH (Regenerative Biology to Reconstructive Therapy); ReGene (Regenerative Medicine and Biology) Grant from the Bundesministerium fur Bildung und Forschung; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); 	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia, Project No. 173020. Work in the laboratories of J.B. at HZI and at MHH was supported by the Excellence Initiative REBIRTH (Regenerative Biology to Reconstructive Therapy), the SFB 738 (Optimierung konventioneller und innovativer Transplantate), and a ReGene (Regenerative Medicine and Biology) Grant from the Bundesministerium fur Bildung und Forschung. M.V.'s work in the lab of J.B. was enabled by the Alexander von Humboldt Foundation Grant (Roman Herzog stipend IV-SER/1121681 STP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker M, 2010, J BIOL CHEM, V285, P37589, DOI 10.1074/jbc.M110.174532; ALVAREZGONZALEZ R, 1989, MUTAT RES, V218, P67, DOI 10.1016/0921-8777(89)90012-8; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; BASU A, 1993, J BIOL CHEM, V268, P4188; BAUKNECHT T, 1995, J VIROL, V69, P1; Beneke S, 2008, NUCLEIC ACIDS RES, V36, P6309, DOI 10.1093/nar/gkn615; Bode J, 2006, J MOL BIOL, V358, P597, DOI 10.1016/j.jmb.2005.11.073; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Burkle A, 2004, EXP GERONTOL, V39, P1599, DOI 10.1016/j.exger.2004.07.010; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chevanne M, 2005, THROMB HAEMOSTASIS, V93, P220, DOI 10.1160/TH04-09-0605; Crawford RS, 2010, SURGERY, V148, P110, DOI 10.1016/j.surg.2009.12.006; Cuzzocrea S, 2005, PHARMACOL RES, V52, P72, DOI 10.1016/j.phrs.2005.02.016; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Faraone-Mennella MR, 2005, BIOCHEM CELL BIOL, V83, P396, DOI 10.1139/o05-042; Fry CJ, 1999, J BIOL CHEM, V274, P29583, DOI 10.1074/jbc.274.42.29583; Garnier P, 2003, J NEUROSCI, V23, P7967; GASTON K, 1994, FEBS LETT, V347, P289, DOI 10.1016/0014-5793(94)00567-2; GASTON K, 1995, GENE, V157, P257, DOI 10.1016/0378-1119(95)00120-U; Giansanti V, 2010, BIOCHEM PHARMACOL, V80, P1869, DOI 10.1016/j.bcp.2010.04.022; Gien LT, 2010, J ONCOL, V2010, DOI 10.1155/2010/151750; Gluch A., 2008, V186, P67, DOI 10.1007/978-3-540-72843-6_4; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Griesenbeck J, 1999, FEBS LETT, V443, P20, DOI 10.1016/S0014-5793(98)01671-8; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; GUO B, 1995, P NATL ACAD SCI USA, V92, P10526, DOI 10.1073/pnas.92.23.10526; He F, 1996, BIOCHEMISTRY-US, V35, P1775, DOI 10.1021/bi9525987; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kirkland JB, 2010, EXP BIOL MED, V235, P561, DOI 10.1258/ebm.2010.009280; Klar M, 2005, GENE, V364, P79, DOI 10.1016/j.gene.2005.07.023; Klar M, 2005, MOL CELL BIOL, V25, P10159, DOI 10.1128/MCB.25.22.10159-10170.2005; Klar M, 2005, THESIS TU BRAUNSCHWE; Klar Martin, 2011, Critical Reviews in Oncogenesis, V16, P239; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; LABRIE C, 1995, NUCLEIC ACIDS RES, V23, P3732, DOI 10.1093/nar/23.18.3732; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laniel MA, 2004, BBA-GENE STRUCT EXPR, V1679, P37, DOI 10.1016/j.bbaexp.2004.04.003; Laniel MA, 2001, J BIOL CHEM, V276, P20766, DOI 10.1074/jbc.M010360200; Li WW, 1997, MOL CELL BIOL, V17, P61, DOI 10.1128/MCB.17.1.61; McNeil S, 1998, J CELL BIOCHEM, V68, P500, DOI 10.1002/(SICI)1097-4644(19980315)68:4<500::AID-JCB9>3.3.CO;2-T; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; Nehlsen K, 2012, MINICIRCLE PLASMID D; Oei SL, 2001, BIOCHEM BIOPH RES CO, V285, P27, DOI 10.1006/bbrc.2001.5115; Oei SL, 2001, BIOCHEM BIOPH RES CO, V284, P450, DOI 10.1006/bbrc.2001.4985; Oei SL, 1997, BIOCHEM BIOPH RES CO, V240, P108, DOI 10.1006/bbrc.1997.7621; OEI SL, 1994, MOL CELL BIOCHEM, V138, P99, DOI 10.1007/BF00928449; Pacini A, 1999, J BIOL CHEM, V274, P35107, DOI 10.1074/jbc.274.49.35107; Peralta-Leal A, 2008, CLIN TRANSL ONCOL, V10, P318, DOI 10.1007/s12094-008-0207-8; POTVIN F, 1992, FEBS LETT, V302, P269, DOI 10.1016/0014-5793(92)80457-R; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Soldatenkov VA, 2002, J BIOL CHEM, V277, P665, DOI 10.1074/jbc.M108551200; Telli Melinda L, 2010, Clin Adv Hematol Oncol, V8, P629; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tulin A, 2003, CURR TOP DEV BIOL, V56, P55, DOI 10.1016/S0070-2153(03)01007-X; Usheva A, 1996, P NATL ACAD SCI USA, V93, P13571, DOI 10.1073/pnas.93.24.13571; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Vidakovic M, 2009, J CELL BIOCHEM, V107, P1205, DOI 10.1002/jcb.22225; Vidakovic M, 2009, J MOL BIOL, V388, P730, DOI 10.1016/j.jmb.2009.03.032; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Walker J M, 1994, Methods Mol Biol, V32, P5; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yelamos J, 2011, AM J CANCER RES, V1, P328; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492; YOKOYAMA Y, 1990, EUR J BIOCHEM, V194, P521, DOI 10.1111/j.1432-1033.1990.tb15647.x; Zaremba T, 2011, BIOCHEM J, V436, P671, DOI 10.1042/BJ20101723; Ziegler M, 2001, BIOESSAYS, V23, P543, DOI 10.1002/bies.1074	83	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44125	10.1371/journal.pone.0044125	http://dx.doi.org/10.1371/journal.pone.0044125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937159	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600079
J	Wang, YW; Zhou, YA; Zhou, HX; Jia, G; Liu, J; Han, B; Cheng, ZX; Jiang, HC; Pan, SH; Sun, B				Wang, Yongwei; Zhou, Yinan; Zhou, Haoxin; Jia, Guang; Liu, Ji; Han, Bing; Cheng, Zhuoxin; Jiang, Hongchi; Pan, Shangha; Sun, Bei			Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; DOWN-REGULATION; CYCLE ARREST; IN-VITRO; INDUCTION; INHIBITION; ACTIVATION; BCL-2; PROLIFERATION; EXPRESSION	Despite rapid advances in chemotherapy and surgical resection strategies, pancreatic cancer remains the fourth leading cause of cancer related deaths in the United States with a 5-year survival rate of less than 5%. Therefore, novel therapeutic agents for the prevention and treatment of pancreatic cancer are urgently needed. The aim of this study was to investigate the effect of pristimerin, a quinonemethide triterpenoid compound isolated from Celastraceae and Hippocrateaceae, on inhibition of cell proliferation and induction of apoptosis in three pancreatic cancer cells, BxPC-3, PANC-1 and AsPC-1, in both monotherapy and in combination with gemcitabine. Treatment with pristimerin decreased the cell proliferation of all three pancreatic cancer cells in a dose-and time-dependent manner. Treatment of pancreatic cancer cells with pristimerin also resulted in G1-phase arrest which was strongly associated with a marked decrease in the level of cyclins (D1 and E) and cyclin-dependent kinases (cdk2, cdk4 and cdk6) with concomitant induction of WAF1/p21 and KIP1/p27. Pristimerin treatment also resulted in apoptotic cell death, cleavage of caspase-3, modulation in the expressions of Bcl-2 family proteins, inhibition of the translocation and DNA-binding activity of NF-kappa B. In addition, pristimerin potentiated the growth inhibition and apoptosis inducing effects of gemcitabine in all three pancreatic cancer cells, at least in part, by inhibiting constitutive as well as gemcitabine-induced activation of NF-kappa B in both its DNA-binding activity and transcriptional activity. Taken together, these data provide the first evidence that pristimerin has strong potential for development as a novel agent against pancreatic cancer.	[Wang, Yongwei; Zhou, Yinan; Zhou, Haoxin; Jia, Guang; Liu, Ji; Han, Bing; Cheng, Zhuoxin; Jiang, Hongchi; Pan, Shangha; Sun, Bei] Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China	Harbin Medical University	Wang, YW (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China.	sunbei70@tom.com	Jiang, HongChi/M-5031-2018	Jiang, HongChi/0000-0001-8215-8984	New Century Support Foundation for Elitist of Chinese Ministry of Education [NCET-07-0248]; Scientific Foundation for Prominent Youth of Heilongjiang Province, China [JC200717]; Scientific and Technological Project of Heilongjiang Province, China [GC09C407-2]; research Special Fund For public welfare industry of health [201202007]; National Natural Scientific Foundation of China [81170431, 81101799]	New Century Support Foundation for Elitist of Chinese Ministry of Education; Scientific Foundation for Prominent Youth of Heilongjiang Province, China; Scientific and Technological Project of Heilongjiang Province, China; research Special Fund For public welfare industry of health; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the New Century Support Foundation for Elitist of Chinese Ministry of Education (NCET-07-0248), the Scientific Foundation for Prominent Youth of Heilongjiang Province, China (JC200717), the Scientific and Technological Project of Heilongjiang Province, China (GC09C407-2), the research Special Fund For public welfare industry of health (201202007) and the National Natural Scientific Foundation of China (81170431, 81101799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Byun JY, 2009, MOL PHARMACOL, V76, P734, DOI 10.1124/mol.109.056259; Call JA, 2008, LANCET ONCOL, V9, P1002, DOI 10.1016/S1470-2045(08)70209-2; Chen H, 2010, J CANCER RES CLIN, V136, P897, DOI 10.1007/s00432-009-0731-0; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Dirsch VM, 1997, EUR J PHARMACOL, V336, P211, DOI 10.1016/S0014-2999(97)01245-4; Duffy John P, 2003, Mol Cancer, V2, P12, DOI 10.1186/1476-4598-2-12; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Greten FR, 2002, GASTROENTEROLOGY, V123, P2052, DOI 10.1053/gast.2002.37075; Gupta S, 2002, ONCOGENE, V21, P3727, DOI 10.1038/sj.onc.1205474; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Kornmann M, 1998, ONCOLOGY-BASEL, V55, P363, DOI 10.1159/000011879; Li L, 2004, CANCER-AM CANCER SOC, V101, P2351, DOI 10.1002/cncr.20605; Liptay S, 2003, INT J CANCER, V105, P735, DOI 10.1002/ijc.11081; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Murtaza I, 2009, INT J CANCER, V125, P2465, DOI 10.1002/ijc.24628; Nakanishi M, 2006, CANCER SCI, V97, P984, DOI 10.1111/j.1349-7006.2006.00289.x; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI 10.1158/1078-0432.CCR-08-1539; Pestell RG, 1999, ENDOCR REV, V20, P501, DOI 10.1210/er.20.4.501; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sliva D, 2004, CURR CANCER DRUG TAR, V4, P327, DOI 10.2174/1568009043332961; Srivastava SK, 2004, CARCINOGENESIS, V25, P1701, DOI 10.1093/carcin/bgh179; Swanton C, 2004, LANCET ONCOL, V5, P27, DOI 10.1016/S1470-2045(03)01321-4; Tiedemann RE, 2009, BLOOD, V113, P4027, DOI 10.1182/blood-2008-09-179796; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Wang YW, 2012, J CANCER RES CLIN, V138, P785, DOI 10.1007/s00432-012-1152-z; Weichert W, 2007, BRIT J CANCER, V97, P523, DOI 10.1038/sj.bjc.6603878; Wu CC, 2005, MOL CANCER THER, V4, P1277, DOI 10.1158/1535-7163.MCT-05-0027; Xiong HQ, 2004, INT J CANCER, V108, P181, DOI 10.1002/ijc.11562; Yang HJ, 2008, J CELL BIOCHEM, V103, P234, DOI 10.1002/jcb.21399; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307	44	55	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43826	10.1371/journal.pone.0043826	http://dx.doi.org/10.1371/journal.pone.0043826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952775	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600048
J	Kuras, Z; Yun, YH; Chimote, AA; Neumeier, L; Conforti, L				Kuras, Zerrin; Yun, Yeo-Heung; Chimote, Ameet A.; Neumeier, Lisa; Conforti, Laura			KCa3.1 and TRPM7 Channels at the Uropod Regulate Migration of Activated Human T Cells	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; NONSELECTIVE CATION CHANNEL; IMMUNOLOGICAL SYNAPSE; KV1.3 CHANNEL; ION CHANNELS; POTASSIUM CHANNELS; CALCIUM INFLUX; LYMPHOCYTES; TRAFFICKING; CRAC	The migration of T lymphocytes is an essential part of the adaptive immune response as T cells circulate around the body to carry out immune surveillance. During the migration process T cells polarize, forming a leading edge at the cell front and a uropod at the cell rear. Our interest was in studying the involvement of ion channels in the migration of activated human T lymphocytes as they modulate intracellular Ca2+ levels. Ca2+ is a key regulator of cellular motility. To this purpose, we created protein surfaces made of the bio-polymer PNMP and coated with ICAM-1, ligand of LFA-1. The LFA-1 and ICAM-1 interaction facilitates T cell movement from blood into tissues and it is critical in immune surveillance and inflammation. Activated human T lymphocytes polarized and migrated on ICAM-1 surfaces by random walk with a mean velocity of similar to 6 mu m/min. Confocal microscopy indicated that Kv1.3, CRAC, and TRPM4 channels positioned in the leading-edge, whereas KCa3.1 and TRPM7 channels accumulated in the uropod. The localization of KCa3.1 and TRPM7 at the uropod was associated with oscillations in intracellular Ca2+ levels that we measured in this cell compartment. Further studies with blockers against Kv1.3 (ShK), KCa3.1 (TRAM-34), CRAC (SKF-96365), TRPM7 (2-APB), and TRPM4 (glibenclamide) indicated that blockade of KCa3.1 and TRPM7, and not Kv1.3, CRAC or TRPM4, inhibits the T cell migration. The involvement of TRPM7 in cell migration was confirmed with siRNAs against TRPM7. Downregulation of TRPM7 significantly reduced the number of migrating T cells and the mean velocity of the migrating T cells. These results indicate that KCa3.1 and TRPM7 selectively localize at the uropod of migrating T lymphocytes and are key components of the T cell migration machinery.	[Kuras, Zerrin; Chimote, Ameet A.; Neumeier, Lisa] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA; [Conforti, Laura] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH USA; [Yun, Yeo-Heung] N Carolina Agr & Tech State Univ, Dept Bioengn, Greensboro, NC USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of North Carolina; North Carolina A&T State University	Kuras, Z (corresponding author), Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA.	Laura.Conforti@uc.edu	Chimote, Ameet A/R-5357-2016	Chimote, Ameet/0000-0001-5163-0123	National Institutes of Health [1R21AI083076, 2R01CA095286]; NATIONAL CANCER INSTITUTE [R01CA095286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by National Institutes of Health grants 1R21AI083076 and 2R01CA095286 to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Cahalan MD, 2005, SEMIN IMMUNOL, V17, P442, DOI 10.1016/j.smim.2005.09.001; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Castillo B, 2010, J BIOMOL SCREEN, V15, P498, DOI 10.1177/1087057110368294; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Cheong A, 2011, CARDIOVASC RES, V89, P282, DOI 10.1093/cvr/cvq305; Chimote AA, 2012, J BIOL CHEM, V287, P2055, DOI 10.1074/jbc.M111.274209; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Inada H, 2006, BIOCHEM BIOPH RES CO, V350, P762, DOI 10.1016/j.bbrc.2006.09.111; Irvine DJ, 2007, SEMIN IMMUNOL, V19, P245, DOI 10.1016/j.smim.2007.02.011; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Katz JS, 2006, LANGMUIR, V22, P353, DOI 10.1021/la0523098; Kindzelskii AL, 2005, EUR BIOPHYS J BIOPHY, V35, P1, DOI 10.1007/s00249-005-0001-2; Kuras Z, 2012, AM J PHYSL CELL PHYS; LEE SC, 1992, J GEN PHYSIOL, V99, P771, DOI 10.1085/jgp.99.5.771; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nicolaou SA, 2007, J IMMUNOL, V179, P346, DOI 10.4049/jimmunol.179.1.346; Nicolaou SA, 2007, AM J PHYSIOL-CELL PH, V292, pC1431, DOI 10.1152/ajpcell.00376.2006; Nicolaou SA, 2010, CELL CALCIUM, V47, P19, DOI 10.1016/j.ceca.2009.11.001; Nicolaou SA, 2009, J IMMUNOL, V183, P6296, DOI 10.4049/jimmunol.0900613; Nutile-McMenemy N, 2007, J NEUROCHEM, V103, P2035, DOI 10.1111/j.1471-4159.2007.04889.x; Panyi G, 2004, IMMUNOL LETT, V92, P55, DOI 10.1016/j.imlet.2003.11.020; Panyi G, 2003, P NATL ACAD SCI USA, V100, P2592, DOI 10.1073/pnas.0438057100; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Robbins JR, 2005, J PHYSIOL-LONDON, V564, P131, DOI 10.1113/jphysiol.2004.081893; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Schwab A, 2008, PHYSIOLOGY, V23, P212, DOI 10.1152/physiol.00003.2008; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Su LT, 2011, BIOCHEM J, V434, P513, DOI 10.1042/BJ20101678; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Szabo I, 1997, PFLUG ARCH EUR J PHY, V433, P626, DOI 10.1007/s004240050323; Varga Z, 2010, IMMUNOL LETT, V130, P19, DOI 10.1016/j.imlet.2009.12.015; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	55	64	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43859	10.1371/journal.pone.0043859	http://dx.doi.org/10.1371/journal.pone.0043859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952790	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800068
J	Ye, W; Qin, F; Zhang, J; Luo, R; Chen, HF				Ye, Wei; Qin, Fang; Zhang, Jian; Luo, Ray; Chen, Hai-Feng			Atomistic Mechanism of MicroRNA Translation Upregulation via Molecular Dynamics Simulations	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; SWISS-MODEL; RNA-BINDING; CRYSTAL-STRUCTURE; KH DOMAIN; RECOGNITION; FXR1; ACTIVATION; MUTATION; MOTIF	MicroRNAs are endogenous 23-25 nt RNAs that play important gene-regulatory roles in animals and plants. Recently, miR369-3 was found to upregulate translation of TNF alpha mRNA in quiescent (G0) mammalian cell lines. Knock down and immunofluorescence experiments suggest that microRNA-protein complexes (with FXR1 and AGO2) are necessary for the translation upregulation. However the molecular mechanism of microRNA translation activation is poorly understood. In this study we constructed the microRNA-mRNA-AGO2-FXR1 quadruple complex by bioinformatics and molecular modeling, followed with all atom molecular dynamics simulations in explicit solvent to investigate the interaction mechanisms for the complex. A combined analysis of experimental and computational data suggests that AGO2-FXR1 complex relocalize microRNA: mRNA duplex to polysomes in G0. The two strands of dsRNA are then separated upon binding of AGO2 and FXR1. Finally, polysomes may improve the translation efficiency of mRNA. The mutation research confirms the stability of microRNA-mRNA-FXR1 and illustrates importance of key residue of Ile304. This possible mechanism can shed more light on the microRNA- dependent upregulation of translation.	[Ye, Wei; Qin, Fang; Chen, Hai-Feng] Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China; [Luo, Ray] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Chen, Hai-Feng] Shanghai Ctr Bioinformat Technol, Dept Computat Biol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of California System; University of California Irvine; Chinese Academy of Sciences	Ye, W (corresponding author), Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	jian.zhang@sjtu.edu.cn; rluo@uci.edu; haifengchen@sjtu.edu.cn	Zhang, Jian/GXA-1303-2022; Luo, Ray/M-3035-2019; Luo, Ray/I-6928-2012; Chen, Haifeng/AAT-7444-2020	Zhang, Jian/0000-0002-6558-791X; Luo, Ray/0000-0002-6346-8271; Luo, Ray/0000-0002-6346-8271; Ye, Wei/0000-0001-6268-2703	Ministry of Science and Technology China [2012CB721003]; National High-tech R&D Program of China (863 Program) [2012AA020403]; Innovation Program of Shanghai Education Committee [12ZZ023]; Shanghai Pujiang Program [10PJD010, 10PJ1406800]; Natural Science Foundation of Shanghai from China [10ZR1414500]; Medical Engineering Cross Fund of Shanghai Jiaotong University [YG2010MS67]	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Innovation Program of Shanghai Education Committee; Shanghai Pujiang Program(Shanghai Pujiang Program); Natural Science Foundation of Shanghai from China; Medical Engineering Cross Fund of Shanghai Jiaotong University	This work was sponsored by grants from Ministry of Science and Technology China (2012CB721003), by National High-tech R&D Program of China (863 Program) (2012AA020403), by Innovation Program of Shanghai Education Committee (grant no. 12ZZ023), by Shanghai Pujiang Program (10PJD010 and 10PJ1406800), by the Natural Science Foundation of Shanghai from China (grant no. 10ZR1414500), and by Medical Engineering Cross Fund of Shanghai Jiaotong University (YG2010MS67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; Bhattacharyya SN, 2007, CELL, V128, P1027, DOI 10.1016/j.cell.2007.02.033; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CASE DA, 2004, AMBER 8; Chen HF, 2008, J CHEM THEORY COMPUT, V4, P1360, DOI 10.1021/ct800030s; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Chen HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006516; Chen HF, 2009, COMPUT BIOL CHEM, V33, P41, DOI 10.1016/j.compbiolchem.2008.07.023; Chen Y, 2010, BIOPOLYMERS, V93, P578, DOI 10.1002/bip.21405; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Garcia-Garcia C, 2003, J MOL BIOL, V331, P75, DOI 10.1016/S0022-2836(03)00615-6; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kirkpatrick LL, 1999, GENOMICS, V59, P193, DOI 10.1006/geno.1999.5868; Kirkpatrick LL, 2001, GENOMICS, V78, P169, DOI 10.1006/geno.2001.6667; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Lwin TZ, 2006, PROTEIN SCI, V15, P2642, DOI 10.1110/ps.062438006; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Macke TJ, 1998, ACS SYM SER, V682, P379; Mortensen RD, 2011, P NATL ACAD SCI USA, V108, P8281, DOI 10.1073/pnas.1105401108; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/16806; Qin F, 2012, PHYS CHEM CHEM PHYS, V14, P538, DOI 10.1039/c1cp22610j; Qin F, 2011, PHYS CHEM CHEM PHYS, V13, P1407, DOI 10.1039/c0cp00701c; Qin F, 2010, RNA, V16, P1053, DOI 10.1261/rna.2008110; Qin F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3224126; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rusk N, 2008, NAT METHODS, V5, P122, DOI 10.1038/nmeth0208-122a; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129	53	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43788	10.1371/journal.pone.0043788	http://dx.doi.org/10.1371/journal.pone.0043788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952765	Green Published, gold			2022-12-27	WOS:000308044800059
J	Zhao, JK; Lama, M; Korenromp, E; Aylward, P; Shargie, E; Filler, S; Komatsu, R; Atun, R				Zhao, Jinkou; Lama, Marcel; Korenromp, Eline; Aylward, Patrick; Shargie, Estifanos; Filler, Scott; Komatsu, Ryuichi; Atun, Rifat			Adoption of Rapid Diagnostic Tests for the Diagnosis of Malaria, a Preliminary Analysis of the Global Fund Program Data, 2005 to 2010	PLOS ONE			English	Article							IMPLEMENTATION	Introduction: The World Health Organization Guidelines for the Treatment of Malaria, in 2006 and 2010, recommend parasitological confirmation of malaria before commencing treatment. Although microscopy has been the mainstay of malaria diagnostics, the magnitude of diagnostic scale up required to follow the Guidelines suggests that rapid diagnostic tests (RDTs) will be a large component. This study analyzes the adoption of rapid diagnostic testing in malaria programs supported by the Global Fund to fight AIDS, Tuberculosis and Malaria (Global Fund), the leading international funder of malaria control globally. Methods and Findings: We analyzed, for the period 2005 to 2010, Global Fund programmatic data for 81 countries on the quantity of RDTs planned; actual quantities of RDTs and artemisinin-based combination treatments (ACTs) procured in 2009 and 2010; RDT-related activities including RDTs distributed, RDTs used, total diagnostic tests including RDTs and microscopy performed, health facilities equipped with RDTs; personnel trained to perform rapid diagnostic malaria test; and grant budgets allocated to malaria diagnosis. In 2010, diagnosis accounted for 5.2% of malaria grant budget. From 2005 to 2010, the procurement plans include 148 million RDTs through 96 malaria grants in 81 countries. Around 115 million parasitological tests, including RDTs, had reportedly been performed from 2005 to 2010. Over this period, 123, 132 health facilities were equipped with RDTs and 137,140 health personnel had been trained to perform RDT examinations. In 2009 and 2010, 41 million RDTs and 136 million ACTs were purchased. The ratio of procured RDTs to ACTs was 0.26 in 2009 and 0.34 in 2010. Conclusions/significance: Global Fund financing has enabled 81 malaria-endemic countries to adopt WHO guidelines by investing in RDTs for malaria diagnosis, thereby helping improve case management of acute febrile illness in children. However, roll-out of parasitological diagnosis lags behind the roll-out of ACT-based treatment, and will require prioritization of investments.	[Zhao, Jinkou; Lama, Marcel; Korenromp, Eline; Aylward, Patrick; Shargie, Estifanos; Filler, Scott; Komatsu, Ryuichi] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Zhao, Jinkou] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Korenromp, Eline] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England	Jiangsu Provincial Center for Disease Control & Prevention; Erasmus University Rotterdam; Erasmus MC; Imperial College London	Zhao, JK (corresponding author), Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.	jinkou.zhao@theglobalfound.org	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983; Zhao, Jinkou/0000-0001-9184-3385	Global Fund to fight AIDS, Tuberculosis and Malaria	Global Fund to fight AIDS, Tuberculosis and Malaria	The analysis was supported by the Global Fund to fight AIDS, Tuberculosis and Malaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgader TM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-11; Abuya TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008937; [Anonymous], 2011, MAL RAP DIAGN TEST P; [Anonymous], 2011, UN ACC MAL DIAGN TES; [Anonymous], 2011, MAK DIFF GLOB FUND R; [Anonymous], GUID TREATM MAL; Atun RA, 2007, INT J INNOV MANAG, V11, P299, DOI 10.1142/S1363919607001709; Bisoffi Z, 2010, MALARIA J, V9, P19; Bjorkman A, 2010, CLIN INFECT DIS, V51, P512, DOI 10.1086/655689; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Graz B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-136; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Reilley B, 2002, TROP MED INT HEALTH, V7, P744, DOI 10.1046/j.1365-3156.2002.00919.x; Roger E.M, 2003, DIFFUSION INNOVATION; Roll Back Malaria, 2008, GLOB MAL ACT PLAN FR; Roll Back Malaria Partnership, 2011, REF UPD GMAP OBJ TAR; The Global Fund, 2012, GLOB FUND STRAT 2012; The Presidents Malaria Initiative, 2011, MAL OP PLANS FISC YE; The Presidents Malaria Initiative, 2011, 5 ANN REP C APR; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; WHO, 2006, GUID TREATM MAL; WHO, 2012, TEST TREAT TRACK INI; World Health Organization, WOLD MAL REP 2011; WORLDHEALTH ORGANIZATION (WHO), 2008, WORLD MAL REP 2008; Zhao JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028932	26	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43549	10.1371/journal.pone.0043549	http://dx.doi.org/10.1371/journal.pone.0043549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952703	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800037
J	Ambrosio, MR; Piccaluga, PP; Ponzoni, M; Rocca, BJ; Malagnino, V; Onorati, M; De Falco, G; Calbi, V; Ogwang, M; Naresh, KN; Pileri, SA; Doglioni, C; Leoncini, L; Lazzi, S				Ambrosio, Maria R.; Piccaluga, Pier P.; Ponzoni, Maurilio; Rocca, Bruno J.; Malagnino, Valeria; Onorati, Monica; De Falco, Giulia; Calbi, Valeria; Ogwang, Martin; Naresh, Kikkeri N.; Pileri, Stefano A.; Doglioni, Claudio; Leoncini, Lorenzo; Lazzi, Stefano			The Alteration of Lipid Metabolism in Burkitt Lymphoma Identifies a Novel Marker: Adipophilin	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; CANCER; EXPRESSION; DROPLETS; PROLIFERATION; BIOLOGY; PROTEIN; TIP47	Background: Recent evidence suggests that lipid pathway is altered in many human tumours. In Burkitt lymphoma this is reflected by the presence of lipid droplets which are visible in the cytoplasm of neoplastic cells in cytological preparations. These vacuoles are not identifiable in biopsy section as lipids are "lost" during tissue processing. Methods and Results: In this study we investigated the expression of genes involved in lipid metabolism, at both RNA and protein level in Burkitt lymphoma and in other B-cell aggressive lymphoma cases. Gene expression profile indicated a significant over-expression of the adipophilin gene and marked up-regulation of other genes involved in lipid metabolism in Burkitt lymphoma. These findings were confirmed by immunohistochemistry on a series od additional histological samples: 45 out of 47 BL cases showed strong adipophilin expression, while only 3 cases of the 33 of the not-Burkitt lymphoma category showed weak adipophilin expression (p<0.05). Conclusions: Our preliminary results suggest that lipid metabolism is altered in BL, and this leads to the accumulation of lipid vacuoles. These vacuoles may be specifically recognized by a monoclonal antibody against adipophilin, which may therefore be a useful marker for Burkitt lymphoma because of its peculiar expression pattern. Moreover this peptide might represent an interesting candidate for interventional strategies.	[Ambrosio, Maria R.; Rocca, Bruno J.; Malagnino, Valeria; Onorati, Monica; De Falco, Giulia; Leoncini, Lorenzo; Lazzi, Stefano] Univ Siena, Anat Pathol Sect, Dept Human Pathol & Oncol, I-53100 Siena, Italy; [Piccaluga, Pier P.; Pileri, Stefano A.] Univ Bologna, S Orsola Malpighi Hosp, Dept Haematol & Oncol L & A Seragnoli, Mol Pathol Lab,Haematopathol Unit, Bologna, Italy; [Ponzoni, Maurilio; Doglioni, Claudio] Univ Sci Inst San Raffaele, Pathol Unit, Dept Oncol, Milan, Italy; [Naresh, Kikkeri N.] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London, England; [Calbi, Valeria; Ogwang, Martin] St Mary Hosp, Lacor Gulu, Uganda	University of Siena; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Imperial College London	Ambrosio, MR (corresponding author), Univ Siena, Anat Pathol Sect, Dept Human Pathol & Oncol, Via Laterina 8, I-53100 Siena, Italy.	leoncinil@unisi.it	LEONCINI, Lorenzo/U-4413-2019; Ambrosio, Maria Raffaella/K-8953-2016; leoncini, lorenzo/P-8361-2018; Piccaluga, Pier Paolo/H-7132-2019; Calbi, Valeria/K-4102-2018; Lazzi, Stefano/P-8265-2018	LEONCINI, Lorenzo/0000-0002-7457-300X; Ambrosio, Maria Raffaella/0000-0002-1172-6902; leoncini, lorenzo/0000-0002-7457-300X; Piccaluga, Pier Paolo/0000-0002-9432-0595; Calbi, Valeria/0000-0003-3514-666X; Lazzi, Stefano/0000-0002-2218-3771; Naresh, Kikkeri N/0000-0003-3807-3638; DOGLIONI, Claudio/0000-0002-4969-5216				Atshaves BP, 2001, J BIOL CHEM, V276, P25324, DOI 10.1074/jbc.M100560200; Bellan C, 2010, HEMATOL ONCOL, V28, P53, DOI 10.1002/hon.916; Bhatt AP, 2012, PNAS; Brasaemle DL, 1997, J LIPID RES, V38, P2249; de Jong D, 2009, HAEMATOL-HEMATOL J, V94, P894, DOI 10.3324/haematol.2009.008128; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Drut R, 2005, J PEDIAT HEMATOL ONC, V27, P370, DOI 10.1097/01.mph.0000173177.40894.8d; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Leoncini L, 2008, WHO CLASSIFICATION T, P262; Muthusamy K, 2006, J CLIN PATHOL, V59, P1166, DOI 10.1136/jcp.2005.033381; Naresh KN, 2011, BJH             0701; Onnis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012960; Ostler DA, 2010, MODERN PATHOL, V23, P567, DOI 10.1038/modpathol.2010.1; Piccaluga PP, 2008, HAEMATOL-HEMATOL J, V93, P1033, DOI 10.3324/haematol.12754; Piccaluga PP, 2011, BLOOD, V117, P3596, DOI 10.1182/blood-2010-08-301556; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Schmidt SM, 2004, CANCER RES, V64, P1164, DOI 10.1158/0008-5472.CAN-03-2538; Straub BK, 2010, MODERN PATHOL, V23, P480, DOI 10.1038/modpathol.2009.191; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036	26	43	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44315	10.1371/journal.pone.0044315	http://dx.doi.org/10.1371/journal.pone.0044315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952953	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300079
J	Loomis, WF; Fuller, D; Gutierrez, E; Groisman, A; Rappel, WJ				Loomis, William F.; Fuller, Danny; Gutierrez, Edgar; Groisman, Alex; Rappel, Wouter-Jan			Innate Non-Specific Cell Substratum Adhesion	PLOS ONE			English	Article							MUTANT-CELLS; WILD-TYPE; DICTYOSTELIUM; MOTILITY; TALIN; CHEMOTAXIS; MIGRATION	Adhesion of motile cells to solid surfaces is necessary to transmit forces required for propulsion. Unlike mammalian cells, Dictyostelium cells do not make integrin mediated focal adhesions. Nevertheless, they can move rapidly on both hydrophobic and hydrophilic surfaces. We have found that adhesion to such surfaces can be inhibited by addition of sugars or amino acids to the buffer. Treating whole cells with alpha-mannosidase to cleave surface oligosaccharides also reduces adhesion. The results indicate that adhesion of these cells is mediated by van der Waals attraction of their surface glycoproteins to the underlying substratum. Since glycoproteins are prevalent components of the surface of most cells, innate adhesion may be a common cellular property that has been overlooked.	[Loomis, William F.; Fuller, Danny] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Gutierrez, Edgar; Groisman, Alex; Rappel, Wouter-Jan] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Rappel, Wouter-Jan] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Loomis, WF (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	wloomis@ucsd.edu	Groisman, Alexander/AAU-7843-2021		National Institutes of Health [PO1 GM078586]; Direct For Mathematical & Physical Scien [1308264] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM078586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (PO1 GM078586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Cornillon S, 2008, EUKARYOT CELL, V7, P1600, DOI 10.1128/EC.00155-08; Decave E, 2002, BIOPHYS J, V82, P2383, DOI 10.1016/S0006-3495(02)75583-5; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fey P, 2002, J CELL BIOL, V159, P1109, DOI 10.1083/jcb.200206067; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; GERISCH G, 1989, CELL MOTIL CYTOSKEL, V14, P75, DOI 10.1002/cm.970140115; Israelachvilli J.N., 1992, INTERMOLECULAR SURFA; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105; Malawista SE, 1997, P NATL ACAD SCI USA, V94, P11577, DOI 10.1073/pnas.94.21.11577; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; NIR S, 1977, J MEMBRANE BIOL, V31, P1, DOI 10.1007/BF01869396; Parsegian VA., 2006, VANDERWAALS FORCES; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Simson R, 1998, BIOPHYS J, V74, P514, DOI 10.1016/S0006-3495(98)77808-7; Skoge M, 2010, INTEGR BIOL-UK, V2, P659, DOI 10.1039/c0ib00033g; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; Tsujioka M, 2008, EUKARYOT CELL, V7, P906, DOI 10.1128/EC.00464-07; Uchida KSK, 2004, J CELL SCI, V117, P1443, DOI 10.1242/jcs.01015; VARNUM B, 1986, DEV BIOL, V113, P218, DOI 10.1016/0012-1606(86)90124-7; WEBER I, 1995, J CELL SCI, V108, P1519; West C. M., 2005, DICTYOSTELIUM GENOMI, P235	29	44	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42033	10.1371/journal.pone.0042033	http://dx.doi.org/10.1371/journal.pone.0042033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952588	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300004
J	Blodget, E; Shen, CY; Aldrovandi, G; Rollie, A; Gupta, SK; Stein, JH; Dube, MP				Blodget, Emily; Shen, Changyu; Aldrovandi, Grace; Rollie, Adrienne; Gupta, Samir K.; Stein, James H.; Dube, Michael P.			Relationship between Microbial Translocation and Endothelial Function in HIV Infected Patients	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; IMMUNE ACTIVATION; DYSFUNCTION; ATHEROSCLEROSIS; ASSOCIATION; PROGRESSION; HEALTH	Background: Circulating levels of microbial products are increased in HIV infection, and provoke endothelial dysfunction in other disease settings. Methodology/Principal Findings: We examined data from a cross-sectional single site study at Indiana University (Indiana, N = 85) and a 24-week multicenter prospective study of antiretroviral therapy (ART) initiation (ACTG 5152s, N = 75). Brachial artery flow-mediated dilation (FMD) was measured by ultrasound. Plasma lipopolysaccharide (LPS) and soluble CD14 (sCD14) levels were measured from stored specimens and correlated with FMD values using Pearson correlations. The Indiana subjects were 63% male with a mean age of 39 years and a median CD4 count of 406 cells/mm(3) (388 not on ART, 464 on ART). The 5152s subjects were 92% were male with a mean age of 35 years and a median CD4 count of 251 cells/mm(3) at entry which increased to 396 cells/mm(3) on ART. When analyzing the two cohorts individually or in combination neither sCD14 nor LPS correlated significantly with FMD. In a pre-specified subgroup analysis of the Indiana subjects receiving ART (N = 46, mean ART duration 40 months) LPS was inversely correlated with FMD (r = -0.33, p = 0.02), but not sCD14 (r = -0.01, p = 0.9). Multivariate analysis confirmed LPS as an independent predictor of FMD in this subgroup (p = 0.02). Conclusions/Significance: In HIV-infected individuals on prolonged ART, higher LPS levels are associated with worse endothelial function but not in untreated subjects or at 24 weeks after ART initiation. Persistent microbial translocation may contribute to arterial dysfunction and the increased cardiovascular disease risk observed in individuals on long-term ART.	[Blodget, Emily; Dube, Michael P.] Univ So Calif, Keck Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90033 USA; [Shen, Changyu] Indiana Univ, Sch Med, Dept Biostat 3, Indianapolis, IN 46204 USA; [Gupta, Samir K.] Indiana Univ, Sch Med 5, Dept Infect Dis, Indianapolis, IN 46204 USA; [Aldrovandi, Grace; Rollie, Adrienne] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Stein, James H.] Univ Wisconsin, Sch Med & Publ Hlth, Div Cardiovasc Med, Madison, WI USA	University of Southern California; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Children's Hospital Los Angeles; University of Wisconsin System; University of Wisconsin Madison	Blodget, E (corresponding author), Univ So Calif, Keck Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90033 USA.	eblodget@usc.edu	Dubé, Marie-Pierre/B-9364-2008	Dubé, Marie-Pierre/0000-0001-8442-4393; Stein, James/0000-0002-2770-8223	NIH [AI091492, HL72711, RR00750, RR16176]; Southern California Clinical Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016176, M01RR000750] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern California Clinical Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI091492, HL72711, RR00750 and RR16176 from the NIH and a pilot grant from the Southern California Clinical Translational Science Institute. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anderson TJ, 2007, CIRCULATION, V115, P2373, DOI 10.1161/CIRCULATIONAHA.107.697045; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Cassol E, 2011, J INFECT DIS, V203, P747, DOI 10.1093/infdis/jiq109; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Dube MP, 2010, AIDS RES HUM RETROV, V26, P847, DOI 10.1089/aid.2010.0007; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Kinlay S, 1997, AM J CARDIOL, V80, pI11, DOI 10.1016/S0002-9149(97)00793-5; Lepper PM, 2011, ATHEROSCLEROSIS, V219, P291, DOI 10.1016/j.atherosclerosis.2011.06.001; Murphy RL, 2010, AIDS, V24, P885, DOI 10.1097/QAD.0b013e3283352ed5; Nolan D, 2003, QJM-INT J MED, V96, P825, DOI 10.1093/qjmed/hcg145; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Redd AD, 2011, J INFECT DIS, V203, P744, DOI 10.1093/infdis/jiq107; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Riddler SA, 2008, JAIDS-J ACQ IMM DEF, V48, P281, DOI 10.1097/QAI.0b013e31817bbbf0; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Solages A, 2006, CLIN INFECT DIS, V42, P1325, DOI 10.1086/503261; Stein JH, 2001, CIRCULATION, V104, P257, DOI 10.1161/01.CIR.104.3.257; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276	27	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e42624	10.1371/journal.pone.0042624	http://dx.doi.org/10.1371/journal.pone.0042624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952600	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206500005
J	Honeycutt, CF; Perreault, EJ				Honeycutt, Claire Fletcher; Perreault, Eric Jon			Planning of Ballistic Movement following Stroke: Insights from the Startle Reflex	PLOS ONE			English	Article							PHASIC MUSCLE ACTIVATION; DECEREBRATE CAT; EXECUTION; CORTEX; ELBOW; ARM; COORDINATION; IMPAIRMENT; GENERATION; LOCOMOTION	Following stroke, reaching movements are slow, segmented, and variable. It is unclear if these deficits result from a poorly constructed movement plan or an inability to voluntarily execute an appropriate plan. The acoustic startle reflex provides a means to initiate a motor plan involuntarily. In the presence of a movement plan, startling acoustic stimulus triggers non-voluntary early execution of planned movement, a phenomenon known as the startReact response. In unimpaired individuals, the startReact response is identical to a voluntarily initiated movement, except that it is elicited 30-40 ms. As the startReact response is thought to be mediated by brainstem pathways, we hypothesized that the startReact response is intact in stroke subjects. If startReact is intact, it may be possible to elicit more task-appropriate patterns of muscle activation than can be elicited voluntarily. We found that startReact responses were intact following stroke. Responses were initiated as rapidly as those in unimpaired subjects, and with muscle coordination patterns resembling those seen during unimpaired volitional movements. Results were striking for elbow flexion movements, which demonstrated no significant differences between the startReact responses elicited in our stroke and unimpaired subject groups. The results during planned extension movements were less straightforward for stroke subjects, since the startReact response exhibited task inappropriate activity in the flexors. This inappropriate activity diminished over time. This adaptation suggests that the inappropriate activity was transient in nature and not related to the underlying movement plan. We hypothesize that the task-inappropriate flexor activity during extension results from an inability to suppress the classic startle reflex, which primarily influences flexor muscles and adapts rapidly with successive stimuli. These results indicate that stroke subjects are capable of planning ballistic elbow movements, and that when these planned movements are involuntarily executed they can be as rapid and appropriate as those in unimpaired individuals.	[Honeycutt, Claire Fletcher; Perreault, Eric Jon] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Honeycutt, Claire Fletcher] Northwestern Univ, Dept Elect Engn & Comp Sci, Chicago, IL 60611 USA; [Perreault, Eric Jon] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Perreault, Eric Jon] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; Northwestern University	Honeycutt, CF (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	c-honeycutt@northwestern.edu	Perreault, Eric/B-7632-2009		National Institutes of Health [K12 GM088020, T32 HD07418-18, R01 NS053813]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health grants K12 GM088020, T32 HD07418-18, and R01 NS053813. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibiglou L, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219592; Beer RF, 2007, MUSCLE NERVE, V36, P242, DOI 10.1002/mus.20817; Blouin JS, 2006, J PHYSIOL-LONDON, V573, P857, DOI 10.1113/jphysiol.2006.108274; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; BROWN SH, 1990, J NEUROPHYSIOL, V63, P455, DOI 10.1152/jn.1990.63.3.455; Buford JA, 2004, EXP BRAIN RES, V159, P284, DOI 10.1007/s00221-004-1956-4; CANEDO A, 1993, J PHYSIOL-LONDON, V463, P475, DOI 10.1113/jphysiol.1993.sp019606; Carlsen AN, 2004, J MOTOR BEHAV, V36, P253, DOI 10.3200/JMBR.36.3.253-264; Carlsen AN, 2003, EXP BRAIN RES, V152, P510, DOI 10.1007/s00221-003-1575-5; Carlsen AN, 2011, NEUROSCI BIOBEHAV R, V35, P366, DOI 10.1016/j.neubiorev.2010.04.009; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; COOKE JD, 1990, J NEUROPHYSIOL, V63, P465, DOI 10.1152/jn.1990.63.3.465; Cressman EK, 2006, EXP BRAIN RES, V171, P278, DOI 10.1007/s00221-006-0459-x; DAVIS M, 1977, J COMP PHYSIOL PSYCH, V91, P549, DOI 10.1037/h0077345; DEWALD JPA, 1995, BRAIN, V118, P495, DOI 10.1093/brain/118.2.495; Hedeker D, 2006, LONGITUDINAL DATA AN; Honeycutt CF, 2010, J NEUROPHYSIOL, V103, P3266, DOI 10.1152/jn.00764.2009; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; Jang SH, 2009, NEUROREHABILITATION, V24, P285, DOI 10.3233/NRE-2009-0480; Jankelowitz SK, 2004, NEUROLOGY, V62, P114, DOI 10.1212/01.WNL.0000101711.48946.35; JINNAI K, 1984, BRAIN RES, V291, P145, DOI 10.1016/0006-8993(84)90661-9; Kamper DG, 2002, ARCH PHYS MED REHAB, V83, P702, DOI 10.1053/apmr.2002.32446; Kandel E., 2000, PRINCIPLES NEURAL SC; Krakauer JW, 2005, SEMIN NEUROL, V25, P384, DOI 10.1055/s-2005-923533; Kumru H, 2006, EXP BRAIN RES, V169, P427, DOI 10.1007/s00221-005-0156-1; Kumru Hatice, 2006, Suppl Clin Neurophysiol, V58, P101; Kuypers H, 1981, AM PHYSL SOC, P597; Lance J, 1980, S SYNOPSIS; LEVIN MF, 1994, BRAIN RES, V657, P23, DOI 10.1016/0006-8993(94)90949-0; Levin MF, 1996, BRAIN, V119, P281, DOI 10.1093/brain/119.1.281; Lyalka VF, 2005, J NEUROPHYSIOL, V94, P3677, DOI 10.1152/jn.00538.2005; Maslovat D, 2011, J NEUROPHYSIOL, V106, P885, DOI 10.1152/jn.00166.2011; MCCREA DA, 1995, J PHYSIOL-LONDON, V487, P527, DOI 10.1113/jphysiol.1995.sp020897; Mohr D, 2009, BEHAV BRAIN RES, V202, P58, DOI 10.1016/j.bbr.2009.03.014; Moore K.L., 2017, CLIN ORIENTED ANATOM, V8th ed.; MORI S, 1987, PROG NEUROBIOL, V28, P161, DOI 10.1016/0301-0082(87)90010-4; Musienko PE, 2008, BEHAV BRAIN RES, V190, P124, DOI 10.1016/j.bbr.2008.02.011; Pearson KG, 1995, CURR OPIN NEUROBIOL, V5, P786, DOI 10.1016/0959-4388(95)80107-3; Perfiliev S, 2010, J NEUROPHYSIOL, V104, P2423, DOI 10.1152/jn.01133.2009; Rho MJ, 1997, J COMP NEUROL, V388, P228, DOI 10.1002/(SICI)1096-9861(19971117)388:2<228::AID-CNE4>3.0.CO;2-3; Rothwell J C, 2006, Suppl Clin Neurophysiol, V58, P223; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Sakai ST, 2009, NEUROSCIENCE, V163, P1158, DOI 10.1016/j.neuroscience.2009.07.036; Saladin K.S., 2012, ANATOMY PHYSL UNITY, V6th ed.).; Sangani SG, 2007, MUSCLE NERVE, V36, P694, DOI 10.1002/mus.20852; Schmit BD, 2000, ARCH PHYS MED REHAB, V81, P269; Shemmell J, 2009, J NEUROSCI, V29, P13255, DOI 10.1523/JNEUROSCI.0892-09.2009; SHIK M. L., 1968, BIOFIZIKA, V13, P127; Siegmund GP, 2008, EXERC SPORT SCI REV, V36, P76, DOI 10.1097/JES.0b013e318168f1ce; Simpson LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019431; Stinear CM, 2009, BRAIN STIMUL, V2, P152, DOI 10.1016/j.brs.2009.01.001; Trumbower RD, 2010, J NEUROPHYSIOL, V104, P3612, DOI 10.1152/jn.00804.2009; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; VallsSole J, 1997, BRAIN RES, V751, P155, DOI 10.1016/S0006-8993(97)00027-9; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; YAMSHON L J, 1949, Arch Phys Med Rehabil, V30, P706; Yao J, 2009, NEUROIMAGE, V45, P490, DOI 10.1016/j.neuroimage.2008.12.002; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; Zackowski KM, 2004, BRAIN, V127, P1035, DOI 10.1093/brain/awh116; [No title captured]; [No title captured]	62	66	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43097	10.1371/journal.pone.0043097	http://dx.doi.org/10.1371/journal.pone.0043097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952634	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206500008
J	Imbert, AM; Garulli, C; Choquet, E; Koubi, M; Aurrand-Lions, M; Chabannon, C				Imbert, Anne-Marie; Garulli, Celine; Choquet, Elodie; Koubi, Myriam; Aurrand-Lions, Michel; Chabannon, Christian			CD146 Expression in Human Breast Cancer Cell Lines Induces Phenotypic and Functional Changes Observed in Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							E-CADHERIN; TUMOR PROGRESSION; POOR-PROGNOSIS; UP-REGULATION; MELANOMA; PROMOTES; SNAIL; MUC18; SLUG; METASTASIS	Background: Metastasis is an important step in tumor progression leading to a disseminated and often incurable disease. First steps of metastasis include down-regulation of cell adhesion molecules, alteration of cell polarity and reorganization of cytoskeleton, modifications associated with enhanced migratory properties and resistance of tumor cells to anoikis. Such modifications resemble Epithelial to Mesenchymal Transition (EMT). In breast cancer CD146 expression is associated with poor prognosis and enhanced motility. Methodology/Principal Findings: On 4 different human breast cancer cell lines, we modified CD146 expression either with shRNA technology in CD146 positive cells or with stable transfection of CD146 in negative cells. Modifications in morphology, growth and migration were evaluated. Using Q-RT-PCR, we analyzed the expression of different EMT markers. We demonstrate that high levels of CD146 are associated with loss of cell-cell contacts, expression of EMT markers, increased cell motility and increased resistance to doxorubicin or docetaxel. Experimental modulation of CD146 expression induces changes consistent with the above described characteristics: morphology, motility, growth in anchorage independent conditions and Slug mRNA variations are strictly correlated with CD146 expression. These changes are associated with modifications of ER (estrogen receptor) and Erb receptors and are enhanced by simultaneous and opposite modulation of JAM-A, or exposure to heregulin, an erb-B4 ligand. Conclusions: CD146 expression is associated with an EMT phenotype. Several molecules are affected by CD146 expression: direct or indirect signaling contributes to EMT by increasing Slug expression. CD146 may also interact with Erb signaling by modifying cell surface expression of ErbB3 and ErbB4 and increased resistance to chemotherapy. Antagonistic effects of JAM-A, a tight junction-associated protein, on CD146 promigratory effects underline the complexity of the adhesion molecules network in tumor cell migration and metastasis.	[Imbert, Anne-Marie; Garulli, Celine; Chabannon, Christian] Ctr Therapie Cellulaire, Ctr Ressources Biol Oncol, Inst Paoli Calmettes, Marseille, France; [Imbert, Anne-Marie; Garulli, Celine; Choquet, Elodie; Koubi, Myriam; Chabannon, Christian] CRCM, Equipe Rech Clin, INSERM, UMR1068, Marseille, France; [Choquet, Elodie; Koubi, Myriam; Aurrand-Lions, Michel; Chabannon, Christian] Univ Aix Marseille, Marseille, France; [Aurrand-Lions, Michel] CRCM, Equipe Mol Adhes & Interact Hote Tumeur, INSERM, UMR1068, Marseille, France	UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Imbert, AM (corresponding author), Ctr Therapie Cellulaire, Ctr Ressources Biol Oncol, Inst Paoli Calmettes, Marseille, France.	imbertam@marseille.fnclcc.fr	Aurrand-Lions, Michel/O-9953-2016; Choquet, Élodie/AAK-6363-2021	Aurrand-Lions, Michel/0000-0002-8361-3034; Choquet, Élodie/0000-0002-9173-0740	Institut Paoli-Calmettes; "Institut National du Cancer" (INCa)	Institut Paoli-Calmettes; "Institut National du Cancer" (INCa)(Institut National du Cancer (INCA) France)	This work was supported in part by Institut Paoli-Calmettes, and by an "Institut National du Cancer" (INCa) "Appel a Projets Libres 2007" to Christian Chabannon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldovini D, 2006, INT J CANCER, V119, P1920, DOI 10.1002/ijc.22082; Atlas E, 2003, MOL CANCER RES, V1, P165; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Chan B, 2005, DEV DYNAM, V232, P232, DOI 10.1002/dvdy.20220; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Cheng LS, 2009, CANCER LETT, V280, P50, DOI 10.1016/j.canlet.2009.02.007; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; GIOANNI J, 1990, BRIT J CANCER, V62, P8, DOI 10.1038/bjc.1990.219; Guezguez B, 2007, J IMMUNOL, V179, P6673, DOI 10.4049/jimmunol.179.10.6673; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kristiansen G, 2003, ANAL CELL PATHOL, V25, P77, DOI 10.1155/2003/574829; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Li G, 2003, ONCOGENE, V22, P6891, DOI 10.1038/sj.onc.1206819; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McSherry EA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2853; McSherry EA, 2009, INT J CANCER, V125, P1343, DOI 10.1002/ijc.24498; Mostert B, 2011, BREAST CANCER RES TR, V127, P33, DOI 10.1007/s10549-010-0879-y; Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057; Naik UP, 2008, CELL ADHES MIGR, V2, P249, DOI 10.4161/cam.2.4.6753; Nava P, 2011, EMBO REP, V12, P314, DOI 10.1038/embor.2011.16; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pickl WF, 1997, J IMMUNOL, V158, P2107; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; SERS C, 1993, P NATL ACAD SCI USA, V90, P8514, DOI 10.1073/pnas.90.18.8514; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Shih IM, 1997, CANCER RES, V57, P3835; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsukamoto Y, 2003, INT J ONCOL, V23, P1671; Wu GJ, 2005, J UROLOGY, V173, P1778, DOI 10.1097/01.ju.0000154643.30048.2c; Wu GJ, 2004, GENE, V327, P201, DOI 10.1016/j.gene.2003.11.018; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215; Zeng GF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-113; Zeng GF, 2012, GENE, V492, P229, DOI 10.1016/j.gene.2011.10.024; Zeng QQ, 2012, P NATL ACAD SCI USA, V109, P1127, DOI 10.1073/pnas.1111053108	44	45	48	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43752	10.1371/journal.pone.0043752	http://dx.doi.org/10.1371/journal.pone.0043752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952755	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206500021
J	Yao, D; Xie, XH; Wang, XL; Wan, C; Lee, YW; Chen, SH; Pei, DQ; Wang, YX; Li, G; Qin, L				Yao, Dong; Xie, Xin-Hui; Wang, Xin-Luan; Wan, Chao; Lee, Yuk-Wai; Chen, Shi-Hui; Pei, Duan-Qing; Wang, Yi-Xiang; Li, Gang; Qin, Ling			Icaritin, an Exogenous Phytomolecule, Enhances Osteogenesis but Not Angiogenesis-An In Vitro Efficacy Study	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; FIBROBLAST-GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; HERBA-EPIMEDII; BONE REGENERATION; BREVICORNUM-MAXIM; RATS; PROLIFERATION; ADIPOGENESIS	We found that Icaritin, an intestinal metabolite of Epimedium-derived flavonoids (EF) enhanced osteoblastic differentiation of mesenchymal stem cells (MSCs) only under osteogenic induction conditions. We also demonstrated its effect on inhibition of adipogenic differentiation of MSCs. Unlike the findings of others on EF compounds, we showed that Icaritin was unable to promote proliferation, migration and tube like structure formation by human umbilical vein endothelial cells (HUVECs) in vitro. These results suggested that the exogenous phytomolecule Icaritin possessed the potential for enhancing bone formation via its osteopromotive but not an osteoinductive mechanism. Though some flavonoids were shown to regulate the coupling process of angiogenesis and osteogenesis during bone repair, our results suggested that Icaritin did not have direct effect on enhancing angiogenesis in vitro.	[Yao, Dong; Xie, Xin-Hui; Wang, Xin-Luan; Lee, Yuk-Wai; Chen, Shi-Hui; Qin, Ling] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Xie, Xin-Hui] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Peoples R China; [Wang, Xin-Luan] Chinese Acad Sci, Translat Med Res & Dev Ctr, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Wan, Chao] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Stem Cell & Regenerat Program, Hong Kong, Hong Kong, Peoples R China; [Wan, Chao] Jinan Univ, Chinese Univ Hong Kong, Minist Educ, Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Pei, Duan-Qing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou, Guangdong, Peoples R China; [Wang, Yi-Xiang] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Li, Gang] Chinese Univ Hong Kong, Sch Biomed Sci, Dept Orthopaed & Traumatol, Stem Cells & Regenerat Program, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Soochow University - China; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong	Yao, D (corresponding author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	lingqin@cuhk.edu.hk	Qin, Ling/J-9047-2018; Li, Gang/J-7830-2018; Lee, Wayne YW/H-8298-2013; Wan, Chao/J-9277-2013; Wang, Yi Xiang/I-5952-2016	Qin, Ling/0000-0001-6173-6167; Li, Gang/0000-0002-3981-2239; Lee, Wayne YW/0000-0002-0486-360X; Wan, Chao/0000-0001-6780-2006; Wang, Yi Xiang/0000-0001-5697-0717; Yao, Dong/0000-0001-8883-5384	Hong Kong Innovation and Technology Support Program ITF Tier 2 [ITS/451/09FP]; Hong Kong General Research Fund [GRF CUHK-473710/473011]	Hong Kong Innovation and Technology Support Program ITF Tier 2; Hong Kong General Research Fund	The project was supported by Hong Kong Innovation and Technology Support Program ITF Tier 2 (ITS/451/09FP) and Hong Kong General Research Fund (GRF CUHK-473710/473011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805; Bocci G, 2002, CANCER RES, V62, P6938; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen KM, 2007, PHARMAZIE, V62, P785, DOI 10.1691/ph.2007.10.7504; Chen KM, 2007, PHARMAZIE, V62, P388, DOI 10.1691/ph.2007.5.6682; Chen KM, 2005, PHARMAZIE, V60, P939; Chen WF, 2011, BRIT J NUTR, V105, P180, DOI 10.1017/S0007114510003247; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Cool SM, 2005, INT J BIOCHEM CELL B, V37, P1739, DOI 10.1016/j.biocel.2005.03.006; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Fotsis T, 1997, CANCER RES, V57, P2916; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Grasser WA, 2007, INT ORTHOP, V31, P759, DOI 10.1007/s00264-007-0407-9; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; Heino TJ, 2004, EXP CELL RES, V294, P458, DOI 10.1016/j.yexcr.2003.11.016; Hidaka S, 1999, PHYTOTHER RES, V13, P14, DOI 10.1002/(SICI)1099-1573(199902)13:1&lt;14::AID-PTR375&gt;3.0.CO;2-V; Hidaka S, 1997, CALCIFIED TISSUE INT, V61, P239, DOI 10.1007/s002239900329; HIRATA S, 1989, ARTHRITIS RHEUM, V32, P1065, DOI 10.1002/anr.1780320903; Huang J, 2007, LIFE SCI, V81, P832, DOI 10.1016/j.lfs.2007.07.015; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kubler N R, 1999, Mund Kiefer Gesichtschir, V3 Suppl 1, pS134, DOI 10.1007/PL00014500; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Li HY, 1999, BIOL PHARM BULL, V22, P391, DOI 10.1248/bpb.22.391; Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002; Liu HY, 2011, BIOMATERIALS, V32, P6773, DOI 10.1016/j.biomaterials.2011.05.080; Ma HP, 2010, J CELL BIOCH; Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911; Meng FH, 2005, PHYTOMEDICINE, V12, P189, DOI 10.1016/j.phymed.2004.03.007; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Neubauer M, 2004, FEBS LETT, V577, P277, DOI 10.1016/j.febslet.2004.10.020; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x; Park JS, 2008, J MICROBIOL BIOTECHN, V18, P110; Peng SL, 2009, BONE, V45, P534, DOI 10.1016/j.bone.2009.05.022; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Qian GF, 2006, ENDOCR J, V53, P87, DOI 10.1507/endocrj.53.87; Qin L, 2005, J BONE MINER METAB, V23, P55, DOI 10.1007/BF03026324; Sakamoto S, 2000, EUR J ENDOCRINOL, V143, P139, DOI 10.1530/eje.0.1430139; Sasamura H, 2002, BRIT J CANCER, V86, P768, DOI 10.1038/sj.bjc.6600152; Schipani E, 2001, GENE DEV, V15, P2865; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S; Sheng Hui H, 2007, J Orthop Surg Res, V2, P15, DOI 10.1186/1749-799X-2-15; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Xie F, 2005, EVID-BASED COMPL ALT, V2, P353, DOI 10.1093/ecam/neh101; Xie XH, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054109; Yuan JP, 2007, MOL NUTR FOOD RES, V51, P765, DOI 10.1002/mnfr.200600262; Zhang G, 2006, BONE, V38, P818, DOI 10.1016/j.bone.2005.11.019; Zhang G, 2009, BONE, V44, P345, DOI 10.1016/j.bone.2008.10.035; Zhao J, 2008, BIOCHEM BIOPH RES CO, V369, P444, DOI 10.1016/j.bbrc.2008.02.054; Zhao JY, 2010, TISSUE ENG PT A, V16, P233, DOI [10.1089/ten.tea.2009.0165, 10.1089/ten.TEA.2009.0165]	63	43	47	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e41264	10.1371/journal.pone.0041264	http://dx.doi.org/10.1371/journal.pone.0041264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952579	gold, Green Published			2022-12-27	WOS:000308206500002
J	Gupta, R; Deedwania, PC; Sharma, K; Gupta, A; Guptha, S; Achari, V; Asirvatham, AJ; Bhansali, A; Gupta, B; Gupta, S; Jali, MV; Mahanta, TG; Maheshwari, A; Saboo, B; Singh, J; Gupta, R				Gupta, Rajeev; Deedwania, Prakash C.; Sharma, Krishnakumar; Gupta, Arvind; Guptha, Soneil; Achari, Vijay; Asirvatham, Arthur J.; Bhansali, Anil; Gupta, Balkishan; Gupta, Sunil; Jali, Mallikarjuna V.; Mahanta, Tulika G.; Maheshwari, Anuj; Saboo, Banshi; Singh, Jitendra; Gupta, Rajiv			Association of Educational, Occupational and Socioeconomic Status with Cardiovascular Risk Factors in Asian Indians: A Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; URBAN-POPULATION; MIDDLE-INCOME; HEALTH; INEQUALITIES; NONRESPONSE; COUNTRIES; SELECTION	Background: To determine correlation of multiple parameters of socioeconomic status with cardiovascular risk factors in India. Methods: The study was performed at eleven cities using cluster sampling. Subjects (n = 6198, men 3426, women 2772) were evaluated for socioeconomic, demographic, biophysical and biochemical factors. They were classified into low, medium and high socioeconomic groups based on educational level (<10, 1015 and >15 yr formal education), occupational class and socioeconomic scale. Risk factor differences were evaluated using multivariate logistic regression. Results: Age-adjusted prevalence (%) of risk factors in men and women was overweight or obesity in 41.1 and 45.2, obesity 8.3 and 15.8, high waist circumference 35.7 and 57.5, high waist-hip ratio 69.0 and 83.8, hypertension 32.5 and 30.4, hypercholesterolemia 24.8 and 25.3, low HDL cholesterol 34.1 and 35.1, high triglycerides 41.2 and 31.5, diabetes 16.7 and 14.4 and metabolic syndrome in 32.2 and 40.4 percent. Lifestyle factors were smoking 12.0 and 0.5, other tobacco use 12.7 and 6.3, high fat intake 51.2 and 48.2, low fruits/vegetables intake 25.3 and 28.9, and physical inactivity in 38.8 and 46.1%. Prevalence of > = 3 risk factors was significantly greater in low (28.0%) vs. middle (23.9%) or high (22.1%) educational groups (p<0.01). In low vs. high educational groups there was greater prevalence of high waist-hip ratio (odds ratio 2.18, confidence interval 1.652.71), low HDL cholesterol (1.51, 1.271.80), hypertriglyceridemia (1.16, 0.991.37), smoking/tobacco use (3.27, 2.664.01), and low physical activity (1.15, 0.971.37); and lower prevalence of high fat diet (0.47, 0.380.57),overweight/obesity (0.68, 0.580.80) and hypercholesterolemia (0.79, 0.660.94). Similar associations were observed with occupational and socioeconomic status. Conclusions: Low educational, occupational and socioeconomic status Asian Indians have greater prevalence of truncal obesity, low HDL cholesterol, hypertriglyceridemia, smoking or tobacco use and low physical activity and clustering of > = 3 major cardiovascular risk factors.	[Gupta, Rajeev; Sharma, Krishnakumar] Fortis Escorts Hosp, Dept Med, Jaipur, Rajasthan, India; [Gupta, Rajeev; Guptha, Soneil] Jaipur Heart Watch Fdn, Jaipur, Rajasthan, India; [Deedwania, Prakash C.] Univ Calif San Francisco, Dept Cardiol, Fresno, CA USA; [Deedwania, Prakash C.] Vet Adm Hosp, Fresno, CA USA; [Achari, Vijay] Patna Med Coll, Dept Med, Patna, Bihar, India; [Gupta, Arvind] Jaipur Diabet Res Ctr, Jaipur, Rajasthan, India; [Asirvatham, Arthur J.] Arthur Asirvatham Hosp, Dept Med, Madurai, Tamil Nadu, India; [Bhansali, Anil] Postgrad Inst Med Educ & Res, Dept Endocrinol, Chandigarh 160012, India; [Gupta, Balkishan] Sardar Patel Med Coll, Dept Med, Bikaner, Rajasthan, India; [Gupta, Sunil] Diabet Care & Res Ctr, Nagpur, Maharashtra, India; [Jali, Mallikarjuna V.] Jawaharlal Nehru Med Coll, Dept Med, Belgaum, Karnataka, India; [Mahanta, Tulika G.] Assam Med Coll, Dept Community Med, Dibrugarh, Assam, India; [Maheshwari, Anuj] Babu Banarasi Das Coll Dent Sci, Dept Med, Lucknow, Uttar Pradesh, India; [Saboo, Banshi] DiaCare & Res, Ahmadabad, Gujarat, India; [Singh, Jitendra] Govt Med Coll, Dept Med, Jammu, Jammu & Kashmir, India; [Gupta, Rajiv] Univ Rajasthan, Dept Sociol, Jaipur 302004, Rajasthan, India	Fortis Escorts Hospital; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Sardar Patel Medical College, Bikaner; K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum; Babu Banarasi Das University; University of Rajasthan	Gupta, R (corresponding author), Fortis Escorts Hosp, Dept Med, Jaipur, Rajasthan, India.	rajeevg@satyam.net.in	Saboo, Banshi/AAE-8515-2020; Gupta, Arvind/AAB-4997-2021; Maheshwari, Anuj/AAA-8246-2021; Jali, Mallikarjun V/AAX-8795-2020	Saboo, Banshi/0000-0001-7293-8864; Gupta, Arvind/0000-0001-9828-8732; Maheshwari, Anuj/0000-0002-0924-7830; 	South Asian Society of Atherosclerosis and Thrombosis, Bangalore, India; Minneapolis, USA	South Asian Society of Atherosclerosis and Thrombosis, Bangalore, India; Minneapolis, USA	The study was funded by South Asian Society of Atherosclerosis and Thrombosis, Bangalore, India and Minneapolis, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ahuja R, 1997, SOCIAL PROBLEMS INDI, P282; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BLANE D, 1993, SOCIOL HEALTH ILL, V15, P2; Brunner E, 2002, STRESS AND THE HEART: PSYCHOSOCIAL PATHWAYS TO CORONARY HEART DISEASE, P181; CHADHA SL, 1990, INDIAN J MED RES-B, V92, P424; Elovainio M, 2011, AM J EPIDEMIOL, V174, P779, DOI 10.1093/aje/kwr149; Fuster, 2010, PROMOTING CARDIOVASC; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gupta R, 2006, INT J CARDIOL, V108, P291, DOI 10.1016/j.ijcard.2005.05.044; Gupta R, 1995, Indian Heart J, V47, P331; Gupta R, 1994, J Cardiovasc Risk, V1, P179; Gupta R, 2011, EUR J CARDIOVASC PRE, DOI 10.1177/1741826711424567; Gupta R, 1994, BMJ-BRIT MED J, V319, P1332; Gupta R, 2012, WORLD J CARDIOL, V4, P112, DOI 10.4330/wjc.v4.i4.112; Gupta R, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-8; Gupta R, 2010, PREV MED, V51, P408, DOI 10.1016/j.ypmed.2010.08.014; Gupta Rajeev, 2009, Indian Heart J, V61, P358; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; Jeemon P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000068; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Johnson TP, 2004, 2003 P SECT SURV RES, P127; KAPLAN GA, 1993, NY TIMES        1026, V88, P1973; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Kinra S, 2010, BMJ-BRIT MED J, V341, pc4974; Krishna A., 2010, ONE ILLNESS AWAY WHY; Luepkar RV, 2002, CARDIOVASCULAR SURVE; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackintosh M., 2001, POVERTY INEQUALITY H; Manor O, 2003, SOC SCI MED, V57, P2217, DOI 10.1016/S0277-9536(03)00097-2; Marmot M, 2002, STRESS AND THE HEART: PSYCHOSOCIAL PATHWAYS TO CORONARY HEART DISEASE, P5; Marmot M., 2004, STATUS SYNDROME YOUR; Marmot M, 2006, SOCIAL DETERMINANTS; Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8; Office of Registrar General of India, 2009, REP CAUS DEATHS IND; Panagariya A, 2008, INDIA EMERGING GIANT, P8; Po JYT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016844; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; SARVOTHAM SG, 1968, CIRCULATION, V37, P939, DOI 10.1161/01.CIR.37.6.939; Stansfeld S, 2002, STRESS AND THE HEART: PSYCHOSOCIAL PATHWAYS TO CORONARY HEART DISEASE, P72; Varma Pavan, 2007, GREAT INDIAN MIDDLE; World Health Organization, 2002, DIET NUTR CHRON DIS; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; YUSUF S, 2001, NY TIMES        1026, V104, P2746; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	49	88	90	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44098	10.1371/journal.pone.0044098	http://dx.doi.org/10.1371/journal.pone.0044098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZC	22952886	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000082
J	Senter, P; Kirkland, JI; DeBlieux, DD				Senter, Phil; Kirkland, James I.; DeBlieux, Donald D.			Martharaptor greenriverensis, a New Theropod Dinosaur from the Lower Cretaceous of Utah	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; THERIZINOSAUROID DINOSAUR; NORTHWESTERN CHINA; EVOLUTION; FEATHERS; AFFINITIES; PYGOSTYLE; MONGOLIA; YUNNAN	Background: The Yellow Cat Member of the Cedar Mountain Formation (Early Cretaceous, Barremian?) of Utah has yielded a rich dinosaur fauna, including the basal therizinosauroid theropod Falcarius utahensis at its base. Recent excavation uncovered a new possible therizinosauroid taxon from a higher stratigraphic level in the Cedar Mountain Formation than F. utahensis. Methodology/Principal Findings: Here we describe a fragmentary skeleton of the new theropod and perform a phylogenetic analysis to determine its phylogenetic position. The skeleton includes fragments of vertebrae, a scapula, forelimb and hindlimb bones, and an ischium. It also includes several well-preserved manual unguals. Manual and pedal morphology show that the specimen is distinct from other theropods from the Cedar Mountain Formation and from previously described therizinosauroids. It is here named as the holotype of a new genus and species, Martharaptor greenriverensis. Phylogenetic analysis places M. greenriverensis within Therizinosauroidea as the sister taxon to Alxasaurus + Therizinosauridae, although support for this placement is weak. Conclusions/Significance: The new specimen adds to the known dinosaurian fauna of the Yellow Cat Member of the Cedar Mountain Formation. If the phylogenetic placement is correct, it also adds to the known diversity of Therizinosauroidea.	[Senter, Phil] Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA; [Kirkland, James I.; DeBlieux, Donald D.] Utah Geol Survey, Salt Lake City, UT USA	University of North Carolina; Fayetteville State University	Senter, P (corresponding author), Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA.	psenter@uncfsu.edu						Barrett PM, 2009, PALAEONTOLOGY, V52, P681, DOI 10.1111/j.1475-4983.2009.00887.x; Barsbold R, 2000, ACTA PALAEONTOL POL, V45, P97; Barsbold R., 1980, Acta Palaeontologica Polonica, V25, P187; BARSBOLD R, 1976, SOVIET MONGOLIAN PAL, V3, P76; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Dong Z., 1979, MESOZOIC CENOZOIC RE, P342; GREENHALGH B.W., 2007, CENTRAL UTAH DIVERSE, V36, P81; Harris J. D., 1998, NEW MEXICO MUSEUM NA, V14, P225; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Kirkland J.I., 1993, HUNTERIA, V2, P1; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kirkland JI, 2001, J VERTEBR PALEONTOL, V21, P410, DOI 10.1671/0272-4634(2001)021[0410:FDTDTF]2.0.CO;2; KIRKLAND JI, 1998, NEW MEXICO MUSEUM NA, V14, P239; Kirkland JI, 2007, UTAH GEOLOGICAL ASS, V35, P1; Li DQ, 2008, CAN J EARTH SCI, V45, P769, DOI 10.1139/E08-021; Li DQ, 2007, ACTA GEOL SIN-ENGL, V81, P539; MALEEV E. A., 1952, DOKLADY AKAD NAUK SSSR, V87, P131; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Owen R, 1842, 11 M BRIT ASS ADV SC, P60; Perle A., 1981, SOVMESTNAYA SOVETSKO, V8, P50; Perle A., 1979, T JOINT SOVIET MONGO, V8, P45; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; Seeley, 1887, P R SOC LONDON, V63, P165; Senter P, 2011, PLOS ONE, V5, P1; Senter P., 2012, PLOS ONE, V7, P1; Senter Phil, 2010, Bulletin of Gunma Museum of Natural History, V14, P1; Senter Phil, 2007, Bulletin of Gunma Museum of Natural History, V11, P1; Suarez MB, 2007, PALAIOS, V22, P513, DOI 10.2110/palo.2006.p06-014r; Swofford DL., 2001, PAUP PHYLOGENETIC AN; VONHUENE F, 1914, CENTRALBLATT MINERAL, P154; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2003, ACTA GEOL SIN-ENGL, V77, P294; Xu X, 2001, J VERTEBR PALEONTOL, V21, P477, DOI 10.1671/0272-4634(2001)021[0477:ANTFTL]2.0.CO;2; Xu Xing, 2002, Vertebrata Palasiatica, V40, P228; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Zanno LE, 2006, J VERTEBR PALEONTOL, V26, P636, DOI 10.1671/0272-4634(2006)26[636:TPGAFO]2.0.CO;2; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang Xiao-Hong, 2001, Vertebrata Palasiatica, V39, P282	41	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43911	10.1371/journal.pone.0043911	http://dx.doi.org/10.1371/journal.pone.0043911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952806	gold, Green Published			2022-12-27	WOS:000308206000059
J	Taylor, WR; Morley, R; Krasavin, A; Gregory, L; Wilkinson, DG; Poliakov, A				Taylor, William R.; Morley, Rosalind; Krasavin, Alexey; Gregory, Lauren; Wilkinson, David G.; Poliakov, Alexei			A Mechanical Model of Cell Segregation Driven by Differential Adhesion	PLOS ONE			English	Article							E-CADHERIN; SIMULATION; RHO	From simulations that begin with a random mix of two cell types, we monitor progress towards segregation driven by contact-mediated linkage of model cells, which is equivalent to the cell-cell adhesion of real cells. In comparison with real cell experiments, we show that this mechanical model can account for the observed extent of segregation obtained by differential adhesion in a 2D cell culture assay of cells with differentially expressed cadherin molecules. Calibration of virtual to real time allowed us to estimate a time course for these experiments that was within 50% agreement for the simulations compared to differential adhesion of cells. In contrast, simulations of differential adhesion do not account for the rate of segregation driven by interactions between EphB2 receptor and ephrinB1 expressing cells which occurs an order of magnitude faster. The latter result suggests that mechanisms additional or alternative to differential adhesion contribute to Eph-ephrin mediated cell segregation.	[Taylor, William R.; Morley, Rosalind; Gregory, Lauren; Wilkinson, David G.; Poliakov, Alexei] MRC Natl Inst Med Res, Div Math Biol, London, England; [Taylor, William R.; Morley, Rosalind; Gregory, Lauren; Wilkinson, David G.; Poliakov, Alexei] MRC Natl Inst Med Res, Div Dev Neurobiol, London, England; [Krasavin, Alexey] Kings Coll London, Dept Phys, London WC2R 2LS, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of London; King's College London	Taylor, WR (corresponding author), MRC Natl Inst Med Res, Div Math Biol, London, England.	wtaylor@nimr.mrc.ac.uk	Poliakov, Alexei/C-6362-2008	Poliakov, Alexei/0000-0001-7428-4040; Wilkinson, David/0000-0001-6757-7080	Medical Research Council (UK); Medical Research Council [MC_U117532048] Funding Source: researchfish; MRC [MC_U117532048] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; STEINBERG MS, 1970, J EXP ZOOL, V173, P395, DOI 10.1002/jez.1401730406; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Taylor W, 2011, J BIOINF COMPUT BIOL, V9, P91, DOI 10.1142/S0219720011005318; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058	19	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43226	10.1371/journal.pone.0043226	http://dx.doi.org/10.1371/journal.pone.0043226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952652	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000026
J	Hicks, KA; Howe, DK; Leung, A; Denver, DR; Estes, S				Hicks, Kiley A.; Howe, Dana K.; Leung, Aubrey; Denver, Dee R.; Estes, Suzanne			In Vivo Quantification Reveals Extensive Natural Variation in Mitochondrial Form and Function in Caenorhabditis briggsae	PLOS ONE			English	Article							C-ELEGANS; LIFE-HISTORY; COMPLEX-I; INTERPOPULATION HYBRIDS; TIGRIOPUS-CALIFORNICUS; PATERNAL MITOCHONDRIA; OXIDATIVE DAMAGE; RNAI SCREEN; MORPHOLOGY; EVOLUTION	In We have analyzed natural variation in mitochondrial form and function among a set of Caenorhabditis briggsae isolates known to harbor mitochondrial DNA structural variation in the form of a heteroplasmic nad5 gene deletion (nad5 Delta) that correlates negatively with organismal fitness. We performed in vivo quantification of 24 mitochondrial phenotypes including reactive oxygen species level, membrane potential, and aspects of organelle morphology, and observed significant amongisolate variation in 18 traits. Although several mitochondrial phenotypes were non-linearly associated with nad5D levels, most of the among-isolate phenotypic variation could be accounted for by phylogeographic clade membership. In particular, isolate-specific mitochondrial membrane potential was an excellent predictor of clade membership. We interpret this result in light of recent evidence for local adaptation to temperature in C. briggsae. Analysis of mitochondrial-nuclear hybrid strains provided support for both mtDNA and nuclear genetic variation as drivers of natural mitochondrial phenotype variation. This study demonstrates that multicellular eukaryotic species are capable of extensive natural variation in organellar phenotypes and highlights the potential of integrating evolutionary and cell biology perspectives.	[Hicks, Kiley A.; Estes, Suzanne] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Howe, Dana K.; Leung, Aubrey; Denver, Dee R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Howe, Dana K.; Leung, Aubrey; Denver, Dee R.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Portland State University; Oregon State University; Oregon State University	Hicks, KA (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.	estess@pdx.edu			National Institutes of Health grant [5 R01 GM087628-02]; PSU Faculty Enhancement grant; American Heart Association Predoctoral Fellowship [11PRE4880069]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087628] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSU Faculty Enhancement grant; American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant 5 R01 GM087628-02 to DRD and SE, PSU Faculty Enhancement grant to SE, and an American Heart Association Predoctoral Fellowship 11PRE4880069 to KAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Arnqvist G, 2010, EVOLUTION, V64, P3354, DOI 10.1111/j.1558-5646.2010.01135.x; Baer CF, 2005, P NATL ACAD SCI USA, V102, P5785, DOI 10.1073/pnas.0406056102; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Biskup S, 2006, BIOESSAYS, V28, P963, DOI 10.1002/bies.20471; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046; Burton RS, 2007, GENE, V403, P53, DOI 10.1016/j.gene.2007.07.026; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Clark K, SELFISH LIT IN PRESS; Cutter AD, 2006, GENETICS, V173, P2021, DOI 10.1534/genetics.106.058651; Cutter AD, 2010, MOL ECOL, V19, P798, DOI 10.1111/j.1365-294X.2009.04491.x; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dingley S., 2009, MITOCHONDRION; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Ellison CK, 2008, J EVOLUTION BIOL, V21, P1844, DOI 10.1111/j.1420-9101.2008.01608.x; Ellison CK, 2010, J EVOLUTION BIOL, V23, P528, DOI 10.1111/j.1420-9101.2009.01917.x; Ellison CK, 2006, EVOLUTION, V60, P1382, DOI 10.1111/j.0014-3820.2006.tb01217.x; Estes S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-11; Falk MJ, 2008, MOL GENET METAB, V93, P388, DOI 10.1016/j.ymgme.2007.11.007; Fangue NA, 2009, J EXP BIOL, V212, P514, DOI 10.1242/jeb.024034; Fontaine KM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000892; Gaskova D, 2007, BIOCHEM BIOPH RES CO, V354, P814, DOI 10.1016/j.bbrc.2007.01.073; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Gotelli NJ, 2004, PRIMER ECOLOGICAL GE; Grad LI, 2005, P NATL ACAD SCI USA, V102, P18367, DOI 10.1073/pnas.0506939102; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Gupta BP., 2007, GENOMICS BIOL NEMATO; Haas RH, 2010, DEV DISABIL RES REV, V16, P144, DOI 10.1002/ddrr.112; Halliwell B., 2007, FREE RADICALS BIOL M; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Howe DK, 2010, GENOME BIOL EVOL, V2, P29, DOI 10.1093/gbe/evp055; Howe DK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-62; Ichishita R, 2008, J BIOCHEM, V143, P449, DOI 10.1093/jb/mvm245; Ienco E. C., 2011, INT J ALZHEIMERS DIS, V2011; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Jovelin R, 2011, GENETICS, V189, P967, DOI 10.1534/genetics.111.132795; Kayser EB, 2004, MECH AGEING DEV, V125, P455, DOI 10.1016/j.mad.2004.04.002; Keller I, 2012, MOL ECOL, V21, P782, DOI 10.1111/j.1365-294X.2011.05397.x; Koboldt DC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-236; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Montooth KL, 2010, EVOLUTION, V64, P3364, DOI 10.1111/j.1558-5646.2010.01077.x; Morley SA, 2009, COMP BIOCHEM PHYS A, V152, P423, DOI 10.1016/j.cbpa.2008.11.015; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pham NA, 2004, MICROSC MICROANAL, V10, P247, DOI 10.1017/S143192760404005X; Prasad A, 2011, EVOLUTION, V65, P52, DOI 10.1111/j.1558-5646.2010.01110.x; Raboin MJ, 2010, MOL BIOL EVOL, V27, P1087, DOI 10.1093/molbev/msp318; Ross JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002174; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Russ J. C., 2002, IMAGE PROCESSING HDB, V4th, DOI DOI 10.1201/9781420040760; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Schon EA, 2010, TRENDS MOL MED; Sedensky MM, 2006, EXP GERONTOL, V41, P237, DOI 10.1016/j.exger.2006.01.004; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Sudhaus W, 2007, ZOOTAXA, P45, DOI 10.11646/zootaxa.1456.1.2; Tuma R, 2001, Sci Aging Knowledge Environ, V2001, poa5; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Ventura N, 2006, EXP GERONTOL, V41, P974, DOI 10.1016/j.exger.2006.06.060; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Weber SB, 2011, P BIOL SCI; Willett CS, 2004, MOL BIOL EVOL, V21, P443, DOI 10.1093/molbev/msh031; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Wolff JN, 2008, GENETICS, V179, P1029, DOI 10.1534/genetics.107.085274; Zhou QH, 2011, CELL RES, V21, P1662, DOI 10.1038/cr.2011.182; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463	90	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43837	10.1371/journal.pone.0043837	http://dx.doi.org/10.1371/journal.pone.0043837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952781	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600050
J	Lu, J; Du, ZX; Kong, J; Chen, LN; Qiu, YH; Li, GF; Meng, XH; Zhu, SF				Lu, Jie; Du, Zhi-Xin; Kong, Jun; Chen, Ling-Na; Qiu, Yan-Hong; Li, Gui-Fen; Meng, Xiao-Hua; Zhu, Shui-Fang			Transcriptome Analysis of Nicotiana tabacum Infected by Cucumber mosaic virus during Systemic Symptom Development	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; RESISTANCE; TOOL; ASSOCIATION; RECOVERY; PLANTS	Virus infection of plants may induce a variety of disease symptoms. However, little is known about the molecular mechanism of systemic symptom development in infected plants. Here we performed the first next-generation sequencing study to identify gene expression changes associated with disease development in tobacco plants (Nicotiana tabacum cv. Xanthi nc) induced by infection with the M strain of Cucumber mosaic virus (M-CMV). Analysis of the tobacco transcriptome by RNA-Seq identified 95,916 unigenes, 34,408 of which were new transcripts by database searches. Deep sequencing was subsequently used to compare the digital gene expression (DGE) profiles of the healthy plants with the infected plants at six sequential disease development stages, including vein clearing, mosaic, severe chlorosis, partial and complete recovery, and secondary mosaic. Thousands of differentially expressed genes were identified, and KEGG pathway analysis of these genes suggested that many biological processes, such as photosynthesis, pigment metabolism and plant-pathogen interaction, were involved in systemic symptom development. Our systematic analysis provides comprehensive transcriptomic information regarding systemic symptom development in virus-infected plants. This information will help further our understanding of the detailed mechanisms of plant responses to viral infection.	[Lu, Jie; Du, Zhi-Xin; Kong, Jun; Chen, Ling-Na; Qiu, Yan-Hong; Li, Gui-Fen; Zhu, Shui-Fang] Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China; [Du, Zhi-Xin; Qiu, Yan-Hong] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Meng, Xiao-Hua] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Inspection & Quarantine; China Agricultural University; Beijing Genomics Institute (BGI)	Lu, J (corresponding author), Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China.	zhushf020420@gmail.com			Basic Scientific Research Foundation of the Chinese Academy of Inspection and Quarantine [2011JK002, 2009JK032]	Basic Scientific Research Foundation of the Chinese Academy of Inspection and Quarantine	This work was supported by the Basic Scientific Research Foundation of the Chinese Academy of Inspection and Quarantine (2011JK002 and 2009JK032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Bajda A, 2009, PHYSIOL PLANTARUM, V135, P351, DOI 10.1111/j.1399-3054.2009.01204.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Grant JJ, 2003, MOL PLANT MICROBE IN, V16, P669, DOI 10.1094/MPMI.2003.16.8.669; Gruden Kristina, 2008, V451, P583, DOI 10.1007/978-1-59745-102-4_40; Guo ZJ, 2004, PLANT MOL BIOL, V55, P607, DOI 10.1007/s11103-004-1521-3; Hagen C, 2008, PHYTOPATHOLOGY, V98, P1029, DOI 10.1094/PHYTO-98-9-1029; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Huang ZL, 2005, PLANT PHYSIOL, V137, P1147, DOI 10.1104/pp.104.056028; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jovel J, 2007, J VIROL, V81, P12285, DOI 10.1128/JVI.01192-07; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Lee YW, 2010, PLANT CELL, V22, P2781, DOI 10.1105/tpc.110.076778; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOSSOP DW, 1976, VIROLOGY, V74, P544, DOI 10.1016/0042-6822(76)90361-5; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; Peng XX, 2009, CURR OPIN MICROBIOL, V12, P432, DOI 10.1016/j.mib.2009.06.003; Pompe-Novak M, 2005, PHYSIOL MOL PLANT P, V67, P237, DOI 10.1016/j.pmpp.2006.02.005; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Shi C, 2005, MOL GENET GENOMICS, V273, P450, DOI 10.1007/s00438-004-1103-8; Smith CM, 2004, NEW PHYTOL, V164, P123, DOI 10.1111/j.1469-8137.2004.01151.x; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Uzarowska A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-15; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	52	74	77	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43447	10.1371/journal.pone.0043447	http://dx.doi.org/10.1371/journal.pone.0043447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952684	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600026
J	Sarkinen, T; Staats, M; Richardson, JE; Cowan, RS; Bakker, FT				Saerkinen, Tiina; Staats, Martijn; Richardson, James E.; Cowan, Robyn S.; Bakker, Freek T.			How to Open the Treasure Chest? Optimising DNA Extraction from Herbarium Specimens	PLOS ONE			English	Article							ANCIENT DNA; AMPLIFICATION; PCR; PRESERVATION; BARCODE; BONES	Herbarium collections are potentially an enormous resource for DNA studies, but the use of herbarium specimens in molecular studies has thus far been slowed down by difficulty in obtaining amplifiable DNA. Here we compare a set of commercially available DNA extraction protocols and their performance in terms of DNA purity and yield, and PCR amplification success as measured by using three differentially sized markers, the rbcL barcoding marker (cpDNA), the LEAFY exon 3 (nrDNA), and the trnL((UAA)) P6 loop (cpDNA). Results reveal large differences between extraction methods, where DNA purity rather than yield is shown to be strongly correlated with PCR success. Amplicon size shows similarly strong correlation with PCR success, with the shortest fragment showing the highest success rate (78%, P6 loop, 10-143 base pairs (bp)) and the largest fragment the lowest success (10%, rbcL, 670 bp). The effect of specimen preparation method on PCR success was also tested. Results show that drying method strongly affects PCR success, especially the availability of fragments longer than 250 bp, where longer fragments are more available for PCR amplification in air dried material compared to alcohol dried specimens. Results from our study indicate that projects relying on poor-quality starting material such as herbarium or scat samples should focus on extracting pure DNA and aim to amplify short target regions (<200-300 bp) in order to maximise outcomes. Development of shorter barcoding regions, or mini-barcodes within existing ones should be of high importance as only a few options are currently available; this is particularly important if we hope to incorporate the millions of herbarium samples available into barcoding initiatives and other molecular studies.	[Saerkinen, Tiina; Richardson, James E.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Saerkinen, Tiina] Nat Hist Museum, London SW7 5BD, England; [Staats, Martijn; Bakker, Freek T.] Wageningen Univ, Biosystemat Grp, Wageningen, Netherlands; [Richardson, James E.] Univ Los Andes, Bogota, Colombia; [Cowan, Robyn S.] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Natural History Museum London; Wageningen University & Research; Universidad de los Andes (Colombia); Royal Botanic Gardens, Kew	Sarkinen, T (corresponding author), Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland.	tiina.sarkinen@nhm.ac.uk	Richardson, James-Edward/L-2768-2016	Richardson, James-Edward/0000-0001-9014-4865; Bakker, Freek T./0000-0003-0227-6687	European Community [226506-CP-CSA-Infra]	European Community(European Commission)	The work was funded by the European Community Research Infrastructures program under FP7 call 'Synthesis of Systematic Resources', grant number 226506-CP-CSA-Infra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shayji Y, 2004, ACTA BIOTECHNOL, V14, P163; Barnwell P, 1998, PLANT MOL BIOL REP, V16, P133, DOI 10.1023/A:1007473302551; Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; Brockington SF, 2008, TAXON, V57, P944, DOI 10.1002/tax.573022; de la Cruz M, 1997, PLANT MOL BIOL REP, V15, P319, DOI 10.1023/A:1007428818078; Doyle J. J., 1987, PHYTOCHEM B, P11; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Drabkova L, 2002, PLANT MOL BIOL REP, V20, P161, DOI 10.1007/BF02799431; Erkens RHJ, 2008, BLUMEA, V53, P407, DOI 10.3767/000651908X608052; Fleischmann A, 2009, ANAL JARDIN BOT MAD, V66, P209, DOI 10.3989/ajbm.2198; Frohlich MW, 1997, INT J PLANT SCI, V158, pS131, DOI 10.1086/297513; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; HANNI C, 1995, NUCLEIC ACIDS RES, V23, P881, DOI 10.1093/nar/23.5.881; HARRIS SA, 1993, PLANT SYST EVOL, V188, P57, DOI 10.1007/BF00937835; Hofreiter M, 2000, MOL ECOL, V9, P1975, DOI 10.1046/j.1365-294X.2000.01106.x; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Holmgren P.K., 1990, INDEX HERBARIORUM 1; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Jankowiak K, 2005, TAXON, V54, P335, DOI 10.2307/25065361; JOBES DV, 1995, TAXON, V44, P379, DOI 10.2307/1223408; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Kalmar T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e67; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Li FW, 2010, MOL ECOL RESOUR, V10, P92, DOI 10.1111/j.1755-0998.2009.02745.x; Medellin-Leal F, 1975, B SOC BOT MEX, V34, P3; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Michiels A, 2003, ANAL BIOCHEM, V315, P85, DOI 10.1016/S0003-2697(02)00665-6; Paabo S., 1990, PCR PROTOCOLS GUIDE, P159; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; PYLE MM, 1989, TAXON, V38, P576, DOI 10.2307/1222632; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; SAVOLAINEN V, 1995, PLANT SYST EVOL, V197, P87, DOI 10.1007/BF00984634; Schenck H, 1889, KEW B, P19; Schenck H, 1888, B TORREY BOT CLUB, P292; Schenck H, 1887, BOT CENTRALBLATT, V35, P175; SHETLER S G, 1969, Proceedings of the Biological Society of Washington, V82, P687; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; SOLTIS PS, 1993, NEW ZEAL J BOT, V31, P203, DOI 10.1080/0028825X.1993.10419497; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Telle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003584; Thompson JF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-217; Weising K., 1995, DNA fingerprinting in plants and fungi.; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	49	162	177	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43808	10.1371/journal.pone.0043808	http://dx.doi.org/10.1371/journal.pone.0043808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952770	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600045
J	Gupta, VA; Kawahara, G; Myers, JA; Chen, AT; Hall, TE; Manzini, MC; Currie, PD; Zhou, Y; Zon, LI; Kunkel, LM; Beggs, AH				Gupta, Vandana A.; Kawahara, Genri; Myers, Jennifer A.; Chen, Aye T.; Hall, Thomas E.; Manzini, M. Chiara; Currie, Peter D.; Zhou, Yi; Zon, Leonard I.; Kunkel, Louis M.; Beggs, Alan H.			A Splice Site Mutation in Laminin-alpha 2 Results in a Severe Muscular Dystrophy and Growth Abnormalities in Zebrafish	PLOS ONE			English	Article							LAMININ ALPHA-2; LAMA2 GENE; MEROSIN; MODEL; MUTANT; POPULATION; PHENOTYPE; MICE	Congenital muscular dystrophy (CMD) is a clinically and genetically heterogeneous group of inherited muscle disorders. In patients, muscle weakness is usually present at or shortly after birth and is progressive in nature. Merosin deficient congenital muscular dystrophy (MDC1A) is a form of CMD caused by a defect in the laminin-alpha 2 gene (LAMA2). Laminin-alpha 2 is an extracellular matrix protein that interacts with the dystrophin-dystroglycan (DGC) complex in membranes providing stability to muscle fibers. In an N-ethyl-N-nitrosourea mutagenesis screen to develop zebrafish models of neuromuscular diseases, we identified a mutant fish that exhibits severe muscular dystrophy early in development. Genetic mapping identified a splice site mutation in the lama2 gene. This splice site is highly conserved in humans and this mutation results in mis-splicing of RNA and a loss of protein function. Homozygous lama2 mutant zebrafish, designated lama2(cl501/cl501), exhibited reduced motor function and progressive degeneration of skeletal muscles and died at 8-15 days post fertilization. The skeletal muscles exhibited damaged myosepta and detachment of myofibers in the affected fish. Laminin-alpha 2 deficiency also resulted in growth defects in the brain and eye of the mutant fish. This laminin-alpha 2 deficient mutant fish represents a novel disease model to develop therapies for modulating splicing defects in congenital muscular dystrophies and to restore the muscle function in human patients with CMD.	[Gupta, Vandana A.; Kawahara, Genri; Myers, Jennifer A.; Manzini, M. Chiara; Kunkel, Louis M.; Beggs, Alan H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Genom Program,Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Gupta, Vandana A.; Kawahara, Genri; Myers, Jennifer A.; Manzini, M. Chiara; Kunkel, Louis M.; Beggs, Alan H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Genet,Manton Ctr Orphan Dis Res, Boston, MA USA; [Chen, Aye T.; Zhou, Yi; Zon, Leonard I.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Chen, Aye T.; Zhou, Yi; Zon, Leonard I.] Harvard Univ, Sch Med, Boston Childrens Hosp, Stem Cell Program, Boston, MA USA; [Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Zon, Leonard I.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Australian Regenerative Medicine Institute; Monash University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Gupta, VA (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Genom Program,Manton Ctr Orphan Dis Res, Boston, MA 02115 USA.	beggs@enders.tch.harvard.edu	Hall, Thomas/J-2125-2014	Hall, Thomas/0000-0002-7718-7614; SanMiguel, Jennifer/0000-0002-5882-0752; Currie, Peter/0000-0001-8874-8862; Beggs, Alan/0000-0001-8818-0568; Manzini, M. Chiara/0000-0001-7175-1096; Gupta, Vandana/0000-0002-4057-8451	Muscular Dystrophy Association [MDA201302]; National Institute of Health (NIH) grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR044345]; Lee and Penny Anderson Family Foundation; William Randolph Hearst Fund; NIH from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [K01 AR062601-01]; National Institute of Child Health and Human Development [P30HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044345, K01AR062601] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institute of Health (NIH) grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; Lee and Penny Anderson Family Foundation; William Randolph Hearst Fund; NIH from the National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Muscular Dystrophy Association (MDA201302); National Institute of Health (NIH) grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR044345); by the Lee and Penny Anderson Family Foundation; and the William Randolph Hearst Fund. VAG was supported by NIH K01 AR062601-01 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. DNA sequencing was performed by the Children's Hospital Boston Genomics Program Molecular Genetics Core supported in part by National Institute of Child Health and Human Development grant (P30HD18655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Di Blasi Claudia, 2011, BMC Res Notes, V4, P534, DOI 10.1186/1756-0500-4-534; Doe JA, 2011, J CELL SCI, V124, P2287, DOI 10.1242/jcs.083311; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; Girgenrath M, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-7; Gupta V, 2011, HUM MOL GENET, V20, P1712, DOI 10.1093/hmg/ddr047; Guyon JR, 2003, HUM MOL GENET, V12, P601, DOI 10.1093/hmg/ddg071; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Jones KJ, 1998, J MED GENET, V35, P379, DOI 10.1136/jmg.35.5.379; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Kuang W, 1999, LAB INVEST, V79, P1601; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Mendell JR, 2006, PEDIATR DEVEL PATHOL, V9, P427, DOI 10.2350/06-07-0127.1; Messina S, 2010, NEUROLOGY, V75, P898, DOI 10.1212/WNL.0b013e3181f11dd5; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q; O'Brien DP, 2001, J NEUROL SCI, V189, P37, DOI 10.1016/S0022-510X(01)00559-7; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Patton BL, 2008, J CELL SCI, V121, P1593, DOI 10.1242/jcs.015354; Philpot J, 1999, ARCH DIS CHILD, V80, P542, DOI 10.1136/adc.80.6.542; Relucio J, 2009, J NEUROSCI, V29, P11794, DOI 10.1523/JNEUROSCI.0888-09.2009; Rooney JE, 2012, AM J PATHOL; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Sztal T, 2011, DEV DYNAM, V240, P422, DOI 10.1002/dvdy.22537; Theodore M, 2011, CURR OPIN PEDIATR, V23, P581, DOI 10.1097/MOP.0b013e32834cd693; Topaloglu H, 1998, NEUROMUSCULAR DISORD, V8, P169, DOI 10.1016/S0960-8966(98)00013-3; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Vigliano P, 2009, EUR J PAEDIATR NEURO, V13, P72, DOI 10.1016/j.ejpn.2008.01.010; Westerfield M, 2007, ZEBRAFISH BOOK; Wewer UM, 1996, NEUROMUSCULAR DISORD, V6, P409, DOI 10.1016/S0960-8966(96)00384-7; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Zhou Y, 2011, METHOD CELL BIOL, V104, P287, DOI 10.1016/B978-0-12-374814-0.00016-1; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	40	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43794	10.1371/journal.pone.0043794	http://dx.doi.org/10.1371/journal.pone.0043794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952766	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800060
J	Loganathan, S; Kandala, PK; Gupta, P; Srivastava, SK				Loganathan, Sivakumar; Kandala, Prabodh K.; Gupta, Parul; Srivastava, Sanjay K.			Inhibition of EGFR-AKT Axis Results in the Suppression of Ovarian Tumors In Vitro and in Preclinical Mouse Model	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL-CYCLE ARREST; CANCER CELLS; LUNG-CANCER; SIGNALING PATHWAY; ACTIVATION; KINASE; CARCINOMA; PHOSPHORYLATION; APOPTOSIS	Ovarian cancer is the leading cause of cancer related deaths in women. Genetic alterations including overexpression of EGFR play a crucial role in ovarian carcinogenesis. Here we evaluated the effect of phenethyl isothiocyanate (PEITC) in ovarian tumor cells in vitro and in vivo. Oral administration of 12 mmol PEITC resulted in drastically suppressing ovarian tumor growth in a preclinical mouse model. Our in vitro studies demonstrated that PEITC suppress the growth of SKOV-3, OVCAR-3 and TOV-21G human ovarian cancer cells by inducing apoptosis in a concentration-dependent manner. Growth inhibitory effects of PEITC were mediated by inhibition of EGFR and AKT, which are known to be overexpressed in ovarian tumors. PEITC treatment caused significant down regulation of constitutive protein levels as well as phosphorylation of EGFR at Tyr1068 in various ovarian cancer cells. In addition, PEITC treatment drastically reduced the phosphorylation of AKT which is downstream to EGFR and disrupted mTOR signaling. PEITC treatment also inhibited the kinase activity of AKT as observed by the down regulation of p-GSK in OVCAR-3 and TOV-21G cells. AKT overexpression or TGF treatment blocked PEITC induced apoptosis in ovarian cancer cells. These results suggest that PEITC targets EGFR/AKT pathway in our model. In conclusion, our study suggests that PEITC could be used alone or in combination with other therapeutic agents to treat ovarian cancer.	[Loganathan, Sivakumar; Srivastava, Sanjay K.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15260 USA; [Loganathan, Sivakumar; Srivastava, Sanjay K.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Kandala, Prabodh K.; Gupta, Parul; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX USA; [Kandala, Prabodh K.; Gupta, Parul; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Loganathan, S (corresponding author), Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15260 USA.	sanjay.srivastava@ttuhsc.edu	GUPTA, PARUL/AAF-1118-2019; Srivastava, Sanjay K./AAE-7635-2020		National Cancer Institute [CA106953, CA129038]; NATIONAL CANCER INSTITUTE [R01CA106953, R01CA129038] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by R01 grants CA106953 and CA129038 (to S.K.S.) awarded by the National Cancer Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Alper O, 2001, J NATL CANCER I, V93, P1375, DOI 10.1093/jnci/93.18.1375; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Medel NIB, 2010, J ONCOL, V2010, DOI 10.1155/2010/314326; Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Boreddy SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025799; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; Bosetti C, 2001, INT J CANCER, V93, P911, DOI 10.1002/ijc.1422; Casanova ML, 2002, CANCER RES, V62, P3402; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Flynn JF, 2009, J ONCOL, V2009, DOI 10.1155/2009/526963; FONTANINI G, 1995, EUR J CANCER, V31A, P178, DOI 10.1016/0959-8049(93)00421-M; Galbaugh T, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-34; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; HECHT SS, 1995, CANCER EPIDEM BIOMAR, V4, P877; Hecht SS, 1996, ADV EXP MED BIOL, V401, P1; Huong LD, 2011, J AGR FOOD CHEM, V59, P8124, DOI 10.1021/jf2006358; Jang K, 2010, ONCOL REP, V24, P787, DOI 10.3892/or_00000922; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji Y, 2005, PHARM RES-DORDR, V22, P1658, DOI 10.1007/s11095-005-7097-z; Johnson SM, 2009, ANTICANCER RES, V29, P3185; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kandala PK, 2012, ONCOTARGET; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kandala PK, 2012, J PHARMACOL EXP THER, V341, P24, DOI 10.1124/jpet.111.188706; Kandala PK, 2010, MOL PHARMACOL, V78, P297, DOI 10.1124/mol.110.063750; Kim SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026615; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Milligan SA, 2009, CLIN CANCER RES, V15, P4885, DOI 10.1158/1078-0432.CCR-09-0109; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nishioka C, 2008, LEUKEMIA RES, V32, P865, DOI 10.1016/j.leukres.2007.09.017; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Ozols RF, 2006, GYNECOL ONCOL, V103, P1, DOI 10.1016/j.ygyno.2006.06.026; PERRIMON N, 1994, CURR OPIN CELL BIOL, V6, P260, DOI 10.1016/0955-0674(94)90145-7; Phelps SLB, 2008, GYNECOL ONCOL, V109, P411, DOI 10.1016/j.ygyno.2008.02.030; Pramanik KC, 2012, ANTIOXID REDOX SIGNA; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Rho JK, 2010, MOL CANCER THER, V9, P3233, DOI 10.1158/1535-7163.MCT-10-0625; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Satyan KS, 2006, GYNECOL ONCOL, V103, P261, DOI 10.1016/j.ygyno.2006.03.002; Sherwood ER, 1998, BRIT J CANCER, V77, P855, DOI 10.1038/bjc.1998.142; Stewart JR, 2004, INVEST NEW DRUG, V22, P107, DOI 10.1023/B:DRUG.0000011787.75522.ec; Suh Y, 2010, CARCINOGENESIS, V31, P1424, DOI 10.1093/carcin/bgq115; Thoennissen NH, 2010, ONCOGENE, V29, P285, DOI 10.1038/onc.2009.335; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Turner T, 1996, CLIN EXP METASTAS, V14, P409, DOI 10.1007/BF00123400; Ueda S, 2006, CANCER RES, V66, P5346, DOI 10.1158/0008-5472.CAN-05-3684; Watanabe H, 1998, Nihon Jibiinkoka Gakkai Kaiho, V101, P967; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Wu HY, 2007, BIOMARK INSIGHTS, V2, P469; Yan HQ, 2011, BRIT J NUTR, V106, P1779, DOI 10.1017/S0007114511002315; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; Zeineldin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/414676; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang M, 2002, BRIT J CANCER, V86, P712, DOI 10.1038/sj.bjc.6600085	59	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43577	10.1371/journal.pone.0043577	http://dx.doi.org/10.1371/journal.pone.0043577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952709	gold, Green Published, Green Accepted			2022-12-27	WOS:000308044800040
J	Qin, J; Huang, ZX; Chen, J; Zou, Q; You, WW; Ke, CH				Qin, Ji; Huang, Zixia; Chen, Jun; Zou, Quan; You, Weiwei; Ke, Caihuan			Sequencing and de novo Analysis of Crassostrea angulata (Fujian Oyster) from 8 Different Developing Phases Using 454 GSFlx	PLOS ONE			English	Article							INSULIN-LIKE SYSTEM; PACIFIC OYSTER; GASTROPOD MOLLUSK; TRANSCRIPTOME; EXPRESSION; GIGAS; METAMORPHOSIS; HEMOCYTES; MORTALITY; SELECTION	Research on the mechanism for early development of shellfish, such as body plan, shell formation, settlement and metamorphosis is currently an active research field. However, studies were still limited and not deep enough because of the lack of genomic resources such as genome or transcriptome sequences. In the present research, de novo transcriptome sequencing was performed for Crassostrea angulata, the most economically important cultured oyster species in China, at eight early developmental stages using the 454 sequencing technology. A total of 555,215 reads were produced with an average length of 309 nucleotides that were then assembled into 10,462 contigs. As determined by GO annotation and KEGG pathway mapping, functional annotation of the unigenes recovered diverse biological functions and processes. Six unique sequences related to settlement, metamorphosis and growth were subsequently analyzed by real-time PCR. Given the lack of whole genome information for oysters, transcriptome and de novo analysis of C. angulata from the eight different developing phases will provide important and useful information on early development mechanism and help genetic breeding of shellfish.	[Qin, Ji; Huang, Zixia; Chen, Jun; You, Weiwei; Ke, Caihuan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Qin, Ji; Huang, Zixia; Chen, Jun; You, Weiwei; Ke, Caihuan] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [Zou, Quan] Xiamen Univ, Coll Informat Sci & Technol, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Qin, J (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	chke@xmu.edu.cn	Huang, Zixia/AAO-6936-2021; Ke, CH/G-4635-2010; Zou, Quan/A-7801-2015	Huang, Zixia/0000-0002-1298-0486	National Basic Research Program of China [2010CB1264000]; Hi-Tech Research and Development (863) Program of China [2010AA10A110]; Shellfish Modern Agro-industry Technology Research System [nycytx-47]	National Basic Research Program of China(National Basic Research Program of China); Hi-Tech Research and Development (863) Program of China; Shellfish Modern Agro-industry Technology Research System	This study was funded by The National Basic Research Program of China (No. 2010CB1264000), Hi-Tech Research and Development (863) Program of China (No. 2010AA10A110) and Shellfish Modern Agro-industry Technology Research System (No. nycytx-47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard SA, 2006, AQUACULTURE, V254, P148, DOI 10.1016/j.aquaculture.2005.10.017; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; BONAR DB, 1990, B MAR SCI, V46, P484; Butt D, 2008, DEV COMP IMMUNOL, V32, P299, DOI 10.1016/j.dci.2007.06.006; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Clark MS, 2010, PLOS ONE, V6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COON SL, 1987, NEUROSCIENCE, V23, P1169, DOI 10.1016/0306-4522(87)90190-4; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Degremont L, 2007, AQUACULTURE, V262, P41, DOI 10.1016/j.aquaculture.2006.10.025; Evans S, 2006, AQUACULTURE, V261, P546, DOI 10.1016/j.aquaculture.2006.07.037; *FAO, 2000, FISHSTAT PLUS UN SOF; Feng BB, 2010, MAR BIOTECHNOL, V12, P282, DOI 10.1007/s10126-009-9216-z; Fiedler TJ, 2010, COMP BIOCHEM PHYS D, V5, P165, DOI 10.1016/j.cbd.2010.03.003; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Gregory DJ, 2004, ANIM GENET, V35, P425, DOI 10.1111/j.1365-2052.2004.01193.x; Gricourt L, 2006, AQUACULTURE, V251, P85, DOI 10.1016/j.aquaculture.2005.05.015; Gricourt L, 2003, GEN COMP ENDOCR, V134, P44, DOI 10.1016/S0016-6480(03)00217-X; Guo X. M., 2004, Bulletin of the Aquaculture Association of Canada, V104, P26; Heyland A, 2011, J EXP ZOOL PART B, V316B, P113, DOI 10.1002/jez.b.21383; Hinman VF, 2003, EVOL DEV, V5, P508, DOI 10.1046/j.1525-142X.2003.03056.x; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huan P, 2012, MAR BIOTECHNOL, V14, P69, DOI 10.1007/s10126-011-9389-0; Jackson D, 2002, INT J DEV BIOL, V46, P679; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Lebel JM, 1996, BIOL CELL, V86, P67, DOI 10.1016/0248-4900(96)89526-8; Li Q, 2011, GENES GENOM, V33, P313, DOI 10.1007/s13258-011-0021-5; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Pedersen TM, 2008, J MARINE SYST, V73, P185, DOI 10.1016/j.jmarsys.2007.10.008; Reyes-Bermudez A, 2009, MAR GENOM, V2, P149, DOI 10.1016/j.margen.2009.07.002; Sauvage C, 2009, VIRUS RES, V142, P181, DOI 10.1016/j.virusres.2009.02.013; Serpentini A, 2000, J EXP ZOOL, V287, P275, DOI 10.1002/1097-010X(20000901)287:4&lt;275::AID-JEZ2&gt;3.0.CO;2-8; Wang HY, 2010, J SHELLFISH RES, V29, P857, DOI 10.2983/035.029.0420; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	37	48	51	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43653	10.1371/journal.pone.0043653	http://dx.doi.org/10.1371/journal.pone.0043653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952730	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800049
J	Adenzato, M; Todisco, P; Ardito, RB				Adenzato, Mauro; Todisco, Patrizia; Ardito, Rita B.			Social Cognition in Anorexia Nervosa: Evidence of Preserved Theory of Mind and Impaired Emotional Functioning	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; TORONTO-ALEXITHYMIA-SCALE; ASPERGER-SYNDROME; EATING-DISORDERS; INTERHEMISPHERIC COOPERATION; MULTIDIMENSIONAL SCALE; AMYGDALA ACTIVATION; BULIMIA-NERVOSA; ACQUIRED THEORY; BODY-IMAGE	Background: The findings of the few studies that have to date investigated the way in which individuals with Anorexia Nervosa (AN) navigate their social environment are somewhat contradictory. We undertook this study to shed new light on the social-cognitive profile of patients with AN, analysing Theory of Mind and emotional functioning. Starting from previous evidence on the role of the amygdala in the neurobiology of AN and in the social cognition, we hypothesise preserved Theory of Mind and impaired emotional functioning in patients with AN. Methodology: Thirty women diagnosed with AN and thirty-two women matched for education and age were involved in the study. Theory of Mind and emotional functioning were assessed with a set of validated experimental tasks. A measure of perceived social support was also used to test the correlations between this dimension and the social-cognitive profile of AN patients. Principal Findings: The performance of patients with AN is significantly worse than that of healthy controls on tasks assessing emotional functioning, whereas patients' performance is comparable to that of healthy controls on the Theory of Mind task. Correlation analyses showed no relationship between scores on any of the social-cognition tasks and either age of onset or duration of illness. A correlation between social support and emotional functioning was found. This latter result seems to suggest a potential role of social support in the treatment and recovery of AN. Conclusions: The pattern of results followed the experimental hypothesis. They may be useful to help us better understand the social-cognitive profile of patients with AN and to contribute to the development of effective interventions based on the ways in which patients with AN actually perceive their social environment.	[Adenzato, Mauro; Ardito, Rita B.] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Adenzato, Mauro] Inst Neurosci, Turin, Italy; [Todisco, Patrizia] Casa Cura Villa Margherita, Ctr Eating Disorders, Vicenza, Italy	University of Turin	Adenzato, M (corresponding author), Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy.	rita.ardito@unito.it	Adenzato, Mauro/I-5127-2012; ARDITO, Rita/AFQ-8659-2022; Adenzato, Mauro/AFQ-8675-2022	Adenzato, Mauro/0000-0002-6997-9283; ARDITO, Rita/0000-0002-5020-6598; Adenzato, Mauro/0000-0002-6997-9283	University of Turin	University of Turin	This work was supported by University of Turin (Ricerca scientifica finanziata dall'Universita, "Correlati cognitivi e neurali della cognizione sociale" and "Cognizione sociale e attaccamento in popolazioni cliniche e non cliniche"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Adenzato M, 2006, SOC BEHAV PERSONAL, V34, P17, DOI 10.2224/sbp.2006.34.1.17; Adenzato M, 2006, THEOR PSYCHOL, V16, P747, DOI 10.1177/0959354306070515; Adenzato M, 2010, NEUROPSYCHOLOGIA, V48, P2, DOI 10.1016/j.neuropsychologia.2009.08.001; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P119, DOI 10.1016/S0028-3932(02)00142-2; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ardito RB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00270; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bailey PE, 2008, AGING MENT HEALTH, V12, P499, DOI 10.1080/13607860802224243; Bara BG, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00007; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baron-Cohen S, 2006, BRAIN COGNITION, V61, P122, DOI 10.1016/j.bandc.2005.12.011; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BOURKE MP, 1992, BRIT J PSYCHIAT, V161, P240, DOI 10.1192/bjp.161.2.240; Calabria M, 2009, BRAIN COGNITION, V70, P247, DOI 10.1016/j.bandc.2009.02.009; Cavallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025948; Cheng YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018905; Christie R., 1970, STUDIES MACHIAVELLIA; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Connan F, 2003, PHYSIOL BEHAV, V79, P13, DOI 10.1016/S0031-9384(03)00101-X; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; DAHLEM NW, 1991, J CLIN PSYCHOL, V47, P756, DOI 10.1002/1097-4679(199111)47:6<756::AID-JCLP2270470605>3.0.CO;2-L; Davis C, 2005, PSYCHOL MED, V35, P377, DOI 10.1017/S0033291704003447; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Duval C, 2011, CONSCIOUS COGN, V20, P627, DOI 10.1016/j.concog.2010.10.025; Dziobek I, 2006, NEUROPSYCHOLOGIA, V44, P1891, DOI 10.1016/j.neuropsychologia.2006.02.005; Eddy KT, 2008, AM J PSYCHIAT, V165, P245, DOI 10.1176/appi.ajp.2007.07060951; Eddy KT, 2002, INT J EAT DISORDER, V31, P191, DOI 10.1002/eat.10016; Ellinson Z, 1998, LANCET, V352, P1192, DOI 10.1016/S0140-6736(05)60529-6; Enrici I, 2011, J COGNITIVE NEUROSCI, V23, P2415, DOI 10.1162/jocn.2010.21594; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Friederich HC, 2012, NEUROIMAGE, V59, P1106, DOI 10.1016/j.neuroimage.2011.09.042; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GARNER DM, 1979, PSYCHOL MED, V9, P273, DOI 10.1017/S0033291700030762; GILLBERG IC, 1995, COMPR PSYCHIAT, V36, P61, DOI 10.1016/0010-440X(95)90100-A; Giordano GD, 2001, J ENDOCRINOL INVEST, V24, P510, DOI 10.1007/BF03343884; Guttman HA, 2000, FAM PROCESS, V39, P345, DOI 10.1111/j.1545-5300.2000.39306.x; Hallerback Maria Unenge, 2009, Cogn Neuropsychiatry, V14, P127, DOI 10.1080/13546800902901518; Hambrook D, 2008, EAT WEIGHT DISORD-ST, V13, P137, DOI 10.1007/BF03327614; Hambrook D, 2008, BRIT J CLIN PSYCHOL, V47, P335, DOI 10.1348/014466507X272475; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Harrison A, 2010, PSYCHOL MED, V40, P1887, DOI 10.1017/S0033291710000036; Harrison A, 2010, BIOL PSYCHIAT, V68, P755, DOI 10.1016/j.biopsych.2010.04.037; Harrison A, 2009, CLIN PSYCHOL PSYCHOT, V16, P348, DOI 10.1002/cpp.628; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Joos AAB, 2011, PSYCHIAT RES-NEUROIM, V191, P189, DOI 10.1016/j.pscychresns.2010.11.008; Keating C, 2010, NEUROSCI BIOBEHAV R, V34, P73, DOI 10.1016/j.neubiorev.2009.07.004; Kim YR, 2011, PSYCHIAT INVEST, V8, P9, DOI 10.4306/pi.2011.8.1.9; Kucharska-Pietura K, 2004, INT J EAT DISORDER, V35, P42, DOI 10.1002/eat.10219; Lee KH, 2012, SOC COGN AFFECT NEUR, V7, P521, DOI 10.1093/scan/nsp001; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Miyake Y, 2010, PSYCHIAT RES-NEUROIM, V181, P183, DOI 10.1016/j.pscychresns.2009.09.001; Miyake Y, 2010, NEUROIMAGE, V50, P1333, DOI 10.1016/j.neuroimage.2009.12.095; Moor BG, 2012, SOC COGN AFFECT NEUR, V7, P44, DOI 10.1093/scan/nsr020; Morris J, 2007, BMJ-BRIT MED J, V334, P894, DOI 10.1136/bmj.39171.616840.BE; Oldershaw A, 2010, PSYCHOSOM MED, V72, P73, DOI 10.1097/PSY.0b013e3181c6c7ca; Paul LK, 2010, J NEURODEV DISORD, V2, P165, DOI 10.1007/s11689-010-9056-1; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Poletti M, 2012, NEUROSCI BIOBEHAV R, V36, P2147, DOI 10.1016/j.neubiorev.2012.07.004; Poletti M, 2011, BEHAV BRAIN RES, V219, P342, DOI 10.1016/j.bbr.2011.01.010; Pollatos O, 2008, PSYCHOSOM MED, V70, P701, DOI 10.1097/PSY.0b013e31817e41e6; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rozenstein MH, 2011, J AFFECT DISORDERS, V134, P386, DOI 10.1016/j.jad.2011.06.009; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Russell TA, 2000, AM J PSYCHIAT, V157, P2040, DOI 10.1176/appi.ajp.157.12.2040; Russell TA, 2009, PSYCHIAT RES, V168, P181, DOI 10.1016/j.psychres.2008.10.028; SCHMIDT U, 1993, COMPR PSYCHIAT, V34, P54, DOI 10.1016/0010-440X(93)90036-4; Schnell K, 2011, NEUROIMAGE, V54, P1743, DOI 10.1016/j.neuroimage.2010.08.024; Seeger G, 2002, NEUROSCI LETT, V326, P25, DOI 10.1016/S0304-3940(02)00312-9; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Slessor G, 2007, PSYCHOL AGING, V22, P639, DOI 10.1037/0882-7974.22.3.639; Speranza M, 2007, J PSYCHOSOM RES, V63, P365, DOI 10.1016/j.jpsychores.2007.03.008; Spitzer RL., 1994, STRUCTURED CLIN INTE; Stewart LH, 2012, J EXP PSYCHOL GEN, V141, P715, DOI 10.1037/a0027950; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; Takano A, 2001, PSYCHIAT RES-NEUROIM, V107, P45, DOI 10.1016/S0925-4927(01)00093-2; Tamietto M, 2007, NEUROPSYCHOLOGIA, V45, P836, DOI 10.1016/j.neuropsychologia.2006.08.012; Tamietto M, 2006, EXP BRAIN RES, V171, P389, DOI 10.1007/s00221-005-0279-4; Taylor G.J., 1997, DISORDERS AFFECT REG; Tchanturia K, 2004, EUR EAT DISORD REV, V12, P361, DOI 10.1002/erv.608; Tiller JM, 1997, INT J EAT DISORDER, V21, P31; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vocks S, 2011, J PSYCHIATR RES, V45, P395, DOI 10.1016/j.jpsychires.2010.07.012; Vocks S, 2010, J PSYCHIATR NEUROSCI, V35, P163, DOI 10.1503/jpn.090048; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Walter H, 2009, SOC COGN AFFECT NEUR, V4, P166, DOI 10.1093/scan/nsn047; Young AW, 2002, FACIAL EXPRESSIONS E; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; Zonnevijlle-Bendek MJS, 2002, EUR CHILD ADOLES PSY, V11, P38, DOI 10.1007/s007870200006; Zucker NL, 2007, PSYCHOL BULL, V133, P976, DOI 10.1037/0033-2909.133.6.976	106	70	70	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44414	10.1371/journal.pone.0044414	http://dx.doi.org/10.1371/journal.pone.0044414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998EY	22952975	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300089
J	Lindstedt, F; Karshikoff, B; Schalling, M; Hoglund, CO; Ingvar, M; Lekander, M; Kosek, E				Lindstedt, Fredrik; Karshikoff, Bianka; Schalling, Martin; Hoglund, Caroline Olgart; Ingvar, Martin; Lekander, Mats; Kosek, Eva			Serotonin-1A Receptor Polymorphism (rs6295) Associated with Thermal Pain Perception	PLOS ONE			English	Article							NOCICEPTIVE FLEXION REFLEX; NOXIOUS CONDITIONING STIMULATION; SPINAL 5-HT1A RECEPTORS; DORSAL RAPHE NEURONS; HEAT PAIN; ANTIDEPRESSANT RESPONSE; SUBJECTIVE EXPERIENCE; POSTOPERATIVE PAIN; GENETIC-VARIATION; NFR THRESHOLD	Background: Serotonin (5-HT) is highly involved in pain regulation and serotonin-1A (5-HT1A) receptors are important in determining central 5-HT tone. Accordingly, variation in the 5-HT1A receptor gene (HTR1A) may contribute to inter-individual differences in human pain sensitivity. The minor G-allele of the HTR1A single nucleotide polymorphism (SNP) rs6295 attenuates firing of serotonergic neurons and reduces postsynaptic expression of the receptor. Experiments in rodents suggest that 5-HT1A-agonism modulates pain in opposite directions at mild compared to high noxious intensities. Based upon this and several other similar observations, we hypothesized that G-carriers would exhibit a relative hypoalgesia at mild thermal stimuli but tend towards hyperalgesia at higher noxious intensities. Methods: Fourty-nine healthy individuals were selectively genotyped for rs6295. Heat-and cold-pain thresholds were assessed along with VAS-ratings of a range of suprathreshold noxious heat intensities (45 degrees C-49 degrees C). Nociceptive-flexion reflex (NFR) thresholds were also assessed. Results: Volunteers did not deviate significantly from Hardy-Weinberg equilibrium. G-carriers were less sensitive to threshold-level thermal pain. This relative hypoalgesia was abolished at suprathreshold noxious intensities where G-carriers instead increased their ratings of heat-pain significantly more than C-homozygotes. No differences with regard to NFR-thresholds emerged. Conclusion/Significance: To the best of our knowledge this is the first study of human pain perception on the basis of variation in HTR1A. The results illustrate the importance of including a range of stimulus intensities in assessments of pain sensitivity. In speculation, we propose that an attenuated serotonergic tone may be related to a 'hypo- to hyperalgesic' response-pattern. The involved mechanisms could be of clinical interest as variation in pain regulation is known to influence the risk of developing pain pathologies. Further investigations are therefore warranted.	[Lindstedt, Fredrik; Karshikoff, Bianka; Hoglund, Caroline Olgart; Ingvar, Martin; Lekander, Mats; Kosek, Eva] Karolinska Inst, Osher Ctr Integrat Med, Stockholm, Sweden; [Lindstedt, Fredrik; Karshikoff, Bianka; Ingvar, Martin; Kosek, Eva] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Hoglund, Caroline Olgart] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Schalling, Martin] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden; [Schalling, Martin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University	Lindstedt, F (corresponding author), Karolinska Inst, Osher Ctr Integrat Med, Stockholm, Sweden.	fredrik.lindstedt@ki.se	Schalling, Martin/F-1518-2015; Karshikoff, Bianka/I-9602-2019	Schalling, Martin/0000-0001-5011-2922; Karshikoff, Bianka/0000-0003-1154-8103; Ingvar, Martin/0000-0002-9041-5714; Kosek, Eva/0000-0003-0488-8177	Karolinska Institute; Swedish Rheumatism Association and Stockholm County Council; Swedish Research Council [2011-4807]; Swedish Heart-Lung Foundation; Petrus and Augusta Hedlunds Stiftelse; Center for Allergy Research; Swedish Council for Working Life and Social Research; Swedish Society for Medicine; National board of Health and Welfare and Stockholm Stress Center	Karolinska Institute(Karolinska Institutet); Swedish Rheumatism Association and Stockholm County Council; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Petrus and Augusta Hedlunds Stiftelse; Center for Allergy Research; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Society for Medicine; National board of Health and Welfare and Stockholm Stress Center	This study was funded by The Karolinska Institute, Swedish Rheumatism Association and Stockholm County Council (EK); The Swedish Research Council (www.vr.se), grant nr 2011-4807 (MS); The Swedish Heart-Lung Foundation (COH); Petrus and Augusta Hedlunds Stiftelse, The Center for Allergy Research, Swedish Heart-Lung Foundation, Swedish Council for Working Life and Social Research, The Swedish Society for Medicine, The National board of Health and Welfare and Stockholm Stress Center (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguglia A, J AFFECTIVE IN PRESS; Albert PR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00035; Albert PR, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-21; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Bar KJ, 2011, J CLIN PSYCHOPHARM, V31, P103, DOI 10.1097/JCP.0b013e3182046797; Bardin L, 2004, EUR J PAIN, V8, P253, DOI 10.1016/j.ejpain.2003.09.002; Bardin L, 2011, BEHAV PHARMACOL, V22, P390, DOI 10.1097/FBP.0b013e328349aae4; Benarroch EE, 2008, NEUROLOGY, V71, P217, DOI 10.1212/01.wnl.0000318225.51122.63; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Bonnefont J, 2005, PAIN, V114, P482, DOI 10.1016/j.pain.2005.01.019; Bouali S, 2003, EUR J NEUROSCI, V18, P2203, DOI 10.1046/j.1460-9568.2003.02960.x; Buono MJ, 2007, PHYSIOL MEAS, V28, P855, DOI 10.1088/0967-3334/28/8/008; Buritova J, 2005, EUR J PHARMACOL, V514, P121, DOI 10.1016/j.ejphar.2005.03.016; Buritova J, 2003, BRAIN RES, V974, P212, DOI 10.1016/S0006-8993(03)02582-4; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Clauw Daniel J, 2009, Am J Med, V122, pS3, DOI 10.1016/j.amjmed.2009.09.006; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Coghill RC, 2010, HEADACHE, V50, P1531, DOI 10.1111/j.1526-4610.2010.01763.x; Corruble E, 2000, PSYCHOPATHOLOGY, V33, P307, DOI 10.1159/000029163; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; Czesak M, 2006, J NEUROSCI, V26, P1864, DOI 10.1523/JNEUROSCI.2643-05.2006; Czesak M, 2012, J BIOL CHEM, V287, P6615, DOI 10.1074/jbc.M111.293027; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; de Almeida J, 2008, J NEUROCHEM, V107, P488, DOI 10.1111/j.1471-4159.2008.05649.x; Dickens C, 2003, PSYCHOSOM MED, V65, P369, DOI 10.1097/01.PSY.0000041622.69462.06; FASMER OB, 1986, PHARMACOL BIOCHEM BE, V25, P883, DOI 10.1016/0091-3057(86)90402-8; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Foulkes T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000086; France CR, 2009, PAIN, V145, P211, DOI 10.1016/j.pain.2009.06.022; Granot M, 2011, CLIN J PAIN; Granot M, 2009, CURR OPIN ANESTHESIO, V22, P425, DOI 10.1097/ACO.0b013e32832a40e1; HOYER D, 1986, BRAIN RES, V376, P85, DOI 10.1016/0006-8993(86)90902-9; Huang YY, 2004, INT J NEUROPSYCHOPH, V7, P441, DOI 10.1017/S1461145704004663; Huo FQ, 2008, PAIN, V139, P398, DOI 10.1016/j.pain.2008.05.013; Huo FQ, 2010, NEUROCHEM INT, V57, P749, DOI 10.1016/j.neuint.2010.08.011; Jovanovic H, 2011, NEUROIMAGE, V55, P1178, DOI 10.1016/j.neuroimage.2010.12.060; Kato M, 2009, AM J MED GENET B, V150B, P115, DOI 10.1002/ajmg.b.30783; Kosek E, 2000, PAIN, V88, P69, DOI 10.1016/S0304-3959(00)00310-9; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; Kosek E, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-37; Kraus A, 2009, PAIN, V143, P179, DOI 10.1016/j.pain.2008.12.018; LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222; Lautenbacher J S, 1998, PSYCHOSOM MED, V61, P822; LAUTENBACHER S, 1992, PERCEPT PSYCHOPHYS, V52, P685, DOI 10.3758/BF03211705; Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Lemonde S, 2004, INT J NEUROPSYCHOPH, V7, P501, DOI 10.1017/S1461145704004699; Lemonde S, 2003, J NEUROSCI, V23, P8788; Leo Raphael J, 2005, Curr Treat Options Neurol, V7, P403, DOI 10.1007/s11940-005-0032-0; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LINDBLOM B, 1988, GENE ANAL TECH, V5, P97, DOI 10.1016/0735-0651(88)90003-9; Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018252; Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017752; Loucif AJC, 2006, J NEUROBIOL, V66, P1475, DOI 10.1002/neu.20321; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Malaguti A, 2011, DEPRESS ANXIETY, V28, P568, DOI 10.1002/da.20815; Markkula R, 2009, EUR J PAIN, V13, P744, DOI 10.1016/j.ejpain.2008.09.007; Martikainen IK, 2007, BRAIN RES, V1172, P21, DOI 10.1016/j.brainres.2007.07.036; Matsukawa T, 2000, CRIT CARE MED, V28, P532, DOI 10.1097/00003246-200002000-00041; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Millan MJ, 1995, SEMIN NEUROSCI, V7, P409, DOI 10.1016/1044-5765(95)90005-5; Neziri AY, 2010, EUROPEAN J IN PRESS; Ohayon MM, 2009, J PSYCHIATR RES, V43, P1243, DOI 10.1016/j.jpsychires.2009.10.007; Ohno Yukihiro, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P148; Orii R, 2003, ANESTHESIOLOGY, V98, P1223, DOI 10.1097/00000542-200305000-00026; Perrin FE, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.98; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Rhudy JL, 2007, PAIN, V128, P244, DOI 10.1016/j.pain.2006.09.024; Riley JL, 1999, PAIN, V81, P225, DOI 10.1016/S0304-3959(98)00258-9; Ruoff GE, 1996, J FAM PRACTICE, V43, pS25; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419; Skljarevski V, 2002, PAIN, V96, P3, DOI 10.1016/S0304-3959(02)00018-0; Sodhi MSK, 2004, INT REV NEUROBIOL, V59, P111; Sommer Claudia, 2006, Curr Pain Headache Rep, V10, P101, DOI 10.1007/s11916-006-0020-4; SPROUSE JS, 1987, SYNAPSE, V1, P3, DOI 10.1002/syn.890010103; Valencia C, 2011, J PAIN, V12, P133, DOI 10.1016/j.jpain.2010.06.002; Wang YY, 2009, J CHEM NEUROANAT, V38, P75, DOI 10.1016/j.jchemneu.2009.04.003; Wasserman Danuta, 2006, Behav Brain Funct, V2, P14, DOI 10.1186/1744-9081-2-14; Wu S, 1999, PSYCHIATR GENET, V9, P105, DOI 10.1097/00041444-199906000-00010; Wust S, 2009, PSYCHONEUROENDOCRINO, V34, P972, DOI 10.1016/j.psyneuen.2009.01.011; YARNITSKY D, 1995, PAIN, V60, P329, DOI 10.1016/0304-3959(94)00132-X; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004; Young EE, 2011, J MED GENETICS; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	91	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43221	10.1371/journal.pone.0043221	http://dx.doi.org/10.1371/journal.pone.0043221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952650	gold, Green Published			2022-12-27	WOS:000308221300010
J	Bosco, A; Crish, SD; Steele, MR; Romero, CO; Inman, DM; Horner, PJ; Calkins, DJ; Vetter, ML				Bosco, Alejandra; Crish, Samuel D.; Steele, Michael R.; Romero, Cesar O.; Inman, Denise M.; Horner, Philip J.; Calkins, David J.; Vetter, Monica L.			Early Reduction of Microglia Activation by Irradiation in a Model of Chronic Glaucoma	PLOS ONE			English	Article							OPTIC-NERVE HEAD; ELEVATED INTRAOCULAR-PRESSURE; RETINAL GANGLION-CELLS; DBA/2 MOUSE MODEL; MICROARRAY ANALYSIS; GENE-EXPRESSION; CRANIAL IRRADIATION; INHERITED GLAUCOMA; GLIAL RESPONSES; MYELOID CELLS	Glaucoma is a neurodegenerative disease that results in the progressive decline and ultimate death of retinal ganglion cells (RGCs). While multiple risk factors are associated with glaucoma, the mechanisms leading to onset and progression of the disease remain unknown. Molecular analysis in various glaucoma models has revealed involvement of non-neuronal cell populations, including astrocytes, Mueller glia and microglia, at early stages of glaucoma. High-dose irradiation was reported to have a significant long-term protective effect in the DBA/2J (D2) mouse model of glaucoma, although the cellular and molecular basis for this effect remains unclear. In particular, the acute effects of irradiation on specific cell populations, including non-neuronal cells, in the D2 retina and nerve have not been assessed. Here we report that irradiation induces transient reduction in proliferating microglia within the optic nerve head and glial lamina within the first week post-irradiation. This was accompanied by reduced microglial activation, with no effect on astrocyte gliosis in those regions. At later stages we confirm that early high-dose irradiation of the mouse head results in improvement of axonal structural integrity and anterograde transport function, without reduction of intraocular pressure. Thus reduced microglial activation induced by irradiation at early stages is associated with reduced optic nerve and retinal neurodegeneration in the D2 mouse model of glaucoma.	[Bosco, Alejandra; Steele, Michael R.; Romero, Cesar O.; Vetter, Monica L.] Univ Utah, Dept Neurobiol, Salt Lake City, UT 84112 USA; [Crish, Samuel D.; Calkins, David J.] Vanderbilt Univ, Dept Ophthalmol & Visual Sci, Nashville, TN USA; [Inman, Denise M.; Horner, Philip J.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA	Utah System of Higher Education; University of Utah; Vanderbilt University; University of Washington; University of Washington Seattle	Bosco, A (corresponding author), Univ Utah, Dept Neurobiol, Salt Lake City, UT 84112 USA.	monica@neuro.utah.edu	Horner, Philip J./AAF-7012-2021; Inman, Denise/AAA-8074-2019	Inman, Denise/0000-0002-8522-4112; Calkins, David/0000-0002-8475-9959; BOSCO, ALEJANDRA/0000-0003-3743-5414; Vetter, Monica/0000-0001-6262-8504	Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation; NIH [R01EY02878]; NATIONAL EYE INSTITUTE [P30EY014800, P30EY008126, R01EY020878] Funding Source: NIH RePORTER	Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funded by a generous grant from the Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation (www.glaucoma.org/) (Catalyst for a Cure to MLV, PJH and DJC) and NIH grant # R01EY02878 to MLV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; Ben Abdallah NMB, 2007, HIPPOCAMPUS, V17, P1230, DOI 10.1002/hipo.20358; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Crish SD, 2011, NEUROSCIENCE, V176, P1, DOI 10.1016/j.neuroscience.2010.12.036; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Fan W, 2010, OPHTHALMOL EYE DIS, V2, P23; Fike JR, 2011, REV NEUROL-FRANCE, V167, P746, DOI 10.1016/j.neurol.2011.07.005; Giuliari GP, 2011, ACTA ONCOL, V50, P6, DOI 10.3109/0284186X.2010.500299; Gupta Abha, 2007, BMC Ophthalmol, V7, P6, DOI 10.1186/1471-2415-7-6; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Horgan N, 2010, CURR OPIN OPHTHALMOL, V21, P233, DOI 10.1097/ICU.0b013e3283386687; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-45; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Howell GR, 2012, J CLIN INVESTIGATION; Hwang SY, 2006, NEUROBIOL DIS, V21, P457, DOI 10.1016/j.nbd.2005.08.006; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kalm M, 2009, J NEUROIMMUNOL, V206, P70, DOI 10.1016/j.jneuroim.2008.11.002; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Lam TT, 2003, INVEST OPHTH VIS SCI, V44, P638, DOI 10.1167/iovs.02-0255; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Miyahara T, 2003, INVEST OPHTH VIS SCI, V44, P4347, DOI 10.1167/iovs.02-1032; Muther PS, 2010, INVEST OPHTH VIS SCI, V51, P4831, DOI 10.1167/iovs.09-4923; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Reichstein D, 2007, EXP EYE RES, V84, P13, DOI 10.1016/j.exer.2006.08.009; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Sarkissian V, 2005, NEUROSCI LETT, V382, P118, DOI 10.1016/j.neulet.2005.02.068; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Sommer A, 1996, Curr Opin Ophthalmol, V7, P93, DOI 10.1097/00055735-199604000-00016; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Whitmore AV, 2005, PROG RETIN EYE RES, V24, P639, DOI 10.1016/j.preteyeres.2005.04.004; Wu KL, 2010, J NEUROPATH EXP NEUR, V69, P272, DOI 10.1097/NEN.0b013e3181d1afe4; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	57	97	98	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43602	10.1371/journal.pone.0043602	http://dx.doi.org/10.1371/journal.pone.0043602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952717	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206500015
J	Chang, CY; Koh, CL; Sam, CK; Chan, XY; Yin, WF; Chan, KG				Chang, Chien-Yi; Koh, Chong-Lek; Sam, Choon-Kook; Chan, Xin-Yue; Yin, Wai Fong; Chan, Kok Gan			Unusual Long-Chain N-Acyl Homoserine Lactone Production by and Presence of Quorum Quenching Activity in Bacterial Isolates from Diseased Tilapia Fish	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SENSING SIGNALS; VIRULENCE; COMMUNICATION; MOLECULES	Growth-dependent cell-cell communication termed quorum sensing is a key regulatory system in bacteria for controlling gene expression including virulence factors. In this study five potential bacterial pathogens including Bacillus sp. W2.2, Klebsiella sp. W4.2, Pseudomonas sp. W3 and W3.1 and Serratia sp. W2.3 were isolated from diseased Tilapia fish in Malaysia, supplied by the leading global fish supplier. Proteolytic activity assays confirmed that with the exception of Klebsiella sp. W4.2, all isolates showed distinct proteolytic activity. Furthermore Bacillus sp. W2.2 and Pseudomonas sp. strains W3 and W3.1 also displayed haemolytic activity. By using high resolution liquid chromatography mass spectrometry, we revealed the presence of unusually long-chain N-(3-oxohexadecanoyl)-homoserine lactone (3-oxo-C16-HSL) from Pseudomonas sp. W3.1 and N-dodecanoyl-homoserine lactone (C12-HSL) from Serratia sp. W2.3, respectively. Interestingly, Pseudomonas sp. W3.1 also produced a wide range of Pseudomonas quinolone signalling (PQS) molecules. Pseudomonas sp. W3 did not show any quorum sensing properties but possessed quorum quenching activity that inactivated AHLs. This study is the first documentation that shows unusual long-chain AHLs production in Serratia sp. and Pseudomonas sp. isolated from diseased fish and the latter also produce a wide range of PQS molecules.	[Chang, Chien-Yi] Univ Nottingham, Ctr Biomol Sci, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Koh, Chong-Lek; Sam, Choon-Kook] Nanyang Technol Univ, Nat Sci & Sci Educ AG, Natl Inst Educ, Singapore, Singapore; [Chan, Xin-Yue; Yin, Wai Fong; Chan, Kok Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur 50603, Malaysia	University of Nottingham; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; Universiti Malaya	Chang, CY (corresponding author), Univ Nottingham, Ctr Biomol Sci, Sch Mol Med Sci, Nottingham NG7 2RD, England.	kokgan@um.edu.my	Chan, Xin Yue/K-9094-2013; Chan, Kok Gan/B-8347-2010; Yin, Wai-Fong/H-3376-2016; Chang, Chien-Yi/E-1338-2012; Chang, Chien-Yi/ABH-6848-2020; Koh, Chong Lek/H-3968-2016	Chan, Xin Yue/0000-0002-3841-3017; Chan, Kok Gan/0000-0002-1883-1115; Yin, Wai-Fong/0000-0003-2177-6169; Chang, Chien-Yi/0000-0003-3570-4019; Chang, Chien-Yi/0000-0003-3570-4019; Koh, Chong Lek/0000-0002-4468-0082	University of Malaya HIR Grant [A000001-50001]	University of Malaya HIR Grant	This work was supported by the University of Malaya HIR Grant (A000001-50001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203; Chan KG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-51; Chan KG, 2010, ANTON LEEUW INT J G, V98, P299, DOI 10.1007/s10482-010-9438-0; Chan KG, 2009, INT J MOL SCI, V10, P345, DOI 10.3390/ijms10010345; Chong TM, 2012, SENSORS-BASEL, V12, P4846, DOI 10.3390/s120404846; Chowdhary PK, 2007, BIOCHEMISTRY-US, V46, P14429, DOI 10.1021/bi701945j; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dong YH, 2005, J MICROBIOL, V43, P101; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Gao MS, 2005, J BACTERIOL, V187, P7931, DOI 10.1128/JB.187.23.7931-7944.2005; Hong KW, 2012, SENSORS-BASEL, V12, P4661, DOI 10.3390/s120404661; JONES S, 1993, EMBO J, V12, P2477, DOI 10.1002/j.1460-2075.1993.tb05902.x; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Pretto-Giordano LG, 2010, AQUAC RES, V41, P1539, DOI 10.1111/j.1365-2109.2009.02449.x; Savka MA, 2011, CURR MICROBIOL, V62, P101, DOI 10.1007/s00284-010-9679-1; Schaefer AL, 2002, J BACTERIOL, V184, P6515, DOI 10.1128/JB.184.23.6515-6521.2002; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; Tamura K, 2011, MOL BIOL EVOLUTION; Teplitski M, 2003, ARCH MICROBIOL, V180, P494, DOI 10.1007/s00203-003-0612-x; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; Wang H, 2006, J MED MICROBIOL, V55, P1751, DOI 10.1099/jmm.0.46756-0; Wei JR, 2006, J BACTERIOL, V188, P1518, DOI 10.1128/JB.188.4.1518-1525.2006; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Wong CS, 2012, WORLD J MICROB BIOT, V28, P453, DOI 10.1007/s11274-011-0836-x; Yin WF, 2012, SENSORS-BASEL, V12, P4065, DOI 10.3390/s120404065; Yin WF, 2012, SENSORS-BASEL, V12, P3472, DOI 10.3390/s120303472; Zhu H, 2004, INVEST OPHTH VIS SCI, V45, P1897, DOI 10.1167/iovs.03-0980; Zhu H, 2002, J MED MICROBIOL, V51, P1063, DOI 10.1099/0022-1317-51-12-1063	33	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44034	10.1371/journal.pone.0044034	http://dx.doi.org/10.1371/journal.pone.0044034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952864	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000071
J	Ji, YN; Wang, Q; Suo, LJ				Ji, Ya-Nan; Wang, Qin; Suo, Li-Jun			CYP1A1 Ile462Val Polymorphism Contributes to Lung Cancer Susceptibility among Lung Squamous Carcinoma and Smokers: A Meta-Analysis	PLOS ONE			English	Article							S-TRANSFERASE GENES; RISK-FACTORS; GSTM1 POLYMORPHISMS; SMOKING; TOBACCO; POPULATION; ASSOCIATION; GENOTYPES; CYP2E1; ONSET	Many studies have examined the association between the CYP1A1 Ile462Val gene polymorphisms and lung cancer risk in various populations, but their results have been inconsistent. To assess this relationship more precisely, a meta-analysis was performed. Ultimately, 43 case-control studies, comprising 19,228 subjects were included. A significantly elevated lung cancer risk was associated with 2 Ile462Val genotype variants (for Val/Val vs Ile/Ile: OR = 1.22, 95% CI = 1.08-1.40; for (Ile/Val + Val/Val) vs Ile/Ile: OR = 1.15, 95% CI = 1.07-1.23) in overall population. In the stratified analysis, a significant association was found in Asians, Caucasians and lung SCC, not lung AC and lung SCLC. Additionally, a significant association was found in smoker population and not found in non-smoker populations. This meta-analysis suggests that the Ile462Val polymorphisms of CYP1A1 correlate with increased lung cancer susceptibility in Asian and Caucasian populations and there is an interaction with smoking status, but these associations vary in different histological types of lung caner.	[Ji, Ya-Nan] Jiangsu Prov Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Wang, Qin] 81 Hosp PLA, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Suo, Li-Jun] Binzhou Med Univ, Dept Resp Med, Affiliated Linzi Dist Peoples Hosp, Zibo, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Binzhou Medical University	Ji, YN (corresponding author), Jiangsu Prov Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China.	jiyanan1128@163.com						Alberg AJ, 2005, J CLIN ONCOL, V23, P3175, DOI 10.1200/JCO.2005.10.462; Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; ALEXANDRIE AK, 1994, CARCINOGENESIS, V15, P1785, DOI 10.1093/carcin/15.9.1785; [白图雅 BAI Tuya], 2011, [中国公共卫生, China Public Health], V27, P723; BUTLER JP, 1993, J AIR WASTE MANAGE, V43, P970, DOI 10.1080/1073161X.1993.10467179; CANTLAY AM, 1995, J CLIN PATHOL-CL MOL, V48, pM210; Chen Senqing, 2001, Mutation Research, V458, P41, DOI 10.1016/S1383-5726(01)00011-5; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cote ML, 2007, LUNG CANCER, V55, P255, DOI 10.1016/j.lungcan.2006.11.002; Cote ML, 2009, CARCINOGENESIS, V30, P626, DOI 10.1093/carcin/bgp033; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong C. T., 2004, J ENV OCCUP MED, V21, P440; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gallegos-Arreola MP, 2008, INT J BIOL MARKER, V23, P24, DOI 10.1177/172460080802300104; Guengerich FP, 1998, MUTAT RES-FUND MOL M, V400, P201; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hong YS, 1998, EXP MOL MED, V30, P192, DOI 10.1038/emm.1998.28; Houlston RS, 2000, PHARMACOGENETICS, V10, P105, DOI 10.1097/00008571-200003000-00002; Hu Y, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P26; Ishibe N, 1997, CANCER EPIDEM BIOMAR, V6, P1075; Kawajiri K, 1996, CANCER RES, V56, P72; KAWAJIRI K, 1990, FEBS LETT, V263, P131, DOI 10.1016/0014-5793(90)80721-T; KIHARA M, 1995, CARCINOGENESIS, V16, P2331, DOI 10.1093/carcin/16.10.2331; Klinchid J, 2009, CANCER GENET CYTOGEN, V195, P143, DOI 10.1016/j.cancergencyto.2009.08.011; Kumar M, 2009, MOL CELL BIOCHEM, V322, P73, DOI 10.1007/s11010-008-9941-z; Larsen JE, 2005, CANCER CAUSE CONTROL, V16, P579, DOI 10.1007/s10552-004-7842-3; Le Marchand L, 1998, CANCER RES, V58, P4858; Le Marchand LC, 2003, CANCER CAUSE CONTROL, V14, P339; Li DR, 2006, CHIN J CANC PREV TRE, V13, P1765; London SJ, 2000, CANCER EPIDEM BIOMAR, V9, P987; MANTEL N, 1959, J NATL CANCER I, V22, P719; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Mota P, 2010, REV PORT PNEUMOL, V16, P89; NAKACHI K, 1993, CANCER RES, V53, P2994; Ng DPK, 2005, CANCER CAUSE CONTROL, V16, P399, DOI 10.1007/s10552-004-5476-0; Pisani P, 2006, CANCER EPIDEM BIOMAR, V15, P667, DOI 10.1158/1055-9965.EPI-05-0667; Quinones L, 2001, CANCER LETT, V174, P35, DOI 10.1016/S0304-3835(01)00686-3; Raimondi S, 2005, MUTAT RES-FUND MOL M, V592, P45, DOI 10.1016/j.mrfmmm.2005.06.002; Ratnasinghe D, 2001, ANTICANCER RES, V21, P1295; Rodriguez V, 2000, AM J IND MED, V38, P644, DOI 10.1002/1097-0274(200012)38:6<644::AID-AJIM5>3.0.CO;2-M; SATO S, 1994, CANCER RES, V54, P5652; Shah PP, 2008, MUTAT RES-FUND MOL M, V639, P1, DOI 10.1016/j.mrfmmm.2007.10.006; Shi XQ, 2008, LUNG CANCER, V59, P155, DOI 10.1016/j.lungcan.2007.08.004; Sobti RC, 2004, MOL CELL BIOCHEM, V266, P1, DOI 10.1023/B:MCBI.0000049127.33458.87; Song N, 2001, CARCINOGENESIS, V22, P11, DOI 10.1093/carcin/22.1.11; Sugimura H, 1998, CANCER EPIDEM BIOMAR, V7, P413; Taioli E, 2003, INT J EPIDEMIOL, V32, P60, DOI 10.1093/ije/dyg001; Taioli E, 1998, CARCINOGENESIS, V19, P813, DOI 10.1093/carcin/19.5.813; Tardon A, 2005, CANCER CAUSE CONTROL, V16, P389, DOI 10.1007/s10552-004-5026-9; Timofeeva MN, 2009, CARCINOGENESIS, V30, P1161, DOI 10.1093/carcin/bgp102; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Wang ZZ, 2011, PROGR ANATOMICAL SCI, V17, P361; Wenzlaff AS, 2005, CARCINOGENESIS, V26, P2207, DOI 10.1093/carcin/bgi191; Wrensch MR, 2005, INT J CANCER, V113, P141, DOI 10.1002/ijc.20537; Wright CM, 2010, EUR RESPIR J, V35, P152, DOI 10.1183/09031936.00120808; WYNDER EL, 1994, CANCER RES, V54, P5284; Xue K, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P125; Xue KX, 1999, CARCINOGENESIS TERAT, V11, P228; Yang M, 2007, LUNG CANCER, V57, P135, DOI 10.1016/j.lungcan.2007.03.005; Yang XHR, 2004, CANCER LETT, V214, P197, DOI 10.1016/j.canlet.2004.06.040; Yoon KA, 2008, LUNG CANCER, V60, P40, DOI 10.1016/j.lungcan.2007.09.009; Zhou X, 2002, OCCUP MED, V19, P355	62	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43397	10.1371/journal.pone.0043397	http://dx.doi.org/10.1371/journal.pone.0043397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952673	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600022
J	Ogawa, H; Hatano, S; Sugiura, N; Nagai, N; Sato, T; Shimizu, K; Kimata, K; Narimatsu, H; Watanabe, H				Ogawa, Hiroyasu; Hatano, Sonoko; Sugiura, Nobuo; Nagai, Naoko; Sato, Takashi; Shimizu, Katsuji; Kimata, Koji; Narimatsu, Hisashi; Watanabe, Hideto			Chondroitin Sulfate Synthase-2 Is Necessary for Chain Extension of Chondroitin Sulfate but Not Critical for Skeletal Development	PLOS ONE			English	Article							MOLECULAR-CLONING; HEPARAN-SULFATE; CAENORHABDITIS-ELEGANS; POLYMERIZING FACTOR; GROWTH-FACTOR; PROTEOGLYCANS; GLUCURONOSYLTRANSFERASE; MORPHOGENESIS; PLEIOTROPHIN; BINDING	Chondroitin sulfate (CS) is a linear polysaccharide consisting of repeating disaccharide units of N-acetyl-D-galactosamine and D-glucuronic acid residues, modified with sulfated residues at various positions. Based on its structural diversity in chain length and sulfation patterns, CS provides specific biological functions in cell adhesion, morphogenesis, neural network formation, and cell division. To date, six glycosyltransferases are known to be involved in the biosynthesis of chondroitin saccharide chains, and a hetero-oligomer complex of chondroitin sulfate synthase-1 (CSS1)/chondroitin synthase-1 and chondroitin sulfate synthase-2 (CSS2)/chondroitin polymerizing factor is known to have the strongest polymerizing activity. Here, we generated and analyzed CSS2(-/-) mice. Although they were viable and fertile, exhibiting no overt morphological abnormalities or osteoarthritis, their cartilage contained CS chains with a shorter length and at a similar number to wild type. Further analysis using CSS2(-/-) chondrocyte culture systems, together with siRNA of CSS1, revealed the presence of two CS chain species in length, suggesting two steps of CS chain polymerization; i.e., elongation from the linkage region up to Mr similar to 10,000, and further extension. There, CSS2 mainly participated in the extension, whereas CSS1 participated in both the extension and the initiation. Our study demonstrates the distinct function of CSS1 and CSS2, providing a clue in the elucidation of the mechanism of CS biosynthesis.	[Ogawa, Hiroyasu; Hatano, Sonoko; Sugiura, Nobuo; Nagai, Naoko; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan; [Sato, Takashi; Narimatsu, Hisashi] Adv Ind Sci & Technol, Res Ctr Med Glycosci, Nagakute, Aichi, Japan; [Ogawa, Hiroyasu; Shimizu, Katsuji] Gifu Univ, Dept Orthopaed Surg, Grad Sch Med, Gifu, Japan	Aichi Medical University; National Institute of Advanced Industrial Science & Technology (AIST); Gifu University	Ogawa, H (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan.	wannabee@aichi-med-u.ac.jp	Narimatsu, Hisashi/M-4757-2018; Sato, Takashi/M-2577-2018	Narimatsu, Hisashi/0000-0002-8402-133X; Sato, Takashi/0000-0002-9973-8923; Watanabe, Hideto/0000-0001-5291-0696; Ogawa, Hiroyasu/0000-0002-4737-6481	MEXT [S1101027]; Grants-in-Aid for Scientific Research [23570176] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (B) (KAKENHI) to H. W., Grants-in-aid for priority areas to H. W., and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015(S1101027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Hogan B, 1994, MANIPULATING MOUSE E; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; Li Y, 2010, AM J HUM GENET, V87, P757, DOI 10.1016/j.ajhg.2010.10.003; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Ogawa H, 2010, J BIOL CHEM, V285, P34155, DOI 10.1074/jbc.M110.109553; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Prydz K, 2000, J CELL SCI, V113, P193; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Sato T, 2011, J BIOL CHEM, V286, P5803, DOI 10.1074/jbc.M110.159244; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Watanabe H, 1998, J BIOCHEM, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166; Watanabe Y, 2010, BIOCHEM J, V432, P47, DOI 10.1042/BJ20100847; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200	40	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43806	10.1371/journal.pone.0043806	http://dx.doi.org/10.1371/journal.pone.0043806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952769	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600044
J	Lee, JY; Lee, HK; Lee, DC; Lee, JW				Lee, Jee-Yon; Lee, Hyang-Kyu; Lee, Duk-Chul; Lee, Ji-Won			Serum Carcinoembryonic Antigen Is Associated with Abdominal Visceral Fat Accumulation in Female Korean Nonsmokers	PLOS ONE			English	Article							ADIPOSE-TISSUE; OBESITY; CARCINOMAS; EXPRESSION; CANCER; WOMEN	Background: Carcinoembryonic antigen (CEA) is a tumor marker overexpressed in adenocarcinoma that has proinflammatory properties. Recent studies have reported that CEA is positively associated with carotid atherosclerosis and metabolic syndrome. Because visceral obesity is a known risk factor for cardiometabolic diseases, CEA may also be associated with visceral adiposity. Therefore, we investigated the relationship between serum CEA concentration and visceral obesity in female Korean nonsmokers. Methods: A total of 270 Korean female nonsmokers were enrolled during their routine health check-ups. Biomarkers of metabolic risk factors were assessed along with body composition by computed tomography. Serum CEA levels were measured by using a chemiluminescence immunoassay analyzer. Results: Serum CEA levels correlated with visceral fat area, fasting glucose, and triglyceride levels after adjusting for age and BMI. The mean visceral fat area increased significantly with the increasing CEA tirtiles. In a step-wise multiple regression analysis, age (beta = 0.26, p<0.01) and visceral fat area (beta = 0.19, p = 0.03) were identified as explanatory variables for serum CEA level. Conclusions: This study suggested that CEA may be a mediator that links metabolic disturbance and tumorigenesis in visceral obesity. Further studies are required to better understand the clinical and pathophysiological significance of our findings.	[Lee, Jee-Yon; Lee, Duk-Chul; Lee, Ji-Won] Yonsei Univ, Severance Hosp, Dept Family Med, Coll Med, Seoul 120749, South Korea; [Lee, Hyang-Kyu] Yonsei Univ, Dept Clin Nursing Sci, Coll Nursing, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, JY (corresponding author), Yonsei Univ, Severance Hosp, Dept Family Med, Coll Med, Seoul 120749, South Korea.	indi5645@yuhs.ac		Lee, Duk Chul/0000-0001-9166-1813; LEE, JI WON/0000-0002-2666-4249	Yonsei University College of Medicine [6-2011-0137]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from Yonsei University College of Medicine for 2011 (6-2011-0137). The authors did not receive any additional financial support from private companies or individuals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; CHAKRABARTY S, 1988, CANCER RES, V48, P4059; DESPRES JP, 1993, NUTRITION, V9, P452; FEINLEIB M, 1985, ANN INTERN MED, V103, P1019, DOI 10.7326/0003-4819-103-6-1019; FLETCHER RH, 1986, ANN INTERN MED, V104, P66, DOI 10.7326/0003-4819-104-1-66; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; GREINER JW, 1991, CANCER RES, V51, P4155; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Ishizaka N, 2008, ARTERIOSCL THROM VAS, V28, P160, DOI 10.1161/ATVBAHA.107.155465; JESSUP JM, 1988, CANCER RES, V48, P1689; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; Lee JW, 2007, CLIN ENDOCRINOL, V66, P572, DOI 10.1111/j.1365-2265.2007.02780.x; Lee JW, 2011, CLIN CHIM ACTA, V412, P527, DOI 10.1016/j.cca.2010.11.033; Lysaght J, 2011, CANC LETT; MANN GV, 1974, NEW ENGL J MED, V291, P178, DOI 10.1056/NEJM197407252910405; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pazaitou-Panayiotou K, 2006, ADIPONECTIN LINK OBE; Percik R, 2009, EXP CLIN ENDOCR DIAB, V117, P563, DOI 10.1055/s-0029-1241870; Ruibal Morell A., 1992, International Journal of Biological Markers, V7, P160; STEVENS DP, 1973, LANCET, V2, P1238; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang D, 2012, J BIOSCIENCES, V37, P91, DOI 10.1007/s12038-011-9172-4; WITHERSPOON LR, 1983, J NUCL MED, V24, P916	26	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43518	10.1371/journal.pone.0043518	http://dx.doi.org/10.1371/journal.pone.0043518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952699	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800035
J	Wall, DP; Dally, R; Luyster, R; Jung, JY; DeLuca, TF				Wall, Dennis P.; Dally, Rebecca; Luyster, Rhiannon; Jung, Jae-Yoon; DeLuca, Todd F.			Use of Artificial Intelligence to Shorten the Behavioral Diagnosis of Autism	PLOS ONE			English	Article							SPECTRUM DISORDERS; INTERVIEW; BIOINFORMATICS; RELIABILITY; RESOURCE	The Autism Diagnostic Interview-Revised (ADI-R) is one of the most commonly used instruments for assisting in the behavioral diagnosis of autism. The exam consists of 93 questions that must be answered by a care provider within a focused session that often spans 2.5 hours. We used machine learning techniques to study the complete sets of answers to the ADI-R available at the Autism Genetic Research Exchange (AGRE) for 891 individuals diagnosed with autism and 75 individuals who did not meet the criteria for an autism diagnosis. Our analysis showed that 7 of the 93 items contained in the ADI-R were sufficient to classify autism with 99.9% statistical accuracy. We further tested the accuracy of this 7-question classifier against complete sets of answers from two independent sources, a collection of 1654 individuals with autism from the Simons Foundation and a collection of 322 individuals with autism from the Boston Autism Consortium. In both cases, our classifier performed with nearly 100% statistical accuracy, properly categorizing all but one of the individuals from these two resources who previously had been diagnosed with autism through the standard ADI-R. Our ability to measure specificity was limited by the small numbers of non-spectrum cases in the research data used, however, both real and simulated data demonstrated a range in specificity from 99% to 93.8%. With incidence rates rising, the capacity to diagnose autism quickly and effectively requires careful design of behavioral assessment methods. Ours is an initial attempt to retrospectively analyze large data repositories to derive an accurate, but significantly abbreviated approach that may be used for rapid detection and clinical prioritization of individuals likely to have an autism spectrum disorder. Such a tool could assist in streamlining the clinical diagnostic process overall, leading to faster screening and earlier treatment of individuals with autism.	[Wall, Dennis P.; Dally, Rebecca; Jung, Jae-Yoon; DeLuca, Todd F.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Wall, Dennis P.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Luyster, Rhiannon] Boston Childrens Hosp, Labs Cognit Neurosci, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital	Wall, DP (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	dpwall@hms.harvard.edu			National Institutes of Health [1R01MH090611-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by the National Institutes of Health under Grant No. 1R01MH090611-01A1 awarded to DPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge FJ, 2012, J AUTISM DEV DISORD, V42, P294, DOI 10.1007/s10803-011-1242-9; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bernier R, 2010, CHILD ADOL PSYCH CL, V19, P855, DOI 10.1016/j.chc.2010.07.005; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Breiman L., 1984, CLASSIFICATION REGRE; Cicchetti DV, 2008, J AUTISM DEV DISORD, V38, P764, DOI 10.1007/s10803-007-0448-3; Cohen WW, 1995, 12 INT C MACH LEARN, P115, DOI DOI 10.1016/B978-1-55860-377-6.50023-2; Eaves LC, 2006, J DEV BEHAV PEDIATR, V27, pS95, DOI 10.1097/00004703-200604002-00007; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Frank E., 2001, P 12 EUR C MACH LEAR, P145, DOI DOI 10.1007/3-540-44795-4_13; Frank E, 1998, GENERATING ACCURATE; Freund Y., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P148; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Gaines B. R., 1995, Journal of Intelligent Information Systems: Integrating Artificial Intelligence and Database Technologies, V5, P211, DOI 10.1007/BF00962234; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gura GF, 2011, J DEV BEHAV PEDIATR, V32, P48, DOI 10.1097/DBP.0b013e3182040aea; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hill A, 2001, PSYCHOPATHOLOGY, V34, P187, DOI 10.1159/000049305; Holmes G PB, 2001, P 13 EUR C MACH LEAR, P161; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Howlin P., 1998, CHILDREN AUTISM ASPE; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 2012, ARCH GEN PSYCHIAT, V69, P306, DOI 10.1001/archgenpsychiatry.2011.148; Martin B., 1995, INSTANCE BASED LEARN; Pinto-Martin JA, 2008, J DEV BEHAV PEDIATR, V29, P345, DOI 10.1097/DBP.0b013e31818914cf; Pisula E, 2003, ARCH PSYCHIAT PSYCHO, V4, P51; Poustka F, 1996, PSYCHOPATHOLOGY, V29, P145, DOI 10.1159/000284984; Quinlan R., 1993, C4 5; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Robins DL, 2001, J AUTISM DEV DISORD, V31, P131, DOI 10.1023/A:1010738829569; Schanding Jr. GT, 2011, J AUTISM DEV DISORD; Shi H., 2007, THESIS U WAIKATO; Wall DP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.10; Warren Z, 2012, AUTISM RES, V5, P31, DOI 10.1002/aur.230; Wiggins LD, 2006, J DEV BEHAV PEDIATR, V27, pS79, DOI 10.1097/00004703-200604002-00005; Wilkinson DJ, 2007, BRIEF BIOINFORM, V8, P109, DOI 10.1093/bib/bbm007	39	81	88	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43855	10.1371/journal.pone.0043855	http://dx.doi.org/10.1371/journal.pone.0043855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952789	gold, Green Submitted, Green Published			2022-12-27	WOS:000308044800067
J	Yilmaz, LS; Loy, A; Wright, ES; Wagner, M; Noguera, DR				Yilmaz, L. Safak; Loy, Alexander; Wright, Erik S.; Wagner, Michael; Noguera, Daniel R.			Modeling Formamide Denaturation of Probe-Target Hybrids for Improved Microarray Probe Design in Microbial Diagnostics	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; OLIGONUCLEOTIDE MICROARRAY; PHYLOGENETIC MICROARRAY; THERMAL-DISSOCIATION; DUPLEX FORMATION; DNA-MICROARRAYS; M-VALUES; HYBRIDIZATION; IDENTIFICATION; DENSITY	Application of high-density microarrays to the diagnostic analysis of microbial communities is challenged by the optimization of oligonucleotide probe sensitivity and specificity, as it is generally unfeasible to experimentally test thousands of probes. This study investigated the adjustment of hybridization stringency using formamide with the idea that sensitivity and specificity can be optimized during probe design if the hybridization efficiency of oligonucleotides with target and non-target molecules can be predicted as a function of formamide concentration. Sigmoidal denaturation profiles were obtained using fluorescently labeled and fragmented 16S rRNA gene amplicon of Escherichia coli as the target with increasing concentrations of formamide in the hybridization buffer. A linear free energy model (LFEM) was developed and microarray-specific nearest neighbor rules were derived. The model simulated formamide melting with a denaturant m-value that increased hybridization free energy (Delta G degrees) by 0.173 kcal/mol per percent of formamide added (v/v). Using the LFEM and specific probe sets, free energy rules were systematically established to predict the stability of single and double mismatches, including bulged and tandem mismatches. The absolute error in predicting the position of experimental denaturation profiles was less than 5% formamide for more than 90 percent of probes, enabling a practical level of accuracy in probe design. The potential of the modeling approach for probe design and optimization is demonstrated using a dataset including the 16S rRNA gene of Rhodobacter sphaeroides as an additional target molecule. The LFEM and thermodynamic databases were incorporated into a computational tool (ProbeMelt) that is freely available at http://DECIPHER.cee.wisc.edu.	[Yilmaz, L. Safak] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Wright, Erik S.; Noguera, Daniel R.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Loy, Alexander; Wagner, Michael] Univ Vienna, Fac Life Sci, Dept Microbial Ecol, Vienna Ecol Ctr, Vienna, Austria	University of Massachusetts System; University of Massachusetts Worcester; University of Wisconsin System; University of Wisconsin Madison; University of Vienna	Yilmaz, LS (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	lutfu.yilmaz@umassmed.edu	Wagner, Michael/A-7801-2011; Loy, Alexander/A-8182-2008	Wagner, Michael/0000-0002-9778-7684; Loy, Alexander/0000-0001-8923-5882; Noguera, Daniel/0000-0003-0372-3063	National Science Foundation [CBET-0606894, CBET-0636533]; Austrian Science Fund [P20185-B17]; Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota); Austrian Science Fund (FWF) [P 20185] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by National Science Foundation grants CBET-0606894 to DRN and CBET-0636533 to DRN and LSY, the Austrian Science Fund (P20185-B17 to AL), and the Austrian Federal Ministry of Science and Research (GEN-AU III InflammoBiota to MW and AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Berthouex P.M., 1994, STAT ENV ENG; Binder H, 2005, LANGMUIR, V21, P9287, DOI 10.1021/la051231s; Bommarito S, 2000, NUCLEIC ACIDS RES, V28, P1929, DOI 10.1093/nar/28.9.1929; Bourdelat-Parks BN, 2004, BIOCHEMISTRY-US, V43, P9918, DOI 10.1021/bi049161w; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Burden C.J., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1095, DOI 10.2202/1544-6115.1095]; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Courtenay ES, 2000, PROTEINS, P72; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; El Fantroussi S, 2003, APPL ENVIRON MICROB, V69, P2377, DOI 10.1128/AEM.69.4.2377-2382.2003; GAMPER HB, 1987, J MOL BIOL, V197, P349, DOI 10.1016/0022-2836(87)90128-8; Goodfellow, 1991, NUCL ACID TECHNIQUES, P177; Halperin A, 2005, BIOPHYS J, V89, P796, DOI 10.1529/biophysj.105.063479; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Hesselsoe M, 2009, ISME J IN PRESS; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; KE SH, 1995, BIOCHEMISTRY-US, V34, P4593, DOI 10.1021/bi00014a012; Kelly JJ, 2005, WATER RES, V39, P3229, DOI 10.1016/j.watres.2005.05.044; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li SZ, 2008, NUCLEIC ACIDS RES, V36, P6585, DOI 10.1093/nar/gkn740; Liu WT, 2001, ENVIRON MICROBIOL, V3, P619, DOI 10.1046/j.1462-2920.2001.00233.x; Loy A, 2005, APPL ENVIRON MICROB, V71, P1373, DOI 10.1128/AEM.71.3.1373-1386.2005; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Naiser T, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-48; Palmer C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj007; Peplies J, 2003, APPL ENVIRON MICROB, V69, P1397, DOI 10.1128/AEM.69.3.1397-1407.2003; Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163; Pozhitkov A, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl133; Pozhitkov Alex E., 2007, Briefings in Functional Genomics & Proteomics, V6, P141, DOI 10.1093/bfgp/elm014; Pozhitkov AE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm154; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Sanguin H, 2006, ENVIRON MICROBIOL, V8, P289, DOI 10.1111/j.1462-2920.2005.00895.x; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Schonmann S, 2009, ENVIRON MICROBIOL, V11, P779, DOI 10.1111/j.1462-2920.2008.01800.x; Seber GAF, 2003, NONLINEAR REGRESSION, Vxx; Shchepinov MS, 1997, NUCLEIC ACIDS RES, V25, P1155, DOI 10.1093/nar/25.6.1155; Siripong S, 2006, ENVIRON MICROBIOL, V8, P1564, DOI 10.1111/j.1462-2920.2006.01047.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Stedtfeld RD, 2007, APPL ENVIRON MICROB, V73, P380, DOI 10.1128/AEM.01785-06; Steger D, 2011, APPL ENVIRON MICROB, V77, P1231, DOI 10.1128/AEM.01352-10; Stralis-Pavese N, 2004, ENVIRON MICROBIOL, V6, P347, DOI 10.1111/j.1462-2920.2004.00582.x; Sugimoto N, 2000, BIOCHEMISTRY-US, V39, P11270, DOI 10.1021/bi000819p; Turner D. H., 2000, NUCL ACIDS STRUCTURE; Urakawa H, 2002, APPL ENVIRON MICROB, V68, P235, DOI 10.1128/AEM.68.1.235-244.2002; Urisman A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r78; Wagner M, 2003, CURR OPIN MICROBIOL, V6, P302, DOI 10.1016/S1369-5274(03)00054-7; Wagner M, 2007, MICROB ECOL, V53, P498, DOI 10.1007/s00248-006-9197-7; Watson M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r190; Wick LM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj024; Wilson KH, 2002, APPL ENVIRON MICROB, V68, P2535, DOI 10.1128/AEM.68.5.2535-2541.2002; Wong CW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r93; Yilmaz LS, 2008, ENVIRON MICROBIOL, V10, P2872, DOI 10.1111/j.1462-2920.2008.01719.x; Yilmaz LS, 2007, BIOTECHNOL BIOENG, V96, P349, DOI 10.1002/bit.21114; Yilmaz LS, 2004, APPL ENVIRON MICROB, V70, P7126, DOI 10.1128/AEM.70.12.7126-7139.2004; Zhang L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1064	66	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43862	10.1371/journal.pone.0043862	http://dx.doi.org/10.1371/journal.pone.0043862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952791	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800069
J	Briffaud, V; Fourcaud-Trocme, N; Messaoudi, B; Buonviso, N; Amat, C				Briffaud, Virginie; Fourcaud-Trocme, Nicolas; Messaoudi, Belkacem; Buonviso, Nathalie; Amat, Corine			The Relationship between Respiration-Related Membrane Potential Slow Oscillations and Discharge Patterns in Mitral/Tufted Cells: What Are the Rules?	PLOS ONE			English	Article							RAT OLFACTORY-BULB; LONG-LASTING DEPOLARIZATIONS; FREELY BREATHING RATS; MITRAL CELLS; UNIT-ACTIVITY; ODOR STIMULATION; CODING SCHEME; IN-VIVO; RESPONSES; CORTEX	Background: A slow respiration-related rhythm strongly shapes the activity of the olfactory bulb. This rhythm appears as a slow oscillation that is detectable in the membrane potential, the respiration-related spike discharge of the mitral/tufted cells and the bulbar local field potential. Here, we investigated the rules that govern the manifestation of membrane potential slow oscillations (MPSOs) and respiration-related discharge activities under various afferent input conditions and cellular excitability states. Methodology and Principal Findings: We recorded the intracellular membrane potential signals in the mitral/tufted cells of freely breathing anesthetized rats. We first demonstrated the existence of multiple types of MPSOs, which were influenced by odor stimulation and discharge activity patterns. Complementary studies using changes in the intracellular excitability state and a computational model of the mitral cell demonstrated that slow oscillations in the mitral/tufted cell membrane potential were also modulated by the intracellular excitability state, whereas the respiration-related spike activity primarily reflected the afferent input. Based on our data regarding MPSOs and spike patterns, we found that cells exhibiting an unsynchronized discharge pattern never exhibited an MPSO. In contrast, cells with a respiration-synchronized discharge pattern always exhibited an MPSO. In addition, we demonstrated that the association between spike patterns and MPSO types appeared complex. Conclusion: We propose that both the intracellular excitability state and input strength underlie specific MPSOs, which, in turn, constrain the types of spike patterns exhibited.	[Briffaud, Virginie; Fourcaud-Trocme, Nicolas; Messaoudi, Belkacem; Buonviso, Nathalie; Amat, Corine] Univ Lyon 1, Lyon Neurosci Res Ctr CRNL, Team Olfact Coding Memory, CNRS,INSERM,UMR 5292,U1028, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Briffaud, V (corresponding author), Univ Lyon 1, Lyon Neurosci Res Ctr CRNL, Team Olfact Coding Memory, CNRS,INSERM,UMR 5292,U1028, F-69365 Lyon, France.	vbriffaud@olfac.univ-lyon1.fr; corine.amat@olfac.univ-lyon1.fr	Fourcaud-Trocmé, Nicolas/N-9109-2017; Buonviso, Nathalie/G-8467-2017; amat, corine/O-1089-2017	Fourcaud-Trocmé, Nicolas/0000-0002-2211-7547; Buonviso, Nathalie/0000-0002-0018-1695; Briffaud, Virginie/0000-0002-9373-9159	"Agence Nationale de la Recherche" [ANR-07-NEURO-030]	"Agence Nationale de la Recherche"(French National Research Agency (ANR))	This work was supported by a grant from the "Agence Nationale de la Recherche" (#ANR-07-NEURO-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Aylwin MDL, 2005, BIOL RES, V38, P13, DOI 10.4067/S0716-97602005000100003; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Balu R, 2007, J NEUROPHYSIOL, V97, P1959, DOI 10.1152/jn.01115.2006; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Cang JH, 2003, J NEUROSCI, V23, P4108; Carey RM, 2011, J NEUROSCI, V31, P10615, DOI 10.1523/JNEUROSCI.1805-11.2011; Carlson GC, 2000, J NEUROSCI, V20, P2011; CHAPUT MA, 1992, EUR J NEUROSCI, V4, P813, DOI 10.1111/j.1460-9568.1992.tb00191.x; Chaput MA, 2000, CHEM SENSES, V25, P695, DOI 10.1093/chemse/25.6.695; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Courtiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016445; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Debarbieux F, 2003, J NEUROSCI, V23, P5553; Egger V, 2008, EUR J NEUROSCI, V27, P2066, DOI 10.1111/j.1460-9568.2008.06170.x; Ennis M., 2007, HDB NEUROCHEMISTRY M, P137, DOI [DOI 10.1007/978-0-387-30374-1_6, 10.1007/978-0-387-30374-1_6]; Fontanini A, 2003, J NEUROSCI, V23, P7993; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Garcia Samuel, 2009, Front Neuroinform, V3, P14, DOI 10.3389/neuro.11.014.2009; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Johnston J, 2010, J NEUROPHYSIOL, V103, P2557, DOI 10.1152/jn.00796.2009; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Lehmkuhle MJ, 2006, J NEUROPHYSIOL, V95, P1369, DOI 10.1152/jn.01334.2004; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Litalidon P, 2008, NEUROSCIENCE, V156, P781, DOI 10.1016/j.neuroscience.2008.07.077; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Migliore M, 2008, J COMPUT NEUROSCI, V24, P207, DOI 10.1007/s10827-007-0051-9; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Phillips ME, 2012, J NEUROSCI, V32, P85, DOI 10.1523/JNEUROSCI.4278-11.2012; RAVEL N, 1987, EXP BRAIN RES, V65, P623; RAVEL N, 1990, NEUROSCI LETT, V115, P213, DOI 10.1016/0304-3940(90)90457-K; Roux SG, 2006, J NEUROSCI METH, V152, P173, DOI 10.1016/j.jneumeth.2005.09.004; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Tristan C, 2009, EUR J NEUROSCI, V29, P921, DOI 10.1111/j.1460-9568.2009.06651.x; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yuan Q, 2006, J NEUROPHYSIOL, V95, P3097, DOI 10.1152/jn.00001.2006	48	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43964	10.1371/journal.pone.0043964	http://dx.doi.org/10.1371/journal.pone.0043964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952828	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300038
J	Valente, RM; Ehlers, E; Xu, DS; Ahmad, H; Steadman, A; Blasnitz, L; Zhou, Y; Kastanek, L; Meng, B; Zhang, LW				Valente, Robert M.; Ehlers, Erica; Xu, Dongsheng; Ahmad, Humera; Steadman, Andrew; Blasnitz, Laura; Zhou, You; Kastanek, Lisa; Meng, Bin; Zhang, Luwen			Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON REGULATORY FACTOR-7; NF-KAPPA-B; DISEASE-ACTIVITY; KAPOSIS SARCOMA; I INTERFERON; LEUKOCYTE INTERFERON; AUTOIMMUNE-DISEASES; INFECTED CELLS; INCREASED RISK	Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus. Toll-like receptor 7 (TLR7) is involved in host innate immunity against pathogens, and its aberrant activation is linked to the development of systemic lupus erythematosus (SLE, also called "lupus"). Type I interferons (IFN) are apparently driving forces for lupus pathogenesis. Previously, we found that EBV latent membrane protein 1 (LMP1) primes cells for IFN production. In this report, the relationship among EBV LMP1, TLRs, and IFN production are examined. We find that TLR7 activation increases the expression of EBV LMP1, and IFN regulatory factor 7 (IRF7) is involved in the stimulation process. TLR7 activation did not induce IFNs from EBV-infected cells, but potentiates those cells for IFN production by TLR3 or TLR9 activation. In addition, we find that LMP1 and IFNs are co-expressed in the same cells in some lupus patients. Therefore, the aberrant activation of TLR7 might induce LMP1 expression and LMP1-expression cells may be producing IFNs in lupus patients. These results suggest EBV might be an exacerbating factor in some lupus patients via promoting IFN production.	[Valente, Robert M.; Kastanek, Lisa] Arthrit Ctr Nebraska, Lincoln, NE USA; [Ehlers, Erica; Xu, Dongsheng; Ahmad, Humera; Steadman, Andrew; Blasnitz, Laura; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Zhou, You; Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Zhou, You] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA; [Meng, Bin] Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Shandong, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Shandong University	Valente, RM (corresponding author), Arthrit Ctr Nebraska, Lincoln, NE USA.	lzhang2@unlnotes.unl.edu			Layman Foundation, National Institutes of Health (NIH) [CA138213, CA108951, RR15635]; Undergraduate Creative Activities and Research Experiences program; IDeA Networks of Biomedical Research Excellence; NATIONAL CANCER INSTITUTE [R01CA108951, R01CA138213] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	Layman Foundation, National Institutes of Health (NIH); Undergraduate Creative Activities and Research Experiences program; IDeA Networks of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by grants from the Layman Foundation, National Institutes of Health (NIH) grants CA138213, CA108951, and RR15635 (LZ). HA was partially supported by The Undergraduate Creative Activities and Research Experiences program. LB was partially supported by the IDeA Networks of Biomedical Research Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAN P, 1990, EMBO J, V9, P147, DOI 10.1002/j.1460-2075.1990.tb08090.x; Baechler EC, 2004, CURR OPIN IMMUNOL, V16, P801, DOI 10.1016/j.coi.2004.09.014; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Beal Eleanor, 2010, Nat Rev Rheumatol, V6, P437, DOI 10.1038/nrrheum.2010.113; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Berner BR, 2005, CELL IMMUNOL, V235, P29, DOI 10.1016/j.cellimm.2005.06.010; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; BOOS H, 1987, VIROLOGY, V159, P161, DOI 10.1016/0042-6822(87)90360-6; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; Crow MK, 2003, ARTHRITIS RHEUM, V48, P2396, DOI 10.1002/art.11226; DESTEFANO E, 1982, J INFECT DIS, V146, P451, DOI 10.1093/infdis/146.4.451; Dror Y, 1998, AM J KIDNEY DIS, V32, P825, DOI 10.1016/S0272-6386(98)70140-4; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Frost V, 2001, J GEN VIROL, V82, P3057, DOI 10.1099/0022-1317-82-12-3057; Fu QO, 2011, ARTHRITIS RHEUM-US, V63, P749, DOI 10.1002/art.30193; Fujii K, 2000, J VIROL, V74, P2550, DOI 10.1128/JVI.74.6.2550-2557.2000; Garcia-Ortiz H, 2010, ANN RHEUM DIS, V69, P1861, DOI 10.1136/ard.2009.124313; Gayed M, 2009, LUPUS, V18, P479, DOI 10.1177/0961203309102556; Gires O, 1997, EMBO J, V16, P6131, DOI 10.1093/emboj/16.20.6131; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; HENDERSON A, 1983, P NATL ACAD SCI-BIOL, V80, P1987, DOI 10.1073/pnas.80.7.1987; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; HURLEY EA, 1991, J VIROL, V65, P3958, DOI 10.1128/JVI.65.7.3958-3963.1991; Incaprera M, 1998, CLIN EXP RHEUMATOL, V16, P289; James JA, 1997, ANN NY ACAD SCI, V815, P124, DOI 10.1111/j.1749-6632.1997.tb52054.x; Kalkner KM, 1998, QJM-MON J ASSOC PHYS, V91, P393, DOI 10.1093/qjmed/91.6.393; KANDA K, 1992, MOL CELL BIOL, V12, P4930, DOI 10.1128/MCB.12.11.4930; Kang I, 2004, J IMMUNOL, V172, P1287, DOI 10.4049/jimmunol.172.2.1287; Kasapcopur O, 2005, RHEUMATOL INT, P1; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawasaki A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3277; Kieff E, 1996, VIROLOGY, P2343; Kono DH, 2003, AUTOIMMUNITY, V36, P503, DOI 10.1080/08916930310001624665; Lam N, 2004, J VIROL, V78, P1657, DOI 10.1128/JVI.78.4.1657-1664.2004; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; McFarland EDC, 1999, ONCOGENE, V18, P6959, DOI 10.1038/sj.onc.1203217; Mitarnun Winyou, 2002, Journal of the Medical Association of Thailand, V85, P552; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Nonkwelo C, 1996, J VIROL, V70, P623, DOI 10.1128/JVI.70.1.623-627.1996; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; Pascual V, 2003, CURR OPIN RHEUMATOL, V15, P548, DOI 10.1097/00002281-200309000-00005; Patole PS, 2005, J AM SOC NEPHROL, V16, P1326, DOI 10.1681/ASN.2004100820; Peters AL, 2010, J IMMUNOL, V185, P4053, DOI 10.4049/jimmunol.0904065; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Ronnblom L, 2001, TRENDS IMMUNOL, V22, P427, DOI 10.1016/S1471-4906(01)01955-X; RONNBLOM LE, 1991, ACTA ONCOL, V30, P537; Salloum R, 2010, ARTHRITIS RHEUM-US, V62, P553, DOI 10.1002/art.27182; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Souza TA, 2005, P NATL ACAD SCI USA, V102, P18093, DOI 10.1073/pnas.0509311102; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Veeranki S, 2010, IMMUNOL LETT, V133, P1, DOI 10.1016/j.imlet.2010.06.008; Verdolini R, 2002, BRIT J DERMATOL, V146, P877, DOI 10.1046/j.1365-2133.2002.04627.x; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wu HL, 2001, INT J PHARM, V220, P63, DOI 10.1016/S0378-5173(01)00671-8; Xu DS, 2008, J VIROL, V82, P6251, DOI 10.1128/JVI.00163-08; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Xu DS, 2006, J BIOL CHEM, V281, P9163, DOI 10.1074/jbc.M511884200; Xu Y, 2001, LUPUS, V10, P841, DOI 10.1191/096120301701548481; Yamazaki M, 2005, CLIN EXP IMMUNOL, V139, P558, DOI 10.1111/j.1365-2249.2004.02704.x; Yu SF, 2005, MED MICROBIOL IMMUN, V194, P115, DOI 10.1007/s00430-004-0230-5; Zacny VL, 1999, J VIROL, V73, P7271, DOI 10.1128/JVI.73.9.7271-7277.1999; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; Zhang J, 2004, J BIOL CHEM, V279, P46335, DOI 10.1074/jbc.M403966200; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700; Zhang LW, 2001, SEMIN CANCER BIOL, V11, P445, DOI 10.1006/scbi.2001.0411; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 2001, J VIROL, V75, P341, DOI 10.1128/JVI.75.1.341-350.2001; Zhang LW, 1999, MOL CELL BIOL, V19, P3216; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000	93	21	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43317	10.1371/journal.pone.0043317	http://dx.doi.org/10.1371/journal.pone.0043317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952664	gold, Green Published			2022-12-27	WOS:000308221300012
J	Wang, ZG; Theeuwes, J				Wang, Zhiguo; Theeuwes, Jan			Dissociable Spatial and Temporal Effects of Inhibition of Return	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; MONKEY SUPERIOR COLLICULUS; VISUAL-SEARCH; OCULOMOTOR INHIBITION; AVERAGING SACCADES; COMPETITIVE INTEGRATION; EFFECT SIZE; TIME-COURSE; ATTENTION; TRAJECTORIES	Inhibition of return (IOR) refers to the relative suppression of processing at locations that have recently been attended. It is frequently explored using a spatial cueing paradigm and is characterized by slower responses to cued than to uncued locations. The current study investigates the impact of IOR on overt visual orienting involving saccadic eye movements. Using a spatial cueing paradigm, our experiments have demonstrated that at a cue-target onset asynchrony (CTOA) of 400 ms saccades to the vicinity of cued locations are not only delayed (temporal cost) but also biased away (spatial effect). Both of these effects are basically no longer present at a CTOA of 1200 ms. At a shorter 200 ms CTOA, the spatial effect becomes stronger while the temporal cost is replaced by a temporal benefit. These findings suggest that IOR has a spatial effect that is dissociable from its temporal effect. Simulations using a neural field model of the superior colliculus (SC) revealed that a theory relying on short-term depression (STD) of the input pathway can explain most, but not all, temporal and spatial effects of IOR.	[Wang, Zhiguo; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Wang, ZG (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	z.wang@vu.nl	Theeuwes, Jan/B-6862-2008; Wang, Zhiguo/AHA-8939-2022; Theeuwes, Jan/ABF-3771-2020	Wang, Zhiguo/0000-0003-4553-0198; Theeuwes, Jan/0000-0002-5849-7721	NWO (Netherlands Organization for Scientific Research) [463-06-014]	NWO (Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	This project was supported by a grant (Grant 463-06-014) from NWO (Netherlands Organization for Scientific Research) to Jan Theeuwes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS RA, 1994, J EXP PSYCHOL HUMAN, V20, P467, DOI 10.1037/0096-1523.20.3.467; Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Al-Aidroos N, 2010, VIS COGN, V18, P26, DOI 10.1080/13506280802456939; Anderson EJ, 2011, J NEUROPHYSIOL, V106, P2273, DOI 10.1152/jn.00286.2011; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bell AH, 2004, J NEUROPHYSIOL, V91, P2172, DOI 10.1152/jn.01080.2003; Bennett PJ, 2001, PSYCHOL SCI, V12, P76, DOI 10.1111/1467-9280.00313; Chou IH, 1999, VISION RES, V39, P4200, DOI 10.1016/S0042-6989(99)00133-9; COREN S, 1972, PERCEPT MOTOR SKILL, V34, P499, DOI 10.2466/pms.1972.34.2.499; Dodd MD, 2009, PSYCHOL SCI, V20, P333, DOI 10.1111/j.1467-9280.2009.02294.x; Dorris MC, 2002, J COGNITIVE NEUROSCI, V14, P1256, DOI 10.1162/089892902760807249; Dorris MC, 1997, J NEUROSCI, V17, P8566; Dorris MC, 2007, J NEUROSCI, V27, P5053, DOI 10.1523/JNEUROSCI.4212-06.2007; Doyle D, 2001, EXP BRAIN RES, V139, P333, DOI 10.1007/s002210100742; Dukewich KR, 2009, PSYCHON B REV, V16, P238, DOI 10.3758/PBR.16.2.238; Fecteau JH, 2005, J COGNITIVE NEUROSCI, V17, P1714, DOI 10.1162/089892905774589235; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; GLIMCHER PW, 1993, EXP BRAIN RES, V95, P429; Godijn R, 2004, J EXP PSYCHOL HUMAN, V30, P538, DOI 10.1037/0096-1523.30.3.538; Godijn R, 2002, PSYCHOL RES-PSYCH FO, V66, P234, DOI 10.1007/s00426-002-0098-1; Howard LA, 1999, J GEN PSYCHOL, V126, P421, DOI 10.1080/00221309909595374; Ibanez-Gijon J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033169; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KLEIN R, 1988, NATURE, V334, P430, DOI 10.1038/334430a0; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Klein RM, 1999, PSYCHOL SCI, V10, P346, DOI 10.1111/1467-9280.00166; KLEIN RM, 1994, INHIBITORY PROCESSES; KOCH C, 1985, HUM NEUROBIOL, V4, P219; KOPECZ K, 1995, BIOL CYBERN, V73, P49, DOI 10.1007/BF00199055; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Lupianez J., 2010, ATTENTION TIME, P17, DOI DOI 10.1093/ACPROF:OSO/9780199563456.003.0002; Macinnes Joseph W, 2003, ScientificWorldJournal, V3, P75; Marino RA, 2012, J COGNITIVE NEUROSCI, V24, P315, DOI 10.1162/jocn_a_00139; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; MAYLOR EA, 1985, J EXP PSYCHOL HUMAN, V11, P777, DOI 10.1037/0096-1523.11.6.777; McSorley E, 2006, J NEUROPHYSIOL, V96, P1420, DOI 10.1152/jn.00315.2006; McSorley E, 2009, BRAIN RES, V1298, P92, DOI 10.1016/j.brainres.2009.08.081; Meredith MA, 1998, J NEUROPHYSIOL, V79, P1597, DOI 10.1152/jn.1998.79.3.1597; Muller HJ, 2000, J EXP PSYCHOL HUMAN, V26, P1591, DOI 10.1037//0096-1523.26.5.1591; Muller-Gethmann H, 2003, PSYCHOPHYSIOLOGY, V40, P597, DOI 10.1111/1469-8986.00061; Munoz DP, 2002, PROG BRAIN RES, V140, P3; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Patel SS, 2010, VISION RES, V50, P1235, DOI 10.1016/j.visres.2010.04.010; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; POSNER MI, 1973, MEM COGNITION, V1, P2, DOI 10.3758/BF03198062; Prime DJ, 2006, BRAIN RES, V1072, P161, DOI 10.1016/j.brainres.2005.11.081; Samuel AG, 2003, PSYCHON B REV, V10, P897, DOI 10.3758/BF03196550; Satel J, 2011, VISION RES, V51, P987, DOI 10.1016/j.visres.2011.02.013; Smith TJ, 2011, ATTEN PERCEPT PSYCHO, V73, P2384, DOI 10.3758/s13414-011-0191-x; Smith TJ, 2011, J VISION, V11, DOI 10.1167/11.1.3; Smith TJ, 2009, VIS COGN, V17, P1083, DOI 10.1080/13506280802678557; Takeda Y, 2000, PERCEPT PSYCHOPHYS, V62, P927, DOI 10.3758/BF03212078; Taylor TL, 2000, J EXP PSYCHOL HUMAN, V26, P1639, DOI 10.1037//0096-1523.26.5.1639; Theeuwes J, 2004, VISION RES, V44, P1485, DOI 10.1016/j.visres.2003.09.035; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Thomas LE, 2009, ATTEN PERCEPT PSYCHO, V71, P1241, DOI 10.3758/APP.71.6.1241; TIPPER SP, 1991, Q J EXP PSYCHOL-A, V43, P289, DOI 10.1080/14640749108400971; Tipper SP, 2001, EXP BRAIN RES, V136, P241, DOI 10.1007/s002210000577; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Van der Stigchel S, 2005, COGNITIVE BRAIN RES, V25, P579, DOI 10.1016/j.cogbrainres.2005.08.001; Van der Stigchel S, 2007, VISION RES, V47, P210, DOI 10.1016/j.visres.2006.11.001; Wang Z., 2011, J EYE MOVEMENT RES, V4, P1; Wang ZG, 2012, VIS COGN, V20, P825, DOI 10.1080/13506285.2012.705358; Wang ZG, 2012, VISION RES, V62, P66, DOI 10.1016/j.visres.2012.03.024; Wang ZG, 2012, EXP BRAIN RES, V218, P441, DOI 10.1007/s00221-012-3033-8; Watanabe K, 2001, EXP BRAIN RES, V138, P330, DOI 10.1007/s002210100709; White B.J., 2011, OXFORD HDB EYE MOVEM, P195, DOI [10.1093/oxfordhb/9780199539789.013.0011, DOI 10.1093/OXFORDHB/9780199539789.013.0011]; White BJ, 2012, J COGNITIVE NEUROSCI, V24, P707, DOI 10.1162/jocn_a_00162	71	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44290	10.1371/journal.pone.0044290	http://dx.doi.org/10.1371/journal.pone.0044290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998EY	22952949	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300075
J	Patwardhan, A; Bilkovski, R				Patwardhan, Avinash; Bilkovski, Robert			Comparison: Flu Prescription Sales Data from a Retail Pharmacy in the US with Google Flu Trends and US ILINet (CDC) Data as Flu Activity Indicator	PLOS ONE			English	Article							SURVEILLANCE	The potential threat of bioterrorism along with the emergence of new or existing drug resistant strains of influenza virus, added to expanded global travel, have increased vulnerability to epidemics or pandemics and their aftermath. The same factors have also precipitated urgency for having better, faster, sensitive, and reliable syndromic surveillance systems. Prescription sales data can provide surrogate information about the development of infectious diseases and therefore serve as a useful tool in syndromic surveillance. This study compared prescription sales data from a large drug retailing pharmacy chain in the United States with Google Flu trends surveillance system data as a flu activity indicator. It was found that the two were highly correlated. The correlation coefficient (Pearson 'r') for five years' aggregate data (2007-2011) was 0.92 (95% CI, 0.90-0.94). The correlation coefficients for each of the five years between 2007 and 2011 were 0.85, 0.92, 0.91, 0.88, and 0.87 respectively. Additionally, prescription sales data from the same large drug retailing pharmacy chain in the United States were also compared with US Outpatient Influenza-like Illness Surveillance Network (ILINet) data for 2007 by Centers for Disease Control and Prevention (CDC). The correlation coefficient (Pearson 'r') was 0.97 (95% CI, 0.95-0.98).	[Patwardhan, Avinash; Bilkovski, Robert] Walgreen Co, Deerfield, IL USA		Patwardhan, A (corresponding author), Walgreen Co, Deerfield, IL USA.	Avinash.Patwardhan@Walgreens.com			Walgreen Co.	Walgreen Co.	This research was funded by Walgreen Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ADV DIS SURVEILL; Aramaki E., 2011, P C EMPIRICAL METHOD, P1568, DOI DOI 10.1016/J.DEUGALCDEP.2015.07.1199; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Buehler James W, 2004, MMWR Suppl, V53, P18; CDC, 2004, MMWR, P53; Centers for Disease Control and Prevention, US SURV DAT 1997 199; Centers for Disease Control and Prevention, OV INFL SURV US; Chen Jian-Hua, 2005, MMWR Suppl, V54, P31; Copeland KR, 2005, P SURV RES METH SECT, P73; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Dukic V, 2009, TRACKING FLU EPIDEMI; Foldy Seth L, 2004, MMWR Suppl, V53, P12; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Google, FREQ ASK QUEST SHOUL; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Kress A, 2004, MORB MORTAL WKLY R S, V53, P247; Mnatsakanyan Z, 2007, ADV DIS SURVEILLANCE, V4, P12; National Institute of Science and Technology Policy Japan, 2010, OMEO H SYNDROMIC SUR, V37, P9; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Patwardhan A, 2012, POPUL HEALTH MANAG, V15, P1; Pavlin JA, 2003, AM J PUBLIC HEALTH, V93, P1230, DOI 10.2105/AJPH.93.8.1230; Pavlin Julie A, 2004, MMWR Suppl, V53, P166; Sosin Daniel M, 2004, MMWR Suppl, V53, P125; Sugawara T, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1881; Valdivia A, 2010, EUROSURVEILLANCE, V15, P19621; van den Wijngaard CC, 2011, EUROSURVEILLANCE, V16, P17; Vergu E, 2006, EMERG INFECT DIS, V12, P416, DOI 10.3201/eid1203.050573	27	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43611	10.1371/journal.pone.0043611	http://dx.doi.org/10.1371/journal.pone.0043611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952719	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500016
J	Guo, CY; Gu, Y; Li, L; Jia, EZ; Li, CJ; Wang, LS; Yang, ZJ; Cao, KJ; Ma, WZ				Guo, Chang-Yan; Gu, Yan; Li, Li; Jia, En-Zhi; Li, Chun-Jian; Wang, Lian-Sheng; Yang, Zhi-Jian; Cao, Ke-Jiang; Ma, Wen-Zhu			Association of SNP Rs6903956 on Chromosome 6p24.1 with Angiographical Characteristics of Coronary Atherosclerosis in a Chinese Population	PLOS ONE			English	Article							ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTOR; SMOKING; MEN	Objective: To explore the association between rs6903956 and severity of coronary artery disease (CAD) in a Chinese population. Methods: A cohort of 1075 consecutive patients who underwent coronary arteriography for suspected or known coronary atherosclerosis was enrolled in our study. Coronary atherosclerosis severity was defined by Gensini's Score System and counts of diseased vessels. Results: Gensini score frequencies and counts of diseased vessels differed among GG, AG, AA genotype groups at the rs6903956 locus (p = 0.025 for Gensini score frequencies vs. p = 0.024 for counts of diseased vessels, respectively). A univariate logistic regression analysis revealed that the genotype distribution of this SNP was associated significantly with angiographical characteristics of coronary atherosclerosis risk (p = 0.030, odds ratio (OR) = 1.444, 95% confidence interval (CI) = 1.036 similar to 2.013 for AG vs. GG; p = 0.021, OR = 5.896, 95% CI = 1.299 similar to 26.750 for AA vs. GG and p = 0.007, OR = 1.564, 95% CI = 1.132 similar to 2.162 for combined (AG+AA) vs. GG). A multivariate logistic regression analysis indicated that the genotype distribution of the rs6903956 polymorphism be associated significantly with the angiographical characteristics of coronary atherosclerosis risk (p = 0.004, OR = 1.578, 95% CI = 1.155 similar to 2.154 for GG vs. AG vs. AA; p = 0.013, OR = 1.541, 95% CI = 1.097 similar to 2.163 for GG vs. GA+AA). A stratification analysis revealed that male subjects and smoking subjects had a higher frequency of the rs6903956 heterozygous mutant among higher Gensini score subjects than among lower Gensini score subjects (p = 0.023, OR = 1.579, 95% CI = 1.064 similar to 2.344 for male subgroup; p = 0.005, OR = 2.075, 95% CI = 1.249 similar to 3.448 for smoking subgroup). Conclusions: Allele A is a risk factor for CAD and the G-to-A allele substitution may underlie the association between rs6903956 and CAD.	[Guo, Chang-Yan; Gu, Yan; Li, Li; Jia, En-Zhi; Li, Chun-Jian; Wang, Lian-Sheng; Yang, Zhi-Jian; Cao, Ke-Jiang; Ma, Wen-Zhu] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Guo, CY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Nanjing, Jiangsu, Peoples R China.	enzhijia@yahoo.cn	Jia, Enzhi/AGX-9137-2022		National Natural Science Foundation of China [30400173, 30971257]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant numbers 30400173 and 30971257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charchar FJ, 2012, LANCET, V379, P915, DOI 10.1016/S0140-6736(11)61453-0; Dandona S, 2010, CAN J CARDIOL, V26, p56A, DOI 10.1016/S0828-282X(10)71064-3; Franceschini N, 2011, CIRC-CARDIOVASC GENE, V4, P662, DOI 10.1161/CIRCGENETICS.111.960096; Franchini M, 2008, TRENDS CARDIOVAS MED, V18, P157, DOI 10.1016/j.tcm.2008.04.003; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Girelli D, 2009, SEMIN THROMB HEMOST, V35, P671, DOI 10.1055/s-0029-1242721; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; Iltumur K, 2005, CRIT CARE, V9, pR416, DOI 10.1186/cc3727; Jia EZ, 2009, CLIN EXP PHARMACOL P, V36, P690, DOI 10.1111/j.1440-1681.2008.05134.x; Kim HJ, 2012, MOL BIOL REP, V39, P5425, DOI 10.1007/s11033-011-1342-9; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Padmanabhan S, 2010, INDIAN J MED RES, V132, P567; Rembek M, 2010, KARDIOL POL, V68, P157; Saito Y, 2010, J ATHEROSCLER THROMB, V17, P270, DOI 10.5551/jat.2782; Satoh H, 2009, J ATHEROSCLER THROMB, V16, P792; Trachsel LD, 2010, SWISS MED WKLY, V140, P133, DOI smw-12955; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Woodward M, 2005, INT J EPIDEMIOL, V34, P1036, DOI 10.1093/ije/dyi104; Yarnell J, 2003, INT J EPIDEMIOL, V32, P71, DOI 10.1093/ije/dyg038	21	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43732	10.1371/journal.pone.0043732	http://dx.doi.org/10.1371/journal.pone.0043732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952750	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000048
J	Kadekar, S; Silins, I; Korhonen, A; Dreij, K; Al-Anati, L; Hogberg, J; Stenius, U				Kadekar, Sandeep; Silins, Ilona; Korhonen, Anna; Dreij, Kristian; Al-Anati, Lauy; Hogberg, Johan; Stenius, Ulla			Exocrine Pancreatic Carcinogenesis and Autotaxin Expression	PLOS ONE			English	Article							ACINAR-CELL CARCINOMAS; LYSOPHOSPHATIDIC ACID; CANCER-RISK; RECEPTORS; LPA; MATRIX-METALLOPROTEINASE-9; INDUCTION; KRAS; DIISOCYANATE; OSTEOBLASTS	Exocrine pancreatic cancer is an aggressive disease with an exceptionally high mortality rate. Genetic analysis suggests a causative role for environmental factors, but consistent epidemiological support is scarce and no biomarkers for monitoring the effects of chemical pancreatic carcinogens are available. With the objective to identify common traits for chemicals inducing pancreatic tumors we studied the National Toxicology Program (NTP) bioassay database. We found that male rats were affected more often than female rats and identified eight chemicals that induced exocrine pancreatic tumors in males only. For a hypothesis generating process we used a text mining tool to analyse published literature for suggested mode of actions (MOA). The resulting MOA analysis suggested inflammatory responses as common feature. In cell studies we found that all the chemicals increased protein levels of the inflammatory protein autotaxin (ATX) in Panc-1, MIA PaCa-2 or Capan-2 cells. Induction of MMP-9 and increased invasive migration were also frequent effects, consistent with ATX activation. Testosterone has previously been implicated in pancreatic carcinogenesis and we found that it increased ATX levels. Our data show that ATX is a target for chemicals inducing pancreatic tumors in rats. Several lines of evidence implicate ATX and its product lysophosphatidic acid in human pancreatic cancer. Mechanisms of action may include stimulated invasive growth and metastasis. ATX may interact with hormones or onco- or suppressor-genes often deregulated in exocrine pancreatic cancer. Our data suggest that ATX is a target for chemicals promoting pancreatic tumor development.	[Kadekar, Sandeep; Silins, Ilona; Dreij, Kristian; Al-Anati, Lauy; Hogberg, Johan; Stenius, Ulla] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Korhonen, Anna] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England	Karolinska Institutet; University of Cambridge	Kadekar, S (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	ilona.silins@ki.se	Dreij, Kristian/I-6083-2012	Dreij, Kristian/0000-0001-8445-4293	Swedish Research Council for Environment, Agriculture Science and Spatial Planning (Formas); Swedish Research Council; Royal Society, UK	Swedish Research Council for Environment, Agriculture Science and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Society, UK(Royal Society of London)	This study was financed by the Swedish Research Council for Environment, Agriculture Science and Spatial Planning (Formas) (http://www.formas.se/), Swedish Research Council (http://www.vr.se/) and the Royal Society, UK (http://royalsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Arita Y, 2008, WORLD J GASTROENTERO, V14, P4473, DOI 10.3748/wjg.14.4473; Azare J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027851; Birk T, 2009, J OCCUP ENVIRON MED, V51, P373, DOI 10.1097/JOM.0b013e3181973e19; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Choi S, 2007, AM J PHYSIOL-GASTR L, V292, pG1366, DOI 10.1152/ajpgi.00516.2006; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dietrich C, 2010, CARCINOGENESIS, V31, P1319, DOI 10.1093/carcin/bgq028; FRENCH DL, 1994, ANN NY ACAD SCI, V732, P324, DOI 10.1111/j.1749-6632.1994.tb24747.x; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Fuss B, 1997, J NEUROSCI, V17, P9095; Genkinger JM, 2010, INT J CANC; Gonzalez-Arenas A, 2008, BBA-MOL CELL RES, V1783, P253, DOI 10.1016/j.bbamcr.2007.11.014; Gorelick FS, 2009, CLIN GASTROENTEROL H, V7, pS10, DOI 10.1016/j.cgh.2009.07.036; Goulioumis AK, 2011, ISRN ONCOL; Graham TR, 2010, BREAST CANCER RES TR, V123, P139, DOI 10.1007/s10549-009-0623-7; Grippo PJ, 2003, CANCER RES, V63, P2016; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hama K, 2006, LIFE SCI, V79, P1736, DOI 10.1016/j.lfs.2006.06.002; Harper K, 2010, CANCER RES, V70, P4634, DOI 10.1158/0008-5472.CAN-09-3813; Hattis D, 2009, CRIT REV TOXICOL, V39, P97, DOI 10.1080/10408440802307467 ; Heid I, 2011, GASTROENTEROLOGY, V141, P719, DOI 10.1053/j.gastro.2011.04.043; Hurst-Kennedy J, 2010, J STEROID BIOCHEM, V122, P264, DOI 10.1016/j.jsbmb.2010.05.010; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Joslin EJ, 2010, MOL BIOSYST, V6, P1293, DOI 10.1039/c003921g; Kadekar S, 2012, TOXICOL PATHOL; Komachi M, 2009, CARCINOGENESIS, V30, P457, DOI 10.1093/carcin/bgp011; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Korhonen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033427; Korhonen A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-303; Kortlever RM, 2008, MOL CANCER RES, V6, P1452, DOI 10.1158/1541-7786.MCR-08-0066; Kunzli BM, 2007, AM J PHYSIOL-GASTR L, V292, pG223, DOI 10.1152/ajpgi.00259.2006; Lau MK, 2010, PANCREAS, V39, P458, DOI 10.1097/MPA.0b013e3181bd6489; Levi F, 2003, PANCREAS, V27, P139, DOI 10.1097/00006676-200308000-00006; LHOSTE E F, 1987, Pancreas, V2, P38, DOI 10.1097/00006676-198701000-00006; LHOSTE EF, 1987, CARCINOGENESIS, V8, P699, DOI 10.1093/carcin/8.5.699; Li HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025941; Li S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-18; Liu PS, 2006, TOXICOL APPL PHARM, V211, P106, DOI 10.1016/j.taap.2005.06.019; Liu PS, 2006, TOXICOLOGY, V219, P167, DOI 10.1016/j.tox.2005.11.012; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; Longnecker D S, 1990, IARC Sci Publ, P241; LONGNECKER DS, 1990, INT J PANCREATOL, V7, P159; Malbon Craig C, 2005, Sci STKE, V2005, ppe35, DOI 10.1126/stke.2922005pe35; Michaud DS, 2010, CANCER CAUSE CONTROL, V21, P1213, DOI 10.1007/s10552-010-9548-z; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Mroczko B, 2009, PANCREAS, V38, P613, DOI 10.1097/MPA.0b013e3181a488a0; Mueller NT, 2010, CANCER EPIDEM BIOMAR, V19, P447, DOI 10.1158/1055-9965.EPI-09-0862; Nakai Y, 2011, CLIN BIOCHEM, V44, P576, DOI 10.1016/j.clinbiochem.2011.03.128; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Nyska A, 2004, ENVIRON HEALTH PERSP, V112, P903, DOI 10.1289/ehp.6869; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Panupinthu N, 2007, J BIOL CHEM, V282, P3403, DOI 10.1074/jbc.M605620200; Park SY, 2010, ONCOGENE; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; RAO MS, 1987, CANCER METAST REV, V6, P665, DOI 10.1007/BF00047473; ROSS J, 1987, GUT, V28, P197, DOI 10.1136/gut.28.Suppl.197; Sautin YY, 2001, AM J PHYSIOL-CELL PH, V281, pC2010, DOI 10.1152/ajpcell.00077.2001; Seifert A, 2009, TOXICOL LETT, V184, P26, DOI 10.1016/j.toxlet.2008.10.026; Shah AU, 2009, AM J PHYSIOL-GASTR L, V297, pG967, DOI 10.1152/ajpgi.00181.2009; Silins I, 2012, INTEGR ENVIRON ASSES, V8, P412, DOI 10.1002/ieam.1278; Sistare FD, 2011, TOXICOL PATHOL, V39, P716, DOI 10.1177/0192623311406935; Stelow EB, 2010, AM J SURG PATHOL, V34, P510, DOI 10.1097/PAS.0b013e3181cfcac7; Stewart Sherri L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Sun L, 2009, P NAT LANG PROC BIOM; Sun WJ, 2010, CELL SIGNAL, V22, P1799, DOI 10.1016/j.cellsig.2010.05.007; Tani Y, 2004, TOXICOL PATHOL, V32, P41, DOI 10.1080/01926230490260952; TERHUNE PG, 1994, MOL CARCINOGEN, V10, P110, DOI 10.1002/mc.2940100209; Terhune PG, 1998, PANCREAS, V16, P6, DOI 10.1097/00006676-199801000-00002; Terhune PG, 1998, CANCER EPIDEM BIOMAR, V7, P515; Tice DA, 2002, J BIOL CHEM, V277, P14329, DOI 10.1074/jbc.M200334200; Vrieling A, 2010, INT J CANCER, V126, P2394, DOI 10.1002/ijc.24907; Wang ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020537; Wolk A, 2012, BR J CANC; WOUTERSEN RA, 1991, MUTAT RES, V248, P291, DOI 10.1016/0027-5107(91)90063-T; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhou J, 2010, CANCER CAUSE CONTROL, V21, P853, DOI 10.1007/s10552-010-9512-y; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	87	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43209	10.1371/journal.pone.0043209	http://dx.doi.org/10.1371/journal.pone.0043209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952646	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206000023
J	Masoudi-Nejad, A; Ansariola, M; Kashani, ZRM; Salehzadeh-Yazdi, A; Khakabimamaghani, S				Masoudi-Nejad, Ali; Ansariola, Mitra; Kashani, Zahra Razaghi Moghadam; Salehzadeh-Yazdi, Ali; Khakabimamaghani, Sahand			CytoKavosh: A Cytoscape Plug-In for Finding Network Motifs in Large Biological Networks	PLOS ONE			English	Article							ALGORITHM; DISCOVERY; TOOL	Network motifs are small connected sub-graphs that have recently gathered much attention to discover structural behaviors of large and complex networks. Finding motifs with any size is one of the most important problems in complex and large networks. It needs fast and reliable algorithms and tools for achieving this purpose. CytoKavosh is one of the best choices for finding motifs with any given size in any complex network. It relies on a fast algorithm, Kavosh, which makes it faster than other existing tools. Kavosh algorithm applies some well known algorithmic features and includes tricky aspects, which make it an efficient algorithm in this field. CytoKavosh is a Cytoscape plug-in which supports us in finding motifs of given size in a network that is formerly loaded into the Cytoscape work-space (directed or undirected). High performance of CytoKavosh is achieved by dynamically linking highly optimized functions of Kavosh's C++ to the Cytoscape Java program, which makes this plug-in suitable for analyzing large biological networks. Some significant attributes of CytoKavosh is efficiency in time usage and memory and having no limitation related to the implementation in motif size. CytoKavosh is implemented in a visual environment Cytoscape that is convenient for the users to interact and create visual options to analyze the structural behavior of a network. This plug-in can work on any given network and is very simple to use and generates graphical results of discovered motifs with any required details. There is no specific Cytoscape plug-in, specific for finding the network motifs, based on original concept. So, we have introduced for the first time, CytoKavosh as the first plug-in, and we hope that this plug-in can be improved to cover other options to make it the best motif-analyzing tool.	[Masoudi-Nejad, Ali; Ansariola, Mitra; Kashani, Zahra Razaghi Moghadam; Salehzadeh-Yazdi, Ali; Khakabimamaghani, Sahand] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran	University of Tehran	Masoudi-Nejad, A (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.	amasoudin@ibb.ut.ac.ir	Salehzadeh-Yazdi, Ali/J-9510-2019; Masoudi-Nejad, Ali/E-7922-2010; Masoudi-Nejad, Ali/ABH-2078-2021	Salehzadeh-Yazdi, Ali/0000-0002-1678-0051; Masoudi-Nejad, Ali/0000-0003-0659-5183; Ansariola, Mitra/0000-0003-0092-1435				Alon N, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn163; Bachmaier C, 2012, HDB GRAPH DRAWING VI; Bode C, 2007, FEBS LETT, V581, P2776, DOI 10.1016/j.febslet.2007.05.021; Chen J., 2006, P ACM KDD, P106, DOI DOI 10.1145/1150402.1150418; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; Fernando Silva PR, 2010, 25 ACM S APPL COMP B; Joshua A, 2007, NETWORK MOTIF DISCOV, P92; Junker B. H., 2008, WILEY SERIES BIOINFO; Kashani ZRM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-318; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Kreher D.L., 1998, COMBINATORIAL ALGORI; Mckay B. D., 1981, C NUMERANTIUM, V30, P45, DOI DOI 10.1016/J.JSC.2013.09.003; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Omidi S, 2009, GENES GENET SYST, V84, P385, DOI 10.1266/ggs.84.385; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038	16	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43287	10.1371/journal.pone.0043287	http://dx.doi.org/10.1371/journal.pone.0043287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952659	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000029
J	Osborn, DPJ; Horsfall, L; Hassiotis, A; Petersen, I; Walters, K; Nazareth, I				Osborn, David P. J.; Horsfall, Laura; Hassiotis, Angela; Petersen, Irene; Walters, Kate; Nazareth, Irwin			Access to Cancer Screening in People with Learning Disabilities in the UK: Cohort Study in the Health Improvement Network, a Primary Care Research Database	PLOS ONE			English	Article							INTELLECTUAL DISABILITIES	Objectives: To assess whether people with learning disability in the UK have poorer access to cancer screening. Design: Four cohort studies comparing people with and without learning disability, within the recommended age ranges for cancer screening in the UK. We used Poisson regression to determine relative incidence rates of cancer screening. Setting: The Health Improvement Network, a UK primary care database with over 450 General practices. Participants: Individuals with a recorded diagnosis of learning disability including general diagnostic terms, specific syndromes, chromosomal abnormalities and autism in their General Practitioner computerised notes. For each type of cancer screening, a comparison cohort of up to six people without learning disability was selected for each person with a learning disability, using stratified sampling on age within GP practice. Main outcome measures: Incidence rate ratios for receiving 1) a cervical smear test, 2) a mammogram, 3) a faecal occult blood test and 4) a prostate specific antigen test. Results: Relative rates of screening for all four cancers were significantly lower for people with learning disability. The adjusted incidence rate ratios (95% confidence intervals) were Cervical smears: Number eligible with learning disability = 6,254; IRR = 0.54 (0.52-0.56). Mammograms: Number eligible with learning disability = 2,956; IRR = 0.76 (0.72-0.81); Prostate Specific Antigen: Number eligible = 3,520; IRR = 0.87 (0.80-0.96) and Faecal Occult Blood Number eligible = 6,566; 0.86 (0.78-0.94). Differences in screening rates were less pronounced in more socially deprived areas. Disparities in cervical screening rates narrowed over time, but were 45% lower in 2008/9, those for breast cancer screening appeared to widen and were 35% lower in 2009. Conclusion: Despite recent incentives, people with learning disability in the UK are significantly less likely to receive screening tests for cancer that those without learning disability. Other methods for reducing inequalities in access to cancer screening should be considered.	[Osborn, David P. J.; Hassiotis, Angela] UCL, Mental Hlth Sci Unit, London, England; [Horsfall, Laura; Petersen, Irene; Walters, Kate; Nazareth, Irwin] UCL, Res Dept Primary Care & Populat Hlth, London, England	University of London; University College London; University of London; University College London	Osborn, DPJ (corresponding author), UCL, Mental Hlth Sci Unit, London, England.	d.osborn@ucl.ac.uk	Petersen, Irene/I-2751-2012; Petersen, Irene/C-5702-2009; Osborn PhD FRCPsych, David/B-8165-2009	Petersen, Irene/0000-0002-0037-7524; Walters, Kate/0000-0003-2173-2430; Hassiotis, Angela/0000-0002-9800-3909; Osborn PhD FRCPsych, David/0000-0003-2519-1539; Nazareth, Irwin/0000-0003-2146-9628	National Health Service (NHS) Cancer Screening Programme on behalf of the Department of Health for England [JP/pat/L1623]	National Health Service (NHS) Cancer Screening Programme on behalf of the Department of Health for England	The study was commissioned by the National Health Service (NHS) Cancer Screening Programme on behalf of the Department of Health for England. (Grant reference: JP/pat/L1623.) The funder had no role in the data collection/extraction, data analysis, decision to publish, or preparation of the manuscript.	Ali A, 2008, BMJ-BRIT MED J, V336, P570, DOI 10.1136/bmj.39490.543137.80; [Anonymous], 2006, CANC SCREEN SER NHS; [Anonymous], 2010, ACC HLTH CAR PEOPL L; Booth N, 1994, Health Libr Rev, V11, P177; Cooper SA, 2004, BMJ-BRIT MED J, V329, P414, DOI 10.1136/bmj.329.7463.414; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Department of Health, 2001, VAL PEOPL NEW STRAT; Disability Rights Commission, 2006, EQ TREATM CLOS GAP H; Disability Rights Commission, 2007, EQ TREATM CLOS GAP O; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; MICHAEL J, 2008, HEALTHCARE ALL INDEP; NHS Employers, DIR ENH SERV 2011 12; Osborn DPJ, 2011, SCHIZOPHR RES, V129, P104, DOI 10.1016/j.schres.2011.04.003; Raftery J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7627; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Stark JR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3601; Townsend P., 1986, INEQUALITIES HLTH NO	17	40	40	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43841	10.1371/journal.pone.0043841	http://dx.doi.org/10.1371/journal.pone.0043841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952783	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206000053
J	Thomsen, PF; Kielgast, J; Iversen, LL; Moller, PR; Rasmussen, M; Willerslev, E				Thomsen, Philip Francis; Kielgast, Jos; Iversen, Lars Lonsmann; Moller, Peter Rask; Rasmussen, Morten; Willerslev, Eske			Detection of a Diverse Marine Fish Fauna Using Environmental DNA from Seawater Samples	PLOS ONE			English	Article							ANCIENT DNA; SEDIMENTS; REVEALS; PLANT; ICE; PALEOECOLOGY; VEGETATION; COLLAPSE; RECOVERY; RECORDS	Marine ecosystems worldwide are under threat with many fish species and populations suffering from human over-exploitation. This is greatly impacting global biodiversity, economy and human health. Intriguingly, marine fish are largely surveyed using selective and invasive methods, which are mostly limited to commercial species, and restricted to particular areas with favourable conditions. Furthermore, misidentification of species represents a major problem. Here, we investigate the potential of using metabarcoding of environmental DNA (eDNA) obtained directly from seawater samples to account for marine fish biodiversity. This eDNA approach has recently been used successfully in freshwater environments, but never in marine settings. We isolate eDNA from 1/2-litre seawater samples collected in a temperate marine ecosystem in Denmark. Using next-generation DNA sequencing of PCR amplicons, we obtain eDNA from 15 different fish species, including both important consumption species, as well as species rarely or never recorded by conventional monitoring. We also detect eDNA from a rare vagrant species in the area; European pilchard (Sardina pilchardus). Additionally, we detect four bird species. Records in national databases confirmed the occurrence of all detected species. To investigate the efficiency of the eDNA approach, we compared its performance with 9 methods conventionally used in marine fish surveys. Promisingly, eDNA covered the fish diversity better than or equal to any of the applied conventional methods. Our study demonstrates that even small samples of seawater contain eDNA from a wide range of local fish species. Finally, in order to examine the potential dispersal of eDNA in oceans, we performed an experiment addressing eDNA degradation in seawater, which shows that even small (100-bp) eDNA fragments degrades beyond detectability within days. Although further studies are needed to validate the eDNA approach in varying environmental conditions, our findings provide a strong proof-of-concept with great perspectives for future monitoring of marine biodiversity and resources.	[Thomsen, Philip Francis; Kielgast, Jos; Rasmussen, Morten; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Iversen, Lars Lonsmann] Univ Copenhagen, Dept Biol, Freshwater Biol Sect, Hillerod, Denmark; [Moller, Peter Rask] Univ Copenhagen, Nat Hist Museum Denmark, Vertebrate Dept, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Thomsen, PF (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade, Copenhagen, Denmark.	pfthomsen@snm.ku.dk; ewillerslev@snm.ku.dk	Møller, Peter/A-8807-2013; Willerslev, Eske/A-9619-2011; Thomsen, Philip Francis/AAE-9354-2019; Willerslev, Eske/AAA-5686-2019	Møller, Peter/0000-0002-0177-0977; Willerslev, Eske/0000-0002-7081-6748; Thomsen, Philip Francis/0000-0002-9867-4366; 	Danish National Research Foundation; Aage V. Jensen Charity Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Aage V. Jensen Charity Foundation	This study was funded as basic research by the Danish National Research Foundation and the Aage V. Jensen Charity Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Baldwin C.C., 1996, METHODS TECHNIQUES U, P11; Beare D, 2004, GLOBAL CHANGE BIOL, V10, P1209, DOI 10.1111/j.1529-8817.2003.00790.x; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; Costanza R, 1999, ECOL ECON, V31, P199, DOI 10.1016/S0921-8009(99)00079-8; Daan N., 2001, ICES CM, V3, P1; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hiiesalu I, 2012, MOL ECOL, V21, P2004, DOI 10.1111/j.1365-294X.2011.05390.x; Hofreiter M, 2003, CURR BIOL, V13, pR693, DOI 10.1016/j.cub.2003.08.039; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; ICES, 2011, MAN BALT INT TRAWL S; ICES, 2010, MAN INT BOTT TRAWL S; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Jorgensen T, 2012, MOL ECOL, V21, P1980, DOI 10.1111/j.1365-294X.2011.05278.x; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Love MS, 2010, B MAR SCI, V86, P35; Lydolph MC, 2005, APPL ENVIRON MICROB, V71, P1012, DOI 10.1128/AEM.71.2.1012-1017.2005; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x	50	484	531	34	550	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e41732	10.1371/journal.pone.0041732	http://dx.doi.org/10.1371/journal.pone.0041732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952584	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000004
J	Watanabe, M; Morimoto, K; Houten, SM; Kaneko-Iwasaki, N; Sugizaki, T; Horai, Y; Mataki, C; Sato, H; Murahashi, K; Arita, E; Schoonjans, K; Suzuki, T; Itoh, H; Auwerx, J				Watanabe, Mitsuhiro; Morimoto, Kohkichi; Houten, Sander M.; Kaneko-Iwasaki, Nao; Sugizaki, Taichi; Horai, Yasushi; Mataki, Chikage; Sato, Hiroyuki; Murahashi, Karin; Arita, Eri; Schoonjans, Kristina; Suzuki, Tatsuya; Itoh, Hiroshi; Auwerx, Johan			Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; TYPE-2 DIABETES-MELLITUS; NEGATIVE FEEDBACK-REGULATION; NUCLEAR RECEPTOR; GLYCEMIC CONTROL; COLESEVELAM HYDROCHLORIDE; GLUCOSE-HOMEOSTASIS; DOUBLE-BLIND; CHOLESTYRAMINE; THERAPY	Background: Besides well-established roles of bile acids (BA) in dietary lipid absorption and cholesterol homeostasis, it has recently become clear that BA is also a biological signaling molecule. We have shown that strategies aimed at activating TGR5 by increasing the BA pool size with BA administration may constitute a significant therapeutic advance to combat the metabolic syndrome and suggest that such strategies are worth testing in a clinical setting. Bile acid binding resin (BABR) is known not only to reduce serum cholesterol levels but also to improve glucose tolerance and insulin resistance in animal models and humans. However, the mechanisms by which BABR affects glucose homeostasis have not been established. We investigated how BABR affects glycemic control in diet-induced obesity models. Methods and Findings: We evaluated the metabolic effect of BABR by administrating colestimide to animal models for the metabolic syndrome. Administration of BABR increased energy expenditure, translating into significant weight reduction and insulin sensitization. The metabolic effects of BABR coincide with activation of cholesterol and BA synthesis in liver and thermogenesis in brown adipose tissue. Interestingly, these effects of BABR occur despite normal food intake and triglyceride absorption. Administration of BABR and BA had similar effects on BA composition and thermogenesis, suggesting that they both are mediated via TGR5 activation. Conclusion: Our data hence suggest that BABR could be useful for the management of the impaired glucose tolerance of the metabolic syndrome, since they not only lower cholesterol levels, but also reduce obesity and improve insulin resistance.	[Watanabe, Mitsuhiro; Morimoto, Kohkichi; Kaneko-Iwasaki, Nao; Sugizaki, Taichi; Horai, Yasushi; Murahashi, Karin; Arita, Eri; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Mataki, Chikage; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Sato, Hiroyuki] Ehime Univ, Grad Sch Med, Dept Biosci, Matsuyama, Ehime 790, Japan; [Suzuki, Tatsuya] Nippon Med Sch, Tokyo 113, Japan; [Watanabe, Mitsuhiro] Keio Univ, Grad Sch Media & Governance, Fujisawa, Kanagawa, Japan	Keio University; University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Ehime University; Nippon Medical School; Keio University	Watanabe, M (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan.	wmitsu@sc.itc.keio.ac.jp; johan.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Houten, Sander/Y-3599-2019	Houten, Sander/0000-0002-6167-9147; Schoonjans, Kristina/0000-0003-1247-4265; Auwerx, Johan/0000-0002-5065-5393	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; NIH; Uehara Memorial Foundation; Takeda science foundation; Sumitomo Foundation; Ono Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Novartis Foundation (Japan) for Promotion of Science; Japan Health Foundation; Kowa life science foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda science foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Ono Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Novartis Foundation (Japan) for Promotion of Science(Novartis); Japan Health Foundation(Japan Health Foundation); Kowa life science foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by grants of the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, NIH, the Uehara Memorial Foundation, Takeda science foundation, the Sumitomo Foundation, Ono Medical Foundation, Astellas Foundation for Research on Metabolic Disorders, the Novartis Foundation (Japan) for Promotion of Science, the Japan Health Foundation, Kowa life science foundation and the Ministry of Education, Culture, Sports, Science and Technology of Japan for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bays HE, 2008, ARCH INTERN MED, V168, P1975, DOI 10.1001/archinte.168.18.1975; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Brufau G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-73; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fonseca VA, 2008, DIABETES CARE, V31, P1479, DOI 10.2337/dc08-0283; GARBUTT JT, 1972, J CLIN INVEST, V51, P2781, DOI 10.1172/JCI107100; GARG A, 1994, ANN INTERN MED, V121, P416, DOI 10.7326/0003-4819-121-6-199409150-00004; Goldberg RB, 2008, ARCH INTERN MED, V168, P1531, DOI 10.1001/archinte.168.14.1531; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Homma Y, 1997, ATHEROSCLEROSIS, V129, P241, DOI 10.1016/S0021-9150(96)06034-0; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Houten SM, 2004, ANN MED, V36, P482, DOI 10.1080/07853890410018790; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kajiyama G, 1996, J CLIN THER MED, V12, P1349; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; KOGIRE M, 1992, PANCREAS, V7, P15, DOI 10.1097/00006676-199201000-00003; KOOP I, 1988, EUR J CLIN INVEST, V18, P517, DOI 10.1111/j.1365-2362.1988.tb01050.x; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; SAKAKURA H, 1993, J CHROMATOGR-BIOMED, V621, P123, DOI 10.1016/0378-4347(93)80087-K; SHIDO O, 1989, JPN J PHYSIOL, V39, P359, DOI 10.2170/jjphysiol.39.359; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stroeve JHM, 2010, LAB INVEST, V90, P1457, DOI 10.1038/labinvest.2010.107; Suzuki T, 2012, J DIABETES COMPLICAT, V26, P34, DOI 10.1016/j.jdiacomp.2011.11.008; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM; YOSHIMATSU H, 1992, BRAIN RES, V597, P298, DOI 10.1016/0006-8993(92)91486-X; Zieve FJ, 2007, CLIN THER, V29, P74, DOI 10.1016/j.clinthera.2007.01.003	49	83	83	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e38286	10.1371/journal.pone.0038286	http://dx.doi.org/10.1371/journal.pone.0038286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952571	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000002
J	Cornelissen, LAHM; de Leeuw, OS; Tacken, MG; Klos, HC; de Vries, RP; de Boer-Luijtze, EA; van Zoelen-Bos, DJ; Rigter, A; Rottier, PJM; Moormann, RJM; de Haan, CAM				Cornelissen, Lisette A. H. M.; de Leeuw, Olav S.; Tacken, Mirriam G.; Klos, Heleen C.; de Vries, Robert P.; de Boer-Luijtze, Els A.; van Zoelen-Bos, Diana J.; Rigter, Alan; Rottier, Peter J. M.; Moormann, Rob J. M.; de Haan, Cornelis A. M.			Protective Efficacy of Newcastle Disease Virus Expressing Soluble Trimeric Hemagglutinin against Highly Pathogenic H5N1 Influenza in Chickens and Mice	PLOS ONE			English	Article							AVIAN INFLUENZA; FUSION PROTEIN; NEUTRALIZING ANTIBODIES; RESPIRATORY-TRACT; LETHAL CHALLENGE; VACCINE VECTORS; FOWLPOX VIRUS; RECOMBINANT; IMMUNIZATION; VIRULENCE	Background: Highly pathogenic avian influenza virus (HPAIV) causes a highly contagious often fatal disease in poultry, resulting in significant economic losses in the poultry industry. HPAIV H5N1 also poses a major public health threat as it can be transmitted directly from infected poultry to humans. One effective way to combat avian influenza with pandemic potential is through the vaccination of poultry. Several live vaccines based on attenuated Newcastle disease virus (NDV) that express influenza hemagglutinin (HA) have been developed to protect chickens or mammalian species against HPAIV. However, the zoonotic potential of NDV raises safety concerns regarding the use of live NDV recombinants, as the incorporation of a heterologous attachment protein may result in the generation of NDV with altered tropism and/or pathogenicity. Methodology/Principal Findings: In the present study we generated recombinant NDVs expressing either full length, membrane-anchored HA of the H5 subtype (NDV-H5) or a soluble trimeric form thereof (NDV-sH5 3). A single intramuscular immunization with NDV-sH5 3 or NDV-H5 fully protected chickens against disease after a lethal challenge with H5N1 and reduced levels of virus shedding in tracheal and cloacal swabs. NDV-sH5 3 was less protective than NDV-H5 (50% vs 80% protection) when administered via the respiratory tract. The NDV-sH5 3 was ineffective in mice, regardless of whether administered oculonasally or intramuscularly. In this species, NDV-H5 induced protective immunity against HPAIV H5N1, but only after oculonasal administration, despite the poor H5-specific serum antibody response it elicited. Conclusions/Significance: Although NDV expressing membrane anchored H5 in general provided better protection than its counterpart expressing soluble H5, chickens could be fully protected against a lethal challenge with H5N1 by using the latter NDV vector. This study thus provides proof of concept for the use of recombinant vector vaccines expressing a soluble form of a heterologous viral membrane protein. Such vectors may be advantageous as they preclude the incorporation of heterologous membrane proteins into the viral vector particles.	[Cornelissen, Lisette A. H. M.; de Leeuw, Olav S.; Tacken, Mirriam G.; Klos, Heleen C.; de Boer-Luijtze, Els A.; van Zoelen-Bos, Diana J.; Moormann, Rob J. M.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [de Vries, Robert P.; Rigter, Alan; Rottier, Peter J. M.; Moormann, Rob J. M.; de Haan, Cornelis A. M.] Univ Utrecht, Fac Vet Med, Div Virol, Dept Infect Dis & Immunol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	Cornelissen, LAHM (corresponding author), Wageningen UR, Cent Vet Inst, Lelystad, Netherlands.	lisette.cornelissen@wur.nl	de Vries, Robert/K-7212-2013	de Haan, Cornelis/0000-0002-4459-9874; de Vries, Robert/0000-0002-1586-4464	Economic Structure Enhancing Fund: "Impulse Veterinary Avian Influenza Research in the Netherlands"	Economic Structure Enhancing Fund: "Impulse Veterinary Avian Influenza Research in the Netherlands"	This work has been financially supported by the Economic Structure Enhancing Fund: "Impulse Veterinary Avian Influenza Research in the Netherlands". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2003, J DIS POULTRY, V11th, P63, DOI DOI 10.1007/S11262-007-0078-Z; ANTIN PB, 1991, DEV BIOL, V143, P111, DOI 10.1016/0012-1606(91)90058-B; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Britton P, 1996, J GEN VIROL, V77, P963, DOI 10.1099/0022-1317-77-5-963; Bukreyev A, 2006, J VIROL, V80, P10293, DOI 10.1128/JVI.00919-06; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Capua I, 2004, EUR J CLIN MICROBIOL, V23, P1, DOI 10.1007/s10096-003-1059-3; CEC, 1992, OFFICIAL J EUROPEA L, VL260, P1; Collins PL, 2008, J VIROL, V82, P9805, DOI 10.1128/JVI.01336-08; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; DiNapoli JM, 2007, J VIROL, V81, P11560, DOI 10.1128/JVI.00713-07; DiNapoli JM, 2010, J VIROL, V84, P1489, DOI 10.1128/JVI.01946-09; Dortmans JCFM, 2009, J GEN VIROL, V90, P2746, DOI 10.1099/vir.0.014118-0; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hierholzer J. C., 1996, P25, DOI 10.1016/B978-012465330-6/50003-8; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; LEENAARS PPAM, 1994, VET IMMUNOL IMMUNOP, V40, P225, DOI 10.1016/0165-2427(94)90022-1; Loeffen WLA, 2011, VACCINE, V29, P1545, DOI 10.1016/j.vaccine.2010.12.096; Luschow D, 2001, VACCINE, V19, P4249, DOI 10.1016/S0264-410X(01)00167-0; Martinez-Sobrido L, 2006, J VIROL, V80, P1130, DOI 10.1128/JVI.80.3.1130-1139.2006; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; Nakaya T, 2001, J VIROL, V75, P11868, DOI 10.1128/JVI.75.23.11868-11873.2001; Nayak B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006509; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Park MS, 2006, P NATL ACAD SCI USA, V103, P8203, DOI 10.1073/pnas.0602566103; Peeters BPH, 2000, ARCH VIROL, V145, P1829, DOI 10.1007/s007050070059; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Pillai SPS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-5; Swayne DE, 2003, AVIAN DIS, V47, P1047, DOI 10.1637/0005-2086-47.s3.1047; TAYLOR J, 1988, VACCINE, V6, P504, DOI 10.1016/0264-410X(88)90101-6; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; van Oirschot JT, 2001, VET QUART, V23, P100, DOI 10.1080/01652176.2001.9695094; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; WENSVOORT G, 1986, VET MICROBIOL, V12, P101, DOI 10.1016/0378-1135(86)90072-6; Wu QF, 2009, MOL IMMUNOL, V46, P2210, DOI 10.1016/j.molimm.2009.04.017; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang LJ, 2008, VIROLOGY, V377, P255, DOI 10.1016/j.virol.2008.04.029; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165	45	23	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44447	10.1371/journal.pone.0044447	http://dx.doi.org/10.1371/journal.pone.0044447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952980	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600104
J	Favre, G; Lavenex, PB; Lavenex, P				Favre, Gregoire; Lavenex, Pamela Banta; Lavenex, Pierre			miRNA Regulation of Gene Expression: A Predictive Bioinformatics Analysis in the Postnatally Developing Monkey Hippocampus	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; RNA INTERFERENCE; MEMORY; MICRORNAS; DATABASE; TARGETS; EVOLUTION; RESOURCE; MIRBASE; CLUSTER	Regulation of gene expression in the postnatally developing hippocampus might contribute to the emergence of selective memory function. However, the mechanisms that underlie the co-regulation of expression of hundreds of genes in different cell types at specific ages in distinct hippocampal regions have yet to be elucidated. By performing genome-wide microarray analyses of gene expression in distinct regions of the monkey hippocampal formation during early postnatal development, we identified one particular group of genes exhibiting a down-regulation of expression, between birth and six months of age in CA1 and after one year of age in CA3, to reach expression levels observed at 6-12 years of age. Bioinformatics analyses using NCBI, miRBase, TargetScan, microRNA.org and Affymetrix tools identified a number of miRNAs capable of regulating the expression of these genes simultaneously in different cell types, i.e., in neurons, astrocytes and oligodendrocytes. Interestingly, sixty-five percent of these miRNAs are conserved across species, from rodents to humans; whereas thirty-five percent are specific to primates, including humans. In addition, we found that some genes exhibiting greater down-regulation of their expression were the predicted targets of a greater number of these miRNAs. In sum, miRNAs may play a fundamental role in the co-regulation of gene expression in different cell types. This mechanism is partially conserved across species, and may thus contribute to the similarity of basic hippocampal characteristics across mammals. This mechanism also exhibits a phylogenetic diversity that may contribute to more subtle species differences in hippocampal structure and function observed at the cellular level.	[Favre, Gregoire; Lavenex, Pamela Banta; Lavenex, Pierre] Univ Fribourg, Lab Brain & Cognit Dev, Dept Med, CH-1700 Fribourg, Switzerland	University of Fribourg	Favre, G (corresponding author), Univ Fribourg, Lab Brain & Cognit Dev, Dept Med, CH-1700 Fribourg, Switzerland.	pierre.lavenex@unifr.ch		Lavenex, Pierre/0000-0002-9278-1312; Banta Lavenex, Pamela/0000-0001-8868-2912	Department of Psychiatry and Behavioral Sciences, University of California Davis; National Alliance for Research on Schizophrenia and Depression (NARSAD); Swiss National Science Foundation [PP00A-106701, PP00P3-124536]; California National Primate Research Center [RR00169]; Department of Medicine, University of Fribourg; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER	Department of Psychiatry and Behavioral Sciences, University of California Davis; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); California National Primate Research Center; Department of Medicine, University of Fribourg; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding came from the Joe P. Tupin award, Department of Psychiatry and Behavioral Sciences, University of California Davis to PL, National Alliance for Research on Schizophrenia and Depression (NARSAD 2004 Young Investigator Award) to PL, the Swiss National Science Foundation, Grant numbers: PP00A-106701; PP00P3-124536 to PL, California National Primate Research Center Grant number: RR00169, and the Department of Medicine, University of Fribourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altemus KL, 2005, NEUROSCIENCE, V136, P741, DOI 10.1016/j.neuroscience.2005.07.001; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer PJ, 2006, TRENDS COGN SCI, V10, P175, DOI 10.1016/j.tics.2006.02.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Boneva NB, 2011, HIPPOCAMPUS, V21, P162, DOI 10.1002/hipo.20732; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Denayer E, 2008, J NEUROSCI, V28, P14443, DOI 10.1523/JNEUROSCI.4698-08.2008; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dinger ME, 2008, J MOL ENDOCRINOL, V40, P151, DOI 10.1677/JME-07-0160; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Fiore Roberto, 2007, ScientificWorldJournal, V7, P167; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jabes A, 2011, J COMP NEUROL, V519, P1051, DOI 10.1002/cne.22549; Jabes A, 2010, EUR J NEUROSCI, V31, P273, DOI 10.1111/j.1460-9568.2009.07061.x; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lavenex PB, 2009, HIPPOCAMPUS, V19, P8, DOI 10.1002/hipo.20485; Lavenex PB, 2006, J NEUROSCI, V26, P4546, DOI 10.1523/JNEUROSCI.5412-05.2006; Lavenex P, 2007, DEV NEUROSCI-BASEL, V29, P179, DOI 10.1159/000096222; Lavenex P, 2011, HIPPOCAMPUS, V21, P142, DOI 10.1002/hipo.20730; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Morris R., 2007, HIPPOCAMPUS BOOK, P581; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Parsons MJ, 2008, MAMM GENOME, V19, P552, DOI 10.1007/s00335-008-9116-y; Peng S, 2010, INT J MOL SCI, V11, P222, DOI 10.3390/ijms11010222; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STANTON PK, 1984, J NEUROSCI, V4, P3080; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094	62	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43435	10.1371/journal.pone.0043435	http://dx.doi.org/10.1371/journal.pone.0043435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952683	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600025
J	Queiroga, CSF; Tomasi, S; Wideroe, M; Alves, PM; Vercelli, A; Vieira, HLA				Queiroga, Claudia S. F.; Tomasi, Simone; Wideroe, Marius; Alves, Paula M.; Vercelli, Alessandro; Vieira, Helena L. A.			Preconditioning Triggered by Carbon Monoxide (CO) Provides Neuronal Protection Following Perinatal Hypoxia-Ischemia	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; BRAIN-DAMAGE; HEME OXYGENASE-1; RAT MODEL; REDUCES APOPTOSIS; CEREBRAL-ISCHEMIA; CELL-DEATH; INJURY; TOLERANCE; NEUROPROTECTION	Perinatal hypoxia-ischemia is a major cause of acute mortality in newborns and cognitive and motor impairments in children. Cerebral hypoxia-ischemia leads to excitotoxicity and necrotic and apoptotic cell death, in which mitochondria play a major role. Increased resistance against major damage can be achieved by preconditioning triggered by subtle insults. CO, a toxic molecule that is also generated endogenously, may have a role in preconditioning as low doses can protect against inflammation and apoptosis. In this study, the role of CO-induced preconditioning on neurons was addressed in vitro and in vivo. The effect of 1 h of CO treatment on neuronal death (plasmatic membrane permeabilization and chromatin condensation) and bcl-2 expression was studied in cerebellar granule cells undergoing to glutamate-induced apoptosis. CO's role was studied in vivo in the Rice-Vannucci model of neonatal hypoxia-ischemia (common carotid artery ligature +75 min at 8% oxygen). Apoptotic cells, assessed by Nissl staining were counted with a stereological approach and cleaved caspase 3-positive profiles in the hippocampus were assessed. Apoptotic hallmarks were analyzed in hippocampal extracts by Western Blot. CO inhibited excitotoxicity-induced cell death and increased Bcl-2 mRNA in primary cultures of neurons. In vivo, CO prevented hypoxia-ischemia induced apoptosis in the hippocampus, limited cytochrome c released from mitochondria and reduced activation of caspase-3. Still, Bcl-2 protein levels were higher in hippocampus of CO pre-treated rat pups. Our results show that CO preconditioning elicits a molecular cascade that limits neuronal apoptosis. This could represent an innovative therapeutic strategy for high-risk cerebral hypoxia-ischemia patients, in particular neonates.	[Queiroga, Claudia S. F.; Alves, Paula M.; Vieira, Helena L. A.] Univ Nova Lisboa, Chron Dis Res Ctr CEDOC, Fac Ciencias Med, P-1200 Lisbon, Portugal; [Queiroga, Claudia S. F.; Vieira, Helena L. A.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, IBET, Oeiras, Portugal; [Tomasi, Simone; Vercelli, Alessandro] AOU San Luigi Gonzaga, NICO, Turin, Italy; [Tomasi, Simone; Vercelli, Alessandro] Univ Turin, Sch Med, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Wideroe, Marius] Norwegian Univ Sci & Technol, Dept Lab Med, N-7034 Trondheim, Norway	Universidade Nova de Lisboa; Universidade Nova de Lisboa; University of Turin; Norwegian University of Science & Technology (NTNU)	Queiroga, CSF (corresponding author), Univ Nova Lisboa, Chron Dis Res Ctr CEDOC, Fac Ciencias Med, P-1200 Lisbon, Portugal.	helena.vieira@fcm.unl.pt	Tomasi, Simone/D-8427-2011; Alves, Paula M/C-1070-2008; Vieira, Helena/AAZ-9562-2021; Vercelli, Alessandro/A-1926-2012	Alves, Paula M/0000-0003-1445-3556; Vieira, Helena/0000-0001-9415-3742; Vercelli, Alessandro/0000-0002-5909-2128; Queiroga, Claudia/0000-0002-3984-9576	Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/SAU-NEU/64327/2006, PTDCS/SAU-NEU/098747/2008, SFRH/BPD/27125/2006, SFRH/BD/43387/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/64327/2006] Funding Source: FCT	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by the Portuguese Fundacao para a Ciencia e Tecnologia (PTDC/SAU-NEU/64327/2006; PTDCS/SAU-NEU/098747/2008) and the Portuguese Fundacao para a Ciencia e Tecnologia, for HLAV's SFRH/BPD/27125/2006 and for CSFQ's SFRH/BD/43387/2008 fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom K, 2009, ACTA ANAESTH SCAND, V53, P1036, DOI 10.1111/j.1399-6576.2009.01992.x; Ahmad AS, 2006, NEUROSCIENCE, V141, P1703, DOI 10.1016/j.neuroscience.2006.05.035; Alkan T, 2008, TURK NEUROSURG, V18, P165; Almeida AS, 2012, J BIOL CHEM, V287, P10761, DOI 10.1074/jbc.M111.306738; Ara J, 2011, NEUROBIOL DIS, V43, P473, DOI 10.1016/j.nbd.2011.04.021; Arpino Carla, 2005, Ann Ist Super Sanita, V41, P229; Biermann J, 2012, INVEST OPHTHALMOL, V51, P3784; Bloch KD, 2007, CARDIOVASC RES, V75, P339, DOI 10.1016/j.cardiores.2007.04.014; Bonifacio SL, 2011, NAT REV NEUROL, V7, P485, DOI 10.1038/nrneurol.2011.119; Cai JM, 2008, NEUROSCI LETT, V441, P167, DOI 10.1016/j.neulet.2008.05.077; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Dirnagl U, 2008, NEUROPHARMACOLOGY, V55, P334, DOI 10.1016/j.neuropharm.2008.02.017; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Fitting S, 2008, HIPPOCAMPUS, V18, P135, DOI 10.1002/hipo.20376; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Ge W, 2011, CELL DEATH DIFFER; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gunn AJ, 2008, CLIN PERINATOL, V35, P735, DOI 10.1016/j.clp.2008.07.012; Hagberg H, 2004, J BIOENERG BIOMEMBR, V36, P369, DOI 10.1023/B:JOBB.0000041770.00567.4f; Heazell AEP, 2008, J OBSTET GYNAECOL, V28, P147, DOI 10.1080/01443610801912618; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; LEVINE S, 1960, AM J PATHOL, V36, P1; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; McAuliffe JJ, 2007, ANESTH ANALG, V104, P1066, DOI 10.1213/01.ane.0000260321.62377.74; Motterlini R, 2007, BIOCHEM SOC T, V35, P1142, DOI 10.1042/BST0351142; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakao A, 2010, J HEART LUNG TRANSPL, V29, P544, DOI 10.1016/j.healun.2009.10.011; Ness JM, 2006, BRAIN RES, V1099, P150, DOI 10.1016/j.brainres.2006.04.132; Otterbein LE, 2005, CELL MOL BIOL, V51, P433, DOI 10.1170/T647; Queiroga CSF, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-10; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robinson BRH, 2009, CURR OPIN CRIT CARE, V15, P1, DOI 10.1097/MCC.0b013e3283220e34; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Sanders RD, 2004, BRIT MED BULL, V71, P115, DOI 10.1093/bmb/ldh034; SCHOUSBOE I, 1989, INT J DEV NEUROSCI, V7, P115, DOI 10.1016/0736-5748(89)90050-6; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Vannucci RC, 1999, J NEUROSCI RES, V55, P158, DOI 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1; Vannucci RC, 1997, ANN NY ACAD SCI, V835, P234, DOI 10.1111/j.1749-6632.1997.tb48634.x; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Wideroe M, 2009, NEUROIMAGE, V45, P880, DOI 10.1016/j.neuroimage.2008.12.007; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zimmermann A, 2007, AM J PHYSIOL-HEART C, V293, pH2501, DOI 10.1152/ajpheart.00354.2007; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003	55	33	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42632	10.1371/journal.pone.0042632	http://dx.doi.org/10.1371/journal.pone.0042632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952602	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600006
J	Sano, W; Nakamura, T; Yoshiuchi, K; Kitajima, T; Tsuchiya, A; Esaki, Y; Yamamoto, Y; Iwata, N				Sano, Wataru; Nakamura, Toru; Yoshiuchi, Kazuhiro; Kitajima, Tsuyoshi; Tsuchiya, Akiko; Esaki, Yuichi; Yamamoto, Yoshiharu; Iwata, Nakao			Enhanced Persistency of Resting and Active Periods of Locomotor Activity in Schizophrenia	PLOS ONE			English	Article							MOTOR-ACTIVITY; NEUROLOGICAL SIGNS; BASAL GANGLIA; OLANZAPINE; RISPERIDONE; ACTIGRAPHY; PSYCHOSIS; RHYTHMS; PEOPLE; SLEEP	Patients with schizophrenia frequently exhibit behavioral abnormalities associated with its pathological symptoms. Therefore, a quantitative evaluation of behavioral dynamics could contribute to objective diagnoses of schizophrenia. However, such an approach has not been fully established because of the absence of quantitative biobehavioral measures. Recently, we studied the dynamical properties of locomotor activity, specifically how resting and active periods are interwoven in daily life. We discovered universal statistical laws ("behavioral organization") and their alterations in patients with major depressive disorder. In this study, we evaluated behavioral organization of schizophrenic patients (n = 19) and healthy subjects (n = 11) using locomotor activity data, acquired by actigraphy, to investigate whether the laws could provide objective and quantitative measures for a possible diagnosis and assessment of symptoms. Specifically, we evaluated the cumulative distributions of resting and active periods, defined as the periods with physical activity counts successively below and above a predefined threshold, respectively. Here we report alterations in the laws governing resting and active periods; resting periods obeyed a power-law cumulative distribution with significantly lower parameter values (power-law scaling exponents), whereas active periods followed a stretched exponential distribution with significantly lower parameter values (stretching exponents), in patients. Our findings indicate enhanced persistency of both lower and higher locomotor activity periods in patients with schizophrenia, probably reflecting schizophrenic pathophysiology.	[Sano, Wataru; Kitajima, Tsuyoshi; Tsuchiya, Akiko; Esaki, Yuichi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi, Japan; [Nakamura, Toru; Yamamoto, Yoshiharu] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo, Japan; [Yoshiuchi, Kazuhiro] Univ Tokyo, Dept Psychosomat Med, Grad Sch Med, Tokyo, Japan	Fujita Health University; University of Tokyo; University of Tokyo	Sano, W (corresponding author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi, Japan.	sano-w@fujita-hu.ac.jp	Kitajima, Tsuyoshi/GQH-5130-2022	nakamura, toru/0000-0002-5340-6333; esaki, yuichi/0000-0001-5165-6171; Yamamoto, Yoshiharu/0000-0002-1132-0355; Kitajima, Tsuyoshi/0000-0002-8785-9330	Ministry of Education, Culture, Sports, Science and Technology [23240094, 23700795]; Core Research for Evolutional Science and Technology from Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23700795, 23240094] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology from Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-In-Aid for Scientific Research (A) [23240094] (to YY) and Grant-In-Aid for Young Scientists (B) [23700795] (to TN) from the Ministry of Education, Culture, Sports, Science and Technology, and by Core Research for Evolutional Science and Technology from Japan Science and Technology Agency (to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2011, PSYCHIAT RES, V189, P62, DOI 10.1016/j.psychres.2010.12.031; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Andreasen NC, 1997, SCHIZOPHR RES, V28, P105, DOI 10.1016/S0920-9964(97)00112-6; Berle Jan O, 2010, BMC Res Notes, V3, P149, DOI 10.1186/1756-0500-3-149; Bombin I, 2005, SCHIZOPHRENIA BULL, V31, P962, DOI 10.1093/schbul/sbi028; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Dazzan P, 2002, BRIT J PSYCHIAT, V181, pS50, DOI 10.1192/bjp.181.43.s50; Deo AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009714; Eklund M, 2004, EUR PSYCHIAT, V19, P34, DOI 10.1016/j.eurpsy.2003.07.008; Farrow TFD, 2005, BRIT J PSYCHIAT, V187, P481, DOI 10.1192/bjp.187.5.481; Farrow Tom F D, 2009, Open Neuroimag J, V3, P48, DOI 10.2174/1874440000903010048; Folsom DP, 2009, SCHIZOPHR RES, V108, P207, DOI 10.1016/j.schres.2008.12.008; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hauge ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016291; HEINRICHS DW, 1988, AM J PSYCHIAT, V145, P11; Henry BL, 2010, NEUROSCI BIOBEHAV R, V34, P1296, DOI 10.1016/j.neubiorev.2010.04.002; Jeste DV, 2011, SCHIZOPHRENIA BULL, V37, P451, DOI 10.1093/schbul/sbr026; Kiang M, 2003, J PSYCHIATR NEUROSCI, V28, P293; Mayoral M, 2012, J CHILD PSYCHOL PSYC, V53, P323, DOI 10.1111/j.1469-7610.2011.02475.x; Minassian A, 2010, J AFFECT DISORDERS, V120, P200, DOI 10.1016/j.jad.2009.04.018; Mizrahi R, 2007, AM J PSYCHIAT, V164, P630, DOI 10.1176/appi.ajp.164.4.630; Morrens M, 2007, SCHIZOPHRENIA BULL, V33, P1038, DOI 10.1093/schbul/sbl051; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Pantelis C, 2009, NEUROPSYCHOL REV, V19, P385, DOI 10.1007/s11065-009-9114-1; Shepherd S, 2012, SCHIZOPHRENIA BULL, V38, P295, DOI 10.1093/schbul/sbq075; Szoke A, 2008, BRIT J PSYCHIAT, V192, P248, DOI 10.1192/bjp.bp.106.029009; TEICHER MH, 1995, HARVARD REV PSYCHIAT, V3, P18, DOI 10.3109/10673229509017161; TEICHER MH, 1988, ARCH GEN PSYCHIAT, V45, P913; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; Walther S, 2011, PSYCHIAT RES-NEUROIM, V192, P117, DOI 10.1016/j.pscychresns.2010.12.002; Walther S, 2011, NEUROBIOL DIS, V42, P276, DOI 10.1016/j.nbd.2011.01.017; Walther S, 2010, J CLIN PSYCHOPHARM, V30, P181, DOI 10.1097/JCP.0b013e3181d2ef6f; Walther S, 2009, PSYCHIAT RES, V169, P187, DOI 10.1016/j.psychres.2008.06.020; Walther S, 2009, NEUROPSYCHOBIOLOGY, V60, P80, DOI 10.1159/000236448; Wichniak A, 2011, J PSYCHIATR RES, V45, P1381, DOI 10.1016/j.jpsychires.2011.05.009; Wirz-Justice A, 2001, SCHIZOPHRENIA BULL, V27, P497, DOI 10.1093/oxfordjournals.schbul.a006890; Wood SJ, 2008, SCHIZOPHRENIA BULL, V34, P322, DOI 10.1093/schbul/sbm149	40	41	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43539	10.1371/journal.pone.0043539	http://dx.doi.org/10.1371/journal.pone.0043539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952701	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600031
J	Okello, E; Kakande, B; Sebatta, E; Kayima, J; Kuteesa, M; Mutatina, B; Nyakoojo, W; Lwabi, P; Mondo, CK; Odoi-Adome, R; Juergen, F				Okello, Emmy; Kakande, Barbara; Sebatta, Elias; Kayima, James; Kuteesa, Monica; Mutatina, Boniface; Nyakoojo, Wilson; Lwabi, Peter; Mondo, Charles K.; Odoi-Adome, Richard; Juergen, Freers			Socioeconomic and Environmental Risk Factors among Rheumatic Heart Disease Patients in Uganda	PLOS ONE			English	Article							FEVER; EPIDEMIOLOGY; DISTANCE; CHILDREN; ACCESS	Background: Although low socioeconomic status, and environmental factors are known risk factors for rheumatic heart disease in other societies, risk factors for rheumatic heart disease remain less well described in Uganda. Aims and Objective: The objective of this study was to investigate the role of socio-economic and environmental factors in the pathogenesis of rheumatic heart disease in Ugandan patients. Methods: This was a case control study in which rheumatic heart disease cases and normal controls aged 5-60 years were recruited and investigated for socioeconomic and environmental risk factors such as income status, employment status, distance from the nearest health centre, number of people per house and space area per person. Results: 486 participants (243 cases and 243 controls) took part in the study. Average age was 32.37+/-14.6 years for cases and 35.75+/-12.6 years for controls. At univariate level, Cases tended to be more overcrowded than controls; 8.0+/-3.0 versus 6.0+/-3.0 persons per house. Controls were better spaced at 25.2 square feet versus 16.9 for cases. More controls than cases were employed; 45.3% versus 21.1%. Controls lived closer to health centers than the cases; 4.8+/-3.8 versus 3.3+/-12.9 kilometers. At multivariate level, the odds of rheumatic heart disease was 1.7 times higher for unemployment status (OR = 1.7, 95% CI = 1.05-8.19) and 1.3 times higher for overcrowding (OR = 1.35, 95% CI = 1.1-1.56). There was interaction between overcrowding and longer distance from the nearest health centre (OR = 1.20, 95% CI = 1.05-1.42). Conclusion: The major findings of this study were that there was a trend towards increased risk of rheumatic heart disease in association with overcrowding and unemployment. There was interaction between overcrowding and distance from the nearest health center, suggesting that the effect of overcrowding on the risk of acquiring rheumatic heart disease increases with every kilometer increase from the nearest health center.	[Okello, Emmy; Kakande, Barbara; Sebatta, Elias; Kayima, James; Mondo, Charles K.; Juergen, Freers] Makerere Univ, Dept Med, Div Cardiol, Kampala, Uganda; [Okello, Emmy; Kakande, Barbara; Sebatta, Elias; Nyakoojo, Wilson; Lwabi, Peter; Mondo, Charles K.] Mulago Hosp, Uganda Heart Inst, Kampala, Uganda; [Odoi-Adome, Richard] Makerere Univ, Sch Pharm, Kampala, Uganda; [Kuteesa, Monica] Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Mutatina, Boniface] Makerere Univ, Coll Hlth Sci, Kampala, Uganda	Makerere University; Mulago National Referral Hospital; Makerere University; University of Sydney; Makerere University	Okello, E (corresponding author), Makerere Univ, Dept Med, Div Cardiol, Kampala, Uganda.	emmkol@hotmail.com	Kawooya, Ismael/O-4541-2016	Kawooya, Ismael/0000-0002-7159-7153; Lwabi, Peter/0000-0002-2895-3626; Okello, Emmy/0000-0002-6109-0092	Office of the United States Global Aids Coordinator; National Institutes of Health and Health Resources and Services Administration; Millennium Science initiative;  [R24TW008861]; FOGARTY INTERNATIONAL CENTER [R24TW008861] Funding Source: NIH RePORTER	Office of the United States Global Aids Coordinator; National Institutes of Health and Health Resources and Services Administration(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millennium Science initiative; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was supported by Grant Number R24TW008861 supported by Office of the United States Global Aids Coordinator, National Institutes of Health and Health Resources and Services Administration, and the Millennium Science initiative. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADANJA B, 1988, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V32, P329; AGARWAL BL, 1981, LANCET, V2, P910; Al-Taiar A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-38; Beaton A, 2011, CARDIOVASC J AFR, V22, pS3; Beaton A, 2012, CIRCULATION, V125, P3127, DOI 10.1161/CIRCULATIONAHA.112.092312; Carapetis JR, 2007, NEW ENGL J MED, V357, P439, DOI 10.1056/NEJMp078039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cheng TO, 2009, INT J CARDIOL, V3, P132; Dobson J, 2012, PEDIATR CARDIOL, V33, P332, DOI 10.1007/s00246-011-0139-x; DODU S R A, 1989, World Health Forum, V10, P203; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; GORDIS L, 1969, J CHRON DIS, V21, P655, DOI 10.1016/0021-9681(69)90037-X; GROVER A, 1993, B WORLD HEALTH ORGAN, V71, P59; IBRAHIMKHALIL S, 1992, J EPIDEMIOL COMMUN H, V46, P477, DOI 10.1136/jech.46.5.477; Jaine R, 2011, PEDIATR INFECT DIS J, V30, P315, DOI 10.1097/INF.0b013e3181fbd85b; KAPLAN EL, 1989, J INFECT DIS, V159, P101, DOI 10.1093/infdis/159.1.101; Kayima J., 2011, CARDIOVASC J AFR, V22, pS9; Kerdemelidis M, 2010, J PAEDIATR CHILD H, V46, P534, DOI 10.1111/j.1440-1754.2010.01854.x; Kleinbaum D. G., 2002, LOGISTIC REGRESSION; Longo-Mbenza B, 1998, INT J CARDIOL, V63, P287, DOI 10.1016/S0167-5273(97)00311-2; MCLAREN MJ, 1975, BRIT MED J, V3, P474, DOI 10.1136/bmj.3.5981.474; Mood E.W., 1986, APHA CDC RECOMMENDED; Noor AM, 2003, TROP MED INT HEALTH, V8, P917, DOI 10.1046/j.1365-3156.2003.01112.x; OTTO CM, 2004, TXB CLIN ECHOCARDIOG, P281; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Prasad BG, 1970, J INDIAN MED ASSOC, V55, P189; Sliwa K, 2010, EUR HEART J, V31, P719, DOI 10.1093/eurheartj/ehp530; Sliwa K, 2010, CLIN RES CARDIOL, V99, P65, DOI 10.1007/s00392-009-0094-1; Steer AC, 2002, J PAEDIATR CHILD H, V38, P229, DOI 10.1046/j.1440-1754.2002.00772.x; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; Veasy LG, 1990, NEW ENGL J MED, V8, P421; VLAJINAC H, 1991, EUR J EPIDEMIOL, V7, P702, DOI 10.1007/BF00218687; VLAJINAC H, 1989, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V33, P471; Wannamaker L., 1954, STREPTOCOCCAL INFECT, P157	34	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43917	10.1371/journal.pone.0043917	http://dx.doi.org/10.1371/journal.pone.0043917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952810	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800075
J	Stoeckle, MY; Kerr, KCR				Stoeckle, Mark Y.; Kerr, Kevin C. R.			Frequency Matrix Approach Demonstrates High Sequence Quality in Avian BARCODEs and Highlights Cryptic Pseudogenes	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA; IDENTIFICATION; GENES; BIRDS; POLYMORPHISM; VARIABILITY; MUTATIONS; ORIGIN; TALE	The accuracy of DNA barcode databases is critical for research and practical applications. Here we apply a frequency matrix to assess sequencing errors in a very large set of avian BARCODEs. Using 11,000 sequences from 2,700 bird species, we show most avian cytochrome c oxidase I (COI) nucleotide and amino acid sequences vary within a narrow range. Except for third codon positions, nearly all (96%) sites were highly conserved or limited to two nucleotides or two amino acids. A large number of positions had very low frequency variants present in single individuals of a species; these were strongly concentrated at the ends of the barcode segment, consistent with sequencing error. In addition, a small fraction (0.1%) of BARCODEs had multiple very low frequency variants shared among individuals of a species; these were found to represent overlooked cryptic pseudogenes lacking stop codons. The calculated upper limit of sequencing error was 8x10(-5) errors/nucleotide, which was relatively high for direct Sanger sequencing of amplified DNA, but unlikely to compromise species identification. Our results confirm the high quality of the avian BARCODE database and demonstrate significant quality improvement in avian COI records deposited in GenBank over the past decade. This approach has potential application for genetic database quality control, discovery of cryptic pseudogenes, and studies of low-level genetic variation.	[Stoeckle, Mark Y.] Rockefeller Univ, Program Human Environm, New York, NY 10021 USA; [Kerr, Kevin C. R.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	Rockefeller University; Royal Ontario Museum	Stoeckle, MY (corresponding author), Rockefeller Univ, Program Human Environm, 1230 York Ave, New York, NY 10021 USA.	mark.stoeckle@rockefeller.edu	Kerr, Kevin/B-8510-2013; Stoeckle, Mark/D-3729-2011	Kerr, Kevin/0000-0002-6784-3884; Stoeckle, Mark/0000-0002-8280-4795	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	KCRK was supported by a post-doctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2001, BBA-PROTEIN STRUCT M, V1544, P1, DOI 10.1016/S0167-4838(00)00241-7; Aliabadian M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004119; Baker AJ, 2009, MOL ECOL RESOUR, V9, P257, DOI 10.1111/j.1755-0998.2009.02650.x; Barraclough TG, 2010, PHILOS T R SOC B, V365, P1801, DOI 10.1098/rstb.2009.0276; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Campagna L, 2011, MOL PHYLOGENET EVOL, V61, P521, DOI 10.1016/j.ympev.2011.07.011; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; CHA RS, 1993, PCR METH APPL, V3, pS18; Coin L, 2004, BIOINFORMATICS, V20, P94, DOI 10.1093/bioinformatics/bth942; Consortium for the Barcode of Life Database Working Group, 2009, DAT STAND BARCODE RE; Cummings SM, 2010, CONSERV GENET, V11, P1095, DOI 10.1007/s10592-009-9864-6; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Dawson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015204; Dubey S, 2009, MOL PHYLOGENET EVOL, V50, P633, DOI 10.1016/j.ympev.2008.12.008; Dunshea G, 2008, B ENTOMOL RES, V98, P239, DOI 10.1017/S0007485308005993; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frey JE, 2004, HEREDITAS, V140, P92, DOI 10.1111/j.1601-5223.2004.01748.x; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Fry AJ, 1999, EVOLUTION, V53, P1617, DOI 10.1111/j.1558-5646.1999.tb05426.x; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; Hayden EC, 2012, NATURE NEWS; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2011, MOL ECOL RESOUR, V11, P1045, DOI 10.1111/j.1755-0998.2011.03049.x; Kerr KCR, 2010, GENOME, V53, P1103, DOI 10.1139/G10-085; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Kobayashi N, 1999, BIOCHEM GENET, V37, P317, DOI 10.1023/A:1018759210666; Kraytsberg Y, 2005, EXPER REV MOL DIAGNO, V5, P1; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwon YS, 2012, MITOCHONDRIAL D 0313; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Menashe I, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-393; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Mirol PM, 2000, HEREDITY, V84, P538, DOI 10.1046/j.1365-2540.2000.00689.x; Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Proutski V, 1998, BIOINFORMATICS, V14, P467, DOI 10.1093/bioinformatics/14.5.467; Ramos A, 2011, MITOCHONDRION, V11, P946, DOI 10.1016/j.mito.2011.08.009; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Schindel DE, 2011, ZOOKEYS, P87, DOI 10.3897/zookeys.152.2473; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Tavares ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028543; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vilaca Sibelle T., 2006, Revista Brasileira de Ornitologia, V14, P7; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Yoo HS, 2006, MOL CELLS, V22, P323; Yoshikawa S, 2003, FEBS LETT, V555, P8, DOI 10.1016/S0014-5793(03)01098-6	58	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43992	10.1371/journal.pone.0043992	http://dx.doi.org/10.1371/journal.pone.0043992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952842	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800085
J	Landry, B; Aliabadi, HM; Samuel, A; Gul-Uludag, H; Jiang, XY; Kutsch, O; Uludag, H				Landry, Breanne; Aliabadi, Hamidreza Montazeri; Samuel, Anuja; Guel-Uludag, Hilal; Jiang, Xiaoyan; Kutsch, Olaf; Uludag, Hasan			Effective Non-Viral Delivery of siRNA to Acute Myeloid Leukemia Cells with Lipid-Substituted Polyethylenimines	PLOS ONE			English	Article							SMALL INTERFERING RNA; GENE-EXPRESSION; DOWN-REGULATION; P-GLYCOPROTEIN; CANCER-CELLS; APOPTOSIS; MEMBRANE; DNA; PROLIFERATION; ACTIVATION	Use of small interfering RNA (siRNA) is a promising approach for AML treatment as the siRNA molecule can be designed to specifically target proteins that contribute to aberrant cell proliferation in this disease. However, a clinical-relevant means of delivering siRNA molecules must be developed, as the cellular delivery of siRNA is problematic. Here, we report amphiphilic carriers combining a cationic polymer (2 kDa polyethyleneimine, PEI2) with lipophilic moieties to facilitate intracellular delivery of siRNA to AML cell lines. Complete binding of siRNA by the designed carriers was achieved at a polymer: siRNA ratio of similar to 0.5 and led to siRNA/polymer complexes of similar to 100 nm size. While the native PEI2 did not display cytotoxicity on AML cell lines THP-1, KG-1 and HL-60, lipid-modification on PEI2 slightly increased the cytotoxicity, which was consistent with increased interaction of polymers with cell membranes. Cellular delivery of siRNA was dependent on the nature of lipid substituent and the extent of lipid substitution, and varied among the three AML cell lines used. Linoleic acid-substituted polymers performed best among the prepared polymers and gave a siRNA delivery equivalent to better performing commercial reagents. Using THP-1 cells and a reporter (GFP) and an endogenous (CXCR4) target, effective silencing of the chosen targets was achieved with 25 to 50 nM of siRNA concentrations, and without adversely affecting subsequent cell growth. We conclude that lipid-substituted PEI2 can serve as an effective delivery of siRNA to leukemic cells and could be employed in molecular therapy of leukemia.	[Landry, Breanne; Aliabadi, Hamidreza Montazeri; Samuel, Anuja; Uludag, Hasan] Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Guel-Uludag, Hilal; Uludag, Hasan] Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB, Canada; [Jiang, Xiaoyan] BC Canc Agcy, Terry Fox Labs, Vancouver, BC, Canada; [Kutsch, Olaf] Univ Alabama Birmingham, Ctr AIDS Res, Birmingham, AL USA; [Uludag, Hasan] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada	University of Alberta; University of Alberta; British Columbia Cancer Agency; University of Alabama System; University of Alabama Birmingham; University of Alberta	Landry, B (corresponding author), Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB, Canada.	hasan.uludag@ualberta.ca		Jiang, Xiaoyan/0000-0002-8974-7340	Alberta Innovates Health Sciences (AIHS); Canadian Institute of Health Research (CIHR); Natural Science and Engineering Research Council of Canada (NSERC); Women & Children's Research Institute (WCHRI); Alberta Cancer Foundation; AIHS Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	Alberta Innovates Health Sciences (AIHS); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Women & Children's Research Institute (WCHRI); Alberta Cancer Foundation; AIHS Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was financially supported by operating grants from Alberta Innovates Health Sciences (AIHS), Canadian Institute of Health Research (CIHR) and Natural Science and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. V. Somayaji for NMR analysis of polymers, Mr. C. Kucharski for technical help with cell culture and Ms. P. Mahdipoor for PCR analysis. We also thank Dr. Artphop Neamnark and Dr. Remant Bahadur K. C. for preparing the polymers for this study and Dr. Orawan Suwantong for help with electrophoresis studies. B. L. was supported by graduate studentships from Women & Children's Research Institute (WCHRI) and Alberta Cancer Foundation. H. M. is supported by an AIHS Fellowship.	Abbasi M, 2010, CANCER-AM CANCER SOC, V116, P5544, DOI 10.1002/cncr.25321; Abbasi S, 2011, CELL BIOCH BIOPHYS, P1; Agatha G, 2004, CANCER LETT, V209, P87, DOI 10.1016/j.canlet.2003.11.022; Agatha G, 2001, CANCER LETT, V173, P139, DOI 10.1016/S0304-3835(01)00674-7; Aichberger KJ, 2009, BLOOD, V114, P5342, DOI 10.1182/blood-2008-08-175190; Aliabadi HM, 2011, MOL PHARMACEUT, V8, P1821, DOI 10.1021/mp200176v; Aliabadi HM, 2011, MACROMOL BIOSCI, V11, P662, DOI 10.1002/mabi.201000402; Arthanari Y, 2010, J CONTROL RELEASE, V145, P272, DOI 10.1016/j.jconrel.2010.04.011; Breunig M, 2008, J CONTROL RELEASE, V130, P57, DOI 10.1016/j.jconrel.2008.05.016; Burnett A, 2000, NEW ENGL J MED, V341, P1051; Campbell NA, 2002, BIOL 6 EDITION MEMBR, P141; Cancer Facts & Figures, 2012, CANC FACTS FIGURES; Chen KC, 2010, J CELL PHYSIOL, V222, P625, DOI 10.1002/jcp.21979; Chen KC, 2010, J CELL BIOCHEM, V109, P245, DOI 10.1002/jcb.22404; Cioca DP, 2003, CANCER GENE THER, V10, P125, DOI 10.1038/sj.cgt.7700544; Coll JL, 1999, HUM GENE THER, V10, P1659, DOI 10.1089/10430349950017662; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Ferrari S, 1997, GENE THER, V4, P1100, DOI 10.1038/sj.gt.3300503; Godbey WT, 1999, P NATL ACAD SCI USA, V96, P5177, DOI 10.1073/pnas.96.9.5177; Grayson ACR, 2006, PHARM RES-DORDR, V23, P1868, DOI 10.1007/s11095-006-9009-2; Greiner J, 2008, CLIN CANCER RES, V14, P7161, DOI 10.1158/1078-0432.CCR-08-1102; Gul H, 2010, LEUKEMIA RES, V34, P235, DOI 10.1016/j.leukres.2009.05.014; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Hartig SM, 2007, BIOMATERIALS, V28, P3843, DOI 10.1016/j.biomaterials.2007.04.027; Hong SP, 2006, BIOCONJUGATE CHEM, V17, P728, DOI 10.1021/bc060077y; Incani V, 2007, J BIOMED MATER RES A, V81A, P493, DOI 10.1002/jbm.a.31249; Incani V, 2010, SOFT MATTER, V6, P2124, DOI 10.1039/b916362j; Jeong JH, 2001, J CONTROL RELEASE, V73, P391, DOI 10.1016/S0168-3659(01)00310-8; Kahn J, 2004, BLOOD, V103, P2942, DOI 10.1182/blood-2003-07-2607; Kaspers GJL, 2007, HAEMATOLOGICA, V92, P1519, DOI 10.3324/haematol.11203; Kloeckner J, 2006, BIOCONJUGATE CHEM, V17, P1339, DOI 10.1021/bc060133v; Koldehoff M, 2010, HAEMATOL-HEMATOL J, V95, P388, DOI 10.3324/haematol.2009.016063; Kwok A, 2011, NANOMED-NANOTECHNOL, V7, P210, DOI 10.1016/j.nano.2010.07.005; Lee JS, 2004, J BIOL CHEM, V279, P9379, DOI 10.1074/jbc.M310638200; Lima TM, 2002, TOXICOL IN VITRO, V16, P741, DOI 10.1016/S0887-2333(02)00095-4; Liu WH, 2009, TOXICOL LETT, V191, P140, DOI 10.1016/j.toxlet.2009.08.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClatchey KD, 2002, CLIN LAB MED; Mehrotra A, 2010, INT J CANCER, V127, P849, DOI 10.1002/ijc.25109; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Neamnark A, 2009, MOL PHARMACEUT, V6, P1798, DOI 10.1021/mp900074d; Ouyang SD, 2009, ZEBRAFISH, V6, P245, DOI 10.1089/zeb.2009.0589; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Puissant A, 2010, LEUKEMIA, V24, P115, DOI 10.1038/leu.2009.233; Sekeres MA, 2008, HAEMATOL-HEMATOL J, V93, P1769, DOI 10.3324/haematol.2008.000497; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Seo SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-199; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Shin JY, 2005, BBA-GEN SUBJECTS, V1725, P377, DOI 10.1016/j.bbagen.2005.05.018; Tallman MS, 2004, J CLIN ONCOL, V22, P1276, DOI 10.1200/JCO.2004.08.060; Taratula O, 2009, J CONTROL RELEASE, V140, P284, DOI 10.1016/j.jconrel.2009.06.019; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Wang XH, 2008, CHEMMEDCHEM, V3, P940, DOI 10.1002/cmdc.200700329; Wightman L, 2001, J GENE MED, V3, P362, DOI 10.1002/jgm.187; Yang JS, 2010, J PHARMACOL EXP THER, V334, P477, DOI 10.1124/jpet.109.165415; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zhu CH, 2010, BIOMATERIALS, V31, P2408, DOI 10.1016/j.biomaterials.2009.11.077; Zhu Q, 2010, MOL CELL BIOCHEM, V340, P275, DOI 10.1007/s11010-010-0428-3; Zintchenko A, 2008, BIOCONJUGATE CHEM, V19, P1448, DOI 10.1021/bc800065f	60	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44197	10.1371/journal.pone.0044197	http://dx.doi.org/10.1371/journal.pone.0044197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952927	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300062
J	Liu, T; Wang, Y; Peng, XR; Zhang, LQ; Cheng, JB; Jin, HJ; Wu, MC; Qian, QJ				Liu, Tao; Wang, Ying; Peng, Xinrong; Zhang, Liqing; Cheng, Jingbo; Jin, Huajun; Wu, Mengchao; Qian, Qijun			Establishment of Mouse Teratocarcinomas Stem Cells Line and Screening Genes Responsible for Malignancy	PLOS ONE			English	Article							SELF-RENEWAL; CANCER; EMBRYOS; DIFFERENTIATION; METASTASIS; EXPRESSION; OCT4; MICE	The sequential transplantation of embryonal carcinoma cells in vivo can accelerate the growth and malignancy of teratocarcinomas. However, the possible molecular mechanisms in this process that reflect cancer formation in the early stage are largely unknown and. To identify which genes are associated with the changes of malignancy of teratocarcinomas, we established a tumorigenesis model in which teratocarcinoma were induced via injecting embryonic stem cells into immuno-deficiency mice, isolating teratocarcinoma stem cell from a teratocarcinoma in serum-free culture medium and injecting teratocarcinoma stem cells into immune-deficient mice continuously. By using high-throughput deep sequence technology, we identified 26 differentially expressed genes related to the changes of characteristics of teratocarcinoma stem cell in which 18 out of 26 genes were down-regulated and 8 genes were up-regulated. Among these genes, several tumor-related genes such as Gata3, Arnt and Tdgf1, epigenetic associated genes such as PHC1 and Uty were identified. Pathway enrichment analysis result revealed that Wnt signaling pathway, primary immunodeficiency pathway, antigen processing and presentation pathway and allograft rejection pathway were involved in the teratocarcinoma tumorigenesis (corrected p value<0.05). In summary, our study established a tumorigenesis model and proposed some candidate genes and signaling pathways that may play a key role in the early stage of cancer occurrence.	[Liu, Tao; Wang, Ying; Peng, Xinrong; Cheng, Jingbo; Jin, Huajun; Wu, Mengchao; Qian, Qijun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Lab Viral & Gene Therapy, Shanghai, Peoples R China; [Zhang, Liqing; Qian, Qijun] Zhejiang Sci Tech Univ, Xinyuan Inst Med & Biotechnol, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Naval Medical University; Zhejiang Sci-Tech University	Liu, T (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Lab Viral & Gene Therapy, Shanghai, Peoples R China.	qianqj@sino-gene.cn	Wang, Ying/AAY-4117-2021	Wang, Ying/0000-0002-1819-294X	National Science Funds for Distinguished Young Scholar [30925037]; Science Fund for Creative Research Group of NSFC [30921006]; National Significant Science and Technology Special Projects of New Drugs Creation [2011ZX09102-010-02]	National Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Science Fund for Creative Research Group of NSFC(Science Fund for Creative Research Groups); National Significant Science and Technology Special Projects of New Drugs Creation	This work was supported by the National Science Funds for Distinguished Young Scholar (No. 30925037), the Science Fund for Creative Research Group of NSFC (No. 30921006) and the National Significant Science and Technology Special Projects of New Drugs Creation (No. 2011ZX09102-010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Yosef T, 1998, MAMM GENOME, V9, P595, DOI 10.1007/s003359900825; Bonner AE, 2004, NEOPLASIA, V6, P490, DOI 10.1593/neo.04124; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Bulic-Jakus F, 2006, COLLEGIUM ANTROPOL, V30, P921; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; DAMJANOV I, 1993, INT J DEV BIOL, V37, P39; DAMJANOV I, 1973, VIRCHOWS ARCH B, V13, P179; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Espada J, 2009, CLIN TRANSL ONCOL, V11, P411, DOI 10.1007/s12094-009-0380-4; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FAWCETT DW, 1950, CANCER RES, V10, P705; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lu D, 2011, ONCOTARGET, V2, P587; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Miyoshi N, 2010, INT J ONCOL, V36, P563, DOI 10.3892/ijo_00000530; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; PAPAIOANNOU VE, 1975, NATURE, V258, P70, DOI 10.1038/258070a0; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; SOLTER D, 1970, NATURE, V227, P503, DOI 10.1038/227503a0; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tanaka SS, 2011, DEV GROWTH DIFFER, V53, P843, DOI 10.1111/j.1440-169X.2011.01292.x; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022129	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43955	10.1371/journal.pone.0043955	http://dx.doi.org/10.1371/journal.pone.0043955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952821	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300037
J	Masters, T; Engl, W; Weng, ZL; Arasi, B; Gauthier, N; Viasnoff, V				Masters, Thomas; Engl, Wilfried; Weng, Zhe L.; Arasi, Bakya; Gauthier, Nils; Viasnoff, Virgile			Easy Fabrication of Thin Membranes with Through Holes. Application to Protein Patterning	PLOS ONE			English	Article							DIP-PEN NANOLITHOGRAPHY; MAMMALIAN-CELLS; SURFACES; ADHESION; ORIENTATION; ENVIRONMENT; GEOMETRY; DIVISION	Since protein patterning on 2D surfaces has emerged as an important tool in cell biology, the development of easy patterning methods has gained importance in biology labs. In this paper we present a simple, rapid and reliable technique to fabricate thin layers of UV curable polymer with through holes. These membranes are as easy to fabricate as microcontact printing stamps and can be readily used for stencil patterning. We show how this microfabrication scheme allows highly reproducible and highly homogeneous protein patterning with micron sized resolution on surfaces as large as 10 cm(2). Using these stencils, fragile proteins were patterned without loss of function in a fully hydrated state. We further demonstrate how intricate patterns of multiple proteins can be achieved by stacking the stencil membranes. We termed this approach microserigraphy.	[Masters, Thomas; Engl, Wilfried; Weng, Zhe L.; Arasi, Bakya; Gauthier, Nils; Viasnoff, Virgile] MechanoBiol Inst Singapore, Singapore, Singapore; [Viasnoff, Virgile] CNRS, ESPCI Paristech, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Masters, T (corresponding author), MechanoBiol Inst Singapore, Singapore, Singapore.	virgile.viasnoff@espci.fr	viasnoff, virgile/H-8832-2012	viasnoff, virgile/0000-0003-3949-2244; WENG, ZHE/0000-0002-1490-9237	MechanoBiology Institute; International Associated Laboratory Cell Adhesion France Singapore	MechanoBiology Institute; International Associated Laboratory Cell Adhesion France Singapore	The work was supported by MechanoBiology Institute seed funding and International Associated Laboratory Cell Adhesion France Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsuta K, 2007, J MICROMECH MICROENG, V17, P496, DOI 10.1088/0960-1317/17/3/011; Azioune A, 2010, METHOD CELL BIOL, V97, P133, DOI 10.1016/S0091-679X(10)97008-8; Azioune A, 2009, LAB CHIP, V9, P1640, DOI 10.1039/b821581m; Bartolo D, 2008, LAB CHIP, V8, P274, DOI 10.1039/b712368j; Brown PS, 2011, ACS APPL MATER INTER, V3, P1204, DOI 10.1021/am2000278; Chen CS, 2005, MRS BULL, V30, P194, DOI 10.1557/mrs2005.52; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Doraiswamy A, 2009, J BIOMED MATER RES B, V89B, P28, DOI 10.1002/jbm.b.31183; Falconnet D, 2004, NANO LETT, V4, P1909, DOI 10.1021/nl0489438; Fink J, 2007, LAB CHIP, V7, P672, DOI 10.1039/b618545b; Frimat JP, 2009, ANAL BIOANAL CHEM, V395, P601, DOI 10.1007/s00216-009-2824-7; Iwanaga S, 2005, BIOMATERIALS, V26, P5395, DOI 10.1016/j.biomaterials.2005.01.021; Jinno S, 2008, J BIOMED MATER RES A, V86A, P278, DOI 10.1002/jbm.a.32030; Kaufmann S, 2011, LAB CHIP, V11, P2403, DOI 10.1039/c1lc20073a; Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172; Lee SW, 2006, ADV MATER, V18, P1133, DOI 10.1002/adma.200600070; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Morel M, 2009, LAB CHIP, V9, P1011, DOI 10.1039/b819090a; Ng E, 2011, APPL NANOSCI, V1, P79, DOI 10.1007/s13204-011-0009-0; Orth RN, 2003, BIOPHYS J, V85, P3066, DOI 10.1016/S0006-3495(03)74725-0; Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m; Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Quist AP, 2010, EXPERT OPIN DRUG DIS, V5, P569, DOI 10.1517/17460441.2010.489606; Ruiz SA, 2007, SOFT MATTER, V3, P168, DOI 10.1039/b613349e; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Wright D, 2008, J BIOMED MATER RES A, V85A, P530, DOI 10.1002/jbm.a.31281; Zheng Y., 2010, BIOMICROFLUIDICS, V4	34	33	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44261	10.1371/journal.pone.0044261	http://dx.doi.org/10.1371/journal.pone.0044261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952944	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300071
J	Zhang, J; Silao, FGS; Bigol, UG; Bungay, AAC; Nicolas, MG; Heitman, J; Chen, YL				Zhang, Jing; Silao, Fitz Gerald S.; Bigol, Ursela G.; Bungay, Alice Alma C.; Nicolas, Marilou G.; Heitman, Joseph; Chen, Ying-Lien			Calcineurin Is Required for Pseudohyphal Growth, Virulence, and Drug Resistance in Candida lusitaniae	PLOS ONE			English	Article							AMPHOTERICIN-B; STRESS-ADAPTATION; OPPORTUNISTIC PATHOGEN; CALCOFLUOR WHITE; ALBICANS; FILAMENTATION; SENSITIVITY; INVOLVEMENT; TOLERANCE; FUNGEMIA	Candida lusitaniae is an emerging fungal pathogen that infects immunocompromised patients including HIV/AIDS, cancer, and neonatal pediatric patients. Though less prevalent than other Candida species, C. lusitaniae is unique in its ability to develop resistance to amphotericin B. We investigated the role of the calcium-activated protein phosphatase calcineurin in several virulence attributes of C. lusitaniae including pseudohyphal growth, serum survival, and growth at 37 degrees C. We found that calcineurin and Crz1, a C. albicans Crz1 homolog acting as a downstream target of calcineurin, are required for C. lusitaniae pseudohyphal growth, a process for which the underlying mechanism remains largely unknown in C. lusitaniae but hyphal growth is fundamental to C. albicans virulence. We demonstrate that calcineurin is required for cell wall integrity, ER stress response, optimal growth in serum, virulence in a murine systemic infection model, and antifungal drug tolerance in C. lusitaniae. To further examine the potential of targeting the calcineurin signaling cascade for antifungal drug development, we examined the activity of a calcineurin inhibitor FK506 in combination with caspofungin against echinocandin resistant C. lusitaniae clinical isolates. Broth microdilution and drug disk diffusion assays demonstrate that FK506 has synergistic fungicidal activity with caspofungin against echinocandin resistant isolates. Our findings reveal that pseudohyphal growth is controlled by the calcineurin signaling cascade, and highlight the potential use of calcineurin inhibitors and caspofungin for emerging drug-resistant C. lusitaniae infections.	[Zhang, Jing; Heitman, Joseph; Chen, Ying-Lien] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Zhang, Jing] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Silao, Fitz Gerald S.; Bungay, Alice Alma C.] Dr Jose G Tamayo Med Univ, Univ Perpetual Help, Dept Microbiol & Parasitol, Binan, Laguna, Philippines; [Bigol, Ursela G.] Dept Sci & Technol, Environm & Biotechnol Div, Bicutan, Philippines; [Bungay, Alice Alma C.; Nicolas, Marilou G.] Univ Philippines, Natl Inst Hlth Philippines, Manila, Philippines	Duke University; Duke University; Department of Science & Technology (DOST), Philippines; University of the Philippines System; University of the Philippines Manila	Zhang, J (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	heitm001@duke.edu; joseph.chen@duke.edu	Heitman, Joseph/ABC-6006-2021	Chen, Ying-Lien/0000-0002-1966-470X	Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH) [2P30 AI064518-06]; NIH/National Institute of Allergy and Infectious Diseases [AI50438]; Astellas Pharma Inc.; Merck Co. Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050438, P30AI064518] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Astellas Pharma Inc.(Astellas Pharmaceuticals); Merck Co. Inc.(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Duke University Center for AIDS Research (CFAR), a National Institutes of Health (NIH)-funded program (2P30 AI064518-06 to Y.-L.C.) and NIH/National Institute of Allergy and Infectious Diseases R01 grant AI50438 (J.H.). This work was also supported by Pilot funds from Astellas Pharma Inc. and Merck & Co. Inc. (J.H. and Y.- L.C.). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Atkinson BJ, 2008, MED MYCOL, V46, P541, DOI 10.1080/13693780801968571; BAKER JG, 1984, DIAGN MICR INFEC DIS, V2, P145, DOI 10.1016/0732-8893(84)90010-5; Blankenship JR, 2005, INFECT IMMUN, V73, P5767, DOI 10.1128/IAI.73.9.5767-5774.2005; Blankenship JR, 2003, EUKARYOT CELL, V2, P422, DOI 10.1128/EC.2.3.422-430.2003; BLINKHORN RJ, 1989, J CLIN MICROBIOL, V27, P236, DOI 10.1128/JCM.27.2.236-240.1989; Boisnard S, 2008, YEAST, V25, P849, DOI 10.1002/yea.1636; Boisnard S, 2008, EUKARYOT CELL, V7, P2179, DOI 10.1128/EC.00262-08; Brand A, 2007, CURR BIOL, V17, P347, DOI 10.1016/j.cub.2006.12.043; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Canton E, 2009, EXPERT REV ANTI-INFE, V7, P107, DOI 10.1586/14787210.7.1.107; Chapeland-Leclerc F, 2007, EUKARYOT CELL, V6, P1782, DOI 10.1128/EC.00155-07; Chen YL, 2012, G3-GENES GENOM GENET, V2, P675, DOI 10.1534/g3.112.002279; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; Chen YL, 2010, CURR FUNGAL INFECT R, V4, P244, DOI 10.1007/s12281-010-0027-5; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Cruz MC, 2001, EMBO J, V20, P1020, DOI 10.1093/emboj/20.5.1020; Desnos-Ollivier M, 2011, J CLIN MICROBIOL, V49, P2304, DOI 10.1128/JCM.00325-11; Dutta A, 2011, PEDIATR INFECT DIS J, V30, P664, DOI 10.1097/INF.0b013e318213da0f; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Favel A, 2003, DIAGN MICR INFEC DIS, V47, P331, DOI 10.1016/S0732-8893(03)00094-4; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; GUINET R, 1983, J CLIN MICROBIOL, V18, P443, DOI 10.1128/JCM.18.2.443-444.1983; Hawkins JL, 2003, CLIN INFECT DIS, V36, pE14, DOI 10.1086/344651; Huynh N, 2012, OCUL IMMUNOL INFLAMM, V20, P100, DOI 10.3109/09273948.2011.646383; Jackson BE, 2007, MICROB PATHOGENESIS, V42, P88, DOI 10.1016/j.micpath.2006.11.005; Jinhee C, 2009, J MICROBIOL BIOTECHN, V19, P11, DOI 10.4014/jmb.0804.268; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; MERZ WG, 1984, J CLIN MICROBIOL, V20, P1194, DOI 10.1128/JCM.20.6.1194-1195.1984; Miller NS, 2006, J CLIN MICROBIOL, V44, P1536, DOI 10.1128/JCM.44.4.1536-1539.2006; Minari A, 2001, CLIN INFECT DIS, V32, P186, DOI 10.1086/318473; Morris MI, 2006, AM J HEALTH-SYST PH, V63, P1693, DOI 10.2146/ajhp050464.p1; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; Onyewu C, 2004, INFECT IMMUN, V72, P7330, DOI 10.1128/IAI.72.12.7330-7333.2004; PAPPAGIANIS D, 1979, ANTIMICROB AGENTS CH, V16, P123, DOI 10.1128/AAC.16.2.123; Parentin F, 2006, OCUL IMMUNOL INFLAMM, V14, P129, DOI 10.1080/09273940500328487; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Ruprich-Robert G, 2008, EUKARYOT CELL, V7, P1071, DOI 10.1128/EC.00066-08; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Santos M, 2005, CURR GENET, V48, P88, DOI 10.1007/s00294-005-0003-8; SEWELL DL, 1994, J CLIN MICROBIOL, V32, P2099, DOI 10.1128/JCM.32.9.2099-2102.1994; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Stokes C, 2007, FUNGAL GENET BIOL, V44, P920, DOI 10.1016/j.fgb.2006.11.014; TUKMACHEV VA, 1979, BIOFIZIKA+, V24, P55; Young LY, 2003, ANTIMICROB AGENTS CH, V47, P2717, DOI 10.1128/AAC.47.9.2717-2724.2003; Young LY, 2000, GENETICS, V155, P17; Zhang Jing, 2012, Commun Integr Biol, V5, P122, DOI 10.4161/cib.18833	50	37	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44192	10.1371/journal.pone.0044192	http://dx.doi.org/10.1371/journal.pone.0044192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952924	gold, Green Submitted, Green Published			2022-12-27	WOS:000308221300061
J	Chintinne, M; Stange, G; Denys, B; Ling, ZD; 't Veld, PI; Pipeleers, D				Chintinne, Marie; Stange, Geert; Denys, Bart; Ling, Zhidong; 't Veld, Peter In; Pipeleers, Daniel			Beta Cell Count Instead of Beta Cell Mass to Assess and Localize Growth in Beta Cell Population following Pancreatic Duct Ligation in Mice	PLOS ONE			English	Article							EXOCRINE PANCREAS; ADULT PANCREAS; ISLET GROWTH; PROGENITORS; NEOGENESIS; ENDOCRINE; BIRTH; DIFFERENTIATION; RATS	Background: Pancreatic-tail duct ligation (PDL) in adult rodents has been reported to induce beta cell generation and increase beta cell mass but increases in beta cell number have not been demonstrated. This study examines whether PDL increases beta cell number and whether this is caused by neogenesis of small clusters and/or their growth to larger aggregates. Methodology: Total beta cell number and its distribution over small (<50 mu m), medium, large (>100 mu m) clusters was determined in pancreatic tails of 10-week-old mice, 2 weeks after PDL or sham. Principal findings: PDL increased total beta cell mass but not total beta cell number. It induced neogenesis of small beta cell clusters (2.2-fold higher number) which contained a higher percent proliferating beta cells (1.9% Ki67+cells) than sham tails (<0.2%); their higher beta cell number represented <5% of total beta cell number and was associated with a similar increase in alpha cell number. It is unknown whether the regenerative process is causally related to the inflammatory infiltration in PDL-tails. Human pancreases with inflammatory infiltration also exhibited activation of proliferation in small beta cell clusters. Conclusions/significance: The PDL model illustrates the advantage of direct beta cell counts over beta cell mass measurements when assessing and localizing beta cell regeneration in the pancreas. It demonstrates the ability of the adult mouse pancreas for neogenesis of small beta cell clusters with activated beta cell proliferation. Further studies should investigate conditions under which neoformed small beta cell clusters grow to larger aggregates and hence to higher total beta cell numbers.	[Chintinne, Marie; Stange, Geert; Denys, Bart; Ling, Zhidong; 't Veld, Peter In; Pipeleers, Daniel] Free Univ Brussels VIB, Diabet Res Ctr, B-1050 Brussels, Belgium; [Chintinne, Marie] UZ Brussel, Dept Pathol, Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University Hospital Brussels	Chintinne, M (corresponding author), Free Univ Brussels VIB, Diabet Res Ctr, B-1050 Brussels, Belgium.	Daniel.Pipeleers@vub.ac.be	Veld, Peter A In't/E-3624-2013; stange, geert m/C-1092-2009	Veld, Peter A In't/0000-0001-5596-7129; stange, geert m/0000-0003-3148-1372; Pipeleers, Daniel/0000-0002-6440-2485	Research Foundation Flanders [FWO-G.0400.07]; Belgian Inter-University Poles of Attraction Program [IUAP P6/40]; 7th EU-framework [GA241883]	Research Foundation Flanders(FWO); Belgian Inter-University Poles of Attraction Program; 7th EU-framework	This work was supported by grants from Research Foundation Flanders (FWO-G.0400.07), the Belgian Inter-University Poles of Attraction Program (IUAP P6/40), the 7th EU-framework (BetaCellTherapy number GA241883). M. Chintinne and B. Denys were Ph.D. fellows of FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertelli E, 1997, AM J PHYSIOL-CELL PH, V273, pC1641, DOI 10.1152/ajpcell.1997.273.5.C1641; Bonner-Weir S, 2000, J MOL ENDOCRINOL, V24, P297, DOI 10.1677/jme.0.0240297; Chintinne M, 2010, DIABETOLOGIA, V53, P2380, DOI 10.1007/s00125-010-1851-4; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Criscimanna A, 2011, GASTROENTEROLOGY; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hakonen E, 2011, DIABETOLOGIA; In't Veld P, 2010, DIABETES, V59, P1702, DOI 10.2337/db09-1698; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Nakamura K, 2011, BIOMED RES-TOKYO, V32, P167, DOI 10.2220/biomedres.32.167; Rooman I, 2002, DIABETES, V51, P686, DOI 10.2337/diabetes.51.3.686; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Svenstrup K, 2002, APMIS, V110, P372, DOI 10.1034/j.1600-0463.2002.100502.x; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	18	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43959	10.1371/journal.pone.0043959	http://dx.doi.org/10.1371/journal.pone.0043959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952825	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500031
J	Helle, M; Cassette, E; Bezdetnaya, L; Pons, T; Leroux, A; Plenat, F; Guillemin, F; Dubertret, B; Marchal, F				Helle, Marion; Cassette, Elsa; Bezdetnaya, Lina; Pons, Thomas; Leroux, Agnes; Plenat, Francois; Guillemin, Francois; Dubertret, Benoit; Marchal, Frederic			Visualisation of Sentinel Lymph Node with Indium-Based near Infrared Emitting Quantum Dots in a Murine Metastatic Breast Cancer Model	PLOS ONE			English	Article							BIOPSY; NANOPARTICLES; CYTOTOXICITY; TOXICITY; BONE; PHARMACOKINETICS; EXPRESSION; CLEARANCE; CELLS; LIGHT	Due to its non-invasiveness, high temporal resolution and lower cost, fluorescence imaging is an interesting alternative to the current method (blue dye and radiocolloid) of sentinel lymph node (SLN) mapping in breast cancer. Near-infrared (NIR) emitting cadmium-based Quantum Dots (QDs) could be used for this purpose; however, their wide application is limited because of the toxicity of heavy metals composing the core. Our recent work demonstrated that indium-based QDs exhibit a weak acute local toxicity in vivo compared to their cadmium-based counterparts. In the present study we confirmed the weak toxicity of CuInS2/ZnS QDs in different in vitro models. Further in vivo studies in healthy mice showed that In-based QDs could be visualised in SLN in a few minutes after administration with a progressive increase in fluorescence until 8 h. The quantity of indium was assessed in selected organs and tissues by inductively coupled plasma - mass spectroscopy (ICP-MS) as a function of post-injection time. QD levels decrease rapidly at the injection point in the first hours after administration with a parallel increase in the lymph nodes and to a lesser extent in the liver and spleen. In addition, we observed that 3.5% of the injected indium dose was excreted in faeces in the first 4 days, with only trace quantities in the urine. Metastatic spread to the lymph nodes may hamper its visualisation. Therefore, we further performed non-invasive fluorescence measurement of QDs in SLN in tumour-bearing mice. Metastatic status was assessed by immunohistology and molecular techniques and revealed the utmost metastatic invasion of 36% of SLN. Fluorescence signal was the same irrespective of SLN status. Thus, near-infrared emitting cadmium-free QDs could be an excellent SLN tracer.	[Helle, Marion; Bezdetnaya, Lina; Guillemin, Francois; Marchal, Frederic] Univ Lorraine, CRAN, UMR 7039, Vandoeuvre Les Nancy, France; [Helle, Marion; Bezdetnaya, Lina; Guillemin, Francois; Marchal, Frederic] CNRS, CRAN, UMR 7039, Vandoeuvre Les Nancy, France; [Helle, Marion; Bezdetnaya, Lina; Guillemin, Francois; Marchal, Frederic] Ctr Alexis Vautrin, Res Unit, Vandoeuvre Les Nancy, France; [Leroux, Agnes; Plenat, Francois] Univ Lorraine, Signalisat EA4421, Genom & Rech Translationnelle Oncol SiGReTO, Vandoeuvre Les Nancy, France; [Cassette, Elsa; Pons, Thomas; Dubertret, Benoit] Univ Paris 06, CNRS, Lab Phys & Etud Mat, Ecole Super Phys & Chim Ind,UMR 8213, Paris, France	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite	Helle, M (corresponding author), Univ Lorraine, CRAN, UMR 7039, Vandoeuvre Les Nancy, France.	l.bolotine@nancy.unicancer.fr	Pons, Thomas/A-8667-2008; Pons, Thomas/J-2751-2019	Pons, Thomas/0000-0001-8800-4302; Pons, Thomas/0000-0001-8800-4302; Cassette, Elsa/0000-0002-1471-6558	Institut National du Cancer (INCa); Ligue Nationale contre le cancer; Lorraine Region; Centre Alexis Vautrin	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Lorraine Region(Region Grand-Est); Centre Alexis Vautrin	This work was supported by the Institut National du Cancer (INCa), the Ligue Nationale contre le cancer, the Lorraine Region and the Centre Alexis Vautrin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus J, 2005, J MOL DIAGN, V7, P327, DOI 10.1016/S1525-1578(10)60561-2; Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j; Barthelmes L, 2010, EJSO-EUR J SURG ONC, V36, P399, DOI 10.1016/j.ejso.2009.10.007; Bonnema J, 2002, ANN ONCOL, V13, P1531, DOI 10.1093/annonc/mdf319; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; CASTRONOVO FP, 1971, BRIT J EXP PATHOL, V52, P543; Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3; Chen HW, 2007, B ENVIRON CONTAM TOX, V78, P5, DOI 10.1007/s00128-007-9037-6; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; CHOULY C, 1994, CLIN MATER, V15, P293, DOI 10.1016/0267-6605(94)90061-2; Crane LMA, 2011, GYNECOL ONCOL, V120, P291, DOI 10.1016/j.ygyno.2010.10.009; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dreau D, 2006, CLIN EXP METASTAS, V23, P41, DOI 10.1007/s10585-006-9016-z; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Estourgie SH, 2003, EUR J SURG ONCOL, V29, P336, DOI 10.1053/ejso.2002.1379; Fischer HC, 2006, ADV FUNCT MATER, V16, P1299, DOI 10.1002/adfm.200500529; Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i; Goyal A, 2005, BREAST J, V11, P188, DOI 10.1111/j.1075-122X.2005.21591.x; Gravier J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3625405; Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284; Hirche C, 2010, ANN SURG ONCOL, V17, P2357, DOI 10.1245/s10434-010-1010-7; Hirche C, 2012, INT J COLORECTAL DIS, V27, P319, DOI 10.1007/s00384-011-1306-5; Hirche C, 2010, BREAST CANCER RES TR, V121, P373, DOI 10.1007/s10549-010-0760-z; Hoet P, 2011, TOXICOL LETT; Hunter F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-5; Jamieson T, 2007, BIOMATERIALS, V28, P4717, DOI 10.1016/j.biomaterials.2007.07.014; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liu YF, 2010, J COLLOID INTERF SCI, V351, P1, DOI 10.1016/j.jcis.2010.07.047; Male KB, 2008, ANAL CHEM, V80, P5487, DOI 10.1021/ac8004555; McMasters KM, 2000, J CLIN ONCOL, V18, P2560, DOI 10.1200/JCO.2000.18.13.2560; Mieog JSD, 2011, ANN SURG ONCOL, V18, P2483, DOI 10.1245/s10434-011-1566-x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; NTP, 2001, TOX CARC STUD IND PH; PIC E, 2009, MOL IMAGING BIOL; Pons T, 2010, ACS NANO, V4, P2531, DOI 10.1021/nn901421v; Riviere JE, 2009, WIRES NANOMED NANOBI, V1, P26, DOI 10.1002/wnan.24; Slowing II, 2009, SMALL, V5, P57, DOI 10.1002/smll.200800926; Tanaka E, 2006, ANN SURG ONCOL, V13, P1671, DOI 10.1245/s10434-006-9194-6; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Tsay JM, 2005, CHEM BIOL, V12, P1159, DOI 10.1016/j.chembiol.2005.11.002; Vincent-Salomon A, 2009, EUR J CANCER, V45, P1979, DOI 10.1016/j.ejca.2009.03.015; Wong Sandra L, 2002, Breast J, V8, P192, DOI 10.1046/j.1524-4741.2002.08402.x; Yong KT, 2010, INTEGR BIOL-UK, V2, P121, DOI 10.1039/b916663g; ZHENG W, 1994, J TOXICOL ENV HEALTH, V43, P483, DOI 10.1080/15287399409531936; Zurrida S, 1999, INT J ONCOL, V15, P475	47	40	41	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44433	10.1371/journal.pone.0044433	http://dx.doi.org/10.1371/journal.pone.0044433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952979	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500071
J	Ibarz-Pavon, AB; Lemos, AP; Gorla, MC; Regueira, M; Gabastou, JM				Ibarz-Pavon, Ana Belen; Lemos, Ana Paula; Gorla, Maria Cecilia; Regueira, Mabel; Gabastou, Jean-Marc		SIREVA II Working Grp	Laboratory-Based Surveillance of Neisseria meningitidis Isolates from Disease Cases in Latin American and Caribbean Countries, SIREVA II 2006-2010	PLOS ONE			English	Article							INVASIVE MENINGOCOCCAL DISEASE; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; CARRIED MENINGOCOCCI; C DISEASE; SEROGROUP; VACCINATION; SUSCEPTIBILITY; EPIDEMIOLOGY; PENICILLIN	Background: Published data on the epidemiology of meningococcal disease in Latin America and the Caribbean region is scarce and, when available, it is often published in Spanish and/or in non-peer-reviewed journals, making it difficult for the international scientific community to have access. Methods: Laboratory data on 4,735 Neisseria meningitidis strains was collected and reported by the National Reference Laboratories in 19 Latin American countries and the Caribbean Epidemiology Centre (CAREC) between 2006 and 2010 as part of the work carried out by the SIREVA II network. Serogroup and MIC to penicillin, rifampin and chloramphenicol were determined. Results: Isolates were mainly obtained from patients < 5 years, but each year around 25% of isolates came from adult patients. Serogroup distribution was highly variable among countries. Serogroup C was the main cause of disease in Brazil; the majority of disease seen in the Southern cone was caused by serogroup B, but serogroup W135 strains have increased in recent years. In the Andean and Mexico, Central America and Caribbean regions, serogroups B and C were equally present, and serogroup Y was frequently isolated. Isolates were generally susceptible to chloramphenicol, penicillin and rifampin, but almost 60% of isolates characterized in Southern cone countries presented intermediate resistance to penicillin. Five rifampin-resistant isolates have been isolated in Uruguay and Brazil. Conclusions: Serogroup distribution is highly variable among countries, but some geographic structuring can be inferred from these data. Epidemiological and laboratory data are scarce among Andean and Mexico, Central America and Caribbean countries. Evaluation and implementation of corrective measures on disease surveillance and reporting systems and the implementation of molecular diagnostic techniques and molecular characterization on meningococcal isolates are advised.	[Ibarz-Pavon, Ana Belen; Gabastou, Jean-Marc] Pan Amer Hlth Org, Washington, DC USA; [Lemos, Ana Paula; Gorla, Maria Cecilia] Adolfo Lutz Inst, Dept Bacteriol, Div Med Biol, Sao Paulo, Brazil; [Regueira, Mabel] ANLIS INEI Dr Carlos G Malbran, Dept Bacteriol, Buenos Aires, DF, Argentina	Pan American Health Organization; Instituto Adolfo Lutz	Ibarz-Pavon, AB (corresponding author), Pan Amer Hlth Org, Washington, DC USA.	ibarzpav@paho.org	Lemos, Ana Paula/ABE-6240-2021	Echaniz-Aviles, Gabriela/0000-0002-3167-0168; Castaneda, Elizabeth/0000-0001-5970-1598	Canadian International Development Agency (CIDA); Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Canadian International Development Agency (CIDA); Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Funding to the SIREVA II network was provided by the Canadian International Development Agency (CIDA). Since 2010, funding for meningococcal disease surveillance in 2010 is provided by Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2009, J INFECTION, V59, P104, DOI 10.1016/j.jinf.2009.06.001; Agudelo C I, 2000, Rev Panam Salud Publica, V8, P181, DOI 10.1590/S1020-49892000000800005; Agudelo CI, 2008, EMERG INFECT DIS, V14, P990, DOI 10.3201/eid1406.071357; Aguilar-Garcia J, 2009, REV CLIN ESP, V209, P221, DOI 10.1016/S0014-2565(09)71238-X; [Anonymous], 1996, EPI Newsl, V18, P6; Baquero F, 1998, Enferm Infecc Microbiol Clin, V16, P85; Barroso DE, 2007, MEM I OSWALDO CRUZ, V102, P773, DOI [10.1590/S0074-02762007005000104, 10.1590/S0074-02762007000600019]; BROOME CV, 1986, J ANTIMICROB CHEMOTH, V18, P25, DOI 10.1093/jac/18.Supplement_A.25; Brown EM, 2010, ANTIMICROB AGENTS CH, V54, P1016, DOI 10.1128/AAC.01077-09; Cano R, 2004, Euro Surveill, V9, P5, DOI 10.2807/esm.09.07.00474-en; Cartwright K., 1995, MENINGOCOCCAL DIS, P115; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Castaneda Elizabeth, 2009, Pediatr Infect Dis J, V28, pe265, DOI 10.1097/INF.0b013e3181a74b22; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Deghmane AE, 2010, J INFECT DIS, V202, P247, DOI 10.1086/653583; Di Fabio JL, 2001, PEDIATR INFECT DIS J, V20, P959, DOI 10.1097/00006454-200110000-00009; Diaz JM, 2001, REV MED CHILE, V129, P719; DiFabio JL, 1997, MICROB DRUG RESIST, V3, P131, DOI 10.1089/mdr.1997.3.131; Doyle TJ, 2010, EMERG INFECT DIS, V16, P113, DOI 10.3201/eid1601.091026; du Plessis M, 2008, J CLIN MICROBIOL, V46, P3208, DOI 10.1128/JCM.00221-08; Gabastou JM, 2008, REV PANAM SALUD PUBL, V24, P1, DOI 10.1590/S1020-49892008000700001; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Harrison LH, 2010, CLIN INFECT DIS, V50, pS37, DOI 10.1086/648963; Hortal M, 2000, Rev Panam Salud Publica, V8, P185, DOI 10.1590/S1020-49892000000800006; Ibarz-Pavon AB, 2011, J INFECT DIS, V204, P1046, DOI 10.1093/infdis/jir466; Jardine A, 2009, COMMUN DIS INTELL, V33, P221; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Kafetzis DA, 2007, CLIN MICROBIOL INFEC, V13, P550, DOI 10.1111/j.1469-0691.2007.01704.x; KUZEMENSKA P, 1984, ZBL BAKT-INT J MED M, V257, P195, DOI 10.1016/S0174-3031(84)80053-0; Lagos R, 1996, PEDIATR INFECT DIS J, V15, P216, DOI 10.1097/00006454-199603000-00008; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Lopez L, 2011, EPIDEMIOLOGY MENINGO; Lovgren M, 2007, J CLIN MICROBIOL, V45, P3184, DOI 10.1128/JCM.00789-07; McEllistrem MC, 2004, EMERG INFECT DIS, V10, P451; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Núñez Niury, 2007, Vaccimonitor, V16, P1; OPS, 2010, INF REG SIREVA 2 201; OPS, 2007, INF REG SIREVA 2 DAT; OPS, 2010, INF REG SIREVA 2 200; OPS, 2008, INF REG SIREVA 2 200; OPS, 2009, INF REG SIREVA 2 200; Safadi MAP, 2010, NEUROL RES, V32, P263, DOI 10.1179/016164110X12644252260754; Parodi V, 1998, REV MED URUG, V14, P221; PELTOLA H, 1982, LANCET, V2, P595; Pereira CS, 2008, J MED MICROBIOL, V57, P338, DOI 10.1099/jmm.0.47631-0; Giffoni GP, 2011, REV PANAM SALUD PUBL, V30, P540, DOI 10.1590/S1020-49892011001200007; Perez Rodriguez A, 1999, Rev Cubana Med Trop, V51, P189; Popovic T, 1998, LAB METHODS DIAGNOSI; Rodriguez AP, 1999, MEM I OSWALDO CRUZ, V94, P433, DOI 10.1590/S0074-02761999000400002; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Russell JE, 2008, MICROBIOL-SGM, V154, P1170, DOI 10.1099/mic.0.2007/014761-0; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; Salisbury D, 2001, J Paediatr Child Health, V37, pS34, DOI 10.1046/j.1440-1754.2001.00738.x; Skoczynska A, 2010, EUROSURVEILLANCE, V15; Sotolongo F, 2008, MEDICC REV, V9, P16; Stefanelli P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-135; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Taylor-Robinson D, 2010, J PUBLIC HEALTH-UK, V32, P32, DOI 10.1093/pubmed/fdp080; Trotter CL, 2002, J MED MICROBIOL, V51, P855, DOI 10.1099/0022-1317-51-10-855; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Weiss D, 2009, CLIN INFECT DIS, V48, P894, DOI 10.1086/597257; Wikler M., 2006, METHODS DILUTION ANT	64	31	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44102	10.1371/journal.pone.0044102	http://dx.doi.org/10.1371/journal.pone.0044102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952888	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500046
J	Watkins, SC; Maniar, S; Mosher, M; Roman, BL; Tsang, M; St Croix, CM				Watkins, Simon C.; Maniar, Salony; Mosher, Mackenzie; Roman, Beth L.; Tsang, Michael; St Croix, Claudette M.			High Resolution Imaging of Vascular Function in Zebrafish	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; ENDOTHELIAL FUNCTION; EUROPEAN-SOCIETY; GENE-EXPRESSION; WORKING GROUP; NITRIC-OXIDE; DANIO-RERIO; BLOOD-FLOW; DYSFUNCTION; CELL	Rationale: The role of the endothelium in the pathogenesis of cardiovascular disease is an emerging field of study, necessitating the development of appropriate model systems and methodologies to investigate the multifaceted nature of endothelial dysfunction including disturbed barrier function and impaired vascular reactivity. Objective: We aimed to develop and test an optimized high-speed imaging platform to obtain quantitative real-time measures of blood flow, vessel diameter and endothelial barrier function in order to assess vascular function in live vertebrate models. Methods and Results: We used a combination of cutting-edge optical imaging techniques, including high-speed, camera-based imaging (up to 1000 frames/second), and 3D confocal methods to collect real time metrics of vascular performance and assess the dynamic response to the thromboxane A(2) (TXA(2)) analogue, U-46619 (1 mu M), in transgenic zebrafish larvae. Data obtained in 3 and 5 day post-fertilization larvae show that these methods are capable of imaging blood flow in a large (1 mm) segment of the vessel of interest over many cardiac cycles, with sufficient speed and sensitivity such that the trajectories of individual erythrocytes can be resolved in real time. Further, we are able to map changes in the three dimensional sizes of vessels and assess barrier function by visualizing the continuity of the endothelial layer combined with measurements of extravasation of fluorescent microspheres. Conclusions: We propose that this system-based microscopic approach can be used to combine measures of physiologic function with molecular behavior in zebrafish models of human vascular disease.	[Watkins, Simon C.; St Croix, Claudette M.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Maniar, Salony; Mosher, Mackenzie; St Croix, Claudette M.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Roman, Beth L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Tsang, Michael] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Watkins, SC (corresponding author), Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15260 USA.	cls13@pitt.edu	St Croix, Claudette/AAA-3338-2022; Watkins, Simon/ABG-2590-2021; TSANG, Michael/E-2758-2013; Tsang, Michael/AAG-9338-2020; Tsang, Michael/ABV-0504-2022; Tsang, Michael W/I-9305-2014	Watkins, Simon/0000-0003-4092-1552; TSANG, Michael/0000-0001-6384-2422; Tsang, Michael/0000-0001-7123-0063; Tsang, Michael W/0000-0001-7123-0063; Roman, Beth/0000-0002-1250-1705	National Institutes of Health [NIH HL081421, NIH HL079108, NIH HL088016, NIH 1 U54 RR022241-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079108, R01HL081421, R01HL088016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from National Institutes of Health NIH HL081421 (CMS); NIH HL079108 (BLR); NIH HL088016 (MT) and NIH 1 U54 RR022241-01 (SCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird William C, 2006, Curr Atheroscler Rep, V8, P69, DOI 10.1007/s11883-006-0067-z; Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020; Bagatto B, 2006, PHYSIOL BIOCHEM ZOOL, V79, P194, DOI 10.1086/498185; Baldessari D, 2008, PHARMACOL THERAPEUT, V118, P206, DOI 10.1016/j.pharmthera.2008.02.010; Bernal PJ, 2008, CIRC RES, V102, P1575, DOI 10.1161/CIRCRESAHA.108.171264; Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; Denvir MA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-21; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Feletou M, PFLUGERS ARCH, V459, P941; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; Fritsche R, 2000, AM J PHYSIOL-REG I, V279, pR2200, DOI 10.1152/ajpregu.2000.279.6.R2200; Glyn MCP, 2000, CARDIOVASC RES, V48, P346, DOI 10.1016/S0008-6363(00)00173-5; Glyn MCP, 2002, J VASC RES, V39, P72, DOI 10.1159/000048995; Hove Jay R, 2004, Birth Defects Res C Embryo Today, V72, P277, DOI 10.1002/bdrc.20019; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Kim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008403; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kopp R, 2010, PHYSIOL GENOMICS, V42A, P8, DOI 10.1152/physiolgenomics.00052.2010; Lai YC, 2011, CIRC RES, V109, P1375, DOI 10.1161/CIRCRESAHA.111.256479; Lang MR, 2010, J THROMB HAEMOST, V8, P1159, DOI 10.1111/j.1538-7836.2010.03815.x; Lucitt MB, 2008, MOL CELL PROTEOMICS, V7, P981, DOI 10.1074/mcp.M700382-MCP200; Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Pelster B, 2005, COMP BIOCHEM PHYS A, V142, P215, DOI 10.1016/j.cbpb.2005.05.036; Roman BL, 2000, BIOESSAYS, V22, P882; Roman BL, 2002, DEVELOPMENT, V129, P3009; Santoro MM, 2009, MECH DEVELOP, V126, P638, DOI 10.1016/j.mod.2009.06.1080; Schwerte T, 2003, COMP BIOCHEM PHYS A, V135, P131, DOI 10.1016/S1095-6433(03)00044-8; Schwerte T, 2000, J EXP BIOL, V203, P1659; SEPICH DS, 1994, DEV BIOL, V161, P84, DOI 10.1006/dbio.1994.1010; Shin JT, 2010, PHYSIOL GENOMICS, V42, P300, DOI 10.1152/physiolgenomics.00206.2009; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Teraoka H, 2009, TOXICOL APPL PHARM, V234, P33, DOI 10.1016/j.taap.2008.09.021; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; WESTERFIELD M, 1995, ZEBRAFISH BOOK; WILLERT CE, 1991, EXP FLUIDS, V10, P181; Xu H, 2011, DEV DYNAM, V240, P278, DOI 10.1002/dvdy.22517; Yeh HC, 2006, PROSTAG LEUKOTR ESS, V75, P397, DOI 10.1016/j.plefa.2006.08.001	44	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44018	10.1371/journal.pone.0044018	http://dx.doi.org/10.1371/journal.pone.0044018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952858	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000308206500043
J	Kizilel, R; Demir, E; Azizoglu, S; Asimgi, H; Kavakli, IH; Kizilel, S				Kizilel, Riza; Demir, Enis; Azizoglu, Selimcan; Asimgi, Hande; Kavakli, Ibrahim Halil; Kizilel, Seda			Investigation of Real-Time Photorepair Activity on DNA via Surface Plasmon Resonance	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTORS; CYCLOBUTANE PYRIMIDINE DIMERS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PHOTOLYASE/CRYPTOCHROME FAMILY; ARABIDOPSIS-THALIANA; PHOTOLYASE ACTIVITY; REACTION-MECHANISM; CRYPTOCHROME; REPAIR	The cyclobutane pyrimidine dimer (CPD) and 6-4 lesion formations along with the specific breaks on strands are the most common type of DNA damage caused by Ultraviolet light (UV) irradiation. CPD photolyase I and II construct two subfamilies of flavoproteins, which have recognition and repair capabilities of CPD sites on both single stranded (ssDNA) and double stranded DNA (dsDNA) with the aid of blue light energy. The other types of flavoprotein family consist of cryptochromes (CRY) that act as photoreceptors in plants, or circadian rhythm regulators in animals. Recent findings showed that a specific type of Cryptochrome-Drosophila, Arabidopsis, Synechocystis, Human (CRY-DASH) has photorepair activity on ssDNA. In this work, real-time interactions between CRY-DASH and ss/dsDNA as well as the interactions between Vibrio cholerae photolyase (VcPHR) and ss/dsDNA were investigated using Surface Plasmon Resonance (SPR). The interactions were then characterized and compared in order to investigate the effect of different types of flavoprotein on UV damaged ss/dsDNA. SPR results confirm the specific binding of VcPHR and CRY-DASH with UV treated DNA. This study is the first instance to quantify the interactions of UV treated and untreated DNA with flavoproteins.	[Kizilel, Riza; Demir, Enis; Azizoglu, Selimcan; Asimgi, Hande; Kavakli, Ibrahim Halil; Kizilel, Seda] Koc Univ, Istanbul, Turkey	Koc University	Kizilel, R (corresponding author), Koc Univ, Istanbul, Turkey.	rkizilel@ku.edu.tr; hkavakli@ku.edu.tr; skizilel@ku.edu.tr	Kizilel, Seda/P-3959-2014; Schmidt, Hande/ABF-2338-2020; Kavakli, Ibrahim/AAF-5468-2020	Kizilel, Seda/0000-0001-9092-2698; Kavakli, Ibrahim/0000-0001-6624-3505	College of Engineering at Koc University in Turkey; TUBITAK [110T423, 105T417]; Marie Curie FP7-IRG-DMIOL [239471]; TUBA-GEBIP	College of Engineering at Koc University in Turkey(Koc University); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Marie Curie FP7-IRG-DMIOL; TUBA-GEBIP(Turkish Academy of Sciences)	This study was supported by grants from the College of Engineering at Koc University in Turkey, TUBITAK-110T423, Marie Curie FP7-IRG-DMIOL-239471, TUBITAK-105T417 and TUBA-GEBIP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimgil H, 2012, PLANT SCI, V185, P190, DOI 10.1016/j.plantsci.2011.10.005; Boon EM, 2002, NAT BIOTECHNOL, V20, P282, DOI 10.1038/nbt0302-282; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; Day YSN, 2003, J PHARM SCI-US, V92, P333, DOI 10.1002/jps.10293; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; FOX ME, 1994, MOL CELL BIOL, V14, P8071, DOI 10.1128/MCB.14.12.8071; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; HEELIS PF, 1993, J PHOTOCH PHOTOBIO B, V17, P219, DOI 10.1016/1011-1344(93)80019-6; Henn C, 2012, ANAL BIOCH; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Huang YH, 2006, P NATL ACAD SCI USA, V103, P17701, DOI 10.1073/pnas.0608554103; HUSAIN I, 1987, J BIOL CHEM, V262, P13188; HUSAIN I, 1987, NUCLEIC ACIDS RES, V15, P1109; Kavakli Ibrahim Halil, 2002, Mol Interv, V2, P484, DOI 10.1124/mi.2.8.484; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; Komori H, 2001, P NATL ACAD SCI USA, V98, P13560, DOI 10.1073/pnas.241371398; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; OKAMURA T, 1991, J AM CHEM SOC, V113, P3143, DOI 10.1021/ja00008a050; Otoshi E, 2000, CANCER RES, V60, P1729; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; Rich RL, 2000, CURR OPIN BIOTECH, V11, P54, DOI 10.1016/S0958-1669(99)00054-3; Roos H, 1998, J MOL RECOGNIT, V11, P204, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<204::AID-JMR424>3.0.CO;2-T; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sancar A, 2000, COLD SPRING HARB SYM, V65, P157, DOI 10.1101/sqb.2000.65.157; SANCAR GB, 1985, BIOCHEMISTRY-US, V24, P1849, DOI 10.1021/bi00329a007; Saxena C, 2005, J AM CHEM SOC, V127, P7984, DOI 10.1021/ja0421607; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; SMITH CA, 1993, J BIOL CHEM, V268, P11143; Svoboda LD, 1993, J BIOL CHEM, V268, P10694; Swinney DC, 2004, NAT REV DRUG DISCOV, V3, P801, DOI 10.1038/nrd1500; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Weber S, 2005, BBA-BIOENERGETICS, V1707, P1, DOI 10.1016/j.bbabio.2004.02.010; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200; Yang KS, 2007, J PHYS CHEM B, V111, P10615, DOI 10.1021/jp071035p; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; Zhao XD, 1997, J BIOL CHEM, V272, P32580, DOI 10.1074/jbc.272.51.32580	43	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44392	10.1371/journal.pone.0044392	http://dx.doi.org/10.1371/journal.pone.0044392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952969	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206000099
J	Poza, M; Gayoso, C; Gomez, MJ; Rumbo-Feal, S; Tomas, M; Aranda, J; Fernandez, A; Bou, G				Poza, Margarita; Gayoso, Carmen; Gomez, Manuel J.; Rumbo-Feal, Soraya; Tomas, Maria; Aranda, Jesus; Fernandez, Ana; Bou, German			Exploring Bacterial Diversity in Hospital Environments by GS-FLX Titanium Pyrosequencing	PLOS ONE			English	Article							RIBOSOMAL-RNA; METAGENOMIC ANALYSIS; MICROBIAL DIVERSITY; INFECTIONS; PATHOGENS; SEQUENCE; DATABASE; DOMAIN	Understanding microbial populations in hospital environments is crucial for improving human health. Hospital-acquired infections are an increasing problem in intensive care units (ICU). In this work we present an exploration of bacterial diversity at inanimate surfaces of the ICU wards of the University Hospital A Coruna (Spain), as an example of confined hospital environment subjected to selective pressure, taking the entrance hall of the hospital, an open and crowded environment, as reference. Surface swab samples were collected from both locations and recovered DNA used as template to amplify a hypervariable region of the bacterial 16S rRNA gene. Sequencing of the amplicons was performed at the Roche 454 Sequencing Center using GS-FLX Titanium procedures. Reads were pre-processed and clustered into OTUs (operational taxonomic units), which were further classified. A total of 16 canonical bacterial phyla were detected in both locations. Members of the phyla Firmicutes (mainly Staphylococcus and Streptococcus) and Actinobacteria (mainly Micrococcaceae, Corynebacteriaceae and Brevibacteriaceae) were over-represented in the ICU with respect to the Hall. The phyllum Proteobacteria was also well represented in the ICU, mainly by members of the families Enterobacteriaceae, Methylobacteriaceae and Sphingomonadaceae. In the Hall sample, the phyla Proteobacteria, Bacteroidetes, Deinococcus-Thermus and Cyanobacteria were over-represented with respect to the ICU. Over-representation of Proteobacteria was mainly due to the high abundance of Enterobacteriaceae members. The presented results demonstrate that bacterial diversity differs at the ICU and entrance hall locations. Reduced diversity detected at ICU, relative to the entrance hall, can be explained by its confined character and by the existence of antimicrobial selective pressure. This is the first study using deep sequencing techniques made in hospital wards showing substantial hospital microbial diversity.	[Poza, Margarita; Gayoso, Carmen; Rumbo-Feal, Soraya; Tomas, Maria; Aranda, Jesus; Fernandez, Ana; Bou, German] Univ Hosp, Microbioloy Dept, Biomed Res Inst, La Coruna, Spain; [Gomez, Manuel J.] CSIC, Astrobiol Ctr INTA, Sequencing & Bioinformat Dept, Madrid, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Poza, M (corresponding author), Univ Hosp, Microbioloy Dept, Biomed Res Inst, La Coruna, Spain.	German.Bou.Arevalo@sergas.es	Gómez, Manuel J/F-8854-2016; ARANDA, JESUS/G-9393-2015; Tomas, Maria/AAQ-5899-2020; M, Poza/AAA-2962-2021; Bou, German/H-6683-2015	Gómez, Manuel J/0000-0002-4111-4835; ARANDA, JESUS/0000-0002-1135-095X; Tomas, Maria/0000-0003-4501-0387; Bou, German/0000-0001-8837-0062; Rumbo-Feal, Soraya/0000-0002-1796-1815; Poza, Margarita/0000-0001-9423-7268	Spanish Network for Research in Infectious Diseases (REIPI) [RD06/0008/0025, RD025/0008]; Fondo de Investigaciones Sanitarias [PI081368, PS09/00687]; SERGAS [PS07/90]; Xunta de Galicia [07CSA050916PR]; SERGAS (Galicia, Spain) [PS08/24]; Isidro Parga Pondal Program (Xunta de Galicia, Spain); INTA-CSIC (Madrid, Spain); Instituto de Salud Carlos III (Spain);  [CSD2007-0005]	Spanish Network for Research in Infectious Diseases (REIPI); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); SERGAS; Xunta de Galicia(Xunta de GaliciaEuropean Commission); SERGAS (Galicia, Spain); Isidro Parga Pondal Program (Xunta de Galicia, Spain)(Xunta de Galicia); INTA-CSIC (Madrid, Spain); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); 	This work was supported by the Spanish Network for Research in Infectious Diseases (REIPI, RD06/0008/0025), grants from Fondo de Investigaciones Sanitarias (PI081368 and PS09/00687), SERGAS (PS07/90) and Xunta de Galicia (07CSA050916PR) to GB and a grant from SERGAS (PS08/24, Galicia, Spain) to MP. MP was supported by the Isidro Parga Pondal Program (Xunta de Galicia, Spain), CG by the Spanish Network for Research in Infectious Diseases (REIPI, RD025/0008), MJG by the project Consolider INGENIO CSD2007-0005 and INTA-CSIC (Madrid, Spain) and SRF, MT, JA and AF by Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Armougom F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-576; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bulut C, 2008, MIKROBIYOL BUL, V42, P685; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Ciric L, 2011, J ANTIMICROB CHEMOTH, V66, P2235, DOI 10.1093/jac/dkr311; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins MD, 2001, INT J SYST EVOL MICR, V51, P1349, DOI 10.1099/00207713-51-4-1349; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ehrlich SD, 2010, GASTROEN CLIN BIOL, V34, pS23, DOI 10.1016/S0399-8320(10)70017-8; Fordyce SL, 2011, BIOTECHNIQUES, V51, P127, DOI 10.2144/000113721; Furrie E, 2006, GUT, V55, P141, DOI 10.1136/gut.2005.081695; Gai ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010018; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hanberger H, 2011, INT J ANTIMICROB AG, V38, P331, DOI 10.1016/j.ijantimicag.2011.05.013; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Lai CC, 2011, J CLIN MICROBIOL, V49, P3329, DOI 10.1128/JCM.01241-11; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Mobberley JM, 2012, ENVIRON MICROBIOL, V14, P82, DOI 10.1111/j.1462-2920.2011.02509.x; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nakamura S, 2011, EXP BIOL MED, V236, P968, DOI 10.1258/ebm.2011.010378; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Scheckenbach F, 2010, P NATL ACAD SCI USA, V107, P115, DOI 10.1073/pnas.0908816106; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang JL, 2009, J CLIN MICROBIOL, V47, P3226, DOI 10.1128/JCM.00034-09; Weber DJ, 1999, CHEST, V115, p34S, DOI 10.1378/chest.115.suppl_1.34S; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yao KH, 2011, DIAGN MICR INFEC DIS, V70, P291, DOI 10.1016/j.diagmicrobio.2011.03.015; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	45	44	44	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44105	10.1371/journal.pone.0044105	http://dx.doi.org/10.1371/journal.pone.0044105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952889	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206000083
J	Arora, P; Nagelkerke, NJD; Jha, P				Arora, Paul; Nagelkerke, Nico J. D.; Jha, Prabhat			A Systematic Review and Meta-Analysis of Risk Factors for Sexual Transmission of HIV in India	PLOS ONE			English	Review							VIRUS TYPE-2 INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; REPRODUCTIVE-TRACT INFECTIONS; TRANSMITTED-DISEASE CLINICS; RANDOMIZED CONTROLLED-TRIAL; POPULATION-BASED SAMPLE; ATTENDING STD CLINICS; ANDHRA-PRADESH STATE; INJECTION-DRUG USERS; SOUTH-INDIA	Background: Approximately 2.4 million people are living with HIV in India. This large disease burden, and potential for epidemic spread in some areas, demands a full understanding of transmission in that country. We wished to quantify the effects of key sexual risk factors for HIV infection for each gender and among high-and low-HIV risk populations in India. Methodology: We conducted a systematic review of sexual risk factors for HIV infection from 35 published studies. Risk factors analyzed were: male circumcision/religion, Herpes Simplex Virus 2, syphilis, gonorrhoea, genital ulcer, multiple sexual partners and commercial sex. Studies were included if they met predetermined criteria. Data were extracted and checked by two researchers and random-effects meta analysis of effects was conducted. Heterogeneity in effect estimates was examined by I-2 statistic. Publication bias was tested by Begg's test and funnel plots. Meta regression was used to assess effect modification by various study attributes. Results: All risk factors were significantly associated with HIV status. The factor most strongly associated with HIV for both sexes was HSV-2 infection (ORmen: 5.87; 95%CI: 2.46-14.03; ORwomen: 6.44; 95%CI: 3.22-12.86). The effect of multiple sexual partners was similar among men (OR = 2.46; 95%CI: 1.91-3.17,) and women (OR = 2.02; 95%CI: 1.43-2.87) and when further stratified by HIV-risk group. The association between HSV-2 and HIV prevalence was consistently stronger than other STIs or self-reported genital ulcer. If the strong associations between HSV-2 and HIV were interpreted causally, these results implied that approximately half of the HIV infections observed in our study population were attributable to HSV-2 infection. Conclusions: The risk factors examined in our analysis should remain targets of HIV prevention programs. Our results confirm that sexual risk factors for HIV infection continue to be an important part of Indian HIV epidemic 26 years after it began.	[Arora, Paul; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Nagelkerke, Nico J. D.] United Arab Emirates Univ, Dept Community Med, Abu Dhabi, U Arab Emirates; [Arora, Paul; Jha, Prabhat] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada	University of Toronto; United Arab Emirates University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Arora, P (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	paul.arora@mail.utoronto.ca		Jha, Prabhat/0000-0001-7067-8341				ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; [Anonymous], 2003, GUID COND HIV SENT S; Anvikar AR, 2009, SEROPREVALENCE SEXUA; Arora P, 2011, SEX TRANSM INFECT, V87, P516, DOI 10.1136/sextrans-2011-050203; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Becker M, 2010, SEX TRANSM DIS, V37, P159, DOI 10.1097/OLQ.0b013e3181bd1007; Becker ML, 2007, AIDS, V21, P739, DOI 10.1097/QAD.0b013e328012b885; Boerma JT, 2005, J INFECT DIS, V191, pS61, DOI 10.1086/425282; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Brahme R, 2006, JAIDS-J ACQ IMM DEF, V41, P107, DOI 10.1097/01.qai.0000179428.49907.6d; Brahme RG, 2005, AIDS CARE, V17, P377, DOI 10.1080/09540120412331299771; Chandhiok N, 2007, REPROD HEALTH MATTER, V15, P53, DOI 10.1016/S0968-8080(07)29309-7; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Chatterjee Ramdas, 2001, Journal of Environmental Pathology Toxicology and Oncology, V20, P113; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Claeson M, 2008, HEALTH AFFAIR, V27, P1091, DOI 10.1377/hlthaff.27.4.1091; Dandona L, 2008, INT J EPIDEMIOL, V37, P1274, DOI 10.1093/ije/dyn161; Das S, 1998, VENEREOLOGY, V11, P19; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; Duttagupta C, 2004, INT J GYNECOL CANCER, V14, P293, DOI 10.1111/j.1048-891X.2004.014213.x; GAJALAKSHMI CK, 1993, ACTA ONCOL, V32, P617, DOI 10.3109/02841869309092439; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; George S, 1997, J ACQ IMMUN DEF SYND, V14, P290, DOI 10.1097/00042560-199703010-00014; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000187; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Hayes R, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000390704.35642.47; Helleringer S, 2009, DEMOGR RES, V21, P428, DOI 10.4054/DemRes.2009.21.15; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOLMBERG SD, 1988, JAMA-J AM MED ASSOC, V259, P1048, DOI 10.1001/jama.259.7.1048; International Institute for Population S Macro ORC, 2006, NAT FAM HLTH SURV 3; Jennings JM, 2008, AM J EPIDEMIOL, V167, P1495, DOI 10.1093/aje/kwn066; Kaul R, 2007, J INFECT DIS, V196, P1692, DOI 10.1086/522006; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; KUMAR R, 2005, NATL COMMISSION MACR, P58; Kumarasamy N, 2010, HIV MED, V11, P178, DOI 10.1111/j.1468-1293.2009.00760.x; Kumta S, 2010, JAIDS-J ACQ IMM DEF, V53, P227, DOI 10.1097/QAI.0b013e3181c354d8; Madhivanan P, 2005, SEX TRANSM DIS, V32, P685, DOI 10.1097/01.olq.0000175405.36124.3b; Madhivanan P, 2009, DOESNT PUBLIC HAVE R, pMar; Madhivanan P, 2007, SEX TRANSM DIS, V34, P935, DOI 10.1097/OLQ.0b013e3180ca965a; Mahanta J, 2008, AIDS, V22, pS59, DOI 10.1097/01.aids.0000343764.62455.9e; Manjunath JV, 2002, INT J STD AIDS, V13, P612, DOI 10.1258/09564620260216317; Mehendale SM, 1996, INDIAN J MED RES, V104, P327; Mehta SH, 2006, JAIDS-J ACQ IMM DEF, V41, P75, DOI 10.1097/01.qai.0000174653.17911.4a; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Mishra S, 2009, EVALUATING IMPACT RA; Mishra S, 2009, SEX TRANSM DIS, V36, P157, DOI 10.1097/OLQ.0b013e31818d64e6; Mishra V, 2009, CONCURRENT SEXUAL PA, P28; Mukhopadhyay Subhalakshmi, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P74, DOI 10.1177/1545109710361641; Munro HL, 2008, AIDS, V22, pS117, DOI 10.1097/01.aids.0000343770.92949.0b; Nag VL, 2009, AUST J RURAL HEALTH, V17, P102, DOI 10.1111/j.1440-1584.2009.01045.x; National AIDS Control Organization (NACO) MoHFWM Government of India, 2006, ANN REP 2006 GOV IND; National AIDS Control Organization (NACO) MoHFWM Government of India, 2011, ANN REP 2010 11 MIN; Neeraj Jindal, 2007, Indian Journal of Community Medicine, V32, P201; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Panchanadeswaran S, 2006, SEX TRANSM INFECT, V82, P491, DOI 10.1136/sti.2006.020768; Panda S, 2005, JAIDS-J ACQ IMM DEF, V39, P9, DOI 10.1097/01.qai.0000160713.94203.9b; Panda S, 2007, SEX TRANSM DIS, V34, P250, DOI 10.1097/01.olq.0000258485.23066.a6; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; RODRIGUES JJ, 1995, BRIT MED J, V311, P283, DOI 10.1136/bmj.311.7000.283; Rothenberg R, 2009, CURR OPIN HIV AIDS, V4, P260, DOI 10.1097/COH.0b013e32832c7cfc; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Samuel NM, 2007, INDIAN J MED RES, V125, P49; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Schmidt FL, 2009, BRIT J MATH STAT PSY, V62, P97, DOI 10.1348/000711007X255327; Schneider JA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-59; Sgaier SK, 2011, SEX TRANSM INFECT, V87, P94, DOI 10.1136/sti.2010.043687; Shahmanesh M, 2009, SEX TRANSM INFECT, V85, P50, DOI 10.1136/sti.2008.030767; Shepherd ME, 2003, J HEALTH POPUL NUTR, V21, P251; Shethwala ND, 2009, INDIAN J PATHOL MICR, V52, P198, DOI 10.4103/0377-4929.48916; Shivaswamy K N, 2005, Indian J Dermatol Venereol Leprol, V71, P26; Singh AE, 1999, CLIN MICROBIOL REV, V12, P187, DOI 10.1128/CMR.12.2.187; Solomon S, 1998, INT J STD AIDS, V9, P98, DOI 10.1258/0956462981921756; Solomon SS, 2010, AIDS BEHAV, V14, P1001, DOI 10.1007/s10461-010-9711-2; Steen R, 2012, CURR OPIN INFECT DIS, V25, P100, DOI 10.1097/QCO.0b013e32834e9ad1; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Subramanian T, 2008, AIDS, V22, pS69, DOI 10.1097/01.aids.0000343765.00573.ce; Talukdar A, 2007, AIDS, V21, P2231, DOI 10.1097/QAD.0b013e3282e9a718; Thomas K, 2002, NATL MED J INDIA, V15, P135; UNAIDS/ WHO/ SACEMA expert group on modelling the impact and cost of male circumcision for HIV prevention, 2009, PLOS MED, V6; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695; Venkataramana CBS, 2001, TROP MED INT HEALTH, V6, P1040, DOI 10.1046/j.1365-3156.2001.00814.x; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427	95	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44094	10.1371/journal.pone.0044094	http://dx.doi.org/10.1371/journal.pone.0044094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22937158	Green Published, gold			2022-12-27	WOS:000308213600078
J	Gao, YJ; Bertuccio, CA; Balut, CM; Watkins, SC; Devor, DC				Gao, Yajuan; Bertuccio, Claudia A.; Balut, Corina M.; Watkins, Simon C.; Devor, Daniel C.			Dynamin- and Rab5-Dependent Endocytosis of a Ca2+-Activated K+ Channel, KCa2.3	PLOS ONE			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; INTERMEDIATE CONDUCTANCE; DEPENDENT REGULATION; POTASSIUM CHANNEL; TERMINAL DOMAIN; EARLY ENDOSOMES; SKCA CHANNELS; TRAFFICKING; HIK1; KCA3.1	Regulation of the number of ion channels at the plasma membrane is a critical component of the physiological response. We recently demonstrated that the Ca2+-activated K+ channel, KCa2.3 is rapidly endocytosed and enters a Rab35- and EPI64C-dependent recycling compartment. Herein, we addressed the early endocytic steps of KCa2.3 using a combination of fluorescence and biotinylation techniques. We demonstrate that KCa2.3 is localized to caveolin-rich domains of the plasma membrane using fluorescence co-localization, transmission electron microscopy and co-immunoprecipitation (co-IP). Further, in cells lacking caveolin-1, we observed an accumulation of KCa2.3 at the plasma membrane as well as a decreased rate of endocytosis, as assessed by biotinylation. We also demonstrate that KCa2.3 and dynamin II are co-localized following endocytosis as well as demonstrating they are associated by co-IP. Further, expression of K44A dynamin II resulted in a 2-fold increase in plasma membrane KCa2.3 as well as a 3-fold inhibition of endocytosis. Finally, we evaluated the role of Rab5 in the endocytosis of KCa2.3. We demonstrate that expression of a dominant active Rab5 (Q79L) results in the accumulation of newly endocytosed KCa2.3 on to the membrane of the Rab5-induced vacuoles. We confirmed this co-localization by coIP; demonstrating that KCa2.3 and Rab5 are associated. As expected, if Rab5 is required for the endocytosis of KCa2.3, expression of a dominant negative Rab5 (S34N) resulted in an approximate 2-fold accumulation of KCa2.3 at the plasma membrane. This was confirmed by siRNA-mediated knockdown of Rab5. Expression of the dominant negative Rab5 also resulted in a decreased rate of KCa2.3 endocytosis. These results demonstrate that KCa2.3 is localized to a caveolin-rich domain within the plasma membrane and is endocytosed in a dynamin-and Rab5-dependent manner prior to entering the Rab35/EPI64C recycling compartment and returning to the plasma membrane.	[Gao, Yajuan; Bertuccio, Claudia A.; Balut, Corina M.; Watkins, Simon C.; Devor, Daniel C.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gao, YJ (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA.	dd2@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [HL092157]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health grant (HL092157) to DCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Balut CM, 2010, AM J PHYSIOL-CELL PH, V299, pC1015, DOI 10.1152/ajpcell.00120.2010; Barbieri MA, 1996, ARCH BIOCHEM BIOPHYS, V326, P64, DOI 10.1006/abbi.1996.0047; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Bomberger JM, 2010, CHANNELS, V4, P150, DOI 10.4161/chan.4.3.11223; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Delaney KA, 2002, J BIOL CHEM, V277, P33439, DOI 10.1074/jbc.M205293200; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Faber ESL, 2008, J NEUROSCI, V28, P10803, DOI 10.1523/JNEUROSCI.1796-08.2008; Frei E, 2006, CELL PHYSIOL BIOCHEM, V18, P165, DOI 10.1159/000097665; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Girault A, 2012, CURR MED CHEM, V19, P697, DOI 10.2174/092986712798992039; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hamilton KL, 2003, J BIOL CHEM, V278, P16690, DOI 10.1074/jbc.M212959200; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Jones HM, 2007, CHANNELS, V1, P80, DOI 10.4161/chan.3999; Jones HM, 2005, J BIOL CHEM, V280, P37257, DOI 10.1074/jbc.M508601200; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Ng EL, 2012, CELL BIOCHEM FUNCT, V30, P515, DOI 10.1002/cbf.2827; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Roncarati R, 2005, MOL CELL NEUROSCI, V28, P314, DOI 10.1016/j.mcn.2004.09.015; Schwab A, 2012, J CELL PHYSIOL, V227, P686, DOI 10.1002/jcp.22776; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233	45	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44150	10.1371/journal.pone.0044150	http://dx.doi.org/10.1371/journal.pone.0044150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952906	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000308213600084
J	Murphy, SM; Wimp, GM; Lewis, D; Denno, RF				Murphy, Shannon M.; Wimp, Gina M.; Lewis, Danny; Denno, Robert F.			Nutrient Presses and Pulses Differentially Impact Plants, Herbivores, Detritivores and Their Natural Enemies	PLOS ONE			English	Article							BOTTOM-UP; SPARTINA-ALTERNIFLORA; RESOURCE PULSES; SALT MARSHES; TOP-DOWN; FOOD-WEB; TERRESTRIAL ECOSYSTEMS; NITROGEN ADDITION; INSECT COMMUNITY; NORTH-CAROLINA	Anthropogenic nutrient inputs into native ecosystems cause fluctuations in resources that normally limit plant growth, which has important consequences for associated food webs. Such inputs from agricultural and urban habitats into nearby natural systems are increasing globally and can be highly variable, spanning the range from sporadic to continuous. Despite the global increase in anthropogenically-derived nutrient inputs into native ecosystems, the consequences of variation in subsidy duration on native plants and their associated food webs are poorly known. Specifically, while some studies have examined the effects of nutrient subsidies on native ecosystems for a single year (a nutrient pulse), repeated introductions of nutrients across multiple years (a nutrient press) better reflect the persistent nature of anthropogenic nutrient enrichment. We therefore contrasted the effects of a one-year nutrient pulse with a four-year nutrient press on arthropod consumers in two salt marshes. Salt marshes represent an ideal system to address the differential impacts of nutrient pulses and presses on ecosystem and community dynamics because human development and other anthropogenic activities lead to recurrent introductions of nutrients into these natural systems. We found that plant biomass and %N as well as arthropod density fell after the nutrient pulse ended but remained elevated throughout the nutrient press. Notably, higher trophic levels responded more strongly than lower trophic levels to fertilization, and the predator/prey ratio increased each year of the nutrient press, demonstrating that food web responses to anthropogenic nutrient enrichment can take years to fully manifest themselves. Vegetation at the two marshes also exhibited an apparent tradeoff between increasing %N and biomass in response to fertilization. Our research emphasizes the need for long-term, spatially diverse studies of nutrient enrichment in order to understand how variation in the duration of anthropogenic nutrient subsidies affects native ecosystems.	[Murphy, Shannon M.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Wimp, Gina M.; Lewis, Danny] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Denno, Robert F.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University of Denver; Georgetown University; University System of Maryland; University of Maryland College Park	Murphy, SM (corresponding author), Univ Denver, Dept Biol Sci, Denver, CO 80208 USA.	Shannon.M.Murphy@du.edu	Wimp, Gina/AAT-3776-2020; Murphy, Shannon M./Q-2139-2017	Murphy, Shannon M./0000-0002-5746-6536	National Parks Ecological Research Fellowship Program; Andrew W. Mellon Foundation	National Parks Ecological Research Fellowship Program; Andrew W. Mellon Foundation	This research was funded by the National Parks Ecological Research Fellowship Program, a partnership between the National Park Service, the Ecological Society of America and the National Park Foundation that was funded by the Andrew W. Mellon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew AM, 2003, BIOL BULL-US, V205, P238, DOI 10.2307/1543273; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Bakelaar GR, 1978, ECOLOGY, V59, P660; Bertness M, 2004, AM SCI, V92, P54; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; Boyer EW, 2002, BIOGEOCHEMISTRY, V57, P137, DOI 10.1023/A:1015709302073; Carmichael RH, 2004, MAR POLLUT BULL, V48, P137, DOI 10.1016/S0025-326X(03)00372-2; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Cole ML, 2004, J ENVIRON QUAL, V33, P124, DOI 10.2134/jeq2004.0124; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Denno RF, 2003, ECOLOGY, V84, P1032, DOI 10.1890/0012-9658(2003)084[1032:PRARSO]2.0.CO;2; Dobel Hartmut G., 1994, P325; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Galvan K, 2008, THESIS STATE U LOUIS; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Gratton C, 2003, ECOLOGY, V84, P2692, DOI 10.1890/02-0666; Gruner DS, 2006, OECOLOGIA, V147, P714, DOI 10.1007/s00442-005-0337-4; Haddad NM, 2000, OECOLOGIA, V124, P73, DOI 10.1007/s004420050026; Hoekman D, 2011, ECOLOGY, V92, P2063, DOI 10.1890/11-0160.1; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Howarth RW, 2002, AMBIO, V31, P88, DOI 10.1639/0044-7447(2002)031[0088:NUITUS]2.0.CO;2; HUNTER MD, 1992, ECOLOGY, V73, P724; HURD LE, 1974, ECOL MONOGR, V44, P465, DOI 10.2307/1942450; Huxel GR, 1998, AM NAT, V152, P460, DOI 10.1086/286182; INOUYE RS, 1995, ECOLOGY, V76, P1872, DOI 10.2307/1940720; KIRCHNER TB, 1977, ECOLOGY, V58, P1334, DOI 10.2307/1935085; Matsumura M, 2004, ECOLOGY, V85, P2601, DOI 10.1890/03-0629; Mayer B, 2002, BIOGEOCHEMISTRY, V57, P171, DOI 10.1023/A:1015744002496; McCall BD, OECOLOGIA IN PRESS; McFarlin CR, 2008, ESTUAR COAST, V31, P313, DOI 10.1007/s12237-008-9036-9; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; MENDELSSOHN IA, 1979, ECOLOGY, V60, P574, DOI 10.2307/1936078; MENDELSSOHN IA, 1979, ESTUARIES, V2, P106, DOI 10.2307/1351634; Murphy SM, 2012, DRYAD DIGITAL REPOSI; Nowlin WH, 2008, ECOLOGY, V89, P647, DOI 10.1890/07-0303.1; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Pennings SC, 2005, OIKOS, V110, P547, DOI 10.1111/j.0030-1299.2005.13792.x; Pennings SC, 2001, ECOLOGY, V82, P1344, DOI 10.1890/0012-9658(2001)082[1344:LDIPPI]2.0.CO;2; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Polis GA, 1998, ECOLOGY, V79, P490, DOI 10.2307/176948; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; Ruxton GD, 2010, ANIM BEHAV, V80, P937, DOI 10.1016/j.anbehav.2010.08.002; Siemann E, 1998, ECOLOGY, V79, P2057, DOI 10.1890/0012-9658(1998)079[2057:ETOEOP]2.0.CO;2; SILVANIMA JVC, 1991, ECOL ENTOMOL, V16, P221, DOI 10.1111/j.1365-2311.1991.tb00212.x; Stiling P, 1997, ECOLOGY, V78, P1602, DOI 10.1890/0012-9658(1997)078[1602:EMOTDA]2.0.CO;2; STRAUSS SY, 1987, ECOLOGY, V68, P1670, DOI 10.2307/1939859; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; TURNER RE, 1976, CONTRIB MAR SCI, V20, P47; VALIELA I, 1978, AM NAT, V112, P461, DOI 10.1086/283290; VALIELA I, 1979, NATURE, V280, P652, DOI 10.1038/280652a0; VALIELA I, 1976, LIMNOL OCEANOGR, V21, P245, DOI 10.4319/lo.1976.21.2.0245; Valiela I, 2002, ENVIRON POLLUT, V118, P239, DOI 10.1016/S0269-7491(01)00316-5; Valiela I, 2002, ECOSYSTEMS, V5, P92, DOI 10.1007/s10021-001-0058-4; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wimp GM, 2010, ECOLOGY, V91, P3303, DOI 10.1890/09-1291.1; Wimp GM, OECOLOGIA IN PRESS; Yang LH, 2004, SCIENCE, V306, P1565, DOI 10.1126/science.1103114; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Zimmer M, 2004, ESTUARIES, V27, P753, DOI 10.1007/BF02912038	63	32	32	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43929	10.1371/journal.pone.0043929	http://dx.doi.org/10.1371/journal.pone.0043929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952814	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600058
J	Ravasi, DF; O'Riain, MJ; Davids, F; Illing, N				Ravasi, Damiana F.; O'Riain, Mannus J.; Davids, Faezah; Illing, Nicola			Phylogenetic Evidence That Two Distinct Trichuris Genotypes Infect both Humans and Non-Human Primates	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BABOONS PAPIO-URSINUS; GASTROINTESTINAL PARASITES; HELMINTH INFECTIONS; PUBLIC-HEALTH; RISK; IDENTIFICATION; DISEASES; ECOLOGY; MUSCLE	Although there has been extensive debate about whether Trichuris suis and Trichuris trichiura are separate species, only one species of the whipworm T. trichiura has been considered to infect humans and non-human primates. In order to investigate potential cross infection of Trichuris sp. between baboons and humans in the Cape Peninsula, South Africa, we sequenced the ITS1-5.8S-ITS2 region of adult Trichuris sp. worms isolated from five baboons from three different troops, namely the Cape Peninsula troop, Groot Olifantsbos troop and Da Gama Park troop. This region was also sequenced from T. trichiura isolated from a human patient from central Africa (Cameroon) for comparison. By combining this dataset with Genbank records for Trichuris isolated from other humans, non-human primates and pigs from several different countries in Europe, Asia, and Africa, we confirmed the identification of two distinct Trichuris genotypes that infect primates. Trichuris sp. isolated from the Peninsula baboons fell into two distinct clades that were found to also infect human patients from Cameroon, Uganda and Jamaica (named the CP-GOB clade) and China, Thailand, the Czech Republic, and Uganda (named the DG clade), respectively. The divergence of these Trichuris clades is ancient and precedes the diversification of T. suis which clustered closely to the CP-GOB clade. The identification of two distinct Trichuris genotypes infecting both humans and non-human primates is important for the ongoing treatment of Trichuris which is estimated to infect 600 million people worldwide. Currently baboons in the Cape Peninsula, which visit urban areas, provide a constant risk of infection to local communities. A reduction in spatial overlap between humans and baboons is thus an important measure to reduce both cross-transmission and zoonoses of helminthes in Southern Africa.	[Ravasi, Damiana F.; O'Riain, Mannus J.] Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa; [Davids, Faezah; Illing, Nicola] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa	University of Cape Town; University of Cape Town	Ravasi, DF (corresponding author), Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa.	Nicola.Illing@uct.ac.za		O'Riain, M. Justin/0000-0001-5233-8327	National Research Foundation (South Africa); University of Cape Town	National Research Foundation (South Africa)(National Research Foundation - South Africa); University of Cape Town	Partial funding was provided by grants from the National Research Foundation (South Africa) and University of Cape Town to M. J. O'Riain and N. Illing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Vera J, 2005, Afr Health Sci, V5, P276; ALLEN AVH, 1970, J CLIN PATHOL, V23, P545, DOI 10.1136/jcp.23.6.545; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cogswell F., 2007, Flynn's parasites of laboratory animals, P693, DOI 10.1002/9780470344552.ch21; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Cutillas C, 2002, PARASITOL RES, V88, P574, DOI 10.1007/s00436-002-0596-5; Cutillas C, 2009, ACTA TROP, V111, P299, DOI 10.1016/j.actatropica.2009.05.011; Cutillas C, 2007, PARASITOL RES, V100, P383, DOI 10.1007/s00436-006-0275-z; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gasser R, 1996, MOL CELL PROBE, V10, P99, DOI 10.1006/mcpr.1996.0014; Hahn NE, 2003, INT J PRIMATOL, V24, P271, DOI 10.1023/A:1023092915171; HAUSFATER G, 1984, NAT HIST, V93, P54; Hoffman TS, 2011, INT J PRIMATOL, V32, P308, DOI 10.1007/s10764-010-9467-6; Hoffman TS, 2012, FRONT ZOOL IN PRESS, V9; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Jones-Engel L, 2006, AM J PRIMATOL, V68, P851, DOI 10.1002/ajp.20292; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; Liu GH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001539; McManus DP, 1996, INT J PARASITOL, V26, P687, DOI 10.1016/0020-7519(96)82612-9; Muriuki SMK, 1998, ACTA TROP, V71, P73, DOI 10.1016/S0001-706X(98)00040-0; Nissen S, 2012, VET PARASIT IN PRESS; OOI HK, 1993, J VET MED SCI, V55, P363, DOI 10.1292/jvms.55.363; Ravasi DF, 2012, S AFR J WIL IN PRESS; ROLLAND RM, 1985, APPL ENVIRON MICROB, V49, P791, DOI 10.1128/AEM.49.4.791-794.1985; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Trueba G, 2012, PLOS NEGLET IN PRESS, V6; Turner J, 2002, PARASITE IMMUNOL, V24, P83, DOI 10.1046/j.0141-9838.2001.00442.x; van Doorn AC, 2010, AM J PRIMATOL, V72, P104, DOI 10.1002/ajp.20759; Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202	38	44	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44187	10.1371/journal.pone.0044187	http://dx.doi.org/10.1371/journal.pone.0044187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952922	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600089
J	Husaini, Y; Qiu, MR; Lockwood, GP; Luo, XW; Shang, P; Kuffner, T; Tsai, VWW; Jiang, LL; Russell, PJ; Brown, DA; Breit, SN				Husaini, Yasmin; Qiu, Min Ru; Lockwood, Glen P.; Luo, Xu Wei; Shang, Ping; Kuffner, Tamara; Tsai, Vicky Wang-Wei; Jiang, Lele; Russell, Pamela J.; Brown, David A.; Breit, Samuel N.			Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Slows Cancer Development but Increases Metastases in TRAMP Prostate Cancer Prone Mice	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; TGF-BETA SUPERFAMILY; GENE-EXPRESSION; TRANSGENIC ADENOCARCINOMA; STROMAL STORES; COLON-CANCER; CELLS; SERUM; MOUSE; MODEL	Macrophage inhibitory cytokine-1 (MIC-1/GDF15), a divergent member of the TGF-beta superfamily, is over-expressed by many common cancers including those of the prostate (PCa) and its expression is linked to cancer outcome. We have evaluated the effect of MIC-1/GDF15 overexpression on PCa development and spread in the TRAMP transgenic model of spontaneous prostate cancer. TRAMP mice were crossed with MIC-1/GDF15 overexpressing mice (MIC-1(fms)) to produce syngeneic TRAMP(fmsmic-1) mice. Survival rate, prostate tumor size, histopathological grades and extent of distant organ metastases were compared. Metastasis of TC1-T5, an androgen independent TRAMP cell line that lacks MIC-1/GDF15 expression, was compared by injecting intravenously into MIC-1(fms) and syngeneic C57BL/6 mice. Whilst TRAMP(fmsmic-1) survived on average 7.4 weeks longer, had significantly smaller genitourinary (GU) tumors and lower PCa histopathological grades than TRAMP mice, more of these mice developed distant organ metastases. Additionally, a higher number of TC1-T5 lung tumor colonies were observed in MIC-1(fms) mice than syngeneic WT C57BL/6 mice. Our studies strongly suggest that MIC-1/GDF15 has complex actions on tumor behavior: it limits local tumor growth but may with advancing disease, promote metastases. As MIC-1/GDF15 is induced by all cancer treatments and metastasis is the major cause of cancer treatment failure and cancer deaths, these results, if applicable to humans, may have a direct impact on patient care.	[Husaini, Yasmin; Lockwood, Glen P.; Luo, Xu Wei; Shang, Ping; Kuffner, Tamara; Tsai, Vicky Wang-Wei; Jiang, Lele; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Husaini, Yasmin; Lockwood, Glen P.; Luo, Xu Wei; Shang, Ping; Kuffner, Tamara; Tsai, Vicky Wang-Wei; Jiang, Lele; Brown, David A.; Breit, Samuel N.] Univ New S Wales, Sydney, NSW, Australia; [Qiu, Min Ru] St Vincents Hosp, Dept Anat Pathol, SydPath, Sydney, NSW 2010, Australia; [Russell, Pamela J.] Queensland Univ Technol, Princess Alexandra Hosp, Australian Prostate Canc Res Ctr Queensland, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; Queensland University of Technology (QUT)	Husaini, Y (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	s.breit@amr.org.au	Russell, Pamela J/G-1685-2010; Russell, Pamela/O-8504-2019	Russell, Pamela J/0000-0002-3995-1239; Brown, David/0000-0003-1382-9419; Jiang, Lele/0000-0002-1326-5871	Prostate Cancer Foundation of Australia; Cancer Council New South Wales; National Health and Medical Research Council of Australia	Prostate Cancer Foundation of Australia; Cancer Council New South Wales(Cancer Council New South Wales); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by the Prostate Cancer Foundation of Australia (http://www.prostate.org.au), Cancer Council New South Wales (http://www.cancercouncil.com.au/) and The National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/). DAB is a National Health and Medical Research Council Biomedical Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertoni M, 2002, ONCOGENE, V21, P4212, DOI 10.1038/sj.onc.1205610; American C, 2011, CANC FACTS FIGURES; Baek KE, 2009, CLIN CHIM ACTA, V401, P128, DOI 10.1016/j.cca.2008.12.008; Baek SJ, 2006, GASTROENTEROLOGY, V131, P1553, DOI 10.1053/j.gastro.2006.09.015; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bauskin AR, 2010, J INTERF CYTOK RES, V30, P389, DOI 10.1089/jir.2009.0052; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Boyle GM, 2009, J INVEST DERMATOL, V129, P383, DOI 10.1038/jid.2008.270; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Brown DC, 2007, AI EDAM, V21, P1, DOI 10.1017/S0890060407070011; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Cheung PK, 2004, CANCER RES, V64, P5929, DOI 10.1158/0008-5472.CAN-04-1216; Fluge O, 2006, THYROID, V16, P161; Foster BA, 1997, CANCER RES, V57, P3325; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gingrich JR, 1996, CANCER RES, V56, P4096; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Huang CY, 2007, CLIN CANCER RES, V13, P5825, DOI 10.1158/1078-0432.CCR-07-1037; Hurwitz Arthur A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2005s45; Jeet V, 2008, PROSTATE, V68, P548, DOI 10.1002/pros.20714; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Joiner MC, 2011, RADIOTHER ONCOL, V101, P233, DOI 10.1016/j.radonc.2011.05.068; Kelly JA, 2009, CANCER LETT, V277, P38, DOI 10.1016/j.canlet.2008.11.013; Kim JS, 2005, MOL CANCER THER, V4, P487; Kim KK, 2008, CARCINOGENESIS, V29, P704, DOI 10.1093/carcin/bgn031; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Lee DH, 2003, CANCER RES, V63, P4648; Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138; Liu T, 2003, CANCER RES, V63, P5034; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Modlich O, 2004, CLIN CANCER RES, V10, P6418, DOI 10.1158/1078-0432.CCR-04-1031; Nakamura T, 2003, BRIT J CANCER, V88, P1101, DOI 10.1038/sj.bjc.6600869; Noorali S, 2007, DIFFERENTIATION, V75, P325, DOI 10.1111/j.1432-0436.2006.00142.x; Pang RP, 2007, CANCER LETT, V251, P268, DOI 10.1016/j.canlet.2006.11.032; Rasiah KK, 2006, CANCER EPIDEM BIOMAR, V15, P711, DOI 10.1158/1055-9965.EPI-05-0752; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/1055-9965.EPI-06-0841; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; Shnaper S, 2009, INT J CANCER, V125, P2624, DOI 10.1002/ijc.24639; Staff AC, 2011, CLIN CANCER RES, V17, P4825, DOI 10.1158/1078-0432.CCR-11-0715; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Suesskind D, 2011, GRAEFES ARCH CLIN EX; Wallin U, 2011, BRIT J CANCER, V104, P1619, DOI 10.1038/bjc.2011.112; Weber F, 2005, J CLIN ENDOCR METAB, V90, P2512, DOI 10.1210/jc.2004-2028; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Yang H, 2003, MOL CANCER THER, V2, P1023; Zhang L, 2009, ORAL ONCOL, V45, P627, DOI 10.1016/j.oraloncology.2008.07.017; Zhao LL, 2009, CANCER RES, V69, P7696, DOI 10.1158/0008-5472.CAN-08-4901; Zimmers TA, 2006, J SURG RES, V130, P45, DOI 10.1016/j.jss.2005.07.036; Zimmers TA, 2010, J CANCER RES CLIN, V136, P571, DOI 10.1007/s00432-009-0691-4	57	53	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43833	10.1371/journal.pone.0043833	http://dx.doi.org/10.1371/journal.pone.0043833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952779	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800064
J	Advani, MJ; Siddiqui, I; Sharma, P; Reddy, H				Advani, Meeta J.; Siddiqui, Imran; Sharma, Pawan; Reddy, Hemalatha			Activity of Trifluoperazine against Replicating, Non-Replicating and Drug Resistant M-tuberculosis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; PHENOTHIAZINES; GROWTH; PROTEIN; THIORIDAZINE; SURVIVAL; STRAINS; AGENTS; CELLS; MODEL	Trifluoperazine, a knowm calmodulin antagonist, belongs to a class of phenothiazine compounds that have multiple sites of action in mycobacteria including lipid synthesis, DNA processes, protein synthesis and respiration. The objective of this study is to evaluate the potential of TFP to be used as a lead molecule for development of novel TB drugs by showing its efficacy on multiple drug resistant (MDR) Mycobacterium tuberculosis (M.tb) and non-replicating dormant M.tb. Wild type and MDR M.tb were treated with TFP under different growth conditions of stress like low pH, starvation, presence of nitric oxide and in THP-1 infection model. Perturbation in growth kinetics of bacilli at different concentrations of TFP was checked to determine the MIC of TFP for active as well as dormant bacilli. Results show that TFP is able to significantly reduce the actively replicating as well as non-replicating bacillary load. It has also shown inhibitory effect on the growth of MDR M.tb. TFP has shown enhanced activity against intracellular bacilli, presumably because phenothiazines are known to get accumulated in macrophages. This concentration was, otherwise, found to be non-toxic to macrophage in vitro. Our results show that TFP has the potential to be an effective killer of both actively growing and non-replicating bacilli including MDR TB. Further evaluation and in vivo studies with Trifluoperazine can finally help us know the feasibility of this compound to be used as either a lead compound for development of new TB drugs or as an adjunct in the current TB chemotherapy.	[Advani, Meeta J.; Reddy, Hemalatha] Univ Delhi, Dept Biochem, Sri Venkateswara Coll, New Delhi, India; [Siddiqui, Imran; Sharma, Pawan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India	University of Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Advani, MJ (corresponding author), Univ Delhi, Dept Biochem, Sri Venkateswara Coll, South Campus, New Delhi, India.	phreddy.svc@gmail.com	Sharma, Pawan/F-7806-2010; Siddiqui, Imran/K-5000-2012	Sharma, Pawan/0000-0002-2525-5451; Siddiqui, Imran/0000-0002-6792-8730	Defence Research and Development Organization, India [LSRB-90/BTB/2006]; University of Delhi	Defence Research and Development Organization, India(Defence Research & Development Organisation (DRDO)); University of Delhi(University of Delhi)	This work is supported by a grant received from Defence Research and Development Organization, India (No. LSRB-90/BTB/2006) and a student fellowship received from the University of Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral L., 2007, Infectious Disorders - Drug Targets, V7, P257, DOI 10.2174/187152607782110022; Amaral L, 2001, J ANTIMICROB CHEMOTH, V47, P505, DOI 10.1093/jac/47.5.505; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Chan YY, 2007, ANTIMICROB AGENTS CH, V51, P623, DOI 10.1128/AAC.01033-06; Cohen T, 2004, MICROB DRUG RESIST, V10, P280, DOI 10.1089/mdr.2004.10.280; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Gadre DV, 1999, J CHEMOTHERAPY, V11, P203, DOI 10.1179/joc.1999.11.3.203; Gadre DV, 1998, INT CLIN PSYCHOPHARM, V13, P129, DOI 10.1097/00004850-199805000-00006; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Garbe TR, 1999, INFECT IMMUN, V67, P460, DOI 10.1128/IAI.67.1.460-465.1999; Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999; Haydel SE, 2010, PHARMACEUTICALS-BASE, V3, P2268, DOI 10.3390/ph3072268; Hussain S, 2009, ANTIMICROB AGENTS CH, V53, P157, DOI 10.1128/AAC.00442-08; Kaatz GW, 2003, ANTIMICROB AGENTS CH, V47, P719, DOI 10.1128/AAC.47.2.719-726.2003; Kim SY, 2008, J MED MICROBIOL, V57, P1473, DOI 10.1099/jmm.0.2008/001545-0; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Koul S, 2009, INDIAN J EXP BIOL, V47, P480; Kristiansen MM, 2006, IN VIVO, V20, P361; Kristiansen MM, 2003, INT J ANTIMICROB AG, V22, P250, DOI 10.1016/S0924-8579(03)00200-0; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Loebel RO, 1933, J BACTERIOL, V26, P167, DOI 10.1128/JB.26.2.167-200.1933; LUNAHERRERA J, 1995, ANTIMICROB AGENTS CH, V39, P440, DOI 10.1128/AAC.39.2.440; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Rao SP, 1995, INDIAN J CLIN BIOCH, V10, P77; RATNAKAR P, 1992, FEMS MICROBIOL LETT, V97, P73; RATNAKAR P, 1993, FEMS MICROBIOL LETT, V110, P291, DOI 10.1111/j.1574-6968.1993.tb06337.x; Reddy MV, 1996, J ANTIMICROB CHEMOTH, V37, P196, DOI 10.1093/jac/37.1.196; Riska Paul F, 2002, Semin Pediatr Infect Dis, V13, P263, DOI 10.1053/spid.2002.127198; SIBLEY LD, 1985, NATURE, V315, P416, DOI 10.1038/315416a0; Sinha I, 2004, J ANTIMICROB CHEMOTH, V53, P1072, DOI 10.1093/jac/dkh241; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Viveiros M, 2003, INT J ANTIMICROB AG, V22, P274, DOI 10.1016/S0924-8579(03)00208-5; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200	39	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44245	10.1371/journal.pone.0044245	http://dx.doi.org/10.1371/journal.pone.0044245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952939	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300069
J	Gomez, AM; Midde, NM; Mactutus, CF; Booze, RM; Zhu, J				Gomez, Adrian M.; Midde, Narasimha M.; Mactutus, Charles F.; Booze, Rosemarie M.; Zhu, Jun			Environmental Enrichment Alters Nicotine-Mediated Locomotor Sensitization and Phosphorylation of DARPP-32 and CREB in Rat Prefrontal Cortex	PLOS ONE			English	Article							CAMP-REGULATED PHOSPHOPROTEIN; BEHAVIORAL SENSITIZATION; ORBITOFRONTAL CORTEX; DOPAMINE TRANSPORTER; 32 KDA; ADDICTION; PROTEIN; RECEPTORS; AMPHETAMINE; ACTIVATION	Exposure within an environmental enrichment paradigm results in neurobiological adaptations and decreases the baseline of locomotor activity. The current study determined activation of DARPP-32 (dopamine-and cAMP-regulated phosphoprotein-32) and CREB (cAMP response element binding protein), and locomotor activity in rats raised in enriched (EC), impoverished (IC), and standard (SC) conditions following repeated administration of nicotine or saline. In the saline-control group, the basal phosphorylation state of DARPP-32 at Threonine-34 site (pDARPP-32 Thr34) in the prefrontal cortex (PFC) was lower in EC compared to IC and SC rats, which was positively correlated with their respective baseline activities. While nicotine (0.35 mg/kg, freebase) produced locomotor sensitization across all housing conditions when the nicotine-mediated locomotor activity was expressed as a percent change from their respective saline control, EC rats displayed greater sensitization to nicotine than IC and SC rats. Consistent with the behavioral findings, repeated nicotine injection increased pDARPP-32 Thr34 in PFC of EC and IC rats and in nucleus accumbens of EC rats; however, the magnitude of change from saline control in nicotine-induced enhancement of pDARPP-32 Thr34 in PFC was strikingly increased in EC rats relative to IC rats. Moreover, EC rats had lower basal phosphorylation levels of CREB at serine 133 in PFC and nucleus accumbens compared to IC and SC rats, whereas the nicotine-induced increase in phosphorylated CREB-Ser133 was more pronounced in PFC of EC rats relative to IC and SC rats. Collectively, these findings suggest innovative insights into advancing our understanding of the molecular mechanisms of enrichment-induced changes in the motivational effects of nicotine, and aiding in the identification of new therapeutic strategies for tobacco smokers.	[Gomez, Adrian M.; Midde, Narasimha M.; Zhu, Jun] Univ S Carolina, Dept Pharmaceut & Biomed Sci, S Carolina Coll Pharm, Columbia, SC 29208 USA; [Mactutus, Charles F.; Booze, Rosemarie M.] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Gomez, AM (corresponding author), Univ S Carolina, Dept Pharmaceut & Biomed Sci, S Carolina Coll Pharm, Columbia, SC 29208 USA.	zhuj@sccp.sc.edu	Booze, Rosemarie/F-7543-2014; Gomez, Adrian/Y-5962-2019	Booze, Rosemarie/0000-0003-3908-8313; Gomez, Adrian/0000-0002-4278-8209	National Institute on Drug Abuse [DA024275, DA026721]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM076277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA026721, R03DA024275] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institute on Drug Abuse to Jun Zhu (DA024275 and DA026721. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolahi A, 2010, EUR J NEUROSCI, V31, P733, DOI 10.1111/j.1460-9568.2010.07114.x; Addy NA, 2007, J NEUROSCI, V27, P8571, DOI 10.1523/JNEUROSCI.2601-07.2007; Balfour DJK, 2002, RESPIRATION, V69, P7, DOI 10.1159/000049362; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; BLANC G, 1980, NATURE, V284, P265, DOI 10.1038/284265a0; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; Castner SA, 2007, BRAIN COGNITION, V63, P94, DOI 10.1016/j.bandc.2006.11.002; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; CLARKE PBS, 1983, BRIT J PHARMACOL, V80, P587, DOI 10.1111/j.1476-5381.1983.tb10733.x; CLARKE PBS, 1983, BRIT J PHARMACOL, V78, P329, DOI 10.1111/j.1476-5381.1983.tb09398.x; Coolon RA, 2009, PHARMACOL BIOCHEM BE, V93, P59, DOI 10.1016/j.pbb.2009.04.007; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Del Arco A, 2007, J NEURAL TRANSM, V114, P43, DOI 10.1007/s00702-006-0565-8; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Gipson CD, 2011, PSYCHOPHARMACOLOGY, V214, P557, DOI 10.1007/s00213-010-2060-z; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Green TA, 2003, PSYCHOPHARMACOLOGY, V170, P235, DOI 10.1007/s00213-003-1538-3; Green TA, 2002, PSYCHOPHARMACOLOGY, V162, P373, DOI 10.1007/s00213-002-1134-y; Green TA, 2010, BIOL PSYCHIAT, V67, P28, DOI 10.1016/j.biopsych.2009.06.022; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hall FS, 1998, PHARMACOL BIOCHEM BE, V59, P859, DOI 10.1016/S0091-3057(97)00510-8; Hamada M, 2005, J PHARMACOL EXP THER, V315, P872, DOI 10.1124/jpet.105.090852; Hamada M, 2004, J NEUROCHEM, V90, P1094, DOI 10.1111/j.1471-4159.2004.02574.x; Harrod SB, 2008, PHARMACOL BIOCHEM BE, V90, P723, DOI 10.1016/j.pbb.2008.05.020; Harrod SB, 2009, PHARMACOL BIOCHEM BE, V94, P296, DOI 10.1016/j.pbb.2009.09.009; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hiroi N, 1999, EUR J NEUROSCI, V11, P1114, DOI 10.1046/j.1460-9568.1999.00570.x; Hotte M, 2006, BEHAV BRAIN RES, V171, P127, DOI 10.1016/j.bbr.2006.03.026; KALIVAS PW, 1995, DRUG ALCOHOL DEPEN, V37, P95, DOI 10.1016/0376-8716(94)01063-Q; KANAREK RB, 1995, PHARMACOL BIOCHEM BE, V51, P725, DOI 10.1016/0091-3057(95)00022-O; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Leshner AI, 2000, AM J MED GENET, V96, P590, DOI 10.1002/1096-8628(20001009)96:5<590::AID-AJMG2>3.0.CO;2-2; Lindskog M, 1999, NEUROSCIENCE, V88, P1005, DOI 10.1016/S0306-4522(98)00411-4; Lynch WJ, 2010, BIOL PSYCHIAT, V68, P774, DOI 10.1016/j.biopsych.2010.06.022; Mathieu-Kia AM, 2002, PSYCHOPHARMACOLOGY, V162, P102, DOI 10.1007/s00213-002-1096-0; MEEUSEN R, 1995, SPORTS MED, V20, P160, DOI 10.2165/00007256-199520030-00004; Midde NM, 2011, PHARMACOL BIOCHEM BE, V98, P587, DOI 10.1016/j.pbb.2011.03.013; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moghaddam B, 2002, BIOL PSYCHIAT, V51, P775, DOI 10.1016/S0006-3223(01)01362-2; Nairn AC, 2004, NEUROPHARMACOLOGY, V47, P14, DOI 10.1016/j.neuropharm.2004.05.010; Nichols JA, 2007, NEUROSCIENCE, V145, P832, DOI 10.1016/j.neuroscience.2006.12.061; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 1997, J NEUROSCI, V17, P8147; POST RM, 1980, LIFE SCI, V26, P1275, DOI 10.1016/0024-3205(80)90085-5; Rhee SH, 2003, ARCH GEN PSYCHIAT, V60, P1256, DOI 10.1001/archpsyc.60.12.1256; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROSENBERG DR, 1995, J COMP NEUROL, V358, P383, DOI 10.1002/cne.903580306; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Solinas M, 2008, P NATL ACAD SCI USA, V105, P17145, DOI 10.1073/pnas.0806889105; Stairs DJ, 2009, PHARMACOL BIOCHEM BE, V92, P377, DOI 10.1016/j.pbb.2009.01.016; Steketee JD, 2003, BRAIN RES REV, V41, P203, DOI 10.1016/S0165-0173(02)00233-3; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; Svenningsson P, 2005, AAPS J, V7, DOI 10.1208/aapsj070235; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; Svenningsson P, 2000, J NEUROCHEM, V75, P248, DOI 10.1046/j.1471-4159.2000.0750248.x; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Tzschentke TM, 2001, PROG NEUROBIOL, V63, P241, DOI 10.1016/S0301-0082(00)00033-2; Valjent E, 2010, NEUROPSYCHOPHARMACOL, V35, P401, DOI 10.1038/npp.2009.143; Vezina P, 2007, PROG NEURO-PSYCHOPH, V31, P1553, DOI 10.1016/j.pnpbp.2007.08.030; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Wong V, 2008, J PHYS CHEM B, V112, P6013, DOI 10.1021/jp0761564; Wooters TE, 2011, BEHAV BRAIN RES, V219, P98, DOI 10.1016/j.bbr.2011.01.001; Zachariou V, 2006, NEUROPSYCHOPHARMACOL, V31, P555, DOI 10.1038/sj.npp.1300832; Zhang Y, 2006, J NEUROSCI, V26, P2645, DOI 10.1523/JNEUROSCI.3923-05.2006; Zhu HW, 2005, BIOL PSYCHIAT, V58, P981, DOI 10.1016/j.biopsych.2005.05.026; Zhu J, 2005, J NEUROCHEM, V93, P1434, DOI 10.1111/j.1471-4159.2005.03130.x; Zhu J, 2004, BEHAV BRAIN RES, V148, P107, DOI 10.1016/S0166-4328(03)00190-6; Zhu J, 2007, J NEUROCHEM, V103, P2575, DOI 10.1111/j.1471-4159.2007.04951.x; Zlebnik NE, 2012, PSYCHOPHARMACOLOGY B	79	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44149	10.1371/journal.pone.0044149	http://dx.doi.org/10.1371/journal.pone.0044149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952905	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300056
J	Hu, BL; Liu, SA; Shen, LD; Zheng, P; Xu, XY; Lou, LP				Hu Baolan; Liu Shuai; Shen Lidong; Zheng Ping; Xu Xiangyang; Lou Liping			Effect of Different Ammonia Concentrations on Community Succession of Ammonia-oxidizing Microorganisms in a Simulated Paddy Soil Column	PLOS ONE			English	Article							MESOPHILIC CRENARCHAEOTA; NITROSPIRA SPP.; IN-SITU; ARCHAEA; BACTERIA; NITRIFICATION; DIVERSITY; OXIDATION; ABUNDANCE; MONOOXYGENASE	Ammonia oxidation is performed by both ammonia-oxidizing bacteria (AOB) and ammonia-oxidizing archaea (AOA). To explore the effect of ammonia concentration on the population dynamic changes of ammonia-oxidizing microorganisms, we examined changes in the abundance and community composition of AOA and AOB in different layers. Most of the archaeal amoA sequences were Nitrosotalea-related and the proportion that Nitrosotalea cluster occupied decreased in the surface layer and increased in the deep layer during the cultivation process. Nitrosopumilus-related sequences were only detected in the deep layer in the first stage and disappeared later. Both phylogenetic and quantitative analysis showed that there were increased Nitrosomonas-related sequences appeared in the surface layer where the ammonia concentration was the highest. Both AOA and AOB OTU numbers in different layers decreased under selective pressure and then recovered. The potential nitrification rates were 25.06 mu g.N.L-1.g(-1) dry soil.h(-1) in the mid layer which was higher than the other two layers. In general, obvious population dynamic changes were found for both AOA and AOB under the selective pressure of exogenous ammonia and the changes were different in three layers of the soil column.	[Hu Baolan; Liu Shuai; Shen Lidong; Zheng Ping; Xu Xiangyang; Lou Liping] Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, BL (corresponding author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China.	baolanhz@hotmail.com	Hu, baolan/K-8163-2012; 郑, 平/B-1890-2014; LOU, Liping/A-4525-2015		National Natural Science Foundation of China [40801198]; National Key Technologies Research and Development program of China [2012BAJ25B00]; Natural Science Foundation of Zhejiang province [Y507227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies Research and Development program of China(National Key Technology R&D Program); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province)	The authors wish to thank the National Natural Science Foundation of China (40801198), National Key Technologies Research and Development program of China (2012BAJ25B00) and the Natural Science Foundation of Zhejiang province (Y507227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SE, 1989, CHEM ANAL ECOLOGICAL; *APHA AWWA, 1998, STAND METH EX WAT WA; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Bohrerova Z, 2004, SOIL TILL RES, V77, P25, DOI 10.1016/j.still.2003.10.006; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Caffrey JM, 2007, ISME J, V1, P660, DOI 10.1038/ismej.2007.79; Chen XP, 2008, ENVIRON MICROBIOL, V10, P1978, DOI 10.1111/j.1462-2920.2008.01613.x; Dang HY, 2010, APPL ENVIRON MICROB, V76, P4691, DOI 10.1128/AEM.02563-09; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Gubry-Rangin C, 2010, FEMS MICROBIOL ECOL, V74, P566, DOI 10.1111/j.1574-6941.2010.00971.x; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hofferle S, 2010, FEMS MICROBIOL ECOL, V74, P302, DOI 10.1111/j.1574-6941.2010.00961.x; Hommes NG, 2003, J BACTERIOL, V185, P6809, DOI 10.1128/JB.185.23.6809-6814.2003; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu QH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002731; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; MCTAVISH H, 1993, J BACTERIOL, V175, P2436, DOI 10.1128/JB.175.8.2436-2444.1993; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nicolaisen MH, 2004, FEMS MICROBIOL ECOL, V49, P359, DOI 10.1016/j.femsec.2004.04.015; Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Santoro AE, 2008, ENVIRON MICROBIOL, V10, P1068, DOI 10.1111/j.1462-2920.2007.01547.x; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmidt I, 2004, MICROBIOL-SGM, V150, P1405, DOI 10.1099/mic.0.26719-0; Schramm A, 1999, APPL ENVIRON MICROB, V65, P3690; Schramm A, 1998, APPL ENVIRON MICROB, V64, P3480; Shen JP, 2008, ENVIRON MICROBIOL, V10, P1601, DOI 10.1111/j.1462-2920.2008.01578.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Zhang LM, 2010, P NATL ACAD SCI USA, V107, P17240, DOI 10.1073/pnas.1004947107	48	12	14	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44122	10.1371/journal.pone.0044122	http://dx.doi.org/10.1371/journal.pone.0044122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952893	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300052
J	Liu, MC; Liu, XQ; Wang, W; Shen, XF; Che, HL; Guo, YY; Zhao, MG; Chen, JY; Luo, WJ				Liu, Ming-Chao; Liu, Xin-Qin; Wang, Wen; Shen, Xue-Feng; Che, Hong-Lei; Guo, Yan-Yan; Zhao, Ming-Gao; Chen, Jing-Yuan; Luo, Wen-Jing			Involvement of Microglia Activation in the Lead Induced Long-Term Potentiation Impairment	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT DENTATE GYRUS; IN-VIVO; EXPOSURE; MEMORY; BRAIN; MINOCYCLINE; MODEL; HIPPOCAMPUS; MANGANESE	Exposure of Lead (Pb), a known neurotoxicant, can impair spatial learning and memory probably via impairing the hippocampal long-term potentiation (LTP) as well as hippocampal neuronal injury. Activation of hippocampal microglia also impairs spatial learning and memory. Thus, we raised the hypothesis that activation of microglia is involved in the Pb exposure induced hippocampal LTP impairment and neuronal injury. To test this hypothesis and clarify its underlying mechanisms, we investigated the Pb-exposure on the microglia activation, cytokine release, hippocampal LTP level as well as neuronal injury in in vivo or in vitro model. The changes of these parameters were also observed after pretreatment with minocycline, a microglia activation inhibitor. Long-term low dose Pb exposure (100 ppm for 8 weeks) caused significant reduction of LTP in acute slice preparations, meanwhile, such treatment also significantly increased hippocampal microglia activation as well as neuronal injury. In vitro Pb-exposure also induced significantly increase of microglia activation, up-regulate the release of cytokines including tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and inducible nitric oxide synthase (iNOS) in microglia culture alone as well as neuronal injury in the co-culture with hippocampal neurons. Inhibiting the microglia activation with minocycline significantly reversed the above-mentioned Pb-exposure induced changes. Our results showed that Pb can cause microglia activation, which can up-regulate the level of IL-1 beta, TNF-alpha and iNOS, these proinflammatory factors may cause hippocampal neuronal injury as well as LTP deficits.	[Liu, Ming-Chao; Liu, Xin-Qin; Shen, Xue-Feng; Che, Hong-Lei; Chen, Jing-Yuan; Luo, Wen-Jing] Fourth Mil Med Univ, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China; [Liu, Ming-Chao; Liu, Xin-Qin; Shen, Xue-Feng; Che, Hong-Lei; Chen, Jing-Yuan; Luo, Wen-Jing] Fourth Mil Med Univ, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Sch Publ Hlth, Xian 710032, Peoples R China; [Wang, Wen] Fourth Mil Med Univ, Dept Anat Histol & Embryol, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Guo, Yan-Yan; Zhao, Ming-Gao] Fourth Mil Med Univ, Dept Pharmacol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Liu, MC (corresponding author), Fourth Mil Med Univ, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China.	jy_chen@fmmu.edu.cn; luowenj@fmmu.edu.cn		Zhao, Ming-gao/0000-0002-7539-3887	National Basic Research Program of China (973 Program) [2012CB525002]; National Natural Science Foundation of China [30830087, 81001233, 30901176]; Program for New Century Excellent Talents in University; Science and Technology Innovation Projects of Shaanxi Province [2011KTCL03-19]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science and Technology Innovation Projects of Shaanxi Province; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by: National Basic Research Program of China (973 Program, #2012CB525002); Grants from National Natural Science Foundation of China: #30830087, URL: http://159.226.244.22/portal/Proj_List. asp; #81001233, URL: http://159.226.244.22/portal/Proj_List.asp; #30901176, URL: http://159.226.244.22/portal/Proj_List.asp; Program for New Century Excellent Talents in University, URL: http://news.fmmu.edu.cn/nr.jsp?urltype = news. NewsContentUrl&wbnewsid = 77637&wbtreeid = 1004; Science and Technology Innovation Projects of Shaanxi Province (#2011KTCL03-19); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saleh I, 2009, J ENVIRON PATHOL TOX, V28, P283, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i4.40; Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Bellinger DC, 2004, PEDIATRICS, V113, P1016; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; BROWN S, 1971, ARCH ENVIRON HEALTH, V22, P370, DOI 10.1080/00039896.1971.10665857; Cao Xiu-Jing, 2010, Shengli Xuebao, V62, P225; Cao XJ, 2009, BIOMED ENVIRON SCI, V22, P70, DOI 10.1016/S0895-3988(09)60025-8; Chu YX, 2010, BRAIN BEHAV IMMUN, V24, P1176, DOI 10.1016/j.bbi.2010.06.001; Espinosa-Oliva AM, 2011, NEUROBIOL AGING, V32, P85, DOI 10.1016/j.neurobiolaging.2009.01.012; Finkelstein Y, 1998, BRAIN RES REV, V27, P168, DOI 10.1016/S0165-0173(98)00011-3; Frigo DE, 2005, TOXICOL LETT, V155, P227, DOI 10.1016/j.toxlet.2004.09.008; Gilbert ME, 2007, NEUROTOXICOL TERATOL, V29, P385, DOI 10.1016/j.ntt.2007.01.006; Keblesh JP, 2009, J NEUROIMMUNE PHARM, V4, P317, DOI 10.1007/s11481-009-9161-7; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Liu MC, 2009, NEUROTOX RES, V16, P42, DOI 10.1007/s12640-009-9045-x; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Needleman HL, 2002, NEUROTOXICOL TERATOL, V24, P711, DOI 10.1016/S0892-0362(02)00269-6; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Reza B, 2008, INDIAN J PHARMACOL, V40, P69, DOI 10.4103/0253-7613.41041; ROSEN JF, 1995, TOXICOLOGY, V97, P11, DOI 10.1016/0300-483X(94)02963-U; Schlegelmilch T, 2011, CURR OPIN NEUROBIOL, V21, P5, DOI 10.1016/j.conb.2010.08.004; She JQ, 2008, N-S ARCH PHARMACOL, V379, P517; Song Bo, 2006, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V24, P399; Tanaka S, 2006, J NEUROSCI RES, V83, P557, DOI 10.1002/jnr.20752; Tanaka S, 2011, J NEUROSCI RES, V89, P506, DOI 10.1002/jnr.22582; Tomas-Camardiel M, 2004, NEUROBIOL DIS, V16, P190, DOI 10.1016/j.nbd.2004.01.010; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Wei F, 2001, NAT NEUROSCI, V4, P164, DOI 10.1038/83993; Xiong HG, 2003, J NEUROSCI RES, V71, P600, DOI 10.1002/jnr.10503; Yang YX, 2003, EXP NEUROL, V184, P489, DOI 10.1016/S0014-4886(03)00272-3; Yin ST, 2008, TOXICOLOGY, V249, P45, DOI 10.1016/j.tox.2008.04.006; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yu ACH, 2005, NEUROCHEM RES, V30, P1289, DOI 10.1007/s11064-005-8800-5; Zhao F, 2009, TOXICOL SCI, V107, P156, DOI 10.1093/toxsci/kfn213; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014; Zhou LJ, 2011, BRAIN BEHAV IMMUN, V25, P322, DOI 10.1016/j.bbi.2010.09.025	40	65	72	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43924	10.1371/journal.pone.0043924	http://dx.doi.org/10.1371/journal.pone.0043924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952811	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300034
J	Larras, F; Bouchez, A; Rimet, F; Montuelle, B				Larras, Floriane; Bouchez, Agnes; Rimet, Frederic; Montuelle, Bernard			Using Bioassays and Species Sensitivity Distributions to Assess Herbicide Toxicity towards Benthic Diatoms	PLOS ONE			English	Article							ECOLOGICAL GUILDS; LIFE-FORMS; ATRAZINE; COMMUNITIES; PERIPHYTON; GROWTH; DIURON; PHOTOSYNTHESIS; ISOPROTURON; ASSEMBLAGES	Although benthic diatoms are widely used in ecological studies of aquatic systems, there is still a dearth of data concerning species sensitivities towards several contaminants. Within the same community, different species may respond differently depending on their physiological and ecological characteristics. This lack of knowledge makes specific appropriate risk assessment impossible. To find out whether species sensitivity distribution (SSD) could be used to estimate the risk of herbicide toxicity for diatoms, we need to know whether their sensitivity depends on their physiological and ecological characteristics. We carried out single-species bioassays on 11 diatom species exposed to 8 herbicides. Dose-responses relationships were used to extrapolate the Effective Concentration 5 (EC5) and the Effective Concentration 50 (EC50) for each exposure. These data were used to fit a SSD curve for each herbicide, and to determine the Hazardous concentration 5 (HC5) and 50 (HC50). Our results revealed a high level of variability of the sensitivity in the set of species tested. For photosystem-II inhibitor (PSII) herbicides, diatoms species displayed a typical grouping of sensitivity levels consistent with their trophic mode and their ecological guild. N-heterotroph and "motile" guild species were more tolerant of PSII inhibitors, while N-autotroph and "low profile" guild species were more sensitive. Comprehensive SSD curves were obtained for 5 herbicides, but not for sulfonylurea herbicides or for dimetachlor, which had toxicity levels that were below the range of concentration tested. The SSD curves provided the following ranking of toxicity: diuron > terbutryn > isoproturon > atrazine > metolachlor. The HC that affected 5% of the species revealed that, even at the usual environmental concentrations of herbicides, diatom assemblages could be affected, especially by isoproturon, terbutryn, and diuron.	[Larras, Floriane; Bouchez, Agnes; Rimet, Frederic; Montuelle, Bernard] INRA, UMR 0042, Carrtel, Thonon, France	INRAE	Larras, F (corresponding author), INRA, UMR 0042, Carrtel, Thonon, France.	floriane.larras@thonon.inra.fr	RIMET, Frédéric/S-2702-2018	RIMET, Frédéric/0000-0002-5514-869X; Bouchez, Agnes/0000-0001-8802-6966	Programme Assessing and reducing environmental risks from plant protection products (PESTICIDES); French Ministry in charge of Ecology and Sustainable Development (project IMPALAC) [CV2100204294]	Programme Assessing and reducing environmental risks from plant protection products (PESTICIDES); French Ministry in charge of Ecology and Sustainable Development (project IMPALAC)	This work was financially supported by the Programme Assessing and reducing environmental risks from plant protection products (PESTICIDES) and funded by the French Ministry in charge of Ecology and Sustainable Development (project IMPALAC), grant CV2100204294. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence de l'eau Adour-Garonne, 2009, QUAL EAUX PROD PHYT; Aldenberg T, 2000, ECOTOX ENVIRON SAFE, V46, P1, DOI 10.1006/eesa.1999.1869; ASTM International, 2007, STAND GUID COND STAT, pE1218; Berard A., 1999, Revue des Sciences de l'Eau, V12, P333; Berthon V, 2011, HYDROBIOLOGIA, V673, P259, DOI 10.1007/s10750-011-0786-1; Boger P, 2003, J PESTIC SCI, V28, P324, DOI 10.1584/jpestics.28.324; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; Chevre N, 2006, ENVIRON SCI TECHNOL, V40, P426, DOI 10.1021/es050239l; de Zwart D, 2002, ENVIRON ECOL RISK AS, P133; Debenest T, 2009, AQUAT TOXICOL, V93, P11, DOI 10.1016/j.aquatox.2009.02.014; Dorigo U, 2010, ARCH ENVIRON CON TOX, V59, P555, DOI 10.1007/s00244-010-9511-8; Dubois A, 2011, BIL PRES MICR MIL AQ, P59; Forbes VE, 2002, HUM ECOL RISK ASSESS, V8, P473, DOI 10.1080/10807030290879781; Guasch H, 1998, J APPL PHYCOL, V10, P203, DOI 10.1023/A:1008035212208; GUERRERO M, 1991, Hydrobiological Bulletin, V25, P117, DOI 10.1007/BF02291241; HOAGLAND KD, 1982, AM J BOT, V69, P188, DOI 10.2307/2443006; Knauert S, 2008, ENVIRON SCI TECHNOL, V42, P6424, DOI 10.1021/es072037q; Kotrikla A., 1999, GLOBAL NEST J, V1, P39; LECOINTE C, 1993, HYDROBIOLOGIA, V269, P509, DOI 10.1007/BF00028048; Lenoir A., 1996, INT S, P29; Loos R, 2009, ENVIRON POLLUT, V157, P561, DOI 10.1016/j.envpol.2008.09.020; Magnusson M, 2008, MAR POLLUT BULL, V56, P1545, DOI 10.1016/j.marpolbul.2008.05.023; Maltby L, 2005, ENVIRON TOXICOL CHEM, V24, P379, DOI 10.1897/04-025R.1; Montuelle B, 2010, HYDROBIOLOGIA, V657, P123, DOI 10.1007/s10750-010-0105-2; Nelson KJ, 1999, ENVIRON TOXICOL CHEM, V18, P1038, DOI [10.1002/etc.5620180531, 10.1897/1551-5028(1999)018&lt;1038:CEOAOT&gt;2.3.CO;2]; Nystrom B, 1998, AQUAT TOXICOL, V43, P25, DOI 10.1016/S0166-445X(97)00093-3; Nystrom B, 1999, AQUAT TOXICOL, V47, P9, DOI 10.1016/S0166-445X(99)00007-7; Ortelli D, 2009, METALS ORGANIC MICRO; Passy SI, 2007, AQUAT BOT, V86, P171, DOI 10.1016/j.aquabot.2006.09.018; Peres F, 1996, ENVIRON POLLUT, V94, P141, DOI 10.1016/S0269-7491(96)00080-2; Pesce S, 2011, REV ENVIRON CONTAM T, V214, P87, DOI 10.1007/978-1-4614-0668-6_5; Posthuma L, 2002, ENVIRON ECOL RISK AS, P3; Ricart M, 2009, CHEMOSPHERE, V76, P1392, DOI 10.1016/j.chemosphere.2009.06.017; Rimet F, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012018; Rimet F, 2011, ECOL INDIC, V11, P489, DOI 10.1016/j.ecolind.2010.07.004; Ritz C, 2005, J STAT SOFTW, V12, P1; Rivard L., 2003, ENV FATE METOLACHLOR; Roubeix V, 2011, ANN LIMNOL-INT J LIM, V47, P239, DOI 10.1051/limn/2011009; Roubeix V, 2011, J ENVIRON MONITOR, V13, P1768, DOI 10.1039/c0em00783h; Rumeau A., 1988, B FRANCAIS P CHE PIS, V309, P1, DOI DOI 10.1051/KMAE:1988009; Schaumburg J, 2004, LIMNOLOGICA, V34, P302, DOI 10.1016/S0075-9511(04)80003-3; Schmitt-Jansen M, 2005, ENVIRON TOXICOL CHEM, V24, P304, DOI 10.1897/03-647.1; Seguin F, 2001, ANN LIMNOL-INT J LIM, V37, P3, DOI 10.1051/limn/2001004; Tang JX, 1997, B ENVIRON CONTAM TOX, V59, P631, DOI 10.1007/s001289900526; Vallotton N, 2008, CHEMOSPHERE, V73, P395, DOI 10.1016/j.chemosphere.2008.05.039; Van Dam Herman, 1994, Netherlands Journal of Aquatic Ecology, V28, P117; van Straalen NM, 2002, ENVIRON TOXICOL PHAR, V11, P167, DOI 10.1016/S1382-6689(01)00114-4; Wheeler JR, 2002, MAR POLLUT BULL, V45, P192, DOI 10.1016/S0025-326X(01)00327-7	49	53	55	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44458	10.1371/journal.pone.0044458	http://dx.doi.org/10.1371/journal.pone.0044458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952981	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206500072
J	Shen, P; Gong, YH; Wang, T; Chen, YY; Jia, J; Ni, SS; Zhou, B; Song, YP; Zhang, L; Zhou, R				Shen, Pei; Gong, Yunhui; Wang, Tao; Chen, Yueyue; Jia, Jin; Ni, Shanshan; Zhou, Bin; Song, Yapin; Zhang, Lin; Zhou, Rong			Expression of Osteoprotegerin in Placenta and Its Association with Preeclampsia	PLOS ONE			English	Article							SERUM OSTEOPROTEGERIN; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; INHIBITORY FACTOR; PREGNANCY; ARTERY; RECEPTORS; LACTATION; CALCIUM; DISEASE	Background: Osteoprotegerin (OPG), a key regulatory factor in bone metabolism, was documented also a potential pro-angiogenic factor, which acts an important role in protecting vascular endothelial cells. Since preeclampsia has gradually been employed to be vascular diseases, we speculated that OPG might be associated with preeclampsia. The study was to evaluate the level of OPG protein and mRNA in placenta, and investigate the relationship between OPG and the pathogenesis of preeclampsia. Methodology/Principal Findings: Placental specimens from 30 term normal pregnancy, 30 severe preeclampsia and 30 mild cases were studied. The expression and levels of OPGs' protein and mRNA were detected by immunohistochemisty, western blot analysis and real-time quantitative PCR analysis respectively. The expression of OPG protein was found in cytoplasm of placenta cytotrophoblasts and syncytiotrophoblasts in three groups. There were no significant differences of OPG protein between the maternal and fetal side in each group. The OPG protein and mRNA levels in severe preeclampsia were significantly higher than those in mild cases and normal pregnancy. However, there were no markedly differences of the OPG protein and mRNA levels between term delivery and preterm delivery in severe cases. In preeclampsia, the OPG protein and mRNA level was positively correlated with systolic blood pressure and 24 h urinary protein respectively. Conclusions/Significance: OPG protein and mRNA level in placentas of preeclampsia were found abnormal compared with normal pregnancy. In preeclampsia, the OPG protein and mRNA levels were closely related with its important clinical parameters. Taken together, OPG might be closely correlated with the pathogenesis of preeclampsia.	[Shen, Pei; Gong, Yunhui; Chen, Yueyue; Jia, Jin; Ni, Shanshan; Zhou, Rong] Sichuan Univ, W China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China; [Wang, Tao; Zhou, Bin; Song, Yapin; Zhang, Lin] Sichuan Univ, W China Univ Hosp 2, Lab Mol & Translat Med, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Shen, P (corresponding author), Sichuan Univ, W China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China.	zhourong_hx@scu.edu.cn	ZHANG, LIN/GYD-9123-2022		National Natural Science Foundation of China [81170593]; Ministry of Education of China [20110181110010]; Office of Science & Technology of Sichuan province [2009SZ0149]; Office of Science & Technology of Chengdu City [10GGYB899SF-023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Office of Science & Technology of Sichuan province; Office of Science & Technology of Chengdu City	National Natural Science Foundation of China (No. 81170593), Ministry of Education of China (20110181110010),the Office of Science & Technology of Sichuan province (No. 2009SZ0149), as well as the Office of Science & Technology of Chengdu City (No. 10GGYB899SF-023)The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2007, AM J CARDIOL, V99, P513, DOI 10.1016/j.amjcard.2006.08.064; ACOG practice bulletin, 2002, OBSTET GYNECOL, V299, P159; Brandstrom H, 2004, BLOOD PRESSURE, V13, P152, DOI 10.1080/08037050410035563; Brodszki J, 2008, ACTA OBSTET GYN SCAN, V87, P154, DOI 10.1080/00016340701733646; Diaz E, 2005, CLIN BIOCHEM, V38, P243, DOI 10.1016/j.clinbiochem.2004.10.013; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Hong JS, 2005, AM J OBSTET GYNECOL, V193, P1011, DOI 10.1016/j.ajog.2005.06.051; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Kim SM, 2005, CLIN ENDOCRINOL, V63, P594, DOI 10.1111/j.1365-2265.2005.02390.x; Kobayashi-Sakamoto M, 2006, FEMS MICROBIOL LETT, V264, P238, DOI 10.1111/j.1574-6968.2006.00458.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood CJ, 2008, AM J PATHOL, V172, P1571, DOI 10.2353/ajpath.2008.070629; Ming Fang, 2008, Zhonghua Fu Chan Ke Za Zhi, V43, P90; Naylor KE, 2003, J CLIN ENDOCR METAB, V88, P5361, DOI 10.1210/jc.2003-030486; Phillips TA, 2001, PLACENTA, V22, P663, DOI 10.1053/plac.2001.0703; Powers RW, 2008, REPROD SCI, V15, P374, DOI 10.1177/1933719107311780; Price PA, 2001, ARTERIOSCL THROM VAS, V21, P1610, DOI 10.1161/hq1001.097102; Shin JY, 2006, DIABETES CARE, V29, P1664, DOI 10.2337/dc06-0631; Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tie WW, 2009, REPROD SCI, V16, P676, DOI 10.1177/1933719109334258; Uemura H, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740353; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yaturu S, 2008, CYTOKINE, V44, P168, DOI 10.1016/j.cyto.2008.07.471; Yucesoy Gulseren, 2005, Archives of Gynecology and Obstetrics, V273, P43, DOI 10.1007/s00404-005-0741-3; Ziegler S, 2005, ATHEROSCLEROSIS, V182, P175, DOI 10.1016/j.atherosclerosis.2005.01.042	28	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44340	10.1371/journal.pone.0044340	http://dx.doi.org/10.1371/journal.pone.0044340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952959	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500062
J	Ali, N; Flutter, B; Rodriguez, RS; Sharif-Paghaleh, E; Barber, LD; Lombardi, G; Nestle, FO				Ali, Niwa; Flutter, Barry; Rodriguez, Robert Sanchez; Sharif-Paghaleh, Ehsan; Barber, Linda D.; Lombardi, Giovanna; Nestle, Frank O.			Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2R gamma(null) Mice Display a T-Effector Memory Phenotype	PLOS ONE			English	Article							CUTANEOUS LYMPHOCYTE ANTIGEN; HUMAN ISLET ALLOREACTIVITY; SELECTIVE HOMING RECEPTOR; GAMMA-CHAIN GENE; BIOMEDICAL-RESEARCH; CELL EXPRESSION; HUMANIZED MICE; MOUSE MODEL; SKIN; GVHD	The occurrence of Graft-versus-Host Disease (GvHD) is a prevalent and potentially lethal complication that develops following hematopoietic stem cell transplantation. Humanized mouse models of xenogeneic-GvHD based upon immunodeficient strains injected with human peripheral blood mononuclear cells (PBMC; "Hu-PBMC mice") are important tools to study human immune function in vivo. The recent introduction of targeted deletions at the interleukin-2 common gamma chain (IL-2R gamma(null)), notably the NOD-scid IL-2R gamma(null) (NSG) and BALB/c-Rag2(null) IL-2R gamma(null) (BRG) mice, has led to improved human cell engraftment. Despite their widespread use, a comprehensive characterisation of engraftment and GvHD development in the Hu-PBMC NSG and BRG models has never been performed in parallel. We compared engrafted human lymphocyte populations in the peripheral blood, spleens, lymph nodes and bone marrow of these mice. Kinetics of engraftment differed between the two strains, in particular a significantly faster expansion of the human CD45(+) compartment and higher engraftment levels of CD3(+) T-cells were observed in NSG mice, which may explain the faster rate of GvHD development in this model. The pathogenesis of human GvHD involves anti-host effector cell reactivity and cutaneous tissue infiltration. Despite this, the presence of T-cell subsets and tissue homing markers has only recently been characterised in the peripheral blood of patients and has never been properly defined in Hu-PBMC models of GvHD. Engrafted human cells in NSG mice shows a prevalence of tissue homing cells with a T-effector memory (T-EM) phenotype and high levels of cutaneous lymphocyte antigen (CLA) expression. Characterization of Hu-PBMC mice provides a strong preclinical platform for the application of novel immunotherapies targeting T-EM-cell driven GvHD.	[Ali, Niwa; Flutter, Barry; Rodriguez, Robert Sanchez; Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Ali, Niwa; Flutter, Barry; Rodriguez, Robert Sanchez; Sharif-Paghaleh, Ehsan; Lombardi, Giovanna; Nestle, Frank O.] NIHR Biomed Res Ctr, London, England; [Ali, Niwa; Sharif-Paghaleh, Ehsan; Lombardi, Giovanna] Kings Coll London, MRC Ctr Transplantat, London WC2R 2LS, England; [Barber, Linda D.] Kings Coll London, Dept Haematol Med, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Ali, N (corresponding author), Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England.	frank.nestle@kcl.ac.uk		Flutter, Barry/0000-0002-8084-6369; Sanchez Rodriguez, Robert/0000-0002-0789-1737; Ali, Niwa/0000-0003-4473-8747	Wellcome Trust [GR078173MA]; Medical Research Council UK [G0601387]; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Medical Research Council (MRC) Centre for Transplantation; British Heart Foundation [RG/08/005/25303] Funding Source: researchfish; Medical Research Council [G0601387, G0600698B, MR/J006742/1] Funding Source: researchfish; MRC [G0601387] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Medical Research Council (MRC) Centre for Transplantation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work would not have been possible without the generous help of healthy volunteers from Guy's and St. Thomas' Hospital, London. The authors acknowledge support from the Wellcome Trust Programme GR078173MA, Medical Research Council UK Programme G0601387. The research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. N.A and E. S. P are supported by PhD studentships from the Medical Research Council (MRC) Centre for Transplantation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; Carroll RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003289; CHAMPLIN R, 1990, BLOOD, V76, P418; Chen BJ, 2007, BLOOD, V109, P3115, DOI 10.1182/blood-2006-04-016410; Chu CC, 2012, J EXPT MED; Engelhardt BG, 2011, BONE MARROW TRANSPL, V46, P436, DOI 10.1038/bmt.2010.127; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Gallardo D, 1997, BONE MARROW TRANSPL, V20, P945, DOI 10.1038/sj.bmt.1701008; Gregoire-Gauthier J, 2012, BONE MARROW TRANSPL, V47, P439, DOI 10.1038/bmt.2011.93; GREINER DL, 1995, AM J PATHOL, V146, P888; HOFFMANNFEZER G, 1993, BLOOD, V81, P3440; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; King M, 2007, ANN NY ACAD SCI, V1103, P90, DOI 10.1196/annals.1394.011; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lee SJ, 2005, BLOOD, V105, P4200, DOI 10.1182/blood-2004-10-4023; LEUNG DYM, 1995, J EXP MED, V181, P747, DOI 10.1084/jem.181.2.747; Matthews K, 2009, HAEMATOL-HEMATOL J, V94, P956, DOI 10.3324/haematol.2008.003103; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; Nervi B, 2007, EXP HEMATOL, V35, P1823, DOI 10.1016/j.exphem.2007.06.007; PICKER LJ, 1993, J IMMUNOL, V150, P1122; Reddy P, 2003, BLOOD REV, V17, P187, DOI 10.1016/S0268-960X(03)00009-2; Sagoo P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002076; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2011, ANN NY ACAD SCI, V1245, P50, DOI 10.1111/j.1749-6632.2011.06310.x; Tsuchiyama J, 2009, BONE MARROW TRANSPL, V43, P863, DOI 10.1038/bmt.2008.392; van Rijn RS, 2007, EXP HEMATOL, V35, P117, DOI 10.1016/j.exphem.2006.09.018; van Rijn RS, 2003, BLOOD, V102, P2522, DOI 10.1182/blood-2002-10-3241; Vlad G, 2009, HUM IMMUNOL, V70, P663, DOI 10.1016/j.humimm.2009.06.001; Wager EJ, 2000, J IMMUNOL, V165, P518, DOI 10.4049/jimmunol.165.1.518; Zheng H, 2009, J IMMUNOL, V182, P5938, DOI 10.4049/jimmunol.0802212	36	117	124	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44219	10.1371/journal.pone.0044219	http://dx.doi.org/10.1371/journal.pone.0044219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937164	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600093
J	Chen, H; Hiler, KA; Tolley, EA; Matta, SG; Sharp, BM				Chen, Hao; Hiler, Katie A.; Tolley, Elizabeth A.; Matta, Shannon G.; Sharp, Burt M.			Genetic Factors Control Nicotine Self-Administration in Isogenic Adolescent Rat Strains	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; SMOKING-CESSATION; CYP2A6 GENOTYPE; GENOME SEQUENCE; INBRED RATS; TOBACCO USE; DEPENDENCE; LEWIS; FISCHER-344; MORPHINE	Adult cigarette smokers usually become dependent on cigarettes during adolescence. Despite recent advances in addiction genetics, little data delineates the genetic factors that account for the vulnerability of humans to smoke tobacco. We studied the operant nicotine self-administration (SA) behavior of six inbred strains of adolescent male rats (Fisher 344, Brown Norway, Dark Agouti, Spontaneous Hypertensive Rat, Wistar Kyoto and Lewis) and six selected F1 hybrids. All rats were trained to press a lever to obtain food starting on postnatal day (PN) 32, and then nicotine (0.03 mg/kg/infusion, i.v.) reinforcement was made available on PN41-42 (10 consecutive daily 2 h sessions). Of the 12 isogenic strains, Fisher rats self-administered the fewest nicotine infusions (1.45+/-0.36/d) during the last 3 d, while Lewis rats took the most nicotine (13.0+/-1.4/d). These strains sorted into high, intermediate and low self-administration groups in 2, 2, and 8 strains, respectively. The influence of heredity on nicotine SA (0.64) is similar to that reported for humans. Therefore, this panel of isogenic rat strains effectively models the overall impact of genetics on the vulnerability to acquire nicotine-reinforced behavior during adolescence. Separate groups of rats responded for food starting on PN41. The correlation between nicotine and food reward was not significant. Hence, the genetic control of the motivation to obtain nicotine is distinctly different from food reward, indicating the specificity of the underlying genetic mechanisms. Lastly, the behavior of F1 hybrids was not predicted from the additive behavior of the parental strains, indicating the impact of significant gene-gene interactions on the susceptibility to nicotine reward. Taken together, the behavioral characteristics of this model indicate its strong potential to identify specific genes mediating the human vulnerability to smoke cigarettes.	[Chen, Hao; Hiler, Katie A.; Matta, Shannon G.; Sharp, Burt M.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Tolley, Elizabeth A.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Chen, H (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA.	hchen@uthsc.edu; bsharp@uthsc.edu	Sharp, Burt/X-6200-2019; Chen, Hao/AAX-5849-2020	Sharp, Burt/0000-0002-3765-8848; Chen, Hao/0000-0002-2680-6921	National Institutes of Health [RC2 DA 028962]; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health RC2 DA 028962. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; AMBROSIO E, 1995, BEHAV PHARMACOL, V6, P229; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Bergen AW, 2009, NEUROPSYCHOPHARMACOL, V34, P2252, DOI 10.1038/npp.2009.52; Chaudhri N, 2005, PSYCHOPHARMACOLOGY, V180, P258, DOI 10.1007/s00213-005-2152-3; Chen H, 2008, NEUROPSYCHOPHARMACOL, V33, P721, DOI 10.1038/sj.npp.1301466; Chen H, 2007, NEUROPSYCHOPHARMACOL, V32, P700, DOI 10.1038/sj.npp.1301135; Chen H, 2011, NEUROPSYCHOPHARMACOL, V36, P2629, DOI 10.1038/npp.2011.149; Contet C, 2010, PSYCHOPHARMACOLOGY, V212, P283, DOI 10.1007/s00213-010-1950-4; Corrigall WA, 2000, PSYCHOPHARMACOLOGY, V149, P107, DOI 10.1007/s002139900355; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; Corrigall WA, 2001, PSYCHOPHARMACOLOGY, V158, P190, DOI 10.1007/s002130100869; De Ruyck K, 2010, PHARMACOGENOMICS, V11, P1053, DOI 10.2217/pgs.10.75; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Eissenberg T, 2000, DRUG ALCOHOL DEPEN, V59, pS41; Falconer D. S., 1996, INTRO QUANTITATIVE G; Feltenstein MW, 2012, DRUG ALCOHOL DEPEN, V121, P240, DOI 10.1016/j.drugalcdep.2011.09.001; Fowler CD, 2011, NEUROPHARMACOLOGY, V61, P687, DOI 10.1016/j.neuropharm.2011.05.012; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GLYNN TJ, 1993, PREV MED, V22, P568, DOI 10.1006/pmed.1993.1049; Haile CN, 2005, BRAIN RES, V1055, P186, DOI 10.1016/j.brainres.2005.07.012; Haile CN, 2001, J PHARMACOL EXP THER, V299, P509; Ho MK, 2009, CLIN PHARMACOL THER, V85, P635, DOI 10.1038/clpt.2009.19; Kendler KS, 2012, NAT NEUROSCI, V15, P181, DOI 10.1038/nn.3018; Kosten TA, 2007, BEHAV NEUROSCI, V121, P380, DOI 10.1037/0735-7044.121.2.380; Lea Rod, 2005, N Z Med J, V118, pU1773; Li MD, 2003, AM J MED SCI, V326, P168, DOI 10.1097/00000441-200310000-00003; Liu T, 2011, ADDICTION, V106, P985, DOI 10.1111/j.1360-0443.2010.03353.x; Martin S, 1999, BRAIN RES, V821, P350, DOI 10.1016/S0006-8993(99)01122-1; Martin S, 2003, BRAIN RES, V973, P205, DOI 10.1016/S0006-8993(03)02482-X; Meyer AC, 2010, GENES BRAIN BEHAV, V9, P790, DOI 10.1111/j.1601-183X.2010.00616.x; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Sanchez-Cardoso P, 2007, NEUROPHARMACOLOGY, V52, P931, DOI 10.1016/j.neuropharm.2006.10.011; Sharp BM, 2011, GENES BRAIN BEHAV, V10, P778, DOI 10.1111/j.1601-183X.2011.00716.x; Suriyaprom K, 2012, J MOL NEUROSCI; Tang X, 2009, PHARMACOGENET GENOM, V19, P345, DOI 10.1097/FPC.0b013e328329893c; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Valentine JD, 1997, PSYCHOPHARMACOLOGY, V133, P300, DOI 10.1007/s002130050405; Verde Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026668; Xian H, 2008, ADDICTION, V103, P1391, DOI 10.1111/j.1360-0443.2008.02243.x	45	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44234	10.1371/journal.pone.0044234	http://dx.doi.org/10.1371/journal.pone.0044234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937166	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600096
J	Shibata, K; Chang, LH; Kim, D; Nanez, JE; Kamitani, Y; Watanabe, T; Sasaki, Y				Shibata, Kazuhisa; Chang, Li-Hung; Kim, Dongho; Nanez, Jose E., Sr.; Kamitani, Yukiyasu; Watanabe, Takeo; Sasaki, Yuka			Decoding Reveals Plasticity in V3A as a Result of Motion Perceptual Learning	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; SURFACE-BASED ANALYSIS; CORTICAL AREA; HUMAN BRAIN; RETINOTOPIC ORGANIZATION; FUNCTIONAL MRI; V1 NEURONS; DORSAL V4; ORIENTATION; DISCRIMINATION	Visual perceptual learning (VPL) is defined as visual performance improvement after visual experiences. VPL is often highly specific for a visual feature presented during training. Such specificity is observed in behavioral tuning function changes with the highest improvement centered on the trained feature and was originally thought to be evidence for changes in the early visual system associated with VPL. However, results of neurophysiological studies have been highly controversial concerning whether the plasticity underlying VPL occurs within the visual cortex. The controversy may be partially due to the lack of observation of neural tuning function changes in multiple visual areas in association with VPL. Here using human subjects we systematically compared behavioral tuning function changes after global motion detection training with decoded tuning function changes for 8 visual areas using pattern classification analysis on functional magnetic resonance imaging (fMRI) signals. We found that the behavioral tuning function changes were extremely highly correlated to decoded tuning function changes only in V3A, which is known to be highly responsive to global motion with human subjects. We conclude that VPL of a global motion detection task involves plasticity in a specific visual cortical area.	[Shibata, Kazuhisa; Chang, Li-Hung; Kim, Dongho; Watanabe, Takeo; Sasaki, Yuka] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Nanez, Jose E., Sr.] Arizona State Univ, Div Social & Behav Sci, Phoenix, AZ USA; [Kamitani, Yukiyasu] Adv Telecommun Res Inst Int, Brain Informat Commun Res Lab Grp, Kyoto, Japan	Brown University; Arizona State University; Arizona State University-Downtown Phoenix; Advanced Telecommunications Research Institute International	Shibata, K (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	takeo_watanabe@brown.edu		Chang, Li-Hung/0000-0002-4245-0152; Sasaki, Yuka/0000-0002-0061-0250; Kim, Dongho/0000-0002-2619-1234	NSF [BCS-0549036]; NIH [R01 EY015980, R01 EY019466, R21 EY018925, R01 AG031941]; NCRR [P41RR14075]; MIND Institute; Athinoula A. Martinos Center for Biomedical Imaging; Uehara Memorial Foundation; Nissan Science Foundation; SRPBS (MEXT, Japan); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015980, R01EY019466, R21EY018925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031941] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MIND Institute; Athinoula A. Martinos Center for Biomedical Imaging; Uehara Memorial Foundation(Uehara Memorial Foundation); Nissan Science Foundation; SRPBS (MEXT, Japan); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NSF (BCS-0549036), NIH (R01 EY015980, R01 EY019466, R21 EY018925, R01 AG031941), NCRR (P41RR14075), MIND Institute, Athinoula A. Martinos Center for Biomedical Imaging, Uehara Memorial Foundation, Nissan Science Foundation, and SRPBS (MEXT, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Adab HZ, 2011, CURR BIOL, V21, P1661, DOI 10.1016/j.cub.2011.08.037; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Braddick OJ, 2000, CURR BIOL, V10, P731, DOI 10.1016/S0960-9822(00)00540-6; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fahle M, 2002, PERCEPTUAL LEARNING; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fize D, 2003, J NEUROSCI, V23, P7395; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gold JI, 2010, CURR BIOL, V20, pR46, DOI 10.1016/j.cub.2009.10.066; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Kahnt T, 2011, NEURON, V70, P549, DOI 10.1016/j.neuron.2011.02.054; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Koyama S, 2005, CURR BIOL, V15, P2027, DOI 10.1016/j.cub.2005.10.069; Koyama S, 2004, PERCEPTION, V33, P1139, DOI 10.1068/p5195; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Li S, 2009, NEURON, V62, P441, DOI 10.1016/j.neuron.2009.03.016; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Vapnik V., 1998, STAT LEARNING THEORY; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	37	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44003	10.1371/journal.pone.0044003	http://dx.doi.org/10.1371/journal.pone.0044003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952849	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600068
J	Singh, SK; Veo, BL; Kagalwala, MN; Shi, WW; Liang, SD; Majumder, S				Singh, Sanjay K.; Veo, Bethany L.; Kagalwala, Mohamedi N.; Shi, Weiwei; Liang, Shoudan; Majumder, Sadhan			Dynamic Status of REST in the Mouse ESC Pluripotency Network	PLOS ONE			English	Article							STEM-CELLS; TRANSCRIPTIONAL NETWORK; DIFFERENTIATION; CHROMATIN; REGULATORS; CIRCUITRY; PROTEIN; FATE	Background: REST is abundantly expressed in mouse embryonic stem cells (ESCs). Many genome-wide analyses have found REST to be an integral part of the ESC pluripotency network. However, experimental systems have produced contradictory findings: (1) REST is required for the maintenance of ESC pluripotency and loss of REST causes increased expression of differentiation markers, (2) REST is not required for the maintenance of ESC pluripotency and loss of REST does not change expression of differentiation markers, and (3) REST is not required for the maintenance of ESC pluripotency but loss of REST causes decreased expression of differentiation markers. These reports highlight gaps in our knowledge of the ESC network. Methods: Employing biochemical and genome-wide analyses of various culture conditions and ESC lines, we have attempted to resolve some of the discrepancies in the literature. Results: We show that Rest+/2 and Rest-/- AB-1 mutant ESCs, which did not exhibit a role of REST in ESC pluripotency when cultured in the presence of feeder cells, did show impaired self-renewal when compared with the parental cells under feeder-free culture conditions, but only in early passage cells. In late passage cells, both Rest+/2 and Rest-/- AB-1 ESCs restored pluripotency, suggesting a passage and culture condition-dependent response. Genome-wide analysis followed by biochemical validation supported this response and further indicated that the restoration of pluripotency was associated by increased expression of the ESC pluripotency factors. E14Tg2a. 4 ESCs with REST-knockdown, which earlier showed a REST-dependent pluripotency when cultured under feeder-free conditions, as well as Rest-/- AB-1 ESCs, showed no REST-dependent pluripotency when cultured in the presence of either feeder cells or laminin, indicating that extracellular matrix components can rescue REST's role in ESC pluripotency. Conclusions: REST regulates ESC pluripotency in culture condition-and ESC line-dependent fashion and ESC pluripotency needs to be evaluated in a context dependent manner.	[Singh, Sanjay K.; Veo, Bethany L.; Kagalwala, Mohamedi N.; Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Shi, Weiwei; Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA; [Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Majumder, Sadhan] Univ Texas Grad Sch Biomed Sci Houston, Program Genes & Dev, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Singh, SK (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ssinghk@gmail.com; smajumder@mdanderson.org			NCI [CA97124, CA81255]; NATIONAL CANCER INSTITUTE [R01CA097124, R01CA081255] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partly supported by grants from the NCI (CA97124 and CA81255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buckley NJ, 2009, NATURE, V457, pE5, DOI 10.1038/nature07784; Chen LY, 2008, HUM MOL GENET, V17, pR23, DOI 10.1093/hmg/ddn050; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Choder M, 2004, TRENDS BIOCHEM SCI, V29, P674, DOI 10.1016/j.tibs.2004.10.007; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; Gekas C, 2010, J EXP MED, V207, P2781, DOI 10.1084/jem.20102428; Gopalakrishnan V, 2009, FUTUR NEUROL, V4, P317, DOI 10.2217/FNL.09.1; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Jorgensen HF, 2010, NATURE, V467, pE3, DOI 10.1038/nature09305; Jorgensen HF, 2009, NATURE, V457, pE4, DOI 10.1038/nature07783; Kagalwala MN, 2008, COLD SH Q B, V73, P227, DOI 10.1101/sqb.2008.73.042; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Loh YH, 2011, ANNU REV GENOM HUM G, V12, P165, DOI 10.1146/annurev-genom-082410-101506; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schulz H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006804; Shiraki N, 2009, BIOCHEM BIOPH RES CO, V381, P694, DOI 10.1016/j.bbrc.2009.02.120; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhu H, 2011, NAT REV GENET, V12, P266, DOI 10.1038/nrg2951	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43659	10.1371/journal.pone.0043659	http://dx.doi.org/10.1371/journal.pone.0043659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952733	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600035
J	Adrianto, I; Lin, CP; Hale, JJ; Levin, AM; Datta, I; Parker, R; Adler, A; Kelly, JA; Kaufman, KM; Lessard, CJ; Moser, KL; Kimberly, RP; Harley, JB; Iannuzzi, MC; Rybicki, BA; Montgomery, CG				Adrianto, Indra; Lin, Chee Paul; Hale, Jessica J.; Levin, Albert M.; Datta, Indrani; Parker, Ryan; Adler, Adam; Kelly, Jennifer A.; Kaufman, Kenneth M.; Lessard, Christopher J.; Moser, Kathy L.; Kimberly, Robert P.; Harley, John B.; Iannuzzi, Michael C.; Rybicki, Benjamin A.; Montgomery, Courtney G.			Genome-Wide Association Study of African and European Americans Implicates Multiple Shared and Ethnic Specific Loci in Sarcoidosis Susceptibility	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MAJOR HISTOCOMPATIBILITY COMPLEX; OCCUPATIONAL RISK-FACTORS; MHC CLASS-II; ENDOTHELIAL-CELLS; CROHNS-DISEASE; LUNG-CANCER; ULCERATIVE-COLITIS; FUNCTIONAL VARIANT; GENE-EXPRESSION	Sarcoidosis is a systemic inflammatory disease characterized by the formation of granulomas in affected organs. Genome-wide association studies (GWASs) of this disease have been conducted only in European population. We present the first sarcoidosis GWAS in African Americans (AAs, 818 cases and 1,088 related controls) followed by replication in independent sets of AAs (455 cases and 557 controls) and European Americans (EAs, 442 cases and 2,284 controls). We evaluated >6 million SNPs either genotyped using the Illumina Omni1-Quad array or imputed from the 1000 Genomes Project data. We identified a novel sarcoidosis-associated locus, NOTCH4, that reached genome-wide significance in the combined AA samples (rs715299, PAA-meta = 6.51 x 10(-10)) and demonstrated the independence of this locus from others in the MHC region in the same sample. We replicated previous European GWAS associations within HLA-DRA, HLA-DRB5, HLA-DRB1, BTNL2, and ANXA11 in both our AA and EA datasets. We also confirmed significant associations to the previously reported HLA-C and HLA-B regions in the EA but not AA samples. We further identified suggestive associations with several other genes previously reported in lung or inflammatory diseases.	[Adrianto, Indra; Lin, Chee Paul; Hale, Jessica J.; Parker, Ryan; Adler, Adam; Kelly, Jennifer A.; Lessard, Christopher J.; Moser, Kathy L.; Montgomery, Courtney G.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Levin, Albert M.; Datta, Indrani; Rybicki, Benjamin A.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Kaufman, Kenneth M.; Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH USA; [Kaufman, Kenneth M.; Harley, John B.] United States Dept Vet Affairs Med Ctr, Cincinnati, OH USA; [Lessard, Christopher J.; Moser, Kathy L.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Kimberly, Robert P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Iannuzzi, Michael C.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY USA	Oklahoma Medical Research Foundation; Henry Ford Health System; Henry Ford Hospital; Cincinnati Children's Hospital Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Adrianto, I (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Courtney-Montgomery@omrf.org	Adrianto, Indra/D-4214-2013; Rybicki, Benjamin/L-4614-2019	Adrianto, Indra/0000-0002-9973-3057; Rybicki, Benjamin/0000-0003-3190-3467; Kelly, Jennifer/0000-0002-3203-2467; Lessard, Christopher J./0000-0003-2440-3843; Montgomery, Courtney/0000-0002-9606-3772; Kimberly, Robert/0000-0002-5330-3086	United States National Institutes of Health (NIH) [1RC2HL101499, R56-AI072727, R01-HL092576, R01-HL54306, U01-HL060263, R01-AR043274, R37-AI024717, R01-AR042460, P20-RR020143, N01-AR62277, P01-AR049084, P01-AI083194]; United States Department of Veterans Affairs; United States Department of Defense [PR094002]; NATIONAL CANCER INSTITUTE [R01CA133996, P50CA093459, P50CA097007] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101499, R01HL054306, U01HL060263, R01HL092576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072727, R37AI024717, P01AI083194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049084, R01AR042460, R01AR043274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the United States National Institutes of Health (NIH) grants: 1RC2HL101499 to CGM, R56-AI072727 and R01-HL092576 to BAR, R01-HL54306 and U01-HL060263 awarded to MCI, R01-AR043274 to KLM, R37-AI024717, R01-AR042460, and P20-RR020143 to JBH, N01-AR62277 to JBH and KLM, P01-AR049084 to JBH and RPK, P01-AI083194 to JBH, KMK and RPK. Other institution supports include the United States Department of Veterans Affairs to JBH and KMK and the United States Department of Defense PR094002 to JBH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Alaedini A, 2008, AUTOIMMUNITY, V41, P19, DOI 10.1080/08916930701619219; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baughman RP, 1999, J CLIN EPIDEMIOL, V52, P1173; Berlin M, 1997, AM J RESP CRIT CARE, V156, P1601, DOI 10.1164/ajrccm.156.5.9704069; BREWERTON DA, 1977, CLIN EXP IMMUNOL, V27, P227; Candi E, 2002, J INVEST DERMATOL, V119, P670, DOI 10.1046/j.1523-1747.2002.01853.x; Cecener G, 2008, TUMORI, V94, P845; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Cozier YC, 2011, CHEST, V139, P144, DOI 10.1378/chest.10-0413; CUMMINGS M M, 1956, Postgrad Med, V19, P437; Demopoulos K, 2002, J CELL MOL MED, V6, P215, DOI 10.1111/j.1582-4934.2002.tb00188.x; Dubaniewicz A, 2007, RESP MED, V101, P2213, DOI 10.1016/j.rmed.2007.06.004; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Duvefelt K, 2004, TISSUE ANTIGENS, V63, P13, DOI 10.1111/j.1399-0039.2004.00135.x; EDMONDSTONE WM, 1985, BRIT J DIS CHEST, V79, P27, DOI 10.1016/0007-0971(85)90004-X; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Franke A, 2008, GASTROENTEROLOGY, V135, P1207, DOI 10.1053/j.gastro.2008.07.017; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Genovese G, 2010, KIDNEY INT, V78, P698, DOI 10.1038/ki.2010.251; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Gray-McGuire C, 2006, HUM GENET, V120, P420, DOI 10.1007/s00439-006-0201-6; Grigorian A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-27; Grunewald J, 2004, AM J RESP CRIT CARE, V169, P696, DOI 10.1164/rccm.200303-459OC; GRUSBY MJ, 1995, ANNU REV IMMUNOL, V13, P417, DOI 10.1146/annurev.iy.13.040195.002221; GUNDELFINGER B, 1961, AM REV RESPIR DIS, V84, P109; Haase D, 2007, ONCOGENE, V26, P4464, DOI 10.1038/sj.onc.1210225; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofmann S, 2011, EUR RESP J; Hofmann S, 2008, NAT GENET, V40, P1103, DOI 10.1038/ng.198; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Iannuzzi MC, 2005, GENES IMMUN, V6, P509, DOI 10.1038/sj.gene.6364235; Iannuzzi MC, 2003, AM J RESP CRIT CARE, V167, P1225, DOI 10.1164/rccm.200209-1097OC; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; IWAI K, 1993, ACTA PATHOL JAPON, V43, P372; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; JAMES DG, 1994, SARCOIDOSIS, V11, P2; James DG, 1997, CLIN CHEST MED, V18, P663, DOI 10.1016/S0272-5231(05)70411-1; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; KIM IG, 1993, J BIOL CHEM, V268, P12682; Kucera GP, 2003, CHEST, V123, P1527, DOI 10.1378/chest.123.5.1527; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Li Y, 2006, THORAX, V61, P273, DOI 10.1136/thx.2005.056564; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Luo XG, 2004, BIOL PSYCHIAT, V55, P112, DOI 10.1016/S0006-3223(03)00588-2; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mehul B, 2006, EXP DERMATOL, V15, P469, DOI 10.1111/j.1600-0625.2006.00433.x; Miniati D, 2010, AM J PHYSIOL-LUNG C, V298, pL169, DOI 10.1152/ajplung.00188.2009; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quillard T, 2010, BIOCHEM PHARMACOL, V80, P2032, DOI 10.1016/j.bcp.2010.07.010; Rasmussen A, 2011, RHEUMATOLOGY, V50, P47, DOI 10.1093/rheumatology/keq302; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Renner M, 2007, GASTROENTEROLOGY, V133, P1499, DOI 10.1053/j.gastro.2007.08.007; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; RUBIN LA, 1994, ARTHRITIS RHEUM, V37, P1212, DOI 10.1002/art.1780370816; Rybicki BA, 2011, GENES IMMUN, V12, P67, DOI 10.1038/gene.2010.56; Rybicki BA, 2005, SARCOIDOSIS VASC DIF, V22, P115; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Rybicki BA, 2005, AM J HUM GENET, V77, P491, DOI 10.1086/444435; Rybicki BA, 2004, SARCOIDOSIS VASC DIF, V21, P49; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; SARTWELL PE, 1974, AM J EPIDEMIOL, V99, P250, DOI 10.1093/oxfordjournals.aje.a121609; Schurmann M, 2001, AM J RESP CRIT CARE, V164, P840, DOI 10.1164/ajrccm.164.5.2007056; Shin MS, 2002, BLOOD, V99, P4094, DOI 10.1182/blood.V99.11.4094; SILTZBACH LE, 1974, AM J MED, V57, P847, DOI 10.1016/0002-9343(74)90160-0; Sklar P, 2001, NAT GENET, V28, P126, DOI 10.1038/88836; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; Uemura N, 2009, INT J CANCER, V124, P2106, DOI 10.1002/ijc.24194; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xu KL, 2012, ADV EXP MED BIOL, V727, P89, DOI 10.1007/978-1-4614-0899-4_7; Xu ZL, 2011, PROSTATE, V71, P881, DOI 10.1002/pros.21304	100	84	85	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43907	10.1371/journal.pone.0043907	http://dx.doi.org/10.1371/journal.pone.0043907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952805	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800074
J	King, AM; MacRae, TH				King, Allison M.; MacRae, Thomas H.			The Small Heat Shock Protein p26 Aids Development of Encysting Artemia Embryos, Prevents Spontaneous Diapause Termination and Protects against Stress	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; MOSQUITO CULEX-PIPIENS; CHAPERONE ACTIVITY; INSECT DIAPAUSE; OVERWINTERING DIAPAUSE; ENVIRONMENTAL-STRESSES; DROSOPHILA-TRIAURARIA; MOLECULAR CHAPERONES; GENE-EXPRESSION; PUPAL DIAPAUSE	Artemia franciscana embryos enter diapause as encysted gastrulae, a physiological state of metabolic dormancy and enhanced stress resistance. The objective of this study was to use RNAi to investigate the function of p26, an abundant, diapause-specific small heat shock protein, in the development and behavior of encysted Artemia embryos (cysts). RNAi methodology was developed where injection of Artemia females with dsRNA specifically eliminated p26 from cysts. p26 mRNA and protein knock down were, respectively, confirmed by RT-PCR and immuno-probing of western blots. ArHsp21 and ArHsp22, diapause-related small heat shock proteins in Artemia cysts sharing a conserved alpha-crystallin domain with p26, were unaffected by injection of females with dsRNA for p26, demonstrating the specificity of protein knock down. Elimination of p26 delayed cyst release from females demonstrating that this molecular chaperone influences the development of diapause-destined embryos. Although development was slowed the metabolic activities of cysts either containing or lacking p26 were similar. p26 inhibited diapause termination after prolonged incubation of cysts in sea water perhaps by a direct effect on termination or indirectly because p26 is necessary for the preservation of diapause maintenance. Cyst diapause was however, terminated by desiccation and freezing, a procedure leading to high mortality within cyst populations lacking p26 and indicating the protein is required for stress tolerance. Cysts lacking p26 were also less resistant to heat shock. This is the first in vivo study to show that knock down of a small heat shock protein slows the development of diapause-destined embryos, suggesting a role for p26 in the developmental process. The same small heat shock protein prevents spontaneous termination of diapause and provides stress protection to encysted embryos.	[King, Allison M.; MacRae, Thomas H.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	King, AM (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	tmacrae@dal.ca			NSERC Discovery Grant [RGPIN/7661-2011]	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by an NSERC Discovery Grant, RGPIN/7661-2011, to THM (URL:http://www.nserc-crsng.gc.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruda AM, 2011, J INSECT PHYSIOL, V57, P665, DOI 10.1016/j.jinsphys.2011.03.007; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Chen J, 2010, J MOL BIOL, V398, P122, DOI 10.1016/j.jmb.2010.02.022; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; Clark MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029365; Clegg JS, 2007, BIOL BULL-US, V212, P74, DOI 10.2307/25066582; Clegg James S., 2002, P129; Clegg JS, 1996, PHYSIOL ZOOL, V69, P49, DOI 10.1086/physzool.69.1.30164200; CLEGG JS, 1995, EXP CELL RES, V219, P1, DOI 10.1006/excr.1995.1197; Clegg JS, 1997, J EXP BIOL, V200, P467; CLEGG JS, 1994, EXP CELL RES, V212, P77, DOI 10.1006/excr.1994.1120; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; Copf T, 2006, DEV BIOL, V298, P87, DOI 10.1016/j.ydbio.2006.07.024; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020187; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; Goto SG, 1998, J INSECT PHYSIOL, V44, P1009, DOI 10.1016/S0022-1910(97)00143-1; Goto SG, 2004, GENE, V326, P117, DOI 10.1016/j.gene.2003.10.017; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hand SC, 2011, J INSECT PHYSIOL, V57, P584, DOI 10.1016/j.jinsphys.2011.02.010; Hilario E, 2011, J MOL BIOL, V408, P74, DOI 10.1016/j.jmb.2011.02.004; Hu Y, 2011, CELL STRESS CHAPERON, V16, P133, DOI 10.1007/s12192-010-0225-7; Jackson SA, 1996, DEV GROWTH DIFFER, V38, P153; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2011, J INSECT PHYSIOL, V57, P538, DOI 10.1016/j.jinsphys.2010.10.006; Lavens P., 1987, P27; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Liang P, 1997, J BIOL CHEM, V272, P19051, DOI 10.1074/jbc.272.30.19051; Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Liao JH, 2009, MOL VIS, V15, P1429; Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051; MacRae TH, 2003, SEMIN CELL DEV BIOL, V14, P251, DOI 10.1016/j.semcdb.2003.09.019; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; McDonald ET, 2012, BIOCHEMISTRY-US, V51, P1257, DOI 10.1021/bi2017624; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; Qiu ZJ, 2008, FEBS J, V275, P3556, DOI 10.1111/j.1742-4658.2008.06501.x; Qiu Z, 2007, MECH DEVELOP, V124, P856, DOI 10.1016/j.mod.2007.09.001; Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Robbins HM, 2010, J EXP BIOL, V213, P1464, DOI 10.1242/jeb.041772; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sim C, 2011, J INSECT PHYSIOL, V57, P628, DOI 10.1016/j.jinsphys.2011.01.012; Sun Y, 2006, FEBS J, V273, P1020, DOI 10.1111/j.1742-4658.2006.05129.x; Sun Y, 2005, FEBS J, V272, P5230, DOI 10.1111/j.1742-4658.2005.04920.x; Sun Y, 2004, J BIOL CHEM, V279, P39999, DOI 10.1074/jbc.M406999200; Takeda K, 2011, J STRUCT BIOL, V174, P92, DOI 10.1016/j.jsb.2010.12.006; Treweek TM, 2010, EXP EYE RES, V91, P691, DOI 10.1016/j.exer.2010.08.015; Villenueve TS, 2006, CELL STRESS CHAPERON, V11, P71, DOI 10.1379/CSC-154R.1; Warner A.H., 1979, Methods in Enzymology, V60, P298; Wu Y, 2010, BIOCHEM CELL BIOL, V88, P937, DOI 10.1139/O10-143; Yang YS, 2003, ASSAY DRUG DEV TECHN, V1, P461, DOI 10.1089/154065803322163777; Yocum GD, 1998, INSECT BIOCHEM MOLEC, V28, P677, DOI 10.1016/S0965-1748(98)00046-0; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032129	57	44	46	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43723	10.1371/journal.pone.0043723	http://dx.doi.org/10.1371/journal.pone.0043723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952748	gold, Green Submitted, Green Published			2022-12-27	WOS:000308044800054
J	Packel, L; Keller, A; Dow, WH; de Walque, D; Nathan, R; Mtenga, S				Packel, Laura; Keller, Ann; Dow, William H.; de Walque, Damien; Nathan, Rose; Mtenga, Sally			Evolving Strategies, Opportunistic Implementation: HIV Risk Reduction in Tanzania in the Context of an Incentive-Based HIV Prevention Intervention	PLOS ONE			English	Article							SERO-DISCORDANT COUPLES; DAR-ES-SALAAM; PREGNANT-WOMEN; CONDOM USE; MARRIAGE; TRANSMISSION; HIV/AIDS; BEHAVIOR; DISCLOSURE; CHALLENGES	Background: Behavior change communication (BCC) interventions, while still a necessary component of HIV prevention, have not on their own been shown to be sufficient to stem the tide of the epidemic. The shortcomings of BCC interventions are partly due to barriers arising from structural or economic constraints. Arguments are being made for combination prevention packages that include behavior change, biomedical, and structural interventions to address the complex set of risk factors that may lead to HIV infection. Methods: In 2009/2010 we conducted 216 in-depth interviews with a subset of study participants enrolled in the RESPECT study - an HIV prevention trial in Tanzania that used cash awards to incentivize safer sexual behaviors. We analyzed community diaries to understand how the study was perceived in the community. We drew on these data to enhance our understanding of how the intervention influenced strategies for risk reduction. Results: We found that certain situations provide increased leverage for sexual negotiation, and these situations facilitated opportunistic implementation of risk reduction strategies. Opportunities enabled by the RESPECT intervention included leveraging conditional cash awards, but participants also emphasized the importance of exploiting new health status knowledge from regular STI testing. Risk reduction strategies included condom use within partnerships and/or with other partners, and an unexpected emphasis on temporary abstinence. Conclusions: Our results highlight the importance of increasing opportunities for implementing risk reduction strategies. We found that an incentive-based intervention could be effective in part by creating such opportunities, particularly among groups such as women with limited sexual agency. The results provide new evidence that expanding regular testing of STIs is another important mechanism for providing opportunities for negotiating behavior change, beyond the direct benefits of testing. Exploiting the latent demand for STI testing should receive renewed attention as part of innovative new combination interventions for HIV prevention.	[Packel, Laura] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Keller, Ann; Dow, William H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [de Walque, Damien] World Bank, World Bank Dev Res Grp, Washington, DC 20433 USA; [Nathan, Rose; Mtenga, Sally] Ifakara Hlth Inst, Dar Es Salaam, Tanzania	University of California System; University of California San Francisco; University of California System; University of California Berkeley; The World Bank; Ifakara Health Institute	Packel, L (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	ljpackel@gmail.com	de Walque, Damien/K-7049-2012; KELLER, ANN/Y-2086-2019	de Walque, Damien/0000-0003-1592-7602; KELLER, ANN/0000-0001-5467-2898; Dow, William/0000-0002-4080-1668	World Bank Research Committee; Spanish Impact Evaluation Fund; Knowledge for Change Program; Berkeley Population Center [R21 HD056581]; CDC dissertation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056581] Funding Source: NIH RePORTER	World Bank Research Committee; Spanish Impact Evaluation Fund; Knowledge for Change Program; Berkeley Population Center; CDC dissertation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded by the World Bank Research Committee, the Spanish Impact Evaluation Fund and the Knowledge for Change Program managed by the World Bank, the William and Flora Hewlett Foundation through the Population Reference Bureau, the Berkeley Population Center (R21 HD056581), and a CDC dissertation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1986, J EXP SOC PSYCHOL, V22, P453, DOI 10.1016/0022-1031(86)90045-4; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; BANDURA A, 1990, EVAL PROGRAM PLANN, V13, P9, DOI 10.1016/0149-7189(90)90004-G; Bankole A, 2011, AIDS EDUC PREV, V23, P313, DOI 10.1521/aeap.2011.23.4.313; Beyeza-Kashesya J, 2009, AFR HEALTH SCI, V9, P2; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Chimbiri AM, 2007, SOC SCI MED, V64, P1102, DOI 10.1016/j.socscimed.2006.10.012; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; De Walque D, 2012, STIMULATING DEMAND A; De Walque D, 2007, POPUL DEV REV, V33, P501, DOI 10.1111/j.1728-4457.2007.00182.x; de Walque D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000747; de Walque D, 2011, STUD FAMILY PLANN, V42, P1, DOI 10.1111/j.1728-4465.2011.00259.x; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Gupta GR, 2011, GLOB PUBLIC HEALTH, V6, pS370, DOI 10.1080/17441692.2011.617381; Gupta P, 2008, LANCET, V6736, P60887; Harrison A, 2010, AIDS BEHAV, V14, P991, DOI 10.1007/s10461-010-9687-y; Hayes R, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000390704.35642.47; Hirsch J. S., 2009, SECRET LOVE MARRIAGE; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kaler A, 2004, SOC SCI MED, V59, P285, DOI 10.1016/j.socscimed.2003.10.023; Kilewo C, 2001, J ACQ IMMUN DEF SYND, V28, P458, DOI 10.1097/00042560-200112150-00009; Kohler HP, 2011, WORLD BANK ECON REV, DOI [10.1093/wber/lhr1041, DOI 10.1093/WBER/LHR1041]; Krishnan S, 2011, POP ASS AM C WASH DC; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; London AJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001193; Maman S, 2001, AIDS CARE, V13, P595, DOI 10.1080/09540120120063223; Moustakas C., 1994, PHENOMENOLOGICAL RES; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Poulin M, 2007, SOC SCI MED, V65, P2383, DOI 10.1016/j.socscimed.2007.05.030; Reniers G, 2008, DEMOGRAPHY, V45, P417, DOI 10.1353/dem.0.0002; Schatz E, 2005, CULT HEALTH SEX, V7, P479, DOI 10.1080/13691050500151255; Schellenberg JA, 2002, POPULATION HLTH DEV, V1, P159; Smith KP, 2005, SOC SCI MED, V60, P649, DOI 10.1016/j.socscimed.2004.06.009; Tavory I, 2009, AM SOCIOL REV, V74, P171, DOI 10.1177/000312240907400201; TEMMERMAN M, 1995, LANCET, V345, P969, DOI 10.1016/S0140-6736(95)90707-6; Thornton RL, 2008, AM ECON REV, V98, P1829, DOI 10.1257/aer.98.5.1829; Watkins SC, 2004, POPUL DEV REV, V30, P673, DOI 10.1111/j.1728-4457.2004.00037.x; Watkins SC, 2009, POETICS, V37, P162, DOI 10.1016/j.poetic.2009.03.002; World Health Organization Joint United Nations Programme on HIV/AIDS, 2010, ADDR VIOL WOM HIV AI	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44058	10.1371/journal.pone.0044058	http://dx.doi.org/10.1371/journal.pone.0044058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	995WH	22952872	gold, Green Published			2022-12-27	WOS:000308044800092
J	Qu, ZL; Chung, D				Qu, Zhilin; Chung, Douglas			Mechanisms and Determinants of Ultralong Action Potential Duration and Slow Rate-Dependence in Cardiac Myocytes	PLOS ONE			English	Article							LONG-QT SYNDROME; INDUCED EARLY AFTERDEPOLARIZATIONS; TORSADE-DE-POINTES; T-WAVE ALTERNANS; TRIGGERED ACTIVITY; VENTRICULAR MYOCYTES; ELECTRICAL ALTERNANS; HEART-CELLS; ARRHYTHMIA; REPOLARIZATION	In normal cardiac myocytes, the action potential duration (APD) is several hundred milliseconds. However, experimental studies showed that under certain conditions, APD could be excessively long (or ultralong), up to several seconds. Unlike the normal APD, the ultralong APD increases sensitively with pacing cycle length even when the pacing rate is very slow, exhibiting a sensitive slow rate-dependence. In addition, these long action potentials may or may not exhibit early afterdepolarizations (EADs). Although these phenomena are well known, the underlying mechanisms and ionic determinants remain incompletely understood. In this study, computer simulations were performed with a simplified action potential model. Modifications to the L-type calcium current (I-Ca,I-L) kinetics and the activation time constant of the delayed rectifier K current were used to investigate their effects on APD. We show that: 1) the ultralong APD and its sensitive slow rate-dependence are determined by the steady-state window and pedestal I-Ca,I-L currents and the activation speed and the recovery of the delayed rectifier K current; 2) whether an ultralong action potential exhibits EADs or not depends on the kinetics of I-Ca,I-L; 3) increasing inward currents elevates the plateau voltage, which in general prolongs APD, however, this can also shorten APD when the APD is already ultralong under certain conditions; and 4) APD alternans occurs at slow pacing rates due to the sensitive slow rate-dependence and the ionic determinants are different from the ones causing APD alternans at fast heart rates.	[Qu, Zhilin; Chung, Douglas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Qu, ZL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA.	zqu@mednet.ucla.edu			National Institutes of Health/National Heart, Lung, and Blood Institute NIH/NHLBI [P01 HL078931, R01 HL093205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093205, P01HL078931] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the National Institutes of Health/National Heart, Lung, and Blood Institute NIH/NHLBI P01 HL078931 and R01 HL093205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Antoons G, 2007, J PHYSIOL-LONDON, V579, P147, DOI 10.1113/jphysiol.2006.124222; Antzelevitch C, 2001, EUR HEART J SUPPL, V3, pK2, DOI 10.1016/S1520-765X(01)90001-X; Antzelevitch C, 1999, J CARDIOVASC ELECTR, V10, P1124, DOI 10.1111/j.1540-8167.1999.tb00287.x; Chang MG, 2012, BIOPHYS J, V102, P2706, DOI 10.1016/j.bpj.2012.05.011; Choi BR, 2002, J PHYSIOL-LONDON, V543, P615, DOI 10.1113/jphysiol.2002.024570; Clancy CE, 2003, CIRCULATION, V107, P2233, DOI 10.1161/01.CIR.0000069273.51375.BD; Clancy CE, 2002, J CLIN INVEST, V110, P1251, DOI 10.1172/JCI200215928; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; DAMIANO BP, 1984, CIRCULATION, V69, P1013, DOI 10.1161/01.CIR.69.5.1013; de Lange E, 2012, BIOPHYS J, V103, P365, DOI 10.1016/j.bpj.2012.06.007; Fox JJ, 2002, AM J PHYSIOL-HEART C, V282, pH516, DOI 10.1152/ajpheart.00612.2001; Greenstein JL, 2000, CIRC RES, V87, P1026, DOI 10.1161/01.RES.87.11.1026; HIRANO Y, 1992, CIRC RES, V70, P445, DOI 10.1161/01.RES.70.3.445; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; JANUARY CT, 1988, CIRC RES, V62, P563, DOI 10.1161/01.RES.62.3.563; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; Keener J., 1998, MATH PHYSL; Koller ML, 1998, AM J PHYSIOL-HEART C, V275, pH1635, DOI 10.1152/ajpheart.1998.275.5.H1635; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Lemay M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002399; Liu GX, 2012, J PHYSIOL-LONDON, V590, P1171, DOI 10.1113/jphysiol.2011.218164; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Madhvani RV, 2011, J PHYSIOL-LONDON, V589, P6081, DOI 10.1113/jphysiol.2011.219600; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; Maoz A, 2009, HEART RHYTHM, V6, P813, DOI 10.1016/j.hrthm.2009.02.043; NOBLE D, 1966, PHYSIOL REV, V46, P1; NORDIN C, 1995, AM J PHYSIOL-HEART C, V268, pH2440, DOI 10.1152/ajpheart.1995.268.6.H2440; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Qu ZL, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00154; SANGUINETTI MC, 1986, J GEN PHYSIOL, V88, P369, DOI 10.1085/jgp.88.3.369; Sarkar AX, 2011, HEART RHYTHM, V8, P1749, DOI 10.1016/j.hrthm.2011.05.023; Sarkar AX, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000914; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Saucerman JJ, 2004, CIRC RES, V95, P1216, DOI 10.1161/01.RES.0000150055.06226.4e; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Tran DX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258103; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; Viswanathan PC, 1999, CARDIOVASC RES, V42, P530, DOI 10.1016/S0008-6363(99)00035-8; Viswanathan PC, 2000, CIRCULATION, V101, P1192, DOI 10.1161/01.CIR.101.10.1192; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wegener FT, 2008, EUROPACE, V10, P112, DOI 10.1093/europace/eum252; Xie YF, 2010, BIOPHYS J, V98, p531A, DOI 10.1016/j.bpj.2009.12.2880; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zhao ZH, 2012, CARDIOVASC RES, V95, P308, DOI 10.1093/cvr/cvs183; Zhao ZZ, 2012, AM J PHYSIOL-HEART C, V302, pH1636, DOI 10.1152/ajpheart.00742.2011	49	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43587	10.1371/journal.pone.0043587	http://dx.doi.org/10.1371/journal.pone.0043587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952713	gold, Green Published, Green Submitted			2022-12-27	WOS:000308044800041
J	Capellier, G; Mockly, H; Charpentier, C; Annane, D; Blasco, G; Desmettre, T; Roch, A; Faisy, C; Cousson, J; Limat, S; Mercier, M; Papazian, L				Capellier, Gilles; Mockly, Helene; Charpentier, Claire; Annane, Djillali; Blasco, Gilles; Desmettre, Thibault; Roch, Antoine; Faisy, Christophe; Cousson, Joel; Limat, Samuel; Mercier, Mariette; Papazian, Laurent			Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; HOSPITAL-ACQUIRED PNEUMONIA; PULMONARY INFECTION SCORE; NOSOCOMIAL PNEUMONIA; CRITICALLY-ILL; THERAPY; MULTICENTER; GUIDELINES; RESOLUTION; MORTALITY	Purpose: The optimal treatment duration for ventilator-associated pneumonia is based on one study dealing with late-onset of the condition. Shortening the length of antibiotic treatment remains a major prevention factor for the emergence of multiresistant bacteria. Objective: To demonstrate that 2 different antibiotic treatment durations (8 versus 15 days) are equivalent in terms of clinical cure for early-onset ventilator-associated pneumonia. Methods: Randomized, prospective, open, multicenter trial carried out from 1998 to 2002. Measurements: The primary endpoint was the clinical cure rate at day 21. The mortality rate was evaluated on days 21 and 90. Results: 225 patients were included in 13 centers. 191 (84.9%) patients were cured: 92 out of 109 (84.4%) in the 15 day cohort and 99 out of 116 (85.3%) in the 8 day cohort (difference = 0.9%, odds ratio = 0.929). 95% two-sided confidence intervals for difference and odds ratio were [28.4% to 10.3%] and [0.448 to 1.928] respectively. Taking into account the limits of equivalence (10% for difference and 2.25 for odds ratio), the objective of demonstrative equivalence between the 2 treatment durations was fulfilled. Although the rate of secondary infection was greater in the 8 day than the 15 day cohort, the number of days of antibiotic treatment remained lower in the 8 day cohort. There was no difference in mortality rate between the 2 groups on days 21 and 90. Conclusion: Our results suggest that an 8-day course of antibiotic therapy is safe for early-onset ventilator-associated pneumonia in intubated patients.	[Capellier, Gilles; Desmettre, Thibault] Pole Urgences SAMU Reanimat CHU, Besancon, Doubs, France; [Capellier, Gilles; Desmettre, Thibault] Univ Fcomte, EA 3920, Besancon, Doubs, France; [Blasco, Gilles] CHU, Serv Reanimat Chirurg Adulte, Besancon, Doubs, France; [Limat, Samuel] Univ Fcomte, EA 4267, Besancon, Doubs, France; [Charpentier, Claire] Hop Cent, Serv Reanimat Chirurg Adulte, Nancy, Lorraine, France; [Annane, Djillali] CHU Raymond Poincare, Assistance Publ Hop Paris, Serv Medicochirurg Adulte, Garches, Ile De France, France; [Roch, Antoine; Papazian, Laurent] Assistance Publ Hop Marseille, Serv Reanimat Med URMITE, Marseille, Bouches Du Rhon, France; [Roch, Antoine; Papazian, Laurent] Univ Aix Marseille 2, CNRS UMR 6236, Marseille, Bouches Du Rhon, France; [Faisy, Christophe] HEGP Assistance Publ Hop Paris, Serv Reanimat Med Adulte, Paris, Ile De France, France; [Cousson, Joel] Hop Robert Debre, Serv Reanimat Polyvalente Adulte, Reims, Champagne, France; [Mercier, Mariette] CHU, Lab Biostat, Besancon, Doubs, France; [Mercier, Mariette] Univ Fcomte, EA3181, Besancon, Doubs, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; CHU de Reims; Universite de Franche-Comte; CHU Besancon	Capellier, G (corresponding author), Pole Urgences SAMU Reanimat CHU, Besancon, Doubs, France.	gilles.capellier@univ-fcomte.fr	Annane, Djillali/R-7947-2019; LIMAT, Samuel/AAC-4762-2022; DESMETTRE, Thibaut/GLT-4326-2022	DESMETTRE, Thibaut/0000-0003-4585-5494	French Ministry of Health (Programme hospitalier de recherche clinique); SRLF (Societe de Reanimation de Langue Francaise); Glaxo and Beecham Laboratory	French Ministry of Health (Programme hospitalier de recherche clinique); SRLF (Societe de Reanimation de Langue Francaise); Glaxo and Beecham Laboratory	French Ministry of Health (Programme hospitalier de recherche clinique), SRLF (Societe de Reanimation de Langue Francaise), Glaxo and Beecham Laboratory. The funders had no role in study desig, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Court CD, 1995, YB INTENSIVE CARE EM, P726; Alvarez-Lerma F, 2001, INTENS CARE MED, V27, P493, DOI 10.1007/s001340000846; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Bregeon F, 1997, JAMA-J AM MED ASSOC, V277, P655, DOI 10.1001/jama.277.8.655; Brun-Buisson C, 1998, CLIN INFECT DIS, V26, P346, DOI 10.1086/516294; Capellier G, 2003, ANN M INT S INT CAR; Capellier G, 2004, ANN M SOC FRANC REAN; Charles PE, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-49; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Combes A, 2002, CHEST, V121, P1618, DOI 10.1378/chest.121.5.1618; Combes A, 2007, CRIT CARE MED, V35, P146, DOI 10.1097/01.CCM.0000249826.81273.E4; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; CRAVEN D E, 1992, Intensive Care Medicine, V18, pS3, DOI 10.1007/BF01752970; Dennesen PJW, 2001, AM J RESP CRIT CARE, V163, P1371, DOI 10.1164/ajrccm.163.6.2007020; DUNNETT CW, 1977, BIOMETRICS, V33, P593, DOI 10.2307/2529457; Esperatti M, 2010, AM J RESP CRIT CARE, V182, P1533, DOI 10.1164/rccm.201001-0094OC; Fagon JY, 2000, AM J RESP CRIT CARE, V161, P753, DOI 10.1164/ajrccm.161.3.9904115; Fagon JY, 1995, PNEUMOPATHIE NOSOCOM, P1; Ferrer M, 2010, CLIN INFECT DIS, V50, P945, DOI 10.1086/651075; GART JJ, 1971, REV INST INT STAT, V39, P148, DOI 10.2307/1402171; Gastmeier P, 2009, ANTIMICROB AGENTS CH, V53, P2714, DOI 10.1128/AAC.01070-08; Giantsou E, 2005, INTENS CARE MED, V31, P1488, DOI 10.1007/s00134-005-2697-y; Giard M, 2008, J CRIT CARE, V23, P27, DOI 10.1016/j.jcrc.2007.08.005; Heyland DK, 2008, CRIT CARE MED, V36, P737, DOI 10.1097/01.CCM.0B013E31816203D6; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; JOSHI N, 1992, AM J MED, V93, P135, DOI 10.1016/0002-9343(92)90042-A; Koeman Mirelle, 2003, Semin Respir Infect, V18, P122; Lancaster JW, 2008, PHARMACOTHERAPY, V28, P852, DOI 10.1592/phco.28.7.852; Leone M, 2007, CRIT CARE MED, V35, P379, DOI 10.1097/01.CCM.0000253404.69418.AA; Luna CM, CRIT CARE MED, V31, P676; Luyt CE, 2004, INTENS CARE MED, V30, P844, DOI 10.1007/s00134-003-2125-0; MARRIE TJ, 1994, CLIN INFECT DIS, V18, P501, DOI 10.1093/clinids/18.4.501; Masterton RG, 2008, J ANTIMICROB CHEMOTH, V62, P5, DOI 10.1093/jac/dkn162; MEDURI GU, 1994, CHEST, V106, P221, DOI 10.1378/chest.106.1.221; Nachtigall I, 2009, CRIT CARE MED, V37, P159, DOI 10.1097/CCM.0b013e3181934f1b; Osmon S, 2003, CHEST, V124, P1021, DOI 10.1378/chest.124.3.1021; Pugh RJ, 2010, J HOSP INFECT, V74, P337, DOI 10.1016/j.jhin.2009.10.009; Rotstein C, 2008, CAN J INFECT DIS MED, V19, P19, DOI 10.1155/2008/593289; SFAR, 1992, ANT MIL CHIR CHEZ AD; Singh N, 2000, AM J RESP CRIT CARE, V162, P505, DOI 10.1164/ajrccm.162.2.9909095; Trouillet JL, 1998, AM J RESP CRIT CARE, V157, P531, DOI 10.1164/ajrccm.157.2.9705064; Verhamme KMC, 2007, INFECT CONT HOSP EP, V28, P389, DOI 10.1086/511702; Vidaur L, 2008, CHEST, V133, P625, DOI 10.1378/chest.07-2020; WEINBERG PF, 1984, AM REV RESPIR DIS, V130, P791	46	73	73	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e41290	10.1371/journal.pone.0041290	http://dx.doi.org/10.1371/journal.pone.0041290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952580	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300003
J	Chen, M; Wang, K; Lin, B				Chen, Miao; Wang, Ke; Lin, Bin			Development and Degeneration of Cone Bipolar Cells Are Independent of Cone Photoreceptors in a Mouse Model of Retinitis Pigmentosa	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; HORIZONTAL CELLS; GLUTAMATE RECEPTORS; SPATIAL ORDER; GENE-THERAPY; RD/RD MOUSE; RAT RETINA; RD MICE; ORGANIZATION; MELANOPSIN	Retinal photoreceptors die during retinal synaptogenesis in a portion of retinal degeneration. Whether cone bipolar cells establish regular retinal mosaics and mature morphologies, and resist degeneration are not completely understood. To explore these issues, we backcrossed a transgenic mouse expressing enhanced green fluorescent protein (EGFP) in one subset of cone bipolar cells (type 7) into rd1 mice, a classic mouse model of retinal degeneration, to examine the development and survival of cone bipolar cells in a background of retinal degeneration. Our data revealed that both the development and degeneration of cone bipolar cells are independent of the normal activity of cone photoreceptors. We found that type 7 cone bipolar cells achieved a uniform tiling of the retinal surface and developed normal dendritic and axonal arbors without the influence of cone photoreceptor innervation. On the other hand, degeneration of type 7 cone bipolar cells, contrary to our belief of central-to-peripheral progression, was spatially uniform across the retina independent of the spatiotemporal pattern of cone degeneration. The results have important implications for the design of more effective therapies to restore vision in retinal degeneration.	[Chen, Miao; Wang, Ke; Lin, Bin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Lin, Bin] Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Pokfulam, Hong Kong, Peoples R China; [Lin, Bin] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chen, M (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	blin@hku.hk	Lin, Bin/E-9871-2010	Lin, Bin/0000-0003-1309-3480	University of Hong Kong; Hong Kong Research Grants Council	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by University of Hong Kong Seed Funding Program for Basic Research and General Research Fund from the Hong Kong Research Grants Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Berntson A, 2000, J PHYSIOL-LONDON, V524, P879, DOI 10.1111/j.1469-7793.2000.00879.x; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BLANKS JC, 1974, J COMP NEUROL, V156, P95, DOI 10.1002/cne.901560108; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chua J, 2009, J COMP NEUROL, V514, P473, DOI 10.1002/cne.22029; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Euler T, 1996, J NEUROSCI, V16, P2934; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Fei YJ, 2002, MOL VIS, V8, P306; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; GARCIAFERNANDEZ JM, 1995, NEUROSCI LETT, V187, P33; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Grunert U, 2003, J COMP NEUROL, V466, P136, DOI 10.1002/cne.10862; Hartveit E, 1997, J NEUROPHYSIOL, V77, P1716, DOI 10.1152/jn.1997.77.4.1716; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; HINDS JW, 1979, J COMP NEUROL, V187, P495, DOI 10.1002/cne.901870303; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Keeley PW, 2010, J NEUROSCI, V30, P1677, DOI 10.1523/JNEUROSCI.5153-09.2010; Keeley PW, 2012, DISR CIRC OUT RET FO; KOLB H, 1974, INVEST OPHTH VISUAL, V13, P487; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LaVail MM, 1997, EXP EYE RES, V65, P45, DOI 10.1006/exer.1997.0308; Lee SCS, 2011, J NEUROSCI, V31, P14126, DOI 10.1523/JNEUROSCI.2844-11.2011; Lin B, 2005, EUR J NEUROSCI, V21, P1257, DOI 10.1111/j.1460-9568.2005.03967.x; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; Petit-Jacquea J, 2005, J NEUROPHYSIOL, V94, P1770, DOI 10.1152/jn.00279.2005; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Puthussery T, 2010, ADV EXP MED BIOL, V664, P525, DOI 10.1007/978-1-4419-1399-9_60; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Raven MA, 2003, INVEST OPHTH VIS SCI, V44, P965, DOI 10.1167/iovs.02-0831; Rich KA, 1997, J COMP NEUROL, V388, P47; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Rossi C, 2003, J NEUROSCI, V23, P9924; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Shi ZW, 2011, J NEUROSCI, V31, P13118, DOI 10.1523/JNEUROSCI.2331-11.2011; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Strettoi E, 2002, J COMP NEUROL, V446, P1, DOI 10.1002/cne.10177; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Strettoi E, 2002, J NEUROSCI, V22, P5492; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; YANAI D, 2003, T AM OPHTHAL SOC, V101, P228; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009	68	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44036	10.1371/journal.pone.0044036	http://dx.doi.org/10.1371/journal.pone.0044036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952865	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300045
J	Frevert, U; Movila, A; Nikolskaia, OV; Raper, J; Mackey, ZB; Abdulla, M; McKerrow, J; Grab, DJ				Frevert, Ute; Movila, Alexandru; Nikolskaia, Olga V.; Raper, Jayne; Mackey, Zachary B.; Abdulla, Maha; McKerrow, James; Grab, Dennis J.			Early Invasion of Brain Parenchyma by African Trypanosomes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRUCEI-BRUCEI; SLEEPING SICKNESS; BARRIER DAMAGE; BLOOD; INFECTION; MODEL; MICE; CELL; MENINGOENCEPHALITIS	Human African trypanosomiasis or sleeping sickness is a vector-borne parasitic disease that has a major impact on human health and welfare in sub-Saharan countries. Based mostly on data from animal models, it is currently thought that trypanosome entry into the brain occurs by initial infection of the choroid plexus and the circumventricular organs followed days to weeks later by entry into the brain parenchyma. However, Trypanosoma brucei bloodstream forms rapidly cross human brain microvascular endothelial cells in vitro and appear to be able to enter the murine brain without inflicting cerebral injury. Using a murine model and intravital brain imaging, we show that bloodstream forms of T. b. brucei and T. b. rhodesiense enter the brain parenchyma within hours, before a significant level of microvascular inflammation is detectable. Extravascular bloodstream forms were viable as indicated by motility and cell division, and remained detectable for at least 3 days post infection suggesting the potential for parasite survival in the brain parenchyma. Vascular inflammation, as reflected by leukocyte recruitment and emigration from cortical microvessels, became apparent only with increasing parasitemia at later stages of the infection, but was not associated with neurological signs. Extravascular trypanosomes were predominantly associated with postcapillary venules suggesting that early brain infection occurs by parasite passage across the neuroimmunological blood brain barrier. Thus, trypanosomes can invade the murine brain parenchyma during the early stages of the disease before meningoencephalitis is fully established. Whether individual trypanosomes can act alone or require the interaction from a quorum of parasites remains to be shown. The significance of these findings for disease development is now testable.	[Frevert, Ute; Movila, Alexandru] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA; [Nikolskaia, Olga V.; Grab, Dennis J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Grab, Dennis J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Raper, Jayne] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Mackey, Zachary B.; Abdulla, Maha; McKerrow, James] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	New York University; Johns Hopkins University; Johns Hopkins University; City University of New York (CUNY) System; Hunter College (CUNY); University of California System; University of California San Francisco	Frevert, U (corresponding author), NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA.	dgrab1@jhmi.edu		Mackey, Zachary/0000-0002-4533-0973; Frevert, Ute/0000-0001-9556-7330; Raper, Jayne/0000-0002-8723-9748	National Institutes of Health (NIH) [5R01AI082695]; Dana Foundation; NIH [S10 RR019288]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082695] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by grants from the National Institutes of Health (NIH)(5R01AI082695) to DJG, and Brain & Immuno Imaging Grant from the Dana Foundation and NIH (S10 RR019288) to UF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; ABOLARIN MO, 1986, T ROY SOC TROP MED H, V80, P618, DOI 10.1016/0035-9203(86)90160-4; Alfonso MO, 1996, 20 INT C ENT FIR IT; Amrouni D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016891; Amrouni D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009211; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Balmer O, 2006, ACTA TROP, V97, P94, DOI 10.1016/j.actatropica.2005.09.002; Belluscio L., 2005, CURR PROTOC NEUROSCI, V32, DOI [10.1002/0471142301.ns0209s32, DOI 10.1002/0471142301.NS0209S32]; Bonkowski D, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-8; Buguet A, 2001, SLEEP MED REV, V5, P139, DOI 10.1053/smrv.2000.0130; Carroll RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013124; Chevrier C, 2005, ACTA TROP, V95, P33, DOI 10.1016/j.actatropica.2005.04.011; Chung YC, 2010, BMB REP, V43, P225, DOI 10.5483/BMBRep.2010.43.4.225; Darsaud A, 2004, TROP MED INT HEALTH, V9, P83, DOI 10.1046/j.1365-3156.2003.01154.x; FINK E, 1979, TROPENMED PARASITOL, V30, P206; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Girard M, 2005, MOL BIOCHEM PARASIT, V139, P41, DOI 10.1016/j.molbiopara.2004.09.008; Grab DJ, 2011, CELL MICROBIOL, V13, P1470, DOI 10.1111/j.1462-5822.2011.01661.x; Grab DJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001249; Grab DJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000479; Grab DJ, 2008, J NEUROVIROL, V14, P344, DOI 10.1080/13550280802282934; Grab DJ, 2004, J PARASITOL, V90, P970, DOI 10.1645/GE-287R; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Holman DW, 2011, BBA-MOL BASIS DIS, V1812, P220, DOI 10.1016/j.bbadis.2010.07.019; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; HUNTER CA, 1992, J NEUROIMMUNOL, V36, P91, DOI 10.1016/0165-5728(92)90040-R; Jennings F W, 1983, Contrib Microbiol Immunol, V7, P147; JENNINGS FW, 1979, INT J PARASITOL, V9, P381, DOI 10.1016/0020-7519(79)90089-4; JENNINGS FW, 1993, T ROY SOC TROP MED H, V87, P224, DOI 10.1016/0035-9203(93)90502-H; JENNINGS FW, 1982, Z PARASITENKD, V67, P337, DOI 10.1007/BF00927669; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; Kennedy PGE, 2004, J CLIN INVEST, V113, P496, DOI 10.1172/JCI200421052; Kennedy PGE, 1997, P NATL ACAD SCI USA, V94, P4167, DOI 10.1073/pnas.94.8.4167; Kennedy PGE, 2003, BRAIN, V126, P1683, DOI 10.1093/brain/awg160; Kristensson K, 2011, NAT REV NEUROSCI, V12, P345, DOI 10.1038/nrn3029; Kristensson K, 2010, PROG NEUROBIOL, V91, P152, DOI 10.1016/j.pneurobio.2009.12.001; LeBowitz JH, 2005, P NATL ACAD SCI USA, V102, P14485, DOI 10.1073/pnas.0507523102; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; MacLean LM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000906; MANUELIDIS ELIAS E., 1965, ACTA NEUROPATHOL, V5, P176; Masocha W, 2008, SCAND J IMMUNOL, V68, P484, DOI 10.1111/j.1365-3083.2008.02170.x; Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045; Moxon CA, 2009, MOL BIOCHEM PARASIT, V166, P99, DOI 10.1016/j.molbiopara.2009.03.006; Mulenga C, 2001, NEUROPATH APPL NEURO, V27, P77, DOI 10.1046/j.0305-1846.2001.00306.x; Nacer A, 2012, NEUROIMMUNOLOG UNPUB; Ngotho M, 2011, ACTA TROP, V119, P14, DOI 10.1016/j.actatropica.2011.02.013; Nikolskaia OV, 2008, J CLIN INVEST, V118, P1974, DOI 10.1172/JCI27798C1; Nikolskaia OV, 2006, J CLIN INVEST, V116, P2739, DOI [10.1172/JC127798, 10.1172/JCI27798.]; Owens T, 2008, J NEUROPATH EXP NEUR, V67, P1113, DOI 10.1097/NEN.0b013e31818f9ca8; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057; PENTREATH VW, 1995, T ROY SOC TROP MED H, V89, P9, DOI 10.1016/0035-9203(95)90637-1; PENTREATH VW, 1992, ANN TROP MED PARASIT, V86, P29, DOI 10.1080/00034983.1992.11812627; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; PHILIP KA, 1994, ANN TROP MED PARASIT, V88, P607, DOI 10.1080/00034983.1994.11812911; POLTERA AA, 1980, CLIN EXP IMMUNOL, V40, P496; POLTERA AA, 1977, VIRCHOWS ARCH A, V373, P249, DOI 10.1007/BF00432240; Pouratian N., 2002, BRAIN MAPPING METHOD, V2nd, P97; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Rodgers J, 2011, AM J TROP MED HYG, V84, P344, DOI 10.4269/ajtmh.2011.10-0487; Ross MH., 1995, HISTOLOGY TEXT ATLAS, V3; SCHMIDT H, 1983, VIRCHOWS ARCH A, V399, P333, DOI 10.1007/BF00612951; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sternberg JM, 2005, J NEUROIMMUNOL, V167, P81, DOI 10.1016/j.jneuroim.2005.06.017; STEVENS DR, 1977, ACTA NEUROPATHOL, V38, P173, DOI 10.1007/BF00688062; Stoppini L, 2000, INT J MED MICROBIOL, V290, P105; Untucht C, 2011, MICROBIOL-SGM, V157, P2933, DOI 10.1099/mic.0.049106-0; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; VANMARCK EAE, 1981, ANN SOC BELG MED TR, V61, P57; WHITELAW DD, 1985, PARASITOLOGY, V90, P255, DOI 10.1017/S0031182000050964; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wolburg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034304; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	76	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43913	10.1371/journal.pone.0043913	http://dx.doi.org/10.1371/journal.pone.0043913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952808	Green Published, gold			2022-12-27	WOS:000308221300033
J	Kyongo, JK; Jespers, V; Goovaerts, O; Michiels, J; Menten, J; Fichorova, RN; Crucitti, T; Vanham, G; Arien, KK				Kyongo, Jordan K.; Jespers, Vicky; Goovaerts, Odin; Michiels, Johan; Menten, Joris; Fichorova, Raina N.; Crucitti, Tania; Vanham, Guido; Arien, Kevin K.			Searching for Lower Female Genital Tract Soluble and Cellular Biomarkers: Defining Levels and Predictors in a Cohort of Healthy Caucasian Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ECTOPIC PROSTATIC TISSUE; VAGINAL EPITHELIAL-CELLS; BACTERIAL VAGINOSIS; HETEROSEXUAL TRANSMISSION; ANTIRETROVIRAL THERAPY; HIV-1 TRANSMISSION; MENSTRUAL-CYCLE; POSITIVE WOMEN; UTERINE CERVIX	Background: High concentrations of pro-inflammatory cytokines have been previously observed in the genital fluids of women enrolled in microbicide trials and may explain observed increased HIV transmission in some of these trials. Although the longitudinal nature of these studies allows within-subject comparisons of post-product levels to baseline levels, the fact that the physiologic variations of these cytokines and other markers of immune activation are not fully defined in different populations, makes it difficult to assess changes that can be directly attributed to microbicide use as opposed to other biological and behavioural factors. Methods: Cervicovaginal lavage samples were collected from 30 healthy Caucasian and assayed for concentrations of ten cytokines/chemokines, total protein content and two antimicrobial proteins using a multiplex immunoassay and ELISA. Cellular markers were characterized by flow cytometry on mononuclear cells collected from the endocervix using flocked swabs. Bacterial quantification was performed using quantitative PCR. Results: Ectopy, menstrual cycle phase, prostate-specific antigen and presence of leucocytes in endocervical cells' supernatant were associated with the concentrations of cyto-/chemokines in cervicovaginal secretions. Approximately 3% of endocervical cells collected were monocytes of which a median of 52% (SD = 17) expressed both CD4 and CCR5 markers. Approximately 1% of the total cells were T-cells with a median of 61% (SD = 10) CD4 and CCR5 expression. Around 5% of the monocytes and 16% of the T-cells expressed the immune activation marker HLA-DR. Higher percentages of T-cells were associated with greater quantities of IL-1RA, GM-CSF and elafin. Conclusion: We demonstrate the presence of selected soluble and cellular immune activation markers and identify their predictors in the female genital tract of healthy women. Future clinical trials should consider ectopy, sexual activity, menstrual cycle phase and presence of bacterial species as possible confounders when evaluating the possible inflammatory effects of microbicide compounds.	[Kyongo, Jordan K.; Michiels, Johan; Vanham, Guido; Arien, Kevin K.] Inst Trop Med, Dept Biomed Sci, Virol Unit, Div Microbiol, B-2000 Antwerp, Belgium; [Jespers, Vicky] Inst Trop Med, ITM HIV AIDS Ctr, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Goovaerts, Odin] Inst Trop Med, Immunol Unit, Div Microbiol, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Menten, Joris] Inst Trop Med, Clin Trials Unit, Dept Clin Sci, B-2000 Antwerp, Belgium; [Fichorova, Raina N.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Lab Genital Tract Biol,Brigham & Womens Hosp, Boston, MA 02115 USA; [Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, B-2000 Antwerp, Belgium; [Vanham, Guido] Univ Brussels, Fac Med & Pharmacol, Brussels, Belgium; [Vanham, Guido] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institute of Tropical Medicine (ITM); University of Antwerp	Kyongo, JK (corresponding author), Inst Trop Med, Dept Biomed Sci, Virol Unit, Div Microbiol, B-2000 Antwerp, Belgium.	karien@itg.be	Crucitti, Tania/AAB-9967-2019; Fichorova, Raina/G-9969-2014; Crucitti, Tania/AAH-1902-2021; Crucitti, Tania/AEQ-9792-2022	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038	European Commission [503558, CHAARM 242135]; Foundation Dormeur, Switzerland	European Commission(European CommissionEuropean Commission Joint Research Centre); Foundation Dormeur, Switzerland	This work was supported by the European Commission [European Microbicides Project 503558 and CHAARM 242135] and by the Foundation Dormeur, Switzerland. The authors are grateful to the participants and the study's physicians, Dr. Ilse Collier, Dr. Christiane Van Ghijseghem and Dr. Kristien Wouters. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 2001, AIDS, V15, P1535, DOI 10.1097/00002030-200108170-00011; Al-Harthi L, 2000, J INTERF CYTOK RES, V20, P719, DOI 10.1089/10799900050116426; Anukam KC, 2006, SEX TRANSM DIS, V33, P59, DOI 10.1097/01.olq.0000175367.15559.c4; Bebell LM, 2008, J INFECT DIS, V198, P710, DOI 10.1086/590503; Berlier W, 2006, HUM REPROD, V21, P1135, DOI 10.1093/humrep/dei496; Breen EC, 2011, CLIN VACCINE IMMUNOL, V18, P1229, DOI 10.1128/CVI.05032-11; Cauci S, 2003, MOL HUM REPROD, V9, P53, DOI 10.1093/molehr/gag003; Cauci S, 2002, AM J REPROD IMMUNOL, V47, P257, DOI 10.1034/j.1600-0897.2002.01096.x; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Crowley-Nowick PA, 2000, J INFECT DIS, V181, P939, DOI 10.1086/315311; Dezzutti CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023136; Dziak R, 2011, CAN SOC FORENSIC SCI, V44, P59, DOI 10.1080/00085030.2011.10768142; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; Fichorova RN, 2011, MBIO, V2, DOI 10.1128/mBio.00168-11; Fichorova RN, 2011, CYTOKINE, V55, P134, DOI 10.1016/j.cyto.2011.03.016; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fichorova RN, 2004, J ACQUIR IMMUNE D S3, V37, P184; Fleming DC, 2003, FERTIL STERIL, V79, P856, DOI 10.1016/S0015-0282(02)04930-0; Francis SC, 2012, INT MICR C SYDN AUST; Gali Y, 2010, ANTIMICROB AGENTS CH, V54, P5105, DOI 10.1128/AAC.00456-10; Gargiulo AR, 2004, FERTIL STERIL, V82, P1226, DOI 10.1016/j.fertnstert.2004.03.039; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; HILLIER SL, 1993, CLIN INFECT DIS, V16, P273; Hwang LY, 2011, J REPROD IMMUNOL, V88, P66, DOI 10.1016/j.jri.2010.07.008; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Jespers V, 2011, AM J REPROD IMMUNOL, V65, P368, DOI 10.1111/j.1600-0897.2010.00938.x; Jespers VA, 2007, JAIDS-J ACQ IMM DEF, V44, P154, DOI 10.1097/QAI.0b013e31802bb35f; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; KLEBANOFF SJ, 1991, J EXP MED, V174, P289, DOI 10.1084/jem.174.1.289; Lajoie J, 2008, MUCOSAL IMMUNOL, V1, P309, DOI 10.1038/mi.2008.18; Lajoie J, 2010, J CLIN IMMUNOL, V30, P90, DOI 10.1007/s10875-009-9343-3; Lieberman JA, 2008, CLIN VACCINE IMMUNOL, V15, P49, DOI 10.1128/CVI.00216-07; McCluggage WG, 2006, AM J SURG PATHOL, V30, P209, DOI 10.1097/01.pas.0000180446.17517.b8; Moreira C, 2009, CLIN INFECT DIS, V49, P991, DOI 10.1086/605540; MOSS GB, 1991, J INFECT DIS, V164, P588, DOI 10.1093/infdis/164.3.588; Myer L, 2006, SEX TRANSM DIS, V33, P683, DOI 10.1097/01.olq.0000216026.67352.f9; Nucci MR, 2000, AM J SURG PATHOL, V24, P1224, DOI 10.1097/00000478-200009000-00005; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; PLOURDE PJ, 1994, J INFECT DIS, V170, P313, DOI 10.1093/infdis/170.2.313; Scott ME, 2011, CYTOKINE, V56, P430, DOI 10.1016/j.cyto.2011.06.011; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sharkey DJ, 2012, J IMMUNOL, V188, P2445, DOI 10.4049/jimmunol.1102736; Spear GT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019560; Spurbeck RR, 2011, FUTURE MICROBIOL, V6, P567, DOI [10.2217/FMB.11.36, 10.2217/fmb.11.36]; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P949, DOI 10.1001/jama.284.8.949; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695; Wallace C, 2001, AM J SURG PATHOL, V25, P1215, DOI 10.1097/00000478-200109000-00016; WHO/CONRAD, 2004, MAN STAND COLP EV VA; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4	59	65	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43951	10.1371/journal.pone.0043951	http://dx.doi.org/10.1371/journal.pone.0043951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952818	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300036
J	Zhu, XY; Li, XP; Chen, WX; Chen, JY; Lu, WJ; Chen, L; Fu, DW				Zhu, Xiaoyang; Li, Xueping; Chen, Weixin; Chen, Jianye; Lu, Wangjin; Chen, Lei; Fu, Danwen			Evaluation of New Reference Genes in Papaya for Accurate Transcript Normalization under Different Experimental Conditions	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; QUANTITATIVE RT-PCR; RELIABLE REFERENCE GENES; REAL-TIME PCR; HOUSEKEEPING GENES; INTERNAL CONTROL; EXPRESSION NORMALIZATION; GOSSYPIUM-HIRSUTUM; VALIDATION; SELECTION	Real-time reverse transcription PCR (RT-qPCR) is a preferred method for rapid and accurate quantification of gene expression studies. Appropriate application of RT-qPCR requires accurate normalization though the use of reference genes. As no single reference gene is universally suitable for all experiments, thus reference gene(s) validation under different experimental conditions is crucial for RT-qPCR analysis. To date, only a few studies on reference genes have been done in other plants but none in papaya. In the present work, we selected 21 candidate reference genes, and evaluated their expression stability in 246 papaya fruit samples using three algorithms, geNorm, NormFinder and RefFinder. The samples consisted of 13 sets collected under different experimental conditions, including various tissues, different storage temperatures, different cultivars, developmental stages, postharvest ripening, modified atmosphere packaging, 1-methylcyclopropene (1-MCP) treatment, hot water treatment, biotic stress and hormone treatment. Our results demonstrated that expression stability varied greatly between reference genes and that different suitable reference gene(s) or combination of reference genes for normalization should be validated according to the experimental conditions. In general, the internal reference genes EIF (Eukaryotic initiation factor 4A), TBP1 (TATA binding protein 1) and TBP2 (TATA binding protein 2) genes had a good performance under most experimental conditions, whereas the most widely present used reference genes, ACTIN (Actin 2), 18S rRNA (18S ribosomal RNA) and GAPDH (Glyceraldehyde-3-phosphate dehydrogenase) were not suitable in many experimental conditions. In addition, two commonly used programs, geNorm and Normfinder, were proved sufficient for the validation. This work provides the first systematic analysis for the selection of superior reference genes for accurate transcript normalization in papaya under different experimental conditions.	[Zhu, Xiaoyang; Li, Xueping; Chen, Weixin; Chen, Jianye; Lu, Wangjin; Chen, Lei; Fu, Danwen] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangdong Key Lab Postharvest Sci & Technol, Coll Hort, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zhu, XY (corresponding author), S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangdong Key Lab Postharvest Sci & Technol, Coll Hort, Guangzhou, Guangdong, Peoples R China.	lxp280477@yahoo.cn	Chen, Jian-ye/V-8278-2019	Chen, Jian-ye/0000-0002-8975-6941	National Natural Science Foundation of China [U0631004]; Guangdong Science Foundation [04020590, 06200670]; National Key Technology R&D Program of China [2011BAD24B02-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science Foundation; National Key Technology R&D Program of China(National Key Technology R&D Program)	The research work was funded by the Project of Guangdong Science Foundation (04020590), National Natural Science Foundation of China (U0631004), Guangdong Science Foundation (06200670), and the National Key Technology R&D Program of China (2011BAD24B02-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Bezier A, 2002, EUR J PLANT PATHOL, V108, P111, DOI 10.1023/A:1015061108045; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Burleigh SH, 2001, PLANT SCI, V160, P899, DOI 10.1016/S0168-9452(00)00460-X; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chen NJ, 2003, FUNCT PLANT BIOL, V30, P433, DOI 10.1071/FP02208; Chen YT, 2003, PLANT SCI, V164, P531, DOI 10.1016/S0168-9452(03)00002-5; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Almeida MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-73; de Capdeville G, 2007, SCI HORTIC-AMSTERDAM, V111, P179, DOI 10.1016/j.scienta.2006.10.003; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Devitt LC, 2006, PLANT SCI, V170, P356, DOI 10.1016/j.plantsci.2005.09.003; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hernandez M, 2007, VACCINE, V25, P4252, DOI 10.1016/j.vaccine.2007.02.080; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Le Bail A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-75; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Manenoi A, 2007, PHYSIOL PLANTARUM, V131, P470, DOI 10.1111/j.1399-3054.2007.00967.x; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reece R.J., 2004, ANAL GENES GENOMES; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Shiga TM, 2009, J AGR FOOD CHEM, V57, P7064, DOI 10.1021/jf900073b; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Xie Fuliang, 2012, Plant Mol Biol; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yu QY, 2008, PLANT J, V53, P124, DOI 10.1111/j.1365-313X.2007.03329.x; Yu QY, 2005, CELL RES, V15, P576, DOI 10.1038/sj.cr.7290327; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8	71	221	235	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44405	10.1371/journal.pone.0044405	http://dx.doi.org/10.1371/journal.pone.0044405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952972	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300088
J	Jorgensen, AL; FitzGerald, RJ; Oyee, J; Pirmohamed, M; Williamson, PR				Jorgensen, Andrea L.; FitzGerald, Richard J.; Oyee, James; Pirmohamed, Munir; Williamson, Paula R.			Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							K EPOXIDE REDUCTASE; GAMMA-GLUTAMYL-CARBOXYLASE; ANTICOAGULATION-RELATED OUTCOMES; COMMON GENETIC-VARIANTS; DOSE REQUIREMENTS; CYTOCHROME P4502C9; COMPLEX SUBUNIT-1; INTERINDIVIDUAL VARIABILITY; ORAL ANTICOAGULATION; DOSAGE REQUIREMENTS	Background: Warfarin is a highly effective anticoagulant however its effectiveness relies on maintaining INR in therapeutic range. Finding the correct dose is difficult due to large inter-individual variability. Two genes, CYP2C9 and VKORC1, have been associated with this variability, leading to genotype-guided dosing tables in warfarin labeling. Nonetheless, it remains unclear how genotypic information should be used in practice. Navigating the literature to determine how genotype will influence warfarin response in a particular patient is difficult, due to significant variation in patient ethnicity, outcomes investigated, study design, and methodological rigor. Our systematic review was conducted to enable fair and accurate interpretation of which variants affect which outcomes, in which patients, and to what extent. Methodology/Principal Findings: A comprehensive search strategy was applied and 117 studies included. Primary outcomes were stable dose, time to stable dose and bleeding events. Methodological quality was assessed using criteria of Jorgensen and Williamson and data synthesized in meta-analyses using advanced methods. Pooled effect estimates were significant in most ethnic groups for CYP2C9*3 and stable dose (mutant types requiring between 1.1(0.7-1.5) and 2.3(1.6-3.0) mg/day). Effect estimates were also significant for VKORC1 and stable dose for most ethnicities, although direction differed between asians and non-asians (mutant types requiring between 0.8(0.4-1.3) and 1.5(1.1-1.8) mg/day more in asians and between 1.5(0.7-2.2) and 3.1(2.7-3.6) mg/day less in non-asians). Several studies were excluded due to inadequate data reporting. Assessing study quality highlighted significant variability in methodological rigor. Notably, there was significant evidence of selective reporting, of outcomes and analysis approaches. Conclusions/Significance: Genetic associations with warfarin response vary between ethnicities. In order to achieve unbiased estimates in different populations, a high level of methodological rigor must be maintained and studies should report sufficient data to enable inclusion in meta-analyses. We propose minimum reporting requirements, suggest methodological guidelines and provide recommendations for reducing the risk of selective reporting.	[Jorgensen, Andrea L.; Oyee, James; Williamson, Paula R.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [FitzGerald, Richard J.; Pirmohamed, Munir] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Jorgensen, AL (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	a.l.jorgensen@liv.ac.uk	Williamson, Paula R/B-6425-2016; Pirmohamed, Munir/H-6004-2011	Williamson, Paula R/0000-0001-9802-6636; Pirmohamed, Munir/0000-0002-7534-7266	UK Department of Health	UK Department of Health	The work reported in this paper was undertaken as part of the corresponding author's PhD which was funded by the UK Department of Health. No funding bodies had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Bertola JP, 2003, THROMB RES, V109, P287, DOI 10.1016/S0049-3848(03)00245-7; Blackshear JL, 1996, LANCET, V348, P633; Bodin L, 2008, J THROMB HAEMOST, V6, P1436, DOI 10.1111/j.1538-7836.2008.03049.x; Borgiani P, 2009, PHARMACOGENOMICS, V10, P261, DOI 10.2217/14622416.10.2.261; Burns M, 1999, J THROMB THROMBOLYS, V7, P137, DOI 10.1023/A:1008829403320; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Caldwell MD, 2007, CLIN MED RES, V5, P8, DOI 10.3121/cmr.2007.724; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; Carlquist JF, 2006, J THROMB THROMBOLYS, V22, P191, DOI 10.1007/s11239-006-9030-7; Chern HD, 2006, CLIN CHIM ACTA, V367, P108, DOI 10.1016/j.cca.2005.11.026; Cho HJ, 2007, PHARMACOGENOMICS, V8, P329, DOI 10.2217/14622416.8.4.329; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Contopoulos-Ioannidis DG, 2006, PHARMACOGENET GENOM, V16, P705, DOI 10.1097/01.fpc.0000236332.11304.8f; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; D'Ambrosio RL, 2004, HAEMATOLOGICA, V89, P1510; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; FDA, 2007, FDA APPR UPD WARF CO; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; Flockhart DA, 2008, GENET MED, V10, P139, DOI 10.1097/GIM.0b013e318163c35f; Freeman BD, 2000, SURGERY, V128, P281, DOI 10.1067/msy.2000.107283; Fukuda T, 2006, CLIN PHARMACOL THER, V80, P553, DOI 10.1016/j.clpt.2006.08.005; Furuya H, 1995, PHARMACOGENETICS, V5, P389, DOI 10.1097/00008571-199512000-00008; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gage BF, 2004, THROMB HAEMOSTASIS, V91, P87, DOI 10.1160/TH03-06-0379; Gan GG, 2004, INT J HEMATOL, V80, P295, DOI 10.1532/IJH97.A20401; Della Valle AG, 2009, CLIN ORTHOP RELAT R, V467, P1773, DOI 10.1007/s11999-008-0641-5; Harrington DJ, 2005, THROMB HAEMOSTASIS, V93, P23, DOI 10.1160/TH04-08-0540; Hatch E, 2008, J THROMB HAEMOST, V6, P1038, DOI 10.1111/j.1538-7836.2008.02974.x; Herman D, 2005, PHARMACOGENOMICS J, V5, P193, DOI 10.1038/sj.tpj.6500308; Herman D, 2006, THROMB HAEMOSTASIS, V95, P782, DOI 10.1160/TH05-10-0678; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hillman MA, 2004, PHARMACOGENETICS, V14, P539, DOI 10.1097/01.fpc.0000114760.08559.dc; Hillman MA, 2005, CLIN MED RES, V3, P137, DOI 10.3121/cmr.3.3.137; Huang SW, 2009, PHARMACOGENET GENOM, V19, P226, DOI 10.1097/FPC.0b013e328326e0c7; Joffe HV, 2004, THROMB HAEMOSTASIS, V91, P1123, DOI 10.1160/TH04-02-0083; Jorgensen AL, INFLUENCE CYP2C9 VKO; Jorgensen AL, 2009, PHARMACOGENET GENOM, V19, P800, DOI 10.1097/FPC.0b013e3283317ab5; Jorgensen AL, 2008, STAT MED, V27, P6547, DOI 10.1002/sim.3420; Kamali F, 2004, CLIN PHARMACOL THER, V75, P204, DOI 10.1016/j.clpt.2003.10.001; Kealey C, 2007, PHARMACOGENOMICS, V8, P217, DOI 10.2217/14622416.8.3.217; Khan T, 2004, BRIT J HAEMATOL, V124, P348, DOI 10.1046/j.1365-2141.2003.04787.x; Kim HS, 2009, PHARMACOGENET GENOM, V19, P103, DOI 10.1097/FPC.0b013e32831a9ae3; Kimmel SE, 2008, PHARMACOGENOMICS J, V8, P53, DOI 10.1038/sj.tpj.6500445; Kimura R, 2007, THROMB RES, V120, P181, DOI 10.1016/j.thromres.2006.09.007; King BP, 2004, PHARMACOGENETICS, V14, P813, DOI 10.1097/00008571-200412000-00004; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Koefoed, 1995, J Thromb Thrombolysis, V2, P125, DOI 10.1007/BF01064380; Kohnke H, 2005, EUR J CLIN PHARMACOL, V61, P381, DOI 10.1007/s00228-005-0936-3; Kosaki K, 2006, PEDIATR CARDIOL, V27, P685, DOI 10.1007/s00246-005-1150-x; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Lal S, 2008, BRIT J CLIN PHARMACO, V65, P260, DOI 10.1111/j.1365-2125.2007.03053.x; Lee S, 2003, ARCH PHARM RES, V26, P967, DOI 10.1007/BF02980207; Lee SC, 2006, CLIN PHARMACOL THER, V79, P197, DOI 10.1016/j.clpt.2005.11.006; Lee VWY, 2005, J THROMB THROMBOLYS, V20, P33, DOI 10.1007/s11239-005-3121-8; Lenzini PA, 2008, J THROMB HAEMOST, V6, P1655, DOI 10.1111/j.1538-7836.2008.03095.x; Leung AYH, 2001, BLOOD, V98, P2584, DOI 10.1182/blood.V98.8.2584; Li C, 2009, BLOOD, V113, P3925, DOI 10.1182/blood-2008-09-176859; Li T, 2006, J MED GENET, V43, P740, DOI 10.1136/jmg.2005.040410; Liang RJ, 2012, THROMB RES, V130, P38, DOI 10.1016/j.thromres.2011.11.043; Lima MV, 2008, EUR J CLIN PHARMACOL, V64, P9, DOI 10.1007/s00228-007-0385-2; Limdi N, 2008, CLIN PHARMACOL THER, V83, P312, DOI 10.1038/sj.clpt.6100290; Limdi NA, 2008, PHARMACOGENOMICS, V9, P1445, DOI 10.2217/14622416.9.10.1445; Limdi NA, 2008, PHARMACOGENOMICS, V9, P511, DOI 10.2217/14622416.9.5.511; Linder MW, 2002, J THROMB THROMBOLYS, V14, P227, DOI 10.1023/A:1025052827305; Lindh JD, 2005, CLIN PHARMACOL THER, V78, P540, DOI 10.1016/j.clpt.2005.08.006; LITTLE J, 2006, HUGENET HUGE REV HDB; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Loebstein R, 2005, CLIN PHARMACOL THER, V77, P365, DOI 10.1016/j.clpt.2005.01.010; Loebstein R, 2001, CLIN PHARMACOL THER, V70, P159, DOI 10.1067/mcp.2001.117444; Loebstein R, 2007, BLOOD, V109, P2477, DOI 10.1182/blood-2006-08-038984; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Margaglione M, 2000, THROMB HAEMOSTASIS, V84, P775; McClain MR, 2008, GENET MED, V10, P89, DOI 10.1097/GIM.0b013e31815bf924; Meckley LM, 2008, THROMB HAEMOSTASIS, V100, P229, DOI 10.1160/TH07-09-0552; Miao LY, 2007, EUR J CLIN PHARMACOL, V63, P1135, DOI 10.1007/s00228-007-0381-6; Michaud V, 2008, CLIN PHARMACOL THER, V83, P740, DOI 10.1038/sj.clpt.6100434; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Momary KM, 2007, PHARMACOGENOMICS, V8, P1535, DOI 10.2217/14622416.8.11.1535; Moridani M, 2006, CLIN BIOCHEM, V39, P606, DOI 10.1016/j.clinbiochem.2006.01.023; Mushiroda T, 2006, J HUM GENET, V51, P249, DOI 10.1007/s10038-005-0354-5; Muszkat M, 2007, CLIN THER, V29, P427, DOI 10.1016/S0149-2918(07)80081-6; Nakai K, 2007, PHARMACOGENOMICS, V8, P713, DOI 10.2217/14622416.8.7.713; Ngow H, 2008, XENOBIOTICA, V38, P641, DOI [10.1080/00498250801999087, 10.1080/00498250801999087 ]; Obayashi K, 2006, CLIN PHARMACOL THER, V80, P169, DOI 10.1016/j.clpt.2006.04.010; Ogg MS, 1999, LANCET, V354, P1124, DOI 10.1016/S0140-6736(05)76918-X; Osman A, 2006, J THROMB HAEMOST, V4, P1723, DOI 10.1111/j.1538-7836.2006.02039.x; Ozgon GO, 2008, EUR J CLIN PHARMACOL, V64, P889, DOI 10.1007/s00228-008-0507-5; Pchelina SN, 2005, THROMB RES, V115, P199, DOI 10.1016/j.thromres.2004.08.020; Perini JA, 2008, CLIN PHARMACOL THER, V84, P722, DOI 10.1038/clpt.2008.166; Peyvandi F, 2004, CLIN PHARMACOL THER, V75, P198, DOI 10.1016/j.clpt.2003.09.015; Redman AR, 2004, CLIN APPL THROMB-HEM, V10, P149, DOI 10.1177/107602960401000205; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Salanti G, 2008, STAT MED, V27, P764, DOI 10.1002/sim.2919; Samardzija M, 2008, COLLEGIUM ANTROPOL, V32, P557; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Schelleman H, 2008, CLIN PHARMACOL THER, V84, P332, DOI 10.1038/clpt.2008.101; Schelleman H, 2007, CLIN PHARMACOL THER, V81, P742, DOI 10.1038/sj.clpt.6100144; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Scordo MG, 2002, CLIN PHARMACOL THER, V72, P702, DOI 10.1067/mcp.2002.129321; Shikata E, 2004, BLOOD, V103, P2630, DOI 10.1182/blood-2003-09-3043; Spreafico M, 2003, J THROMB HAEMOST, V1, P2252, DOI 10.1046/j.1538-7836.2003.00442.x; Tabrizi AR, 2002, J AM COLL SURGEONS, V194, P267, DOI 10.1016/S1072-7515(01)01163-2; Tai GY, 2005, PHARMACOGENET GENOM, V15, P475, DOI 10.1097/01.fpc.0000162005.80857.98; Takahashi H, 2004, BLOOD, V103, P3055, DOI 10.1182/blood-2003-07-2521; Takahashi H, 2003, CLIN PHARMACOL THER, V73, P253, DOI 10.1067/mcp.2003.26a; Takahashi H, 2006, PHARMACOGENET GENOM, V16, P101, DOI 10.1097/01.fpc.0000184955.08453.a8; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Tanira MO, 2007, COMMUNITY GENET, V10, P32, DOI 10.1159/000096279; Taube J, 2000, BLOOD, V96, P1816, DOI 10.1182/blood.V96.5.1816.h8001816_1816_1819; Tham LS, 2006, CLIN PHARMACOL THER, V80, P346, DOI 10.1016/j.clpt.2006.06.009; Topic E, 2004, CLIN CHEM LAB MED, V42, P72, DOI 10.1515/CCLM.2004.014; Vecsler M, 2006, THROMB HAEMOSTASIS, V95, P205, DOI 10.1160/TH05-06-0446; Veenstra DL, 2005, PHARMACOGENET GENOM, V15, P687, DOI 10.1097/01.fpc.0000174789.77614.68; Veenstra DL, 2005, CLIN PHARMACOL THER, V77, P353, DOI 10.1016/j.clpt.2005.01.019; Verstuyft C, 2003, EUR J CLIN PHARMACOL, V58, P739, DOI 10.1007/s00228-002-0538-2; Voora D, 2005, THROMB HAEMOSTASIS, V93, P700, DOI 10.1160/TH04-08-0542; Wadelius M, 2007, PHARMACOGENOMICS J, V7, P99, DOI 10.1038/sj.tpj.6500417; Wadelius M, 2005, PHARMACOGENOMICS J, V5, P262, DOI 10.1038/sj.tpj.6500313; Wadelius M, 2004, PHARMACOGENOMICS J, V4, P40, DOI 10.1038/sj.tpj.6500220; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; Wang DX, 2008, BLOOD, V112, P1013, DOI 10.1182/blood-2008-03-144899; Wang TL, 2008, CLIN CHIM ACTA, V396, P76, DOI 10.1016/j.cca.2008.07.005; Wen MS, 2008, CLIN PHARMACOL THER, V84, P83, DOI 10.1038/sj.clpt.6100453; Whitehead A., 2003, METAANALYSIS CONTROL; Wilke RA, 2005, CLIN MED RES, V3, P207, DOI 10.3121/cmr.3.4.207; Wu AHB, 2008, PHARMACOGENOMICS, V9, P169, DOI 10.2217/14622416.9.2.169; Yildirim H, 2008, MED PRIN PRACT, V17, P464, DOI 10.1159/000151568; Yin T, 2008, THROMB RES, V122, P179, DOI 10.1016/j.thromres.2007.09.015; Yuan HY, 2005, HUM MOL GENET, V14, P1745, DOI 10.1093/hmg/ddi180; Zhao F, 2004, CLIN PHARMACOL THER, V76, P210, DOI 10.1016/j.clpt.2004.05.005; Zhu Y, 2007, CLIN CHEM, V53, P1199, DOI 10.1373/clinchem.2006.078139	141	113	121	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44064	10.1371/journal.pone.0044064	http://dx.doi.org/10.1371/journal.pone.0044064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952875	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206000076
J	Li, X; Li, JJ; Yang, JY; Wang, DS; Zhao, W; Song, WJ; Li, WM; Wang, JF; Han, W; Zhang, ZC; Yu, Y; Cao, DY; Dou, KF				Li, Xiao; Li, Jun-Jie; Yang, Jing-Yue; Wang, De-Sheng; Zhao, Wei; Song, Wen-Jie; Li, Wei-Min; Wang, Jian-Feng; Han, Wei; Zhang, Zhuo-Chao; Yu, Yong; Cao, Da-Yong; Dou, Ke-Feng			Tolerance Induction by Exosomes from Immature Dendritic Cells and Rapamycin in a Mouse Cardiac Allograft Model	PLOS ONE			English	Article							TRANSPLANTATION; DISEASE; ALLOANTIGEN; GENERATION; EXPOSURE	Background: Dendritic cells (DCs) release bioactive exosomes that play an important role in immune regulation. Because they express low levels of class I major histocompatibility complex (MHC) and co-stimulatory molecules, exosomes derived from donor immature DCs (imDex) prolong allograft survival by inhibiting T-cell activation. However, this effect is limited and does not induce immunological tolerance when imDex are administered alone. Thus, we tested the effect of combined treatment with donor imDex and low-dose rapamycin on inducing tolerance in a mouse cardiac transplantation model. Methods: ImDex were obtained from the culture supernatant of immature DCs derived from donor mouse (C57BL/6) bone marrow and were injected with suboptimal doses of rapamycin into recipient mouse (BALB/c) before and after transplantation. The capacity of this treatment to induce immune tolerance was analyzed in vitro and in vivo using the mouse cardiac transplantation model. Results: Donor imDex expressed moderate levels of MHC class II and low levels of MHC class I and co-stimulatory molecules, but neither imDex nor subtherapeutic rapamycin dose alone induced cardiac allograft tolerance. Combined treatment with imDex and rapamycin, however, led to donor specific cardiac allograft tolerance. This effect was accompanied by decreased anti-donor antigen cellular response and an increased percentage of spleen CD4(+)CD25(+) T cells in recipients. Furthermore, this donor specific tolerance could be further transferred to naive allograft recipients through injection of splenocytes, but not serum, from tolerant recipients. Conclusion: Combined with immunosuppressive treatment, donor imDex can prolong cardiac allograft survival and induce donor specific allograft tolerance.	[Li, Xiao; Li, Jun-Jie; Wang, De-Sheng; Zhao, Wei; Song, Wen-Jie; Li, Wei-Min; Wang, Jian-Feng; Han, Wei; Zhang, Zhuo-Chao; Yu, Yong; Cao, Da-Yong; Dou, Ke-Feng] Fourth Mil Med Univ, Dept Hepatobiliary Surg, Xijing Hosp, Xian 710032, Shaanxi Provinc, Peoples R China; [Yang, Jing-Yue] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Oncol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Li, X (corresponding author), Fourth Mil Med Univ, Dept Hepatobiliary Surg, Xijing Hosp, Xian 710032, Shaanxi Provinc, Peoples R China.	caody777@sina.com; gdwkgwx@fmmu.edu.cn			National High Technology Research and Development Program of China [2012AA021000]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The study was supported by grants from National High Technology Research and Development Program of China (2012AA021000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bianco NR, 2009, ARTHRITIS RHEUM-US, V60, P380, DOI 10.1002/art.24229; Cai ZJ, 2012, CELL RES, V22, P607, DOI 10.1038/cr.2011.196; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; CHEN ZH, 1991, TRANSPLANTATION, V52, P1099, DOI 10.1097/00007890-199112000-00035; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kim SH, 2005, J IMMUNOL, V174, P6440, DOI 10.4049/jimmunol.174.10.6440; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mendieta-Zeron H, 2011, IMMUNOTHERAPY-UK, V3, P1499, DOI [10.2217/IMT.11.142, 10.2217/imt.11.142]; Montecalvo A, 2008, J IMMUNOL, V180, P3081, DOI 10.4049/jimmunol.180.5.3081; Monti P, 2008, DIABETES, V57, P2341, DOI 10.2337/db08-0138; Morelli AE, 2006, AM J TRANSPLANT, V6, P254, DOI 10.1111/j.1600-6143.2005.01197.x; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Morse MA, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-9; Muthana M, 2004, J IMMUNOL METHODS, V294, P165, DOI 10.1016/j.jim.2004.09.006; Niimi M, 2001, J HEART LUNG TRANSPL, V20, P1123, DOI 10.1016/S1053-2498(01)00309-6; Peche H, 2005, AM J TRANSPLANT, V5, P255, DOI 10.1111/j.1600-6143.2004.00683.x; Peche H, 2003, TRANSPLANTATION, V76, P1503, DOI 10.1097/01.TP.0000092494.75313.38; Pliszczynski J, 2011, TRANSPL P, V43, P3657, DOI 10.1016/j.transproceed.2011.10.052; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schonder KS, 2011, CRIT CARE NURS CLIN, V23, P405, DOI 10.1016/j.ccell.2011.06.001; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Taner T, 2005, AM J TRANSPLANT, V5, P228, DOI 10.1046/j.1600-6143.2004.00673.x; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; van Kooten C, 2011, TRANSPLANTATION, V91, P2, DOI 10.1097/TP.0b013e31820263b3; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Yang XJ, 2011, J SURG RES, V171, P826, DOI 10.1016/j.jss.2010.05.021; Yang XJ, 2010, SCAND J GASTROENTERO, V45, P1168, DOI 10.3109/00365521.2010.490596	34	77	80	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44045	10.1371/journal.pone.0044045	http://dx.doi.org/10.1371/journal.pone.0044045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952868	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000073
J	Roberts, KL; Shelton, H; Stilwell, P; Barclay, WS				Roberts, Kim L.; Shelton, Holly; Stilwell, Peter; Barclay, Wendy S.			Transmission of a 2009 H1N1 Pandemic Influenza Virus Occurs before Fever Is Detected, in the Ferret Model	PLOS ONE			English	Article							A H1N1; INFECTIOUS-DISEASE; OUTBREAK; PATHOGENESIS; REPLICATION; DYNAMICS; ILLNESS; SIGNS; MICE	During the early phase of the 2009 influenza pandemic, attempts were made to contain the spread of the virus. Success of reactive control measures may be compromised if the proportion of transmission that occurs before overt clinical symptoms develop is high. In this study we investigated the timing of transmission of an early prototypic strain of pandemic H1N1 2009 influenza virus in the ferret model. Ferrets are the only animal model in which this can be assessed because they display typical influenza-like clinical signs including fever and sneezing after infection. We assessed transmission from infected animals to sentinels that were placed either in direct contact or in adjacent cages, the latter reflecting the respiratory droplet (RD) transmission route. We found that pre-symptomatic influenza transmission occurred via both contact and respiratory droplet exposure before the earliest clinical sign, fever, developed. Three of 3 animals exposed in direct contact between day 1 and 2 after infection of the donor animals became infected, and 2/3 of the animals exposed at this time period by the RD route acquired the infection, with the third animal becoming seropositive indicating either a low level infection or significant exposure. Moreover, this efficient transmission did not temporally correlate with respiratory symptoms, such as coughs and sneezes, but rather with the peak viral titre in the nose. Indeed respiratory droplet transmission did not occur late in infection, even though this was when sneezing and coughing were most apparent. None of the 3 animals exposed at this time by the RD route became infected and these animals remained seronegative at the end of the experiment. These data have important implications for pandemic planning strategies and suggest that successful containment is highly unlikely for a human-adapted influenza virus that transmits efficiently within a population.	[Roberts, Kim L.; Shelton, Holly; Stilwell, Peter; Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, Virol Sect, London, England	Imperial College London	Roberts, KL (corresponding author), Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland.	w.barclay@imperial.ac.uk		Stilwell, Peter/0000-0002-4169-4200; shelton, Holly/0000-0002-5776-0735; Barclay, Wendy/0000-0002-3948-0895	Medical Research Council [G06000504]; National Institute for Health Research (NIHR) Imperial Biomedical Research Centre [P26591]; MRC [G0600504] Funding Source: UKRI; Medical Research Council [G0600504] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Imperial Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Medical Research Council project grant G06000504 to WB and by a National Institute for Health Research (NIHR) Imperial Biomedical Research Centre award P26591 to WB and KR. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Charleston B, 2011, SCIENCE, V332, P726, DOI 10.1126/science.1199884; COATES DM, 1985, J GEN VIROL, V66, P1627, DOI 10.1099/0022-1317-66-7-1627; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Cui FQ, 2011, J EPIDEMIOL, V21, P271, DOI 10.2188/jea.JE20100119; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Duan SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001022; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Gu Y, 2011, EMERG INFECT DIS, V17, P1737, DOI 10.3201/eid1709.101411; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Herlocher ML, 2001, J INFECT DIS, V184, P542, DOI 10.1086/322801; Hermes J, 2011, INFLUENZA OTHER RESP; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Piso RJ, 2011, INFECTION, V39, P149, DOI 10.1007/s15010-011-0084-x; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Roberts KL, 2011, J GEN VIROL; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; SCHULMAN JL, 1963, J EXP MED, V118, P257, DOI 10.1084/jem.118.2.257; SCHULMAN JL, 1963, J EXP MED, V118, P267, DOI 10.1084/jem.118.2.267; Sheat K, 1992, COMMUNICABLE DIS NZ, V92, P18; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Yamagishi T, 2010, JPN J INFECT DIS, V63, P327	44	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43303	10.1371/journal.pone.0043303	http://dx.doi.org/10.1371/journal.pone.0043303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952661	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206000030
J	Barker, G; Lim, R; Georgiou, HM; Lappas, M				Barker, Gillian; Lim, Ratana; Georgiou, Harry M.; Lappas, Martha			Omentin-1 Is Decreased in Maternal Plasma, Placenta and Adipose Tissue of Women with Pre-Existing Obesity	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; FACTOR-KAPPA-B; INSULIN-RESISTANCE; IN-VITRO; CIRCULATING OMENTIN; GENE-EXPRESSION; PREGNANCY; GLUCOSE; ADIPOCYTOKINE; INFLAMMATION	Objective: The aim of this study was to determine (i) the effect of maternal obesity and gestational diabetes mellitus (GDM) on (i) the circulating levels of omentin-1 in cord and maternal plasma, and (ii) gene expression and release of omentin-1 from human placenta and adipose tissue. The effect of pregnancy on circulating omentin-1 levels was also determined. Design: Omentin-1 levels were measured in maternal and cord plasma from obese and non-obese normal glucose tolerant women (NGT; n = 44) and women with GDM (n = 39) at the time of term elective Caesarean section. Placenta and adipose tissue expression and release of omentin-1 was measured from 22 NGT and 22 GDM women collected at the time of term elective Caesarean section. Omentin-1 levels were also measured in maternal plasma from 13 NGT women at 11 and 28 weeks gestation and 7 weeks postpartum. Results: Maternal obesity was associated with significantly lower omentin-1 levels in maternal plasma; however, there was no effect of maternal obesity on cord omentin levels. Omentin-1 gene expression was lower in placenta and adipose tissue obtained from women with pre-existing obesity. In addition to this, adipose tissue release of omentin-1 was significantly lower from obese pregnant women. Omentin-1 levels were significantly lower in non-obese GDM compared to non-obese NGT women. However, there was no difference in omentin-1 levels between obese NGT and obese GDM women. There was no effect of GDM on cord omentin levels, and placental and adipose tissue omentin-1 expression. Maternal omentin-1 levels were negatively correlated with fetal birthweight and fetal ponderal index. Conclusions: The data presented in this study demonstrate that pre-existing maternal obesity is associated with lower omentin-1 expression in placenta, adipose tissue and maternal plasma. Alteration in omentin-1 in pregnancy may influence the development of metabolic disorders in offspring later in life.	[Barker, Gillian; Lim, Ratana; Georgiou, Harry M.; Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Australia Mercy Perinatal Res Ctr, Mercy Hosp Women, Heidelberg, Vic, Australia	University of Melbourne	Barker, G (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Australia Mercy Perinatal Res Ctr, Mercy Hosp Women, Heidelberg, Vic, Australia.	mlappas@unimelb.edu.au	Georgiou, A/Prof Harry/C-7143-2008	Georgiou, A/Prof Harry/0000-0003-0553-9489	National Health and Medical Research Council (NHMRC) [454777]; NHMRC [454310]; Medical Research Foundation for Women and Babies	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Foundation for Women and Babies	Dr Martha Lappas was a recipient of a National Health and Medical Research Council (NHMRC) RD Wright Fellowship (grant no. 454777). The work described in this manuscript was funded by a project grant from the NHMRC (grant no. 454310). Funding for the iQ5 multicolour RT-PCR machine (in-part) and xMark Microplate Absorbance Spectrophotometer was provided by the Medical Research Foundation for Women and Babies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal MM, 2005, DIABETIC MED, V22, P1731, DOI 10.1111/j.1464-5491.2005.01706.x; Auguet T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-60; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Baptiste-Roberts K, 2009, AM J MED, V122, P207, DOI 10.1016/j.amjmed.2008.09.034; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Barker G, 2012, J MATERNAL FETAL NEO; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Briana DD, 2011, METABOLISM, V60, P486, DOI 10.1016/j.metabol.2010.04.014; Cai Run-Ce, 2009, Zhonghua Yi Xue Za Zhi, V89, P381; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Colomiere M, 2010, J MOL ENDOCRINOL, V44, P213, DOI 10.1677/JME-09-0091; Colomiere M, 2009, EUR J ENDOCRINOL, V160, P567, DOI 10.1530/EJE-09-0031; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Fu M, 2004, DIABETES, V53, pA59; Georgiou HM, 2008, ACTA DIABETOL, V45, P157, DOI 10.1007/s00592-008-0037-8; Hehir MP, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-6; KRZYSZTOF L, 2010, GINEKOL POL, V81, P907; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P2365, DOI 10.1210/jc.2003-031385; Lappas M, 2003, J CLIN ENDOCR METAB, V88, P1723, DOI 10.1210/jc.2002-021677; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; Lappas M, 2011, BIOL REPROD, V84, P167, DOI 10.1095/biolreprod.110.086983; Lehingue Y, 1998, AM J HUM BIOL, V10, P327, DOI 10.1002/(SICI)1520-6300(1998)10:3<327::AID-AJHB8>3.0.CO;2-F; Liu R, 2011, DIABETES RES CLIN PR, V93, P21, DOI 10.1016/j.diabres.2011.03.001; Moreno-Navarrete JM, 2011, OBESITY, V19, P1552, DOI 10.1038/oby.2010.351; Moreno-Navarrete JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-27; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Pan HY, 2010, DIABETES RES CLIN PR, V88, P29, DOI 10.1016/j.diabres.2010.01.013; Pathmaperuma AN, 2010, PLACENTA, V31, P230, DOI 10.1016/j.placenta.2009.12.013; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; Salihu HM, 2009, OBSTET GYNECOL, V114, P333, DOI 10.1097/AOG.0b013e3181ae9a47; Tan BK, 2008, DIABETES, V57, P801, DOI 10.2337/db07-0990; Yamawaki H, 2011, BIOCHEM BIOPH RES CO, V408, P339, DOI 10.1016/j.bbrc.2011.04.039; Yan P, 2011, EXP CLIN ENDOCR DIAB, V119, P257, DOI 10.1055/s-0030-1269912; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yang RZ, 2003, DIABETES, V52, pA1; Zhong X, 2011, ACTA PHARMACOL SIN, V32, P873, DOI 10.1038/aps.2011.26	39	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42943	10.1371/journal.pone.0042943	http://dx.doi.org/10.1371/journal.pone.0042943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952622	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600010
J	Kumari, S; Mukhopadhyay, G; Tyagi, RK				Kumari, Sangeeta; Mukhopadhyay, Gauranga; Tyagi, Rakesh K.			Transcriptional Regulation of Mouse PXR Gene: An Interplay of Transregulatory Factors	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; ENHANCER COMPLEX; C-MYB; ACTIVATION; EXPRESSION; CYP3A4; INDUCTION; PROMOTER; INHIBITION	Pregnane X Receptor (PXR) is an important ligand-activated nuclear receptor functioning as a 'master regulator' of expression of phase I, phase II drug metabolizing enzymes, and members of the drug transporters. PXR is primarily expressed in hepatic tissues and to lesser extent in other non-hepatic tissues both in human and in mice. Although its expression profile is well studied but little is known about the regulatory mechanisms that govern PXR gene expression in these cells. In the present study, we have cloned and characterized over 5 kb (-4963 to +54) region lying upstream of mouse PXR transcription start site. Promoter-reporter assays revealed that the proximal promoter region of up to 1 kb is sufficient to support the expression of PXR in the mouse liver cell lines. It was evident that the 500 bp proximal promoter region contains active binding sites for Ets, Tcf, Ikarose and nuclear factor families of transcription factors. Electrophoretic mobility shift assays demonstrated that the minimal region of 134 bp PXR promoter was able to bind Ets-1 and beta-catenin proteins. This result was further confirmed by chromatin immunoprecipitation analysis. In summary, the present study identified a promoter region of mouse PXR gene and the transregulatory factors responsible for PXR promoter activity. The results presented herein are expected to provide important cues to gain further insight into the regulatory mechanisms of PXR function.	[Kumari, Sangeeta; Mukhopadhyay, Gauranga; Tyagi, Rakesh K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Kumari, S (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	garunga@hotmail.com; rktyagi@yahoo.com	Kumari, Sangeeta/AAB-7154-2022	Kumari, Sangeeta/0000-0002-0692-0452	Department of Science and Technology (DST), India [SR/SO/bb-17/2006]; Council of Scientific and Industrial Research (CSIR), India	Department of Science and Technology (DST), India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The research work presented in this paper was financially supported by a research grant to RKT from the Department of Science and Technology (DST), India [Grant no. SR/SO/bb-17/2006]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sangeeta Kumari, acknowledges Council of Scientific and Industrial Research (CSIR), India, for the award of Research Fellowship. Infrastructural facilities supported by UGC-SAP (DRS-1) to our centre is thankfully acknowledged.	Aouabdi S, 2006, DRUG METAB DISPOS, V34, P138, DOI 10.1124/dmd.105.006064; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Goodwin B, 2001, MOL PHARMACOL, V60, P427; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Iwazaki N, 2008, DRUG METAB PHARMACOK, V23, P59, DOI 10.2133/dmpk.23.59; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; Jung D, 2006, J BIOL CHEM, V281, P19081, DOI 10.1074/jbc.M600116200; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Kliewer SA, 2002, J LIPID RES, V43, P359; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lau AJ, 2012, DRUG METAB DISPOS, V40, P178, DOI 10.1124/dmd.111.042879; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lemaire G, 2004, BIOCHEM PHARMACOL, V68, P2347, DOI 10.1016/j.bcp.2004.07.041; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Li YY, 2009, CANCER SCI, V100, P396, DOI 10.1111/j.1349-7006.2008.01059.x; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Pascussi JM, 2000, MOL PHARMACOL, V58, P361, DOI 10.1124/mol.58.2.361; Pascussi JM, 1999, BIOCHEM BIOPH RES CO, V260, P377, DOI 10.1006/bbrc.1999.0745; Pongubala JMR, 1997, P NATL ACAD SCI USA, V94, P127, DOI 10.1073/pnas.94.1.127; RASCHELLA G, 1992, CANCER RES, V52, P4221; Raynal C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-46; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; Saradhi M., 2006, Journal of Endocrinology and Reproduction, V10, P1; Sharma M, 2007, BIOCHEM BIOPH RES CO, V358, P379, DOI 10.1016/j.bbrc.2007.04.149; Shi DS, 2010, BIOCHEM PHARMACOL, V80, P1274, DOI 10.1016/j.bcp.2010.06.043; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Wisniewska MB, 2010, J NEUROSCI, V30, P4957, DOI 10.1523/JNEUROSCI.1425-09.2010	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44126	10.1371/journal.pone.0044126	http://dx.doi.org/10.1371/journal.pone.0044126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952895	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600080
J	Seehase, S; Lauenstein, HD; Schlumbohm, C; Switalla, S; Neuhaus, V; Forster, C; Fieguth, HG; Pfennig, O; Fuchs, E; Kaup, FJ; Bleyer, M; Hohlfeld, JM; Braun, A; Sewald, K; Knauf, S				Seehase, Sophie; Lauenstein, Hans-Dieter; Schlumbohm, Christina; Switalla, Simone; Neuhaus, Vanessa; Foerster, Christine; Fieguth, Hans-Gerd; Pfennig, Olaf; Fuchs, Eberhard; Kaup, Franz-Josef; Bleyer, Martina; Hohlfeld, Jens M.; Braun, Armin; Sewald, Katherina; Knauf, Sascha			LPS-Induced Lung Inflammation in Marmoset Monkeys - An Acute Model for Anti-Inflammatory Drug Testing	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CALLITHRIX-JACCHUS; NONHUMAN PRIMATE; COMMON MARMOSET; ANIMAL-MODELS; PHOSPHODIESTERASE-4 INHIBITOR; LIPOPOLYSACCHARIDE EXPOSURE; BACTERIAL-ENDOTOXIN; HEALTHY-SUBJECTS; ROFLUMILAST	Increasing incidence and substantial morbidity and mortality of respiratory diseases requires the development of new human-specific anti-inflammatory and disease-modifying therapeutics. Therefore, new predictive animal models that closely reflect human lung pathology are needed. In the current study, a tiered acute lipopolysaccharide (LPS)-induced inflammation model was established in marmoset monkeys (Callithrix jacchus) to reflect crucial features of inflammatory lung diseases. Firstly, in an ex vivo approach marmoset and, for the purposes of comparison, human precision-cut lung slices (PCLS) were stimulated with LPS in the presence or absence of the phosphodiesterase-4 (PDE4) inhibitor roflumilast. Pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha) and macrophage inflammatory protein-1 beta (MIP-1 beta) were measured. The corticosteroid dexamethasone was used as treatment control. Secondly, in an in vivo approach marmosets were pre-treated with roflumilast or dexamethasone and unilaterally challenged with LPS. Ipsilateral bronchoalveolar lavage (BAL) was conducted 18 hours after LPS challenge. BAL fluid was processed and analyzed for neutrophils, TNF-alpha, and MIP-1 beta. TNF-alpha release in marmoset PCLS correlated significantly with human PCLS. Roflumilast treatment significantly reduced TNF-alpha secretion ex vivo in both species, with comparable half maximal inhibitory concentration (IC50). LPS instillation into marmoset lungs caused a profound inflammation as shown by neutrophilic influx and increased TNF-alpha and MIP-1 beta levels in BAL fluid. This inflammatory response was significantly suppressed by roflumilast and dexamethasone. The close similarity of marmoset and human lungs regarding LPS-induced inflammation and the significant anti-inflammatory effect of approved pharmaceuticals assess the suitability of marmoset monkeys to serve as a promising model for studying anti-inflammatory drugs.	[Seehase, Sophie; Lauenstein, Hans-Dieter; Switalla, Simone; Neuhaus, Vanessa; Hohlfeld, Jens M.; Braun, Armin; Sewald, Katherina; Knauf, Sascha] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Seehase, Sophie; Lauenstein, Hans-Dieter; Kaup, Franz-Josef; Bleyer, Martina; Knauf, Sascha] Leibniz Inst Primate Res, Pathol Unit, German Primate Ctr, Gottingen, Germany; [Schlumbohm, Christina; Fuchs, Eberhard] Encepharm GmbH, Gottingen, Germany; [Foerster, Christine; Pfennig, Olaf] Klinikum Reg Hannover Klinikum Nordstadt, Inst Pathol, Hannover, Germany; [Fieguth, Hans-Gerd] Klinikum Reg Hannover Klinikum Oststadt Heidehaus, Div Thorac Surg, Hannover, Germany	Fraunhofer Gesellschaft; Deutsches Primatenzentrum (DPZ)	Seehase, S (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany.	katherina.sewald@item.fraunhofer.de; sascha.knauf@item.fraunhofer.de	Braun, Armin/B-8750-2009; Knauf, Sascha/F-1661-2017	Braun, Armin/0000-0002-1142-1463; Knauf, Sascha/0000-0001-5744-4946; Hohlfeld, Jens/0000-0003-2646-6186; Fieguth, Hans G./0000-0003-1559-158X	Fraunhofer Society; AstraZeneca; Novartis; Nycomed; Pfizer	Fraunhofer Society; AstraZeneca(AstraZeneca); Novartis(Novartis); Nycomed; Pfizer(Pfizer)	The work was funded by the Fraunhofer Society. The Fraunhofer ITEM is a public non-profit research organisation doing contract research for e. g. pharmaceutical and biotech industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fraunhofer ITEM is a public non-profit research organisation doing contract research for e. g. pharmaceutical and biotech industry. The institution of JMH has received research grants from AstraZeneca, Novartis, Nycomed, and Pfizer to conduct clinical trials using LPS-induced inflammation. Encepharm is a research organisation doing contract research for e. g. pharmaceutical and biotech industry. The institution has received no grants to conduct preclinical trials using LPS-induced inflammation in marmoset monkeys. Encepharm confirms that this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. CF declares affiliation to the company Klinikum Region Hannover GmbH. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barbier A, 2000, RESP PHYSIOL, V120, P167, DOI 10.1016/S0034-5687(00)00105-5; Barnes PJ, 2006, LAB INVEST, V86, P867, DOI 10.1038/labinvest.3700456; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Bergers WWA, 2004, INHAL TOXICOL, V16, P141, DOI 10.1080/08958370490270963; Bundschuh DS, 2001, J PHARMACOL EXP THER, V297, P280; Cazzola M, 2012, EUR RESP J; Chrousos G.P., 1986, Advances in Experimental Medicine and Biology, V196, P129; Coffman RL, 2005, J EXP MED, V201, P1875, DOI 10.1084/jem.20050901; de Marco R, 2007, AM J RESP CRIT CARE, V175, P32, DOI 10.1164/rccm.200603-381OC; European Medicines Agency, 2009, EMEAHC001109; Fabbri LM, 2010, NAT REV DRUG DISCOV, V9, P761, DOI 10.1038/nrd3276; Faffe DS, 2000, EUR RESPIR J, V15, P85, DOI 10.1183/09031936.00.15108500; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Gross NJ, 2010, COPD, V7, P141, DOI 10.3109/15412551003758304; Hanania NA, 2011, RESPIR MED SER, P1, DOI 10.1007/978-1-59745-357-8; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Hicks A, 2010, INFLAMMATION, V33, P144, DOI 10.1007/s10753-009-9168-5; Hohlfeld JM, 2008, PULM PHARMACOL THER, V21, P616, DOI 10.1016/j.pupt.2008.02.002; Igarashi T, 1997, ARCH BIOCHEM BIOPHYS, V339, P85, DOI 10.1006/abbi.1996.9852; Jagessar SA, 2011, J NEUROIMMUNE PHARM; Kap YS, 2010, J NEUROIMMUNE PHARM, V5, P220, DOI 10.1007/s11481-009-9178-y; KENNEDY SM, 1987, AM REV RESPIR DIS, V135, P194; Kohu K, 2008, TOHOKU J EXP MED, V215, P167, DOI 10.1620/tjem.215.167; Kurata Y, 1997, TOXICOL LETT, V92, P209, DOI 10.1016/S0378-4274(97)00059-3; Lamontagne F, 2010, J CRIT CARE, V25, P420, DOI 10.1016/j.jcrc.2009.08.009; Lunniss CJ, 2009, BIOORG MED CHEM LETT, V19, P1380, DOI 10.1016/j.bmcl.2009.01.045; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Maris NA, 2005, AM J RESP CRIT CARE, V172, P878, DOI 10.1164/rccm.200503-451OC; Martinez FJ, 2011, LANCET, V378, P1027, DOI 10.1016/S0140-6736(11)61047-7; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Michel O, 2007, PULM PHARMACOL THER, V20, P676, DOI 10.1016/j.pupt.2006.08.002; Mitchell LA, 2010, AM J PHYSIOL-LUNG C, V299, pL891, DOI 10.1152/ajplung.00366.2009; NEUBERT R, 1997, DRUG TOXICITY EMBRYO, P41; O'Grady NP, 2001, AM J RESP CRIT CARE, V163, P1591, DOI 10.1164/ajrccm.163.7.2009111; Plopper CG, 2008, PULM PHARMACOL THER, V21, P755, DOI 10.1016/j.pupt.2008.01.008; Rocco PRM, 2003, EUR RESPIR J, V22, P20, DOI 10.1183/09031936.03.00108603; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sakuma T, 1997, CARCINOGENESIS, V18, P1985, DOI 10.1093/carcin/18.10.1985; SANDSTROM T, 1992, EUR RESPIR J, V5, P992; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Seehase S, 2011, J APPL PHYSIOL, V111, P791, DOI 10.1152/japplphysiol.00162.2011; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Smith D, 2001, LAB ANIM-UK, V35, P117, DOI 10.1258/0023677011911444; Switalla S., 2010, TOXICOL APPL PHARM; Thorn J, 1998, THORAX, V53, P1047, DOI 10.1136/thx.53.12.1047; Toward TJ, 2001, J PHARMACOL EXP THER, V298, P298; Tralau-Stewart CJ, 2011, J PHARMACOL EXP THER, V337, P145, DOI 10.1124/jpet.110.173690; Vernooy JHJ, 2002, AM J RESP CELL MOL, V26, P152, DOI 10.1165/ajrcmb.26.1.4652; Whelan G, 1999, LAB ANIM, V33, P24, DOI 10.1258/002367799780578453; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	52	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43709	10.1371/journal.pone.0043709	http://dx.doi.org/10.1371/journal.pone.0043709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952743	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600038
J	Gu, ZP; Li, YR; Lee, P; Liu, T; Wan, CD; Wang, ZX				Gu, Zhongping; Li, Yirong; Lee, Peng; Liu, Tao; Wan, Chidan; Wang, Zhengxin			Protein Arginine Methyltransferase 5 Functions in Opposite Ways in the Cytoplasm and Nucleus of Prostate Cancer Cells	PLOS ONE			English	Article							RECEPTOR COFACTOR P44; CAJAL BODIES; SM PROTEINS; GERM-CELLS; METHYLATION; PRMT5; HISTONE; COMPLEX; EXPRESSION; GENE	Protein arginine methyltransferase 5 (PRMT5) plays multiple roles in a large number of cellular processes, and its subcellular localization is dynamically regulated during mouse development and cellular differentiation. However, little is known of the functional differences between PRMT5 in the cytoplasm and PRMT5 in the nucleus. Here, we demonstrated that PRMT5 predominantly localized in the cytoplasm of prostate cancer cells. Subcellular localization assays designed to span the entire open-reading frame of the PRMT5 protein revealed the presence of three nuclear exclusion signals (NESs) in the PRMT5 protein. PRMT5 and p44/MED50/WD45/WDR77 co-localize in the cytoplasm, and both are required for the growth of prostate cancer cells in an PRMT5 methyltransferase activity-dependent manner. In contrast, PRMT5 in the nucleus inhibited cell growth in a methyltransferase activity-independent manner. Consistent with these observations, PRMT5 localized in the nucleus in benign prostate epithelium, whereas it localized in the cytoplasm in prostate premalignant and cancer tissues. We further found that PRMT5 alone methylated both histone H4 and SmD3 proteins but PRMT5 complexed with p44 and pICln methylated SmD3 but not histone H4. These results imply a novel mechanism by which PRMT5 controls cell growth and contributes to prostate tumorigenesis.	[Gu, Zhongping; Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Gu, Zhongping] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China; [Li, Yirong; Lee, Peng] NYU, Langone Med Ctr, Dept Pathol & Urol, New York, NY USA; [Liu, Tao; Wan, Chidan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Air Force Military Medical University; New York University; NYU Langone Medical Center; Huazhong University of Science & Technology	Gu, ZP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	zhenwang@mdanderson.org			National Institute of Diabetes and Digestive and Kidney Diseases, United States National Institutes of Health (NIH) [1R01 DK065156 01]; Cancer Center Support (Core) grant from the National Cancer Institute, NIH [CA16672]; NYUSOM Urology Center of Excellence; National Natural Science Foundation of China [81171922]; Key Project Research Fund of Shaanxi Provincial Science and Technology Program, China [2008K27G01]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065156] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, United States National Institutes of Health (NIH); Cancer Center Support (Core) grant from the National Cancer Institute, NIH; NYUSOM Urology Center of Excellence; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project Research Fund of Shaanxi Provincial Science and Technology Program, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grant 1R01 DK065156 01 from the National Institute of Diabetes and Digestive and Kidney Diseases, United States National Institutes of Health (NIH) (to ZW), by the Cancer Center Support (Core) grant CA16672 from the National Cancer Institute, NIH to The University of Texas MD Anderson Cancer Center, by NYUSOM Urology Center of Excellence funding to PL, and by National Natural Science Foundation of China (81171922) and Key Project Research Fund of Shaanxi Provincial Science and Technology Program, China. (2008K27G01) to ZP. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amente S, 2005, FEBS LETT, V579, P683, DOI 10.1016/j.febslet.2004.12.045; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Eckert D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-106; Eguizabal C, 2009, DIFFERENTIATION, V78, P116, DOI 10.1016/j.diff.2009.07.001; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Gao S, 2010, ENDOCRINOLOGY, V151, P3941, DOI 10.1210/en.2009-1080; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Gu ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022395; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Hayward SW, 1996, ACTA ANAT, V155, P81; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; KELLOKUMPULEHTINEN P, 1985, BIOL NEONATE, V48, P157; Kroiss M, 2009, FLY, V3, P221; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Liang JJ, 2007, J UROLOGY, V177, P1918, DOI 10.1016/j.juro.2007.01.017; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Morgan GT, 2000, J STRUCT BIOL, V129, P258, DOI 10.1006/jsbi.2000.4231; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Peng Y, 2008, AM J PATHOL, V172, P225, DOI 10.2353/ajpath.2008.070065; Pesiridis GS, 2009, J BIOL CHEM, V284, P21347, DOI 10.1074/jbc.M109.015578; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Ren JQ, 2010, J BIOL CHEM, V285, P12695, DOI 10.1074/jbc.M110.103911; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Shen JC, 1998, MOL CARCINOGEN, V23, P13, DOI 10.1002/(SICI)1098-2744(199809)23:1<13::AID-MC2>3.0.CO;2-I; Spector DL, 2001, J CELL SCI, V114, P2891; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; TIMMS BG, 1994, J UROLOGY, V151, P1427, DOI 10.1016/S0022-5347(17)35273-4; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Yang M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000514; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhou LR, 2006, J MOL ENDOCRINOL, V37, P283, DOI 10.1677/jme.1.02062; Zhou ZW, 2010, CELL RES, V20, P1023, DOI 10.1038/cr.2010.56	52	68	86	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44033	10.1371/journal.pone.0044033	http://dx.doi.org/10.1371/journal.pone.0044033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952863	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800090
J	Yanez, C; Canete-Rosales, P; Castillo, JP; Catalan, N; Undabeytia, T; Morillo, E				Yanez, Claudia; Canete-Rosales, Paulina; Pablo Castillo, Juan; Catalan, Nicole; Undabeytia, Tomas; Morillo, Esmeralda			Cyclodextrin Inclusion Complex to Improve Physicochemical Properties of Herbicide Bentazon: Exploring Better Formulations	PLOS ONE			English	Article							BETA-CYCLODEXTRIN; PHOTODEGRADATION; NORFLURAZON; SOLUBILITY; DEGRADATION; TOXICITY; SOILS	The knowledge of the host-guest complexes using cyclodextrins (CDs) has prompted an increase in the development of new formulations. The capacity of these organic host structures of including guest within their hydrophobic cavities, improves physicochemical properties of the guest. In the case of pesticides, several inclusion complexes with cyclodextrins have been reported. However, in order to explore rationally new pesticide formulations, it is essential to know the effect of cyclodextrins on the properties of guest molecules. In this study, the inclusion complexes of bentazon (Btz) with native beta CD and two derivatives, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and sulfobutylether-beta-cyclodextrin (SBECD), were prepared by two methods: kneading and freeze-drying, and their characterization was investigated with different analytical techniques including Fourier transform infrared spectroscopy (FT-IR), differential thermal analysis (DTA), X-ray diffractometry (XRD) and differential pulse voltammetry (DPV). All these approaches indicate that Btz forms inclusion complexes with CDs in solution and in solid state, with a stoichiometry of 1: 1, although some of them are obtained in mixtures with free Btz. The calculated association constant of the Btz/HPCD complex by DPV was 244 +/- 19 M-1 being an intermediate value compared with those obtained with beta CD and SBECD. The use of CDs significantly increases Btz photostability, and depending on the CDs, decreases the surface tension. The results indicated that bentazon forms inclusion complexes with CDs showing improved physicochemical properties compared to free bentazon indicating that CDs may serve as excipient in herbicide formulations.	[Yanez, Claudia; Canete-Rosales, Paulina; Pablo Castillo, Juan; Catalan, Nicole] Univ Chile, Dept Quim Organ & Fisicoquim, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Undabeytia, Tomas; Morillo, Esmeralda] CSIC, Inst Recursos Nat & Agrobiol, Seville, Spain	Universidad de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS)	Yanez, C (corresponding author), Univ Chile, Dept Quim Organ & Fisicoquim, Fac Ciencias Quim & Farmaceut, Santiago, Chile.	cyanez@ciq.uchile.cl	Yañez, Claudia A/I-2840-2013; Sierra-Rosales, Paulina/K-4733-2019; Morillo, Esmeralda/E-2180-2017	Sierra-Rosales, Paulina/0000-0001-7077-785X; Morillo, Esmeralda/0000-0002-4485-2315	Fondecyt [1090254]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This research was supported by Fondecyt, grant 1090254 (http://www.fondecyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Agency USEP Programs OoP], 1985, CHEM FACT SHEET BENT; ALKHATIB K, 1995, WEED TECHNOL, V9, P426, DOI 10.1017/S0890037X00023630; Carrizosa MJ, 2004, SOIL SCI SOC AM J, V68, P1863, DOI 10.2136/sssaj2004.1863; Davezza M, 2012, CHEMOSPHERE, V86, P335, DOI 10.1016/j.chemosphere.2011.09.011; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Dodziuk H., 2006, CYCLODEXTRINS THEIR; Dua Kamal, 2007, Current Drug Delivery, V4, P21, DOI 10.2174/156720107779314776; Food and Agriculture Organization Of The United Nations F, 1999, SPEC SPEC EV PLANT P; Galhano V, 2010, ENVIRON TOXICOL, V25, P147, DOI 10.1002/tox.20486; de Araujo MV, 2007, BIOORGAN MED CHEM, V15, P5752, DOI 10.1016/j.bmc.2007.06.013; Ge X, 2011, SPECTROCHIM ACTA A, V81, P397, DOI 10.1016/j.saa.2011.06.028; Hanna K, 2004, SCI TOTAL ENVIRON, V332, P51, DOI 10.1016/j.scitotenv.2004.04.022; Hashimoto H, 2002, J INCL PHENOM MACRO, V44, P57, DOI 10.1023/A:1023036406829; Ibrahim MS, 2002, J PHARMACEUT BIOMED, V28, P217, DOI 10.1016/S0731-7085(01)00624-0; [International Program on Chemical S International Labour O World Health O United Nations Environment P], 1990, BENT HLTH SAF GUID; Job P, 1928, ANN CHIM FRANCE, V9, P113; KAMIYA M, 1995, ENVIRON INT, V21, P299, DOI 10.1016/0160-4120(95)00026-H; Kawasaki N, 2001, J COLLOID INTERF SCI, V238, P215, DOI 10.1006/jcis.2001.7517; Leclercq L, 2007, J COLLOID INTERF SCI, V307, P481, DOI 10.1016/j.jcis.2006.12.001; Loftsson T, 1996, J PHARM SCI, V85, P1017, DOI 10.1021/js950534b; Mayo D. W., 2004, COURSE NOTES INTERPR; Misiuk W, 2009, CARBOHYD POLYM, V77, P482, DOI 10.1016/j.carbpol.2009.01.033; Morillo E, 2006, CYCLODEXTRINS THEIR, P459; Mount D, 2005, Patent No. [6,896,892, 6896892]; Nogueiras-Nieto L, 2009, J PHYS CHEM B, V113, P2773, DOI 10.1021/jp809806w; Orgovanyi J, 2005, MICROCHEM J, V79, P77, DOI 10.1016/j.microc.2004.10.022; Perez-Martinez JI, 1999, CHEMOSPHERE, V39, P2047, DOI 10.1016/S0045-6535(99)00093-4; Peschka M, 2007, ANAL BIOANAL CHEM, V388, P1227, DOI 10.1007/s00216-007-1349-1; Porini JA, 2011, ANAL METHODS-UK, V3, P1494, DOI 10.1039/c1ay05028a; POURATA R, 2009, DESALINATION, V249, P301, DOI [DOI 10.1016/J.DESAL.2008.10.033, DOI 10.1016/j.desal.2008.10.033]; Ribeiro AB, 2011, SEP PURIF TECHNOL, V79, P193, DOI 10.1016/j.seppur.2011.01.045; Szejtli J, 2004, PURE APPL CHEM, V76, P1825, DOI 10.1351/pac200476101825; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Ureta-Zanartu MS, 2004, J ELECTROANAL CHEM, V569, P275, DOI 10.1016/j.jelechem.2004.03.011; Villaverde J, 2005, CHEMOSPHERE, V60, P656, DOI 10.1016/j.chemosphere.2005.01.030; Villaverde J, 2004, J AGR FOOD CHEM, V52, P864, DOI 10.1021/jf0350358; Villaverde J, 2007, CHEMOSPHERE, V69, P575, DOI 10.1016/j.chemosphere.2007.03.022; Villaverde J, 2007, J HAZARD MATER, V142, P184, DOI 10.1016/j.jhazmat.2006.08.005; Yanez C, 2003, ELECTROANAL, V15, P1771, DOI 10.1002/elan.200302720; Yanez C, 2010, J INCL PHENOM MACRO, V68, P237, DOI 10.1007/s10847-010-9750-3; Yanez C, 2007, J PHYS ORG CHEM, V20, P499, DOI 10.1002/poc.1186; Zeng Q, 2003, B ENVIRON CONTAM TOX, V71, P668, DOI 10.1007/s00128-003-0185-z	42	46	46	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e41072	10.1371/journal.pone.0041072	http://dx.doi.org/10.1371/journal.pone.0041072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952577	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800004
J	Zang, QS; Martinez, B; Yao, X; Maass, DL; Ma, LS; Wolf, SE; Minei, JP				Zang, Qun S.; Martinez, Bobbie; Yao, Xiao; Maass, David L.; Ma, Lisha; Wolf, Steven E.; Minei, Joseph P.			Sepsis-Induced Cardiac Mitochondrial Dysfunction Involves Altered Mitochondrial-Localization of Tyrosine Kinase Src and Tyrosine Phosphatase SHP2	PLOS ONE			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; ORGAN DYSFUNCTION; BURN INJURY; OXIDATIVE-PHOSPHORYLATION; SEPTIC SHOCK; IDENTIFICATION; PROTEINS; FAILURE; ASSOCIATION; SUPEROXIDE	Our previous research demonstrated that sepsis produces mitochondrial dysfunction with increased mitochondrial oxidative stress in the heart. The present study investigated the role of mitochondria-localized signaling molecules, tyrosine kinase Src and tyrosine phosphatase SHP2, in sepsis-induced cardiac mitochondrial dysfunction using a rat pneumonia-related sepsis model. SD rats were given an intratracheal injection of Streptococcus pneumoniae, 4610 6 CFU per rat, (or vehicle for shams); heart tissues were then harvested and subcellular fractions were prepared. By Western blot, we detected a gradual and significant decrease in Src and an increase in SHP2 in cardiac mitochondria within 24 hours post-inoculation. Furthermore, at 24 hours post-inoculation, sepsis caused a near 70% reduction in tyrosine phosphorylation of all cardiac mitochondrial proteins. Decreased tyrosine phosphorylation of certain mitochondrial structural proteins (porin, cyclophilin D and cytochrome C) and functional proteins (complex II subunit 30kD and complex I subunit NDUFB8) were evident in the hearts of septic rats. In vitro, pre-treatment of mitochondrial fractions with recombinant active Src kinase elevated OXPHOS complex I and II-III activity, whereas the effect of SHP2 phosphatase was opposite. Neither Src nor SHP2 affected complex IV and V activity under the same conditions. By immunoprecipitation, we showed that Src and SHP2 consistently interacted with complex I and III in the heart, suggesting that complex I and III contain putative substrates of Src and SHP2. In addition, in vitro treatment of mitochondrial fractions with active Src suppressed sepsis-associated mtROS production and protected aconitase activity, an indirect marker of mitochondrial oxidative stress. On the contrary, active SHP2 phosphatase overproduced mtROS and deactivated aconitase under the same in vitro conditions. In conclusion, our data suggest that changes in mitochondria-localized signaling molecules Src and SHP2 constitute a potential signaling pathway to affect mitochondrial dysfunction in the heart during sepsis.	[Zang, Qun S.; Martinez, Bobbie; Yao, Xiao; Maass, David L.; Ma, Lisha; Wolf, Steven E.; Minei, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zang, QS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA.	qun.zang@utsouthwestern.edu		Zang, Qun (Sophia)/0000-0002-6397-8896; Wolf, Steven/0000-0003-2972-3440	American Heart Association [09BGIA2220114]; University of Texas Southwestern Medical Center (UTSW) Department of Surgery	American Heart Association(American Heart Association); University of Texas Southwestern Medical Center (UTSW) Department of Surgery	This project was supported by American Heart Association south central affiliate Beginning-in-Aid Grant 09BGIA2220114 and University of Texas Southwestern Medical Center (UTSW) Department of Surgery internal funding to Q. S. Zang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Arachiche A, 2008, J BIOL CHEM, V283, P24406, DOI 10.1074/jbc.M709217200; Augereau O, 2005, CELL MOL LIFE SCI, V62, P1478, DOI 10.1007/s00018-005-5005-7; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Budas GR, 2010, CARDIOVASC RES, V88, P83, DOI 10.1093/cvr/cvq154; Cairns CB, 1997, J TRAUMA, V42, P532, DOI 10.1097/00005373-199703000-00023; Callahan LA, 2007, J APPL PHYSIOL, V102, P44, DOI 10.1152/japplphysiol.01204.2005; Chatelain EH, 2011, CELL MOL LIFE SCI, V68, P2603, DOI 10.1007/s00018-010-0573-6; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chou HC, 2010, FREE RADICAL BIO MED, V49, P96, DOI 10.1016/j.freeradbiomed.2010.04.001; Court O, 2002, CRIT CARE, V6, P500, DOI 10.1186/cc1822; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117; Di Pancrazio F, 2006, PROTEOMICS, V6, P921, DOI 10.1002/pmic.200500077; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Feng JH, 2010, AM J PHYSIOL-CELL PH, V298, pC740, DOI 10.1152/ajpcell.00310.2009; Fink MP, 2002, CRIT CARE, V6, P491, DOI 10.1186/cc1824; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Fullerton JN, 2011, SEMIN RESP CRIT CARE, V32, P581, DOI 10.1055/s-0031-1287866; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Gu YP, 2001, MOL CELL BIOCHEM, V223, P35, DOI 10.1023/A:1017941625858; Guo JF, 2010, AM J PHYSIOL-CELL PH, V299, pC770, DOI 10.1152/ajpcell.00170.2010; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Hebert-Chatelain E, 2012, BBA-BIOENERGETICS, V1817, P718, DOI 10.1016/j.bbabio.2012.01.014; Jakob S, 2009, AGING-US, V1, P664, DOI 10.18632/aging.100063; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; KAYAR SR, 1987, RESP PHYSIOL, V70, P275, DOI 10.1016/0034-5687(87)90010-7; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy RJ, 2007, SHOCK, V28, P24, DOI 10.1097/01.shk.0000235089.30550.2d; Lewandrowski U, 2008, FEBS LETT, V582, P1104, DOI 10.1016/j.febslet.2008.02.077; LUNARDI J, 1991, J BIOL CHEM, V266, P16534; Melendez J, 2004, J BIOL CHEM, V279, P53516, DOI 10.1074/jbc.M408475200; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; Puceat M, 1998, J CELL BIOL, V141, P1637, DOI 10.1083/jcb.141.7.1637; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Ruggieri AJ, 2010, CRIT CARE CLIN, V26, P567, DOI 10.1016/j.ccc.2010.04.007; Sabri A, 2003, J BIOL CHEM, V278, P11714, DOI 10.1074/jbc.M213091200; Salvi M, 2002, BBA-MOL CELL RES, V1589, P181, DOI 10.1016/S0167-4889(02)00174-X; Salvi M, 2007, FEBS LETT, V581, P5579, DOI 10.1016/j.febslet.2007.11.005; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheeran PW, 1998, J SURG RES, V76, P192, DOI 10.1006/jsre.1998.5352; Starkov AA, 2010, METHODS MOL BIOL, V648, P245, DOI 10.1007/978-1-60761-756-3_16; Tao WK, 2005, SHOCK, V24, P495, DOI 10.1097/01.shk.0000183431.78973.cd; Tibaldi E, 2008, J CELL BIOCHEM, V104, P840, DOI 10.1002/jcb.21670; Tsutsui Hiroyuki, 2008, Circ J, V72 Suppl A, pA31, DOI 10.1253/circj.CJ-08-0014; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; Wang L, 2010, BURNS, V36, P232, DOI 10.1016/j.burns.2009.02.019; Wang YX, 2011, AM J PHYSIOL-CELL PH, V301, pC695, DOI 10.1152/ajpcell.00322.2010; Watts JA, 2004, J MOL CELL CARDIOL, V36, P141, DOI 10.1016/j.yjmcc.2003.10.015; White J, 2003, AM J PHYSIOL-HEART C, V285, pH47, DOI 10.1152/ajpheart.00833.2002; Zang Q, 2007, J APPL PHYSIOL, V102, P103, DOI 10.1152/japplphysiol.00359.2006; Zang Qun, 2007, Surg Infect (Larchmt), V8, P41, DOI 10.1089/sur.2006.033; Zang QS, 2012, AM J PHYSIOL-HEART C, V302, pH1847, DOI 10.1152/ajpheart.00203.2011; Zang QS, 2010, AM J PHYSIOL-HEART C, V298, pH1951, DOI 10.1152/ajpheart.00927.2009; Zanotti-Cavazzoni SL, 2009, CURR OPIN CRIT CARE, V15, P392, DOI 10.1097/MCC.0b013e3283307a4e; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	66	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43424	10.1371/journal.pone.0043424	http://dx.doi.org/10.1371/journal.pone.0043424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952679	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800031
J	Mazemondet, O; John, M; Leye, S; Rolfs, A; Uhrmacher, AM				Mazemondet, Orianne; John, Mathias; Leye, Stefan; Rolfs, Arndt; Uhrmacher, Adelinde M.			Elucidating the Sources of beta-Catenin Dynamics in Human Neural Progenitor Cells	PLOS ONE			English	Article							EXACT STOCHASTIC SIMULATION; SIGNALING PROTEINS; NOISE-REDUCTION; FEEDBACK LOOP; STEM-CELLS; WNT; DIFFERENTIATION; PATHWAY; INHIBITOR; THERAPY	Human neural progenitor cells (hNPCs) form a new prospect for replacement therapies in the context of neurodegenerative diseases. The Wnt/beta-catenin signaling pathway is known to be involved in the differentiation process of hNPCs. RVM cells form a common cell model of hNPCs for in vitro investigation. Previous observations in RVM cells raise the question of whether observed kinetics of the Wnt/beta-catenin pathway in later differentiation phases are subject to self-induced signaling. However, a concern when investigating RVM cells is that experimental results are possibly biased by the asynchrony of cells w.r.t. the cell cycle. In this paper, we present, based on experimental data, a computational modeling study on the Wnt/beta-catenin signaling pathway in RVM cell populations asynchronously distributed w.r.t. to their cell cycle phases. Therefore, we derive a stochastic model of the pathway in single cells from the reference model in literature and extend it by means of cell populations and cell cycle asynchrony. Based on this, we show that the impact of the cell cycle asynchrony on wet-lab results that average over cell populations is negligible. We then further extend our model and the thus-obtained simulation results provide additional evidence that self-induced Wnt signaling occurs in RVM cells. We further report on significant stochastic effects that directly result from model parameters provided in literature and contradict experimental observations.	[Mazemondet, Orianne; Leye, Stefan; Uhrmacher, Adelinde M.] Univ Rostock, Inst Comp Sci, Modelling & Simulat Grp, Rostock, Germany; [John, Mathias] Univ Lille 1, BioComp Grp, Lille, France; [Rolfs, Arndt] Univ Rostock, Ctr Mental Hlth, Albrecht Kossel Inst Neuroregenerat AKos, Rostock, Germany	University of Rostock; Universite de Lille - ISITE; Universite de Lille; University of Rostock	Mazemondet, O (corresponding author), Univ Rostock, Inst Comp Sci, Modelling & Simulat Grp, Rostock, Germany.	lin@informatik.uni-rostock.de			research training group dIEM oSiRiS (The integrative development of modeling and simulation methods for regenerative systems); research project dIER MoSiS (Discrete event multi-level modeling and simulation for systems biology); German foundation for research	research training group dIEM oSiRiS (The integrative development of modeling and simulation methods for regenerative systems); research project dIER MoSiS (Discrete event multi-level modeling and simulation for systems biology); German foundation for research(German Research Foundation (DFG))	This work has been supported as part of the research training group dIEM oSiRiS (The integrative development of modeling and simulation methods for regenerative systems) and the research project dIER MoSiS (Discrete event multi-level modeling and simulation for systems biology), both financed by the German foundation for research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2004, BIOTECHNOL BIOENG, V88, P332, DOI 10.1002/bit.20246; Bundschuh R, 2003, J THEOR BIOL, V220, P261, DOI 10.1006/jtbi.2003.3164; Canning CA, 2007, DEV BIOL, V305, P276, DOI 10.1016/j.ydbio.2007.02.009; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Ciocchetta F, 2009, LECT NOTES COMPUT SC, V5750, P45; Clelland CD, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E8; Cotter D, 1999, ACTA NEUROPATHOL, V98, P465, DOI 10.1007/s004010051111; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Fradkin LG, 2010, TRENDS NEUROSCI, V33, P84, DOI 10.1016/j.tins.2009.11.005; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Himmelspach J, 2007, PROC ANNU SIMUL SYMP, P137, DOI 10.1109/ANSS.2007.34; HOOKE R, 1961, J ACM, V8, P212, DOI 10.1145/321062.321069; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kofahl B, 2010, BIOCHEM SOC T, V38, P1281, DOI 10.1042/BST0381281; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lorenowicz MJ, 2009, EXP CELL RES, V315, P2683, DOI 10.1016/j.yexcr.2009.06.015; Lu WY, 2010, BIOCHEMISTRY-US, V49, P4635, DOI 10.1021/bi1001486; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mazemondet O, 2011, CELL MOL BIOL LETT, V16, P515, DOI 10.2478/s11658-011-0021-0; Mazemondet O, 2009, WINT SIMUL C PROC, P878; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Mirams GR, 2010, J MATH BIOL, V60, P131, DOI 10.1007/s00285-009-0262-y; Morgan PJ, 2009, NEUROREPORT, V20, P1225, DOI 10.1097/WNR.0b013e32832fbf49; Morishita Y, 2004, J THEOR BIOL, V228, P315, DOI 10.1016/j.jtbi.2004.01.007; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Olivier BG, 2004, BIOINFORMATICS, V20, P2143, DOI 10.1093/bioinformatics/bth200; Orrell D, 2006, PHYSICA D, V217, P64, DOI 10.1016/j.physd.2006.03.010; Schilling M, 2005, FEBS J, V272, P6400, DOI 10.1111/j.1742-4658.2005.05037.x; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; Schmitz Y, 2011, J THEOR BIOL, V279, P132, DOI 10.1016/j.jtbi.2011.03.018; Schmole AC, 2010, BIOORGAN MED CHEM, V18, P6785, DOI 10.1016/j.bmc.2010.07.045; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031882; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tymchyshyn O, 2008, LECT N BIOINFORMAT, V5054, P63, DOI 10.1007/978-3-540-68413-8_5; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; Wawra C, 2007, FEBS LETT, V581, P4043, DOI 10.1016/j.febslet.2007.07.043; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wolkenhauer O, 2004, IEEE T NANOBIOSCI, V3, P200, DOI 10.1109/TNB.2004.833694; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455	59	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42792	10.1371/journal.pone.0042792	http://dx.doi.org/10.1371/journal.pone.0042792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22952611	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800028
J	Kot, BCW; Zhang, ZJ; Lee, AWC; Leung, VYF; Fu, SN				Kot, Brian Chin Wing; Zhang, Zhi Jie; Lee, Arthur Wai Chun; Leung, Vivian Yee Fong; Fu, Siu Ngor			Elastic Modulus of Muscle and Tendon with Shear Wave Ultrasound Elastography: Variations with Different Technical Settings	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; SKELETAL-MUSCLE; HEALTHY	Standardization on Shear wave ultrasound elastography (SWUE) technical settings will not only ensure that the results are accurate, but also detect any differences over time that may be attributed to true physiological changes. The present study evaluated the variations of elastic modulus of muscle and tendon using SWUE when different technical aspects were altered. The results of this study indicated that variations of elastic modulus of muscle and tendon were found when different transducer's pressure and region of interest (ROI)'s size were applied. No significant differences in elastic modulus of the rectus femoris muscle and patellar tendon were found with different acquisition times of the SWUE sonogram. The SWUE on the muscle and tendon should be performed with the lightest transducer's pressure, a shorter acquisition time for the SWUE sonogram, while measuring the mean elastic modulus regardless the ROI's size.	[Kot, Brian Chin Wing; Zhang, Zhi Jie; Lee, Arthur Wai Chun; Fu, Siu Ngor] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Leung, Vivian Yee Fong] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Chinese University of Hong Kong; Prince of Wales Hospital	Kot, BCW (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	briankot@yahoo.co.uk; rsamyfu@polyu.edu.hk	Zhang, Zhi Jie/AAR-1686-2020	FU, Amy/0000-0003-4405-015X; Kot, Brian Chin Wing/0000-0002-8932-1884	Dr and Mrs Lui Che Woo Special Centre for the Knee, Department of Rehabilitation Sciences, The Hong Kong Polytechnic University	Dr and Mrs Lui Che Woo Special Centre for the Knee, Department of Rehabilitation Sciences, The Hong Kong Polytechnic University	Funding of the project was supported by Dr and Mrs Lui Che Woo Special Centre for the Knee, Department of Rehabilitation Sciences, The Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basford JR, 2002, ARCH PHYS MED REHAB, V83, P1530, DOI 10.1053/apmr.2002.35472; Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P1523, DOI 10.1109/TUFFC.2004.1367494; Cowan S. M., 2000, PHYS THER SPORT, V1, P129, DOI DOI 10.1054/PTSP.2000.0036; Garra Brian Stephen, 2007, Ultrasound Q, V23, P255, DOI 10.1097/ruq.0b013e31815b7ed6; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; Klauser AS, 2010, SEMIN MUSCULOSKEL R, V14, P323, DOI 10.1055/s-0030-1254521; Lee AC, 2007, SCI FDN PRINCIPLES P, P1; Leonard CT, 2003, ARCH PHYS MED REHAB, V84, P928, DOI 10.1016/S0003-9993(03)00006-6; Muller M, 2009, ULTRASOUND MED BIOL, V35, P219, DOI 10.1016/j.ultrasmedbio.2008.08.018; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Papazoglou S, 2006, MAGN RESON MED, V56, P489, DOI 10.1002/mrm.20993; Ringleb SI, 2007, J MAGN RESON IMAGING, V25, P301, DOI 10.1002/jmri.20817; Sebag F, 2010, J CLIN ENDOCR METAB, V95, P5281, DOI 10.1210/jc.2010-0766; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Weismann C, 2011, BREAST CARE, V6, P98, DOI 10.1159/000327504; Zhang ZJ, 2011, J ULTRAS MED, V37, pS141	19	187	202	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44348	10.1371/journal.pone.0044348	http://dx.doi.org/10.1371/journal.pone.0044348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952961	Green Published, gold			2022-12-27	WOS:000308221300084
J	Newbold, T; Butchart, SHM; Sekercioglu, CH; Purves, DW; Scharlemann, JPW				Newbold, Tim; Butchart, Stuart H. M.; Sekercioglu, Cagan H.; Purves, Drew W.; Scharlemann, Joern P. W.			Mapping Functional Traits: Comparing Abundance and Presence-Absence Estimates at Large Spatial Scales	PLOS ONE			English	Article							BODY-SIZE; ECOSYSTEM PROCESSES; DIVERSITY; ECOLOGY; CONSERVATION; RICHNESS; PATTERNS; BIRDS; BIODIVERSITY; COMPONENTS	Efforts to quantify the composition of biological communities increasingly focus on functional traits. The composition of communities in terms of traits can be summarized in several ways. Ecologists are beginning to map the geographic distribution of trait-based metrics from various sources of data, but the maps have not been tested against independent data. Using data for birds of the Western Hemisphere, we test for the first time the most commonly used method for mapping community trait composition - overlaying range maps, which assumes that the local abundance of a given species is unrelated to the traits in question - and three new methods that as well as the range maps include varying degrees of information about interspecific and geographic variation in abundance. For each method, and for four traits (body mass, generation length, migratory behaviour, diet) we calculated community-weighted mean of trait values, functional richness and functional divergence. The maps based on species ranges and limited abundance data were compared with independent data on community species composition from the American Christmas Bird Count (CBC) scheme coupled with data on traits. The correspondence with observed community composition at the CBC sites was mostly positive (62/73 correlations) but varied widely depending on the metric of community composition and method used (R-2 : 5.6 x 10(-7) to 0.82, with a median of 0.12). Importantly, the commonly-used range-overlap method resulted in the best fit (21/22 correlations positive; R-2 : 0.004 to 0.8, with a median of 0.33). Given the paucity of data on the local abundance of species, overlaying range maps appears to be the best available method for estimating patterns of community composition, but the poor fit for some metrics suggests that local abundance data are urgently needed to allow more accurate estimates of the composition of communities.	[Newbold, Tim; Scharlemann, Joern P. W.] World Conservat Monitoring Ctr, United Nations Environm Programme, Cambridge, England; [Newbold, Tim; Purves, Drew W.] Microsoft Res Cambridge, Computat Sci Lab, Cambridge, England; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Sekercioglu, Cagan H.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Microsoft; BirdLife International; Utah System of Higher Education; University of Utah	Newbold, T (corresponding author), World Conservat Monitoring Ctr, United Nations Environm Programme, Cambridge, England.	Tim.Newbold@unep-wcmc.org	Sekercioglu, Cagan H/A-2331-2013; Butchart, Stuart HM/Y-2711-2018; Newbold, Tim/R-8958-2019; Butchart, Stuart/AAJ-1852-2021; Newbold, Tim/D-1524-2012; Scharlemann, Jorn/A-4737-2008	Sekercioglu, Cagan H/0000-0001-9639-294X; Newbold, Tim/0000-0001-7361-0051; Butchart, Stuart/0000-0002-1140-4049; Newbold, Tim/0000-0001-7361-0051; Scharlemann, Jorn/0000-0002-2834-6367; Sekercioglu, Cagan H./0000-0003-3193-0377				[Anonymous], 2010, R LANG ENV STAT COMP; Barber C., 2012, GEOMETRY MESH GENERA; Bivand R, 2012, SPDEP SPATIAL DEPEND; Chessel D, 2012, ADE4 ANAL ECOLOGICAL; Cumming GS, 2009, PHILOS T R SOC B, V364, P1683, DOI 10.1098/rstb.2008.0317; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2003, TRENDS ECOL EVOL, V18, P140, DOI 10.1016/S0169-5347(03)00007-7; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Dunning J.B., 2007, CRC HDB AVIAN BODY M, V2nd ed., DOI [10.1201/9781420064452, DOI 10.1201/9781420064452]; Elliott A., 1992, HDB BIRDS WORLD ALIV; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Fritz SA, 2010, P ROY SOC B-BIOL SCI, V277, P2435, DOI 10.1098/rspb.2010.0030; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; IUCN Standards and Petitions Subcommittee, 2010, GUID US IUCN RED LIS; Jetz W, 2008, CONSERV BIOL, V22, P110, DOI 10.1111/j.1523-1739.2007.00847.x; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kissling WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P328, DOI 10.1111/j.1466-8238.2011.00679.x; Laliberte E., 2011, FD MEASURING FUNCTIO; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Menezes S, 2010, J APPL ECOL, V47, P711, DOI 10.1111/j.1365-2664.2010.01819.x; National Audubon Society, 2010, CHRISTM BIRD COUNT H; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Philpott SM, 2009, ECOL APPL, V19, P1858, DOI 10.1890/08-1928.1; Pocock MJO, 2011, P ROY SOC B-BIOL SCI, V278, P1532, DOI 10.1098/rspb.2010.1971; Ramirez L, 2008, GLOBAL ECOL BIOGEOGR, V17, P100, DOI 10.1111/j.1466-8238.2007.00346.x; Ricotta C, 2009, THEOR POPUL BIOL, V76, P299, DOI 10.1016/j.tpb.2009.10.001; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; Rodriguez MA, 2006, GLOBAL ECOL BIOGEOGR, V15, P173, DOI 10.1111/j.1466-822x.2006.00206.x; Schieck J, 1997, CONDOR, V99, P179, DOI 10.2307/1370236; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Sekercioglu CH, 2007, CURR BIOL, V17, pR283, DOI 10.1016/j.cub.2007.02.019; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Skov F, 2004, ECOGRAPHY, V27, P366, DOI 10.1111/j.0906-7590.2004.03823.x; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Williams RJ, 2011, ECOLOGY, V92, P1849, DOI 10.1890/11-0200.1	53	29	29	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44019	10.1371/journal.pone.0044019	http://dx.doi.org/10.1371/journal.pone.0044019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952859	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308221300042
J	Yao, JX; Buschman, LL; Oppert, B; Khajuria, C; Zhu, KY				Yao, Jianxiu; Buschman, Lawrent L.; Oppert, Brenda; Khajuria, Chitvan; Zhu, Kun Yan			Characterization of cDNAs Encoding Serine Proteases and Their Transcriptional Responses to Cry1Ab Protoxin in the Gut of Ostrinia nubilalis Larvae	PLOS ONE			English	Article							MAMESTRA-CONFIGURATA LEPIDOPTERA; EARLY TRYPSIN ACTIVITY; INSECT RESISTANCE; HELICOVERPA-ZEA; PROTEINASE ACTIVITIES; HELIOTHIS-VIRESCENS; AGROTIS-IPSILON; COTTON BOLLWORM; CORN-BORER; MIDGUT	Serine proteases, such as trypsin and chymotrypsin, are the primary digestive enzymes in lepidopteran larvae, and are also involved in Bacillus thuringiensis (Bt) protoxin activation and protoxin/toxin degradation. We isolated and sequenced 34 cDNAs putatively encoding trypsins, chymotrypsins and their homologs from the European corn borer (Ostrinia nubilalis) larval gut. Our analyses of the cDNA-deduced amino acid sequences indicated that 12 were putative trypsins, 12 were putative chymotrypsins, and the remaining 10 were trypsin and chymotrypsin homologs that lack one or more conserved residues of typical trypsins and chymotrypsins. Reverse transcription PCR analysis indicated that all genes were highly expressed in gut tissues, but one group of phylogenetically-related trypsin genes, OnTry-G2, was highly expressed in larval foregut and midgut, whereas another group, OnTry-G3, was highly expressed in the midgut and hindgut. Real-time quantitative PCR analysis indicated that several trypsin genes (OnTry5 and OnTry6) were significantly up-regulated in the gut of third-instar larvae after feeding on Cry1Ab protoxin from 2 to 24 h, whereas one trypsin (OnTry2) was down-regulated at all time points. Four chymotrypsin and chymotrypsin homolog genes (OnCTP2, OnCTP5, OnCTP12 and OnCTP13) were up-regulated at least 2-fold in the gut of the larvae after feeding on Cry1Ab protoxin for 24 h. Our data represent the first in-depth study of gut transcripts encoding expanded families of protease genes in O. nubilalis larvae and demonstrate differential expression of protease genes that may be related to Cry1Ab intoxication and/or resistance.	[Yao, Jianxiu; Buschman, Lawrent L.; Khajuria, Chitvan; Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Oppert, Brenda] ARS, USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA	Kansas State University; United States Department of Agriculture (USDA)	Yao, JX (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	kzhu@ksu.edu	Khajuria, Chitvan/E-7690-2012	Zhu, Kun Yan/0000-0001-9372-8030	Kansas Agricultural Experiment Station; K-State Arthropod Genomics Center; K-State Targeted Excellence program at Kansas State University	Kansas Agricultural Experiment Station; K-State Arthropod Genomics Center; K-State Targeted Excellence program at Kansas State University	This research was supported in part by the Kansas Agricultural Experiment Station and the K-State Arthropod Genomics Center funded by the K-State Targeted Excellence program at Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunkumar KP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-338; Baptista AM, 1998, J MOL EVOL, V47, P353, DOI 10.1007/PL00006393; BARILLASMURY CV, 1995, INSECT BIOCHEM MOLEC, V25, P241, DOI 10.1016/0965-1748(94)00061-L; Barlow V, 2004, SAMPLING EUROPEAN CO; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bown DP, 1997, INSECT BIOCHEM MOLEC, V27, P625, DOI 10.1016/S0965-1748(97)00043-X; Brioschi D, 2007, INSECT BIOCHEM MOLEC, V37, P1283, DOI 10.1016/j.ibmb.2007.07.016; Campbell PM, 2008, INSECT BIOCHEM MOLEC, V38, P950, DOI 10.1016/j.ibmb.2008.07.009; CHOMA CT, 1990, EUR J BIOCHEM, V189, P523, DOI 10.1111/j.1432-1033.1990.tb15518.x; Coates BS, 2008, INSECT MOL BIOL, V17, P607, DOI 10.1111/j.1365-2583.2008.00833.x; COHEN AC, 1993, J INSECT PHYSIOL, V39, P823, DOI 10.1016/0022-1910(93)90114-7; DEHAEN C, 1974, BIOCHEMISTRY-US, V13, P2673, DOI 10.1021/bi00710a002; Diaz-Mendoza M, 2005, INSECT BIOCHEM MOLEC, V35, P1005, DOI 10.1016/j.ibmb.2005.04.003; EBORA RV, 1994, J ECON ENTOMOL, V87, P1122, DOI 10.1093/jee/87.4.1122; Erlandson MA, 2010, ARCH INSECT BIOCHEM, V75, P70, DOI 10.1002/arch.20381; Forcada C, 1996, ARCH INSECT BIOCHEM, V31, P257, DOI 10.1002/(SICI)1520-6327(1996)31:3&lt;257::AID-ARCH2&gt;3.0.CO;2-V; Forcada C, 1999, ARCH INSECT BIOCHEM, V42, P51, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;51::AID-ARCH6&gt;3.0.CO;2-6; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Giri AP, 1998, PLANT PHYSIOL, V116, P393, DOI 10.1104/pp.116.1.393; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hegedus D, 2003, ARCH INSECT BIOCHEM, V53, P30, DOI 10.1002/arch.10084; Herrero S, 2005, INSECT BIOCHEM MOLEC, V35, P1073, DOI 10.1016/j.ibmb.2005.05.006; HILDER VA, 1987, NATURE, V330, P160, DOI 10.1038/330160a0; Hosseininaveh V, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.7001; Hughes J, 2006, INSECT BIOCHEM MOLEC, V36, P584, DOI 10.1016/j.ibmb.2006.04.007; JOHNSON R, 1989, P NATL ACAD SCI USA, V86, P9871, DOI 10.1073/pnas.86.24.9871; JOHNSTON KA, 1991, INSECT BIOCHEM, V21, P389, DOI 10.1016/0020-1790(91)90005-Y; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khajuria C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-286; LAROCQUE AM, 1990, J INSECT PHYSIOL, V36, P691, DOI 10.1016/0022-1910(90)90075-Q; LEE MK, 1992, J BIOL CHEM, V267, P3115; Li HR, 2005, INSECT BIOCHEM MOLEC, V35, P847, DOI 10.1016/j.ibmb.2005.03.004; Li HR, 2004, INSECT BIOCHEM MOLEC, V34, P753, DOI 10.1016/j.ibmb.2004.03.010; LIPKE H, 1954, J AGR FOOD CHEM, V2, P410, DOI 10.1021/jf60028a003; Liu Y, 2009, ARCH INSECT BIOCHEM, V72, P74, DOI 10.1002/arch.20324; Lopes AR, 2009, ARCH INSECT BIOCHEM, V70, P188, DOI 10.1002/arch.20289; Lopes AR, 2004, ARCH INSECT BIOCHEM, V55, P140, DOI 10.1002/arch.10134; Lu SJ, 2006, INSECT BIOCHEM MOLEC, V36, P336, DOI 10.1016/j.ibmb.2006.01.011; Ma WZ, 2005, BIOPHYS J, V89, P1183, DOI 10.1529/biophysj.104.057158; Mazumdar-Leighton S, 2001, INSECT BIOCHEM MOLEC, V31, P645, DOI 10.1016/S0965-1748(00)00169-7; Mazumdar-Leighton S, 2001, INSECT BIOCHEM MOLEC, V31, P633, DOI 10.1016/S0965-1748(00)00168-5; Mazumdar-Leighton S, 2000, INSECT BIOCHEM MOLEC, V30, P57, DOI 10.1016/S0965-1748(99)00097-1; Nation JL, 2001, INSECT PHYSL BIOCH, P43; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Oppert B, 1996, INSECT BIOCHEM MOLEC, V26, P571, DOI 10.1016/S0965-1748(96)00013-6; Oppert B, 1999, ARCH INSECT BIOCHEM, V42, P1, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;1::AID-ARCH2&gt;3.0.CO;2-#; Oppert B, 2012, COMP BIOCHEM PHYS D, V7, P233, DOI 10.1016/j.cbd.2012.03.005; Oppert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034624; Oppert B, 2010, COMP BIOCHEM PHYS D, V5, P280, DOI 10.1016/j.cbd.2010.08.001; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; PASHLEY DP, 1988, FLA ENTOMOL, V71, P227, DOI 10.2307/3495425; Patankar AG, 2001, INSECT BIOCHEM MOLEC, V31, P453, DOI 10.1016/S0965-1748(00)00150-8; PETERSON AM, 1995, INSECT BIOCHEM MOLEC, V25, P765, DOI 10.1016/0965-1748(94)00092-V; PETERSON AM, 1994, INSECT BIOCHEM MOLEC, V24, P463, DOI 10.1016/0965-1748(94)90041-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puntheeranurak T, 2004, MOL MEMBR BIOL, V21, P67, DOI 10.1080/09687680310001625792; PURCELL JP, 1992, INSECT BIOCHEM MOLEC, V22, P41, DOI 10.1016/0965-1748(92)90098-Y; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Reddy ST, 1998, BIOTECHNOL LETT, V20, P279, DOI 10.1023/A:1005338205018; Rodriguez-Cabrera L, 2010, ENVIRON MICROBIOL, V12, P2894, DOI 10.1111/j.1462-2920.2010.02259.x; SAS Institute, 1996, SAS 9 1 3; Shao ZZ, 1998, J INVERTEBR PATHOL, V72, P73, DOI 10.1006/jipa.1998.4757; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Showers WB, 1989, N CENTRAL REGIONAL E; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; Sui YP, 2009, INSECT MOL BIOL, V18, P443, DOI 10.1111/j.1365-2583.2009.00884.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Venancio TM, 2009, INSECT MOL BIOL, V18, P33, DOI 10.1111/j.1365-2583.2008.00845.x; Volpicella M, 2003, EUR J BIOCHEM, V270, P10, DOI 10.1046/j.1432-1033.2003.03368.x; Wang S, 1999, INSECT BIOCHEM MOLEC, V25, P899; Witkowski JF, 1997, N CENTRAL REGIONAL E; Yan YL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-405, 10.1186/1471-2164-11-11]; Zhan QL, 2011, ARCH INSECT BIOCHEM, V76, P130, DOI 10.1002/arch.20353; Zhu YC, 2000, INSECT BIOCHEM MOLEC, V30, P1027, DOI 10.1016/S0965-1748(00)00073-4; Zhu YC, 2011, J INVERTEBR PATHOL, V106, P296, DOI 10.1016/j.jip.2010.10.007	77	13	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44090	10.1371/journal.pone.0044090	http://dx.doi.org/10.1371/journal.pone.0044090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952884	Green Published, gold			2022-12-27	WOS:000308221300050
J	Abate, E; Belayneh, M; Gelaw, A; Idh, J; Getachew, A; Alemu, S; Diro, E; Fikre, N; Britton, S; Elias, D; Aseffa, A; Stendahl, O; Schon, T				Abate, Ebba; Belayneh, Meseret; Gelaw, Aschalew; Idh, Jonna; Getachew, Assefa; Alemu, Shitaye; Diro, Ermias; Fikre, Nigussu; Britton, Sven; Elias, Daniel; Aseffa, Abraham; Stendahl, Olle; Schon, Thomas			The Impact of Asymptomatic Helminth Co-Infection in Patients with Newly Diagnosed Tuberculosis in North-West Ethiopia	PLOS ONE			English	Article							INFECTION; RESPONSES; RISK	Background: Areas endemic of helminth infection, tuberculosis (TB) and HIV are to a large extent overlapping. The aim of this study was to assess the impact of asymptomatic helminth infection on the immunological response among TB patients with and without HIV, their house hold contacts and community controls. Methodology: Consecutive smear positive TB patients (n = 112), their household contacts (n = 71) and community controls (n = 112) were recruited in Gondar town, Ethiopia. Stool microscopy, HIV serology, serum IgE level, eosinophil and CD4 counts were performed and tuberculosis patients were followed up for 3 months after initiation of anti-TB treatment. Results: Helminth co-infection rate was 29% in TB patients and 21% in both community control and household contacts (p = 0.3) where Ascaris lumbricoides was the most prevalent parasite. In TB patients the seroprevalence of HIV was 47% (53/112). Eosinophilia and elevated IgE level were significantly associated with asymptomatic helminth infection. During TB treatment, the worm infection rate of HIV+/TB patients declined from 31% (10/32) at week 0 to 9% (3/32) at week 2 of TB treatment, whereas HIV2/TB patients showed no change from baseline to week 2, 29% (13/45) vs. 22.2% (10/45). This trend was stable at week 8 and 12 as well. Conclusion: One third of smear positive TB patients were infected with helminths. Eosinophilia and elevated IgE level correlated with asymptomatic worm infection, indicating an effect on host immunity. The rate of worm infection declined during TB treatment in HIV+/TB co-infected patients whereas no decline was seen in HIV2/TB group.	[Abate, Ebba; Gelaw, Aschalew] Univ Gondar, Dept Immunol & Mol Biol, Gondar, Ethiopia; [Abate, Ebba; Idh, Jonna; Stendahl, Olle; Schon, Thomas] Linkoping Univ, Dept Med Microbiol, S-58185 Linkoping, Sweden; [Belayneh, Meseret] Univ Addis Ababa, Sch Med Lab Sci, Fac Med, Addis Ababa, Ethiopia; [Getachew, Assefa] Univ Gondar, Dept Radiol, Gondar, Ethiopia; [Alemu, Shitaye; Diro, Ermias] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [Fikre, Nigussu] Univ Addis Ababa, Fac Med, Dept Parasitol, Addis Ababa, Ethiopia; [Britton, Sven] Karolinska Hosp, Dept Infect Dis, S-10401 Stockholm, Sweden; [Elias, Daniel] Univ So Denmark, Inst Mol Med, Dept Canc & Inflammat, Odense, Denmark; [Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Schon, Thomas] Kalmar Cty Hosp, Dept Clin Microbiol, Kalmar, Sweden	University of Gondar; Linkoping University; Addis Ababa University; University of Gondar; University of Gondar; Addis Ababa University; Karolinska Institutet; Karolinska University Hospital; University of Southern Denmark	Abate, E (corresponding author), Univ Gondar, Dept Immunol & Mol Biol, Gondar, Ethiopia.	ebbaabate@yahoo.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150	Swedish Agency for Research Cooperation with Developing Countries; Swedish International Development Cooperation Agency (SAREC/SIDA); European-Developing Countries Clinical Trials Partnership (EU/EDCTP) [JP 10800.006]; Swedish Research Council; Swedish Heart and Lung Foundation (Oscar II Jubilee Foundation)	Swedish Agency for Research Cooperation with Developing Countries; Swedish International Development Cooperation Agency (SAREC/SIDA); European-Developing Countries Clinical Trials Partnership (EU/EDCTP); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation (Oscar II Jubilee Foundation)	This study was supported by Swedish Agency for Research Cooperation with Developing Countries and Swedish International Development Cooperation Agency (SAREC/SIDA), European-Developing Countries Clinical Trials Partnership (EU/EDCTP) JP 10800.006, the Swedish Research Council and the Swedish Heart and Lung Foundation (Oscar II Jubilee Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentwich Z, 1996, CLIN EXP IMMUNOL, V103, P239, DOI 10.1046/j.1365-2249.1996.d01-612.x; Borkow G, 2001, SCAND J INFECT DIS, V33, P568, DOI 10.1080/00365540110026656; Carr A, 1998, LANCET, V351, P256, DOI 10.1016/S0140-6736(97)07529-6; Chiodini PL, 2001, ATLAS MED HELMINTHOL, P13; Diniz LM, 2010, CLIN EXP IMMUNOL, V161, P142, DOI 10.1111/j.1365-2249.2010.04164.x; Elias D, 2006, TROP MED INT HEALTH, V11, P551, DOI 10.1111/j.1365-3156.2006.01578.x; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Fehintola FA, 2009, T R SOC TROP MED HYG, V77, P363; Hagan P, 1985, CLIN EXPT IMMUNOLOGY, V161, P142; Kassu A, 2007, TROP DOCT, V37, P222, DOI 10.1258/004947507782333026; MacDonald AS, 2002, INFECT IMMUN, V70, P427, DOI 10.1128/IAI.70.2.427-433.2002; Mele R, 2003, INT J PARASITOL, V33, P757, DOI 10.1016/S0020-7519(03)00093-6; MILLER HRP, 1971, IMMUNOLOGY, V20, P277; Murphy L, 2011, PARASITE IMMUNOL, V33, P287, DOI 10.1111/j.1365-3024.2011.01281.x; Co TR, 2007, CLIN EXP IMMUNOL, V147, P45, DOI 10.1111/j.1365-2249.2006.03247.x; SLEIGH A, 1982, T ROY SOC TROP MED H, V76, P403, DOI 10.1016/0035-9203(82)90201-2; STURROCK RF, 1983, T ROY SOC TROP MED H, V77, P363, DOI 10.1016/0035-9203(83)90166-9; Tristão-Sá Ricardo, 2002, Rev. Soc. Bras. Med. Trop., V35, P533, DOI 10.1590/S0037-86822002000500020; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Valerie G, 2006, AM J RESP CRIT CARE, V173, P7803; Wakabi W, 2008, LANCET, V372, P880, DOI 10.1016/S0140-6736(08)61381-1; Wilson MS, 2004, CLIN REV ALLERG IMMU, V26, P35, DOI 10.1385/CRIAI:26:1:35	22	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e42901	10.1371/journal.pone.0042901	http://dx.doi.org/10.1371/journal.pone.0042901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952620	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000014
J	Fraser, JA; Alves-Pereira, A; Junqueira, AB; Peroni, N; Clement, CR				Fraser, James Angus; Alves-Pereira, Alessandro; Junqueira, Andre Braga; Peroni, Nivaldo; Clement, Charles Roland			Convergent Adaptations: Bitter Manioc Cultivation Systems in Fertile Anthropogenic Dark Earths and Floodplain Soils in Central Amazonia	PLOS ONE			English	Article							MANIHOT-ESCULENTA CRANTZ; GENETIC DIVERSITY; TRADITIONAL MANAGEMENT; CASSAVA; DYNAMICS; DOMESTICATION; CONSERVATION; ECOLOGY	Shifting cultivation in the humid tropics is incredibly diverse, yet research tends to focus on one type: long-fallow shifting cultivation. While it is a typical adaptation to the highly-weathered nutrient-poor soils of the Amazonian terra firme, fertile environments in the region offer opportunities for agricultural intensification. We hypothesized that Amazonian people have developed divergent bitter manioc cultivation systems as adaptations to the properties of different soils. We compared bitter manioc cultivation in two nutrient-rich and two nutrient-poor soils, along the middle Madeira River in Central Amazonia. We interviewed 249 farmers in 6 localities, sampled their manioc fields, and carried out genetic analysis of bitter manioc landraces. While cultivation in the two richer soils at different localities was characterized by fast-maturing, low-starch manioc landraces, with shorter cropping periods and shorter fallows, the predominant manioc landraces in these soils were generally not genetically similar. Rather, predominant landraces in each of these two fertile soils have emerged from separate selective trajectories which produced landraces that converged for fast-maturing low-starch traits adapted to intensified swidden systems in fertile soils. This contrasts with the more extensive cultivation systems found in the two poorer soils at different localities, characterized by the prevalence of slow-maturing high-starch landraces, longer cropping periods and longer fallows, typical of previous studies. Farmers plant different assemblages of bitter manioc landraces in different soils and the most popular landraces were shown to exhibit significantly different yields when planted in different soils. Farmers have selected different sets of landraces with different perceived agronomic characteristics, along with different fallow lengths, as adaptations to the specific properties of each agroecological micro-environment. These findings open up new avenues for research and debate concerning the origins, evolution, history and contemporary cultivation of bitter manioc in Amazonia and beyond.	[Fraser, James Angus] Univ Andes Bogota, Dept Anthropol, Cundinamarca, Colombia; [Fraser, James Angus] Univ Andes Bogota, Dept Hist, Cundinamarca, Colombia; [Fraser, James Angus] Univ Sussex, Dept Anthropol, E Sussex, England; [Alves-Pereira, Alessandro] Univ Sao Paulo, Postgrad Program Genet & Plant Breeding, Piracicaba, SP, Brazil; [Alves-Pereira, Alessandro; Clement, Charles Roland] Univ Fed Amazonas, Lab Evolucao Aplicada, Manaus, Amazonas, Brazil; [Junqueira, Andre Braga; Clement, Charles Roland] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Junqueira, Andre Braga] Wageningen Univ, Ctr Crop Syst Anal Technol, Wageningen, Gelderland, Netherlands; [Junqueira, Andre Braga] Wageningen Univ, Agr Dev Grp, Wageningen, Gelderland, Netherlands; [Peroni, Nivaldo] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil	University of Sussex; Universidade de Sao Paulo; Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia; Wageningen University & Research; Wageningen University & Research; Universidade Federal de Santa Catarina (UFSC)	Fraser, JA (corresponding author), Univ Andes Bogota, Dept Anthropol, Cundinamarca, Colombia.	james.angus.fraser@gmail.com	Clement, Charles Roland/G-6081-2010; Peroni, Nivaldo/AAU-4701-2020; Fraser, James A/E-6119-2014; Peroni, Nivaldo/ABA-2663-2021; Peroni, Nivaldo/G-2091-2012; Alves-Pereira, Alessandro/I-6595-2012; Junqueira, Andre Braga/M-1142-2016	Clement, Charles Roland/0000-0002-8421-1029; Peroni, Nivaldo/0000-0002-6770-5377; Peroni, Nivaldo/0000-0002-6770-5377; Peroni, Nivaldo/0000-0002-6770-5377; Alves-Pereira, Alessandro/0000-0002-3012-6355; Junqueira, Andre Braga/0000-0003-3681-1705; Fraser, James/0000-0003-0718-6832	Leverhulme Trust [F/00 230/W]; CNPq (Brazilian National Research Council) (CT Amazonia) [575588/08-0]	Leverhulme Trust(Leverhulme Trust); CNPq (Brazilian National Research Council) (CT Amazonia)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research was funded by Leverhulme Trust (Grant F/00 230/W) and the CNPq (Brazilian National Research Council) (CT Amazonia 575588/08-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves Pereira A, 2011, DINAMICA EVOLUTIVA M; Alves-Pereira A, 2011, GENETICA, V139, P1259, DOI 10.1007/s10709-011-9627-4; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Arroyo-Kalin M., 2010, Diversity, V2, P473; Arroyo-Kalin M, 2012, QUATERN INT, V249, P4, DOI 10.1016/j.quaint.2011.08.004; Barker G, 2012, RAINFOREST FORAGING; Bernard H. R., 2017, RES METHODS ANTHR; Boserup E, 1993, CONDITIONS AGR GROWT; Boster J., 1984, ADV EC BOT, V1, P34; BOSTER JS, 1985, ECON BOT, V39, P310, DOI 10.1007/BF02858802; BROOKFIELD H, 1994, ENVIRONMENT, V36, P6, DOI 10.1080/00139157.1994.9929164; Bryman A., 2008, SOCIAL RES METHODS, V3rd; Chavarriaga-Aguirre P, 1998, THEOR APPL GENET, V97, P493, DOI 10.1007/s001220050922; CONKLIN HC, 1961, CURR ANTHROPOL, V2, P27, DOI 10.1086/200160; de Castro F, 2009, AMAZON PEASANT SOCIETIES IN A CHANGING ENVIRONMENT, P157, DOI 10.1007/978-1-4020-9283-1_8; de Lima RMB, 2000, CENTRAL AMAZON FLOODPLAIN: ACTUAL USE AND OPTIONS FOR A SUSTAINABLE MANAGEMENT, P243; Deletre M, 2011, P NATL ACAD SCI USA, V108, P18249, DOI 10.1073/pnas.1106259108; Denevan William M., 2001, CULTIVATED LANDSCAPE; Denevan WM, 1996, ANN ASSOC AM GEOGR, V86, P654, DOI 10.1111/j.1467-8306.1996.tb01771.x; DENEVAN WM, 1984, FRONTIER EXPANSION A, P311; Denham T, 2008, HOLOCENE, V18, P481, DOI 10.1177/0959683607087936; Elias M, 2000, ACTA OECOL, V21, P223, DOI 10.1016/S1146-609X(00)00053-9; Elias M, 2004, ECON BOT, V58, P242, DOI 10.1663/0013-0001(2004)058[0242:GDOTSA]2.0.CO;2; Elias M, 2001, EUPHYTICA, V120, P143, DOI 10.1023/A:1017501017031; Elias M, 2001, MOL ECOL, V10, P1895, DOI 10.1046/j.0962-1083.2001.01331.x; Elias Marianne, 2000, Journal of Ethnobiology, V20, P239; Ellen R., 2012, Ethnobotany Research and Applications, V10, P15; Emperaire L., 1998, NAT SCI SOC, V6, P27, DOI DOI 10.1016/S1240-1307(98)80006-X; Emperaire L, 2007, HUM ECOL, V35, P761, DOI 10.1007/s10745-007-9121-x; Erickson CL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P157, DOI 10.1007/978-0-387-74907-5_11; Fraser J. A., 2010, Diversity, V2, P586; Fraser J A, 2009, THESIS U SUSSEX; Fraser J, 2011, AREA, V43, P264, DOI 10.1111/j.1475-4762.2011.00999.x; Fraser JA, 2010, HUM ECOL, V38, P651, DOI 10.1007/s10745-010-9338-y; Fraser James A., 2008, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V3, P175; Fraser JA, 2011, HUM ECOL, V39, P395, DOI 10.1007/s10745-011-9405-z; German L, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P179, DOI 10.1007/1-4020-2597-1_10; German LA, 2004, HUM ECOL, V32, P653, DOI 10.1007/s10745-004-6831-1; German LA, 2003, GEODERMA, V111, P307, DOI 10.1016/S0016-7061(02)00270-7; GERMAN LA, 2001, THESIS U GEORGIA; Glaser B., 2004, AMAZONIAN DARK EARTH; Glaser B, 2012, GEOCHIM COSMOCHIM AC, V82, P39, DOI 10.1016/j.gca.2010.11.029; GRENAND F, 1993, MAN BIOSPH, V13, P447; Gutjahr E, 2000, CENTRAL AMAZON FLOODPLAIN: ACTUAL USE AND OPTIONS FOR A SUSTAINABLE MANAGEMENT, P141; Harlan JR, 1992, CROPS MAN, V2nd; Heckenberger M, 2009, ANNU REV ANTHROPOL, V38, P251, DOI 10.1146/annurev-anthro-091908-164310; Heckler S, 2008, HUM ECOL, V36, P679, DOI 10.1007/s10745-008-9193-2; Hershey CH, 1994, INT CROP NETWORK SER; Hiraoka M, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P387, DOI 10.1007/1-4020-2597-1_20; Iglesias MP, 2002, ENCICLOPEDIA FLOREST, P147; Irion G., 1984, AMAZON LIMNOLOGY LAN, P201, DOI DOI 10.1007/978-94-009-6542-3_7; Jones W. O., 1959, MANIOC IN AFRICA; Kensinger KM, 1975, CASHINAHUA E PERU, V1, P9; Kingwell-Banham E, 2012, QUATERN INT, V249, P84, DOI 10.1016/j.quaint.2011.05.025; Kuzyakov Y, 2009, SOIL BIOL BIOCHEM, V41, P210, DOI 10.1016/j.soilbio.2008.10.016; Lathrap DW, 1970, UPPER AMAZON; Lebot V., 2008, Tropical root and tuber crops: cassava, sweet potato, yams and aroids, pxv, DOI 10.1079/9781845934248.0000; LEHMANN J, 2003, AMAZONIAN DARK EARTH; Lima Deborah, 2012, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V7, P371; Mba REC, 2001, THEOR APPL GENET, V102, P21, DOI 10.1007/s001220051614; McCune B, 2002, ANAL ECOLOGICAL COMM; McKey D, 2001, GENET SEL EVOL, V33, pS465, DOI 10.1186/BF03500895; McKey D, 2010, CHEMOECOLOGY, V20, P109, DOI 10.1007/s00049-010-0047-1; Meggers B. J, 1971, AMAZONIA MAN CULTURE; Neumann K, 2012, QUATERN INT, V249, P53, DOI 10.1016/j.quaint.2011.03.024; Neves EG, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P359, DOI 10.1007/978-0-387-74907-5_20; Noda SD, 2000, CENTRAL AMAZON FLOODPLAIN: ACTUAL USE AND OPTIONS FOR A SUSTAINABLE MANAGEMENT, P215; Nye P. H., 1960, TECHNICAL COMMUNICAT; Ohly JJ, 1999, ADV ECON BOTANY, V13, P283; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pereira KJC, 2008, THESIS U SAO PAULO S; Peroni N, 1998, THESIS U SAO PAULO S; Peroni N, 2007, GENET RESOUR CROP EV, V54, P1333, DOI 10.1007/s10722-006-9116-2; Peterson J.B., 2001, UNKNOWN AMAZON CULTU, P86; Pujol B, 2002, ECON BOT, V56, P366, DOI [10.1663/0013-0001(2002)056[0366:GEOCME]2.0.CO;2, 10.1111/j.1461-0248.2004.00708.x]; Pujol B, 2007, BIOL CONSERV, V136, P541, DOI 10.1016/j.biocon.2006.12.025; Ricardo CA, 2000, POVOS INDIGENAS BRAS; Rival L, 2008, CURR ANTHROPOL, V49, P1116, DOI 10.1086/593119; Roosevelt A. C., 1980, PARMANA PREHISTORIC; Salick J, 1997, ECON BOT, V51, P6, DOI 10.1007/BF02910400; Schmidt MJ, 2010, THESIS U FLORIDA; SMITH NJH, 1980, ANN ASSOC AM GEOGR, V70, P553, DOI 10.1111/j.1467-8306.1980.tb01332.x; SMITH NJH, 1999, AMAZON RIVER FOREST; Stahl PW, 2002, REV ARCHAEOLOGY, V23, P39; Steward J., 1948, B BUREAU AM ETHNOLOG, V143; Steward Julian, 1948, HDB S AM INDIANS, V143; STOCKER P, 2006, THESIS U EDINBURGH; Sutrop Urmas, 2001, FIELD METHOD, V13, P263; Wilson W, 2002, CULTURE AGR, V24, P20; Woods W.I., 2009, AMAZONIAN DARK EARTH; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694	91	29	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43636	10.1371/journal.pone.0043636	http://dx.doi.org/10.1371/journal.pone.0043636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952727	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000308206000045
J	Sasidharan, K; Soga, T; Tomita, M; Murray, DB				Sasidharan, Kalesh; Soga, Tomoyoshi; Tomita, Masaru; Murray, Douglas B.			A Yeast Metabolite Extraction Protocol Optimised for Time-Series Analyses	PLOS ONE			English	Article							RESPIRATORY OSCILLATION; SACCHAROMYCES-CEREVISIAE; GLUTATHIONE; ACID; QUANTIFICATION	There is an increasing call for the absolute quantification of time-resolved metabolite data. However, a number of technical issues exist, such as metabolites being modified/degraded either chemically or enzymatically during the extraction process. Additionally, capillary electrophoresis mass spectrometry (CE-MS) is incompatible with high salt concentrations often used in extraction protocols. In microbial systems, metabolite yield is influenced by the extraction protocol used and the cell disruption rate. Here we present a method that rapidly quenches metabolism using dry-ice ethanol bath and methanol N-ethylmaleimide solution (thus stabilising thiols), disrupts cells efficiently using bead-beating and avoids artefacts created by live-cell pelleting. Rapid sample processing minimised metabolite leaching. Cell weight, number and size distribution was used to calculate metabolites to an attomol/cell level. We apply this method to samples obtained from the respiratory oscillation that occurs when yeast are grown continuously.	[Sasidharan, Kalesh; Soga, Tomoyoshi; Tomita, Masaru; Murray, Douglas B.] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Keio University	Sasidharan, K (corresponding author), Keio Univ, Inst Adv Biosci, Nipponkoku 403-1, Tsuruoka, Yamagata, Japan.	dougie@ttck.keio.ac.jp	Soga, Tomoyoshi/B-8105-2014	Soga, Tomoyoshi/0000-0001-9502-2509	Tsuruoka city; Yamagata prefecture; JST-BBSRC	Tsuruoka city(Tsuruoka City Government); Yamagata prefecture; JST-BBSRC	The authors are grateful to Tsuruoka city and Yamagata prefecture for supporting this work. In part this work was funded by a joint JST-BBSRC grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban E, 2012, ELECTROPHORESIS, V33, P2, DOI 10.1002/elps.201100344; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Barri T, 2012, ANAL CHIM ACTA, V718, P47, DOI 10.1016/j.aca.2011.12.065; Bolten CJ, 2008, BIOTECHNOL LETT, V30, P1993, DOI 10.1007/s10529-008-9789-z; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Buchholz A, 2001, ANAL BIOCHEM, V295, P129, DOI 10.1006/abio.2001.5183; Canelas AB, 2008, METABOLOMICS, V4, P226, DOI 10.1007/s11306-008-0116-4; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; D'Agostino LA, 2011, J PROTEOME RES, V10, P592, DOI 10.1021/pr100771g; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; ELLIOTT B, 1993, YEAST, V9, P33, DOI 10.1002/yea.320090105; Faijes M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-27; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Machne R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037906; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Murray DB, 1999, MICROBIOL-SGM, V145, P2739, DOI 10.1099/00221287-145-10-2739; Murray DB, 2007, BIOSYSTEMS, V90, P287, DOI 10.1016/j.biosystems.2006.09.032; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Murray DB, 2011, BBA-GEN SUBJECTS, V1810, P945, DOI 10.1016/j.bbagen.2011.04.005; Ohta D, 2010, CURR OPIN BIOTECH, V21, P35, DOI 10.1016/j.copbio.2010.01.012; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; Sasidharan K, 2012, YEAST; SATROUTDINOV AD, 1992, FEMS MICROBIOL LETT, V98, P261, DOI 10.1016/0378-1097(92)90167-M; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Sohn HY, 2005, BIOSCI BIOTECH BIOCH, V69, P2450, DOI 10.1271/bbb.69.2450; Sohn HY, 2005, J MICROBIOL, V43, P375; Sohn HY, 2001, ARCH MICROBIOL, V176, P69, DOI 10.1007/s002030100295; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Theobald U, 1997, BIOTECHNOL BIOENG, V55, P305, DOI 10.1002/(SICI)1097-0290(19970720)55:2<305::AID-BIT8>3.0.CO;2-M; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308	34	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44283	10.1371/journal.pone.0044283	http://dx.doi.org/10.1371/journal.pone.0044283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952947	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206000097
J	Streitburger, DP; Moller, HE; Tittgemeyer, M; Hund-Georgiadis, M; Schroeter, ML; Mueller, K				Streitbuerger, Daniel-Paolo; Moeller, Harald E.; Tittgemeyer, Marc; Hund-Georgiadis, Margret; Schroeter, Matthias L.; Mueller, Karsten			Investigating Structural Brain Changes of Dehydration Using Voxel-Based Morphometry	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CLUSTER-SIZE INFERENCE; VENTRICULAR ENLARGEMENT; ALZHEIMERS-DISEASE; GRAY-MATTER; PERMUTATION METHODS; MULTIPLE-SCLEROSIS; RANDOM-FIELD; VOLUME; PROGRESSION	Dehydration can affect the volume of brain structures, which might imply a confound in volumetric and morphometric studies of normal or diseased brain. Six young, healthy volunteers were repeatedly investigated using three-dimensional T-1-weighted magnetic resonance imaging during states of normal hydration, hyperhydration, and dehydration to assess volume changes in gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). The datasets were analyzed using voxel-based morphometry (VBM), a widely used voxel-wise statistical analysis tool, FreeSurfer, a fully automated volumetric segmentation measure, and SIENAr a longitudinal brain-change detection algorithm. A significant decrease of GM and WM volume associated with dehydration was found in various brain regions, most prominently, in temporal and sub-gyral parietal areas, in the left inferior orbito-frontal region, and in the extra-nuclear region. Moreover, we found consistent increases in CSF, that is, an expansion of the ventricular system affecting both lateral ventricles, the third, and the fourth ventricle. Similar degrees of shrinkage in WM volume and increase of the ventricular system have been reported in studies of mild cognitive impairment or Alzheimer's disease during disease progression. Based on these findings, a potential confound in GM and WM or ventricular volume studies due to the subjects' hydration state cannot be excluded and should be appropriately addressed in morphometric studies of the brain.	[Streitbuerger, Daniel-Paolo; Moeller, Harald E.; Hund-Georgiadis, Margret; Schroeter, Matthias L.; Mueller, Karsten] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Tittgemeyer, Marc] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Schroeter, Matthias L.] Univ Leipzig, Clin Cognit Neurol, Leipzig, Germany	Max Planck Society; Max Planck Society; Leipzig University	Streitburger, DP (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	paolo@cbs.mpg.de	Moller, Harald E/A-1565-2008; Möller, Harald/AAB-4679-2019	Moller, Harald E/0000-0002-5659-1925; Möller, Harald/0000-0002-5659-1925				Apostolova LG, 2010, MOVEMENT DISORD, V25, P687, DOI 10.1002/mds.22799; Armstrong LE, 2010, INT J SPORT NUTR EXE, V20, P145, DOI 10.1123/ijsnem.20.2.145; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barta PE, 1997, J NEUROSCI METH, V75, P111, DOI 10.1016/S0165-0270(97)00049-6; Bendel P, 2010, AM J NEURORADIOL, V31, P370, DOI 10.3174/ajnr.A1804; Bendfeldt K, 2009, NEUROIMAGE, V45, P60, DOI 10.1016/j.neuroimage.2008.10.006; Berk L, 2006, J SUPPORT ONCOL, V4, P455; Berk Lawrence, 2006, J Support Oncol, V4, P447; Brex PA, 2000, NEUROLOGY, V54, P1689, DOI 10.1212/WNL.54.8.1689; Dickson JM, 2005, INT J SPORTS MED, V26, P481, DOI 10.1055/s-2004-821318; Duning T, 2005, NEUROLOGY, V64, P548, DOI 10.1212/01.WNL.0000150542.16969.CC; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; GULLANS SR, 1993, ANNU REV MED, V44, P289, DOI 10.1146/annurev.me.44.020193.001445; Guo XJ, 2010, NEUROSCI LETT, V468, P146, DOI 10.1016/j.neulet.2009.10.086; Hagemann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014655; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kempton MJ, 2011, HUM BRAIN MAPP, V32, P71, DOI 10.1002/hbm.20999; Kempton MJ, 2009, HUM BRAIN MAPP, V30, P291, DOI 10.1002/hbm.20500; Kinkingnehum S, 2008, NEUROLOGY, V70, P2201, DOI 10.1212/01.wnl.0000303960.01039.43; Koo MS, 2006, ARCH GEN PSYCHIAT, V63, P1090, DOI 10.1001/archpsyc.63.10.1090; Righini NC, 2005, SWISS MED WKLY, V135, P440; Schols JMGA, 2009, J NUTR HEALTH AGING, V13, P150, DOI 10.1007/s12603-009-0023-z; Schott JM, 2005, NEUROLOGY, V65, P119, DOI 10.1212/01.wnl.0000167542.89697.0f; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Tardif CL, 2010, HUM BRAIN MAPP, V31, P943, DOI 10.1002/hbm.20908; Turner B, 2001, NEURORADIOLOGY, V43, P608, DOI 10.1007/s002340000457; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6; Worsley KJ, 2009, OHBM; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16	35	103	103	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44195	10.1371/journal.pone.0044195	http://dx.doi.org/10.1371/journal.pone.0044195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952926	gold, Green Published			2022-12-27	WOS:000308206000092
J	Alisi, A; Arciello, M; Petrini, S; Conti, B; Missale, G; Balsano, C				Alisi, Anna; Arciello, Mario; Petrini, Stefania; Conti, Beatrice; Missale, Gabriele; Balsano, Clara			Focal Adhesion Kinase (FAK) Mediates the Induction of Pro-Oncogenic and Fibrogenic Phenotypes in Hepatitis C Virus (HCV)-Infected Cells	PLOS ONE			English	Article							HCV CORE PROTEIN; HEPATOCELLULAR-CARCINOMA; STELLATE CELLS; LIVER-CANCER; THERAPEUTIC STRATEGIES; VIRAL-HEPATITIS; EXPRESSION; PROLIFERATION; ACTIVATION; MIGRATION	Hepatitis C Virus (HCV) infection is one of the most common etiological factors involved in fibrosis development and its progression to hepatocellular carcinoma (HCC). The pivotal role of hepatic stellate cells (HCSs) and extracellular matrix (ECM) in fibrogenesis is now certainly accepted, while the network of molecular interactions connecting HCV is emerging as a master regulator of several biological processes including proliferation, inflammation, cytoskeleton and ECM remodeling. In this study, the effects of HCV proteins expression on liver cancer cells, both pro-invasive and pro-fibrogenic phenotypes were explored. As a model of HCV infection, we used permissive Huh7.5.1 hepatoma cells infected with JFH1-derived ccHCV. Conditioned medium from these cells was used to stimulate LX-2 cells, a line of HSCs. We found that the HCV infection of Huh7.5.1 cells decreased adhesion, increased migration and caused the delocalization of alpha-actinin from plasma membrane to cytoplasm and increased expression levels of paxillin. The treatment of LX-2 cells, with conditioned medium from HCV-infected Huh7.5.1 cells, caused an increase in cell proliferation, expression of alpha-smooth muscle actin, hyaluronic acid release and apoptosis rate measured as cleaved poly ADP-ribose polymerase (PARP). These effects were accompanied in Huh7.5.1 cells by an HCV-dependent increasing of FAK activation that physically interacts with phosphorylated paxillin and alpha-actinin, and a rising of tumor necrosis factor alpha production/release. Silencing of FAK by siRNA reverted all effects of HCV infection, both those directed on Huh7.5.1 cells, and those indirect effects on the LX-2 cells. Moreover and interestingly, FAK inhibition enhances apoptosis in HCV-conditioned LX-2 cells. In conclusion, our findings demonstrate that HCV, through FAK activation, may promote cytoskeletal reorganization and a pro-oncogenic phenotype in hepatocyte-like cells, and a fibrogenic phenotype in HSCs.	[Alisi, Anna] Bambino Gesu Pediat Hosp, IRCCS, Confocal Microscopy Facil, Liver Res Unit, Rome, Italy; [Arciello, Mario; Conti, Beatrice; Balsano, Clara] Univ Roma La Sapienza, A Cesalpino Fdn, Lab Mol Virol & Oncol, Rome, Italy; [Arciello, Mario; Conti, Beatrice] Univ Aquila, Dept Internal Med, I-67100 Laquila, Italy; [Missale, Gabriele] Azienda Osped Univ Parma, Unit Infect Dis & Hepatol, Parma, Italy; [Balsano, Clara] IBPM, Rome, Italy	IRCCS Bambino Gesu; Sapienza University Rome; University of L'Aquila; University of Parma; University Hospital of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Alisi, A (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Confocal Microscopy Facil, Liver Res Unit, Rome, Italy.	anna.alisi@opbg.net; clara.balsano@uniroma1.it	Balsano, Clara/AAK-9870-2020; Missale, Gabriele/J-6083-2016; Petrini, Stefania/I-1464-2018; Arciello, Mario/G-9278-2016; Alisi, Anna/A-6469-2010	Balsano, Clara/0000-0002-9615-7031; Missale, Gabriele/0000-0001-6691-8701; Petrini, Stefania/0000-0002-3249-0003; Arciello, Mario/0000-0001-8599-6297; Alisi, Anna/0000-0001-7241-6329	A. Cesalpino Foundation; Associazione Italiana Per La Ricerca Sul Cancro (AIRC) Grant	A. Cesalpino Foundation; Associazione Italiana Per La Ricerca Sul Cancro (AIRC) Grant(Fondazione AIRC per la ricerca sul cancro)	This study was supported by A. Cesalpino Foundation, and Associazione Italiana Per La Ricerca Sul Cancro (AIRC) Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2005, J CELL PHYSIOL, V205, P25, DOI 10.1002/jcp.20363; Alisi A, 2003, ONCOGENE, V22, P2573, DOI 10.1038/sj.onc.1206333; Alisi A, 2011, J HEPATOL, V54, P956, DOI 10.1016/j.jhep.2010.08.016; Alisi A, 2009, INT J MOL MED, V24, P319, DOI 10.3892/ijmm_00000235; Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Ariumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014517; Bai XM, 2009, ONCOL REP, V21, P129, DOI 10.3892/or_00000199; Balsano C, 2007, DIG LIVER DIS S1, pS46; Balsano C, 2009, CURR DRUG TARGETS, V10, P505, DOI 10.2174/138945009788488459; Battaglia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004355; Boosani CS, 2009, INVEST OPHTH VIS SCI, V50, P4567, DOI 10.1167/iovs.09-3473; Carloni V, 1997, GASTROENTEROLOGY, V112, P522, DOI 10.1053/gast.1997.v112.pm9024306; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fang CY, 2006, PROTEOMICS, V6, P519, DOI 10.1002/pmic.200500233; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Fujii T, 2004, J HEPATOL, V41, P104, DOI 10.1016/j.jhep.2004.03.029; Giannelli G, 2003, HISTOL HISTOPATHOL, V18, P1267, DOI 10.14670/HH-18.1267; GONZALEZAMARO R, 1994, J EXP MED, V179, P841, DOI 10.1084/jem.179.3.841; Hosomura N, 2011, DIGEST DIS SCI, V56, P1057, DOI 10.1007/s10620-010-1395-y; Itoh S, 2004, CLIN CANCER RES, V10, P2812, DOI 10.1158/1078-0432.CCR-1046-03; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Jiang HQ, 2004, WORLD J GASTROENTERO, V10, P3001; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li HG, 2005, WORLD J GASTROENTERO, V11, P1445; Li JT, 2008, J GASTROENTEROL, V43, P419, DOI 10.1007/s00535-008-2180-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Mehal W, 2010, SEMIN LIVER DIS, V30, P226, DOI 10.1055/s-0030-1255352; Mon NN, 2006, ANN NY ACAD SCI, V1086, P199, DOI 10.1196/annals.1377.019; Neuman MG, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/231210; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Sancho-Bru P, 2010, LIVER INT, V30, P31, DOI 10.1111/j.1478-3231.2009.02161.x; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Talaat RM, 2010, VIRAL IMMUNOL, V23, P151, DOI 10.1089/vim.2009.0089; Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; von Sengbusch A, 2005, AM J PATHOL, V166, P585, DOI 10.1016/S0002-9440(10)62280-8; Wu X Z, 2006, Minerva Gastroenterol Dietol, V52, P407; Wu YM, 2009, CELL BIOL INT, V33, P199, DOI 10.1016/j.cellbi.2008.11.006; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yuan Z, 2010, J CANCER RES CLIN, V136, P1489, DOI 10.1007/s00432-010-0806-y; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	51	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44147	10.1371/journal.pone.0044147	http://dx.doi.org/10.1371/journal.pone.0044147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937161	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600082
J	Fernandez-Caggiano, M; Barallobre-Barreiro, J; Rego-Perez, I; Crespo-Leiro, MG; Paniagua, MJ; Grille, Z; Blanco, FJ; Domenech, N				Fernandez-Caggiano, Mariana; Barallobre-Barreiro, Javier; Rego-Perez, Ignacio; Crespo-Leiro, Maria G.; Jesus Paniagua, Maria; Grille, Zulaika; Blanco, Francisco J.; Domenech, Nieves			Mitochondrial Haplogroups H and J: Risk and Protective Factors for Ischemic Cardiomyopathy	PLOS ONE			English	Article							DEGENERATIVE DISEASES; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; MTDNA VARIATION; DNA; ATHEROSCLEROSIS; ASSOCIATION; CANCER; HYPERTENSION; LONGEVITY	Background: Since mitochondria are the principal source of reactive oxygen species (ROS), these organelles may play an important role in ischemic cardiomyopathy (IC) development. The mitochondrial genome may influence this disease. The aim of the present study was to test the relationship between IC development and the impact of single nucleotide polymorphisms (SNPs) in mitochondrial DNA (mtDNA) defining the mitochondrial haplogroups in a population study. Methodology and principal findings: Ten major European haplogroups were identified by using the single base extension technique and by polymerase chain reaction-restriction fragment length polymorphism. Frequencies and Odds Ratios for the association between IC patients (n = 358) and healthy controls (n = 423) were calculated. No convincing associations between classical risk factors for ischemic cardiomyopathy development and haplogroups were found. However, compared to healthy controls, the prevalence of haplogroup H was significantly higher in IC patients (40.0% vs 50.0%, p-value = 0.039) while the frequency of haplogroup J was significantly lower (11.1% vs 5.6%, p-value = 0.048). The analysis of the SNPs characterizing the European mtDNA haplogroups showed that the m. 7028C allele (40.0% vs 50.0%, p-value = 0.005) and m. 14766C allele (43.0% vs 54.2%, p-value = 0.002) were overrepresented in IC patients, meanwhile the m. 10398G allele (19.8% vs 13.1%, p-value = 0.015) and m. 4216C allele (22.2% vs 16.5%, p-value = 0.044) were found as protective factors against IC. Conclusions and significance: Our results showed that the haplogroups H and J were found as a risk and protective factors for ischemic cardiomyopathy development, respectively.	[Fernandez-Caggiano, Mariana; Barallobre-Barreiro, Javier; Domenech, Nieves] INIBIC Complejo Hosp Univ A Coruna, Cardiac Biomarkers Grp, Res Unit, La Coruna, Spain; [Rego-Perez, Ignacio; Blanco, Francisco J.] INIBIC Complejo Hosp Univ A Coruna, Genom Lab, Div Rheumatol, La Coruna, Spain; [Crespo-Leiro, Maria G.; Jesus Paniagua, Maria; Grille, Zulaika] INIBIC Complejo Hosp Univ A Coruna, Dept Cardiol, Adv Heart Failure & Heart Transplant Unit, La Coruna, Spain; [Crespo-Leiro, Maria G.; Jesus Paniagua, Maria; Grille, Zulaika] Inst Salud Carlos III, Spanish Cardiovasc Res Network RECAVA, Madrid, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Instituto de Salud Carlos III	Fernandez-Caggiano, M (corresponding author), INIBIC Complejo Hosp Univ A Coruna, Cardiac Biomarkers Grp, Res Unit, La Coruna, Spain.	nieves.domenech.garcia@sergas.es	; DOMENECH, NIEVES/E-5812-2012; Blanco Garcia, Francisco J/C-3192-2014; Rego-Perez, Ignacio/B-1665-2012	Fernandez-Caggiano, Mariana/0000-0001-5180-0866; DOMENECH, NIEVES/0000-0002-2056-9400; Barallobre-Barreiro, Javier/0000-0001-6236-2304; Blanco Garcia, Francisco J/0000-0001-9821-7635; Crespo-Leiro, Maria Generosa/0000-0002-3085-167X; Rego-Perez, Ignacio/0000-0003-1754-1164	Fondo de Investigacion Sanitaria [PS09/00840]; Conselleria de Educacion	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Conselleria de Educacion	The work described in this manuscript was supported by grants from Fondo de Investigacion Sanitaria-PS09/00840. Contrato Maria Barbeito from Conselleria de Educacion supported MFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Beckstead WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005836; Benn M, 2008, CIRCULATION, V117, P2492, DOI 10.1161/CIRCULATIONAHA.107.756809; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cai XY, 2009, PLOS ONE, V29, p4(7); Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421; Gallardo ME, 2012, EUR HEART J, V33, P346, DOI 10.1093/eurheartj/ehr280; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; Kobayashi S, 2003, ARTERIOSCL THROM VAS, V23, P1398, DOI 10.1161/01.ATV.0000081637.36475.BC; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; Kondo T, 2009, J ATHEROSCLER THROMB, V16, P532, DOI 10.5551/jat.1255; Li XY, 2011, MITOCHONDRION, V11, P27, DOI 10.1016/j.mito.2010.06.005; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mozaffari MS, 2003, HYPERTENSION, V42, P1042, DOI 10.1161/01.HYP.0000095614.91961.40; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Nishigaki Y, 2007, HUM GENET, V120, P827, DOI 10.1007/s00439-006-0269-z; Palacin M, 2011, MITOCHONDRION, V11, P176, DOI 10.1016/j.mito.2010.09.004; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Radford Martha J, 2005, Circulation, V112, P1888, DOI 10.1161/CIRCULATIONAHA.105.170073; Rego I, 2010, ANN RHEUM DIS, V69, P210, DOI 10.1136/ard.2008.105254; Rego-Perez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659; Rosa A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-57; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Santoro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012037; Sawabe M, 2011, J ATHEROSCLER THROMB, V18, P166, DOI 10.5551/jat.6742; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Torroni A, 1996, GENETICS, V144, P1835; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	42	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44128	10.1371/journal.pone.0044128	http://dx.doi.org/10.1371/journal.pone.0044128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937160	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600081
J	Kuypers, KPC; Legrand, SA; Ramaekers, JG; Verstraete, AG				Kuypers, Kim Paula Colette; Legrand, Sara-Ann; Ramaekers, Johannes Gerardus; Verstraete, Alain Gaston			A Case-Control Study Estimating Accident Risk for Alcohol, Medicines and Illegal Drugs	PLOS ONE			English	Article							ORAL FLUID; CANNABIS; DRIVERS; CRASHES	Background: The aim of the present study was to assess the risk of having a traffic accident after using alcohol, single drugs, or a combination, and to determine the concentrations at which this risk is significantly increased. Methods: A population-based case-control study was carried out, collecting whole blood samples of both cases and controls, in which a number of drugs were detected. The risk of having an accident when under the influence of drugs was estimated using logistic regression adjusting for gender, age and time period of accident (cases)/sampling (controls). The main outcome measures were odds ratio (OR) for accident risk associated with single and multiple drug use. In total, 337 cases (negative: 176; positive: 161) and 2726 controls (negative: 2425; positive: 301) were included in the study. Results: Main findings were that 1) alcohol in general (all the concentrations together) caused an elevated crash risk; 2) cannabis in general also caused an increase in accident risk; at a cut-off of 2 ng/mL THC the risk of having an accident was four times the risk associated with the lowest THC concentrations; 3) when ranking the adjusted OR from lowest to highest risk, alcohol alone or in combination with other drugs was related to a very elevated crash risk, with the highest risk for stimulants combined with sedatives. Conclusion: The study demonstrated a concentration-dependent crash risk for THC positive drivers. Alcohol and alcohol-drug combinations are by far the most prevalent substances in drivers and subsequently pose the largest risk in traffic, both in terms of risk and scope.	[Kuypers, Kim Paula Colette; Ramaekers, Johannes Gerardus] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Kuypers, Kim Paula Colette; Legrand, Sara-Ann; Verstraete, Alain Gaston] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	Maastricht University; Ghent University	Kuypers, KPC (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands.	k.kuypers@maastrichtuniversity.nl	Kuypers, Kim/L-1206-2019; Verstraete, Alain G/B-4150-2013	Kuypers, Kim/0000-0001-7634-3809; Verstraete, Alain G/0000-0002-0956-3315	European Commission within EU	European Commission within EU	This article has been produced under the project Driving Under Influence of Drugs, Alcohol and Medicines (DRUID, www.druid-project.eu) financed by the European Commission within the framework of the EU 6th Framework Program. This report reflects only the authors' view. The European commission is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AAAM, 2008, INT INJ SCAL; Blomberg RD, 2005, CRASH RISK ALCOHOL I; Borkenstein R.F., 1974, BLUTALKOHOL, V11, P1; Brookhuis K, 1998, HUM PSYCHOPHARM CLIN, V13, pS64; Charlier C, 1998, Rev Med Liege, V53, P25; Dassanayake T, 2011, DRUG SAFETY, V34, P125, DOI 10.2165/11539050-000000000-00000; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Drummer Olaf H., 2009, P93, DOI 10.1007/978-3-7643-9923-8_7; EMCDDA, 2007, SEL ISS 2007 DRUGS D; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Gjerde H, 2011, ACCIDENT ANAL PREV, V43, P1197, DOI 10.1016/j.aap.2010.12.034; Gjerde H, 2010, FORENSIC SCI INT, V195, P153, DOI 10.1016/j.forsciint.2009.12.011; Houwing S., 2011, PREVALENCE ALCOHOL 1; Houwing Sjoerd, 2009, P107, DOI 10.1007/978-3-7643-9923-8_8; Isalberti C., 2011, PREVALENCE ALCOHOL O; Khiabani Hassan Z, 2006, Traffic Inj Prev, V7, P111, DOI 10.1080/15389580600550172; Kruger HP, 2004, ACCIDENT ANAL PREV, V36, P125, DOI 10.1016/S0001-4575(02)00134-3; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Moskowitz H, 2002, REV EXPT STUDIES LOW, P4; Movig KLL, 2004, ACCIDENT ANAL PREV, V36, P631, DOI 10.1016/S0001-4575(03)00084-8; Mura P, 2003, FORENSIC SCI INT, V133, P79, DOI 10.1016/S0379-0738(03)00052-5; Nemes S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-56; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Raes E, 2008, FORENSIC SCI HDB ANA, P646; Ramaekers JG, 2006, DRUG ALCOHOL DEPEN, V85, P114, DOI 10.1016/j.drugalcdep.2006.03.015; Ramaekers JG, 2004, DRUG ALCOHOL DEPEN, V73, P109, DOI 10.1016/j.drugalcdep.2003.10.008; Romano E, 2011, J STUD ALCOHOL DRUGS, V72, P567, DOI 10.15288/jsad.2011.72.567; Wille SMR, 2009, THER DRUG MONIT, V31, P511, DOI 10.1097/FTD.0b013e3181ae46ea; Woratanarat P, 2009, ACCIDENT ANAL PREV, V41, P651, DOI 10.1016/j.aap.2009.03.002	30	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43496	10.1371/journal.pone.0043496	http://dx.doi.org/10.1371/journal.pone.0043496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22952694	gold, Green Published			2022-12-27	WOS:000308213600028
J	Bargaje, R; Gupta, S; Sarkeshik, A; Park, R; Xu, T; Sarkar, M; Halimani, M; Roy, SS; Yates, J; Pillai, B				Bargaje, Rhishikesh; Gupta, Shivani; Sarkeshik, Ali; Park, Robin; Xu, Tao; Sarkar, Maharnob; Halimani, Mahantappa; Roy, Soumya Sinha; Yates, John; Pillai, Beena			Identification of Novel Targets for miR-29a Using miRNA Proteomics	PLOS ONE			English	Article							TANDEM MASS-SPECTRA; TUMOR-SUPPRESSOR; MICRORNA TARGETS; DOWN-REGULATION; MIR-34 FAMILY; GENE LISTS; PROTEIN; CANCER; APOPTOSIS; EXPRESSION	MicroRNAs (miRNAs) are short regulatory RNA molecules that interfere with the expression of target mRNA by binding to complementary sequences. Currently, the most common method for identification of targets of miRNAs is computational prediction based on free energy change calculations, target site accessibility and conservation. Such algorithms predict hundreds of targets for each miRNA, necessitating tedious experimentation to identify the few functional targets. Here we explore the utility of miRNA-proteomics as an approach to identifying functional miRNA targets. We used Stable Isotope Labeling by amino acids in cell culture (SILAC) based proteomics to detect differences in protein expression induced by the over-expression of miR-34a and miR-29a. Over-expression of miR-29a, a miRNA expressed in the brain and in cells of the blood lineage, resulted in the differential expression of a set of proteins. Gene Ontology based classification showed that a significant sub-set of these targets, including Voltage Dependent Anion Channel 1 and 2 (VDAC1 and VDAC2) and ATP synthetase, were mitochondrial proteins involved in apoptosis. Using reporter assays, we established that miR-29a targets the 39 Untranslated Regions (39 UTR) of VDAC1 and VDAC2. However, due to the limited number of proteins identified using this approach and the inability to differentiate between primary and secondary effects we conclude that miRNA-proteomics is of limited utility as a high-throughput alternative for sensitive and unbiased miRNA target identification. However, this approach was valuable for rapid assessment of the impact of the miRNAs on the cellular proteome and its biological role in apoptosis.	[Bargaje, Rhishikesh; Gupta, Shivani; Sarkar, Maharnob; Halimani, Mahantappa; Roy, Soumya Sinha; Pillai, Beena] Inst Genom & Integrat Biol, Funct Genom Unit, Council Sci Ind Res, Delhi, India; [Sarkeshik, Ali; Park, Robin; Xu, Tao; Yates, John] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Scripps Research Institute	Bargaje, R (corresponding author), Inst Genom & Integrat Biol, Funct Genom Unit, Council Sci Ind Res, Delhi, India.	jyates@scripps.edu; beena@igib.in		Sinha Roy, Soumya/0000-0002-4135-0141; Pillai, Beena/0000-0002-9302-9878	Council of Scientific and Industrial Research, India, "Cutting Edge Technology Network on Proteomics" of ISTAD, CSIR, and Comparative genomics and biology of Non-coding RNA in the human genome [NWP0036]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	Council of Scientific and Industrial Research, India, "Cutting Edge Technology Network on Proteomics" of ISTAD, CSIR, and Comparative genomics and biology of Non-coding RNA in the human genome; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Council of Scientific and Industrial Research, India, "Cutting Edge Technology Network on Proteomics" of ISTAD, CSIR, and Comparative genomics and biology of Non-coding RNA in the human genome (NWP0036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beitzinger M, 2011, METHODS MOL BIOL, V732, P153, DOI 10.1007/978-1-61779-083-6_12; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen QR, 2011, J PROTEOME RES, V10, P479, DOI 10.1021/pr1006697; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; Cora D, 2011, PLOS ONE, V6; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Ferdin J, 2010, TECHNOL CANCER RES T, V9, P123, DOI 10.1177/153303461000900202; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jovanovic M, 2010, NAT METHODS, V7, P837, DOI [10.1038/NMETH.1504, 10.1038/nmeth.1504]; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li XH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-44; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Park SK, 2010, CURR PROTOC BIOINFOR, DOI 10.1002/0471250953.bi1312s29; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Roshan R, 2012, RNA BIOL, V9, P891, DOI 10.4161/rna.19876; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wen JY, 2011, RNA, V17, P820, DOI 10.1261/rna.2387911; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yan GR, 2011, PROTEOMICS, V11, P912, DOI 10.1002/pmic.201000539; Yang Y, 2010, MOL BIOSYST, V6, P1873, DOI 10.1039/c004401f; Yang Y, 2009, PROTEOMICS, V9, P1374, DOI 10.1002/pmic.200800551; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356	66	40	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43243	10.1371/journal.pone.0043243	http://dx.doi.org/10.1371/journal.pone.0043243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952654	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800024
J	Knops, JMH; Koenig, WD				Knops, Johannes M. H.; Koenig, Walter D.			Sex Allocation in California Oaks: Trade-Offs or Resource Tracking?	PLOS ONE			English	Article							LIFE-HISTORY; VALLEY OAK; QUERCUS-LOBATA; SIZE; REPRODUCTION; GROWTH; PLANTS; EVOLUTION; RATIO; POPULATION	Trade-offs in sex resource allocation are commonly inferred from a negative correlation between male and female reproduction. We found that for three California oak species, aboveground annual net productivity (ANP) differences among individuals were primarily correlated with water availability and soil fertility. Reproductive biomass increased with ANP, but the relative allocation to reproduction was constant, indicating that reproduction tracked productivity, which in turn tracked site quality. Although there was a negative correlation between male and female reproduction, this was not the result of a resource investment trade-off, but rather a byproduct of the positive correlation between female reproductive biomass and ANP combined with the greater overall resource allocation to female, compared to male, function. Thus, we reject the hypothesis of a trade-off between these key life-history components within individuals of these species. For long-lived individuals, a plastic resource tracking response to environmental fluctuations may be more adaptive than directly linking life-history traits through trade-offs.	[Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA; [Koenig, Walter D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Koenig, Walter D.] Cornell Univ, Ornithol Lab, Ithaca, NY USA	University of Nebraska System; University of Nebraska Lincoln; Cornell University; Cornell University	Knops, JMH (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.	jknops2@unl.edu	Knops, Johannes/AAA-8546-2020	Koenig, Walter/0000-0001-6207-1427	University of California's Integrated Hardwoods Range Management Program; National Science Foundation [DEB-0816691]; Direct For Biological Sciences [0816691] Funding Source: National Science Foundation	University of California's Integrated Hardwoods Range Management Program; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Data collection was supported by the University of California's Integrated Hardwoods Range Management Program and National Science Foundation grant DEB-0816691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no other external funding sources for this study.	Abraham ST, 2011, INT J PLANT SCI, V172, P691, DOI 10.1086/659646; ASHMAN TL, 1994, AM NAT, V144, P300, DOI 10.1086/285676; Barrett SCH, 1998, TRENDS PLANT SCI, V3, P335, DOI 10.1016/S1360-1385(98)01299-0; Barringer BC, 2012, OECOLOGIA IN PRESS; BURD M, 1988, EVOLUTION, V42, P403, DOI 10.2307/2409245; Campbell DR, 2000, TRENDS ECOL EVOL, V15, P227, DOI 10.1016/S0169-5347(00)01872-3; Cattelino P. J., 1986, Northern Journal of Applied Forestry, V3, P73; CHARNOV E L, 1982; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; DEJONG G, 1993, FUNCT ECOL, V7, P75, DOI 10.2307/2389869; DEJONG TJ, 1994, J ECOL, V82, P399, DOI 10.2307/2261307; Dorken ME, 2008, AM NAT, V171, P828; Dow BD, 1998, J HERED, V89, P62, DOI 10.1093/jhered/89.1.62; FOX JF, 1991, ECOLOGY, V72, P1013, DOI 10.2307/1940601; FREEMAN DC, 1976, SCIENCE, V193, P597, DOI 10.1126/science.193.4253.597; FREEMAN DC, 1980, OECOLOGIA, V47, P222, DOI 10.1007/BF00346825; FREEMAN DC, 1981, EVOLUTION, V35, P194, DOI 10.1111/j.1558-5646.1981.tb04875.x; Friedman J, 2011, EVOLUTION, V65, P2061, DOI 10.1111/j.1558-5646.2011.01284.x; Galen C, 2000, AM NAT, V156, P72, DOI 10.1086/303373; Guillon JM, 2006, J EVOLUTION BIOL, V19, P500, DOI 10.1111/j.1420-9101.2005.01012.x; HAYNES RJ, 1980, COMMUN SOIL SCI PLAN, V11, P459, DOI 10.1080/00103628009367053; Hesse E, 2011, ANN BOT-LONDON, V107, P1039, DOI 10.1093/aob/mcr046; HORVITZ CC, 1988, ECOLOGY, V69, P1741, DOI 10.2307/1941152; Hulshof CM, 2012, ECOLOGY, V93, P180, DOI 10.1890/11-0740.1; Ishida TA, 2005, J PLANT RES, V118, P193, DOI 10.1007/s10265-005-0206-6; Kazuhiko M, 2007, AM J BOT, V94, P1450, DOI 10.3732/ajb.94.9.1450; Klinkhamer PGL, 1997, TRENDS ECOL EVOL, V12, P260, DOI 10.1016/S0169-5347(97)01078-1; Knops J. M., 1994, MADRONO, V41, P290; Knops JMH, 1996, ECOL MONOGR, V66, P159, DOI 10.2307/2963473; Knops JMH, 1997, PLANT ECOL, V130, P121, DOI 10.1023/A:1009798327200; Knops Johannes M. H., 2000, Madrono, V47, P106; Knops JMH, 2007, P NATL ACAD SCI USA, V104, P16982, DOI 10.1073/pnas.0704251104; Koenig WD, 2009, AM NAT, V173, P682, DOI 10.1086/597605; Koenig WD, 2005, AM SCI, V93, P340, DOI 10.1511/2005.54.970; Koenig WD, 2003, TRENDS ECOL EVOL, V18, P157, DOI 10.1016/S0169-5347(03)00034-X; KOENIG WD, 1994, ECOLOGY, V75, P99, DOI 10.2307/1939386; LINHART YB, 1985, AM J BOT, V72, P181, DOI 10.2307/2443545; LLOYD DG, 1980, NEW PHYTOL, V86, P69, DOI 10.1111/j.1469-8137.1980.tb00780.x; LLOYD DG, 1984, EVOL BIOL, V17, P255; LOWTHER JR, 1980, COMMUN SOIL SCI PLAN, V11, P175, DOI 10.1080/00103628009367026; Masaka K, 2006, J THEOR BIOL, V240, P114, DOI 10.1016/j.jtbi.2005.09.001; Ne'eman G, 2011, ANN BOT-LONDON, V108, P197, DOI 10.1093/aob/mcr104; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Pillsbury NH, 1978, HARWOOD VOLUME WEIGH; Reekie EG, 1987, AM NAT, V129, P987; Sakai A, 2003, J THEOR BIOL, V222, P283, DOI 10.1016/S0022-5193(03)00024-9; SAMSON DA, 1986, AM NAT, V127, P667, DOI 10.1086/284512; Sarkissian TS, 2001, ECOLOGY, V82, P360, DOI 10.1890/0012-9658(2001)082[0360:GVISLA]2.0.CO;2; Satake A, 2000, J THEOR BIOL, V203, P63, DOI 10.1006/jtbi.1999.1066; Satake A, 2002, ECOLOGY, V83, P993, DOI 10.1890/0012-9658(2002)083[0993:SLPEAA]2.0.CO;2; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; SOLOMON BP, 1989, AM MIDL NAT, V121, P209, DOI 10.2307/2426024; Sork VL, 2002, MOL ECOL, V11, P1657, DOI 10.1046/j.1365-294X.2002.01574.x; SORK VL, 2002, 5 S OAK WOODL OAKS C, P427; Stearns S.C., 1992, pi; Stehlik I, 2008, P NATL ACAD SCI USA, V105, P10847, DOI 10.1073/pnas.0801964105; TRAVESET A, 1992, AM MIDL NAT, V127, P309, DOI 10.2307/2426537; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; WOLF B, 1982, COMMUN SOIL SCI PLAN, V13, P1035, DOI 10.1080/00103628209367332; Yasumura Y, 2006, FOREST ECOL MANAG, V229, P228, DOI 10.1016/j.foreco.2006.04.003; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zhang D.-Y., 2006, ECOLOGY EVOLUTION FL, P41, DOI DOI 10.1034/J.1600-0706.2001.950118.X; Zhang DY, 2002, J EVOLUTION BIOL, V15, P74, DOI 10.1046/j.1420-9101.2002.00369.x	63	11	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43492	10.1371/journal.pone.0043492	http://dx.doi.org/10.1371/journal.pone.0043492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952692	gold, Green Published			2022-12-27	WOS:000308044800033
J	Liu, J; Chen, M; Li, R; Yang, F; Shi, XR; Zhu, LC; Wang, HM; Yao, W; Liu, QJ; Meng, FG; Sun, JP; Pang, Q; Yu, X				Liu, Jing; Chen, Ming; Li, Rong; Yang, Fan; Shi, Xuanren; Zhu, Lichao; Wang, Hong-Mei; Yao, Wei; Liu, Qiji; Meng, Fan-Guo; Sun, Jin-Peng; Pang, Qi; Yu, Xiao			Biochemical and Functional Studies of Lymphoid-Specific Tyrosine Phosphatase (Lyp) Variants S201F and R266W	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROTEIN-KINASE P50(CSK); OF-FUNCTION VARIANT; PTPN22; RECEPTOR; ASSOCIATION; POLYMORPHISM; CELLS; IDENTIFICATION; ACTIVATION	The Lymphoid specific tyrosine phosphatase (Lyp) has elicited tremendous research interest due to the high risk of its missense mutation R620W in a wide spectrum of autoimmune diseases. While initially characterized as a gain-of-function mutant, R620W was thought to lead to autoimmune diseases through loss-of-function in T cell signaling by a recent study. Here we investigate the biochemical characters and T cell signaling functions of two uncharacterized Lyp variants S201F and R266W, together with a previously characterized Lyp variant R263Q, which had reduced risk in several autoimmune diseases, including systemic lupus erythematosus (SLE), ulcerative colitis (UC) and rheumatoid arthritis (RA). Our kinetic and functional studies of R263Q polymorphism basically reproduced previous findings that it was a loss-of-function mutant. The other variant S201F reduced Lyp phosphatase activity moderately and decreased Lyp function in T cell slightly, while R266W severely impaired phosphatase activity and was a loss-of-function variant in T cell signaling. A combined kinetic and structure analysis suggests that the R266W variant may decrease its phosphatase activity through perturbing either the Q-loop or the WPD loop of Lyp. As both R266W and R263Q significantly change their phosphatase activity and T cell functions, future work could be considered to evaluate these mutants in a broader spectrum of autoimmune diseases.	[Liu, Jing; Li, Rong; Yang, Fan; Shi, Xuanren; Zhu, Lichao; Wang, Hong-Mei; Yao, Wei; Liu, Qiji; Sun, Jin-Peng; Yu, Xiao] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China; [Chen, Ming] 309th Hosp PLA, Beijing, Peoples R China; [Meng, Fan-Guo] Tsinghua Univ, Yangtze Delta Reg Inst, Hangzhou, Zhejiang, Peoples R China; [Sun, Jin-Peng; Pang, Qi] Shandong Univ, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Tsinghua University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Liu, J (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China.	pangqi@sdu.edu.cn; yuxiao@sdu.edu.cn	SUN, JINPENG/F-9551-2013; wang, hongmei/HGT-7374-2022; sun, Jinpeng/AAR-9196-2020	wang, hongmei/0000-0002-6975-9467; Yu, Xiao/0000-0003-1119-8334; Pang, Qi/0000-0001-8333-5647	National Natural Science Foundation of China [31000362, 31100580]; Foundation for Excellent Young Scientists of Shandong University [2010JQ014]; "Eleventh Five-year Plan" for Medical Science Development of PLA [10MA017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scientists of Shandong University; "Eleventh Five-year Plan" for Medical Science Development of PLA	This work was supported by grants from the National Natural Science Foundation of China (31000362, 31100580), the Foundation for Excellent Young Scientists of Shandong University (2010JQ014), and the "Eleventh Five-year Plan" for Medical Science Development of PLA (10MA017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Diaz-Gallo LM, 2011, INFLAMM BOWEL DIS, V17, P2287, DOI 10.1002/ibd.21630; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Keng YF, 1999, EUR J BIOCHEM, V259, P809, DOI 10.1046/j.1432-1327.1999.00090.x; Kleppe M, 2011, BLOOD, V117, P7090, DOI 10.1182/blood-2010-10-314286; Kosco KA, 2008, MOL IMMUNOL, V45, P510, DOI 10.1016/j.molimm.2007.05.024; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lamsyah H, 2009, TISSUE ANTIGENS, V74, P228, DOI 10.1111/j.1399-0039.2009.01304.x; Lea WW, 2011, LUPUS, V20, P51, DOI 10.1177/0961203310381774; Maziarz M, 2010, GENES IMMUN, V11, P406, DOI 10.1038/gene.2010.12; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Pedersen AK, 2004, BIOCHEM J, V378, P421, DOI 10.1042/BJ20030565; Rodriguez-Rodriguez L, 2011, ARTHRITIS RHEUM-US, V63, P365, DOI 10.1002/art.30145; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Totaro MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024292; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Wang WQ, 2004, J BIOL CHEM, V279, P30459, DOI 10.1074/jbc.M402217200; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Yu X, 2011, J BIOL CHEM, V286, P30526, DOI 10.1074/jbc.M111.254722; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang YL, 1999, BIOCHEMISTRY-US, V38, P12111, DOI 10.1021/bi990836i; Zhang ZY, 2003, PROG NUCLEIC ACID RE, V73, P171, DOI 10.1016/S0079-6603(03)01006-7; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624; Zhu JW, 2011, IMMUNITY, V35, P757, DOI 10.1016/j.immuni.2011.09.011	41	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43631	10.1371/journal.pone.0043631	http://dx.doi.org/10.1371/journal.pone.0043631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952725	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800047
J	Treas, JN; Tyagi, T; Singh, KP				Treas, Justin N.; Tyagi, Tulika; Singh, Kamaleshwar P.			Effects of Chronic Exposure to Arsenic and Estrogen on Epigenetic Regulatory Genes Expression and Epigenetic Code in Human Prostate Epithelial Cells	PLOS ONE			English	Article							HISTONE MODIFICATION PATTERNS; DNA METHYLATION; TRANSCRIPTIONAL ACTIVATION; CANCER; METHYLTRANSFERASE; HYPERMETHYLATION; IDENTIFICATION; TUMORIGENESIS; ACETYLATION; DIAGNOSIS	Chronic exposures to arsenic and estrogen are known risk factors for prostate cancer. Though the evidence suggests that exposure to arsenic or estrogens can disrupt normal DNA methylation patterns and histone modifications, the mechanisms by which these chemicals induce epigenetic changes are not fully understood. Moreover, the epigenetic effects of co-exposure to these two chemicals are not known. Therefore, the objective of this study was to evaluate the effects of chronic exposure to arsenic and estrogen, both alone and in combination, on the expression of epigenetic regulatory genes, their consequences on DNA methylation, and histone modifications. Human prostate epithelial cells, RWPE-1, chronically exposed to arsenic and estrogen alone and in combination were used for analysis of epigenetic regulatory genes expression, global DNA methylation changes, and histone modifications at protein level. The result of this study revealed that exposure to arsenic, estrogen, and their combination alters the expression of epigenetic regulatory genes and changes global DNA methylation and histone modification patterns in RWPE-1 cells. These changes were significantly greater in arsenic and estrogen combination treated group than individually treated group. The findings of this study will help explain the epigenetic mechanism of arsenic- and/or estrogen-induced prostate carcinogenesis.	[Treas, Justin N.; Tyagi, Tulika; Singh, Kamaleshwar P.] Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth TIEHH, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Treas, JN (corresponding author), Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth TIEHH, Lubbock, TX 79409 USA.	kamaleshwar.singh@TIEHH.TTU.edu	Singh, Kamaleshwar Prasad/AAE-9166-2020					Albany C, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/580318; Aoyama T, 2008, BIOCHEM BIOPH RES CO, V365, P124, DOI 10.1016/j.bbrc.2007.10.135; Ayotte JD, 2003, ENVIRON SCI TECHNOL, V37, P2075, DOI 10.1021/es026211g; Barman HK, 2008, BIOCHEM BIOPH RES CO, V373, P624, DOI 10.1016/j.bbrc.2008.06.100; Benbrahim-Tallaa L, 2005, TOXICOL APPL PHARM, V206, P288, DOI 10.1016/j.taap.2004.11.017; Benbrahim-Tallaa L, 2008, ENVIRON HEALTH PERSP, V116, P158, DOI 10.1289/ehp.10423; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chai CY, 2007, TOXICOL LETT, V173, P48, DOI 10.1016/j.toxlet.2007.06.006; Chanda S, 2006, TOXICOL SCI, V89, P431, DOI 10.1093/toxsci/kfj030; CHEN CJ, 1990, CANCER RES, V50, P5470; Chen H, 2004, CARCINOGENESIS, V25, P1779, DOI 10.1093/carcin/bgh161; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cooper CS, 2009, BRIT J CANCER, V100, P240, DOI 10.1038/sj.bjc.6604771; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Cui X, 2006, HUM PATHOL, V37, P298, DOI 10.1016/j.humpath.2005.10.013; Deng T, 2009, BIOCHEM BIOPH RES CO, V387, P611, DOI 10.1016/j.bbrc.2009.07.093; Dobosy JR, 2007, J UROLOGY, V177, P822, DOI 10.1016/j.juro.2006.10.063; Espada J, 2004, J BIOL CHEM, V279, P37175, DOI 10.1074/jbc.M404842200; Fukushige S, 2008, BIOCHEM BIOPH RES CO, V377, P600, DOI 10.1016/j.bbrc.2008.10.016; Gonzalgo ML, 1997, CANCER RES, V57, P594; GRAFF JR, 1995, CANCER RES, V55, P5195; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Henckel A, 2009, HUM MOL GENET, V18, P3375, DOI 10.1093/hmg/ddp277; Hu WY, 2011, ENDOCRINOLOGY, V152, P2150, DOI 10.1210/en.2010-1377; IARC (International Agency for Research on Cancer), 2004, IARC MONOGR EVAL CAR, V84, P39; Jensen TJ, 2009, TOXICOL APPL PHARM, V235, P39, DOI 10.1016/j.taap.2008.10.013; Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kapaj S, 2006, J ENVIRON SCI HEAL A, V41, P2399, DOI 10.1080/10934520600873571; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Li LC, 2005, JNCI-J NATL CANCER I, V97, P103, DOI 10.1093/jnci/dji010; Liang GG, 2002, METHODS, V27, P150, DOI 10.1016/S1046-2023(02)00068-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Patra SK, 2003, BIOCHEM BIOPH RES CO, V302, P759, DOI 10.1016/S0006-291X(03)00253-5; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Ramirez T, 2008, CHROMOSOMA, V117, P147, DOI 10.1007/s00412-007-0133-5; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Ruzov A, 2009, DEVELOPMENT, V136, P2277, DOI 10.1242/dev.032227; Sansom OJ, 2003, ONCOGENE, V22, P7130, DOI 10.1038/sj.onc.1206850; Schulz WA, 2009, SEMIN CANCER BIOL, V19, P172, DOI 10.1016/j.semcancer.2009.02.006; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Singh KP, 2011, CHEM RES TOXICOL, V24, P340, DOI 10.1021/tx1003112; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102; Tokar EJ, 2011, TOXICOL SCI, V120, pS192, DOI 10.1093/toxsci/kfq342; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Waalkes MP, 2004, JNCI-J NATL CANCER I, V96, P466, DOI 10.1093/jnci/djh070; Walton TJ, 2008, PROSTATE, V68, P210, DOI 10.1002/pros.20673; Wong YC, 2003, INT REV CYTOL, V227, P65, DOI 10.1016/S0074-7696(03)01008-8; Woodson K, 2003, PROSTATE, V55, P199, DOI 10.1002/pros.10236; Xiong YN, 2005, GYNECOL ONCOL, V96, P601, DOI 10.1016/j.ygyno.2004.11.047; Yamagata Y, 2009, HUM REPROD, V24, P1126, DOI 10.1093/humrep/dep015; Yao S, 2011, CANCER CAUSE CONTROL, V22, P1121, DOI 10.1007/s10552-011-9787-7; Yu S, 2011, CANCER LETT, V304, P8, DOI 10.1016/j.canlet.2011.01.003; Zhang H, 2012, J BIOL CHEM, V287, P6573, DOI 10.1074/jbc.M111.312637	60	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43880	10.1371/journal.pone.0043880	http://dx.doi.org/10.1371/journal.pone.0043880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952798	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800071
J	Catalogna, M; Cohen, E; Fishman, S; Halpern, Z; Nevo, U; Ben-Jacob, E				Catalogna, Merav; Cohen, Eyal; Fishman, Sigal; Halpern, Zamir; Nevo, Uri; Ben-Jacob, Eshel			Artificial Neural Networks Based Controller for Glucose Monitoring during Clamp Test	PLOS ONE			English	Article							FEEDFORWARD NETWORKS; DECISION-SUPPORT; ALGORITHM; METABOLISM; MODEL; PREDICTION; RESISTANCE; ENSEMBLE	Insulin resistance (IR) is one of the most widespread health problems in modern times. The gold standard for quantification of IR is the hyperinsulinemic-euglycemic glucose clamp technique. During the test, a regulated glucose infusion is delivered intravenously to maintain a constant blood glucose concentration. Current control algorithms for regulating this glucose infusion are based on feedback control. These models require frequent sampling of blood, and can only partly capture the complexity associated with regulation of glucose. Here we present an improved clamp control algorithm which is motivated by the stochastic nature of glucose kinetics, while using the minimal need in blood samples required for evaluation of IR. A glucose pump control algorithm, based on artificial neural networks model was developed. The system was trained with a data base collected from 62 rat model experiments, using a back-propagation Levenberg-Marquardt optimization. Genetic algorithm was used to optimize network topology and learning features. The predictive value of the proposed algorithm during the temporal period of interest was significantly improved relative to a feedback control applied at an equivalent low sampling interval. Robustness to noise analysis demonstrates the applicability of the algorithm in realistic situations.	[Catalogna, Merav; Nevo, Uri] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel; [Cohen, Eyal] HEMDA, Ctr Sci Educ, Tel Aviv, Israel; [Fishman, Sigal; Halpern, Zamir] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol & Hepatol, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University	Catalogna, M (corresponding author), Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.	eshel@tamar.tau.ac.il			Maugy-Glass Chair in Physics of Complex Systems; Tauber Family Foundation at Tel-Aviv University; Colton Family Foundation; FP7 (IRG) program	Maugy-Glass Chair in Physics of Complex Systems; Tauber Family Foundation at Tel-Aviv University; Colton Family Foundation; FP7 (IRG) program	This research has been supported in part by the Maugy-Glass Chair in Physics of Complex Systems and the Tauber Family Foundation at Tel-Aviv University. UN is supported by the Colton Family Foundation and the FP7 (IRG) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fahoum AS, 1999, MED BIOL ENG COMPUT, V37, P566, DOI 10.1007/BF02513350; Ambrosiadou BV, 1996, MED INFORM, V21, P23, DOI 10.3109/14639239609009008; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Andrianasy F, 1997, APPL NEURAL NETWORKS, P182; Ao SI, 2011, APPL SOFT COMPUT, V11, P1718, DOI 10.1016/j.asoc.2010.05.014; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Ben-Shlomo S, 2012, OBESITY, V20, P151, DOI 10.1038/oby.2011.261; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Bequette B Wayne, 2009, J Diabetes Sci Technol, V3, P1005; CLEMENS AH, 1982, CLIN CHEM, V28, P1899; Damour C, 2010, J FOOD ENG, V99, P225, DOI 10.1016/j.jfoodeng.2010.02.027; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; FURLER SM, 1986, MED BIOL ENG COMPUT, V24, P365, DOI 10.1007/BF02442689; HAGAN MT, 1994, IEEE T NEURAL NETWOR, V5, P989, DOI 10.1109/72.329697; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Leung FHF, 2003, IEEE T NEURAL NETWOR, V14, P79, DOI 10.1109/TNN.2002.804317; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; Montana D. J., 1989, P 11 INT JOINT C ART, V1; Mougiakakou SG, 2005, P ANN INT IEEE EMBS, P298, DOI 10.1109/IEMBS.2005.1616403; Naftaly U, 1997, NETWORK-COMP NEURAL, V8, P283, DOI 10.1088/0954-898X/8/3/004; Nguyen HT, 2008, DIABETES, V57, pA122; PACINI G, 1982, DIABETES, V31, P432, DOI 10.2337/diabetes.31.5.432; Papaloukas C, 2002, ARTIF INTELL MED, V24, P167, DOI 10.1016/S0933-3657(01)00100-2; Pappada Scott M, 2008, J Diabetes Sci Technol, V2, P792; Perez-Gandia C, 2010, DIABETES TECHNOL THE, V12, P81, DOI 10.1089/dia.2009.0076; Reed R. D., 1999, NEURAL SMITHING SUPE; Ritchie MD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-28; Satyanarayana Dondeti, 2005, GENETIC ALGORITHM OP; Shanker MS, 1996, J CHEM INF COMP SCI, V36, P35, DOI 10.1021/ci950063e; Silipo R, 1998, IEEE T SIGNAL PROCES, V46, P1417, DOI 10.1109/78.668803; Sivanandam S., 2008, INTRO GENETIC ALGORI, P15; SMITH D, 1987, METABOLISM, V36, P1167, DOI 10.1016/0026-0495(87)90244-7; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; WHITLEY D, 1990, PARALLEL COMPUT, V14, P347, DOI 10.1016/0167-8191(90)90086-O; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organisation, 2011, DIABETES	38	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44587	10.1371/journal.pone.0044587	http://dx.doi.org/10.1371/journal.pone.0044587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952998	Green Submitted, gold, Green Published			2022-12-27	WOS:000308221300102
J	Elphick, MR				Elphick, Maurice R.			The Protein Precursors of Peptides That Affect the Mechanics of Connective Tissue and/or Muscle in the Echinoderm Apostichopus japonicus	PLOS ONE			English	Article							STARFISH ASTERIAS-RUBENS; CUCUMBER HOLOTHURIA-GLABERRIMA; SALMFAMIDE NEUROPEPTIDES S1; SEA-CUCUMBER; HEPTAPEPTIDE GFSKLYFAMIDE; POLYCLONAL ANTIBODIES; VASOPRESSIN; RELAXATION; PROHORMONE; DOMAINS	Peptides that cause muscle relaxation or contraction or that modulate electrically-induced muscle contraction have been discovered in the sea cucumber Apostichopus japonicus (Phylum Echinodermata; Class Holothuroidea). By analysing transcriptome sequence data, here the protein precursors of six of these myoactive peptides (the SALMFamides Sticho-MFamide-1 and -2, NGIWYamide, stichopin, GN-19 and GLRFA) have been identified, providing novel insights on neuropeptide and endocrine-type signalling systems in echinoderms. The A. japonicus SALMFamide precursor comprises eight putative neuropeptides including both L-type and F-type SALMFamides, which contrasts with previous findings from the sea urchin Strongylocentrotus purpuratus where L-type and F-type SALMFamides are encoded by different genes. The NGIWYamide precursor contains five copies of NGIWYamide but, unlike other NG peptide-type neuropeptide precursors in deuterostomian invertebrates, the NGIWYamide precursor does not have a C-terminal neurophysin domain, indicating loss of this character in holothurians. NGIWYamide was originally discovered as a muscle contractant, but it also causes stiffening of mutable connective tissue in the body wall of A. japonicus, whilst holokinins (PLGYMFR and derivative peptides) cause softening of the body wall. However, the mechanisms by which these peptides affect the stiffness of body wall connective tissue are unknown. Interestingly, analysis of the A. japonicus transcriptome reveals that the only protein containing the holokinin sequence PLGYMFR is an alpha-5 type collagen. This suggests that proteolysis of collagen may generate peptides (holokinins) that affect body wall stiffness in sea cucumbers, providing a novel perspective on mechanisms of mutable connective tissue in echinoderms.	Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Elphick, MR (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	M.R.Elphick@qmul.ac.uk		Elphick, Maurice/0000-0002-9169-0048				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birenheide R, 1998, BIOL BULL-US, V194, P253, DOI 10.2307/1543095; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Campbell DJ, 2003, INT J BIOCHEM CELL B, V35, P784, DOI 10.1016/S1357-2725(02)00262-5; Cluzel C, 2004, J BIOL CHEM, V279, P9811, DOI 10.1074/jbc.M311803200; de Bree FM, 1998, CELL MOL NEUROBIOL, V18, P173, DOI 10.1023/A:1022564803093; de Bree FM, 2000, J NEUROENDOCRINOL, V12, P589, DOI 10.1046/j.1365-2826.2000.00521.x; DIAZMIRANDA L, 1995, J COMP NEUROL, V352, P626, DOI 10.1002/cne.903520410; DIAZMIRANDA L, 1995, COMP BIOCHEM PHYS C, V110, P171, DOI 10.1016/0742-8413(94)00094-Q; DIAZMIRANDA L, 1992, BIOL BULL, V182, P241, DOI 10.2307/1542117; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Elphick MR, 2010, GENE, V458, P20, DOI 10.1016/j.gene.2010.03.004; Elphick MR, 2009, J EXP BIOL, V212, P1067, DOI 10.1242/jeb.027599; Elphick MR, 2005, J EXP BIOL, V208, P4273, DOI 10.1242/jeb.01910; Elphick MR, 2001, J EXP BIOL, V204, P875; ELPHICK MR, 1995, J EXP BIOL, V198, P2519; ELPHICK MR, 1991, P ROY SOC B-BIOL SCI, V243, P121, DOI 10.1098/rspb.1991.0020; GREENBERG MJ, 1983, ANNU REV PHYSIOL, V45, P271, DOI 10.1146/annurev.ph.45.030183.001415; Inoue M, 1999, P BIOL SCI, V266; IWAKOSHI E, 1995, PEPTIDE CH, P261; Kato S, 2009, DEV BIOL, V326, P169, DOI 10.1016/j.ydbio.2008.11.003; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; Melarange R, 2003, J EXP BIOL, V206, P893, DOI 10.1242/jeb.00197; Melarange R, 1999, P ROY SOC B-BIOL SCI, V266, P1785, DOI 10.1098/rspb.1999.0847; MOORE SJ, 1993, CELL TISSUE RES, V274, P605, DOI 10.1007/BF00314559; NEWMAN SJ, 1995, P ROY SOC B-BIOL SCI, V261, P187, DOI 10.1098/rspb.1995.0135; NEWMAN SJ, 1995, P ROY SOC B-BIOL SCI, V261, P139, DOI 10.1098/rspb.1995.0128; Ohtani M, 1999, PEPTIDE SCIENCE - PRESENT AND FUTURE, P419; OSHEA M, 1985, ANNU REV NEUROSCI, V8, P171; Priyam A., SEQUENCESERVER UNPUB; Rowe ML, 2010, MAR GENOM, V3, P91, DOI 10.1016/j.margen.2010.08.003; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Strand FL, 1999, NEUROPEPTIDES REGULA; Tamori M, 2007, P ROY SOC B-BIOL SCI, V274, P2279, DOI 10.1098/rspb.2007.0583; Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2; Wilkie IC, 2005, PROG MOLEC, V39, P221; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	39	29	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44492	10.1371/journal.pone.0044492	http://dx.doi.org/10.1371/journal.pone.0044492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952987	Green Submitted, gold, Green Published			2022-12-27	WOS:000308221300095
J	Pacheco, SE; Anderson, LM; Sandrof, MA; Vantangoli, MM; Hall, SJ; Boekelheide, K				Pacheco, Sara E.; Anderson, Linnea M.; Sandrof, Moses A.; Vantangoli, Marguerite M.; Hall, Susan J.; Boekelheide, Kim			Sperm mRNA Transcripts Are Indicators of Sub-Chronic Low Dose Testicular Injury in the Fischer 344 Rat	PLOS ONE			English	Article							MARINESCO-SJOGREN-SYNDROME; GERM-CELL APOPTOSIS; GENE-EXPRESSION; 2,5-HEXANEDIONE INTOXICATION; SPERMATOZOAL RNA; CARBENDAZIM; TESTIS; EPIDIDYMIS; TOXICITY; PROTEINS	Current human reproductive risk assessment methods rely on semen and serum hormone analyses, which are not easily comparable to the histopathological endpoints and mating studies used in animal testing. Because of these limitations, there is a need to develop universal evaluations that reliably reflect male reproductive function. We hypothesized that toxicant-induced testicular injury can be detected in sperm using mRNA transcripts as indicators of insult. To test this, we exposed adult male Fischer 344 rats to low doses of model testicular toxicants and classically characterized the testicular injury while simultaneously evaluating sperm mRNA transcripts from the same animals. Overall, this study aimed to: 1) identify sperm transcripts altered after exposure to the model testicular toxicant, 2,5-hexanedione (HD) using microarrays; 2) expand on the HD-induced transcript changes in a comprehensive time course experiment using qRT-PCR arrays; and 3) test these injury indicators after exposure to another model testicular toxicant, carbendazim (CBZ). Microarray analysis of HD-treated adult Fischer 344 rats identified 128 altered sperm mRNA transcripts when compared to control using linear models of microarray analysis (q < 0.05). All transcript alterations disappeared after 3 months of post-exposure recovery. In the time course experiment, time-dependent alterations were observed for 12 candidate transcripts selected from the microarray data based upon fold change and biological relevance, and 8 of these transcripts remained significantly altered after the 3-month recovery period (p < 0.05). In the last experiment, 8 candidate transcripts changed after exposure to CBZ (p < 0.05). The two testicular toxicants produced distinct molecular signatures with only 4 overlapping transcripts between them, each occurring in opposite directions. Overall, these results suggest that sperm mRNA transcripts are indicators of low dose toxicant-induced testicular injury in the rat.	[Pacheco, Sara E.; Anderson, Linnea M.; Sandrof, Moses A.; Vantangoli, Marguerite M.; Hall, Susan J.; Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Brown University	Pacheco, SE (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Kim_Boekelheide@Brown.edu		Vantangoli, Marguerite/0000-0001-8757-440X	Superfund Research Program (National Institute of Health/National Institute of Environmental Health Science) [P42ES013660]; National Institute of Environmental Health Science "Training in Environmental Pathology'' training grant [T32ES007272-17]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013660, T32ES007272] Funding Source: NIH RePORTER	Superfund Research Program (National Institute of Health/National Institute of Environmental Health Science); National Institute of Environmental Health Science "Training in Environmental Pathology'' training grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Superfund Research Program (National Institute of Health/National Institute of Environmental Health Science) grant [P42ES013660] and by the National Institute of Environmental Health Science "Training in Environmental Pathology'' training grant [T32ES007272-17] (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373; Allanach K, 2008, AM J TRANSPLANT, V8, P1006, DOI 10.1111/j.1600-6143.2008.02199.x; Anton E, 2012, SYST BIOL REPROD MED, V58, P41, DOI 10.3109/19396368.2011.637152; Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Aveic S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026097; Belleannee C, 2011, J PROTEOMICS, V74, P59, DOI 10.1016/j.jprot.2010.07.013; BOEKELHEIDE K, 1988, TOXICOL APPL PHARM, V92, P18, DOI 10.1016/0041-008X(88)90223-2; BOEKELHEIDE K, 1988, TOXICOL APPL PHARM, V94, P76, DOI 10.1016/0041-008X(88)90338-9; Boekelheide K, 2003, ANNU REV PHARMACOL, V43, P125, DOI 10.1146/annurev.pharmtox.43.100901.135930; Boekelheide K, 2005, SERTOLI CELL BIOL, P345; Boerke A, 2007, THERIOGENOLOGY, V68, pS147, DOI 10.1016/j.theriogenology.2007.05.058; Bryant BH, 2008, TOXICOL PATHOL, V36, P552, DOI 10.1177/0192623308317426; Buck Wayne R., 2008, V460, P23, DOI 10.1007/978-1-60327-048-9_2; Campion SN, 2010, TOXICOL SCI, V117, P457, DOI 10.1093/toxsci/kfq204; CARTER SD, 1987, BIOL REPROD, V37, P709, DOI 10.1095/biolreprod37.3.709; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Correa LM, 2001, BIOL REPROD, V64, P1644, DOI 10.1095/biolreprod64.6.1644; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Goncalves RF, 2008, ANIM REPROD SCI, V106, P188, DOI 10.1016/j.anireprosci.2007.12.019; GRAY LE, 1990, FUND APPL TOXICOL, V15, P281, DOI 10.1016/0272-0590(90)90055-O; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Hess RA, 1998, J REPROD FERTIL, P247; HOWARD RJ, 1980, J CELL BIOL, V87, P55, DOI 10.1083/jcb.87.1.55; Kempisty B, 2008, REPROD FERT DEVELOP, V20, P513, DOI 10.1071/RD07211; Laatikainen LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024456; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Lim JH, 1997, TOXICOL APPL PHARM, V142, P401, DOI 10.1006/taap.1996.8042; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Miller D, 2005, TRENDS MOL MED, V11, P156, DOI 10.1016/j.molmed.2005.02.006; Miller D, 2006, HUM REPROD UPDATE, V12, P757, DOI 10.1093/humupd/dml037; Moffit JS, 2007, TOXICOL PATHOL, V35, P719, DOI 10.1080/01926230701481931; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Neuer A, 1999, Infect Dis Obstet Gynecol, V7, P10, DOI 10.1155/S1064744999000034; Nuwaysir EF, 1999, MOL CARCINOGEN, V24, P153, DOI 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Pacheco SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020280; Pacheco SE, 2012, J ANDROL; Peng JS, 2002, MOL BIOL REP, V29, P353, DOI 10.1023/A:1021232518628; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; QUINLAN RA, 1980, J CELL SCI, V46, P341; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Sorrentino C, 1998, BIOL REPROD, V59, P843, DOI 10.1095/biolreprod59.4.843; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Winder BS, 2001, TOXICOL SCI, V59, P138, DOI 10.1093/toxsci/59.1.138; Yamasaki H, 2010, TOXICOL SCI, V117, P449, DOI 10.1093/toxsci/kfq203; Yon JM, 2007, J REPROD DEVELOP, V53, P1007, DOI 10.1262/jrd.19032; Yu G, 2009, TOXICOL IND HEALTH, V25, P41, DOI 10.1177/0748233709103033; Zhang KX, 2005, ARCH ANDROLOGY, V51, P7, DOI 10.1080/014850190512914; Zhao LH, 2010, HUM MOL GENET, V19, P25, DOI 10.1093/hmg/ddp464	52	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44280	10.1371/journal.pone.0044280	http://dx.doi.org/10.1371/journal.pone.0044280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952946	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300073
J	Wang, XJ; Wang, JP; Zhang, J				Wang, Xiujun; Wang, Jiaping; Zhang, Juan			Comparisons of Three Methods for Organic and Inorganic Carbon in Calcareous Soils of Northwestern China	PLOS ONE			English	Article							LOSS-ON-IGNITION; WALKLEY-BLACK ANALYSIS; MATTER; SEDIMENTS; QUANTIFICATION; RECOVERY	With increasing interest in the carbon cycle on arid land, there is an urgent need to quantify both soil organic carbon (SOC) and inorganic carbon (SIC) thus to assess various methods. Here, we present a study employing three methods for determinations of SOC and SIC in the Yanqi Basin of northwest China. We use an elemental analyzer for both SOC and SIC, the Walkley-Black method for SOC, a modified pressure calcimeter method for SIC, and a simple loss-on-ignition (LOI) procedure for determinations of SOC and SIC. Our analyses show that all three approaches produce consistently low values for SOC (1-14 g kg(-1)) and high values for SIC (8-53 g kg(-1)). The Walkley-Black method provides an accurate estimate of SOC with 100% recovery for most soil samples. The pressure calcimeter method is as accurate as the elemental analysis for measuring SIC. In addition, SOC and SIC can be accurately estimated using a two-step LOI approach, i.e., (1) combustion at 375 degrees C for 17 hours to estimate SOC, and (2) subsequent combustion at 800 degrees C for 12 hours to estimate SIC. There are strong linear relationships for both SOC and SIC between the elemental analysis and LOI method, which demonstrates the capability of the two-step LOI technique for estimating SOC and SIC in this arid region.	[Wang, Xiujun; Wang, Jiaping; Zhang, Juan] Chinese Acad Sci, State Key Lab Desert & Oasis Ecol, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China; [Wang, Xiujun] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Wang, Jiaping; Zhang, Juan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XJ (corresponding author), Chinese Acad Sci, State Key Lab Desert & Oasis Ecol, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China.	wwang@essic.umd.edu	Wang, Xiujun/F-2641-2010; Zhang, Juan/GRX-2638-2022	Wang, Xiujun/0000-0002-2859-8011; 	Chinese Academy of Sciences [O972021001]; Program of 100 Talented Young Scientists	Chinese Academy of Sciences(Chinese Academy of Sciences); Program of 100 Talented Young Scientists	This study is financially supported by the Program of 100 Talented Young Scientists with the Chinese Academy of Sciences (O972021001)(http://www.cas.cn/ggzy/rcpy/brjh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella SR, 2007, SOIL SCI SOC AM J, V71, P545, DOI 10.2136/sssaj2006.0136; Allison L.E., 1965, METHODS SOIL ANAL, P1379, DOI DOI 10.2134/AGRONMONOGR9.2.C40; BALL DF, 1964, J SOIL SCI, V15, P84, DOI 10.1111/j.1365-2389.1964.tb00247.x; Beaudoin A, 2003, J PALEOLIMNOL, V29, P387, DOI 10.1023/A:1023972116573; BYERS SC, 1978, HYDROBIOLOGIA, V58, P43, DOI 10.1007/BF00018894; Chatterjee A, 2009, CRIT REV PLANT SCI, V28, P164, DOI 10.1080/07352680902776556; Conyers MK, 2011, SOIL RES, V49, P27, DOI 10.1071/SR10103; DAVID MB, 1988, COMMUN SOIL SCI PLAN, V19, P1593, DOI 10.1080/00103628809368037; De Vos B, 2007, SOIL USE MANAGE, V23, P221, DOI 10.1111/j.1475-2743.2007.00084.x; De Vos B, 2005, COMMUN SOIL SCI PLAN, V36, P2899, DOI 10.1080/00103620500306080; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dreimanis A., 1962, J SEDIMENT PETROL, V32, P520, DOI DOI 10.1306/74D70D08-2B21-11D7-8648000102C1865D; Eswaran H, 2000, GLOBAL CLIMATE CHANGE AND PEDOGENIC CARBONATES, P15; FAO/UNESCO, 1988, 60 FAOUNESCO; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Konen ME, 2002, SOIL SCI SOC AM J, V66, P1878, DOI 10.2136/sssaj2002.1878; Lal R, 2000, GLOBAL CLIMATE CHANGE AND PEDOGENIC CARBONATES, P1; Lettens S, 2007, EUR J SOIL SCI, V58, P1244, DOI 10.1111/j.1365-2389.2007.00916.x; Loeppert R. H., 1996, Methods of soil analysis. Part 3 - chemical methods., P437; McKeague J. A., 1976, MANUAL SOIL SAMPLING; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; PRESLEY BJ, 1975, J SEDIMENT PETROL, V45, P745; Pribyl DW, 2010, GEODERMA, V156, P75, DOI 10.1016/j.geoderma.2010.02.003; RABENHORST MC, 1988, SOIL SCI SOC AM J, V52, P965, DOI 10.2136/sssaj1988.03615995005200040012x; Santisteban JI, 2004, J PALEOLIMNOL, V32, P287, DOI 10.1023/B:JOPL.0000042999.30131.5b; Scharpenseel HW, 2000, GLOBAL CLIMATE CHANGE AND PEDOGENIC CARBONATES, P27; Sherrod LA, 2002, SOIL SCI SOC AM J, V66, P299, DOI 10.2136/sssaj2002.0299; Sleutel S, 2007, COMMUN SOIL SCI PLAN, V38, P2647, DOI 10.1080/00103620701662877; Stone R, 2008, SCIENCE, V320, P1409, DOI 10.1126/science.320.5882.1409; Szava-Kovats R, 2009, COMMUN SOIL SCI PLAN, V40, P2712, DOI 10.1080/00103620903173764; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wang QR, 2011, ENVIRON MONIT ASSESS, V174, P241, DOI 10.1007/s10661-010-1454-z; Wang XJ, 1996, AUST J SOIL RES, V34, P545, DOI 10.1071/SR9960545; Wright AL, 2008, COMMUN SOIL SCI PLAN, V39, P3074, DOI 10.1080/00103620802432931; Xie JX, 2009, ENVIRON GEOL, V56, P953, DOI 10.1007/s00254-008-1197-0; Zhang WJ, 2010, BIOGEOSCIENCES, V7, P409, DOI 10.5194/bg-7-409-2010	37	51	58	7	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44334	10.1371/journal.pone.0044334	http://dx.doi.org/10.1371/journal.pone.0044334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952957	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300083
J	Aleman-Muench, GR; Mendoza, V; Stenvers, K; Garcia-Zepeda, EA; Lopez-Casillas, F; Raman, C; Soldevila, G				Aleman-Muench, German R.; Mendoza, Valentin; Stenvers, Kaye; Garcia-Zepeda, Eduardo A.; Lopez-Casillas, Fernando; Raman, Chander; Soldevila, Gloria			Betaglycan (T beta RIII) Is Expressed in the Thymus and Regulates T Cell Development by Protecting Thymocytes from Apoptosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEINS; III RECEPTOR; INHIBIN BINDING; PROLIFERATION; SUPERFAMILY; CORECEPTOR; ACTIVATION; MIGRATION; TGFBR3	TGF-beta type III receptor (T beta RIII) is a coreceptor for TGF beta family members required for high-affinity binding of these ligands to their receptors, potentiating their cellular functions. TGF-beta [1-3], bone morphogenetic proteins (BMP2/4) and inhibins regulate different checkpoints during T cell differentiation. Although T beta RIII is expressed on hematopoietic cells, the role of this receptor in the immune system remains elusive. Here, we provide the first evidence that T beta RIII is developmentally expressed during T cell ontogeny, and plays a crucial role in thymocyte differentiation. Blocking of endogenous T beta RIII in fetal thymic organ cultures led to a delay in DN-DP transition. In addition, in vitro development of T beta RIII-/- thymic lobes also showed a significant reduction in absolute thymocyte numbers, which correlated with increased thymocyte apoptosis, resembling the phenotype reported in Inhibin alpha(-/-) thymic lobes. These data suggest that Inhibins and T beta RIII may function as a molecular pair regulating T cell development.	[Aleman-Muench, German R.; Garcia-Zepeda, Eduardo A.; Soldevila, Gloria] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Mendoza, Valentin; Lopez-Casillas, Fernando] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular, Mexico City 04510, DF, Mexico; [Stenvers, Kaye] Prince Henrys Inst Med Res, Reprod Dev & Canc Lab, Clayton, Vic, Australia; [Raman, Chander] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Dept Med, Birmingham, AL USA; [Raman, Chander] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Dept Microbiol, Birmingham, AL USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Prince Henry's Institute of Medical Research; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Aleman-Muench, GR (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico.	soldevi@servidor.unam.mx		Soldevila, Gloria/0000-0003-1539-2548	DGAPA, UNAM (PAPIIT) [IN228205]; CONACyT [208213]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076562] Funding Source: NIH RePORTER	DGAPA, UNAM (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in GS's lab was supported by a grant from DGAPA, UNAM (PAPIIT #IN228205). GRAM was a recipient of a doctoral fellowship #208213 from CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair CR, 2011, BBA-MOL CELL RES, V1813, P332, DOI 10.1016/j.bbamcr.2010.12.005; Brooks SP, 1998, AIDS, V12, P481, DOI 10.1097/00002030-199805000-00009; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Chapman SC, 2002, MOL CELL ENDOCRINOL, V196, P79, DOI 10.1016/S0303-7207(02)00227-7; Chen YG, 2006, EXP BIOL MED, V231, P534; Chu WF, 2011, J CELL PHYSIOL, V226, P2586, DOI 10.1002/jcp.22604; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Ethier JF, 2002, MOL ENDOCRINOL, V16, P2754, DOI 10.1210/me.2002-0014; Farnworth PG, 2007, ENDOCRINOLOGY, V148, P5355, DOI 10.1210/en.2007-0155; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Graf D, 2002, J EXP MED, V196, P163, DOI 10.1084/jem.20020276; KADIN ME, 1994, P NATL ACAD SCI USA, V91, P6002, DOI 10.1073/pnas.91.13.6002; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Licona P, 2006, DEV DYNAM, V235, P1124, DOI 10.1002/dvdy.20707; Licona-Limon P, 2007, IMMUNOL LETT, V109, P1, DOI 10.1016/j.imlet.2006.12.010; Licona-Limon P, 2009, BIOCHEM BIOPH RES CO, V381, P229, DOI 10.1016/j.bbrc.2009.02.029; Looyenga BD, 2010, MOL ENDOCRINOL, V24, P608, DOI 10.1210/me.2008-0374; Lopez-Casillas F, 2003, J BIOL CHEM, V278, P382, DOI 10.1074/jbc.M208520200; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Margulis V, 2008, CLIN CANCER RES, V14, P5722, DOI 10.1158/1078-0432.CCR-08-0546; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mythreye K, 2009, CELL CYCLE, V8, P3069, DOI 10.4161/cc.8.19.9419; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; Rosendahl A, 2003, INT IMMUNOL, V15, P1401, DOI 10.1093/intimm/dxg139; SANKAR S, 1995, J BIOL CHEM, V270, P13567, DOI 10.1074/jbc.270.22.13567; Sarraj MA, 2007, GROWTH FACTORS, V25, P334, DOI 10.1080/08977190701833619; Sarraj MA, 2010, BIOL REPROD, V82, P153, DOI 10.1095/biolreprod.109.078766; SCHICK BP, 1995, J CELL PHYSIOL, V165, P96, DOI 10.1002/jcp.1041650113; Slimani H, 2003, BBA-BIOMEMBRANES, V1617, P80, DOI 10.1016/j.bbamem.2003.09.006; Sporer KRB, 2007, VET IMMUNOL IMMUNOP, V118, P19, DOI 10.1016/j.vetimm.2007.04.002; Stenvers KL, 2010, TRENDS ENDOCRIN MET, V21, P174, DOI 10.1016/j.tem.2009.11.009; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Varas A, 2003, TRENDS IMMUNOL, V24, P197, DOI 10.1016/S1471-4906(03)00033-4; Walker KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018723; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e44217	10.1371/journal.pone.0044217	http://dx.doi.org/10.1371/journal.pone.0044217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952931	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206000094
J	Kishko, I; Harish, B; Zayats, V; Reha, D; Tenner, B; Beri, D; Gustavsson, T; Ettrich, R; Carey, J				Kishko, Iryna; Harish, Balasubramanian; Zayats, Vasilina; Reha, David; Tenner, Brian; Beri, Dhananjay; Gustavsson, Tobias; Ettrich, Ruediger; Carey, Jannette			Biphasic Kinetic Behavior of E. coli WrbA, an FMN-Dependent NAD(P)H: Quinone Oxidoreductase	PLOS ONE			English	Article							ESCHERICHIA-COLI; DT-DIAPHORASE; DEHYDROGENASE; MECHANISM; FAMILY	The E. coli protein WrbA is an FMN-dependent NAD(P)H: quinone oxidoreductase that has been implicated in oxidative defense. Three subunits of the tetrameric enzyme contribute to each of four identical, cavernous active sites that appear to accommodate NAD(P)H or various quinones, but not simultaneously, suggesting an obligate tetramer with a ping-pong mechanism in which NAD departs before oxidized quinone binds. The present work was undertaken to evaluate these suggestions and to characterize the kinetic behavior of WrbA. Steady-state kinetics results reveal that WrbA conforms to a ping-pong mechanism with respect to the constancy of the apparent Vmax to Km ratio with substrate concentration. However, the competitive/non-competitive patterns of product inhibition, though consistent with the general class of bisubstrate reactions, do not exclude a minor contribution from additional forms of the enzyme. NMR results support the presence of additional enzyme forms. Docking and energy calculations find that electron-transfer-competent binding sites for NADH and benzoquinone present severe steric overlap, consistent with the ping-pong mechanism. Unexpectedly, plots of initial velocity as a function of either NADH or benzoquinone concentration present one or two Michaelis-Menten phases depending on the temperature at which the enzyme is held prior to assay. The effect of temperature is reversible, suggesting an intramolecular conformational process. WrbA shares these and other details of its kinetic behavior with mammalian DT-diaphorase, an FAD-dependent NAD(P)H: quinone oxidoreductase. An extensive literature review reveals several other enzymes with two-plateau kinetic plots, but in no case has a molecular explanation been elucidated. Preliminary sedimentation velocity analysis of WrbA indicates a large shift in size of the multimer with temperature, suggesting that subunit assembly coupled to substrate binding may underlie the two-plateau behavior. An additional aim of this report is to bring under wider attention the apparently widespread phenomenon of two-plateau Michaelis-Menten plots.	[Kishko, Iryna; Zayats, Vasilina; Reha, David; Ettrich, Ruediger] Acad Sci Czech Republ, Global Change Res Ctr, Inst Nanobiol & Struct Biol, Nove Hrady, Czech Republic; [Kishko, Iryna; Zayats, Vasilina; Ettrich, Ruediger] Univ S Bohemia, Fac Sci, Nove Hrady, Czech Republic; [Harish, Balasubramanian; Tenner, Brian; Beri, Dhananjay; Carey, Jannette] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Gustavsson, Tobias] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden	Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Princeton University; Lund University	Kishko, I (corresponding author), Acad Sci Czech Republ, Global Change Res Ctr, Inst Nanobiol & Struct Biol, Nove Hrady, Czech Republic.	ettrich@nh.cas.cz; jcarey@princeton.edu	Reha, David/ABB-9836-2021; Kiško, Irina/O-4840-2018; Ettrich, Rudi H/C-1463-2011; Zayats, Vasilina/H-7836-2014; Reha, David/D-7256-2016	Ettrich, Rudi H/0000-0001-8624-7706; , Harish/0000-0002-7672-0851; Zayats, Vasilina/0000-0002-9355-8171; Reha, David/0000-0002-9500-0569	Ministry of Education, Youth and Sports of the Czech Republic [MSM6007665808, Aktion 64p1]; Academy of Sciences of the Czech Republic [AVOZ60870520]; Grant Agency of the Czech Republic [P207/10/1934]; joint Czech - US National Science Foundation International Research Cooperation [OISE08-53423, ME09016]; University of South Bohemia [GAJU 170/2010/P]; Div Of Biological Infrastructure [1004830] Funding Source: National Science Foundation; Office Of Internatl Science &Engineering [0853423] Funding Source: National Science Foundation	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); joint Czech - US National Science Foundation International Research Cooperation; University of South Bohemia; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	Access to METACentrum supercomputing facilities was provided under the research intent MSM6383917201. The authors thank Curt Hillegas, Director of Research Computing at the Princeton University Office of Information Technology, for access to the high-performance computing center, and Prof. James Cole, director of the national AUC facility, for assistance with the sedimentation velocity experiments and data analysis. The authors gratefully acknowledge support from the Ministry of Education, Youth and Sports of the Czech Republic (MSM6007665808, Aktion 64p1), Academy of Sciences of the Czech Republic (AVOZ60870520), Grant Agency of the Czech Republic (P207/10/1934 to R.E.), and joint Czech - US National Science Foundation International Research Cooperation (OISE08-53423 to J.C., and ME09016 to R.E.). Additionally, I. K. and V.Z. were supported by the University of South Bohemia, Grant GAJU 170/2010/P. I. K. would like to thank Alena Lukesova for sponsoring lab facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SLA, 2007, J BACTERIOL, V189, P9101, DOI 10.1128/JB.01336-07; [Anonymous], 2011, MAESTR 9 2; [Anonymous], 2011, GLID 5 7; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Carey J, 2007, PROTEIN SCI, V16, P2301, DOI 10.1110/ps.073018907; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; CORWIN LM, 1968, J BIOL CHEM, V243, P3517; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; ERNSTER L, 1987, CHEM SCRIPTA, V27A, P1; Frisch M. J., 2019, GAUSSIAN 16 REVISION; GELB WG, 1970, BIOCHEMISTRY-US, V9, P3228, DOI 10.1021/bi00818a016; GRANDORI R, 1994, PROTEIN SCI, V3, P2185, DOI 10.1002/pro.5560031204; Grandori R, 1998, J BIOL CHEM, V273, P20960, DOI 10.1074/jbc.273.33.20960; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hall JM, 1972, STRUCTURE FUNCTION O, P433; HOLLANDER PM, 1975, ARCH BIOCHEM BIOPHYS, V169, P568, DOI 10.1016/0003-9861(75)90201-5; HOSODA S, 1974, J BIOL CHEM, V249, P6416; Jensen KA, 2002, APPL ENVIRON MICROB, V68, P2699, DOI 10.1128/AEM.68.6.2699-2703.2002; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; KAGAN ZS, 1973, BIOCHIM BIOPHYS ACTA, V302, P110, DOI 10.1016/0005-2744(73)90014-4; KATO G, 1972, J BIOL CHEM, V247, P3186; LEJOHN HB, 1968, J BIOL CHEM, V243, P3447; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; MARCUS RA, 1956, J CHEM PHYS, V24, P966, DOI 10.1063/1.1742723; Noll G, 2006, LANGMUIR, V22, P2378, DOI 10.1021/la051423n; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; RUAN K, 1989, BIOCHEMISTRY-US, V28, P2144, DOI 10.1021/bi00431a028; Schrodinger LLC, 2011, IMP 5 7; Schrodinger LLC, 2011, QSIT 5 7; SOMERO GN, 1969, BIOCHEM J, V114, P237, DOI 10.1042/bj1140237; SOMERO GN, 1969, NATURE, V223, P194, DOI 10.1038/223194a0; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; WALSH CT, 1979, ENZYMATIC REACTION M; Wolfova J, 2009, BBA-PROTEINS PROTEOM, V1794, P1288, DOI 10.1016/j.bbapap.2009.08.001; YANG WP, 1993, P NATL ACAD SCI USA, V90, P5796, DOI 10.1073/pnas.90.12.5796; ZEIJLEMAKER WP, 1969, BIOCHIM BIOPHYS ACTA, V178, P213, DOI 10.1016/0005-2744(69)90391-X	37	18	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43902	10.1371/journal.pone.0043902	http://dx.doi.org/10.1371/journal.pone.0043902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952804	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206000058
J	Tull, SP; Bevins, A; Kuravi, SJ; Satchell, SC; Al-Ani, B; Young, SP; Harper, L; Williams, JM; Rainger, GE; Savage, COS				Tull, Samantha P.; Bevins, Anne; Kuravi, Sahithi Jyothsna; Satchell, Simon C.; Al-Ani, Bahjat; Young, Stephen P.; Harper, Lorraine; Williams, Julie M.; Rainger, George Ed; Savage, Caroline O. S.			PR3 and Elastase Alter PAR1 Signaling and Trigger vWF Release via a Calcium-Independent Mechanism from Glomerular Endothelial Cells	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; VON-WILLEBRAND-FACTOR; NEUTROPHIL SERINE PROTEINASES; FUNCTIONAL THROMBIN RECEPTOR; C RECEPTOR; SURFACE EXPRESSION; EPITHELIAL-CELLS; ALPHA-THROMBIN; TISSUE FACTOR; INTERNALIZATION	Neutrophil proteases, proteinase-3 (PR3) and elastase play key roles in glomerular endothelial cell (GEC) injury during glomerulonephritis. Endothelial protease-activated receptors (PARs) are potential serine protease targets in glomerulonephritis. We investigated whether PAR1/2 are required for alterations in GEC phenotype that are mediated by PR3 or elastase during active glomerulonephritis. Endothelial PARs were assessed by flow cytometry. Thrombin, trypsin and agonist peptides for PAR1 and PAR2, TFLLR-NH2 and SLIGKV-NH2, respectively, were used to assess alterations in PAR activation induced by PR3 or elastase. Endothelial von Willebrand Factor (vWF) release and calcium signaling were used as PAR activation markers. Both PR3 and elastase induced endothelial vWF release, with elastase inducing the highest response. PAR1 peptide induced GEC vWF release to the same extent as PR3. However, knockdown of PARs by small interfering RNA showed that neither PAR1 nor PAR2 activation caused PR3 or elastase-mediated vWF release. Both proteases interacted with and disarmed surface GEC PAR1, but there was no detectable interaction with cellular PAR2. Neither protease induced a calcium response in GEC. Therefore, PAR signaling and serine protease-induced alterations in endothelial function modulate glomerular inflammation via parallel but independent pathways.	[Tull, Samantha P.; Bevins, Anne; Kuravi, Sahithi Jyothsna; Young, Stephen P.; Harper, Lorraine; Savage, Caroline O. S.] Univ Birmingham, Sch Immun, Coll Med & Dent, Birmingham, W Midlands, England; [Williams, Julie M.] Queen Elizabeth Hosp, WTCRF, Birmingham B15 2TH, W Midlands, England; [Satchell, Simon C.; Williams, Julie M.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Al-Ani, Bahjat] King Khalid Univ, Coll Med, Dept Physiol, Abha, Saudi Arabia; [Tull, Samantha P.; Bevins, Anne; Kuravi, Sahithi Jyothsna; Young, Stephen P.; Harper, Lorraine; Savage, Caroline O. S.] Univ Birmingham, Sch Infect, Coll Med & Dent, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Bristol; King Khalid University; University of Birmingham	Tull, SP (corresponding author), Univ Birmingham, Sch Immun, Coll Med & Dent, Birmingham, W Midlands, England.	s.p.tull@bham.ac.uk	tull, samantha p/A-9825-2013; Young, Stephen P/A-7380-2008	Tull, Samantha/0000-0001-9337-4690; harper, lorraine/0000-0003-1343-9234; Young, Stephen P/0000-0002-6355-3361	Medical Research Council; Kidney Research UK; Medical Research Council [G9818340B, G0600069] Funding Source: researchfish; MRC [G0600069] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by external funding from Medical Research Council and Kidney Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ani B, 2003, J PHARMACOL EXP THER, V304, P1120, DOI 10.1124/jpet.102.043844; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Boehme MWJ, 2002, IMMUNOLOGY, V107, P340, DOI 10.1046/j.1365-2567.2002.01469.x; BRASS LF, 1994, J BIOL CHEM, V269, P2943; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Calderwood JW, 2005, J LEUKOCYTE BIOL, V77, P33, DOI 10.1189/jlb.0104054; Carruthers DM, 1996, CLIN EXP IMMUNOL, V105, P291, DOI 10.1046/j.1365-2249.1996.d01-768.x; Cirino G, 2006, CURR OPIN PHARMACOL, V6, P428, DOI 10.1016/j.coph.2006.05.001; COLLINS PW, 1993, THROMB HAEMOSTASIS, V70, P346; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; COOKE BM, 1993, MICROVASC RES, V45, P33, DOI 10.1006/mvre.1993.1004; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grandaliano G, 2003, J AM SOC NEPHROL, V14, P2072, DOI 10.1097/01.ASN.0000080315.37254.A1; Gupta A, 2009, FORM METHOD SYST DES, V35, P1, DOI 10.1007/s10703-009-0072-2; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Haubitz M, 1997, ARTHRITIS RHEUM, V40, P1680, DOI 10.1002/art.1780400918; HENSHAW TJ, 1994, ARTHRITIS RHEUM, V37, P104, DOI 10.1002/art.1780370116; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; HUNG DT, 1992, J CLIN INVEST, V89, P1350, DOI 10.1172/JCI115721; Jiang B, 2010, CLIN EXP RHEUMATOL, V28, pS56; JOHNSON RJ, 1988, J EXP MED, V168, P1169, DOI 10.1084/jem.168.3.1169; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Kawamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034045; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Klarenbach SW, 2003, CIRC RES, V92, P272, DOI 10.1161/01.RES.0000057386.15390.A3; Kuravi SJ, 2012, NEPHROL DIA IN PRESS; Langer F, 1999, BRIT J HAEMATOL, V105, P542; LEVINE L, 1994, PROSTAGLANDINS, V47, P437, DOI 10.1016/0090-6980(94)90044-2; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Massberg S, 2010, NAT MED; Moussa L, 2007, AM J PATHOL, V171, P800, DOI 10.2353/ajpath.2007.061155; Nomura K, 2007, LAB INVEST, V87, P150, DOI 10.1038/labinvest.3700502; Oh P, 2012, J BIOL CHEM, V287, P17353, DOI 10.1074/jbc.M111.338897; Preston GA, 2002, J AM SOC NEPHROL, V13, P2840, DOI 10.1097/01.ASN.0000034911.03334.C3; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Russo A, 2009, MOL INTERV, V9, P87, DOI 10.1124/mi.9.2.8; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Sarangi PP, 2010, BRIT J HAEMATOL, V148, P817, DOI 10.1111/j.1365-2141.2009.08020.x; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Steppich BA, 2008, THROMB HAEMOSTASIS, V100, P1068, DOI 10.1160/TH08-05-0293; STORCK J, 1995, THROMB RES, V77, P249, DOI 10.1016/0049-3848(95)91612-O; Suzuki T, 2009, AM J RESP CELL MOL, V41, P742, DOI 10.1165/rcmb.2008-0157OC; Tanaka M, 2005, KIDNEY INT, V67, P2123, DOI 10.1111/j.1523-1755.2005.00317.x; Tull SP, 2006, CIRC RES, V98, P98, DOI 10.1161/01.RES.0000198386.69355.87; Uehara A, 2003, J IMMUNOL, V170, P5690, DOI 10.4049/jimmunol.170.11.5690; Uehara A, 2002, J IMMUNOL, V169, P4594, DOI 10.4049/jimmunol.169.8.4594; Vesey DA, 2007, AM J PHYSIOL-RENAL, V293, pF1441, DOI 10.1152/ajprenal.00088.2007; Villegas-Mendez A, 2007, J THROMB HAEMOST, V5, P980, DOI 10.1111/j.1538-7836.2007.02480.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Xiao YP, 2011, J BIOL CHEM, V286, P22991, DOI 10.1074/jbc.M110.204271; XU YC, 1995, AM J PATHOL, V146, P101	59	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2012	7	8							e43916	10.1371/journal.pone.0043916	http://dx.doi.org/10.1371/journal.pone.0043916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZC	22952809	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206000060
J	Gallardo-Romero, NF; Drew, CP; Weiss, SL; Metcalfe, MG; Nakazawa, YJ; Smith, SK; Emerson, GL; Hutson, CL; Salzer, JS; Bartlett, JH; Olson, VA; Clemmons, CJ; Davidson, WB; Zaki, SR; Karem, KL; Damon, IK; Carroll, DS				Gallardo-Romero, Nadia F.; Drew, Clifton P.; Weiss, Sonja L.; Metcalfe, Maureen G.; Nakazawa, Yoshinori J.; Smith, Scott K.; Emerson, Ginny L.; Hutson, Christina L.; Salzer, Johanna S.; Bartlett, Jeanine H.; Olson, Victoria A.; Clemmons, Cody J.; Davidson, Whitni B.; Zaki, Sherif R.; Karem, Kevin L.; Damon, Inger K.; Carroll, Darin S.			The Pox in the North American Backyard: Volepox Virus Pathogenesis in California Mice (Peromyscus californicus)	PLOS ONE			English	Article							ORTHOPOXVIRUS; ANIMALS	Volepox virus (VPXV) was first isolated in 1985 from a hind foot scab of an otherwise healthy California vole (Microtus californicus). Subsequent surveys in San Mateo County, CA, revealed serological evidence suggesting that VPXV is endemic to this area, and a second viral isolate from a Pinyon mouse (Peromyscus truei) was collected in 1988. Since then, few studies have been conducted regarding the ecology, pathology, and pathogenicity of VPXV, and its prevalence and role as a potential zoonotic agent remain unknown. To increase our understanding of VPXV disease progression, we challenged 24 California mice (Peromyscus californicus) intranasally with 1.6x10(3) PFU of purified VPXV. By day five post infection (pi) we observed decreased activity level, conjunctivitis, ruffled hair, skin lesions, facial edema, and crusty noses. A mortality rate of 54% was noted by day eight pi. In addition, internal organ necrosis and hemorrhages were observed during necropsy of deceased or euthanized animals. Viral loads in tissues (brain, gonad, kidney, liver, lung, spleen, submandibular lymph node, and adrenal gland), bodily secretions (saliva, and tears), and excretions (urine, and/or feces) were evaluated and compared using real time-PCR and tissue culture. Viral loads measured as high as 2x10(9) PFU/mL in some organs. Our results suggest that VPXV can cause extreme morbidity and mortality within rodent populations sympatric with the known VPXV reservoirs.	[Gallardo-Romero, Nadia F.; Weiss, Sonja L.; Nakazawa, Yoshinori J.; Smith, Scott K.; Emerson, Ginny L.; Hutson, Christina L.; Salzer, Johanna S.; Olson, Victoria A.; Clemmons, Cody J.; Davidson, Whitni B.; Karem, Kevin L.; Damon, Inger K.; Carroll, Darin S.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Drew, Clifton P.; Metcalfe, Maureen G.; Bartlett, Jeanine H.; Zaki, Sherif R.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Salzer, Johanna S.] Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University	Gallardo-Romero, NF (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.	hfa5@cdc.gov						Alexander A.D., 1972, Journal Wildl Dis, V8, P119; BAUER DF, 1972, J AM STAT ASSOC, V67, P687, DOI 10.2307/2284469; CAVALLARO KF, 1992, VIROLOGY, V190, P434, DOI 10.1016/0042-6822(92)91229-N; Che-Sheng C, 1998, J VIROL, V72, P1577; CHERRY JD, 1977, J INFECT DIS, V135, P176, DOI 10.1093/infdis/135.1.176; Damon IK, 2007, FIELDS VIROLOGY, P2947; DEMKOWICZ WE, 1992, J VIROL, V66, P386, DOI 10.1128/JVI.66.1.386-398.1992; Emerson GL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007666; ESPOSITO JJ, 1978, VIROLOGY, V89, P53, DOI 10.1016/0042-6822(78)90039-9; Fenner F, 1998, EPIDEMIOLOGY SAMLLPO, P169; Fenner Frank, 1994, V5, P27; Gallardo-Romero NF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-313; GORDON J, 1988, VIROLOGY, V167, P361, DOI 10.1016/S0042-6822(88)90096-7; Guarner J, 2004, EMERG INFECT DIS, V10, P426, DOI 10.3201/eid1003.030878; Hollander M., 1973, NONPARAMETRIC STAT M; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2010, VIROLOGY, V402, P72, DOI 10.1016/j.virol.2010.03.012; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006; KNIGHT JC, 1992, VIROLOGY, V190, P423, DOI 10.1016/0042-6822(92)91228-M; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; REGNERY DC, 1987, ARCH VIROL, V94, P159, DOI 10.1007/BF01313734; Regnery RL, 2007, WILDLIFE EMERGING ZO, P522; SEKI M, 1990, VIROLOGY, V175, P372, DOI 10.1016/0042-6822(90)90422-N; Smith SK, 2011, J VIROL, V85, P9176, DOI 10.1128/JVI.02173-10; VANSLYKE JK, 1991, VIROLOGY, V183, P467, DOI 10.1016/0042-6822(91)90976-I; Wu PJ, 1999, J ZOO WILDLIFE MED, V30, P589	27	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43881	10.1371/journal.pone.0043881	http://dx.doi.org/10.1371/journal.pone.0043881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952799	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600053
J	Sage, J; Leblanc-Noblesse, E; Nizard, C; Sasaki, T; Schnebert, S; Perrier, E; Kurfurst, R; Bromme, D; Lalmanach, G; Lecaille, F				Sage, Juliette; Leblanc-Noblesse, Emmanuelle; Nizard, Carine; Sasaki, Takako; Schnebert, Sylvianne; Perrier, Eric; Kurfurst, Robin; Broemme, Dieter; Lalmanach, Gilles; Lecaille, Fabien			Cleavage of Nidogen-1 by Cathepsin S Impairs Its Binding to Basement Membrane Partners	PLOS ONE			English	Article							THYROGLOBULIN TYPE-1 DOMAIN; LYSOSOMAL CYSTEINE PROTEINASES; EXTRACELLULAR-MATRIX; SJOGRENS-SYNDROME; HUMAN MACROPHAGES; BASAL LAMINA; IN-VITRO; INHIBITOR; DEGRADATION; PROTEASES	Cathepsin S (catS), which is expressed in normal human keratinocytes and localized close to the dermal-epidermal junction (DEJ) degrades some of major basement membrane (BM) constituents. Among them, catS readily hydrolyzed in a time and dose dependent manner human nidogen-1 (nid-1) and nidogen-2, which are key proteins in the BM structure. CatS preferentially cleaved nid-1 at both acid and neutral pH. Hydrolysis of nid-1 was hampered in murine ctss(-/-) spleen lysates pretreated with inhibitors of other classes of proteases. Nid-1 was cleaved within its G2 and G3 globular domains that are both involved in interactions with other BM components. Binding assays with soluble and immobilized ligands indicated that catS altered the formation of complexes between nid-1 and other BM components. Assuming that the cleavage of nid-1 impairs its ability to crosslink with BM partners and perturbs the viscoelastic properties of BM matrix, these data indicate that catS may participate in BM proteolysis, in addition to already identified proteases.	[Sage, Juliette; Lalmanach, Gilles; Lecaille, Fabien] INSERM, UMR 1100, Ctr Etud Pathol Resp, Tours, France; [Sage, Juliette; Lalmanach, Gilles; Lecaille, Fabien] Univ Tours, UMR 1100, Tours, France; [Sage, Juliette; Leblanc-Noblesse, Emmanuelle; Nizard, Carine; Schnebert, Sylvianne; Perrier, Eric; Kurfurst, Robin] Louis Vuitton Moet Hennessy LVMH Rech, St Jean De Braye, France; [Nizard, Carine] Ctr Rech Cordeliers, Lab Pharmacol Cellulaire, Ecole Prat Hautes Etud, Paris, France; [Sasaki, Takako] Univ Erlangen Nurnberg, Dept Expt Med 1, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Broemme, Dieter] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Universite Paris Cite; University of Erlangen Nuremberg; University of British Columbia	Sage, J (corresponding author), INSERM, UMR 1100, Ctr Etud Pathol Resp, Tours, France.	fabien.lecaille@univ-tours.fr	Lecaille, Fabien/GRY-5313-2022	Lecaille, Fabien/0000-0003-1060-4222; Lalmanach, Gilles/0000-0001-8562-4821	LVMH Recherche (Saint Jean de Braye, France); Institut National de la Sante et de la Recherche Medicale (INSERM); Canada Research Chair award; Association Nationale de la Recherche Technique (ANRT, France; CIFRE)	LVMH Recherche (Saint Jean de Braye, France); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Association Nationale de la Recherche Technique (ANRT, France; CIFRE)	This work was financially supported by LVMH Recherche (Saint Jean de Braye, France) and by institutional funding from the Institut National de la Sante et de la Recherche Medicale (INSERM). DB was supported by a Canada Research Chair award. JS holds a doctoral fellowship from the Association Nationale de la Recherche Technique (ANRT, France; CIFRE PhD funding). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BATTAGLIA C, 1992, EUR J BIOCHEM, V208, P359, DOI 10.1111/j.1432-1033.1992.tb17195.x; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Breitkreutz D, 2004, J CELL SCI, V117, P2611, DOI 10.1242/jcs.01127; Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0; Buth H, 2004, EUR J CELL BIOL, V83, P781, DOI 10.1078/0171-9335-00428; Dalet-Fumeron V, 1998, ARCH BIOCHEM BIOPHYS, V358, P283, DOI 10.1006/abbi.1998.0868; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; DZIADEK M, 1988, EUR J BIOCHEM, V172, P219, DOI 10.1111/j.1432-1033.1988.tb13876.x; EKBLOM P, 1994, DEVELOPMENT, V120, P2003; ENGEL J, 1980, MOL IMMUNOL, V17, P675, DOI 10.1016/0161-5890(80)90166-2; FLEISCHMAJER R, 1995, J INVEST DERMATOL, V105, P597, DOI 10.1111/1523-1747.ep12323604; Fowlkes JL, 1997, ENDOCRINOLOGY, V138, P2280, DOI 10.1210/en.138.6.2280; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; GUINEC N, 1992, FEBS LETT, V308, P305, DOI 10.1016/0014-5793(92)81299-2; Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Kwon YJ, 2006, ARTHRITIS RHEUM, V54, P3465, DOI 10.1002/art.22177; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Lenarcic B, 1997, J BIOL CHEM, V272, P13899; Lenarcic B, 1999, J BIOL CHEM, V274, P563, DOI 10.1074/jbc.274.2.563; Lenarcic B, 1998, BIOL CHEM, V379, P105; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; MAYER U, 1993, EUR J BIOCHEM, V217, P877, DOI 10.1111/j.1432-1033.1993.tb18316.x; MAYER U, 1995, EUR J BIOCHEM, V227, P681, DOI 10.1111/j.1432-1033.1995.tb20188.x; Meh P, 2005, BIOL CHEM, V386, P75, DOI 10.1515/BC.2005.010; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Molina F, 1996, EUR J BIOCHEM, V240, P125, DOI 10.1111/j.1432-1033.1996.0125h.x; NAGAYOSHI T, 1989, DNA-J MOLEC CELL BIO, V8, P581, DOI 10.1089/dna.1989.8.581; Novinec M, 2006, MOL BIOL EVOL, V23, P744, DOI 10.1093/molbev/msj082; OHMAN H, 1994, ACTA DERM-VENEREOL, V74, P375; PAULSSON M, 1986, EUR J BIOCHEM, V156, P467, DOI 10.1111/j.1432-1033.1986.tb09605.x; Pungercic G, 2002, BIOL CHEM, V383, P1809, DOI 10.1515/BC.2002.202; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Ries A, 2001, EUR J BIOCHEM, V268, P5119, DOI 10.1046/j.0014-2956.2001.02437.x; Schonefuss A, 2010, EXP DERMATOL, V19, pE80, DOI 10.1111/j.1600-0625.2009.00990.x; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; SIRES UI, 1993, J BIOL CHEM, V268, P2069; Small DM, 2011, CLIN REV BONE MINER, V9, P122, DOI 10.1007/s12018-011-9095-5; Sohar N, 2005, CLIN BIOCHEM, V38, P1120, DOI 10.1016/j.clinbiochem.2005.09.003; Titz B, 2004, CELL MOL LIFE SCI, V61, P1826, DOI 10.1007/s00018-004-4105-0; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; Yamashita M, 1996, J BIOL CHEM, V271, P1282, DOI 10.1074/jbc.271.3.1282; Zullani T, 2005, FREE RADICAL BIO MED, V38, P307, DOI 10.1016/j.freeradbiomed.2004.09.021	53	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43494	10.1371/journal.pone.0043494	http://dx.doi.org/10.1371/journal.pone.0043494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952693	Green Submitted, Green Published, gold			2022-12-27	WOS:000308213600027
J	Crequer, A; Picard, C; Patin, E; D'Amico, A; Abhyankar, A; Munzer, M; Debre, M; Zhang, SY; de Saint-Basile, G; Fischer, A; Abel, L; Orth, G; Casanova, JL; Jouanguy, E				Crequer, Amandine; Picard, Capucine; Patin, Etienne; D'Amico, Aurelia; Abhyankar, Avinash; Munzer, Martine; Debre, Marianne; Zhang, Shen-Ying; de Saint-Basile, Genevieve; Fischer, Alain; Abel, Laurent; Orth, Gerard; Casanova, Jean-Laurent; Jouanguy, Emmanuelle			Inherited MST1 Deficiency Underlies Susceptibility to EV-HPV Infections	PLOS ONE			English	Article							SEQUENCING-BASED DISCOVERY; STEM-CELL TRANSPLANTATION; EPIDERMODYSPLASIA-VERRUCIFORMIS; HUMAN PAPILLOMAVIRUSES; XERODERMA-PIGMENTOSUM; JAPANESE PATIENT; REFERENCE VALUES; EVER1/TMC6 GENE; DNA-REPAIR; MUTATION	Epidermodysplasia verruciformis (EV) is characterized by persistent cutaneous lesions caused by a specific group of related human papillomavirus genotypes (EV-HPVs) in otherwise healthy individuals. Autosomal recessive (AR) EVER1 and EVER2 deficiencies account for two thirds of known cases of EV. AR RHOH deficiency has recently been described in two siblings with EV-HPV infections as well as other infectious and tumoral manifestations. We report here the whole-exome based discovery of AR MST1 deficiency in a 19-year-old patient with a T-cell deficiency associated with EV-HPV, bacterial and fungal infections. MST1 deficiency has recently been described in seven patients from three unrelated kindreds with profound T-cell deficiency and various viral and bacterial infections. The patient was also homozygous for a rare ERCC3 variation. Our findings broaden the clinical range of infections seen in MST1 deficiency and provide a new genetic etiology of susceptibility to EV-HPV infections. Together with the recent discovery of RHOH deficiency, they suggest that T cells are involved in the control of EV-HPVs, at least in some individuals.	[Crequer, Amandine; D'Amico, Aurelia; Abhyankar, Avinash; Zhang, Shen-Ying; Abel, Laurent; Casanova, Jean-Laurent; Jouanguy, Emmanuelle] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Crequer, Amandine; Picard, Capucine; Fischer, Alain; Abel, Laurent; Casanova, Jean-Laurent; Jouanguy, Emmanuelle] Paris Descartes Univ, Sorbonne Paris Cite, Fac Med Necker, Paris, France; [Picard, Capucine; Zhang, Shen-Ying; Abel, Laurent; Casanova, Jean-Laurent; Jouanguy, Emmanuelle] INSERM, U980, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiencies, Paris, France; [Patin, Etienne] Inst Pasteur, CNRS, Genomes & Genet Dept, Human Evolutionary Genet URA 3012, Paris, France; [Munzer, Martine] Ctr Hosp Reg & Univ CHU Reims, Amer Mem Hosp, Dept Pediat, Reims, France; [Debre, Marianne; Fischer, Alain; Casanova, Jean-Laurent] Hop Necker Enfants Malad, AP HP, Pediat Immunohematol Unit, Paris, France; [de Saint-Basile, Genevieve; Fischer, Alain] INSERM, U768, Lab Normal & Pathol Dev Immune Syst, Paris, France; [Orth, Gerard] Inst Pasteur, Dept Virol, Paris, France	Rockefeller University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU de Reims; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Crequer, A (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.	Emmanuelle.jouanguy@inserm.fr	Jouanguy, Emmanuelle/H-7901-2017; Casanova, Jean-Laurent/I-3418-2017; Zhang, Shen-Ying/I-2685-2017; Picard, Capucine/H-3914-2017; ORTH, Gérard C/C-2518-2009; Abel, Laurent/H-8888-2017; de Saint Basile, Genevieve/G-9731-2017	Jouanguy, Emmanuelle/0000-0002-7358-9157; Zhang, Shen-Ying/0000-0002-9449-3672; Picard, Capucine/0000-0001-8788-5056; Abel, Laurent/0000-0001-7016-6493; Casanova, Jean-Laurent/0000-0002-7782-4169; Patin, Etienne/0000-0002-9911-4459; Crequer-Grandhomme, Amandine/0000-0003-4866-7085; de Saint Basile, Genevieve/0000-0002-1913-5269	INSERM; University Paris Descartes; Rockefeller University; Rockefeller University CTSA grant [5UL1RR024143]; St. Giles Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes; Rockefeller University; Rockefeller University CTSA grant; St. Giles Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from INSERM, University Paris Descartes, the Rockefeller University, the Rockefeller University CTSA grant number 5UL1RR024143, and the St. Giles Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Andre-Schmutz I, 2002, LANCET, V360, P130, DOI 10.1016/S0140-6736(02)09413-8; Aochi S, 2007, BRIT J DERMATOL, V157, P1265, DOI 10.1111/j.1365-2133.2007.08206.x; Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Berthelot C, 2007, J AM ACAD DERMATOL, V56, P882, DOI 10.1016/j.jaad.2007.01.036; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Cockayne EA, 1933, INHERITED ABNORMALIT; Crequer A, 2012, J CLIN INVE IN PRESS; Daly ML, 2012, CURR OPIN INFECT DIS; de Saint Basile G, 2004, J CLIN INVEST, V114, P1512, DOI 10.1172/JCI200422588; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Eidenschenk C, 2006, J IMMUNOL, V177, P8835, DOI 10.4049/jimmunol.177.12.8835; Eller MS, 1997, P NATL ACAD SCI USA, V94, P12627, DOI 10.1073/pnas.94.23.12627; Gober MD, 2007, J INVEST DERMATOL, V127, P817, DOI 10.1038/sj.jid.5700641; GROSS G, 1988, J INVEST DERMATOL, V91, P43, DOI 10.1111/1523-1747.ep12463287; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 1917, J EXP MED, V208, P1635; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Lutzner M A, 1985, Clin Dermatol, V3, P165, DOI 10.1016/0738-081X(85)90061-6; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Oh KS, 2006, HUM MUTAT, V27, P1092, DOI 10.1002/humu.20392; Orth G, 2008, CURR TOP MICROBIOL, V321, P59; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; Rady PL, 2007, BRIT J DERMATOL, V157, P831, DOI 10.1111/j.1365-2133.2007.08123.x; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Rogers HD, 2009, J AM ACAD DERMATOL, V60, P315, DOI 10.1016/j.jaad.2008.08.035; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Sun XK, 2005, CLIN EXP DERMATOL, V30, P573, DOI 10.1111/j.1365-2230.2005.01858.x; Tan MJA, 2012, P NATL ACAD SCI USA, V109, pE1473, DOI 10.1073/pnas.1205991109; Tate G, 2004, J HUM GENET, V49, P223, DOI 10.1007/s10038-004-0135-6; Tunnacliffe A, 1989, Int Immunol, V1, P546, DOI 10.1093/intimm/1.5.546; Wang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn641; WEEDA G, 1991, NUCLEIC ACIDS RES, V19, P6301, DOI 10.1093/nar/19.22.6301; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105; Zuo YG, 2006, J DERMATOL SCI, V44, P153, DOI 10.1016/j.jdermsci.2006.08.013	50	89	89	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44010	10.1371/journal.pone.0044010	http://dx.doi.org/10.1371/journal.pone.0044010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952854	gold, Green Submitted, Green Published			2022-12-27	WOS:000308044800088
J	Dave, SS; Copas, A; Richens, J; White, RG; Kosambiya, JK; Desai, VK; Stephenson, JM				Dave, Sangeeta S.; Copas, Andrew; Richens, John; White, Richard G.; Kosambiya, Jayendrakumar K.; Desai, Vikas K.; Stephenson, Judith M.			HIV and STI Prevalence and Determinants among Male Migrant Workers in India	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS; MALE RURAL MIGRANTS; NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; URINE SPECIMENS; SOUTH-AFRICA; RISK-FACTORS; INFECTION; MEN	Background: Our objective was to estimate for the first time the prevalence and determinants of human immunodeficiency virus type 1 (HIV-1) and sexually transmitted infections (STIs) among male migrants in India. Methodology/Principal Findings: We conducted a multi-stage stratified probability sample survey of migrant (defined as not born in Surat city) men aged 18 to 49 years working in the diamond and textile industries in Surat city. Behavioural and biological data were collected. Biological data included laboratory diagnosed herpes simplex virus type 2 (HSV-2), syphilis, chlamydia, gonorrhoea, Trichomonas vaginalis (together defined as 'any STI') and HIV-1. Likely recently acquired STIs included chlamydia, gonorrhoea, T. vaginalis and syphilis with rapid plasma reagin >= 1.8. The response rate was 77% (845/1099). Among 841 participants, HIV-1 prevalence was 1.0%, 'any STI' prevalence was 9.5% and 38.9% of these STIs were likely to have been recently acquired. Being a diamond worker, Surat resident for 10+ years and recent antibiotic use were each associated with higher odds of 'any STI' (aORs 1.83 (95% CI 1.09-3.09), 1.98 (95% CI 1.22-3.22) and 2.57 (95% CI 1.17-5.64), respectively) after adjusting for the other two factors and age. The main study limitation was social desirability bias for self-reported sexual behaviour; STIs were diagnosed in some self-reported virgins. Conclusions/Significance: HIV and STI prevalence were lower than expected, but prevention interventions remain necessary in Surat since almost 40% of STIs among participants were probably recently acquired and sentinel surveillance HIV prevalence remains high. The participants had a similar HIV prevalence to Surat antenatal clinic attendees, a proxy for the general population. This suggests migrants are not always at higher risk of HIV compared to the general population in their migration destination. Our findings highlight the need to contextualise research findings from a specific setting with other local information to guide HIV/STI prevention interventions.	[Dave, Sangeeta S.; Stephenson, Judith M.] UCL, Inst Womens Hlth, London, England; [Copas, Andrew; Richens, John] UCL, Ctr Sexual Hlth & HIV Res, London, England; [White, Richard G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Kosambiya, Jayendrakumar K.; Desai, Vikas K.] Govt Med Coll, Dept Community Med, Surat, Gujarat, India	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Dave, SS (corresponding author), UCL, Inst Womens Hlth, London, England.	sangeeta_s_dave@yahoo.co.uk	White, Richard G/D-5407-2009; Richens, John/C-1876-2008	White, Richard G/0000-0003-4410-6635; Copas, Andrew/0000-0001-8968-5963	Wellcome Trust Health Consequences of Population Change Fellowship [WT074061AIA]; Medical Research Council (UK) Methodology Research Fellowship [G0802414]; Bill & Melinda Gates Foundation [19790.01]; EU FP7 [242061]; MRC [G0802414] Funding Source: UKRI; Medical Research Council [G0802414] Funding Source: researchfish	Wellcome Trust Health Consequences of Population Change Fellowship(Wellcome Trust); Medical Research Council (UK) Methodology Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); EU FP7(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SSD was funded by a Wellcome Trust Health Consequences of Population Change Fellowship (WT074061AIA, http://www.wellcome.ac.uk). RGW is funded by a Medical Research Council (UK) Methodology Research Fellowship (G0802414, www.mrc.ac.uk/), the Bill & Melinda Gates Foundation (19790.01, www.gatesfoundation.org/), and the EU FP7 (242061, http://ec.europa.eu/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; Boerma JT, 2005, J INFECT DIS, V191, pS61, DOI 10.1086/425282; Boerma JT, 2003, SEX TRANSM DIS, V30, P779, DOI 10.1097/01.OLQ.0000078820.62897.A6; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Deering KN, 2008, AIDS, V22, pS165, DOI 10.1097/01.aids.0000343774.59776.95; Faisel A, 2006, SEX TRANSM INFECT, V82, P307, DOI 10.1136/sti.2005.018762; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Goh BT, 2005, SEX TRANSM INFECT, V81, P448, DOI 10.1136/sti.2005.015875; Hawkes S, 2002, SEX TRANSM INFECT, V78, pI31, DOI 10.1136/sti.78.suppl_1.i31; He N, 2009, INT J STD AIDS, V20, P112, DOI 10.1258/ijsa.2008.008217; He N, 2005, SEX TRANSM DIS, V32, P286, DOI 10.1097/01.olq.0000152219.58592.9b; Health & Family Welfare Department Government of Gujarat, 2006, GUJ STAT AIDS CONTR; Health & Family Welfare Department Government of Gujarat, 2005, GUJ STAT AIDS CONTR; Health & Family Welfare Department Government of Gujarat, 2008, GUJ STAT AIDS CONTR; Health & Family Welfare Department Government of Gujarat, 2007, GUJ STAT AIDS CONTR; IIPS, 2007, IND NAT FAM HLTH SUR, V1; KANE F, 1993, AIDS, V7, P1261, DOI 10.1097/00002030-199309000-00017; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Lindan C, 2005, J CLIN MICROBIOL, V43, P1674, DOI 10.1128/JCM.43.4.1674-1677.2005; Lowndes CM, 2012, AIDS BEHAV, V16, P1054, DOI 10.1007/s10461-011-0004-1; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Morre SA, 2000, J CLIN MICROBIOL, V38, P1679; National AIDS Control Organisation Ministry of Health and Family Welfare Government of India, 2006, D91 SECURESCM; National AIDS Control Organisation Ministry of Health and Family Welfare Government of India, 2006, NAT BEH SURV SURV BS; National AIDS Control Organization Department of AIDS Control Ministry of Health and Family Welfare Government of India, 2010, POL STRAT OP PLAN HI; Poudel KC, 2003, TROP MED INT HEALTH, V8, P933, DOI 10.1046/j.1365-3156.2003.01110.x; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Saggurti N, 2009, AIDS BEHAV, V13, P921, DOI 10.1007/s10461-009-9564-8; Todd J, 2001, SEX TRANSM INFECT, V77, P37, DOI 10.1136/sti.77.1.37; UNAIDS, 2010, REP GLOB AIDS EP; Van der Pol B, 2001, J CLIN MICROBIOL, V39, P3092, DOI 10.1128/JCM.39.9.3092-3098.2001; Wang W, 2010, INT J STD AIDS, V21, P410, DOI 10.1258/ijsa.2009.008518; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; White RG, 2003, INT J EPIDEMIOL, V32, P753, DOI 10.1093/ije/dyg265	37	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43576	10.1371/journal.pone.0043576	http://dx.doi.org/10.1371/journal.pone.0043576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952708	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000308044800039
J	Petre, B; Morin, E; Tisserant, E; Hacquard, S; Da Silva, C; Poulain, J; Delaruelle, C; Martin, F; Rouhier, N; Kohler, A; Duplessis, S				Petre, Benjamin; Morin, Emmanuelle; Tisserant, Emilie; Hacquard, Stephane; Da Silva, Corinne; Poulain, Julie; Delaruelle, Christine; Martin, Francis; Rouhier, Nicolas; Kohler, Annegret; Duplessis, Sebastien			RNA-Seq of Early-Infected Poplar Leaves by the Rust Pathogen Melampsora larici-populina Uncovers PtSultr3;5, a Fungal-Induced Host Sulfate Transporter	PLOS ONE			English	Article							GENOME-WIDE ANALYSES; LEAF RUST; OBLIGATE BIOTROPHY; SECRETED PROTEINS; LACCARIA-BICOLOR; EFFECTOR PROTEIN; FLAX RUST; PLANT; EXPRESSION; GENES	Biotroph pathogens establish intimate interactions with their hosts that are conditioned by the successful secretion of effectors in infected tissues and subsequent manipulation of host physiology. The identification of early-expressed pathogen effectors and early-modulated host functions is currently a major goal to understand the molecular basis of biotrophy. Here, we report the 454-pyrosequencing transcriptome analysis of early stages of poplar leaf colonization by the rust fungus Melampsora larici-populina. Among the 841,301 reads considered for analysis, 616,879 and 649 were successfully mapped to Populus trichocarpa and M. larici-populina genome sequences, respectively. From a methodological aspect, these results indicate that this single approach is not appropriate to saturate poplar transcriptome and to follow transcript accumulation of the pathogen. We identified 19 pathogen transcripts encoding early-expressed small-secreted proteins representing candidate effectors of interest for forthcoming studies. Poplar RNA-Seq data were validated by oligoarrays and quantitatively analysed, which revealed a highly stable transcriptome with a single transcript encoding a sulfate transporter (herein named PtSultr3; 5, POPTR_0006s16150) showing a dramatic increase upon colonization by either virulent or avirulent M. larici-populina strains. Perspectives connecting host sulfate transport and biotrophic lifestyle are discussed.	[Petre, Benjamin; Morin, Emmanuelle; Tisserant, Emilie; Hacquard, Stephane; Delaruelle, Christine; Martin, Francis; Rouhier, Nicolas; Kohler, Annegret; Duplessis, Sebastien] Univ Lorraine, Ctr INRA Nancy, UMR Interact Arbres Microorgan 1136, INRA, Champenoux, France; [Da Silva, Corinne; Poulain, Julie] CEA Genoscope, Ctr Natl Sequencage, Evry, France	INRAE; Universite de Lorraine; CEA; UDICE-French Research Universities; Universite Paris Saclay	Petre, B (corresponding author), Univ Lorraine, Ctr INRA Nancy, UMR Interact Arbres Microorgan 1136, INRA, Champenoux, France.	duplessi@nancy.inra.fr	Petre, Benjamin/AAF-1156-2019; , DUPLESSIS/G-4150-2011; morin, emmanuelle/AAA-1246-2019; Kohler, Annegret/AAD-1876-2019	Petre, Benjamin/0000-0002-3204-4249; , DUPLESSIS/0000-0002-2072-2989; morin, emmanuelle/0000-0002-7268-972X; DA SILVA, Corinne/0000-0002-7618-7831; Rouhier, Nicolas/0000-0002-2036-7884; Poulain, Julie/0000-0002-8744-3116	CG Lorraine (France); INRA innovating grant	CG Lorraine (France); INRA innovating grant	This work was founded by grants of the CG Lorraine (France) to S. Duplessis and F. Martin and an INRA innovating grant to S. Duplessis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sequencing was supported by the CEA-Genoscope in the frame of a collaborative project. The CEA-Genoscope had no role in the study design, analysis of the data or preparation of the manuscript. The CEA-Genoscope was in charge of 454-data production and collection, and provided agreement on the final version of the manuscript prior publication.	Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Azaiez A, 2009, MOL PLANT MICROBE IN, V22, P190, DOI 10.1094/MPMI-22-2-0190; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boyle B, 2005, APPL ENVIRON MICROB, V71, P1546, DOI 10.1128/AEM.71.3.1546-1552.2005; Boyle B, 2010, PLANT BIOLOGY, V12, P364, DOI 10.1111/j.1438-8677.2009.00310.x; Caillaud MC, 2012, PLANT J, V69, P252, DOI 10.1111/j.1365-313X.2011.04787.x; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; de Jonge R, 2011, CURR OPIN PLANT BIOL, V14, P400, DOI 10.1016/j.pbi.2011.03.005; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dowkiw A, 2003, PHYTOPATHOLOGY, V93, P421, DOI 10.1094/PHYTO.2003.93.4.421; Durr J, 2010, PLANT MOL BIOL, V72, P499, DOI 10.1007/s11103-009-9587-6; Duplessis S., 2012, EFFECTORS PLANT MICR; Duplessis S, 2011, MOL PLANT MICROBE IN, V24, P808, DOI 10.1094/MPMI-01-11-0006; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Duplessis S, 2009, CRIT REV PLANT SCI, V28, P309, DOI 10.1080/07352680903241063; Felten J, 2009, PLANT PHYSIOL, V151, P1991, DOI 10.1104/pp.109.147231; Fernandez D, 2012, MOL PLANT PATHOL, V5, P515; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hacquard S, 2011, J PATHOG, V2011, DOI 10.4061/2011/716041; Hacquard S, 2012, MOL PLANT MICROBE IN, V25, P279, DOI 10.1094/MPMI-09-11-0238; Hacquard S, 2011, PHYSIOL MOL PLANT P, V75, P106, DOI 10.1016/j.pmpp.2010.10.003; Hacquard S, 2010, MOL PLANT MICROBE IN, V23, P1275, DOI 10.1094/MPMI-05-10-0111; Hahn M, 1997, MOL PLANT MICROBE IN, V10, P427, DOI 10.1094/MPMI.1997.10.4.427; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Hok S, 2010, MOL PLANT MICROBE IN, V23, P1253, DOI 10.1094/MPMI-04-10-0103; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kataoka T, 2004, PLANT PHYSIOL, V136, P4198, DOI 10.1104/pp.104.045625; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Koeck M, 2011, CELL MICROBIOL, V13, P1849, DOI 10.1111/j.1462-5822.2011.01665.x; Krusell L, 2005, PLANT CELL, V17, P1625, DOI 10.1105/tpc.104.030106; Kumar S, 2011, FUNCT INTEGR GENOMIC, V11, P259, DOI 10.1007/s10142-010-0207-y; Laurans E, 1999, PHYTOPATHOLOGY, V89, P233, DOI 10.1094/PHYTO.1999.89.3.233; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Nirmala J, 2010, MOL PLANT MICROBE IN, V23, P1635, DOI 10.1094/MPMI-06-10-0136; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Schmidt SM, 2011, CURR OPIN PLANT BIOL, V14, P392, DOI 10.1016/j.pbi.2011.03.006; Schneider D, 2010, IEEE SPECTRUM, V47, P48, DOI 10.1109/MSPEC.2010.5372501; Schneider KT, 2011, PLANT PHYSIOL, V157, P355, DOI 10.1104/pp.111.181149; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schulze-Lefert P, 2011, TRENDS PLANT SCI, V16, P117, DOI 10.1016/j.tplants.2011.01.001; Simon SA, 2009, ANNU REV PLANT BIOL, V60, P305, DOI 10.1146/annurev.arplant.043008.092032; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Talbot NJ, 2010, NATURE, V510, P468; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wessling R, 2012, FUNGAL GENET BIOL, V49, P470, DOI 10.1016/j.fgb.2012.04.001; Wienkoop S, 2003, PLANT PHYSIOL, V131, P1080, DOI 10.1104/pp.102.015362; Wise RP, 2007, ANNU REV PHYTOPATHOL, V45, P329, DOI 10.1146/annurev.phyto.45.011107.143944; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	72	50	51	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44408	10.1371/journal.pone.0044408	http://dx.doi.org/10.1371/journal.pone.0044408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952974	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500069
J	Zhang, T; Mu, YG				Zhang, Tong; Mu, Yuguang			Initial Binding of Ions to the Interhelical Loops of Divalent Ion Transporter CorA: Replica Exchange Molecular Dynamics Simulation Study	PLOS ONE			English	Article							MAGNESIUM TRANSPORT; CRYSTAL-STRUCTURE; MG2+; CHEMISTRY; CATION; DNA	Crystal structures of Thermotoga maritima magnesium transporter CorA, reported in 2006, revealed its homo-pentameric constructions. However, the structure of the highly conserved extracellular interhelical loops remains unsolved, due to its high flexibility. We have explored the configurations of the loops through extensive replica exchange molecular dynamics simulations in explicit solvent model with the presence of either Co(III) Hexamine ions or Mg2+ ions. We found that there are multiple binding sites available on the interhelical loops in which the negatively charged residues, E316 and E320, are located notably close to the positively charged ions during the simulations. Our simulations resolved the distinct binding patterns of the two kinds of ions: Co(III) Hexamine ions were found to bind stronger with the loop than Mg2+ ions with binding free energy -7.3 kJ/mol lower, which is nicely consistent with the previous data. Our study provides an atomic basis description of the initial binding process of Mg2+ ions on the extracellular interhelical loops of CorA and the detailed inhibition mechanism of Co(III) Hexamine ions on CorA ions transportation.	[Zhang, Tong; Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhang, T (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	ygmu@ntu.edu.sg		Zhang, Tong/0000-0003-1011-5189; Zhang, Tong/0000-0002-2046-4502	Nanyang Technological University Tier 1 grant [RG23/11]; Info-communications Development Authority of Singapore Cloud Computing Call 4	Nanyang Technological University Tier 1 grant(Nanyang Technological University); Info-communications Development Authority of Singapore Cloud Computing Call 4	This work is supported by Nanyang Technological University Tier 1 grant RG23/11 and the Info-communications Development Authority of Singapore Cloud Computing Call 4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELYAEV ND, 1988, MOL BIOL+, V22, P1332; Case D, 2006, AMBER 9; Cheatham TE, 1997, STRUCTURE, V5, P1297, DOI 10.1016/S0969-2126(97)00282-7; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dalmas O, 2010, STRUCTURE, V18, P868, DOI 10.1016/j.str.2010.04.009; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frisch G. W., 2013, GAUSSIAN 09; Hansmann UHE, 1997, CHEM PHYS LETT, V281, P140, DOI 10.1016/S0009-2614(97)01198-6; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Hu J, 2009, J BIOL CHEM, V284, P15619, DOI 10.1074/jbc.M901581200; Kiriukhin MY, 2002, BIOPHYS CHEM, V99, P155, DOI 10.1016/S0301-4622(02)00153-9; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Moomaw AS, 2010, BIOCHEMISTRY-US, V49, P5998, DOI 10.1021/bi1005656; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Shao Y, 2006, PHYS CHEM CHEM PHYS, V8, P3172, DOI 10.1039/b517914a; SILVER S, 1969, P NATL ACAD SCI USA, V62, P764, DOI 10.1073/pnas.62.3.764; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Xia Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.222166	32	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43872	10.1371/journal.pone.0043872	http://dx.doi.org/10.1371/journal.pone.0043872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22952795	Green Published, gold			2022-12-27	WOS:000308206500025
J	Wang, CJ; Li, YQ; Wang, L; Li, LL; Guo, YR; Zhang, LY; Zhang, MX; Bie, RH				Wang, Chong-Jian; Li, Yu-Qian; Wang, Ling; Li, Lin-Lin; Guo, Yi-Rui; Zhang, Ling-Yun; Zhang, Mei-Xi; Bie, Rong-Hai			Development and Evaluation of a Simple and Effective Prediction Approach for Identifying Those at High Risk of Dyslipidemia in Rural Adult Residents	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; LOGISTIC-REGRESSION; INCIDENT HYPERTENSION; LDL-CHOLESTEROL; COHORT; CARE	Background: Dyslipidemia is an extremely prevalent but preventable risk factor for cardiovascular disease. However, many dyslipidemia patients remain undetected in resource limited settings. The study was performed to develop and evaluate a simple and effective prediction approach without biochemical parameters to identify those at high risk of dyslipidemia in rural adult population. Methods: Demographic, dietary and lifestyle, and anthropometric data were collected by a cross-sectional survey from 8,914 participants living in rural areas aged 35-78 years. There were 6,686 participants randomly selected into a training group for constructing the artificial neural network (ANN) and logistic regression (LR) prediction models. The remaining 2,228 participants were assigned to a validation group for performance comparisons of ANN and LR models. The predictors of dyslipidemia risk were identified from the training group using multivariate logistic regression analysis. Predictive performance was evaluated by receiver operating characteristic (ROC) curve. Results: Some risk factors were significantly associated with dyslipidemia, including age, gender, educational level, smoking, high-fat diet, vegetable and fruit intake, family history, physical activity, and central obesity. For the ANN model, the sensitivity, specificity, positive and negative likelihood ratio, positive and negative predictive values were 90.41%, 76.66%, 3.87, 0.13, 76.33%, and 90.58%, respectively, while LR model were only 57.37%, 70.91%, 1.97, 0.60, 62.09%, and 66.73%, respectively. The area under the ROC cure (AUC) value of the ANN model was 0.86 +/- 0.01, showing more accurate overall performance than traditional LR model (AUC = 0.68 +/- 0.01, P<0.001). Conclusion: The ANN model is a simple and effective prediction approach to identify those at high risk of dyslipidemia, and it can be used to screen undiagnosed dyslipidemia patients in rural adult population. Further work is planned to confirm these results by incorporating multi-center and longer follow-up data.	[Wang, Chong-Jian; Wang, Ling; Li, Lin-Lin; Guo, Yi-Rui; Zhang, Mei-Xi; Bie, Rong-Hai] Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol & Biostat, Zhengzhou, Henan, Peoples R China; [Li, Yu-Qian] Zhengzhou Univ, Dept Clin Pharmacol, Sch Pharmaceut Sci, Zhengzhou, Henan, Peoples R China; [Zhang, Ling-Yun] Mil Hosp Henan Prov, Dept Endocrinol, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Wang, CJ (corresponding author), Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol & Biostat, Zhengzhou, Henan, Peoples R China.	bierh2012@gmail.com		Wang, Chongjian/0000-0001-5091-6621	National High Technology Research and Development Program of China [2006BAI01A01]; China Postdoctoral Science Foundation [201104375]; Medical Scientific Research Foundation of Health Department of Henan Province [201004042]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Medical Scientific Research Foundation of Health Department of Henan Province	This research was supported by the National High Technology Research and Development Program of China (Grant No: 2006BAI01A01), China Postdoctoral Science Foundation (Grant No: 201104375), and Medical Scientific Research Foundation of Health Department of Henan Province (Grant No: 201004042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; China Adult Dyslipidemia Prevention Committee, 2007, CHIN AD DYSL PREV GU; Chinese Nutrition Society, 2008, CHIN DIET GUID; Crouch R, 2011, INT J EVID-BASED HEA, V9, P236, DOI 10.1111/j.1744-1609.2011.00226.x; Freitas MPD, 2011, CAD SAUDE PUBLICA, V27, pS351, DOI 10.1590/S0102-311X2011001500005; Dumont TM, 2011, WORLD NEUROSURG, V75, P57, DOI 10.1016/j.wneu.2010.07.007; Ergun U, 2004, COMPUT BIOL MED, V34, P389, DOI 10.1016/S0010-4825(03)00085-4; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Forberg JL, 2009, J ELECTROCARDIOL, V42, P58, DOI 10.1016/j.jelectrocard.2008.07.010; Grossi E, 2007, EUR J GASTROEN HEPAT, V19, P1046, DOI 10.1097/MEG.0b013e3282f198a0; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; International Physical Activity and Questionnaire, 2012, SHORT LAST 7 DAYS SE; Iwasaki Y, 2006, CLIN CHEM, V52, P886, DOI 10.1373/clinchem.2005.053983; Kazemnejad A., 2010, Eastern Mediterranean Health Journal, V16, P615; Ke Wan-Sheng, 2010, Adv Appl Bioinform Chem, V3, P39; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Lin CC, 2010, J CLIN PSYCHIAT, V71, P225, DOI 10.4088/JCP.08m04628yel; Lin CS, 2011, MED DECIS MAKING, V31, P308, DOI 10.1177/0272989X10379648; Park J, 2001, ARTIF INTELL MED, V23, P277, DOI 10.1016/S0933-3657(01)00086-0; Patel JL, 2007, CURR CLIN PHARMACOL, V2, P217, DOI 10.2174/157488407781668811; Petrella RJ, 2007, CLIN THER, V29, P742, DOI 10.1016/j.clinthera.2007.04.009; Robbins CL, 2011, PREV CHRONIC DIS, V8; Santos-Garcia G, 2004, ARTIF INTELL MED, V30, P61, DOI 10.1016/S0933-3657(03)00059-9; Sato F, 2005, CANCER-AM CANCER SOC, V103, P1596, DOI 10.1002/cncr.20938; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Smith DG, 2007, AM J MANAG CARE, V13, pS68; Snow V, 2004, ANN INTERN MED, V140, P644, DOI 10.7326/0003-4819-140-8-200404200-00012; Walker HJ, 1990, CLIN METHODS HIST PH; WHO, 2002, RED RISKS PROM HLTH; World Health and Organization, 2000, INT ASS STUD OB AS P; Xin Z, 2010, J CLIN EPIDEMIOL, V63, P1030, DOI 10.1016/j.jclinepi.2009.11.012; Yamada K, 2010, CLIN LAB, V56, P327; Yang YX., 2009, CHINA FOOD COMPOSITI; Zou Jinming, 2008, V458, P15	36	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43834	10.1371/journal.pone.0043834	http://dx.doi.org/10.1371/journal.pone.0043834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952780	Green Submitted, gold, Green Published			2022-12-27	WOS:000308213600049
J	Zhan, HM; Xu, SZ				Zhan, Haimao; Xu, Shizhong			Adaptive Ridge Regression for Rare Variant Detection	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; LIPID-METABOLISM; COMMON DISEASES; SUSCEPTIBILITY; SELECTION; ANGPTL3; LOCI; TRIGLYCERIDES; TESTS; RISK	It is widely believed that both common and rare variants contribute to the risks of common diseases or complex traits and the cumulative effects of multiple rare variants can explain a significant proportion of trait variances. Advances in high-throughput DNA sequencing technologies allow us to genotype rare causal variants and investigate the effects of such rare variants on complex traits. We developed an adaptive ridge regression method to analyze the collective effects of multiple variants in the same gene or the same functional unit. Our model focuses on continuous trait and incorporates covariate factors to remove potential confounding effects. The proposed method estimates and tests multiple rare variants collectively but does not depend on the assumption of same direction of each rare variant effect. Compared with the Bayesian hierarchical generalized linear model approach, the state-of-the-art method of rare variant detection, the proposed new method is easy to implement, yet it has higher statistical power. Application of the new method is demonstrated using the well-known data from the Dallas Heart Study.	[Zhan, Haimao; Xu, Shizhong] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Zhan, HM (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	shizhong.xu@ucr.edu			USDA National Institute of Food and Agriculture [2007-02784]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	The project was supported by the USDA National Institute of Food and Agriculture Grant 2007-02784 to SX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antoniadis A, 2001, J AM STAT ASSOC, V96, P939, DOI 10.1198/016214501753208942; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; CHURCHILL GA, 1994, GENETICS, V138, P963; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Crainiceanu CM, 2004, J ROY STAT SOC B, V66, P165, DOI 10.1111/j.1467-9868.2004.00438.x; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; GRANDVALET Y, 1998, INT C ART NEUR NETW; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; HARTLEY HO, 1967, BIOMETRIKA, V54, P93, DOI 10.1093/biomet/54.1-2.93; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Pan W, 2011, GENET EPIDEMIOL, V35, P381, DOI 10.1002/gepi.20586; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xu SZ, 1998, HEREDITY, V80, P364, DOI 10.1046/j.1365-2540.1998.00307.x; Yi NJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002382; Yi NJ, 2011, GENET EPIDEMIOL, V35, P57, DOI 10.1002/gepi.20554; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x	43	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44173	10.1371/journal.pone.0044173	http://dx.doi.org/10.1371/journal.pone.0044173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22952918	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600088
J	Xiong, CJ; Huang, B; Zhou, Y; Cun, YP; Liu, LT; Wang, J; Li, CQ; Pan, Y; Wang, H				Xiong, Cheng-jie; Huang, Bo; Zhou, Yue; Cun, Yan-ping; Liu, Lan-tao; Wang, Jian; Li, Chang-qing; Pan, Yong; Wang, Hai			Macrophage Migration Inhibitory Factor Inhibits the Migration of Cartilage End Plate-Derived Stem Cells by Reacting with CD74	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL DISC; MESENCHYMAL STROMAL CELLS; NUCLEUS PULPOSUS; PROGENITOR CELLS; EXPRESSION; IDENTIFICATION; CHONDROCYTES; TARGET; MIF	Background: Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine that regulates inflammatory reactions and the pathophysiology of many inflammatory diseases. Intervertebral disc (IVD) degeneration is characterized by an inflammatory reaction, but the potential role of MIF in IVD degeneration has not been determined. Recent studies have shown that MIF and its receptor, CD74, are involved in regulating the migration of human mesenchymal stem cells (MSCs); Thus, MIF might impair the ability of mesenchymal stem cells (MSCs) to home to injured tissues. Our previous studies indicated that cartilage endplate (CEP)-derived stem cells (CESCs) as a type of MSCs exist in human degenerate IVDs. Here, we investigate the role of MIF in regulating the migration of CESCs. Methods and Findings: CESCs were isolated and identified. We have shown that MIF was distributed in human degenerate IVD tissues and was subject to regulation by the pro-inflammatory cytokine TNF-alpha. Furthermore, in vitro cell migration assays revealed that nucleus pulposus (NP) cells inhibited the migration of CESCs in a number-dependent manner, and ELISA assays revealed that the amount of MIF in conditioned medium (CM) was significantly increased as a function of increasing cell number. Additionally, recombinant human MIF (r-MIF) inhibited the migration of CESCs in a dose-dependent manner. CESCs migration was restored when an antagonist of MIF, (S, R)-3(4-hydroxyphenyl)-4, 5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1), was added. Finally, a CD74 activating antibody (CD74Ab) was used to examine the effect of CD74 on CESCs motility and inhibited the migration of CESCs in a dose-dependent manner. Conclusions: We have identified and characterized a novel regulatory mechanism governing cell migration during IVD degeneration. The results will benefit understanding of another possible mechanism for IVD degeneration, and might provide a new method to repair degenerate IVD by enhancing CESCs migration to degenerated NP tissues to exert their regenerative effects.	[Xiong, Cheng-jie; Huang, Bo; Zhou, Yue; Liu, Lan-tao; Wang, Jian; Li, Chang-qing; Pan, Yong; Wang, Hai] Third Millitary Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Cun, Yan-ping] Third Mil Med Univ, Ctr Canc, Daping Hosp, Chongqing, Peoples R China; [Cun, Yan-ping] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Xiong, CJ (corresponding author), Third Millitary Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China.	happyzhou@vip.163.com			National Natural Science Foundation of China [81101364]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81101364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol S, 2010, TURK NEUROSURG, V20, P492, DOI 10.5137/1019-5149.JTN.3394-10.1; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Barrilleaux BL, 2010, IN VITRO CELL DEV-AN, V46, P566, DOI 10.1007/s11626-010-9279-1; Barrilleaux BL, 2009, TISSUE ENG PT A, V15, P2335, DOI 10.1089/ten.tea.2008.0434; Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004; Beswick EJ, 2009, WORLD J GASTROENTERO, V15, P2855, DOI 10.3748/wjg.15.2855; Blanco JF, 2010, SPINE, V35, P2259, DOI 10.1097/BRS.0b013e3181cb8828; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; BUCKWALTER JA, 1994, MICROSC RES TECHNIQ, V28, P398, DOI 10.1002/jemt.1070280506; Burke JG, 2003, SPINE, V28, P2685, DOI 10.1097/01.BRS.0000103341.45133.F3; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cao WG, 2006, HUM REPROD, V21, P421, DOI 10.1093/humrep/dei315; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Feng G, 2010, J BONE JOINT SURG AM, V92A, P675, DOI 10.2106/JBJS.H.01672; Fischer-Valuck BW, 2010, BIOTECHNOL LETT, V32, P19, DOI 10.1007/s10529-009-0110-6; Gabr MA, J ORTHOPAEDIC RES; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Henriksson HB, 2009, SPINE, V34, P2278, DOI 10.1097/BRS.0b013e3181a95ad2; Huang B, 2011, EUROPEAN SPINE J, P1; Kim H, 2009, SPINE, V34, P1834, DOI 10.1097/BRS.0b013e3181ae18ba; Kim KW, 2009, SPINE J, V9, P323, DOI 10.1016/j.spinee.2008.05.003; Kim KW, 2003, SPINE, V28, P982, DOI 10.1097/00007632-200305150-00005; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Leng L, 2005, CRIT CARE MED, V33, pS475, DOI 10.1097/01.CCM.0000191278.04636.D8; Leung VYL, 2006, EUR SPINE J, V15, pS406, DOI 10.1007/s00586-006-0183-z; Liu LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026285; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Morales TI, 2007, OSTEOARTHR CARTILAGE, V15, P861, DOI 10.1016/j.joca.2007.02.022; Niu CC, 2010, J ORTHOPAEDIC RES; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; Roberts S, 1996, SPINE, V21, P415, DOI 10.1097/00007632-199602150-00003; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Sinclair SM, 2011, SPINE, V36, P1190, DOI 10.1097/BRS.0b013e3181ebdb43; Studer RK, 2007, SPINE, V32, P2827, DOI 10.1097/BRS.0b013e31815b757a; Takahashi H, 1996, SPINE, V21, P218, DOI 10.1097/00007632-199601150-00011; Weiler C, 2002, EUR SPINE J, V11, P308, DOI 10.1007/s00586-002-0472-0; Yang H, 2010, SPINE J	41	23	29	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43984	10.1371/journal.pone.0043984	http://dx.doi.org/10.1371/journal.pone.0043984			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22952837	gold, Green Submitted, Green Published			2022-12-27	WOS:000308044800084
J	Ma, WN; Lu, S; Pan, P; Sadatmousavi, P; Yuan, YF; Chen, P				Ma, Weina; Lu, Sheng; Pan, Pei; Sadatmousavi, Parisa; Yuan, Yongfang; Chen, P.			Pharmacokinetics of Peptide Mediated Delivery of Anticancer Drug Ellipticine	PLOS ONE			English	Article							INDUCED APOPTOSIS; CANCER-CELLS	The amino acid pairing peptide EAK16-II (EAK) has shown the ability to stabilize the hydrophobic anticancer agent ellipticine (EPT) in aqueous solution. In this study, we investigate pharmacokinetics of the formulation of EAK-EPT complexes in vivo. The developed formulation can achieve a sufficiently high drug concentration required in vivo animal models. The nanostructure and surface properties of EAK-EPT complexes or nanoparticle were characterized by transmission electron microscopy (TEM) and zeta potential measurements, respectively. 12 healthy male SD rats were divided into EPT group and EAK-EPT group randomly. Rats in EPT group were tail intravenously injected with the EPT (20 mg/kg); rats in EAK-EPT group were injected with EAK-EPT complexes (EPT's concentration is 20 mg/kg). EPT was extracted from rat plasma with dexamethasone sodium phosphate as internal standards (IS). The pharmacokinetic parameters were obtained using high pressure liquid chromatography (HPLC). Significant differences in main pharmacokinetic parameters between EPT and EAK-EPT complexes were observed, demonstrating that the complexation with EAK prolongs the residence time of the drug and enlarges the area under the concentration-time curve (AUC). This means that EAK can serve as a suitable carrier to increase the bioavailability of EPT.	[Ma, Weina; Pan, Pei; Yuan, Yongfang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Pharm, Shanghai 200030, Peoples R China; [Lu, Sheng; Sadatmousavi, Parisa; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	Shanghai Jiao Tong University; University of Waterloo	Ma, WN (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Pharm, Shanghai 200030, Peoples R China.	nmxyyf@yahoo.cn			Shanghai Committee of Science and Technology, China [10410711300]; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canada Research Chairs Program	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs Program(Canada Research Chairs)	This project was supported by the Shanghai Committee of Science and Technology, China (Grant No. 10410711300). This research was financially supported by the Natural Sciences and Engineering Research Council of Canada, Canadian Foundation for Innovation and the Canada Research Chairs Program for one of the co-authors (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bawa R, 2011, NANOMEDICIN IN PRESS; Fang K, 2009, LUNG CANCER, V63, P227, DOI 10.1016/j.lungcan.2008.05.026; Fung SY, 2006, J PHYS CHEM A, V110, P11446, DOI 10.1021/jp062778y; Fung SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001956; Fung SY, 2011, BIOMATERIALS, V32, P4000, DOI 10.1016/j.biomaterials.2011.02.005; FUNG SY, 2005, HDB NANOSTRUCTURED B, P1; Garbett Nichola C., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P149, DOI 10.2174/1568011043482070; Kuo PL, 2005, CANCER LETT, V223, P293, DOI 10.1016/j.canlet.2004.09.046; Kuo YC, 2006, LIFE SCI, V78, P2550, DOI 10.1016/j.lfs.2005.10.041; Peng YH, 2003, ONCOGENE, V22, P4478, DOI 10.1038/sj.onc.1206777; Stiborova M, 2006, GEN PHYSIOL BIOPHYS, V25, P245; Stiborova Marie, 2006, Biomedical Papers (Olomouc), V150, P13; SUREAU F, 1993, BIOPHYS J, V65, P1767, DOI 10.1016/S0006-3495(93)81273-6; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	14	44	44	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43684	10.1371/journal.pone.0043684	http://dx.doi.org/10.1371/journal.pone.0043684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	23236514	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300022
J	Li, WD; Zhou, Y; Tian, XL; Kim, TY; Ito, N; Watanabe, K; Tsuji, A; Niimi, K; Aoyama, Y; Arai, T; Takahashi, E				Li, Weidong; Zhou, Ying; Tian, Xiaoli; Kim, Tae Yeon; Ito, Namiko; Watanabe, Kaori; Tsuji, Akiko; Niimi, Kimie; Aoyama, Yo; Arai, Takashi; Takahashi, Eiki			New Ataxic Tottering-6j Mouse Allele Containing a Cacna1a Gene Mutation	PLOS ONE			English	Article							DEPENDENT CALCIUM-CHANNEL; CORTICAL SPREADING DEPRESSION; GATED CA2+ CHANNELS; NEUROTRANSMITTER RELEASE; MISSENSE MUTATION; ROLLING-NAGOYA; PURKINJE-CELLS; MUTANT MOUSE; MICE; DYSFUNCTION	Voltage-gated Ca2+ (Ca-v) channels control neuronal functions including neurotransmitter release and gene expression. The Cacna1a gene encodes the alpha 1 subunit of the pore-forming Ca(v)2.1 channel. Mice with mutations in this gene form useful tools for defining channel functions. The recessive ataxic tottering-6j strain that was generated in the Neuroscience Mutagenesis Facility at The Jackson Laboratory has a mutation in the Cacna1a gene. However, the effect of this mutation has not been investigated in detail. In this study, mutation analysis shows a base substitution (C-to-A) in the consensus splice acceptor sequence linked to exon 5, which results in the skipping of exon 5 and the splicing of exon 4 directly to exon 6. The effect of this mutation is expected to be severe as the expressed alpha 1 subunit protein lacks a significant part of the S4-S5 linker, S5, and part of S5-S6 linker in domain I. Tottering-6j mice display motor dysfunctions in the footprint, rotating rod, and hind-limb extension tests. Although cytoarchitecture of the mutant brains appears normal, tyrosine hydroxylase was persistently expressed in cerebellar Purkinje cells in the adult mutant mice. These results indicate that tottering-6j is a useful model for functional studies of the Ca(v)2.1 channel.	[Li, Weidong; Zhou, Ying; Takahashi, Eiki] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Tian, Xiaoli] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Kim, Tae Yeon; Ito, Namiko; Watanabe, Kaori; Tsuji, Akiko; Niimi, Kimie; Aoyama, Yo; Arai, Takashi; Takahashi, Eiki] RIKEN Brain Sci Inst, Res Resources Ctr, Saitama, Japan	Shanghai Jiao Tong University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RIKEN	Li, WD (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	liwd@sjtu.edu.cn; etakahashi@brain.riken.jp	Niimi, Kimie/S-8264-2019; Takahashi, Eiki/N-6998-2015	Niimi, Kimie/0000-0001-5240-5745; Dubnau, Josh/0000-0002-9285-7444; Hammell, Molly/0000-0003-0405-8392; Li, Weidong/0000-0001-5384-4838	KAKENHI [22500396]; China 973 Program [2010CB529604]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); China 973 Program(National Basic Research Program of China)	This work was supported by Grants-in-Aid for Scientific Research KAKENHI (22500396) to ET and China 973 Program (2010CB529604) to WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN MC, 1992, MOL BRAIN RES, V15, P227, DOI 10.1016/0169-328X(92)90113-P; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Day NC, 1997, J NEUROSCI, V17, P6226; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FU XD, 1995, RNA, V1, P663; Jaworski DM, 2006, J NEUROBIOL, V66, P82, DOI 10.1002/neu.20205; Kaja S, 2007, EUR J NEUROSCI, V25, P2009, DOI 10.1111/j.1460-9568.2007.05438.x; Liu L, 2003, J BIOENERG BIOMEMBR, V35, P671, DOI 10.1023/B:JOBB.0000008031.12485.ee; Lorenzon NM, 1998, J NEUROSCI, V18, P4482; Miki T, 2008, NEUROSCIENCE, V155, P31, DOI 10.1016/j.neuroscience.2008.05.028; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Mori Y, 2000, J NEUROSCI, V20, P5654, DOI 10.1523/JNEUROSCI.20-15-05654.2000; MURAMOTO O, 1981, BRAIN RES, V215, P295, DOI 10.1016/0006-8993(81)90508-4; Niimi K, 2009, PHYSIOL BEHAV, V96, P464, DOI 10.1016/j.physbeh.2008.11.012; Oda S, 1973, Jikken Dobutsu, V22, P281; Ogura H, 2001, BEHAV BRAIN RES, V122, P215, DOI 10.1016/S0166-4328(01)00187-5; Pietrobon D, 2005, CURR OPIN NEUROBIOL, V15, P257, DOI 10.1016/j.conb.2005.05.010; Pietrobon D, 2010, PFLUG ARCH EUR J PHY, V460, P375, DOI 10.1007/s00424-010-0802-8; Plomp JJ, 2000, BRAIN, V123, P463, DOI 10.1093/brain/123.3.463; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; Rhyu IJ, 1999, NEUROSCIENCE, V90, P717, DOI 10.1016/S0306-4522(98)00518-1; Rhyu IJ, 1999, NEUROSCI LETT, V266, P49, DOI 10.1016/S0304-3940(99)00254-2; Takahashi E., 2012, CALCIUM SIGNALING, P149; Takahashi E, 2009, BRAIN RES, V1279, P50, DOI 10.1016/j.brainres.2009.05.016; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Tokuda S, 2007, BRAIN RES, V1133, P168, DOI 10.1016/j.brainres.2006.10.086; Van Damme P, 2003, NEUROSCI LETT, V343, P81, DOI 10.1016/S0304-3940(03)00314-8; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; van den Maagdenberg AMJM, 2010, ANN NEUROL, V67, P85, DOI 10.1002/ana.21815; Watase K, 2008, P NATL ACAD SCI USA, V105, P11987, DOI 10.1073/pnas.0804350105; Xie G, 2007, GENES BRAIN BEHAV, V6, P717, DOI 10.1111/j.1601-183X.2007.00302.x; Zwingman TA, 2001, J NEUROSCI, V21, P1169	38	85	87	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44230	10.1371/journal.pone.0044230	http://dx.doi.org/10.1371/journal.pone.0044230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952933	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300065
J	Li, CY; Zhang, XT; Cao, RL; Yu, BH; Liang, HS; Zhou, M; Li, DY; Wang, YH; Liu, EZ				Li, Changyu; Zhang, Xiangtong; Cao, Ronglong; Yu, Bohai; Liang, Hongsheng; Zhou, Min; Li, Dayong; Wang, Yuehua; Liu, Enzhong			Allografts of the Acellular Sciatic Nerve and Brain-Derived Neurotrophic Factor Repair Spinal Cord Injury in Adult Rats	PLOS ONE			English	Article							SUPERIOR COLLICULUS; CHEMICAL-EXTRACTION; REGENERATION; GRAFTS; CELLS; MOTOR; TRANSECTION; IMPROVEMENT; SCAFFOLDS; MEMBRANE	Objective: We aimed to investigate whether an innovative growth factor-laden scaffold composed of acellular sciatic nerve (ASN) and brain-derived neurotrophic factor (BDNF) could promote axonal regeneration and functional recovery after spinal cord injury (SCI). Methods: Following complete transection at the thoracic level (T9), we immediately transplanted the grafts between the stumps of the severed spinal cords. We evaluated the functional recovery of the hindlimbs of the operated rats using the BBB locomotor rating scale system every week. Eight weeks after surgery, axonal regeneration was examined using the fluorogold (FG) retrograde tracing method. Electrophysiological analysis was carried out to evaluate the improvement in the neuronal circuits. Immunohistochemistry was employed to identify local injuries and recovery. Results: The results of the Basso-Beattie-Bresnahan (BBB) scale indicated that there was no significant difference between the individual groups. The FG retrograde tracing and electrophysiological analyses indicated that the transplantation of ASN-BDNF provided a permissive environment to support neuron regeneration. Conclusion: The ASN-BDNF transplantation provided a promising therapeutic approach to promote axonal regeneration and recovery after SCI, and can be used as part of a combinatory treatment strategy for SCI management.	[Li, Changyu; Zhang, Xiangtong; Cao, Ronglong; Liang, Hongsheng; Wang, Yuehua; Liu, Enzhong] Harbin Med Univ, Affiliated Hosp 1, Key Lab Cell Transplantat, Minist Hlth China,Dept Neurosurg, Harbin, Heilongjiang Pr, Peoples R China; [Yu, Bohai] Harbin Med Univ, Dept Microbiol, Immun & Infect Pathogen Biol Key Lab, Harbin, Heilongjiang Pr, Peoples R China; [Zhou, Min] Harbin Med Univ, Affiliated Hosp 1, Dept Pathol, Harbin, Heilongjiang Pr, Peoples R China; [Li, Dayong] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, CY (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Key Lab Cell Transplantat, Minist Hlth China,Dept Neurosurg, Harbin, Heilongjiang Pr, Peoples R China.	enzhongliu@163.com			HeiLongJiang Province Sanitation Department Scientific Research Topic [2010-027]; Science Foundation of the China Postdoctor [2011M500687]	HeiLongJiang Province Sanitation Department Scientific Research Topic; Science Foundation of the China Postdoctor	This work was supported by HeiLongJiang Province Sanitation Department Scientific Research Topic (2010-027), and the Science Foundation of the China Postdoctor (2011M500687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; CARTER DA, 1989, J NEUROSCI, V9, P4042; Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782; Cote MP, 2011, NEUROTHERAPEUTICS, V8, P294, DOI 10.1007/s13311-011-0024-6; Cote MP, 2010, EXP NEUROL, V225, P173, DOI 10.1016/j.expneurol.2010.06.011; Fang MR, 2011, ANAT REC, V294, P24, DOI 10.1002/ar.21281; Guzen FP, 2012, RESTOR NEUROL NEUROS, V30, P265, DOI 10.3233/RNN-2012-110184; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; Koopmans G, 2009, INT REV NEUROBIOL, V87, P363, DOI 10.1016/S0074-7742(09)87019-0; Lee YS, 2010, EXP NEUROL, V224, P429, DOI 10.1016/j.expneurol.2010.05.003; Levi ADO, 2002, J NEUROSURG, V96, P197, DOI 10.3171/spi.2002.96.2.0197; Liang HS, 2009, ACTA NEUROCHIR, V151, P1113, DOI 10.1007/s00701-009-0322-5; Nordblom J, 2009, RESTOR NEUROL NEUROS, V27, P285, DOI 10.3233/RNN-2009-0478; Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6; Sieck GC, 2009, RESP PHYSIOL NEUROBI, V169, P218, DOI 10.1016/j.resp.2009.08.008; Sondell M, 1998, BRAIN RES, V795, P44, DOI 10.1016/S0006-8993(98)00251-0; Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; Zhang YJ, 2010, BIOMATERIALS, V31, P5312, DOI 10.1016/j.biomaterials.2010.03.029; Zhong HB, 2007, J RECONSTR MICROSURG, V23, P479, DOI 10.1055/s-2007-992340	23	45	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42813	10.1371/journal.pone.0042813	http://dx.doi.org/10.1371/journal.pone.0042813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	23028587	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600008
J	Sanchez-Vidal, A; Canals, M; Calafat, AM; Lastras, G; Pedrosa-Pamies, R; Menendez, M; Medina, R; Company, JB; Hereu, B; Romero, J; Alcoverro, T				Sanchez-Vidal, Anna; Canals, Miquel; Calafat, Antoni M.; Lastras, Galderic; Pedrosa-Pamies, Rut; Menendez, Melisa; Medina, Raul; Company, Joan B.; Hereu, Bernat; Romero, Javier; Alcoverro, Teresa			Impacts on the Deep-Sea Ecosystem by a Severe Coastal Storm	PLOS ONE			English	Article							MARINE-SEDIMENTS; ORGANIC-MATTER; INNER-SHELF; DYNAMICS; MODEL; PRESERVATION; OCEAN; GULF; SIZE	Major coastal storms, associated with strong winds, high waves and intensified currents, and occasionally with heavy rains and flash floods, are mostly known because of the serious damage they can cause along the shoreline and the threats they pose to navigation. However, there is a profound lack of knowledge on the deep-sea impacts of severe coastal storms. Concurrent measurements of key parameters along the coast and in the deep-sea are extremely rare. Here we present a unique data set showing how one of the most extreme coastal storms of the last decades lashing the Western Mediterranean Sea rapidly impacted the deep-sea ecosystem. The storm peaked the 26th of December 2008 leading to the remobilization of a shallow-water reservoir of marine organic carbon associated with fine particles and resulting in its redistribution across the deep basin. The storm also initiated the movement of large amounts of coarse shelf sediment, which abraded and buried benthic communities. Our findings demonstrate, first, that severe coastal storms are highly efficient in transporting organic carbon from shallow water to deep water, thus contributing to its sequestration and, second, that natural, intermittent atmospheric drivers sensitive to global climate change have the potential to tremendously impact the largest and least known ecosystem on Earth, the deep-sea ecosystem.	[Sanchez-Vidal, Anna; Canals, Miquel; Calafat, Antoni M.; Lastras, Galderic; Pedrosa-Pamies, Rut] Univ Barcelona, Grp Recerca Consilidat GRC Geociencies Marines, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain; [Menendez, Melisa; Medina, Raul] Univ Cantabria, Inst Hidraul Ambiental IH Cantabria, E-39005 Santander, Spain; [Company, Joan B.] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Hereu, Bernat; Romero, Javier] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Alcoverro, Teresa] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain	University of Barcelona; Universidad de Cantabria; IHCantabria - Instituto de Hidraulica Ambiental de la Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Sanchez-Vidal, A (corresponding author), Univ Barcelona, Grp Recerca Consilidat GRC Geociencies Marines, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain.	anna.sanchez@ub.edu	Romero, Javier/A-8905-2013; Sanchez-Vidal, Anna/B-6919-2016; Menendez, Melisa/L-4600-2014; Pamies, Rut Pedrosa/I-1119-2015; Hereu, Bernat/K-9150-2015; Company, Joan B./K-7274-2014; Lastras, Galderic/A-6487-2013; Alcoverro, Teresa/J-9258-2012; Medina, Raul/L-2456-2014; Calafat, Antoni/J-5848-2017; Canals, Miquel/F-4922-2013; Etter, Andres/E-1860-2011	Romero, Javier/0000-0002-2772-8486; Sanchez-Vidal, Anna/0000-0002-8209-1959; Menendez, Melisa/0000-0002-5168-257X; Pamies, Rut Pedrosa/0000-0003-3504-4727; Hereu, Bernat/0000-0001-6247-7638; Company, Joan B./0000-0002-5878-7155; Lastras, Galderic/0000-0002-8756-3855; Alcoverro, Teresa/0000-0002-3910-9594; Medina, Raul/0000-0002-0126-2710; Calafat, Antoni/0000-0001-7927-3105; Canals, Miquel/0000-0001-5267-7601; Etter, Andres/0000-0003-0665-9300	European Community [226354, PERG04-GA-2008-239175]; Spanish project ROV-CANONES [CTM2009-06778]; Spanish project GRACCIE-CONSOLIDER [CSD2007-00067]; Spanish project DOS MARES [CTM2010-21810-C03]; Spanish project REDECO [CTM2008-04973-E]; Spanish project PIE-CSIC [200430E599]; Catalan Government Grups de Recerca Consolidats [2009 SGR 1305]	European Community(European Commission); Spanish project ROV-CANONES; Spanish project GRACCIE-CONSOLIDER; Spanish project DOS MARES; Spanish project REDECO; Spanish project PIE-CSIC; Catalan Government Grups de Recerca Consolidats	This work was supported by the European Community's Seventh Framework Programme projects HERMIONE (226354) and ARISTEUS (PERG04-GA-2008-239175), the Spanish projects ROV-CANONES (CTM2009-06778), GRACCIE-CONSOLIDER (CSD2007-00067), DOS MARES (CTM2010-21810-C03), REDECO (CTM2008-04973-E) and PIE-CSIC (200430E599) and a Catalan Government Grups de Recerca Consolidats grant (2009 SGR 1305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnarson TS, 2007, GEOCHIM COSMOCHIM AC, V71, P3545, DOI 10.1016/j.gca.2007.04.027; Bolanos R, 2009, J MARINE SYST, V77, P237, DOI 10.1016/j.jmarsys.2007.12.018; Canals M, 2004, MAR GEOL, V213, P9, DOI 10.1016/j.margeo.2004.10.001; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Dee DP, 2009, Q J ROY METEOR SOC, V135, P1830, DOI 10.1002/qj.493; Dickens AF, 2006, GEOCHIM COSMOCHIM AC, V70, P666, DOI 10.1016/j.gca.2005.10.024; Ferre B, 2005, CONT SHELF RES, V25, P2410, DOI 10.1016/j.csr.2005.08.017; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; Garcia-Rubies A, 2009, PLIN C; Guillen J, 2006, MAR GEOL, V234, P129, DOI 10.1016/j.margeo.2006.09.018; Guillen J, 2000, SCI MAR, V64, P427, DOI 10.3989/scimar.2000.64n4427; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; HEUSSNER S, 1990, CONT SHELF RES, V10, P943, DOI 10.1016/0278-4343(90)90069-X; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Keil RG, 1998, GEOCHIM COSMOCHIM AC, V62, P1347, DOI 10.1016/S0016-7037(98)00080-5; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Lastras G, 2011, MAR GEOL, V280, P20, DOI 10.1016/j.margeo.2010.11.005; Li MZ, 2001, COMPUT GEOSCI-UK, V27, P619, DOI 10.1016/S0098-3004(00)00120-5; Lionello P, 2006, DEV EARTH ENV SCI, V4, P5463; Marcos M, 2011, GLOBAL PLANET CHANGE, V77, P116, DOI 10.1016/j.gloplacha.2011.04.002; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; Mendoza ET, 2009, P I CIVIL ENG-MAR EN, V162, P127, DOI 10.1680/maen.2009.162.3.127; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; Skamarock W.C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Tolman HL, 2002, 222 NOAA NWS NCEP MM, P133; Ulbrich U, 2009, THEOR APPL CLIMATOL, V96, P117, DOI 10.1007/s00704-008-0083-8; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	31	158	166	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30395	10.1371/journal.pone.0030395	http://dx.doi.org/10.1371/journal.pone.0030395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	22952816	Green Published, gold			2022-12-27	WOS:000301640600029
J	Zeng, YJ; Yang, X; Wang, J; Fan, JJ; Kong, QY; Yu, XQ				Zeng, Youjia; Yang, Xiao; Wang, Juan; Fan, Jinjin; Kong, Qingyu; Yu, Xueqing			Aristolochic Acid I Induced Autophagy Extenuates Cell Apoptosis via ERK 1/2 Pathway in Renal Tubular Epithelial Cells	PLOS ONE			English	Article							HT-29 CELLS; INHIBITION; DEATH; MACROAUTOPHAGY; TOXICITY; INJURY; VITRO	Autophagy is a lysosomal degradation pathway that is essential for cell survival and tissue homeostasis. However, limited information is available about autophagy in aristolochic acid (AA) nephropathy. In this study, we investigated the role of autophagy and related signaling pathway during progression of AAI-induced injury to renal tubular epithelial cells (NRK52E cells). The results showed that autophagy in NRK52E cells was detected as early as 3-6 hrs after low dose of AAI (10 mu M) exposure as indicated by an up-regulated expression of LC3-II and Beclin 1 proteins. The appearance of AAI-induced punctated staining of autophagosome-associated LC3-II upon GFP-LC3 transfection in NRK52E cells provided further evidence for autophagy. However, cell apoptosis was not detected until 12 hrs after AAI treatment. Blockade of autophagy with Wortmannin or 3-Methyladenine (two inhibitors of phosphoinositede 3-kinases) or small-interfering RNA knockdown of Beclin 1 or Atg7 sensitized the tubular cells to apoptosis. Treatment of NRK52E cells with AAI caused a time-dependent increase in extracellular signal-regulated kinase 1 and 2 (ERK1/2) activity, but not c-Jun N-terminal kinase (JNK) and p38. Pharmacological inhibition of ERK1/2 phosphorylation with U0126 resulted in a decreased AAI-induced autophagy that was accompanied by an increased apoptosis. Taken together, our study demonstrated for the first time that autophagy occurred earlier than apoptosis during AAI-induced tubular epithelial cell injury. Autophagy induced by AAI via ERK1/2 pathway might attenuate apoptosis, which may provide a protective mechanism for cell survival under AAI-induced pathological condition.	[Zeng, Youjia; Yang, Xiao; Wang, Juan; Fan, Jinjin; Kong, Qingyu; Yu, Xueqing] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zeng, YJ (corresponding author), Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China.	yangx826@yahoo.com.cn	; Zhao, Xiubo/AAZ-9058-2021	Yu, Hai/0000-0002-6386-9761; Wang, Jiqian/0000-0002-7525-5943; Zhao, Xiubo/0000-0002-4620-2893	Chinese National Natural Science Research Grant [30873432, 81073138]	Chinese National Natural Science Research Grant	This work is supported by the Chinese National Natural Science Research Grant (Grant number 30873432, 81073138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Bakhiya N, 2009, TOXICOLOGY, V264, P74, DOI 10.1016/j.tox.2009.07.014; Balachandran P, 2005, KIDNEY INT, V67, P1797, DOI 10.1111/j.1523-1755.2005.00277.x; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gao RT, 2000, CHINESE MED J-PEKING, V113, P418; Hsin YH, 2006, APOPTOSIS, V11, P2167, DOI 10.1007/s10495-006-0289-0; Inoue K, 2010, CLIN EXP NEPHROL, V14, P112, DOI 10.1007/s10157-009-0254-7; Ioset JR, 2003, FOOD CHEM TOXICOL, V41, P29, DOI 10.1016/S0278-6915(02)00219-3; Ito M, 2010, CANCER GENE THER, V17, P633, DOI 10.1038/cgt.2010.20; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kovacs AL, 2000, CELL TISSUE RES, V302, P253, DOI 10.1007/s004410000275; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li J, 2010, TOXICOL IN VITRO, V24, P1092, DOI 10.1016/j.tiv.2010.03.012; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pozdzik AA, 2008, KIDNEY INT, V73, P595, DOI 10.1038/sj.ki.5002714; Qi XM, 2007, TOXICOL APPL PHARM, V222, P105, DOI 10.1016/j.taap.2007.03.029; Sivaprasad U, 2008, J CELL MOL MED, V12, P1265, DOI 10.1111/j.1582-4934.2008.00282.x; VOM DS, 2001, BIOCHEM J, V354, P31; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yu FY, 2011, TOXICOL IN VITRO, V25, P810, DOI 10.1016/j.tiv.2011.01.016	29	128	136	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30312	10.1371/journal.pone.0030312	http://dx.doi.org/10.1371/journal.pone.0030312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276178	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100034
J	Aaltonen, KJ; Virkki, LM; Malmivaara, A; Konttinen, YT; Nordstrom, DC; Blom, M				Aaltonen, Kalle J.; Virkki, Liisa M.; Malmivaara, Antti; Konttinen, Yrjo T.; Nordstrom, Dan C.; Blom, Marja			Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis	PLOS ONE			English	Review							ANTITUMOR NECROSIS FACTOR; ALPHA MONOCLONAL-ANTIBODY; RECEIVING CONCOMITANT METHOTREXATE; DOUBLE-BLIND; PLUS METHOTREXATE; PHASE-III; COMBINATION ETANERCEPT; INADEQUATE RESPONSE; TAIWANESE PATIENTS; DOSE METHOTREXATE	Background and Objectives: Five-tumour necrosis factor (TNF)-blockers (infliximab, etanercept, adalimumab, certolizumab pegol and golimumab) are available for treatment of rheumatoid arthritis. Only few clinical trials compare one TNF-blocker to another. Hence, a systematic review is required to indirectly compare the substances. The aim of our study is to estimate the efficacy and the safety of TNF-blockers in the treatment of rheumatoid arthritis (RA) and indirectly compare all five currently available blockers by combining the results from included randomized clinical trials (RCT). Methods: A systematic literature review was conducted using databases including: MEDLINE, SCOPUS (including EMBASE), Cochrane library and electronic search alerts. Only articles reporting double-blind RCTs of TNF-blockers vs. placebo, with or without concomitant methotrexate (MTX), in treatment of RA were selected. Data collected were information of patients, interventions, controls, outcomes, study methods and eventual sources of bias. Results: Forty-one articles reporting on 26 RCTs were included in the systematic review and meta-analysis. Five RCTs studied infliximab, seven etanercept, eight adalimumab, three golimumab and three certolizumab. TNF-blockers were more efficacious than placebo at all time points but were comparable to MTX. TNF-blocker and MTX combination was superior to either MTX or TNF-blocker alone. Increasing doses did not improve the efficacy. TNF-blockers were relatively safe compared to either MTX or placebo. Conclusions: No single substance clearly rose above others in efficacy, but the results of the safety analyses suggest that etanercept might be the safest alternative. Interestingly, MTX performs nearly identically considering both efficacy and safety aspects with a margin of costs.	[Aaltonen, Kalle J.; Blom, Marja] Univ Helsinki, Fac Pharm, Helsinki, Finland; [Aaltonen, Kalle J.; Virkki, Liisa M.; Konttinen, Yrjo T.] Univ Helsinki, Fac Med, Helsinki, Finland; [Malmivaara, Antti] Natl Inst Hlth & Welf THL, Ctr Hlth & Social Econ, Helsinki, Finland; [Konttinen, Yrjo T.] COXA Hosp Joint Replacement, Tampere, Finland; [Nordstrom, Dan C.] Univ Helsinki, Cent Hosp HUCH, Helsinki, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Coxa Hospital for Joint Replacement; University of Helsinki	Aaltonen, KJ (corresponding author), Univ Helsinki, Fac Pharm, Helsinki, Finland.	yrjo.konttinen@helsinki.fi	; li, jiong/L-6534-2014; Obel, Carsten/H-9605-2016	li, jiong/0000-0003-1125-026X; li, jiong/0000-0002-1716-8067; Obel, Carsten/0000-0001-5004-1933; Kristensen, Jette Kolding/0000-0002-2648-5750	ORTON Orthopaedic Hospital of the ORTON Foundation; National PhD Graduate School in Musculoskeletal Diseases and Biomaterials	ORTON Orthopaedic Hospital of the ORTON Foundation; National PhD Graduate School in Musculoskeletal Diseases and Biomaterials	This study was supported by an unlimited grant from the ORTON Orthopaedic Hospital of the ORTON Foundation and by the National PhD Graduate School in Musculoskeletal Diseases and Biomaterials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, J RHEUMATOL, V33, P37; Aho K, 1998, SEMIN ARTHRITIS RHEU, V27, P325, DOI 10.1016/S0049-0172(98)80053-X; Allaart CF, 2006, CLIN EXP RHEUMATOL, V24, pS77; Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52; Antoni C, 1999, CLIN EXP RHEUMATOL, V17, pS73; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bankhurst AD, 1999, CLIN EXP RHEUMATOL, V17, pS69; Bathon JM, 2003, CLIN EXP RHEUMATOL, V21, pS195; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Bessette L, 2007, J RHEUMATOL, V34, P1627; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Chen DY, 2009, J FORMOS MED ASSOC, V108, P310, DOI 10.1016/S0929-6646(09)60071-1; Chen Y-F, 2006, HEALTH TECHNOL ASSES, V10, P248; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Durez P, 2004, ANN RHEUM DIS, V63, P1069, DOI 10.1136/ard.2003.012914; Durez P, 2007, ARTHRITIS RHEUM-US, V56, P3919, DOI 10.1002/art.23055; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2010, ARTHRITIS RHEUM-US, V62, P674, DOI 10.1002/art.27268; Emery P, 2009, ARTHRITIS RHEUM-US, V60, P2272, DOI 10.1002/art.24638; Ericson ML, 1999, ARTHRITIS RHEUM, V42, pS82; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Fleischmann R, 2009, ANN RHEUM DIS, V68, P805, DOI 10.1136/ard.2008.099291; Fleischmann RM, 2008, ARTHRITIS RHEUM, V58, pS530; Furst DE, 2003, J RHEUMATOL, V30, P2563; Gao Guo-hua, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P724; Genovese MC, 2002, ARTHRITIS RHEUM, V46, P1443, DOI 10.1002/art.10308; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Huang Feng, 2009, Zhonghua Nei Ke Za Zhi, V48, P916; Jamal S, 2009, CLIN RHEUMATOL, V28, P413, DOI 10.1007/s10067-008-1064-0; Kavanaugh A, 2008, ANN RHEUM DIS, V67, P1444, DOI 10.1136/ard.2008.094524; Kavanaugh A, 2000, J RHEUMATOL, V27, P841; Kavanaugh AF, 1996, ARTHRITIS RHEUM, V39, P575; Kay J, 2007, ANN RHEUM DIS, V66, P175; Kay J, 2006, ANN RHEUM DIS, V65, P323; Kay J, 2008, ARTHRITIS RHEUM-US, V58, P964, DOI 10.1002/art.23383; Keystone, 2009, ARTHRITIS RHEUM, V60, P1249, DOI 10.1002/art.24667; Keystone E, 2001, ARTHRITIS RHEUM, V44, pS213; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Keystone EC, 2003, CLIN EXP RHEUMATOL, V21, pS198; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P353, DOI 10.1002/art.20019; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; KIM HY, 2007, APLAR J RHEUMATOL, V10, P9, DOI DOI 10.1111/J.1479-8077.2007.00248.X; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kristensen LE, 2007, SCAND J RHEUMATOL, V36, P411, DOI 10.1080/03009740701607067; Lan JL, 2004, J FORMOS MED ASSOC, V103, P618; Launois R, 2011, J RHEUMATOL, V38, P835, DOI 10.3899/jrheum.100665; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Maini RN, 2004, ARTHRITIS RHEUM-US, V50, P1051, DOI 10.1002/art.20159; Miceli-Richard C, 2008, ANN RHEUM DIS, V67, P478, DOI 10.1136/ard.2007.074104; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Rahman MU, 2007, ANN RHEUM DIS, V66, P1233, DOI 10.1136/ard.2006.065995; Ronald VV, 2008, SCAND J RHEUMATOL, V37, P52; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Smolen J, 2009, ANN RHEUM DIS, V68, P797, DOI 10.1136/ard.2008.101659; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Smolen JS, 2006, ARTHRITIS RHEUM-US, V54, P702, DOI 10.1002/art.21678; Symmons D, 2002, RHEUMATOLOGY, V41, P793, DOI 10.1093/rheumatology/41.7.793; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van de Putte LBA, 2003, ANN RHEUM DIS, V62, P1168, DOI 10.1136/ard.2003.009563; van der Bijl AE, 2007, ARTHRITIS RHEUM-US, V56, P2129, DOI 10.1002/art.22718; van der Heijde D, 2007, ARTHRITIS RHEUM, V56, P3928, DOI 10.1002/art.23141; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; van Riel PLCM, 2006, ANN RHEUM DIS, V65, P1478, DOI 10.1136/ard.2005.043299; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Weisman MH, 2007, RHEUMATOLOGY, V46, P1122, DOI 10.1093/rheumatology/kem033; Westhovens R, 2006, ARTHRITIS RHEUM-US, V54, P1075, DOI 10.1002/art.21734; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Wiens A, 2009, CLIN RHEUMATOL, V28, P1365, DOI 10.1007/s10067-009-1233-9; Wiens A, 2009, SCAND J IMMUNOL, V70, P337, DOI 10.1111/j.1365-3083.2009.02296.x; Yocum D, 2004, ARTHRITIS RHEUM, V50, pS659; Zhang F, 2006, APLAR J RHEUMATOL, V9, P127, DOI DOI 10.1111/J.1479-8077.2006.00186.X; Zhang Wen, 2009, Zhonghua Yi Xue Za Zhi, V89, P1876	87	197	206	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30275	10.1371/journal.pone.0030275	http://dx.doi.org/10.1371/journal.pone.0030275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22952698	Green Published, Green Submitted, gold			2022-12-27	WOS:000301454400100
J	Li, HF; Zou, Y; Ding, GQ				Li, Haifeng; Zou, Yan; Ding, Gangqiang			Dietary Factors Associated with Dental Erosion: A Meta-Analysis	PLOS ONE			English	Article							TOOTH WEAR; PREVALENCE; CHILDREN; ADOLESCENTS; SCHOOLCHILDREN	Background: Some diet factors are risk factors for dental erosion. Methods: We performed computer searches of PubMed, Cochrane Library, EBSCO, CALIS, et al., to search for studies investigating risk factors for dental erosion. For risk factors investigated in a comparative way, we computed pooled odds ratios (ORs) using the Mantel and Haenszel method. Results: A total of 9 studies met the inclusion criteria, and 6 risk factors were considered, including soft drinks, sports drinks, juice, vitamin C, milk, and yoghourt. The following associations were found for soft drinks (OR = 2.41, 95% CI = 2.03-2.85) and vitamin C (OR = 1.16, 95% CI = 1.10-1.22). While juice (OR = 0.90, 95% CI = 0.25-3.24), sports drinks (OR = 1.58, 95% CI = 0.88-2.85), milk (OR = 0.67, 95% CI = 0.11-4.01), and yoghourt products (OR = 1.05, 95% CI = 0.28-3.96) were not associated with dental erosion. Conclusions: This meta-analysis provides comprehensive evidence-based assessment of diet-related factors for dental erosion. Preventive strategies should be taken to reduce dental erosion.	[Li, Haifeng] Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zou, Yan; Ding, Gangqiang] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention	Li, HF (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	zouyan0573@163.com	ding, gangqiang/AHD-5012-2022	Qiu, Peng-cheng/0000-0002-4826-4094; Zhang, Bang-Le/0000-0001-9008-5391				Bartlett DW, 1998, BRIT DENT J, V184, P125, DOI 10.1038/sj.bdj.4809560; Chadwick R G, 2005, J Clin Pediatr Dent, V29, P157; Chen Ya-gang, 2009, Hua Xi Kou Qiang Yi Xue Za Zhi, V27, P565; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dugmore CR, 2004, BRIT DENT J, V196, P283, DOI 10.1038/sj.bdj.4811041; El Aidi H, 2011, J DENT, V39, P558, DOI 10.1016/j.jdent.2011.06.001; El Kanim IA, 2007, COMMUNITY DENT HLTH, V24, P176; Eriksson J H, 1986, Tandlakartidningen, V78, P541; Ganss C, 2006, MG ORAL SCI, V20, P9, DOI 10.1159/000093344; Gatou T, 2012, CLIN ORAL INVEST, V16, P923, DOI 10.1007/s00784-011-0586-z; Gurgel CV, 2011, INT J PAEDIATR DENT, V21, P50, DOI 10.1111/j.1365-263X.2010.01090.x; Hasselkvist A, 2010, SWED DENT J, V34, P187; Holbrook WP, 2009, J DENT RES, V88, P422, DOI 10.1177/0022034509336530; Jager DHJ, 2008, CARIES RES, V42, P98, DOI 10.1159/000116118; Kreulen CM, 2010, CARIES RES, V44, P151, DOI 10.1159/000308567; Luo Y, 2005, J DENT, V33, P115, DOI 10.1016/j.jdent.2004.08.007; Lussi A., 2004, Caries Research, V38, P34, DOI 10.1159/000074360; Milosevic A, 1997, Community Dent Health, V14, P143; Milosevic A, 2004, BRIT DENT J, V197, P475, DOI 10.1038/sj.bdj.4811747; Milosevic A, 2004, BR DENT J, V197, P3; MILOSEVIC A, 2004, BR DENT J, V197, P505, DOI DOI 10.1038/SJ.BDJ.4811747.505; Correa MSNP, 2011, INT J PAEDIATR DENT, V21, P451, DOI 10.1111/j.1365-263X.2011.01150.x; Piangprach T, 2009, J AM DENT ASSOC, V140, P1137, DOI 10.14219/jada.archive.2009.0341; Ratnayake N, 2010, CARIES RES, V44, P14, DOI 10.1159/000271592; Sutton AJAK, 2000, METHODS METAANALYSIS; Waterhouse PJ, 2008, INT J PAEDIATR DENT, V18, P353, DOI 10.1111/j.1365-263X.2008.00919.x; Williams D, 1999, INT DENT J, V49, P211, DOI 10.1111/j.1875-595X.1999.tb00524.x; Yamaguchi K, 2006, J DENT, V34, P230, DOI 10.1016/j.jdent.2005.06.005; Zero DT, 1996, EUR J ORAL SCI, V104, P162, DOI 10.1111/j.1600-0722.1996.tb00065.x	29	83	85	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42626	10.1371/journal.pone.0042626	http://dx.doi.org/10.1371/journal.pone.0042626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952601	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300008
